{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": []
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "code",
      "execution_count": 1,
      "metadata": {
        "id": "PE-dCM2TMuNx"
      },
      "outputs": [],
      "source": [
        "#!/usr/bin/env python3\n",
        "\n",
        "# Import relevant libraries to make HTTP requests and parse JSON response\n",
        "import requests\n",
        "import json\n",
        "import csv\n",
        "import io\n",
        "\n",
        "from collections import defaultdict\n",
        "from time import time\n",
        "from sklearn import metrics\n",
        "from sklearn.feature_extraction.text import TfidfVectorizer\n"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Set disease_id variable for triple-negative breast cancer\n",
        "disease_id = \"EFO_0005537\"\n",
        "\n",
        "# Build query string to get target information as well as count\n",
        "query_string = \"\"\"\n",
        "query KnownDrugs {\n",
        "  disease(efoId: \"EFO_0005537\") {\n",
        "    id\n",
        "    name\n",
        "\t\tassociatedTargets (page: {size: 3, index: 0}) {\n",
        "      rows{\n",
        "        score\n",
        "        target{\n",
        "          id\n",
        "          approvedName\n",
        "          approvedSymbol\n",
        "          knownDrugs{\n",
        "            rows{\n",
        "              drug{\n",
        "                name\n",
        "                id\n",
        "              }\n",
        "            }\n",
        "          }\n",
        "        }\n",
        "      }\n",
        "    }\n",
        "}\n",
        "}\n",
        "\"\"\""
      ],
      "metadata": {
        "id": "S58u_mh3NT7W"
      },
      "execution_count": 2,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Set variables object of arguments to be passed to endpoint\n",
        "variables = {\"efoId\": disease_id}\n",
        "\n",
        "# Set base URL of GraphQL API endpoint\n",
        "base_url = \"https://api.platform.opentargets.org/api/v4/graphql\"\n",
        "\n",
        "# Perform POST request and check status code of response\n",
        "r = requests.post(base_url, json={\"query\": query_string, \"variables\": variables})\n",
        "print(r.status_code)\n",
        "\n",
        "#Transform API response from JSON into Python dictionary and print in console\n",
        "api_response = json.loads(r.text)\n",
        "print('done')\n",
        "#print(api_response)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "VOSv_cELNhqv",
        "outputId": "eac2822a-eb73-46d9-89ab-7a0b815abf86"
      },
      "execution_count": 3,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "200\n",
            "done\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "a=0\n",
        "#create list of target IDs by calling them from dictionary\n",
        "target_ids = api_response['data']['disease']['associatedTargets']['rows']\n",
        "#print(target_ids)\n",
        "target_id_list = []\n",
        "#pull IDs from dictionary and add to new list\n",
        "while a < len(target_ids):\n",
        "    target_id_list.append(target_ids[a]['target'].get('id'))\n",
        "    a+=1\n",
        "print(target_id_list)\n"
      ],
      "metadata": {
        "id": "mkDGecW5OAG2"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Create new dictionary assigning assays to to each target, and assigning compounds to each assay using PUG REST\n",
        "# Able to write dictionary at a speed of 4 targets/second\n",
        "\n",
        "a=0\n",
        "target_id_assay_dict = {}\n",
        "counter = 0\n",
        "for target_id in target_id_list:\n",
        "    counter = counter + 1\n",
        "    if counter > 3 :\n",
        "      break\n",
        "# get raw AIDs (Assay IDs) for each Ensemble ID in JSON format using PUG REST\n",
        "    r = requests.get('https://pubchem.ncbi.nlm.nih.gov/rest/pug/gene/synonym/Ensemble:' + target_id + '/aids/json')\n",
        "# convert JSON to Python Dictionary\n",
        "    raw_aids = r.json()\n",
        "    #print(type(raw_aids))\n",
        "# isolate raw_aids into a list containing just the AIDs from the dictionary\n",
        "    try:\n",
        "        aids = raw_aids['InformationList']['Information'][0]['AID']\n",
        "    except:\n",
        "        pass\n",
        "# assign each Ensamble Target ID to dictionary entry with associated Assay IDs\n",
        "    #target_id_assay_dict[id] =  aids\n",
        "\n",
        "    #create sub-dictionary for compounds within each assay\n",
        "    target_id_assay_dict[target_id] =  {}\n",
        "    for aid in aids:\n",
        "        aid = str(aid)\n",
        "        print(aid)\n",
        "        #get raw CIDS (Compound IDs) for each Assay in JSON format using PUG REST\n",
        "        r = requests.get('https://pubchem.ncbi.nlm.nih.gov/assay/pcget.cgi?query=download&record_type=datatable&actvty=active&response_type=display&aid=' + aid)\n",
        "\n",
        "        loose_data = r.text\n",
        "\n",
        "        listed_data = loose_data.split(',')\n",
        "        try:\n",
        "            cid_index = listed_data.index(\"PUBCHEM_CID\")\n",
        "        except:\n",
        "            continue\n",
        "        #print(cid_index)\n",
        "        #print(type(cid_index))\n",
        "\n",
        "        activity_index = listed_data.index(\"PUBCHEM_ACTIVITY_SCORE\")\n",
        "        #print(activity_index)\n",
        "        #print(type(activity_index))\n",
        "\n",
        "\n",
        "        fhand = io.StringIO(loose_data)\n",
        "\n",
        "        cids_with_activities = []\n",
        "\n",
        "        for line in fhand:\n",
        "            line = line.split(',')\n",
        "\n",
        "            while ('' in line):\n",
        "                line.remove('')\n",
        "            try:\n",
        "                int(line[0])\n",
        "                int(line[cid_index])\n",
        "                float(line[activity_index])\n",
        "            except:\n",
        "                line = \"\"\n",
        "                continue\n",
        "            cid_with_activity = (line[cid_index], line[activity_index])\n",
        "            cids_with_activities.append(cid_with_activity)\n",
        "        #isolate raw_cids into a list containing just the CIDs from the dictionary\n",
        "        if len(cids_with_activities) > 0:\n",
        "            #assign CIDs to associated AID dictionary entry\n",
        "            target_id_assay_dict[target_id][aid] = cids_with_activities\n",
        "            print(\"Compounds found! Adding compounds to dictionary and passing to next assay.\")\n",
        "        else:\n",
        "            print(\"No compounds found for assay. Passing to next assay.\")\n",
        "            continue\n",
        "\n",
        "    a+=1\n",
        "    display(a)\n",
        "print(target_id_assay_dict)"
      ],
      "metadata": {
        "id": "phkFLvoAOkAs"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "#Precautions to ensure the code works right and the the Assay ID numbrs line up right\n",
        "print(aids)\n",
        "print(len(aids))\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "gPxUPZ7Zjr3i",
        "outputId": "3f98e930-ff10-4d27-ccfa-1c40e8597ec9"
      },
      "execution_count": 21,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "[1904, 56396, 56397, 56398, 56399, 56400, 56401, 56402, 56403, 56404, 56405, 56406, 56407, 56408, 56409, 56410, 56411, 56412, 56413, 56414, 56415, 56416, 56417, 56418, 56419, 56420, 56541, 56542, 56543, 56544, 56545, 56546, 56547, 56548, 56549, 56550, 56551, 56552, 56553, 56554, 56555, 56556, 56557, 56558, 56559, 56560, 56561, 56562, 56563, 56564, 56565, 56566, 56567, 56568, 56569, 56570, 56571, 56572, 56573, 56574, 56575, 56576, 56577, 56699, 56700, 56701, 56702, 56703, 56704, 56705, 56706, 56707, 56708, 56709, 56710, 56711, 56712, 56713, 56714, 56715, 56716, 56717, 56718, 56719, 56720, 56721, 56722, 56723, 56724, 56725, 56726, 56727, 56728, 56729, 56730, 56731, 56732, 56733, 56864, 56865, 56866, 56867, 56868, 56869, 56870, 56871, 56872, 56873, 56874, 56875, 56876, 56877, 56878, 56879, 56880, 56881, 56882, 56883, 56884, 56885, 56886, 56887, 56888, 56889, 56890, 56891, 56892, 56893, 56894, 56895, 56896, 56897, 56898, 56899, 56900, 56901, 57032, 57033, 57034, 57035, 57036, 57037, 57038, 57039, 57040, 57041, 57042, 57043, 210938, 210939, 210940, 210941, 210942, 210943, 210944, 210945, 210946, 210947, 210948, 210949, 211091, 211092, 211093, 211094, 211095, 211097, 211098, 211099, 211100, 211101, 211102, 211103, 211104, 211105, 211106, 211107, 211108, 211109, 211110, 211111, 211112, 211113, 211114, 211115, 211116, 211117, 224610, 228425, 228426, 231982, 232993, 239726, 239852, 240049, 240097, 240620, 241607, 242837, 243219, 243220, 243221, 243223, 243224, 243225, 243226, 243386, 243387, 243388, 243437, 243438, 244262, 244263, 244264, 244265, 244266, 244267, 250096, 251002, 252286, 252287, 252288, 252289, 252290, 252291, 256508, 256678, 258767, 264545, 268635, 268636, 268637, 269042, 269043, 269110, 269203, 283903, 283904, 286262, 286403, 286404, 286405, 286406, 286407, 286413, 286414, 286415, 286416, 286421, 286422, 286423, 286424, 286438, 286439, 286440, 287709, 287710, 287711, 287712, 293172, 293480, 293481, 293483, 296073, 297066, 299311, 299312, 300366, 300367, 309604, 312293, 312295, 314508, 314509, 317452, 322713, 328779, 328780, 331449, 331828, 333055, 333057, 334464, 334465, 334466, 336292, 344134, 345172, 345173, 346586, 350320, 353083, 354858, 358916, 361234, 361235, 361236, 361444, 361445, 361450, 361451, 361452, 362301, 366208, 366217, 376730, 377538, 378110, 379271, 379272, 379273, 379824, 380032, 380033, 380253, 385404, 389683, 393312, 393754, 396403, 396771, 402038, 408919, 408920, 408923, 409902, 411410, 411411, 414753, 418336, 422411, 422412, 422413, 431825, 431826, 431827, 431833, 431834, 431835, 431854, 432397, 432398, 432399, 432401, 432403, 432404, 433914, 434819, 434821, 436178, 436387, 436713, 436714, 436715, 436716, 449570, 449571, 453108, 453806, 456247, 456248, 458062, 460543, 460544, 462323, 462324, 462741, 462742, 467763, 467764, 470667, 476071, 478033, 478041, 478056, 480105, 480106, 480992, 481164, 481165, 481166, 481167, 481168, 481169, 481171, 481172, 481173, 481429, 481430, 485536, 486649, 487689, 487695, 490081, 490170, 494546, 497152, 497153, 511233, 511234, 527478, 527479, 536035, 536036, 536901, 537376, 537377, 537378, 537379, 547370, 547371, 547372, 551007, 551009, 551010, 551014, 551015, 551016, 551263, 552714, 565888, 565889, 565890, 577548, 577549, 577550, 578682, 578683, 590398, 591643, 591644, 592162, 592163, 595841, 595842, 599168, 600204, 600208, 600209, 600210, 600211, 600216, 606654, 606747, 607456, 608854, 608855, 610760, 611200, 611201, 612419, 612420, 615989, 617145, 620745, 620746, 620747, 620748, 620749, 620798, 620799, 624099, 632907, 635424, 636881, 636882, 636883, 644574, 644575, 644777, 651810, 651811, 657775, 657776, 657777, 657778, 657779, 657780, 657781, 657916, 657917, 657918, 666765, 673453, 677826, 677830, 677840, 677841, 696326, 696327, 696328, 696329, 696330, 699139, 699140, 699141, 699143, 699145, 699147, 699149, 699150, 699151, 699152, 699153, 699154, 699155, 699156, 699159, 701776, 701777, 702828, 702851, 702856, 702857, 704299, 704300, 709686, 711426, 711429, 714170, 714171, 720710, 724041, 724051, 724052, 724053, 725344, 725345, 725730, 725731, 725732, 725734, 729747, 730195, 735940, 736320, 736814, 743121, 743454, 745329, 746647, 747370, 747371, 747461, 747462, 748349, 749698, 756448, 761189, 767198, 768623, 770644, 771322, 771323, 771547, 771548, 774972, 775817, 775824, 776101, 776102, 776105, 776106, 776649, 776654, 779453, 779454, 780350, 780351, 780352, 780933, 780934, 780938, 780939, 1061257, 1061259, 1061261, 1063330, 1075781, 1075782, 1075783, 1075784, 1075785, 1075794, 1075795, 1075796, 1075797, 1075855, 1075856, 1075857, 1076036, 1076081, 1076082, 1095219, 1095226, 1095227, 1095228, 1096583, 1096585, 1117281, 1117357, 1121257, 1122073, 1138548, 1142522, 1142523, 1142524, 1142525, 1142526, 1143108, 1143109, 1143384, 1155282, 1155283, 1159506, 1159578, 1159584, 1165010, 1165011, 1165391, 1165392, 1165393, 1165394, 1165395, 1165396, 1167481, 1167482, 1169487, 1169488, 1175659, 1175660, 1175661, 1175662, 1175663, 1175664, 1175665, 1179938, 1182588, 1182589, 1182590, 1182607, 1185511, 1187845, 1194058, 1194769, 1194770, 1195269, 1197367, 1197378, 1197846, 1197849, 1198386, 1201343, 1201344, 1203574, 1203584, 1203585, 1203586, 1203587, 1206840, 1206841, 1206843, 1206844, 1224830, 1225979, 1226759, 1227434, 1227436, 1228597, 1228598, 1228599, 1228600, 1231675, 1231676, 1236890, 1236891, 1239195, 1239196, 1239197, 1240569, 1244074, 1244077, 1245883, 1245884, 1250350, 1250351, 1250352, 1250353, 1250357, 1250358, 1250359, 1250360, 1251496, 1251505, 1252045, 1252046, 1252049, 1252051, 1254805, 1254806, 1254807, 1254810, 1264620, 1265043, 1268056, 1268057, 1268058, 1269401, 1273775, 1273776, 1274490, 1274495, 1274535, 1274800, 1274801, 1279113, 1284053, 1284054, 1284066, 1284067, 1287948, 1287949, 1288087, 1288088, 1288328, 1288329, 1294874, 1294922, 1302329, 1302342, 1306065, 1306928, 1306930, 1306932, 1306934, 1309918, 1309919, 1310522, 1322189, 1322190, 1322191, 1324294, 1325811, 1326452, 1326609, 1326614, 1326622, 1326623, 1327275, 1327276, 1327277, 1327631, 1327633, 1327805, 1327808, 1327956, 1333371, 1333372, 1333373, 1333374, 1337469, 1337470, 1337481, 1337482, 1337582, 1337583, 1339692, 1339693, 1346045, 1347618, 1347619, 1347620, 1352095, 1352096, 1358575, 1359176, 1361510, 1363189, 1363190, 1363340, 1363341, 1363365, 1363366, 1374093, 1374094, 1378651, 1382328, 1382329, 1382330, 1382599, 1382600, 1382607, 1382608, 1383386, 1383387, 1383388, 1383389, 1383390, 1383391, 1383392, 1387408, 1387409, 1387410, 1387411, 1390166, 1390167, 1390176, 1390177, 1390208, 1390209, 1390210, 1390211, 1390212, 1396987, 1400707, 1400708, 1400711, 1401812, 1401813, 1401818, 1401819, 1401820, 1401822, 1401823, 1401824, 1401825, 1401826, 1401830, 1401831, 1407988, 1413829, 1415044, 1426110, 1426112, 1428609, 1428613, 1428614, 1428615, 1428616, 1428617, 1428618, 1428690, 1428691, 1428700, 1428701, 1428712, 1428713, 1428714, 1428715, 1431482, 1431483, 1442286, 1443965, 1443966, 1443967, 1443978, 1443979, 1447300, 1447301, 1447305, 1447306, 1447307, 1448230, 1453061, 1453062, 1453394, 1457569, 1472923, 1472924, 1472925, 1472926, 1472927, 1472928, 1472929, 1472930, 1472931, 1472932, 1472933, 1472934, 1472935, 1472936, 1472937, 1472938, 1472940, 1472941, 1472942, 1472947, 1472948, 1472950, 1472951, 1472952, 1478721, 1478722, 1478733, 1478734, 1481805, 1481806, 1481807, 1486385, 1486759, 1486765, 1500678, 1500679, 1500681, 1507687, 1507689, 1507694, 1507695, 1507750, 1508588, 1520397, 1520398, 1520399, 1520400, 1537211, 1544044, 1544048, 1544049, 1544050, 1544057, 1544058, 1544059, 1544060, 1544061, 1544067, 1544068, 1544069, 1544070, 1544076, 1551202, 1551203, 1551900, 1562002, 1562003, 1562010, 1562011, 1562101, 1562102, 1563007, 1563008, 1563009, 1563013, 1563014, 1563015, 1564585, 1566675, 1566676, 1566743, 1566744, 1566745, 1566778, 1577582, 1577583, 1585186, 1585187, 1585188, 1585189, 1585190, 1585191, 1585192, 1585193, 1601654, 1601657, 1601658, 1601659, 1609804, 1609821, 1609822, 1609823, 1609824, 1609825, 1609859, 1610469, 1631081, 1638092, 1638093, 1648729, 1648730, 1648731, 1651221, 1651222, 1651223, 1651224, 1651225, 1651226, 1655966, 1655967, 1655968, 1655970, 1655971, 1655972, 1655973, 1659501, 1659502, 1659503, 1667417, 1667418, 1673144, 1673146, 1673147, 1673148, 1673149, 1673154, 1673156, 1689290, 1689313, 1692473, 1701969, 1702012, 1702822, 1702823, 1702824, 1702825, 1702826, 1703217, 1703218, 1703219, 1703331, 1703332, 1708523, 1708533, 1708534, 1713804, 1713805, 1723562, 1724032, 1727988, 1727989, 1727990, 1728398, 1728414, 1732040, 1733013, 1736595, 1736602, 1736603, 1736606, 1736607, 1736608, 1737446, 1737447, 1737448, 1737449, 1737450, 1738949, 1740932, 1740933, 1758341, 1758342, 1758988, 1759310, 1759311, 1759312, 1759313, 1759314, 1763576, 1763577, 1763578, 1763579, 1765566, 1765569, 1779158, 1779194, 1779228, 1779229, 1779298, 1781535, 1798415, 1803398, 1808044, 1808045, 1808046, 1808048, 1808049, 1808050, 1808110, 1810247, 1810249, 1810251, 1810252, 1811235, 1811236, 1817036, 1823979, 1823980, 1823981, 1823982, 1823983, 1826593, 1826602, 1830490, 1830496, 1849130, 1849131, 1854846, 1858607, 1859455, 1859464, 1859467, 1859469, 1862078, 1862079, 1862088, 1867660, 1867663, 1877736, 1877737, 1877738, 1884188, 1884189, 1885559, 1885561, 1885562, 1888016, 1888017, 1888018, 1888019, 1888020, 1888021, 1888022, 1888023, 1888036, 1888037, 1888098, 1891163, 1891164, 1891165, 1891166, 1891167, 1891168, 1894518, 1899156, 1906038, 1911379, 1911380, 1911382, 1911684, 1911685]\n",
            "1137\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "#Thomas Passaro working on my own request using the URL From John Marinelli.\n",
        "\n",
        "from os import X_OK\n",
        "\n",
        "#List made to hold all the Assay Descriptions\n",
        "Assay_Descriptions_List = []\n",
        "\n",
        "#Counter used to break out for test purposes\n",
        "Count = 0\n",
        "\n",
        "#A for loop used to cycle through the Assay ID numbers.\n",
        "for i in aids:\n",
        "\n",
        "  #this prints the Assay ID number before the name of the Assay. I find this gives more information for the user.\n",
        "  print(str(i))\n",
        "\n",
        "  #count to stop after a certain number of Assays (For test purposes)\n",
        "  #Count = Count +1\n",
        "  #if Count > 40:\n",
        "    #break\n",
        "  #this is the calling of the request from the URL and it includes the cycling of Assay ID numbers.\n",
        "  description_requests = requests.get('https://pubchem.ncbi.nlm.nih.gov/rest/pug/assay/aid/'+ str(i) +'/description/JSON')\n",
        "  URL_Dict = description_requests.json()\n",
        "\n",
        "  #Assay_Names is URL_Dict after it went through a few indexs\n",
        "  Assay_Names = URL_Dict['PC_AssayContainer'][0]['assay']['descr']['name']\n",
        "  print(Assay_Names)\n",
        "\n",
        "  #Assay_Descriptions is the URL_Dict after it went through a few indexs to get the decriptions of each Assay\n",
        "  Assay_Descriptions = URL_Dict['PC_AssayContainer'][0]['assay']['descr']['description']\n",
        "\n",
        "  #Makes the descriptions all one string instead of multiple\n",
        "  Assay_Descriptions_Joined = ' '.join(Assay_Descriptions)\n",
        "  print(Assay_Descriptions_Joined)\n",
        "\n",
        "  #adds the Descriptions of the Assays to the Assay Description List\n",
        "  Assay_Descriptions_List.append(Assay_Descriptions_Joined)\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "umOdqHwaPb54",
        "outputId": "388b7109-1cd8-46ce-a19b-f4dfff286952"
      },
      "execution_count": 38,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "1904\n",
            "siRNA Circadian Assay\n",
            "Description:  To identify additional clock genes and modifiers, we conducted a genome-wide screen of ~90,000 siRNAs (QIAGEN Inc) in a human cellular model of clock function. Knockdown of nearly a thousand genes reduced rhythm amplitude; these are presumably due to toxic effects on cells. Hundreds of genes potently modified period length or increased amplitude.\n",
            "56396\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Agarose Gel Electrophoresis test at concentration 100 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56397\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Agarose Gel Electrophoresis test at concentration 100 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56398\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Agarose Gel Electrophoresis test at concentration 250 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56399\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Agarose Gel Electrophoresis test at concentration 250 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56400\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Agarose Gel Electrophoresis test at concentration 25 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56401\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Agarose Gel Electrophoresis test at concentration 25 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56402\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Agarose Gel Electrophoresis test at concentration 50 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56403\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Agarose Gel Electrophoresis test at concentration 50 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56404\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Fluorescence assay using Ethidium Bromide after heat denaturation of pBR322 DNA at concentration 100 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56405\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Fluorescence assay using Ethidium Bromide after heat denaturation of pBR322 DNA at concentration 100 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56406\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Fluorescence assay using Ethidium Bromide after heat denaturation of pBR322 DNA at concentration 250 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56407\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Fluorescence assay using Ethidium Bromide after heat denaturation of pBR322 DNA at concentration 250 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56408\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Fluorescence assay using Ethidium Bromide after heat denaturation of pBR322 DNA at concentration 25 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56409\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Fluorescence assay using Ethidium Bromide after heat denaturation of pBR322 DNA at concentration 25 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56410\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Fluorescence assay using Ethidium Bromide after heat denaturation of pBR322 DNA at concentration 50 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56411\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Fluorescence assay using Ethidium Bromide after heat denaturation of pBR322 DNA at concentration 50 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56412\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Fluorescence assay using Ethidium Bromide after heat denaturation of pBR322 DNA at concentration 75 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56413\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Fluorescence assay using Ethidium Bromide before heat denaturation of pBR322 DNA at concentration 100 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56414\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Fluorescence assay using Ethidium Bromide before heat denaturation of pBR322 DNA at concentration 100 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56415\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Fluorescence assay using Ethidium Bromide before heat denaturation of pBR322 DNA at concentration 250 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56416\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Fluorescence assay using Ethidium Bromide before heat denaturation of pBR322 DNA at concentration 250 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56417\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Fluorescence assay using Ethidium Bromide before heat denaturation of pBR322 DNA at concentration 25 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56418\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Fluorescence assay using Ethidium Bromide before heat denaturation of pBR322 DNA at concentration 25 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56419\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Fluorescence assay using Ethidium Bromide before heat denaturation of pBR322 DNA at concentration 50 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56420\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Fluorescence assay using Ethidium Bromide before heat denaturation of pBR322 DNA at concentration 50 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56541\n",
            "Topoisomerase I DNA relaxation activity was evaluated by Fluorescence assay using Ethidium Bromide before heat denaturation of pBR322 DNA at concentration 75 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56542\n",
            "Topoisomerase I in the absence of DNA was evaluated by Fluorescence assay using Ethidium Bromide after heat denaturation of pBR322 DNA at concentration 100 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56543\n",
            "Topoisomerase I in the absence of DNA was evaluated by Fluorescence assay using Ethidium Bromide after heat denaturation of pBR322 DNA at concentration 100 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56544\n",
            "Topoisomerase I in the absence of DNA was evaluated by Fluorescence assay using Ethidium Bromide after heat denaturation of pBR322 DNA at concentration 250 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56545\n",
            "Topoisomerase I in the absence of DNA was evaluated by Fluorescence assay using Ethidium Bromide after heat denaturation of pBR322 DNA at concentration 250 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56546\n",
            "Topoisomerase I in the absence of DNA was evaluated by Fluorescence assay using Ethidium Bromide after heat denaturation of pBR322 DNA at concentration 25 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56547\n",
            "Topoisomerase I in the absence of DNA was evaluated by Fluorescence assay using Ethidium Bromide after heat denaturation of pBR322 DNA at concentration 25 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56548\n",
            "Topoisomerase I in the absence of DNA was evaluated by Fluorescence assay using Ethidium Bromide after heat denaturation of pBR322 DNA at concentration 50 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56549\n",
            "Topoisomerase I in the absence of DNA was evaluated by Fluorescence assay using Ethidium Bromide after heat denaturation of pBR322 DNA at concentration 50 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56550\n",
            "Topoisomerase I in the absence of DNA was evaluated by Fluorescence assay using Ethidium Bromide before heat denaturation of pBR322 DNA at concentration 100 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56551\n",
            "Topoisomerase I in the absence of DNA was evaluated by Fluorescence assay using Ethidium Bromide before heat denaturation of pBR322 DNA at concentration 100 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56552\n",
            "Topoisomerase I in the absence of DNA was evaluated by Fluorescence assay using Ethidium Bromide before heat denaturation of pBR322 DNA at concentration 250 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56553\n",
            "Topoisomerase I in the absence of DNA was evaluated by Fluorescence assay using Ethidium Bromide before heat denaturation of pBR322 DNA at concentration 250 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56554\n",
            "Topoisomerase I in the absence of DNA was evaluated by Fluorescence assay using Ethidium Bromide before heat denaturation of pBR322 DNA at concentration 25 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56555\n",
            "Topoisomerase I in the absence of DNA was evaluated by Fluorescence assay using Ethidium Bromide before heat denaturation of pBR322 DNA at concentration 25 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56556\n",
            "Topoisomerase I in the absence of DNA was evaluated by Fluorescence assay using Ethidium Bromide before heat denaturation of pBR322 DNA at concentration 50 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56557\n",
            "Topoisomerase I in the absence of DNA was evaluated by Fluorescence assay using Ethidium Bromide before heat denaturation of pBR322 DNA at concentration 50 uM\n",
            "Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.\n",
            "56558\n",
            "Antibacterial activity against Escherichia coli DNA topoisomerase I\n",
            "Title: seco-Cyclothialidines: new concise synthesis, inhibitory activity toward bacterial and human DNA topoisomerases, and antibacterial properties.  Abstract: seco-Cyclothialidines are a promising class of bacterial DNA gyrase B subunit inhibitors. A new seco-cyclothialidine derivative containing a dioxazine moiety, BAY 50-7952, was synthesized through a new concise pathway. One key step of the synthesis is the straightforward formation of the 2-aminothiazole derivative of S-tritylcysteine. In biological tests, BAY 50-7952 and other known seco-cyclothialidines exhibited high and selective activity toward bacterial DNA gyrase and toward Gram-positive bacteria. The dioxazine moiety and other similar groups were found to be important for the ability of the seco-cyclothialidines to penetrate bacterial membranes. The opposite enantiomer ((S)-form) of BAY 50-7952 was also synthesized, and neither significant target activity nor in vitro antibacterial activity were found, suggesting a highly selective fit of the (R)-form. Despite promising in vitro activity, only poor activity was found in the murine infection model.\n",
            "56559\n",
            "Inhibition against DNA topoisomerase I by direct assay with activated DNA and 25 uM dNTPs including [3H]dTTP\n",
            "Title: Inhibition of herpes simplex virus type 1 helicase-primase by (dichloroanilino)purines and -pyrimidines.  Abstract: Herpes simplex virus type 1 (HSV1) encodes a heterotrimeric helicase-primase comprised of the products of three of the seven DNA replication-specific genes. Several dihalo-substituted derivatives of N2-phenylguanines and 2-anilinoadenines weakly inhibited the intrinsic DNA-dependent NTPase activity of the HSV1 helicase-primase, and these compounds inhibited the DNA-unwinding activity of the enzyme. The primase activity of the enzyme was strongly inhibited by 3,4- and 3,5-dichloroanilino derivatives of adenine and 2-aminopyrimidines. These compounds and nucleoside analogs of 2-(3,5-dichloroanilino)purines inhibited viral DNA synthesis in HSV1-infected HeLa cells in culture but also inhibited cellular DNA synthesis, likely as a result of inhibition of cellular primase and/or DNA polymerases.\n",
            "56560\n",
            "Inhibition against DNA topoisomerase I by direct assay with activated DNA and 25 uM dNTPs including [3H]dTTP\n",
            "Title: Inhibition of herpes simplex virus type 1 helicase-primase by (dichloroanilino)purines and -pyrimidines.  Abstract: Herpes simplex virus type 1 (HSV1) encodes a heterotrimeric helicase-primase comprised of the products of three of the seven DNA replication-specific genes. Several dihalo-substituted derivatives of N2-phenylguanines and 2-anilinoadenines weakly inhibited the intrinsic DNA-dependent NTPase activity of the HSV1 helicase-primase, and these compounds inhibited the DNA-unwinding activity of the enzyme. The primase activity of the enzyme was strongly inhibited by 3,4- and 3,5-dichloroanilino derivatives of adenine and 2-aminopyrimidines. These compounds and nucleoside analogs of 2-(3,5-dichloroanilino)purines inhibited viral DNA synthesis in HSV1-infected HeLa cells in culture but also inhibited cellular DNA synthesis, likely as a result of inhibition of cellular primase and/or DNA polymerases.\n",
            "56561\n",
            "Inhibitory activity against DNA topoisomerase I\n",
            "Title: Quantized surface complementarity diversity (QSCD): a model based on small molecule-target complementarity.  Abstract: A model of molecular diversity is presented. The model, termed \"Quantized Surface Complementarity Diversity\" (QSCD), defines molecular diversity by measuring molecular complementarity to a fully enumerated set of theoretical target surfaces. Molecular diversity space is defined as the molecular complement to this set of enumerated surfaces. Using a set of known test compounds, the model is shown to be biologically relevant, consistently scoring known actives as similar. At the resolution of the model, which examines molecules \"quantized\" into 4.24 A cubic units and treats four points of specific energetic complementarity, the minimum number of compounds needed to fully cover molecular diversity space up to volume 1070 cubic A is estimated to be on the order of 24 million molecules. Most importantly, QSCD allows for individual points in diversity space to be filled by direct modeling of molecular libraries into detailed 3D templates of shape and functionality.\n",
            "56562\n",
            "Cytotoxicity against DNA topoisomerase I purified from calf thymus\n",
            "Title: Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity.  Abstract: Water-soluble analogues of the antitumor alkaloid camptothecin (1) were prepared in which aminoalkyl groups were introduced into ring A or B. Most of the analogues were prepared by oxidation of camptothecin to 10-hydroxycamptothecin (2) followed by a Mannich reaction to give N-substituted 9-(aminomethyl)-10-hydroxycamptothecins (4-12) or by subsequent modification of Mannich product 4 (13, 15, 17, 19, 21). Others were obtained by modification of the hydroxyl group of 2 (25,26) or by total synthesis (35,42,43). These analogues, as well as some of their synthetic precursors, were evaluated for inhibition of topoisomerase I, cytotoxicity, and antitumor activity. Although there was not a quantitative correlation between these assays, compounds that inhibited topoisomerase I were also cytotoxic and demonstrated antitumor activity in vivo. Further evaluation of the most active water-soluble analogue led to the selection of 9-[(dimethylamino)methyl]-10-hydroxycamptothecin (4, SK&F 104864) for development as an antitumor agent. In addition to its water solubility, ease of synthesis from natural camptothecin, and high potency, 4 demonstrated broad-spectrum activity in preclinical tumor models and is currently undergoing Phase I clinical trials in cancer patients.\n",
            "56563\n",
            "Concentration that produces 50% DNA cleavage mediated by DNA topoisomerase I\n",
            "Title: Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity.  Abstract: Several camptothecin derivatives containing a modified hydroxy lactone ring have been synthesized and evaluated for inhibition of topoisomerase I and cytotoxicity to mammalian cells. Each of the groups of the hydroxy lactone moiety, the carbonyl oxygen, the ring lactone oxygen, and the 20-hydroxy group, were shown to be critical for enzyme inhibition. For example the lactol, lactam, thiolactone, and 20-deoxy derivatives did not stabilize the covalent DNA-topoisomerase I complex. With a few exceptions, those compounds that did not inhibit topoisomerase I were not cytotoxic to mammalian cells. Two cytotoxic derivatives that did not inhibit topoisomerase I were shown to produce non-protein-associated DNA single-strand breaks and are likely to have a different mechanism of action. One of these compounds was tested for antitumor activity and was found to be inactive. The present findings, as well as other reports that the hydroxy lactone ring of camptothecin is critical for antitumor activity in vivo, correlate with the structure-activity relationships at the level of topoisomerase I and support the hypothesis that antitumor activity is related to inhibition of this target enzyme.\n",
            "56564\n",
            "Concentration that produces 50% DNA cleavage mediated by DNA topoisomerase I; neg= negative is no enzyme mediated DNA cleavage at the highest conc tested at 50 uM\n",
            "Title: Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity.  Abstract: Several camptothecin derivatives containing a modified hydroxy lactone ring have been synthesized and evaluated for inhibition of topoisomerase I and cytotoxicity to mammalian cells. Each of the groups of the hydroxy lactone moiety, the carbonyl oxygen, the ring lactone oxygen, and the 20-hydroxy group, were shown to be critical for enzyme inhibition. For example the lactol, lactam, thiolactone, and 20-deoxy derivatives did not stabilize the covalent DNA-topoisomerase I complex. With a few exceptions, those compounds that did not inhibit topoisomerase I were not cytotoxic to mammalian cells. Two cytotoxic derivatives that did not inhibit topoisomerase I were shown to produce non-protein-associated DNA single-strand breaks and are likely to have a different mechanism of action. One of these compounds was tested for antitumor activity and was found to be inactive. The present findings, as well as other reports that the hydroxy lactone ring of camptothecin is critical for antitumor activity in vivo, correlate with the structure-activity relationships at the level of topoisomerase I and support the hypothesis that antitumor activity is related to inhibition of this target enzyme.\n",
            "56565\n",
            "Antibacterial activity against calf thymus Topo I.\n",
            "Title: seco-Cyclothialidines: new concise synthesis, inhibitory activity toward bacterial and human DNA topoisomerases, and antibacterial properties.  Abstract: seco-Cyclothialidines are a promising class of bacterial DNA gyrase B subunit inhibitors. A new seco-cyclothialidine derivative containing a dioxazine moiety, BAY 50-7952, was synthesized through a new concise pathway. One key step of the synthesis is the straightforward formation of the 2-aminothiazole derivative of S-tritylcysteine. In biological tests, BAY 50-7952 and other known seco-cyclothialidines exhibited high and selective activity toward bacterial DNA gyrase and toward Gram-positive bacteria. The dioxazine moiety and other similar groups were found to be important for the ability of the seco-cyclothialidines to penetrate bacterial membranes. The opposite enantiomer ((S)-form) of BAY 50-7952 was also synthesized, and neither significant target activity nor in vitro antibacterial activity were found, suggesting a highly selective fit of the (R)-form. Despite promising in vitro activity, only poor activity was found in the murine infection model.\n",
            "56566\n",
            "Average concentration of compound to cause 50% inhibition of topoisomerase-1\n",
            "Title: Water soluble inhibitors of topoisomerase I: quaternary salt derivatives of camptothecin.  Abstract: Eleven water soluble 7-substituted quaternary ammonium salt derivatives of 10,11-(methylenedioxy)- and 10,11-(ethylenedioxy)-(20S)-camptothecin were synthesized via the Friedlander reaction followed by nucleophilic displacement with an aromatic amine. All of these compounds were more potent than camptothecin in the in vitro cleavable complex assay. These inherently charged camptothecin derivatives were cytotoxic against three different human tumor cell lines (SKOV3, an ovarian adenocarcinoma; SKVLB a multidrug resistant ovarian adenocarcinoma; and HT-29, a colon carcinoma). A selected group of five compounds was evaluated in the nude mouse HT-29 xenograft model. Two of these quaternary salts (17 and 18) were more efficacious than Topotecan in delaying tumor growth. In an extended in vivo model, 18 demonstrated tumor regression.\n",
            "56567\n",
            "Average concentration of compound to cause 50% inhibition of topoisomerase-1 isolated from calf thymus\n",
            "Title: Water soluble inhibitors of topoisomerase I: quaternary salt derivatives of camptothecin.  Abstract: Eleven water soluble 7-substituted quaternary ammonium salt derivatives of 10,11-(methylenedioxy)- and 10,11-(ethylenedioxy)-(20S)-camptothecin were synthesized via the Friedlander reaction followed by nucleophilic displacement with an aromatic amine. All of these compounds were more potent than camptothecin in the in vitro cleavable complex assay. These inherently charged camptothecin derivatives were cytotoxic against three different human tumor cell lines (SKOV3, an ovarian adenocarcinoma; SKVLB a multidrug resistant ovarian adenocarcinoma; and HT-29, a colon carcinoma). A selected group of five compounds was evaluated in the nude mouse HT-29 xenograft model. Two of these quaternary salts (17 and 18) were more efficacious than Topotecan in delaying tumor growth. In an extended in vivo model, 18 demonstrated tumor regression.\n",
            "56568\n",
            "Compound was evaluated for the inhibition of DNA topoisomerase I of calf thymus; Not determined\n",
            "Title: Naphthazarin derivatives (II): formation of glutathione conjugate, inhibition of DNA topoisomerase-I and cytotoxicity.  Abstract: 6-(1-Hydroxyalkyl)-5,8-dimethoxy-1,4-naphthoquinones, expressing a higher reactivity in conjugation with glutathione, showed a greater potency in the inhibition of DNA topoisomerase-I and the cytotoxicity against L1210 cells than 2-(1-hydroxyalkyl)-DMNQ derivatives, implying the participation of electrophilic arylation in the bioactivities. In further study 6-(1-Hydroxyalkyl)-5,8-dimethoxy-1,4-naphthoquinones with an alkyl group of shorter chain length (C2-C6) exerted a greater bioactivities than those with longer chain length(>C6).\n",
            "56569\n",
            "Compound was evaluated for the inhibition of DNA topoisomerase-1 of calf thymus\n",
            "Title: Naphthazarin derivatives (II): formation of glutathione conjugate, inhibition of DNA topoisomerase-I and cytotoxicity.  Abstract: 6-(1-Hydroxyalkyl)-5,8-dimethoxy-1,4-naphthoquinones, expressing a higher reactivity in conjugation with glutathione, showed a greater potency in the inhibition of DNA topoisomerase-I and the cytotoxicity against L1210 cells than 2-(1-hydroxyalkyl)-DMNQ derivatives, implying the participation of electrophilic arylation in the bioactivities. In further study 6-(1-Hydroxyalkyl)-5,8-dimethoxy-1,4-naphthoquinones with an alkyl group of shorter chain length (C2-C6) exerted a greater bioactivities than those with longer chain length(>C6).\n",
            "56570\n",
            "Inhibition of topoisomerase I activity was determined in vitro by using the cleavable complex assay(calf thymus)\n",
            "Title: Synthesis and antitumor activity of novel water soluble derivatives of camptothecin as specific inhibitors of topoisomerase I.  Abstract: The synthesis and antitumor activities of the novel water soluble camptothecin derivatives 7-[(4-methylpiperazino)methyl]-10,11-(methylenedioxy)-(20S)-campto thecin trifluoroacetate (6) and 7-[(4-methylpiperazino)methyl]-10,11-(ethylenedioxy)-(20S)-camptot hecin trifluoroacetate (7) are described. The solubilities of compounds 6 and 7 were measured to be 4.5 and 5.8 mg/mL, respectively, in pH 5 acetate buffer in contrast to < 0.003 mg/mL for camptothecin in the same buffer. In the purified topoisomerase I cleavable complex enzyme assay, compounds 6 and 7 demonstrated potent inhibition of topoisomerase I with IC50's of 300 and 416 nM, respectively, in comparison to 679 nM for camptothecin and 1028 nM for topotecan. In human tumor cell cytotoxicity assays, compounds 6 and 7 demonstrated potent antitumor activity against ovarian (SKOV3), ovarian with upregulated MDRp-glycoprotein (SKVLB), melanoma (LOX), breast (T47D), and colon (HT29) with IC50's ranging from 0.5 to 102 nM. Compounds 6 and 7 induced tumor regressions in the HT29 human colon tumor xenograft model and demonstrated similar rank order of potency compared to in vitro assay results.\n",
            "56571\n",
            "Inhibitory activity against topoisomerase I.\n",
            "Title: Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.  Abstract: The human immunodeficiency virus type one integrase (HIV-1 integrase) is required for integration of a double-stranded DNA copy of the viral RNA genome into a host chromosome and for HIV replication. We have previously reported that phenolic moieties in compounds such as flavones, caffeic acid phenethyl ester (CAPE), tyrphostins, and curcumin confer inhibitory activity against HIV-1 integrase. We have investigated the actions of several recently described protease inhibitors, possessing novel structural features, on HIV-1 integrase. NSC 158393, which contains four 4-hydroxycoumarin residues, was found to exhibit antiviral, antiprotease, and antiintegrase activity. Both the DNA binding and catalytic activities (3'-processing and strand transfer) of integrase were inhibited at micromolar concentrations. Disintegration catalyzed by an integrase mutant containing only the central catalytic domain was also inhibited, indicating that the binding site for these compounds resides in the central 50-212 amino acids of HIV-1 integrase. Binding at or near the integrase catalytic site was also suggested by a global inhibition of the choice of attacking nucleophile in the 3'-processing reaction. NSC 158393 inhibited HIV-2, feline, and simian immunodeficiency virus integrases while eukaryotic topoisomerase I was inhibited at higher concentrations, suggesting selective inhibition of retroviral integrases. Molecular modeling studies revealed that the two hydroxyls and two carbonyl moieties in NSC 158393 may represent essential elements of the pharmacophore. Antiviral efficacy was observed with NSC 158393 derivatives that inhibited both HIV protease and integrase, and the most potent integrase inhibitors also inhibited HIV protease. Hydroxycoumarins may provide lead compounds for development of novel antiviral agents based upon the concurrent inhibition of two viral targets, HIV-1 integrase and protease.\n",
            "56572\n",
            "Inhibitory activity against the calf thymus DNA topoisomerase I\n",
            "Title: Synthesis, topoisomerase I inhibition and structure-activity relationship study of 2,4,6-trisubstituted pyridine derivatives.  Abstract: For the development of new anticancer agents, phenyl, 2-pyridyl, 2-furyl, 2-thienyl, 2-furylvinyl and 2-thienylvinyl substituted derivatives on 2,4,6-position in pyridine moiety were prepared and evaluated for their topoisomerase I inhibitory activity. Among the thirteen prepared compounds, four compounds exhibited strong topoisomerase I inhibitory activity. A structure-activity relationship study indicated that the 2-thienyl-4-furylpyridine skeleton was important for topoisomerase I inhibitory activity.\n",
            "56573\n",
            "Inhibitory concentration against topoisomerase I obtained from calf thymus\n",
            "Title: Rigid analogs of camptothecin as DNA topoisomerase I inhibitors.  Abstract: Substituted 8-ethyl-2-(2-oxo-1,2-dihydroindol-3-ylidene)-8-hydroxy-2,3,5,8- tetrahydro-6-oxa-3a-azacyclopenta[b]naphthalene-1,4,7-triones were synthesized and evaluated as topoisomerase I inhibitors in an in vitro cleavable complex assay. The activity of these compounds may be attributed to their rigid, planar geometry, and an attempt was made to correlate the SAR in this series to known attributes of camptothecin.\n",
            "56574\n",
            "In vitro fragmentation of DNA in the presence of excess calf thymus topoisomerase.\n",
            "Title: Synthesis, topoisomerase I inhibitory activity, and in vivo evaluation of 11-azacamptothecin analogs.  Abstract: A series of analogs based on a novel template, 11-aza-(20S)-camptothecin, were obtained from total synthesis and tested as potential anticancer drugs in the topoisomerase I enzyme cleavable complex assay. The parent compound 11-aza-(20S)-camptothecin (8) was derived from a Friedlander condensation between the known aminopyridine derivative 3-(3-amino-4-picolylidene)-p-toluidine and optically active tricyclic ketone 7. Compound 8 had activity approximately twice that of (20S)-camptothecin in the calf thymus topoisomerase I cleavable complex assay. Compounds were prepared wherein the 11-aza nitrogen atom was quaternized as either the corresponding N-oxide or methyl iodide. Compounds with quaternized N-11 showed improved water solubility and were equipotent to the clinically investigated camptothecin analog topotecan in the cleavable complex assay. These compounds were evaluated in vivo in nude mice bearing HT-29 human colon carcinoma xenografts. The analog 11-aza-(20S)-camptothecin 11-N-oxide was found to significantly retard tumor growth when compared to untreated controls. Finally, 7,10-disubstituted 11-azacamptothecin analogs were synthesized using Pd(0) coupling reactions of 10-bromo-7-alkyl-11-aza-(20S)-camptothecins 19 and 20, which in turn were available from a Friedlander condensation of the novel bromopyridine derivatives 17a and 17b with 7. Among the 10-substituted series, a number of analogs displayed extremely high in vitro potency against topoisomerase I and improved aqueous solubility. A significant number of the compounds were found to be active in whole cell cytotoxicity assays and several were evaluated in nude mice bearing the HT-29 tumor xenografts. The most effective of these proved to be (S)-11-aza-7-ethyl-10-(aminohydroximinomethyl)camptothecin trifluoracetic acid salt (27), a potent topoisomerase I inhibitor which demonstrated excellent efficacy in both short term and in extended in vivo assays. A comparison between in vitro enzyme data and in vivo data from nude mouse studies in other compounds in this series revealed a poor overall correlation between topoisomerase inhibition in vitro and antitumor efficacy in vivo.\n",
            "56575\n",
            "Minimum concentration that produced 50% fragmentation of DNA was measured in the presence of excess calf thymus topoisomerase.\n",
            "Title: Synthesis, topoisomerase I inhibitory activity, and in vivo evaluation of 11-azacamptothecin analogs.  Abstract: A series of analogs based on a novel template, 11-aza-(20S)-camptothecin, were obtained from total synthesis and tested as potential anticancer drugs in the topoisomerase I enzyme cleavable complex assay. The parent compound 11-aza-(20S)-camptothecin (8) was derived from a Friedlander condensation between the known aminopyridine derivative 3-(3-amino-4-picolylidene)-p-toluidine and optically active tricyclic ketone 7. Compound 8 had activity approximately twice that of (20S)-camptothecin in the calf thymus topoisomerase I cleavable complex assay. Compounds were prepared wherein the 11-aza nitrogen atom was quaternized as either the corresponding N-oxide or methyl iodide. Compounds with quaternized N-11 showed improved water solubility and were equipotent to the clinically investigated camptothecin analog topotecan in the cleavable complex assay. These compounds were evaluated in vivo in nude mice bearing HT-29 human colon carcinoma xenografts. The analog 11-aza-(20S)-camptothecin 11-N-oxide was found to significantly retard tumor growth when compared to untreated controls. Finally, 7,10-disubstituted 11-azacamptothecin analogs were synthesized using Pd(0) coupling reactions of 10-bromo-7-alkyl-11-aza-(20S)-camptothecins 19 and 20, which in turn were available from a Friedlander condensation of the novel bromopyridine derivatives 17a and 17b with 7. Among the 10-substituted series, a number of analogs displayed extremely high in vitro potency against topoisomerase I and improved aqueous solubility. A significant number of the compounds were found to be active in whole cell cytotoxicity assays and several were evaluated in nude mice bearing the HT-29 tumor xenografts. The most effective of these proved to be (S)-11-aza-7-ethyl-10-(aminohydroximinomethyl)camptothecin trifluoracetic acid salt (27), a potent topoisomerase I inhibitor which demonstrated excellent efficacy in both short term and in extended in vivo assays. A comparison between in vitro enzyme data and in vivo data from nude mouse studies in other compounds in this series revealed a poor overall correlation between topoisomerase inhibition in vitro and antitumor efficacy in vivo.\n",
            "56576\n",
            "Inhibition of bovine topoisomerase I, using cleavable complex assay.\n",
            "Title: Rigid analogs of camptothecin as DNA topoisomerase I inhibitors.  Abstract: Substituted 8-ethyl-2-(2-oxo-1,2-dihydroindol-3-ylidene)-8-hydroxy-2,3,5,8- tetrahydro-6-oxa-3a-azacyclopenta[b]naphthalene-1,4,7-triones were synthesized and evaluated as topoisomerase I inhibitors in an in vitro cleavable complex assay. The activity of these compounds may be attributed to their rigid, planar geometry, and an attempt was made to correlate the SAR in this series to known attributes of camptothecin.\n",
            "56577\n",
            "In vitro inhibition of DNA topoisomerase I activity (ATP-independent DNA relaxation) at a concentration of 50 uM\n",
            "In vitro inhibition of DNA topoisomerase I activity (ATP-independent DNA relaxation) at a concentration of 50 uM\n",
            "56699\n",
            "In vitro inhibition of DNA topoisomerase I activity (ATP-independent DNA relaxation) at a concentration of 50 uM; no activity\n",
            "In vitro inhibition of DNA topoisomerase I activity (ATP-independent DNA relaxation) at a concentration of 50 uM; no activity\n",
            "56700\n",
            "Inhibitory activity towards Topoisomerase 1 from calf thymus.\n",
            "Title: Structure-activity relationships in a series of substituted indolocarbazoles: topoisomerase I and protein kinase C inhibition and antitumoral and antimicrobial properties.  Abstract: A series of compounds structurally related to staurosporine, rebeccamycin, and corresponding aglycones was synthesized, and their activities toward protein kinase C and topoisomerases I and II were tested together with their in vitro antitumor efficiency against murine B16 melanoma and P388 leukemia cells. Their antimicrobial activities were also examined against a Gram-negative bacterium (Escherichia coli), a yeast (Candida albicans), and three Gram-positive bacteria (Bacillus cereus, Streptomyces chartreusis, and Streptomyces griseus). To avoid side effects expected with protein kinase C inhibitors, we introduced substitution on the maleimide nitrogen and/or a sugar moiety linked to one of the indole nitrogens to obtain specific inhibitors of topoisomerase I with minimal activities on protein kinase C. As expected, these structures were inefficient on topoisomerase II, and some of them exhibited a strong activity against topoisomerase I. Generally, dechlorinated compounds were found to be more active than chlorinated analogues against both purified topoisomerase I and protein kinase C. On the other hand, opposite results were obtained in the cell antiproliferative assays. These results suggest lack of cell membrane permeability in the absence of the chlorine residue or cleavage of carbon-chlorine bonds inside the cell.\n",
            "56701\n",
            "Minimum inhibitory concentration against DNA topoisomerase I\n",
            "Title: Syntheses and biological activities of rebeccamycin analogues. Introduction of a halogenoacetyl substituent.  Abstract: In the course of structure-activity relationships on rebeccamycin analogues, a series of compounds bearing a halogenoacetyl substituent were synthesized with the expectation of increasing the interaction with DNA, possibly via covalent reaction with the double helix. Two rebeccamycin analogues bearing an acetyl instead of a bromoacetyl substituent were prepared to gain an insight into the role of the halogen atom. The new compounds show very little effect on protein kinase C and no covalent reaction with DNA was detected. However, the drugs behave as typical topoisomerase I poisons, and they are significantly more toxic toward P388 leukemia cells than to P388/CPT5 cells resistant to camptothecin. The introduction of a bromo- or chloro-acetyl substituent does not affect the capacity of the drug to interfere with topoisomerase I either in vitro or in cells. One of the bromoacetyl derivatives, compound 8, is the most cytotoxic rebeccamycin derivative among the hundred of derivatives we have synthesized to date. In addition, we determined the antimicrobial activities against two Gram-positive bacteria, Bacillus cereus and Streptomyces chartreusis, and against the Gram-negative bacterium Escherichia coli. The effect of the drugs on Candida albicans yeast growth and their anti-HIV-1 activities were also measured.\n",
            "56702\n",
            "Effective concentration against Topoisomerase-I (purified from calf thymus gland) mediated DNA cleavage relative to Hoechst 33342\n",
            "Title: Substituted 2,5'-Bi-1H-benzimidazoles: topoisomerase I inhibition and cytotoxicity.  Abstract: Several 2'-aryl-5-substituted-2,5'bi-1H-benzimidazole derivatives were synthesized and evaluated as topoisomerase I poisons and for their cytotoxicity toward the human lymphoblast cell line RPMI 8402. This study focused on 18 2,5'-bi-1H-benzimidazole derivatives which contained either a 5-cyano, a 5-(aminocarbonyl), or a 5-(4-methylpiperazinyl) group. Among these bibenzimidazoles, the pharmacological activity of 2'-phenyl derivatives and the influence of the different positional isomers of either a 2'-tolyl group or a 2'-naphthyl moiety on cytotoxicity and topoisomerase I inhibitory activity were determined.\n",
            "56703\n",
            "Relative activity against DNA topoisomerase I was measured at concentration of 12 uM to that of camptothecin\n",
            "Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.\n",
            "56704\n",
            "Relative activity against DNA topoisomerase I was measured at concentration of 166 uM to that of camptothecin; Inactive\n",
            "Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.\n",
            "56705\n",
            "Relative activity against DNA topoisomerase I was measured at concentration of 200 uM to that of camptothecin; Inactive\n",
            "Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.\n",
            "56706\n",
            "Relative activity against DNA topoisomerase I was measured at concentration of 277 uM to that of camptothecin; inactive\n",
            "Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.\n",
            "56707\n",
            "Relative activity against DNA topoisomerase I was measured at concentration of 418 uM to that of camptothecin; Active, 40 fold less than camptothecin\n",
            "Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.\n",
            "56708\n",
            "Relative activity against DNA topoisomerase I was measured at concentration of 554 uM to that of camptothecin; Active, 50 fold less than camptothecin\n",
            "Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.\n",
            "56709\n",
            "Relative activity against DNA topoisomerase I was measured at concentration of 625 uM to that of camptothecin; Inactive\n",
            "Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.\n",
            "56710\n",
            "Relative activity against DNA topoisomerase I was measured at concentration of 83 uM to that of camptothecin; Active, 10 fold less than camptothecin\n",
            "Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.\n",
            "56711\n",
            "Relative activity against DNA topoisomerase I was measured at concentration of 833 uM to that of camptothecin; Inactive\n",
            "Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.\n",
            "56712\n",
            "Relative activity against DNA topoisomerase I was measured at concentration of 833 uM to that of camptothecin; Inactive\n",
            "Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.\n",
            "56713\n",
            "Relative activity against Topoisomerase I was measured at concentration of 360 uM to that of camptothecin; Active, 35 fold less than camptothecin\n",
            "Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.\n",
            "56714\n",
            "The compound was tested for topoisomerase-1 mediated DNA cleavage, activity is expressed as REC(relative effective concentration) i.e., concentration relative to Hoechst 33342.\n",
            "Title: Synthesis and evaluation of terbenzimidazoles as topoisomerase I inhibitors.  Abstract: The synthesis and pharmacological activity of a series of terbenzimidazoles are described. The ability of these derivatives to induce DNA cleavage in the presence of topoisomerase I was evaluated in vitro. These analogs were also assayed for their cytotoxicity in RPMI 8402 cells and the camptothecin-resistant CPT-K5 cells. In addition the potential for these compounds to serve as substrates for MDR1 was also determined. Several terbenzimidazoles exhibited similar cytotoxicity against variants of human tumor cells that either overexpress MDR1 or are camptothecin-resistant.\n",
            "56715\n",
            "Activity to produce DNA topoisomerase I-mediated DNA cleavage at concentration up to 10 uM\n",
            "Title: Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-camptothecin hybrids.  Abstract: The indenoisoquinolines are a novel class of topoisomerase I (top1) inhibitors that are cytotoxic in cancer cell cultures and are therefore under development as potential anticancer agents. As inhibitors of the DNA religation reaction occurring after DNA cleavage by the enzyme, they are classified as top1 poisons, similar to the camptothecins. Two strategies were employed in order to further develop the structure-activity relationships of the indenoisoquinolines and enhance their therapeutic potential. The first strategy involved the synthesis of indenoisoquinoline-camptothecin hybrid molecules to take advantage of a proposed structural analogy between the indenoisoquinolines and camptothecin. The desired hybrids were synthesized by reaction of halogenated phthalides with a dihydropyrroloquinoline. The second strategy involved the attachment of various alkenyl substituents to the C-11 position of the indenoisoquinolines, which were assumed to project into the DNA minor groove. The required C-11-substituted indenoisoquinolines were synthesized by McMurry reactions of 11-ketoindenoisoquinolines with aldehydes, and the geometries of the resulting alkenes were established by nuclear Overhauser effect difference NMR spectroscopy. All of the new indenoisoquinolines were examined for cytotoxicity in human cancer cell cultures as well as for activity vs top1. Although the indenoisoquinoline-camptothecin hybrid molecules proved to be less cytotoxic and displayed less activity against top1, an analogue incorporating a 3'-aminoalkenyl substituent at the C-11 position of the indenoisoquinoline system was significantly more potent than the prototype indenoisoquinoline in both assays. These results indicate that C-11 aminoalkyl substituents that are assumed to project into the minor groove enhance the cytotoxicity and top1 inhibitory activity of the parent indenoisoquinoline system.\n",
            "56716\n",
            "Activity to produce DNA topoisomerase I-mediated DNA cleavage at concentration up to 10 uM; ++, indicates similar activity as the parent compound 2\n",
            "Title: Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-camptothecin hybrids.  Abstract: The indenoisoquinolines are a novel class of topoisomerase I (top1) inhibitors that are cytotoxic in cancer cell cultures and are therefore under development as potential anticancer agents. As inhibitors of the DNA religation reaction occurring after DNA cleavage by the enzyme, they are classified as top1 poisons, similar to the camptothecins. Two strategies were employed in order to further develop the structure-activity relationships of the indenoisoquinolines and enhance their therapeutic potential. The first strategy involved the synthesis of indenoisoquinoline-camptothecin hybrid molecules to take advantage of a proposed structural analogy between the indenoisoquinolines and camptothecin. The desired hybrids were synthesized by reaction of halogenated phthalides with a dihydropyrroloquinoline. The second strategy involved the attachment of various alkenyl substituents to the C-11 position of the indenoisoquinolines, which were assumed to project into the DNA minor groove. The required C-11-substituted indenoisoquinolines were synthesized by McMurry reactions of 11-ketoindenoisoquinolines with aldehydes, and the geometries of the resulting alkenes were established by nuclear Overhauser effect difference NMR spectroscopy. All of the new indenoisoquinolines were examined for cytotoxicity in human cancer cell cultures as well as for activity vs top1. Although the indenoisoquinoline-camptothecin hybrid molecules proved to be less cytotoxic and displayed less activity against top1, an analogue incorporating a 3'-aminoalkenyl substituent at the C-11 position of the indenoisoquinoline system was significantly more potent than the prototype indenoisoquinoline in both assays. These results indicate that C-11 aminoalkyl substituents that are assumed to project into the minor groove enhance the cytotoxicity and top1 inhibitory activity of the parent indenoisoquinoline system.\n",
            "56717\n",
            "Activity to produce DNA topoisomerase I-mediated DNA cleavage at concentration up to 10 uM; +++, greater activity than the parent compound 2\n",
            "Title: Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-camptothecin hybrids.  Abstract: The indenoisoquinolines are a novel class of topoisomerase I (top1) inhibitors that are cytotoxic in cancer cell cultures and are therefore under development as potential anticancer agents. As inhibitors of the DNA religation reaction occurring after DNA cleavage by the enzyme, they are classified as top1 poisons, similar to the camptothecins. Two strategies were employed in order to further develop the structure-activity relationships of the indenoisoquinolines and enhance their therapeutic potential. The first strategy involved the synthesis of indenoisoquinoline-camptothecin hybrid molecules to take advantage of a proposed structural analogy between the indenoisoquinolines and camptothecin. The desired hybrids were synthesized by reaction of halogenated phthalides with a dihydropyrroloquinoline. The second strategy involved the attachment of various alkenyl substituents to the C-11 position of the indenoisoquinolines, which were assumed to project into the DNA minor groove. The required C-11-substituted indenoisoquinolines were synthesized by McMurry reactions of 11-ketoindenoisoquinolines with aldehydes, and the geometries of the resulting alkenes were established by nuclear Overhauser effect difference NMR spectroscopy. All of the new indenoisoquinolines were examined for cytotoxicity in human cancer cell cultures as well as for activity vs top1. Although the indenoisoquinoline-camptothecin hybrid molecules proved to be less cytotoxic and displayed less activity against top1, an analogue incorporating a 3'-aminoalkenyl substituent at the C-11 position of the indenoisoquinoline system was significantly more potent than the prototype indenoisoquinoline in both assays. These results indicate that C-11 aminoalkyl substituents that are assumed to project into the minor groove enhance the cytotoxicity and top1 inhibitory activity of the parent indenoisoquinoline system.\n",
            "56718\n",
            "Activity to produce DNA topoisomerase I-mediated DNA cleavage at concentration up to 10 uM; +, indicates weak activity\n",
            "Title: Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-camptothecin hybrids.  Abstract: The indenoisoquinolines are a novel class of topoisomerase I (top1) inhibitors that are cytotoxic in cancer cell cultures and are therefore under development as potential anticancer agents. As inhibitors of the DNA religation reaction occurring after DNA cleavage by the enzyme, they are classified as top1 poisons, similar to the camptothecins. Two strategies were employed in order to further develop the structure-activity relationships of the indenoisoquinolines and enhance their therapeutic potential. The first strategy involved the synthesis of indenoisoquinoline-camptothecin hybrid molecules to take advantage of a proposed structural analogy between the indenoisoquinolines and camptothecin. The desired hybrids were synthesized by reaction of halogenated phthalides with a dihydropyrroloquinoline. The second strategy involved the attachment of various alkenyl substituents to the C-11 position of the indenoisoquinolines, which were assumed to project into the DNA minor groove. The required C-11-substituted indenoisoquinolines were synthesized by McMurry reactions of 11-ketoindenoisoquinolines with aldehydes, and the geometries of the resulting alkenes were established by nuclear Overhauser effect difference NMR spectroscopy. All of the new indenoisoquinolines were examined for cytotoxicity in human cancer cell cultures as well as for activity vs top1. Although the indenoisoquinoline-camptothecin hybrid molecules proved to be less cytotoxic and displayed less activity against top1, an analogue incorporating a 3'-aminoalkenyl substituent at the C-11 position of the indenoisoquinoline system was significantly more potent than the prototype indenoisoquinoline in both assays. These results indicate that C-11 aminoalkyl substituents that are assumed to project into the minor groove enhance the cytotoxicity and top1 inhibitory activity of the parent indenoisoquinoline system.\n",
            "56719\n",
            "Activity to produce DNA topoisomerase I-mediated DNA cleavage at concentration up to 10 uM; +/-\n",
            "Title: Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-camptothecin hybrids.  Abstract: The indenoisoquinolines are a novel class of topoisomerase I (top1) inhibitors that are cytotoxic in cancer cell cultures and are therefore under development as potential anticancer agents. As inhibitors of the DNA religation reaction occurring after DNA cleavage by the enzyme, they are classified as top1 poisons, similar to the camptothecins. Two strategies were employed in order to further develop the structure-activity relationships of the indenoisoquinolines and enhance their therapeutic potential. The first strategy involved the synthesis of indenoisoquinoline-camptothecin hybrid molecules to take advantage of a proposed structural analogy between the indenoisoquinolines and camptothecin. The desired hybrids were synthesized by reaction of halogenated phthalides with a dihydropyrroloquinoline. The second strategy involved the attachment of various alkenyl substituents to the C-11 position of the indenoisoquinolines, which were assumed to project into the DNA minor groove. The required C-11-substituted indenoisoquinolines were synthesized by McMurry reactions of 11-ketoindenoisoquinolines with aldehydes, and the geometries of the resulting alkenes were established by nuclear Overhauser effect difference NMR spectroscopy. All of the new indenoisoquinolines were examined for cytotoxicity in human cancer cell cultures as well as for activity vs top1. Although the indenoisoquinoline-camptothecin hybrid molecules proved to be less cytotoxic and displayed less activity against top1, an analogue incorporating a 3'-aminoalkenyl substituent at the C-11 position of the indenoisoquinoline system was significantly more potent than the prototype indenoisoquinoline in both assays. These results indicate that C-11 aminoalkyl substituents that are assumed to project into the minor groove enhance the cytotoxicity and top1 inhibitory activity of the parent indenoisoquinoline system.\n",
            "56720\n",
            "Compound was tested for its inhibitory activity against DNA topoisomerase I greater activity than the parent compound 1\n",
            "Title: Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen.  Abstract: The indenoisoquinolines are a class of noncamptothecin topoisomerase I inhibitors that display significant cytotoxicity in human cancer cell cultures. They offer a number of potential advantages over the camptothecins, including greater chemical stability, formation of more persistent cleavage complexes, and induction of a unique pattern of DNA cleavage sites. Molecular modeling has suggested that substituents on the indenoisoquinoline lactam nitrogen would protrude out of the DNA duplex in the ternary cleavage complex through the major groove. This indicates that relatively large substituents in that location would be tolerated without compromising biological activity. As a strategy for increasing the potencies and potential therapeutic usefulness of the indenoisoquinolines, a series of compounds was synthesized containing polyamine side chains on the lactam nitrogen. The rationale for the synthesis of these compounds was that the positively charged ammonium cations would increase DNA affinity through electrostatic binding to the negatively charged DNA backbone, and the polyamines might also facilitate cellular uptake by utilization of polyamine transporters. The key step in the synthesis involved the condensation of Schiff bases, containing protected amine side chains, with substituted homophthalic anhydrides, to afford cis-3-aryl-4-carboxy-1-isoquinolones. These isoquinolones were then converted to indenoisoquinolines with thionyl chloride. Although monoamines were much more potent than the lead compound, no significant increase in potency was observed through incorporation of additional amino groups in the side chain. However, one of the monoamine analogues, which features a bis(2-hydroxyethyl)amino group in the side chain, proved to be one of the most cytotoxic indenoisoquinoline synthesized to date, with a GI50 mean-graph midpoint (MGM) of 0.07 microM in the NIH human cancer cell culture screen, and topoisomerase I inhibitory activity comparable to that of camptothecin.\n",
            "56721\n",
            "Compound was tested for its inhibitory activity against DNA topoisomerase I; No activity\n",
            "Title: Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen.  Abstract: The indenoisoquinolines are a class of noncamptothecin topoisomerase I inhibitors that display significant cytotoxicity in human cancer cell cultures. They offer a number of potential advantages over the camptothecins, including greater chemical stability, formation of more persistent cleavage complexes, and induction of a unique pattern of DNA cleavage sites. Molecular modeling has suggested that substituents on the indenoisoquinoline lactam nitrogen would protrude out of the DNA duplex in the ternary cleavage complex through the major groove. This indicates that relatively large substituents in that location would be tolerated without compromising biological activity. As a strategy for increasing the potencies and potential therapeutic usefulness of the indenoisoquinolines, a series of compounds was synthesized containing polyamine side chains on the lactam nitrogen. The rationale for the synthesis of these compounds was that the positively charged ammonium cations would increase DNA affinity through electrostatic binding to the negatively charged DNA backbone, and the polyamines might also facilitate cellular uptake by utilization of polyamine transporters. The key step in the synthesis involved the condensation of Schiff bases, containing protected amine side chains, with substituted homophthalic anhydrides, to afford cis-3-aryl-4-carboxy-1-isoquinolones. These isoquinolones were then converted to indenoisoquinolines with thionyl chloride. Although monoamines were much more potent than the lead compound, no significant increase in potency was observed through incorporation of additional amino groups in the side chain. However, one of the monoamine analogues, which features a bis(2-hydroxyethyl)amino group in the side chain, proved to be one of the most cytotoxic indenoisoquinoline synthesized to date, with a GI50 mean-graph midpoint (MGM) of 0.07 microM in the NIH human cancer cell culture screen, and topoisomerase I inhibitory activity comparable to that of camptothecin.\n",
            "56722\n",
            "Inhibitory activity against DNA topoisomerase I; greater activity than the parent compound 1\n",
            "Title: Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen.  Abstract: The indenoisoquinolines are a class of noncamptothecin topoisomerase I inhibitors that display significant cytotoxicity in human cancer cell cultures. They offer a number of potential advantages over the camptothecins, including greater chemical stability, formation of more persistent cleavage complexes, and induction of a unique pattern of DNA cleavage sites. Molecular modeling has suggested that substituents on the indenoisoquinoline lactam nitrogen would protrude out of the DNA duplex in the ternary cleavage complex through the major groove. This indicates that relatively large substituents in that location would be tolerated without compromising biological activity. As a strategy for increasing the potencies and potential therapeutic usefulness of the indenoisoquinolines, a series of compounds was synthesized containing polyamine side chains on the lactam nitrogen. The rationale for the synthesis of these compounds was that the positively charged ammonium cations would increase DNA affinity through electrostatic binding to the negatively charged DNA backbone, and the polyamines might also facilitate cellular uptake by utilization of polyamine transporters. The key step in the synthesis involved the condensation of Schiff bases, containing protected amine side chains, with substituted homophthalic anhydrides, to afford cis-3-aryl-4-carboxy-1-isoquinolones. These isoquinolones were then converted to indenoisoquinolines with thionyl chloride. Although monoamines were much more potent than the lead compound, no significant increase in potency was observed through incorporation of additional amino groups in the side chain. However, one of the monoamine analogues, which features a bis(2-hydroxyethyl)amino group in the side chain, proved to be one of the most cytotoxic indenoisoquinoline synthesized to date, with a GI50 mean-graph midpoint (MGM) of 0.07 microM in the NIH human cancer cell culture screen, and topoisomerase I inhibitory activity comparable to that of camptothecin.\n",
            "56723\n",
            "Compound was tested for its inhibitory activity against DNA topoisomerase I; similar activity as 1 uM camptothecin\n",
            "Title: Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen.  Abstract: The indenoisoquinolines are a class of noncamptothecin topoisomerase I inhibitors that display significant cytotoxicity in human cancer cell cultures. They offer a number of potential advantages over the camptothecins, including greater chemical stability, formation of more persistent cleavage complexes, and induction of a unique pattern of DNA cleavage sites. Molecular modeling has suggested that substituents on the indenoisoquinoline lactam nitrogen would protrude out of the DNA duplex in the ternary cleavage complex through the major groove. This indicates that relatively large substituents in that location would be tolerated without compromising biological activity. As a strategy for increasing the potencies and potential therapeutic usefulness of the indenoisoquinolines, a series of compounds was synthesized containing polyamine side chains on the lactam nitrogen. The rationale for the synthesis of these compounds was that the positively charged ammonium cations would increase DNA affinity through electrostatic binding to the negatively charged DNA backbone, and the polyamines might also facilitate cellular uptake by utilization of polyamine transporters. The key step in the synthesis involved the condensation of Schiff bases, containing protected amine side chains, with substituted homophthalic anhydrides, to afford cis-3-aryl-4-carboxy-1-isoquinolones. These isoquinolones were then converted to indenoisoquinolines with thionyl chloride. Although monoamines were much more potent than the lead compound, no significant increase in potency was observed through incorporation of additional amino groups in the side chain. However, one of the monoamine analogues, which features a bis(2-hydroxyethyl)amino group in the side chain, proved to be one of the most cytotoxic indenoisoquinoline synthesized to date, with a GI50 mean-graph midpoint (MGM) of 0.07 microM in the NIH human cancer cell culture screen, and topoisomerase I inhibitory activity comparable to that of camptothecin.\n",
            "56724\n",
            "Compound was tested for its inhibitory activity against DNA topoisomerase I; similar activity as parent compound 1\n",
            "Title: Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen.  Abstract: The indenoisoquinolines are a class of noncamptothecin topoisomerase I inhibitors that display significant cytotoxicity in human cancer cell cultures. They offer a number of potential advantages over the camptothecins, including greater chemical stability, formation of more persistent cleavage complexes, and induction of a unique pattern of DNA cleavage sites. Molecular modeling has suggested that substituents on the indenoisoquinoline lactam nitrogen would protrude out of the DNA duplex in the ternary cleavage complex through the major groove. This indicates that relatively large substituents in that location would be tolerated without compromising biological activity. As a strategy for increasing the potencies and potential therapeutic usefulness of the indenoisoquinolines, a series of compounds was synthesized containing polyamine side chains on the lactam nitrogen. The rationale for the synthesis of these compounds was that the positively charged ammonium cations would increase DNA affinity through electrostatic binding to the negatively charged DNA backbone, and the polyamines might also facilitate cellular uptake by utilization of polyamine transporters. The key step in the synthesis involved the condensation of Schiff bases, containing protected amine side chains, with substituted homophthalic anhydrides, to afford cis-3-aryl-4-carboxy-1-isoquinolones. These isoquinolones were then converted to indenoisoquinolines with thionyl chloride. Although monoamines were much more potent than the lead compound, no significant increase in potency was observed through incorporation of additional amino groups in the side chain. However, one of the monoamine analogues, which features a bis(2-hydroxyethyl)amino group in the side chain, proved to be one of the most cytotoxic indenoisoquinoline synthesized to date, with a GI50 mean-graph midpoint (MGM) of 0.07 microM in the NIH human cancer cell culture screen, and topoisomerase I inhibitory activity comparable to that of camptothecin.\n",
            "56725\n",
            "Compound was tested for its inhibitory activity against DNA topoisomerase I; similar activity as that of the parent compound 1\n",
            "Title: Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen.  Abstract: The indenoisoquinolines are a class of noncamptothecin topoisomerase I inhibitors that display significant cytotoxicity in human cancer cell cultures. They offer a number of potential advantages over the camptothecins, including greater chemical stability, formation of more persistent cleavage complexes, and induction of a unique pattern of DNA cleavage sites. Molecular modeling has suggested that substituents on the indenoisoquinoline lactam nitrogen would protrude out of the DNA duplex in the ternary cleavage complex through the major groove. This indicates that relatively large substituents in that location would be tolerated without compromising biological activity. As a strategy for increasing the potencies and potential therapeutic usefulness of the indenoisoquinolines, a series of compounds was synthesized containing polyamine side chains on the lactam nitrogen. The rationale for the synthesis of these compounds was that the positively charged ammonium cations would increase DNA affinity through electrostatic binding to the negatively charged DNA backbone, and the polyamines might also facilitate cellular uptake by utilization of polyamine transporters. The key step in the synthesis involved the condensation of Schiff bases, containing protected amine side chains, with substituted homophthalic anhydrides, to afford cis-3-aryl-4-carboxy-1-isoquinolones. These isoquinolones were then converted to indenoisoquinolines with thionyl chloride. Although monoamines were much more potent than the lead compound, no significant increase in potency was observed through incorporation of additional amino groups in the side chain. However, one of the monoamine analogues, which features a bis(2-hydroxyethyl)amino group in the side chain, proved to be one of the most cytotoxic indenoisoquinoline synthesized to date, with a GI50 mean-graph midpoint (MGM) of 0.07 microM in the NIH human cancer cell culture screen, and topoisomerase I inhibitory activity comparable to that of camptothecin.\n",
            "56726\n",
            "Compound was tested for the inhibition of human DNA topoisomerase I at a compound concentration of 10 occurred\n",
            "Title: Benzo[f]azino[2,1-a]phthalazinium cations: novel DNA intercalating chromophores with antiproliferative activity.  Abstract: New azaquinolizinium-type cations have been obtained from isochromane. The synthesis was completed over seven steps and included as the key feature an intramolecular Westphal condensation. This first example of the intramolecular process allowed the preparation of benzo[f]pyrido[2,1-a]phthalazinium and benzo[f]quino[2,1-a]phthalazinium salts, which were evaluated as DNA intercalators, DNA topoisomerase I inhibitors, and antiproliferative compounds. Both cationic systems behave as DNA intercalators and exhibit antiproliferative activity. The pentacyclic benzo[f]quino[2,1-a]phthalazinium cations also have an inhibitory effect on the catalytic activity of DNA topoisomerase I, without trapping of cleavage complexes. Structural characterization using density functional theory indicates that the fused ring systems are slightly nonplanar, and additional molecular modeling studies suggest a preferred orientation for the intercalating chromophores within a typical CpG or TpG intercalation site.\n",
            "56727\n",
            "Compound was tested for the inhibition of human DNA topoisomerase I at a compound concentration of 10 occurred\n",
            "Title: Benzo[f]azino[2,1-a]phthalazinium cations: novel DNA intercalating chromophores with antiproliferative activity.  Abstract: New azaquinolizinium-type cations have been obtained from isochromane. The synthesis was completed over seven steps and included as the key feature an intramolecular Westphal condensation. This first example of the intramolecular process allowed the preparation of benzo[f]pyrido[2,1-a]phthalazinium and benzo[f]quino[2,1-a]phthalazinium salts, which were evaluated as DNA intercalators, DNA topoisomerase I inhibitors, and antiproliferative compounds. Both cationic systems behave as DNA intercalators and exhibit antiproliferative activity. The pentacyclic benzo[f]quino[2,1-a]phthalazinium cations also have an inhibitory effect on the catalytic activity of DNA topoisomerase I, without trapping of cleavage complexes. Structural characterization using density functional theory indicates that the fused ring systems are slightly nonplanar, and additional molecular modeling studies suggest a preferred orientation for the intercalating chromophores within a typical CpG or TpG intercalation site.\n",
            "56728\n",
            "Compound was tested for the inhibition of human DNA topoisomerase I at a compound concentration of 5 occurred\n",
            "Title: Benzo[f]azino[2,1-a]phthalazinium cations: novel DNA intercalating chromophores with antiproliferative activity.  Abstract: New azaquinolizinium-type cations have been obtained from isochromane. The synthesis was completed over seven steps and included as the key feature an intramolecular Westphal condensation. This first example of the intramolecular process allowed the preparation of benzo[f]pyrido[2,1-a]phthalazinium and benzo[f]quino[2,1-a]phthalazinium salts, which were evaluated as DNA intercalators, DNA topoisomerase I inhibitors, and antiproliferative compounds. Both cationic systems behave as DNA intercalators and exhibit antiproliferative activity. The pentacyclic benzo[f]quino[2,1-a]phthalazinium cations also have an inhibitory effect on the catalytic activity of DNA topoisomerase I, without trapping of cleavage complexes. Structural characterization using density functional theory indicates that the fused ring systems are slightly nonplanar, and additional molecular modeling studies suggest a preferred orientation for the intercalating chromophores within a typical CpG or TpG intercalation site.\n",
            "56729\n",
            "DNA topoisomerase I mediated cleavage activity tested up to a concentration of 100 uM\n",
            "Title: Synthesis of new dihydroindeno[1,2-c]isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model.  Abstract: A number of novel dihydroindenoisoquinolines and indenoisoquinolinium salts were synthesized and examined for cytotoxicity in cancer cell cultures and for inhibition of topoisomerase I (top1). The top1-mediated DNA cleavage patterns produced in the presence of several of the new analogues were also investigated, and a few of the more potent compounds were examined for activity in hollow fiber animal models. Very cytotoxic dihydroindenoisoquinoline and isoquinolinium salts were obtained with mean graph midpoints (MGMs) for growth inhibition in the low submicromolar range. Two of the new dihydroindenoisoquinolines were found to be weaker top1 inhibitors than the lead compound 1, while two of the indenoisoquinolinium salts were more potent. The top1-mediated DNA cleavage patterns of the indenoisoquinolines examined were found to be similar to each other but different from that of camptothecin. Several of the more potent indenoisoquinolines displayed promising anticancer activities in hollow fiber animal models.\n",
            "56730\n",
            "DNA topoisomerase I mediated cleavage activity tested up to a concentration of 100 uM; Active or inactive\n",
            "Title: Synthesis of new dihydroindeno[1,2-c]isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model.  Abstract: A number of novel dihydroindenoisoquinolines and indenoisoquinolinium salts were synthesized and examined for cytotoxicity in cancer cell cultures and for inhibition of topoisomerase I (top1). The top1-mediated DNA cleavage patterns produced in the presence of several of the new analogues were also investigated, and a few of the more potent compounds were examined for activity in hollow fiber animal models. Very cytotoxic dihydroindenoisoquinoline and isoquinolinium salts were obtained with mean graph midpoints (MGMs) for growth inhibition in the low submicromolar range. Two of the new dihydroindenoisoquinolines were found to be weaker top1 inhibitors than the lead compound 1, while two of the indenoisoquinolinium salts were more potent. The top1-mediated DNA cleavage patterns of the indenoisoquinolines examined were found to be similar to each other but different from that of camptothecin. Several of the more potent indenoisoquinolines displayed promising anticancer activities in hollow fiber animal models.\n",
            "56731\n",
            "DNA topoisomerase I mediated cleavage activity tested up to a concentration of 100 uM; Greater activity than compound 1\n",
            "Title: Synthesis of new dihydroindeno[1,2-c]isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model.  Abstract: A number of novel dihydroindenoisoquinolines and indenoisoquinolinium salts were synthesized and examined for cytotoxicity in cancer cell cultures and for inhibition of topoisomerase I (top1). The top1-mediated DNA cleavage patterns produced in the presence of several of the new analogues were also investigated, and a few of the more potent compounds were examined for activity in hollow fiber animal models. Very cytotoxic dihydroindenoisoquinoline and isoquinolinium salts were obtained with mean graph midpoints (MGMs) for growth inhibition in the low submicromolar range. Two of the new dihydroindenoisoquinolines were found to be weaker top1 inhibitors than the lead compound 1, while two of the indenoisoquinolinium salts were more potent. The top1-mediated DNA cleavage patterns of the indenoisoquinolines examined were found to be similar to each other but different from that of camptothecin. Several of the more potent indenoisoquinolines displayed promising anticancer activities in hollow fiber animal models.\n",
            "56732\n",
            "DNA topoisomerase I mediated cleavage activity tested up to a concentration of 100 uM; Same activity as compound 1\n",
            "Title: Synthesis of new dihydroindeno[1,2-c]isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model.  Abstract: A number of novel dihydroindenoisoquinolines and indenoisoquinolinium salts were synthesized and examined for cytotoxicity in cancer cell cultures and for inhibition of topoisomerase I (top1). The top1-mediated DNA cleavage patterns produced in the presence of several of the new analogues were also investigated, and a few of the more potent compounds were examined for activity in hollow fiber animal models. Very cytotoxic dihydroindenoisoquinoline and isoquinolinium salts were obtained with mean graph midpoints (MGMs) for growth inhibition in the low submicromolar range. Two of the new dihydroindenoisoquinolines were found to be weaker top1 inhibitors than the lead compound 1, while two of the indenoisoquinolinium salts were more potent. The top1-mediated DNA cleavage patterns of the indenoisoquinolines examined were found to be similar to each other but different from that of camptothecin. Several of the more potent indenoisoquinolines displayed promising anticancer activities in hollow fiber animal models.\n",
            "56733\n",
            "DNA topoisomerase I mediated cleavage activity tested up to a concentration of 100 uM; week activity\n",
            "Title: Synthesis of new dihydroindeno[1,2-c]isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model.  Abstract: A number of novel dihydroindenoisoquinolines and indenoisoquinolinium salts were synthesized and examined for cytotoxicity in cancer cell cultures and for inhibition of topoisomerase I (top1). The top1-mediated DNA cleavage patterns produced in the presence of several of the new analogues were also investigated, and a few of the more potent compounds were examined for activity in hollow fiber animal models. Very cytotoxic dihydroindenoisoquinoline and isoquinolinium salts were obtained with mean graph midpoints (MGMs) for growth inhibition in the low submicromolar range. Two of the new dihydroindenoisoquinolines were found to be weaker top1 inhibitors than the lead compound 1, while two of the indenoisoquinolinium salts were more potent. The top1-mediated DNA cleavage patterns of the indenoisoquinolines examined were found to be similar to each other but different from that of camptothecin. Several of the more potent indenoisoquinolines displayed promising anticancer activities in hollow fiber animal models.\n",
            "56864\n",
            "DNA topoisomerase I cleavage at 1 uM relative to SN38\n",
            "Title: Synthesis and pharmacological evaluation of novel non-lactone analogues of camptothecin.  Abstract: Ten novel camptothecin (CPT) derivatives devoid of the lactone function in the E-ring were synthesized and evaluated as anticancer agents. Several of these CPT analogues bearing a five-membered E-ring are potent inhibitors of the DNA relaxation and cleavage reactions catalyzed by topoisomerase I and exhibit promising cytotoxic activities with IC(50) values in the nM range. This is the first successful design of lactone-free CPT, providing thus a new avenue to the development of topoisomerase I targeted antitumor agents.\n",
            "56865\n",
            "Inhibitory activity of compound against human recombinant DNA topoisomerase I mediated DNA cleavage; Greater activity\n",
            "Title: Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitors.  Abstract: In an attempt to design and synthesize potential anticancer agents acting by inhibition of topoisomerase I (top1), a new series of indenoisoquinolines was prepared and tested for cytotoxicity in human cancer cell cultures and for activity against top1. The synthesis relied on the condensation of substituted Schiff bases with homophthalic anhydrides to produce cis-3-aryl-4-carboxyisoquinolones that were cyclized to indenoisoquinolines in the presence of thionyl chloride. Both top1 inhibitory activity and cytotoxicity maximized in a single compound, 6-[3-(2-hydroxyethyl)aminopropyl]-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride (19a), which proved to be a very potent top1 inhibitor having a 110 nM mean graph midpoint (MGM) when tested for cytotoxicity in 55 human cancer cell cultures. A number of structurally related indenoisoquinolines were also obtained that had both potent cytotoxicity as well as top1 inhibitory activity. The key feature of the more potent compounds was the presence of an aminoalkyl side chain on the indenoisoquinoline nitrogen atom. The DNA cleavage patterns induced by top1 in the presence of the indenoisoquinolines were different from those seen with camptothecin. Some of the cleavage sites induced by the indenoisoquinolines were different from those seen with camptothecin, and conversely, camptothecin induced unique cleavage sites not apparent with the indenoisoquinolines. However, both camptothecin and the indenoisoquinolines also induced DNA cleavage sites that were the same in both series but varied in intensity. In addition, some of the DNA cleavages seen with the free base of 19a (compound 18c) in the presence of top1 were inhibited at higher drug concentrations, suggesting either a direct inhibition of the enzyme or an alternative mechanism involving DNA intercalation. Consistent with intercalation, compound 18c did unwind DNA.\n",
            "56866\n",
            "Inhibitory activity of compound against human recombinant DNA topoisomerase I mediated DNA cleavage; Similar activity\n",
            "Title: Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitors.  Abstract: In an attempt to design and synthesize potential anticancer agents acting by inhibition of topoisomerase I (top1), a new series of indenoisoquinolines was prepared and tested for cytotoxicity in human cancer cell cultures and for activity against top1. The synthesis relied on the condensation of substituted Schiff bases with homophthalic anhydrides to produce cis-3-aryl-4-carboxyisoquinolones that were cyclized to indenoisoquinolines in the presence of thionyl chloride. Both top1 inhibitory activity and cytotoxicity maximized in a single compound, 6-[3-(2-hydroxyethyl)aminopropyl]-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride (19a), which proved to be a very potent top1 inhibitor having a 110 nM mean graph midpoint (MGM) when tested for cytotoxicity in 55 human cancer cell cultures. A number of structurally related indenoisoquinolines were also obtained that had both potent cytotoxicity as well as top1 inhibitory activity. The key feature of the more potent compounds was the presence of an aminoalkyl side chain on the indenoisoquinoline nitrogen atom. The DNA cleavage patterns induced by top1 in the presence of the indenoisoquinolines were different from those seen with camptothecin. Some of the cleavage sites induced by the indenoisoquinolines were different from those seen with camptothecin, and conversely, camptothecin induced unique cleavage sites not apparent with the indenoisoquinolines. However, both camptothecin and the indenoisoquinolines also induced DNA cleavage sites that were the same in both series but varied in intensity. In addition, some of the DNA cleavages seen with the free base of 19a (compound 18c) in the presence of top1 were inhibited at higher drug concentrations, suggesting either a direct inhibition of the enzyme or an alternative mechanism involving DNA intercalation. Consistent with intercalation, compound 18c did unwind DNA.\n",
            "56867\n",
            "Inhibitory activity against human DNA topoisomerase I mediated DNA cleavage; Weak activity\n",
            "Title: Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitors.  Abstract: In an attempt to design and synthesize potential anticancer agents acting by inhibition of topoisomerase I (top1), a new series of indenoisoquinolines was prepared and tested for cytotoxicity in human cancer cell cultures and for activity against top1. The synthesis relied on the condensation of substituted Schiff bases with homophthalic anhydrides to produce cis-3-aryl-4-carboxyisoquinolones that were cyclized to indenoisoquinolines in the presence of thionyl chloride. Both top1 inhibitory activity and cytotoxicity maximized in a single compound, 6-[3-(2-hydroxyethyl)aminopropyl]-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride (19a), which proved to be a very potent top1 inhibitor having a 110 nM mean graph midpoint (MGM) when tested for cytotoxicity in 55 human cancer cell cultures. A number of structurally related indenoisoquinolines were also obtained that had both potent cytotoxicity as well as top1 inhibitory activity. The key feature of the more potent compounds was the presence of an aminoalkyl side chain on the indenoisoquinoline nitrogen atom. The DNA cleavage patterns induced by top1 in the presence of the indenoisoquinolines were different from those seen with camptothecin. Some of the cleavage sites induced by the indenoisoquinolines were different from those seen with camptothecin, and conversely, camptothecin induced unique cleavage sites not apparent with the indenoisoquinolines. However, both camptothecin and the indenoisoquinolines also induced DNA cleavage sites that were the same in both series but varied in intensity. In addition, some of the DNA cleavages seen with the free base of 19a (compound 18c) in the presence of top1 were inhibited at higher drug concentrations, suggesting either a direct inhibition of the enzyme or an alternative mechanism involving DNA intercalation. Consistent with intercalation, compound 18c did unwind DNA.\n",
            "56868\n",
            "Inhibitory activity of compound against human recombinant topoisomerase 1DNA topoisomerase I cleavage; Weak activity\n",
            "Title: Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitors.  Abstract: In an attempt to design and synthesize potential anticancer agents acting by inhibition of topoisomerase I (top1), a new series of indenoisoquinolines was prepared and tested for cytotoxicity in human cancer cell cultures and for activity against top1. The synthesis relied on the condensation of substituted Schiff bases with homophthalic anhydrides to produce cis-3-aryl-4-carboxyisoquinolones that were cyclized to indenoisoquinolines in the presence of thionyl chloride. Both top1 inhibitory activity and cytotoxicity maximized in a single compound, 6-[3-(2-hydroxyethyl)aminopropyl]-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride (19a), which proved to be a very potent top1 inhibitor having a 110 nM mean graph midpoint (MGM) when tested for cytotoxicity in 55 human cancer cell cultures. A number of structurally related indenoisoquinolines were also obtained that had both potent cytotoxicity as well as top1 inhibitory activity. The key feature of the more potent compounds was the presence of an aminoalkyl side chain on the indenoisoquinoline nitrogen atom. The DNA cleavage patterns induced by top1 in the presence of the indenoisoquinolines were different from those seen with camptothecin. Some of the cleavage sites induced by the indenoisoquinolines were different from those seen with camptothecin, and conversely, camptothecin induced unique cleavage sites not apparent with the indenoisoquinolines. However, both camptothecin and the indenoisoquinolines also induced DNA cleavage sites that were the same in both series but varied in intensity. In addition, some of the DNA cleavages seen with the free base of 19a (compound 18c) in the presence of top1 were inhibited at higher drug concentrations, suggesting either a direct inhibition of the enzyme or an alternative mechanism involving DNA intercalation. Consistent with intercalation, compound 18c did unwind DNA.\n",
            "56869\n",
            "Antibacterial activity against human DNA Topo I.\n",
            "Title: seco-Cyclothialidines: new concise synthesis, inhibitory activity toward bacterial and human DNA topoisomerases, and antibacterial properties.  Abstract: seco-Cyclothialidines are a promising class of bacterial DNA gyrase B subunit inhibitors. A new seco-cyclothialidine derivative containing a dioxazine moiety, BAY 50-7952, was synthesized through a new concise pathway. One key step of the synthesis is the straightforward formation of the 2-aminothiazole derivative of S-tritylcysteine. In biological tests, BAY 50-7952 and other known seco-cyclothialidines exhibited high and selective activity toward bacterial DNA gyrase and toward Gram-positive bacteria. The dioxazine moiety and other similar groups were found to be important for the ability of the seco-cyclothialidines to penetrate bacterial membranes. The opposite enantiomer ((S)-form) of BAY 50-7952 was also synthesized, and neither significant target activity nor in vitro antibacterial activity were found, suggesting a highly selective fit of the (R)-form. Despite promising in vitro activity, only poor activity was found in the murine infection model.\n",
            "56870\n",
            "Concentration required to inhibit human DNA topoisomerase I (Topo I)\n",
            "Title: Indolocarbazole poisons of human topoisomerase I: regioisomeric analogues of ED-110.  Abstract: All four \"symmetrical\" regioisomers of ED-110, an indolocarbazole derivative having potent activity against human topoisomerase I (Topo I) were synthesized. The isomer containing hydroxyl groups in the 3- and 9-positions was approximately ten-fold more active against Topo I, and 5- to 35-fold more active against human solid tumor cell lines in vitro, relative to ED-110.\n",
            "56871\n",
            "Inhibitory activity against DNA topoisomerase-1 obtained from Hela cells\n",
            "Title: Acylshikonin analogues: synthesis and inhibition of DNA topoisomerase-I.  Abstract: Compounds bearing an acyl group of a various size at 1'-OH of shikonin were synthesized as acyl analogues of shikonin, which was isolated from the root of Lithospermum erythrorhizon, and evaluated for inhibitory effect on topoisomerase-I activity. A selective acylation at 1'-OH of shikonin in the presence of dicyclohexylcarbodiimide and 4-(dimethylamino)pyridine gave rise to a good yield of corresponding acylshikonin derivatives. In general, analogues with an acyl group of shorter chain lengths (C2-C6) exerted a stronger inhibitory action than those with longer chain lengths (C7-C20). While the halogen substitution at C-2 of the acetyl moiety failed to increase the inhibitory potency, the placement of double bonds in the acyl group (C5-C7) augmented the potency remarkably. Of the 32 derivatives evaluated, 15 compounds exhibited a higher inhibitory effect than shikonin. Noteworthy, the inhibitory potency of acetylshikonin, propanoylshikonin, and 4-pentenoylshikonin was approximately 4-fold greater than that of camptothecin. All these data suggest that the size of acyl moiety is important for the enhancement of potency, and the presence of olefinic double bonds is also beneficial.\n",
            "56872\n",
            "Inhibitory activity against DNA topoisomerase I at dose 100 uM\n",
            "Title: Antitumor agents. 166. Synthesis and biological evaluation of 5,6,7,8-substituted-2-phenylthiochromen-4-ones.  Abstract: As a continuation of our structure--activity relationship study of substituted 2-phenyl-4-quinolones and flavonoids as antitumor and antiviral agents, a series of 5,6,7,8-substituted-2-phenylthiochromen-4-ones has been synthesized by condensation of substituted thiophenols and ethyl benzoylacetates. Target compounds were evaluated for biological activity. Among them, compounds 7, 10, 12, and 13 displayed significant growth inhibitory action against a panel of tumor cell lines including human ileocecal carcinoma (HCT-8), murine leukemia (P-388), human melanoma (RPMI), and human central nervous system tumor (TE671) cells. Compounds 10, 12, and 19 displayed DNA topoisomerase I inhibitory activity in vitro and compound 11 was an in vitro, inhibitor of DNA topoisomerase II. Compound 11 was most active (ED50 value, 0.65 microM) against HIV in acutely infected H9 lymphocytes and had a therapeutic index of about 5.\n",
            "56873\n",
            "Inhibitory activity against Human DNA topoisomerase I at dose 100 uM\n",
            "Title: Antitumor agents. 166. Synthesis and biological evaluation of 5,6,7,8-substituted-2-phenylthiochromen-4-ones.  Abstract: As a continuation of our structure--activity relationship study of substituted 2-phenyl-4-quinolones and flavonoids as antitumor and antiviral agents, a series of 5,6,7,8-substituted-2-phenylthiochromen-4-ones has been synthesized by condensation of substituted thiophenols and ethyl benzoylacetates. Target compounds were evaluated for biological activity. Among them, compounds 7, 10, 12, and 13 displayed significant growth inhibitory action against a panel of tumor cell lines including human ileocecal carcinoma (HCT-8), murine leukemia (P-388), human melanoma (RPMI), and human central nervous system tumor (TE671) cells. Compounds 10, 12, and 19 displayed DNA topoisomerase I inhibitory activity in vitro and compound 11 was an in vitro, inhibitor of DNA topoisomerase II. Compound 11 was most active (ED50 value, 0.65 microM) against HIV in acutely infected H9 lymphocytes and had a therapeutic index of about 5.\n",
            "56874\n",
            "Inhibitory activity against Human DNA topoisomerase I at dose 100 uM; ND = Not determined\n",
            "Title: Antitumor agents. 166. Synthesis and biological evaluation of 5,6,7,8-substituted-2-phenylthiochromen-4-ones.  Abstract: As a continuation of our structure--activity relationship study of substituted 2-phenyl-4-quinolones and flavonoids as antitumor and antiviral agents, a series of 5,6,7,8-substituted-2-phenylthiochromen-4-ones has been synthesized by condensation of substituted thiophenols and ethyl benzoylacetates. Target compounds were evaluated for biological activity. Among them, compounds 7, 10, 12, and 13 displayed significant growth inhibitory action against a panel of tumor cell lines including human ileocecal carcinoma (HCT-8), murine leukemia (P-388), human melanoma (RPMI), and human central nervous system tumor (TE671) cells. Compounds 10, 12, and 19 displayed DNA topoisomerase I inhibitory activity in vitro and compound 11 was an in vitro, inhibitor of DNA topoisomerase II. Compound 11 was most active (ED50 value, 0.65 microM) against HIV in acutely infected H9 lymphocytes and had a therapeutic index of about 5.\n",
            "56875\n",
            "Inhibitory activity against human DNA topoisomerase I at dose 100 uM\n",
            "Title: Antitumor agents. 166. Synthesis and biological evaluation of 5,6,7,8-substituted-2-phenylthiochromen-4-ones.  Abstract: As a continuation of our structure--activity relationship study of substituted 2-phenyl-4-quinolones and flavonoids as antitumor and antiviral agents, a series of 5,6,7,8-substituted-2-phenylthiochromen-4-ones has been synthesized by condensation of substituted thiophenols and ethyl benzoylacetates. Target compounds were evaluated for biological activity. Among them, compounds 7, 10, 12, and 13 displayed significant growth inhibitory action against a panel of tumor cell lines including human ileocecal carcinoma (HCT-8), murine leukemia (P-388), human melanoma (RPMI), and human central nervous system tumor (TE671) cells. Compounds 10, 12, and 19 displayed DNA topoisomerase I inhibitory activity in vitro and compound 11 was an in vitro, inhibitor of DNA topoisomerase II. Compound 11 was most active (ED50 value, 0.65 microM) against HIV in acutely infected H9 lymphocytes and had a therapeutic index of about 5.\n",
            "56876\n",
            "In vitro inhibition of human DNA topoisomerase I activity.\n",
            "Title: 6-Arylamino-7-chloro-quinazoline-5,8-diones as novel cytotoxic and DNA topoisomerase inhibitory agents.  Abstract: A series of 6-arylamino-7-chloro-quinazoline-5,8-diones were prepared and evaluated for their in vitro cytotoxicity in cultured human cancer cell lines A549 (lung cancer), Col2 (colon cancer), and SNU-638 (stomach cancer). The preliminary structure-activity relationship has been described for providing further development of potent antitumor agents. To further investigate the cytotoxic mechanism, the effects of test compounds on DNA topoisomerase I and II activities have been assessed.\n",
            "56877\n",
            "Inhibitory activity of compound against human recombinant DNA topoisomerase I mediated DNA cleavage; No data\n",
            "Title: Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitors.  Abstract: In an attempt to design and synthesize potential anticancer agents acting by inhibition of topoisomerase I (top1), a new series of indenoisoquinolines was prepared and tested for cytotoxicity in human cancer cell cultures and for activity against top1. The synthesis relied on the condensation of substituted Schiff bases with homophthalic anhydrides to produce cis-3-aryl-4-carboxyisoquinolones that were cyclized to indenoisoquinolines in the presence of thionyl chloride. Both top1 inhibitory activity and cytotoxicity maximized in a single compound, 6-[3-(2-hydroxyethyl)aminopropyl]-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride (19a), which proved to be a very potent top1 inhibitor having a 110 nM mean graph midpoint (MGM) when tested for cytotoxicity in 55 human cancer cell cultures. A number of structurally related indenoisoquinolines were also obtained that had both potent cytotoxicity as well as top1 inhibitory activity. The key feature of the more potent compounds was the presence of an aminoalkyl side chain on the indenoisoquinoline nitrogen atom. The DNA cleavage patterns induced by top1 in the presence of the indenoisoquinolines were different from those seen with camptothecin. Some of the cleavage sites induced by the indenoisoquinolines were different from those seen with camptothecin, and conversely, camptothecin induced unique cleavage sites not apparent with the indenoisoquinolines. However, both camptothecin and the indenoisoquinolines also induced DNA cleavage sites that were the same in both series but varied in intensity. In addition, some of the DNA cleavages seen with the free base of 19a (compound 18c) in the presence of top1 were inhibited at higher drug concentrations, suggesting either a direct inhibition of the enzyme or an alternative mechanism involving DNA intercalation. Consistent with intercalation, compound 18c did unwind DNA.\n",
            "56878\n",
            "Inhibitory activity of compound against human recombinant DNA topoisomerase I mediated DNA cleavage; Weak activity\n",
            "Title: Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitors.  Abstract: In an attempt to design and synthesize potential anticancer agents acting by inhibition of topoisomerase I (top1), a new series of indenoisoquinolines was prepared and tested for cytotoxicity in human cancer cell cultures and for activity against top1. The synthesis relied on the condensation of substituted Schiff bases with homophthalic anhydrides to produce cis-3-aryl-4-carboxyisoquinolones that were cyclized to indenoisoquinolines in the presence of thionyl chloride. Both top1 inhibitory activity and cytotoxicity maximized in a single compound, 6-[3-(2-hydroxyethyl)aminopropyl]-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride (19a), which proved to be a very potent top1 inhibitor having a 110 nM mean graph midpoint (MGM) when tested for cytotoxicity in 55 human cancer cell cultures. A number of structurally related indenoisoquinolines were also obtained that had both potent cytotoxicity as well as top1 inhibitory activity. The key feature of the more potent compounds was the presence of an aminoalkyl side chain on the indenoisoquinoline nitrogen atom. The DNA cleavage patterns induced by top1 in the presence of the indenoisoquinolines were different from those seen with camptothecin. Some of the cleavage sites induced by the indenoisoquinolines were different from those seen with camptothecin, and conversely, camptothecin induced unique cleavage sites not apparent with the indenoisoquinolines. However, both camptothecin and the indenoisoquinolines also induced DNA cleavage sites that were the same in both series but varied in intensity. In addition, some of the DNA cleavages seen with the free base of 19a (compound 18c) in the presence of top1 were inhibited at higher drug concentrations, suggesting either a direct inhibition of the enzyme or an alternative mechanism involving DNA intercalation. Consistent with intercalation, compound 18c did unwind DNA.\n",
            "56879\n",
            "Concentration relative to topotecan for topoisomerase DNA topoisomerase I cleavage\n",
            "Title: 5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones and related compounds as TOP1-targeting agents: influence of structure on the ternary cleavable complex formation.  Abstract: In this paper, we present our results from a docking study of the title compounds with the DNA/topoisomerase I complex based on the recently published X-ray crystal structure of the topotecan/DNA/topoisomerase I ternary cleavable complex (Staker, B.L., et al. PNAS 2002, 99, 15387) using the Autodock program. Simple intermolecular docking energies (E(dock)) correlate well with in vitro DNA cleavage data suggesting that the binding mode from the crystal structure is a reasonable binding mode for these compounds.\n",
            "56880\n",
            "Effective concentration required to cleave DNA, mediated by human DNA topoisomerase I (TOP1) reported as REC i.e. concentration relative to topotecan (assumed as 1)\n",
            "Title: Nitro and amino substitution in the D-ring of 5-(2-dimethylaminoethyl)- 2,3-methylenedioxy-5H-dibenzo[c,h][1,6]naphthyridin-6-ones: effect on topoisomerase-I targeting activity and cytotoxicity.  Abstract: 5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)-2,3-methylenedioxydibenzo[c,h][1,6]naphthyridin-6-one exhibits potent TOP1-targeting activity and pronounced antitumor activity. It was hypothesized that replacement of the two methoxyl groups with a nitro substituent would allow for retention of similar activity. In this study 8-, 9-, and 10-nitro-5H-2,3-methylenedioxy-5-(2-N,N-dimethylaminoethyl)dibenzo[c,h][1,6]naphthyridin-6-one and their amino derivatives were synthesized and assessed for their relative TOP1-targeting activity and cytotoxicity. In the case of both the 8- and 9-nitro analogues, their TOP1-targeting activity and cytotoxicity are greater than that of camptothecin and comparable to that of 5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)-2,3-methylenedioxydibenzo[c,h][1,6]naphthyridin-6-one.\n",
            "56881\n",
            "TOP-1 mediated DNA cleavage measured as effective concentration relative to topotecan = 1\n",
            "Title: Diaza- and triazachrysenes: potent topoisomerase-targeting agents with exceptional antitumor activity against the human tumor xenograft, MDA-MB-435.  Abstract: Several 5,12-diazachrysen-6-ones and 5,6,11-triazachrysen-12-ones were synthesized with varied substituents at the 5- or 11-position, respectively. Each compound was evaluated for its potential to stabilize the cleavable complex formed with TOP1 and DNA. Two analogues with very potent TOP1-targeting activity, 3a and 4a, exhibited cytotoxic activity with IC(50) values at or below 2nM against RPMI8402. Compound 3a was active in vivo by either ip or po administration in the human tumor xenograft athymic nude mice model.\n",
            "56882\n",
            "Stimulation of pKMp27 DNA cleavage by human DNA topoisomerase I in presence of 0.1 uM of compound\n",
            "Title: Topoisomerase I-mediated antiproliferative activity of enantiomerically pure fluorinated homocamptothecins.  Abstract: Homocamptothecin (hCPT) is an E-ring modified camptothecin (CPT) analogue bearing a methylene spacer between the alcohol and carboxyl functions of the CPT lactone. Combining pronounced inhibitory activity of topoisomerase I (Topo I) with enhanced plasma stability, hCPT constitutes an attractive template for the elaboration of new anticancer agents. Fluorinated hCPT analogues, prepared in enantiomerically pure form, were assayed by their stimulation of Topo I-mediated DNA cleavage. Translation into cytotoxicity against tumor cells was evaluated on HT29 human colon adenocarcinoma and on the multidrug resistant lung and bladder tumor cell lines, A549 and T24r. Good correlation is observed between the ability of the drugs to stimulate Topo I-mediated DNA cleavage and the respective 50% inhibitory concentrations (IC(50) values) of the HT29, A549, and T24r cell growth. Fluorine substitution in the A-ring of hCPT was found to have a pronounced influence on biological activity, providing several compounds which are up to 100-fold more potent than CPT in terms of IC(50). Among these, 10,11-difluoro-hCPT has been selected for further development.\n",
            "56883\n",
            "Inhibitory activity against the wheat germ DNA topoisomerase I\n",
            "Title: Synthesis, topoisomerase I inhibition and structure-activity relationship study of 2,4,6-trisubstituted pyridine derivatives.  Abstract: For the development of new anticancer agents, phenyl, 2-pyridyl, 2-furyl, 2-thienyl, 2-furylvinyl and 2-thienylvinyl substituted derivatives on 2,4,6-position in pyridine moiety were prepared and evaluated for their topoisomerase I inhibitory activity. Among the thirteen prepared compounds, four compounds exhibited strong topoisomerase I inhibitory activity. A structure-activity relationship study indicated that the 2-thienyl-4-furylpyridine skeleton was important for topoisomerase I inhibitory activity.\n",
            "56884\n",
            "Relative activity against Topoisomerase I was measured at concentration of 25 uM to that of camptothecin; Inactive\n",
            "Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.\n",
            "56885\n",
            "Inhibitory activity against DNA topoisomerase I cleavage was determined at a concentration ranging up to 10 uM\n",
            "Title: Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.  Abstract: Indenoisoquinolines and dihydroindenoisoquinolines have been synthesized possessing a nitro-substituted isoquinoline ring in an effort to explore the effects of electron-withdrawing substituents on biological activity. The in vitro anticancer activities of these molecules have been tested in the National Cancer Institute's screen of 55 cell lines. The compounds have also been tested for topoisomerase I (top1) inhibition. The results indicate that these substances are a potent class of top1 inhibitors with sub-micromolar cytotoxicity mean graph midpoints (MGM) and top1 inhibition equal to camptothecin.\n",
            "56886\n",
            "Inhibitory activity against DNA topoisomerase I cleavage was determined at a concentration ranging up to 10uM; '+' indicates weak activity\n",
            "Title: Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.  Abstract: Indenoisoquinolines and dihydroindenoisoquinolines have been synthesized possessing a nitro-substituted isoquinoline ring in an effort to explore the effects of electron-withdrawing substituents on biological activity. The in vitro anticancer activities of these molecules have been tested in the National Cancer Institute's screen of 55 cell lines. The compounds have also been tested for topoisomerase I (top1) inhibition. The results indicate that these substances are a potent class of top1 inhibitors with sub-micromolar cytotoxicity mean graph midpoints (MGM) and top1 inhibition equal to camptothecin.\n",
            "56887\n",
            "Inhibitory activity against DNA topoisomerase I cleavage was determined at a concentration ranging up to 10 uM; ''++'' indicates similar activity as the parent compound 25\n",
            "Title: Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.  Abstract: Indenoisoquinolines and dihydroindenoisoquinolines have been synthesized possessing a nitro-substituted isoquinoline ring in an effort to explore the effects of electron-withdrawing substituents on biological activity. The in vitro anticancer activities of these molecules have been tested in the National Cancer Institute's screen of 55 cell lines. The compounds have also been tested for topoisomerase I (top1) inhibition. The results indicate that these substances are a potent class of top1 inhibitors with sub-micromolar cytotoxicity mean graph midpoints (MGM) and top1 inhibition equal to camptothecin.\n",
            "56888\n",
            "Inhibitory activity against DNA topoisomerase I cleavage was determined at a concentration ranging up to 10 uM; ''+++'' indicates greater activity than the parent compound 25\n",
            "Title: Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.  Abstract: Indenoisoquinolines and dihydroindenoisoquinolines have been synthesized possessing a nitro-substituted isoquinoline ring in an effort to explore the effects of electron-withdrawing substituents on biological activity. The in vitro anticancer activities of these molecules have been tested in the National Cancer Institute's screen of 55 cell lines. The compounds have also been tested for topoisomerase I (top1) inhibition. The results indicate that these substances are a potent class of top1 inhibitors with sub-micromolar cytotoxicity mean graph midpoints (MGM) and top1 inhibition equal to camptothecin.\n",
            "56889\n",
            "Inhibitory activity against DNA topoisomerase I cleavage was determined at a concentration ranging uM camptothecin\n",
            "Title: Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.  Abstract: Indenoisoquinolines and dihydroindenoisoquinolines have been synthesized possessing a nitro-substituted isoquinoline ring in an effort to explore the effects of electron-withdrawing substituents on biological activity. The in vitro anticancer activities of these molecules have been tested in the National Cancer Institute's screen of 55 cell lines. The compounds have also been tested for topoisomerase I (top1) inhibition. The results indicate that these substances are a potent class of top1 inhibitors with sub-micromolar cytotoxicity mean graph midpoints (MGM) and top1 inhibition equal to camptothecin.\n",
            "56890\n",
            "Inhibitory activity against DNA topoisomerase I cleavage was determined at a concentration ranging up to 10 uM; ''+/-'' No description in the article\n",
            "Title: Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.  Abstract: Indenoisoquinolines and dihydroindenoisoquinolines have been synthesized possessing a nitro-substituted isoquinoline ring in an effort to explore the effects of electron-withdrawing substituents on biological activity. The in vitro anticancer activities of these molecules have been tested in the National Cancer Institute's screen of 55 cell lines. The compounds have also been tested for topoisomerase I (top1) inhibition. The results indicate that these substances are a potent class of top1 inhibitors with sub-micromolar cytotoxicity mean graph midpoints (MGM) and top1 inhibition equal to camptothecin.\n",
            "56891\n",
            "Inhibitory activity against DNA topoisomerase I cleavage was determined at a concentration ranging up to 10 uM; NT- Not tested\n",
            "Title: Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.  Abstract: Indenoisoquinolines and dihydroindenoisoquinolines have been synthesized possessing a nitro-substituted isoquinoline ring in an effort to explore the effects of electron-withdrawing substituents on biological activity. The in vitro anticancer activities of these molecules have been tested in the National Cancer Institute's screen of 55 cell lines. The compounds have also been tested for topoisomerase I (top1) inhibition. The results indicate that these substances are a potent class of top1 inhibitors with sub-micromolar cytotoxicity mean graph midpoints (MGM) and top1 inhibition equal to camptothecin.\n",
            "56892\n",
            "Inhibitory activity against Topoisomerase I was determined by the supercoiled DNA unwinding assay method; Greater activity than Camptothecin\n",
            "Title: Synthesis of new 3-arylisoquinolinamines: effect on topoisomerase I inhibition and cytotoxicity.  Abstract: To investigate the structure-activity relationships of 3-arylisoquinolines, diverse substituted 3-aryisoquinolinamines were synthesized and tested in vitro antitumor activity against four tumor cell lines. Some of the compounds showed potent topoisomerase I inhibitory activity. Docking study of 7d with topoisomerase I-DNA complex was also performed.\n",
            "56893\n",
            "Inhibitory activity against Topoisomerase I was determined by the supercoiled DNA unwinding assay method; NT=not tested\n",
            "Title: Synthesis of new 3-arylisoquinolinamines: effect on topoisomerase I inhibition and cytotoxicity.  Abstract: To investigate the structure-activity relationships of 3-arylisoquinolines, diverse substituted 3-aryisoquinolinamines were synthesized and tested in vitro antitumor activity against four tumor cell lines. Some of the compounds showed potent topoisomerase I inhibitory activity. Docking study of 7d with topoisomerase I-DNA complex was also performed.\n",
            "56894\n",
            "Inhibitory activity against Topoisomerase I in supercoiled DNA unwinding assay method; Weak activity\n",
            "Title: Synthesis of new 3-arylisoquinolinamines: effect on topoisomerase I inhibition and cytotoxicity.  Abstract: To investigate the structure-activity relationships of 3-arylisoquinolines, diverse substituted 3-aryisoquinolinamines were synthesized and tested in vitro antitumor activity against four tumor cell lines. Some of the compounds showed potent topoisomerase I inhibitory activity. Docking study of 7d with topoisomerase I-DNA complex was also performed.\n",
            "56895\n",
            "Inhibitory activity against Topoisomerase I was determined by the supercoiled DNA unwinding assay method; similar activity as the camptothecin\n",
            "Title: Synthesis of new 3-arylisoquinolinamines: effect on topoisomerase I inhibition and cytotoxicity.  Abstract: To investigate the structure-activity relationships of 3-arylisoquinolines, diverse substituted 3-aryisoquinolinamines were synthesized and tested in vitro antitumor activity against four tumor cell lines. Some of the compounds showed potent topoisomerase I inhibitory activity. Docking study of 7d with topoisomerase I-DNA complex was also performed.\n",
            "56896\n",
            "Inhibitory concentration against relaxation activity of DNA topoisomerase I by detecting the conversion of supercoiled pBR322 DNA to its relaxed form\n",
            "Title: Inhibitory activities against topoisomerase I and II by polyhydroxybenzoyl amide derivatives and their structure-activity relationship.  Abstract: o-, m-, p-Phenylenediamines having 2,3,4-trihydroxy, 3,4 dihydroxy, and 4-hydroxybenzoyl moieties were prepared and their inhibitory activities were measured against topoisomerase I and II. More hydroxy groups on two aromatic rings increased the activities. Bis(trihydroxybenzoyl)-o-phenylenediamide showed IC(50)=0.90 and 0.09 microM against topoisomerase I and II, respectively. Compounds with hydroxy groups protected by acetyl moiety still had the activities. Less hydroxy groups decreased their activities. Benzothiazole derivatives also indicated the activities.\n",
            "56897\n",
            "Inhibition of relaxation activities of DNA topoisomerase I with respect to pBR322 DNA\n",
            "Title: Inhibitory activities against topoisomerase I and II by polyhydroxybenzoyl amide derivatives and their structure-activity relationship.  Abstract: o-, m-, p-Phenylenediamines having 2,3,4-trihydroxy, 3,4 dihydroxy, and 4-hydroxybenzoyl moieties were prepared and their inhibitory activities were measured against topoisomerase I and II. More hydroxy groups on two aromatic rings increased the activities. Bis(trihydroxybenzoyl)-o-phenylenediamide showed IC(50)=0.90 and 0.09 microM against topoisomerase I and II, respectively. Compounds with hydroxy groups protected by acetyl moiety still had the activities. Less hydroxy groups decreased their activities. Benzothiazole derivatives also indicated the activities.\n",
            "56898\n",
            "The activity was examined against DNA topoisomerase I mediated DNA cleavage using 3''-End-labelled 161 BP plasmid DNA. + indicates between 20 and 50% of the activity of 1 uM camptothecin\n",
            "Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.\n",
            "56899\n",
            "The activity was examined against DNA topoisomerase I mediated DNA cleavage using 3''-End-labelled 161 BP plasmid DNA. + indicates between 20 and 50% of the activity of 1 uM camptothecin\n",
            "Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.\n",
            "56900\n",
            "The activity was examined against DNA topoisomerase I mediated DNA cleavage using 3''-End-labelled 161 BP plasmid DNA. ++ indicates greater than 50% of the activity 0f 1 uM camptothecin\n",
            "Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.\n",
            "56901\n",
            "The activity was examined against DNA topoisomerase I mediated DNA cleavage using 3''-End-labelled 161 BP plasmid DNA. ++ indicates greater than 50% of the activity of 1 uM camptothecin\n",
            "Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.\n",
            "57032\n",
            "The activity was examined against DNA topoisomerase I mediated DNA cleavage using 3''-End-labelled 161 BP plasmid DNA. +/- indicates less than 20% of the activity 0f 1 uM camptothecin\n",
            "Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.\n",
            "57033\n",
            "The activity was examined against DNA topoisomerase I mediated DNA cleavage using 3''-End-labelled 161 BP plasmid DNA. +/- indicates less than 20% of the activity of 1 uM camptothecin\n",
            "Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.\n",
            "57034\n",
            "The activity was examined against DNA topoisomerase I mediated DNA cleavage using 3''-End-labelled 161 BP plasmid DNA. +/- less than 20% of the activity 0f 1 uM camptothecin\n",
            "Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.\n",
            "57035\n",
            "The activity was examined against DNA topoisomerase I mediated DNA cleavage using 3'-End-labelled 161 BP plasmid DNA. 0 indicates inactive\n",
            "Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.\n",
            "57036\n",
            "The activity was examined against DNA topoisomerase I mediated DNA cleavage using 3'-End-labelled 161 BP plasmid DNA. 0 indicates inactive\n",
            "Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.\n",
            "57037\n",
            "The activity was examined against DNA topoisomerase I mediated DNA cleavage using 3''-End-labelled 161 BP plasmid DNA.+ indicates between 20 and 50% of the activity of 1 uM camptothecin\n",
            "Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.\n",
            "57038\n",
            "The activity was examined against DNA topoisomerase I mediated DNA cleavage using 3''-End-labelled 161 BP plasmid DNA.++ indicates greater than 50% of the activity of 1 uM camptothecin\n",
            "Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.\n",
            "57039\n",
            "The activity was examined against DNA topoisomerase I mediated DNA cleavage using 3''-End-labelled 161 BP plasmid DNA.+/- indicates less than 20% of the activity of 1 uM camptothecin\n",
            "Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.\n",
            "57040\n",
            "The activity was examined against DNA topoisomerase I mediated DNA cleavage using 3'-End-labelled 161 BP plasmid DNA.0 indicates inactive\n",
            "Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.\n",
            "57041\n",
            "The activity was examined against DNA topoisomerase I mediated DNA cleavage using 3''-End-labelled 161 BP plasmid DNA; + indicates between 20 and 50% of the activity 0f 1 uM camptothecin\n",
            "Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.\n",
            "57042\n",
            "The activity was examined against DNA topoisomerase I mediated DNA cleavage using 3''-End-labelled 161 BP plasmid DNA; +/- less than 20% of the activity of 1 uM camptothecin\n",
            "Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.\n",
            "57043\n",
            "The activity was examined against DNA topoisomerase I mediated DNA cleavage using 3'-End-labelled 161 BP plasmid DNA; 0 indicates inactive\n",
            "Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.\n",
            "210938\n",
            "Effect on Topo-I-mediated relaxation of supercoiled pUC19 plasmid DNA in calf thymus at 100 uM\n",
            "Title: Homocamptothecins: synthesis and antitumor activity of novel E-ring-modified camptothecin analogues.  Abstract: Homocamptothecin (hCPT), a camptothecin (CPT) analogue with a seven membered beta-hydroxylactone which combines enhanced plasma stability and potent topoisomerase I (Topo I)-mediated activity, is an attractive template for the elaboration of new anticancer agents. Like CPT, hCPT carries an asymmetric tertiary alcohol and displays stereoselective inhibition of Topo I. The preparation and biological screening of racemic hCPT analogues are described. The 10 hCPTs tested were better Topo I inhibitors than CPT. Fluorinated hCPTs 23c, d,f,g were found to have potent cytotoxic activity on A427 and PC-3 tumor cell lines. Their cytotoxicity remained high on the K562adr and MCF7mdr cell lines, which overexpress a functionally active P-glycoprotein. Fluorinated hCPTs were more efficacious in vivo than CPT on HT-29 xenografts. In this model, a tumor growth delay of 25 days was reached with hCPT 23g at a daily dose of 0.32 mg/kg, compared to 4 days with CPT at 0.625 mg/kg. Thus difluorinated hCPT 23g warrants further investigation as a novel Topo I inhibitor with high cytotoxicity toward tumor cells and promising in vivo efficacy.\n",
            "210939\n",
            "Concentration that produces 50% DNA cleavage mediated by topoisomerase I; neg= negative is no enzyme mediated DNA cleavage at the highest conc tested at 50 uM\n",
            "Title: Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity.  Abstract: Several camptothecin derivatives containing a modified hydroxy lactone ring have been synthesized and evaluated for inhibition of topoisomerase I and cytotoxicity to mammalian cells. Each of the groups of the hydroxy lactone moiety, the carbonyl oxygen, the ring lactone oxygen, and the 20-hydroxy group, were shown to be critical for enzyme inhibition. For example the lactol, lactam, thiolactone, and 20-deoxy derivatives did not stabilize the covalent DNA-topoisomerase I complex. With a few exceptions, those compounds that did not inhibit topoisomerase I were not cytotoxic to mammalian cells. Two cytotoxic derivatives that did not inhibit topoisomerase I were shown to produce non-protein-associated DNA single-strand breaks and are likely to have a different mechanism of action. One of these compounds was tested for antitumor activity and was found to be inactive. The present findings, as well as other reports that the hydroxy lactone ring of camptothecin is critical for antitumor activity in vivo, correlate with the structure-activity relationships at the level of topoisomerase I and support the hypothesis that antitumor activity is related to inhibition of this target enzyme.\n",
            "210940\n",
            "Ability (200 uM) to satbilize DNA-topoisomerase (from calf) I-compound ternary complex was determined; not active\n",
            "Ability (200 uM) to satbilize DNA-topoisomerase (from calf) I-compound ternary complex was determined; not active\n",
            "210941\n",
            "Ability to satbilize DNA-topoisomerase (from calf) I-compound ternary complex was determined\n",
            "Ability to satbilize DNA-topoisomerase (from calf) I-compound ternary complex was determined\n",
            "210942\n",
            "Ability to inhibit calf thymus topoisomerase I when assayed in the cleavable complex formation\n",
            "Ability to inhibit calf thymus topoisomerase I when assayed in the cleavable complex formation\n",
            "210943\n",
            "Compound was evaluated for in vitro percent inhibition of purified calf thymus topoisomerase I at 100 uM\n",
            "Compound was evaluated for in vitro percent inhibition of purified calf thymus topoisomerase I at 100 uM\n",
            "210944\n",
            "Inhibition of calf thymus Topoisomerase-I\n",
            "Title: Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group.  Abstract: As a part of studies on structure-activity relationships, several potential topoisomerase I inhibitors were prepared. Different analogues of the antitumor antibiotic rebeccamycin substituted on the imide nitrogen with a methyl group were synthesized. These compounds bore either the sugar residue of rebeccamycin, with or without the chlorine atoms on the indole moieties, or modified sugar residues (galactopyranosyl, glucopyranosyl, or fucopyranosyl) linked to the aglycone via a beta- or alpha-N-glycosidic bond. Their inhibitory properties toward protein kinase C, topoisomerase I, and topoisomerase II were examined, and their DNA-binding properties were investigated. Their in vitro antitumor activities against murine B16 melanoma and P388 leukemia cells were determined. Their antimicrobial activities were tested against Gram-positive bacteria Bacillus cereus and Streptomyces chartreusis, Gram-negative bacterium Escherichia coli, and yeast Candida albicans. These compounds are inactive toward topoisomerase II but inhibit topoisomerase I. A substitution with a methyl group on the imide nitrogen led to a loss of proteine kinase C inhibition in the maleimide indolocarbazole series but did not prevent topoisomerase I inhibition. Compounds possessing a beta-N-glycosidic bond, which fully intercalated into DNA, were more efficient at inhibiting topoisomerase I than their analogues with an alpha-N-glycosidic bond; however, both were equally toxic toward P388 leukemia cells. Dechlorinated rebeccamycin possessing a methyl group on the imide nitrogen was about 10 times more efficient in terms of cytotoxicity and inhibition of topoisomerase I than the natural metabolite.\n",
            "210945\n",
            "Inhibition of topoisomerase I\n",
            "Title: Synthesis and evaluation of new 6-amino-substituted benzo[c]phenanthridine derivatives.  Abstract: Different 7,8,9,10-tetrahydrobenzo[c]phenanthridin-6(5H)-ones (10a-e) were prepared by using a one-pot procedure which includes the preparation of various 6- and 7-alkoxy-1-naphthylisocyanates from 1-naphthylamines and triphosgene, followed by addition of 1-N-morpholino-1-cyclohexenes, and cyclization of the resulting amides upon heating in the presence of hydrogen chloride. Subsequent aromatization, chlorination, and substitution with (dimethylamino)alkylamines, followed by a demethylation or a selective desisopropylation, allowed us to synthesize the derivatives 6a-i and 7a-h bearing a [(dimethylamino)alkyl]amino side chain at their 6-position. These compounds, as the other analogs 5a-b, were devised to further study the structure-activity relationships in the benzo[c]phenanthridine family of antitumor alkaloids led by fagaronine (1a) and nitidine (1b). Topoisomerases I and II cleavable complex assay and evaluation of the cytotoxicity and antitumor properties were performed. In vitro cytotoxicity (L1210 and Calc 18) shows a relationship between the cytotoxicity of these compounds and their topoisomerase poisoning properties. However, all these compounds were devoid of significant antitumor effect on the P388 murine leukemia system.\n",
            "210946\n",
            "Inhibition of Topoisomerase I by cleavage complex formation in human HL-60 cells\n",
            "Title: Plant antitumor agents. 30. Synthesis and structure activity of novel camptothecin analogs.  Abstract: A large number of camptothecin (CPT) analogs have been prepared in the 20S, 20RS, and 20R configurations with a number of ring A substituents. Topoisomerase I (T-I) inhibition data (IC50) have been obtained by standard procedures. In general, substitution at the 9 or 10 positions with amino, halogeno, or hydroxyl groups in compounds with 20S configuration results in compounds with enhanced T-I inhibition. Compounds in the 20RS configuration were less active in vitro and in vivo and those in the 20R configuration were inactive. Compounds with 10,11-methylenedioxy substitution on ring A displayed a marked increase in potency in the T-I inhibition assay. The activities of some of the analogs as determined in a variety of in vivo assays including the L-1210 mouse leukemia assay were, in general, in accord with T-I inhibition. A number of water-soluble analogs such as 20-glycinate esters, 9-glycinamides, or hydrolyzed lactone salts were prepared and tested in in vitro and in vivo assays. In general, these compounds were less active than CPT both in terms of T-I inhibition and life prolongation in the L-1210 assay. However, certain 20-glycinate esters showed good in vivo activity after iv administration.\n",
            "210947\n",
            "Inhibition of Topoisomerase I by cleavage complex formation in intact human HL-60 cells\n",
            "Title: Plant antitumor agents. 30. Synthesis and structure activity of novel camptothecin analogs.  Abstract: A large number of camptothecin (CPT) analogs have been prepared in the 20S, 20RS, and 20R configurations with a number of ring A substituents. Topoisomerase I (T-I) inhibition data (IC50) have been obtained by standard procedures. In general, substitution at the 9 or 10 positions with amino, halogeno, or hydroxyl groups in compounds with 20S configuration results in compounds with enhanced T-I inhibition. Compounds in the 20RS configuration were less active in vitro and in vivo and those in the 20R configuration were inactive. Compounds with 10,11-methylenedioxy substitution on ring A displayed a marked increase in potency in the T-I inhibition assay. The activities of some of the analogs as determined in a variety of in vivo assays including the L-1210 mouse leukemia assay were, in general, in accord with T-I inhibition. A number of water-soluble analogs such as 20-glycinate esters, 9-glycinamides, or hydrolyzed lactone salts were prepared and tested in in vitro and in vivo assays. In general, these compounds were less active than CPT both in terms of T-I inhibition and life prolongation in the L-1210 assay. However, certain 20-glycinate esters showed good in vivo activity after iv administration.\n",
            "210948\n",
            "The compound was tested for top1-induced DNA cleavage activity; + indicates comparable to CPT\n",
            "Title: Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.  Abstract: The present studies provide a three-dimensional model for the postulated ternary cleavable complex of topoisomerase I (top1), DNA, and camptothecin (CPT). Molecular simulations were done using the AMBER force field. The results suggest that a ternary cleavable complex might be stabilized by several hydrogen bonds in the binding site. In this proposed \"drug-stacking\" model, CPT is pseudointercalated in the top1-linked DNA cleavage site and interacts with the protein near its catalytic tyrosine through hydrogen bonding and stacking. The structural model is consistent with the following experimental observations: (i) the N3 position of the 5' terminal purine of the cleaved DNA strand is readily alkylated by 7-chloromethyl 10,11-methylenedioxy CPT; (ii) CPT generally tolerates substituents at positions 7, 9, and 10 but is inactivated by additions at position 12; (iii) 10,11-methylenedioxy (MDO) CPT is much more potent than 10,11-dimethoxy (DMO) CPT; (iv) the lactone portion of CPT is essential for top1 inhibitory activity; (v) 20S derivatives of CPT are much more potent than the 20R analogues; (vi) a catalytic tyrosine hydroxyl in top1 covalently links to the 3' terminal base, T, of the cleaved DNA strand; and (vii) top1 mutation Asn722Ser leads to CPT resistance. A total of 18 camptothecin derivatives with different DNA cleavage potencies were docked into the hypothetical cleavable complex binding site to test and refine the model. These studies provide insight into a possible mechanism of top1 inhibition by CPT derivatives and suggest rational approaches for the design of new CPT derivatives.\n",
            "210949\n",
            "The compound was tested for top1-induced DNA cleavage activity; ++ indicates more potent than CPT\n",
            "Title: Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.  Abstract: The present studies provide a three-dimensional model for the postulated ternary cleavable complex of topoisomerase I (top1), DNA, and camptothecin (CPT). Molecular simulations were done using the AMBER force field. The results suggest that a ternary cleavable complex might be stabilized by several hydrogen bonds in the binding site. In this proposed \"drug-stacking\" model, CPT is pseudointercalated in the top1-linked DNA cleavage site and interacts with the protein near its catalytic tyrosine through hydrogen bonding and stacking. The structural model is consistent with the following experimental observations: (i) the N3 position of the 5' terminal purine of the cleaved DNA strand is readily alkylated by 7-chloromethyl 10,11-methylenedioxy CPT; (ii) CPT generally tolerates substituents at positions 7, 9, and 10 but is inactivated by additions at position 12; (iii) 10,11-methylenedioxy (MDO) CPT is much more potent than 10,11-dimethoxy (DMO) CPT; (iv) the lactone portion of CPT is essential for top1 inhibitory activity; (v) 20S derivatives of CPT are much more potent than the 20R analogues; (vi) a catalytic tyrosine hydroxyl in top1 covalently links to the 3' terminal base, T, of the cleaved DNA strand; and (vii) top1 mutation Asn722Ser leads to CPT resistance. A total of 18 camptothecin derivatives with different DNA cleavage potencies were docked into the hypothetical cleavable complex binding site to test and refine the model. These studies provide insight into a possible mechanism of top1 inhibition by CPT derivatives and suggest rational approaches for the design of new CPT derivatives.\n",
            "211091\n",
            "The compound was tested for top1-induced DNA cleavage activity; +++ indicates much more potent than CPT\n",
            "Title: Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.  Abstract: The present studies provide a three-dimensional model for the postulated ternary cleavable complex of topoisomerase I (top1), DNA, and camptothecin (CPT). Molecular simulations were done using the AMBER force field. The results suggest that a ternary cleavable complex might be stabilized by several hydrogen bonds in the binding site. In this proposed \"drug-stacking\" model, CPT is pseudointercalated in the top1-linked DNA cleavage site and interacts with the protein near its catalytic tyrosine through hydrogen bonding and stacking. The structural model is consistent with the following experimental observations: (i) the N3 position of the 5' terminal purine of the cleaved DNA strand is readily alkylated by 7-chloromethyl 10,11-methylenedioxy CPT; (ii) CPT generally tolerates substituents at positions 7, 9, and 10 but is inactivated by additions at position 12; (iii) 10,11-methylenedioxy (MDO) CPT is much more potent than 10,11-dimethoxy (DMO) CPT; (iv) the lactone portion of CPT is essential for top1 inhibitory activity; (v) 20S derivatives of CPT are much more potent than the 20R analogues; (vi) a catalytic tyrosine hydroxyl in top1 covalently links to the 3' terminal base, T, of the cleaved DNA strand; and (vii) top1 mutation Asn722Ser leads to CPT resistance. A total of 18 camptothecin derivatives with different DNA cleavage potencies were docked into the hypothetical cleavable complex binding site to test and refine the model. These studies provide insight into a possible mechanism of top1 inhibition by CPT derivatives and suggest rational approaches for the design of new CPT derivatives.\n",
            "211092\n",
            "The compound was tested for top1-induced DNA cleavage activity; - indicates inactive\n",
            "Title: Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.  Abstract: The present studies provide a three-dimensional model for the postulated ternary cleavable complex of topoisomerase I (top1), DNA, and camptothecin (CPT). Molecular simulations were done using the AMBER force field. The results suggest that a ternary cleavable complex might be stabilized by several hydrogen bonds in the binding site. In this proposed \"drug-stacking\" model, CPT is pseudointercalated in the top1-linked DNA cleavage site and interacts with the protein near its catalytic tyrosine through hydrogen bonding and stacking. The structural model is consistent with the following experimental observations: (i) the N3 position of the 5' terminal purine of the cleaved DNA strand is readily alkylated by 7-chloromethyl 10,11-methylenedioxy CPT; (ii) CPT generally tolerates substituents at positions 7, 9, and 10 but is inactivated by additions at position 12; (iii) 10,11-methylenedioxy (MDO) CPT is much more potent than 10,11-dimethoxy (DMO) CPT; (iv) the lactone portion of CPT is essential for top1 inhibitory activity; (v) 20S derivatives of CPT are much more potent than the 20R analogues; (vi) a catalytic tyrosine hydroxyl in top1 covalently links to the 3' terminal base, T, of the cleaved DNA strand; and (vii) top1 mutation Asn722Ser leads to CPT resistance. A total of 18 camptothecin derivatives with different DNA cleavage potencies were docked into the hypothetical cleavable complex binding site to test and refine the model. These studies provide insight into a possible mechanism of top1 inhibition by CPT derivatives and suggest rational approaches for the design of new CPT derivatives.\n",
            "211093\n",
            "Inhibition of human Topoisomerase I\n",
            "Title: Syntheses and biological evaluation of indolocarbazoles, analogues of rebeccamycin, modified at the imide heterocycle.  Abstract: A series of 10 indolocarbazole derivatives, analogues to the antitumor antibiotic rebeccamycin, bearing modifications at the imide heterocycle were synthesized. They bear an N-methyl imide, N-methyl amide, or anhydride function instead of the original imide. Their inhibitory potencies toward topoisomerase I were examined using a DNA relaxation assay and by analyzing the drug-induced cleavage of 32P-labeled DNA. Protein kinase C (PKC) inhibition and interaction with DNA were also studied together with the in vitro antiproliferative activities against B16 melanoma and P388 leukemia cells. The antimicrobial activities against two Gram-positive bacteria (Bacillus cereus and Streptomyces chartreusis), a Gram-negative bacterium (Escherichia coli), and a yeast (Candida albicans) were tested as well as their antiviral activities toward HIV-1. The efficiency of the anhydride compounds was compared to that of the parent compound rebeccamycin and its dechlorinated analogue. All the compounds studied were inactive against PKC. The structural requirements for PKC and topoisomerase I inhibition are markedly different. In sharp contrast with the structure-PKC inhibition relationships, we found that an anhydride function does not affect topoisomerase I inhibition, whereas a methyl group on the indole nitrogen prevents the poisoning of topoisomerase I. The compounds exhibiting a marked toxicity to P388 leukemia cells had little or no effect on the growth of P388CPT5 cells which are resistant to the topoisomerase I inhibitor camptothecin. This study reinforces the conclusion that the DNA-topoisomerase I cleavable complex is the primary cellular target of the indolocarbazoles and significantly contributes to their cytotoxicity and possibly to their weak but noticeable anti-HIV-1 activities. The structure-activity relationships are also discussed.\n",
            "211094\n",
            "Topoisomerase I mediated DNA cleavage\n",
            "Title: Terbenzimidazoles: influence of 2\"-, 4-, and 5-substituents on cytotoxicity and relative potency as topoisomerase I poisons.  Abstract: Terbenzimidazoles poison the nuclear enzyme topoisomerase I and possess significant cytotoxic activity against several human tumor cell lines. The relative pharmacological activity of 4,5- and 5,6-benzoterbenzimidazoles was compared to that of 5-phenylterbenzimidazole (3). 5,6-Benzoterbenzimidazole is inactive as a topoisomerase I poison and did not exhibit significant cytotoxic activity. In contrast, 4,5-benzoterbenzimidazole retained activity as a topoisomerase I poison but exhibited weak cytotoxic activity relative to 3. While 5-(1-naphthyl)terbenzimidazole is less potent than 3 as a topoisomerase I poison and cytotoxic agent, 5-(2-naphthyl)-terbenzimidazole has comparable activity to 3. The presence of a p-methoxy or p-chloro substituent on the phenyl moiety did not dramatically alter the pharmacological activity of 3. Several analogs of 3 were synthesized wherein the 2\"-substituent varied from methyl, ethyl, propyl, isopropyl, phenyl to p-methoxyphenyl. Evaluation of the intrinsic activity of these analogs as topoisomerase I poisons indicates that topoisomerase I poisoning was not diminished by the presence of a methyl, ethyl, propyl, and isopropyl substituent at the 2\"-position. Among the various 2\"-substituted analogs evaluated, only in the case of 2\"-(p-methoxyphenyl)-5-phenylterbenzimidazole was a significant decrease in cytotoxicity observed.\n",
            "211095\n",
            "Relative effective concentration that produces the same degree of cleavage on the plasmid DNA in the presence of human topoisomerase-1\n",
            "Title: Heterocyclic bibenzimidazole derivatives as topoisomerase I inhibitors.  Abstract: A series of 2'-heterocyclic derivatives of 5-phenyl-2,5'-1H-bibenzimidazoles were evaluated for topoisomerase I poisoning activity and cytotoxicity. Topo I poisoning activity was associated with 2'-derivatives that possessed a hydrogen atom capable of hydrogen bond formation, suggesting that the interatomic distances between such hydrogen atoms and the heteroatoms on the adjacent benzimidazole influence activity.\n",
            "211097\n",
            "Inhibitory effect on topoisomerase-1 mediated DNA cleavage using supercoiled pBR322 plasmid DNA\n",
            "Title: Synthesis and biological activities of NB-506 analogues modified at the glucose group.  Abstract: A new indolocarbazole compound, NB-506 (1), modified at the glucose group yielded a beta-D-glucopyranoside, J-107,088 (2), which showed potent anticancer activity. A beta-D-ribofuranoside, J-109,534 (3), was found to be 6 times more potent than J-107,088 at inhibiting topoisomerase I.\n",
            "211098\n",
            "In vitro inhibition of Topoisomerase I-mediated DNA cleavage using supercoiled pBR322 plasmid DNA.\n",
            "Title: Synthesis and biological activities of NB-506 analogues: Effects of the positions of two hydroxyl groups at the indole rings.  Abstract: In the course of a study of 6-N-amino-substituted analogues of NB-506 (1), a more potent anticancer drug, J-109,404 (2), in which the formyl group of NB-506 was replaced with a 1,3-dihydroxypropane group, was reported. A study of further modification in the positions of two hydroxyl groups at the indole rings of 2 resulted in the discovery of a 2,10-dihydroxy analogue, J-107,088 (3), which is a promising anticancer agent with a broader therapeutic window than J-109,404.\n",
            "211099\n",
            "Compound was tested in vitro for inhibition of topoisomerase I.\n",
            "Compound was tested in vitro for inhibition of topoisomerase I.\n",
            "211100\n",
            "Inhibit supercoil relaxation property of topoisomerase I.\n",
            "Title: Camptothecin and minor-groove binder hybrid molecules: synthesis, inhibition of topoisomerase I, and anticancer cytotoxicity in vitro.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of 14 camptothecin derivatives of polypyrrolecarboxamide (lexitropsin) conjugates of two structural classes: (A) camptothecin-NHCO-lexitropsin 44-51 and (B) camptothecin-CONH-lexitropsin 38-43 are described. All 16 compounds tested, 14 conjugates plus two functionalized camptothecin controls, inhibit topoisomerase I in the concentration range 1.12-16.6 microM that divide into three distinct categories based on activity. The most active enzyme inhibitors belong to structure class A with either cationic dimethylaminium or neutral amide end groups. Generally class B conjugates are less effective in inhibiting topoisomerase I. Cytotoxic potencies of the drugs was tested against four representative human tumor cell lines: SKOV3, SKLVB, HT29, and KB. All 16 drugs gave measurable IC50 values against the KB cell line and fell into two categories with IC50 values of 0.049-0.66 microM (largely structure class B) and 1.0-48 microM (largely class A). Thus the class B conjugates, while less potent against the enzyme, contain two of the most potent drugs, 38 and 39, against KB cell lines. In contrast, in the case of the cell lines SKOV3 and HT29 there was a general correlation between the better topoisomerase inhibitors and their cell cytotoxicities.\n",
            "211101\n",
            "Concentration required to inhibit 50% relaxation of 250 ng of SV40 DNA obtained with 0.5 I.U topoisomerase I at 37 degrees C for 30 min\n",
            "Concentration required to inhibit 50% relaxation of 250 ng of SV40 DNA obtained with 0.5 I.U topoisomerase I at 37 degrees C for 30 min\n",
            "211102\n",
            "Compound was tested for the inhibition of Topoisomerase I when administered at a dose of 25 ug/mL\n",
            "Compound was tested for the inhibition of Topoisomerase I when administered at a dose of 25 ug/mL\n",
            "211103\n",
            "In vitro inhibition against topoisomerase I activity Measured as ATP independent relaxation of supercoiled plasmid DNA compared to enzyme and DNA control reaction relative to Camptothecin (100 uM)\n",
            "Title: Antitumor agents. 185. Synthesis and biological evaluation of tridemethylthiocolchicine analogues as novel topoisomerase II inhibitors.  Abstract: Several 1,2,3-tridemethyldeacetylthiocolchicine derivatives have been synthesized and evaluated for cytotoxic activity against various human tumor cell lines and for their inhibitory effects on DNA topoisomerases in vitro. Exhaustive demethylation of thiocolchicine analogues completely changes their biological profiles. Instead of displaying antitubulin activity, most target compounds inhibited topoisomerase II activity. Only compounds with a larger side chain, such as 15a, 23a, and 24a, did not interfere with topoisomerase II enzymatic functions. The cytotoxicity of target compounds was reduced by 3 orders of magnitude compared to that of colchicine in most cell lines. The hydrophilicity of phenolic compounds might prevent drug passage through the cell plasma membrane and, thus, be responsible for the relatively weak cytotoxicity. To test this hypothesis, 27-30 were prepared from 16a by protecting all hydroxy groups with esters with an aim to facilitate drug transportation. In vitro cytotoxicity assays indicated that 27 was more potent than its parent compound in all tested tumor cell lines and showed tissue selective cytotoxicity with a significant inhibitory effect against KB cells (IC50 = 2.7 microg/mL). Therefore, we propose that 27 acts as a prodrug, liberating 16a to exert its antitopoisomerase activity and, finally, to cause cell death.\n",
            "211104\n",
            "In vitro inhibitory activity at 100 uM against topoisomerase I measured as ATP-dependent unknotting of P4 DNA compared to enzyme and DNA control.\n",
            "Title: Antitumor agents. 185. Synthesis and biological evaluation of tridemethylthiocolchicine analogues as novel topoisomerase II inhibitors.  Abstract: Several 1,2,3-tridemethyldeacetylthiocolchicine derivatives have been synthesized and evaluated for cytotoxic activity against various human tumor cell lines and for their inhibitory effects on DNA topoisomerases in vitro. Exhaustive demethylation of thiocolchicine analogues completely changes their biological profiles. Instead of displaying antitubulin activity, most target compounds inhibited topoisomerase II activity. Only compounds with a larger side chain, such as 15a, 23a, and 24a, did not interfere with topoisomerase II enzymatic functions. The cytotoxicity of target compounds was reduced by 3 orders of magnitude compared to that of colchicine in most cell lines. The hydrophilicity of phenolic compounds might prevent drug passage through the cell plasma membrane and, thus, be responsible for the relatively weak cytotoxicity. To test this hypothesis, 27-30 were prepared from 16a by protecting all hydroxy groups with esters with an aim to facilitate drug transportation. In vitro cytotoxicity assays indicated that 27 was more potent than its parent compound in all tested tumor cell lines and showed tissue selective cytotoxicity with a significant inhibitory effect against KB cells (IC50 = 2.7 microg/mL). Therefore, we propose that 27 acts as a prodrug, liberating 16a to exert its antitopoisomerase activity and, finally, to cause cell death.\n",
            "211105\n",
            "Binding constant was measured against inhibition of DNA relaxation by topoisomerase I at 17 uM concentration\n",
            "Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.\n",
            "211106\n",
            "Binding constant was measured against inhibition of DNA relaxation by topoisomerase I at 18 uM concentration; Not determined\n",
            "Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.\n",
            "211107\n",
            "Binding constant was measured against inhibition of DNA relaxation by topoisomerase I at 20 uM concentration\n",
            "Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.\n",
            "211108\n",
            "Binding constant was measured against inhibition of DNA relaxation by topoisomerase I at 20 uM concentration; Not determined\n",
            "Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.\n",
            "211109\n",
            "Binding constant was measured against inhibition of DNA relaxation by topoisomerase I at 9 uM concentration; Not determined\n",
            "Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.\n",
            "211110\n",
            "Compound was tested for anti microbial activity against topoisomerase I.\n",
            "Title: Synthesis, mode of action, and biological activities of rebeccamycin bromo derivatives.  Abstract: Bromo analogues of the natural metabolite rebeccamycin with and without a methyl substituent on the imide nitrogen were synthesized. The effects of the drugs on protein kinase C, the binding to DNA, and the effect on topoisomerase I were determined. The drugs' uptake and their antiproliferative activities against P388 leukemia cells sensitive and resistant to camptothecin, their antimicrobial activity against a Gram-positive bacterium (B. cereus), and their anti-HIV-1 activity were measured and compared to those of the chlorinated and dechlorinated analogues. Dibrominated imide 5 shows a remarkable activity against topoisomerase I, affecting both the kinase and DNA cleavage activity of the enzyme. The marked cytotoxic potency of this compound depends essentially on its capacity to inhibit topoisomerase I.\n",
            "211111\n",
            "Inhibition of topoisomerase-1 compared to SN-38.\n",
            "Title: Synthesis and antitumor activity of ring A- and F-modified hexacyclic camptothecin analogues.  Abstract: Nineteen ring A- and F-modified hexacyclic analogues of camptothecin were synthesized by Friedlnder condensation of appropriately substituted bicyclic amino ketones with tricyclic ketone and were evaluated for cytotoxicity and topoisomerase I inhibitory activity. Seventeen of the compounds showed cytotoxic effects comparable or superior to those of 7-ethyl-10-hydroxycamptothecin (SN-38) against mouse leukemia P388 and human tumor cell lines HOC-21 and QG-56. Introduction of a compact and inductively electron-withdrawing substituent such as a hydroxy, methoxy, chloro, or fluoro group into position 5 of ring A of the hexacyclic compound remarkably increased the antitumor activity. The potency of topoisomerase I inhibition of these compounds showed good correlation with their cytotoxicity. Among them, the 4-methyl-5-fluoro hexacyclic compound was the most potent of all and was 10 times as active as SN-38 in in vitro antitumor activity.\n",
            "211112\n",
            "Ratio of DNA relaxation times by topoisomerase in presence of 17 uM of compound (t1/e(+drug) / t 1/e(-drug)); Initial complete inhibition\n",
            "Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.\n",
            "211113\n",
            "Ratio of DNA relaxation times by topoisomerase in presence of 18 uM of compound (t1/e(+drug) / t 1/e(-drug))\n",
            "Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.\n",
            "211114\n",
            "Ratio of DNA relaxation times by topoisomerase in presence of 20 uM of compound (t1/e(+drug) / t 1/e(-drug)); Complete inhibition\n",
            "Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.\n",
            "211115\n",
            "Ratio of DNA relaxation times by topoisomerase in presence of 20 uM of compound (t1/e(+drug) / t 1/e(-drug)); Initial complete inhibition\n",
            "Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.\n",
            "211116\n",
            "Ratio of DNA relaxation times by topoisomerase in presence of 2 uM of compound (t1/e(+drug) / t 1/e(-drug))\n",
            "Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.\n",
            "211117\n",
            "Ratio of DNA relaxation times by topoisomerase in presence of 9 uM of compound (t1/e(+drug) / t 1/e(-drug))\n",
            "Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.\n",
            "224610\n",
            "In vitro activity against topoisomerase-1 mediated cleavage of supercoiled pBR322 plasmid DNA\n",
            "Title: Synthesis and biological activities of topoisomerase I inhibitors, 6-N-amino analogues of NB-506.  Abstract: 6-N-Amino analogues of NB-506 [6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13-(beta-D-glucopyranosyl) -5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione] (3b) were synthesized and tested with respect to topoisomerase inhibition, cytotoxicity and anticancer effects. Among them, a 1,3-dihydroxypropane analogue (J-109,404, 5t) showed more than ten times more potent anticancer activity in MKN-45 human stomach cancer cells implanted in mice than NB-506.\n",
            "228425\n",
            "Compound was tested for 50% DNA cleavage in presence of calf thymus topoisomerase I between hoechst 33342 and drug\n",
            "Compound was tested for 50% DNA cleavage in presence of calf thymus topoisomerase I between hoechst 33342 and drug\n",
            "228426\n",
            "Inhibition of topoisomerase I\n",
            "Title: Inhibition of topoisomerase I by naphthoquinone derivatives.  Abstract: Alkannin and shikonin are naturally occurring naphthoquinones. We have tested several derivatives of the title compounds and we have found that naphthoquinones bearing at least one phenolic hydroxyl group are potent inhibitors of topoisomerase I. The ability of the tested compounds to complex Zn++ parallels with a few exceptions their topoisomerase I inhibition properties while their intercalation and redox properties do not.\n",
            "231982\n",
            "Ratio of effective concentration for inducing single strand breaks in the DNA substrate by topoisomerase I compared to camptothecin\n",
            "Title: Design and synthesis of a fluoroindolocarbazole series as selective topoisomerase I active agents. Discovery of water-soluble 3,9-difluoro-12,13-dihydro-13-[6-amino-beta-D-glucopyranosyl]-5H,13H-benzo[b]- thienyl[2,3-a]pyrrolo[3,4-c]carbazole- 5,7(6H)-dione (BMS-251873) with curative antitumor activity against prostate carcinoma xenograft tumor model.  Abstract: A series of fluoroindolocarbazoles were studied with respect to their topoisomerase I activity, cytotoxicity, selectivity, and in vivo antitumor activity. Emerging from this series was BMS-251873, a potential clinical candidate possessing a robust pharmacological profile including curative antitumor activity against prostate carcinoma.\n",
            "232993\n",
            "Concentration formed during 5 min incubation of quinone (1 mM) with GSH (5 mM)\n",
            "Title: Naphthazarin derivatives (II): formation of glutathione conjugate, inhibition of DNA topoisomerase-I and cytotoxicity.  Abstract: 6-(1-Hydroxyalkyl)-5,8-dimethoxy-1,4-naphthoquinones, expressing a higher reactivity in conjugation with glutathione, showed a greater potency in the inhibition of DNA topoisomerase-I and the cytotoxicity against L1210 cells than 2-(1-hydroxyalkyl)-DMNQ derivatives, implying the participation of electrophilic arylation in the bioactivities. In further study 6-(1-Hydroxyalkyl)-5,8-dimethoxy-1,4-naphthoquinones with an alkyl group of shorter chain length (C2-C6) exerted a greater bioactivities than those with longer chain length(>C6).\n",
            "239726\n",
            "Michaelis constant against DNA topoisomerase I activity\n",
            "Title: Inhibitory activities against topoisomerase I and II by isoaurostatin derivatives and their structure-activity relationships.  Abstract: Isoaurostatin A (IAS-A) isolated from Thermomonospora alba showed weak inhibition against topoisomerase (topo) I (IC(50)=307microM). To get more strong inhibition, derivatives of IAS-A were prepared and their structure-activity relationships against topo I and II were investigated. The addition of hydroxyl group on aromatic rings increased the activities, 3-(3,4,5-trihydroxybenzylidene)-5-hydroxy-3H-benzofuran-2-one (IAS-9) showed strong inhibition (IC(50)=3microM) against topo I. And also, the increasing of hydroxyl group increased growth inhibition against a variety of cancer cells, and IAS-9 showed most potent inhibition. Unlike camptothecin and etoposide, IAS-9 neither stabilized DNA-topo cleavable complex nor intercalated into DNA, and it inhibited topo I and II noncompetitively. The inhibitory activities also increased by opening of lactone ring in the molecule of IAS-9.\n",
            "239852\n",
            "Relative effective concentration to cleave plasmid DNA with human topoisomerase I; compared to camptothecin=1\n",
            "Title: Dimethoxybenzo[i]phenanthridine-12-carboxylic acid derivatives and 6H-dibenzo[c,h][2,6]naphthyridin-5-ones with potent topoisomerase I-targeting activity and cytotoxicity.  Abstract: The exceptional TOP1-targeting activity and antitumor activity of ARC-111, 1, prompted studies on similarly substituted benzo[i]phenanthridine-12-carboxylic ester and amide derivatives. These studies were extended to include 6-substituted 8,9-dimethoxy-2,3-methylenedioxy-dibenzo[c,h][2,6]naphthyridin-5-ones, which represent reversed lactam analogues of 1. Several of these analogues retained the potent TOP1-targeting activity and cytotoxicity observed for ARC-111.\n",
            "240049\n",
            "Effective concentration against DNA topoisomerase I\n",
            "Title: Camptothecin analogs with bulky, hydrophobic substituents at the 7-position via a Grignard reaction.  Abstract: By developing a new synthetic procedure for introduction of side chains onto the camptothecin ring system, we were able to achieve the preparation of a number of analogs bearing bulky, hydrophobic groups directly attached to the 7-position. These include 7-tert-butylcamptothecin, 7-benzylcamptothecin and the corresponding 10,11-methylenedioxycamptothecins. This method involves the reaction of an appropriate orthoaminobenzonitrile with various Grignard reagents to give the corresponding orthoaminoketones. Friedlander condensation of the latter with the key tricyclic ketone leads to 7-substituted camptothecin analogs. We report the activity of these compounds as topoisomerase I poisons and their ability to inhibit growth of selected tumor cell lines.\n",
            "240097\n",
            "Topoisomerase I activity for single-strand breaks in the DNA substrate\n",
            "Title: Discovery of a fluoroindolo[2,3-a]carbazole clinical candidate with broad spectrum antitumor activity in preclinical tumor models superior to the marketed oncology drug, CPT-11.  Abstract: A series of fluoroglycosylated fluoroindolocarbazoles was examined with respect to their topoisomerase I activity, cytotoxicity, and selectivity. The lead clinical candidate from this series, BMS-250749, displays broad spectrum antitumor activity superior to CPT-11 against some preclinical xenograft models, including curative antitumor activity against Lewis lung carcinoma.\n",
            "240620\n",
            "Inhibitory concentration against DNA topoisomerase I activity\n",
            "Title: Inhibitory activities against topoisomerase I and II by isoaurostatin derivatives and their structure-activity relationships.  Abstract: Isoaurostatin A (IAS-A) isolated from Thermomonospora alba showed weak inhibition against topoisomerase (topo) I (IC(50)=307microM). To get more strong inhibition, derivatives of IAS-A were prepared and their structure-activity relationships against topo I and II were investigated. The addition of hydroxyl group on aromatic rings increased the activities, 3-(3,4,5-trihydroxybenzylidene)-5-hydroxy-3H-benzofuran-2-one (IAS-9) showed strong inhibition (IC(50)=3microM) against topo I. And also, the increasing of hydroxyl group increased growth inhibition against a variety of cancer cells, and IAS-9 showed most potent inhibition. Unlike camptothecin and etoposide, IAS-9 neither stabilized DNA-topo cleavable complex nor intercalated into DNA, and it inhibited topo I and II noncompetitively. The inhibitory activities also increased by opening of lactone ring in the molecule of IAS-9.\n",
            "241607\n",
            "Inhibition of topoisomerase I-DNA complex in trapping assay\n",
            "Title: Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex.  Abstract: Human topoisomerase I (top1) is the molecular target of a diverse set of anticancer compounds, including the camptothecins, indolocarbazoles, and indenoisoquinolines. These compounds bind to a transient top1-DNA covalent complex and inhibit the resealing of a single-strand nick that the enzyme creates to relieve superhelical tension in duplex DNA. (Hertzberg, R. P.; et al. Biochem. 1989, 28, 4629-4638. Hsiang, Y. H.; et al. J. Biol. Chem 1985, 260, 14873-14878. Champoux, J. J. Annu. Rev. Biochem. 2001, 70, 369-413. Stewart, L.; et al. Science 1998, 729, 1534-1541.) We report the X-ray crystal structures of the human top1-DNA complex bound with camptothecin and representative members of the indenoisoquinoline and indolocarbazole classes of top1 poisons. The planar nature of all three structurally diverse classes allows them to intercalate between DNA base pairs at the site of single-strand cleavage. All three classes of compounds have a free electron pair near Arg364, a residue that if mutated confers resistance to all three classes of drugs. The common intercalative binding mode is augmented by unexpected chemotype-specific contacts with amino acid residues Asn352 and Glu356, which adopt alternative side-chain conformations to accommodate the bound compounds. These new X-ray structures explain how very different molecules can stabilize top1-DNA covalent complexes and will aid the rational design of completely novel structural classes of anticancer drugs.\n",
            "242837\n",
            "Stability constant for DNA topoisomerase I complex in competitive DNA assay\n",
            "Title: Camptothecin analogs with bulky, hydrophobic substituents at the 7-position via a Grignard reaction.  Abstract: By developing a new synthetic procedure for introduction of side chains onto the camptothecin ring system, we were able to achieve the preparation of a number of analogs bearing bulky, hydrophobic groups directly attached to the 7-position. These include 7-tert-butylcamptothecin, 7-benzylcamptothecin and the corresponding 10,11-methylenedioxycamptothecins. This method involves the reaction of an appropriate orthoaminobenzonitrile with various Grignard reagents to give the corresponding orthoaminoketones. Friedlander condensation of the latter with the key tricyclic ketone leads to 7-substituted camptothecin analogs. We report the activity of these compounds as topoisomerase I poisons and their ability to inhibit growth of selected tumor cell lines.\n",
            "243219\n",
            "Effect on DNA breakge as nicked FormII at 1 uM with topoisomerase I\n",
            "Title: DNA topoisomerase I inhibitors from Rinorea anguifera.  Abstract: An organic extract prepared from Rinorea anguifera was investigated in order to identify the natural principle(s) responsible for stabilization of a topoisomerase I-DNA covalent binary complex. Bioassay-guided fractionation resulted in the isolation of mauritianin and (+)-syringaresinol as new topoisomerase I inhibitors, and also of the known inhibitor camptothecin.\n",
            "243220\n",
            "Effect on DNA breakge as nicked FormII at 0.25 uM with topoisomerase I\n",
            "Title: DNA topoisomerase I inhibitors from Rinorea anguifera.  Abstract: An organic extract prepared from Rinorea anguifera was investigated in order to identify the natural principle(s) responsible for stabilization of a topoisomerase I-DNA covalent binary complex. Bioassay-guided fractionation resulted in the isolation of mauritianin and (+)-syringaresinol as new topoisomerase I inhibitors, and also of the known inhibitor camptothecin.\n",
            "243221\n",
            "Effect on DNA breakge as nicked FormII at 2 uM without topoisomerase I\n",
            "Title: DNA topoisomerase I inhibitors from Rinorea anguifera.  Abstract: An organic extract prepared from Rinorea anguifera was investigated in order to identify the natural principle(s) responsible for stabilization of a topoisomerase I-DNA covalent binary complex. Bioassay-guided fractionation resulted in the isolation of mauritianin and (+)-syringaresinol as new topoisomerase I inhibitors, and also of the known inhibitor camptothecin.\n",
            "243223\n",
            "Effect on DNA breakge as nicked FormII at 100 uM without topoisomerase I\n",
            "Title: DNA topoisomerase I inhibitors from Rinorea anguifera.  Abstract: An organic extract prepared from Rinorea anguifera was investigated in order to identify the natural principle(s) responsible for stabilization of a topoisomerase I-DNA covalent binary complex. Bioassay-guided fractionation resulted in the isolation of mauritianin and (+)-syringaresinol as new topoisomerase I inhibitors, and also of the known inhibitor camptothecin.\n",
            "243224\n",
            "Effect on stabilization of human topoisomerase I-DNA covalent complex at 100 uM\n",
            "Title: DNA topoisomerase I inhibitors from Rinorea anguifera.  Abstract: An organic extract prepared from Rinorea anguifera was investigated in order to identify the natural principle(s) responsible for stabilization of a topoisomerase I-DNA covalent binary complex. Bioassay-guided fractionation resulted in the isolation of mauritianin and (+)-syringaresinol as new topoisomerase I inhibitors, and also of the known inhibitor camptothecin.\n",
            "243225\n",
            "Effect on stabilization of human topoisomerase I-DNA covalent complex at 2 uM\n",
            "Title: DNA topoisomerase I inhibitors from Rinorea anguifera.  Abstract: An organic extract prepared from Rinorea anguifera was investigated in order to identify the natural principle(s) responsible for stabilization of a topoisomerase I-DNA covalent binary complex. Bioassay-guided fractionation resulted in the isolation of mauritianin and (+)-syringaresinol as new topoisomerase I inhibitors, and also of the known inhibitor camptothecin.\n",
            "243226\n",
            "Effect on stabilization of human topoisomerase I-DNA covalent complex at 100 uM\n",
            "Title: DNA topoisomerase I inhibitors from Rinorea anguifera.  Abstract: An organic extract prepared from Rinorea anguifera was investigated in order to identify the natural principle(s) responsible for stabilization of a topoisomerase I-DNA covalent binary complex. Bioassay-guided fractionation resulted in the isolation of mauritianin and (+)-syringaresinol as new topoisomerase I inhibitors, and also of the known inhibitor camptothecin.\n",
            "243386\n",
            "Topoisomerase-I mediated DNA Cleavage activity at 30 degree C for 30 min relative to NSC 314622; Range = 25-75%\n",
            "Title: Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis.  Abstract: Several norindenoisoquinolines substituted with methoxy or methylenedioxy groups have been prepared and their anticancer properties evaluated in cancer cell cultures and in topoisomerase I inhibition assays. 2,3-Dimethoxy-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline hydrochloride (14) is a strong topoisomerase I inhibitor and also displays very high cytotoxicity in the NCI cancer cell culture screen (mean graph midpoint of 50 nM). The X-ray crystal structure of norindenoisoquinoline 14 in complex with topoisomerase I and DNA has been solved, providing insight into the structure-activity relationships within this class of new anticancer agents. The number and position of the norindenoisoquinoline substituents have a significant influence on biological activity and demonstrate that substitution on the nitrogen atom is not an absolute requirement for the antitumor effect of the indenoisoquinolines. Removal of the 11-keto group from the lead compound 1 and replacement of the N-alkyllactam with an unsubstituted pyridine ring causes the indenoisoquinoline ring system to flip over in the DNA-enzyme-inhibitor ternary complex. This allows the nitrogen atom to assume the hydrogen bond acceptor role of the 11-keto group, resulting in hydrogen bonding to Arg364.\n",
            "243387\n",
            "Topoisomerase-I mediated DNA Cleavage activity at 30 degree C for 30 min relative to NSC 314622; Range = 75-175%\n",
            "Title: Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis.  Abstract: Several norindenoisoquinolines substituted with methoxy or methylenedioxy groups have been prepared and their anticancer properties evaluated in cancer cell cultures and in topoisomerase I inhibition assays. 2,3-Dimethoxy-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline hydrochloride (14) is a strong topoisomerase I inhibitor and also displays very high cytotoxicity in the NCI cancer cell culture screen (mean graph midpoint of 50 nM). The X-ray crystal structure of norindenoisoquinoline 14 in complex with topoisomerase I and DNA has been solved, providing insight into the structure-activity relationships within this class of new anticancer agents. The number and position of the norindenoisoquinoline substituents have a significant influence on biological activity and demonstrate that substitution on the nitrogen atom is not an absolute requirement for the antitumor effect of the indenoisoquinolines. Removal of the 11-keto group from the lead compound 1 and replacement of the N-alkyllactam with an unsubstituted pyridine ring causes the indenoisoquinoline ring system to flip over in the DNA-enzyme-inhibitor ternary complex. This allows the nitrogen atom to assume the hydrogen bond acceptor role of the 11-keto group, resulting in hydrogen bonding to Arg364.\n",
            "243388\n",
            "Topoisomerase-I mediated DNA Cleavage activity at 30 degree C for 30 min relative to NSC 314622; Range = 175-325%\n",
            "Title: Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis.  Abstract: Several norindenoisoquinolines substituted with methoxy or methylenedioxy groups have been prepared and their anticancer properties evaluated in cancer cell cultures and in topoisomerase I inhibition assays. 2,3-Dimethoxy-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline hydrochloride (14) is a strong topoisomerase I inhibitor and also displays very high cytotoxicity in the NCI cancer cell culture screen (mean graph midpoint of 50 nM). The X-ray crystal structure of norindenoisoquinoline 14 in complex with topoisomerase I and DNA has been solved, providing insight into the structure-activity relationships within this class of new anticancer agents. The number and position of the norindenoisoquinoline substituents have a significant influence on biological activity and demonstrate that substitution on the nitrogen atom is not an absolute requirement for the antitumor effect of the indenoisoquinolines. Removal of the 11-keto group from the lead compound 1 and replacement of the N-alkyllactam with an unsubstituted pyridine ring causes the indenoisoquinoline ring system to flip over in the DNA-enzyme-inhibitor ternary complex. This allows the nitrogen atom to assume the hydrogen bond acceptor role of the 11-keto group, resulting in hydrogen bonding to Arg364.\n",
            "243437\n",
            "Inhibitory activity against DNA-Topoisomerase I\n",
            "Title: On the binding of indeno[1,2-c]isoquinolines in the DNA-topoisomerase I cleavage complex.  Abstract: An ab initio quantum mechanics calculation is reported which predicts the orientation of indenoisoquinoline 4 in the ternary cleavage complex formed from DNA and topoisomerase I (top1). The results of this calculation are consistent with the hypothetical structures previously proposed for the indenoisoquinoline-DNA-top1 ternary complexes based on molecular modeling, the crystal structure of a recently reported ternary complex, and the biological results obtained with a pair of diaminoalkyl-substituted indenoisoquinoline enantiomers. The results of these studies indicate that the pi-pi stacking interactions between the indenoisoquinolines and the neighboring DNA base pairs play a major role in determining binding orientation. The calculation of the electrostatic potential surface maps of the indenoisoquinolines and the adjacent DNA base pairs shows electrostatic complementarity in the observed binding orientation, leading to the conclusion that electrostatic attraction between the intercalators and the base pairs in the cleavage complex plays a major stabilizing role. On the other hand, the calculation of LUMO and HOMO energies of indenoisoquinoline 13b and neighboring DNA base pairs in conjunction with NBO analysis indicates that charge transfer complex formation plays a relatively minor role in stabilizing the ternary complexes derived from indenoisoquinolines, DNA, and top1. The results of these studies are important in understanding the existing structure-activity relationships for the indenoisoquinolines as top1 inhibitors and as anticancer agents, and they will be important in the future design of indenoisoquinoline-based top1 inhibitors.\n",
            "243438\n",
            "Inhibitory activity against DNA-Topoisomerase I \n",
            "Title: On the binding of indeno[1,2-c]isoquinolines in the DNA-topoisomerase I cleavage complex.  Abstract: An ab initio quantum mechanics calculation is reported which predicts the orientation of indenoisoquinoline 4 in the ternary cleavage complex formed from DNA and topoisomerase I (top1). The results of this calculation are consistent with the hypothetical structures previously proposed for the indenoisoquinoline-DNA-top1 ternary complexes based on molecular modeling, the crystal structure of a recently reported ternary complex, and the biological results obtained with a pair of diaminoalkyl-substituted indenoisoquinoline enantiomers. The results of these studies indicate that the pi-pi stacking interactions between the indenoisoquinolines and the neighboring DNA base pairs play a major role in determining binding orientation. The calculation of the electrostatic potential surface maps of the indenoisoquinolines and the adjacent DNA base pairs shows electrostatic complementarity in the observed binding orientation, leading to the conclusion that electrostatic attraction between the intercalators and the base pairs in the cleavage complex plays a major stabilizing role. On the other hand, the calculation of LUMO and HOMO energies of indenoisoquinoline 13b and neighboring DNA base pairs in conjunction with NBO analysis indicates that charge transfer complex formation plays a relatively minor role in stabilizing the ternary complexes derived from indenoisoquinolines, DNA, and top1. The results of these studies are important in understanding the existing structure-activity relationships for the indenoisoquinolines as top1 inhibitors and as anticancer agents, and they will be important in the future design of indenoisoquinoline-based top1 inhibitors.\n",
            "244262\n",
            "Induction of topoisomerase I mediated DNA cleavage; weak activity\n",
            "Title: Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase I inhibitors lacking substituents on the aromatic rings.  Abstract: The indenoisoquinolines are a class of cytotoxic topoisomerase I inhibitors that offer certain advantages over the camptothecins, including the greater stabilities of the compounds themselves, as well as the greater stabilities of their drug-enzyme-DNA cleavage complexes. To investigate the possible biological roles of the di(methoxy) and methylenedioxy substituents present on the aromatic rings of the previously synthesized indenoisoquinoline topoisomerase I inhibitors, a series of compounds lacking these substituents was synthesized and tested for both cytotoxicity in cancer cell cultures and for enzyme inhibitory activity. The results indicate that the aromatic substituents make a small, but consistently observable contribution to the biological activity. Molecular models derived for the binding of the unsubstituted indenoisoquinolines in ternary complex with DNA and topoisomerase I indicate that the substituents on the lactam nitrogen project out of the major groove, and the carbonyl group is directed out of the minor groove, where it is involved in a hydrogen bonding interaction with the side chain guanidine group of Arg364. The DNA cleavage patterns observed in the presence of topoisomerase I and various indenoisoquinolines were similar, although significant differences were detected. There were also variations in the DNA cleavage pattern seen with camptothecin vs the indenoisoquinolines, which indicates that these two classes of topoisomerase I inhibitors are likely to target the cancer cell genome differently, resulting in different spectra of anticancer activity. The most cytotoxic of the presently synthesized indenoisoquinolines has a 4-amino-n-butyl group on the lactam nitrogen.\n",
            "244263\n",
            "Induction of topoisomerase I mediated DNA cleavage; Activity similar to 1 uM camptothecin\n",
            "Title: Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase I inhibitors lacking substituents on the aromatic rings.  Abstract: The indenoisoquinolines are a class of cytotoxic topoisomerase I inhibitors that offer certain advantages over the camptothecins, including the greater stabilities of the compounds themselves, as well as the greater stabilities of their drug-enzyme-DNA cleavage complexes. To investigate the possible biological roles of the di(methoxy) and methylenedioxy substituents present on the aromatic rings of the previously synthesized indenoisoquinoline topoisomerase I inhibitors, a series of compounds lacking these substituents was synthesized and tested for both cytotoxicity in cancer cell cultures and for enzyme inhibitory activity. The results indicate that the aromatic substituents make a small, but consistently observable contribution to the biological activity. Molecular models derived for the binding of the unsubstituted indenoisoquinolines in ternary complex with DNA and topoisomerase I indicate that the substituents on the lactam nitrogen project out of the major groove, and the carbonyl group is directed out of the minor groove, where it is involved in a hydrogen bonding interaction with the side chain guanidine group of Arg364. The DNA cleavage patterns observed in the presence of topoisomerase I and various indenoisoquinolines were similar, although significant differences were detected. There were also variations in the DNA cleavage pattern seen with camptothecin vs the indenoisoquinolines, which indicates that these two classes of topoisomerase I inhibitors are likely to target the cancer cell genome differently, resulting in different spectra of anticancer activity. The most cytotoxic of the presently synthesized indenoisoquinolines has a 4-amino-n-butyl group on the lactam nitrogen.\n",
            "244264\n",
            "Induction of topoisomerase I mediated DNA cleavage; Activity similar to parent compound 1\n",
            "Title: Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase I inhibitors lacking substituents on the aromatic rings.  Abstract: The indenoisoquinolines are a class of cytotoxic topoisomerase I inhibitors that offer certain advantages over the camptothecins, including the greater stabilities of the compounds themselves, as well as the greater stabilities of their drug-enzyme-DNA cleavage complexes. To investigate the possible biological roles of the di(methoxy) and methylenedioxy substituents present on the aromatic rings of the previously synthesized indenoisoquinoline topoisomerase I inhibitors, a series of compounds lacking these substituents was synthesized and tested for both cytotoxicity in cancer cell cultures and for enzyme inhibitory activity. The results indicate that the aromatic substituents make a small, but consistently observable contribution to the biological activity. Molecular models derived for the binding of the unsubstituted indenoisoquinolines in ternary complex with DNA and topoisomerase I indicate that the substituents on the lactam nitrogen project out of the major groove, and the carbonyl group is directed out of the minor groove, where it is involved in a hydrogen bonding interaction with the side chain guanidine group of Arg364. The DNA cleavage patterns observed in the presence of topoisomerase I and various indenoisoquinolines were similar, although significant differences were detected. There were also variations in the DNA cleavage pattern seen with camptothecin vs the indenoisoquinolines, which indicates that these two classes of topoisomerase I inhibitors are likely to target the cancer cell genome differently, resulting in different spectra of anticancer activity. The most cytotoxic of the presently synthesized indenoisoquinolines has a 4-amino-n-butyl group on the lactam nitrogen.\n",
            "244265\n",
            "Induction of topoisomerase I mediated DNA cleavage; Greater activity than parent compound 1\n",
            "Title: Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase I inhibitors lacking substituents on the aromatic rings.  Abstract: The indenoisoquinolines are a class of cytotoxic topoisomerase I inhibitors that offer certain advantages over the camptothecins, including the greater stabilities of the compounds themselves, as well as the greater stabilities of their drug-enzyme-DNA cleavage complexes. To investigate the possible biological roles of the di(methoxy) and methylenedioxy substituents present on the aromatic rings of the previously synthesized indenoisoquinoline topoisomerase I inhibitors, a series of compounds lacking these substituents was synthesized and tested for both cytotoxicity in cancer cell cultures and for enzyme inhibitory activity. The results indicate that the aromatic substituents make a small, but consistently observable contribution to the biological activity. Molecular models derived for the binding of the unsubstituted indenoisoquinolines in ternary complex with DNA and topoisomerase I indicate that the substituents on the lactam nitrogen project out of the major groove, and the carbonyl group is directed out of the minor groove, where it is involved in a hydrogen bonding interaction with the side chain guanidine group of Arg364. The DNA cleavage patterns observed in the presence of topoisomerase I and various indenoisoquinolines were similar, although significant differences were detected. There were also variations in the DNA cleavage pattern seen with camptothecin vs the indenoisoquinolines, which indicates that these two classes of topoisomerase I inhibitors are likely to target the cancer cell genome differently, resulting in different spectra of anticancer activity. The most cytotoxic of the presently synthesized indenoisoquinolines has a 4-amino-n-butyl group on the lactam nitrogen.\n",
            "244266\n",
            "Induction of topoisomerase I mediated DNA cleavage; greater activity than parent compound 1\n",
            "Title: Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase I inhibitors lacking substituents on the aromatic rings.  Abstract: The indenoisoquinolines are a class of cytotoxic topoisomerase I inhibitors that offer certain advantages over the camptothecins, including the greater stabilities of the compounds themselves, as well as the greater stabilities of their drug-enzyme-DNA cleavage complexes. To investigate the possible biological roles of the di(methoxy) and methylenedioxy substituents present on the aromatic rings of the previously synthesized indenoisoquinoline topoisomerase I inhibitors, a series of compounds lacking these substituents was synthesized and tested for both cytotoxicity in cancer cell cultures and for enzyme inhibitory activity. The results indicate that the aromatic substituents make a small, but consistently observable contribution to the biological activity. Molecular models derived for the binding of the unsubstituted indenoisoquinolines in ternary complex with DNA and topoisomerase I indicate that the substituents on the lactam nitrogen project out of the major groove, and the carbonyl group is directed out of the minor groove, where it is involved in a hydrogen bonding interaction with the side chain guanidine group of Arg364. The DNA cleavage patterns observed in the presence of topoisomerase I and various indenoisoquinolines were similar, although significant differences were detected. There were also variations in the DNA cleavage pattern seen with camptothecin vs the indenoisoquinolines, which indicates that these two classes of topoisomerase I inhibitors are likely to target the cancer cell genome differently, resulting in different spectra of anticancer activity. The most cytotoxic of the presently synthesized indenoisoquinolines has a 4-amino-n-butyl group on the lactam nitrogen.\n",
            "244267\n",
            "Induction of topoisomerase I mediated DNA cleavage; Activity similar to 1 uM camptothecin; weak activity\n",
            "Title: Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase I inhibitors lacking substituents on the aromatic rings.  Abstract: The indenoisoquinolines are a class of cytotoxic topoisomerase I inhibitors that offer certain advantages over the camptothecins, including the greater stabilities of the compounds themselves, as well as the greater stabilities of their drug-enzyme-DNA cleavage complexes. To investigate the possible biological roles of the di(methoxy) and methylenedioxy substituents present on the aromatic rings of the previously synthesized indenoisoquinoline topoisomerase I inhibitors, a series of compounds lacking these substituents was synthesized and tested for both cytotoxicity in cancer cell cultures and for enzyme inhibitory activity. The results indicate that the aromatic substituents make a small, but consistently observable contribution to the biological activity. Molecular models derived for the binding of the unsubstituted indenoisoquinolines in ternary complex with DNA and topoisomerase I indicate that the substituents on the lactam nitrogen project out of the major groove, and the carbonyl group is directed out of the minor groove, where it is involved in a hydrogen bonding interaction with the side chain guanidine group of Arg364. The DNA cleavage patterns observed in the presence of topoisomerase I and various indenoisoquinolines were similar, although significant differences were detected. There were also variations in the DNA cleavage pattern seen with camptothecin vs the indenoisoquinolines, which indicates that these two classes of topoisomerase I inhibitors are likely to target the cancer cell genome differently, resulting in different spectra of anticancer activity. The most cytotoxic of the presently synthesized indenoisoquinolines has a 4-amino-n-butyl group on the lactam nitrogen.\n",
            "250096\n",
            "Topoisomerase I-mediated cleavage value on the plasmid DNA\n",
            "Title: 5-(2-aminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: variation of n-alkyl substituents modulates sensitivity to efflux transporters associated with multidrug resistance.  Abstract: 5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)-2,3-methylenedioxydibenzo[c,h][1,6]naphthyridin-6-one (ARC-111) has potent TOP1-targeting activity and pronounced antitumor activity. Several analogues of ARC-111 were synthesized with NH2, N-alkyl, N,N-dialkyl, pyrrolidinyl, piperidinyl, and piperazinyl substituents at the 2-position of the 5-ethyl group. The relative TOP1-targeting activity and cytotoxicity of these structural analogues were assessed in RPMI8402 and P388 tumor cells and their camptothecin-resistant variants CPT-K5 and P388/CPT45, respectively. Potent TOP1-targeting activity was retained within a series of mono N-alkyl analogues that included NHCH2CH3, NHCH(CH3)2, and NHC(CH3)3. TOP1-targeting activity was diminished by the presence of a N-benzyl moiety. In a comparison of a series of N-alkyl-N-isopropyl analogues, activity decreased in the order CH3 > CH2CH3 > CH(CH3)2. Cytotoxicity in RPMI8402 and P388 did correlate with TOP1-targeting activity. Cytotoxic activity was also determined in KB3-1 cells and its variants KB/V-1 and KBH5.0. As KB/V-1 cells overexpress MDR1 and KBH5.0 cells overexpress BCRP, decreased cytotoxicity in these cell lines relative to the parent cell line is indicative of compounds that are substrates for these efflux transporters. In view of their diminished cytotoxicity in KB/V-1 cells, it appears that the likely demethylated metabolites of ARC-111, i.e., where NH2 or NHCH3 replaces the N(CH3)2 at the 2-position of the 5-ethyl substituent, are substrates for MDR1. In contrast, no significant difference in cytotoxicity among these three cell lines was observed with other N-alkyl analogues, including NHC2H5, NHCH(CH3)2, NHC(CH3)3, N(CH3)2, N(CH2CH3)2, NCH3(CH(CH3)2), and either the pyrrolidinyl or the piperidinyl analogues. The 2-(piperazinyl) analogues were associated with diminished cytotoxicity in KB/V-1 cells, suggesting that the second basic amino substituent is associated with their recognition as substrates by MDR1. Comparative studies on the antitumor activity of ARC-111 and its N-demethylated derivatives (the NHCH3 and NH2 analogues) against SJ-BT45 medulloblastoma xenografts in scid mice revealed that the secondary amine metabolite is at least as active as ARC-111 in vivo, although the primary amine derivative was significantly less potent.\n",
            "251002\n",
            "Relative topoisomerase I-mediated plasmid DNA cleavage compared to topotecan\n",
            "Title: 5-(2-aminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: variation of n-alkyl substituents modulates sensitivity to efflux transporters associated with multidrug resistance.  Abstract: 5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)-2,3-methylenedioxydibenzo[c,h][1,6]naphthyridin-6-one (ARC-111) has potent TOP1-targeting activity and pronounced antitumor activity. Several analogues of ARC-111 were synthesized with NH2, N-alkyl, N,N-dialkyl, pyrrolidinyl, piperidinyl, and piperazinyl substituents at the 2-position of the 5-ethyl group. The relative TOP1-targeting activity and cytotoxicity of these structural analogues were assessed in RPMI8402 and P388 tumor cells and their camptothecin-resistant variants CPT-K5 and P388/CPT45, respectively. Potent TOP1-targeting activity was retained within a series of mono N-alkyl analogues that included NHCH2CH3, NHCH(CH3)2, and NHC(CH3)3. TOP1-targeting activity was diminished by the presence of a N-benzyl moiety. In a comparison of a series of N-alkyl-N-isopropyl analogues, activity decreased in the order CH3 > CH2CH3 > CH(CH3)2. Cytotoxicity in RPMI8402 and P388 did correlate with TOP1-targeting activity. Cytotoxic activity was also determined in KB3-1 cells and its variants KB/V-1 and KBH5.0. As KB/V-1 cells overexpress MDR1 and KBH5.0 cells overexpress BCRP, decreased cytotoxicity in these cell lines relative to the parent cell line is indicative of compounds that are substrates for these efflux transporters. In view of their diminished cytotoxicity in KB/V-1 cells, it appears that the likely demethylated metabolites of ARC-111, i.e., where NH2 or NHCH3 replaces the N(CH3)2 at the 2-position of the 5-ethyl substituent, are substrates for MDR1. In contrast, no significant difference in cytotoxicity among these three cell lines was observed with other N-alkyl analogues, including NHC2H5, NHCH(CH3)2, NHC(CH3)3, N(CH3)2, N(CH2CH3)2, NCH3(CH(CH3)2), and either the pyrrolidinyl or the piperidinyl analogues. The 2-(piperazinyl) analogues were associated with diminished cytotoxicity in KB/V-1 cells, suggesting that the second basic amino substituent is associated with their recognition as substrates by MDR1. Comparative studies on the antitumor activity of ARC-111 and its N-demethylated derivatives (the NHCH3 and NH2 analogues) against SJ-BT45 medulloblastoma xenografts in scid mice revealed that the secondary amine metabolite is at least as active as ARC-111 in vivo, although the primary amine derivative was significantly less potent.\n",
            "252286\n",
            "Concentration tested for Top1-mediated DNA cleavage;+: weak activity\n",
            "Title: Dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines.  Abstract: Dihydroindenoisoquinolines are analogs of cytotoxic indenoisoquinoline topoisomerase I (Top1) inhibitors, exhibiting potent cytotoxicity but weak inhibitory activity toward Top1. Through COMPARE analysis, cytotoxicity studies in Top1-deficient cells, chemical synthesis and biological evaluation of methylated dihydroindenoisoquinoline 5, we demonstrated that dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines in cancer cells.\n",
            "252287\n",
            "Concentration tested for Top1-mediated DNA cleavage (concentration taken upto 100 uM)\n",
            "Title: Dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines.  Abstract: Dihydroindenoisoquinolines are analogs of cytotoxic indenoisoquinoline topoisomerase I (Top1) inhibitors, exhibiting potent cytotoxicity but weak inhibitory activity toward Top1. Through COMPARE analysis, cytotoxicity studies in Top1-deficient cells, chemical synthesis and biological evaluation of methylated dihydroindenoisoquinoline 5, we demonstrated that dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines in cancer cells.\n",
            "252288\n",
            "Concentration tested for Top1-mediated DNA cleavage (concentration taken upto 100 uM);0: no activity\n",
            "Title: Dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines.  Abstract: Dihydroindenoisoquinolines are analogs of cytotoxic indenoisoquinoline topoisomerase I (Top1) inhibitors, exhibiting potent cytotoxicity but weak inhibitory activity toward Top1. Through COMPARE analysis, cytotoxicity studies in Top1-deficient cells, chemical synthesis and biological evaluation of methylated dihydroindenoisoquinoline 5, we demonstrated that dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines in cancer cells.\n",
            "252289\n",
            "Concentration tested for Top1-mediated DNA cleavage (concentration taken upto 100 uM);+: weak activity\n",
            "Title: Dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines.  Abstract: Dihydroindenoisoquinolines are analogs of cytotoxic indenoisoquinoline topoisomerase I (Top1) inhibitors, exhibiting potent cytotoxicity but weak inhibitory activity toward Top1. Through COMPARE analysis, cytotoxicity studies in Top1-deficient cells, chemical synthesis and biological evaluation of methylated dihydroindenoisoquinoline 5, we demonstrated that dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines in cancer cells.\n",
            "252290\n",
            "Concentration tested for Top1-mediated DNA cleavage (concentration taken upto 100 uM); +++: Good activity\n",
            "Title: Dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines.  Abstract: Dihydroindenoisoquinolines are analogs of cytotoxic indenoisoquinoline topoisomerase I (Top1) inhibitors, exhibiting potent cytotoxicity but weak inhibitory activity toward Top1. Through COMPARE analysis, cytotoxicity studies in Top1-deficient cells, chemical synthesis and biological evaluation of methylated dihydroindenoisoquinoline 5, we demonstrated that dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines in cancer cells.\n",
            "252291\n",
            "Concentration tested for Top1-mediated DNA cleavage (concentration taken upto 100 uM); ++: similar activity as the parent compound 3a\n",
            "Title: Dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines.  Abstract: Dihydroindenoisoquinolines are analogs of cytotoxic indenoisoquinoline topoisomerase I (Top1) inhibitors, exhibiting potent cytotoxicity but weak inhibitory activity toward Top1. Through COMPARE analysis, cytotoxicity studies in Top1-deficient cells, chemical synthesis and biological evaluation of methylated dihydroindenoisoquinoline 5, we demonstrated that dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines in cancer cells.\n",
            "256508\n",
            "Inhibitory activity against Topoisomerase I\n",
            "Title: A new synthesis of isoaurones: cytotoxic activity of compounds related to the alleged structure of isoaurostatin.  Abstract: A new synthesis of isoaurones related to the alleged structure of isoaurostatin, via Heck intramolecular cyclization of cinnamic esters of 2-iodophenols, is reported. The cytotoxic activity of these isoaurones is lower than that of the structurally very similar 4-arylcoumarins.\n",
            "256678\n",
            "Inhibition of topoisomerase-1 at 100 uM\n",
            "Title: Total and semisynthesis and in vitro studies of both enantiomers of 20-fluorocamptothecin.  Abstract: Both enantiomers of 20-fluorocamptothecin and the racemate have been prepared by total synthesis. The (R)-enantiomer is essentially inactive in a topoisomerase-I/DNA assay, while the (S)-enantiomer is much less active than (20S)-camptothecin. The lactone ring of 20-fluorocamptothecin hydrolyzes more rapidly than that of camptothecin in PBS. The results provide insight into the role of the 20-hydroxy group in the binding of camptothecin to topoisomerase-I and DNA.\n",
            "258767\n",
            "Inhibition of Topoisomerase 1 mediated DNA cleavage activity in a cell free assay at 100 uM\n",
            "Title: Aza-analogues of the marine pyrroloquinoline alkaloids wakayin and tsitsikammamines: synthesis and topoisomerase inhibition.  Abstract: Two aza-analogues of the marine pyrroloquinoline alkaloids wakayin and tsitsikammamines A and B have been synthesized. The strategy used was based on a 1,3-dipolar cycloaddition reaction between indole 4,7-dione and a diazo-aminopropane derivative. One of the two analogues partially inhibits human topoisomerase I, whereas synthetic intermediates inhibit the enzyme DNA cleavage activity at a concentration comparable to that of the control drug camptothecin.\n",
            "264545\n",
            "Inhibition of topoisomerase 1 DNA cleavage activity\n",
            "Title: Synthesis and antitumor characterization of pyrazolic analogues of the marine pyrroloquinoline alkaloids: wakayin and tsitsikammamines.  Abstract: A series of aza analogues of the marine alkaloids wakayin and tsitsikammamines A and B have been synthesized. The strategy used was based on [3 + 2] cycloaddition reactions involving 3-ethylamine-indole-4,7-dione and different diazo reagents. All the compounds were evaluated in vitro for antiproliferative activity against five distinct cancer cell lines and for their inhibitory effect on topoisomerase isoenzymes I and II. Some of the compounds inhibited the topoisomerase I and/or II catalyzed relaxation of supercoiled DNA at a concentration comparable to the drugs camptothecin and etoposide. Only a few of them exhibited cytotoxic activity with IC50 values in the micromolar range.\n",
            "268635\n",
            "Inhibition of DNA relaxation catalysed by topoisomerase1 at 1 uM\n",
            "Title: CA224, a non-planar analogue of fascaplysin, inhibits Cdk4 but not Cdk2 and arrests cells at G0/G1 inhibiting pRB phosphorylation.  Abstract: Tryptamine derivatives, non-planar and potentially less toxic analogues of the anti-cancer agent fascaplysin, have been synthesised. They specifically inhibit Cdk4-D1 vis a vis Cdk2-A but, unlike fascaplysin, do not bind or intercalate DNA. CA224 is the most potent compound identified (Cdk4-D1 IC(50) approximately 5.5 microM). As would be expected of a Cdk4 inhibitor that does not inhibit Cdk2, it maintains a G(0)/G(1) block in synchronised cancer cells and inhibits Cdk4-specific phosphorylation of the retinoblastoma protein.\n",
            "268636\n",
            "Inhibition of DNA relaxation catalysed by topoisomerase1 at 10 uM\n",
            "Title: CA224, a non-planar analogue of fascaplysin, inhibits Cdk4 but not Cdk2 and arrests cells at G0/G1 inhibiting pRB phosphorylation.  Abstract: Tryptamine derivatives, non-planar and potentially less toxic analogues of the anti-cancer agent fascaplysin, have been synthesised. They specifically inhibit Cdk4-D1 vis a vis Cdk2-A but, unlike fascaplysin, do not bind or intercalate DNA. CA224 is the most potent compound identified (Cdk4-D1 IC(50) approximately 5.5 microM). As would be expected of a Cdk4 inhibitor that does not inhibit Cdk2, it maintains a G(0)/G(1) block in synchronised cancer cells and inhibits Cdk4-specific phosphorylation of the retinoblastoma protein.\n",
            "268637\n",
            "Inhibition of DNA relaxation catalysed by topoisomerase1 at 100 uM\n",
            "Title: CA224, a non-planar analogue of fascaplysin, inhibits Cdk4 but not Cdk2 and arrests cells at G0/G1 inhibiting pRB phosphorylation.  Abstract: Tryptamine derivatives, non-planar and potentially less toxic analogues of the anti-cancer agent fascaplysin, have been synthesised. They specifically inhibit Cdk4-D1 vis a vis Cdk2-A but, unlike fascaplysin, do not bind or intercalate DNA. CA224 is the most potent compound identified (Cdk4-D1 IC(50) approximately 5.5 microM). As would be expected of a Cdk4 inhibitor that does not inhibit Cdk2, it maintains a G(0)/G(1) block in synchronised cancer cells and inhibits Cdk4-specific phosphorylation of the retinoblastoma protein.\n",
            "269042\n",
            "Unwinding of DNA mediated by topoisomerase 1 at 20 uM\n",
            "Title: Antitumor agents. 5. synthesis, structure-activity relationships, and biological evaluation of dimethyl-5H-pyridophenoxazin-5-ones, tetrahydro-5h-benzopyridophenoxazin-5-ones, and 5h-benzopyridophenoxazin-5-ones with potent antiproliferative activity.  Abstract: New antiproliferative compounds, dimethyl-5H-pyrido[3,2-a]phenoxazin-5-ones (1-6), tetrahydro-5H-benzopyrido[2,3-j]phenoxazin-5-ones (7-9), and 5H-benzopyrido[3,2-a]phenoxazin-5-ones (10-12) were synthesized and evaluated against representative human neoplastic cell lines. Dimethyl derivatives 1-6 were more active against carcinoma than leukemia cell lines. The tetrahydrobenzo derivatives 7-9 were scarcely active, whereas the corresponding benzo derivatives 10-12 showed notable cytotoxicity against a majority of the tested cell lines. Molecular modeling studies indicated that the high potency of 10 and 11, the most cytotoxic compounds of the whole series, could be due to the position of the condensed benzene ring, which favors pi-pi stacking interactions with purine and pyrimidine bases in the DNA active site. Biological studies suggested that 10-12 have no effect on human topoisomerases I and II and that they induce arrest at the G2/M phase.\n",
            "269043\n",
            "Promotion of human topoisomerase 1-mediated DNA cleavage\n",
            "Title: Antitumor agents. 5. synthesis, structure-activity relationships, and biological evaluation of dimethyl-5H-pyridophenoxazin-5-ones, tetrahydro-5h-benzopyridophenoxazin-5-ones, and 5h-benzopyridophenoxazin-5-ones with potent antiproliferative activity.  Abstract: New antiproliferative compounds, dimethyl-5H-pyrido[3,2-a]phenoxazin-5-ones (1-6), tetrahydro-5H-benzopyrido[2,3-j]phenoxazin-5-ones (7-9), and 5H-benzopyrido[3,2-a]phenoxazin-5-ones (10-12) were synthesized and evaluated against representative human neoplastic cell lines. Dimethyl derivatives 1-6 were more active against carcinoma than leukemia cell lines. The tetrahydrobenzo derivatives 7-9 were scarcely active, whereas the corresponding benzo derivatives 10-12 showed notable cytotoxicity against a majority of the tested cell lines. Molecular modeling studies indicated that the high potency of 10 and 11, the most cytotoxic compounds of the whole series, could be due to the position of the condensed benzene ring, which favors pi-pi stacking interactions with purine and pyrimidine bases in the DNA active site. Biological studies suggested that 10-12 have no effect on human topoisomerases I and II and that they induce arrest at the G2/M phase.\n",
            "269110\n",
            "Inhibition of human recombinant Top1-mediated DNA cleavage upto 10 uM\n",
            "Title: Synthesis and biological evaluation of bisindenoisoquinolines as topoisomerase I inhibitors.  Abstract: The indenoisoquinolines represent a class of non-camptothecin topoisomerase I (Top1) inhibitors that exert cytotoxicity by trapping the covalent complex formed between DNA and Top1 during relaxation of DNA supercoils. As an ongoing evaluation of Top1 inhibition and anticancer activity, indenoisoquinolines were linked via their lactam side chains to provide polyamines end-capped with intercalating motifs. The resulting bisindenoisoquinolines were evaluated for cytotoxicity in the National Cancer Institute's human cancer cell screen and for Top1 inhibition. Preliminary findings suggested that the 2-3-2 and 3-3-3 linkers, referring to the number of carbons between nitrogen atoms, were optimal for both potent Top1 inhibition and cytotoxicity. Using optimized linkers, bisindenoisoquinolines were synthesized with nitro and methoxy substituents on the aromatic rings. The biological results for substituted compounds revealed a disagreement between the structure-activity relationships of monomeric indenoisoquinolines and bisindenoisoquinolines as Top1 inhibitors, but cytotoxicity was maintained for both series of compounds.\n",
            "269203\n",
            "Activity against human Top1-mediated DNA cleavage after 10 mins\n",
            "Title: Synthesis and cytotoxic activity of polyamine analogues of camptothecin.  Abstract: A number of derivatives of camptothecin with a polyamine chain linked to position 7 of camptothecin via an amino, imino, or oxyiminomethyl group were synthesized and tested for their biological activity. All compounds showed marked growth inhibitory activity against the H460 human lung carcinoma cell line. In particular, the iminomethyl derivatives where the amino groups of the chain were protected with Boc groups exhibited a high potency, with IC50 values of approximately 10(-8) M. The pattern of DNA cleavage in vitro and the persistence of the cleavable ternary complex drug-DNA-topoisomerase I observed with polyamine conjugates containing free amino groups support a contribution of specific drug interaction with DNA as a determinant of activity. Modeling of compound 7c in the complex with topoisomerase 1 and DNA is consistent with this hypothesis. The lack of a specific correlation between stabilization of the cleavable complex and growth inhibition likely reflects multiple factors including the cellular pharmacokinetic behavior related to the variable lipophilicity of the conjugate, and the nature and linkage of the polyamine moiety.\n",
            "283903\n",
            "Inhibition of human topoisomerase 1-mediated DNA relaxation activity at 200 uM relative to control\n",
            "Title: Synthesis of 6-chloroisoquinoline-5,8-diones and pyrido[3,4-b]phenazine-5,12-diones and evaluation of their cytotoxicity and DNA topoisomerase II inhibitory activity.  Abstract: The substituted chloroisoquinolinediones and pyrido[3,4-b]phenazinediones were synthesized, and the cytotoxic activity and topoisomerase II inhibitory activity of the prepared compounds were evaluated. Chloroisoquinolinediones have been prepared by the reported method employing 6,7-dichloroisoquinoline-5,8-dione. The cyclization to pyrido[3,4-b]phenazinediones was achieved by adding the aqueous sodium azide solution to the dimethylformamide solution of corresponding chloroisoquinoline-5,8-dione. The cytotoxicity of the synthesized compounds was evaluated by a SRB (Sulforhodamine B) assay against various cancer cell lines such as A549 (human lung cancer cell line), SNU-638 (human stomach cancer cell), Col2 (human colon cancer cell line), HT1080 (human fibrosarcoma cell line), and HL-60 (human leukemia cell line). Almost all the synthesized pyrido[3,4-b]phenazinediones showed greater cytotoxic potential than ellipticine (IC(50)=1.82-5.97 microM). In general, the cytotoxicity of the pyrido[3,4-b]phenazinediones was higher than that of the corresponding chloroisoquinolinediones. The caco-2 cell permeability of selected compounds was 0.62 x 10(-6)-35.3 x 10(-6)cm/s. The difference in cytotoxic activity among tested compounds was correlated with the difference in permeability to some degree. To further investigate the cytotoxic mechanism, the topoisomerase II inhibitory activity of the synthesized compounds was estimated by a plasmid cleavage assay. Most of compounds showed the topoisomerase II inhibitory activity (28-100%) at 200 microM. IC(50) values for the most active compound 6a were 0.082 microM. However, the compounds were inactive for DNA relaxation by topoisomerase I at 200 microM.\n",
            "283904\n",
            "Inhibition of human topoisomerase 1-mediated DNA relaxation activity at 100 uM relative to control\n",
            "Title: Synthesis of 6-chloroisoquinoline-5,8-diones and pyrido[3,4-b]phenazine-5,12-diones and evaluation of their cytotoxicity and DNA topoisomerase II inhibitory activity.  Abstract: The substituted chloroisoquinolinediones and pyrido[3,4-b]phenazinediones were synthesized, and the cytotoxic activity and topoisomerase II inhibitory activity of the prepared compounds were evaluated. Chloroisoquinolinediones have been prepared by the reported method employing 6,7-dichloroisoquinoline-5,8-dione. The cyclization to pyrido[3,4-b]phenazinediones was achieved by adding the aqueous sodium azide solution to the dimethylformamide solution of corresponding chloroisoquinoline-5,8-dione. The cytotoxicity of the synthesized compounds was evaluated by a SRB (Sulforhodamine B) assay against various cancer cell lines such as A549 (human lung cancer cell line), SNU-638 (human stomach cancer cell), Col2 (human colon cancer cell line), HT1080 (human fibrosarcoma cell line), and HL-60 (human leukemia cell line). Almost all the synthesized pyrido[3,4-b]phenazinediones showed greater cytotoxic potential than ellipticine (IC(50)=1.82-5.97 microM). In general, the cytotoxicity of the pyrido[3,4-b]phenazinediones was higher than that of the corresponding chloroisoquinolinediones. The caco-2 cell permeability of selected compounds was 0.62 x 10(-6)-35.3 x 10(-6)cm/s. The difference in cytotoxic activity among tested compounds was correlated with the difference in permeability to some degree. To further investigate the cytotoxic mechanism, the topoisomerase II inhibitory activity of the synthesized compounds was estimated by a plasmid cleavage assay. Most of compounds showed the topoisomerase II inhibitory activity (28-100%) at 200 microM. IC(50) values for the most active compound 6a were 0.082 microM. However, the compounds were inactive for DNA relaxation by topoisomerase I at 200 microM.\n",
            "286262\n",
            "Inhibition of human recombinant topoisomerase 1-mediated DNA cleavage after 30 mins\n",
            "Title: Investigation of the lactam side chain length necessary for optimal indenoisoquinoline topoisomerase I inhibition and cytotoxicity in human cancer cell cultures.  Abstract: Indenoisoquinolines with lactam substituents such as ethylamino, propylamino, and butylamino have previously demonstrated potent biological activity, but an optimal length has never been established. In the present study, a series of simplified indenoisoquinoline analogues possessing a linker spacing of 0-12 carbon atoms between the lactam nitrogen and the terminal amino group have been prepared, determining that 2-4-atom lengths are optimal for topoisomerase I inhibition and cytotoxicity. Using these lengths, analogues were prepared with the amino group and portions of the linker replaced by a pyridine ring. A three-carbon spacer within the pyridine series still demonstrated potent topoisomerase I inhibition.\n",
            "286403\n",
            "Induction of topoisomerase 1-DNA complexes in K562 cells assessed as integrated green fluorescence at 175 uM after 0.5 hrs by TARDIS assay\n",
            "Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.\n",
            "286404\n",
            "Induction of topoisomerase 1-DNA complexes in K562 cells assessed as integrated green fluorescence at 175 uM after 2 hrs by TARDIS assay\n",
            "Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.\n",
            "286405\n",
            "Induction of topoisomerase 1-DNA complexes in K562 cells assessed as integrated green fluorescence at 175 uM after 6 hrs by TARDIS assay\n",
            "Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.\n",
            "286406\n",
            "Induction of topoisomerase 1-DNA complexes in K562 cells assessed as integrated green fluorescence at 175 uM after 24 hrs by TARDIS assay\n",
            "Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.\n",
            "286407\n",
            "Induction of topoisomerase 1-DNA complexes in K562 cells assessed as integrated green fluorescence at 10 uM after 1 hr by TARDIS assay\n",
            "Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.\n",
            "286413\n",
            "Induction of topoisomerase 1-DNA complexes in K562 cells assessed as integrated green fluorescence at 146 uM after 0.5 hrs by TARDIS assay\n",
            "Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.\n",
            "286414\n",
            "Induction of topoisomerase 1-DNA complexes in K562 cells assessed as integrated green fluorescence at 146 uM after 2 hrs by TARDIS assay\n",
            "Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.\n",
            "286415\n",
            "Induction of topoisomerase 1-DNA complexes in K562 cells assessed as integrated green fluorescence at 146 uM after 6 hrs by TARDIS assay\n",
            "Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.\n",
            "286416\n",
            "Induction of topoisomerase 1-DNA complexes in K562 cells assessed as integrated green fluorescence at 146 uM after 24 hrs by TARDIS assay\n",
            "Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.\n",
            "286421\n",
            "Inhibition of topoisomerase 1 assessed as reduction of camptothecin-induced topo 1-DNA complexes in K562 cells by measuring integrated fluorescence at 17 uM after 24 hrs by TARDIS assay\n",
            "Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.\n",
            "286422\n",
            "Inhibition of topoisomerase 1 assessed as reduction of camptothecin-induced topo 1-DNA complexes in K562 cells by measuring integrated fluorescence at 175 uM after 24 hrs by TARDIS assay\n",
            "Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.\n",
            "286423\n",
            "Inhibition of topoisomerase 1 assessed as reduction of camptothecin-induced topo 1-DNA complexes in K562 cells by measuring integrated fluorescence at 14 uM after 24 hrs by TARDIS assay\n",
            "Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.\n",
            "286424\n",
            "Inhibition of topoisomerase 1 assessed as reduction of camptothecin-induced topo 1-DNA complexes in K562 cells by measuring integrated fluorescence at 146 uM after 24 hrs by TARDIS assay\n",
            "Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.\n",
            "286438\n",
            "Induction of topoisomerase 1-DNA complexes in K562 cells assessed as integrated green fluorescence at 10 times their IC50 after 2 hrs by TARDIS assay\n",
            "Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.\n",
            "286439\n",
            "Induction of topoisomerase 1-DNA complexes in K562 cells assessed as integrated green fluorescence at 10 times their IC50 after 8 hrs by TARDIS assay\n",
            "Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.\n",
            "286440\n",
            "Induction of topoisomerase 1-DNA complexes in K562 cells assessed as integrated green fluorescence at 10 times their IC50 after 24 hrs by TARDIS assay\n",
            "Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.\n",
            "287709\n",
            "Inhibition of topoisomerase 1 assessed as attenuation of DNA relaxation\n",
            "Title: Naphthoindole-based analogues of tryptophan and tryptamine: synthesis and cytotoxic properties.  Abstract: The efficacy of anthracycline based anticancer drugs is limited by pleiotropic drug resistance of tumor cells. Aiming at the design of anthracyclinone congeners capable of circumventing drug resistance, we synthesized naphthoindole containing derivatives of tryptophan and tryptamine. In doing so we adapted the traditional, gramine based approach for tryptophan and tryptamine synthesis. The most potent new compound, 3-(2-aminoethyl)-4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione (16), was equally cytotoxic (IC(50) within low micromolar concentrations) for human K562 leukemia and HCT116 colon carcinoma cell lines and their isogenic sublines with genetically defined determinants of altered drug response, that is, the expression of the multidrug transporter P-glycoprotein and loss of pro-apoptotic p53. Each of these mechanisms conferred resistance to the reference drug adriamycin. In contrast, naphthotryptamine 16, although less potent than adriamycin, was equally toxic for wild type cell lines and drug resistant counterparts. Moreover, at 3-5 microM 16 inhibited topoisomerase I in vitro. Thus, our novel naphthoindole based derivative of tryptamine gained new activities important for anticancer therapy, namely, suppression of topoisomerase I and the ability to overcome resistance mediated by P-glycoprotein expression and p53 dysfunction.\n",
            "287710\n",
            "Inhibition of topoisomerase 1 assessed as attenuation of DNA relaxation at >10 uM\n",
            "Title: Naphthoindole-based analogues of tryptophan and tryptamine: synthesis and cytotoxic properties.  Abstract: The efficacy of anthracycline based anticancer drugs is limited by pleiotropic drug resistance of tumor cells. Aiming at the design of anthracyclinone congeners capable of circumventing drug resistance, we synthesized naphthoindole containing derivatives of tryptophan and tryptamine. In doing so we adapted the traditional, gramine based approach for tryptophan and tryptamine synthesis. The most potent new compound, 3-(2-aminoethyl)-4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione (16), was equally cytotoxic (IC(50) within low micromolar concentrations) for human K562 leukemia and HCT116 colon carcinoma cell lines and their isogenic sublines with genetically defined determinants of altered drug response, that is, the expression of the multidrug transporter P-glycoprotein and loss of pro-apoptotic p53. Each of these mechanisms conferred resistance to the reference drug adriamycin. In contrast, naphthotryptamine 16, although less potent than adriamycin, was equally toxic for wild type cell lines and drug resistant counterparts. Moreover, at 3-5 microM 16 inhibited topoisomerase I in vitro. Thus, our novel naphthoindole based derivative of tryptamine gained new activities important for anticancer therapy, namely, suppression of topoisomerase I and the ability to overcome resistance mediated by P-glycoprotein expression and p53 dysfunction.\n",
            "287711\n",
            "Inhibition of topoisomerase 1 at 3 uM\n",
            "Title: Naphthoindole-based analogues of tryptophan and tryptamine: synthesis and cytotoxic properties.  Abstract: The efficacy of anthracycline based anticancer drugs is limited by pleiotropic drug resistance of tumor cells. Aiming at the design of anthracyclinone congeners capable of circumventing drug resistance, we synthesized naphthoindole containing derivatives of tryptophan and tryptamine. In doing so we adapted the traditional, gramine based approach for tryptophan and tryptamine synthesis. The most potent new compound, 3-(2-aminoethyl)-4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione (16), was equally cytotoxic (IC(50) within low micromolar concentrations) for human K562 leukemia and HCT116 colon carcinoma cell lines and their isogenic sublines with genetically defined determinants of altered drug response, that is, the expression of the multidrug transporter P-glycoprotein and loss of pro-apoptotic p53. Each of these mechanisms conferred resistance to the reference drug adriamycin. In contrast, naphthotryptamine 16, although less potent than adriamycin, was equally toxic for wild type cell lines and drug resistant counterparts. Moreover, at 3-5 microM 16 inhibited topoisomerase I in vitro. Thus, our novel naphthoindole based derivative of tryptamine gained new activities important for anticancer therapy, namely, suppression of topoisomerase I and the ability to overcome resistance mediated by P-glycoprotein expression and p53 dysfunction.\n",
            "287712\n",
            "Inhibition of topoisomerase 1 at >50 uM\n",
            "Title: Naphthoindole-based analogues of tryptophan and tryptamine: synthesis and cytotoxic properties.  Abstract: The efficacy of anthracycline based anticancer drugs is limited by pleiotropic drug resistance of tumor cells. Aiming at the design of anthracyclinone congeners capable of circumventing drug resistance, we synthesized naphthoindole containing derivatives of tryptophan and tryptamine. In doing so we adapted the traditional, gramine based approach for tryptophan and tryptamine synthesis. The most potent new compound, 3-(2-aminoethyl)-4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione (16), was equally cytotoxic (IC(50) within low micromolar concentrations) for human K562 leukemia and HCT116 colon carcinoma cell lines and their isogenic sublines with genetically defined determinants of altered drug response, that is, the expression of the multidrug transporter P-glycoprotein and loss of pro-apoptotic p53. Each of these mechanisms conferred resistance to the reference drug adriamycin. In contrast, naphthotryptamine 16, although less potent than adriamycin, was equally toxic for wild type cell lines and drug resistant counterparts. Moreover, at 3-5 microM 16 inhibited topoisomerase I in vitro. Thus, our novel naphthoindole based derivative of tryptamine gained new activities important for anticancer therapy, namely, suppression of topoisomerase I and the ability to overcome resistance mediated by P-glycoprotein expression and p53 dysfunction.\n",
            "293172\n",
            "Binding affinity to topoisomerase 1 assessed as concentration needed for complete DNA re-supercoiling by Topo1 assay\n",
            "Title: Binding mode and affinity studies of DNA-binding agents using topoisomerase I DNA unwinding assay.  Abstract: A topoisomerase I DNA unwinding assay has been used to determine the relative DNA-binding affinities of a model pair of homologous naphthalene diimides. Binding affinity data were corroborated using calorimetric (ITC) and spectrophotometric (titration and T(m)) studies, with substituent size playing a significant role in binding. The assay was also used to investigate the mode of binding adopted by several known DNA-binding agents, including SYBR Green and PicoGreen. Some of the compounds exhibited unexpected binding modes.\n",
            "293480\n",
            "Inhibition of human topoisomerase 1-mediated DNA relaxation activity at 100 uM after 10 mins relative to control\n",
            "Title: Synthesis, cytotoxicity, and DNA topoisomerase II inhibitory activity of benzofuroquinolinediones.  Abstract: Benzofuroquinolinediones (7c and 7d) were synthesized by base-catalyzed condensation of dichloroquinolinediones with phenolic derivatives. Their dialkylaminoalkoxy derivatives (8i-8p) were prepared by reaction with various dialkylaminoalkyl chlorides. The cytotoxicity of the synthesized compounds was evaluated against eight types of human cancer cell lines, and their topoisomerase II inhibition was assessed. In general, the cytotoxicity of benzofuroquinolinediones (8i-8p) was similar or superior to that of doxorubicin and showed more potent inhibitory activity than naphthofurandiones (8a-8h). Also, most of the compounds exhibited excellent topoisomerase II inhibitory activity at a concentration of 5 microM and two compounds, 8d and 8i, showed IC50 values of 1.19 and 0.68 microM, respectively, and were much more potent than etoposide (IC50=78.4 microM), but similar to doxorubicin (IC50=2.67 microM). However their inhibitory activity on topoisomerase I was lower, and 8d and 8i showed IC50 values of 42.0 and 64.3 microM, respectively.\n",
            "293481\n",
            "Inhibition of human topoisomerase 1-mediated DNA relaxation activity at 5 uM after 10 mins relative to control\n",
            "Title: Synthesis, cytotoxicity, and DNA topoisomerase II inhibitory activity of benzofuroquinolinediones.  Abstract: Benzofuroquinolinediones (7c and 7d) were synthesized by base-catalyzed condensation of dichloroquinolinediones with phenolic derivatives. Their dialkylaminoalkoxy derivatives (8i-8p) were prepared by reaction with various dialkylaminoalkyl chlorides. The cytotoxicity of the synthesized compounds was evaluated against eight types of human cancer cell lines, and their topoisomerase II inhibition was assessed. In general, the cytotoxicity of benzofuroquinolinediones (8i-8p) was similar or superior to that of doxorubicin and showed more potent inhibitory activity than naphthofurandiones (8a-8h). Also, most of the compounds exhibited excellent topoisomerase II inhibitory activity at a concentration of 5 microM and two compounds, 8d and 8i, showed IC50 values of 1.19 and 0.68 microM, respectively, and were much more potent than etoposide (IC50=78.4 microM), but similar to doxorubicin (IC50=2.67 microM). However their inhibitory activity on topoisomerase I was lower, and 8d and 8i showed IC50 values of 42.0 and 64.3 microM, respectively.\n",
            "293483\n",
            "Inhibition of human topoisomerase 1 at 200 uM\n",
            "Title: Synthesis, cytotoxicity, and DNA topoisomerase II inhibitory activity of benzofuroquinolinediones.  Abstract: Benzofuroquinolinediones (7c and 7d) were synthesized by base-catalyzed condensation of dichloroquinolinediones with phenolic derivatives. Their dialkylaminoalkoxy derivatives (8i-8p) were prepared by reaction with various dialkylaminoalkyl chlorides. The cytotoxicity of the synthesized compounds was evaluated against eight types of human cancer cell lines, and their topoisomerase II inhibition was assessed. In general, the cytotoxicity of benzofuroquinolinediones (8i-8p) was similar or superior to that of doxorubicin and showed more potent inhibitory activity than naphthofurandiones (8a-8h). Also, most of the compounds exhibited excellent topoisomerase II inhibitory activity at a concentration of 5 microM and two compounds, 8d and 8i, showed IC50 values of 1.19 and 0.68 microM, respectively, and were much more potent than etoposide (IC50=78.4 microM), but similar to doxorubicin (IC50=2.67 microM). However their inhibitory activity on topoisomerase I was lower, and 8d and 8i showed IC50 values of 42.0 and 64.3 microM, respectively.\n",
            "296073\n",
            "Inhibition of human topoisomerase 1 by DNA relaxation assay\n",
            "Title: Design, synthesis and biological evaluation of new oligopyrrole carboxamides linked with tricyclic DNA-intercalators as potential DNA ligands or topoisomerase inhibitors.  Abstract: In the context of the design and synthesis of minor groove binding and intercalating DNA ligands some new oligopyrrole carboxamides were synthesized. These hybrid molecules (combilexins) possess a variable and conformatively flexible spacer at the N-terminal end. As intercalating tricyclic systems acridone, acridine, anthraquinones and in a special case iminostilbene terminate the N-terminal end of the pyrrole chain. The cytotoxicity was examined by the NCI antitumor screening, furthermore, biophysical as well as biochemical studies were performed in order to get some information about the DNA binding properties and topoisomerase inhibition effect of this new series of molecules.\n",
            "297066\n",
            "Inhibition of human topoisomerase 1 by DNA unwinding test\n",
            "Title: 2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin- 5-yl}carbamoyl)acetamide (UNBS3157), a novel nonhematotoxic naphthalimide derivative with potent antitumor activity.  Abstract: Amonafide (1), a naphthalimide which binds to DNA by intercalation and poisons topoisomerase IIalpha, has demonstrated activity in phase II breast cancer trials, but has failed thus far to enter clinical phase III because of dose-limiting bone marrow toxicity. Compound 17 (one of 41 new compounds synthesized) is a novel anticancer naphthalimide with a distinct mechanism of action, notably inducing autophagy and senescence in cancer cells. Compound 17 (2,2,2-trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-5-yl}carbamoyl)acetamide (UNBS3157)) was found to have a 3-4-fold higher maximum tolerated dose compared to amonafide and not to provoke hematotoxicity in mice at doses that display significant antitumor effects. Furthermore, 17 has shown itself to be superior to amonafide in vivo in models of (i) L1210 murine leukemia, (ii) MXT-HI murine mammary adenocarcinoma, and (iii) orthotopic models of human A549 NSCLC and BxPC3 pancreatic cancer. Compound 17, therefore, merits further investigation as a potential anticancer agent.\n",
            "299311\n",
            "Inhibition of human topoisomerase 1 using supercoiled pBR32 DNA substrate\n",
            "Title: Design, docking, and synthesis of novel indeno[1,2-c]isoquinolines for the development of antitumor agents as topoisomerase I inhibitors.  Abstract: An intramolecular radical cyclization reaction of 4-bromo-3-arylisoquinolines 11a-c allowed the efficient synthesis of 11-methylindenoisoquinolines 2a-c. 5-(2-Aminoethylamino)indeno[1,2-c]isoquinolin-11-one 4 was also prepared in the convenient manner. The synthesized compounds were tested in vitro for cytotoxicity and DNA-topoisomerase 1 (top 1) inhibitory activity. The dramatic enhancement of top 1 inhibitory activity of 4 was explained by a docking study using the FlexX program.\n",
            "299312\n",
            "Inhibition of human topoisomerase 1\n",
            "Title: Design, docking, and synthesis of novel indeno[1,2-c]isoquinolines for the development of antitumor agents as topoisomerase I inhibitors.  Abstract: An intramolecular radical cyclization reaction of 4-bromo-3-arylisoquinolines 11a-c allowed the efficient synthesis of 11-methylindenoisoquinolines 2a-c. 5-(2-Aminoethylamino)indeno[1,2-c]isoquinolin-11-one 4 was also prepared in the convenient manner. The synthesized compounds were tested in vitro for cytotoxicity and DNA-topoisomerase 1 (top 1) inhibitory activity. The dramatic enhancement of top 1 inhibitory activity of 4 was explained by a docking study using the FlexX program.\n",
            "300366\n",
            "Inhibition of topoisomerase 1\n",
            "Title: Synthesis and biological activities of isogranulatimide analogues.  Abstract: The synthesis of new isogranulatimide analogues, their inhibitory activities toward the Checkpoint 1 kinase (Chk1), and their in vitro cytotoxicities toward four tumor cell lines (one murine L1210 leukemia, and three human cell lines: DU145 prostate carcinoma, A549 non-small cell lung carcinoma, and HT29 colon carcinoma) are described. The affinity for DNA of some representative compounds and their ability to induce DNA cleavage mediated by topoisomerase I have been examined. In some of the newly synthesized compounds, the imidazole heterocycle of isogranulatimide is replaced by a pyrrole and/or the indole unit is replaced by a 7-azaindole. Compounds in which a sugar part is attached to the 7-azaindole moiety have also been prepared. Some of the newly synthesized compounds are more potent Chk1 inhibitors than granulatimide. The selectivity of two potent Chk1 inhibitors 24 and 26 has been evaluated using various kinases. The strongest inhibitory properties are found toward Chk1.\n",
            "300367\n",
            "Inhibition of topoisomerase 1 upto 50 uM\n",
            "Title: Synthesis and biological activities of isogranulatimide analogues.  Abstract: The synthesis of new isogranulatimide analogues, their inhibitory activities toward the Checkpoint 1 kinase (Chk1), and their in vitro cytotoxicities toward four tumor cell lines (one murine L1210 leukemia, and three human cell lines: DU145 prostate carcinoma, A549 non-small cell lung carcinoma, and HT29 colon carcinoma) are described. The affinity for DNA of some representative compounds and their ability to induce DNA cleavage mediated by topoisomerase I have been examined. In some of the newly synthesized compounds, the imidazole heterocycle of isogranulatimide is replaced by a pyrrole and/or the indole unit is replaced by a 7-azaindole. Compounds in which a sugar part is attached to the 7-azaindole moiety have also been prepared. Some of the newly synthesized compounds are more potent Chk1 inhibitors than granulatimide. The selectivity of two potent Chk1 inhibitors 24 and 26 has been evaluated using various kinases. The strongest inhibitory properties are found toward Chk1.\n",
            "309604\n",
            "Inhibition of topoisomerase 1 by supercoiled DNA unwinding method relative to camptothecin\n",
            "Title: Convenient synthesis of indeno[1,2-c]isoquinolines as constrained forms of 3-arylisoquinolines and docking study of a topoisomerase I inhibitor into DNA-topoisomerase I complex.  Abstract: 11-hydroxyindeno[1,2-c]isoquinolines 12a-c were prepared as constrained forms of 3-arylisoquinolines through an intramolecular cyclization reaction. Among the synthesized compounds, the 11-(i)butoxy analog 15l displayed potent in vitro cytotoxicity against four different tumor cell lines as well as topoisomerase 1 inhibitory activity. A FlexX docking study was performed to explain the topoisomerase 1 activity of 15l.\n",
            "312293\n",
            "Binding affinity to topoisomerase 1 in human K562 cells assessed as stability of topoisomerase 1-DNA complex at 70 uM after 48 hrs by TARDIS assay\n",
            "Title: Curcumin induces high levels of topoisomerase I- and II-DNA complexes in K562 leukemia cells.  Abstract: Recent data suggest that curcumin, a phytochemical with cancer chemopreventive potential, might be useful in the treatment of several solid and hematological malignancies. DNA topoisomerases (topos) are the target of several drugs commonly used in cancer chemotherapy. These drugs induce topo-DNA complexes with either topo I or topo II; then cellular processing converts these complexes into permanent DNA strand breaks that trigger cell death. Using the TARDIS in vivo assay, this study shows for the first time that curcumin induces topo I and topo II (alpha and beta)-DNA complexes in K562 leukemia cells. A comparative analysis revealed that the levels of these complexes were higher than those induced by several standard topo I and topo II inhibitors at equitoxic doses. Curcumin-induced topo I and topo II-DNA complexes were prevented by the antioxidant N-acetylcysteine; this suggests that, unlike the standard topo inhibitors, reactive oxygen species may mediate the formation of these complexes. Overall, this work shows that curcumin is capable of inducing topo-DNA complexes in cells with both topo I and topo II and increases the evidence suggesting that this dietary agent has potential to be tested in cancer chemotherapy.\n",
            "312295\n",
            "Reversal of drug-induced topoisomerase 1-DNA complex in presence of N-acetyl cysteine at 70 uM after 24 hrs\n",
            "Title: Curcumin induces high levels of topoisomerase I- and II-DNA complexes in K562 leukemia cells.  Abstract: Recent data suggest that curcumin, a phytochemical with cancer chemopreventive potential, might be useful in the treatment of several solid and hematological malignancies. DNA topoisomerases (topos) are the target of several drugs commonly used in cancer chemotherapy. These drugs induce topo-DNA complexes with either topo I or topo II; then cellular processing converts these complexes into permanent DNA strand breaks that trigger cell death. Using the TARDIS in vivo assay, this study shows for the first time that curcumin induces topo I and topo II (alpha and beta)-DNA complexes in K562 leukemia cells. A comparative analysis revealed that the levels of these complexes were higher than those induced by several standard topo I and topo II inhibitors at equitoxic doses. Curcumin-induced topo I and topo II-DNA complexes were prevented by the antioxidant N-acetylcysteine; this suggests that, unlike the standard topo inhibitors, reactive oxygen species may mediate the formation of these complexes. Overall, this work shows that curcumin is capable of inducing topo-DNA complexes in cells with both topo I and topo II and increases the evidence suggesting that this dietary agent has potential to be tested in cancer chemotherapy.\n",
            "314508\n",
            "Effect on stabilization of human recombinant topoisomerase 1-mediated DNA cleavage after 30 mins\n",
            "Title: Synthesis and cytotoxic activity of a new series of topoisomerase I inhibitors.  Abstract: A series of structurally simple analogues of natural topopyrone C were synthesized and tested for cytotoxic and topoisomerase I inhibitory activities. The removal of the hydroxyl groups at the 5 and 9 positions resulted in an increased cytotoxic potency and ability to stabilize topoisomerase-mediated cleavage. In addition, the results suggest that some structural features, such as the pyrone ring and a polar group in position 11, are fundamental for topoisomerase I inhibitory effect. These structural requirements are also consistent with the cytotoxic activity.\n",
            "314509\n",
            "Inhibition of human recombinant topoisomerase 1 assessed as DNA plasmid relaxation after 30 mins\n",
            "Title: Synthesis and cytotoxic activity of a new series of topoisomerase I inhibitors.  Abstract: A series of structurally simple analogues of natural topopyrone C were synthesized and tested for cytotoxic and topoisomerase I inhibitory activities. The removal of the hydroxyl groups at the 5 and 9 positions resulted in an increased cytotoxic potency and ability to stabilize topoisomerase-mediated cleavage. In addition, the results suggest that some structural features, such as the pyrone ring and a polar group in position 11, are fundamental for topoisomerase I inhibitory effect. These structural requirements are also consistent with the cytotoxic activity.\n",
            "317452\n",
            "Inhibition of topoisomerase 1-mediated DNA relaxation\n",
            "Title: Synthesis and biological evaluation of bengacarboline derivatives.  Abstract: Novel derivatives of the marine alkaloid bengacarboline have been synthesized. The seco derivatives 11 and 12 were evaluated for topoisomerase inhibition, DNA damages, cytotoxicity and cell cycle perturbation. The two synthetic analogs are more potent cytotoxic agents than bengacarboline and they both induce an accumulation of cells in the S phase of DNA synthesis. They do not function as topoisomerase inhibitors but trigger DNA damages in cells.\n",
            "322713\n",
            "Inhibition of human DNA topoisomerase 1 at 100 uM\n",
            "Title: 1-deoxyrubralactone, a novel specific inhibitor of families X and Y of eukaryotic DNA polymerases from a fungal strain derived from sea algae.  Abstract: Talaroflavone (1) and 1-deoxyrubralactone (2) are natural compounds isolated from cultures of a fungal strain derived from sea algae, and their structures were determined by spectroscopic analyses. Compound 2 is a novel rubralactone derivative, 6-hydroxy-8-methoxy-1-methyl-1,2,3a,9b-tetrahydrocyclopenta[c]isochromene-3,5-dione. These compounds selectively inhibited the activities of families X and Y of eukaryotic DNA polymerases (pols), and compound 2 was a stronger inhibitor than compound 1. The IC(50) values of compound 2 on rat pol beta, which is a pol of family X, and human pol kappa, which is a pol of family Y, were 11.9 and 59.8 microM, respectively. On the other hand, compounds 1 and 2 did not influence the activities of the other families of eukaryotic pols, such as family A (i.e., pol gamma) and family B (i.e., pols alpha, delta, and epsilon), and showed no effect even on the activities of plant pols alpha and beta, prokaryotic pols, and other DNA metabolic enzymes, such as calf primase of pol alpha, human immunodeficiency virus type-1 (HIV-1) reverse transcriptase, human telomerase, T7 RNA polymerase, mouse IMP dehydrogenase (type II), human topoisomerase I and II, T4 polynucleotide kinase, and bovine deoxyribonuclease I. This is the first report about the selective inhibitors of families X and Y of eukaryotic pols.\n",
            "328779\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 200 uM by agarose gel electrophoresis\n",
            "Title: Isoindolo[2,1-a]quinoxaline derivatives, novel potent antitumor agents with dual inhibition of tubulin polymerization and topoisomerase I.  Abstract: Isoindoloquinoxalines 4 and 5 were obtained by refluxing 2-(2'-aminoaryl)-1-cyanoisoindoles 3a- e in acetic or formic acid. All derivatives were screened by the National Cancer Institute (Bethesda, MD) for the in vitro one dose primary anticancer assay against a 3-cell line panel. Compounds 4a- e, screened against a panel of about 60 human tumor cell lines, showed remarkable antineoplastic activity; they had GI 50 values in the low micromolar or submicromolar range and reached, in the case of 4c, nanomolar concentrations on 88% of the 59 tested cell lines. Flow cytometric analysis of cell cycle after treatment with 4c demonstrated an arrest of the cell cycle in G2/M phase. This effect was accompanied with apoptosis of the cells, mitochondrial depolarization, generation of reactive oxygen species, and activation of caspase-3 and caspase-9. Moreover, 4c induced a clear increase in the mitotic index, inhibited microtubule assembly in vitro, and interestingly also acted as a topoisomerase I inhibitor.\n",
            "328780\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 20 uM by agarose gel electrophoresis\n",
            "Title: Isoindolo[2,1-a]quinoxaline derivatives, novel potent antitumor agents with dual inhibition of tubulin polymerization and topoisomerase I.  Abstract: Isoindoloquinoxalines 4 and 5 were obtained by refluxing 2-(2'-aminoaryl)-1-cyanoisoindoles 3a- e in acetic or formic acid. All derivatives were screened by the National Cancer Institute (Bethesda, MD) for the in vitro one dose primary anticancer assay against a 3-cell line panel. Compounds 4a- e, screened against a panel of about 60 human tumor cell lines, showed remarkable antineoplastic activity; they had GI 50 values in the low micromolar or submicromolar range and reached, in the case of 4c, nanomolar concentrations on 88% of the 59 tested cell lines. Flow cytometric analysis of cell cycle after treatment with 4c demonstrated an arrest of the cell cycle in G2/M phase. This effect was accompanied with apoptosis of the cells, mitochondrial depolarization, generation of reactive oxygen species, and activation of caspase-3 and caspase-9. Moreover, 4c induced a clear increase in the mitotic index, inhibited microtubule assembly in vitro, and interestingly also acted as a topoisomerase I inhibitor.\n",
            "331449\n",
            "Effect on human topoisomerase 1-mediated plasmid DNA cleavage relative to topotecan\n",
            "Title: Facile formation of hydrophilic derivatives of 5H-8,9-dimethoxy-5-[2-(N,N-dimethylamino)ethyl]-2,3-methylenedioxydibenzo[c,h] [1,6]naphthyridin-6-one (ARC-111) and its 12-aza analog via quaternary ammonium intermediates.  Abstract: Several new TOP1-targeting agents were prepared using as intermediates the N,N,N-trimethyl quaternary ammonium salts of either ARC-111 or its 12-aza analog (ARC-31), 3 and 4, respectively. Direct displacement of the quaternary ammonium group with water, imidazole, alkylethylenediamines, or polyhydroxylated alkylamines provides a convenient means for furthering the structure-activity relationships associated with these non-camptothecin TOP1-targeting agents.\n",
            "331828\n",
            "Stimulation of human topoisomerase 1-mediated DNA damage at 10 uM after 10 mins in presence of sodium chloride\n",
            "Title: E-ring-modified 7-oxyiminomethyl camptothecins: Synthesis and preliminary in vitro and in vivo biological evaluation.  Abstract: In contrast to five-membered E-ring analogues, 7-oxyiminomethyl derivatives of homocamptothecins showed ability to form stable ternary complexes with DNA and topoisomerase I. The 7-oxyiminomethyl derivatives of homocamptothecins were evaluated as a racemic mixture. Following the isolation of the two enantiomers, the 20 (R)-hydroxy isomer confirms the best activity. By using a panel of human tumor cells, all tested homocamptothecins showed a potent antiproliferative activity, correlating to the persistence of the cleavable complex. No significant difference was observed between the natural scaffold and the corresponding homocamptothecin homologue. A selected compound of this series exhibited an excellent antitumor activity against human gastrointestinal tumor xenografts.\n",
            "333055\n",
            "Inhibition of topoisomerase 1-mediated relaxation of supercoiled DNA assessed as DNA cleavage at 9 uM relative to control\n",
            "Title: Cytotoxic pyrroloiminoquinones from four new species of South African latrunculid sponges.  Abstract: An examination of organic extracts of four new species of South African latrunculid sponges, Tsitsikamma pedunculata, T. favus, Latrunculia bellae, and Strongylodesma algoaensis, yielded 13 known and eight new pyrroloiminoquinone alkaloids, 3-dihydro-7,8-dehydrodiscorhabdin C (4), 14-bromo-3-dihydro-7,8-dehydrodiscorhabdin C (5), discorhabdin V (6), 14-bromo-1-hydroxydiscorhabdin V (7), tsitsikammamine A N-18 oxime (10), tsitsikammamine B N-18 oxime (11), 1-methoxydiscorhabdin D (12), and 1-aminodiscorhabdin D (13). Standard spectroscopic methods provided the structures of the pyrroloiminoquinone metabolites, while chiral GC-MS analysis of the acylated ozonolysis products of 21 confirmed the stereochemistry of the l-histidine residue in this compound. The anticancer activity of 20 pyrroloiminoquinone compounds was explored in the HCT-116 cancer cell line screen, and the DNA intercalation of the tsitsikammamines, together with their ability to cleave DNA through topoisomerase I inhibition, is discussed.\n",
            "333057\n",
            "Inhibition of topoisomerase 1-mediated relaxation of supercoiled DNA assessed as DNA cleavage at 500 uM relative to control\n",
            "Title: Cytotoxic pyrroloiminoquinones from four new species of South African latrunculid sponges.  Abstract: An examination of organic extracts of four new species of South African latrunculid sponges, Tsitsikamma pedunculata, T. favus, Latrunculia bellae, and Strongylodesma algoaensis, yielded 13 known and eight new pyrroloiminoquinone alkaloids, 3-dihydro-7,8-dehydrodiscorhabdin C (4), 14-bromo-3-dihydro-7,8-dehydrodiscorhabdin C (5), discorhabdin V (6), 14-bromo-1-hydroxydiscorhabdin V (7), tsitsikammamine A N-18 oxime (10), tsitsikammamine B N-18 oxime (11), 1-methoxydiscorhabdin D (12), and 1-aminodiscorhabdin D (13). Standard spectroscopic methods provided the structures of the pyrroloiminoquinone metabolites, while chiral GC-MS analysis of the acylated ozonolysis products of 21 confirmed the stereochemistry of the l-histidine residue in this compound. The anticancer activity of 20 pyrroloiminoquinone compounds was explored in the HCT-116 cancer cell line screen, and the DNA intercalation of the tsitsikammamines, together with their ability to cleave DNA through topoisomerase I inhibition, is discussed.\n",
            "334464\n",
            "Inhibition of human COLO201 cellular topoisomerase-1 mediated plasmid DNA cleavage by electrophoresis in presence of 70 units of enzyme\n",
            "Title: A strategy for identifying novel, mechanistically unique inhibitors of topoisomerase I.  Abstract: While the design of molecules that inhibit or antagonize the functions of specific macromolecules is now well precedented, in many cases the structural information requisite to the design process is lacking. The tools of molecular biology can now furnish the target macromolecules for use in mechanism-based exploration; highly defined assays can be devised based upon the known biochemistry of these macromolecules to permit the discovery of novel inhibitors or antagonists present in chemical collections. Presently, we describe a set of assays directed toward the discovery of novel inhibitors of eukaryotic topoisomerase I, an enzyme critical to maintenance of chromosomal DNA topology and therefore essential for normal replication and transcription. The identification of chebulagic acid as an extraordinarily potent and mechanically novel inhibitor of topoisomerase I illustrates the potential of this approach.\n",
            "334465\n",
            "Inhibition of human COLO201 cellular topoisomerase-1 mediated plasmid DNA cleavage by electrophoresis in presence of 14 units of enzyme\n",
            "Title: A strategy for identifying novel, mechanistically unique inhibitors of topoisomerase I.  Abstract: While the design of molecules that inhibit or antagonize the functions of specific macromolecules is now well precedented, in many cases the structural information requisite to the design process is lacking. The tools of molecular biology can now furnish the target macromolecules for use in mechanism-based exploration; highly defined assays can be devised based upon the known biochemistry of these macromolecules to permit the discovery of novel inhibitors or antagonists present in chemical collections. Presently, we describe a set of assays directed toward the discovery of novel inhibitors of eukaryotic topoisomerase I, an enzyme critical to maintenance of chromosomal DNA topology and therefore essential for normal replication and transcription. The identification of chebulagic acid as an extraordinarily potent and mechanically novel inhibitor of topoisomerase I illustrates the potential of this approach.\n",
            "334466\n",
            "Inhibition of human COLO201 cellular topoisomerase-1 mediated plasmid DNA cleavage by electrophoresis in presence of very low concentration of enzyme\n",
            "Title: A strategy for identifying novel, mechanistically unique inhibitors of topoisomerase I.  Abstract: While the design of molecules that inhibit or antagonize the functions of specific macromolecules is now well precedented, in many cases the structural information requisite to the design process is lacking. The tools of molecular biology can now furnish the target macromolecules for use in mechanism-based exploration; highly defined assays can be devised based upon the known biochemistry of these macromolecules to permit the discovery of novel inhibitors or antagonists present in chemical collections. Presently, we describe a set of assays directed toward the discovery of novel inhibitors of eukaryotic topoisomerase I, an enzyme critical to maintenance of chromosomal DNA topology and therefore essential for normal replication and transcription. The identification of chebulagic acid as an extraordinarily potent and mechanically novel inhibitor of topoisomerase I illustrates the potential of this approach.\n",
            "336292\n",
            "Inhibition of DNA topoisomerase 1\n",
            "Inhibition of DNA topoisomerase 1\n",
            "344134\n",
            "Inhibition of topoisomerase 1 mediated DNA relaxation activity\n",
            "Title: Synthesis and evaluation of unsymmetrical polyamine derivatives as antitumor agents.  Abstract: A series of unsymmetrically substituted polyamine derivatives were prepared and their cytotoxicities in mouse leukemia L1210, melanoma B16, and HeLa cells were investigated. The in vitro cytotoxicity revealed that these conjugates could recognize the polyamine transporter, and the N-ethyl modified homospermidine moiety may be another efficient carrier as homospermidine even though the introduction of terminal alkyl groups led to reduced cytotoxicity in comparison with the un-substituted counterpart 1. The ornithine decarboxylase and topoisomerase II inhibition experiments indicated that ODC and TOPO II were potential, but not unique targets of these conjugates. Furthermore, the in vivo antitumor activities illustrated that the representative conjugate 2f and the homospermidine analogue 1 evidently inhibited the tumor growth and significantly increased the survival time of mice-bearing sarcoma 180 cells.\n",
            "345172\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA up to 6.25 ug/mL after 30 mins by agarose gel electrophoresis\n",
            "Title: The contribution of plukenetione A to the anti-tumoral activity of Cuban propolis.  Abstract: Increasing efforts are directed toward finding applications for natural products and their derivatives in the treatment of human diseases. Among such products, propolis, a resinous substance produced by honey bees from various plant sources, has been found to be a promising source of potential therapeutics. In the present work, we aimed at studying the perspective of Cuban propolis as a source of possible anti-cancer agents. We found an anti-metastatic effect in mice and considerable cytotoxicity without cross-resistance in both wild-type and chemoresistant human tumor cell lines. Plukenetione A--identified for the first time in Cuban propolis--induced G0/G1 arrest and DNA fragmentation in colon carcinoma cells. Furthermore, the activities of both topoisomerase I and DNA polymerase were inhibited, while the expression of topoisomerase II-beta, EGF receptor, and multidrug resistance-related protein genes was found repressed. We assume that plukenetione A contributes to the anti-tumoral effect of Cuban propolis mainly by targeting topoisomerase I as well as DNA polymerase.\n",
            "345173\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA up to 12.5 ug/mL after 30 mins by agarose gel electrophoresis\n",
            "Title: The contribution of plukenetione A to the anti-tumoral activity of Cuban propolis.  Abstract: Increasing efforts are directed toward finding applications for natural products and their derivatives in the treatment of human diseases. Among such products, propolis, a resinous substance produced by honey bees from various plant sources, has been found to be a promising source of potential therapeutics. In the present work, we aimed at studying the perspective of Cuban propolis as a source of possible anti-cancer agents. We found an anti-metastatic effect in mice and considerable cytotoxicity without cross-resistance in both wild-type and chemoresistant human tumor cell lines. Plukenetione A--identified for the first time in Cuban propolis--induced G0/G1 arrest and DNA fragmentation in colon carcinoma cells. Furthermore, the activities of both topoisomerase I and DNA polymerase were inhibited, while the expression of topoisomerase II-beta, EGF receptor, and multidrug resistance-related protein genes was found repressed. We assume that plukenetione A contributes to the anti-tumoral effect of Cuban propolis mainly by targeting topoisomerase I as well as DNA polymerase.\n",
            "346586\n",
            "Induction of human recombinant topoisomerase 1-mediated SV40 DNA cleavage at 1 to 50 uM after 30 mins by PAGE\n",
            "Title: Semisynthesis, biological activity, and molecular modeling studies of C-ring-modified camptothecins.  Abstract: The synthesis, biological activity, and molecular modeling studies of C-ring-modified camptothecins are reported. A general synthetic protocol, based on \"C-5 camptothecin (C-5-CPT) enolate chemistry\", allows one to obtain various C5-substituted analogues. All new compounds, obtained as 1:1 epimeric mixtures, were tested for their antiproliferative activity. Experimental data showed that all novel derivatives are less active than the reference compounds and that one of the two epimers is more active than the other. Molecular docking simulations were performed to achieve more insight into the interactions between the new C5-modified CPTs and Topo I. A good correlation was observed when the data of cytotoxicity and the values calculated for the free binding energy were combined.\n",
            "350320\n",
            "Inhibition of human DNA topoisomerase 1-mediated DNA cleavage assessed as relaxation of supercoiled pBR322 plasmid DNA after 15 mins by densitometer\n",
            "Title: Synthesis and biological activities of topoisomerase I inhibitors, 6-arylmethylamino analogues of edotecarin.  Abstract: The replacement of 1,3-dihydroxy-2-propylamino moiety at the N6-position of edotecarin (1) by arylmethylamino groups yielded a number of more potent topoisomerase I inhibitors with better cytotoxic (CTX) activities in vitro than edotecarin. Among them, the three most potent pyridylmethyl analogues, compounds 22g, 22m, and 23c, showed better antitumor activities against MKN-45 human stomach cancer or MX-1 human breast cancer xenografted mice than those of edotecarin. Furthermore, compounds 22m and 23c exhibited complete response against MX-1 cells implanted in mice.\n",
            "353083\n",
            "Inhibition of DNA topoisomerase 1 assessed as relaxation of supercoiled Escherichia coli pBR322 DNA at 100 uM\n",
            "Title: Molecular design, synthesis and docking study of benz[b]oxepines and 12-oxobenzo[c]phenanthridinones as topoisomerase 1 inhibitors.  Abstract: Benz[b]oxepines 4a-g and 12-oxobenzo[c]phenanthridines 5a-d were designed and synthesized as constrained forms of 3-arylisoquinolines through an intramolecular radical cyclization reaction. Radical cyclization of O-vinyl compounds preferentially led to the 7-endo-trig cyclization pathway to the benz[b]oxepines and 12-oxobenzo[c]phenanthridines through 6-exo-trig path as minor products. Among the synthesized compounds, benz[b]oxepine derivative 4e exhibited potent in vitro cytotoxicity against three different tumor cell lines, as well as topoisomerase 1 inhibitory activity. A Surflex-Dock docking study was performed to clarify the topoisomerase 1 activity of 4e.\n",
            "354858\n",
            "Inhibition of DNA topoisomerase 1\n",
            "Title: DNA topoisomerase I inhibitors: cytotoxic flavones from Lethedon tannaensis.  Abstract: From ethyl acetate and methanolic extracts of Lethedon tannaensis leaves, which were cytotoxic against murine leukemia (P-388) and human nasopharynx carcinoma (KB) cells, one new and six known 5-hydroxy-7-methoxyflavones variously substituted on the B ring were isolated and their structures determined by spectral analysis. Compounds active against KB cells were velutin (4) (IC50 4.8 microM), 7,3',5'-tri-O-methyltricetin (2) (IC50 22.2 microM), genkwanin (6) (IC50 30.6 microM), and the novel compound, 7,3',4'-tri-O-methyltricetin, named lethedocin (1) (IC50 47.6 microM). These flavones required the presence of hydroxyl groups at C-5 and C-4' and methoxyl groups at C-7 and C-3' for inhibition of calf thymus DNA topoisomerase I activity.\n",
            "358916\n",
            "Inhibition of human topoisomerase 1 assessed as relaxation of supercoiled pBR322 DNA up to 200 uM by agarose gel electrophoresis\n",
            "Title: Screening of triterpenoids isolated from Phyllanthus flexuosus for DNA topoisomerase inhibitory activity.  Abstract: DNA topoisomerases (Topos) are enzymes that play a crucial role in DNA metabolism events such as replication, transcription, recombination, and chromosome segregation at mitosis. Thus, Topo inhibitors could be expected to have antitumor effects. Naturally occurring lupane- and oleanane-type triterpenoids isolated from the bark of Phyllanthus flexuosus were screened for human Topos I and II inhibitory activities. Olean-12-en-3 beta,15 alpha-diol (1), olean-12-en-3 beta,15 alpha,24-triol (3), lupeol (4), and betulin (6) were found to be selective catalytic inhibitors of human Topo II activity with IC(50) values in the range of 10-39 microM.\n",
            "361234\n",
            "Inhibition topoisomerase 1 in human A549 cells assessed as conversion of supercoiled pBR322 DNA to relaxed form\n",
            "Title: Isoaurostatin, a novel topoisomerase inhibitor produced by Thermomonospora alba.  Abstract: A novel inhibitor of topoisomerase I designated as isoaurostatin (1) was isolated from the culture filtrate of Thermomonospora alba strain No. 1520. The structure of 1 was determined to be 6,4'-dihydroxyisoaurone on the basis of spectroscopic (NMR and MS) methods. Compound 1 inhibited the relaxation activity of calf thymus topoisomerase I in a noncompetitive manner and did not inhibit the relaxation and decatenation of human placenta topoisomerase II. Compound 1 is an inhibitor belonging to cleavable complex-nonforming type without DNA intercalation.\n",
            "361235\n",
            "Inhibition topoisomerase 1 in human COLO201 cells assessed as conversion of supercoiled pBR322 DNA to relaxed form\n",
            "Title: Isoaurostatin, a novel topoisomerase inhibitor produced by Thermomonospora alba.  Abstract: A novel inhibitor of topoisomerase I designated as isoaurostatin (1) was isolated from the culture filtrate of Thermomonospora alba strain No. 1520. The structure of 1 was determined to be 6,4'-dihydroxyisoaurone on the basis of spectroscopic (NMR and MS) methods. Compound 1 inhibited the relaxation activity of calf thymus topoisomerase I in a noncompetitive manner and did not inhibit the relaxation and decatenation of human placenta topoisomerase II. Compound 1 is an inhibitor belonging to cleavable complex-nonforming type without DNA intercalation.\n",
            "361236\n",
            "Inhibition topoisomerase 1 in human HeLa cells assessed as conversion of supercoiled pBR322 DNA to relaxed form\n",
            "Title: Isoaurostatin, a novel topoisomerase inhibitor produced by Thermomonospora alba.  Abstract: A novel inhibitor of topoisomerase I designated as isoaurostatin (1) was isolated from the culture filtrate of Thermomonospora alba strain No. 1520. The structure of 1 was determined to be 6,4'-dihydroxyisoaurone on the basis of spectroscopic (NMR and MS) methods. Compound 1 inhibited the relaxation activity of calf thymus topoisomerase I in a noncompetitive manner and did not inhibit the relaxation and decatenation of human placenta topoisomerase II. Compound 1 is an inhibitor belonging to cleavable complex-nonforming type without DNA intercalation.\n",
            "361444\n",
            "Inhibition of human DNA topoisomerase 1\n",
            "Title: Total synthesis and biological evaluation of (5Z,9Z)-5,9-hexadecadienoic acid, an inhibitor of human topoisomerase I.  Abstract: The naturally occurring (5Z,9Z)-5,9-hexadecadienoic acid was synthesized stereochemically pure in six steps starting with commercially available 1,5-hexadiyne. The title compound was antimicrobial against the Gram-positive bacteria Staphylococcus aureus (MIC 80 microM) and Streptococcus faecalis (MIC 200 microM), but inactive against Gram-negative bacteria such as Pseudomonas aeruginosa. In addition, the (5Z,9Z)-5,9-hexadecadienoic acid completely inhibits human topoisomerase I at a concentration of 800 microM, while 5,9-hexadecadiynoic acid and hexadecanoic acid do not inhibit topoisomerase I (>1000 microM). This comparison reveals that the cis double bond geometry in the title compound is required for topoisomerase I inhibition. Moreover, these results suggest that the antimicrobial activity of (5Z,9Z)-5,9-hexadecadienoic acid against either S. aureus or S. faecalis could be a result, at least in part, of the inhibitory activity of the acid against topoisomerases.\n",
            "361445\n",
            "Inhibition of DNA topoisomerase 1\n",
            "Title: Total synthesis and biological evaluation of (5Z,9Z)-5,9-hexadecadienoic acid, an inhibitor of human topoisomerase I.  Abstract: The naturally occurring (5Z,9Z)-5,9-hexadecadienoic acid was synthesized stereochemically pure in six steps starting with commercially available 1,5-hexadiyne. The title compound was antimicrobial against the Gram-positive bacteria Staphylococcus aureus (MIC 80 microM) and Streptococcus faecalis (MIC 200 microM), but inactive against Gram-negative bacteria such as Pseudomonas aeruginosa. In addition, the (5Z,9Z)-5,9-hexadecadienoic acid completely inhibits human topoisomerase I at a concentration of 800 microM, while 5,9-hexadecadiynoic acid and hexadecanoic acid do not inhibit topoisomerase I (>1000 microM). This comparison reveals that the cis double bond geometry in the title compound is required for topoisomerase I inhibition. Moreover, these results suggest that the antimicrobial activity of (5Z,9Z)-5,9-hexadecadienoic acid against either S. aureus or S. faecalis could be a result, at least in part, of the inhibitory activity of the acid against topoisomerases.\n",
            "361450\n",
            "Inhibition of human DNA topoisomerase 1 assessed as inhibition of uncoiling of supercoiled Tetrahymena pHOT1 DNA at 800 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Total synthesis and biological evaluation of (5Z,9Z)-5,9-hexadecadienoic acid, an inhibitor of human topoisomerase I.  Abstract: The naturally occurring (5Z,9Z)-5,9-hexadecadienoic acid was synthesized stereochemically pure in six steps starting with commercially available 1,5-hexadiyne. The title compound was antimicrobial against the Gram-positive bacteria Staphylococcus aureus (MIC 80 microM) and Streptococcus faecalis (MIC 200 microM), but inactive against Gram-negative bacteria such as Pseudomonas aeruginosa. In addition, the (5Z,9Z)-5,9-hexadecadienoic acid completely inhibits human topoisomerase I at a concentration of 800 microM, while 5,9-hexadecadiynoic acid and hexadecanoic acid do not inhibit topoisomerase I (>1000 microM). This comparison reveals that the cis double bond geometry in the title compound is required for topoisomerase I inhibition. Moreover, these results suggest that the antimicrobial activity of (5Z,9Z)-5,9-hexadecadienoic acid against either S. aureus or S. faecalis could be a result, at least in part, of the inhibitory activity of the acid against topoisomerases.\n",
            "361451\n",
            "Inhibition of human DNA topoisomerase 1 assessed as inhibition of uncoiling of supercoiled Tetrahymena pHOT1 DNA at > 1000 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Total synthesis and biological evaluation of (5Z,9Z)-5,9-hexadecadienoic acid, an inhibitor of human topoisomerase I.  Abstract: The naturally occurring (5Z,9Z)-5,9-hexadecadienoic acid was synthesized stereochemically pure in six steps starting with commercially available 1,5-hexadiyne. The title compound was antimicrobial against the Gram-positive bacteria Staphylococcus aureus (MIC 80 microM) and Streptococcus faecalis (MIC 200 microM), but inactive against Gram-negative bacteria such as Pseudomonas aeruginosa. In addition, the (5Z,9Z)-5,9-hexadecadienoic acid completely inhibits human topoisomerase I at a concentration of 800 microM, while 5,9-hexadecadiynoic acid and hexadecanoic acid do not inhibit topoisomerase I (>1000 microM). This comparison reveals that the cis double bond geometry in the title compound is required for topoisomerase I inhibition. Moreover, these results suggest that the antimicrobial activity of (5Z,9Z)-5,9-hexadecadienoic acid against either S. aureus or S. faecalis could be a result, at least in part, of the inhibitory activity of the acid against topoisomerases.\n",
            "361452\n",
            "Inhibition of human DNA topoisomerase 1 assessed as inhibition of uncoiling of supercoiled Tetrahymena pHOT1 DNA at 2000 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Total synthesis and biological evaluation of (5Z,9Z)-5,9-hexadecadienoic acid, an inhibitor of human topoisomerase I.  Abstract: The naturally occurring (5Z,9Z)-5,9-hexadecadienoic acid was synthesized stereochemically pure in six steps starting with commercially available 1,5-hexadiyne. The title compound was antimicrobial against the Gram-positive bacteria Staphylococcus aureus (MIC 80 microM) and Streptococcus faecalis (MIC 200 microM), but inactive against Gram-negative bacteria such as Pseudomonas aeruginosa. In addition, the (5Z,9Z)-5,9-hexadecadienoic acid completely inhibits human topoisomerase I at a concentration of 800 microM, while 5,9-hexadecadiynoic acid and hexadecanoic acid do not inhibit topoisomerase I (>1000 microM). This comparison reveals that the cis double bond geometry in the title compound is required for topoisomerase I inhibition. Moreover, these results suggest that the antimicrobial activity of (5Z,9Z)-5,9-hexadecadienoic acid against either S. aureus or S. faecalis could be a result, at least in part, of the inhibitory activity of the acid against topoisomerases.\n",
            "362301\n",
            "Inhibition of human topoisomerase 1 expressed in Escherichia coli assessed as YepG plasmid DNA cleavage\n",
            "Title: Syntheses and biological evaluation of topoisomerase I-targeting agents related to 11-[2-(N,N-dimethylamino)ethyl]-2,3-dimethoxy-8,9-methylenedioxy-11H-isoquino[4,3-c]cinnolin-12-one (ARC-31).  Abstract: Several 11-ethyl-2,3-dimethoxy-8,9-methylenedioxy-11H-isoquino[4,3-c]cinnolin-12-ones with varied functionality on the ethyl substituent have exhibited potent topoisomerase I (TOP1) targeting activity and antitumor activity. The influence of various polar substituents at the 2-position of the 11-ethyl substituent, including N-methylamine, N-isopropylamine, hydroxyl, and hydroxylamino groups, on TOP1-targeting activity and cytotoxicity was assessed. The N-methylamine and N-isopropylamine derivatives were also evaluated as antitumor agents in athymic nude mice with MDA-MB-435 human tumor xenografts. Both compounds were active as antitumor agents upon either parenteral or oral administration.\n",
            "366208\n",
            "Inhibition of human recombinant topoisomerase 1 assessed as DNA cleavage relative to 1 uM camptothecin\n",
            "Title: Design, synthesis, and biological evaluation of 14-substituted aromathecins as topoisomerase I inhibitors.  Abstract: The aromathecin or \"rosettacin\" class of topoisomerase I (top1) inhibitors is effectively a \"composite\" of the natural products camptothecin and luotonin A and the synthetic indenoisoquinolines. The aromathecins have aroused considerable interest following the isolation and total synthesis of 22-hydroxyacuminatine, a rare cytotoxic natural product containing the 12 H-5,11a-diazadibenzo[ b, h]fluoren-11-one system. We have developed two novel syntheses of this system and prepared a series of 14-substituted aromathecins as novel antiproliferative topoisomerase I poisons. These inhibitors are proposed to act via an intercalation and \"poisoning\" mechanism identical to camptothecin and the indenoisoquinolines. Many of these compounds possess greater antiproliferative activity and anti-top1 activity than the parent unsubstituted compound (rosettacin) and previously synthesized aromathecins, as well as greater top1 inhibitory activity than 22-hydroxyacuminatine. In addition to potentially aiding solubility and localization to the DNA-enzyme complex, nitrogenous substituents located at the 14-position of the aromathecin system have been proposed to project into the major groove of the top1-DNA complex and hydrogen-bond to major-groove amino acids, thereby stabilizing the ternary complex.\n",
            "366217\n",
            "Induction of human recombinant topoisomerase 1-mediated DNA cleavage at 100 uM\n",
            "Title: Design, synthesis, and biological evaluation of 14-substituted aromathecins as topoisomerase I inhibitors.  Abstract: The aromathecin or \"rosettacin\" class of topoisomerase I (top1) inhibitors is effectively a \"composite\" of the natural products camptothecin and luotonin A and the synthetic indenoisoquinolines. The aromathecins have aroused considerable interest following the isolation and total synthesis of 22-hydroxyacuminatine, a rare cytotoxic natural product containing the 12 H-5,11a-diazadibenzo[ b, h]fluoren-11-one system. We have developed two novel syntheses of this system and prepared a series of 14-substituted aromathecins as novel antiproliferative topoisomerase I poisons. These inhibitors are proposed to act via an intercalation and \"poisoning\" mechanism identical to camptothecin and the indenoisoquinolines. Many of these compounds possess greater antiproliferative activity and anti-top1 activity than the parent unsubstituted compound (rosettacin) and previously synthesized aromathecins, as well as greater top1 inhibitory activity than 22-hydroxyacuminatine. In addition to potentially aiding solubility and localization to the DNA-enzyme complex, nitrogenous substituents located at the 14-position of the aromathecin system have been proposed to project into the major groove of the top1-DNA complex and hydrogen-bond to major-groove amino acids, thereby stabilizing the ternary complex.\n",
            "376730\n",
            "Inhibition of topoisomerase 1\n",
            "Title: Lyngbyastatin 2 and norlyngbyastatin 2, analogues of dolastatin G and nordolastatin G from the marine cyanobacterium Lyngbya majuscula.  Abstract: Lyngbyastatin 2 (1) and norlyngbyastatin 2 (2), new cytotoxic analogues of dolastatin G (3) and nordolastatin G (4), respectively, have been isolated as constituents from a Guamanian variety of the marine cyanobacterium Lyngbya majuscula. Structure elucidation of these cyclic depsipeptides relied on extensive application of 2D NMR techniques. The finding of these new metabolites further supports the proposal that many compounds originally isolated from the sea hare Dolabella auricularia are most likely of cyanobacterial origin.\n",
            "377538\n",
            "Inhibition of human topoisomerase 1 assessed as stability of enzyme-pBr322 plasmid DNA covalent binary complex at 20 uM after 60 mins by electrophoretic assay\n",
            "Title: Use of COMPARE analysis to discover new natural product drugs: isolation of camptothecin and 9-methoxycamptothecin from a new source.  Abstract: Analysis of cytotoxicity data of extracts from the National Cancer Institute's Active Repository by the COMPARE protocol was carried out using camptothecin as a reference point. Extracts identified by this process were further characterized by a selective yeast bioassay for inhibitors of topoisomerase I and by a biochemical assay for compounds that stabilize the topoisomerase I-DNA covalent binary complex. Five of the extracts were positive in the yeast bioassay, and eight extracts showed activity on the assay that monitors stabilization of the topoisomerase I-DNA complex. Four of the latter extracts were inactive in the yeast bioassay, and thus would not have been identified as hits without the COMPARE preselection process. One of the extracts, from Pyrenacantha klaineana, was selected for detailed investigation, and fractionation of this extract yielded camptothecin and 9-methoxycamptothecin as the bioactive constituents.\n",
            "378110\n",
            "Inhibition of topoisomerase 1 at 10 to 100 uM\n",
            "Title: Cytotoxic sesquiterpenoids from Ratibida columnifera.  Abstract: Bioassay-directed fractionation of the flowers and leaves of Ratibida columnifera using a hormone-dependent human prostate (LNCaP) cancer cell line led to the isolation of 10 cytotoxic substances, composed of five novel xanthanolide derivatives (2-4, 7, and 8), a novel nerolidol derivative (9), and three known sesquiterpene lactones, 9alpha-hydroxy-seco-ratiferolide-5alpha-O-angelate+ ++ (1), 9alpha-hydroxy-seco-ratiferolide-5alpha-O-(2-methylbut yrate) (5), 9-oxo-seco-ratiferolide-5alpha-O-(2-methylbutyrate) (6), as well as a known flavonoid, hispidulin (10). On the basis of its cytotoxicity profile, compound 5 was selected for further biological evaluation, and was found to induce G1 arrest and slow S traverse time in parental wild type p53 A2780S cells, but only G2/M arrest in p53 mutant A2780R cells, with strong apoptosis shown for both cell lines. The activity of 5 was not mediated by the multidrug resistance (MDR) pump, and it was not active against several anticancer molecular targets (i.e., tubulin polymerization/depolymerization, topoisomerases, and DNA intercalation). While these results indicate that compound 5 acts as a cytotoxic agent via a novel mechanism, this substance was inactive in in vivo evaluations using the murine lung carcinoma (M109) and human colon carcinoma (HCT116) models.\n",
            "379271\n",
            "Induction of human recombinant topoisomerase 1-mediated pBR322 plasmid DNA cleavage assessed as increase in nicked form 2 at 100 uM after 60 mins\n",
            "Title: Isolation and biochemical characterization of a new topoisomerase I inhibitor from Ocotea leucoxylon.  Abstract: In a continuation of our search for potential tumor inhibitors from plants, we found that a crude extract from Ocotea leucoxylon showed selective activity typical of inhibitors of the enzyme topoisomerase I in a yeast assay for DNA-damaging agents. Using a bioassay-directed fractionation approach, the major bioactive compound was isolated and identified as the known aporphine alkaloid dicentrinone (4); the inactive alkaloid dicentrine (3) was also isolated. Compound 4 showed selective bioactivity against the rad52 repair-deficient yeast strain RS322 (IC(12) 49 microg/mL) and was inactive against the rad52- and topo1-deficient strain RS321 (IC(12) > 2000 microg/mL) and against the repair-proficient strain RJ03 (IC(12) > 2000 microg/mL). Biochemical studies with recombinant human topoisomerase I indicated that dicentrinone (4) is an inhibitor of the human enzyme. Colony formation studies suggest that it is weakly cytotoxic, but that its mechanism of toxicity differs from that of camptothecin and its derivatives.\n",
            "379272\n",
            "Induction of human recombinant topoisomerase 1-mediated pBR322 plasmid DNA cleavage assessed as increase in nicked form 2 at 50 uM after 60 mins\n",
            "Title: Isolation and biochemical characterization of a new topoisomerase I inhibitor from Ocotea leucoxylon.  Abstract: In a continuation of our search for potential tumor inhibitors from plants, we found that a crude extract from Ocotea leucoxylon showed selective activity typical of inhibitors of the enzyme topoisomerase I in a yeast assay for DNA-damaging agents. Using a bioassay-directed fractionation approach, the major bioactive compound was isolated and identified as the known aporphine alkaloid dicentrinone (4); the inactive alkaloid dicentrine (3) was also isolated. Compound 4 showed selective bioactivity against the rad52 repair-deficient yeast strain RS322 (IC(12) 49 microg/mL) and was inactive against the rad52- and topo1-deficient strain RS321 (IC(12) > 2000 microg/mL) and against the repair-proficient strain RJ03 (IC(12) > 2000 microg/mL). Biochemical studies with recombinant human topoisomerase I indicated that dicentrinone (4) is an inhibitor of the human enzyme. Colony formation studies suggest that it is weakly cytotoxic, but that its mechanism of toxicity differs from that of camptothecin and its derivatives.\n",
            "379273\n",
            "Inhibition of human recombinant DNA topoisomerase 1-mediated pBR322 DNA relaxation activity at 20 to 200 uM after 30 mins by gel electrophoresis\n",
            "Title: Isolation and biochemical characterization of a new topoisomerase I inhibitor from Ocotea leucoxylon.  Abstract: In a continuation of our search for potential tumor inhibitors from plants, we found that a crude extract from Ocotea leucoxylon showed selective activity typical of inhibitors of the enzyme topoisomerase I in a yeast assay for DNA-damaging agents. Using a bioassay-directed fractionation approach, the major bioactive compound was isolated and identified as the known aporphine alkaloid dicentrinone (4); the inactive alkaloid dicentrine (3) was also isolated. Compound 4 showed selective bioactivity against the rad52 repair-deficient yeast strain RS322 (IC(12) 49 microg/mL) and was inactive against the rad52- and topo1-deficient strain RS321 (IC(12) > 2000 microg/mL) and against the repair-proficient strain RJ03 (IC(12) > 2000 microg/mL). Biochemical studies with recombinant human topoisomerase I indicated that dicentrinone (4) is an inhibitor of the human enzyme. Colony formation studies suggest that it is weakly cytotoxic, but that its mechanism of toxicity differs from that of camptothecin and its derivatives.\n",
            "379824\n",
            "Inhibition of human DNA topoisomerase 1 assessed as effect on relaxation of superhelical plasmid\n",
            "Title: A cyclitol derivative as a replication inhibitor from the marine sponge Petrosia sp.  Abstract: A bioactive cyclitol derivative (1) was isolated from the marine sponge Petrosia sp. The chemical structure of 1 was determined as (2S)-1-O-(2',3',4',5'-tetrahydroxycyclopentyl)-3-O-(10' '-methylhexadecyl)glycerol. Compound 1 inhibited DNA replication in vitro at the level of initiation.\n",
            "380032\n",
            "Inhibition of topoisomerase 1 at 5 ug/mL\n",
            "Title: Isolation, structure determination, and biological activity of Lyngbyabellin A from the marine cyanobacterium lyngbya majuscula.  Abstract: Lyngbyabellin A (1), a significantly cytotoxic compound with unusual structural features, was isolated from a Guamanian strain of the marine cyanobacterium Lyngbya majuscula. This novel peptolide is structurally related to dolabellin (2) in that both depsipeptides bear a dichlorinated beta-hydroxy acid and two functionalized thiazole carboxylic acid units. Its gross structure has been elucidated by spectral analysis, including 2D NMR techniques. The absolute stereochemistry of 1 was determined by chiral HPLC analysis of hydrolysis products and by characterization of the degradation products methyl 7,7-dichloro-3-hydroxy-2,2-dimethyloctanoate (3) and the corresponding acid 4. The total structure was further supported by molecular modeling studies. The isolation of 1 from L. majuscula once more supports the proposal that many compounds originally isolated from the sea hare Dolabella auricularia are of cyanobacterial origin. Lyngbyabellin A (1) was shown to be a potent disrupter of the cellular microfilament network.\n",
            "380033\n",
            "Inhibition of topoisomerase 1 at 10 ug/mL\n",
            "Title: Isolation, structure determination, and biological activity of Lyngbyabellin A from the marine cyanobacterium lyngbya majuscula.  Abstract: Lyngbyabellin A (1), a significantly cytotoxic compound with unusual structural features, was isolated from a Guamanian strain of the marine cyanobacterium Lyngbya majuscula. This novel peptolide is structurally related to dolabellin (2) in that both depsipeptides bear a dichlorinated beta-hydroxy acid and two functionalized thiazole carboxylic acid units. Its gross structure has been elucidated by spectral analysis, including 2D NMR techniques. The absolute stereochemistry of 1 was determined by chiral HPLC analysis of hydrolysis products and by characterization of the degradation products methyl 7,7-dichloro-3-hydroxy-2,2-dimethyloctanoate (3) and the corresponding acid 4. The total structure was further supported by molecular modeling studies. The isolation of 1 from L. majuscula once more supports the proposal that many compounds originally isolated from the sea hare Dolabella auricularia are of cyanobacterial origin. Lyngbyabellin A (1) was shown to be a potent disrupter of the cellular microfilament network.\n",
            "380253\n",
            "Inhibition of topoisomerase 1-mediated SV40 DNA cleavage at 1 to 50 uM by gel electrophoresis\n",
            "Title: Cucurbitane triterpenes from the fruiting bodies and cultivated mycelia of Leucopaxillus gentianeus.  Abstract: A reinvestigation of the fruiting bodies of the mushroom Leucopaxillus gentianeus, allowed the isolation of two minor cucurbitane triterpenes, namely, cucurbitacin D (5) and the new metabolite 16-deoxycucurbitacin B (6). The latter compound lacks an oxygenated substituent at C-16, an unprecedented structural feature among congeners of cucurbitacin B. The cucurbitanes present in the fruiting bodies were compared with those extracted from mycelia grown on the modified Melin-Norkans (MMN) culture medium. Cucurbitacins B (1) and D (5), as well as leucopaxillones A (3) and B (4), were isolated from both sources; in contrast, 16-deoxycucurbitacin B (6) and a mixture of fatty acid esters of cucurbitacin B (2) were absent in the mycelia. A new triterpene, 18-deoxyleucopaxillone A (7), was isolated from the mycelia, but was not detected in the fruiting bodies. The antiproliferative activity of the isolated triterpenes was determined against the NCI-H460 human tumor cell line, in comparison with the antitumor compound topotecan, a well-known topoisomerase I inhibitor.\n",
            "385404\n",
            "Inhibition of human DNA topoisomerase 1 at 100 uM relative to control\n",
            "Title: Novel azaphilones, kasanosins A and B, which are specific inhibitors of eukaryotic DNA polymerases beta and lambda from Talaromyces sp.  Abstract: Kasanosins A (1) and B (2) are novel azaphilones isolated from cultures of Talaromyces sp. derived from seaweed, and their structures were determined by spectroscopic analyses. These compounds selectively inhibited the activities of eukaryotic DNA polymerases beta and lambda (pols beta and lambda) in family X of pols, and compound 1 was a stronger inhibitor than compound 2. The IC(50) values of compound 1 on rat pol beta and human pol lambda were 27.3 and 35.0 microM, respectively. On the other hand, compounds 1 and 2 did not influence the activities of terminal deoxynucleotidyl transferase (TdT), which is a pol of family X, and the other families of eukaryotic pols, such as family A (i.e., pol gamma), family B (i.e., pols alpha, delta, and epsilon) and family Y (i.e., pols eta, iota, and kappa), and showed no effect even on the activities of plant pol alpha, fish pol delta, prokaryotic pols, and other DNA metabolic enzymes, such as calf primase of pol alpha, human immunodeficiency virus type-1 (HIV-1) reverse transcriptase, human telomerase, T7 RNA polymerase, mouse inosine 5'-monophosphate (IMP) dehydrogenase (type II), human topoisomerases I and II, T4 polynucleotide kinase, and bovine deoxyribonuclease I. The results suggested that these novel compounds could identify the inhibition between pols beta, lambda, and TdT in family X.\n",
            "389683\n",
            "Inhibition of human topoisomerase 1 mediated DNA cleavage assessed as effective drug concentration causing 10% YepG plasmid cleavage relative to camptothecin\n",
            "Title: Synthesis of N-substituted 5-[2-(N-alkylamino)ethyl]dibenzo[c,h][1,6]naphthyridines as novel topoisomerase I-targeting antitumor agents.  Abstract: Several N-alkyl and N,N-dialkyl 5H-8,9-dimethoxy-5-(2-aminoethyl)-2,3-methylenedioxydibenzo[c,h][1,6]naphthyridin-6-ones have been identified as topoisomerase I-targeting agents with potent antitumor activity. In the present study, the impact on biological activity of substitution of a trifluoromethyl, cyano, aminocarbonyl, or ethynyl group on a N-methyl substituent of N,N-dimethyl-, N-methyl-N-ethyl-, and N-methyl-N-isopropyl 5H-8,9-dimethoxy-5-(2-aminoethyl)-2,3-methylenedioxydibenzo[c,h][1,6]naphthyridin-6-ones was assessed.\n",
            "393312\n",
            "Inhibition of topoisomerase 1-mediate pHot DNA relaxation measured by electrophoretic mobility\n",
            "Title: Synthesis and cytotoxic properties of 4,11-bis[(aminoethyl)amino]anthra[2,3-b]thiophene-5,10-diones, novel analogues of antitumor anthracene-9,10-diones.  Abstract: We developed the synthesis of a series of thiophene-fused tetracyclic analogues of the antitumor drug ametantrone. The reactions included nucleophilic substitution of methoxy groups in 4,11-dimethoxyanthra[2,3-b]thiophene-5,10-diones with ethylenediamines, producing the derivatives of 4,11-diaminoanthra[2,3-b]thiophene-5,10-dione in good yields. Several compounds showed marked antiproliferative potency against doxorubicin-selected, P-glycoprotein-expressing tumor cells and p53(-/-) cells. The cytotoxicity of some novel compounds for P-glycoprotein-positive cells is highly dependent on N-substituent at the terminal amino group of ethylenediamine moiety. The cytotoxic potency of selected compounds correlated with their ability to attenuate the functions of topoisomerase I and telomerase, strongly suggesting that these enzymes are the major targets of antitumor activity of anthra[2,3-b]thiophene-5,10-dione derivatives.\n",
            "393754\n",
            "Inhibition of human DNA topoisomerase 1 at 100 uM\n",
            "Title: Penicilliols A and B, novel inhibitors specific to mammalian Y-family DNA polymerases.  Abstract: Penicilliols A (1) and B (2) are novel 5-methoxy-3(2H)-furanones isolated from cultures of a fungus (Penicillium daleae K.M. Zalessky) derived from a sea moss, and their structures were determined by spectroscopic analyses. These compounds selectively inhibited activities of eukaryotic Y-family DNA polymerases (pols) (i.e., pols eta, iota and kappa), and compound 1 was a stronger inhibitor than compound 2. Among mammalian Y-family pols, mouse pol iota activity was most strongly inhibited by compounds 1 and 2, with IC(50) values of 19.8 and 32.5 microM, respectively. On the other hand, activities of many other pols, such as A-family (i.e., pol gamma), B-family (i.e., pols alpha, delta and epsilon) or X-family (i.e., pols beta, lambda and terminal deoxynucleotidyl transferase), and some DNA metabolic enzymes, such as calf primase of pol alpha, human immunodeficiency virus type-1 (HIV-1) reverse transcriptase, human telomerase, T7 RNA polymerase, mouse IMP dehydrogenase (type II), human topoisomerases I and II, T4 polynucleotide kinase or bovine deoxyribonuclease I, are not influenced by these compounds. In conclusion, this is the first report on potent inhibitors of mammalian Y-family pols.\n",
            "396403\n",
            "Inhibition of human topoisomerase 1 assessed as stabilization of enzyme-cleaved DNA complex by gel electrophoresis\n",
            "Title: Novel imidazo[1,2-a]naphthyridinic systems (part 1): synthesis, antiproliferative and DNA-intercalating activities.  Abstract: Novel imidazo[1,2-a]naphthyridinic systems 6a-15a and 6b-15b were obtained from Friedlnder's reaction in imidazo[1,2-a]pyridine series. Most of the compounds were evaluated for their antitumor activity in the NCIs in vitro human tumor cell line screening panel. Among them, pentacyclic derivatives 13b and 14a exhibited in vitro activity comparable to anticancer agent such as amsacrine. Their mechanism of cytotoxicity action was unrelated to poisoning or inhibiting abilities against topo1. On the contrary, we highlighted a direct intercalation of the drugs into DNA by electrophoresis on agarose gel.\n",
            "396771\n",
            "Inhibition of topoisomerase 1 assessed as conversion of supercoiled DNA to open circular DNA at 100 uM\n",
            "Title: Design and synthesis of N-methylmaleimide indolocarbazole bearing modified 2-acetamino acid moieties as Topoisomerase I inhibitors.  Abstract: A novel series of N-methylmaleimide indolocarbazole derivatives bearing modified 2-acetamino acid moieties are first reported. The cytotoxic effects of these compounds were tested in five human tumor cell lines. The potent compounds 9a, 9b, 9d, and 9e have been further evaluated for their effect on Topoisomerase I (TOPO I) and cancer cell cycle. It is concluded that the indolocarbazoles with alkyl piperazine or morpholine substituent groups instead of esters or glycosyl residues would have better activities against tumors.\n",
            "402038\n",
            "Inhibition of human recombinant DNA topoisomerase1\n",
            "Title: Indole alkaloids and other constituents of Rauwolfia serpentina.  Abstract: From the dried roots of Rauwolfia serpentina were isolated five new indole alkaloids, N(b)-methylajmaline (1), N(b)-methylisoajmaline (2), 3-hydroxysarpagine (3), yohimbinic acid (4), isorauhimbinic acid (5), a new iridoid glucoside, 7-epiloganin (6), and a new sucrose derivative, 6'-O-(3,4,5-trimethoxybenzoyl)glomeratose A (7), together with 20 known compounds. The structures of the new compounds were determined by spectroscopic and chemical means. The inhibitory activities of the selected alkaloids on topoisomerase I and II and their cytotoxicity against the human promyelocytic leukemia (HL-60) cell lines were assessed.\n",
            "408919\n",
            "Inhibition of DNA topoisomerase 1-mediated supercoiled pBR322 DNA relaxation at 25 uM by agarose gel electrophoresis\n",
            "Title: Antitumor agents 6. Synthesis, structure-activity relationships, and biological evaluation of spiro[imidazolidine-4,3'-thieno[2,3-g]quinoline]-tetraones and spiro[thieno[2,3-g]quinoline-3,5'-[1,2,4]triazinane]-tetraones with potent antiproliferative activity.  Abstract: Two series of quinolinquinone derivatives, 2'H-spiro[imidazolidine-4,3'-thieno[2,3-g]quinoline]-2,4',5,9'-tetraones (2a-n) and 2H-spiro[thieno[2,3-g]quinoline-3,5'-[1,2,4]triazinane]-3',4,6',9-tetraones (3a-e), were designed and synthesized using the previously described ethyl 3-amino-4,9-dioxo-2,3,4,9-tetrahydrothieno[2,3-g]quinoline-3-carboxylate (1) as a starting material. All compounds were evaluated for their antiproliferative activity against a panel of representative liquid and solid human tumor cell lines and exhibit IC(50) values in the micromolar/submicromolar range. Series 2 displayed higher cytotoxicity than did series 3. The nature of the substituents on both imidazoline and triazinane N1 nitrogen markedly affected the activity profile of these series. Spectrophotometric and fluorescence measurements as well as unwinding assays performed on the most cytotoxic compounds, 2c, 2g, and 2k, showed that they are nonintercalative DNA agents and inhibit the catalytic activity of Topo II in a concentration-dependent mode. 2g was the most active Topo II inhibitor with activity levels comparable to those of VP-16.\n",
            "408920\n",
            "Inhibition of DNA topoisomerase 1-mediated supercoiled pBR322 DNA relaxation at 5 to 10 uM by agarose gel electrophoresis\n",
            "Title: Antitumor agents 6. Synthesis, structure-activity relationships, and biological evaluation of spiro[imidazolidine-4,3'-thieno[2,3-g]quinoline]-tetraones and spiro[thieno[2,3-g]quinoline-3,5'-[1,2,4]triazinane]-tetraones with potent antiproliferative activity.  Abstract: Two series of quinolinquinone derivatives, 2'H-spiro[imidazolidine-4,3'-thieno[2,3-g]quinoline]-2,4',5,9'-tetraones (2a-n) and 2H-spiro[thieno[2,3-g]quinoline-3,5'-[1,2,4]triazinane]-3',4,6',9-tetraones (3a-e), were designed and synthesized using the previously described ethyl 3-amino-4,9-dioxo-2,3,4,9-tetrahydrothieno[2,3-g]quinoline-3-carboxylate (1) as a starting material. All compounds were evaluated for their antiproliferative activity against a panel of representative liquid and solid human tumor cell lines and exhibit IC(50) values in the micromolar/submicromolar range. Series 2 displayed higher cytotoxicity than did series 3. The nature of the substituents on both imidazoline and triazinane N1 nitrogen markedly affected the activity profile of these series. Spectrophotometric and fluorescence measurements as well as unwinding assays performed on the most cytotoxic compounds, 2c, 2g, and 2k, showed that they are nonintercalative DNA agents and inhibit the catalytic activity of Topo II in a concentration-dependent mode. 2g was the most active Topo II inhibitor with activity levels comparable to those of VP-16.\n",
            "408923\n",
            "Inhibition of DNA topoisomerase 1-mediated supercoiled pBR322 DNA relaxation at 5 uM by agarose gel electrophoresis\n",
            "Title: Antitumor agents 6. Synthesis, structure-activity relationships, and biological evaluation of spiro[imidazolidine-4,3'-thieno[2,3-g]quinoline]-tetraones and spiro[thieno[2,3-g]quinoline-3,5'-[1,2,4]triazinane]-tetraones with potent antiproliferative activity.  Abstract: Two series of quinolinquinone derivatives, 2'H-spiro[imidazolidine-4,3'-thieno[2,3-g]quinoline]-2,4',5,9'-tetraones (2a-n) and 2H-spiro[thieno[2,3-g]quinoline-3,5'-[1,2,4]triazinane]-3',4,6',9-tetraones (3a-e), were designed and synthesized using the previously described ethyl 3-amino-4,9-dioxo-2,3,4,9-tetrahydrothieno[2,3-g]quinoline-3-carboxylate (1) as a starting material. All compounds were evaluated for their antiproliferative activity against a panel of representative liquid and solid human tumor cell lines and exhibit IC(50) values in the micromolar/submicromolar range. Series 2 displayed higher cytotoxicity than did series 3. The nature of the substituents on both imidazoline and triazinane N1 nitrogen markedly affected the activity profile of these series. Spectrophotometric and fluorescence measurements as well as unwinding assays performed on the most cytotoxic compounds, 2c, 2g, and 2k, showed that they are nonintercalative DNA agents and inhibit the catalytic activity of Topo II in a concentration-dependent mode. 2g was the most active Topo II inhibitor with activity levels comparable to those of VP-16.\n",
            "409902\n",
            "Inhibition of human topoisomerase 1 expressed in Escherichia coli assessed as drug level causing 10% mediated DNA cleavage relative to topotecan\n",
            "Title: 11-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine derivatives as novel topoisomerase I-targeting agents.  Abstract: Several 11-substituted benzo[i]phenanthridine derivatives were synthesized, and their TOP1-targeting activity and cytotoxicity were assessed. Comparative data indicate that TOP1-targeting was often the primary molecular target associated with their cytotoxicity. Several 11-aminoalkyl derivatives, 11-aminocarboxy derivatives as well as the 11-[(2-dimethylamino)ethyl]carboxamide of 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine were synthesized and did exhibit considerable cytotoxicity with IC(50) values ranging from 20 to 120 nM in the human lymphoblast tumor cell line RPMI8402.\n",
            "411410\n",
            "Inhibition of human DNA topoisomerase 1-induced unwinding activity using Escherichia coli pUC19 DNA assessed as minimum compound concentration required for complete re-supercoiling\n",
            "Title: Substituent control of DNA binding modes in a series of chalcogenoxanthylium photosensitizers as determined by isothermal titration calorimetry and topoisomerase I DNA unwinding assay.  Abstract: The DNA binding efficacy and preferred mode of binding of a series of rhodamine-related chalcogenoxanthylium dyes was investigated by isothermal titration calorimetry (ITC) using ctDNA, [poly(dCdG)](2) and [poly(dAdT)](2), and by a topoisomerase I DNA unwinding (Topo I) assay. The dyes of this study showed tight binding to ctDNA with binding constants, K(b), on the order of 10(6)-10(7)M(-1). The ITC and Topo I assay studies suggested that the 9-substituent has a strong impact on binding modes ranging from an apparent preference for intercalation with a 9-2-thienyl substituent (similar binding to [poly(dCdG)](2) and [poly(dAdT)](2), re-supercoiling of DNA in the Topo I assay at <10(-5)M dye), to mixed binding modes with 9-phenyl derivatives (2- to 3-fold preference for binding to [poly(dAdT)](2), re-supercoiling of DNA in the Topo I assay at approximately 2 x 10(-5)M dye), to minor groove binding in a 9-(2-thienyl-5-diethylcarboxamide) derivative (strong preference for binding to [poly(dAdT)](2), did not show complete re-supercoiling in the Topo I assay). No binding to ctDNA was observed in one derivative with a 9-(3-thienyl-2-diethylcarboxamide) substituent, which cannot be co-planar with the xanthylium core. In series of dyes where the chalcogen atom was varied, the selenoxanthylium derivatives had 2- to 3-fold higher values of K(b) than the corresponding xanthylium, thioxanthylium, or telluroxanthylium derivatives, which all showed comparable values of K(b). The chalcogen atom appeared to have little influence on binding mode.\n",
            "411411\n",
            "Inhibition of human DNA topoisomerase 1-induced unwinding activity using Escherichia coli pUC19 DNA assessed as bound compound per nucleotide pair at 24 uM\n",
            "Title: Substituent control of DNA binding modes in a series of chalcogenoxanthylium photosensitizers as determined by isothermal titration calorimetry and topoisomerase I DNA unwinding assay.  Abstract: The DNA binding efficacy and preferred mode of binding of a series of rhodamine-related chalcogenoxanthylium dyes was investigated by isothermal titration calorimetry (ITC) using ctDNA, [poly(dCdG)](2) and [poly(dAdT)](2), and by a topoisomerase I DNA unwinding (Topo I) assay. The dyes of this study showed tight binding to ctDNA with binding constants, K(b), on the order of 10(6)-10(7)M(-1). The ITC and Topo I assay studies suggested that the 9-substituent has a strong impact on binding modes ranging from an apparent preference for intercalation with a 9-2-thienyl substituent (similar binding to [poly(dCdG)](2) and [poly(dAdT)](2), re-supercoiling of DNA in the Topo I assay at <10(-5)M dye), to mixed binding modes with 9-phenyl derivatives (2- to 3-fold preference for binding to [poly(dAdT)](2), re-supercoiling of DNA in the Topo I assay at approximately 2 x 10(-5)M dye), to minor groove binding in a 9-(2-thienyl-5-diethylcarboxamide) derivative (strong preference for binding to [poly(dAdT)](2), did not show complete re-supercoiling in the Topo I assay). No binding to ctDNA was observed in one derivative with a 9-(3-thienyl-2-diethylcarboxamide) substituent, which cannot be co-planar with the xanthylium core. In series of dyes where the chalcogen atom was varied, the selenoxanthylium derivatives had 2- to 3-fold higher values of K(b) than the corresponding xanthylium, thioxanthylium, or telluroxanthylium derivatives, which all showed comparable values of K(b). The chalcogen atom appeared to have little influence on binding mode.\n",
            "414753\n",
            "Inhibition of human topoisomerase 1 expressed in sf9 cells assessed as drug level causing 10% mediated DNA cleavage relative to topotecan\n",
            "Title: 12-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridines as novel topoisomerase I-targeting antitumor agents.  Abstract: 2,3-Dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine and a few of its 12-substituted analogs are active as TOP1-targeting agents. Studies were performed to further evaluate the potential of this series of non-camptothecin TOP1-targeting agents. The influence of a hydroxymethyl, formyl, N,N-dimethylaminomethyl, 2-(N,N-dimethylamino)ethyl, 3-(N,N-dimethylamino)propyl), and 4-(N,N-dimethylamino)butyl substituent at the 12-position on TOP1-targeting activity and tumor cell growth was evaluated. In addition, the relative pharmacologic activities of the 12-carboxamide analog, as well as its N-methyl and N,N-dimethyl derivatives were assessed.\n",
            "418336\n",
            "Inhibition of human topoisomerase 1\n",
            "Title: Synthesis of new camptothecin analogs with improved antitumor activities.  Abstract: Novel hexacyclic camptothecin analogs containing cyclic amidine, urea, or thiourea moiety were designed and synthesized based on the proposed 3D-structure of the topoisomerase I (Topo I)/DNA/camptothecin ternary complex. The analogs were prepared from 9-nitrocamptothecin via 7,9-diaminocamptothecin derivatives as a key intermediate. Among them, 7c exhibited in vivo antitumor activities superior to CPT-11 in human cancer xenograft models in mice at their maximum tolerated doses though its in vitro antiproliferative activity was comparable to SN-38 against corresponding cell lines.\n",
            "422411\n",
            "Induction of human DNA topoisomerase 1-mediated DNA cleavage at 1 to 10 uM by polyacrylamide gel electrophoresis\n",
            "Title: Calothrixins, a new class of human DNA topoisomerase I poisons.  Abstract: Calothrixins A (1) and B (2) were converted to their O- and N-methylated derivatives, respectively. All four compounds were found to act as poisons of DNA topoisomerase I and to do so reversibly. Three of the calothrixins (1-3) were tested for their cytotoxicity toward cultured (p53 proficient) CEM leukemia cells and found to exhibit IC(50) values ranging from 0.20 to 5.13 muM. The cell cycle effects of calothrixins 1-3 were also studied. Calothrixin B (2) produced G(1) arrest at 0.1 muM concentration, while higher concentrations of calothrixins 1 and 3 resulted in cell accumulation in both the S and G(2)/M phases of the cell cycle. The cell cycle effects produced by the calothrixins were more readily reversible upon removal of the compounds than those produced by camptothecin.\n",
            "422412\n",
            "Induction of human DNA topoisomerase 1-mediated DNA cleavage at 1 uM by polyacrylamide gel electrophoresis\n",
            "Title: Calothrixins, a new class of human DNA topoisomerase I poisons.  Abstract: Calothrixins A (1) and B (2) were converted to their O- and N-methylated derivatives, respectively. All four compounds were found to act as poisons of DNA topoisomerase I and to do so reversibly. Three of the calothrixins (1-3) were tested for their cytotoxicity toward cultured (p53 proficient) CEM leukemia cells and found to exhibit IC(50) values ranging from 0.20 to 5.13 muM. The cell cycle effects of calothrixins 1-3 were also studied. Calothrixin B (2) produced G(1) arrest at 0.1 muM concentration, while higher concentrations of calothrixins 1 and 3 resulted in cell accumulation in both the S and G(2)/M phases of the cell cycle. The cell cycle effects produced by the calothrixins were more readily reversible upon removal of the compounds than those produced by camptothecin.\n",
            "422413\n",
            "Reversal of drug-stabilized human DNA topoisomerase 1-DNA binary complex at 5 uM within 5 mins by polyacrylamide gel electrophoresis in presence of 0.35 M NaCl\n",
            "Title: Calothrixins, a new class of human DNA topoisomerase I poisons.  Abstract: Calothrixins A (1) and B (2) were converted to their O- and N-methylated derivatives, respectively. All four compounds were found to act as poisons of DNA topoisomerase I and to do so reversibly. Three of the calothrixins (1-3) were tested for their cytotoxicity toward cultured (p53 proficient) CEM leukemia cells and found to exhibit IC(50) values ranging from 0.20 to 5.13 muM. The cell cycle effects of calothrixins 1-3 were also studied. Calothrixin B (2) produced G(1) arrest at 0.1 muM concentration, while higher concentrations of calothrixins 1 and 3 resulted in cell accumulation in both the S and G(2)/M phases of the cell cycle. The cell cycle effects produced by the calothrixins were more readily reversible upon removal of the compounds than those produced by camptothecin.\n",
            "431825\n",
            "Inhibition of DNA topoisomerase 1-mediated supercoiled Escherichia coli pBR322 DNA relaxation at 100 to 1000 uM after 30 mins\n",
            "Title: Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification.  Abstract: A novel series of topoisomerase I (Top I) inhibitors were designed on the basis of camptothecin using scaffold modification strategy. Thirty-one new compounds were synthesized and evaluated for anticell proliferation activity. The most potent compound 26 presented a significant inhibitory effect on Top I, leading to Top I-mediated cleavage and influences on Top I expression at the cellular level. Moreover, 26 was proved to induce cell death via apoptosis and accelerated DNA strand breaks without significant alteration in cell cycle populations. All of the experimental results herein indicated that 26 could interact with DNA-Top I complex and induce cancer cell apoptosis to produce antitumor effects. The in vivo evaluation of 26 on the growth of HT-29 tumor xenografts in nude mice suggested its therapeutic potential for further development.\n",
            "431826\n",
            "Inhibition of DNA topoisomerase 1-mediated supercoiled Escherichia coli pBR322 DNA relaxation upto 12.5 uM after 30 mins\n",
            "Title: Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification.  Abstract: A novel series of topoisomerase I (Top I) inhibitors were designed on the basis of camptothecin using scaffold modification strategy. Thirty-one new compounds were synthesized and evaluated for anticell proliferation activity. The most potent compound 26 presented a significant inhibitory effect on Top I, leading to Top I-mediated cleavage and influences on Top I expression at the cellular level. Moreover, 26 was proved to induce cell death via apoptosis and accelerated DNA strand breaks without significant alteration in cell cycle populations. All of the experimental results herein indicated that 26 could interact with DNA-Top I complex and induce cancer cell apoptosis to produce antitumor effects. The in vivo evaluation of 26 on the growth of HT-29 tumor xenografts in nude mice suggested its therapeutic potential for further development.\n",
            "431827\n",
            "Inhibition of DNA topoisomerase 1-mediated supercoiled Escherichia coli pBR322 DNA relaxation upto 25 uM after 30 mins\n",
            "Title: Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification.  Abstract: A novel series of topoisomerase I (Top I) inhibitors were designed on the basis of camptothecin using scaffold modification strategy. Thirty-one new compounds were synthesized and evaluated for anticell proliferation activity. The most potent compound 26 presented a significant inhibitory effect on Top I, leading to Top I-mediated cleavage and influences on Top I expression at the cellular level. Moreover, 26 was proved to induce cell death via apoptosis and accelerated DNA strand breaks without significant alteration in cell cycle populations. All of the experimental results herein indicated that 26 could interact with DNA-Top I complex and induce cancer cell apoptosis to produce antitumor effects. The in vivo evaluation of 26 on the growth of HT-29 tumor xenografts in nude mice suggested its therapeutic potential for further development.\n",
            "431833\n",
            "Induction of human recombinant topoisomerase 1-mediated cleavage of 32P-labeled linearized pRYG plasmid DNA at 10 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification.  Abstract: A novel series of topoisomerase I (Top I) inhibitors were designed on the basis of camptothecin using scaffold modification strategy. Thirty-one new compounds were synthesized and evaluated for anticell proliferation activity. The most potent compound 26 presented a significant inhibitory effect on Top I, leading to Top I-mediated cleavage and influences on Top I expression at the cellular level. Moreover, 26 was proved to induce cell death via apoptosis and accelerated DNA strand breaks without significant alteration in cell cycle populations. All of the experimental results herein indicated that 26 could interact with DNA-Top I complex and induce cancer cell apoptosis to produce antitumor effects. The in vivo evaluation of 26 on the growth of HT-29 tumor xenografts in nude mice suggested its therapeutic potential for further development.\n",
            "431834\n",
            "Induction of human recombinant topoisomerase 1-mediated cleavage of 32P-labeled linearized pRYG plasmid DNA at 2.5 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification.  Abstract: A novel series of topoisomerase I (Top I) inhibitors were designed on the basis of camptothecin using scaffold modification strategy. Thirty-one new compounds were synthesized and evaluated for anticell proliferation activity. The most potent compound 26 presented a significant inhibitory effect on Top I, leading to Top I-mediated cleavage and influences on Top I expression at the cellular level. Moreover, 26 was proved to induce cell death via apoptosis and accelerated DNA strand breaks without significant alteration in cell cycle populations. All of the experimental results herein indicated that 26 could interact with DNA-Top I complex and induce cancer cell apoptosis to produce antitumor effects. The in vivo evaluation of 26 on the growth of HT-29 tumor xenografts in nude mice suggested its therapeutic potential for further development.\n",
            "431835\n",
            "Induction of human recombinant topoisomerase 1-mediated cleavage of 32P-labeled linearized pRYG plasmid DNA at 25 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification.  Abstract: A novel series of topoisomerase I (Top I) inhibitors were designed on the basis of camptothecin using scaffold modification strategy. Thirty-one new compounds were synthesized and evaluated for anticell proliferation activity. The most potent compound 26 presented a significant inhibitory effect on Top I, leading to Top I-mediated cleavage and influences on Top I expression at the cellular level. Moreover, 26 was proved to induce cell death via apoptosis and accelerated DNA strand breaks without significant alteration in cell cycle populations. All of the experimental results herein indicated that 26 could interact with DNA-Top I complex and induce cancer cell apoptosis to produce antitumor effects. The in vivo evaluation of 26 on the growth of HT-29 tumor xenografts in nude mice suggested its therapeutic potential for further development.\n",
            "431854\n",
            "Induction of human topoisomerase 1-mediated chromosomal DNA strand breaks in HT-29 cells at 10 uM after 1 hr by comet assay\n",
            "Title: Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification.  Abstract: A novel series of topoisomerase I (Top I) inhibitors were designed on the basis of camptothecin using scaffold modification strategy. Thirty-one new compounds were synthesized and evaluated for anticell proliferation activity. The most potent compound 26 presented a significant inhibitory effect on Top I, leading to Top I-mediated cleavage and influences on Top I expression at the cellular level. Moreover, 26 was proved to induce cell death via apoptosis and accelerated DNA strand breaks without significant alteration in cell cycle populations. All of the experimental results herein indicated that 26 could interact with DNA-Top I complex and induce cancer cell apoptosis to produce antitumor effects. The in vivo evaluation of 26 on the growth of HT-29 tumor xenografts in nude mice suggested its therapeutic potential for further development.\n",
            "432397\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of supercoiled plasmid O6#7 DNA at 8 uM after 30 mins by gel electrophoresis\n",
            "Title: On the role of topoisomerase I in mediating the cytotoxicity of 9-aminoacridine-based anticancer agents.  Abstract: The cytotoxicity and mechanism of action of a series of substituted 9-aminoacridines is evaluated using topoisomerase I and cancer cell growth inhibition assays. In previous work, compounds of this type were shown to catalytically inhibit topoisomerase II, leading to a G1-S phase arrest of the cell cycle and apoptosis in pancreatic cancer cells in vitro and in vivo. The present study expands the potential utility of these compounds in the development of cancer therapeutics by showing that these compounds inhibit proliferation of cell lines derived from the nine most common human cancers. Further results show that at least one of the compounds effectively stabilizes topoisomerase I-DNA adduct formation in intact cells. RNA interference experiments, however, indicate that this interaction does not contribute to the drug-induced killing of cancer cells indicating the compounds may be non-lethal poisons of topoisomerase I.\n",
            "432398\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of supercoiled plasmid O6#7 DNA at 100 uM after 30 mins by gel electrophoresis\n",
            "Title: On the role of topoisomerase I in mediating the cytotoxicity of 9-aminoacridine-based anticancer agents.  Abstract: The cytotoxicity and mechanism of action of a series of substituted 9-aminoacridines is evaluated using topoisomerase I and cancer cell growth inhibition assays. In previous work, compounds of this type were shown to catalytically inhibit topoisomerase II, leading to a G1-S phase arrest of the cell cycle and apoptosis in pancreatic cancer cells in vitro and in vivo. The present study expands the potential utility of these compounds in the development of cancer therapeutics by showing that these compounds inhibit proliferation of cell lines derived from the nine most common human cancers. Further results show that at least one of the compounds effectively stabilizes topoisomerase I-DNA adduct formation in intact cells. RNA interference experiments, however, indicate that this interaction does not contribute to the drug-induced killing of cancer cells indicating the compounds may be non-lethal poisons of topoisomerase I.\n",
            "432399\n",
            "Induction of covalent human topoisomerase 1-plasmid O6#7 DNA adduct stabilization assessed as appearance of nicked plasmid at 100 uM by agarose gel electrophoresis\n",
            "Title: On the role of topoisomerase I in mediating the cytotoxicity of 9-aminoacridine-based anticancer agents.  Abstract: The cytotoxicity and mechanism of action of a series of substituted 9-aminoacridines is evaluated using topoisomerase I and cancer cell growth inhibition assays. In previous work, compounds of this type were shown to catalytically inhibit topoisomerase II, leading to a G1-S phase arrest of the cell cycle and apoptosis in pancreatic cancer cells in vitro and in vivo. The present study expands the potential utility of these compounds in the development of cancer therapeutics by showing that these compounds inhibit proliferation of cell lines derived from the nine most common human cancers. Further results show that at least one of the compounds effectively stabilizes topoisomerase I-DNA adduct formation in intact cells. RNA interference experiments, however, indicate that this interaction does not contribute to the drug-induced killing of cancer cells indicating the compounds may be non-lethal poisons of topoisomerase I.\n",
            "432401\n",
            "Induction of covalent topoisomerase 1-DNA adduct stabilization in human MIA PaCa cells at 20 uM after 1 hr by ICE assay\n",
            "Title: On the role of topoisomerase I in mediating the cytotoxicity of 9-aminoacridine-based anticancer agents.  Abstract: The cytotoxicity and mechanism of action of a series of substituted 9-aminoacridines is evaluated using topoisomerase I and cancer cell growth inhibition assays. In previous work, compounds of this type were shown to catalytically inhibit topoisomerase II, leading to a G1-S phase arrest of the cell cycle and apoptosis in pancreatic cancer cells in vitro and in vivo. The present study expands the potential utility of these compounds in the development of cancer therapeutics by showing that these compounds inhibit proliferation of cell lines derived from the nine most common human cancers. Further results show that at least one of the compounds effectively stabilizes topoisomerase I-DNA adduct formation in intact cells. RNA interference experiments, however, indicate that this interaction does not contribute to the drug-induced killing of cancer cells indicating the compounds may be non-lethal poisons of topoisomerase I.\n",
            "432403\n",
            "Induction of covalent human topoisomerase 1-plasmid O6#7 DNA adduct stabilization assessed as appearance of nicked plasmid at 1.6 uM by agarose gel electrophoresis\n",
            "Title: On the role of topoisomerase I in mediating the cytotoxicity of 9-aminoacridine-based anticancer agents.  Abstract: The cytotoxicity and mechanism of action of a series of substituted 9-aminoacridines is evaluated using topoisomerase I and cancer cell growth inhibition assays. In previous work, compounds of this type were shown to catalytically inhibit topoisomerase II, leading to a G1-S phase arrest of the cell cycle and apoptosis in pancreatic cancer cells in vitro and in vivo. The present study expands the potential utility of these compounds in the development of cancer therapeutics by showing that these compounds inhibit proliferation of cell lines derived from the nine most common human cancers. Further results show that at least one of the compounds effectively stabilizes topoisomerase I-DNA adduct formation in intact cells. RNA interference experiments, however, indicate that this interaction does not contribute to the drug-induced killing of cancer cells indicating the compounds may be non-lethal poisons of topoisomerase I.\n",
            "432404\n",
            "Induction of covalent topoisomerase 1-DNA adduct stabilization in human MIA PaCa cells at 100 uM after 1 hr by ICE assay\n",
            "Title: On the role of topoisomerase I in mediating the cytotoxicity of 9-aminoacridine-based anticancer agents.  Abstract: The cytotoxicity and mechanism of action of a series of substituted 9-aminoacridines is evaluated using topoisomerase I and cancer cell growth inhibition assays. In previous work, compounds of this type were shown to catalytically inhibit topoisomerase II, leading to a G1-S phase arrest of the cell cycle and apoptosis in pancreatic cancer cells in vitro and in vivo. The present study expands the potential utility of these compounds in the development of cancer therapeutics by showing that these compounds inhibit proliferation of cell lines derived from the nine most common human cancers. Further results show that at least one of the compounds effectively stabilizes topoisomerase I-DNA adduct formation in intact cells. RNA interference experiments, however, indicate that this interaction does not contribute to the drug-induced killing of cancer cells indicating the compounds may be non-lethal poisons of topoisomerase I.\n",
            "433914\n",
            "Effect on human topoisomerase 1 expressed in Sf9 insect cells assessed as effective concentration required for 10% cleavage of plasmid DNA relative to topotecan\n",
            "Title: Novel topoisomerase I-targeting antitumor agents synthesized from the N,N,N-trimethylammonium derivative of ARC-111, 5H-2,3-dimethoxy-8,9-methylenedioxy-5-[(2-N,N,N-trimethylammonium)ethyl]dibenzo[c,h][1,6]naphthyridin-6-one iodide.  Abstract: Several new TOP1-targeting agents were prepared using as an intermediate the N,N,N-trimethyl quaternary ammonium salt 2 of ARC-111. Direct displacement of the quaternary ammonium group with hydroxide, cyclopropylamine, imidazole, 1H-1,2,3-triazole, alkylethylenediamines, ethanolamine, and polyhydroxylated alkylamines provides a convenient means for furthering insight into the structure-activity relationships within this series of non-camptothecin TOP1-targeting agents. The relative TOP1-targeting activities and cytotoxicities were evaluated in RPMI8402 and P388 cells and their camptothecin-resistant variants. Their potential to serve as substrates for the efflux transporters MDR1 and BCRP, which are associated with multidrug resistance, was also assessed.\n",
            "434819\n",
            "Inhibition of human topoisomerase 1-mediated DNA relaxation assessed as lack of nicking form by agarose gel electrophoresis\n",
            "Title: Photochemical electrocyclisation of 3-vinylindoles to pyrido[2,3-a]-, pyrido[4,3-a]- and thieno[2,3-a]-carbazoles: design, synthesis, DNA binding and antitumor cell cytotoxicity.  Abstract: In the context of the design and synthesis of DNA ligands, some new hetarene annelated carbazoles were synthesized. As lead structure the intercalating tetracyclic systems pyrido[2,3-a]- and pyrido[4,3-a]-carbazoles and in one case a thieno[2,3-a]-carbazole were taken into account. A dialkyl amino amidic chain was introduced to the planar chromophoric system with the intent to generate minor groove binding properties. The cytotoxicity of some compounds was examined by the NCI antitumor screening. Furthermore, biophysical as well as biochemical studies were performed in order to get some information about the DNA-binding properties and inhibition of DNA related functional enzymes of this new series of molecules.\n",
            "434821\n",
            "Inhibition of human topoisomerase 1-mediated DNA relaxation assessed as topoisomerase profile\n",
            "Title: Photochemical electrocyclisation of 3-vinylindoles to pyrido[2,3-a]-, pyrido[4,3-a]- and thieno[2,3-a]-carbazoles: design, synthesis, DNA binding and antitumor cell cytotoxicity.  Abstract: In the context of the design and synthesis of DNA ligands, some new hetarene annelated carbazoles were synthesized. As lead structure the intercalating tetracyclic systems pyrido[2,3-a]- and pyrido[4,3-a]-carbazoles and in one case a thieno[2,3-a]-carbazole were taken into account. A dialkyl amino amidic chain was introduced to the planar chromophoric system with the intent to generate minor groove binding properties. The cytotoxicity of some compounds was examined by the NCI antitumor screening. Furthermore, biophysical as well as biochemical studies were performed in order to get some information about the DNA-binding properties and inhibition of DNA related functional enzymes of this new series of molecules.\n",
            "436178\n",
            "Inhibition of human topoisomerase 1\n",
            "Title: A 2-substituted prodiginine, 2-(p-hydroxybenzyl)prodigiosin, from Pseudoalteromonas rubra.  Abstract: In the course of work aimed at the discovery of new pharmaceutical lead compounds from marine bacteria, a lipophilic extract of the bacterium Pseudoalteromonas rubra displayed significant cytotoxicity against SKOV-3, a human ovarian adenocarcinoma cell line. Bioassay-directed fractionation of this extract resulted in the isolation of a series of known and new prodiginine-type azafulvenes. The structure of the major metabolite was elucidated by interpretation of spectroscopic data as a 2-substituted prodigiosin, which we named 2-(p-hydroxybenzyl)prodigiosin (HBPG).\n",
            "436387\n",
            "Inhibition of human topoisomerase 1-mediated DNA cleavage\n",
            "Title: Synthesis and antitumoral activity of novel thiazolobenzotriazole, thiazoloindolo[3,2-c]quinoline and quinolinoquinoline derivatives.  Abstract: The biological evaluation of some novel thiazoloindolo[3,2-c]quinoline, 8-substituted-11H-indolo[3,2-c]quinolines is described. These compounds were obtained via Graebe-Ullmann thermal cyclization from appropriated N-arylated benzotriazoles. 7H-4,7-Diaza-benzo[de]anthracene, a reaction by-product structurally closed to the pyridoacridine skeleton was also identified. All thiazolobenzotriazole intermediates were tested in vitro for their capacity to inhibit the growth of two breast cancer cell lines, MCF-7 and MDA-MB-231. In parallel, the newly synthesized skeletons were evaluated for DNA interaction, topoisomerases' inhibition, and cytotoxicity against HL60 and HL60/MX2 human leukemia cells. Most compounds showed a potent growth inhibitory effect on all the tested cell lines, with IC(50) in the muM range.\n",
            "436713\n",
            "Inhibition of DNA topoisomerase 1 assessed as inhibition of unwinding of supercoiled pBR322 DNA at 10 to 20 uM by agarose gel electrophoresis\n",
            "Title: Reaction of the antitumor antibiotic olivomycin I with aryl diazonium salts. Synthesis, cytotoxic and antiretroviral potency of 5-aryldiazenyl-6-O-deglycosyl derivatives of olivomycin I.  Abstract: The azo coupling of the antibiotic olivomycin I (1) with aryl diazonium tetrafluoroborates produced 5-aryldiazenyl-6-O-deglycosyl derivatives of 1. The structures of new compounds were confirmed by (1)H NMR and mass spectrometry analysis. A quantum-chemical study was performed to analyze the possible directions of electrophilic substitution of 1 and the easiness of 6-O-disaccharide hydrolysis in the course of azo coupling. The antiproliferative and anti-retroviral activities of novel derivatives were studied.\n",
            "436714\n",
            "Inhibition of DNA topoisomerase 1 assessed as partial inhibition of unwinding of supercoiled pBR322 DNA at 5 uM by agarose gel electrophoresis\n",
            "Title: Reaction of the antitumor antibiotic olivomycin I with aryl diazonium salts. Synthesis, cytotoxic and antiretroviral potency of 5-aryldiazenyl-6-O-deglycosyl derivatives of olivomycin I.  Abstract: The azo coupling of the antibiotic olivomycin I (1) with aryl diazonium tetrafluoroborates produced 5-aryldiazenyl-6-O-deglycosyl derivatives of 1. The structures of new compounds were confirmed by (1)H NMR and mass spectrometry analysis. A quantum-chemical study was performed to analyze the possible directions of electrophilic substitution of 1 and the easiness of 6-O-disaccharide hydrolysis in the course of azo coupling. The antiproliferative and anti-retroviral activities of novel derivatives were studied.\n",
            "436715\n",
            "Inhibition of DNA topoisomerase 1 assessed as inhibition of unwinding of supercoiled pBR322 DNA at 20 uM by agarose gel electrophoresis\n",
            "Title: Reaction of the antitumor antibiotic olivomycin I with aryl diazonium salts. Synthesis, cytotoxic and antiretroviral potency of 5-aryldiazenyl-6-O-deglycosyl derivatives of olivomycin I.  Abstract: The azo coupling of the antibiotic olivomycin I (1) with aryl diazonium tetrafluoroborates produced 5-aryldiazenyl-6-O-deglycosyl derivatives of 1. The structures of new compounds were confirmed by (1)H NMR and mass spectrometry analysis. A quantum-chemical study was performed to analyze the possible directions of electrophilic substitution of 1 and the easiness of 6-O-disaccharide hydrolysis in the course of azo coupling. The antiproliferative and anti-retroviral activities of novel derivatives were studied.\n",
            "436716\n",
            "Inhibition of DNA topoisomerase 1 assessed as partial inhibition of unwinding of supercoiled pBR322 DNA at 20 uM by agarose gel electrophoresis\n",
            "Title: Reaction of the antitumor antibiotic olivomycin I with aryl diazonium salts. Synthesis, cytotoxic and antiretroviral potency of 5-aryldiazenyl-6-O-deglycosyl derivatives of olivomycin I.  Abstract: The azo coupling of the antibiotic olivomycin I (1) with aryl diazonium tetrafluoroborates produced 5-aryldiazenyl-6-O-deglycosyl derivatives of 1. The structures of new compounds were confirmed by (1)H NMR and mass spectrometry analysis. A quantum-chemical study was performed to analyze the possible directions of electrophilic substitution of 1 and the easiness of 6-O-disaccharide hydrolysis in the course of azo coupling. The antiproliferative and anti-retroviral activities of novel derivatives were studied.\n",
            "449570\n",
            "Inhibition of topoisomerase I relaxation activity assessed as supercoiled pBR322 DNA at 8 ug/ml\n",
            "Title: Synthesis of gibberellin derivatives with anti-tumor bioactivities.  Abstract: A series of gibberellin based molecules were designed and synthesized. Gibberellin derivatives bearing two alpha,beta-unsaturated ketone units showed strong anticancer activities in MTT assay towards a number of human cancer cell lines including HT29, A549, HepG2 and MKN28. The most potent gibberellin derivative (compound 10, IC(50)=2.9 microM against HT29) inhibited completely the topoisomerase I activity at 8 microg/mL level.\n",
            "449571\n",
            "Inhibition of topoisomerase I relaxation activity assessed as supercoiled pBR322 DNA\n",
            "Title: Synthesis of gibberellin derivatives with anti-tumor bioactivities.  Abstract: A series of gibberellin based molecules were designed and synthesized. Gibberellin derivatives bearing two alpha,beta-unsaturated ketone units showed strong anticancer activities in MTT assay towards a number of human cancer cell lines including HT29, A549, HepG2 and MKN28. The most potent gibberellin derivative (compound 10, IC(50)=2.9 microM against HT29) inhibited completely the topoisomerase I activity at 8 microg/mL level.\n",
            "453108\n",
            "Inhibition of topoisomerase 1 relative to etoposide\n",
            "Title: Synthesis, tautomerism, and antimicrobial, anti-HCV, anti-SSPE, antioxidant, and antitumor activities of arylazobenzosuberones.  Abstract: 2-Dimethylaminomethylene-1-benzosuberone 1 was coupled with diazotized aniline derivatives to afford a series of the hitherto unreported 2-arylazo-1-benzosuberones 3a-i. The tautomeric structure and the effect of substituents on the tautomeric form (s) of the products 3a-i were discussed. Similar coupling of the enaminone 1 with diazonium salts of heterocyclic amines gave the respective fused azolotriazino-benzosuberones. Some of the newly synthesized compounds showed potent antimicrobial, anti-HCV, antioxidant, antitumor (as topoisomerase I inhibitors), and antimicrobial activities.\n",
            "453806\n",
            "Inhibition of human DNA topoisomerase 1 assessed as induction of enzyme-dependent DNA cleavage relative to 1 uM camptothecin\n",
            "Title: Synthesis and biological evaluation of 14-(aminoalkyl-aminomethyl)aromathecins as topoisomerase I inhibitors: investigating the hypothesis of shared structure-activity relationships.  Abstract: The aromathecin topoisomerase I (top1) inhibitors offer promising scaffolds for the development of novel cancer chemotherapeutics. They are 'composites' of the camptothecin and indenoisoquinoline top1 inhibitors. Interestingly, some structure-activity relationship (SAR) overlap between the aromathecins and the indenoisoquinolines has been observed. For both classes, placement of certain polar groups in similar regions of the heteroaromatic system improves top1 inhibitory and antiproliferative activities. A series of water-soluble aromathecins substituted at position 14 with diaminoalkanes of various lengths has been prepared. These compounds all possess similar antiproliferative potency, but a general trend is observed: aromathecins with longer diaminoalkane substituents (>6 carbons) possess lower anti-top1 activity than their smaller counterparts (2-4 carbons), presumably as a result of unfavorable hydrophobic interactions. This trend is also noted with the indenoisoquinolines, revealing additional SAR overlap that supports the hypothesis that there is a 'universal' top1 inhibitor SAR.\n",
            "456247\n",
            "Inhibition of human recombinant DNA topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 100 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: 2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.  Abstract: Designed and synthesized 60 2-thienyl-4-furyl-6-aryl pyridine derivatives were evaluated for their topoisomerase I and II inhibitory activities at 20 microM and 100 microM and cytotoxicity against several human cancer cell lines. Compounds 8, 9, 11-29 showed significant topoisomerase II inhibitory activity and compounds 10 and 11 showed significant topoisomerase I inhibitory activity. Most of the compounds (7-21) possessing 2-(5-chlorothiophen-2-yl)-4-(furan-3-yl) moiety showed higher or similar cytotoxicity against HCT15 cell line as compared to standards. Most of the selected compounds displayed moderate cytotoxicity against MCF-7, HeLa, DU145, and K562 cell lines. Structure-activity relationship study revealed that 2-(5-chlorothiophen-2-yl)-4-(furan-3-yl) moiety has an important role in displaying biological activities.\n",
            "456248\n",
            "Inhibition of human recombinant DNA topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 20 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: 2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.  Abstract: Designed and synthesized 60 2-thienyl-4-furyl-6-aryl pyridine derivatives were evaluated for their topoisomerase I and II inhibitory activities at 20 microM and 100 microM and cytotoxicity against several human cancer cell lines. Compounds 8, 9, 11-29 showed significant topoisomerase II inhibitory activity and compounds 10 and 11 showed significant topoisomerase I inhibitory activity. Most of the compounds (7-21) possessing 2-(5-chlorothiophen-2-yl)-4-(furan-3-yl) moiety showed higher or similar cytotoxicity against HCT15 cell line as compared to standards. Most of the selected compounds displayed moderate cytotoxicity against MCF-7, HeLa, DU145, and K562 cell lines. Structure-activity relationship study revealed that 2-(5-chlorothiophen-2-yl)-4-(furan-3-yl) moiety has an important role in displaying biological activities.\n",
            "458062\n",
            "Inhibition of human recombinant topoisomerase-1-mediated 117bp DNA oligonucleotide cleavage at 10 uM by PAGE\n",
            "Title: Structure-based design, synthesis, and biological studies of new anticancer norindenoisoquinoline topoisomerase I inhibitors.  Abstract: On the basis of the superimposition of the crystal structures of norindenoisoquinoline 5 and topotecan (2) bound in the topoisomerase I-DNA covalent complex, as well as molecular docking and quantum chemical calculations, the substituted norindenoisoquinoline 14a was designed by transporting the 9-dimethylaminomethyl group of topotecan to the 10-position of the norindenoisoquinoline 5. The desired compound 14a was synthesized and found to possess topoisomerase I inhibitory activity that was slightly better than that of the starting compound 5. A focused set of 10-substitued norindenoisoquinoline analogues were then synthesized. The imidazole-substituted compound 14c was highly cytotoxic when evaluated in a series of human leukemia, ovarian, and breast cancer cells.\n",
            "460543\n",
            "Inhibition of human recombinant topoisomerase 1-mediated pBR322 DNA relaxation at 100 uM by gel electrophoresis\n",
            "Title: New benzoxanthone derivatives as topoisomerase inhibitors and DNA cross-linkers.  Abstract: We synthesized 12 benzoxanthone derivatives classified as three different groups based on the tetracyclic ring shapes and evaluated their pharmacological activities to find potential anticancer agents. In the cytotoxicity test, most compounds showed effective cancer cell growth inhibition against the HT29 and DU145 cell lines. Among the compounds tested, compound 19 was the most effective in the cancer cell lines tested. Compound 9 showed dual inhibitory activities against DNA relaxation by topoisomerases I and II. The% inhibition of compound 9 on topoisomerase I was comparable to that of camptothecin. Compound 9 efficiently blocked topoisomerase II function by almost threefold than etoposide at 20 microM. Compound 19 had selective topoisomerase II inhibitory activity at 100 microM. The DNA cross-linking test revealed that only compounds 8 and 19, which possess epoxy groups, cross-linked DNA duplex, while 14 did not. From the combined pharmacological results, we proposed that the target through which compound 19 inhibits cancer cell growth may be the DNA duplex itself and/or DNA-topoisomerase II complex.\n",
            "460544\n",
            "Inhibition of human recombinant topoisomerase 1-mediated pBR322 DNA relaxation at 20 uM by gel electrophoresis\n",
            "Title: New benzoxanthone derivatives as topoisomerase inhibitors and DNA cross-linkers.  Abstract: We synthesized 12 benzoxanthone derivatives classified as three different groups based on the tetracyclic ring shapes and evaluated their pharmacological activities to find potential anticancer agents. In the cytotoxicity test, most compounds showed effective cancer cell growth inhibition against the HT29 and DU145 cell lines. Among the compounds tested, compound 19 was the most effective in the cancer cell lines tested. Compound 9 showed dual inhibitory activities against DNA relaxation by topoisomerases I and II. The% inhibition of compound 9 on topoisomerase I was comparable to that of camptothecin. Compound 9 efficiently blocked topoisomerase II function by almost threefold than etoposide at 20 microM. Compound 19 had selective topoisomerase II inhibitory activity at 100 microM. The DNA cross-linking test revealed that only compounds 8 and 19, which possess epoxy groups, cross-linked DNA duplex, while 14 did not. From the combined pharmacological results, we proposed that the target through which compound 19 inhibits cancer cell growth may be the DNA duplex itself and/or DNA-topoisomerase II complex.\n",
            "462323\n",
            "Inhibition of human recombinant topoisomerase 1 assessed as inhibition of relaxation of supercoiled pBR322 DNA at 100 uM by agarose gel electrophoresis\n",
            "Title: Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.  Abstract: A series of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives were designed, synthesized, and evaluated for their topoisomerase I and II inhibition and cytotoxic activity against several human cancer cell lines. Compounds 10-19 showed moderate topoisomerase I and II inhibitory activity and 20-29 showed significant topoisomerase II inhibitory activity. Structure-activity relationship study revealed that 4-(5-chlorofuran-2-yl)-2-(thiophen-3-yl) moiety has an important role in displaying topoisomerase II inhibition.\n",
            "462324\n",
            "Inhibition of human recombinant topoisomerase 1 assessed as inhibition of relaxation of supercoiled pBR322 DNA at 20 uM by agarose gel electrophoresis\n",
            "Title: Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.  Abstract: A series of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives were designed, synthesized, and evaluated for their topoisomerase I and II inhibition and cytotoxic activity against several human cancer cell lines. Compounds 10-19 showed moderate topoisomerase I and II inhibitory activity and 20-29 showed significant topoisomerase II inhibitory activity. Structure-activity relationship study revealed that 4-(5-chlorofuran-2-yl)-2-(thiophen-3-yl) moiety has an important role in displaying topoisomerase II inhibition.\n",
            "462741\n",
            "Inhibition of topoisomerase 1-mediated unwinding of supercoiled plasmid DNA at 10 uM\n",
            "Title: Synthesis and antiproliferative evaluation of certain indolo[3,2-c]quinoline derivatives.  Abstract: The present report describes the synthesis and antiproliferative evaluation of certain indolo[3,2-c]quinoline derivatives. For the C(6) anilino-substituted derivatives, (11H-indolo[3,2-c]quinolin-6-yl)phenylamine (6a) was inactive. Structural optimization of 6a by the introduction of a hydroxyl group at the anilino-moiety resulted in the enhancement of antiproliferative activity in which the activity decreased in an order of para-OH, 7a>meta-OH, 8a>ortho-OH, 9a. For the C(6) alkylamino-substituted derivatives, 11a, 12a, 13a, 14a, and 15a exhibited comparable antiproliferative activities against all cancer cells tested and the skin Detroit 551 normal fibroblast cells. Three cancer cells, HeLa, A549, and SKHep, are very susceptible with IC(50) of less than 2.17 microM while PC-3 is relatively resistant to this group of indolo[3,2-c]quinolines. For the 2-phenylethylamino derivatives, compound 20a is active against the growth of HeLa with an IC(50) of 0.52 microM, but is less effective against the growth of Detroit 551 with an IC(50) of 19.32 microM. For the bis-indolo[3,2-c]quinolines, N,N-bis-[3-(11H-indolo[3,2-c]quinolin-6-yl)aminopropyl]amine hydrochloride (25) is more active than its N-methyl derivative 26 and the positive Doxorubicin. Mechanism studies indicated 25 can induce caspase-3 activation, gamma-H2AX phosphorylation, cleavage of poly(ADP-ribose)polymerase and DNA fragmentation. These results provide evidence that DNA, topo I, and topo II are the primary targets of indolo[3,2-c]quinoline derivatives and that consequently inhibits proliferation and causes apoptosis in cancer cells.\n",
            "462742\n",
            "Inhibition of topoisomerase 1-mediated unwinding of supercoiled plasmid DNA at 0.1 to 1.0 uM\n",
            "Title: Synthesis and antiproliferative evaluation of certain indolo[3,2-c]quinoline derivatives.  Abstract: The present report describes the synthesis and antiproliferative evaluation of certain indolo[3,2-c]quinoline derivatives. For the C(6) anilino-substituted derivatives, (11H-indolo[3,2-c]quinolin-6-yl)phenylamine (6a) was inactive. Structural optimization of 6a by the introduction of a hydroxyl group at the anilino-moiety resulted in the enhancement of antiproliferative activity in which the activity decreased in an order of para-OH, 7a>meta-OH, 8a>ortho-OH, 9a. For the C(6) alkylamino-substituted derivatives, 11a, 12a, 13a, 14a, and 15a exhibited comparable antiproliferative activities against all cancer cells tested and the skin Detroit 551 normal fibroblast cells. Three cancer cells, HeLa, A549, and SKHep, are very susceptible with IC(50) of less than 2.17 microM while PC-3 is relatively resistant to this group of indolo[3,2-c]quinolines. For the 2-phenylethylamino derivatives, compound 20a is active against the growth of HeLa with an IC(50) of 0.52 microM, but is less effective against the growth of Detroit 551 with an IC(50) of 19.32 microM. For the bis-indolo[3,2-c]quinolines, N,N-bis-[3-(11H-indolo[3,2-c]quinolin-6-yl)aminopropyl]amine hydrochloride (25) is more active than its N-methyl derivative 26 and the positive Doxorubicin. Mechanism studies indicated 25 can induce caspase-3 activation, gamma-H2AX phosphorylation, cleavage of poly(ADP-ribose)polymerase and DNA fragmentation. These results provide evidence that DNA, topo I, and topo II are the primary targets of indolo[3,2-c]quinoline derivatives and that consequently inhibits proliferation and causes apoptosis in cancer cells.\n",
            "467763\n",
            "Inhibition of human topoisomerase 1 at 20 uM\n",
            "Title: Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.  Abstract: A total of seven new oxyranylmethyloxy or thiiranylmethyloxy group substituted 5-azaxanthones and -acridones analogues were synthesized and tested for their biological activities for cancer cell lines and topoisomerases. Among the compounds, compound 5, 3-thiiranylmethyloxy-1-hydroxy-5-azaxanthone, showed effective topoisomerase I inhibitory activity, 50% and 27% inhibition ratio at 100 and 20muM, respectively. This result is the first finding of the function of 5-azaxanthone compounds for topoisomerase I inhibition and can provide a novel skeleton for the anticancer drug development process.\n",
            "467764\n",
            "Inhibition of human topoisomerase 1 at 100 uM\n",
            "Title: Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.  Abstract: A total of seven new oxyranylmethyloxy or thiiranylmethyloxy group substituted 5-azaxanthones and -acridones analogues were synthesized and tested for their biological activities for cancer cell lines and topoisomerases. Among the compounds, compound 5, 3-thiiranylmethyloxy-1-hydroxy-5-azaxanthone, showed effective topoisomerase I inhibitory activity, 50% and 27% inhibition ratio at 100 and 20muM, respectively. This result is the first finding of the function of 5-azaxanthone compounds for topoisomerase I inhibition and can provide a novel skeleton for the anticancer drug development process.\n",
            "470667\n",
            "Inhibition of topoisomerase 1 catalytic activity assessed as relaxation of supercoiled plasmid DNA at 100 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Rational design and semisynthesis of betulinic acid analogues as potent topoisomerase inhibitors.  Abstract: Chemical transformation studies were conducted on betulinic acid (1), a common plant-derived lupane-type triterpene. Eleven new rationally designed derivatives of 1 (2-5 and 7-13) were synthesized based on docking studies and tested for their topoisomerase I and IIalpha inhibitory activity. Semisynthetic reactions targeted C-3, C-20, and C-28 in 1. Structures of the new compounds were confirmed by spectroscopic methods (1D and 2D NMR and MS). Compound 9, 3-O-[N-(phenylsulfonyl)carbamoyl-17beta-N-(phenylsulfonyl)amide]betulinic acid, showed 1.5-fold the activity of CPT in a topoisomerase I DNA relaxation assay. Four out of 14 betulinic acid analogues (5, 9, 11, and 12) showed 1.5-fold the activity of etoposide in a topoisomerase II assay. The new analogues exhibited better cytotoxic activities against the human colon cancer cells SW948 and HCT-116 and the breast cancer cell line MDA-MB-231 compared to the parent (1). Betulinic acid (1) is a potential scaffold for the design of new topoisomerase I and IIalpha inhibitors.\n",
            "476071\n",
            "Inhibition of human DNA topoisomerase 1 up to 100 uM\n",
            "Title: 4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors.  Abstract: Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is an enzyme that catalyzes the hydrolysis of 3'-phosphotyrosyl bonds. Such linkages form in vivo when topoisomerase I (Top1) processes DNA. For this reason, Tdp1 has been implicated in the repair of irreversible Top1-DNA covalent complexes. Tdp1 inhibitors have been regarded as potential therapeutics in combination with Top1 inhibitors, such as the camptothecin derivatives, topotecan, and irinotecan, which are used to treat human cancers. Using a novel high-throughput screening assay, we have identified the C21-substituted progesterone derivative, NSC 88915 (1), as a potential Tdp1 inhibitor. Secondary screening and cross-reactivity studies with related DNA processing enzymes confirmed that compound 1 possesses specific Tdp1 inhibitory activity. Deconstruction of compound 1 into discrete functional groups reveals that both components are required for inhibition of Tdp1 activity. Moreover, the synthesis of analogues of compound 1 has provided insight into the structural requirements for the inhibition of Tdp1. Surface plasmon resonance shows that compound 1 binds to Tdp1, whereas an inactive analogue fails to interact with the enzyme. On the basis of molecular docking and mechanistic studies, we propose that these compounds are competitive inhibitors, which mimics the oligonucleotide-peptide Tdp1 substrate. These steroid derivatives represent a novel chemotype and provide a new scaffold for developing small molecule inhibitors of Tdp1.\n",
            "478033\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of pBR322 at 100 uM\n",
            "Title: A series of alpha-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity.  Abstract: A series of novel thiosemicarbazone derivatives bearing condensed heterocyclic carboxaldehyde moieties were designed and synthesized. Among them, TSC24 exhibited broad antiproliferative activity in a panel of human tumor cells and suppressed tumor growth in mice. The mechanism research revealed that TSC24 was not only an iron chelator but also a topoisomerase IIalpha catalytic inhibitor. Its inhibition on topoisomerase IIalpha was due to direct interaction with the ATPase domain of topoisomerase IIalpha which led to the block of ATP hydrolysis. Molecular docking predicted that TSC24 might bind at the ATP binding site, which was confirmed by the competitive inhibition assay. These results about the mechanisms involved in the anticancer activities of thiosemicarbazones will aid in the rational design of novel topoisomerase II-targeted drugs and will provide insights into the discovery and development of novel cancer therapeutics based on the dual activity to chelate iron and to inhibit the catalytic activity of topoisomerase IIalpha.\n",
            "478041\n",
            "Inhibition of topoisomerase 1-mediated unwinding of supercoiled DNA assessed as DNA intercalation\n",
            "Title: A series of alpha-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity.  Abstract: A series of novel thiosemicarbazone derivatives bearing condensed heterocyclic carboxaldehyde moieties were designed and synthesized. Among them, TSC24 exhibited broad antiproliferative activity in a panel of human tumor cells and suppressed tumor growth in mice. The mechanism research revealed that TSC24 was not only an iron chelator but also a topoisomerase IIalpha catalytic inhibitor. Its inhibition on topoisomerase IIalpha was due to direct interaction with the ATPase domain of topoisomerase IIalpha which led to the block of ATP hydrolysis. Molecular docking predicted that TSC24 might bind at the ATP binding site, which was confirmed by the competitive inhibition assay. These results about the mechanisms involved in the anticancer activities of thiosemicarbazones will aid in the rational design of novel topoisomerase II-targeted drugs and will provide insights into the discovery and development of novel cancer therapeutics based on the dual activity to chelate iron and to inhibit the catalytic activity of topoisomerase IIalpha.\n",
            "478056\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of pBR322 up to 125 uM\n",
            "Title: A series of alpha-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity.  Abstract: A series of novel thiosemicarbazone derivatives bearing condensed heterocyclic carboxaldehyde moieties were designed and synthesized. Among them, TSC24 exhibited broad antiproliferative activity in a panel of human tumor cells and suppressed tumor growth in mice. The mechanism research revealed that TSC24 was not only an iron chelator but also a topoisomerase IIalpha catalytic inhibitor. Its inhibition on topoisomerase IIalpha was due to direct interaction with the ATPase domain of topoisomerase IIalpha which led to the block of ATP hydrolysis. Molecular docking predicted that TSC24 might bind at the ATP binding site, which was confirmed by the competitive inhibition assay. These results about the mechanisms involved in the anticancer activities of thiosemicarbazones will aid in the rational design of novel topoisomerase II-targeted drugs and will provide insights into the discovery and development of novel cancer therapeutics based on the dual activity to chelate iron and to inhibit the catalytic activity of topoisomerase IIalpha.\n",
            "480105\n",
            "Inhibition of human recombinant TOP1-mediated relaxation of supercoiled Escherichia coli pBR322 DNA at 100 uM after 30 mins by transillumination\n",
            "Title: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines.  Abstract: A new series of 2,4-diphenyl-6-aryl pyridines containing hydroxyl group(s) at the ortho, meta, or para position of the phenyl ring were synthesized, and evaluated for topoisomerase I and II inhibitory activity and cytotoxicity against several human cancer cell lines for the development of novel anticancer agents. Structure-activity relationship study revealed that the substitution of hydroxyl group(s) increased topoisomerase I and II inhibitory activity in the order of meta > para > ortho position. Substitution of hydroxyl group on the para position showed better cytotoxicity.\n",
            "480106\n",
            "Inhibition of human recombinant TOP1-mediated relaxation of supercoiled Escherichia coli pBR322 DNA at 20 uM after 30 mins by transillumination\n",
            "Title: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines.  Abstract: A new series of 2,4-diphenyl-6-aryl pyridines containing hydroxyl group(s) at the ortho, meta, or para position of the phenyl ring were synthesized, and evaluated for topoisomerase I and II inhibitory activity and cytotoxicity against several human cancer cell lines for the development of novel anticancer agents. Structure-activity relationship study revealed that the substitution of hydroxyl group(s) increased topoisomerase I and II inhibitory activity in the order of meta > para > ortho position. Substitution of hydroxyl group on the para position showed better cytotoxicity.\n",
            "480992\n",
            "Inhibition of human DNA topoisomerase 1-mediated relaxation of supercoiled DNA by gel electrophoresis\n",
            "Title: Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.  Abstract: Cytotoxicity and inhibition on human DNA topoisomerase I (TOP1) and II (TOP2) of 74 plant-originated triterpenoids and triterpenoid glycosides were investigated. The cytotoxic compounds are primarily polyhydroxylated oleananes (GI(50) of A549: 1.0-10.19 microM). Sixteen cytotoxic aesculiosides isolated from Aesculus pavia inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, hydrolysis of six active aesculiosides (1, 4, 6, 8, 10, and 23) lost their TOP1 activities but enhanced their cytotoxicities. None of the test compounds showed any activity against TOP2. Structure-activity relationship (SAR) investigations indicated that cytotoxic oleananes required at least one angeloyl moiety at either C-21 or C-22 but the sugar moiety at C-3 may decrease their cytotoxicities. An angeloyl or tigeloyl group at C-21 is required for oleananes to bind the free TOP1 enzyme although the type and length of acyl moiety at C-22 also affects their activity. However, sugar moiety at C-3 is necessary for their TOP1 activities.\n",
            "481164\n",
            "Inhibition of human DNA topoisomerase 1 assessed as intercalate into DNA at 312 uM\n",
            "Title: Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.  Abstract: Cytotoxicity and inhibition on human DNA topoisomerase I (TOP1) and II (TOP2) of 74 plant-originated triterpenoids and triterpenoid glycosides were investigated. The cytotoxic compounds are primarily polyhydroxylated oleananes (GI(50) of A549: 1.0-10.19 microM). Sixteen cytotoxic aesculiosides isolated from Aesculus pavia inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, hydrolysis of six active aesculiosides (1, 4, 6, 8, 10, and 23) lost their TOP1 activities but enhanced their cytotoxicities. None of the test compounds showed any activity against TOP2. Structure-activity relationship (SAR) investigations indicated that cytotoxic oleananes required at least one angeloyl moiety at either C-21 or C-22 but the sugar moiety at C-3 may decrease their cytotoxicities. An angeloyl or tigeloyl group at C-21 is required for oleananes to bind the free TOP1 enzyme although the type and length of acyl moiety at C-22 also affects their activity. However, sugar moiety at C-3 is necessary for their TOP1 activities.\n",
            "481165\n",
            "Inhibition of human DNA topoisomerase 1-mediated relaxation of supercoiled DNA at 63 uM\n",
            "Title: Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.  Abstract: Cytotoxicity and inhibition on human DNA topoisomerase I (TOP1) and II (TOP2) of 74 plant-originated triterpenoids and triterpenoid glycosides were investigated. The cytotoxic compounds are primarily polyhydroxylated oleananes (GI(50) of A549: 1.0-10.19 microM). Sixteen cytotoxic aesculiosides isolated from Aesculus pavia inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, hydrolysis of six active aesculiosides (1, 4, 6, 8, 10, and 23) lost their TOP1 activities but enhanced their cytotoxicities. None of the test compounds showed any activity against TOP2. Structure-activity relationship (SAR) investigations indicated that cytotoxic oleananes required at least one angeloyl moiety at either C-21 or C-22 but the sugar moiety at C-3 may decrease their cytotoxicities. An angeloyl or tigeloyl group at C-21 is required for oleananes to bind the free TOP1 enzyme although the type and length of acyl moiety at C-22 also affects their activity. However, sugar moiety at C-3 is necessary for their TOP1 activities.\n",
            "481166\n",
            "Inhibition of human DNA topoisomerase 1-mediated relaxation of supercoiled DNA at >125 uM\n",
            "Title: Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.  Abstract: Cytotoxicity and inhibition on human DNA topoisomerase I (TOP1) and II (TOP2) of 74 plant-originated triterpenoids and triterpenoid glycosides were investigated. The cytotoxic compounds are primarily polyhydroxylated oleananes (GI(50) of A549: 1.0-10.19 microM). Sixteen cytotoxic aesculiosides isolated from Aesculus pavia inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, hydrolysis of six active aesculiosides (1, 4, 6, 8, 10, and 23) lost their TOP1 activities but enhanced their cytotoxicities. None of the test compounds showed any activity against TOP2. Structure-activity relationship (SAR) investigations indicated that cytotoxic oleananes required at least one angeloyl moiety at either C-21 or C-22 but the sugar moiety at C-3 may decrease their cytotoxicities. An angeloyl or tigeloyl group at C-21 is required for oleananes to bind the free TOP1 enzyme although the type and length of acyl moiety at C-22 also affects their activity. However, sugar moiety at C-3 is necessary for their TOP1 activities.\n",
            "481167\n",
            "Inhibition of human DNA topoisomerase 1-mediated relaxation of supercoiled DNA at 312 uM\n",
            "Title: Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.  Abstract: Cytotoxicity and inhibition on human DNA topoisomerase I (TOP1) and II (TOP2) of 74 plant-originated triterpenoids and triterpenoid glycosides were investigated. The cytotoxic compounds are primarily polyhydroxylated oleananes (GI(50) of A549: 1.0-10.19 microM). Sixteen cytotoxic aesculiosides isolated from Aesculus pavia inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, hydrolysis of six active aesculiosides (1, 4, 6, 8, 10, and 23) lost their TOP1 activities but enhanced their cytotoxicities. None of the test compounds showed any activity against TOP2. Structure-activity relationship (SAR) investigations indicated that cytotoxic oleananes required at least one angeloyl moiety at either C-21 or C-22 but the sugar moiety at C-3 may decrease their cytotoxicities. An angeloyl or tigeloyl group at C-21 is required for oleananes to bind the free TOP1 enzyme although the type and length of acyl moiety at C-22 also affects their activity. However, sugar moiety at C-3 is necessary for their TOP1 activities.\n",
            "481168\n",
            "Inhibition of human DNA topoisomerase 1-mediated relaxation of supercoiled DNA at 63 to 125 uM\n",
            "Title: Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.  Abstract: Cytotoxicity and inhibition on human DNA topoisomerase I (TOP1) and II (TOP2) of 74 plant-originated triterpenoids and triterpenoid glycosides were investigated. The cytotoxic compounds are primarily polyhydroxylated oleananes (GI(50) of A549: 1.0-10.19 microM). Sixteen cytotoxic aesculiosides isolated from Aesculus pavia inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, hydrolysis of six active aesculiosides (1, 4, 6, 8, 10, and 23) lost their TOP1 activities but enhanced their cytotoxicities. None of the test compounds showed any activity against TOP2. Structure-activity relationship (SAR) investigations indicated that cytotoxic oleananes required at least one angeloyl moiety at either C-21 or C-22 but the sugar moiety at C-3 may decrease their cytotoxicities. An angeloyl or tigeloyl group at C-21 is required for oleananes to bind the free TOP1 enzyme although the type and length of acyl moiety at C-22 also affects their activity. However, sugar moiety at C-3 is necessary for their TOP1 activities.\n",
            "481169\n",
            "Inhibition of human DNA topoisomerase 1-mediated relaxation of supercoiled DNA at 450 uM\n",
            "Title: Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.  Abstract: Cytotoxicity and inhibition on human DNA topoisomerase I (TOP1) and II (TOP2) of 74 plant-originated triterpenoids and triterpenoid glycosides were investigated. The cytotoxic compounds are primarily polyhydroxylated oleananes (GI(50) of A549: 1.0-10.19 microM). Sixteen cytotoxic aesculiosides isolated from Aesculus pavia inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, hydrolysis of six active aesculiosides (1, 4, 6, 8, 10, and 23) lost their TOP1 activities but enhanced their cytotoxicities. None of the test compounds showed any activity against TOP2. Structure-activity relationship (SAR) investigations indicated that cytotoxic oleananes required at least one angeloyl moiety at either C-21 or C-22 but the sugar moiety at C-3 may decrease their cytotoxicities. An angeloyl or tigeloyl group at C-21 is required for oleananes to bind the free TOP1 enzyme although the type and length of acyl moiety at C-22 also affects their activity. However, sugar moiety at C-3 is necessary for their TOP1 activities.\n",
            "481171\n",
            "Inhibition of human DNA topoisomerase 1 at free enzyme state\n",
            "Title: Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.  Abstract: Cytotoxicity and inhibition on human DNA topoisomerase I (TOP1) and II (TOP2) of 74 plant-originated triterpenoids and triterpenoid glycosides were investigated. The cytotoxic compounds are primarily polyhydroxylated oleananes (GI(50) of A549: 1.0-10.19 microM). Sixteen cytotoxic aesculiosides isolated from Aesculus pavia inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, hydrolysis of six active aesculiosides (1, 4, 6, 8, 10, and 23) lost their TOP1 activities but enhanced their cytotoxicities. None of the test compounds showed any activity against TOP2. Structure-activity relationship (SAR) investigations indicated that cytotoxic oleananes required at least one angeloyl moiety at either C-21 or C-22 but the sugar moiety at C-3 may decrease their cytotoxicities. An angeloyl or tigeloyl group at C-21 is required for oleananes to bind the free TOP1 enzyme although the type and length of acyl moiety at C-22 also affects their activity. However, sugar moiety at C-3 is necessary for their TOP1 activities.\n",
            "481172\n",
            "Inhibition of human DNA topoisomerase 1 assessed as prevention of DNA-enzyme complex formation\n",
            "Title: Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.  Abstract: Cytotoxicity and inhibition on human DNA topoisomerase I (TOP1) and II (TOP2) of 74 plant-originated triterpenoids and triterpenoid glycosides were investigated. The cytotoxic compounds are primarily polyhydroxylated oleananes (GI(50) of A549: 1.0-10.19 microM). Sixteen cytotoxic aesculiosides isolated from Aesculus pavia inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, hydrolysis of six active aesculiosides (1, 4, 6, 8, 10, and 23) lost their TOP1 activities but enhanced their cytotoxicities. None of the test compounds showed any activity against TOP2. Structure-activity relationship (SAR) investigations indicated that cytotoxic oleananes required at least one angeloyl moiety at either C-21 or C-22 but the sugar moiety at C-3 may decrease their cytotoxicities. An angeloyl or tigeloyl group at C-21 is required for oleananes to bind the free TOP1 enzyme although the type and length of acyl moiety at C-22 also affects their activity. However, sugar moiety at C-3 is necessary for their TOP1 activities.\n",
            "481173\n",
            "Inhibition of human DNA topoisomerase 1 assessed as stabilize DNA-enzyme covalent complex\n",
            "Title: Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.  Abstract: Cytotoxicity and inhibition on human DNA topoisomerase I (TOP1) and II (TOP2) of 74 plant-originated triterpenoids and triterpenoid glycosides were investigated. The cytotoxic compounds are primarily polyhydroxylated oleananes (GI(50) of A549: 1.0-10.19 microM). Sixteen cytotoxic aesculiosides isolated from Aesculus pavia inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, hydrolysis of six active aesculiosides (1, 4, 6, 8, 10, and 23) lost their TOP1 activities but enhanced their cytotoxicities. None of the test compounds showed any activity against TOP2. Structure-activity relationship (SAR) investigations indicated that cytotoxic oleananes required at least one angeloyl moiety at either C-21 or C-22 but the sugar moiety at C-3 may decrease their cytotoxicities. An angeloyl or tigeloyl group at C-21 is required for oleananes to bind the free TOP1 enzyme although the type and length of acyl moiety at C-22 also affects their activity. However, sugar moiety at C-3 is necessary for their TOP1 activities.\n",
            "481429\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of circular DNA\n",
            "Title: Antimicrobial activity of tryptanthrins in Escherichia coli.  Abstract: Tryptanthrins have potential therapeutic activity against a wide variety of pathogenic organisms, although little is known about their mechanism. Activity against Escherichia coli, however, has not been examined. The effects of tryptanthrin (indolo[2,1-b]quinazolin-6,12-dione) and nine derivatives on growth, survival, and mutagenesis in E. coli were examined. Analogues with a nitrogen atom at the 4-position of tryptanthrin stopped log phase growth of E. coli cultures at concentrations as low as 5 microM. Tryptanthrins decreased viability during incubation with cells in buffer by factors of 10(-2) to <10(-6) at 0.2-40 microM. Derivatives with an oxime group at the 6-position exhibited the greatest bactericidal activity. Most tryptanthrins were not mutagenic in several independent assays, although the 4-aza and 4 aza-8-fluoro derivatives increased frameshift mutations about 22- and 4-fold, respectively. Given the structure of trypanthrins, binding to DNA may occur by intercalation. From analysis using a sensitive linking number assay, several tryptanthrins, especially the 4-aza and 6-oximo derivatives, intercalate into DNA.\n",
            "481430\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of circular DNA at 100 ug/ml\n",
            "Title: Antimicrobial activity of tryptanthrins in Escherichia coli.  Abstract: Tryptanthrins have potential therapeutic activity against a wide variety of pathogenic organisms, although little is known about their mechanism. Activity against Escherichia coli, however, has not been examined. The effects of tryptanthrin (indolo[2,1-b]quinazolin-6,12-dione) and nine derivatives on growth, survival, and mutagenesis in E. coli were examined. Analogues with a nitrogen atom at the 4-position of tryptanthrin stopped log phase growth of E. coli cultures at concentrations as low as 5 microM. Tryptanthrins decreased viability during incubation with cells in buffer by factors of 10(-2) to <10(-6) at 0.2-40 microM. Derivatives with an oxime group at the 6-position exhibited the greatest bactericidal activity. Most tryptanthrins were not mutagenic in several independent assays, although the 4-aza and 4 aza-8-fluoro derivatives increased frameshift mutations about 22- and 4-fold, respectively. Given the structure of trypanthrins, binding to DNA may occur by intercalation. From analysis using a sensitive linking number assay, several tryptanthrins, especially the 4-aza and 6-oximo derivatives, intercalate into DNA.\n",
            "485536\n",
            "Inhibition of topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 20 uM after 20 mins using ethidium bromide staining by electrophoresis relative to control\n",
            "Title: Design, synthesis and biological evaluation of a novel series of anthrapyrazoles linked with netropsin-like oligopyrrole carboxamides as anticancer agents.  Abstract: Anticancer drugs that bind to DNA and inhibit DNA-processing enzymes represent an important class of anticancer drugs. Combilexin molecules, which combine DNA minor groove binding and intercalating functionalities, have the potential for increased DNA binding affinity and increased selectivity due to their dual mode of DNA binding. This study describes the synthesis of DNA minor groove binder netropsin analogs containing either one or two N-methylpyrrole carboxamide groups linked to DNA-intercalating anthrapyrazoles. Those hybrid molecules which had both two N-methylpyrrole groups and terminal (dimethylamino)alkyl side chains displayed submicromolar cytotoxicity towards K562 human leukemia cells. The combilexins were also evaluated for DNA binding by measuring the increase in DNA melting temperature, for DNA topoisomerase IIalpha-mediated double strand cleavage of DNA, for inhibition of DNA topoisomerase IIalpha decatenation activity, and for inhibition of DNA topoisomerase I relaxation of DNA. Several of the compounds stabilized the DNA-topoisomerase IIalpha covalent complex indicating that they acted as topoisomerase IIalpha poisons. Some of the combilexins had higher affinity for DNA than their parent anthrapyrazoles. In conclusion, a novel group of compounds combining DNA intercalating anthrapyrazole groups and minor groove binding netropsin analogs have been designed, synthesized and biologically evaluated as possible novel anticancer agents.\n",
            "486649\n",
            "Inhibition of DNA topoisomerase 1-mediated relaxation of supercoiled plasmid DNA at 100 uM after 3 hrs by gel electrophoresis\n",
            "Title: Synthesis and structure-activity relationship study of novel cytotoxic carbamate and N-acylheterocyclic bearing derivatives of betulin and betulinic acid.  Abstract: Chemical transformation studies were conducted on betulin and betulinic acid, common plant-derived lupane-type triterpenes. The concise synthesis, via a stepwise approach, of betulin and betulinic acid carbamate and N-acylheterocyclic containing derivatives is described. All new compounds, as well as betulinic acid were tested in vitro for their cytotoxic activity. Most of the compounds have shown a better cytotoxic profile than betulinic acid, including the synthesized betulin derivatives. Compounds 25 and 32 were the most promising derivatives, being up to 12-fold more potent than betulinic acid against human PC-3 cell lines (IC(50) values of 1.1 and 1.8 microM, respectively).\n",
            "487689\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pBR19 by agarose gel electrophoresis\n",
            "Title: Synthesis and biological evaluation of dialkylaminoalkylamino benzo[c][1,7] and [1,8]phenanthrolines as antiproliferative agents.  Abstract: Benzo[c][1,7] and [1,8]phenanthroline substituted by dialkylaminoalkyl side chains at position C2 and C1, respectively, were synthesized and their biological activity evaluated. These compounds displayed more potent cytotoxicity toward L1210 cells than the parent unsubstituted compounds, associated with strong DNA interaction. The moderate TopoI inhibitory activity induced by the novel compounds suggests that other cellular targets should be responsible for the antiproliferative activity.\n",
            "487695\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pBR19 at 1 to 5 uM by agarose gel electrophoresis\n",
            "Title: Synthesis and biological evaluation of dialkylaminoalkylamino benzo[c][1,7] and [1,8]phenanthrolines as antiproliferative agents.  Abstract: Benzo[c][1,7] and [1,8]phenanthroline substituted by dialkylaminoalkyl side chains at position C2 and C1, respectively, were synthesized and their biological activity evaluated. These compounds displayed more potent cytotoxicity toward L1210 cells than the parent unsubstituted compounds, associated with strong DNA interaction. The moderate TopoI inhibitory activity induced by the novel compounds suggests that other cellular targets should be responsible for the antiproliferative activity.\n",
            "490081\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of pUC18 DNA assessed as formation of nicked DNA up to 50 uM using ethidium bromide staining by agarose gel electrophoresis\n",
            "Title: Montmorillonite K-10 catalyzed cyclization of N-ethoxycarbonyl-N'-arylguanidines: access to pyrimido[4,5-c]carbazole and pyrimido[5,4-b]indole derivatives.  Abstract: Two new heterocycles, pyrimido[4,5-c]carbazole and pyrimido[5,4-b]indole, were prepared in three steps from 3-aminocarbazole and 3-aminoindole, respectively. The key Friedel-Crafts intramolecular cyclization was realized under microwave irradiation using montmorillonite K-10 clay as a catalyst. The pyrimido[4,5-c]carbazole derivative shows significant micromolar IC(50) against cancer cell lines. Unlike similar carbazole and indolocarbazole compounds, the molecule does not interfere with topoisomerase activity.\n",
            "490170\n",
            "Inhibition of topoisomerase 1-mediated supercoiled pBR322 relaxation assessed as change in band intensity by electrophoresis relative to camptothecin\n",
            "Title: Cytotoxicity and topo I targeting activity of substituted 10--nitrogenous heterocyclic aromatic group derivatives of SN-38.  Abstract: A series of 10-position substituted nitrogenous heterocyclic aromatic group derivatives of SN-38 were prepared. Most of these compounds possessed lower cytotoxicities than CPT. Compound 13 revealed potent cytotoxicity similar to CPT, and compounds 17, 18, and 19 showed similar cytotoxic activity to topotecan. All of the pyridine salt derivatives (7-16) revealed comparable or superior topo I inhibitory activity in relation to CPT. Ethyl in the 7-position of these compounds can increase the cytotoxicity and inhibitory activity to topo I compared with corresponding pyridine salts CPT derivatives (7a-13a) and simultaneously maintain good water solubility. This result is consistent with the SAR of CPT.\n",
            "494546\n",
            "Inhibition of topoisomerase 1\n",
            "Title: Synthesis and biological evaluation of novel benzodioxinocarbazoles (BDCZs) as potential anticancer agents.  Abstract: We report the efficient synthesis and biological evaluation of new benzodioxinoindolocarbazoles heterocycles (BDCZs) designed as potential anticancer agents. Indolic substitution and maleimide variations were performed to design a new library of BDCZs and their cytotoxicity were evaluated on two representative cancer cell lines. Several derivatives have shown a marked cytotoxicity with IC(50) values in the nanomolar range. Results are reported in this Letter.\n",
            "497152\n",
            "Inhibition of human recombinant Top1-mediated DNA cleavage at 1 uM after 20 mins relative to camptothecin\n",
            "Title: The structure-activity relationships of A-ring-substituted aromathecin topoisomerase I inhibitors strongly support a camptothecin-like binding mode.  Abstract: Aromathecins are inhibitors of human topoisomerase I (Top1). These compounds are composites of several heteroaromatic systems, namely the camptothecins and indenoisoquinolines, and they possess notable Top1 inhibition and cytotoxicity when substituted at position 14. The SAR of these compounds overlaps with indenoisoquinolines, suggesting that they may intercalate into the Top1-DNA complex similarly. Nonetheless, the proposed binding mode for aromathecins is purely hypothetical, as an X-ray structure is unavailable. In the present communication, we have synthesized eight novel series of A-ring-substituted (positions 1-3) aromathecins, through a simple, modular route, as part of a comprehensive SAR study. Certain groups (such as 2,3-ethylenedioxy) moderately improve Top1 inhibition, and, often, antiproliferative activity, whereas other groups (2,3-dimethoxy and 3-substituents) attenuate bioactivity. Strikingly, these trends are very similar to those previously observed for the A-ring of camptothecins, and this considerable SAR overlap lends further support (in the absence of crystallographic data) to the hypothesis that aromathecins bind in the Top1 cleavage complex as interfacial inhibitors in a 'camptothecin-like' pose.\n",
            "497153\n",
            "Inhibition of human recombinant Top1-mediated DNA cleavage at 0.1 to 100 uM after 20 mins relative to camptothecin\n",
            "Title: The structure-activity relationships of A-ring-substituted aromathecin topoisomerase I inhibitors strongly support a camptothecin-like binding mode.  Abstract: Aromathecins are inhibitors of human topoisomerase I (Top1). These compounds are composites of several heteroaromatic systems, namely the camptothecins and indenoisoquinolines, and they possess notable Top1 inhibition and cytotoxicity when substituted at position 14. The SAR of these compounds overlaps with indenoisoquinolines, suggesting that they may intercalate into the Top1-DNA complex similarly. Nonetheless, the proposed binding mode for aromathecins is purely hypothetical, as an X-ray structure is unavailable. In the present communication, we have synthesized eight novel series of A-ring-substituted (positions 1-3) aromathecins, through a simple, modular route, as part of a comprehensive SAR study. Certain groups (such as 2,3-ethylenedioxy) moderately improve Top1 inhibition, and, often, antiproliferative activity, whereas other groups (2,3-dimethoxy and 3-substituents) attenuate bioactivity. Strikingly, these trends are very similar to those previously observed for the A-ring of camptothecins, and this considerable SAR overlap lends further support (in the absence of crystallographic data) to the hypothesis that aromathecins bind in the Top1 cleavage complex as interfacial inhibitors in a 'camptothecin-like' pose.\n",
            "511233\n",
            "Inhibition of human topoisomerase 1 assessed as decrease in pBR322 mobility on agarose gel at 10 uM by electrophoresis\n",
            "Title: Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives. Part 2.  Abstract: Certain indeno[1,2-c]quinoline derivatives were synthesized and evaluated for their antiproliferation, DNA binding affinity, and topoisomerases (topo I and topo II) inhibitory activities. The preliminary results are the following: (1) substituent of the aminoalkoxyimino side chain at C11 is important for antiproliferative activities in which the terminal amine preferred to be a tertiary or the cyclic five-membered pyrrolidino ring; (2) among the indeno[1,2-c]quinoline derivatives evaluated, (E)-6-hydroxy-9-methoxy-11H-indeno[1,2-c]quinolin-11-one O-2-(pyrrolidin-1-yl)ethyl oxime (8c) was found to be one of the most cytotoxic agents with a GI50 value of 0.84, 0.89, and 0.79 microM against SAS, A549, and BT483, respectively, which is more active than camptothecin; (3) substituent at C6 is crucial for the selective cytotoxicity in which the OH group is the most preferred while hydrogen or piperazine exhibited cytotoxicity on both cancer cells and Detroit-551; (4) a positive correlation of antiproliferative activity, DNA binding affinity, and topo I and topo II inhibitory activities has been observed for indeno[1,2-c]quinoline derivatives; (5) compound 8c induced DNA fragmentation may through caspase-3 activation, phosphorylation of the histone protein H2AX at Ser139 (gamma-H2AX), and PARP cleavage; (6) compound 8c demonstrated significant tumor regression in the human breast xenograft model; (7) indeno[1,2-c]quinoline derivatives are a new class of molecules that have the potential to be developed as dual topo I and topo II inhibitory agents.\n",
            "511234\n",
            "Inhibition of human topoisomerase 1 assessed as decrease in pBR322 mobility on agarose gel by electrophoresis\n",
            "Title: Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives. Part 2.  Abstract: Certain indeno[1,2-c]quinoline derivatives were synthesized and evaluated for their antiproliferation, DNA binding affinity, and topoisomerases (topo I and topo II) inhibitory activities. The preliminary results are the following: (1) substituent of the aminoalkoxyimino side chain at C11 is important for antiproliferative activities in which the terminal amine preferred to be a tertiary or the cyclic five-membered pyrrolidino ring; (2) among the indeno[1,2-c]quinoline derivatives evaluated, (E)-6-hydroxy-9-methoxy-11H-indeno[1,2-c]quinolin-11-one O-2-(pyrrolidin-1-yl)ethyl oxime (8c) was found to be one of the most cytotoxic agents with a GI50 value of 0.84, 0.89, and 0.79 microM against SAS, A549, and BT483, respectively, which is more active than camptothecin; (3) substituent at C6 is crucial for the selective cytotoxicity in which the OH group is the most preferred while hydrogen or piperazine exhibited cytotoxicity on both cancer cells and Detroit-551; (4) a positive correlation of antiproliferative activity, DNA binding affinity, and topo I and topo II inhibitory activities has been observed for indeno[1,2-c]quinoline derivatives; (5) compound 8c induced DNA fragmentation may through caspase-3 activation, phosphorylation of the histone protein H2AX at Ser139 (gamma-H2AX), and PARP cleavage; (6) compound 8c demonstrated significant tumor regression in the human breast xenograft model; (7) indeno[1,2-c]quinoline derivatives are a new class of molecules that have the potential to be developed as dual topo I and topo II inhibitory agents.\n",
            "527478\n",
            "Inhibition of human recombinant DNA topoisomerase 1-mediated DNA cleavage assessed as relaxation of supercoiled pBR322 plasmid DNA at 50 uM after 25 mins by ethidium bromide staining\n",
            "Title: Novel synthetic 2-amino-10-(3,5-dimethoxy)benzyl-9(10H)-acridinone derivatives as potent DNA-binding antiproliferative agents.  Abstract: A series of novel 9(10H)-acridinone derivatives with terminal amino substituents at C2 position on the acridinone ring were synthesized and studied for their antiproliferative activity and underlying mechanisms. These compounds demonstrated promising cytotoxicity to leukemia cells CCRF-CEM, displaying IC(50) values in the low micromolar range. Structure-activity relationships (SAR) indicated that the compound 6d bearing a pyrrolidine substituent and 8a with a methyl ammonium side chain displayed higher cytotoxicity to CCRF-CEM cells and also solid tumor cells A549, HepG2, and MCF7. Furthermore, the compounds 6d and 8a had strong binding activity to calf thymus DNA (ct DNA), as detected by UV absorption and fluorescence quenching assays, but limited inhibitory activity to human topoisomerase 1 (topo 1). Taken together, this study discovered a series of new synthetic 9(10H)-acridinone derivatives with potent DNA binding and anticancer activity.\n",
            "527479\n",
            "Inhibition of human recombinant DNA topoisomerase 1-mediated DNA cleavage assessed as relaxation of supercoiled pBR322 plasmid DNA at 250 uM after 25 mins by ethidium bromide staining\n",
            "Title: Novel synthetic 2-amino-10-(3,5-dimethoxy)benzyl-9(10H)-acridinone derivatives as potent DNA-binding antiproliferative agents.  Abstract: A series of novel 9(10H)-acridinone derivatives with terminal amino substituents at C2 position on the acridinone ring were synthesized and studied for their antiproliferative activity and underlying mechanisms. These compounds demonstrated promising cytotoxicity to leukemia cells CCRF-CEM, displaying IC(50) values in the low micromolar range. Structure-activity relationships (SAR) indicated that the compound 6d bearing a pyrrolidine substituent and 8a with a methyl ammonium side chain displayed higher cytotoxicity to CCRF-CEM cells and also solid tumor cells A549, HepG2, and MCF7. Furthermore, the compounds 6d and 8a had strong binding activity to calf thymus DNA (ct DNA), as detected by UV absorption and fluorescence quenching assays, but limited inhibitory activity to human topoisomerase 1 (topo 1). Taken together, this study discovered a series of new synthetic 9(10H)-acridinone derivatives with potent DNA binding and anticancer activity.\n",
            "536035\n",
            "Effect on human DNA topoisomerase 1-mediated relaxation of supercoiled pUC19 DNA at 1 to 2 uM after 2 hrs using ethidium bromide staining by agarose gel electrophoresis\n",
            "Title: Indeno[1,2-c]isoquinolin-5,11-diones conjugated to amino acids: Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties.  Abstract: Three series of indeno[1,2-c]isoquinolin-5,11-dione-amino acid conjugates were designed and synthesized. Amino acids were connected to the tetracycle through linkers with lengths of n=2 and 3 atoms using ester (series I), amide (series II), and secondary amine (series III) functions. DNA binding was evaluated by thermal denaturation and fluorescence measurements. Lysine and arginine substituted derivatives with n=3 provided the highest DNA binding. Arginine derivative 32 (n=2, series II) and glycine derivative 34 (n=2, series III) displayed high topoisomerase II inhibition. Incrementing the length of the N-6 side chain from two to three methylene units provided a significant increase in DNA affinity but a substantial loss in topoisomerase II inhibition. The most cytotoxic compounds toward HL60 leukemia cells were 19, 33, and 34 displaying micromolar IC(50) values. When tested with the topoisomerase II-mutated HL60/MX2 cell line, little variation of IC(50) values was found, suggesting that topoisomerase II might not be the main target of these compounds and that additional targets could be involved.\n",
            "536036\n",
            "Effect on human DNA topoisomerase 1-mediated relaxation of supercoiled pUC19 DNA at 5 to 10 uM after 2 hrs using ethidium bromide staining by agarose gel electrophoresis\n",
            "Title: Indeno[1,2-c]isoquinolin-5,11-diones conjugated to amino acids: Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties.  Abstract: Three series of indeno[1,2-c]isoquinolin-5,11-dione-amino acid conjugates were designed and synthesized. Amino acids were connected to the tetracycle through linkers with lengths of n=2 and 3 atoms using ester (series I), amide (series II), and secondary amine (series III) functions. DNA binding was evaluated by thermal denaturation and fluorescence measurements. Lysine and arginine substituted derivatives with n=3 provided the highest DNA binding. Arginine derivative 32 (n=2, series II) and glycine derivative 34 (n=2, series III) displayed high topoisomerase II inhibition. Incrementing the length of the N-6 side chain from two to three methylene units provided a significant increase in DNA affinity but a substantial loss in topoisomerase II inhibition. The most cytotoxic compounds toward HL60 leukemia cells were 19, 33, and 34 displaying micromolar IC(50) values. When tested with the topoisomerase II-mutated HL60/MX2 cell line, little variation of IC(50) values was found, suggesting that topoisomerase II might not be the main target of these compounds and that additional targets could be involved.\n",
            "536901\n",
            "Inhibition of human recombinant topoisomerase 1-mediated supercoiled pUC19 DNA relaxation up to 100 uM after 2 hrs by agarose gel electrophoresis analysis\n",
            "Title: Design, synthesis, and DNA-binding of N-alkyl(anilino)quinazoline derivatives.  Abstract: New N-alkylanilinoquinazoline derivatives 5, 12, 20, and 22 have been prepared from 4-chloro-6,7-dimethoxyquinazoline 3, 4-chloro-6,7-methylenedioxyquinazoline 19, and commercially available anilines. Differents classes of compounds substituted by an aryloxygroup (6a-c, 16a,b, and 17a,b), (aminophenyl)ureas (12a,b and 13a-f), anilines (4a-m, 20a,b), N-alkyl(aniline) (5a-m, 21a,b, 22a,d), and N-aminoalkyl(aniline) (22e-g) have been synthesized. These molecules were evaluated for their cytotoxic activities and as potential DNA intercalating agents. We studied the strength and mode of binding to DNA of these molecules by DNA melting temperature measurements, fluorescence emission, and circular dichroism. The results of various spectral and gel electrophoresis techniques obtained with the different compounds, in particular compounds 5g and 22f, revealed significant DNA interaction. These experiments confirm that the N-aminoalkyl(anilino)-6,7-dimethoxyquinazoline nucleus is an efficient pharmacophore to trigger binding to DNA, via an intercalative binding process.\n",
            "537376\n",
            "Inhibition of DNA topoisomerase 1-mediated supercoiled Escherichia coli pBR322 DNA relaxation at 1 to 50 uM by UV transilluminator analysis\n",
            "Title: Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents.  Abstract: Human topoisomerase I (TopoI) is recognized as a valuable target for the development of effective antitumor agents. Structure-based virtual screening was applied to the discovery of structurally diverse TopoI inhibitors. From 23 compounds selected by virtual screening, a total of 14 compounds were found to be TopoI inhibitors. Five hits (compounds 1, 14, 20, 21, and 23) also showed moderate to good in vitro antitumor activity. These novel structures can be considered as good starting points for the development of new antitumor lead compounds. Hit 20 (evodiamine) was chosen for preliminary structure-activity relationship studies. Various groups, including alkyl, benzoyl, benzyl and ester, were introduced to the indole nitrogen atom of evodiamine. The substituted benzoyl groups were found to be favorable for the antitumor activity and spectrum. The 4-Cl benzoyl derivative, compound 29u, was the most active one with IC(50) values in the range 0.049-2.6 M.\n",
            "537377\n",
            "Inhibition of DNA topoisomerase 1-mediated supercoiled Escherichia coli pBR322 DNA relaxation at 10 uM by UV transilluminator analysis\n",
            "Title: Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents.  Abstract: Human topoisomerase I (TopoI) is recognized as a valuable target for the development of effective antitumor agents. Structure-based virtual screening was applied to the discovery of structurally diverse TopoI inhibitors. From 23 compounds selected by virtual screening, a total of 14 compounds were found to be TopoI inhibitors. Five hits (compounds 1, 14, 20, 21, and 23) also showed moderate to good in vitro antitumor activity. These novel structures can be considered as good starting points for the development of new antitumor lead compounds. Hit 20 (evodiamine) was chosen for preliminary structure-activity relationship studies. Various groups, including alkyl, benzoyl, benzyl and ester, were introduced to the indole nitrogen atom of evodiamine. The substituted benzoyl groups were found to be favorable for the antitumor activity and spectrum. The 4-Cl benzoyl derivative, compound 29u, was the most active one with IC(50) values in the range 0.049-2.6 M.\n",
            "537378\n",
            "Inhibition of DNA topoisomerase 1-mediated supercoiled Escherichia coli pBR322 DNA relaxation at 100 uM by UV transilluminator analysis\n",
            "Title: Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents.  Abstract: Human topoisomerase I (TopoI) is recognized as a valuable target for the development of effective antitumor agents. Structure-based virtual screening was applied to the discovery of structurally diverse TopoI inhibitors. From 23 compounds selected by virtual screening, a total of 14 compounds were found to be TopoI inhibitors. Five hits (compounds 1, 14, 20, 21, and 23) also showed moderate to good in vitro antitumor activity. These novel structures can be considered as good starting points for the development of new antitumor lead compounds. Hit 20 (evodiamine) was chosen for preliminary structure-activity relationship studies. Various groups, including alkyl, benzoyl, benzyl and ester, were introduced to the indole nitrogen atom of evodiamine. The substituted benzoyl groups were found to be favorable for the antitumor activity and spectrum. The 4-Cl benzoyl derivative, compound 29u, was the most active one with IC(50) values in the range 0.049-2.6 M.\n",
            "537379\n",
            "Inhibition of DNA topoisomerase 1-mediated supercoiled Escherichia coli pBR322 DNA relaxation by UV transilluminator analysis\n",
            "Title: Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents.  Abstract: Human topoisomerase I (TopoI) is recognized as a valuable target for the development of effective antitumor agents. Structure-based virtual screening was applied to the discovery of structurally diverse TopoI inhibitors. From 23 compounds selected by virtual screening, a total of 14 compounds were found to be TopoI inhibitors. Five hits (compounds 1, 14, 20, 21, and 23) also showed moderate to good in vitro antitumor activity. These novel structures can be considered as good starting points for the development of new antitumor lead compounds. Hit 20 (evodiamine) was chosen for preliminary structure-activity relationship studies. Various groups, including alkyl, benzoyl, benzyl and ester, were introduced to the indole nitrogen atom of evodiamine. The substituted benzoyl groups were found to be favorable for the antitumor activity and spectrum. The 4-Cl benzoyl derivative, compound 29u, was the most active one with IC(50) values in the range 0.049-2.6 M.\n",
            "547370\n",
            "Inhibition of human topoisomerase 1 assessed as induction of DNA cleavage at base-pair 97 using 161 base-pair fragment form pBluescript SK(-) phagemid DNA substrate by DNA cleavage assay\n",
            "Title: Design, synthesis, and evaluation of dibenzo[c,h][1,6]naphthyridines as topoisomerase I inhibitors and potential anticancer agents.  Abstract: Indenoisoquinoline topoisomerase I (Top1) inhibitors are a novel class of anticancer agents. Modifications of the indenoisoquinoline A, B, and D rings have been extensively studied in order to optimize Top1 inhibitory activity and cytotoxicity. To improve understanding of the forces that stabilize drug-Top1-DNA ternary complexes, the five-membered cyclopentadienone C-ring of the indenoisoquinoline system was replaced by six-membered nitrogen heterocyclic rings, resulting in dibenzo[c,h][1,6]naphthyridines that were synthesized by a novel route and tested for Top1 inhibition. This resulted in several compounds that have unique DNA cleavage site selectivities and potent antitumor activities in a number of cancer cell lines.\n",
            "547371\n",
            "Inhibition of human topoisomerase 1 assessed as induction of DNA damage using 161 base-pair fragment form pBluescript SK(-) phagemid DNA substrate by DNA cleavage assay\n",
            "Title: Design, synthesis, and evaluation of dibenzo[c,h][1,6]naphthyridines as topoisomerase I inhibitors and potential anticancer agents.  Abstract: Indenoisoquinoline topoisomerase I (Top1) inhibitors are a novel class of anticancer agents. Modifications of the indenoisoquinoline A, B, and D rings have been extensively studied in order to optimize Top1 inhibitory activity and cytotoxicity. To improve understanding of the forces that stabilize drug-Top1-DNA ternary complexes, the five-membered cyclopentadienone C-ring of the indenoisoquinoline system was replaced by six-membered nitrogen heterocyclic rings, resulting in dibenzo[c,h][1,6]naphthyridines that were synthesized by a novel route and tested for Top1 inhibition. This resulted in several compounds that have unique DNA cleavage site selectivities and potent antitumor activities in a number of cancer cell lines.\n",
            "547372\n",
            "Inhibition of human topoisomerase 1 assessed as induction of DNA cleavage at base-pair 119 using 161 base-pair fragment form pBluescript SK(-) phagemid DNA substrate by DNA cleavage assay\n",
            "Title: Design, synthesis, and evaluation of dibenzo[c,h][1,6]naphthyridines as topoisomerase I inhibitors and potential anticancer agents.  Abstract: Indenoisoquinoline topoisomerase I (Top1) inhibitors are a novel class of anticancer agents. Modifications of the indenoisoquinoline A, B, and D rings have been extensively studied in order to optimize Top1 inhibitory activity and cytotoxicity. To improve understanding of the forces that stabilize drug-Top1-DNA ternary complexes, the five-membered cyclopentadienone C-ring of the indenoisoquinoline system was replaced by six-membered nitrogen heterocyclic rings, resulting in dibenzo[c,h][1,6]naphthyridines that were synthesized by a novel route and tested for Top1 inhibition. This resulted in several compounds that have unique DNA cleavage site selectivities and potent antitumor activities in a number of cancer cell lines.\n",
            "551007\n",
            "Inhibition of human recombinant DNA topoisomerase 1-mediated DNA cleavage assessed as decrease in relaxation of supercoiled plasmid substrate DNA at 100 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Cytotoxicity and topoisomerase I/II inhibition of glycosylated 2-phenyl-indoles, 2-phenyl-benzo[b]thiophenes and 2-phenyl-benzo[b]furans.  Abstract: A panel of glycosylated DNA binding agents (1-12) designed as functional anthracycline mimics was screened against three solid-tumor cell lines (MCF-7, HT 29 and HepG2/C3A) and three non-tumor cell lines by the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) cell viability assay. Several compounds showed better in vitro cytotoxicity and selectivity against MCF-7 cells than daunomycin and doxorubicin, two known DNA binding agents that are clinically-used anti-cancer agents. Although the selectivity for HT 29 and HepG2/C3A cells is generally lower, the IC(50) values of some analogs against these two cancer cell lines were of the same magnitude as doxorubicin. Because there was no correlation between DNA binding affinity and cytotoxicity, and because topoisomerase (Topo) inhibition is another biological mechanism of action of most anthracycline drugs, Topo I/II inhibition assays with 1-12 were performed. Some of the compounds showed strong inhibition against these enzymes at 100M, but there was no clear correlation between cytotoxicity and Topo I/II inhibition ability. Topo I/II inhibition mode assays were also performed, which verified that these compounds are topoisomerase suppressors, not poisons. Based on these results, we conclude that although DNA binding and/or topoisomerase inhibition may contribute to the observed cytotoxicity of 1-12, other mechanisms of action are also likely to be important.\n",
            "551009\n",
            "Inhibition of human recombinant DNA topoisomerase 1-mediated DNA cleavage assessed as decrease in relaxation of supercoiled plasmid substrate DNA at 40 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Cytotoxicity and topoisomerase I/II inhibition of glycosylated 2-phenyl-indoles, 2-phenyl-benzo[b]thiophenes and 2-phenyl-benzo[b]furans.  Abstract: A panel of glycosylated DNA binding agents (1-12) designed as functional anthracycline mimics was screened against three solid-tumor cell lines (MCF-7, HT 29 and HepG2/C3A) and three non-tumor cell lines by the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) cell viability assay. Several compounds showed better in vitro cytotoxicity and selectivity against MCF-7 cells than daunomycin and doxorubicin, two known DNA binding agents that are clinically-used anti-cancer agents. Although the selectivity for HT 29 and HepG2/C3A cells is generally lower, the IC(50) values of some analogs against these two cancer cell lines were of the same magnitude as doxorubicin. Because there was no correlation between DNA binding affinity and cytotoxicity, and because topoisomerase (Topo) inhibition is another biological mechanism of action of most anthracycline drugs, Topo I/II inhibition assays with 1-12 were performed. Some of the compounds showed strong inhibition against these enzymes at 100M, but there was no clear correlation between cytotoxicity and Topo I/II inhibition ability. Topo I/II inhibition mode assays were also performed, which verified that these compounds are topoisomerase suppressors, not poisons. Based on these results, we conclude that although DNA binding and/or topoisomerase inhibition may contribute to the observed cytotoxicity of 1-12, other mechanisms of action are also likely to be important.\n",
            "551010\n",
            "Inhibition of human recombinant DNA topoisomerase 1-mediated DNA cleavage assessed as decrease in relaxation of supercoiled plasmid substrate DNA at 5 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Cytotoxicity and topoisomerase I/II inhibition of glycosylated 2-phenyl-indoles, 2-phenyl-benzo[b]thiophenes and 2-phenyl-benzo[b]furans.  Abstract: A panel of glycosylated DNA binding agents (1-12) designed as functional anthracycline mimics was screened against three solid-tumor cell lines (MCF-7, HT 29 and HepG2/C3A) and three non-tumor cell lines by the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) cell viability assay. Several compounds showed better in vitro cytotoxicity and selectivity against MCF-7 cells than daunomycin and doxorubicin, two known DNA binding agents that are clinically-used anti-cancer agents. Although the selectivity for HT 29 and HepG2/C3A cells is generally lower, the IC(50) values of some analogs against these two cancer cell lines were of the same magnitude as doxorubicin. Because there was no correlation between DNA binding affinity and cytotoxicity, and because topoisomerase (Topo) inhibition is another biological mechanism of action of most anthracycline drugs, Topo I/II inhibition assays with 1-12 were performed. Some of the compounds showed strong inhibition against these enzymes at 100M, but there was no clear correlation between cytotoxicity and Topo I/II inhibition ability. Topo I/II inhibition mode assays were also performed, which verified that these compounds are topoisomerase suppressors, not poisons. Based on these results, we conclude that although DNA binding and/or topoisomerase inhibition may contribute to the observed cytotoxicity of 1-12, other mechanisms of action are also likely to be important.\n",
            "551014\n",
            "Induction of poisoning activity in human recombinant DNA topoisomerase 1 assessed as enhancement of in relaxation of supercoiled plasmid substrate DNA at 100 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Cytotoxicity and topoisomerase I/II inhibition of glycosylated 2-phenyl-indoles, 2-phenyl-benzo[b]thiophenes and 2-phenyl-benzo[b]furans.  Abstract: A panel of glycosylated DNA binding agents (1-12) designed as functional anthracycline mimics was screened against three solid-tumor cell lines (MCF-7, HT 29 and HepG2/C3A) and three non-tumor cell lines by the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) cell viability assay. Several compounds showed better in vitro cytotoxicity and selectivity against MCF-7 cells than daunomycin and doxorubicin, two known DNA binding agents that are clinically-used anti-cancer agents. Although the selectivity for HT 29 and HepG2/C3A cells is generally lower, the IC(50) values of some analogs against these two cancer cell lines were of the same magnitude as doxorubicin. Because there was no correlation between DNA binding affinity and cytotoxicity, and because topoisomerase (Topo) inhibition is another biological mechanism of action of most anthracycline drugs, Topo I/II inhibition assays with 1-12 were performed. Some of the compounds showed strong inhibition against these enzymes at 100M, but there was no clear correlation between cytotoxicity and Topo I/II inhibition ability. Topo I/II inhibition mode assays were also performed, which verified that these compounds are topoisomerase suppressors, not poisons. Based on these results, we conclude that although DNA binding and/or topoisomerase inhibition may contribute to the observed cytotoxicity of 1-12, other mechanisms of action are also likely to be important.\n",
            "551015\n",
            "Induction of poisoning activity in human recombinant DNA topoisomerase 1 assessed as enhancement of in relaxation of supercoiled plasmid substrate DNA at 75 to 100 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Cytotoxicity and topoisomerase I/II inhibition of glycosylated 2-phenyl-indoles, 2-phenyl-benzo[b]thiophenes and 2-phenyl-benzo[b]furans.  Abstract: A panel of glycosylated DNA binding agents (1-12) designed as functional anthracycline mimics was screened against three solid-tumor cell lines (MCF-7, HT 29 and HepG2/C3A) and three non-tumor cell lines by the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) cell viability assay. Several compounds showed better in vitro cytotoxicity and selectivity against MCF-7 cells than daunomycin and doxorubicin, two known DNA binding agents that are clinically-used anti-cancer agents. Although the selectivity for HT 29 and HepG2/C3A cells is generally lower, the IC(50) values of some analogs against these two cancer cell lines were of the same magnitude as doxorubicin. Because there was no correlation between DNA binding affinity and cytotoxicity, and because topoisomerase (Topo) inhibition is another biological mechanism of action of most anthracycline drugs, Topo I/II inhibition assays with 1-12 were performed. Some of the compounds showed strong inhibition against these enzymes at 100M, but there was no clear correlation between cytotoxicity and Topo I/II inhibition ability. Topo I/II inhibition mode assays were also performed, which verified that these compounds are topoisomerase suppressors, not poisons. Based on these results, we conclude that although DNA binding and/or topoisomerase inhibition may contribute to the observed cytotoxicity of 1-12, other mechanisms of action are also likely to be important.\n",
            "551016\n",
            "Induction of poisoning activity in human recombinant DNA topoisomerase 1 assessed as enhancement of in relaxation of supercoiled plasmid substrate DNA at 25 to 50 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Cytotoxicity and topoisomerase I/II inhibition of glycosylated 2-phenyl-indoles, 2-phenyl-benzo[b]thiophenes and 2-phenyl-benzo[b]furans.  Abstract: A panel of glycosylated DNA binding agents (1-12) designed as functional anthracycline mimics was screened against three solid-tumor cell lines (MCF-7, HT 29 and HepG2/C3A) and three non-tumor cell lines by the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) cell viability assay. Several compounds showed better in vitro cytotoxicity and selectivity against MCF-7 cells than daunomycin and doxorubicin, two known DNA binding agents that are clinically-used anti-cancer agents. Although the selectivity for HT 29 and HepG2/C3A cells is generally lower, the IC(50) values of some analogs against these two cancer cell lines were of the same magnitude as doxorubicin. Because there was no correlation between DNA binding affinity and cytotoxicity, and because topoisomerase (Topo) inhibition is another biological mechanism of action of most anthracycline drugs, Topo I/II inhibition assays with 1-12 were performed. Some of the compounds showed strong inhibition against these enzymes at 100M, but there was no clear correlation between cytotoxicity and Topo I/II inhibition ability. Topo I/II inhibition mode assays were also performed, which verified that these compounds are topoisomerase suppressors, not poisons. Based on these results, we conclude that although DNA binding and/or topoisomerase inhibition may contribute to the observed cytotoxicity of 1-12, other mechanisms of action are also likely to be important.\n",
            "551263\n",
            "Inhibition of topoisomerase 1\n",
            "Title: 3-Arylisoquinolines as novel topoisomerase I inhibitors.  Abstract: Topoisomerase I (topo I) is an essential enzyme for vital cellular processes. Inhibition of topo I activities is lethal and leads to cell death, thus establishing topo I as a promising target for cancer treatment. Camptothecin, a natural alkaloid, inhibits topo I. Topotecan and irinotecan, synthetic derivatives of camptothecin, are the most potent anticancer drugs in clinical use. However, several limitations of camptothecins such as solubility, toxicity, stability, resistance and the required high drug dose have encouraged the development of non-camptothecin topo I inhibitors. Natural alkaloid benzo[c]phenanthridines and synthetic indenoisoquinolines have been extensively studied as alternatives to camptothecin. Interestingly, these non-camptothecin topo I inhibitors share a common 3-arylisoquinoline scaffold. This review will describe the development of novel indeno[1,2-c]isoquinolines, isoindolo[2,1-b]isoquinolines, 12-oxobenzo[c]phenanthridines and benz[b]oxepines with a 3-arylisoquinoline nucleus as topo I inhibitors.\n",
            "552714\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of supercoiled pBR322 at 100 uM by agarose gel electrophoresis\n",
            "Title: Synthesis and topoisomerase II inhibitory and cytotoxic activity of oxiranylmethoxy- and thiiranylmethoxy-chalcone derivatives.  Abstract: In order to find potential anticancer drug candidate targeting topoisomerases enzyme, we have designed and synthesized oxiranylmethoxy- and thiiranylmethoxy-retrochalcone derivatives and evaluated their pharmacological activity including topoisomerases inhibitory and cytotoxic activity. Of the compounds prepared compound 25 showed comparable or better cytotoxic activity against cancer cell lines tested. Compound 25 inhibited MCF7 (IC(50): 0.49  0.21 M) and HCT15 (IC(50): 0.23  0.02 M) carcinoma cell growth more efficiently than references. In the topoisomerases inhibition test, all the compounds were inactive to topoisomerase I but moderate inhibitors to topoisomerase II enzyme. Especially, compound 25 inhibited topoisomerase II activity with comparable extent to etoposide at 100 M concentrations. Correlation between cytotoxicity and topoisomerase II inhibitory activity implies that compound 25 can be a possible lead compound for anticancer drug impeding the topoisomerase II function.\n",
            "565888\n",
            "Inhibition of topoisomerase 1-mediated relaxation of DNA at 0.5 uM by agarose gel electrophoresis\n",
            "Title: The first series of 4,11-bis[(2-aminoethyl)amino]anthra[2,3-b]furan-5,10-diones: Synthesis and anti-proliferative characteristics.  Abstract: We developed the synthesis of a series of furan-fused tetracyclic analogues of the antitumor agent ametantrone. The reactions included nucleophilic substitution of propoxy groups in 4,11-dipropoxyanthra[2,3-b]furan-5,10-diones with ethylenediamines, producing the derivatives of 4,11-diaminoanthra[2,3-b]furan-5,10-dione in good yields. Studies of anti-proliferative activity on a panel of mammalian tumor cell lines demonstrated that anthra[2,3-b]furan-5,10-diones were the most potent derivatives among heteroarene-fused ametantrone analogues with one heteroatom. We identified several compounds that evoked a growth inhibitory effect at submicromolar concentrations. The anthra[2,3-b]furan-5,10-dione 9 with distal methylamino groups was markedly potent against drug-resistant cell lines with P-glycoprotein overexpression or p53 gene deletion. Furthermore, this derivative attenuated in vitro topoisomerase I-mediated DNA uncoiling at low micromolar concentrations. These results demonstrate that anthrafurandiones are a new class of heterocyclic anthraquinone derivatives with the properties potentially valuable for anticancer therapy.\n",
            "565889\n",
            "Inhibition of topoisomerase 1-mediated relaxation of DNA at 0.1 uM by agarose gel electrophoresis\n",
            "Title: The first series of 4,11-bis[(2-aminoethyl)amino]anthra[2,3-b]furan-5,10-diones: Synthesis and anti-proliferative characteristics.  Abstract: We developed the synthesis of a series of furan-fused tetracyclic analogues of the antitumor agent ametantrone. The reactions included nucleophilic substitution of propoxy groups in 4,11-dipropoxyanthra[2,3-b]furan-5,10-diones with ethylenediamines, producing the derivatives of 4,11-diaminoanthra[2,3-b]furan-5,10-dione in good yields. Studies of anti-proliferative activity on a panel of mammalian tumor cell lines demonstrated that anthra[2,3-b]furan-5,10-diones were the most potent derivatives among heteroarene-fused ametantrone analogues with one heteroatom. We identified several compounds that evoked a growth inhibitory effect at submicromolar concentrations. The anthra[2,3-b]furan-5,10-dione 9 with distal methylamino groups was markedly potent against drug-resistant cell lines with P-glycoprotein overexpression or p53 gene deletion. Furthermore, this derivative attenuated in vitro topoisomerase I-mediated DNA uncoiling at low micromolar concentrations. These results demonstrate that anthrafurandiones are a new class of heterocyclic anthraquinone derivatives with the properties potentially valuable for anticancer therapy.\n",
            "565890\n",
            "Inhibition of topoisomerase 1-mediated relaxation of DNA at 2.5 uM by agarose gel electrophoresis\n",
            "Title: The first series of 4,11-bis[(2-aminoethyl)amino]anthra[2,3-b]furan-5,10-diones: Synthesis and anti-proliferative characteristics.  Abstract: We developed the synthesis of a series of furan-fused tetracyclic analogues of the antitumor agent ametantrone. The reactions included nucleophilic substitution of propoxy groups in 4,11-dipropoxyanthra[2,3-b]furan-5,10-diones with ethylenediamines, producing the derivatives of 4,11-diaminoanthra[2,3-b]furan-5,10-dione in good yields. Studies of anti-proliferative activity on a panel of mammalian tumor cell lines demonstrated that anthra[2,3-b]furan-5,10-diones were the most potent derivatives among heteroarene-fused ametantrone analogues with one heteroatom. We identified several compounds that evoked a growth inhibitory effect at submicromolar concentrations. The anthra[2,3-b]furan-5,10-dione 9 with distal methylamino groups was markedly potent against drug-resistant cell lines with P-glycoprotein overexpression or p53 gene deletion. Furthermore, this derivative attenuated in vitro topoisomerase I-mediated DNA uncoiling at low micromolar concentrations. These results demonstrate that anthrafurandiones are a new class of heterocyclic anthraquinone derivatives with the properties potentially valuable for anticancer therapy.\n",
            "577548\n",
            "Inhibition of human recombinant DNA topoisomerase 1-mediated DNA cleavage at 0.1 to 100 uM after 20 mins\n",
            "Title: Electron paramagnetic resonance (EPR) study of spin-labeled camptothecin derivatives: a different look of the ternary complex.  Abstract: Camptothecin (CPT) derivatives are clinically effective poisons of DNA topoisomerase I (Top1) able to form a ternary complex with the Top1-DNA complex. The aim of this investigation was to examine the dynamic aspects of the ternary complex formation by means of site-directed spin labeling electron paramagnetic resonance (SDSL-EPR). Two semisynthetic CPT derivatives bearing the paramagnetic moiety were synthesized, and their biological activity was tested. A 22-mer DNA oligonucleotide sequence with high affinity cleavage site for Top1 was also synthesized. EPR experiments were carried out on modified CPT in the presence of DNA, of Top1, or of both. In the last case, a slow motion component in the EPR signal appeared, indicating the formation of the ternary complex. Deconvolution of the EPR spectrum allowed to obtain the relative drug amounts in the complex. It was also possible to demonstrate that the residence time of CPT \"trapped\" in the ternary complex is longer than hundreds of microseconds.\n",
            "577549\n",
            "Reversible inhibition of human recombinant DNA topoisomerase 1-mediated DNA cleavage at 0.1 to 100 uM after 20 mins\n",
            "Title: Electron paramagnetic resonance (EPR) study of spin-labeled camptothecin derivatives: a different look of the ternary complex.  Abstract: Camptothecin (CPT) derivatives are clinically effective poisons of DNA topoisomerase I (Top1) able to form a ternary complex with the Top1-DNA complex. The aim of this investigation was to examine the dynamic aspects of the ternary complex formation by means of site-directed spin labeling electron paramagnetic resonance (SDSL-EPR). Two semisynthetic CPT derivatives bearing the paramagnetic moiety were synthesized, and their biological activity was tested. A 22-mer DNA oligonucleotide sequence with high affinity cleavage site for Top1 was also synthesized. EPR experiments were carried out on modified CPT in the presence of DNA, of Top1, or of both. In the last case, a slow motion component in the EPR signal appeared, indicating the formation of the ternary complex. Deconvolution of the EPR spectrum allowed to obtain the relative drug amounts in the complex. It was also possible to demonstrate that the residence time of CPT \"trapped\" in the ternary complex is longer than hundreds of microseconds.\n",
            "577550\n",
            "Binding affinity to human recombinant DNA topoisomerase 1 at 20 uM by electron paramagnetic resonance analysis\n",
            "Title: Electron paramagnetic resonance (EPR) study of spin-labeled camptothecin derivatives: a different look of the ternary complex.  Abstract: Camptothecin (CPT) derivatives are clinically effective poisons of DNA topoisomerase I (Top1) able to form a ternary complex with the Top1-DNA complex. The aim of this investigation was to examine the dynamic aspects of the ternary complex formation by means of site-directed spin labeling electron paramagnetic resonance (SDSL-EPR). Two semisynthetic CPT derivatives bearing the paramagnetic moiety were synthesized, and their biological activity was tested. A 22-mer DNA oligonucleotide sequence with high affinity cleavage site for Top1 was also synthesized. EPR experiments were carried out on modified CPT in the presence of DNA, of Top1, or of both. In the last case, a slow motion component in the EPR signal appeared, indicating the formation of the ternary complex. Deconvolution of the EPR spectrum allowed to obtain the relative drug amounts in the complex. It was also possible to demonstrate that the residence time of CPT \"trapped\" in the ternary complex is longer than hundreds of microseconds.\n",
            "578682\n",
            "Inhibition of DNA topoisomerase 1 relative to 0.1 uM camptothecin\n",
            "Title: Design, synthesis and docking study of 5-amino substituted indeno[1,2-c]isoquinolines as novel topoisomerase I inhibitors.  Abstract: Various 5-amino group-substituted indeno[1,2-c]isoquinolines 7a-f were synthesized based on the previous QSAR study as rigid structures of 3-arylisoquinolines. Amino group-substituted compounds, especially 5-piperazinyl indeno[1,2-c]isoquinoline 7f, displayed potent topoisomerase I inhibitory activity as well as cytotoxicities against five different tumor cell lines. A Surflex-Dock docking model of 7f was also studied.\n",
            "578683\n",
            "Inhibition of DNA topoisomerase 1-mediated supercoiled DNA relaxation at 0.1 mg/mL by agarose gel electrophoresis\n",
            "Title: Design, synthesis and docking study of 5-amino substituted indeno[1,2-c]isoquinolines as novel topoisomerase I inhibitors.  Abstract: Various 5-amino group-substituted indeno[1,2-c]isoquinolines 7a-f were synthesized based on the previous QSAR study as rigid structures of 3-arylisoquinolines. Amino group-substituted compounds, especially 5-piperazinyl indeno[1,2-c]isoquinoline 7f, displayed potent topoisomerase I inhibitory activity as well as cytotoxicities against five different tumor cell lines. A Surflex-Dock docking model of 7f was also studied.\n",
            "590398\n",
            "Inhibition of topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 6.25 to 100 uM after 30 mins by SDS-PAGE\n",
            "Title: Synthesis and antitumor activity of 10-arylcamptothecin derivatives.  Abstract: A series of 10-arylcamptothecin derivatives was designed and synthesized. The key step of the synthesis was achieved by employing Suzuki cross-coupling chemistry. All of the new derivatives were tested for cytotoxicity against three human tumor cell lines, BEL-7402, A549, and HL-60; most of the derivatives exhibited potent cytotoxicity. The stability study showed that compound 30 was more stable than its lead compound 10-hydroxycamptothecin under the physiological condition. Mechanistic study demonstrated that compound 30 and its hydrochloride 31 had a pharmacological profile similar with camptothecin.\n",
            "591643\n",
            "Inhibition of human DNA topoisomerase 1-mediated relaxation of supercoiled pGEM1 plasmid DNA at 250 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Structural simplification of bioactive natural products with multicomponent synthesis. 3. Fused uracil-containing heterocycles as novel topoisomerase-targeting agents.  Abstract: After the initial discovery of antiproliferative and apoptosis-inducing properties of a camptothecin-inspired pentacycle based on a 1H-indeno[2',1':5,6]dihydropyrido[2,3-d]pyrimidine scaffold, a library of its analogues as well as their oxidized planar counterparts were prepared utilizing a practical multicomponent synthetic protocol. The synthesized compounds exhibited submicromolar to low micromolar antiproliferative potencies toward a panel of human cancer cell lines. Biochemical experiments are consistent with the dihydropyridine library members undergoing intracellular oxidation to the corresponding planar pyridines, which then inhibit topoisomerase II activity, leading to inhibition of proliferation and cell death. Because of facile synthetic preparation and promising antitopoisomerase activity, both the dihydropyridine and planar pyridine-based compounds represent a convenient starting point for anticancer drug discovery.\n",
            "591644\n",
            "Effect on human DNA topoisomerase 1-mediated supercoiled pGEM1 plasmid DNA cleavage complex stabilization at up to 100 uM by agarose gel electrophoresis\n",
            "Title: Structural simplification of bioactive natural products with multicomponent synthesis. 3. Fused uracil-containing heterocycles as novel topoisomerase-targeting agents.  Abstract: After the initial discovery of antiproliferative and apoptosis-inducing properties of a camptothecin-inspired pentacycle based on a 1H-indeno[2',1':5,6]dihydropyrido[2,3-d]pyrimidine scaffold, a library of its analogues as well as their oxidized planar counterparts were prepared utilizing a practical multicomponent synthetic protocol. The synthesized compounds exhibited submicromolar to low micromolar antiproliferative potencies toward a panel of human cancer cell lines. Biochemical experiments are consistent with the dihydropyridine library members undergoing intracellular oxidation to the corresponding planar pyridines, which then inhibit topoisomerase II activity, leading to inhibition of proliferation and cell death. Because of facile synthetic preparation and promising antitopoisomerase activity, both the dihydropyridine and planar pyridine-based compounds represent a convenient starting point for anticancer drug discovery.\n",
            "592162\n",
            "Inhibition of human DNA topoisomerase 1-mediated relaxation of supercoiled pGEM1 plasmid DNA at 10 to 250 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Structural simplification of bioactive natural products with multicomponent synthesis. 3. Fused uracil-containing heterocycles as novel topoisomerase-targeting agents.  Abstract: After the initial discovery of antiproliferative and apoptosis-inducing properties of a camptothecin-inspired pentacycle based on a 1H-indeno[2',1':5,6]dihydropyrido[2,3-d]pyrimidine scaffold, a library of its analogues as well as their oxidized planar counterparts were prepared utilizing a practical multicomponent synthetic protocol. The synthesized compounds exhibited submicromolar to low micromolar antiproliferative potencies toward a panel of human cancer cell lines. Biochemical experiments are consistent with the dihydropyridine library members undergoing intracellular oxidation to the corresponding planar pyridines, which then inhibit topoisomerase II activity, leading to inhibition of proliferation and cell death. Because of facile synthetic preparation and promising antitopoisomerase activity, both the dihydropyridine and planar pyridine-based compounds represent a convenient starting point for anticancer drug discovery.\n",
            "592163\n",
            "Inhibition of human DNA topoisomerase 1-mediated relaxation of supercoiled pGEM1 plasmid DNA at 100 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Structural simplification of bioactive natural products with multicomponent synthesis. 3. Fused uracil-containing heterocycles as novel topoisomerase-targeting agents.  Abstract: After the initial discovery of antiproliferative and apoptosis-inducing properties of a camptothecin-inspired pentacycle based on a 1H-indeno[2',1':5,6]dihydropyrido[2,3-d]pyrimidine scaffold, a library of its analogues as well as their oxidized planar counterparts were prepared utilizing a practical multicomponent synthetic protocol. The synthesized compounds exhibited submicromolar to low micromolar antiproliferative potencies toward a panel of human cancer cell lines. Biochemical experiments are consistent with the dihydropyridine library members undergoing intracellular oxidation to the corresponding planar pyridines, which then inhibit topoisomerase II activity, leading to inhibition of proliferation and cell death. Because of facile synthetic preparation and promising antitopoisomerase activity, both the dihydropyridine and planar pyridine-based compounds represent a convenient starting point for anticancer drug discovery.\n",
            "595841\n",
            "Inhibition of human topoisomerase I mediated DNA relaxation at 1 to 100 uM\n",
            "Title: Solid phase synthesis and biological activity of tuftsin conjugates.  Abstract: New tuftsin/retro-tuftsin conjugates were designed and synthesized using a classical fluorenylmethoxycarbonyl (Fmoc) solid phase procedure. All the peptide conjugates were divided into three series: 1,4-dihydroxyanthraquinone (type A), 1-nitroacridine (type B), and 4-carboxyacridone (type C) derivatives. In type A conjugates, the N-terminal group of the peptide chain is directly connected to the anthraquinone ring at C1 (Scheme 1), whereas types B and C conjugates possess an amide bond formed between the carboxyl group of heterocyclic molecule and the N-termini of the tuftsin chain. The in vitro cytotoxic activity of the tuftsin conjugates and their precursors using two human tumor cell lines (lung adenocarcinoma (A549) and myeloblastic leukemia (HL-60)) was investigated. The analogues from groups A and C exhibited low cytotoxic activity, whereas several compounds of type B showed a potent and selective cytotoxic activity against tested tumor cell lines. None of the examined tuftsin conjugates demonstrated any significant effect on the catalytic activity of types I and II DNA topoisomerases.\n",
            "595842\n",
            "Inhibition of human topoisomerase II mediated DNA relaxation at 1 to 100 uM\n",
            "Title: Solid phase synthesis and biological activity of tuftsin conjugates.  Abstract: New tuftsin/retro-tuftsin conjugates were designed and synthesized using a classical fluorenylmethoxycarbonyl (Fmoc) solid phase procedure. All the peptide conjugates were divided into three series: 1,4-dihydroxyanthraquinone (type A), 1-nitroacridine (type B), and 4-carboxyacridone (type C) derivatives. In type A conjugates, the N-terminal group of the peptide chain is directly connected to the anthraquinone ring at C1 (Scheme 1), whereas types B and C conjugates possess an amide bond formed between the carboxyl group of heterocyclic molecule and the N-termini of the tuftsin chain. The in vitro cytotoxic activity of the tuftsin conjugates and their precursors using two human tumor cell lines (lung adenocarcinoma (A549) and myeloblastic leukemia (HL-60)) was investigated. The analogues from groups A and C exhibited low cytotoxic activity, whereas several compounds of type B showed a potent and selective cytotoxic activity against tested tumor cell lines. None of the examined tuftsin conjugates demonstrated any significant effect on the catalytic activity of types I and II DNA topoisomerases.\n",
            "599168\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 20 uM after 30 mins using ethidium bromide staining by transillumination analysis\n",
            "Title: Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase II catalytic inhibitor.  Abstract: Epoxide ring-opened xanthone derivatives were synthesized and tested for their topoisomerase inhibitory activity and cytotoxicity. Most of the compounds showed topo II specific inhibitory activity. To clarify the mechanism of action of these compounds, the most potent compound (compound 14) of the synthesized analogues was further studied by testing its ATPase inhibitory activity and through molecular docking experiments. The results showed that the topo II inhibitory activity of compound 14 was inversely proportional to ATP concentration. In the ATPase inhibitory test, ATP hydrolysis was reduced less efficiently by compound 14 (28.54.6%) than novobiocin (60.48.1%). Molecular docking study revealed compound 14 to have a stable binding pattern to the ATP-binding domain of human topo II.\n",
            "600204\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pUC19 DNA assessed as formation of nicked DNA at 1 to 50 uM using ethidium bromide staining by agarose gel electrophoresis\n",
            "Title: Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents.  Abstract: Benzo[c]phenanthrolines and benzo[c]phenanthrolinones substituted by dialkylaminoalkyl side chains at position N5 and C6, respectively, were synthesised and their biological activity evaluated. They displayed interessant cytotoxicity associated with some DNA interactions. However, the low topoisomerase 1 affinity suggests that other cellular targets are responsible for the antiproliferative activity.\n",
            "600208\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pUC19 DNA assessed as formation of nicked DNA at 0.2 to 10 uM using ethidium bromide staining by agarose gel electrophoresis\n",
            "Title: Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents.  Abstract: Benzo[c]phenanthrolines and benzo[c]phenanthrolinones substituted by dialkylaminoalkyl side chains at position N5 and C6, respectively, were synthesised and their biological activity evaluated. They displayed interessant cytotoxicity associated with some DNA interactions. However, the low topoisomerase 1 affinity suggests that other cellular targets are responsible for the antiproliferative activity.\n",
            "600209\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pUC19 DNA assessed as formation of nicked DNA at 0.1 to 5 uM using ethidium bromide staining by agarose gel electrophoresis\n",
            "Title: Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents.  Abstract: Benzo[c]phenanthrolines and benzo[c]phenanthrolinones substituted by dialkylaminoalkyl side chains at position N5 and C6, respectively, were synthesised and their biological activity evaluated. They displayed interessant cytotoxicity associated with some DNA interactions. However, the low topoisomerase 1 affinity suggests that other cellular targets are responsible for the antiproliferative activity.\n",
            "600210\n",
            "Inhibition of human recombinant topoisomerase 1 assessed as cleavage of 117-mer DNA fragment at 0.5 to 5 uM using ethidium bromide staining by agarose gel electrophoresis analysis\n",
            "Title: Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents.  Abstract: Benzo[c]phenanthrolines and benzo[c]phenanthrolinones substituted by dialkylaminoalkyl side chains at position N5 and C6, respectively, were synthesised and their biological activity evaluated. They displayed interessant cytotoxicity associated with some DNA interactions. However, the low topoisomerase 1 affinity suggests that other cellular targets are responsible for the antiproliferative activity.\n",
            "600211\n",
            "Inhibition of human recombinant topoisomerase 1 assessed as cleavage of 117-mer DNA fragment at 20 to 50 uM using ethidium bromide staining by agarose gel electrophoresis analysis\n",
            "Title: Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents.  Abstract: Benzo[c]phenanthrolines and benzo[c]phenanthrolinones substituted by dialkylaminoalkyl side chains at position N5 and C6, respectively, were synthesised and their biological activity evaluated. They displayed interessant cytotoxicity associated with some DNA interactions. However, the low topoisomerase 1 affinity suggests that other cellular targets are responsible for the antiproliferative activity.\n",
            "600216\n",
            "Inhibition of camptothecin-induced poisoning effect of human topoisomerase 1 assessed as suppression of CPT-induced 117 bp DNA cleavage by SDS-PAGE analysis\n",
            "Title: Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents.  Abstract: Benzo[c]phenanthrolines and benzo[c]phenanthrolinones substituted by dialkylaminoalkyl side chains at position N5 and C6, respectively, were synthesised and their biological activity evaluated. They displayed interessant cytotoxicity associated with some DNA interactions. However, the low topoisomerase 1 affinity suggests that other cellular targets are responsible for the antiproliferative activity.\n",
            "606654\n",
            "Inhibition of human topoisomerase 1 mediated relaxation of super coiled pBR322 plasmid DNA at 30 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Discovery of 4-anilinofuro[2,3-b]quinoline derivatives as selective and orally active compounds against non-small-cell lung cancers.  Abstract: We have reported the preparation and anticancer evaluation of certain 4-anilinofuro[2,3-b]quinolines. However, drawbacks such as lack of selective cytotoxicity, poor oral bioavailability, and poor water solubility exhibited by these compounds prompted us to search for newer derivatives. Among them, (E)-1-(4-(furo[2,3-b]quinolin-4-ylamino)phenyl)ethanone O-2-aminoethyloxime (13a) is selectively active against the growth of NCI-H460 and is highly water-soluble (63 g/mL). Its hydrochloride salt, 13aHCl exhibited not only excellent water solubility (1049 g/mL) but also a high oral bioavailability (57.1%). Compound 13a may cause cancer cell apoptosis through inducing mitotic arrest and mitotic catastrophe mechanism. Xenographic studies indicated the tumor size with 13aHCl treated nude mice was significantly lower than control. Further evaluation in an orthotopic lung cancer model indicated that 13aHCl can be absorbed readily through oral administration, distributed to lung tissue, and exhibited significant efficacy in inhibiting the growth of lung cancers.\n",
            "606747\n",
            "Inhibition of topoisomerase 1\n",
            "Title: Structure-activity relationships of carboline and carbazole derivatives as a novel class of ATP-competitive kinesin spindle protein inhibitors.  Abstract: The kinesin spindle protein (KSP) is a mitotic kinesin involved in the establishment of a functional bipolar mitotic spindle during cell division. It is considered to be an attractive target for cancer chemotherapy with reduced side effects. Based on natural product scaffold-derived fused indole-based inhibitors and known biphenyl-type KSP inhibitors, various carboline and carbazole derivatives were synthesized and biologically evaluated. -Carboline and lactam-fused carbazole derivatives exhibited remarkably potent KSP inhibitory activity and mitotic arrest in prometaphase with formation of an irregular monopolar spindle. The planar tri- and tetracyclic analogs inhibited KSP ATPase in an ATP-competitive manner just like biphenyl-type inhibitors.\n",
            "607456\n",
            "Inhibition of human topoisomerase 1 assessed as minimum concentration required for complete re-supercoiling of pUC19 DNA after 1 hr using ethidium bromide staining by agarose gel electrophoresis\n",
            "Title: Substituent effect on the preferred DNA binding mode and affinity of a homologous series of naphthalene diimides.  Abstract: A combination of isothermal titration calorimetry (ITC), topoisomerase I DNA unwinding assays, and ethidium bromide displacement studies were employed to investigate the binding of a homologous series of naphthalene diimides (NDI) to DNA. Our results suggest that the nature of the substituent plays a significant role in both the preferred binding mode and relative binding affinity of the compounds of this study. Only intercalative-type binding (K=15310(6)M(-1)) was observed for the NDI with the smallest substituent (trimethyl-ethylamino), while larger members of the series (diethylmethyl-, dipropylmethyl- and dibutylmethyl-ethylamino substituents) adopted an additional binding mode of higher affinity (K(1)=31-7810(6)M(-1)).\n",
            "608854\n",
            "Inhibition of human recombinant DNA topoisomerase 1 assessed as inhibition of supercoiled pBR322 DNA relaxation at 20 uM after 30 mins by gel electrophoresis\n",
            "Title: Synthesis of 2,4-diaryl chromenopyridines and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.  Abstract: Designed and synthesized were a series of 5H-chromeno[4,3-b]pyridines with substitution at 2- and 4-positions with various 5- or 6-membered heteroaromatics as antitumor agents. They were evaluated for topoisomerase I and II inhibitory activities as well as cytotoxicities against several human cancer cell lines. Structure-activity relationship study showed that 2-furyl or 2-thienyl at 2- or 4-position of central pyridine is crucial in displaying topo I or II inhibitory activity and cytotoxicity.\n",
            "608855\n",
            "Inhibition of human recombinant DNA topoisomerase 1 assessed as inhibition of supercoiled pBR322 DNA relaxation at 100 uM after 30 mins by gel electrophoresis\n",
            "Title: Synthesis of 2,4-diaryl chromenopyridines and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.  Abstract: Designed and synthesized were a series of 5H-chromeno[4,3-b]pyridines with substitution at 2- and 4-positions with various 5- or 6-membered heteroaromatics as antitumor agents. They were evaluated for topoisomerase I and II inhibitory activities as well as cytotoxicities against several human cancer cell lines. Structure-activity relationship study showed that 2-furyl or 2-thienyl at 2- or 4-position of central pyridine is crucial in displaying topo I or II inhibitory activity and cytotoxicity.\n",
            "610760\n",
            "Binding affinity to topoisomerase 1\n",
            "Title: Inverse virtual screening of antitumor targets: pilot study on a small database of natural bioactive compounds.  Abstract: An inverse virtual screening in silico approach has been applied to natural bioactive molecules to screen their efficacy against proteins involved in cancer processes, with the aim of directing future experimental assays. Docking studies were performed on a panel of 126 protein targets extracted from the Protein Data Bank, to analyze their possible interactions with a small library of 43 bioactive compounds. Analysis of the molecular docking results was performed through the use of tables containing energy data organized in a matrix. The application of this approach may facilitate the prediction of the activity of unknown ligands for known targets involved in the development of cancer and could be applied to other models based on different libraries of ligands and different panels of targets.\n",
            "611200\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 250 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Synthesis and evaluation of mansonone F derivatives as topoisomerase inhibitors.  Abstract: A series of mansonone F (MF) derivatives were designed and synthesized. These compounds were found to be strong inhibitors for topoisomerases, with much more significant inhibition for topoisomerase II rather than topoisomerase I. The best inhibitor showed 20 times stronger anti-topoisomerase II activity than a positive control Etoposide. The cytotoxic activity of these MF derivatives was evaluated against human cancer cell lines CNE-2 and Glc-82, which showed that these compounds were potent antitumor agents. The structure-activity relationships (SARs) study revealed that o-quinone group and pyran ring are important for their cytotoxic activity.\n",
            "611201\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 150 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Synthesis and evaluation of mansonone F derivatives as topoisomerase inhibitors.  Abstract: A series of mansonone F (MF) derivatives were designed and synthesized. These compounds were found to be strong inhibitors for topoisomerases, with much more significant inhibition for topoisomerase II rather than topoisomerase I. The best inhibitor showed 20 times stronger anti-topoisomerase II activity than a positive control Etoposide. The cytotoxic activity of these MF derivatives was evaluated against human cancer cell lines CNE-2 and Glc-82, which showed that these compounds were potent antitumor agents. The structure-activity relationships (SARs) study revealed that o-quinone group and pyran ring are important for their cytotoxic activity.\n",
            "612419\n",
            "Stimulation of human recombinant DNA topoisomerase 1-mediated 751-bp BamHI-EcoRV fragment of SV40 DNA cleavage at 1 to 50 uM after 30 mins by polyacrylamide gel-electrophoresis\n",
            "Title: Synthesis and topoisomerase I inhibitory activity of a novel diazaindeno[2,1-b]phenanthrene analogue of Lamellarin D.  Abstract: A novel 5-oxa-6a,8-diazaindeno[2,1-b]phenanthren-7-one scaffold was designed and synthesized as an active analogue of the cytotoxic marine alkaloid Lamellarin D. The design was based on molecular modeling of the site of interaction of Lamellarin D with DNA-topoisomerase I cleavable complex, whereas the synthesis capitalized on a simple Friedel-Crafts cyclization of indole to a -carbolinone nucleus. The product exhibited topoisomerase I poisoning activity and submicromolar cytotoxicity on human non-small cell lung cancer H460 cell line.\n",
            "612420\n",
            "Stimulation of human recombinant DNA topoisomerase 1-mediated 751-bp BamHI-EcoRV fragment of SV40 DNA cleavage at 100 uM after 30 mins by polyacrylamide gel-electrophoresis\n",
            "Title: Synthesis and topoisomerase I inhibitory activity of a novel diazaindeno[2,1-b]phenanthrene analogue of Lamellarin D.  Abstract: A novel 5-oxa-6a,8-diazaindeno[2,1-b]phenanthren-7-one scaffold was designed and synthesized as an active analogue of the cytotoxic marine alkaloid Lamellarin D. The design was based on molecular modeling of the site of interaction of Lamellarin D with DNA-topoisomerase I cleavable complex, whereas the synthesis capitalized on a simple Friedel-Crafts cyclization of indole to a -carbolinone nucleus. The product exhibited topoisomerase I poisoning activity and submicromolar cytotoxicity on human non-small cell lung cancer H460 cell line.\n",
            "615989\n",
            "Inhibition of recombinant human TOP1 mediated DNA cleavage after 20 mins by gel electrophoresis relative to camptothecin\n",
            "Title: Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase I inhibitors: investigating the relationships involving stereochemistry, hydrogen bonding, and biological activity.  Abstract: The DNA-relaxing enzyme topoisomerase I (Top1) can be inhibited by heterocyclic compounds such as indolocarbazoles and indenoisoquinolines. Carbohydrate and hydroxyl-containing side chains are essential for the biological activity of indolocarbazoles. The current study investigated how similar functionalities could be \"translated\" to the indenoisoquinoline system and how stereochemistry and hydrogen bonding affect biological activity. Herein is described the preparation and assay of indenoisoquinolines substituted with short-chain alcohols, diols, and carbohydrates. Several compounds (including those derived from sugars) display potent Top1 poisoning and antiproliferative activities. The Top1 poisoning activity of diol-substituted indenoisoquinolines is dependent upon stereochemistry. Although the effect is striking, molecular modeling and docking studies do not indicate any reason for the difference in activity due to similar calculated interactions between the ligand and Top1-DNA complex and ambiguity about the binding mode. A stereochemical dependence was also observed for carbohydrate-derived indenoisoquinolines. Although similar trends were observed in other classes of Top1 inhibitors, the exact nature of this effect has yet to be elucidated.\n",
            "617145\n",
            "Inhibition of DNA topoisomerase 1 using DNA substrate after 0.5 hrs by gel electrophoresis\n",
            "Title: Synthesis, structure-activity relationship and biological evaluation of anticancer activity for novel N-substituted sophoridinic acid derivatives.  Abstract: Sophoridine (1), a natural anticancer drug, has been used in China for decades. A series of novel N-substituted sophoridinic acid derivatives were synthesized and evaluated for their cytotoxicity with 1 as the lead. The structure-activity relationship indicated that introduction of an aliphatic acyl on the nitrogen atom might significantly enhance the anticancer activity. Among the compounds, 6b bearing bromoacetyl side-chain afforded a potential effect against four human tumor cell lines (liver, colon, breast, and lung). The mechanism of action of 6b is to inhibit the activity of DNA topoisomerase I, followed by the S-phase arrest and then cause apoptotic cell death, similar to that of its parent 1. We consider 6b promising for further anticancer investigation.\n",
            "620745\n",
            "Inhibition of human topoisomerase 1 assessed as inhibition of radiolabeled DNA fragment cleavage up to 100 uM after 20 mins by gel-based phosphoimaging relative to control\n",
            "Title: 7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents.  Abstract: A series of 7-azaindenoisoquinoline topoisomerase I (Top1) inhibitors have been prepared to investigate the effect of increased electron affinity of the aromatic system on the ability to stabilize the Top1-DNA cleavage complex. Ab initio calculations suggest that introduction of nitrogen into the aromatic system of the indenoisoquinolines would facilitate charge transfer complex formation with DNA, thus improving the - stacking interactions. The present study shows that 7-azaindenoisoquinolines demonstrate improved water solubility without any decrease in Top1 inhibitory activity or cytotoxicity. Analysis of the biological results reveals that smaller lactam ring substituents enable intercalation into both free DNA and Top1-DNA cleavage complex, whereas larger substituents only allow binding to the cleavage complex but not free DNA. Free DNA binding suppresses Top1-catalyzed DNA cleavage at high drug concentrations, whereas DNA cleavage and inhibition of religation occurs at low drug concentration.\n",
            "620746\n",
            "Inhibition of human topoisomerase 1 assessed as inhibition of radiolabeled DNA fragment cleavage after 20 mins by gel-based phosphoimaging relative to control\n",
            "Title: 7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents.  Abstract: A series of 7-azaindenoisoquinoline topoisomerase I (Top1) inhibitors have been prepared to investigate the effect of increased electron affinity of the aromatic system on the ability to stabilize the Top1-DNA cleavage complex. Ab initio calculations suggest that introduction of nitrogen into the aromatic system of the indenoisoquinolines would facilitate charge transfer complex formation with DNA, thus improving the - stacking interactions. The present study shows that 7-azaindenoisoquinolines demonstrate improved water solubility without any decrease in Top1 inhibitory activity or cytotoxicity. Analysis of the biological results reveals that smaller lactam ring substituents enable intercalation into both free DNA and Top1-DNA cleavage complex, whereas larger substituents only allow binding to the cleavage complex but not free DNA. Free DNA binding suppresses Top1-catalyzed DNA cleavage at high drug concentrations, whereas DNA cleavage and inhibition of religation occurs at low drug concentration.\n",
            "620747\n",
            "Inhibition of human topoisomerase 1 assessed as inhibition of radiolabeled DNA fragment cleavage 0.1 to 100 uM after 20 mins by gel-based phosphoimaging relative to control\n",
            "Title: 7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents.  Abstract: A series of 7-azaindenoisoquinoline topoisomerase I (Top1) inhibitors have been prepared to investigate the effect of increased electron affinity of the aromatic system on the ability to stabilize the Top1-DNA cleavage complex. Ab initio calculations suggest that introduction of nitrogen into the aromatic system of the indenoisoquinolines would facilitate charge transfer complex formation with DNA, thus improving the - stacking interactions. The present study shows that 7-azaindenoisoquinolines demonstrate improved water solubility without any decrease in Top1 inhibitory activity or cytotoxicity. Analysis of the biological results reveals that smaller lactam ring substituents enable intercalation into both free DNA and Top1-DNA cleavage complex, whereas larger substituents only allow binding to the cleavage complex but not free DNA. Free DNA binding suppresses Top1-catalyzed DNA cleavage at high drug concentrations, whereas DNA cleavage and inhibition of religation occurs at low drug concentration.\n",
            "620748\n",
            "Inhibition of human topoisomerase 1-mediated DNA relaxation assessed as DNA intercalation at compound concentration above 3 uM after 30 mins by gel electrophoresis relative to control\n",
            "Title: 7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents.  Abstract: A series of 7-azaindenoisoquinoline topoisomerase I (Top1) inhibitors have been prepared to investigate the effect of increased electron affinity of the aromatic system on the ability to stabilize the Top1-DNA cleavage complex. Ab initio calculations suggest that introduction of nitrogen into the aromatic system of the indenoisoquinolines would facilitate charge transfer complex formation with DNA, thus improving the - stacking interactions. The present study shows that 7-azaindenoisoquinolines demonstrate improved water solubility without any decrease in Top1 inhibitory activity or cytotoxicity. Analysis of the biological results reveals that smaller lactam ring substituents enable intercalation into both free DNA and Top1-DNA cleavage complex, whereas larger substituents only allow binding to the cleavage complex but not free DNA. Free DNA binding suppresses Top1-catalyzed DNA cleavage at high drug concentrations, whereas DNA cleavage and inhibition of religation occurs at low drug concentration.\n",
            "620749\n",
            "Inhibition of human topoisomerase 1-mediated DNA relaxation assessed as DNA intercalation at 100 uM after 30 mins by gel electrophoresis relative to control\n",
            "Title: 7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents.  Abstract: A series of 7-azaindenoisoquinoline topoisomerase I (Top1) inhibitors have been prepared to investigate the effect of increased electron affinity of the aromatic system on the ability to stabilize the Top1-DNA cleavage complex. Ab initio calculations suggest that introduction of nitrogen into the aromatic system of the indenoisoquinolines would facilitate charge transfer complex formation with DNA, thus improving the - stacking interactions. The present study shows that 7-azaindenoisoquinolines demonstrate improved water solubility without any decrease in Top1 inhibitory activity or cytotoxicity. Analysis of the biological results reveals that smaller lactam ring substituents enable intercalation into both free DNA and Top1-DNA cleavage complex, whereas larger substituents only allow binding to the cleavage complex but not free DNA. Free DNA binding suppresses Top1-catalyzed DNA cleavage at high drug concentrations, whereas DNA cleavage and inhibition of religation occurs at low drug concentration.\n",
            "620798\n",
            "Inhibition of human topoisomerase 1-mediated DNA relaxation assessed as DNA intercalation at 1 to 100 uM after 30 mins by gel electrophoresis relative to control\n",
            "Title: 7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents.  Abstract: A series of 7-azaindenoisoquinoline topoisomerase I (Top1) inhibitors have been prepared to investigate the effect of increased electron affinity of the aromatic system on the ability to stabilize the Top1-DNA cleavage complex. Ab initio calculations suggest that introduction of nitrogen into the aromatic system of the indenoisoquinolines would facilitate charge transfer complex formation with DNA, thus improving the - stacking interactions. The present study shows that 7-azaindenoisoquinolines demonstrate improved water solubility without any decrease in Top1 inhibitory activity or cytotoxicity. Analysis of the biological results reveals that smaller lactam ring substituents enable intercalation into both free DNA and Top1-DNA cleavage complex, whereas larger substituents only allow binding to the cleavage complex but not free DNA. Free DNA binding suppresses Top1-catalyzed DNA cleavage at high drug concentrations, whereas DNA cleavage and inhibition of religation occurs at low drug concentration.\n",
            "620799\n",
            "Inhibition of human topoisomerase 1 assessed as inhibition of radiolabeled DNA fragment cleavage at 1 uM after 20 mins by gel-based phosphoimaging relative to control\n",
            "Title: 7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents.  Abstract: A series of 7-azaindenoisoquinoline topoisomerase I (Top1) inhibitors have been prepared to investigate the effect of increased electron affinity of the aromatic system on the ability to stabilize the Top1-DNA cleavage complex. Ab initio calculations suggest that introduction of nitrogen into the aromatic system of the indenoisoquinolines would facilitate charge transfer complex formation with DNA, thus improving the - stacking interactions. The present study shows that 7-azaindenoisoquinolines demonstrate improved water solubility without any decrease in Top1 inhibitory activity or cytotoxicity. Analysis of the biological results reveals that smaller lactam ring substituents enable intercalation into both free DNA and Top1-DNA cleavage complex, whereas larger substituents only allow binding to the cleavage complex but not free DNA. Free DNA binding suppresses Top1-catalyzed DNA cleavage at high drug concentrations, whereas DNA cleavage and inhibition of religation occurs at low drug concentration.\n",
            "624099\n",
            "An siRNA screen for human genes that are involved in human papilloma virus (HPV) E2 transcriptional repression of the E6 and E7 oncogenes\n",
            "An essential step in the pathogenesis of human papillomavirus (HPV)-associated cancers is the dysregulated expression of the viral oncogenes. The papillomavirus E2 protein can silence the long control region (LCR) promoter that controls viral E6 and E7 oncogene expression. The mechanisms by which E2 represses oncogene expression and the cellular factors through which E2 mediates this silencing are largely unknown. We conducted an unbiased, genome-wide siRNA screen and series of secondary screens that identified 96 cellular genes that contribute to the repression of the HPV18 LCR. In addition to confirming a role for the E2-binding bromodomain protein Brd4 in E2-mediated silencing, we identified a number of genes that have not previously been implicated in E2 repression, including the demethylase JARID1C/SMCX as well as EP400, a component of the NuA4/TIP60 histone acetyltransferase complex. Each of these genes contributes independently and additively to E2-mediated silencing, indicating that E2 functions through several distinct cellular complexes to repress E6 and E7 expression.  This screen was conducted in the lab of Peter Howley (Harvard Medical School) at the ICCB-Longwood Screening Facility, Harvard Medical School.\n",
            "632907\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA\n",
            "Title: Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.  Abstract: From the methanol extract of the bulbs of Pancratium illyricum L., three phenanthridine type alkaloids, ungeremine (1), (-)-lycorine (2) and (+)-vittatine (3) were isolated. For the evaluation of their anticancer and antibacterial potential, compounds 1-3 were tested against human (I, II) and bacterial (IA, IV) topoisomerases. Our data demonstrated that ungeremine impairs the activity of both, human and bacterial topoisomerases. Remarkably, ungeremine was found to largely increments the DNA cleavage promoted by bacterial topoisomerase IA, a new target in antimicrobial chemotherapy.\n",
            "635424\n",
            "Inhibition of topoisomerase-1-mediated relaxation of supercoiled pBR322 DNA at 20 uM after 20 mins using ethidium bromide staining by electrophoresis relative to control\n",
            "Title: Design, synthesis, and biological evaluation of a novel series of bisintercalating DNA-binding piperazine-linked bisanthrapyrazole compounds as anticancer agents.  Abstract: A series of bisintercalating DNA binding bisanthrapyrazole compounds containing piperazine linkers were designed by molecular modeling and docking techniques. Because the anthrapyrazoles are not quinones they are unable to be reductively activated like doxorubicin and other anthracyclines and thus they should not be cardiotoxic. The concentration dependent increase in DNA melting temperature was used to determine the strength of DNA binding and the bisintercalation potential of the compounds. Compounds with more than a three-carbon linker that could span four DNA base pairs achieved bisintercalation. All of the bisanthrapyrazoles inhibited human erythroleukemic K562 cell growth in the low to submicromolar concentration range. They also strongly inhibited the decatenation activity of topoisomerase II and the relaxation activity of topoisomerase I. However, as measured by their ability to induce double strand breaks in plasmid DNA, the bisanthrapyrazole compounds did not act as topoisomerase II poisons. In conclusion, a novel group of bisanthrapyrazole compounds were designed, synthesized, and biologically evaluated as potential anticancer agents.\n",
            "636881\n",
            "Inhibition of human topoisomerase 1-mediated relation of supercoiled DNA after 45 mins\n",
            "Title: Catalytic inhibition of eukaryotic topoisomerases I and II by flavonol glycosides extracted from Vicia faba and Lotus edulis.  Abstract: Topoisomerases are essential enzymes involved in all processes of DNA metabolism, and their inhibitors have been identified as potential anticancer agents. The present study examined the effect of nine polyphenolic compounds derived from parts of two unique varieties of the Leguminosae, Vicia faba and Lotus edulis, on the activity of eukaryotic topoisomerases. We identified polyphenolic compounds that act as catalytic inhibitors of wheat germ topoisomerase I (IC50: 120-350 M), human topoisomerase I (IC50: 110-260 M), and human topoisomerase II (IC50: 240-600 M) activities. Some compounds inhibited all enzymatic activities to a similar extent, while others exhibited specificity toward individual enzymes. The strongest catalytic inhibitor of all the examined enzymes was a kaempherol glycoside with an acetyl group linked to a sugar moiety. In addition, this compound inhibited the growth of human cancer cell lines MCF7, HeLa, and HepG2. The inhibition of topoisomerase I and II activities observed by the specific compounds possibly implies a role as potential agents in the prevention and therapy of cancer.\n",
            "636882\n",
            "Inhibition of human topoisomerase 1-mediated relation of supercoiled DNA at 100 uM after 45 mins\n",
            "Title: Catalytic inhibition of eukaryotic topoisomerases I and II by flavonol glycosides extracted from Vicia faba and Lotus edulis.  Abstract: Topoisomerases are essential enzymes involved in all processes of DNA metabolism, and their inhibitors have been identified as potential anticancer agents. The present study examined the effect of nine polyphenolic compounds derived from parts of two unique varieties of the Leguminosae, Vicia faba and Lotus edulis, on the activity of eukaryotic topoisomerases. We identified polyphenolic compounds that act as catalytic inhibitors of wheat germ topoisomerase I (IC50: 120-350 M), human topoisomerase I (IC50: 110-260 M), and human topoisomerase II (IC50: 240-600 M) activities. Some compounds inhibited all enzymatic activities to a similar extent, while others exhibited specificity toward individual enzymes. The strongest catalytic inhibitor of all the examined enzymes was a kaempherol glycoside with an acetyl group linked to a sugar moiety. In addition, this compound inhibited the growth of human cancer cell lines MCF7, HeLa, and HepG2. The inhibition of topoisomerase I and II activities observed by the specific compounds possibly implies a role as potential agents in the prevention and therapy of cancer.\n",
            "636883\n",
            "Inhibition of human topoisomerase 1-mediated relation of supercoiled DNA at 500 uM after 45 mins\n",
            "Title: Catalytic inhibition of eukaryotic topoisomerases I and II by flavonol glycosides extracted from Vicia faba and Lotus edulis.  Abstract: Topoisomerases are essential enzymes involved in all processes of DNA metabolism, and their inhibitors have been identified as potential anticancer agents. The present study examined the effect of nine polyphenolic compounds derived from parts of two unique varieties of the Leguminosae, Vicia faba and Lotus edulis, on the activity of eukaryotic topoisomerases. We identified polyphenolic compounds that act as catalytic inhibitors of wheat germ topoisomerase I (IC50: 120-350 M), human topoisomerase I (IC50: 110-260 M), and human topoisomerase II (IC50: 240-600 M) activities. Some compounds inhibited all enzymatic activities to a similar extent, while others exhibited specificity toward individual enzymes. The strongest catalytic inhibitor of all the examined enzymes was a kaempherol glycoside with an acetyl group linked to a sugar moiety. In addition, this compound inhibited the growth of human cancer cell lines MCF7, HeLa, and HepG2. The inhibition of topoisomerase I and II activities observed by the specific compounds possibly implies a role as potential agents in the prevention and therapy of cancer.\n",
            "644574\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of supercoiled plasmid pUC19 DNA at 20 uM by agarose gel electrophoresis\n",
            "Title: Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues: a novel DYRK1A inhibitor class.  Abstract: A library of substituted chromeno[3,4-b]indoles was developed as Lamellarin isosters. Synthesis was achieved from indoles after a four-step pathway sequence involving C-3 iodination, a Suzuki cross-coupling reaction, and a one pot deprotection/lactonisation step. Twenty final compounds were tested in order to determine their activity against topoisomerase I and kinases, the two major biological activities of Lamellarins. One newly synthesized derivative exhibited a strong topoisomerase activity comparable to reference compounds such as campthotecin and Lamellarin with only a weak kinase inhibition. Two other lead compounds were identified as new nanomolar DYRK1A inhibitors and several other drugs affected the kinases in the sub-micromolar range. These results will enable us to use the chromeno[3,4-b]indole as a pharmacophore to develop potent treatments for neurological or oncological disorders in which DYRK1A is fully involved.\n",
            "644575\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of supercoiled plasmid pUC19 DNA at 100 uM by agarose gel electrophoresis\n",
            "Title: Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues: a novel DYRK1A inhibitor class.  Abstract: A library of substituted chromeno[3,4-b]indoles was developed as Lamellarin isosters. Synthesis was achieved from indoles after a four-step pathway sequence involving C-3 iodination, a Suzuki cross-coupling reaction, and a one pot deprotection/lactonisation step. Twenty final compounds were tested in order to determine their activity against topoisomerase I and kinases, the two major biological activities of Lamellarins. One newly synthesized derivative exhibited a strong topoisomerase activity comparable to reference compounds such as campthotecin and Lamellarin with only a weak kinase inhibition. Two other lead compounds were identified as new nanomolar DYRK1A inhibitors and several other drugs affected the kinases in the sub-micromolar range. These results will enable us to use the chromeno[3,4-b]indole as a pharmacophore to develop potent treatments for neurological or oncological disorders in which DYRK1A is fully involved.\n",
            "644777\n",
            "Inhibition of recombinant human DNA topoisomerase 1 using supercoiled pBR322 DNA as substrate at 100 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Dihydroxylated 2,4,6-triphenyl pyridines: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.  Abstract: Twelve dihydroxylated 2,4,6-triphenyl pyridines were designed and synthesized which contain hydroxyl groups at ortho, meta or para position of 2- and 6-phenyl, or 2- and 4-phenyl rings attached to the central pyridine. They were evaluated for topoisomerase I and II inhibitory activity, and cytotoxicity against several human cancer cell lines for the development of novel anticancer agents. Generally, dihydroxylated 2,4,6-triphenyl pyridines exhibited stronger topoisomerase II inhibitory activity, and cytotoxicity compared to those of monohydroxylated 2,4,6-triphenyl pyridines. The concrete structure-activity relationship was observed that dihydroxylated 2,4,6-triphenyl pyridines with hydroxyl group at meta or para position of 2-phenyl ring displayed significant topoisomerase II inhibitory activity as well as cytotoxicity. Positive correlation between topoisomerase II inhibitory activity and cytotoxicity was observed for compounds 10, 12, 13, 17-20 and 22.\n",
            "651810\n",
            "Genome-wide high-content siRNA screens for regulators of Parkin translocation in selective mitophagy (Dharmacon Library)\n",
            "High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagy  An increasing body of evidence points to mitochondrial dysfunction as a contributor to the molecular pathogenesis of neurodegenerative diseases such as Parkinson's (1).  Recent studies of the PD-associated genes PINK12 and PARK2 (Parkin) (3) suggest that they may act in a quality control pathway preventing the accumulation of dysfunctional mitochondria (4-7).  Following the loss of mitochondrial membrane potential, the kinase Pink1 and the E3-ubiquitin ligase Parkin coordinate a rapid proteasomal (8) and autophagic (mitophagy) (6) response that may attenuate cell death (9-11).  Given that enhanced mitophagy may ameliorate the deleterious consequences of mitochondrial dysfunction (12-14), we hypothesized that genes regulating Parkin translocation would be useful drug targets for increasing mitochondrial quality control.  However, the mechanism of Parkin recruitment following Pink1 accumulation on the outer mitochondrial membrane is too poorly understood to target, and may involve a host of coordinated events.  To identify genes important for the Pink1-dependent recruitment of Parkin to damaged mitochondria, we conducted two diverse genome-wide siRNA screens with high-throughput automation.  Our screening approach took advantage of the well-characterized phenotype of Parkin accumulation on depolarized mitochondria in cells (6).  Cells stably expressing GFP-Parkin and a mitochondrial-targeted red fluorescent protein were transfected with siRNA duplexes in 384-well plates.  After a 48 hour siRNA knockdown, the proton ionophore carbonyl cyanide 3-chlorophenylhydrazone (CCCP) was added to each well to induce rapid mitochondrial depolarization.  Following bulk mitochondrial depolarization in all cells within each well, GFP-Parkin translocation to the damaged mitochondria was allowed to progress for 2.5 hours and then cells were fixed.  The degree of Parkin translocation to the mitochondria of each cell was assessed by high-content analysis.  Primary screening yielded gene candidates involved in an array of diverse cellular processes that were validated in confirmatory assays.        References: 1.) Schapira, A. H. & Tolosa, E. Molecular and clinical prodrome of Parkinson disease: implications for treatment. Nat Rev Neurol 6, 309-317, (2010). 2.) Valente, E. M. et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158-1160, (2004). 3.) Kitada, T. et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608, (1998). 4.) Vives-Bauza, C. et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A 107, 378-383, (2010). 5.) Narendra, D. P. et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8, e1000298, (2010). 6.) Narendra, D., Tanaka, A., Suen, D. F. & Youle, R. J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183, 795-803, (2008). 7.) Geisler, S. et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12, 119-131, (2010). 8.) Chan, N. C. et al. Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum Mol Genet 20, 1726-1737, (2011). 9.) Bouman, L. et al. Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stress. Cell Death Differ 18, 769-782, (2011). 10.) Darios, F. et al. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum Mol Genet 12, 517-526, (2003). 11.) Gautier, C. A., Kitada, T. & Shen, J. Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci U S A 105, 11364-11369, (2008). 12.) Pimenta de Castro, I. et al. Genetic analysis of mitochondrial protein misfolding in Drosophila melanogaster. Cell Death Differ, (2012). 13.) Suen, D. F., Narendra, D. P., Tanaka, A., Manfredi, G. & Youle, R. J. Parkin overexpression selects against a deleterious mtDNA mutation in heteroplasmic cybrid cells. Proc Natl Acad Sci U S A 107, 11835-11840, (2010). 14.) Burman, J. L., Yu, S., Poole, A. C., Decal, R. B. & Pallanck, L. Analysis of neural subtypes reveals selective mitochondrial dysfunction in dopaminergic neurons from parkin mutants. Proc Natl Acad Sci U S A, (2012). Keywords:  Parkin, PARK2, PINK1, mitophagy, autophagy, CCCP, mitochondrial damage, Parkinson's disease, neurodegeneration, siRNA, RNAi screen, HTS, genome-wide, functional genomics, assay, high content screening, 384 well, National Institutes of Health, National Center for Advancing Translational Sciences, NIH Center for Translational Therapeutics, National Institute of Neurological Disorders and Stroke\n",
            "651811\n",
            "Genome-wide high-content siRNA screens for regulators of Parkin translocation in selective mitophagy (Ambion Library)\n",
            "High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagy  An increasing body of evidence points to mitochondrial dysfunction as a contributor to the molecular pathogenesis of neurodegenerative diseases such as Parkinson's (1).  Recent studies of the PD-associated genes PINK12 and PARK2 (Parkin) (3) suggest that they may act in a quality control pathway preventing the accumulation of dysfunctional mitochondria (4-7).  Following the loss of mitochondrial membrane potential, the kinase Pink1 and the E3-ubiquitin ligase Parkin coordinate a rapid proteasomal (8) and autophagic (mitophagy) (6) response that may attenuate cell death (9-11).  Given that enhanced mitophagy may ameliorate the deleterious consequences of mitochondrial dysfunction (12-14), we hypothesized that genes regulating Parkin translocation would be useful drug targets for increasing mitochondrial quality control.  However, the mechanism of Parkin recruitment following Pink1 accumulation on the outer mitochondrial membrane is too poorly understood to target, and may involve a host of coordinated events.  To identify genes important for the Pink1-dependent recruitment of Parkin to damaged mitochondria, we conducted two diverse genome-wide siRNA screens with high-throughput automation.  Our screening approach took advantage of the well-characterized phenotype of Parkin accumulation on depolarized mitochondria in cells (6).  Cells stably expressing GFP-Parkin and a mitochondrial-targeted red fluorescent protein were transfected with siRNA duplexes in 384-well plates.  After a 48 hour siRNA knockdown, the proton ionophore carbonyl cyanide 3-chlorophenylhydrazone (CCCP) was added to each well to induce rapid mitochondrial depolarization.  Following bulk mitochondrial depolarization in all cells within each well, GFP-Parkin translocation to the damaged mitochondria was allowed to progress for 2.5 hours and then cells were fixed.  The degree of Parkin translocation to the mitochondria of each cell was assessed by high-content analysis.  Primary screening yielded gene candidates involved in an array of diverse cellular processes that were validated in confirmatory assays.  References: 1.) Schapira, A. H. & Tolosa, E. Molecular and clinical prodrome of Parkinson disease: implications for treatment. Nat Rev Neurol 6, 309-317, (2010). 2.) Valente, E. M. et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158-1160, (2004). 3.) Kitada, T. et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608, (1998). 4.) Vives-Bauza, C. et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A 107, 378-383, (2010). 5.) Narendra, D. P. et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8, e1000298, (2010). 6.) Narendra, D., Tanaka, A., Suen, D. F. & Youle, R. J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183, 795-803, (2008). 7.) Geisler, S. et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12, 119-131, (2010). 8.) Chan, N. C. et al. Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum Mol Genet 20, 1726-1737, (2011). 9.) Bouman, L. et al. Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stress. Cell Death Differ 18, 769-782, (2011). 10.) Darios, F. et al. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum Mol Genet 12, 517-526, (2003). 11.) Gautier, C. A., Kitada, T. & Shen, J. Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci U S A 105, 11364-11369, (2008). 12.) Pimenta de Castro, I. et al. Genetic analysis of mitochondrial protein misfolding in Drosophila melanogaster. Cell Death Differ, (2012). 13.) Suen, D. F., Narendra, D. P., Tanaka, A., Manfredi, G. & Youle, R. J. Parkin overexpression selects against a deleterious mtDNA mutation in heteroplasmic cybrid cells. Proc Natl Acad Sci U S A 107, 11835-11840, (2010). 14.) Burman, J. L., Yu, S., Poole, A. C., Decal, R. B. & Pallanck, L. Analysis of neural subtypes reveals selective mitochondrial dysfunction in dopaminergic neurons from parkin mutants. Proc Natl Acad Sci U S A, (2012). Keywords:  Parkin, PARK2, PINK1, mitophagy, autophagy, CCCP, mitochondrial damage, Parkinson's disease, neurodegeneration, siRNA, RNAi screen, HTS, genome-wide, functional genomics, assay, high content screening, 384 well, National Institutes of Health, National Center for Advancing Translational Sciences, NIH Center for Translational Therapeutics, National Institute of Neurological Disorders and Stroke\n",
            "657775\n",
            "Inhibition of recombinant human topoisomerase 1-mediated unwinding of supercoiled plasmid DNA assessed as DNA intercalation at 12.5 to 100 uM by gel electrophoresis\n",
            "Title: Imidazonaphthyridine systems (part 2): Functionalization of the phenyl ring linked to the pyridine pharmacophore and its replacement by a pyridinone ring produces intriguing differences in cytocidal activity.  Abstract: We recently discovered that five- and pseudo-five-fused-ring derivatives in an imidazonaphthyridine series were promising hit compounds for the development of new DNA-intercalators. In this study, novel (dihydro)imidazo[1,6] and [1,7]naphthyridi(no)nes were prepared including pseudo-pentacycles. All the compounds synthesized were screened against four tumor cell lines. Compounds 3(b-d) showed significant in vitro cytotoxicity, and DNA intercalation properties were demonstrated at 25 M. Imidazonaphthyridinones exhibited no DNA binding affinity despite significant growth inhibition activity. Interestingly, when a pyridinone pharmacophore was linked to the imidazo[1,2-a]pyridine scaffold, the geometric orientation of the link had a strong impact on the growth inhibition activity. From these results we conclude that the moderate cytotoxicity observed for these compounds is independent of their DNA-binding and topoisomerase inhibition activities.\n",
            "657776\n",
            "Inhibition of recombinant human topoisomerase 1-mediated unwinding of supercoiled plasmid DNA assessed as formation of nicked open circular DNA at 12.5 to 100 uM after 2 hrs by gel electrophoresis\n",
            "Title: Imidazonaphthyridine systems (part 2): Functionalization of the phenyl ring linked to the pyridine pharmacophore and its replacement by a pyridinone ring produces intriguing differences in cytocidal activity.  Abstract: We recently discovered that five- and pseudo-five-fused-ring derivatives in an imidazonaphthyridine series were promising hit compounds for the development of new DNA-intercalators. In this study, novel (dihydro)imidazo[1,6] and [1,7]naphthyridi(no)nes were prepared including pseudo-pentacycles. All the compounds synthesized were screened against four tumor cell lines. Compounds 3(b-d) showed significant in vitro cytotoxicity, and DNA intercalation properties were demonstrated at 25 M. Imidazonaphthyridinones exhibited no DNA binding affinity despite significant growth inhibition activity. Interestingly, when a pyridinone pharmacophore was linked to the imidazo[1,2-a]pyridine scaffold, the geometric orientation of the link had a strong impact on the growth inhibition activity. From these results we conclude that the moderate cytotoxicity observed for these compounds is independent of their DNA-binding and topoisomerase inhibition activities.\n",
            "657777\n",
            "Inhibition of recombinant human topoisomerase 1-mediated unwinding of supercoiled plasmid DNA assessed as DNA intercalation at 50 uM after 2 hrs by gel electrophoresis\n",
            "Title: Imidazonaphthyridine systems (part 2): Functionalization of the phenyl ring linked to the pyridine pharmacophore and its replacement by a pyridinone ring produces intriguing differences in cytocidal activity.  Abstract: We recently discovered that five- and pseudo-five-fused-ring derivatives in an imidazonaphthyridine series were promising hit compounds for the development of new DNA-intercalators. In this study, novel (dihydro)imidazo[1,6] and [1,7]naphthyridi(no)nes were prepared including pseudo-pentacycles. All the compounds synthesized were screened against four tumor cell lines. Compounds 3(b-d) showed significant in vitro cytotoxicity, and DNA intercalation properties were demonstrated at 25 M. Imidazonaphthyridinones exhibited no DNA binding affinity despite significant growth inhibition activity. Interestingly, when a pyridinone pharmacophore was linked to the imidazo[1,2-a]pyridine scaffold, the geometric orientation of the link had a strong impact on the growth inhibition activity. From these results we conclude that the moderate cytotoxicity observed for these compounds is independent of their DNA-binding and topoisomerase inhibition activities.\n",
            "657778\n",
            "Inhibition of recombinant human topoisomerase 1-mediated unwinding of supercoiled plasmid DNA assessed as DNA intercalation at 25 uM after 2 hrs by gel electrophoresis\n",
            "Title: Imidazonaphthyridine systems (part 2): Functionalization of the phenyl ring linked to the pyridine pharmacophore and its replacement by a pyridinone ring produces intriguing differences in cytocidal activity.  Abstract: We recently discovered that five- and pseudo-five-fused-ring derivatives in an imidazonaphthyridine series were promising hit compounds for the development of new DNA-intercalators. In this study, novel (dihydro)imidazo[1,6] and [1,7]naphthyridi(no)nes were prepared including pseudo-pentacycles. All the compounds synthesized were screened against four tumor cell lines. Compounds 3(b-d) showed significant in vitro cytotoxicity, and DNA intercalation properties were demonstrated at 25 M. Imidazonaphthyridinones exhibited no DNA binding affinity despite significant growth inhibition activity. Interestingly, when a pyridinone pharmacophore was linked to the imidazo[1,2-a]pyridine scaffold, the geometric orientation of the link had a strong impact on the growth inhibition activity. From these results we conclude that the moderate cytotoxicity observed for these compounds is independent of their DNA-binding and topoisomerase inhibition activities.\n",
            "657779\n",
            "Inhibition of recombinant human topoisomerase 1-mediated unwinding of supercoiled plasmid DNA assessed as formation of nicked open circular DNA at after 2 hrs by gel electrophoresis\n",
            "Title: Imidazonaphthyridine systems (part 2): Functionalization of the phenyl ring linked to the pyridine pharmacophore and its replacement by a pyridinone ring produces intriguing differences in cytocidal activity.  Abstract: We recently discovered that five- and pseudo-five-fused-ring derivatives in an imidazonaphthyridine series were promising hit compounds for the development of new DNA-intercalators. In this study, novel (dihydro)imidazo[1,6] and [1,7]naphthyridi(no)nes were prepared including pseudo-pentacycles. All the compounds synthesized were screened against four tumor cell lines. Compounds 3(b-d) showed significant in vitro cytotoxicity, and DNA intercalation properties were demonstrated at 25 M. Imidazonaphthyridinones exhibited no DNA binding affinity despite significant growth inhibition activity. Interestingly, when a pyridinone pharmacophore was linked to the imidazo[1,2-a]pyridine scaffold, the geometric orientation of the link had a strong impact on the growth inhibition activity. From these results we conclude that the moderate cytotoxicity observed for these compounds is independent of their DNA-binding and topoisomerase inhibition activities.\n",
            "657780\n",
            "Inhibition of recombinant human topoisomerase 1-mediated unwinding of supercoiled plasmid DNA assessed as DNA intercalation after 2 hrs by gel electrophoresis\n",
            "Title: Imidazonaphthyridine systems (part 2): Functionalization of the phenyl ring linked to the pyridine pharmacophore and its replacement by a pyridinone ring produces intriguing differences in cytocidal activity.  Abstract: We recently discovered that five- and pseudo-five-fused-ring derivatives in an imidazonaphthyridine series were promising hit compounds for the development of new DNA-intercalators. In this study, novel (dihydro)imidazo[1,6] and [1,7]naphthyridi(no)nes were prepared including pseudo-pentacycles. All the compounds synthesized were screened against four tumor cell lines. Compounds 3(b-d) showed significant in vitro cytotoxicity, and DNA intercalation properties were demonstrated at 25 M. Imidazonaphthyridinones exhibited no DNA binding affinity despite significant growth inhibition activity. Interestingly, when a pyridinone pharmacophore was linked to the imidazo[1,2-a]pyridine scaffold, the geometric orientation of the link had a strong impact on the growth inhibition activity. From these results we conclude that the moderate cytotoxicity observed for these compounds is independent of their DNA-binding and topoisomerase inhibition activities.\n",
            "657781\n",
            "Inhibition of recombinant human topoisomerase 1-mediated unwinding of supercoiled plasmid DNA assessed as DNA intercalation at 100 to 200 uM after 2 hrs by gel electrophoresis\n",
            "Title: Imidazonaphthyridine systems (part 2): Functionalization of the phenyl ring linked to the pyridine pharmacophore and its replacement by a pyridinone ring produces intriguing differences in cytocidal activity.  Abstract: We recently discovered that five- and pseudo-five-fused-ring derivatives in an imidazonaphthyridine series were promising hit compounds for the development of new DNA-intercalators. In this study, novel (dihydro)imidazo[1,6] and [1,7]naphthyridi(no)nes were prepared including pseudo-pentacycles. All the compounds synthesized were screened against four tumor cell lines. Compounds 3(b-d) showed significant in vitro cytotoxicity, and DNA intercalation properties were demonstrated at 25 M. Imidazonaphthyridinones exhibited no DNA binding affinity despite significant growth inhibition activity. Interestingly, when a pyridinone pharmacophore was linked to the imidazo[1,2-a]pyridine scaffold, the geometric orientation of the link had a strong impact on the growth inhibition activity. From these results we conclude that the moderate cytotoxicity observed for these compounds is independent of their DNA-binding and topoisomerase inhibition activities.\n",
            "657916\n",
            "Inhibition of human recombinant topoisomerase 1-mediated DNA cleavage using [32P]-3'-end-labeled 117-bp DNA fragment as substrate at 1 uM after 20 mins by SDS-PAGE analysis\n",
            "Title: Azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents: a systematic study of structure-activity relationships.  Abstract: A comprehensive study of a series of azaindenoisoquinoline topoisomerase I (Top1) inhibitors is reported. The synthetic pathways have been developed to prepare 7-, 8-, 9-, and 10-azaindenoisoquinolines. The present study shows that 7-azaindenoisoquinolines possess the greatest Top1 inhibitory activity and cytotoxicity. Additionally, the introduction of a methoxy group into the D-ring of 7-azaindenoisoquinolines improved their biological activities, leading to new lead molecules for further development. A series of QM calculations were performed on the model \"sandwich\" complexes of azaindenoisoquinolines with flanking DNA base pairs from the Drug-Top1-DNA ternary complex. The results of these calculations demonstrate how changes in two forces contributing to the - stacking (dispersion and charge-transfer interactions) affect the binding of the drug to the Top1-DNA cleavage complex and thus modulate the drug's Top1 inhibitory activity.\n",
            "657917\n",
            "Inhibition of human recombinant topoisomerase 1-mediated DNA cleavage using [32P]-3'-end-labeled 117-bp DNA fragment as substrate at 100 uM after 20 mins by SDS-PAGE analysis\n",
            "Title: Azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents: a systematic study of structure-activity relationships.  Abstract: A comprehensive study of a series of azaindenoisoquinoline topoisomerase I (Top1) inhibitors is reported. The synthetic pathways have been developed to prepare 7-, 8-, 9-, and 10-azaindenoisoquinolines. The present study shows that 7-azaindenoisoquinolines possess the greatest Top1 inhibitory activity and cytotoxicity. Additionally, the introduction of a methoxy group into the D-ring of 7-azaindenoisoquinolines improved their biological activities, leading to new lead molecules for further development. A series of QM calculations were performed on the model \"sandwich\" complexes of azaindenoisoquinolines with flanking DNA base pairs from the Drug-Top1-DNA ternary complex. The results of these calculations demonstrate how changes in two forces contributing to the - stacking (dispersion and charge-transfer interactions) affect the binding of the drug to the Top1-DNA cleavage complex and thus modulate the drug's Top1 inhibitory activity.\n",
            "657918\n",
            "Inhibition of human recombinant topoisomerase 1-mediated DNA cleavage using [32P]-3'-end-labeled 117-bp DNA fragment as substrate at 0.1 to 100 uM after 20 mins by SDS-PAGE analysis\n",
            "Title: Azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents: a systematic study of structure-activity relationships.  Abstract: A comprehensive study of a series of azaindenoisoquinoline topoisomerase I (Top1) inhibitors is reported. The synthetic pathways have been developed to prepare 7-, 8-, 9-, and 10-azaindenoisoquinolines. The present study shows that 7-azaindenoisoquinolines possess the greatest Top1 inhibitory activity and cytotoxicity. Additionally, the introduction of a methoxy group into the D-ring of 7-azaindenoisoquinolines improved their biological activities, leading to new lead molecules for further development. A series of QM calculations were performed on the model \"sandwich\" complexes of azaindenoisoquinolines with flanking DNA base pairs from the Drug-Top1-DNA ternary complex. The results of these calculations demonstrate how changes in two forces contributing to the - stacking (dispersion and charge-transfer interactions) affect the binding of the drug to the Top1-DNA cleavage complex and thus modulate the drug's Top1 inhibitory activity.\n",
            "666765\n",
            "Inhibition of topo 1-mediated relaxation of supercoiled pBR322 at 10 to 100 uM after 30 mins using ethidium bromide by agarose-gel electrophoresis\n",
            "Title: Synthesis and biological evaluation of new homocamptothecin analogs.  Abstract: In order to increase the stability of E-ring of homocamptothecins, the electron-withdrawing group -OH or -OAc was induced to  position of ring-E lactone. Ten new homocamptothecin analogs were synthesized. Most compounds showed potent in vitro anticancer activity and potent Topo I inhibition, which was equal or superior to that of CPT, SN-38 and 10-HCPT. The stability studies of this series also displayed significant improvement of the stability.\n",
            "673453\n",
            "Inhibition of human recombinant Top1-mediated DNA cleavage by polyacrylamide gel electrophoresis relative to camptothecin\n",
            "Title: Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors.  Abstract: Substances with dual tyrosyl-DNA phosphodiesterase I-topoisomerase I inhibitory activity in one low molecular weight compound would constitute a unique class of anticancer agents that could potentially have significant advantages over drugs that work against the individual enzymes. The present study demonstrates the successful synthesis and evaluation of the first dual Top1-Tdp1 inhibitors, which are based on the indenoisoquinoline chemotype. One bis(indenoisoquinoline) had significant activity against human Tdp1 (IC(50) = 1.52  0.05 M), and it was also equipotent to camptothecin as a Top1 inhibitor. Significant insights into enzyme-drug interactions were gained via structure-activity relationship studies of the series. The present results also document the failure of the previously reported sulfonyl ester pharmacophore to confer Tdp1 inhibition in this indenoisoquinoline class of inhibitors even though it was demonstrated to work well for the steroid NSC 88915 (7). The current study will facilitate future efforts to optimize dual Top1-Tdp1 inhibitors.\n",
            "677826\n",
            "Inhibition of human topoisomerase 1-mediated supercoiled pUC19 plasmid DNA relaxation at 10 uM incubated for 45 mins followed by enzyme addition measured after 30 mins by agarose gel electrophoresis\n",
            "Title: Novel substituted benzothiophene and thienothiophene carboxanilides and quinolones: synthesis, photochemical synthesis, DNA-binding properties, antitumor evaluation and 3D-derived QSAR analysis.  Abstract: A series of new N,N-dimethylaminopropyl- and 2-imidazolinyl-substituted derivatives of benzo[b]thienyl- and thieno[2,3-b]thienylcarboxanilides and benzo[b]thieno[2,3-c]- and thieno[3',2':4,5]thieno[2,3-c]quinolones were prepared. Quinolones were prepared by the reaction of photochemical dehydrohalogenation of corresponding anilides. Carboxanilides and quinolones were tested for the antiproliferative activity. 2-Imidazolinyl-substituted derivatives showed very prominent activity. By use of the experimentally obtained antitumor measurements, 3D-derived QSAR analysis was performed for the set of compounds. Highly predictive 3D-derived QSAR models were obtained, and molecular properties that have the highest impact on antitumor activity were identified. Carboxanilides 6a-c and quinolones 9a-c and 11a were evaluated for DNA binding propensities and topoisomerases I and II inhibition as part of their mechanism of action assessment. The evaluated differences in the mode of action nicely correlate with the results of the 3D-QSAR analysis. Taken together, the results indicate which modifications of the compounds from the series should further improve their anticancer properties.\n",
            "677830\n",
            "Inhibition of human topoisomerase 1-mediated DNA cleavage at 10 uM incubated for 45 mins followed by enzyme addition measured after 30 mins by agarose gel electrophoresis\n",
            "Title: Novel substituted benzothiophene and thienothiophene carboxanilides and quinolones: synthesis, photochemical synthesis, DNA-binding properties, antitumor evaluation and 3D-derived QSAR analysis.  Abstract: A series of new N,N-dimethylaminopropyl- and 2-imidazolinyl-substituted derivatives of benzo[b]thienyl- and thieno[2,3-b]thienylcarboxanilides and benzo[b]thieno[2,3-c]- and thieno[3',2':4,5]thieno[2,3-c]quinolones were prepared. Quinolones were prepared by the reaction of photochemical dehydrohalogenation of corresponding anilides. Carboxanilides and quinolones were tested for the antiproliferative activity. 2-Imidazolinyl-substituted derivatives showed very prominent activity. By use of the experimentally obtained antitumor measurements, 3D-derived QSAR analysis was performed for the set of compounds. Highly predictive 3D-derived QSAR models were obtained, and molecular properties that have the highest impact on antitumor activity were identified. Carboxanilides 6a-c and quinolones 9a-c and 11a were evaluated for DNA binding propensities and topoisomerases I and II inhibition as part of their mechanism of action assessment. The evaluated differences in the mode of action nicely correlate with the results of the 3D-QSAR analysis. Taken together, the results indicate which modifications of the compounds from the series should further improve their anticancer properties.\n",
            "677840\n",
            "Inhibition of human topoisomerase 1-mediated supercoiled pUC19 plasmid DNA relaxation at 50 uM incubated for 45 mins followed by enzyme addition measured after 30 mins by agarose gel electrophoresis\n",
            "Title: Novel substituted benzothiophene and thienothiophene carboxanilides and quinolones: synthesis, photochemical synthesis, DNA-binding properties, antitumor evaluation and 3D-derived QSAR analysis.  Abstract: A series of new N,N-dimethylaminopropyl- and 2-imidazolinyl-substituted derivatives of benzo[b]thienyl- and thieno[2,3-b]thienylcarboxanilides and benzo[b]thieno[2,3-c]- and thieno[3',2':4,5]thieno[2,3-c]quinolones were prepared. Quinolones were prepared by the reaction of photochemical dehydrohalogenation of corresponding anilides. Carboxanilides and quinolones were tested for the antiproliferative activity. 2-Imidazolinyl-substituted derivatives showed very prominent activity. By use of the experimentally obtained antitumor measurements, 3D-derived QSAR analysis was performed for the set of compounds. Highly predictive 3D-derived QSAR models were obtained, and molecular properties that have the highest impact on antitumor activity were identified. Carboxanilides 6a-c and quinolones 9a-c and 11a were evaluated for DNA binding propensities and topoisomerases I and II inhibition as part of their mechanism of action assessment. The evaluated differences in the mode of action nicely correlate with the results of the 3D-QSAR analysis. Taken together, the results indicate which modifications of the compounds from the series should further improve their anticancer properties.\n",
            "677841\n",
            "Inhibition of human topoisomerase 1-mediated supercoiled pUC19 plasmid DNA relaxation at 0.5 to 2 uM incubated for 45 mins followed by enzyme addition measured after 30 mins by agarose gel electrophoresis\n",
            "Title: Novel substituted benzothiophene and thienothiophene carboxanilides and quinolones: synthesis, photochemical synthesis, DNA-binding properties, antitumor evaluation and 3D-derived QSAR analysis.  Abstract: A series of new N,N-dimethylaminopropyl- and 2-imidazolinyl-substituted derivatives of benzo[b]thienyl- and thieno[2,3-b]thienylcarboxanilides and benzo[b]thieno[2,3-c]- and thieno[3',2':4,5]thieno[2,3-c]quinolones were prepared. Quinolones were prepared by the reaction of photochemical dehydrohalogenation of corresponding anilides. Carboxanilides and quinolones were tested for the antiproliferative activity. 2-Imidazolinyl-substituted derivatives showed very prominent activity. By use of the experimentally obtained antitumor measurements, 3D-derived QSAR analysis was performed for the set of compounds. Highly predictive 3D-derived QSAR models were obtained, and molecular properties that have the highest impact on antitumor activity were identified. Carboxanilides 6a-c and quinolones 9a-c and 11a were evaluated for DNA binding propensities and topoisomerases I and II inhibition as part of their mechanism of action assessment. The evaluated differences in the mode of action nicely correlate with the results of the 3D-QSAR analysis. Taken together, the results indicate which modifications of the compounds from the series should further improve their anticancer properties.\n",
            "696326\n",
            "Inhibition of DNA topoisomerase 1 in human KB cells using [C14]thymidine assessed as protein-linked DNA breaks formation at 2.5 uM after 30 mins by agarose gel electrophoresis analysis\n",
            "Title: Antitumor agents 294. Novel E-ring-modified camptothecin-4-anilino-4'-O-demethyl-epipodophyllotoxin conjugates as DNA topoisomerase I inhibitors and cytotoxic agents.  Abstract: Two conjugates (1 and 2) of camptothecin (CPT) and 4-anilino-4'-O-demethylepipodophyllotoxin were previously shown to exert antitumor activity through inhibition of topoisomerase I (topo I). In this current study, two novel conjugates (1E and 2E) with an open E-ring in the CPT moiety were first synthesized and evaluated for biological activity in comparison with their intact E-ring congeners. This novel class of CPT-derivatives exhibits its antitumor effect against CPT-sensitive and -resistant cells, in part, by inhibiting topo I-linked DNA (TLD) religation. An intact E-ring was not essential for the inhibition of TLD religation, although conjugates with an open E-ring were less potent than the closed ring analogs. This lower religation potency resulted in decreased formation of protein-linked DNA breaks (PLDBs), and hence, less cell growth inhibition. In addition to their impact on topo I, conjugates 1E, 2, and 2E exhibited a minor inhibitory effect on topo II-induced DNA cleavage. The novel structures of 1E and 2E may present scaffolds for further development of dual function topo I and II inhibitors with improved pharmacological profiles and physicochemical properties.\n",
            "696327\n",
            "Inhibition of DNA topoisomerase 1 in human KB cells using [C14]thymidine assessed as protein-linked DNA breaks formation at 22.5 uM after 30 mins by agarose gel electrophoresis analysis\n",
            "Title: Antitumor agents 294. Novel E-ring-modified camptothecin-4-anilino-4'-O-demethyl-epipodophyllotoxin conjugates as DNA topoisomerase I inhibitors and cytotoxic agents.  Abstract: Two conjugates (1 and 2) of camptothecin (CPT) and 4-anilino-4'-O-demethylepipodophyllotoxin were previously shown to exert antitumor activity through inhibition of topoisomerase I (topo I). In this current study, two novel conjugates (1E and 2E) with an open E-ring in the CPT moiety were first synthesized and evaluated for biological activity in comparison with their intact E-ring congeners. This novel class of CPT-derivatives exhibits its antitumor effect against CPT-sensitive and -resistant cells, in part, by inhibiting topo I-linked DNA (TLD) religation. An intact E-ring was not essential for the inhibition of TLD religation, although conjugates with an open E-ring were less potent than the closed ring analogs. This lower religation potency resulted in decreased formation of protein-linked DNA breaks (PLDBs), and hence, less cell growth inhibition. In addition to their impact on topo I, conjugates 1E, 2, and 2E exhibited a minor inhibitory effect on topo II-induced DNA cleavage. The novel structures of 1E and 2E may present scaffolds for further development of dual function topo I and II inhibitors with improved pharmacological profiles and physicochemical properties.\n",
            "696328\n",
            "Inhibition of recombinant DNA topoisomerase1-mediated topo1-linked DNA relegation activity in human KB cells after 30 mins by agarose gel electrophoresis\n",
            "Title: Antitumor agents 294. Novel E-ring-modified camptothecin-4-anilino-4'-O-demethyl-epipodophyllotoxin conjugates as DNA topoisomerase I inhibitors and cytotoxic agents.  Abstract: Two conjugates (1 and 2) of camptothecin (CPT) and 4-anilino-4'-O-demethylepipodophyllotoxin were previously shown to exert antitumor activity through inhibition of topoisomerase I (topo I). In this current study, two novel conjugates (1E and 2E) with an open E-ring in the CPT moiety were first synthesized and evaluated for biological activity in comparison with their intact E-ring congeners. This novel class of CPT-derivatives exhibits its antitumor effect against CPT-sensitive and -resistant cells, in part, by inhibiting topo I-linked DNA (TLD) religation. An intact E-ring was not essential for the inhibition of TLD religation, although conjugates with an open E-ring were less potent than the closed ring analogs. This lower religation potency resulted in decreased formation of protein-linked DNA breaks (PLDBs), and hence, less cell growth inhibition. In addition to their impact on topo I, conjugates 1E, 2, and 2E exhibited a minor inhibitory effect on topo II-induced DNA cleavage. The novel structures of 1E and 2E may present scaffolds for further development of dual function topo I and II inhibitors with improved pharmacological profiles and physicochemical properties.\n",
            "696329\n",
            "Inhibition of recombinant DNA topoismerase1-mediated cleavage activity at 25 uM after 15 mins by agarose gel electrophoresis\n",
            "Title: Antitumor agents 294. Novel E-ring-modified camptothecin-4-anilino-4'-O-demethyl-epipodophyllotoxin conjugates as DNA topoisomerase I inhibitors and cytotoxic agents.  Abstract: Two conjugates (1 and 2) of camptothecin (CPT) and 4-anilino-4'-O-demethylepipodophyllotoxin were previously shown to exert antitumor activity through inhibition of topoisomerase I (topo I). In this current study, two novel conjugates (1E and 2E) with an open E-ring in the CPT moiety were first synthesized and evaluated for biological activity in comparison with their intact E-ring congeners. This novel class of CPT-derivatives exhibits its antitumor effect against CPT-sensitive and -resistant cells, in part, by inhibiting topo I-linked DNA (TLD) religation. An intact E-ring was not essential for the inhibition of TLD religation, although conjugates with an open E-ring were less potent than the closed ring analogs. This lower religation potency resulted in decreased formation of protein-linked DNA breaks (PLDBs), and hence, less cell growth inhibition. In addition to their impact on topo I, conjugates 1E, 2, and 2E exhibited a minor inhibitory effect on topo II-induced DNA cleavage. The novel structures of 1E and 2E may present scaffolds for further development of dual function topo I and II inhibitors with improved pharmacological profiles and physicochemical properties.\n",
            "696330\n",
            "Inhibition of recombinant DNA topoisomerase1-mediated topo1-linked DNA relegation activity at 25 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Antitumor agents 294. Novel E-ring-modified camptothecin-4-anilino-4'-O-demethyl-epipodophyllotoxin conjugates as DNA topoisomerase I inhibitors and cytotoxic agents.  Abstract: Two conjugates (1 and 2) of camptothecin (CPT) and 4-anilino-4'-O-demethylepipodophyllotoxin were previously shown to exert antitumor activity through inhibition of topoisomerase I (topo I). In this current study, two novel conjugates (1E and 2E) with an open E-ring in the CPT moiety were first synthesized and evaluated for biological activity in comparison with their intact E-ring congeners. This novel class of CPT-derivatives exhibits its antitumor effect against CPT-sensitive and -resistant cells, in part, by inhibiting topo I-linked DNA (TLD) religation. An intact E-ring was not essential for the inhibition of TLD religation, although conjugates with an open E-ring were less potent than the closed ring analogs. This lower religation potency resulted in decreased formation of protein-linked DNA breaks (PLDBs), and hence, less cell growth inhibition. In addition to their impact on topo I, conjugates 1E, 2, and 2E exhibited a minor inhibitory effect on topo II-induced DNA cleavage. The novel structures of 1E and 2E may present scaffolds for further development of dual function topo I and II inhibitors with improved pharmacological profiles and physicochemical properties.\n",
            "699139\n",
            "Dissociation of human topo 1-CPT-DNA ternary complex assessed as reduction in nicked DNA formation at 160 uM after 10 mins by dilution DNA cleavage assay relative to untreated-control\n",
            "Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.\n",
            "699140\n",
            "Dissociation of human topo 1-CPT-DNA ternary complex assessed as reduction in nicked DNA formation at 160 uM after 10 mins by dilution DNA cleavage assay in presence of 2.5 uM CPT\n",
            "Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.\n",
            "699141\n",
            "Dissociation of human topo 1-CPT-DNA ternary complex assessed as reduction in nicked DNA formation at 160 uM after 10 mins by dilution DNA cleavage assay\n",
            "Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.\n",
            "699143\n",
            "Dissociation of human topo 1-CPT-DNA ternary complex assessed as reduction in nicked DNA formation measuring remaining ternary complex at 150 uM after 20 mins by two-step DNA cleavage assay\n",
            "Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.\n",
            "699145\n",
            "Dissociation of human topo 1-CPT-DNA ternary complex assessed as reduction in nicked DNA formation at 150 uM by two-step DNA cleavage assay\n",
            "Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.\n",
            "699147\n",
            "Stimulation of human topoisomerase 1-mediated DNA cleavage at 7.5 uM after 10 mins by agarose gel electrophoresis\n",
            "Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.\n",
            "699149\n",
            "Inhibition of human topoisomerase 1-mediated plasmid DNA cleavage preincubated at 150 uM for 5 mins before addition of poison measured after 10 mins by agarose gel electrophoresis\n",
            "Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.\n",
            "699150\n",
            "Inhibition of human topoisomerase 1-mediated plasmid DNA cleavage at 25 to 200 uM after 10 mins by agarose gel electrophoresis\n",
            "Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.\n",
            "699151\n",
            "Stimulation of human topoisomerase 1-mediated plasmid DNA cleavage at 25 to 200 uM after 10 mins by agarose gel electrophoresis\n",
            "Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.\n",
            "699152\n",
            "Ratio of CPT IC50 to compound IC50 for human topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA\n",
            "Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.\n",
            "699153\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA after 15 to 30 mins by agarose gel electrophoresis\n",
            "Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.\n",
            "699154\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 50 to 400 uM after 15 to 30 mins by agarose gel electrophoresis in presence of 200 mM potassium glutamate\n",
            "Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.\n",
            "699155\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 50 to 400 uM after 15 to 30 mins by agarose gel electrophoresis in presence of 100 mM NaCl\n",
            "Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.\n",
            "699156\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 50 to 400 uM after 15 to 30 mins by agarose gel electrophoresis in presence of 1 mM magnesium\n",
            "Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.\n",
            "699159\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 50 to 400 uM after 15 to 30 mins by agarose gel electrophoresis\n",
            "Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.\n",
            "701776\n",
            "Inhibition of human topoisomerase 1 assessed as reduction in pBR322 DNA relaxation of relaxation at 5 uM by DNA unwinding assay\n",
            "Title: 3,6-bis(3-alkylguanidino)acridines as DNA-intercalating antitumor agents.  Abstract: A series of 3,6-bis(3-alkylguanidino) acridines was prepared and the interaction of these novel compounds with calf thymus DNA was investigated with UV-vis, fluorescence and circular dichroism spectroscopy, in addition to DNA melting techniques. The binding constants K were estimated to range from 1.25 to 5.26  10(5) M(-1), and the percentage of hypochromism was found to be 17-42% (from spectral titration). UV-vis, fluorescence and circular dichroism measurements indicated that the compounds act as effective DNA-intercalating agents. Electrophoretic separation proved that ligands 6a-e relaxed topoisomerase I at a concentration of 60 M, although only those with longer alkyl chains were able to penetrate cell membranes and suppress cell proliferation effectively. The biological activity of novel compounds was assessed using different techniques (cell cycle distribution, phosphatidylserine externalization, caspase-3 activation, changes in mitochondrial membrane potential) and demonstrated mostly transient cytostatic action of the ethyl 6c and pentyl 6d derivatives. The hexyl derivative 6e proved to be the most cytotoxic. Different patterns of cell penetration were also observed for individual derivatives. Principles of molecular dynamics were applied to explore DNA-ligand interactions at the molecular level.\n",
            "701777\n",
            "Inhibition of human topoisomerase 1 assessed as reduction in pBR322 DNA relaxation of relaxation at 60 uM by DNA unwinding assay\n",
            "Title: 3,6-bis(3-alkylguanidino)acridines as DNA-intercalating antitumor agents.  Abstract: A series of 3,6-bis(3-alkylguanidino) acridines was prepared and the interaction of these novel compounds with calf thymus DNA was investigated with UV-vis, fluorescence and circular dichroism spectroscopy, in addition to DNA melting techniques. The binding constants K were estimated to range from 1.25 to 5.26  10(5) M(-1), and the percentage of hypochromism was found to be 17-42% (from spectral titration). UV-vis, fluorescence and circular dichroism measurements indicated that the compounds act as effective DNA-intercalating agents. Electrophoretic separation proved that ligands 6a-e relaxed topoisomerase I at a concentration of 60 M, although only those with longer alkyl chains were able to penetrate cell membranes and suppress cell proliferation effectively. The biological activity of novel compounds was assessed using different techniques (cell cycle distribution, phosphatidylserine externalization, caspase-3 activation, changes in mitochondrial membrane potential) and demonstrated mostly transient cytostatic action of the ethyl 6c and pentyl 6d derivatives. The hexyl derivative 6e proved to be the most cytotoxic. Different patterns of cell penetration were also observed for individual derivatives. Principles of molecular dynamics were applied to explore DNA-ligand interactions at the molecular level.\n",
            "702828\n",
            "Inhibition of Top1 assessed as suppression of supercoiled pBR322 DNA relaxation measuring appearance of short DNA fragments at 100 uM incubated for 15 mins by electrophoresis method\n",
            "Title: New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations.  Abstract: Evodiamine is a quinazolinocarboline alkaloid isolated from the fruits of traditional Chinese herb  Evodiae fructus . Previously, we identified N13-substituted evodiamine derivatives as potent topoisomerase I inhibitors by structure-based virtual screening and lead optimization. Herein, a library of novel evodiamine derivatives bearing various substitutions or modified scaffold were synthesized. Among them, a number of evodiamine derivatives showed substantial increase of the antitumor activity, with GI(50) values lower than 3 nM. Moreover, these highly potent compounds can effectively induce the apoptosis of A549 cells. Interestingly, further computational target prediction calculations in combination with biological assays confirmed that the evodiamine derivatives acted by dual inhibition of topoisomerases I and II. Moreover, several hydroxyl derivatives, such as 10-hydroxyl evodiamine (10j) and 3-amino-10-hydroxyl evodiamine (18g), also showed good in vivo antitumor efficacy and low toxicity at the dose of 1 mg/kg or 2 mg/kg. They represent promising candidates for the development of novel antitumor agents.\n",
            "702851\n",
            "Inhibition of Top1 assessed as stabilization of Top1-pUC19 DNA cleavage complex measuring increase of nicked DNA at 100 uM incubated for 15 mins by electrophoresis method\n",
            "Title: New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations.  Abstract: Evodiamine is a quinazolinocarboline alkaloid isolated from the fruits of traditional Chinese herb  Evodiae fructus . Previously, we identified N13-substituted evodiamine derivatives as potent topoisomerase I inhibitors by structure-based virtual screening and lead optimization. Herein, a library of novel evodiamine derivatives bearing various substitutions or modified scaffold were synthesized. Among them, a number of evodiamine derivatives showed substantial increase of the antitumor activity, with GI(50) values lower than 3 nM. Moreover, these highly potent compounds can effectively induce the apoptosis of A549 cells. Interestingly, further computational target prediction calculations in combination with biological assays confirmed that the evodiamine derivatives acted by dual inhibition of topoisomerases I and II. Moreover, several hydroxyl derivatives, such as 10-hydroxyl evodiamine (10j) and 3-amino-10-hydroxyl evodiamine (18g), also showed good in vivo antitumor efficacy and low toxicity at the dose of 1 mg/kg or 2 mg/kg. They represent promising candidates for the development of novel antitumor agents.\n",
            "702856\n",
            "Inhibition of Top1 assessed as suppression of supercoiled pBR322 DNA relaxation measuring appearance of short DNA fragments at 50 uM incubated for 15 mins by electrophoresis method\n",
            "Title: New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations.  Abstract: Evodiamine is a quinazolinocarboline alkaloid isolated from the fruits of traditional Chinese herb  Evodiae fructus . Previously, we identified N13-substituted evodiamine derivatives as potent topoisomerase I inhibitors by structure-based virtual screening and lead optimization. Herein, a library of novel evodiamine derivatives bearing various substitutions or modified scaffold were synthesized. Among them, a number of evodiamine derivatives showed substantial increase of the antitumor activity, with GI(50) values lower than 3 nM. Moreover, these highly potent compounds can effectively induce the apoptosis of A549 cells. Interestingly, further computational target prediction calculations in combination with biological assays confirmed that the evodiamine derivatives acted by dual inhibition of topoisomerases I and II. Moreover, several hydroxyl derivatives, such as 10-hydroxyl evodiamine (10j) and 3-amino-10-hydroxyl evodiamine (18g), also showed good in vivo antitumor efficacy and low toxicity at the dose of 1 mg/kg or 2 mg/kg. They represent promising candidates for the development of novel antitumor agents.\n",
            "702857\n",
            "Inhibition of Top1 assessed as suppression of supercoiled pBR322 DNA relaxation measuring appearance of short DNA fragments at 500 uM incubated for 15 mins by electrophoresis method\n",
            "Title: New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations.  Abstract: Evodiamine is a quinazolinocarboline alkaloid isolated from the fruits of traditional Chinese herb  Evodiae fructus . Previously, we identified N13-substituted evodiamine derivatives as potent topoisomerase I inhibitors by structure-based virtual screening and lead optimization. Herein, a library of novel evodiamine derivatives bearing various substitutions or modified scaffold were synthesized. Among them, a number of evodiamine derivatives showed substantial increase of the antitumor activity, with GI(50) values lower than 3 nM. Moreover, these highly potent compounds can effectively induce the apoptosis of A549 cells. Interestingly, further computational target prediction calculations in combination with biological assays confirmed that the evodiamine derivatives acted by dual inhibition of topoisomerases I and II. Moreover, several hydroxyl derivatives, such as 10-hydroxyl evodiamine (10j) and 3-amino-10-hydroxyl evodiamine (18g), also showed good in vivo antitumor efficacy and low toxicity at the dose of 1 mg/kg or 2 mg/kg. They represent promising candidates for the development of novel antitumor agents.\n",
            "704299\n",
            "Inhibition of recombinant human DNA topoisomerase-1-mediated relaxation of supercoiled pBR322 at 20 uM after 30 mins using ethidium bromide staining by agarose gel electrophoresis\n",
            "Title: Design, synthesis, and antitumor evaluation of 2,4,6-triaryl pyridines containing chlorophenyl and phenolic moiety.  Abstract: We have designed and synthesized a series of 2,4,6-triaryl pyridine derivatives containing chlorophenyl and phenolic moeity at 2- and 4- position of the central pyridine, respectively, resulting in a total of 42 compounds. They were evaluated for topoisomerase I and II inhibitory activities as well as cytotoxicities against several human cancer cell lines. Most compounds showed better topoisomerase II inhibitory activity compared to topoisomerase I inhibitory activity. Compounds 19, 20, 26-28, and 47-50 especially showed stronger topo II inhibitory activity than etoposide.\n",
            "704300\n",
            "Inhibition of recombinant human DNA topoisomerase-1-mediated relaxation of supercoiled pBR322 at 100 uM after 30 mins using ethidium bromide staining by agarose gel electrophoresis\n",
            "Title: Design, synthesis, and antitumor evaluation of 2,4,6-triaryl pyridines containing chlorophenyl and phenolic moiety.  Abstract: We have designed and synthesized a series of 2,4,6-triaryl pyridine derivatives containing chlorophenyl and phenolic moeity at 2- and 4- position of the central pyridine, respectively, resulting in a total of 42 compounds. They were evaluated for topoisomerase I and II inhibitory activities as well as cytotoxicities against several human cancer cell lines. Most compounds showed better topoisomerase II inhibitory activity compared to topoisomerase I inhibitory activity. Compounds 19, 20, 26-28, and 47-50 especially showed stronger topo II inhibitory activity than etoposide.\n",
            "709686\n",
            "Inhibition of human recombinant Top1-mediated DNA cleavage after 20 mins by SDS-PAGE analysis relative to camptothecin\n",
            "Title: Identification, synthesis, and biological evaluation of metabolites of the experimental cancer treatment drugs indotecan (LMP400) and indimitecan (LMP776) and investigation of isomerically hydroxylated indenoisoquinoline analogues as topoisomerase I poisons.  Abstract: Hydroxylated analogues of the anticancer topoisomerase I (Top1) inhibitors indotecan (LMP400) and indimitecan (LMP776) have been prepared because (1) a variety of potent Top1 poisons are known that contain strategically placed hydroxyl groups, which provides a clear rationale for incorporating them in the present case, and (2) the hydroxylated compounds could conceivably serve as synthetic standards for the identification of metabolites. Indeed, incubating LMP400 and LMP776 with human liver microsomes resulted in two major metabolites of each drug, which had HPLC retention times and mass fragmentation patterns identical to those of the synthetic standards. The hydroxylated indotecan and indimitecan metabolites and analogues were tested as Top1 poisons and for antiproliferative activity in a variety of human cancer cell cultures and in general were found to be very potent. Differences in activity resulting from the placement of the hydroxyl group are explained by molecular modeling analyses.\n",
            "711426\n",
            "Inhibition of topoisomerase 1 in human HuH7 cells\n",
            "Title: Lanostanoids from fungi: a group of potential anticancer compounds.  Abstract: Lanostanes are a group of tetracyclic triterpenoids derived from lanosterol. They have relevant biological and pharmacological properties, such as their cytotoxic effects via induction of apoptosis. This review compiles the most relevant lanostanoids studied from 2000 to 2011, principally those isolated from Ganoderma lucidum and other related fungi, such as Poria cocos, Laetiporus sulphureus, Inonotus obliquus, Antrodia camphorata, Daedalea dickinsii, and Elfvingia applanata, which have great potential as anticancer agents because of their cytotoxic or apoptotic effects. The compounds were selected on the basis of their proapoptotic mechanisms, through their ability to modify transcriptional activities via nuclear factors or genes and the activation or inhibition of pro- or antiapoptotic proteins; studies based only on their cytotoxicity were excluded from this review in the absence of complementary studies on their mechanisms of action. A total of 81 compounds from Ganoderma lucidum and other species from this genus are included, as well as 96 compounds isolated from other fungi, principally Poria cocos. Some of these compounds were found to arrest the cell cycle in the G1 phase, increase levels of p53 and Bax, or inhibit the phosphorylation of Erk1/2 or the activation of NF-B and AP-1. Other lanostanes have inhibitory effects on the growth of androgen prostate carcinoma through increasing the expression of p21, which activates the tumor suppressor protein p53, while other compounds have been shown to selectively inhibit topo II activity without affecting topo I. General considerations concerning the chemical structure-biological activities of these compounds are also discussed.\n",
            "711429\n",
            "Inhibition of topoisomerase 1\n",
            "Title: Lanostanoids from fungi: a group of potential anticancer compounds.  Abstract: Lanostanes are a group of tetracyclic triterpenoids derived from lanosterol. They have relevant biological and pharmacological properties, such as their cytotoxic effects via induction of apoptosis. This review compiles the most relevant lanostanoids studied from 2000 to 2011, principally those isolated from Ganoderma lucidum and other related fungi, such as Poria cocos, Laetiporus sulphureus, Inonotus obliquus, Antrodia camphorata, Daedalea dickinsii, and Elfvingia applanata, which have great potential as anticancer agents because of their cytotoxic or apoptotic effects. The compounds were selected on the basis of their proapoptotic mechanisms, through their ability to modify transcriptional activities via nuclear factors or genes and the activation or inhibition of pro- or antiapoptotic proteins; studies based only on their cytotoxicity were excluded from this review in the absence of complementary studies on their mechanisms of action. A total of 81 compounds from Ganoderma lucidum and other species from this genus are included, as well as 96 compounds isolated from other fungi, principally Poria cocos. Some of these compounds were found to arrest the cell cycle in the G1 phase, increase levels of p53 and Bax, or inhibit the phosphorylation of Erk1/2 or the activation of NF-B and AP-1. Other lanostanes have inhibitory effects on the growth of androgen prostate carcinoma through increasing the expression of p21, which activates the tumor suppressor protein p53, while other compounds have been shown to selectively inhibit topo II activity without affecting topo I. General considerations concerning the chemical structure-biological activities of these compounds are also discussed.\n",
            "714170\n",
            "Inhibition of topoisomerase-1 in human U251 cells assessed as inhibition of HIF-1-mediated hypoxia-induced VEGF expression after 24 hrs by luciferase reporter gene assay\n",
            "Title: Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.  Abstract: Tumor hypoxia has been recognized as a common feature of solid tumors and a negative prognostic factor for response to treatment and survival of cancer patients. The discovery of hypoxia-inducible factor-1 (HIF-1), a molecular determinant of responses to hypoxia in mammalian cells, has renewed enthusiasm for discovery and development of targeted therapies exploiting the hypoxic tumor microenvironment. HIF-1 activity in tumors depends on availability of the HIF-1 subunit, the levels of which increase under hypoxic conditions and through activation of oncogenes and/or inactivation of tumor suppressor genes. Increased HIF-1 has been correlated with increased angiogenesis, aggressive tumor growth, and poor patient prognosis, leading to current interest in HIF-1 as promising anticancer drug target. In spite of an ever increasing number of putative small molecule inhibitors of HIF-1, only a few are progressing through preclinical and early clinical development. In this review, we will discuss recent advances in discovery and development of small molecule inhibitors that target the HIF-1 pathway as potential anticancer agents.\n",
            "714171\n",
            "Inhibition of topoisomerase-1 in human U251 cells assessed as inhibition of hypoxia-induced HIF-1alpha accumulation in nuclear extract after 6 to 24 hrs by immunoblot analysis\n",
            "Title: Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.  Abstract: Tumor hypoxia has been recognized as a common feature of solid tumors and a negative prognostic factor for response to treatment and survival of cancer patients. The discovery of hypoxia-inducible factor-1 (HIF-1), a molecular determinant of responses to hypoxia in mammalian cells, has renewed enthusiasm for discovery and development of targeted therapies exploiting the hypoxic tumor microenvironment. HIF-1 activity in tumors depends on availability of the HIF-1 subunit, the levels of which increase under hypoxic conditions and through activation of oncogenes and/or inactivation of tumor suppressor genes. Increased HIF-1 has been correlated with increased angiogenesis, aggressive tumor growth, and poor patient prognosis, leading to current interest in HIF-1 as promising anticancer drug target. In spite of an ever increasing number of putative small molecule inhibitors of HIF-1, only a few are progressing through preclinical and early clinical development. In this review, we will discuss recent advances in discovery and development of small molecule inhibitors that target the HIF-1 pathway as potential anticancer agents.\n",
            "720710\n",
            "Break-induced replication repair of damaged forks induces genomic duplications in human cells\n",
            "Title: Break-induced replication repair of damaged forks induces genomic duplications in human cells  Abstract: In budding yeast, one-ended DNA double-strand breaks (DSBs) and damaged replication forks are repaired by break-induced replication (BIR), a homologous recombination pathway that requires the Pol32 subunit of DNA polymerase delta. DNA replication stress is prevalent in cancer, but BIR has not been characterized in mammals. In a cyclin E overexpression model of DNA replication stress, POLD3, the human ortholog of POL32, was required for cell cycle progression and processive DNA synthesis. Segmental genomic duplications induced by cyclin E overexpression were also dependent on POLD3, as were BIR-mediated recombination events captured with a specialized DSB repair assay. We propose that BIR repairs damaged replication forks in mammals, accounting for the high frequency of genomic duplications in human cancers.  This RNAi screen aimed to identify genes whose functional inhibition would sensitize U-2 OS cells overexpressing cyclin-E (CCNE1) to oncogene induced DNA replication stress.\n",
            "724041\n",
            "Inhibition of recombinant Top1 (unknown origin) using 3'-[32P]-end-labeled 117 bp oligonucleotide as substrate after 20 mins by SDS-PAGE analysis\n",
            "Title: Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1).  Abstract: Tyrosyl-DNA phosphodiesterase I (Tdp1) plays a key role in the repair of damaged DNA resulting from the topoisomerase I (Top1) inhibitor camptothecin and a variety of other DNA-damaging anticancer agents. This report documents the design, synthesis, and evaluation of new indenoisoquinolines that are dual inhibitors of both Tdp1 and Top1. Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures were used to establish structure-activity relationships. The potencies of the indenoisoquinolines against Tdp1 ranged from 5 M to 111 M, which places the more active compounds among the most potent known inhibitors of this target. The cytotoxicity mean graph midpoints ranged from 0.02 to 2.34 M. Dual Tdp1-Top1 inhibitors are of interest because the Top1 and Tdp1 inhibitory activities could theoretically work synergistically to create more effective anticancer agents.\n",
            "724051\n",
            "Inhibition of recombinant Top1 (unknown origin) using 3'-[32P]-end-labeled 117 bp oligonucleotide as substrate assessed as suppression of DNA cleavage at 100 uM by SDS-PAGE analysis\n",
            "Title: Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1).  Abstract: Tyrosyl-DNA phosphodiesterase I (Tdp1) plays a key role in the repair of damaged DNA resulting from the topoisomerase I (Top1) inhibitor camptothecin and a variety of other DNA-damaging anticancer agents. This report documents the design, synthesis, and evaluation of new indenoisoquinolines that are dual inhibitors of both Tdp1 and Top1. Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures were used to establish structure-activity relationships. The potencies of the indenoisoquinolines against Tdp1 ranged from 5 M to 111 M, which places the more active compounds among the most potent known inhibitors of this target. The cytotoxicity mean graph midpoints ranged from 0.02 to 2.34 M. Dual Tdp1-Top1 inhibitors are of interest because the Top1 and Tdp1 inhibitory activities could theoretically work synergistically to create more effective anticancer agents.\n",
            "724052\n",
            "Inhibition of recombinant Top1 (unknown origin) using 3'-[32P]-end-labeled 117 bp oligonucleotide as substrate after 20 mins by SDS-PAGE analysis relative to 1 uM camptothecin\n",
            "Title: Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1).  Abstract: Tyrosyl-DNA phosphodiesterase I (Tdp1) plays a key role in the repair of damaged DNA resulting from the topoisomerase I (Top1) inhibitor camptothecin and a variety of other DNA-damaging anticancer agents. This report documents the design, synthesis, and evaluation of new indenoisoquinolines that are dual inhibitors of both Tdp1 and Top1. Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures were used to establish structure-activity relationships. The potencies of the indenoisoquinolines against Tdp1 ranged from 5 M to 111 M, which places the more active compounds among the most potent known inhibitors of this target. The cytotoxicity mean graph midpoints ranged from 0.02 to 2.34 M. Dual Tdp1-Top1 inhibitors are of interest because the Top1 and Tdp1 inhibitory activities could theoretically work synergistically to create more effective anticancer agents.\n",
            "724053\n",
            "Inhibition of recombinant Top1 (unknown origin) using 3'-[32P]-end-labeled 117 bp oligonucleotide as substrate after 20 mins by SDS-PAGE analysis relative to 1 uM MJ-3-65\n",
            "Title: Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1).  Abstract: Tyrosyl-DNA phosphodiesterase I (Tdp1) plays a key role in the repair of damaged DNA resulting from the topoisomerase I (Top1) inhibitor camptothecin and a variety of other DNA-damaging anticancer agents. This report documents the design, synthesis, and evaluation of new indenoisoquinolines that are dual inhibitors of both Tdp1 and Top1. Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures were used to establish structure-activity relationships. The potencies of the indenoisoquinolines against Tdp1 ranged from 5 M to 111 M, which places the more active compounds among the most potent known inhibitors of this target. The cytotoxicity mean graph midpoints ranged from 0.02 to 2.34 M. Dual Tdp1-Top1 inhibitors are of interest because the Top1 and Tdp1 inhibitory activities could theoretically work synergistically to create more effective anticancer agents.\n",
            "725344\n",
            "Inhibition of human topoisomerase 1-mediated supercoiled plasmid DNA cleavage at 10 to 20 uM after 2 hrs by agarose gel electrophoresis\n",
            "Title: Synthesis, antiproliferative activity and tubulin targeting effect of acridinone and dioxophenothiazine derivatives.  Abstract: The synthesis of new acridinone and dioxophenothiazine derivatives along with their tubulin polymerization inhibitory and antiproliferative activities is reported. The analysis of correlation for cytotoxic and antitubulin potential of tested compounds showed that 4-methoxyphenylethyl derivatives 18a and 19a were highly cytotoxic but were regarded to have no significant antitubulin activity. However, the introduction of a 3-hydroxy substituent leading to compounds 18e and 19e, strongly increased the antitubulin potential but was associated with a loss of the antiproliferative activity. Modeling studies, topoisomerase inhibition assays and cell cycle analysis have been performed to better investigate the mechanism of action of such compounds.\n",
            "725345\n",
            "Inhibition of human topoisomerase 1-mediated supercoiled plasmid DNA cleavage at 20 uM after 2 hrs by agarose gel electrophoresis\n",
            "Title: Synthesis, antiproliferative activity and tubulin targeting effect of acridinone and dioxophenothiazine derivatives.  Abstract: The synthesis of new acridinone and dioxophenothiazine derivatives along with their tubulin polymerization inhibitory and antiproliferative activities is reported. The analysis of correlation for cytotoxic and antitubulin potential of tested compounds showed that 4-methoxyphenylethyl derivatives 18a and 19a were highly cytotoxic but were regarded to have no significant antitubulin activity. However, the introduction of a 3-hydroxy substituent leading to compounds 18e and 19e, strongly increased the antitubulin potential but was associated with a loss of the antiproliferative activity. Modeling studies, topoisomerase inhibition assays and cell cycle analysis have been performed to better investigate the mechanism of action of such compounds.\n",
            "725730\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pUC18 plasmid DNA in human MCF7 cells nuclear extracts at 10 uM after 30 mins by ethidium bromide staining based gel electrophoresis analysis\n",
            "Title: Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.  Abstract: The plant alkaloid lycobetaine has potent topoisomerase-targeting properties and shows anticancer activity. Based on these findings, several lycobetaine analogs were synthesized mainly differing in their substituents at 2, 8 and 9 position and their biological activities were evaluated. The topoisomerase-targeting properties and cytotoxicity of these structural analogs were assessed in the human gastric carcinoma cell line GXF251L. Performing a plasmid relaxation assay, an increased inhibition of topoisomerase I was found with N-methylphenanthridinium chlorides bearing a 8,9-methylenedioxy moiety or a methoxy group in 2-position. Furthermore, quaternized phenanthridinium derivatives bearing either a 2-methoxy or a 8,9-methylenedioxy moiety in conjunction with a 2-hydroxy or 2-methoxy group display potent topoisomerase II inhibition as shown by decatenation of kinetoplast DNA. In general, the N-methylphenanthridinium chlorides possess more potency in inhibiting topoisomerase I than topoisomerase II. All quaternized derivatives also exhibited potent inhibition of tumor cell growth in the low micromolar concentration range. Hence, N-methylphenanthridinium compounds were found to represent a promising class of compounds, potently inhibiting both, topoisomerases I and II, and may be further developed into clinically useful topoisomerase inhibitors.\n",
            "725731\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pUC18 plasmid DNA in human MCF7 cells nuclear extracts at 50 uM after 30 mins by ethidium bromide staining based gel electrophoresis analysis\n",
            "Title: Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.  Abstract: The plant alkaloid lycobetaine has potent topoisomerase-targeting properties and shows anticancer activity. Based on these findings, several lycobetaine analogs were synthesized mainly differing in their substituents at 2, 8 and 9 position and their biological activities were evaluated. The topoisomerase-targeting properties and cytotoxicity of these structural analogs were assessed in the human gastric carcinoma cell line GXF251L. Performing a plasmid relaxation assay, an increased inhibition of topoisomerase I was found with N-methylphenanthridinium chlorides bearing a 8,9-methylenedioxy moiety or a methoxy group in 2-position. Furthermore, quaternized phenanthridinium derivatives bearing either a 2-methoxy or a 8,9-methylenedioxy moiety in conjunction with a 2-hydroxy or 2-methoxy group display potent topoisomerase II inhibition as shown by decatenation of kinetoplast DNA. In general, the N-methylphenanthridinium chlorides possess more potency in inhibiting topoisomerase I than topoisomerase II. All quaternized derivatives also exhibited potent inhibition of tumor cell growth in the low micromolar concentration range. Hence, N-methylphenanthridinium compounds were found to represent a promising class of compounds, potently inhibiting both, topoisomerases I and II, and may be further developed into clinically useful topoisomerase inhibitors.\n",
            "725732\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pUC18 plasmid DNA in human MCF7 cells nuclear extracts at 100 uM after 30 mins by ethidium bromide staining based gel electrophoresis analysis\n",
            "Title: Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.  Abstract: The plant alkaloid lycobetaine has potent topoisomerase-targeting properties and shows anticancer activity. Based on these findings, several lycobetaine analogs were synthesized mainly differing in their substituents at 2, 8 and 9 position and their biological activities were evaluated. The topoisomerase-targeting properties and cytotoxicity of these structural analogs were assessed in the human gastric carcinoma cell line GXF251L. Performing a plasmid relaxation assay, an increased inhibition of topoisomerase I was found with N-methylphenanthridinium chlorides bearing a 8,9-methylenedioxy moiety or a methoxy group in 2-position. Furthermore, quaternized phenanthridinium derivatives bearing either a 2-methoxy or a 8,9-methylenedioxy moiety in conjunction with a 2-hydroxy or 2-methoxy group display potent topoisomerase II inhibition as shown by decatenation of kinetoplast DNA. In general, the N-methylphenanthridinium chlorides possess more potency in inhibiting topoisomerase I than topoisomerase II. All quaternized derivatives also exhibited potent inhibition of tumor cell growth in the low micromolar concentration range. Hence, N-methylphenanthridinium compounds were found to represent a promising class of compounds, potently inhibiting both, topoisomerases I and II, and may be further developed into clinically useful topoisomerase inhibitors.\n",
            "725734\n",
            "Stabilization of topoisomerase 1/DNA complex in human A431 cells\n",
            "Title: Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.  Abstract: The plant alkaloid lycobetaine has potent topoisomerase-targeting properties and shows anticancer activity. Based on these findings, several lycobetaine analogs were synthesized mainly differing in their substituents at 2, 8 and 9 position and their biological activities were evaluated. The topoisomerase-targeting properties and cytotoxicity of these structural analogs were assessed in the human gastric carcinoma cell line GXF251L. Performing a plasmid relaxation assay, an increased inhibition of topoisomerase I was found with N-methylphenanthridinium chlorides bearing a 8,9-methylenedioxy moiety or a methoxy group in 2-position. Furthermore, quaternized phenanthridinium derivatives bearing either a 2-methoxy or a 8,9-methylenedioxy moiety in conjunction with a 2-hydroxy or 2-methoxy group display potent topoisomerase II inhibition as shown by decatenation of kinetoplast DNA. In general, the N-methylphenanthridinium chlorides possess more potency in inhibiting topoisomerase I than topoisomerase II. All quaternized derivatives also exhibited potent inhibition of tumor cell growth in the low micromolar concentration range. Hence, N-methylphenanthridinium compounds were found to represent a promising class of compounds, potently inhibiting both, topoisomerases I and II, and may be further developed into clinically useful topoisomerase inhibitors.\n",
            "729747\n",
            "Inhibition of DNA topoisomerase 1 (unknown origin)-mediated relaxation of supercoiled pHOT DNA at 25 to 100 uM after 30 to 45 mins by agarose gel electrophoresis\n",
            "Title: Novel antitumor indolizino[6,7-b]indoles with multiple modes of action: DNA cross-linking and topoisomerase I and II inhibition.  Abstract: A series of bis(hydroxymethyl)indolizino[6,7-b]indoles and their bis(alkylcarbamates) were synthesized for antitumor studies. These agents were designed as hybrid molecules of -carboline (topoisomerase inhibition moiety) and bis(hydroxymethyl)pyrrole (DNA cross-linking moiety). The preliminary antitumor studies indicated that these agents exhibited significant cytotoxicity against a variety of human tumor cells in vitro. Treatment of human breast carcinoma MX-1 xenograft-bearing nude mice with compounds 18b and 28c achieved more than 99% tumor remission. We also observed that 18a displayed potent therapeutic efficacy against human lung adenocarcinoma A549 and colon cancer HT-29 xenografts. These results revealed that compound 18a was more potent than irinotecan against HT-29 cells and was as potent as irinotecan against A549 cells in xenograft models. Furthermore, we demonstrated that these derivatives possess multiple modes of action, such as induction of DNA cross-linking, inhibition of topoisomerase I and II, and cell-cycle arrest at the S-phase.\n",
            "730195\n",
            "Inhibition of DNA topoisomerase 1 (unknown origin)-mediated relaxation of supercoiled pHOT DNA at 25 to 200 uM after 30 to 45 mins by agarose gel electrophoresis\n",
            "Title: Novel antitumor indolizino[6,7-b]indoles with multiple modes of action: DNA cross-linking and topoisomerase I and II inhibition.  Abstract: A series of bis(hydroxymethyl)indolizino[6,7-b]indoles and their bis(alkylcarbamates) were synthesized for antitumor studies. These agents were designed as hybrid molecules of -carboline (topoisomerase inhibition moiety) and bis(hydroxymethyl)pyrrole (DNA cross-linking moiety). The preliminary antitumor studies indicated that these agents exhibited significant cytotoxicity against a variety of human tumor cells in vitro. Treatment of human breast carcinoma MX-1 xenograft-bearing nude mice with compounds 18b and 28c achieved more than 99% tumor remission. We also observed that 18a displayed potent therapeutic efficacy against human lung adenocarcinoma A549 and colon cancer HT-29 xenografts. These results revealed that compound 18a was more potent than irinotecan against HT-29 cells and was as potent as irinotecan against A549 cells in xenograft models. Furthermore, we demonstrated that these derivatives possess multiple modes of action, such as induction of DNA cross-linking, inhibition of topoisomerase I and II, and cell-cycle arrest at the S-phase.\n",
            "735940\n",
            "Inhibition of topoisomerase-1 (unknown origin)-mediated DNA cleavage after 15 mins by agarose gel electrophoresis\n",
            "Title: Solphenazines A-F, glycosylated phenazines from Streptomyces sp. strain DL-93.  Abstract: During a survey of actinobacteria known to suppress the growth of Streptomyces scabies (the causative agent of potato scab disease) in vivo, six new rhamnosylated alkaloids, the solphenazines A-F (1-6), were isolated from a biological control strain of Streptomyces (DL-93). The known rhamnosyl analogue of paraben (9) was also isolated along with a new rhamnosylated derivative of N-methyl-p-aminobenzoic acid (10). None of the compounds exhibited any antibacterial or antifungal activity against a standard panel of microorganisms, but compounds 1, 2, and 6 displayed some cytotoxicity against HCT-116 cancer cells. Additional in vitro testing provided data suggesting that the cytotoxic activity is not due to DNA intercalation or topoisomerase inhibition.\n",
            "736320\n",
            "Binding affinity to topoisomerase 1 (unknown origin)\n",
            "Title: Polycyclic hybrid isoprenoids from a reed rhizosphere soil derived Streptomyces sp. CHQ-64.  Abstract: Two new hybrid isoprenoids, named indotertine B (2) and drimentine H (3), along with the known analogue drimentine C (4), were isolated from the reed rhizosphere soil derived actinomycete Streptomyces sp. CHQ-64. The structures of these compounds, including absolute configurations, were elucidated by extensive NMR, MS, and CD analyses. Indotertine B (2) exists as a pair of rotamers about the N-C(O) bond with a 2:1 ratio and displays activities against HCT-8 and A549 tumor cell lines with IC50 values of 6.96 and 4.88 M, respectively.\n",
            "736814\n",
            "Inhibition of human DNA topoisomerase 1 assessed as effect on relaxation of negatively super colied DNA at 100 uM incubated for 30 mins at 37 degC by agarose-gel electrophoresis\n",
            "Title: Indenoindolone derivatives as topoisomerase II-inhibiting anticancer agents.  Abstract: Based on known heterocyclic topoisomerase II inhibitors and anticancer agents, various indenoindolone derivatives were predicted as potential topoisomerase II-inhibiting anticancer agents. They are hydrazones, (thio)semicarbazones, and oximes of indenoindolones, and indenoindolols. These derivatives with suitable substitutions exhibited potent specific inhibition of human DNA TopoII while not showing inhibition of topoisomerase I and DNA intercalation, despite the fact that parent indenoindolones are known poor/moderate inhibitors of topoisomerase II. The potent topoisomerase II inhibitor indenoindolone derivatives exhibited good anticancer activities compared to etoposide and 5-fluorouracil, and relatively low toxicity to normal cells. These derivatizations of indenoindolones were found to result in enhancement of anticancer activities.\n",
            "743121\n",
            "Druggable Genome siRNA Screen for Enhancers of Camptothecin in MDA-MB-231 Breast Cancer Cells\n",
            "Camptothecin, a specific topoisomerase I inhibitor is a potent anticancer drug, especially against solid tumors. This agent produces well-characterized double-strand breaks upon collision of replication forks with topoisomerase I cleavage complexes. In an attempt to improve its efficacy, we conducted a synthetic lethal siRNA screening using a library that targets nearly 7000 human genes. Depletion of ATR, the main transducer of replication stress-induced DNA damage response exacerbated cytotoxic response to both camptothecin and the indenoisoquinoline LMP-400, a novel class of topoisomerase inhibitors in clinical trial. Inhibition of ATR by the recently developed specific inhibitor VE-821 induced synergistic antiproliferative activity when combined with either topoisomerase inhibitor.\n",
            "743454\n",
            "RNAi screen for vorinostat resistance genes - Primary Screen\n",
            "Assay description will be published shortly and manuscript citation added here.\n",
            "745329\n",
            "Inhibition of topoisomerase 1 (unknown origin)-mediated DNA cleavage at 1 uM relative to SN-38\n",
            "Title: Evolution in medicinal chemistry of E-ring-modified Camptothecin analogs as anticancer agents.  Abstract: Camptothecin (CPT), a natural topoisomerase (Topo) I inhibitor, exhibits powerful antineoplastic activity against colorectal, breast, lung and ovarian cancers. However, the poor solubility and the inherent instability of the lactone E-ring in physiological pH resulted in low therapeutic efficacy and severe toxicity. In the past several decades' substantial progress toward understanding its pharmacology, lots of analogs have been prepared to overcome its drawbacks. The review provides a detailed discussion of the evolution in medicinal chemistry of CPT analogs with modification of the E-ring lactone.\n",
            "746647\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of supercoiled plasmid DNA assessed as formation of linear DNA at 100 uM by agarose gel electrophoresis\n",
            "Title: Synthesis, cytotoxicity and topoisomerase II inhibitory activity of lomefloxacin derivatives.  Abstract: A novel series of amide derivatives of lomefloxacin were synthesized and evaluated for their topoisomerase I and II inhibitory activity as well as cytotoxicity against a panel of five human cancer cell lines. Of the compounds prepared compounds 9d and 9g exhibited strong inhibition against topoisomerase II at 100M. In addition, docking studies were performed to predict the inhibition mode.\n",
            "747370\n",
            "Inhibition of human topoisomerase 1-mediated supercoiled pUC19 DNA relaxation assessed as formation of open circle form after 45 mins using ethidium bromide staining by agarose gel electrophoresis\n",
            "Title: New anticancer active and selective phenylene-bisbenzothiazoles: synthesis, antiproliferative evaluation and DNA binding.  Abstract: Novel amidino-derivatives of phenylene-bisbenzothiazoles were synthesized and tested for their antiproliferative activity against several human cancer cell lines, as well as DNA-binding properties. The synthetic approach used for preparation of isomeric amidino substituted-phenylene-bis-benzothyazoles 3a-3f was achieved by condensation reaction of isophthaloyl dichloride 1a and terephthaloyl dichloride 1b or with phthalic acid 1c with 5-amidinium-2-aminobenzothiolate 2a and 5-(imidazolinium-2-yl)-2-aminobenzothiolate 2b in good yields. The targeted compounds were converted in the desired water soluble dihydrochloride salts by reaction of appropriate free base with concd HCl in ethanol or acetic acid. All tested compounds (3a-3f) showed antiproliferative effects on tumour cells in a concentration-dependant manner. The strongest activity and cytotoxicity was observed for diimidazolinyl substituted phenylene-bisbenzothiazole compound 3b. These effects were shown to be related to DNA-binding properties, topoisomerase I and II poisoning effects and apoptosis induction. The highest tested selectivity towards tumour cells was observed for the imidazolyl substituted phenylene-benzothiazole 3d that showed no cytotoxic effects on normal fibroblasts making it an excellent candidate for further chemical optimization and preclinical evaluation.\n",
            "747371\n",
            "Inhibition of human topoisomerase 1-mediated supercoiled pUC19 DNA relaxation at 1 to 50 uM after 45 mins by agarose gel electrophoresis\n",
            "Title: New anticancer active and selective phenylene-bisbenzothiazoles: synthesis, antiproliferative evaluation and DNA binding.  Abstract: Novel amidino-derivatives of phenylene-bisbenzothiazoles were synthesized and tested for their antiproliferative activity against several human cancer cell lines, as well as DNA-binding properties. The synthetic approach used for preparation of isomeric amidino substituted-phenylene-bis-benzothyazoles 3a-3f was achieved by condensation reaction of isophthaloyl dichloride 1a and terephthaloyl dichloride 1b or with phthalic acid 1c with 5-amidinium-2-aminobenzothiolate 2a and 5-(imidazolinium-2-yl)-2-aminobenzothiolate 2b in good yields. The targeted compounds were converted in the desired water soluble dihydrochloride salts by reaction of appropriate free base with concd HCl in ethanol or acetic acid. All tested compounds (3a-3f) showed antiproliferative effects on tumour cells in a concentration-dependant manner. The strongest activity and cytotoxicity was observed for diimidazolinyl substituted phenylene-bisbenzothiazole compound 3b. These effects were shown to be related to DNA-binding properties, topoisomerase I and II poisoning effects and apoptosis induction. The highest tested selectivity towards tumour cells was observed for the imidazolyl substituted phenylene-benzothiazole 3d that showed no cytotoxic effects on normal fibroblasts making it an excellent candidate for further chemical optimization and preclinical evaluation.\n",
            "747461\n",
            "Inhibition of human topoisomerase 1 at 20 uM relative to control\n",
            "Title: Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents.  Abstract: In order to diversify the pharmacological activity of chalcones and extend the scaffold of topoisomerase and cathepsins B and L inhibitors, we have designed and synthesized total 18 chalcone compounds and tested their biological activity. In the topoisomerase inhibition test, most analogues in group III and IV except compound 11 exhibited more efficient topoisomerase I inhibitory activity than camptothecin at 20 M. Compounds 15, 16 and 18 in group IV showed significant cathepsin B and L inhibitory activity. Among the compounds, compound 15 was most active with IC50 values of 1.810.05 M on cathepsin B and 3.150.07 M on cathepsin L, respectively. Compound 15 also showed most potent cytotoxic activity against T47D and SNU638 cells with IC50 values of 1.370.05 M and 0.620.01 M, respectively. Overall, although more compounds should be tested and analyzed for clear SAR against topoisomerase I and cathepsin B and L, compound 15 showed consistent inhibitory ability on the tested assays, which can implicate the cytotoxic activity of compound 15 on topoisomerase I and cathepsin B and L inhibitory pathways.\n",
            "747462\n",
            "Inhibition of human topoisomerase 1 at 100 uM relative to control\n",
            "Title: Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents.  Abstract: In order to diversify the pharmacological activity of chalcones and extend the scaffold of topoisomerase and cathepsins B and L inhibitors, we have designed and synthesized total 18 chalcone compounds and tested their biological activity. In the topoisomerase inhibition test, most analogues in group III and IV except compound 11 exhibited more efficient topoisomerase I inhibitory activity than camptothecin at 20 M. Compounds 15, 16 and 18 in group IV showed significant cathepsin B and L inhibitory activity. Among the compounds, compound 15 was most active with IC50 values of 1.810.05 M on cathepsin B and 3.150.07 M on cathepsin L, respectively. Compound 15 also showed most potent cytotoxic activity against T47D and SNU638 cells with IC50 values of 1.370.05 M and 0.620.01 M, respectively. Overall, although more compounds should be tested and analyzed for clear SAR against topoisomerase I and cathepsin B and L, compound 15 showed consistent inhibitory ability on the tested assays, which can implicate the cytotoxic activity of compound 15 on topoisomerase I and cathepsin B and L inhibitory pathways.\n",
            "748349\n",
            "Inhibition of human DNA topoisomerase 1 at 200 uM relative to control\n",
            "Title: Selective inhibition of bacterial and human topoisomerases by N-arylacyl O-sulfonated aminoglycoside derivatives.  Abstract: Numerous therapeutic applications have been proposed for molecules that bind heparin-binding proteins. Development of such compounds has primarily focused on optimizing the degree and orientation of anionic groups on a scaffold, but utility of these polyanions has been diminished by their typically large size and non-specific interactions with many proteins. In this study N-arylacyl O-sulfonated aminoglycosides were synthesized and evaluated for their ability to selectively inhibit structurally similar bacterial and human topoisomerases. It is demonstrated that the structure of the aminoglycoside and of the N-arylacyl moiety imparts selective inhibition of different topoisomerases and alters mechanism. The results here outline a strategy that will be applicable to identifying small, structurally defined oligosaccharides that bind heparin-binding proteins with a high degree of selectivity.\n",
            "749698\n",
            "Inhibition of topoisomerase-1 (unknown origin) assessed as reduction of pBR322 plasmid DNA relaxation at 50 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Dual-acting histone deacetylase-topoisomerase I inhibitors.  Abstract: Current chemotherapy regimens are comprised mostly of single-target drugs which are often plagued by toxic side effects and resistance development. A pharmacological strategy for circumventing these drawbacks could involve designing multivalent ligands that can modulate multiple targets while avoiding the toxicity of a single-targeted agent. Two attractive targets, histone deacetylase (HDAC) and topoisomerase I (Topo I), are cellular modulators that can broadly arrest cancer proliferation through a range of downstream effects. Both are clinically validated targets with multiple inhibitors in therapeutic use. We describe herein the design and synthesis of dual-acting histone deacetylase-topoisomerase I inhibitors. We also show that these dual-acting agents retain activity against HDAC and Topo I, and potently arrest cancer proliferation.\n",
            "756448\n",
            "Inhibition of topoisomerase 1 (unknown origin)-mediated supercoiled pBR322 pDNA relaxation at 100 uM after 60 mins by agarose gel electrophoresis\n",
            "Title: Synthesis and biological evaluation of novel tamoxifen analogues.  Abstract: A collection of compounds, structurally related to the anticancer drug tamoxifen, used in breast cancer therapy, were designed and synthesized as potential anticancer agents. McMurry coupling reaction was used as the key synthetic step in the preparation of these analogues and the structural assignment of E, Z isomers was determined on the basis of 2D-NOESY experiments. The compounds were evaluated for their antiproliferative activity on breast cancer (MCF-7), cervix adenocarcinoma (HeLa) and biphasic mesothelioma (MSTO-211H) human tumor cell lines. The estrogen like properties of the novel compounds were compared with those of the untreated controls using an estrogen responsive element-based (ERE) luciferase reporter assay and compared to 17-estradiol (E2). Finally, with the aim to correlate the antiproliferative activity with an intracellular target(s), the effect on relaxation activity of DNA topoisomerases I and II was assayed.\n",
            "761189\n",
            "Inhibition of human recombinant DNA topoisomerase-1 assessed as relaxation of pBR322 DNA at 25 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Novel synthetic acridine derivatives as potent DNA-binding and apoptosis-inducing antitumor agents.  Abstract: Acridine derivatives have been explored as DNA-binding anticancer agents. Some derivatives show undesired pharmacokinetic properties and new derivatives need to be explored. In this work, a series of novel acridine analogues were synthesized by modifying previously unexplored linkers between the acridine and benzene groups and their antiproliferative activity and the DNA-binding ability were evaluated. Among these derivatives, compound 5c demonstrated DNA-binding capability and topoisomerase I inhibitory activity. In K562 cell lines, 5c induced apoptosis through mitochondria-dependent intrinsic pathways. These data suggested that compound 5c and other acridine derivatives with modified linkers between the acridine and benzene groups might be potent DNA-binding agents.\n",
            "767198\n",
            "Inhibition of human topoisomerase-1 using supercoiled DNA as substrate assessed as inhibition of supercoiled DNA relaxation at 100 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Synthesis of imine-pyrazolopyrimidinones and their mechanistic interventions on anticancer activity.  Abstract: Design, synthesis and anticancer activity of a series of imine-pyrazolopyrimidinones is reported for the first time. Compounds 9d, 9n and 9o in the series show encouraging in vitro anticancer activity with low micromolar IC50 values against prostate (PC3) and breast (MCF7) cancer cell lines. Some notions about structure-activity relationships and plausible mechanism of biological activity are presented.\n",
            "768623\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 2 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: 4-[4'-(1-(Aryl)ureido)benzamide]podophyllotoxins as DNA topoisomerase I and II inhibitors and apoptosis inducing agents.  Abstract: A series of 4-[4'-(1-(aryl)ureido)benzamide]podophyllotoxin congeners (11a-l) were synthesized and evaluated for their cytotoxic activity against six human cancer cell lines. Some of the compounds like 11a, 11h, 11k and 11l showed significant anti-proliferative activity in Colo-205 cells and were superior to etoposide. The flow-cytometric analysis studies indicated that these compounds show strong G1 cell cycle arrest, as well exhibited improved inhibitory activities on DNA topoisomerase I and II enzymes. These compounds induce apoptosis by up regulating caspase-3 protein as observed by ELISA and Western blotting analysis. In addition, a brief structure-activity relationship studies within the series along with docking results of representative compounds 11a, 11h, 11k, 11l were presented.\n",
            "770644\n",
            "Inhibition of DNA topoisomerase 1 (unknown origin)-mediated relaxation of supercoiled pBR322 at 50 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Design, synthesis and biological evaluation of novel mansonone E derivatives prepared via CuAAC click chemistry as topoisomerase II inhibitors.  Abstract: Two series of novel C-9 chloro- and bromo-substituted mansonone E derivatives with triazole moieties at the C-3 position were prepared by using copper-catalysed azide-alkyne cycloaddition click chemistry. These compounds were found as potent inhibitors of topoisomerase II (Topo II) and topoisomerase I (Topo I). The Topo II-mediated pBR322 DNA relaxation and cleavage assay showed that the derivatives might act as catalytic inhibitors. Their cytotoxic activities against A549, HL-60, K562 and HeLa cells were evaluated, indicating that these compounds were potent antitumour agents. Their structure activity relationships and molecular docking study revealed that the substituents of the triazole were particularly important for cytotoxicity.\n",
            "771322\n",
            "Inhibition of recombinant DNA topoisomerase 1 (unknown origin) assessed as inhibition of topoisomerase 1-mediated DNA cleavage at 1 to 100 uM after 20 mins by SDS-PAGE analysis relative to control\n",
            "Title: Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin topoisomerase I (Top1) inhibitors.  Abstract: In search for a novel chemotype to develop topoisomerase I (Top1) inhibitors, the pyrazolo[1,5-a]quinazoline nucleus, structurally related to the indenoisoquinoline system precursor of well-known Top1 poisons, was variously decorated (i.e., a substituted phenyl ring at 2- or 3-position, a protonable side chain at 4- or 5-position), affording a number of Top1 inhibitors with cleavage patterns common to CPT and MJ-III-65. SARs data were rationalized by means of an advanced docking protocol.\n",
            "771323\n",
            "Inhibition of recombinant DNA topoisomerase 1 (unknown origin) assessed as inhibition of topoisomerase 1-mediated DNA cleavage at 1 uM after 20 mins by SDS-PAGE analysis\n",
            "Title: Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin topoisomerase I (Top1) inhibitors.  Abstract: In search for a novel chemotype to develop topoisomerase I (Top1) inhibitors, the pyrazolo[1,5-a]quinazoline nucleus, structurally related to the indenoisoquinoline system precursor of well-known Top1 poisons, was variously decorated (i.e., a substituted phenyl ring at 2- or 3-position, a protonable side chain at 4- or 5-position), affording a number of Top1 inhibitors with cleavage patterns common to CPT and MJ-III-65. SARs data were rationalized by means of an advanced docking protocol.\n",
            "771547\n",
            "Inhibition of human DNA topoisomerase 1 assessed as decrease in mobility of relaxed isomers of supercoiled pBR322 DNA at 18 to 36 uM after 30 mins\n",
            "Title: Discovery, synthesis and biological evaluation of cycloprotoberberine derivatives as potential antitumor agents.  Abstract: A series of new 1,13-cycloprotoberberine derivatives defined through variations at the 9-position were designed, synthesized and evaluated for their cytotoxicities in human HepG2 (hepatoma), HT1080 (fibrosarcoma) and HCT116 (colon cancer) cells. The preliminary structure-activity relationship (SAR) revealed that the replacement of 9-methoxyl with an ester moiety might significantly enhance the antiproliferative activity in vitro. Notably, compound 7f demonstrated equipotent cytotoxicity activity against breast cancer MCF-7 (parent) and doxorubicin (DOX)-resistant MCF-7 (MCF-7/ADrR) cells, indicating a mode of action different from that of DOX. Further mechanism study showed that 7f significantly inhibited activity of DNA topoisomerase I (Top I) and Top II. G2/M phase arrest and tumor cell growth reduction was observed thereafter. Thus, we consider cycloprotoberberine analogues to be a new family of promising antitumor agents with an advantage of inhibiting drug-resistant cancer cells.\n",
            "771548\n",
            "Inhibition of human DNA topoisomerase 1 assessed as decrease in mobility of relaxed isomers of supercoiled pBR322 DNA at 15 uM after 30 mins\n",
            "Title: Discovery, synthesis and biological evaluation of cycloprotoberberine derivatives as potential antitumor agents.  Abstract: A series of new 1,13-cycloprotoberberine derivatives defined through variations at the 9-position were designed, synthesized and evaluated for their cytotoxicities in human HepG2 (hepatoma), HT1080 (fibrosarcoma) and HCT116 (colon cancer) cells. The preliminary structure-activity relationship (SAR) revealed that the replacement of 9-methoxyl with an ester moiety might significantly enhance the antiproliferative activity in vitro. Notably, compound 7f demonstrated equipotent cytotoxicity activity against breast cancer MCF-7 (parent) and doxorubicin (DOX)-resistant MCF-7 (MCF-7/ADrR) cells, indicating a mode of action different from that of DOX. Further mechanism study showed that 7f significantly inhibited activity of DNA topoisomerase I (Top I) and Top II. G2/M phase arrest and tumor cell growth reduction was observed thereafter. Thus, we consider cycloprotoberberine analogues to be a new family of promising antitumor agents with an advantage of inhibiting drug-resistant cancer cells.\n",
            "774972\n",
            "Inhibition of recombinant human DNA topoisomerase-1 assessed as relaxation of supercoiled pBR322 DNA at 20 uM after 30 mins by agarose gel electrophoresis relative to control\n",
            "Title: 3-(3-Butylamino-2-hydroxy-propoxy)-1-hydroxy-xanthen-9-one acts as a topoisomerase II catalytic inhibitor with low DNA damage.  Abstract: As a continuous study we prepared several alkylamine (n = 3-6) and evaluated for the pharmacological activity and mode of action. In the topoisomerase II (topo II) inhibition test, compound 4 showed strongest inhibitory activity among the compounds at 10 M. Inhibitory activities of the compounds are in the order of 4 (n = 4) > 1 (n = 3) >> 5 (n = 5)  6 (n = 6); 8 (n = 4) >> 7 (n = 3)  9 (n = 5)  10 (n = 6) where n is the number of carbon in the aliphatic side chain in ring C and compounds 7-10 have additional methoxy group in ring A compared to compounds 1, 4-6. Compound 4 showed efficient cytotoxicities against T47D (IC: 0.93  0.04 M) and HCT15 (IC50: 0.78  0.01 M) cells, which are higher than etoposide. Compound 4 was also an ATP-competitive human topo II catalytic inhibitor with partially blocking human topo II-catalyzed ATP hydrolysis and intercalating into DNA. Compound 4 induced much less DNA damage than etoposide in HCT15 human colorectal carcinoma cells. Overall, compound 4 can be a potential anticancer agent acting as topo II catalytic inhibitor with low DNA damage.\n",
            "775817\n",
            "Inhibition of topoisomerase1 (unknown origin)-mediated DNA cleavage at 100 uM after 15 mins by SDS-PAGE analysis\n",
            "Title: A new strategy to improve the metabolic stability of lactone: discovery of (20S,21S)-21-fluorocamptothecins as novel, hydrolytically stable topoisomerase I inhibitors.  Abstract: Lactone is a common structural motif in biologically active natural products. However, the metabolic instability of lactone significantly reduces their in vivo potency. In the present investigation, a new strategy to improve the metabolic stability of lactone was provided by the design of -fluoro ether as a novel bioisostere of lactone. The effectiveness of the -fluoro ether/lactone replacement was validated by the discovery of (20S,21S)-21-fluorocamptothecins as hydrolytically stable topoisomerase I inhibitors. A highly potent camptothecin derivative, 8l, was successfully identified, which showed excellent in vitro and in vivo antitumor activities and represents a promising lead for the discovery of novel antitumor agents. Interestingly, this study also provided a new structure-activity relationship for the C21-carbonyl group of camptothecin, which has been regarded as an essential pharmacophore. Our results revealed that the conserved C21-carbonyl group can be replaced by a fluorine substituent. -Fluoro ether may have general application in improving the metabolic stability of lactone.\n",
            "775824\n",
            "Inhibition of topoisomerase1 (unknown origin)-mediated supercoiled DNA relaxation at 100 uM after 15 mins by SDS-PAGE analysis\n",
            "Title: A new strategy to improve the metabolic stability of lactone: discovery of (20S,21S)-21-fluorocamptothecins as novel, hydrolytically stable topoisomerase I inhibitors.  Abstract: Lactone is a common structural motif in biologically active natural products. However, the metabolic instability of lactone significantly reduces their in vivo potency. In the present investigation, a new strategy to improve the metabolic stability of lactone was provided by the design of -fluoro ether as a novel bioisostere of lactone. The effectiveness of the -fluoro ether/lactone replacement was validated by the discovery of (20S,21S)-21-fluorocamptothecins as hydrolytically stable topoisomerase I inhibitors. A highly potent camptothecin derivative, 8l, was successfully identified, which showed excellent in vitro and in vivo antitumor activities and represents a promising lead for the discovery of novel antitumor agents. Interestingly, this study also provided a new structure-activity relationship for the C21-carbonyl group of camptothecin, which has been regarded as an essential pharmacophore. Our results revealed that the conserved C21-carbonyl group can be replaced by a fluorine substituent. -Fluoro ether may have general application in improving the metabolic stability of lactone.\n",
            "776101\n",
            "Inhibition of human topoisomerase 1-mediated unwinding of pHOT1 plasmid DNA up to 1000 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity.  Abstract: A group of novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids was prepared. One-dose anticancer test results indicated that compounds 3a and 3g exhibited the highest ability to inhibit the proliferation of different cancer cell lines. Compound 3a exhibited a broad-spectrum of anti-tumor activity without pronounced selectivity while compound 3g revealed high selectivity toward the leukemia subpanel with selectivity ratio of 6.71 at GI level. Moreover, compounds 3e and 3j have shown remarkable topo II inhibitory activity compared to etoposide at 100 M and 20 M concentrations. Compounds 3e and 3j exhibited comparably potent topo I inhibitory activity at 20 M concentration compared to camptothecin. Compounds 3e and 3j exhibited strong topo II inhibitory activities compared to topo I at 20 M concentration. Studying of the solubility and partition coefficient revealed higher lipophilicity of the hybrids 3a-j compared to the parent ciprofloxacin.\n",
            "776102\n",
            "Inhibition of human topoisomerase 1-mediated unwinding of pHOT1 plasmid DNA after 30 mins by agarose gel electrophoresis\n",
            "Title: Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity.  Abstract: A group of novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids was prepared. One-dose anticancer test results indicated that compounds 3a and 3g exhibited the highest ability to inhibit the proliferation of different cancer cell lines. Compound 3a exhibited a broad-spectrum of anti-tumor activity without pronounced selectivity while compound 3g revealed high selectivity toward the leukemia subpanel with selectivity ratio of 6.71 at GI level. Moreover, compounds 3e and 3j have shown remarkable topo II inhibitory activity compared to etoposide at 100 M and 20 M concentrations. Compounds 3e and 3j exhibited comparably potent topo I inhibitory activity at 20 M concentration compared to camptothecin. Compounds 3e and 3j exhibited strong topo II inhibitory activities compared to topo I at 20 M concentration. Studying of the solubility and partition coefficient revealed higher lipophilicity of the hybrids 3a-j compared to the parent ciprofloxacin.\n",
            "776105\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 20 uM after 30 mins by agarose gel electrophoresis relative to control\n",
            "Title: Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity.  Abstract: A group of novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids was prepared. One-dose anticancer test results indicated that compounds 3a and 3g exhibited the highest ability to inhibit the proliferation of different cancer cell lines. Compound 3a exhibited a broad-spectrum of anti-tumor activity without pronounced selectivity while compound 3g revealed high selectivity toward the leukemia subpanel with selectivity ratio of 6.71 at GI level. Moreover, compounds 3e and 3j have shown remarkable topo II inhibitory activity compared to etoposide at 100 M and 20 M concentrations. Compounds 3e and 3j exhibited comparably potent topo I inhibitory activity at 20 M concentration compared to camptothecin. Compounds 3e and 3j exhibited strong topo II inhibitory activities compared to topo I at 20 M concentration. Studying of the solubility and partition coefficient revealed higher lipophilicity of the hybrids 3a-j compared to the parent ciprofloxacin.\n",
            "776106\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 100 uM after 30 mins by agarose gel electrophoresis relative to control\n",
            "Title: Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity.  Abstract: A group of novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids was prepared. One-dose anticancer test results indicated that compounds 3a and 3g exhibited the highest ability to inhibit the proliferation of different cancer cell lines. Compound 3a exhibited a broad-spectrum of anti-tumor activity without pronounced selectivity while compound 3g revealed high selectivity toward the leukemia subpanel with selectivity ratio of 6.71 at GI level. Moreover, compounds 3e and 3j have shown remarkable topo II inhibitory activity compared to etoposide at 100 M and 20 M concentrations. Compounds 3e and 3j exhibited comparably potent topo I inhibitory activity at 20 M concentration compared to camptothecin. Compounds 3e and 3j exhibited strong topo II inhibitory activities compared to topo I at 20 M concentration. Studying of the solubility and partition coefficient revealed higher lipophilicity of the hybrids 3a-j compared to the parent ciprofloxacin.\n",
            "776649\n",
            "Inhibition of topoisomerase 1 (unknown origin) relaxation of supercoiled pBR322 at 50 uM by agarose gel electrophoresis\n",
            "Title: Synthesis, cytotoxicity and DNA binding of oxoazabenzo[de]anthracenes derivatives in colon cancer Caco-2 cells.  Abstract: New oxoazabenzo[de]anthracenes derivatives were synthesised and characterised. Their interactions with calf thymus DNA were studied by UV spectrophotometric analysis and a competitive ethidium bromide displacement assay. Cytotoxicity was determined by MTT assay, against colon adenocarcinoma (Caco-2 cells). Among all the oxoazabenzo[de]anthracenes derivatives reported herein only the piperidino derivative exhibited strong DNA binding properties and cytotoxic activity with IC values in the range of 16  1.5 M (72-h treatment). In addition, the piperidino derivative did not directly inhibit topoisomerase I and topoisomerase II enzymes. The results confirm that the presence of the oxoazabenzo[de]anthracenes together with the piperidino functionality is crucial in exerting DNA binding and cytotoxic properties, hence demonstrating promise as a chemical scaffold for further development of new anticancer agents.\n",
            "776654\n",
            "Inhibition of topoisomerase 1 (unknown origin) relaxation of supercoiled pBR322 at 50 to 100 uM by agarose gel electrophoresis\n",
            "Title: Synthesis, cytotoxicity and DNA binding of oxoazabenzo[de]anthracenes derivatives in colon cancer Caco-2 cells.  Abstract: New oxoazabenzo[de]anthracenes derivatives were synthesised and characterised. Their interactions with calf thymus DNA were studied by UV spectrophotometric analysis and a competitive ethidium bromide displacement assay. Cytotoxicity was determined by MTT assay, against colon adenocarcinoma (Caco-2 cells). Among all the oxoazabenzo[de]anthracenes derivatives reported herein only the piperidino derivative exhibited strong DNA binding properties and cytotoxic activity with IC values in the range of 16  1.5 M (72-h treatment). In addition, the piperidino derivative did not directly inhibit topoisomerase I and topoisomerase II enzymes. The results confirm that the presence of the oxoazabenzo[de]anthracenes together with the piperidino functionality is crucial in exerting DNA binding and cytotoxic properties, hence demonstrating promise as a chemical scaffold for further development of new anticancer agents.\n",
            "779453\n",
            "Inhibition of DNA topoisomerase 1 (unknown origin)-mediated relaxation of supercoiled pBSKS plasmid DNA assessed as formation of nicked form of DNA at 1 00 uM after 30 mins by agarose gel electrophoresis in presence of ethidium bromide\n",
            "Title: Synthesis and study of antiproliferative, antitopoisomerase II, DNA-intercalating and DNA-damaging activities of arylnaphthalimides.  Abstract: A series of arylnaphthalimides were designed and synthesized to overcome the dose-limiting cytotoxicity of N-acetylated metabolites arising from amonafide, the prototypical antitumour naphthalimide whose biomedical properties have been related to its ability to intercalate the DNA and poison the enzyme Topoisomerase II. Thus, these arylnaphthalimides were first evaluated for their antiproliferative activity against two tumour cell lines and for their antitopoisomerase II in vitro activities, together with their ability to intercalate the DNA in vitro and also through docking modelization. Then, the well-known DNA damage response in Saccharomyces cerevisiae was employed to critically evaluate whether these novel compounds can damage the DNA in vivo. By performing all these assays we conclude that the 5-arylsubstituted naphthalimides not only keep but also improve amonafide's biological activities.\n",
            "779454\n",
            "Inhibition of DNA topoisomerase 1 (unknown origin)-mediated DNA cleavage assessed as decrease in relaxation of supercoiled pBSKS plasmid at 1 00 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Synthesis and study of antiproliferative, antitopoisomerase II, DNA-intercalating and DNA-damaging activities of arylnaphthalimides.  Abstract: A series of arylnaphthalimides were designed and synthesized to overcome the dose-limiting cytotoxicity of N-acetylated metabolites arising from amonafide, the prototypical antitumour naphthalimide whose biomedical properties have been related to its ability to intercalate the DNA and poison the enzyme Topoisomerase II. Thus, these arylnaphthalimides were first evaluated for their antiproliferative activity against two tumour cell lines and for their antitopoisomerase II in vitro activities, together with their ability to intercalate the DNA in vitro and also through docking modelization. Then, the well-known DNA damage response in Saccharomyces cerevisiae was employed to critically evaluate whether these novel compounds can damage the DNA in vivo. By performing all these assays we conclude that the 5-arylsubstituted naphthalimides not only keep but also improve amonafide's biological activities.\n",
            "780350\n",
            "Inhibition of recombinant human DNA topoisomerase 1-mediated relaxation of supercoiled pHOT DNA at 50 uM after 45 mins by agarose gel electrophoresis\n",
            "Title: Design, synthesis and antiproliferative evaluation of fluorenone analogs with DNA topoisomerase I inhibitory properties.  Abstract: A series of 2,7-diamidofluorenones were designed, synthesized, and screened by SRB assay. Some synthesized compounds exhibited antitumor activities in submicromolar range. Ten compounds (3a, 3b, 3c, 3g, 3j, 3l, 4a, 4h, 4i, and 4j) were also selected by NCI screening system and 3c (GI50=1.66 M) appeared to be the most active agent of this series. Furthermore, 3c attenuated topoisomerase I-mediated DNA relaxation at low micromolar concentrations. These results indicated that fluorenones have potential to be further developed into anticancer drugs.\n",
            "780351\n",
            "Inhibition of recombinant human DNA topoisomerase 1-mediated relaxation of supercoiled pHOT DNA at 25 to 50 uM after 45 mins by agarose gel electrophoresis\n",
            "Title: Design, synthesis and antiproliferative evaluation of fluorenone analogs with DNA topoisomerase I inhibitory properties.  Abstract: A series of 2,7-diamidofluorenones were designed, synthesized, and screened by SRB assay. Some synthesized compounds exhibited antitumor activities in submicromolar range. Ten compounds (3a, 3b, 3c, 3g, 3j, 3l, 4a, 4h, 4i, and 4j) were also selected by NCI screening system and 3c (GI50=1.66 M) appeared to be the most active agent of this series. Furthermore, 3c attenuated topoisomerase I-mediated DNA relaxation at low micromolar concentrations. These results indicated that fluorenones have potential to be further developed into anticancer drugs.\n",
            "780352\n",
            "Inhibition of recombinant human DNA topoisomerase 1-mediated relaxation of supercoiled pHOT DNA after 45 mins by agarose gel electrophoresis\n",
            "Title: Design, synthesis and antiproliferative evaluation of fluorenone analogs with DNA topoisomerase I inhibitory properties.  Abstract: A series of 2,7-diamidofluorenones were designed, synthesized, and screened by SRB assay. Some synthesized compounds exhibited antitumor activities in submicromolar range. Ten compounds (3a, 3b, 3c, 3g, 3j, 3l, 4a, 4h, 4i, and 4j) were also selected by NCI screening system and 3c (GI50=1.66 M) appeared to be the most active agent of this series. Furthermore, 3c attenuated topoisomerase I-mediated DNA relaxation at low micromolar concentrations. These results indicated that fluorenones have potential to be further developed into anticancer drugs.\n",
            "780933\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pBR322 at 500 uM after 60 mins by agarose gel electrophoresis\n",
            "Title: Quinazolinecarboline alkaloid evodiamine as scaffold for targeting topoisomerase I and sirtuins.  Abstract: This paper reports the synthesis of a series of evodiamine derivatives. We assayed the ability to inhibit cell growth on three human tumour cell lines (H460, MCF-7 and HepG2) and we evaluated the capacity to interfere with the catalytic activity of topoisomerase I both by the relaxation assay and the occurrence of the cleavable complex. Moreover, whose effect on sirtuins 1, 2 and 3 was investigated. Finally, molecular docking analyses were performed in an attempt to rationalize the biological results.\n",
            "780934\n",
            "Inhibition of human recombinant topoisomerase 1-mediated DNA cleavage assessed as formation of nicked DNA from supercoiled pBR322 DNA up to 100 uM after 60 mins by agarose gel electrophoresis\n",
            "Title: Quinazolinecarboline alkaloid evodiamine as scaffold for targeting topoisomerase I and sirtuins.  Abstract: This paper reports the synthesis of a series of evodiamine derivatives. We assayed the ability to inhibit cell growth on three human tumour cell lines (H460, MCF-7 and HepG2) and we evaluated the capacity to interfere with the catalytic activity of topoisomerase I both by the relaxation assay and the occurrence of the cleavable complex. Moreover, whose effect on sirtuins 1, 2 and 3 was investigated. Finally, molecular docking analyses were performed in an attempt to rationalize the biological results.\n",
            "780938\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pBR322 at 50 to 100 uM after 60 mins by agarose gel electrophoresis\n",
            "Title: Quinazolinecarboline alkaloid evodiamine as scaffold for targeting topoisomerase I and sirtuins.  Abstract: This paper reports the synthesis of a series of evodiamine derivatives. We assayed the ability to inhibit cell growth on three human tumour cell lines (H460, MCF-7 and HepG2) and we evaluated the capacity to interfere with the catalytic activity of topoisomerase I both by the relaxation assay and the occurrence of the cleavable complex. Moreover, whose effect on sirtuins 1, 2 and 3 was investigated. Finally, molecular docking analyses were performed in an attempt to rationalize the biological results.\n",
            "780939\n",
            "Inhibition of human recombinant topoisomerase 1-mediated DNA cleavage assessed as formation of nicked DNA from supercoiled pBR322 DNA at 0.5 uM after 60 mins by agarose gel electrophoresis\n",
            "Title: Quinazolinecarboline alkaloid evodiamine as scaffold for targeting topoisomerase I and sirtuins.  Abstract: This paper reports the synthesis of a series of evodiamine derivatives. We assayed the ability to inhibit cell growth on three human tumour cell lines (H460, MCF-7 and HepG2) and we evaluated the capacity to interfere with the catalytic activity of topoisomerase I both by the relaxation assay and the occurrence of the cleavable complex. Moreover, whose effect on sirtuins 1, 2 and 3 was investigated. Finally, molecular docking analyses were performed in an attempt to rationalize the biological results.\n",
            "1061257\n",
            "Inhibition of topoisomerase 1 (unknown origin)-mediated relaxation of supercoiled plasmid DNA at 100 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Rational design and synthesis of topoisomerase I and II inhibitors based on oleanolic acid moiety for new anti-cancer drugs.  Abstract: Semisynthetic reactions were conducted on oleanolic acid, a common plant-derived oleanane-type triterpene. Ten rationally designed derivatives of oleanolic acid were synthesized based on docking studies and tested for their topoisomerase I and II inhibitory activity. Semisynthetic reactions targeted C-3, C-12, C-13, and C-17. Nine of the synthesized compounds were identified as new compounds. The structures of these compounds were confirmed by spectroscopic methods (1D, 2D NMR and MS). Five oleanolic acid analogues (S2, S3, S5, S7 and S9) showed higher activity than camptothecin (CPT) in the topoisomerase I DNA relaxation assay. Four oleanolic acid analogues (S2, S3, S5 and S6) showed higher activity than etoposide in a topoisomerase II assay. The results indicated that the C12-C13 double bond of the oleanolic acid skeleton is important for the inhibitory activity against both types of topoisomerases, while insertion of a longer chain at either position 3 or 17 increases the activity against topoisomerases by various degrees. Some of the synthesized compounds act as dual inhibitors for both topoisomerase I and II.\n",
            "1061259\n",
            "Inhibition of topoisomerase 1 (unknown origin)-mediated relaxation of supercoiled plasmid DNA assessed as intensity of supercoiled DNA after 30 mins by agarose gel electrophoresis relative to camptothecin\n",
            "Title: Rational design and synthesis of topoisomerase I and II inhibitors based on oleanolic acid moiety for new anti-cancer drugs.  Abstract: Semisynthetic reactions were conducted on oleanolic acid, a common plant-derived oleanane-type triterpene. Ten rationally designed derivatives of oleanolic acid were synthesized based on docking studies and tested for their topoisomerase I and II inhibitory activity. Semisynthetic reactions targeted C-3, C-12, C-13, and C-17. Nine of the synthesized compounds were identified as new compounds. The structures of these compounds were confirmed by spectroscopic methods (1D, 2D NMR and MS). Five oleanolic acid analogues (S2, S3, S5, S7 and S9) showed higher activity than camptothecin (CPT) in the topoisomerase I DNA relaxation assay. Four oleanolic acid analogues (S2, S3, S5 and S6) showed higher activity than etoposide in a topoisomerase II assay. The results indicated that the C12-C13 double bond of the oleanolic acid skeleton is important for the inhibitory activity against both types of topoisomerases, while insertion of a longer chain at either position 3 or 17 increases the activity against topoisomerases by various degrees. Some of the synthesized compounds act as dual inhibitors for both topoisomerase I and II.\n",
            "1061261\n",
            "Inhibition of topoisomerase 1 (unknown origin)-mediated relaxation of supercoiled plasmid DNA assessed as concentration of the compound exhibiting activity of 100 uM camptothecin after 30 mins by agarose gel electrophoresis\n",
            "Title: Rational design and synthesis of topoisomerase I and II inhibitors based on oleanolic acid moiety for new anti-cancer drugs.  Abstract: Semisynthetic reactions were conducted on oleanolic acid, a common plant-derived oleanane-type triterpene. Ten rationally designed derivatives of oleanolic acid were synthesized based on docking studies and tested for their topoisomerase I and II inhibitory activity. Semisynthetic reactions targeted C-3, C-12, C-13, and C-17. Nine of the synthesized compounds were identified as new compounds. The structures of these compounds were confirmed by spectroscopic methods (1D, 2D NMR and MS). Five oleanolic acid analogues (S2, S3, S5, S7 and S9) showed higher activity than camptothecin (CPT) in the topoisomerase I DNA relaxation assay. Four oleanolic acid analogues (S2, S3, S5 and S6) showed higher activity than etoposide in a topoisomerase II assay. The results indicated that the C12-C13 double bond of the oleanolic acid skeleton is important for the inhibitory activity against both types of topoisomerases, while insertion of a longer chain at either position 3 or 17 increases the activity against topoisomerases by various degrees. Some of the synthesized compounds act as dual inhibitors for both topoisomerase I and II.\n",
            "1063330\n",
            "Inhibition of human topoisomerase 1-mediated DNA cleavage assessed as accumulation of nicked DNA at 1 to 50 uM by agarose gel electrophoresis\n",
            "Title: Anilides and quinolones with nitrogen-bearing substituents from benzothiophene and thienothiophene series: synthesis, photochemical synthesis, cytostatic evaluation, 3D-derived QSAR analysis and DNA-binding properties.  Abstract: A series of new anilides (2a-c, 4-7, 17a-c, 18) and quinolones (3a-b, 8a-b, 9a-b, 10-15, 19) with nitrogen-bearing substituents from benzo[b]thiophene and thieno[2,3-c]thiophene series are prepared. Benzo[b]thieno[2,3-c]- and thieno[3',2':4,5]thieno[2,3-c]quinolones (3a-b, 8a-b) are synthesized by the reaction of photochemical dehydrohalogenation from corresponding anilides. Anilides and quinolones were tested for the antiproliferative activity. Fused quinolones bearing protonated aminium group, quaternary ammonium group, N-methylated and protonated aminium group, amino and protonated amino group (8a, 9b, 10-12) showed very prominent anticancer activity, whereby the hydrochloride salt of N',N'-dimethylaminopropyl-substituted quinolone (14) was the most active one, having the IC50 concentration at submicromolar range in accordance with previous QSAR predictions. On the other hand, flexible anilides were among the less active. Chemometric analysis of investigated compounds was performed. 3D-derived QSAR analysis identified solubility, metabolitic stability and the possibility of the compound to be ionized at pH 4-8 as molecular properties that are positively correlated with anticancer activity of investigated compounds, while molecular flexibility, polarizability and sum of hydrophobic surface areas were found to be negatively correlated. Anilides 2a-b, 4-7 and quinolones 3a-b, 8a-b, 9b and 10-14 were evaluated for DNA binding propensities and topoisomerases I/II inhibition as part of their mechanism of action. Among the anilides, only compound 7 presented some DNA binding propensity whereas the quinolones 8b, 9b and 10-14 intercalate in the DNA base pairs, compounds 8b, 9b and 14 being the most efficient ones. The strongest DNA intercalators, compounds 8b, 9b and 14, were clearly distinguished from the other compounds according to their molecular descriptors by the PCA and PLS analysis.\n",
            "1075781\n",
            "Inhibition of human recombinant topoisomerase 1 in human HCT116 cells assessed as DNA-protein cross linking at 1 uM incubated for 1 hr followed by compound washout measured after 1 hr\n",
            "Title: Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells.  Abstract: Optimization of the lactam -aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities. The new compounds 14-17 and 19 exhibited mean graph midpoint cytotoxicity (GI50) values of 21-71 nM in the NCI panel of 60 human cancer cell cultures. Ternary 7-azaindenoisoquinoline-DNA-Top1 cleavage complexes that persist for up to 6 h were detected in HCT116 colon cancer cells. Ternary complexes containing 7-azaindenoisoquinolines were significantly more stable than those in which camptothecin was incorporated. DNA content distribution histograms showed S-phase block 3 h after drug removal. Drug-induced DNA damage in HCT116 cells was revealed by induction of the histone -H2AX marker. The 7-azaindenoisoquinolines were able to partially overcome resistance in several drug-resistant cell lines, and they were not substrates for the ABCB1 drug efflux transporter. Molecular modeling studies indicate that the 7-azaindenoisoquinolines intercalate at the DNA cleavage site in DNA-Top1 covalent complexes with the lactam side chain projecting into the major groove. Overall, the results indicate that the 7-azaindenoisoquinolines are promising anticancer agents that merit further development.\n",
            "1075782\n",
            "Inhibition of human recombinant topoisomerase 1 in human HCT116 cells assessed as DNA-protein cross linking at 1 uM after 1 hr\n",
            "Title: Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells.  Abstract: Optimization of the lactam -aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities. The new compounds 14-17 and 19 exhibited mean graph midpoint cytotoxicity (GI50) values of 21-71 nM in the NCI panel of 60 human cancer cell cultures. Ternary 7-azaindenoisoquinoline-DNA-Top1 cleavage complexes that persist for up to 6 h were detected in HCT116 colon cancer cells. Ternary complexes containing 7-azaindenoisoquinolines were significantly more stable than those in which camptothecin was incorporated. DNA content distribution histograms showed S-phase block 3 h after drug removal. Drug-induced DNA damage in HCT116 cells was revealed by induction of the histone -H2AX marker. The 7-azaindenoisoquinolines were able to partially overcome resistance in several drug-resistant cell lines, and they were not substrates for the ABCB1 drug efflux transporter. Molecular modeling studies indicate that the 7-azaindenoisoquinolines intercalate at the DNA cleavage site in DNA-Top1 covalent complexes with the lactam side chain projecting into the major groove. Overall, the results indicate that the 7-azaindenoisoquinolines are promising anticancer agents that merit further development.\n",
            "1075783\n",
            "Inhibition of human recombinant topoisomerase 1 in human HCT116 cells assessed as reversal of topoisomerase 1-DNA cleavage complex stabilization at 1 uM incubated for 1 hr followed by compound washout measured after 24 hrs by DNA immunoblotting analysis\n",
            "Title: Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells.  Abstract: Optimization of the lactam -aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities. The new compounds 14-17 and 19 exhibited mean graph midpoint cytotoxicity (GI50) values of 21-71 nM in the NCI panel of 60 human cancer cell cultures. Ternary 7-azaindenoisoquinoline-DNA-Top1 cleavage complexes that persist for up to 6 h were detected in HCT116 colon cancer cells. Ternary complexes containing 7-azaindenoisoquinolines were significantly more stable than those in which camptothecin was incorporated. DNA content distribution histograms showed S-phase block 3 h after drug removal. Drug-induced DNA damage in HCT116 cells was revealed by induction of the histone -H2AX marker. The 7-azaindenoisoquinolines were able to partially overcome resistance in several drug-resistant cell lines, and they were not substrates for the ABCB1 drug efflux transporter. Molecular modeling studies indicate that the 7-azaindenoisoquinolines intercalate at the DNA cleavage site in DNA-Top1 covalent complexes with the lactam side chain projecting into the major groove. Overall, the results indicate that the 7-azaindenoisoquinolines are promising anticancer agents that merit further development.\n",
            "1075784\n",
            "Inhibition of human recombinant topoisomerase 1 in human HCT116 cells assessed as reversal of topoisomerase 1-DNA cleavage complex stabilization at 1 uM incubated for 1 hr followed by compound washout measured up to 6 hrs by DNA immunoblotting analysis\n",
            "Title: Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells.  Abstract: Optimization of the lactam -aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities. The new compounds 14-17 and 19 exhibited mean graph midpoint cytotoxicity (GI50) values of 21-71 nM in the NCI panel of 60 human cancer cell cultures. Ternary 7-azaindenoisoquinoline-DNA-Top1 cleavage complexes that persist for up to 6 h were detected in HCT116 colon cancer cells. Ternary complexes containing 7-azaindenoisoquinolines were significantly more stable than those in which camptothecin was incorporated. DNA content distribution histograms showed S-phase block 3 h after drug removal. Drug-induced DNA damage in HCT116 cells was revealed by induction of the histone -H2AX marker. The 7-azaindenoisoquinolines were able to partially overcome resistance in several drug-resistant cell lines, and they were not substrates for the ABCB1 drug efflux transporter. Molecular modeling studies indicate that the 7-azaindenoisoquinolines intercalate at the DNA cleavage site in DNA-Top1 covalent complexes with the lactam side chain projecting into the major groove. Overall, the results indicate that the 7-azaindenoisoquinolines are promising anticancer agents that merit further development.\n",
            "1075785\n",
            "Inhibition of human recombinant topoisomerase 1 in human HCT116 cells assessed as stabilization of topoisomerase 1-DNA cleavage complex at 1 uM after 1 hr by DNA immunoblotting analysis\n",
            "Title: Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells.  Abstract: Optimization of the lactam -aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities. The new compounds 14-17 and 19 exhibited mean graph midpoint cytotoxicity (GI50) values of 21-71 nM in the NCI panel of 60 human cancer cell cultures. Ternary 7-azaindenoisoquinoline-DNA-Top1 cleavage complexes that persist for up to 6 h were detected in HCT116 colon cancer cells. Ternary complexes containing 7-azaindenoisoquinolines were significantly more stable than those in which camptothecin was incorporated. DNA content distribution histograms showed S-phase block 3 h after drug removal. Drug-induced DNA damage in HCT116 cells was revealed by induction of the histone -H2AX marker. The 7-azaindenoisoquinolines were able to partially overcome resistance in several drug-resistant cell lines, and they were not substrates for the ABCB1 drug efflux transporter. Molecular modeling studies indicate that the 7-azaindenoisoquinolines intercalate at the DNA cleavage site in DNA-Top1 covalent complexes with the lactam side chain projecting into the major groove. Overall, the results indicate that the 7-azaindenoisoquinolines are promising anticancer agents that merit further development.\n",
            "1075794\n",
            "Inhibition of human recombinant topoisomerase 1 using radiolabeled DNA as substrate after 20 mins by SDS-PAGE\n",
            "Title: Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells.  Abstract: Optimization of the lactam -aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities. The new compounds 14-17 and 19 exhibited mean graph midpoint cytotoxicity (GI50) values of 21-71 nM in the NCI panel of 60 human cancer cell cultures. Ternary 7-azaindenoisoquinoline-DNA-Top1 cleavage complexes that persist for up to 6 h were detected in HCT116 colon cancer cells. Ternary complexes containing 7-azaindenoisoquinolines were significantly more stable than those in which camptothecin was incorporated. DNA content distribution histograms showed S-phase block 3 h after drug removal. Drug-induced DNA damage in HCT116 cells was revealed by induction of the histone -H2AX marker. The 7-azaindenoisoquinolines were able to partially overcome resistance in several drug-resistant cell lines, and they were not substrates for the ABCB1 drug efflux transporter. Molecular modeling studies indicate that the 7-azaindenoisoquinolines intercalate at the DNA cleavage site in DNA-Top1 covalent complexes with the lactam side chain projecting into the major groove. Overall, the results indicate that the 7-azaindenoisoquinolines are promising anticancer agents that merit further development.\n",
            "1075795\n",
            "Inhibition of human recombinant topoisomerase 1 using radiolabeled DNA as substrate at 0.1 to 100 uM after 20 mins by SDS-PAGE\n",
            "Title: Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells.  Abstract: Optimization of the lactam -aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities. The new compounds 14-17 and 19 exhibited mean graph midpoint cytotoxicity (GI50) values of 21-71 nM in the NCI panel of 60 human cancer cell cultures. Ternary 7-azaindenoisoquinoline-DNA-Top1 cleavage complexes that persist for up to 6 h were detected in HCT116 colon cancer cells. Ternary complexes containing 7-azaindenoisoquinolines were significantly more stable than those in which camptothecin was incorporated. DNA content distribution histograms showed S-phase block 3 h after drug removal. Drug-induced DNA damage in HCT116 cells was revealed by induction of the histone -H2AX marker. The 7-azaindenoisoquinolines were able to partially overcome resistance in several drug-resistant cell lines, and they were not substrates for the ABCB1 drug efflux transporter. Molecular modeling studies indicate that the 7-azaindenoisoquinolines intercalate at the DNA cleavage site in DNA-Top1 covalent complexes with the lactam side chain projecting into the major groove. Overall, the results indicate that the 7-azaindenoisoquinolines are promising anticancer agents that merit further development.\n",
            "1075796\n",
            "Inhibition of human recombinant topoisomerase 1 using radiolabeled DNA as substrate at 100 uM after 20 mins by SDS-PAGE\n",
            "Title: Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells.  Abstract: Optimization of the lactam -aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities. The new compounds 14-17 and 19 exhibited mean graph midpoint cytotoxicity (GI50) values of 21-71 nM in the NCI panel of 60 human cancer cell cultures. Ternary 7-azaindenoisoquinoline-DNA-Top1 cleavage complexes that persist for up to 6 h were detected in HCT116 colon cancer cells. Ternary complexes containing 7-azaindenoisoquinolines were significantly more stable than those in which camptothecin was incorporated. DNA content distribution histograms showed S-phase block 3 h after drug removal. Drug-induced DNA damage in HCT116 cells was revealed by induction of the histone -H2AX marker. The 7-azaindenoisoquinolines were able to partially overcome resistance in several drug-resistant cell lines, and they were not substrates for the ABCB1 drug efflux transporter. Molecular modeling studies indicate that the 7-azaindenoisoquinolines intercalate at the DNA cleavage site in DNA-Top1 covalent complexes with the lactam side chain projecting into the major groove. Overall, the results indicate that the 7-azaindenoisoquinolines are promising anticancer agents that merit further development.\n",
            "1075797\n",
            "Inhibition of human recombinant topoisomerase 1 using radiolabeled DNA as substrate at 1 uM after 20 mins by SDS-PAGE\n",
            "Title: Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells.  Abstract: Optimization of the lactam -aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities. The new compounds 14-17 and 19 exhibited mean graph midpoint cytotoxicity (GI50) values of 21-71 nM in the NCI panel of 60 human cancer cell cultures. Ternary 7-azaindenoisoquinoline-DNA-Top1 cleavage complexes that persist for up to 6 h were detected in HCT116 colon cancer cells. Ternary complexes containing 7-azaindenoisoquinolines were significantly more stable than those in which camptothecin was incorporated. DNA content distribution histograms showed S-phase block 3 h after drug removal. Drug-induced DNA damage in HCT116 cells was revealed by induction of the histone -H2AX marker. The 7-azaindenoisoquinolines were able to partially overcome resistance in several drug-resistant cell lines, and they were not substrates for the ABCB1 drug efflux transporter. Molecular modeling studies indicate that the 7-azaindenoisoquinolines intercalate at the DNA cleavage site in DNA-Top1 covalent complexes with the lactam side chain projecting into the major groove. Overall, the results indicate that the 7-azaindenoisoquinolines are promising anticancer agents that merit further development.\n",
            "1075855\n",
            "Inhibition of recombinant human DNA top1-mediated relaxation of pBR322 plasmid at 100 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Further constituents of Galianthe thalictroides (Rubiaceae) and inhibition of DNA topoisomerases I and II by its cytotoxic -carboline alkaloids.  Abstract: A new cytotoxic -carboline alkaloid, 1-methyl-3-(2-hydroxypropan-2-yl)-2-(5-methoxy-9H--carbolin-1-yl)-cyclopentanol (1), was isolated from roots of Galianthe thalictroides, together with the alkaloid 1-(hydroxymethyl)-3-(2-hydroxypropan-2-yl)-2-(5-methoxy-9H--carbolin-1-yl)-cyclopentanol (2), the anthraquinones 1-methyl-alizarin and morindaparvin-A, the coumarin scopoletin, homovanillic alcohol, (-)-epicatechin, and the steroids stigmast-4-en-3-one, 4,22-stigmastadien-3-one, campest-4-en-3-one, stigmast-4-en-3,6-dione, 6--hydroxy-stigmast-4-en-3-one, stigmasterol, campesterol, -sitosterol, and -sitosterol-3-O--D-glucopyranoside. Among the previously known compounds, homovanillic alcohol is a novel finding in Rubiaceae, while 1-methyl-alizarin, morindaparvin-A, scopoletin, stigmast-4-en-3-one, 4,22-stigmastadien-3-one, campest-4-en-3-one, stigmast-4-en-3,6-dione, and 6--hydroxy-stigmast-4-en-3-one is reported for the first time in the genus Galianthe. The cytotoxic -carboline alkaloids 1 and 2 exhibited potent antitopoisomerase I and II activities and strong evidence is provided for their action as topoisomerase II poisons and redox-independent inhibitors.\n",
            "1075856\n",
            "Inhibition of recombinant human DNA top1-mediated relaxation of pBR322 plasmid at 1 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Further constituents of Galianthe thalictroides (Rubiaceae) and inhibition of DNA topoisomerases I and II by its cytotoxic -carboline alkaloids.  Abstract: A new cytotoxic -carboline alkaloid, 1-methyl-3-(2-hydroxypropan-2-yl)-2-(5-methoxy-9H--carbolin-1-yl)-cyclopentanol (1), was isolated from roots of Galianthe thalictroides, together with the alkaloid 1-(hydroxymethyl)-3-(2-hydroxypropan-2-yl)-2-(5-methoxy-9H--carbolin-1-yl)-cyclopentanol (2), the anthraquinones 1-methyl-alizarin and morindaparvin-A, the coumarin scopoletin, homovanillic alcohol, (-)-epicatechin, and the steroids stigmast-4-en-3-one, 4,22-stigmastadien-3-one, campest-4-en-3-one, stigmast-4-en-3,6-dione, 6--hydroxy-stigmast-4-en-3-one, stigmasterol, campesterol, -sitosterol, and -sitosterol-3-O--D-glucopyranoside. Among the previously known compounds, homovanillic alcohol is a novel finding in Rubiaceae, while 1-methyl-alizarin, morindaparvin-A, scopoletin, stigmast-4-en-3-one, 4,22-stigmastadien-3-one, campest-4-en-3-one, stigmast-4-en-3,6-dione, and 6--hydroxy-stigmast-4-en-3-one is reported for the first time in the genus Galianthe. The cytotoxic -carboline alkaloids 1 and 2 exhibited potent antitopoisomerase I and II activities and strong evidence is provided for their action as topoisomerase II poisons and redox-independent inhibitors.\n",
            "1075857\n",
            "Inhibition of recombinant human DNA top1-mediated relaxation of pBR322 plasmid at 25 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Further constituents of Galianthe thalictroides (Rubiaceae) and inhibition of DNA topoisomerases I and II by its cytotoxic -carboline alkaloids.  Abstract: A new cytotoxic -carboline alkaloid, 1-methyl-3-(2-hydroxypropan-2-yl)-2-(5-methoxy-9H--carbolin-1-yl)-cyclopentanol (1), was isolated from roots of Galianthe thalictroides, together with the alkaloid 1-(hydroxymethyl)-3-(2-hydroxypropan-2-yl)-2-(5-methoxy-9H--carbolin-1-yl)-cyclopentanol (2), the anthraquinones 1-methyl-alizarin and morindaparvin-A, the coumarin scopoletin, homovanillic alcohol, (-)-epicatechin, and the steroids stigmast-4-en-3-one, 4,22-stigmastadien-3-one, campest-4-en-3-one, stigmast-4-en-3,6-dione, 6--hydroxy-stigmast-4-en-3-one, stigmasterol, campesterol, -sitosterol, and -sitosterol-3-O--D-glucopyranoside. Among the previously known compounds, homovanillic alcohol is a novel finding in Rubiaceae, while 1-methyl-alizarin, morindaparvin-A, scopoletin, stigmast-4-en-3-one, 4,22-stigmastadien-3-one, campest-4-en-3-one, stigmast-4-en-3,6-dione, and 6--hydroxy-stigmast-4-en-3-one is reported for the first time in the genus Galianthe. The cytotoxic -carboline alkaloids 1 and 2 exhibited potent antitopoisomerase I and II activities and strong evidence is provided for their action as topoisomerase II poisons and redox-independent inhibitors.\n",
            "1076036\n",
            "Inhibition of recombinant topoisomerase-1 (unknown origin) assessed as inhibition of 3'-[32P]-labeled DNA cleavage at 0.1 to 100 uM after 20 mins by PAGE analysis relative to control\n",
            "Title: Synthesis and biological evaluation of new carbohydrate-substituted indenoisoquinoline topoisomerase I inhibitors and improved syntheses of the experimental anticancer agents indotecan (LMP400) and indimitecan (LMP776).  Abstract: Carbohydrate moieties were strategically transported from the indolocarbazole topoisomerase I (Top1) inhibitor class to the indenoisoquinoline system in search of structurally novel and potent Top1 inhibitors. The syntheses and biological evaluation of 20 new indenoisoquinolines glycosylated with linear and cyclic sugar moieties are reported. Aromatic ring substitution with 2,3-dimethoxy-8,9-methylenedioxy or 3-nitro groups exerted strong effects on antiproliferative and Top1 inhibitory activities. While the length of the carbohydrate side chain clearly correlated with antiproliferative activity, the relationship between stereochemistry and biological activity was less clearly defined. Twelve of the new indenoisoquinolines exhibit Top1 inhibitory activity equal to or better than that of camptothecin. An advanced synthetic intermediate from this study was also used to efficiently prepare indotecan (LMP400) and indimitecan (LMP776), two anticancer agents currently under investigation in a Phase I clinical trial at the National Institutes of Health.\n",
            "1076081\n",
            "Inhibition of topoisomerase 1 (unknown origin)-mediated relaxation of supercoiled pBR322 DNA at 10 uM by agarose gel electrophoresis\n",
            "Title: Suzuki coupling based synthesis and in vitro cytotoxic evaluation of 7-heteroaryl-substituted camptothecin analogs.  Abstract: In an effort to discover potent antitumor agents, a series of novel C-7-heteroaryl-substituted camptothecin derivatives were designed and synthesized via microwave-promoted Suzuki coupling reaction. These analogs were then assessed for cytotoxicity against three human tumor cell lines, A549, HCT116, HT-29, and inhibitory effects on topoisomerase I. All of the new compounds showed potent inhibition of human tumor cell growth, among which compound 10a showed higher cytotoxic activity than that of SN-38. Furthermore, this series of compounds retained or enhanced Topo I inhibition.\n",
            "1076082\n",
            "Inhibition of topoisomerase 1 (unknown origin)-mediated relaxation of supercoiled pBR322 DNA at 100 uM by agarose gel electrophoresis\n",
            "Title: Suzuki coupling based synthesis and in vitro cytotoxic evaluation of 7-heteroaryl-substituted camptothecin analogs.  Abstract: In an effort to discover potent antitumor agents, a series of novel C-7-heteroaryl-substituted camptothecin derivatives were designed and synthesized via microwave-promoted Suzuki coupling reaction. These analogs were then assessed for cytotoxicity against three human tumor cell lines, A549, HCT116, HT-29, and inhibitory effects on topoisomerase I. All of the new compounds showed potent inhibition of human tumor cell growth, among which compound 10a showed higher cytotoxic activity than that of SN-38. Furthermore, this series of compounds retained or enhanced Topo I inhibition.\n",
            "1095219\n",
            "Inhibition of DNA topoisomerase 1 (unknown origin)\n",
            "Inhibition of DNA topoisomerase 1 (unknown origin)\n",
            "1095226\n",
            "Inhibition of DNA topoisomerase 1 in Homo sapiens (human) SW480 cells\n",
            "Inhibition of DNA topoisomerase 1 in Homo sapiens (human) SW480 cells\n",
            "1095227\n",
            "Inhibition of DNA topoisomerase 1 in Homo sapiens (human) VACO 241 cells\n",
            "Inhibition of DNA topoisomerase 1 in Homo sapiens (human) VACO 241 cells\n",
            "1095228\n",
            "Inhibition of DNA topoisomerase 1 in Homo sapiens (human) HCT116 cells\n",
            "Inhibition of DNA topoisomerase 1 in Homo sapiens (human) HCT116 cells\n",
            "1096583\n",
            "Inhibition of Homo sapiens (human) topoisomerase 1 assessed as relaxation of supercoiled DNA up to 25 uM by agarose gel electrophoresis\n",
            "Inhibition of Homo sapiens (human) topoisomerase 1 assessed as relaxation of supercoiled DNA up to 25 uM by agarose gel electrophoresis\n",
            "1096585\n",
            "Inhibition of Homo sapiens (human) topoisomerase 1 assessed as production of nicked DNA up to 25 uM by agarose gel electrophoresis\n",
            "Inhibition of Homo sapiens (human) topoisomerase 1 assessed as production of nicked DNA up to 25 uM by agarose gel electrophoresis\n",
            "1117281\n",
            "A whole genome RNAi screen highlights components of the ER/Golgi as a prominent source of resistance to immunotoxin-mediated cytotoxicity\n",
            "Immunotoxins (antibody-toxin fusion proteins) target surface antigens on cancer cells and kill these cells via toxin-mediated inhibition of protein synthesis leading to apoptosis.  To identify genes controlling this process, a whole RNAi genome screen (approximately 22,000 genes at 3 siRNAs per gene) was conducted via monitoring the cytotoxicity of the mesothelin-directed immunotoxin, SS1P.  SS1P, a Pseudomonas exotoxin-based immunotoxin, was chosen because it is now in clinical trials and has produced some significant tumor regressions in patients.  High and low concentrations of SS1P were chosen to allow for the identification of both mitigators and sensitizers, respectively.  As expected, silencing known essential genes in the immunotoxin pathway such as mesothelin, furin, KDEL receptor 2 or the members of the diphthamide pathway protected cells.  Of potential greater interest was the observation that many RNAi targets increased immunotoxin sensitivity, indicating that these gene products normally contribute to inefficiencies in the killing pathway.  Of top sensitizers, many genes encode proteins that locate to either the ER or Golgi and in particular are annotated as part of the secretory system.  Our results highlight new potential targets for chemical intervention that could increase immunotoxin killing of cancer cells and enhance our understanding of toxin trafficking.\n",
            "1117357\n",
            "InfectX: Pathogen infection siRNA screens\n",
            "Pathogen infection siRNA screens for Bartonella henselae, Brucella abortus and Salmonella typhimurium performed within the InfectX consortium (http://www.infectx.ch).\n",
            "1121257\n",
            "Inhibition of human topoisomerase 1 activity assessed as DNA triplex formation and presence of supercoiled DNA by microplate assay\n",
            "Inhibition of human topoisomerase 1 activity assessed as DNA triplex formation and presence of supercoiled DNA by microplate assay\n",
            "1122073\n",
            "Inhibition of human DNA topoisomerase 1 assessed as inhibition of DNA cleavage\n",
            "Inhibition of human DNA topoisomerase 1 assessed as inhibition of DNA cleavage\n",
            "1138548\n",
            "Inhibition of human topoisomerase 1-mediated pHOT-1 DNA relaxation at 10 to 150 uM treated with pHOT-1 substrate for 15 mins prior to enzyme addition for 30 mins by agarose gel electrophoresis\n",
            "Title: Haloemodin as novel antibacterial agent inhibiting DNA gyrase and bacterial topoisomerase I.  Abstract: Drug-resistant bacterial infections and lack of available antibacterial agents in clinical practice are becoming serious risks to public health. We synthesized a new class of haloemodins by modifying a traditional Chinese medicine component, emodin. The novel haloemodin exerts strong inhibitory activity on bacterial topoisomerase I and DNA gyrase, and not on the topoisomerases of human origin. In principle, it shows remarkable antibacterial activities against laboratory and clinically isolated Gram-positive bacteria, including vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus. We further expanded its antibacterial spectrum into against Gram-negative bacteria with the assistance of polymyxin B nonapeptide, which helps haloemodin to penetrate through the bacterial outer membrane. Finally, the therapeutic effect of haloemodin in vivo was confirmed in curing S. aureus-induced keratitis on rabbit model. With distinctive structural difference from the antibiotics we used, the haloemodins are of value as promising antibacterial pharmacophore, especially for combat the infections caused by drug-resistant pathogens.\n",
            "1142522\n",
            "Inhibition of human topoisomerase 1-mediated pUC19 supercoiled DNA relaxation at 5 uM\n",
            "Title: Synthesis, antiproliferative activity and DNA binding properties of novel 5-aminobenzimidazo[1,2-a]quinoline-6-carbonitriles.  Abstract: The synthesis of 5-amino substituted benzimidazo[1,2-a]quinolines prepared by microwave assisted amination from halogeno substituted precursor was described. The majority of compounds were active at micromolar concentrations against colon, lung and breast carcinoma cell lines in vitro. The N,N-dimethylaminopropyl 9 and piperazinyl substituted derivative 19 showed the most pronounced activity towards all of the three tested tumor cell lines, which could be correlated to the presence of another N heteroatom and its potential interactions with biological targets. The DNA binding studies, consisting of UV/Visible absorbency, melting temperature studies, and fluorescence and circular dichroism titrations, revealed that compounds 9, 19 and 20 bind to DNA as strong intercalators. The cellular distribution analysis, based on compounds' intrinsic fluorescence, showed that compound 20 does not enter the cell, while compounds 9 and 19 do, which is in agreement with their cytotoxic effects. Compound 9 efficiently targets the nucleus whereas 19, which also showed DNA intercalating properties in vitro, was mostly localised in the cytoplasm suggesting that the antitumor mechanism of action is DNA-independent.\n",
            "1142523\n",
            "Inhibition of human topoisomerase 1-mediated pUC19 supercoiled DNA relaxation at 2 uM\n",
            "Title: Synthesis, antiproliferative activity and DNA binding properties of novel 5-aminobenzimidazo[1,2-a]quinoline-6-carbonitriles.  Abstract: The synthesis of 5-amino substituted benzimidazo[1,2-a]quinolines prepared by microwave assisted amination from halogeno substituted precursor was described. The majority of compounds were active at micromolar concentrations against colon, lung and breast carcinoma cell lines in vitro. The N,N-dimethylaminopropyl 9 and piperazinyl substituted derivative 19 showed the most pronounced activity towards all of the three tested tumor cell lines, which could be correlated to the presence of another N heteroatom and its potential interactions with biological targets. The DNA binding studies, consisting of UV/Visible absorbency, melting temperature studies, and fluorescence and circular dichroism titrations, revealed that compounds 9, 19 and 20 bind to DNA as strong intercalators. The cellular distribution analysis, based on compounds' intrinsic fluorescence, showed that compound 20 does not enter the cell, while compounds 9 and 19 do, which is in agreement with their cytotoxic effects. Compound 9 efficiently targets the nucleus whereas 19, which also showed DNA intercalating properties in vitro, was mostly localised in the cytoplasm suggesting that the antitumor mechanism of action is DNA-independent.\n",
            "1142524\n",
            "Inhibition of human topoisomerase 1-mediated pUC19 supercoiled DNA relaxation at 5 to 50 uM\n",
            "Title: Synthesis, antiproliferative activity and DNA binding properties of novel 5-aminobenzimidazo[1,2-a]quinoline-6-carbonitriles.  Abstract: The synthesis of 5-amino substituted benzimidazo[1,2-a]quinolines prepared by microwave assisted amination from halogeno substituted precursor was described. The majority of compounds were active at micromolar concentrations against colon, lung and breast carcinoma cell lines in vitro. The N,N-dimethylaminopropyl 9 and piperazinyl substituted derivative 19 showed the most pronounced activity towards all of the three tested tumor cell lines, which could be correlated to the presence of another N heteroatom and its potential interactions with biological targets. The DNA binding studies, consisting of UV/Visible absorbency, melting temperature studies, and fluorescence and circular dichroism titrations, revealed that compounds 9, 19 and 20 bind to DNA as strong intercalators. The cellular distribution analysis, based on compounds' intrinsic fluorescence, showed that compound 20 does not enter the cell, while compounds 9 and 19 do, which is in agreement with their cytotoxic effects. Compound 9 efficiently targets the nucleus whereas 19, which also showed DNA intercalating properties in vitro, was mostly localised in the cytoplasm suggesting that the antitumor mechanism of action is DNA-independent.\n",
            "1142525\n",
            "Inhibition of human topoisomerase 1-mediated pUC19 supercoiled DNA relaxation at 0.5 to 10 uM\n",
            "Title: Synthesis, antiproliferative activity and DNA binding properties of novel 5-aminobenzimidazo[1,2-a]quinoline-6-carbonitriles.  Abstract: The synthesis of 5-amino substituted benzimidazo[1,2-a]quinolines prepared by microwave assisted amination from halogeno substituted precursor was described. The majority of compounds were active at micromolar concentrations against colon, lung and breast carcinoma cell lines in vitro. The N,N-dimethylaminopropyl 9 and piperazinyl substituted derivative 19 showed the most pronounced activity towards all of the three tested tumor cell lines, which could be correlated to the presence of another N heteroatom and its potential interactions with biological targets. The DNA binding studies, consisting of UV/Visible absorbency, melting temperature studies, and fluorescence and circular dichroism titrations, revealed that compounds 9, 19 and 20 bind to DNA as strong intercalators. The cellular distribution analysis, based on compounds' intrinsic fluorescence, showed that compound 20 does not enter the cell, while compounds 9 and 19 do, which is in agreement with their cytotoxic effects. Compound 9 efficiently targets the nucleus whereas 19, which also showed DNA intercalating properties in vitro, was mostly localised in the cytoplasm suggesting that the antitumor mechanism of action is DNA-independent.\n",
            "1142526\n",
            "Effect on human topoisomerase 1 poisoning activity using pUC19 supercoiled DNA\n",
            "Title: Synthesis, antiproliferative activity and DNA binding properties of novel 5-aminobenzimidazo[1,2-a]quinoline-6-carbonitriles.  Abstract: The synthesis of 5-amino substituted benzimidazo[1,2-a]quinolines prepared by microwave assisted amination from halogeno substituted precursor was described. The majority of compounds were active at micromolar concentrations against colon, lung and breast carcinoma cell lines in vitro. The N,N-dimethylaminopropyl 9 and piperazinyl substituted derivative 19 showed the most pronounced activity towards all of the three tested tumor cell lines, which could be correlated to the presence of another N heteroatom and its potential interactions with biological targets. The DNA binding studies, consisting of UV/Visible absorbency, melting temperature studies, and fluorescence and circular dichroism titrations, revealed that compounds 9, 19 and 20 bind to DNA as strong intercalators. The cellular distribution analysis, based on compounds' intrinsic fluorescence, showed that compound 20 does not enter the cell, while compounds 9 and 19 do, which is in agreement with their cytotoxic effects. Compound 9 efficiently targets the nucleus whereas 19, which also showed DNA intercalating properties in vitro, was mostly localised in the cytoplasm suggesting that the antitumor mechanism of action is DNA-independent.\n",
            "1143108\n",
            "Inhibition of human recombinant topoisomerase 1-mediated 117 bp DNA cleavage at 0.1 to 100 uM by agarose gel electrophoresis\n",
            "Title: Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitors.  Abstract: Tyrosyl-DNA phosphodiesterase I (TDP1) repairs stalled topoisomerase I (Top1)-DNA covalent complexes and has been proposed to be a promising and attractive target for cancer treatment. Inhibitors of TDP1 could conceivably act synergistically with Top1 inhibitors and thereby potentiate the effects of Top1 poisons. This study describes the successful design and synthesis of 2-position-modified indenoisoquinolines as dual Top1-TDP1 inhibitors using a structure-based drug design approach. Enzyme inhibition studies indicate that indenoisoquinolines modified at the 2-position with three-carbon side chains ending with amino substituents show both promising Top1 and TDP1 inhibitory activity. Molecular modeling of selected target compounds bound to Top1 and TDP1 was used to rationalize the enzyme inhibition results and structure-activity relationship analysis.\n",
            "1143109\n",
            "Inhibition of human recombinant topoisomerase 1-mediated 117 bp DNA cleavage by agarose gel electrophoresis\n",
            "Title: Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitors.  Abstract: Tyrosyl-DNA phosphodiesterase I (TDP1) repairs stalled topoisomerase I (Top1)-DNA covalent complexes and has been proposed to be a promising and attractive target for cancer treatment. Inhibitors of TDP1 could conceivably act synergistically with Top1 inhibitors and thereby potentiate the effects of Top1 poisons. This study describes the successful design and synthesis of 2-position-modified indenoisoquinolines as dual Top1-TDP1 inhibitors using a structure-based drug design approach. Enzyme inhibition studies indicate that indenoisoquinolines modified at the 2-position with three-carbon side chains ending with amino substituents show both promising Top1 and TDP1 inhibitory activity. Molecular modeling of selected target compounds bound to Top1 and TDP1 was used to rationalize the enzyme inhibition results and structure-activity relationship analysis.\n",
            "1143384\n",
            "Inhibition of human topoisomerase 1 activity assessed as decrease in mobility of relaxed isomers of supercoiled pBR322 DNA at 15 mg/ml after 20 mins incubation by agarose gel electrophoresis\n",
            "Title: Novel N-substituted sophoridinol derivatives as anticancer agents.  Abstract: Using sophoridine (1) as the lead compound, a series of new N-substituted sophoridinic acid derivatives were designed, synthesized and evaluated for their cytotoxicity. SAR analysis indicated that introduction of a chlorobenzyl on the 12-nitrogen atom of sophoridinol might significantly enhance the antiproliferative activity. Of the newly synthesized compounds, sophoridinol analogue 9k exhibited a potent effect against six human tumor cell lines (liver, colon, breast, lung, glioma and nasopharyngeal). The mode of action of 9k was to inhibit the DNA topoisomerase I activity, followed by the G0/G1 phase arrest. It also showed a moderate oral bioavailability and good safety in vivo. Therefore, compound 9k has been selected as a novel-scaffold lead for further structural optimizations or as a chemical probe for exploring anticancer pathways of this kinds of compounds.\n",
            "1155282\n",
            "Inhibition of recombinant human DNA topoisomerase-1-mediated relaxation of supercoiled DNA pBR322 at 100 uM after 7 hrs using ethidium bromide staining by agarose gel electrophoresis analysis\n",
            "Title: Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.  Abstract: A series of 3-heteroarylisoquinolinamines were designed, synthesized and evaluated for cytotoxicity, topoisomerases (topos) inhibitory activities and cell cycle inhibition. Several of the 3-heteroarylisoquinolines exhibited selective cytotoxicity against human ductal breast epithelial tumor (T47D) cells over non-cancerous human breast epithelial (MCF-10A) and human prostate cancer (DU145) cells. Most of the derivatives showed greater cytotoxicity in human colorectal adenocarcinoma (HCT-15) cells than camptothecin (CPT), etoposide and doxorubicin (DOX). Generally, 3-heteroarylisoquinolinamines displayed greater affinity for topo I than topo II. 3-Heteroarylisoquinolinamines with greater topo I inhibitory effect exhibited potent cytotoxicity. Piperazine-substituted derivative, 5b, with potent topo I and moderate topo II activities intercalated between DNA bases and interacted with topos through H-bonds at the DNA cleavage site of a docking model. Moreover, flow cytometry indicated that cytotoxic 3-heteroarylisoquinolinamines led to accumulation of human cervical (HeLa) cancer cells in the different phases of the cell cycle before apoptosis. Taken together, 3-heteroarylisoquinolinamines possessed potent cytotoxicity with topos and cell cycle inhibitory activities.\n",
            "1155283\n",
            "Inhibition of recombinant human DNA topoisomerase-1-mediated relaxation of supercoiled DNA pBR322 at 20 uM after 7 hrs using ethidium bromide staining by agarose gel electrophoresis analysis\n",
            "Title: Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.  Abstract: A series of 3-heteroarylisoquinolinamines were designed, synthesized and evaluated for cytotoxicity, topoisomerases (topos) inhibitory activities and cell cycle inhibition. Several of the 3-heteroarylisoquinolines exhibited selective cytotoxicity against human ductal breast epithelial tumor (T47D) cells over non-cancerous human breast epithelial (MCF-10A) and human prostate cancer (DU145) cells. Most of the derivatives showed greater cytotoxicity in human colorectal adenocarcinoma (HCT-15) cells than camptothecin (CPT), etoposide and doxorubicin (DOX). Generally, 3-heteroarylisoquinolinamines displayed greater affinity for topo I than topo II. 3-Heteroarylisoquinolinamines with greater topo I inhibitory effect exhibited potent cytotoxicity. Piperazine-substituted derivative, 5b, with potent topo I and moderate topo II activities intercalated between DNA bases and interacted with topos through H-bonds at the DNA cleavage site of a docking model. Moreover, flow cytometry indicated that cytotoxic 3-heteroarylisoquinolinamines led to accumulation of human cervical (HeLa) cancer cells in the different phases of the cell cycle before apoptosis. Taken together, 3-heteroarylisoquinolinamines possessed potent cytotoxicity with topos and cell cycle inhibitory activities.\n",
            "1159506\n",
            "Identification of proteins required for the processing of the EWS-FLI1 nascent transcript\n",
            "Ewing sarcoma (ES) cells depend on the EWS-FLI1 fusion transcription factor for cell survival. Using an assay of EWS-FLI1 activity and genome-wide siRNA screening we have identified proteins required for the processing of the EWS-FLI1 nascent transcript. Parallel genome-wide siRNA-mediated RNAi screens were conducted in Ewing sarcoma TC32 cell lines expressing a luciferase (luc) reporter protein driven by either the promoter of the EWS-FLI1 target gene NR0B1 (TC32-NR0B1-luc) or the CMV promoter (TC32-CMV-luc). Luciferase activity was assessed 48 hours post siRNA-transfection.\n",
            "1159578\n",
            "A screen to identify genes that regulate lymphatic endothelial cell migration - Primary Screen\n",
            "Genome wide siRNA screen for modulators of lymphatic endothelial cell migration\n",
            "1159584\n",
            "A screen to identify synthetic lethal interactions with E-cadherin in an MCF10A isogenic cell line\n",
            "Genome wide protein coding siRNA screen to identify synthetic lethal interactions with E-cadherin in an MCF10A isogenic cell line\n",
            "1165010\n",
            "Inhibition of human recombinant DNA topoisomerase 1 assessed as reduction in relaxation of supercoiled pHOT DNA at 25 to 50 uM incubated for 45 mins by ethidium bromide staining based gel electrophoresis\n",
            "Title: Ring fusion strategy for the synthesis of anthra[2,3-d]oxazole-2-thione-5,10-dione homologues as DNA topoisomerase inhibitors and as antitumor agents.  Abstract: The efficient synthesis of mono-substituted anthraquinones and ring fusion into anthra[2,3-d]oxazole-2-thione-5,10-dione derivatives were developed, and all the compounds were tested for their cytotoxicity against PC-3 cancer cell lines. Compounds 8, 14, 17 and 23 were selected by the NCI and 12, 17 and 19 were evaluated for topoisomerase I-mediated DNA relaxation. Among them, 17 appeared to be the most active compound of this series and not only showed higher inhibition when indicated from the low IC50 values against PC-3 cancer cell line but also attenuated the in vitro topoisomerase I-mediated DNA relaxation at low micromolar concentrations. All test compounds exhibited different cytostatic and cytotoxic activities for further developing potential anticancer drugs.\n",
            "1165011\n",
            "Inhibition of human recombinant DNA topoisomerase 1 assessed as reduction in relaxation of supercoiled pHOT DNA at 6.25 to 25 uM incubated for 45 mins by ethidium bromide staining based gel electrophoresis\n",
            "Title: Ring fusion strategy for the synthesis of anthra[2,3-d]oxazole-2-thione-5,10-dione homologues as DNA topoisomerase inhibitors and as antitumor agents.  Abstract: The efficient synthesis of mono-substituted anthraquinones and ring fusion into anthra[2,3-d]oxazole-2-thione-5,10-dione derivatives were developed, and all the compounds were tested for their cytotoxicity against PC-3 cancer cell lines. Compounds 8, 14, 17 and 23 were selected by the NCI and 12, 17 and 19 were evaluated for topoisomerase I-mediated DNA relaxation. Among them, 17 appeared to be the most active compound of this series and not only showed higher inhibition when indicated from the low IC50 values against PC-3 cancer cell line but also attenuated the in vitro topoisomerase I-mediated DNA relaxation at low micromolar concentrations. All test compounds exhibited different cytostatic and cytotoxic activities for further developing potential anticancer drugs.\n",
            "1165391\n",
            "Inhibition of human topoisomerase 1 (unknown origin)-mediated relaxation of supercoiled pBR322 after 30 mins by agarose gel electrophoresis\n",
            "Title: Synthesis and evaluation of new antitumor 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones.  Abstract: A series of new 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones 6-13 bearing the cyclic diamine in the position 3 of the indole ring was synthesized. The majority of new compounds demonstrated a superior cytotoxicity than doxorubicin against a panel of mammalian tumor cells with determinants of altered drug response, that is, Pgp expression or p53 inactivation. For naphtho[2,3-f]indole-5,10-diones 6-9 bearing 3-aminopyrrolidine in the side chains, the ability to bind double-stranded DNA and inhibit topoisomerases 1 and 2 mediated relaxation of supercoiled DNA were demonstrated. Only one isomer, (R)-4,11-dihydroxy-3-((pyrrolidin-3-ylamino)methyl)-1H-naphtho[2,3-f]indole-5,10-dione (7) induced the formation of specific DNA cleavage products similar to the known topoisomerase 1 inhibitors camptothecin and indenoisoquinoline MJ-III-65, suggesting a role of the structure of the side chain of 3-aminomethylnaphtho[2,3-f]indole-5,10-diones in interaction with the target. Compound 7 demonstrated an antitumor activity in mice with P388 leukemia transplants whereas its enantiomer 6 was inactive. Thus, 3-aminomethyl derivatives of 4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione emerge as a new prospective chemotype for the search of antitumor agents.\n",
            "1165392\n",
            "Inhibition of human topoisomerase 1 (unknown origin)-mediated relaxation of supercoiled pBR322 after 30 mins at 0.5 to 5 uM by agarose gel electrophoresis\n",
            "Title: Synthesis and evaluation of new antitumor 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones.  Abstract: A series of new 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones 6-13 bearing the cyclic diamine in the position 3 of the indole ring was synthesized. The majority of new compounds demonstrated a superior cytotoxicity than doxorubicin against a panel of mammalian tumor cells with determinants of altered drug response, that is, Pgp expression or p53 inactivation. For naphtho[2,3-f]indole-5,10-diones 6-9 bearing 3-aminopyrrolidine in the side chains, the ability to bind double-stranded DNA and inhibit topoisomerases 1 and 2 mediated relaxation of supercoiled DNA were demonstrated. Only one isomer, (R)-4,11-dihydroxy-3-((pyrrolidin-3-ylamino)methyl)-1H-naphtho[2,3-f]indole-5,10-dione (7) induced the formation of specific DNA cleavage products similar to the known topoisomerase 1 inhibitors camptothecin and indenoisoquinoline MJ-III-65, suggesting a role of the structure of the side chain of 3-aminomethylnaphtho[2,3-f]indole-5,10-diones in interaction with the target. Compound 7 demonstrated an antitumor activity in mice with P388 leukemia transplants whereas its enantiomer 6 was inactive. Thus, 3-aminomethyl derivatives of 4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione emerge as a new prospective chemotype for the search of antitumor agents.\n",
            "1165393\n",
            "Inhibition of human topoisomerase 1 (unknown origin)-mediated DNA cleavage after 30 mins at 1 uM by agarose gel electrophoresis\n",
            "Title: Synthesis and evaluation of new antitumor 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones.  Abstract: A series of new 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones 6-13 bearing the cyclic diamine in the position 3 of the indole ring was synthesized. The majority of new compounds demonstrated a superior cytotoxicity than doxorubicin against a panel of mammalian tumor cells with determinants of altered drug response, that is, Pgp expression or p53 inactivation. For naphtho[2,3-f]indole-5,10-diones 6-9 bearing 3-aminopyrrolidine in the side chains, the ability to bind double-stranded DNA and inhibit topoisomerases 1 and 2 mediated relaxation of supercoiled DNA were demonstrated. Only one isomer, (R)-4,11-dihydroxy-3-((pyrrolidin-3-ylamino)methyl)-1H-naphtho[2,3-f]indole-5,10-dione (7) induced the formation of specific DNA cleavage products similar to the known topoisomerase 1 inhibitors camptothecin and indenoisoquinoline MJ-III-65, suggesting a role of the structure of the side chain of 3-aminomethylnaphtho[2,3-f]indole-5,10-diones in interaction with the target. Compound 7 demonstrated an antitumor activity in mice with P388 leukemia transplants whereas its enantiomer 6 was inactive. Thus, 3-aminomethyl derivatives of 4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione emerge as a new prospective chemotype for the search of antitumor agents.\n",
            "1165394\n",
            "Inhibition of human topoisomerase 1 (unknown origin)-mediated DNA cleavage after 30 mins by agarose gel electrophoresis\n",
            "Title: Synthesis and evaluation of new antitumor 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones.  Abstract: A series of new 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones 6-13 bearing the cyclic diamine in the position 3 of the indole ring was synthesized. The majority of new compounds demonstrated a superior cytotoxicity than doxorubicin against a panel of mammalian tumor cells with determinants of altered drug response, that is, Pgp expression or p53 inactivation. For naphtho[2,3-f]indole-5,10-diones 6-9 bearing 3-aminopyrrolidine in the side chains, the ability to bind double-stranded DNA and inhibit topoisomerases 1 and 2 mediated relaxation of supercoiled DNA were demonstrated. Only one isomer, (R)-4,11-dihydroxy-3-((pyrrolidin-3-ylamino)methyl)-1H-naphtho[2,3-f]indole-5,10-dione (7) induced the formation of specific DNA cleavage products similar to the known topoisomerase 1 inhibitors camptothecin and indenoisoquinoline MJ-III-65, suggesting a role of the structure of the side chain of 3-aminomethylnaphtho[2,3-f]indole-5,10-diones in interaction with the target. Compound 7 demonstrated an antitumor activity in mice with P388 leukemia transplants whereas its enantiomer 6 was inactive. Thus, 3-aminomethyl derivatives of 4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione emerge as a new prospective chemotype for the search of antitumor agents.\n",
            "1165395\n",
            "Inhibition of human topoisomerase 1 (unknown origin)-mediated relaxation of supercoiled pBR322 after 30 mins at 5 uM by agarose gel electrophoresis\n",
            "Title: Synthesis and evaluation of new antitumor 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones.  Abstract: A series of new 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones 6-13 bearing the cyclic diamine in the position 3 of the indole ring was synthesized. The majority of new compounds demonstrated a superior cytotoxicity than doxorubicin against a panel of mammalian tumor cells with determinants of altered drug response, that is, Pgp expression or p53 inactivation. For naphtho[2,3-f]indole-5,10-diones 6-9 bearing 3-aminopyrrolidine in the side chains, the ability to bind double-stranded DNA and inhibit topoisomerases 1 and 2 mediated relaxation of supercoiled DNA were demonstrated. Only one isomer, (R)-4,11-dihydroxy-3-((pyrrolidin-3-ylamino)methyl)-1H-naphtho[2,3-f]indole-5,10-dione (7) induced the formation of specific DNA cleavage products similar to the known topoisomerase 1 inhibitors camptothecin and indenoisoquinoline MJ-III-65, suggesting a role of the structure of the side chain of 3-aminomethylnaphtho[2,3-f]indole-5,10-diones in interaction with the target. Compound 7 demonstrated an antitumor activity in mice with P388 leukemia transplants whereas its enantiomer 6 was inactive. Thus, 3-aminomethyl derivatives of 4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione emerge as a new prospective chemotype for the search of antitumor agents.\n",
            "1165396\n",
            "Inhibition of human topoisomerase 1 (unknown origin)-mediated relaxation of supercoiled pBR322 after 30 mins at >10 uM by agarose gel electrophoresis\n",
            "Title: Synthesis and evaluation of new antitumor 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones.  Abstract: A series of new 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones 6-13 bearing the cyclic diamine in the position 3 of the indole ring was synthesized. The majority of new compounds demonstrated a superior cytotoxicity than doxorubicin against a panel of mammalian tumor cells with determinants of altered drug response, that is, Pgp expression or p53 inactivation. For naphtho[2,3-f]indole-5,10-diones 6-9 bearing 3-aminopyrrolidine in the side chains, the ability to bind double-stranded DNA and inhibit topoisomerases 1 and 2 mediated relaxation of supercoiled DNA were demonstrated. Only one isomer, (R)-4,11-dihydroxy-3-((pyrrolidin-3-ylamino)methyl)-1H-naphtho[2,3-f]indole-5,10-dione (7) induced the formation of specific DNA cleavage products similar to the known topoisomerase 1 inhibitors camptothecin and indenoisoquinoline MJ-III-65, suggesting a role of the structure of the side chain of 3-aminomethylnaphtho[2,3-f]indole-5,10-diones in interaction with the target. Compound 7 demonstrated an antitumor activity in mice with P388 leukemia transplants whereas its enantiomer 6 was inactive. Thus, 3-aminomethyl derivatives of 4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione emerge as a new prospective chemotype for the search of antitumor agents.\n",
            "1167481\n",
            "Inhibition of human topoisomerase 1 assessed as topoisomerase poison activity by measuring generation of open circular DNA using supercoiled pUC19 DNA at 20 to 50 uM by agarose gel electrophoresis\n",
            "Title: Novel phenyl and pyridyl substituted derivatives of isoindolines: Synthesis, antitumor activity and DNA binding features.  Abstract: Novel phenyl-substituted (3a-3d, 4a, 5, 8a, 8b and 9a) and pyridyl-substituted (3e-3i, 4b, 8c-8e, 9b and 9c) isoindolines were prepared in the reaction of o-phthalaldehyde and corresponding substituted aromatic and heteroaromatic amines by modification of reaction conditions from low to high temperature and from neutral to acidic environment. The antiproliferative activity of chosen substituted isoindolines was assessed on a panel of tumour cell lines and normal human fibroblasts. The majority of tested compounds was active at the highest tested concentrations phenyl-substituted isoindolines 3a and 3b and pyridyl-substituted isoindoline 3g showed a selective effect at micromolar concentrations on HepG2 cell line in comparison with other tested tumour cell lines and normal human fibroblasts. The strongest yet non-selective effect was observed for the pyridyl-substituted isoindoline 8c. These isoindoline derivatives showed diverse mechanism of action on tumour cell death induction as compounds 3a and 8c probably induced mitotic catastrophe while compound 3b induced apoptosis. Indeed, DNA binding properties evidenced that compounds 8a, 8c and 8d bind to DNA as highly potent DNA intercalators. By contrast, compounds 3b, 3e, 3i, 4a and 5 did not target the DNA. At last, the phenyl-substituted compound 8b proved to be a strong DNA binding compound with sequence selective binding and without DNA intercalation profile.\n",
            "1167482\n",
            "Inhibition of human topoisomerase 1 assessed as topoisomerase poison activity by measuring generation of open circular DNA using supercoiled pUC19 DNA at 5 to 50 uM by agarose gel electrophoresis\n",
            "Title: Novel phenyl and pyridyl substituted derivatives of isoindolines: Synthesis, antitumor activity and DNA binding features.  Abstract: Novel phenyl-substituted (3a-3d, 4a, 5, 8a, 8b and 9a) and pyridyl-substituted (3e-3i, 4b, 8c-8e, 9b and 9c) isoindolines were prepared in the reaction of o-phthalaldehyde and corresponding substituted aromatic and heteroaromatic amines by modification of reaction conditions from low to high temperature and from neutral to acidic environment. The antiproliferative activity of chosen substituted isoindolines was assessed on a panel of tumour cell lines and normal human fibroblasts. The majority of tested compounds was active at the highest tested concentrations phenyl-substituted isoindolines 3a and 3b and pyridyl-substituted isoindoline 3g showed a selective effect at micromolar concentrations on HepG2 cell line in comparison with other tested tumour cell lines and normal human fibroblasts. The strongest yet non-selective effect was observed for the pyridyl-substituted isoindoline 8c. These isoindoline derivatives showed diverse mechanism of action on tumour cell death induction as compounds 3a and 8c probably induced mitotic catastrophe while compound 3b induced apoptosis. Indeed, DNA binding properties evidenced that compounds 8a, 8c and 8d bind to DNA as highly potent DNA intercalators. By contrast, compounds 3b, 3e, 3i, 4a and 5 did not target the DNA. At last, the phenyl-substituted compound 8b proved to be a strong DNA binding compound with sequence selective binding and without DNA intercalation profile.\n",
            "1169487\n",
            "Inhibition of human DNA topoisomerase 1-mediated relaxation of supercoiled pBR322 plasmid DNA at 5 to 100 uM after 30 mins by agarose gel electrophoresis relative to untreated control\n",
            "Title: 11H-Pyrido[3',2':4,5]pyrrolo[3,2-c]cinnoline and pyrido[3',2':4,5]pyrrolo[1,2-c][1,2,3]benzotriazine: two new ring systems with antitumor activity.  Abstract: Derivatives of new ring systems 11H-pyrido[3',2':4,5]pyrrolo[3,2-c]cinnoline and pyrido[3',2':4,5]pyrrolo[1,2-c][1,2,3]benzotriazine have been prepared from the key intermediates 2-(1H-pyrrolo[2,3-b]pyridin-2-yl)anilines in excellent yields (94-99%) and screened by the National Cancer Institute (Bethesda, MD) on about 60 human tumor cell lines derived from nine cancer cell types. The tested compounds exhibited antiproliferative activity against all the human cell lines, showing comparable MG_MID (mean graph midpoint) values in the range of 0.74-1.15 M. A particular efficacy was observed against the leukemia subpanel (GI50 = 0.73-0.0090 M). Flow cytometric analysis of the cell cycle demonstrated an increase in the percentage of cells in the G2/M phase. The compounds caused apoptosis of the cells, mitochondrial depolarization, generation of reactive oxygen species, and activation of caspase-3, caspase-8, and caspase-9. Moreover, they acted as topoisomerase I inhibitors.\n",
            "1169488\n",
            "Inhibition of human DNA topoisomerase 1-mediated DNA single strand cleavage at 5 to 100 uM after 30 mins by agarose gel electrophoresis relative to untreated control\n",
            "Title: 11H-Pyrido[3',2':4,5]pyrrolo[3,2-c]cinnoline and pyrido[3',2':4,5]pyrrolo[1,2-c][1,2,3]benzotriazine: two new ring systems with antitumor activity.  Abstract: Derivatives of new ring systems 11H-pyrido[3',2':4,5]pyrrolo[3,2-c]cinnoline and pyrido[3',2':4,5]pyrrolo[1,2-c][1,2,3]benzotriazine have been prepared from the key intermediates 2-(1H-pyrrolo[2,3-b]pyridin-2-yl)anilines in excellent yields (94-99%) and screened by the National Cancer Institute (Bethesda, MD) on about 60 human tumor cell lines derived from nine cancer cell types. The tested compounds exhibited antiproliferative activity against all the human cell lines, showing comparable MG_MID (mean graph midpoint) values in the range of 0.74-1.15 M. A particular efficacy was observed against the leukemia subpanel (GI50 = 0.73-0.0090 M). Flow cytometric analysis of the cell cycle demonstrated an increase in the percentage of cells in the G2/M phase. The compounds caused apoptosis of the cells, mitochondrial depolarization, generation of reactive oxygen species, and activation of caspase-3, caspase-8, and caspase-9. Moreover, they acted as topoisomerase I inhibitors.\n",
            "1175659\n",
            "Inhibition of purified Topo 1 (unknown origin)-mediated supercoiled pBR322 DNA cleavage at 12.5 uM after 15 mins by agarose gel electrophoresis\n",
            "Title: Synthesis of novel 10-hydroxycamptothecin derivatives utilizing topotecan hydrochloride as ortho-quinonemethide precursor.  Abstract: A series of 9-(alkylthiomethyl)-10-hydroxycamptothecins and pyrano-fused camptothecin derivatives were synthesized via the reaction of topotecan hydrochloride with various thiols and alkyl vinyl ethers respectively. In the reactions, topotecan hydrochloride was utilized as ortho-quinonemethide (o-QM) precursor. The configuration of 19 was determined by (1)H NMR and NOESY spectra as syn-isomers, suggesting that the cycloaddition of topotecan with alkyl vinyl ethers could undergo a hetero Diels-Alder reaction. All the synthesized compounds were screened on cancer cell lines HepG2, KB, HCT-8 and SGC7901. Some compounds were selected to assess their inhibitory activity against Topo I via Topo I mediated DNA cleavage assays. The results showed that among those tested 9-(alkylthiomethyl)-10-hydroxycamptothecins, the compounds with bulkier hydrophobic side chains at 9-position have better bioactivities. As well as all pyrano-fused camptothecins possess antiproliferative activity against the tested cancer cell lines. Docking studies suggested that there are more interactions between the novel analogues and the binding site of Topo I.\n",
            "1175660\n",
            "Inhibition of human recombinant topoisomerase-1 assessed as conversion of super-coiled plasmid DNA pBR322 to relaxed DNA at 100 uM after 30 mins by ethidium bromide staining-based agarose gel electrophoresis (Rvb = 45.2%)\n",
            "Title: Design and synthesis of novel 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives, and their evaluation of topoisomerase inhibitory activity and cytotoxicity.  Abstract: For the development of potential anticancer agents, we designed and synthesized 30 new 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives containing aryl moiety such as furyl, thienyl, pyridyl, and phenyl at 2- and 4-position of 5H-indeno[1,2-b]pyridine. They were evaluated for topoisomerase I and II inhibitory activity, and cytotoxicity against several human cancer cell lines. Among prepared 30 compounds, 7, 8, 9, 10, 12, 14, 16, 19, 20, 22, and 23 with 2- or 3-furyl and/or 2- or 3-thienyl either at 2- or 4-position of central pyridine showed the significant or moderate topoisomerase II inhibitory activity. Compounds 7, 8, 11, 12, 13, and 22 with 2-furyl, 2-thienyl or 3-thienyl at 2-position of central pyridine showed the significant or moderate topoisomerase I inhibitory activity. Especially, compound 12 with strong topoisomerase II inhibitory activity at 100 M and 20 M, and moderate topoisomerase I inhibitory activity displayed strong cytotoxicity against several human cancer cell lines.\n",
            "1175661\n",
            "Inhibition of human recombinant topoisomerase-1 assessed as conversion of super-coiled plasmid DNA pBR322 to relaxed DNA at 100 uM after 30 mins by ethidium bromide staining-based agarose gel electrophoresis (Rvb = 51.5%)\n",
            "Title: Design and synthesis of novel 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives, and their evaluation of topoisomerase inhibitory activity and cytotoxicity.  Abstract: For the development of potential anticancer agents, we designed and synthesized 30 new 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives containing aryl moiety such as furyl, thienyl, pyridyl, and phenyl at 2- and 4-position of 5H-indeno[1,2-b]pyridine. They were evaluated for topoisomerase I and II inhibitory activity, and cytotoxicity against several human cancer cell lines. Among prepared 30 compounds, 7, 8, 9, 10, 12, 14, 16, 19, 20, 22, and 23 with 2- or 3-furyl and/or 2- or 3-thienyl either at 2- or 4-position of central pyridine showed the significant or moderate topoisomerase II inhibitory activity. Compounds 7, 8, 11, 12, 13, and 22 with 2-furyl, 2-thienyl or 3-thienyl at 2-position of central pyridine showed the significant or moderate topoisomerase I inhibitory activity. Especially, compound 12 with strong topoisomerase II inhibitory activity at 100 M and 20 M, and moderate topoisomerase I inhibitory activity displayed strong cytotoxicity against several human cancer cell lines.\n",
            "1175662\n",
            "Inhibition of human recombinant topoisomerase-1 assessed as conversion of super-coiled plasmid DNA pBR322 to relaxed DNA at 100 uM after 30 mins by ethidium bromide staining-based agarose gel electrophoresis (Rvb = 62.9%)\n",
            "Title: Design and synthesis of novel 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives, and their evaluation of topoisomerase inhibitory activity and cytotoxicity.  Abstract: For the development of potential anticancer agents, we designed and synthesized 30 new 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives containing aryl moiety such as furyl, thienyl, pyridyl, and phenyl at 2- and 4-position of 5H-indeno[1,2-b]pyridine. They were evaluated for topoisomerase I and II inhibitory activity, and cytotoxicity against several human cancer cell lines. Among prepared 30 compounds, 7, 8, 9, 10, 12, 14, 16, 19, 20, 22, and 23 with 2- or 3-furyl and/or 2- or 3-thienyl either at 2- or 4-position of central pyridine showed the significant or moderate topoisomerase II inhibitory activity. Compounds 7, 8, 11, 12, 13, and 22 with 2-furyl, 2-thienyl or 3-thienyl at 2-position of central pyridine showed the significant or moderate topoisomerase I inhibitory activity. Especially, compound 12 with strong topoisomerase II inhibitory activity at 100 M and 20 M, and moderate topoisomerase I inhibitory activity displayed strong cytotoxicity against several human cancer cell lines.\n",
            "1175663\n",
            "Inhibition of human recombinant topoisomerase-1 assessed as conversion of super-coiled plasmid DNA pBR322 to relaxed DNA at 100 uM after 30 mins by ethidium bromide staining-based agarose gel electrophoresis relative to camptothecin\n",
            "Title: Design and synthesis of novel 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives, and their evaluation of topoisomerase inhibitory activity and cytotoxicity.  Abstract: For the development of potential anticancer agents, we designed and synthesized 30 new 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives containing aryl moiety such as furyl, thienyl, pyridyl, and phenyl at 2- and 4-position of 5H-indeno[1,2-b]pyridine. They were evaluated for topoisomerase I and II inhibitory activity, and cytotoxicity against several human cancer cell lines. Among prepared 30 compounds, 7, 8, 9, 10, 12, 14, 16, 19, 20, 22, and 23 with 2- or 3-furyl and/or 2- or 3-thienyl either at 2- or 4-position of central pyridine showed the significant or moderate topoisomerase II inhibitory activity. Compounds 7, 8, 11, 12, 13, and 22 with 2-furyl, 2-thienyl or 3-thienyl at 2-position of central pyridine showed the significant or moderate topoisomerase I inhibitory activity. Especially, compound 12 with strong topoisomerase II inhibitory activity at 100 M and 20 M, and moderate topoisomerase I inhibitory activity displayed strong cytotoxicity against several human cancer cell lines.\n",
            "1175664\n",
            "Inhibition of human recombinant topoisomerase-1 assessed as conversion of super-coiled plasmid DNA pBR322 to relaxed DNA at 20 uM after 30 mins by ethidium bromide staining-based agarose gel electrophoresis (Rvb = 25.9%)\n",
            "Title: Design and synthesis of novel 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives, and their evaluation of topoisomerase inhibitory activity and cytotoxicity.  Abstract: For the development of potential anticancer agents, we designed and synthesized 30 new 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives containing aryl moiety such as furyl, thienyl, pyridyl, and phenyl at 2- and 4-position of 5H-indeno[1,2-b]pyridine. They were evaluated for topoisomerase I and II inhibitory activity, and cytotoxicity against several human cancer cell lines. Among prepared 30 compounds, 7, 8, 9, 10, 12, 14, 16, 19, 20, 22, and 23 with 2- or 3-furyl and/or 2- or 3-thienyl either at 2- or 4-position of central pyridine showed the significant or moderate topoisomerase II inhibitory activity. Compounds 7, 8, 11, 12, 13, and 22 with 2-furyl, 2-thienyl or 3-thienyl at 2-position of central pyridine showed the significant or moderate topoisomerase I inhibitory activity. Especially, compound 12 with strong topoisomerase II inhibitory activity at 100 M and 20 M, and moderate topoisomerase I inhibitory activity displayed strong cytotoxicity against several human cancer cell lines.\n",
            "1175665\n",
            "Inhibition of human recombinant topoisomerase-1 assessed as conversion of super-coiled plasmid DNA pBR322 to relaxed DNA at 20 uM after 30 mins by ethidium bromide staining-based agarose gel electrophoresis (Rvb = 19.6%)\n",
            "Title: Design and synthesis of novel 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives, and their evaluation of topoisomerase inhibitory activity and cytotoxicity.  Abstract: For the development of potential anticancer agents, we designed and synthesized 30 new 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives containing aryl moiety such as furyl, thienyl, pyridyl, and phenyl at 2- and 4-position of 5H-indeno[1,2-b]pyridine. They were evaluated for topoisomerase I and II inhibitory activity, and cytotoxicity against several human cancer cell lines. Among prepared 30 compounds, 7, 8, 9, 10, 12, 14, 16, 19, 20, 22, and 23 with 2- or 3-furyl and/or 2- or 3-thienyl either at 2- or 4-position of central pyridine showed the significant or moderate topoisomerase II inhibitory activity. Compounds 7, 8, 11, 12, 13, and 22 with 2-furyl, 2-thienyl or 3-thienyl at 2-position of central pyridine showed the significant or moderate topoisomerase I inhibitory activity. Especially, compound 12 with strong topoisomerase II inhibitory activity at 100 M and 20 M, and moderate topoisomerase I inhibitory activity displayed strong cytotoxicity against several human cancer cell lines.\n",
            "1179938\n",
            "Inhibition of DNA topoisomerase-1 (unknown origin) assessed as inhibition of supercoiled pBR322 relaxation up to 100 uM after 15 mins by gel electrophoresis\n",
            "Title: Topoisomerase II inhibitors from the roots of Stellera chamaejasme L.  Abstract: Three new compounds, including one daphnane diterpene (1), one sesquiterpene (6), and one lignan (7) have been isolated from the Stellera chamaejasme L., together with five other known compounds, including four daphnane diterpenenoids (2-5) and one lignan (8). The structures of the new compounds were elucidated by spectroscopic analysis. The cytotoxicities of compounds 1-8 towards human lung adenocarcinoma cells (A549 cells) were evaluated using a sulforhodamine B assay. All of the compounds displayed significant cytotoxicity, with IC values in the ranging of 0.2 nM to 2.0 M. Mechanistic studies revealed that the antitumor activities of compounds 1-3 and 7 were derived from their inhibition of topoisomerase II (Topo II). Furthermore, as a Topo II inhibitor, compound 1 was found to effectively induced G2-M phase cell cycle arrest and apoptosis in cancer cells.\n",
            "1182588\n",
            "Inhibition of human recombinant topoisomerase 1 at 3 uM preincubated for 20 mins before addition of supercoiled plasmid DNA by ethidium bromide dye based gel electrophoresis\n",
            "Title: Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agents.  Abstract: Twelve novel 20-sulfonylamidine derivatives (9a-9l) of camptothecin (1) were synthesized via a Cu-catalyzed three-component reaction. They showed similar or superior cytotoxicity compared with that of irinotecan (3) against A-549, DU-145, KB, and multidrug-resistant (MDR) KBvin tumor cell lines. Compound 9a demonstrated better cytotoxicity against MDR cells compared with that of 1 and 3. Mechanistically, 9a induced significant DNA damage by selectively inhibiting Topoisomerase (Topo) I and activating the ATM/Chk related DNA damage-response pathway. In xenograft models, 9a demonstrated significant activity without overt adverse effects at 5 and 10 mg/kg, comparable to 3 at 100 mg/kg. Notably, 9a at 300 mg/kg (i.p.) showed no overt toxicity in contrast to 1 (LD50 56.2 mg/kg, i.p.) and 3 (LD50 177.5 mg/kg, i.p.). Intact 9a inhibited Topo I activity in a cell-free assay in a manner similar to that of 1, confirming that 9a is a new class of Topo I inhibitor. 20-Sulfonylamidine 1-derivative 9a merits development as an anticancer clinical trial candidate.\n",
            "1182589\n",
            "Inhibition of human recombinant topoisomerase 1 at 100 nM preincubated for 20 mins before addition of supercoiled plasmid DNA by ethidium bromide dye based gel electrophoresis\n",
            "Title: Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agents.  Abstract: Twelve novel 20-sulfonylamidine derivatives (9a-9l) of camptothecin (1) were synthesized via a Cu-catalyzed three-component reaction. They showed similar or superior cytotoxicity compared with that of irinotecan (3) against A-549, DU-145, KB, and multidrug-resistant (MDR) KBvin tumor cell lines. Compound 9a demonstrated better cytotoxicity against MDR cells compared with that of 1 and 3. Mechanistically, 9a induced significant DNA damage by selectively inhibiting Topoisomerase (Topo) I and activating the ATM/Chk related DNA damage-response pathway. In xenograft models, 9a demonstrated significant activity without overt adverse effects at 5 and 10 mg/kg, comparable to 3 at 100 mg/kg. Notably, 9a at 300 mg/kg (i.p.) showed no overt toxicity in contrast to 1 (LD50 56.2 mg/kg, i.p.) and 3 (LD50 177.5 mg/kg, i.p.). Intact 9a inhibited Topo I activity in a cell-free assay in a manner similar to that of 1, confirming that 9a is a new class of Topo I inhibitor. 20-Sulfonylamidine 1-derivative 9a merits development as an anticancer clinical trial candidate.\n",
            "1182590\n",
            "Inhibition of human recombinant topoisomerase 1 preincubated for 20 mins before addition of supercoiled plasmid DNA by ethidium bromide dye based gel electrophoresis\n",
            "Title: Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agents.  Abstract: Twelve novel 20-sulfonylamidine derivatives (9a-9l) of camptothecin (1) were synthesized via a Cu-catalyzed three-component reaction. They showed similar or superior cytotoxicity compared with that of irinotecan (3) against A-549, DU-145, KB, and multidrug-resistant (MDR) KBvin tumor cell lines. Compound 9a demonstrated better cytotoxicity against MDR cells compared with that of 1 and 3. Mechanistically, 9a induced significant DNA damage by selectively inhibiting Topoisomerase (Topo) I and activating the ATM/Chk related DNA damage-response pathway. In xenograft models, 9a demonstrated significant activity without overt adverse effects at 5 and 10 mg/kg, comparable to 3 at 100 mg/kg. Notably, 9a at 300 mg/kg (i.p.) showed no overt toxicity in contrast to 1 (LD50 56.2 mg/kg, i.p.) and 3 (LD50 177.5 mg/kg, i.p.). Intact 9a inhibited Topo I activity in a cell-free assay in a manner similar to that of 1, confirming that 9a is a new class of Topo I inhibitor. 20-Sulfonylamidine 1-derivative 9a merits development as an anticancer clinical trial candidate.\n",
            "1182607\n",
            "Inhibition of topoisomerase 1 in human A549 cells assessed as reduction in relaxation of supercoiled DNA substrate at 30 to 100 nM incubated for 30 mins by ethidium bromide staining based gel electrophoresis\n",
            "Title: Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agents.  Abstract: Twelve novel 20-sulfonylamidine derivatives (9a-9l) of camptothecin (1) were synthesized via a Cu-catalyzed three-component reaction. They showed similar or superior cytotoxicity compared with that of irinotecan (3) against A-549, DU-145, KB, and multidrug-resistant (MDR) KBvin tumor cell lines. Compound 9a demonstrated better cytotoxicity against MDR cells compared with that of 1 and 3. Mechanistically, 9a induced significant DNA damage by selectively inhibiting Topoisomerase (Topo) I and activating the ATM/Chk related DNA damage-response pathway. In xenograft models, 9a demonstrated significant activity without overt adverse effects at 5 and 10 mg/kg, comparable to 3 at 100 mg/kg. Notably, 9a at 300 mg/kg (i.p.) showed no overt toxicity in contrast to 1 (LD50 56.2 mg/kg, i.p.) and 3 (LD50 177.5 mg/kg, i.p.). Intact 9a inhibited Topo I activity in a cell-free assay in a manner similar to that of 1, confirming that 9a is a new class of Topo I inhibitor. 20-Sulfonylamidine 1-derivative 9a merits development as an anticancer clinical trial candidate.\n",
            "1185511\n",
            "Inhibition of recombinant human DNA topoisomerase 1 assessed as relaxation of supercoiled DNA pBR322 at 100 uM after 30 mins using ethidium bromide staining by agarose gel electrophoresis\n",
            "Title: Synthesis, antitumor activity, and structure-activity relationship study of trihydroxylated 2,4,6-triphenyl pyridines as potent and selective topoisomerase II inhibitors.  Abstract: A series of eighteen trihydroxylated 2,4,6-triphenyl pyridines were designed and synthesized which contain hydroxyl groups at ortho, meta or para position of each phenyl rings attached to the central pyridine. They were evaluated for topoisomerase I and II inhibitory activity, and cytotoxicity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds exhibited strong and selective topoisomerase II inhibitory activity compared to the positive control, etoposide, and also displayed significant cytotoxicity in low micromolar range. Trihydroxylated 2,4,6-triphenyl pyridines were more potent than mono- and di-hydroxylated 2,4,6-triphenyl pyridines, which have been previously studied in our research group. Positive correlation between topoisomerase II inhibitory activity and cytotoxicity was observed for the most compounds. Molecular docking study shows qualitatively consistent with the results of biological assays.\n",
            "1187845\n",
            "Inhibition of topoisomerase 1 (unknown origin)-mediated relaxation of supercoiled pBR322 at 1 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Novel multi-targeting anthra[2,3-b]thiophene-5,10-diones with guanidine-containing side chains: interaction with telomeric G-quadruplex, inhibition of telomerase and topoisomerase I and cytotoxic properties.  Abstract: Novel generations of antitumor anthraquinones are expected to be advantageous over the conventional chemotherapeutic agents. Previous structure-activity relationship studies demonstrated an importance of the positively charged side chains conjugated to anthra[2,3-b]thiophene-5,10-dione scaffolds. Exploring a role of individual side chain moieties in binding to the duplex and G-quadruplex DNA, modulation of telomerase and topoisomerase I activities, intracellular accumulation and cytostatic potency, we herein analyzed a series of reported and newly synthesized guanidine-containing derivatives of anthra[2,3-b]thiophene-5,10-dione. We found that the number of cationic side chains (namely, two) is critical for a tight interaction with human telomeric G-quadruplex (TelQ). Along with a larger drug-TelQ association constant, the telomerase attenuation by anthrathiophenediones with two basic groups in the side chains was more pronounced than by the analogs bearing one basic group. For mono-guanidinated compounds the substituent with the amino group in the side chain provided better TelQ affinity than the methylamine residue. The intracellular uptake of the mono-guanidino derivative with two side chains was >2-fold higher than the respective value for the bis(guanidino) derivative. This difference can explain a lower antiproliferative potency of bis(guanidine) containing compounds. Thus, the modifications of side chains of anthra[2,3-b]thiophene-5,10-dione differently modulated drug-target interactions and cellular effects. Nevertheless, the selected compound 11-(3-aminopropylamino)-4-(2-guanidinoethylamino)anthra[2,3-b]thiophene-5,10-dione 13 demonstrated a high affinity to TelQ and the ability to stabilize the quadruplex structure. These properties were paralleled by reasonable potency of 13 as a telomerase/topoisomerase I inhibitor and an antiproliferative agent. These results indicate that the structural elements of anthra[2,3-b]thiophene-5,10-dione derivatives can be balanced to yield a candidate for further preclinical study.\n",
            "1194058\n",
            "Inhibition of recombinant human DNA topoisomerase 1 assessed as relaxation of plasmid DNA pBR322 at 50 uM by agarose gel electrophoresis\n",
            "Title: Synthesis and biological evaluation of benzimidazole acridine derivatives as potential DNA-binding and apoptosis-inducing agents.  Abstract: The discovery of new effective DNA-targeted antitumor agent is needed because of their clinical significance. As acridines can intercalate into DNA and benzimidazoles have the ability to bind in the DNA minor groove, a series of novel benzimidazole acridine derivatives were designed and synthesized to be new DNA-targeted compounds. MTT assay indicated that most of the synthesized compounds displayed good antiproliferative activity, among which compound 8l demonstrated the highest activity against both K562 and HepG-2 cells. Further experiments showed that 8l displayed good DNA-binding capability and inhibited topoisomerase I activity. Moreover, compound 8l could induce apoptosis in K562 cell lines through mitochondrial pathway. These data suggested that compound 8l might be potential as new DNA-binding and apoptosis-inducing antitumor agents.\n",
            "1194769\n",
            "Inhibition of topoisomerase 1 (unknown origin) at 100 uM using supercoiled pBR322 DNA substrate by ethidium bromide staining based electrophoresis method\n",
            "Title: Design, synthesis and biological evaluation of novel homocamptothecin analogues as potent antitumor agents.  Abstract: Fifteen novel homocamptothecin derivatives with -OMe substituted E-rings were designed and synthesized. All of the derivatives exhibited similar or superior cytotoxicities compared with that of SN-38, and they inhibited Topo I activity in a cell-free assay in a manner similar to that of SN-38, confirming that they represent a new class of Topo I inhibitors. Notably, the water soluble compound 36o (1.2 mg/mL) exhibited increased lactone stability, and at 0.5 mg/kg and 3.0 mg/kg, it demonstrated significant antitumor activity in mice bearing a xenograft model using human colon cancer cell line HT-29. On the basis of these positive results, further development of 36o-related compounds as potential anticancer clinical trial candidates is definitely warranted.\n",
            "1194770\n",
            "Inhibition of topoisomerase 1 (unknown origin) at 10 uM using supercoiled pBR322 DNA substrate by ethidium bromide staining based electrophoresis method\n",
            "Title: Design, synthesis and biological evaluation of novel homocamptothecin analogues as potent antitumor agents.  Abstract: Fifteen novel homocamptothecin derivatives with -OMe substituted E-rings were designed and synthesized. All of the derivatives exhibited similar or superior cytotoxicities compared with that of SN-38, and they inhibited Topo I activity in a cell-free assay in a manner similar to that of SN-38, confirming that they represent a new class of Topo I inhibitors. Notably, the water soluble compound 36o (1.2 mg/mL) exhibited increased lactone stability, and at 0.5 mg/kg and 3.0 mg/kg, it demonstrated significant antitumor activity in mice bearing a xenograft model using human colon cancer cell line HT-29. On the basis of these positive results, further development of 36o-related compounds as potential anticancer clinical trial candidates is definitely warranted.\n",
            "1195269\n",
            "Inhibition of human DNA topoisomerase 1 using pHOT1 supercoiled DNA substrate incubated for 30 mins by ethidium bromide staining based gel electrophoresis method\n",
            "Title: Synthesis of novel C5-curcuminoid-fatty acid conjugates and mechanistic investigation of their anticancer activity.  Abstract: The first synthesis of C5-curcumin-fatty acid (C5-Curc-FA) conjugates was successfully performed. Through a two-step synthetic route, 10 analogs were synthesized for a structure-activity relationship (SAR) study. It was found that C5-Curc-FA conjugates containing either decanoic acid or palmitic acid moieties were cytotoxic against colorectal adenocarcinoma cell (CCL-229) at IC50s ranging from 22.5 to 56.1g/mL, being 5c the most active C5-Curc-FA conjugate. Our results strongly suggests that a decanoic acid moiety at the meta position in C5-Curc-FA conjugates is important for their anticancer activity effect. Possible mechanisms for the anticancer activity of C5-Curc-FA conjugates were also investigated including apoptosis induction, mitochondrial damage and caspases activation. It was shown that 5c inhibited the luminescence activity of NFB, a key signaling molecule involved in cell apoptosis and cell proliferation, at IC50=18.2g/mL. In addition, it was demonstrated that 5c displayed significant apoptotic effect at GI50=46.0g/mL in colorectal adenocarcinoma cell line (ATCC CCL-222), which can be explained by the significant mitochondrial membrane permeabilization and caspases 3 and 7 activation effect of 5c. Finally, it was investigated that C5-Curc-FA conjugates can affect the replication process of cancer cells, since compounds 5c, 5e, and 6c inhibited the relaxing activity of the human DNA topoisomerase I at minimum inhibitory concentrations (MICs) that range from 50 to 250g/mL. Our results strongly support the hypothesis that the inhibition of both NFB and DNA topoisomerase I by C5-Curc-FA conjugates is associated with their anticancer activity.\n",
            "1197367\n",
            "Inhibition of Topo 1 (unknown origin)-mediated relaxation of supercoiled pBR322 plasmid at 25 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors.  Abstract: A novel series of benzo[a]phenazin derivatives bearing alkylamino side chains were designed, synthesized and evaluated for their topoisomerases inhibitory activity as well as cytotoxicity against four human cancer cell lines (HL-60, K-562, HeLa, and A549). These compounds were found to be dual inhibitors of topoisomerase (Topo) I and Topo II, and exhibited excellent antiproliferative activity, in particular against HL-60 cells with submicromolar IC50 values. Further mechanistic studies showed that this class of compounds acted as Topo I poisons by stabilizing the Topo I-DNA cleavage complexes and Topo II catalytic inhibitors by inhibiting the ATPase activity of hTopo II. Molecular docking studies revealed the binding modes of these compounds for Topo I and Topo II.\n",
            "1197378\n",
            "Induction of Topo 1-DNA cleavage complex formation in human HL60 cells after 1 hr by ICE assay\n",
            "Title: Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors.  Abstract: A novel series of benzo[a]phenazin derivatives bearing alkylamino side chains were designed, synthesized and evaluated for their topoisomerases inhibitory activity as well as cytotoxicity against four human cancer cell lines (HL-60, K-562, HeLa, and A549). These compounds were found to be dual inhibitors of topoisomerase (Topo) I and Topo II, and exhibited excellent antiproliferative activity, in particular against HL-60 cells with submicromolar IC50 values. Further mechanistic studies showed that this class of compounds acted as Topo I poisons by stabilizing the Topo I-DNA cleavage complexes and Topo II catalytic inhibitors by inhibiting the ATPase activity of hTopo II. Molecular docking studies revealed the binding modes of these compounds for Topo I and Topo II.\n",
            "1197846\n",
            "Inhibition of recombinant human topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 10 uM after 60 mins by agarose gel electrophoresis\n",
            "Title: Boehmeriasin A as new lead compound for the inhibition of topoisomerases and SIRT2.  Abstract: Two synthetic approaches to boehmeriasin A are described. A gram scale racemic preparation is accompanied by an efficient preparation of both the pure enantiomers using the conformationally stable 2-piperidin-2-yl acetaldehyde as starting material. The anti-proliferative activity in three cancer cell lines (CEM, HeLa and L1210) and two endothelial cell lines (HMEC-1, BAEC) indicates promising activity at the nanomolar range. Topoisomerases and SIRT2 are identified as biological targets and the experimental data has been supported by docking studies.\n",
            "1197849\n",
            "Stabilization of recombinant human topoisomerase 1-pBR322 DNA cleavage complex assessed as linear DNA formation at 0.5 uM after 60 mins by agarose gel electrophoresis\n",
            "Title: Boehmeriasin A as new lead compound for the inhibition of topoisomerases and SIRT2.  Abstract: Two synthetic approaches to boehmeriasin A are described. A gram scale racemic preparation is accompanied by an efficient preparation of both the pure enantiomers using the conformationally stable 2-piperidin-2-yl acetaldehyde as starting material. The anti-proliferative activity in three cancer cell lines (CEM, HeLa and L1210) and two endothelial cell lines (HMEC-1, BAEC) indicates promising activity at the nanomolar range. Topoisomerases and SIRT2 are identified as biological targets and the experimental data has been supported by docking studies.\n",
            "1198386\n",
            "Inhibition of recombinant human Topo1-mediated relation of supercoiled pBR322 DNA at 50 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Molecular design, synthesis and biological research of novel pyridyl acridones as potent DNA-binding and apoptosis-inducing agents.  Abstract: A series of novel pyridyl acridone derivatives comprised of a pseudo-five-cyclic system to extend the -conjugated acridone chromophore, were designed and synthesized as potent DNA binding antitumor compounds. Most synthesized compounds displayed good activity against human leukemia K562 cells in MTT tests, with compound 6d exhibiting the highest activity with IC50 value at 0.46 M. Moreover, 6d showed potent activities against solid tumor cell lines (0.16-3.79 M). Several experimental studies demonstrated that the antitumor mode of action of compound 6d involves DNA intercalation, topoisomerase I inhibition, and apoptosis induction through the mitochondrial pathway. In summary, compound 6d represents a novel and promising lead structure for the development of new potent anticancer DNA-binding agents.\n",
            "1201343\n",
            "Inhibition of human recombinant topoisomerase 1-dependent DNA cleavage using 751-bp BamHI-EcoRI fragment of SV40 DNA at 1 to 50 uM incubated for 30 mins by PAGE method\n",
            "Title: Water-soluble isoindolo[2,1-a]quinoxalin-6-imines: in vitro antiproliferative activity and molecular mechanism(s) of action.  Abstract: Water-soluble isoindoloquinoxalin (IIQ) imines and the corresponding acetates were conveniently prepared from the key intermediates 2-(2'-aminophenyl)-2H-isoindole-1-carbonitriles obtained by a Strecker reaction between substituted 1,2-dicarbaldehydes and 1,2-phenylenediamines. Both series were screened by the National Cancer Institute (Bethesda, MD) and showed potent antiproliferative activity against a panel of 60 human tumor cell lines. Several of the novel compounds showed GI50 values at a nanomolar level on the majority of the tested cell lines. Among IIQ derivatives, methoxy substituents at positions 3 and 8 or/and 9 were especially effective in impairing cell cycle progression and inducing apoptosis in cancer cells. These effects were associated to IIQ-mediated impairment of tubulin polymerization at pharmacologically significant concentrations of tested compounds. In addition, impaired DNA topoisomerase I functions and perturbation in telomere architecture were observed in cells exposed to micromolar concentrations of IIQ derivatives. The above results suggest that IIQ derivatives exhibit multi-target cytotoxic activities.\n",
            "1201344\n",
            "Inhibition of human recombinant topoisomerase 1-dependent DNA cleavage using 751-bp BamHI-EcoRI fragment of SV40 DNA at 50 uM incubated for 30 mins by PAGE method\n",
            "Title: Water-soluble isoindolo[2,1-a]quinoxalin-6-imines: in vitro antiproliferative activity and molecular mechanism(s) of action.  Abstract: Water-soluble isoindoloquinoxalin (IIQ) imines and the corresponding acetates were conveniently prepared from the key intermediates 2-(2'-aminophenyl)-2H-isoindole-1-carbonitriles obtained by a Strecker reaction between substituted 1,2-dicarbaldehydes and 1,2-phenylenediamines. Both series were screened by the National Cancer Institute (Bethesda, MD) and showed potent antiproliferative activity against a panel of 60 human tumor cell lines. Several of the novel compounds showed GI50 values at a nanomolar level on the majority of the tested cell lines. Among IIQ derivatives, methoxy substituents at positions 3 and 8 or/and 9 were especially effective in impairing cell cycle progression and inducing apoptosis in cancer cells. These effects were associated to IIQ-mediated impairment of tubulin polymerization at pharmacologically significant concentrations of tested compounds. In addition, impaired DNA topoisomerase I functions and perturbation in telomere architecture were observed in cells exposed to micromolar concentrations of IIQ derivatives. The above results suggest that IIQ derivatives exhibit multi-target cytotoxic activities.\n",
            "1203574\n",
            "Inhibition of human recombinant Top1 expressed in baculovirus-infected insect Sf9 cells using 3'-[32P]-end-labeled 117 bp DNA as substrate assessed as inhibition of DNA cleavage after 20 mins by PAGE analysis relative to 1 uM camptothecin\n",
            "Title: Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.  Abstract: The structure-activity relationships and hit-to-lead optimization of dual Top1-TDP1 inhibitors in the indenoisoquinoline drug class were investigated. A series of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines were synthesized and evaluated. Several compounds displayed potent dual Top1-TDP1 inhibition. The 9-hydroxy series exhibited potencies and cytotoxicities vs Top1 that surpassed those of camptothecin (CPT), the natural alkaloid that is being used as a standard in the Top1-mediated DNA cleavage assay. One member of this series was a more potent Top1 inhibitor at a concentration of 5 nM and produced a more stable ternary drug-DNA-Top1 cleavage complex than CPT.\n",
            "1203584\n",
            "Inhibition of human recombinant Top1 expressed in baculovirus-infected insect Sf9 cells using 3'-[32P]-end-labeled 117 bp DNA as substrate assessed as inhibition of DNA cleavage after 20 mins by PAGE analysis\n",
            "Title: Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.  Abstract: The structure-activity relationships and hit-to-lead optimization of dual Top1-TDP1 inhibitors in the indenoisoquinoline drug class were investigated. A series of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines were synthesized and evaluated. Several compounds displayed potent dual Top1-TDP1 inhibition. The 9-hydroxy series exhibited potencies and cytotoxicities vs Top1 that surpassed those of camptothecin (CPT), the natural alkaloid that is being used as a standard in the Top1-mediated DNA cleavage assay. One member of this series was a more potent Top1 inhibitor at a concentration of 5 nM and produced a more stable ternary drug-DNA-Top1 cleavage complex than CPT.\n",
            "1203585\n",
            "Poisoning activity at human recombinant Top1 expressed in baculovirus-infected insect Sf9 cells using 3'-[32P]-end-labeled 117 bp DNA as substrate assessed as trapping of enzyme cleavage complex at 0.005 to 100 uM measured after 20 mins by PAGE analysis\n",
            "Title: Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.  Abstract: The structure-activity relationships and hit-to-lead optimization of dual Top1-TDP1 inhibitors in the indenoisoquinoline drug class were investigated. A series of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines were synthesized and evaluated. Several compounds displayed potent dual Top1-TDP1 inhibition. The 9-hydroxy series exhibited potencies and cytotoxicities vs Top1 that surpassed those of camptothecin (CPT), the natural alkaloid that is being used as a standard in the Top1-mediated DNA cleavage assay. One member of this series was a more potent Top1 inhibitor at a concentration of 5 nM and produced a more stable ternary drug-DNA-Top1 cleavage complex than CPT.\n",
            "1203586\n",
            "Poisoning activity at human recombinant Top1 expressed in baculovirus-infected insect Sf9 cells using 3'-[32P]-end-labeled 117 bp DNA as substrate assessed as trapping of enzyme cleavage complex at 5 nM measured after 20 mins by PAGE analysis\n",
            "Title: Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.  Abstract: The structure-activity relationships and hit-to-lead optimization of dual Top1-TDP1 inhibitors in the indenoisoquinoline drug class were investigated. A series of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines were synthesized and evaluated. Several compounds displayed potent dual Top1-TDP1 inhibition. The 9-hydroxy series exhibited potencies and cytotoxicities vs Top1 that surpassed those of camptothecin (CPT), the natural alkaloid that is being used as a standard in the Top1-mediated DNA cleavage assay. One member of this series was a more potent Top1 inhibitor at a concentration of 5 nM and produced a more stable ternary drug-DNA-Top1 cleavage complex than CPT.\n",
            "1203587\n",
            "Poisoning activity at human recombinant Top1 expressed in baculovirus-infected insect Sf9 cells using 3'-[32P]-end-labeled 117 bp DNA as substrate assessed as delay in reversal of drug-enzyme-DNA cleavage complex formation at 1 uM measured over 10 mins by PAGE analysis\n",
            "Title: Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.  Abstract: The structure-activity relationships and hit-to-lead optimization of dual Top1-TDP1 inhibitors in the indenoisoquinoline drug class were investigated. A series of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines were synthesized and evaluated. Several compounds displayed potent dual Top1-TDP1 inhibition. The 9-hydroxy series exhibited potencies and cytotoxicities vs Top1 that surpassed those of camptothecin (CPT), the natural alkaloid that is being used as a standard in the Top1-mediated DNA cleavage assay. One member of this series was a more potent Top1 inhibitor at a concentration of 5 nM and produced a more stable ternary drug-DNA-Top1 cleavage complex than CPT.\n",
            "1206840\n",
            "Inhibition of human topoisomerase 1-mediated DNA cleavage assessed as accumulation of nicked DNA at 100 uM by ethidium bromide staining based electrophoregram\n",
            "Title: Stereoselective synthesis of 11-phenylundeca-5Z,9Z-dienoic acid and investigation of its human topoisomerase I and II inhibitory activity.  Abstract: (5Z,9Z)-11-Phenylundeca-5,9-dienoic acid was stereoselectively synthesized, based on original cross-cyclomagnesiation of 2-(hepta-5,6-dien-1-yloxy)tetrahydro-2H-pyran and buta-2,3-dien-1-ylbenzene with EtMgBr in the presence of Cp2TiCl2 catalyst giving 2,5-dialkylidenemagnesacyclopentane in 86% yield. The acid hydrolysis of the product and the Jones oxidation of the resulting 2-{[(5Z,9Z)-11-phenylundeca-5,9-dien-1-yl]oxy}tetrahydro-2-pyran afforded (5Z,9Z)-11-phenylundeca-5,9-dienoic acid in an overall yield of 75%. A high inhibitory activity of the synthesized acid with respect to human topoisomerase I (hTop1) and II (hTop2) was determined.\n",
            "1206841\n",
            "Inhibition of human topoisomerase 1-mediated DNA cleavage assessed as accumulation of nicked DNA at 0.06 to 10 uM by ethidium bromide staining based electrophoregram\n",
            "Title: Stereoselective synthesis of 11-phenylundeca-5Z,9Z-dienoic acid and investigation of its human topoisomerase I and II inhibitory activity.  Abstract: (5Z,9Z)-11-Phenylundeca-5,9-dienoic acid was stereoselectively synthesized, based on original cross-cyclomagnesiation of 2-(hepta-5,6-dien-1-yloxy)tetrahydro-2H-pyran and buta-2,3-dien-1-ylbenzene with EtMgBr in the presence of Cp2TiCl2 catalyst giving 2,5-dialkylidenemagnesacyclopentane in 86% yield. The acid hydrolysis of the product and the Jones oxidation of the resulting 2-{[(5Z,9Z)-11-phenylundeca-5,9-dien-1-yl]oxy}tetrahydro-2-pyran afforded (5Z,9Z)-11-phenylundeca-5,9-dienoic acid in an overall yield of 75%. A high inhibitory activity of the synthesized acid with respect to human topoisomerase I (hTop1) and II (hTop2) was determined.\n",
            "1206843\n",
            "Inhibition of human topoisomerase 1-mediated DNA cleavage assessed as accumulation of nicked DNA by ethidium bromide staining based electrophoregram\n",
            "Title: Stereoselective synthesis of 11-phenylundeca-5Z,9Z-dienoic acid and investigation of its human topoisomerase I and II inhibitory activity.  Abstract: (5Z,9Z)-11-Phenylundeca-5,9-dienoic acid was stereoselectively synthesized, based on original cross-cyclomagnesiation of 2-(hepta-5,6-dien-1-yloxy)tetrahydro-2H-pyran and buta-2,3-dien-1-ylbenzene with EtMgBr in the presence of Cp2TiCl2 catalyst giving 2,5-dialkylidenemagnesacyclopentane in 86% yield. The acid hydrolysis of the product and the Jones oxidation of the resulting 2-{[(5Z,9Z)-11-phenylundeca-5,9-dien-1-yl]oxy}tetrahydro-2-pyran afforded (5Z,9Z)-11-phenylundeca-5,9-dienoic acid in an overall yield of 75%. A high inhibitory activity of the synthesized acid with respect to human topoisomerase I (hTop1) and II (hTop2) was determined.\n",
            "1206844\n",
            "Inhibition of human topoisomerase 1-mediated DNA cleavage assessed as accumulation of nicked DNA at 0.06 to 10 uM by electrophoregram\n",
            "Title: Stereoselective synthesis of 11-phenylundeca-5Z,9Z-dienoic acid and investigation of its human topoisomerase I and II inhibitory activity.  Abstract: (5Z,9Z)-11-Phenylundeca-5,9-dienoic acid was stereoselectively synthesized, based on original cross-cyclomagnesiation of 2-(hepta-5,6-dien-1-yloxy)tetrahydro-2H-pyran and buta-2,3-dien-1-ylbenzene with EtMgBr in the presence of Cp2TiCl2 catalyst giving 2,5-dialkylidenemagnesacyclopentane in 86% yield. The acid hydrolysis of the product and the Jones oxidation of the resulting 2-{[(5Z,9Z)-11-phenylundeca-5,9-dien-1-yl]oxy}tetrahydro-2-pyran afforded (5Z,9Z)-11-phenylundeca-5,9-dienoic acid in an overall yield of 75%. A high inhibitory activity of the synthesized acid with respect to human topoisomerase I (hTop1) and II (hTop2) was determined.\n",
            "1224830\n",
            "Genome-wide siRNA screen of genes regulating the Lipopolysaccharide-induced TNF-alpha response in human macrophages_Primary screen TNF readout\n",
            "The mammalian innate immune system senses many bacterial stimuli through the toll-like receptor (TLR) family. Activation of the TLR4 receptor by bacterial lipopolysaccharide (LPS) is the most widely studied TLR pathway due to its central role in host responses to gram-negative bacterial infection and its contribution to endotoxemia and sepsis. Here we describe a genome-wide siRNA screen to identify genes regulating the human macrophage TNF-alpha response to LPS. We also conducted a secondary validation screen with six independent siRNAs per gene to facilitate removal of off-target screen hits, and we generated microarray data from the same LPS-treated macrophage cells to facilitate downstream data analysis. These data provide a resource for analyzing gene function in the predominant pathway driving inflammatory cytokine expression in human macrophages.\n",
            "1225979\n",
            "Inhibition of topoisomerase1 (unknown origin)-mediated pBR322 DNA relaxation at 50 uM after 15 mins by agarose gel electrophoresis\n",
            "Title: Discovery of Novel Multiacting Topoisomerase I/II and Histone Deacetylase Inhibitors.  Abstract: Designing multitarget drugs remains a significant challenge in current antitumor drug discovery. Because of the synergistic effect between topoisomerase and HDAC inhibitors, the present study reported the first-in-class triple inhibitors of topoisomerase I/II and HDAC. On the basis of 3-amino-10-hydroxylevodiamine and SAHA, a series of hybrid molecules was successfully designed and synthesized. In particular, compound 8c was proven to be a potent inhibitor of topoisomerase I/II and HDAC with good antiproliferative and apoptotic activities. This proof-of-concept study also validated the effectiveness of discovering triple topoisomerase I/II and HDAC inhibitors as novel antitumor agents.\n",
            "1226759\n",
            "Inhibition of human topoisomerase-1 assessed as reduction in enzyme-mediated relaxation of negatively supercoiled pRYG DNA at 100 uM incubated for 30 mins by ethidium bromide staining based gel electrophoresis method\n",
            "Title: Switch in Site of Inhibition: A Strategy for Structure-Based Discovery of Human Topoisomerase II Catalytic Inhibitors.  Abstract: A study of structure-based modulation of known ligands of hTopoII, an important enzyme involved in DNA processes, coupled with synthesis and in vitro assays led to the establishment of a strategy of rational switch in mode of inhibition of the enzyme's catalytic cycle. 6-Arylated derivatives of known imidazopyridine ligands were found to be selective inhibitors of hTopoII, while not showing TopoI inhibition and DNA binding. Interestingly, while the parent imidazopyridines acted as ATP-competitive inhibitors, arylated derivatives inhibited DNA cleavage similar to merbarone, indicating a switch in mode of inhibition from ATP-hydrolysis to the DNA-cleavage stage of catalytic cycle of the enzyme. The 6-aryl-imidazopyridines were relatively more cytotoxic than etoposide in cancer cells and less toxic to normal cells. Such unprecedented strategy will encourage research on \"choice-based change\" in target-specific mode of action for rapid drug discovery.\n",
            "1227434\n",
            "Inhibition of human DNA topoisomerase-1 using supercoiled pBAD-GFPuv plasmid DNA as substrate assessed as prevention of supercoiled DNA template from relaxation after 30 mins by agarose gel electrophoresis\n",
            "Title: Selective Inhibition of Bacterial Topoisomerase I by alkynyl-bisbenzimidazoles.  Abstract: Hoechst dyes are well known DNA binders that non-selectively inhibit the function of mammalian topoisomerase I and II. Herein, we show that Hoechst 33258 based bisbenzimidazoles (DPA 151-154), containing a terminal alkyne, are effective and selective inhibitors of E. coli. topoisomerase I. These bisbenzimidazoles displayed topoisomerase I inhibition much better than Hoechst 33342 or Hoechst 33258 with IC50 values in the range of 2.47-6.63 M. Bisbenzimidazoles DPA 151-154 also display selective inhibition of E. coli. topoisomerase I over DNA gyrase and Human topoisomerases I and II, and effectively inhibit bacterial growth.\n",
            "1227436\n",
            "Inhibition of human DNA topoisomerase-1 using supercoiled pBAD-GFPuv plasmid DNA as substrate assessed as prevention of supercoiled DNA template from relaxation at 50 uM after 30 mins by agarose gel electrophoresis relative to control\n",
            "Title: Selective Inhibition of Bacterial Topoisomerase I by alkynyl-bisbenzimidazoles.  Abstract: Hoechst dyes are well known DNA binders that non-selectively inhibit the function of mammalian topoisomerase I and II. Herein, we show that Hoechst 33258 based bisbenzimidazoles (DPA 151-154), containing a terminal alkyne, are effective and selective inhibitors of E. coli. topoisomerase I. These bisbenzimidazoles displayed topoisomerase I inhibition much better than Hoechst 33342 or Hoechst 33258 with IC50 values in the range of 2.47-6.63 M. Bisbenzimidazoles DPA 151-154 also display selective inhibition of E. coli. topoisomerase I over DNA gyrase and Human topoisomerases I and II, and effectively inhibit bacterial growth.\n",
            "1228597\n",
            "Inhibition of recombinant topoisomerase 1 (unknown origin) assessed as DNA cleavage using 3'-[32P]-labeled 117-bp DNA oligonucleotide at 0.1 uM by PAGE assay\n",
            "Title: Discovery of potent indenoisoquinoline topoisomerase I poisons lacking the 3-nitro toxicophore.  Abstract: 3-Nitroindenoisoquinoline human topoisomerase IB (Top1) poisons have potent antiproliferative effects on cancer cells. The undesirable nitro toxicophore could hypothetically be replaced by other functional groups that would retain the desired biological activities and minimize potential safety risks. Eleven series of indenoisoquinolines bearing 3-nitro bioisosteres were synthesized. The molecules were evaluated in the Top1-mediated DNA cleavage assay and in the National Cancer Institute's 60 cell line cytotoxicity assay. The data reveal that fluorine and chlorine may substitute for the 3-nitro group with minimal loss of Top1 poisoning activity. The new information gained from these efforts can be used to design novel indenoisoquinolines with improved safety.\n",
            "1228598\n",
            "Inhibition of recombinant topoisomerase 1 (unknown origin) assessed as DNA cleavage using 3'-[32P]-labeled 117-bp DNA oligonucleotide at 1 uM by PAGE assay\n",
            "Title: Discovery of potent indenoisoquinoline topoisomerase I poisons lacking the 3-nitro toxicophore.  Abstract: 3-Nitroindenoisoquinoline human topoisomerase IB (Top1) poisons have potent antiproliferative effects on cancer cells. The undesirable nitro toxicophore could hypothetically be replaced by other functional groups that would retain the desired biological activities and minimize potential safety risks. Eleven series of indenoisoquinolines bearing 3-nitro bioisosteres were synthesized. The molecules were evaluated in the Top1-mediated DNA cleavage assay and in the National Cancer Institute's 60 cell line cytotoxicity assay. The data reveal that fluorine and chlorine may substitute for the 3-nitro group with minimal loss of Top1 poisoning activity. The new information gained from these efforts can be used to design novel indenoisoquinolines with improved safety.\n",
            "1228599\n",
            "Inhibition of recombinant topoisomerase 1 (unknown origin) assessed as DNA cleavage using 3'-[32P]-labeled 117-bp DNA oligonucleotide at 10 uM by PAGE assay\n",
            "Title: Discovery of potent indenoisoquinoline topoisomerase I poisons lacking the 3-nitro toxicophore.  Abstract: 3-Nitroindenoisoquinoline human topoisomerase IB (Top1) poisons have potent antiproliferative effects on cancer cells. The undesirable nitro toxicophore could hypothetically be replaced by other functional groups that would retain the desired biological activities and minimize potential safety risks. Eleven series of indenoisoquinolines bearing 3-nitro bioisosteres were synthesized. The molecules were evaluated in the Top1-mediated DNA cleavage assay and in the National Cancer Institute's 60 cell line cytotoxicity assay. The data reveal that fluorine and chlorine may substitute for the 3-nitro group with minimal loss of Top1 poisoning activity. The new information gained from these efforts can be used to design novel indenoisoquinolines with improved safety.\n",
            "1228600\n",
            "Inhibition of recombinant topoisomerase 1 (unknown origin) assessed as DNA cleavage using 3'-[32P]-labeled 117-bp DNA oligonucleotide at 100 uM by PAGE assay\n",
            "Title: Discovery of potent indenoisoquinoline topoisomerase I poisons lacking the 3-nitro toxicophore.  Abstract: 3-Nitroindenoisoquinoline human topoisomerase IB (Top1) poisons have potent antiproliferative effects on cancer cells. The undesirable nitro toxicophore could hypothetically be replaced by other functional groups that would retain the desired biological activities and minimize potential safety risks. Eleven series of indenoisoquinolines bearing 3-nitro bioisosteres were synthesized. The molecules were evaluated in the Top1-mediated DNA cleavage assay and in the National Cancer Institute's 60 cell line cytotoxicity assay. The data reveal that fluorine and chlorine may substitute for the 3-nitro group with minimal loss of Top1 poisoning activity. The new information gained from these efforts can be used to design novel indenoisoquinolines with improved safety.\n",
            "1231675\n",
            "Inhibition of recombinant human DNA topoisomerase-1 assessed as relaxation of supercoiled DNA pBR322 at 100 uM after 30 mins by agarose gel electrophoresis relative to control\n",
            "Title: Topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of dihydroxylated 2,6-diphenyl-4-aryl pyridines.  Abstract: A new series of thirty-six dihydroxylated 2,6-diphenyl-4-aryl pyridines containing hydroxyl groups at the ortho, meta, or para position of 2- and 6-phenyl rings attached to the central pyridine were designed and synthesized. They were evaluated for topoisomerase I and II inhibitory activity and cytotoxicity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds with hydroxyl moiety either at the meta or para position of 2- or 6-phenyl ring in combination with thienyl or furyl group at 4-position of central pyridine displayed significant topoisomerase II inhibitory activity and cytotoxicity. Positive correlation between topoisomerase II inhibitory activity and cytotoxicity was observed for the compounds 9-11, 15-17, 19, 21-23, 28, and 41. Among all the synthesized compounds, compound 17 emerged as the most promising topoisomerase II inhibitor with significant cytotoxicity.\n",
            "1231676\n",
            "Inhibition of recombinant human DNA topoisomerase-1 assessed as relaxation of supercoiled DNA pBR322 at 20 uM after 30 mins by agarose gel electrophoresis relative to control\n",
            "Title: Topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of dihydroxylated 2,6-diphenyl-4-aryl pyridines.  Abstract: A new series of thirty-six dihydroxylated 2,6-diphenyl-4-aryl pyridines containing hydroxyl groups at the ortho, meta, or para position of 2- and 6-phenyl rings attached to the central pyridine were designed and synthesized. They were evaluated for topoisomerase I and II inhibitory activity and cytotoxicity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds with hydroxyl moiety either at the meta or para position of 2- or 6-phenyl ring in combination with thienyl or furyl group at 4-position of central pyridine displayed significant topoisomerase II inhibitory activity and cytotoxicity. Positive correlation between topoisomerase II inhibitory activity and cytotoxicity was observed for the compounds 9-11, 15-17, 19, 21-23, 28, and 41. Among all the synthesized compounds, compound 17 emerged as the most promising topoisomerase II inhibitor with significant cytotoxicity.\n",
            "1236890\n",
            "Inhibition of human recombinant DNA topoisomerse 1 using pBR322 as substrate assessed as inhibition of conversion of supercoiled pBR322 to relaxed form at 100 uM after 30 mins by ethidium bromide staining-based electrophoresis analysis\n",
            "Title: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines.  Abstract: A series of novel twenty-eight rigid 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines were synthesized and evaluated for their topoisomerase inhibitory activity as well as their cytotoxicity against several human cancer cell lines. Generally, hydroxylated compounds (16-18, 22-25, and 29-31) containing furyl or thienyl moiety at 4-position of central pyridine exhibited strong topoisomerase I and II inhibitory activity compared to positive control, camptothecin and etoposide, respectively, in low micromolar range. Structure-activity relationship study revealed that indenopyridine compounds with hydroxyl group at 2-phenyl ring in combination with furyl or thienyl moiety at 4-position are important for topoisomerase inhibition. Compounds (22-25) which contain hydroxyl group at meta position of the 2-phenyl ring at 2-position and furanyl or thienyl substitution at 4-position of indenopyridine, showed concrete correlations between topo I and II inhibitory activity, and cytotoxicity against evaluated human cancer cell lines.\n",
            "1236891\n",
            "Inhibition of human recombinant DNA topoisomerse 1 using pBR322 as substrate assessed as inhibition of conversion of supercoiled pBR322 to relaxed form at 20 uM after 30 mins by ethidium bromide staining-based electrophoresis analysis\n",
            "Title: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines.  Abstract: A series of novel twenty-eight rigid 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines were synthesized and evaluated for their topoisomerase inhibitory activity as well as their cytotoxicity against several human cancer cell lines. Generally, hydroxylated compounds (16-18, 22-25, and 29-31) containing furyl or thienyl moiety at 4-position of central pyridine exhibited strong topoisomerase I and II inhibitory activity compared to positive control, camptothecin and etoposide, respectively, in low micromolar range. Structure-activity relationship study revealed that indenopyridine compounds with hydroxyl group at 2-phenyl ring in combination with furyl or thienyl moiety at 4-position are important for topoisomerase inhibition. Compounds (22-25) which contain hydroxyl group at meta position of the 2-phenyl ring at 2-position and furanyl or thienyl substitution at 4-position of indenopyridine, showed concrete correlations between topo I and II inhibitory activity, and cytotoxicity against evaluated human cancer cell lines.\n",
            "1239195\n",
            "Inhibition of Top1 (unknown origin)-mediated pBR322 DNA cleavage using ethidium bromide staining at 200 uM after 15 mins by electrophoresis analysis\n",
            "Title: Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents.  Abstract: A critical question in natural product-based drug discovery is how to translate the product into drug-like molecules with optimal pharmacological properties. The generation of natural product-inspired scaffold diversity is an effective but challenging strategy to investigate the broader chemical space and identify promising drug leads. Extending our efforts to the natural product evodiamine, a diverse library containing 11 evodiamine-inspired novel scaffolds and their derivatives were designed and synthesized. Most of them showed good to excellent antitumor activity against various human cancer cell lines. In particular, 3-chloro-10-hydroxyl thio-evodiamine (66c) showed excellent in vitro and in vivo antitumor efficacy with good tolerability and low toxicity. Antitumor mechanism and target profiling studies indicate that compound 66c is the first-in-class triple topoisomerase I/topoisomerase II/tubulin inhibitor. Overall, this study provided an effective strategy for natural product-based drug discovery.\n",
            "1239196\n",
            "Inhibition of Top1 (unknown origin)-mediated pBR322 DNA cleavage using ethidium bromide staining at 100 uM after 15 mins by electrophoresis analysis\n",
            "Title: Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents.  Abstract: A critical question in natural product-based drug discovery is how to translate the product into drug-like molecules with optimal pharmacological properties. The generation of natural product-inspired scaffold diversity is an effective but challenging strategy to investigate the broader chemical space and identify promising drug leads. Extending our efforts to the natural product evodiamine, a diverse library containing 11 evodiamine-inspired novel scaffolds and their derivatives were designed and synthesized. Most of them showed good to excellent antitumor activity against various human cancer cell lines. In particular, 3-chloro-10-hydroxyl thio-evodiamine (66c) showed excellent in vitro and in vivo antitumor efficacy with good tolerability and low toxicity. Antitumor mechanism and target profiling studies indicate that compound 66c is the first-in-class triple topoisomerase I/topoisomerase II/tubulin inhibitor. Overall, this study provided an effective strategy for natural product-based drug discovery.\n",
            "1239197\n",
            "Inhibition of Top1 (unknown origin)-mediated pBR322 DNA cleavage using ethidium bromide staining at 50 uM after 15 mins by electrophoresis analysis\n",
            "Title: Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents.  Abstract: A critical question in natural product-based drug discovery is how to translate the product into drug-like molecules with optimal pharmacological properties. The generation of natural product-inspired scaffold diversity is an effective but challenging strategy to investigate the broader chemical space and identify promising drug leads. Extending our efforts to the natural product evodiamine, a diverse library containing 11 evodiamine-inspired novel scaffolds and their derivatives were designed and synthesized. Most of them showed good to excellent antitumor activity against various human cancer cell lines. In particular, 3-chloro-10-hydroxyl thio-evodiamine (66c) showed excellent in vitro and in vivo antitumor efficacy with good tolerability and low toxicity. Antitumor mechanism and target profiling studies indicate that compound 66c is the first-in-class triple topoisomerase I/topoisomerase II/tubulin inhibitor. Overall, this study provided an effective strategy for natural product-based drug discovery.\n",
            "1240569\n",
            "Inhibition of human topoisomerase-1 assessed as reduction in enzyme-mediated DNA relaxation at 100 uM incubated for 30 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Imine/amide-imidazole conjugates derived from 5-amino-4-cyano-N1-substituted benzyl imidazole: Microwave-assisted synthesis and anticancer activity via selective topoisomerase-II- inhibition.  Abstract: Microwave-accelerated synthesis and anticancer activity of novel imine/amide-imidazole conjugates derived from 5-amino-4-cyano-N1-substituted benzyl imidazole against a panel of seven cancer cell lines are reported for the first time. Compounds ARK-4, 10 and 12 in the series show promising in vitro anti proliferative activity with low micromolar IC50 values against A-459 (lung), Hep-G2 (liver) and H-460 (liver) cancer cell lines. Compounds caused the increase in ROS levels as well as mitochondrial membrane depolarization, which might induce apoptosis. Further, mechanistic interventions on biological and molecular modeling data supported that compounds inhibited topoisomerase-II selectively.\n",
            "1244074\n",
            "Induction of recombinant Top1 (unknown origin) assessed as 3'-[32P]-labeled 117-bp DNA oligonucleotide cleavage after 20 mins\n",
            "Title: Synthesis and biological evaluation of 6-substituted indolizinoquinolinediones as catalytic DNA topoisomerase I inhibitors.  Abstract: In our previous work, indolizinoquinolinedione derivative 1 was identified as a Top1 catalytic inhibitor. Herein, a series of 6-substituted indolizinoquinolinedione derivatives were synthesized through modification of the parent compound 1. Top1 cleavage and relaxation assays indicate that none of these novel compounds act as classical Top1 poison, and that the compounds with alkylamino terminus at C-6 side chain, including 8, 11-16, 18-21, 25, 26 and 28-30, are the most potent Top1 catalytic inhibitors. Top1-mediated unwinding assay demonstrated that 14, 22 and 26 were Top1 catalytic inhibitors without Top1-mediated unwinding effect. Moreover, MTT results showed that compounds 26, 28-30 exhibit significant cytotoxicity against human leukemia HL-60 cells, and that compound 26 exerts potent cytotoxicity against A549 lung cancer cells at nanomolar range.\n",
            "1244077\n",
            "Inhibition of Top1 (unknown origin)-mediated unwinding of relaxed pBR322 DNA preincubated for 10 mins measured after 30 mins by UV transilluminator analysis\n",
            "Title: Synthesis and biological evaluation of 6-substituted indolizinoquinolinediones as catalytic DNA topoisomerase I inhibitors.  Abstract: In our previous work, indolizinoquinolinedione derivative 1 was identified as a Top1 catalytic inhibitor. Herein, a series of 6-substituted indolizinoquinolinedione derivatives were synthesized through modification of the parent compound 1. Top1 cleavage and relaxation assays indicate that none of these novel compounds act as classical Top1 poison, and that the compounds with alkylamino terminus at C-6 side chain, including 8, 11-16, 18-21, 25, 26 and 28-30, are the most potent Top1 catalytic inhibitors. Top1-mediated unwinding assay demonstrated that 14, 22 and 26 were Top1 catalytic inhibitors without Top1-mediated unwinding effect. Moreover, MTT results showed that compounds 26, 28-30 exhibit significant cytotoxicity against human leukemia HL-60 cells, and that compound 26 exerts potent cytotoxicity against A549 lung cancer cells at nanomolar range.\n",
            "1245883\n",
            "Inhibition of human recombinant DNA topoisomerase 1 assessed as relaxation of supercoiled pBR322 DNA at 100 uM after 30 mins using ethidium bromide staining by agarose gel electrophoresis\n",
            "Title: Design and synthesis of conformationally constrained hydroxylated 4-phenyl-2-aryl chromenopyridines as novel and selective topoisomerase II-targeted antiproliferative agents.  Abstract: To develop novel selective topoisomerase II inhibitors, we designed and synthesized a series of conformationally constrained hydroxylated 4-phenyl-2-aryl chromenopyridines and evaluated their topoisomerase inhibitory activity and cytotoxicity against three human cancer cell lines (DU145, HCT15, and T47D) and a normal cell line (MCF10A). All of the prepared compounds displayed stronger or similar topoisomerase II inhibitory activity as well as cytotoxicity against three human cancer cell lines compared to etoposide. Compounds 10a, 10g, 11a, 11f, 11g, 12a, 12f, and 12g especially showed stronger topoisomerase II inhibitory activity as compared to etoposide at both 100 M and 20 M. A structure-activity relationship study revealed that hydroxyphenyl moiety at 4-position of pyridine and ortho-hydroxyphenyl or thienyl moiety at 2-position of pyridine has an important role in displaying selective topoisomerase II inhibition. The compound 12b with para-hydroxyphenyl and meta-hydroxyphenyl at 4- and 2-position of pyridine, respectively, showed the most significant cytotoxicity against all three cancer cell lines, whereas less cytotoxicity to a normal cell line as compared to adriamycin.\n",
            "1245884\n",
            "Inhibition of human recombinant DNA topoisomerase 1 assessed as relaxation of supercoiled pBR322 DNA at 20 uM after 30 mins using ethidium bromide staining by agarose gel electrophoresis\n",
            "Title: Design and synthesis of conformationally constrained hydroxylated 4-phenyl-2-aryl chromenopyridines as novel and selective topoisomerase II-targeted antiproliferative agents.  Abstract: To develop novel selective topoisomerase II inhibitors, we designed and synthesized a series of conformationally constrained hydroxylated 4-phenyl-2-aryl chromenopyridines and evaluated their topoisomerase inhibitory activity and cytotoxicity against three human cancer cell lines (DU145, HCT15, and T47D) and a normal cell line (MCF10A). All of the prepared compounds displayed stronger or similar topoisomerase II inhibitory activity as well as cytotoxicity against three human cancer cell lines compared to etoposide. Compounds 10a, 10g, 11a, 11f, 11g, 12a, 12f, and 12g especially showed stronger topoisomerase II inhibitory activity as compared to etoposide at both 100 M and 20 M. A structure-activity relationship study revealed that hydroxyphenyl moiety at 4-position of pyridine and ortho-hydroxyphenyl or thienyl moiety at 2-position of pyridine has an important role in displaying selective topoisomerase II inhibition. The compound 12b with para-hydroxyphenyl and meta-hydroxyphenyl at 4- and 2-position of pyridine, respectively, showed the most significant cytotoxicity against all three cancer cell lines, whereas less cytotoxicity to a normal cell line as compared to adriamycin.\n",
            "1250350\n",
            "Inhibition of wild type recombinant human Top1 expressed in baculovirus infected insect Sf9 cells assessed as decrease in supercoiled pBS(SK+) DNA isomer relaxation preincubated for 5 mins followed by pBS(SK+) DNA addition by agarose gel electrophoresis\n",
            "Title: Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.  Abstract: DNA topoisomerase I is a potential chemotherapeutic target. Here, we designed and synthesized a library comprising of hydantoin and thiohydantoin derivatives and tested them against human and Leishmania Top1. One of the thiohydantoin compounds with substituted thiophenyl as the central moiety (compound 15) exhibited potent inhibition of human Top1 (HTop1) through stabilization of Top1-DNA cleavage complexes and showed selective anticancer activity against human cervical carcinoma (HeLa) and breast carcinoma (MCF-7) cell lines. Molecular modeling studies with HTop1 rationalized the inhibitory mechanism of compound 15.\n",
            "1250351\n",
            "Inhibition of wild type recombinant human Top1 expressed in baculovirus infected insect Sf9 cells assessed as decrease in supercoiled pBS(SK+) DNA isomer relaxation at 10 uM preincubated for 5 mins followed by pBS(SK+) DNA addition by agarose gel electrophoresis\n",
            "Title: Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.  Abstract: DNA topoisomerase I is a potential chemotherapeutic target. Here, we designed and synthesized a library comprising of hydantoin and thiohydantoin derivatives and tested them against human and Leishmania Top1. One of the thiohydantoin compounds with substituted thiophenyl as the central moiety (compound 15) exhibited potent inhibition of human Top1 (HTop1) through stabilization of Top1-DNA cleavage complexes and showed selective anticancer activity against human cervical carcinoma (HeLa) and breast carcinoma (MCF-7) cell lines. Molecular modeling studies with HTop1 rationalized the inhibitory mechanism of compound 15.\n",
            "1250352\n",
            "Inhibition of wild type recombinant human Top1 expressed in baculovirus infected insect Sf9 cells assessed as decrease in supercoiled pBS(SK+) DNA isomer relaxation at 5 to 200 uM incubated simultaneously with enzyme and pBS(SK+) DNA for 30 mins by agarose gel electrophoresis\n",
            "Title: Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.  Abstract: DNA topoisomerase I is a potential chemotherapeutic target. Here, we designed and synthesized a library comprising of hydantoin and thiohydantoin derivatives and tested them against human and Leishmania Top1. One of the thiohydantoin compounds with substituted thiophenyl as the central moiety (compound 15) exhibited potent inhibition of human Top1 (HTop1) through stabilization of Top1-DNA cleavage complexes and showed selective anticancer activity against human cervical carcinoma (HeLa) and breast carcinoma (MCF-7) cell lines. Molecular modeling studies with HTop1 rationalized the inhibitory mechanism of compound 15.\n",
            "1250353\n",
            "Inhibition of wild type recombinant human Top1 expressed in baculovirus infected insect Sf9 cells assessed as decrease in supercoiled pBS(SK+) DNA isomer relaxation at 10 uM incubated simultaneously with enzyme and pBS(SK+) DNA for 30 mins by agarose gel electrophoresis\n",
            "Title: Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.  Abstract: DNA topoisomerase I is a potential chemotherapeutic target. Here, we designed and synthesized a library comprising of hydantoin and thiohydantoin derivatives and tested them against human and Leishmania Top1. One of the thiohydantoin compounds with substituted thiophenyl as the central moiety (compound 15) exhibited potent inhibition of human Top1 (HTop1) through stabilization of Top1-DNA cleavage complexes and showed selective anticancer activity against human cervical carcinoma (HeLa) and breast carcinoma (MCF-7) cell lines. Molecular modeling studies with HTop1 rationalized the inhibitory mechanism of compound 15.\n",
            "1250357\n",
            "Inhibition of human Top1 in human MCF7 cells assessed as decrease in supercoiled pBS(SK+) DNA isomer relaxation at 5 to 200 uM preincubated for 5 mins followed by pBS(SK+) DNA addition by agarose gel electrophoresis\n",
            "Title: Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.  Abstract: DNA topoisomerase I is a potential chemotherapeutic target. Here, we designed and synthesized a library comprising of hydantoin and thiohydantoin derivatives and tested them against human and Leishmania Top1. One of the thiohydantoin compounds with substituted thiophenyl as the central moiety (compound 15) exhibited potent inhibition of human Top1 (HTop1) through stabilization of Top1-DNA cleavage complexes and showed selective anticancer activity against human cervical carcinoma (HeLa) and breast carcinoma (MCF-7) cell lines. Molecular modeling studies with HTop1 rationalized the inhibitory mechanism of compound 15.\n",
            "1250358\n",
            "Inhibition of human Top1 in human MCF7 cells assessed as decrease in supercoiled pBS(SK+) DNA isomer relaxation at 5 to 200 uM incubated simultaneously with enzyme and pBS(SK+) DNA for 30 mins by agarose gel electrophoresis\n",
            "Title: Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.  Abstract: DNA topoisomerase I is a potential chemotherapeutic target. Here, we designed and synthesized a library comprising of hydantoin and thiohydantoin derivatives and tested them against human and Leishmania Top1. One of the thiohydantoin compounds with substituted thiophenyl as the central moiety (compound 15) exhibited potent inhibition of human Top1 (HTop1) through stabilization of Top1-DNA cleavage complexes and showed selective anticancer activity against human cervical carcinoma (HeLa) and breast carcinoma (MCF-7) cell lines. Molecular modeling studies with HTop1 rationalized the inhibitory mechanism of compound 15.\n",
            "1250359\n",
            "Inhibition of wild type recombinant human Top1 expressed in baculovirus infected insect Sf9 cells assessed as stabilization of Top1-cleavage complexes at 50 to 200 uM incubated for 30 mins by agarose gel electrophoresis\n",
            "Title: Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.  Abstract: DNA topoisomerase I is a potential chemotherapeutic target. Here, we designed and synthesized a library comprising of hydantoin and thiohydantoin derivatives and tested them against human and Leishmania Top1. One of the thiohydantoin compounds with substituted thiophenyl as the central moiety (compound 15) exhibited potent inhibition of human Top1 (HTop1) through stabilization of Top1-DNA cleavage complexes and showed selective anticancer activity against human cervical carcinoma (HeLa) and breast carcinoma (MCF-7) cell lines. Molecular modeling studies with HTop1 rationalized the inhibitory mechanism of compound 15.\n",
            "1250360\n",
            "Inhibition of wild type recombinant human Top1 expressed in baculovirus infected insect Sf9 cells assessed as stabilization of Top1-cleavage complexes at 50 uM incubated for 30 mins by agarose gel electrophoresis\n",
            "Title: Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.  Abstract: DNA topoisomerase I is a potential chemotherapeutic target. Here, we designed and synthesized a library comprising of hydantoin and thiohydantoin derivatives and tested them against human and Leishmania Top1. One of the thiohydantoin compounds with substituted thiophenyl as the central moiety (compound 15) exhibited potent inhibition of human Top1 (HTop1) through stabilization of Top1-DNA cleavage complexes and showed selective anticancer activity against human cervical carcinoma (HeLa) and breast carcinoma (MCF-7) cell lines. Molecular modeling studies with HTop1 rationalized the inhibitory mechanism of compound 15.\n",
            "1251496\n",
            "Inhibition of recombinant human DNA topoisomerase-1 assessed as relaxation of supercoiled pBR322 DNA after 30 mins by agarose gel electrophoresis\n",
            "Title: Design, synthesis and antitumor activity of non-camptothecin topoisomerase I inhibitors.  Abstract: Three groups of non-camptothecin compounds with four to five fused rings have been designed and synthesized. Their in vitro anti-proliferative activity has been evaluated with five different cancer cell lines (HCT116, PC3, U87MG, HepG2, SK-OV-3). Compounds B-2 and B-3 showed the most potent cell growth inhibition with IC50 of 169 nM and 325 nM against U87MG cell line correspondingly.\n",
            "1251505\n",
            "Inhibition of recombinant human DNA topoisomerase-1 assessed as relaxation of supercoiled pBR322 DNA at 50 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Design, synthesis and antitumor activity of non-camptothecin topoisomerase I inhibitors.  Abstract: Three groups of non-camptothecin compounds with four to five fused rings have been designed and synthesized. Their in vitro anti-proliferative activity has been evaluated with five different cancer cell lines (HCT116, PC3, U87MG, HepG2, SK-OV-3). Compounds B-2 and B-3 showed the most potent cell growth inhibition with IC50 of 169 nM and 325 nM against U87MG cell line correspondingly.\n",
            "1252045\n",
            "Inhibition of human recombinant topoisomerase 1 assessed as blocking of supercoiled pHOT DNA relaxation at 50 uM incubated for 25 mins at 37 degC by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Structure-based hybridization, synthesis and biological evaluation of novel tetracyclic heterocyclic azathioxanthone analogues as potential antitumor agents.  Abstract: A series of tetracyclic heterocyclic azathioxanthones were synthesized and evaluated for cell proliferations, topoisomerase inhibitions, and NCI-60 cell panel assay, respectively. Compounds 5, 7, 8, 16, and 19 were selected for topoisomerase assay after MTT assay. 7 not only showed cytotoxic effect (IC50 = 2.84  0.64 M) in PC-3 cells but also revealed topoisomerases inhibition with IC50 (10-25 M) and increased apoptotic cleavage of PARP and caspase 3 activity. The overall of novel azathioxanthones with different cytostatic and cytotoxic activities should be further developed as new potential candidates for anticancer drugs.\n",
            "1252046\n",
            "Inhibition of human recombinant topoisomerase 1 assessed as blocking of supercoiled pHOT DNA relaxation at 25 uM incubated for 25 mins at 37 degC by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Structure-based hybridization, synthesis and biological evaluation of novel tetracyclic heterocyclic azathioxanthone analogues as potential antitumor agents.  Abstract: A series of tetracyclic heterocyclic azathioxanthones were synthesized and evaluated for cell proliferations, topoisomerase inhibitions, and NCI-60 cell panel assay, respectively. Compounds 5, 7, 8, 16, and 19 were selected for topoisomerase assay after MTT assay. 7 not only showed cytotoxic effect (IC50 = 2.84  0.64 M) in PC-3 cells but also revealed topoisomerases inhibition with IC50 (10-25 M) and increased apoptotic cleavage of PARP and caspase 3 activity. The overall of novel azathioxanthones with different cytostatic and cytotoxic activities should be further developed as new potential candidates for anticancer drugs.\n",
            "1252049\n",
            "Inhibition of human recombinant topoisomerase 1 assessed as blocking of supercoiled pHOT DNA relaxation at 10 uM incubated for 25 mins at 37 degC by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Structure-based hybridization, synthesis and biological evaluation of novel tetracyclic heterocyclic azathioxanthone analogues as potential antitumor agents.  Abstract: A series of tetracyclic heterocyclic azathioxanthones were synthesized and evaluated for cell proliferations, topoisomerase inhibitions, and NCI-60 cell panel assay, respectively. Compounds 5, 7, 8, 16, and 19 were selected for topoisomerase assay after MTT assay. 7 not only showed cytotoxic effect (IC50 = 2.84  0.64 M) in PC-3 cells but also revealed topoisomerases inhibition with IC50 (10-25 M) and increased apoptotic cleavage of PARP and caspase 3 activity. The overall of novel azathioxanthones with different cytostatic and cytotoxic activities should be further developed as new potential candidates for anticancer drugs.\n",
            "1252051\n",
            "Inhibition of human recombinant topoisomerase 1 assessed as blocking of supercoiled pHOT DNA relaxation incubated for 25 mins at 37 degC by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Structure-based hybridization, synthesis and biological evaluation of novel tetracyclic heterocyclic azathioxanthone analogues as potential antitumor agents.  Abstract: A series of tetracyclic heterocyclic azathioxanthones were synthesized and evaluated for cell proliferations, topoisomerase inhibitions, and NCI-60 cell panel assay, respectively. Compounds 5, 7, 8, 16, and 19 were selected for topoisomerase assay after MTT assay. 7 not only showed cytotoxic effect (IC50 = 2.84  0.64 M) in PC-3 cells but also revealed topoisomerases inhibition with IC50 (10-25 M) and increased apoptotic cleavage of PARP and caspase 3 activity. The overall of novel azathioxanthones with different cytostatic and cytotoxic activities should be further developed as new potential candidates for anticancer drugs.\n",
            "1254805\n",
            "Potency index, ratio of compound activity to CPT activity for inhibition of recombinant human topoisomerase 1 at 100 uM\n",
            "Title: Substituted 2-arylquinazolinones: Design, synthesis, and evaluation of cytotoxicity and inhibition of topoisomerases.  Abstract: A series of 2-arylquinazolinones with structural homology to known 3-arylisoquinolines were designed and synthesized in order to develop safe, effective, and selective cytotoxic agents targeting topoisomerases (topos). 2-Arylquinzolinones with various substitutions on the aromatic rings were obtained by thermal cyclodehydration/dehydrogenation on reacting anthranilamides and benzaldehydes. The compounds had superior topo I-inhibitory activities but were generally inactive against topo II. Among the 6-methyl-, 6-amino-, and 7-methylquinazolinones, 6-amino-substituted derivatives displayed potent cytotoxicity at submicromolar to nanomolar concentrations against human colorectal adenocarcinoma cells (HCT-15), human ductal breast epithelial tumor cells (T47D), and cervical cancer cells (HeLa). There was a good correlation between topo I inhibition and the cytotoxic effects of 6-aminoquinazolinones. Docking models demonstrated that topo I inhibition by these compounds is owing to intercalation and H-bond interactions with the DNA bases and amino acid residues at the enzymatic site.\n",
            "1254806\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as relaxation of supercoiled plasmid DNA pBR322 at 100 uM incubated for 30 mins by agarose gel electrophoresis\n",
            "Title: Substituted 2-arylquinazolinones: Design, synthesis, and evaluation of cytotoxicity and inhibition of topoisomerases.  Abstract: A series of 2-arylquinazolinones with structural homology to known 3-arylisoquinolines were designed and synthesized in order to develop safe, effective, and selective cytotoxic agents targeting topoisomerases (topos). 2-Arylquinzolinones with various substitutions on the aromatic rings were obtained by thermal cyclodehydration/dehydrogenation on reacting anthranilamides and benzaldehydes. The compounds had superior topo I-inhibitory activities but were generally inactive against topo II. Among the 6-methyl-, 6-amino-, and 7-methylquinazolinones, 6-amino-substituted derivatives displayed potent cytotoxicity at submicromolar to nanomolar concentrations against human colorectal adenocarcinoma cells (HCT-15), human ductal breast epithelial tumor cells (T47D), and cervical cancer cells (HeLa). There was a good correlation between topo I inhibition and the cytotoxic effects of 6-aminoquinazolinones. Docking models demonstrated that topo I inhibition by these compounds is owing to intercalation and H-bond interactions with the DNA bases and amino acid residues at the enzymatic site.\n",
            "1254807\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as relaxation of supercoiled plasmid DNA pBR322 at 20 uM incubated for 30 mins by agarose gel electrophoresis\n",
            "Title: Substituted 2-arylquinazolinones: Design, synthesis, and evaluation of cytotoxicity and inhibition of topoisomerases.  Abstract: A series of 2-arylquinazolinones with structural homology to known 3-arylisoquinolines were designed and synthesized in order to develop safe, effective, and selective cytotoxic agents targeting topoisomerases (topos). 2-Arylquinzolinones with various substitutions on the aromatic rings were obtained by thermal cyclodehydration/dehydrogenation on reacting anthranilamides and benzaldehydes. The compounds had superior topo I-inhibitory activities but were generally inactive against topo II. Among the 6-methyl-, 6-amino-, and 7-methylquinazolinones, 6-amino-substituted derivatives displayed potent cytotoxicity at submicromolar to nanomolar concentrations against human colorectal adenocarcinoma cells (HCT-15), human ductal breast epithelial tumor cells (T47D), and cervical cancer cells (HeLa). There was a good correlation between topo I inhibition and the cytotoxic effects of 6-aminoquinazolinones. Docking models demonstrated that topo I inhibition by these compounds is owing to intercalation and H-bond interactions with the DNA bases and amino acid residues at the enzymatic site.\n",
            "1254810\n",
            "Potency index, ratio of compound activity to CPT activity for inhibition of recombinant human topoisomerase 1 at 20 uM\n",
            "Title: Substituted 2-arylquinazolinones: Design, synthesis, and evaluation of cytotoxicity and inhibition of topoisomerases.  Abstract: A series of 2-arylquinazolinones with structural homology to known 3-arylisoquinolines were designed and synthesized in order to develop safe, effective, and selective cytotoxic agents targeting topoisomerases (topos). 2-Arylquinzolinones with various substitutions on the aromatic rings were obtained by thermal cyclodehydration/dehydrogenation on reacting anthranilamides and benzaldehydes. The compounds had superior topo I-inhibitory activities but were generally inactive against topo II. Among the 6-methyl-, 6-amino-, and 7-methylquinazolinones, 6-amino-substituted derivatives displayed potent cytotoxicity at submicromolar to nanomolar concentrations against human colorectal adenocarcinoma cells (HCT-15), human ductal breast epithelial tumor cells (T47D), and cervical cancer cells (HeLa). There was a good correlation between topo I inhibition and the cytotoxic effects of 6-aminoquinazolinones. Docking models demonstrated that topo I inhibition by these compounds is owing to intercalation and H-bond interactions with the DNA bases and amino acid residues at the enzymatic site.\n",
            "1264620\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as decrease in PBR322 DNA relaxation at 5 to 40 uM after 30 mins by ethidium bromide staining-based agarose gel electrophoresis\n",
            "Title: Versixanthones A-F, Cytotoxic Xanthone-Chromanone Dimers from the Marine-Derived Fungus Aspergillus versicolor HDN1009.  Abstract: Six unusual xanthone-chromanone dimers, versixanthones A-F (1-6), featuring different formal linkages of tetrahydroxanthone and 2,2-disubstituted chroman-4-one monomers, were isolated from a culture of the mangrove-derived fungus Aspergillus versicolor HDN1009. The absolute configurations of 1-6, representing the central and axial chirality elements or preferred helicities, were established by a combination of X-ray diffraction analysis, chemical conversions, and TDDFT-ECD calculations. The interconversion of different biaryl linkages between 1 and 4 and between 2 and 3 in DMSO by a retro-oxa-Michael mechanism provided insight into the formation of the xanthone-chromanone dimers and supported the assignments of their absolute configurations. Compounds 1-6 exhibited cytotoxicities against the seven tested cancer cell lines, with the best IC50 value of 0.7 M. Compound 5 showed further inhibitory activity against topoisomerase I.\n",
            "1265043\n",
            "Inhibition of human topoisomerase-1-mediated relaxation of supercoiled plasmid pBR322 DNA at 1 to 100 uM after 30 mins by ethidium bromide staining\n",
            "Title: Synthesis of functionalized new conjugates of batracylin with tuftsin/retro-tuftsin derivatives and their biological evaluation.  Abstract: New batracylin conjugates with tuftsin/retro-tuftsin derivatives were designed and synthesized using T3P as a coupling agent. The conjugates possess an amide bond formed between the carboxyl group of heterocyclic molecule and the N-termini of the tuftsin/retro-tuftsin chain. The in vitro cytotoxic activity of the new analogues and their precursors was evaluated using a series of human and murine tumor cells. BAT conjugates containing retro-tuftsin with branched side aminoacid chain, in particular with leucine or isoleucine, were about 10-fold more cytotoxic toward two human tumor cell lines (lung adenocarcinoma (A549) and myeloblastic leukemia (HL-60)). These compounds showed about 10-fold increased cytotoxicity against the two types of tumor cells compared to parent BAT. We have not observed important differences in the mechanism of action between BAT and its cytotoxic tuftsin/retro-tuftsin conjugates. We propose that high biological activity of the most active BAT conjugates is a result of their greatly increased intracellular accumulation.\n",
            "1268056\n",
            "Inhibition of Top1 (unknown origin)-mediated relaxation of pBR322 DNA at 2.5 uM incubated for 30 mins by ethidium bromide staining-based gel electrophoresis assay\n",
            "Title: Synthesis and Characterization of 4,11-Diaminoanthra[2,3-b]furan-5,10-diones: Tumor Cell Apoptosis through tNOX-Modulated NAD(+)/NADH Ratio and SIRT1.  Abstract: A series of new 4,11-diaminoanthra[2,3-b]furan-5,10-dione derivatives with different side chains were synthesized. Selected 2-unsubstituted derivatives 11-14 showed high antiproliferative potency on a panel of mammalian tumor cell lines including multidrug resistance variants. Compounds 11-14 utilized multiple mechanisms of cytotoxicity including inhibition of Top1/Top2-mediated DNA relaxation, reduced NAD(+)/NADH ratio through tNOX inhibition, suppression of a NAD(+)-dependent sirtuin 1 (SIRT1) deacetylase activity, and activation of caspase-mediated apoptosis. Here, for the first time, we report that tumor-associated NADH oxidase (tNOX) and SIRT1 are important cellular targets of antitumor anthracene-9,10-diones.\n",
            "1268057\n",
            "Inhibition of Top1 (unknown origin)-mediated relaxation of pBR322 DNA at 0.5 to 10 uM incubated for 30 mins by ethidium bromide staining-based gel electrophoresis assay\n",
            "Title: Synthesis and Characterization of 4,11-Diaminoanthra[2,3-b]furan-5,10-diones: Tumor Cell Apoptosis through tNOX-Modulated NAD(+)/NADH Ratio and SIRT1.  Abstract: A series of new 4,11-diaminoanthra[2,3-b]furan-5,10-dione derivatives with different side chains were synthesized. Selected 2-unsubstituted derivatives 11-14 showed high antiproliferative potency on a panel of mammalian tumor cell lines including multidrug resistance variants. Compounds 11-14 utilized multiple mechanisms of cytotoxicity including inhibition of Top1/Top2-mediated DNA relaxation, reduced NAD(+)/NADH ratio through tNOX inhibition, suppression of a NAD(+)-dependent sirtuin 1 (SIRT1) deacetylase activity, and activation of caspase-mediated apoptosis. Here, for the first time, we report that tumor-associated NADH oxidase (tNOX) and SIRT1 are important cellular targets of antitumor anthracene-9,10-diones.\n",
            "1268058\n",
            "Inhibition of Top1 (unknown origin)-mediated relaxation of pBR322 DNA at 0.5 uM incubated for 30 mins by ethidium bromide staining-based gel electrophoresis assay\n",
            "Title: Synthesis and Characterization of 4,11-Diaminoanthra[2,3-b]furan-5,10-diones: Tumor Cell Apoptosis through tNOX-Modulated NAD(+)/NADH Ratio and SIRT1.  Abstract: A series of new 4,11-diaminoanthra[2,3-b]furan-5,10-dione derivatives with different side chains were synthesized. Selected 2-unsubstituted derivatives 11-14 showed high antiproliferative potency on a panel of mammalian tumor cell lines including multidrug resistance variants. Compounds 11-14 utilized multiple mechanisms of cytotoxicity including inhibition of Top1/Top2-mediated DNA relaxation, reduced NAD(+)/NADH ratio through tNOX inhibition, suppression of a NAD(+)-dependent sirtuin 1 (SIRT1) deacetylase activity, and activation of caspase-mediated apoptosis. Here, for the first time, we report that tumor-associated NADH oxidase (tNOX) and SIRT1 are important cellular targets of antitumor anthracene-9,10-diones.\n",
            "1269401\n",
            "Inhibition of topoisomerase-1 (unknown origin)-mediated super-coiled DNA relaxation after 30 mins by agarose gel electrophoresis\n",
            "Title: Design, synthesis and biological evaluation of 3-substituted indenoisoquinoline derivatives as topoisomerase I inhibitors.  Abstract: A new series of indenoisoquinoline derivatives was designed and synthesized. The in vitro anti-proliferative activity of these novel compounds was evaluated in HepG2, A549 and HCT-116 cell lines. Compounds 9a, 9b, 10a, 10c, 10e, 18a and 18b manifested potent inhibitory activity against the three tested cancer cell lines. Nineteen compounds were also tested for Top I inhibition at 50 M. Almost all the tested compounds showed potent Top I inhibition activity at this concentration. The most potent compounds 9a and 10a demonstrated more cytotoxicity than HCPT and TPT and was comparable to CPT in inhibitory activities on Top I in our biological assay.\n",
            "1273775\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as relaxation of supercoiled pHOT1 at 10 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: 3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression.  Abstract: A series of unknown 3-(alkyl(dialkyl)amino)benzofuro[2,3-f]quinazolin-1(2H)-ones 4-17 has been synthesized as new ellipticine analogs, in which the carbazole moiety and the pyridine ring were replaced by a dibenzofuran residue and a pyrimidine ring, respectively. The synthesis of these benzofuroquinazolinones 4-17 was performed in a simple one-pot reaction using 3-aminodibenzofuran or its 2-methoxy derivative, as starting materials. From 3-(dipropylamino)-5-methoxybenzofuro[2,3-f] quinazolin-1(2H)-one (13), we prepared 3-(dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (18), referred to as DPA-HBFQ-1. The cytotoxic activities of all the synthesized compounds, tested in different human breast cancer cell lines, revealed that DPA-HBFQ-1 was the most active compound. In particular, the latter was able to inhibit anchorage-dependent and -independent cell growth and to induce apoptosis in estrogen receptor alpha (ER)-positive and -negative breast cancer cells. It did not affect proliferation and apoptotic responses in MCF-10A normal breast epithelial cells. The observed effects have been ascribed to an enhanced p21(Cip1/WAF1) expression in a p53-dependent manner of tumor suppressor and to a selective inhibition of human topoisomerase II. In addition, DPA-HBFQ-1 exerted growth inhibitory effects also in other cancer cell lines, even though with a lower cytotoxic activity. Our results indicate DPA-HBFQ-1 as a good candidate to be useful as cancer therapeutic agent, particularly for breast cancer.\n",
            "1273776\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as relaxation of supercoiled pHOT1 at 50 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: 3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression.  Abstract: A series of unknown 3-(alkyl(dialkyl)amino)benzofuro[2,3-f]quinazolin-1(2H)-ones 4-17 has been synthesized as new ellipticine analogs, in which the carbazole moiety and the pyridine ring were replaced by a dibenzofuran residue and a pyrimidine ring, respectively. The synthesis of these benzofuroquinazolinones 4-17 was performed in a simple one-pot reaction using 3-aminodibenzofuran or its 2-methoxy derivative, as starting materials. From 3-(dipropylamino)-5-methoxybenzofuro[2,3-f] quinazolin-1(2H)-one (13), we prepared 3-(dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (18), referred to as DPA-HBFQ-1. The cytotoxic activities of all the synthesized compounds, tested in different human breast cancer cell lines, revealed that DPA-HBFQ-1 was the most active compound. In particular, the latter was able to inhibit anchorage-dependent and -independent cell growth and to induce apoptosis in estrogen receptor alpha (ER)-positive and -negative breast cancer cells. It did not affect proliferation and apoptotic responses in MCF-10A normal breast epithelial cells. The observed effects have been ascribed to an enhanced p21(Cip1/WAF1) expression in a p53-dependent manner of tumor suppressor and to a selective inhibition of human topoisomerase II. In addition, DPA-HBFQ-1 exerted growth inhibitory effects also in other cancer cell lines, even though with a lower cytotoxic activity. Our results indicate DPA-HBFQ-1 as a good candidate to be useful as cancer therapeutic agent, particularly for breast cancer.\n",
            "1274490\n",
            "Inhibition of recombinant human topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 50 uM incubated for 30 mins by agarose gel electrophoresis\n",
            "Title: Synthesis and Mechanism Studies of 1,3-Benzoazolyl Substituted Pyrrolo[2,3-b]pyrazine Derivatives as Nonintercalative Topoisomerase II Catalytic Inhibitors.  Abstract: Novel topoisomerase II (Topo II) inhibitors have gained considerable interest for the development of anticancer agents. In this study, a series of 1,3-benzoazolyl-substituted pyrrolo[2,3-b]pyrazine derivatives were designed, synthesized, and evaluated as potential Topo II catalytic inhibitors. It was found that some of derivatives had good antiproliferative activity on seven cancer cell lines, especially on HL-60/MX2, a cancer cell line derivative from HL-60 that is resistant to Topo II poison. Topo II mediated DNA relaxation assay results showed that derivatives could significantly inhibit the activity of Topo II, and the structure-activity relationship studies indicated the importance of the alkylamino side chain and the benzoazolyl group. Further mechanism studies revealed that derivatives function as Topo II nonintercalative catalytic inhibitors and may block the ATP binding site of Topo II. Moreover, flow cytometric analysis showed that this class of compounds could induce apoptosis of HL-60 cells.\n",
            "1274495\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as interacaltion of pBR322 DNA at 50 uM pre-incubated with DNA followed by incubation with enzyme for 30 mins by agarose gel electrophoresis\n",
            "Title: Synthesis and Mechanism Studies of 1,3-Benzoazolyl Substituted Pyrrolo[2,3-b]pyrazine Derivatives as Nonintercalative Topoisomerase II Catalytic Inhibitors.  Abstract: Novel topoisomerase II (Topo II) inhibitors have gained considerable interest for the development of anticancer agents. In this study, a series of 1,3-benzoazolyl-substituted pyrrolo[2,3-b]pyrazine derivatives were designed, synthesized, and evaluated as potential Topo II catalytic inhibitors. It was found that some of derivatives had good antiproliferative activity on seven cancer cell lines, especially on HL-60/MX2, a cancer cell line derivative from HL-60 that is resistant to Topo II poison. Topo II mediated DNA relaxation assay results showed that derivatives could significantly inhibit the activity of Topo II, and the structure-activity relationship studies indicated the importance of the alkylamino side chain and the benzoazolyl group. Further mechanism studies revealed that derivatives function as Topo II nonintercalative catalytic inhibitors and may block the ATP binding site of Topo II. Moreover, flow cytometric analysis showed that this class of compounds could induce apoptosis of HL-60 cells.\n",
            "1274535\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as interacaltion of pBR322 DNA at 0.6 to 5 uM pre-incubated with DNA followed by incubation with enzyme for 30 mins by agarose gel electrophoresis\n",
            "Title: Synthesis and Mechanism Studies of 1,3-Benzoazolyl Substituted Pyrrolo[2,3-b]pyrazine Derivatives as Nonintercalative Topoisomerase II Catalytic Inhibitors.  Abstract: Novel topoisomerase II (Topo II) inhibitors have gained considerable interest for the development of anticancer agents. In this study, a series of 1,3-benzoazolyl-substituted pyrrolo[2,3-b]pyrazine derivatives were designed, synthesized, and evaluated as potential Topo II catalytic inhibitors. It was found that some of derivatives had good antiproliferative activity on seven cancer cell lines, especially on HL-60/MX2, a cancer cell line derivative from HL-60 that is resistant to Topo II poison. Topo II mediated DNA relaxation assay results showed that derivatives could significantly inhibit the activity of Topo II, and the structure-activity relationship studies indicated the importance of the alkylamino side chain and the benzoazolyl group. Further mechanism studies revealed that derivatives function as Topo II nonintercalative catalytic inhibitors and may block the ATP binding site of Topo II. Moreover, flow cytometric analysis showed that this class of compounds could induce apoptosis of HL-60 cells.\n",
            "1274800\n",
            "Inhibition of human DNA topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 100 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Discovery of indeno[1,2-b]quinoxaline derivatives as potential anticancer agents.  Abstract: We have synthesized certain indeno[1,2-b]quinoxaline derivatives for antiproliferative evaluation. Among them, 11-{[3-(dimethylamino)propoxy]imino}-N-[3-(dimethylamino) propyl]-11H-indeno[1,2-b]quinoxaline-6-carboxamide (10a) was active against the growth of MDA-MB231, PC-3, and Huh-7 with IC50 values of 0.87 (selectivity index, SI = 36.22), 0.82 (SI = 38.43), and 0.64 M (SI = 49.23) respectively. Compound 10a was inactive against the growth of normal human fetal lung fibroblast cell line (MRC-5) with an IC50 value of 31.51 M. Its analogs, 10b and 10c, were also active against the growth of MB231, PC-3, and Huh-7 with IC50 values of <1.0 M in each case. Our results have also indicated compounds 10a-10c exhibited comparable inhibitory activities against topo I and topo II with the positive compound 2 at a concentration of 10 M. Mechanism studies indicated that compound 10a induced cell cycle arrest at S phase via activation of caspase-3, -7 and an increase in the protein expression of Bad and Bax but a decrease in expression of Bcl-2 and PARP, which consequently cause cell death. In addition, compound 10a attenuated the levels of phosphorylated Src, Akt-1, and Akt-2 protein levels but did not affect the total protein expression of Akt. We have also implanted human hepatocellular carcinoma cells into the yolk sac of zebrafish larvae and incubated larvae with various concentrations of 10a. Our results of the zebrafish xenograft assay confirmed the anti-tumor effect of 10ain vivo.\n",
            "1274801\n",
            "Inhibition of human DNA topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 10 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Discovery of indeno[1,2-b]quinoxaline derivatives as potential anticancer agents.  Abstract: We have synthesized certain indeno[1,2-b]quinoxaline derivatives for antiproliferative evaluation. Among them, 11-{[3-(dimethylamino)propoxy]imino}-N-[3-(dimethylamino) propyl]-11H-indeno[1,2-b]quinoxaline-6-carboxamide (10a) was active against the growth of MDA-MB231, PC-3, and Huh-7 with IC50 values of 0.87 (selectivity index, SI = 36.22), 0.82 (SI = 38.43), and 0.64 M (SI = 49.23) respectively. Compound 10a was inactive against the growth of normal human fetal lung fibroblast cell line (MRC-5) with an IC50 value of 31.51 M. Its analogs, 10b and 10c, were also active against the growth of MB231, PC-3, and Huh-7 with IC50 values of <1.0 M in each case. Our results have also indicated compounds 10a-10c exhibited comparable inhibitory activities against topo I and topo II with the positive compound 2 at a concentration of 10 M. Mechanism studies indicated that compound 10a induced cell cycle arrest at S phase via activation of caspase-3, -7 and an increase in the protein expression of Bad and Bax but a decrease in expression of Bcl-2 and PARP, which consequently cause cell death. In addition, compound 10a attenuated the levels of phosphorylated Src, Akt-1, and Akt-2 protein levels but did not affect the total protein expression of Akt. We have also implanted human hepatocellular carcinoma cells into the yolk sac of zebrafish larvae and incubated larvae with various concentrations of 10a. Our results of the zebrafish xenograft assay confirmed the anti-tumor effect of 10ain vivo.\n",
            "1279113\n",
            "Activity at recombinant Top1 (unknown origin) using 3'-[32P]-labeled double-stranded DNA (117 bp) as substrate assessed as suppression of DNA cleavage at 0.1 to 100 uM incubated for 20 mins by electrophoretic assay relative to 1 uM camptothecin\n",
            "Title: Synthesis and biological evaluation of new fluorinated and chlorinated indenoisoquinoline topoisomerase I poisons.  Abstract: Fluorine and chlorine are metabolically stable, but generally less active replacements for a nitro group at the 3-position of indenoisoquinoline topoisomerase IB (Top1) poisons. A number of strategies were employed in the present investigation to enhance the Top1 inhibitory potencies and cancer cell growth inhibitory activities of halogenated indenoisoquinolines. In several cases, the new compounds' activities were found to rival or surpass those of similarly substituted 3-nitroindenoisoquinolines, and several unusually potent analogs were discovered through testing in human cancer cell cultures. A hydroxyethylaminopropyl side chain on the lactam nitrogen of two halogenated indenoisoquinoline Top1 inhibitors was found to also impart inhibitory activity against tyrosyl DNA phosphodiesterases 1 and 2 (TDP1 and TDP2), which are enzymes that participate in the repair of DNA damage induced by Top1 poisons.\n",
            "1284053\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as attenuation of enzyme-mediated relaxation of supercoiled pBR322 DNA after 30 mins by agarose gel electrophoresis\n",
            "Title: Discovery of antitumor anthra[2,3-b]furan-3-carboxamides: Optimization of synthesis and evaluation of antitumor properties.  Abstract: Anthraquinones and their analogues, in particular heteroarene-fused anthracendiones, are prospective scaffolds for new compounds with improved antitumor characteristics. We herein report the use of a 'scaffold hopping' approach for the replacement of the core structure in the previously discovered hit compound naphtho[2,3-f]indole-5,10-dione 2 with an alternative anthra[2,3-b]furan-5,10-dione scaffold. Among 13 newly synthesized derivatives the majority of 4,11-dihydroxy-2-methyl-5,10-dioxoanthra[2,3-b]furan-3-carboxamides demonstrated a high antiproliferative potency against a panel of wild type and drug resistant tumor cell lines, a property superior over the reference drug doxorubicin or lead naphtho[2,3-f]indole-5,10-dione 2. At low micromolar concentrations the selected derivative of (R)-3-aminopyrrolidine 3c and its stereoisomer (S)-3-aminopyrrolidine 3d caused an apoptotic cell death preceded by an arrest in the G2/M phase. Studies of intracellular targets showed that 3c and 3d formed stable intercalative complexes with the duplex DNA as determined by spectral analysis and molecular docking. Both 3c and 3d attenuated topoisomerase 1 and 2 mediated unwinding of the supercoiled DNA via a mechanism different from conventional DNA-enzyme tertiary complex formation. Furthermore, 3d decreased the activity of selected human protein kinases in vitro, indicating multiple targeting by the new chemotype. Finally, 3d demonstrated an antitumor activity in a model of murine intraperitoneally transplanted P388 leukemia, achieving the increase of animal life span up to 262% at tolerable doses. Altogether, the 'scaffold hopping' demonstrated its productivity for obtaining new perspective antitumor drug candidates.\n",
            "1284054\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as attenuation of enzyme-mediated relaxation of supercoiled pBR322 DNA up to 1 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Discovery of antitumor anthra[2,3-b]furan-3-carboxamides: Optimization of synthesis and evaluation of antitumor properties.  Abstract: Anthraquinones and their analogues, in particular heteroarene-fused anthracendiones, are prospective scaffolds for new compounds with improved antitumor characteristics. We herein report the use of a 'scaffold hopping' approach for the replacement of the core structure in the previously discovered hit compound naphtho[2,3-f]indole-5,10-dione 2 with an alternative anthra[2,3-b]furan-5,10-dione scaffold. Among 13 newly synthesized derivatives the majority of 4,11-dihydroxy-2-methyl-5,10-dioxoanthra[2,3-b]furan-3-carboxamides demonstrated a high antiproliferative potency against a panel of wild type and drug resistant tumor cell lines, a property superior over the reference drug doxorubicin or lead naphtho[2,3-f]indole-5,10-dione 2. At low micromolar concentrations the selected derivative of (R)-3-aminopyrrolidine 3c and its stereoisomer (S)-3-aminopyrrolidine 3d caused an apoptotic cell death preceded by an arrest in the G2/M phase. Studies of intracellular targets showed that 3c and 3d formed stable intercalative complexes with the duplex DNA as determined by spectral analysis and molecular docking. Both 3c and 3d attenuated topoisomerase 1 and 2 mediated unwinding of the supercoiled DNA via a mechanism different from conventional DNA-enzyme tertiary complex formation. Furthermore, 3d decreased the activity of selected human protein kinases in vitro, indicating multiple targeting by the new chemotype. Finally, 3d demonstrated an antitumor activity in a model of murine intraperitoneally transplanted P388 leukemia, achieving the increase of animal life span up to 262% at tolerable doses. Altogether, the 'scaffold hopping' demonstrated its productivity for obtaining new perspective antitumor drug candidates.\n",
            "1284066\n",
            "Poisoning activity at topoisomerase 1 (unknown origin) using 3'-[32P]dGTP labelled 117bp oligonucleotide assessed as induction of DNA cleavage incubated for 20 mins by SDS-PAGE analysis\n",
            "Title: Discovery of antitumor anthra[2,3-b]furan-3-carboxamides: Optimization of synthesis and evaluation of antitumor properties.  Abstract: Anthraquinones and their analogues, in particular heteroarene-fused anthracendiones, are prospective scaffolds for new compounds with improved antitumor characteristics. We herein report the use of a 'scaffold hopping' approach for the replacement of the core structure in the previously discovered hit compound naphtho[2,3-f]indole-5,10-dione 2 with an alternative anthra[2,3-b]furan-5,10-dione scaffold. Among 13 newly synthesized derivatives the majority of 4,11-dihydroxy-2-methyl-5,10-dioxoanthra[2,3-b]furan-3-carboxamides demonstrated a high antiproliferative potency against a panel of wild type and drug resistant tumor cell lines, a property superior over the reference drug doxorubicin or lead naphtho[2,3-f]indole-5,10-dione 2. At low micromolar concentrations the selected derivative of (R)-3-aminopyrrolidine 3c and its stereoisomer (S)-3-aminopyrrolidine 3d caused an apoptotic cell death preceded by an arrest in the G2/M phase. Studies of intracellular targets showed that 3c and 3d formed stable intercalative complexes with the duplex DNA as determined by spectral analysis and molecular docking. Both 3c and 3d attenuated topoisomerase 1 and 2 mediated unwinding of the supercoiled DNA via a mechanism different from conventional DNA-enzyme tertiary complex formation. Furthermore, 3d decreased the activity of selected human protein kinases in vitro, indicating multiple targeting by the new chemotype. Finally, 3d demonstrated an antitumor activity in a model of murine intraperitoneally transplanted P388 leukemia, achieving the increase of animal life span up to 262% at tolerable doses. Altogether, the 'scaffold hopping' demonstrated its productivity for obtaining new perspective antitumor drug candidates.\n",
            "1284067\n",
            "Poisoning activity at topoisomerase 1 (unknown origin) using 3'-[32P]dGTP labelled 117bp oligonucleotide assessed as induction of DNA cleavage at 1 uM incubated for 20 mins by SDS-PAGE analysis\n",
            "Title: Discovery of antitumor anthra[2,3-b]furan-3-carboxamides: Optimization of synthesis and evaluation of antitumor properties.  Abstract: Anthraquinones and their analogues, in particular heteroarene-fused anthracendiones, are prospective scaffolds for new compounds with improved antitumor characteristics. We herein report the use of a 'scaffold hopping' approach for the replacement of the core structure in the previously discovered hit compound naphtho[2,3-f]indole-5,10-dione 2 with an alternative anthra[2,3-b]furan-5,10-dione scaffold. Among 13 newly synthesized derivatives the majority of 4,11-dihydroxy-2-methyl-5,10-dioxoanthra[2,3-b]furan-3-carboxamides demonstrated a high antiproliferative potency against a panel of wild type and drug resistant tumor cell lines, a property superior over the reference drug doxorubicin or lead naphtho[2,3-f]indole-5,10-dione 2. At low micromolar concentrations the selected derivative of (R)-3-aminopyrrolidine 3c and its stereoisomer (S)-3-aminopyrrolidine 3d caused an apoptotic cell death preceded by an arrest in the G2/M phase. Studies of intracellular targets showed that 3c and 3d formed stable intercalative complexes with the duplex DNA as determined by spectral analysis and molecular docking. Both 3c and 3d attenuated topoisomerase 1 and 2 mediated unwinding of the supercoiled DNA via a mechanism different from conventional DNA-enzyme tertiary complex formation. Furthermore, 3d decreased the activity of selected human protein kinases in vitro, indicating multiple targeting by the new chemotype. Finally, 3d demonstrated an antitumor activity in a model of murine intraperitoneally transplanted P388 leukemia, achieving the increase of animal life span up to 262% at tolerable doses. Altogether, the 'scaffold hopping' demonstrated its productivity for obtaining new perspective antitumor drug candidates.\n",
            "1287948\n",
            "Inhibition of human recombinant DNA topoisomerase 1 at 100 uM assessed as relaxation of supercoiled DNA pBR322 after 30 mins by Agarose gel electrophoresis\n",
            "Title: Effect of chlorine substituent on cytotoxic activities: Design and synthesis of systematically modified 2,4-diphenyl-5H-indeno[1,2-b]pyridines.  Abstract: In continuation of our previous work, six hydroxylated 2,4-diphenyl-5H-indeno[1,2-b]pyridine analogs were modified by introducing one chlorine functionality at ortho, meta or para position of the 2- or 4-phenyl ring. Eighteen new chlorinated compounds were thus prepared and assessed for topoisomerase inhibitory activity and cytotoxicity against HCT15, T47D, and HeLa cancer cell lines. All of the chlorinated compounds displayed significant cytotoxic effect, revealing potent anticancer activity against T47D breast cancer cells. This functional group modification allowed us to explore the importance of chlorine group substitution for the cytotoxic properties. The information reported here provides valuable insight for further study to develop new anticancer agents using related scaffolds.\n",
            "1287949\n",
            "Inhibition of human recombinant DNA topoisomerase 1 at 20 uM assessed as relaxation of supercoiled DNA pBR322 after 30 mins by Agarose gel electrophoresis\n",
            "Title: Effect of chlorine substituent on cytotoxic activities: Design and synthesis of systematically modified 2,4-diphenyl-5H-indeno[1,2-b]pyridines.  Abstract: In continuation of our previous work, six hydroxylated 2,4-diphenyl-5H-indeno[1,2-b]pyridine analogs were modified by introducing one chlorine functionality at ortho, meta or para position of the 2- or 4-phenyl ring. Eighteen new chlorinated compounds were thus prepared and assessed for topoisomerase inhibitory activity and cytotoxicity against HCT15, T47D, and HeLa cancer cell lines. All of the chlorinated compounds displayed significant cytotoxic effect, revealing potent anticancer activity against T47D breast cancer cells. This functional group modification allowed us to explore the importance of chlorine group substitution for the cytotoxic properties. The information reported here provides valuable insight for further study to develop new anticancer agents using related scaffolds.\n",
            "1288087\n",
            "Inhibition of human recombinant topoisomerase 1 assessed as relaxation of supercoiled plasmid DNA pBR322 at 100 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to camptothecin\n",
            "Title: A new series of 2-phenol-4-aryl-6-chlorophenyl pyridine derivatives as dual topoisomerase I/II inhibitors: Synthesis, biological evaluation and 3D-QSAR study.  Abstract: As a continuous effort to develop novel antitumor agents, a new series of forty-five 2-phenol-4-aryl-6-chlorophenyl pyridine compounds were synthesized and evaluated for cytotoxicity against four different human cancer cell lines (DU145, HCT15, T47D, and HeLa), and topoisomerase I and II inhibitory activity. Several compounds (10-15, 20, 22, 24, 28, 42, and 49) displayed strong to moderate dual topoisomerase I and II inhibitory activity at 100 M. It was observed that hydroxyl and chlorine moiety at meta or para position of phenyl ring is favorable for dual topoisomerase inhibitory activity and cytotoxicity. Most of the compounds displayed stronger cytotoxicities than those of all positive controls against the HCT15 and T47D cell lines. For investigation of the structure-activity relationships, a 3D-QSAR analysis using the method of comparative molecular field analysis (CoMFA) was performed. The generated 3D contour maps can be used for further rational design of novel terpyridine derivatives as highly selective and potent cytotoxic agents.\n",
            "1288088\n",
            "Inhibition of human recombinant topoisomerase 1 assessed as relaxation of supercoiled plasmid DNA pBR322 at 20 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to camptothecin\n",
            "Title: A new series of 2-phenol-4-aryl-6-chlorophenyl pyridine derivatives as dual topoisomerase I/II inhibitors: Synthesis, biological evaluation and 3D-QSAR study.  Abstract: As a continuous effort to develop novel antitumor agents, a new series of forty-five 2-phenol-4-aryl-6-chlorophenyl pyridine compounds were synthesized and evaluated for cytotoxicity against four different human cancer cell lines (DU145, HCT15, T47D, and HeLa), and topoisomerase I and II inhibitory activity. Several compounds (10-15, 20, 22, 24, 28, 42, and 49) displayed strong to moderate dual topoisomerase I and II inhibitory activity at 100 M. It was observed that hydroxyl and chlorine moiety at meta or para position of phenyl ring is favorable for dual topoisomerase inhibitory activity and cytotoxicity. Most of the compounds displayed stronger cytotoxicities than those of all positive controls against the HCT15 and T47D cell lines. For investigation of the structure-activity relationships, a 3D-QSAR analysis using the method of comparative molecular field analysis (CoMFA) was performed. The generated 3D contour maps can be used for further rational design of novel terpyridine derivatives as highly selective and potent cytotoxic agents.\n",
            "1288328\n",
            "Inhibition of human recombinant topoisomerase 1 assessed as relaxation of supercoiled plasmid DNA pBR322 at 100 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase II catalytic inhibitor.  Abstract: A series of pyrazoline derivatives (5) were synthesized in 92-96% yields from chalcones (3) and hydrazides (4). Subsequently, topo-I and II-mediated relaxation and antiproliferative activity assays were evaluated for 5. Among the tested compounds, 5h had a very strong topo-I activity of 97% (Camptothecin, 74%) at concentration of 100 M. Nevertheless, all the compounds 5a-5i showed significant topo II inhibitory activity in the range of 90-94% (Etoposide, 96%) at the same concentration. Cytotoxic potential of these compounds was tested in a panel of three human tumor cell lines, HCT15, BT474 and T47D. All the compounds showed strong activity against HCT15 cell line with IC50 at the range of 1.9-10.4 M (Adriamycin, 23.0; Etoposide, 6.9; and Camptothecin, 7.1 M). Moreover, compounds 5c, 5f and 5i were observed to have strong antiproliferative activity against BT474 cell lines. Since, compound 5d showed antiproliferative activity at a very low IC50 thus 5d was then selected to study on their mode of action with diverse methods of ATP competition assay, ATPase assay and DNA-topo II cleavable complex assay and the results revealed that it functioned as a ATP-competitive human topoisomerase II catalytic inhibitor. Further evaluation of endogenous topo-mediated DNA relaxation in cells has been conducted to find that, 5d inhibited endogenous topo-mediated pBR322 plasmid relaxation is more efficient (78.0  4.7% at 50 M) than Etoposide (36.0  1.7% at 50 M).\n",
            "1288329\n",
            "Inhibition of human recombinant topoisomerase 1 assessed as relaxation of supercoiled plasmid DNA pBR322 at 20 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase II catalytic inhibitor.  Abstract: A series of pyrazoline derivatives (5) were synthesized in 92-96% yields from chalcones (3) and hydrazides (4). Subsequently, topo-I and II-mediated relaxation and antiproliferative activity assays were evaluated for 5. Among the tested compounds, 5h had a very strong topo-I activity of 97% (Camptothecin, 74%) at concentration of 100 M. Nevertheless, all the compounds 5a-5i showed significant topo II inhibitory activity in the range of 90-94% (Etoposide, 96%) at the same concentration. Cytotoxic potential of these compounds was tested in a panel of three human tumor cell lines, HCT15, BT474 and T47D. All the compounds showed strong activity against HCT15 cell line with IC50 at the range of 1.9-10.4 M (Adriamycin, 23.0; Etoposide, 6.9; and Camptothecin, 7.1 M). Moreover, compounds 5c, 5f and 5i were observed to have strong antiproliferative activity against BT474 cell lines. Since, compound 5d showed antiproliferative activity at a very low IC50 thus 5d was then selected to study on their mode of action with diverse methods of ATP competition assay, ATPase assay and DNA-topo II cleavable complex assay and the results revealed that it functioned as a ATP-competitive human topoisomerase II catalytic inhibitor. Further evaluation of endogenous topo-mediated DNA relaxation in cells has been conducted to find that, 5d inhibited endogenous topo-mediated pBR322 plasmid relaxation is more efficient (78.0  4.7% at 50 M) than Etoposide (36.0  1.7% at 50 M).\n",
            "1294874\n",
            "Inhibition of human topoisomerase 1 assessed as reduction in enzyme-mediated relaxation of supercoiled pBR322 DNA at 50 to 100 uM after 10 to 15 mins by agarose gel electrophoresis\n",
            "Title: Synthesis and antiproliferative activity of 9-benzylamino-6-chloro-2-methoxy-acridine derivatives as potent DNA-binding ligands and topoisomerase II inhibitors.  Abstract: A series of 9-benzylamino acridine derivatives were synthesized as an extension of our discovery of acridine antitumor agents. Most of these acridine compounds displayed good antiproliferative activity with IC50 values in low micromole range and structure-activity relationships were studied. Topo I- and II- mediated relaxation studies suggested that all of our compounds displayed strong Topo II inhibitory activity at 100 M, while only four exhibited moderate Topo I inhibitory activity. The typical compound 8p could penetrate A549 cancer cells efficiently. Compound 8p could intercalate within the double-stranded DNA structure and induce DNA damage. Moreover, compound 8p could induce A549 cells apoptosis through caspase-dependent intrinsic pathway and arrest A549 cells at the G2/M phase.\n",
            "1294922\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as reduction in enzyme-mediated relaxation of supercoiled pBR322 DNA at 100 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: 10-Boronic acid substituted camptothecin as prodrug of SN-38.  Abstract: Malignant tumor cells have been found to have high levels of reactive oxygen species such as hydrogen peroxide (H2O2), supporting the hypothesis that a prodrug could be activated by intracellular H2O2 and lead to a potential antitumor therapy. In this study, the 7-ethyl-10-boronic acid camptothecin (B1) was synthesized for the first time as prodrug of SN-38, by linking a cleavable aryl carbon-boron bond to the SN-38. Prodrug B1 selectively activated by H2O2, converted rapidly to the active form SN-38 under favorable oxidative conditions in cancer cells with elevated levels of H2O2. The cell survival assay showed that prodrug B1 was equally or more effective in inhibiting the growth of six different cancer cells, as compared to SN-38. Unexpectedly, prodrug B1 displayed even more potent Topo I inhibitory activity than SN-38, suggesting that it was not only a prodrug of SN-38 but also a typical Topo I inhibitor. Prodrug B1 also demonstrated a significant antitumor activity at 2.0 mg/kg in a xenograft model using human brain star glioblastoma cell lines U87MG.\n",
            "1302329\n",
            "Activity at recombinant top1 (unknown origin) assessed as DNA cleavage using 3'-[32P]-labeled 117-bp DNA as substrate at 1 uM after 20 mins by SDS-PAGE\n",
            "Title: Investigation of the Structure-Activity Relationships of Aza-A-Ring Indenoisoquinoline Topoisomerase I Poisons.  Abstract: Several indenoisoquinolines have shown promise as anticancer agents in clinical trials. Incorporation of a nitrogen atom into the indenoisoquinoline scaffold offers the possibility of favorably modulating ligand-binding site interactions, physicochemical properties, and biological activities. Four series of aza-A-ring indenoisoquinolines were synthesized in which the nitrogen atom was systematically rotated through positions 1, 2, 3, and 4. The resulting compounds were tested to establish the optimal nitrogen position for topoisomerase IB (Top1) enzyme poisoning activity and cytotoxicity to human cancer cells. The 4-aza compounds were the most likely to yield derivatives with high Top1 inhibitory activity. However, the relationship between structure and cytotoxicity was more complicated since the potency was influenced strongly by the side chains on the lactam nitrogen. The most cytotoxic azaindenoisoquinolines 45 and 46 had nitrogen in the 2- or 3-positions and a 3'-dimethylaminopropyl side chain, and they had MGM GI50 values that were slightly better than the corresponding indenoisoquinoline 64.\n",
            "1302342\n",
            "Activity at recombinant top1 (unknown origin) assessed as DNA cleavage using 3'-[32P]-labeled 117-bp DNA as substrate at 0.1 to 100 uM after 20 mins by SDS-PAGE\n",
            "Title: Investigation of the Structure-Activity Relationships of Aza-A-Ring Indenoisoquinoline Topoisomerase I Poisons.  Abstract: Several indenoisoquinolines have shown promise as anticancer agents in clinical trials. Incorporation of a nitrogen atom into the indenoisoquinoline scaffold offers the possibility of favorably modulating ligand-binding site interactions, physicochemical properties, and biological activities. Four series of aza-A-ring indenoisoquinolines were synthesized in which the nitrogen atom was systematically rotated through positions 1, 2, 3, and 4. The resulting compounds were tested to establish the optimal nitrogen position for topoisomerase IB (Top1) enzyme poisoning activity and cytotoxicity to human cancer cells. The 4-aza compounds were the most likely to yield derivatives with high Top1 inhibitory activity. However, the relationship between structure and cytotoxicity was more complicated since the potency was influenced strongly by the side chains on the lactam nitrogen. The most cytotoxic azaindenoisoquinolines 45 and 46 had nitrogen in the 2- or 3-positions and a 3'-dimethylaminopropyl side chain, and they had MGM GI50 values that were slightly better than the corresponding indenoisoquinoline 64.\n",
            "1306065\n",
            "Inhibition of human topoisomerase1 activity at 20 uM using pBR322 plasmid DNA as substrate incubated for 30 mins by EtBr-based gel electrophoresis\n",
            "Title: Synthesis and biological activity of pyrazole analogues of the staurosporine aglycon K252c.  Abstract: A derivative of the staurosporine aglycon (K252c), in which the lactam ring was replaced by a pyrazole moiety, was synthesized. The resulting indolopyrazolocarbazole (3) inhibited Pim isoforms 1-3 whereas it did not impair the activity of two known targets of K252c, protein kinase C isoforms  and . Compound 3 exhibited moderate cytotoxic activity toward human leukemia and colon carcinoma cell lines (K562 and HCT116), strongly suggesting that this new scaffold deserves further investigations for treatment of malignancies associated with Pim activity.\n",
            "1306928\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pBS (SK+) DNA at 60 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pBS (SK+) DNA at 60 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "1306930\n",
            "Poisoning activity at human recombinant topoisomerase 1 assessed as stabilization of enzyme-supercoiled pBS (SK+) DNA complex at 60 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Poisoning activity at human recombinant topoisomerase 1 assessed as stabilization of enzyme-supercoiled pBS (SK+) DNA complex at 60 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "1306932\n",
            "Poisoning activity at topoisomerase 1 in human MCF7 cells at 10 uM after 12 hrs by immunoband depletion assay\n",
            "Poisoning activity at topoisomerase 1 in human MCF7 cells at 10 uM after 12 hrs by immunoband depletion assay\n",
            "1306934\n",
            "Inhibition of CPT mediated formation of topoisomerase 1-supercoiled pBS (SK+) DNA complex in human MCF7 cells at 10 uM preincubated for 2 hrs followed by CPT addition measured after 4 to 12 hrs by immunoband depletion assay\n",
            "Inhibition of CPT mediated formation of topoisomerase 1-supercoiled pBS (SK+) DNA complex in human MCF7 cells at 10 uM preincubated for 2 hrs followed by CPT addition measured after 4 to 12 hrs by immunoband depletion assay\n",
            "1309918\n",
            "Inhibition of human recombinant Top1 expressed in baculovirus using [32P]-3-end labeled 117 bp DNA oligonucleotide as substrate assessed as enzyme mediated DNA cleavage at 0.1 to 100 uM after 20 mins by SDS-PAGE analysis relative to camptothecin\n",
            "Title: Design, Synthesis, and Biological Evaluation of Potential Prodrugs Related to the Experimental Anticancer Agent Indotecan (LMP400).  Abstract: Indenoisoquinoline topoisomerase I (Top1) inhibitors are a novel class of anticancer agents with two compounds in clinical trials. Recent metabolism studies of indotecan (LMP400) led to the discovery of the biologically active 2-hydroxylated analogue and 3-hydroxylated metabolite, thus providing strategically placed functional groups for the preparation of a variety of potential ester prodrugs of these two compounds. The current study details the design and synthesis of two series of indenoisoquinoline prodrugs, and it also reveals how substituents on the O-2 and O-3 positions of the A ring, which are next to the cleaved DNA strand in the drug-DNA-Top1 ternary cleavage complex, affect Top1 inhibitory activity and cytotoxicity. Many of the indenoisoquinoline prodrugs were very potent antiproliferative agents with GI50 values below 10 nM in a variety of human cancer cell lines.\n",
            "1309919\n",
            "Inhibition of human recombinant Top1 expressed in baculovirus using [32P]-3-end labeled 117 bp DNA oligonucleotide as substrate assessed as enzyme mediated DNA cleavage after 20 mins by SDS-PAGE analysis relative to camptothecin\n",
            "Title: Design, Synthesis, and Biological Evaluation of Potential Prodrugs Related to the Experimental Anticancer Agent Indotecan (LMP400).  Abstract: Indenoisoquinoline topoisomerase I (Top1) inhibitors are a novel class of anticancer agents with two compounds in clinical trials. Recent metabolism studies of indotecan (LMP400) led to the discovery of the biologically active 2-hydroxylated analogue and 3-hydroxylated metabolite, thus providing strategically placed functional groups for the preparation of a variety of potential ester prodrugs of these two compounds. The current study details the design and synthesis of two series of indenoisoquinoline prodrugs, and it also reveals how substituents on the O-2 and O-3 positions of the A ring, which are next to the cleaved DNA strand in the drug-DNA-Top1 ternary cleavage complex, affect Top1 inhibitory activity and cytotoxicity. Many of the indenoisoquinoline prodrugs were very potent antiproliferative agents with GI50 values below 10 nM in a variety of human cancer cell lines.\n",
            "1310522\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pBR322 plasmid DNA at 100 uM after 60 mins by electrophoretic analysis\n",
            "Title: 4-(1,2-diarylbut-1-en-1-yl)isobutyranilide derivatives as inhibitors of topoisomerase II.  Abstract: The synthesis and biological evaluation of a new library of 4-(1,2-diarylbut-1-en-1-yl)isobutyranilides is described. The new compounds were found to be cytotoxic in the micromolar range in two human tumor cell lines, MCF-7 (mammary gland adenocarcinoma) and HeLa (cervix adenocarcinoma) and two human ovarian cancer cell lines (A2780 and OVCAR5). Detailed studies on the most active compound 6g show that it was able to induce apoptosis and suggest topoisomerase II as a possible intracellular target. The relevance of the interaction of the most active compound with topoisomerase II is demonstrated and supported by docking studies.\n",
            "1322189\n",
            "Inhibition of DNA topoisomerase-1 (unknown origin)-mediated supercoiled pBR322 DNA relaxation at 25 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Design, synthesis and biological evaluation of lapachol derivatives possessing indole scaffolds as topoisomerase I inhibitors.  Abstract: A series of novel lapachol derivatives possessing indole scaffolds was designed and synthesized. The in vitro anti-proliferative activity of these novel compounds was evaluated in Eca109 and Hela cell lines. Almost all the tested compounds showed manifested potent inhibitory activity against the two tested cancer cell lines. Topo I-mediated DNA relaxation activity indicated that these novel compounds have potent Topoisomerase I inhibition activity. The most potent compounds 4n and 4k demonstrated more cytotoxicity than camptothecin and was comparable to camptothecin in inhibitory activities on Topoisomerase I in our biological assay. In addition, the Hoechst 33342 staining method also showed that the complex can induce Hela cell apoptosis.\n",
            "1322190\n",
            "Inhibition of DNA topoisomerase-1 (unknown origin)-mediated supercoiled pBR322 DNA relaxation at 100 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Design, synthesis and biological evaluation of lapachol derivatives possessing indole scaffolds as topoisomerase I inhibitors.  Abstract: A series of novel lapachol derivatives possessing indole scaffolds was designed and synthesized. The in vitro anti-proliferative activity of these novel compounds was evaluated in Eca109 and Hela cell lines. Almost all the tested compounds showed manifested potent inhibitory activity against the two tested cancer cell lines. Topo I-mediated DNA relaxation activity indicated that these novel compounds have potent Topoisomerase I inhibition activity. The most potent compounds 4n and 4k demonstrated more cytotoxicity than camptothecin and was comparable to camptothecin in inhibitory activities on Topoisomerase I in our biological assay. In addition, the Hoechst 33342 staining method also showed that the complex can induce Hela cell apoptosis.\n",
            "1322191\n",
            "Inhibition of DNA topoisomerase-1 (unknown origin)-mediated supercoiled pBR322 DNA relaxation at 5 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Design, synthesis and biological evaluation of lapachol derivatives possessing indole scaffolds as topoisomerase I inhibitors.  Abstract: A series of novel lapachol derivatives possessing indole scaffolds was designed and synthesized. The in vitro anti-proliferative activity of these novel compounds was evaluated in Eca109 and Hela cell lines. Almost all the tested compounds showed manifested potent inhibitory activity against the two tested cancer cell lines. Topo I-mediated DNA relaxation activity indicated that these novel compounds have potent Topoisomerase I inhibition activity. The most potent compounds 4n and 4k demonstrated more cytotoxicity than camptothecin and was comparable to camptothecin in inhibitory activities on Topoisomerase I in our biological assay. In addition, the Hoechst 33342 staining method also showed that the complex can induce Hela cell apoptosis.\n",
            "1324294\n",
            "Inhibition of human DNA TOP1 assessed as suppression of supercoiled plasmid HOT1 relaxation at 10 to 20 uM preincubated with enzyme followed by substrate addition measured after 30 mins by ethidium bromide dye-based agarose gel electrophoresis\n",
            "Title: Synthesis of novel ethyl 2,4-disubstituted 8-(trifluoromethyl)pyrido[2',3':3,4]pyrazolo[1,5-a]pyrimidine-9-carboxylate derivatives as promising anticancer agents.  Abstract: A series of novel pyrido[2',3':3,4] pyrazolo[1,5-a]pyrimidine derivatives 6-9 were prepared in single step starting from 3-amino-6-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxylate 5 on reaction with symmetrical and unsymmetrical aliphatic and aromatic 1,3-diketones/, unsaturated ketones/, unsaturated keto ethers under conventional method. All the final compounds 6a-c, 8a-b and 9a-l were screened for anticancer activity against five human cancer cell lines such as PC-3 (CRL-1435), MDA-MB-231 (HTB-26), Hep G2 (HB-8065), HeLa (CCL-2) and normal HUVEC (CRL-1730). Compounds 8a, 9f and 9k which showed promising anticancer activity have been identified. Further, the promising compounds (8a and 9f) were able to inhibit the human topoisomerase I (TopI) activity similar to that of camptothecin.\n",
            "1325811\n",
            "Inhibition of human Topo1-mediated DNA relaxation using negatively supercoiled DNA as substrate at 100 uM preincubated for 30 mins measured after 15 mins by ethidium bromide/SDS-based agarose gel electrophoresis\n",
            "Title: Scaffold-Hopping of Aurones: 2-Arylideneimidazo[1,2-a]pyridinones as Topoisomerase II-Inhibiting Anticancer Agents.  Abstract: Scaffold-hopping of bioactive natural product aurones has been studied for the first time. 2-Arylideneimidazo[1,2-a]pyridinones as potential topoisomerase II (hTopoII)-targeting anticancer compounds were considered. A multifunctional activator, polyphosphoric acid, enabled to realize a cascade reaction of 2-aminopyridine with 2,3-epoxyesters toward synthesis of 2-arylideneimidazo[1,2-a]pyridinones. Most of the compounds exhibited hTopoII-selective poison activity with efficiency more than etoposide and DNA-binding property, while not interacting with hTopo I. The compounds showed pronounced antiproliferative activities in nanomolar range with relatively poor toxicity to normal cells, inhibition of invasiveness, and apoptotic effect. The activities for inhibition of tubulin assembly, CDK1 and pCDK1, were also observed. Interestingly, the hTopoII inhibitory (in vitro and ex vivo studies) and antiproliferative activities of representative potent compounds were found to be manifold higher compared to corresponding parent aurones bearing alike substitutions, indicating the importance of such scaffold-hopping strategy in medicinal chemistry research.\n",
            "1326452\n",
            "Inhibition of human DNA topoisomerase 1-mediated relaxation of negatively supercoiled DNA at 100 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Scaffold-hopping of bioactive flavonoids: Discovery of aryl-pyridopyrimidinones as potent anticancer agents that inhibit catalytic role of topoisomerase II.  Abstract: A strategy of scaffold-hopping of bioactive natural products, flavones and isoflavones, leading to target-based discovery of potent anticancer agents has been reported for the first time. Scaffold-hopped flavones, 2-aryl-4H-pyrido[1,2-a]pyrimidin-4-ones and the scaffold-hopped isoflavones, 3-aryl-pyrido[1,2-a]pyrimidin-4-ones were synthesized via Pd-catalyzed activation-arylation methods. Most of the compounds were found to exhibit pronounced human topoisomerase II (hTopoII) inhibitory activities and several compounds were found to be more potent than etoposide (a hTopoII-inhibiting anticancer drug). These classes of compounds were found to be hTopoII-selective catalytic inhibitors while not interfering with topoisomerase I and interacted with DNA plausibly in groove domain. Cytotoxicities against various cancer cells, low toxicity in normal cells, and apoptotic effects were observed. Interestingly, compared to parent flavones/isoflavones, their scaffold-hopped analogs bearing alike functionalities showed significant/enhanced hTopoII-inhibitory and cytotoxic properties, indicating the importance of a natural product-based scaffold-hopping strategy in the drug discovery.\n",
            "1326609\n",
            "Inhibition of DNA topoisomerase 1 (unknown origin) assessed as reduction in relaxation of supercoiled pBR322 plasmid DNA at 100 uM incubated for 30 mins by agarose gel electrophoresis relative to control\n",
            "Title: Novel securinine derivatives as topoisomerase I based antitumor agents.  Abstract: DNA topoisomerase I (Topo I) has been validated as a target for anticancer agents. In this study, a series of novel securinine derivatives bearing '-hydroxy-,-unsaturated ketone moiety were designed and synthesized via a Baylis-Hillman reaction for screening as Topo I inhibitors and antitumor agents. Their topoisomerase I inhibitory activity as well as their cytotoxicity against four human cancer cell lines (A549, HeLa, HepG2, SH-SY5Y) were evaluated, and two pairs of diastereomers 4a-1 and 4a-6 with significant Topo I inhibitory activity and potent anti-proliferative activity against cancer cell lines were identified. The diastereomers were separated, and absolute configurations of five pairs of diastereomers were identified based on X-ray crystallographic analysis and circular dichroism (CD) spectra analysis. Further mechanism studies of the most active compounds 4a-1-R and 4a-1-S indicated that this kind of securinine derivative exhibits a different inhibitory mechanism from that of camptothecin, an established Topo I inhibitor. Unlike camptothecin, compounds 4a-1-R and 4a-1-S specifically inhibits the combination of Topo I and DNA rather than forming the drug-enzyme-DNA covalent ternary complex. In addition, molecular docking and molecular dynamic studies revealed the binding patterns of these compounds with Topo I.\n",
            "1326614\n",
            "Inhibition of DNA topoisomerase 1 (unknown origin) assessed as reduction in relaxation of supercoiled pBR322 plasmid DNA incubated for 30 mins by agarose gel electrophoresis\n",
            "Title: Novel securinine derivatives as topoisomerase I based antitumor agents.  Abstract: DNA topoisomerase I (Topo I) has been validated as a target for anticancer agents. In this study, a series of novel securinine derivatives bearing '-hydroxy-,-unsaturated ketone moiety were designed and synthesized via a Baylis-Hillman reaction for screening as Topo I inhibitors and antitumor agents. Their topoisomerase I inhibitory activity as well as their cytotoxicity against four human cancer cell lines (A549, HeLa, HepG2, SH-SY5Y) were evaluated, and two pairs of diastereomers 4a-1 and 4a-6 with significant Topo I inhibitory activity and potent anti-proliferative activity against cancer cell lines were identified. The diastereomers were separated, and absolute configurations of five pairs of diastereomers were identified based on X-ray crystallographic analysis and circular dichroism (CD) spectra analysis. Further mechanism studies of the most active compounds 4a-1-R and 4a-1-S indicated that this kind of securinine derivative exhibits a different inhibitory mechanism from that of camptothecin, an established Topo I inhibitor. Unlike camptothecin, compounds 4a-1-R and 4a-1-S specifically inhibits the combination of Topo I and DNA rather than forming the drug-enzyme-DNA covalent ternary complex. In addition, molecular docking and molecular dynamic studies revealed the binding patterns of these compounds with Topo I.\n",
            "1326622\n",
            "Inhibition of DNA topoisomerase 1 (unknown origin) assessed as reduction in topoisomerase 1-DNA complex formation preincubated for 20 mins followed by supercoiled pBR322 plasmid DNA addition measured after 3 mins by electrophoretic mobility shift assay\n",
            "Title: Novel securinine derivatives as topoisomerase I based antitumor agents.  Abstract: DNA topoisomerase I (Topo I) has been validated as a target for anticancer agents. In this study, a series of novel securinine derivatives bearing '-hydroxy-,-unsaturated ketone moiety were designed and synthesized via a Baylis-Hillman reaction for screening as Topo I inhibitors and antitumor agents. Their topoisomerase I inhibitory activity as well as their cytotoxicity against four human cancer cell lines (A549, HeLa, HepG2, SH-SY5Y) were evaluated, and two pairs of diastereomers 4a-1 and 4a-6 with significant Topo I inhibitory activity and potent anti-proliferative activity against cancer cell lines were identified. The diastereomers were separated, and absolute configurations of five pairs of diastereomers were identified based on X-ray crystallographic analysis and circular dichroism (CD) spectra analysis. Further mechanism studies of the most active compounds 4a-1-R and 4a-1-S indicated that this kind of securinine derivative exhibits a different inhibitory mechanism from that of camptothecin, an established Topo I inhibitor. Unlike camptothecin, compounds 4a-1-R and 4a-1-S specifically inhibits the combination of Topo I and DNA rather than forming the drug-enzyme-DNA covalent ternary complex. In addition, molecular docking and molecular dynamic studies revealed the binding patterns of these compounds with Topo I.\n",
            "1326623\n",
            "Inhibition of DNA topoisomerase 1 (unknown origin) assessed as reduction in topoisomerase 1-DNA complex formation at 50 to 100 uM preincubated for 20 mins followed by supercoiled pBR322 plasmid DNA addition measured after 3 mins by electrophoretic mobility shift assay\n",
            "Title: Novel securinine derivatives as topoisomerase I based antitumor agents.  Abstract: DNA topoisomerase I (Topo I) has been validated as a target for anticancer agents. In this study, a series of novel securinine derivatives bearing '-hydroxy-,-unsaturated ketone moiety were designed and synthesized via a Baylis-Hillman reaction for screening as Topo I inhibitors and antitumor agents. Their topoisomerase I inhibitory activity as well as their cytotoxicity against four human cancer cell lines (A549, HeLa, HepG2, SH-SY5Y) were evaluated, and two pairs of diastereomers 4a-1 and 4a-6 with significant Topo I inhibitory activity and potent anti-proliferative activity against cancer cell lines were identified. The diastereomers were separated, and absolute configurations of five pairs of diastereomers were identified based on X-ray crystallographic analysis and circular dichroism (CD) spectra analysis. Further mechanism studies of the most active compounds 4a-1-R and 4a-1-S indicated that this kind of securinine derivative exhibits a different inhibitory mechanism from that of camptothecin, an established Topo I inhibitor. Unlike camptothecin, compounds 4a-1-R and 4a-1-S specifically inhibits the combination of Topo I and DNA rather than forming the drug-enzyme-DNA covalent ternary complex. In addition, molecular docking and molecular dynamic studies revealed the binding patterns of these compounds with Topo I.\n",
            "1327275\n",
            "Poison activity at human DNA topoisomerase 1 assessed as increase in intensity of nicked form of DNA using pUC19 supercoiled plasmid DNA as substrate preincubated for 15 mins followed by DNA topoisomerase 1 addition measured after 30 mins by agarose gel electrophoresis\n",
            "Title: Amino substituted benzimidazo[1,2-a]quinolines: Antiproliferative potency, 3D QSAR study and DNA binding properties.  Abstract: We describe the synthesis, 3D-derived quantitative structure-activity relationship (QSAR), antiproliferative activity and DNA binding properties of a series of 2-amino, 5-amino and 2,5-diamino substituted benzimidazo[1,2-a]quinolines prepared by environmentally friendly uncatalyzed microwave assisted amination. The antiproliferative activities were assessed in vitro against colon, lung and breast carcinoma cell lines; activities ranged from submicromolar to micromolar. The strongest antiproliferative activity was demonstrated by 2-amino-substituted analogues, whereas 5-amino and or 2,5-diamino substituted derivatives resulted in much less activity. Derivatives bearing 4-methyl- or 3,5-dimethyl-1-piperazinyl substituents emerged as the most active. DNA binding properties and the mode of interaction of chosen substituted benzimidazo[1,2-a]quinolines prepared herein were studied using melting temperature studies, a series of spectroscopic studies (UV/Visible, fluorescence, and circular dichroism), and biochemical experiments (topoisomerase I-mediated DNA relaxation and DNase I footprinting experiments). Both compound 36 and its bis-quaternary iodide salt 37 intercalate between adjacent base pairs of the DNA helix while compound 33 presented a very weak topoisomerase I poisoning activity. A 3D-QSAR analysis was performed to identify hydrogen bonding properties, hydrophobicity, molecular flexibility and distribution of hydrophobic regions as these molecular properties had the highest impact on the antiproliferative activity against the three cell lines.\n",
            "1327276\n",
            "Poison activity at human DNA topoisomerase 1 assessed as increase in intensity of nicked form of DNA at 100 uM using pUC19 supercoiled plasmid DNA as substrate preincubated for 15 mins followed by DNA topoisomerase 1 addition measured after 30 mins by agarose gel electrophoresis\n",
            "Title: Amino substituted benzimidazo[1,2-a]quinolines: Antiproliferative potency, 3D QSAR study and DNA binding properties.  Abstract: We describe the synthesis, 3D-derived quantitative structure-activity relationship (QSAR), antiproliferative activity and DNA binding properties of a series of 2-amino, 5-amino and 2,5-diamino substituted benzimidazo[1,2-a]quinolines prepared by environmentally friendly uncatalyzed microwave assisted amination. The antiproliferative activities were assessed in vitro against colon, lung and breast carcinoma cell lines; activities ranged from submicromolar to micromolar. The strongest antiproliferative activity was demonstrated by 2-amino-substituted analogues, whereas 5-amino and or 2,5-diamino substituted derivatives resulted in much less activity. Derivatives bearing 4-methyl- or 3,5-dimethyl-1-piperazinyl substituents emerged as the most active. DNA binding properties and the mode of interaction of chosen substituted benzimidazo[1,2-a]quinolines prepared herein were studied using melting temperature studies, a series of spectroscopic studies (UV/Visible, fluorescence, and circular dichroism), and biochemical experiments (topoisomerase I-mediated DNA relaxation and DNase I footprinting experiments). Both compound 36 and its bis-quaternary iodide salt 37 intercalate between adjacent base pairs of the DNA helix while compound 33 presented a very weak topoisomerase I poisoning activity. A 3D-QSAR analysis was performed to identify hydrogen bonding properties, hydrophobicity, molecular flexibility and distribution of hydrophobic regions as these molecular properties had the highest impact on the antiproliferative activity against the three cell lines.\n",
            "1327277\n",
            "Poison activity at human DNA topoisomerase 1 assessed as increase in intensity of nicked form of DNA at 20 to 100 uM using pUC19 supercoiled plasmid DNA as substrate preincubated for 15 mins followed by DNA topoisomerase 1 addition measured after 30 mins by agarose gel electrophoresis\n",
            "Title: Amino substituted benzimidazo[1,2-a]quinolines: Antiproliferative potency, 3D QSAR study and DNA binding properties.  Abstract: We describe the synthesis, 3D-derived quantitative structure-activity relationship (QSAR), antiproliferative activity and DNA binding properties of a series of 2-amino, 5-amino and 2,5-diamino substituted benzimidazo[1,2-a]quinolines prepared by environmentally friendly uncatalyzed microwave assisted amination. The antiproliferative activities were assessed in vitro against colon, lung and breast carcinoma cell lines; activities ranged from submicromolar to micromolar. The strongest antiproliferative activity was demonstrated by 2-amino-substituted analogues, whereas 5-amino and or 2,5-diamino substituted derivatives resulted in much less activity. Derivatives bearing 4-methyl- or 3,5-dimethyl-1-piperazinyl substituents emerged as the most active. DNA binding properties and the mode of interaction of chosen substituted benzimidazo[1,2-a]quinolines prepared herein were studied using melting temperature studies, a series of spectroscopic studies (UV/Visible, fluorescence, and circular dichroism), and biochemical experiments (topoisomerase I-mediated DNA relaxation and DNase I footprinting experiments). Both compound 36 and its bis-quaternary iodide salt 37 intercalate between adjacent base pairs of the DNA helix while compound 33 presented a very weak topoisomerase I poisoning activity. A 3D-QSAR analysis was performed to identify hydrogen bonding properties, hydrophobicity, molecular flexibility and distribution of hydrophobic regions as these molecular properties had the highest impact on the antiproliferative activity against the three cell lines.\n",
            "1327631\n",
            "Inhibition of human Top1 using pHOT as substrate assessed as suppression of relaxation of DNA supercoil at >50 uM after 30 mins by ethidium bromide-based agarose gel electrophoresis\n",
            "Title: Short Route to the Total Synthesis of Natural Muricadienin and Investigation of Its Cytotoxic Properties.  Abstract: An original synthesis of the acetogenin muricadienin, the bioprecursor of solamin, has been developed. The key step in the five-step 41% overall yield synthesis is the catalytic cross-cyclomagnesiation reaction of functionally substituted 1,2-dienes with EtMgBr in the presence of Cp2TiCl2 and magnesium metal. It has been demonstrated for the first time that muricadienin exhibits a moderate in vitro inhibitory activity against topoisomerases I and II, key cell cycle enzymes. Using flow cytometry, muricadienin was shown to have high cytotoxicity toward the HEK293 kidney cancer cells (IC50 0.39 M).\n",
            "1327633\n",
            "Inhibition of human Top1 using pHOT as substrate assessed as suppression of relaxation of DNA supercoil at >400 uM after 30 mins by ethidium bromide-based agarose gel electrophoresis\n",
            "Title: Short Route to the Total Synthesis of Natural Muricadienin and Investigation of Its Cytotoxic Properties.  Abstract: An original synthesis of the acetogenin muricadienin, the bioprecursor of solamin, has been developed. The key step in the five-step 41% overall yield synthesis is the catalytic cross-cyclomagnesiation reaction of functionally substituted 1,2-dienes with EtMgBr in the presence of Cp2TiCl2 and magnesium metal. It has been demonstrated for the first time that muricadienin exhibits a moderate in vitro inhibitory activity against topoisomerases I and II, key cell cycle enzymes. Using flow cytometry, muricadienin was shown to have high cytotoxicity toward the HEK293 kidney cancer cells (IC50 0.39 M).\n",
            "1327805\n",
            "Inhibition of human DNA topoisomerase 1 using pHOT1 as substrate after 30 mins by agarose gel electrophoresis\n",
            "Title: The synthesis and biological evaluation of alkyl and benzyl naphthyridinium analogs of eupolauridine as potential antimicrobial and cytotoxic agents.  Abstract: Eupolauridine, an indenonaphthyridine alkaloid, has been previously reported by us to exhibit antifungal activity. This study describes the synthesis of new alkyl and benzyl naphthyridinium/pyridinium analogs of eupolauridine as potential antifungal agents. A majority of the analogs exhibited antifungal activity against opportunistic pathogens such as Candida albicans and Cryptococcus neoformans. Several of them were also effective against bacteria (Staphylococcus aureus, MRS, Pseudomonas and Mycobacterium) and the malaria parasite (Plasmodium falciparum) to variable extents. A number of analogs were also cytotoxic to human cancer cell lines.\n",
            "1327808\n",
            "Inhibition of human DNA topoisomerase 1 using pHOT1 as substrate at 10 ug/ml after 30 mins by agarose gel electrophoresis\n",
            "Title: The synthesis and biological evaluation of alkyl and benzyl naphthyridinium analogs of eupolauridine as potential antimicrobial and cytotoxic agents.  Abstract: Eupolauridine, an indenonaphthyridine alkaloid, has been previously reported by us to exhibit antifungal activity. This study describes the synthesis of new alkyl and benzyl naphthyridinium/pyridinium analogs of eupolauridine as potential antifungal agents. A majority of the analogs exhibited antifungal activity against opportunistic pathogens such as Candida albicans and Cryptococcus neoformans. Several of them were also effective against bacteria (Staphylococcus aureus, MRS, Pseudomonas and Mycobacterium) and the malaria parasite (Plasmodium falciparum) to variable extents. A number of analogs were also cytotoxic to human cancer cell lines.\n",
            "1327956\n",
            "Inhibition of DNA topoisomerase 1 (unknown origin)-mediated relaxation of supercoiled pBR322 plasmid DNA at 100 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Synthesis and biological evaluation of 6-fluoro-3-phenyl-7-piperazinyl quinolone derivatives as potential topoisomerase I inhibitors.  Abstract: The design and synthesis of a new series of 6-fluoro-3-phenyl-7-piperazinyl quinolone derivatives, built on the structure of 1-ethyl-3-(6-nitrobenzoxazol-2-yl)-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4(1H)-quinolone, are described. These compounds provide new scaffold for the discovery of Topoisomerase I (Top I) inhibitors and target based assay showed that they can obviously inhibited Top I at 100 M. The in vitro anti-proliferative activity of these new compounds was evaluated against A549, Hela, BGC-823, and HepG2 cell lines. Compounds 18a-g showed potent inhibitory activity against the growth of those cancer cell lines. The most positive compounds 18f and 18g demonstrated as potent as camptothecin in Top I inhibition assay and MTT assay. Compounds 18f and 18g led to an obvious increase in the percentage of S phase of the cells in 24 h. The in vivo data showed that 18f and 18g inhibited tumor growth with the inhibitory rate of 29.25% and 42.75% at 20 mg/kg, respectively. The data suggested the therapeutic potential for further development.\n",
            "1333371\n",
            "Inhibition of human recombinant topoisomerase 1 catalytic activity assessed as decrease in relaxation of supercoiled pBR322 DNA at 100 uM after 60 mins by agarose gel electrophoresis\n",
            "Title: A new scaffold of topoisomerase I inhibitors: Design, synthesis and biological evaluation.  Abstract: The synthesis of a new hexacyclic system was realized starting from tryptamines and exploiting as a key step a sequential Pd-catalyzed N-arylation/acylation reaction. Having topoisomerases as biological target and the campthotecins class as benchmark, the new scaffold was decorated with substituents having different polarity and tested as Topoisomerase I inhibitors.\n",
            "1333372\n",
            "Poison activity at human recombinant topoisomerase 1 assessed as enzyme-supercoiled pBR322 DNA cleavable complex at 25 to 100 uM after 60 mins by agarose gel electrophoresis\n",
            "Title: A new scaffold of topoisomerase I inhibitors: Design, synthesis and biological evaluation.  Abstract: The synthesis of a new hexacyclic system was realized starting from tryptamines and exploiting as a key step a sequential Pd-catalyzed N-arylation/acylation reaction. Having topoisomerases as biological target and the campthotecins class as benchmark, the new scaffold was decorated with substituents having different polarity and tested as Topoisomerase I inhibitors.\n",
            "1333373\n",
            "Poison activity at human recombinant topoisomerase 1 assessed as enzyme-supercoiled pBR322 DNA cleavable complex at 500 uM after 60 mins by agarose gel electrophoresis\n",
            "Title: A new scaffold of topoisomerase I inhibitors: Design, synthesis and biological evaluation.  Abstract: The synthesis of a new hexacyclic system was realized starting from tryptamines and exploiting as a key step a sequential Pd-catalyzed N-arylation/acylation reaction. Having topoisomerases as biological target and the campthotecins class as benchmark, the new scaffold was decorated with substituents having different polarity and tested as Topoisomerase I inhibitors.\n",
            "1333374\n",
            "Poison activity at human recombinant topoisomerase 1 assessed as enzyme-supercoiled pBR322 DNA cleavable complex at 0.5 uM after 60 mins by agarose gel electrophoresis\n",
            "Title: A new scaffold of topoisomerase I inhibitors: Design, synthesis and biological evaluation.  Abstract: The synthesis of a new hexacyclic system was realized starting from tryptamines and exploiting as a key step a sequential Pd-catalyzed N-arylation/acylation reaction. Having topoisomerases as biological target and the campthotecins class as benchmark, the new scaffold was decorated with substituents having different polarity and tested as Topoisomerase I inhibitors.\n",
            "1337469\n",
            "Inhibition of human DNA topoisomerase-1 at 100 uM using supercoiled pBR322 DNA as substrate after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to control\n",
            "Title: Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors.  Abstract: On the basis of previous reports on the importance of thienyl, furyl or phenol group substitution on 5H-indeno[1,2-b]pyridine skeleton, a new series of rigid 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridine derivatives were systematically designed and synthesized. Topoisomerase inhibitory activity and antiproliferative activity of all the synthesized compounds were determined using human colorectal (HCT15), breast (T47D), prostate (DU145) and cervix (HeLa) cancer cells. Compounds 9, 10, 12, 13, 15, 16, 18 and 19 with thienyl or furyl moiety at the 2-position and hydroxyl group at the meta or para positions of 4-phenyl ring displayed strong to moderate topoisomerase II (topo II) inhibitory activity and significant antiproliferative activity. The evaluation of compound 16 to determine its mechanism of action was performed with topo II-DNA cleavable complex, topo II-mediated ATPase assay, DNA unwinding and in vitro and ex vivo topo II relaxation assay. Compound 16 functioned as a DNA non-intercalative topo II catalytic inhibitor with better potency than etoposide in T47D breast cancer cells. Molecular docking study revealed that compound 16 cannot intercalate into regularly stacked base-pairs of DNA duplex but can interact or intercalate to topo II-bound DNA.\n",
            "1337470\n",
            "Inhibition of human DNA topoisomerase-1 at 20 uM using supercoiled pBR322 DNA as substrate after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to control\n",
            "Title: Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors.  Abstract: On the basis of previous reports on the importance of thienyl, furyl or phenol group substitution on 5H-indeno[1,2-b]pyridine skeleton, a new series of rigid 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridine derivatives were systematically designed and synthesized. Topoisomerase inhibitory activity and antiproliferative activity of all the synthesized compounds were determined using human colorectal (HCT15), breast (T47D), prostate (DU145) and cervix (HeLa) cancer cells. Compounds 9, 10, 12, 13, 15, 16, 18 and 19 with thienyl or furyl moiety at the 2-position and hydroxyl group at the meta or para positions of 4-phenyl ring displayed strong to moderate topoisomerase II (topo II) inhibitory activity and significant antiproliferative activity. The evaluation of compound 16 to determine its mechanism of action was performed with topo II-DNA cleavable complex, topo II-mediated ATPase assay, DNA unwinding and in vitro and ex vivo topo II relaxation assay. Compound 16 functioned as a DNA non-intercalative topo II catalytic inhibitor with better potency than etoposide in T47D breast cancer cells. Molecular docking study revealed that compound 16 cannot intercalate into regularly stacked base-pairs of DNA duplex but can interact or intercalate to topo II-bound DNA.\n",
            "1337481\n",
            "Poison activity at human DNA topoisomerase-1 assessed as DNA intercalation by measuring DNA unwinding up to 1000 uM using pHOT1 DNA as substrate after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors.  Abstract: On the basis of previous reports on the importance of thienyl, furyl or phenol group substitution on 5H-indeno[1,2-b]pyridine skeleton, a new series of rigid 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridine derivatives were systematically designed and synthesized. Topoisomerase inhibitory activity and antiproliferative activity of all the synthesized compounds were determined using human colorectal (HCT15), breast (T47D), prostate (DU145) and cervix (HeLa) cancer cells. Compounds 9, 10, 12, 13, 15, 16, 18 and 19 with thienyl or furyl moiety at the 2-position and hydroxyl group at the meta or para positions of 4-phenyl ring displayed strong to moderate topoisomerase II (topo II) inhibitory activity and significant antiproliferative activity. The evaluation of compound 16 to determine its mechanism of action was performed with topo II-DNA cleavable complex, topo II-mediated ATPase assay, DNA unwinding and in vitro and ex vivo topo II relaxation assay. Compound 16 functioned as a DNA non-intercalative topo II catalytic inhibitor with better potency than etoposide in T47D breast cancer cells. Molecular docking study revealed that compound 16 cannot intercalate into regularly stacked base-pairs of DNA duplex but can interact or intercalate to topo II-bound DNA.\n",
            "1337482\n",
            "Poison activity at human DNA topoisomerase-1 assessed as DNA intercalation by measuring DNA unwinding using pHOT1 DNA as substrate after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors.  Abstract: On the basis of previous reports on the importance of thienyl, furyl or phenol group substitution on 5H-indeno[1,2-b]pyridine skeleton, a new series of rigid 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridine derivatives were systematically designed and synthesized. Topoisomerase inhibitory activity and antiproliferative activity of all the synthesized compounds were determined using human colorectal (HCT15), breast (T47D), prostate (DU145) and cervix (HeLa) cancer cells. Compounds 9, 10, 12, 13, 15, 16, 18 and 19 with thienyl or furyl moiety at the 2-position and hydroxyl group at the meta or para positions of 4-phenyl ring displayed strong to moderate topoisomerase II (topo II) inhibitory activity and significant antiproliferative activity. The evaluation of compound 16 to determine its mechanism of action was performed with topo II-DNA cleavable complex, topo II-mediated ATPase assay, DNA unwinding and in vitro and ex vivo topo II relaxation assay. Compound 16 functioned as a DNA non-intercalative topo II catalytic inhibitor with better potency than etoposide in T47D breast cancer cells. Molecular docking study revealed that compound 16 cannot intercalate into regularly stacked base-pairs of DNA duplex but can interact or intercalate to topo II-bound DNA.\n",
            "1337582\n",
            "Inhibition of human topoisomerase-1 assessed as inhibition of relaxation of supercoiled pBR322 plasmid DNA at 100 uM measured after 1 hr by ethidium bromide staining based agarose gel electrophoresis relative to control\n",
            "Title: Fluorescein hydrazones: A series of novel non-intercalative topoisomerase II catalytic inhibitors induce G1 arrest and apoptosis in breast and colon cancer cells.  Abstract: Fluorescein hydrazones (5 and 7) were synthesized in three/four steps with 82-92% yields. All synthesized compounds were evaluated by topoisomerase I (topo I) and topoisomerase II (topo II)-mediated relaxation and cell viability assays. Among them, most of the compounds showed topo I & II inhibitory activity and nineteen compounds showed strong anti-proliferative activity against various cell lines. In brief, 5e inhibited 53% topo II (etoposide 29%) at 20 M and showed excellent antiproliferative activity against DU145 (1.43  0.04 M), HCT15 (2.4  0.03 M) and MCF7 (11.4  0.5 M) cell lines in comparison with adriamycin, etoposide, and camptothecin. Compounds 5e, 5g and 5h were further evaluated to determine their mode of action. Compounds 5e, 5g and 5h functioned as non-intercalative topo II catalytic inhibitor with induction of G1 arrest and activation of apoptotic proteins in dose-dependent manner.\n",
            "1337583\n",
            "Inhibition of human topoisomerase-1 assessed as inhibition of relaxation of supercoiled pBR322 plasmid DNA at 20 uM measured after 1 hr by ethidium bromide staining based agarose gel electrophoresis relative to control\n",
            "Title: Fluorescein hydrazones: A series of novel non-intercalative topoisomerase II catalytic inhibitors induce G1 arrest and apoptosis in breast and colon cancer cells.  Abstract: Fluorescein hydrazones (5 and 7) were synthesized in three/four steps with 82-92% yields. All synthesized compounds were evaluated by topoisomerase I (topo I) and topoisomerase II (topo II)-mediated relaxation and cell viability assays. Among them, most of the compounds showed topo I & II inhibitory activity and nineteen compounds showed strong anti-proliferative activity against various cell lines. In brief, 5e inhibited 53% topo II (etoposide 29%) at 20 M and showed excellent antiproliferative activity against DU145 (1.43  0.04 M), HCT15 (2.4  0.03 M) and MCF7 (11.4  0.5 M) cell lines in comparison with adriamycin, etoposide, and camptothecin. Compounds 5e, 5g and 5h were further evaluated to determine their mode of action. Compounds 5e, 5g and 5h functioned as non-intercalative topo II catalytic inhibitor with induction of G1 arrest and activation of apoptotic proteins in dose-dependent manner.\n",
            "1339692\n",
            "Inhibition of DNA topoisomerase-1 (unknown origin) assessed as decrease in relaxation of supercoiled pRYG DNA at 12.5 to 100 uM after 50 mins by ethidium bromide staining-based agarose gel electrophoresis\n",
            "Inhibition of DNA topoisomerase-1 (unknown origin) assessed as decrease in relaxation of supercoiled pRYG DNA at 12.5 to 100 uM after 50 mins by ethidium bromide staining-based agarose gel electrophoresis\n",
            "1339693\n",
            "Inhibition of DNA topoisomerase-1 (unknown origin) assessed as decrease in relaxation of supercoiled pRYG DNA at 100 uM after 50 mins by ethidium bromide staining-based agarose gel electrophoresis\n",
            "Inhibition of DNA topoisomerase-1 (unknown origin) assessed as decrease in relaxation of supercoiled pRYG DNA at 100 uM after 50 mins by ethidium bromide staining-based agarose gel electrophoresis\n",
            "1346045\n",
            "Human DNA topoisomerase I (5.99.1.2 DNA Topoisomerases)\n",
            "This assay details affinity data for ligands at human DNA topoisomerase I, part of the family \"5.99.1.2 DNA Topoisomerases\", as described in the published literature. Where possible the data described are at transfected receptors expressed in cell lines and the ligands described are those that are potent, selective, endogenous, or those used as prescription medications.\n",
            "1347618\n",
            "Inhibition of human DNA topoisomerase 1 assessed as decrease in relaxation of pBR322 at 20 uM after 30 to 40 mins by agarose gel electrophoresis\n",
            "Title: Aminomethylation of heliomycin: Preparation and anticancer characterization of the first series of semi-synthetic derivatives.  Abstract: A series of 4-aminomethyl derivatives of heliomycin 1 was prepared using the Mannich reaction. The modification significantly improved aqueous solubility of the initially poorly soluble antibiotic. Testing the antiproliferative efficacy revealed a potent activity of heliomycin as well as its new derivatives on a panel of mammalian tumor cells including drug resistant variants. In contrast to 1 the new derivatives 7a, 7l, 7p generated a high level of ROS associated with induction of apoptosis in T24 bladder cancer cells. Introduction of 4-aminomethyl moiety increased the affinity to DNA and the ability to inhibit topoisomerase 1 making 7p the most promising candidate for further preclinical evaluation. Thus, aminomethylation is the first-in-class successful transformation of the antibiotic 1 resulting in an improved water solubility of derivatives and promising properties in search of novel anticancer drug candidates.\n",
            "1347619\n",
            "Inhibition of human DNA topoisomerase 1 assessed as decrease in relaxation of pBR322 at <= 20 uM after 30 to 40 mins by agarose gel electrophoresis\n",
            "Title: Aminomethylation of heliomycin: Preparation and anticancer characterization of the first series of semi-synthetic derivatives.  Abstract: A series of 4-aminomethyl derivatives of heliomycin 1 was prepared using the Mannich reaction. The modification significantly improved aqueous solubility of the initially poorly soluble antibiotic. Testing the antiproliferative efficacy revealed a potent activity of heliomycin as well as its new derivatives on a panel of mammalian tumor cells including drug resistant variants. In contrast to 1 the new derivatives 7a, 7l, 7p generated a high level of ROS associated with induction of apoptosis in T24 bladder cancer cells. Introduction of 4-aminomethyl moiety increased the affinity to DNA and the ability to inhibit topoisomerase 1 making 7p the most promising candidate for further preclinical evaluation. Thus, aminomethylation is the first-in-class successful transformation of the antibiotic 1 resulting in an improved water solubility of derivatives and promising properties in search of novel anticancer drug candidates.\n",
            "1347620\n",
            "Inhibition of human DNA topoisomerase 1 assessed as decrease in relaxation of pBR322 at 5 to 20 uM after 30 to 40 mins by agarose gel electrophoresis\n",
            "Title: Aminomethylation of heliomycin: Preparation and anticancer characterization of the first series of semi-synthetic derivatives.  Abstract: A series of 4-aminomethyl derivatives of heliomycin 1 was prepared using the Mannich reaction. The modification significantly improved aqueous solubility of the initially poorly soluble antibiotic. Testing the antiproliferative efficacy revealed a potent activity of heliomycin as well as its new derivatives on a panel of mammalian tumor cells including drug resistant variants. In contrast to 1 the new derivatives 7a, 7l, 7p generated a high level of ROS associated with induction of apoptosis in T24 bladder cancer cells. Introduction of 4-aminomethyl moiety increased the affinity to DNA and the ability to inhibit topoisomerase 1 making 7p the most promising candidate for further preclinical evaluation. Thus, aminomethylation is the first-in-class successful transformation of the antibiotic 1 resulting in an improved water solubility of derivatives and promising properties in search of novel anticancer drug candidates.\n",
            "1352095\n",
            "Inhibition of topoisomerase-1 (unknown origin) at 50 uM using negatively supercoiled pBR322 DNA as substrate after 30 mins by agarose gel electrophoresis method\n",
            "Title: Synthesis of carbazole derivatives containing chalcone analogs as non-intercalative topoisomerase II catalytic inhibitors and apoptosis inducers.  Abstract: Novel topoisomerase II (Topo II) inhibitors have gained considerable interest for the development of anticancer agents. In this study, a series of carbazole derivatives containing chalcone analogs (CDCAs) were synthesized and investigated for their Topo II inhibition and cytotoxic activities. The results from Topo II mediated DNA relaxation assay showed that CDCAs could significantly inhibit the activity of Topo II, and the structure-activity relationship indicated the halogen substituent in phenyl ring play an important role in the activity. Further mechanism studies revealed that CDCAs function as non-intercalative Topo II catalytic inhibitors. Moreover, some CDCAs showed micromolar cytotoxic activities. The most potent compound 3h exhibited notable growth inhibition against four human cancer cell lines. Flow cytometric analysis revealed that compounds 3d and 3h arrested the HL-60cells in sub G1 phase by induction of apoptosis. It was further confirmed by Annexin-V-FITC binding assay. Western blot analysis revealed that compound 3h induces apoptosis likely through the activation of caspase proteins.\n",
            "1352096\n",
            "Inhibition of topoisomerase-1 (unknown origin) at 100 uM using negatively supercoiled pBR322 DNA as substrate after 30 mins by agarose gel electrophoresis method\n",
            "Title: Synthesis of carbazole derivatives containing chalcone analogs as non-intercalative topoisomerase II catalytic inhibitors and apoptosis inducers.  Abstract: Novel topoisomerase II (Topo II) inhibitors have gained considerable interest for the development of anticancer agents. In this study, a series of carbazole derivatives containing chalcone analogs (CDCAs) were synthesized and investigated for their Topo II inhibition and cytotoxic activities. The results from Topo II mediated DNA relaxation assay showed that CDCAs could significantly inhibit the activity of Topo II, and the structure-activity relationship indicated the halogen substituent in phenyl ring play an important role in the activity. Further mechanism studies revealed that CDCAs function as non-intercalative Topo II catalytic inhibitors. Moreover, some CDCAs showed micromolar cytotoxic activities. The most potent compound 3h exhibited notable growth inhibition against four human cancer cell lines. Flow cytometric analysis revealed that compounds 3d and 3h arrested the HL-60cells in sub G1 phase by induction of apoptosis. It was further confirmed by Annexin-V-FITC binding assay. Western blot analysis revealed that compound 3h induces apoptosis likely through the activation of caspase proteins.\n",
            "1358575\n",
            "Inhibition of Top1 (unknown origin) assessed as decrease in relaxation of supercoiled pBR322 DNA at 25 uM\n",
            "Title: Synthesis and structure-activity relationship of furoquinolinediones as inhibitors of Tyrosyl-DNA phosphodiesterase 2 (TDP2).  Abstract: Tyrosyl-DNA phosphodiesterase 2 (TDP2) is a recently discovered enzyme specifically repairing topoisomerase II (TOP2)-mediated DNA damage. It has been shown that inhibition of TDP2 synergize with TOP2 inhibitors. Herein, we report the discovery of the furoquinolinedione chemotype as a suitable skeleton for the development of selective TDP2 inhibitors. Compound 1 was identified as a TDP2 inhibitor as a result of screening our in-house compound library for compounds selective for TDP2 vs. TDP1. Further SAR studies provide several selective TDP2 inhibitors at low-micromolar range. The most potent compound 74 shows inhibitory activity with IC50 of 1.9 and 2.1M against recombinant TDP2 and TDP2 in whole cell extracts (WCE), respectively.\n",
            "1359176\n",
            "Inhibition of human Top1B expressed in Top1B deficient Saccharomyces cerevisiae EKY3 assessed as decrease in relaxation of supercoiled pSK DNA preincubated for 15 mins followed by DNA addition and measured after 1 to 16 mins by agarose gel electrophoresis\n",
            "Title: Substituted 1,5-naphthyridine derivatives as novel antileishmanial agents. Synthesis and biological evaluation.  Abstract: Visceral leishmaniasis is a parasitic disease that affects, among other areas, both sides of the Mediterranean Basin. The drugs classically used in clinical practice are pentavalent antimonials (SbV) and amphotericin B, which are nephrotoxic, require parenteral administration, and increasing drug resistance in visceral leishmaniasis has been observed. These circumstances justify the search of new families of compounds to find effective drugs against the disease. Eukaryotic type I DNA topoisomerase (TopIB) has been found essential for the viability of the parasites, and therefore represents a promising target in the development of an antileishmanial therapy. In this search, heterocyclic compounds, such as 1,5-naphthyridines, have been prepared by cycloaddition reaction between N-(3-pyridyl)aldimines and acetylenes and their antileishmanial activity on promastigotes and amastigote-infected splenocytes of Leishmania infantum has been evaluated. In addition, the cytotoxic effects of newly synthesized compounds were assessed on host murine splenocytes in order to calculate the corresponding selective indexes (SI). Excellent antileishmanial activity of 1,5-naphthyridine 19, 21, 22, 24 and 27 has been observed with similar activity than the standard drug amphotericin B and higher selective index (SI>100) towards L. infantum amastigotes than amphotericin B (SI>62.5). Special interest shows the 1,5-naphthyridine 22 with an IC50 value (0.580.03M) similar to the standard drug amphotericin B (0.320.05M) and with the highest selective index (SI=271.5). In addition, this compound shows remarkable inhibition on leishmanial TopIB. However, despite these interesting results, further studies are needed to disclose other potential targets involved in the antileishmanial effect of these novel compounds.\n",
            "1361510\n",
            "Inhibition of recombinant human topoisomerase-1-mediated relaxation of supercoiled pBR322 DNA at 500 uM after 30 mins by ethidium bromide staining based assay\n",
            "Title: Novel indolo-sophoridinic scaffold as Topo I inhibitors: Design, synthesis and biological evaluation as anticancer agents.  Abstract: Based on the mechanism of action, novel scaffolds as Topo I inhibitors bearing indole and sophoridinine were designed. Preliminary docking study revealed that some molecules among the designed series possessed promising Topo I inhibitor properties. Subsequently, thirty new compounds were synthesized and characterized by 1H NMR, 13C NMR, and Mass spectral analyses. The compounds were then screened for their antiproliferative and enzymatic inhibitory activities. The results affirmed the consistency between docking and activities and the rationality of the design strategy. Furthermore, compound 10b was chosen as a representative compound to test its anticancer effects in vitro and in vivo. The results showed that 10b caused prominent S phase cell cycle arrest and significantly suppressed tumor growth in HepG2 cell derived mouse model. These findings present a promising series of lead molecules which can serve as potential Topo I inhibitors for the treatment of cancer and a theoretical basis for structural modifications.\n",
            "1363189\n",
            "Inhibition of human topoisomerase 1 using supercoiled pBR322 plasmid DNA as substrate at 100 uM after 30 mins by agarose gel electrophoresis method relative to control\n",
            "Title: A new phenolic series of indenopyridinone as topoisomerase inhibitors: Design, synthesis, and structure-activity relationships.  Abstract: DNA Topoisomerase II (topo II) is one of the most effective therapeutic targets to control cancer. In an effort to develop novel and effective topo II targeting anti-proliferative agent, a phenolic series of indenopyridinone and indenopyridinol were designed and prepared using efficient multi-component one pot synthetic method. Total twenty-two synthesized compounds were assessed for topo I and II inhibition, and anti-proliferation in three different human cancer cell lines. Overall structure-activity relationship study explored the significance of meta-phenolic group at 4-position and para-phenolic group at 2- and/or 4-position of indenopyridinone skeleton for strong topo II-selective inhibition and anti-proliferative activity against human cervix (HeLa) and colorectal (HCT15) cell lines. Compound 12 with excellent topo II inhibition (93.7%) was confirmed as a DNA intercalator that could be a new promising lead to develop effective topo II-targeted anticancer agents.\n",
            "1363190\n",
            "Inhibition of human topoisomerase 1 using supercoiled pBR322 plasmid DNA as substrate at 20 uM after 30 mins by agarose gel electrophoresis method relative to control\n",
            "Title: A new phenolic series of indenopyridinone as topoisomerase inhibitors: Design, synthesis, and structure-activity relationships.  Abstract: DNA Topoisomerase II (topo II) is one of the most effective therapeutic targets to control cancer. In an effort to develop novel and effective topo II targeting anti-proliferative agent, a phenolic series of indenopyridinone and indenopyridinol were designed and prepared using efficient multi-component one pot synthetic method. Total twenty-two synthesized compounds were assessed for topo I and II inhibition, and anti-proliferation in three different human cancer cell lines. Overall structure-activity relationship study explored the significance of meta-phenolic group at 4-position and para-phenolic group at 2- and/or 4-position of indenopyridinone skeleton for strong topo II-selective inhibition and anti-proliferative activity against human cervix (HeLa) and colorectal (HCT15) cell lines. Compound 12 with excellent topo II inhibition (93.7%) was confirmed as a DNA intercalator that could be a new promising lead to develop effective topo II-targeted anticancer agents.\n",
            "1363340\n",
            "Inhibition of recombinant TOP1 (unknown origin)-mediated 3'-[32P]-labeled 117-bp DNA oligonucleotide cleavage assessed as induction of protein-DNA covalent cleavage complex formation at 1 uM after 20 mins by PAGE analysis relative to camptothecin\n",
            "Title: Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.  Abstract: Tyrosyl-DNA phosphodiesterase 1 (TDP1) is a recently discovered enzyme repairing DNA lesions resulting from stalled topoisomerase IB (TOP1)-DNA covalent complex. Inhibiting TDP1 in conjunction with TOP1 inhibitors can boost the action of the latter. Herein, we report the discovery of the natural product oxynitidine scaffold as a novel chemotype for the development of TOP1 and TDP1 inhibitors. Three kinds of analogues, benzophenanthridinone, dihydrobenzophenanthridine, and benzophenanthridine derivatives, were synthesized and evaluated for both TOP1 and TDP1 inhibition and cytotoxicity. Analogue 19a showed high TOP1 inhibition (+++) and induced the formation of cellular TOP1cc and DNA damage, resulting in cancer cells apoptosis at nanomolar concentration range. In vivo studies indicated that 19a exhibits antitumor efficiency in HCT116 xenograft model. 41a exhibited additional TDP1 inhibition with IC50 value of 7 M and synergistic effect with camptothecin in MCF-7 cells. This work will facilitate future efforts for the discovery of natural product-based TOP1 and TDP1 inhibitors.\n",
            "1363341\n",
            "Inhibition of recombinant TOP1 (unknown origin)-mediated 3'-[32P]-labeled 117-bp DNA oligonucleotide cleavage assessed as induction of protein-DNA covalent cleavage complex formation after 20 mins by PAGE analysis\n",
            "Title: Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.  Abstract: Tyrosyl-DNA phosphodiesterase 1 (TDP1) is a recently discovered enzyme repairing DNA lesions resulting from stalled topoisomerase IB (TOP1)-DNA covalent complex. Inhibiting TDP1 in conjunction with TOP1 inhibitors can boost the action of the latter. Herein, we report the discovery of the natural product oxynitidine scaffold as a novel chemotype for the development of TOP1 and TDP1 inhibitors. Three kinds of analogues, benzophenanthridinone, dihydrobenzophenanthridine, and benzophenanthridine derivatives, were synthesized and evaluated for both TOP1 and TDP1 inhibition and cytotoxicity. Analogue 19a showed high TOP1 inhibition (+++) and induced the formation of cellular TOP1cc and DNA damage, resulting in cancer cells apoptosis at nanomolar concentration range. In vivo studies indicated that 19a exhibits antitumor efficiency in HCT116 xenograft model. 41a exhibited additional TDP1 inhibition with IC50 value of 7 M and synergistic effect with camptothecin in MCF-7 cells. This work will facilitate future efforts for the discovery of natural product-based TOP1 and TDP1 inhibitors.\n",
            "1363365\n",
            "Inhibition of TOP1-mediated DNA cleavage in human HCT116 cells assessed as induction of protein-DNA covalent cleavage complex formation after 1 hr by immunodetection method\n",
            "Title: Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.  Abstract: Tyrosyl-DNA phosphodiesterase 1 (TDP1) is a recently discovered enzyme repairing DNA lesions resulting from stalled topoisomerase IB (TOP1)-DNA covalent complex. Inhibiting TDP1 in conjunction with TOP1 inhibitors can boost the action of the latter. Herein, we report the discovery of the natural product oxynitidine scaffold as a novel chemotype for the development of TOP1 and TDP1 inhibitors. Three kinds of analogues, benzophenanthridinone, dihydrobenzophenanthridine, and benzophenanthridine derivatives, were synthesized and evaluated for both TOP1 and TDP1 inhibition and cytotoxicity. Analogue 19a showed high TOP1 inhibition (+++) and induced the formation of cellular TOP1cc and DNA damage, resulting in cancer cells apoptosis at nanomolar concentration range. In vivo studies indicated that 19a exhibits antitumor efficiency in HCT116 xenograft model. 41a exhibited additional TDP1 inhibition with IC50 value of 7 M and synergistic effect with camptothecin in MCF-7 cells. This work will facilitate future efforts for the discovery of natural product-based TOP1 and TDP1 inhibitors.\n",
            "1363366\n",
            "Inhibition of TOP1-mediated DNA cleavage in human HCT116 cells assessed as induction of protein-DNA covalent cleavage complex formation by measuring gammaH2AX foci formation at 1 uM after 3 hrs by DAPI staining-based immunofluorescence microscopic method\n",
            "Title: Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.  Abstract: Tyrosyl-DNA phosphodiesterase 1 (TDP1) is a recently discovered enzyme repairing DNA lesions resulting from stalled topoisomerase IB (TOP1)-DNA covalent complex. Inhibiting TDP1 in conjunction with TOP1 inhibitors can boost the action of the latter. Herein, we report the discovery of the natural product oxynitidine scaffold as a novel chemotype for the development of TOP1 and TDP1 inhibitors. Three kinds of analogues, benzophenanthridinone, dihydrobenzophenanthridine, and benzophenanthridine derivatives, were synthesized and evaluated for both TOP1 and TDP1 inhibition and cytotoxicity. Analogue 19a showed high TOP1 inhibition (+++) and induced the formation of cellular TOP1cc and DNA damage, resulting in cancer cells apoptosis at nanomolar concentration range. In vivo studies indicated that 19a exhibits antitumor efficiency in HCT116 xenograft model. 41a exhibited additional TDP1 inhibition with IC50 value of 7 M and synergistic effect with camptothecin in MCF-7 cells. This work will facilitate future efforts for the discovery of natural product-based TOP1 and TDP1 inhibitors.\n",
            "1374093\n",
            "Inhibition of human recombinant topoisomerase-1 assessed as inhibition of relaxation of supercoiled pBR322 plasmid DNA at 100 uM measured after 1 hr by ethidium bromide staining based agarose gel electrophoresis relative to control\n",
            "Title: Design, synthesis, and structure-activity relationships of new benzofuro[3,2-b]pyridin-7-ols as DNA topoisomerase II inhibitors.  Abstract: Human DNA topoisomerases have become attractive targets for developing more effective anticancer drugs. In this study, a series of new benzofuro[3,2-b]pyridin-7-ols were designed and synthesized for the first time and screened for their topoisomerase I and II inhibitory and antiproliferative activity. Structure-activity relationships revealed the position of ortho- and para-hydroxyl group at 2-phenyl ring, and meta-hydroxyl group at 4-phenyl ring of benzofuro[3,2-b]pyridin-7-ol are important for potent and selective topo II inhibitory activity. Compound 11 showed the most selective and potent topo II inhibition (100% inhibition at 100M) and strongest antiproliferative activity (IC50=0.86M) than all the positive controls in HeLa cell line.\n",
            "1374094\n",
            "Inhibition of human recombinant topoisomerase-1 assessed as inhibition of relaxation of supercoiled pBR322 plasmid DNA at 20 uM measured after 1 hr by ethidium bromide staining based agarose gel electrophoresis relative to control\n",
            "Title: Design, synthesis, and structure-activity relationships of new benzofuro[3,2-b]pyridin-7-ols as DNA topoisomerase II inhibitors.  Abstract: Human DNA topoisomerases have become attractive targets for developing more effective anticancer drugs. In this study, a series of new benzofuro[3,2-b]pyridin-7-ols were designed and synthesized for the first time and screened for their topoisomerase I and II inhibitory and antiproliferative activity. Structure-activity relationships revealed the position of ortho- and para-hydroxyl group at 2-phenyl ring, and meta-hydroxyl group at 4-phenyl ring of benzofuro[3,2-b]pyridin-7-ol are important for potent and selective topo II inhibitory activity. Compound 11 showed the most selective and potent topo II inhibition (100% inhibition at 100M) and strongest antiproliferative activity (IC50=0.86M) than all the positive controls in HeLa cell line.\n",
            "1378651\n",
            "Inhibition of human topoisomerase-1 expressed in baculovirus infected insect cells at 80 uM using supercoiled pGEM-5Zf(+) plasmid DNA as substrate after 30 mins by agarose gel electrophoresis method\n",
            "Title: Design, synthesis and antiproliferative activity of decarbonyl luotonin analogues.  Abstract: A small library of benzimidazole-fused pyrrolo[3,4-b]quinoline has been synthesized from readily available benzimidazole 2-carbaldehyde and various substituted arylamines in good to excellent yields utilizing an intramolecular Povarov reaction catalyzed by boron trifluoride diethyl etharate as the key final step. The compounds thus synthesized can be considered as decarbonyl analogues of the anticancer alkaloid luotonin A and were evaluated in a DNA relaxation assay for their ability to inhibit human topoisomerase I. Interestingly, two of the compounds showed a remarkable activity that is comparable to that of the standard drug camptothecin. The compounds were also evaluated for their cytotoxic effect in four highly aggressive human cancer cell lines, namely KB, MDA-MB231 (breast), LNCap (prostate), and HT1080 (fibrosarcoma). Some of the compounds obtained showed promising cytotoxicities for these four cell lines.\n",
            "1382328\n",
            "Inhibition of human topoisomerase-1 at 1 to 30 uM using supercoiled pBR322 DNA as substrate after 30 mins by agarose gel electrophoresis method\n",
            "Title: New antitumor anthra[2,3-b]furan-3-carboxamides: Synthesis and structure-activity relationship.  Abstract: Chemical modifications of the anthraquinone scaffold are aimed at optimization of this exceptionally productive class of antitumor drugs. In particular, our previously reported anthra[2,3-b]furan-3-carboxamides demonstrated a high cytotoxic potency in cell culture and in vivo. In this study, we expanded our series of anthra[2,3-b]furan-3-carboxamides by modifying the key functional groups and dissected the structure-activity relationship within this chemotype. The majority of new compounds inhibited the growth of mammalian tumor cell lines at submicromolar to low micromolar concentrations. We found that 4,11-hydroxy groups as well as the carbonyl moiety in the carboxamide fragment were critical for cytotoxicity whereas the substituent at the 2-position of anthra[2,3-b]furan was not. Importantly, the new derivatives were similarly potent against wild type cells and their variants resistant to doxorubicin due to P-glycoprotein (Pgp) expression or p53 inactivation. The most cytotoxic derivatives 6 and 9 attenuated plasmid DNA relaxation by topoisomerase 1. Finally, we demonstrated that 6 and 9at 1M induced intracellular oxidative stress, accumulation in G2/M phase of the cell cycle, and apoptosis in gastric carcinoma cell lines regardless of their p53 status. These results further substantiate the potential of anthra[2,3-b]furan-3-carboxamides as antitumor drug candidates.\n",
            "1382329\n",
            "Inhibition of human topoisomerase-1 at 10 uM using supercoiled pBR322 DNA as substrate after 30 mins by agarose gel electrophoresis method\n",
            "Title: New antitumor anthra[2,3-b]furan-3-carboxamides: Synthesis and structure-activity relationship.  Abstract: Chemical modifications of the anthraquinone scaffold are aimed at optimization of this exceptionally productive class of antitumor drugs. In particular, our previously reported anthra[2,3-b]furan-3-carboxamides demonstrated a high cytotoxic potency in cell culture and in vivo. In this study, we expanded our series of anthra[2,3-b]furan-3-carboxamides by modifying the key functional groups and dissected the structure-activity relationship within this chemotype. The majority of new compounds inhibited the growth of mammalian tumor cell lines at submicromolar to low micromolar concentrations. We found that 4,11-hydroxy groups as well as the carbonyl moiety in the carboxamide fragment were critical for cytotoxicity whereas the substituent at the 2-position of anthra[2,3-b]furan was not. Importantly, the new derivatives were similarly potent against wild type cells and their variants resistant to doxorubicin due to P-glycoprotein (Pgp) expression or p53 inactivation. The most cytotoxic derivatives 6 and 9 attenuated plasmid DNA relaxation by topoisomerase 1. Finally, we demonstrated that 6 and 9at 1M induced intracellular oxidative stress, accumulation in G2/M phase of the cell cycle, and apoptosis in gastric carcinoma cell lines regardless of their p53 status. These results further substantiate the potential of anthra[2,3-b]furan-3-carboxamides as antitumor drug candidates.\n",
            "1382330\n",
            "Inhibition of human topoisomerase-1 using supercoiled pBR322 DNA as substrate after 30 mins by agarose gel electrophoresis method\n",
            "Title: New antitumor anthra[2,3-b]furan-3-carboxamides: Synthesis and structure-activity relationship.  Abstract: Chemical modifications of the anthraquinone scaffold are aimed at optimization of this exceptionally productive class of antitumor drugs. In particular, our previously reported anthra[2,3-b]furan-3-carboxamides demonstrated a high cytotoxic potency in cell culture and in vivo. In this study, we expanded our series of anthra[2,3-b]furan-3-carboxamides by modifying the key functional groups and dissected the structure-activity relationship within this chemotype. The majority of new compounds inhibited the growth of mammalian tumor cell lines at submicromolar to low micromolar concentrations. We found that 4,11-hydroxy groups as well as the carbonyl moiety in the carboxamide fragment were critical for cytotoxicity whereas the substituent at the 2-position of anthra[2,3-b]furan was not. Importantly, the new derivatives were similarly potent against wild type cells and their variants resistant to doxorubicin due to P-glycoprotein (Pgp) expression or p53 inactivation. The most cytotoxic derivatives 6 and 9 attenuated plasmid DNA relaxation by topoisomerase 1. Finally, we demonstrated that 6 and 9at 1M induced intracellular oxidative stress, accumulation in G2/M phase of the cell cycle, and apoptosis in gastric carcinoma cell lines regardless of their p53 status. These results further substantiate the potential of anthra[2,3-b]furan-3-carboxamides as antitumor drug candidates.\n",
            "1382599\n",
            "Inhibition of DNA topoisomerase-1 (unknown origin) using supercoiled pBR322 DNA as substrate preincubated with enzyme followed by substrate addition measured after 30 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Structure-based discovery of cytotoxic dimeric tetrahydroxanthones as potential topoisomerase I inhibitors from a marine-derived fungus.  Abstract: DNA topoisomerase I (Topo I) is an important anticancer drug target, and xanthone dimers are considered to be a new kind of Topo I inhibitor chemotypes. Based on the characteristics of dimeric xanthone structures, five new dimeric xanthones (1-5) and two known SAD isomers (6 and 7) were isolated from the mangrove-derived fungus Aspergillus vericolor. The absolute configurations of compounds 1-7, entailing both central and axial chirality elements, were established by a combination of ECD comparison, chemical conversions, and biogenetic considerations. Compounds 1-7 possessed high structural diversity and exhibited cytotoxicity at different levels. The selected new compounds 1, 2, and 5 showed Topo I inhibition properties and the most potent compound 1, an atropisomer of compound 2, was confirmed to inhibit Topo I-mediated DNA relaxation by targeting Topo I, thereby, arresting the cell cycle process and inducing necrosis in cancer cells. Molecular docking studies showed that compound 1 could bind DNA by - interaction and DNA Topo I by hydrogen bonds to form a ternary complex.\n",
            "1382600\n",
            "Inhibition of DNA topoisomerase-1 (unknown origin) up to 40 uM using supercoiled pBR322 DNA as substrate preincubated with enzyme followed by substrate addition measured after 30 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Structure-based discovery of cytotoxic dimeric tetrahydroxanthones as potential topoisomerase I inhibitors from a marine-derived fungus.  Abstract: DNA topoisomerase I (Topo I) is an important anticancer drug target, and xanthone dimers are considered to be a new kind of Topo I inhibitor chemotypes. Based on the characteristics of dimeric xanthone structures, five new dimeric xanthones (1-5) and two known SAD isomers (6 and 7) were isolated from the mangrove-derived fungus Aspergillus vericolor. The absolute configurations of compounds 1-7, entailing both central and axial chirality elements, were established by a combination of ECD comparison, chemical conversions, and biogenetic considerations. Compounds 1-7 possessed high structural diversity and exhibited cytotoxicity at different levels. The selected new compounds 1, 2, and 5 showed Topo I inhibition properties and the most potent compound 1, an atropisomer of compound 2, was confirmed to inhibit Topo I-mediated DNA relaxation by targeting Topo I, thereby, arresting the cell cycle process and inducing necrosis in cancer cells. Molecular docking studies showed that compound 1 could bind DNA by - interaction and DNA Topo I by hydrogen bonds to form a ternary complex.\n",
            "1382607\n",
            "Inhibition of DNA topoisomerase-1 (unknown origin) at 10 uM using supercoiled pBR322 DNA as substrate preincubated for 1 to 30 mins followed by substrate addition by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Structure-based discovery of cytotoxic dimeric tetrahydroxanthones as potential topoisomerase I inhibitors from a marine-derived fungus.  Abstract: DNA topoisomerase I (Topo I) is an important anticancer drug target, and xanthone dimers are considered to be a new kind of Topo I inhibitor chemotypes. Based on the characteristics of dimeric xanthone structures, five new dimeric xanthones (1-5) and two known SAD isomers (6 and 7) were isolated from the mangrove-derived fungus Aspergillus vericolor. The absolute configurations of compounds 1-7, entailing both central and axial chirality elements, were established by a combination of ECD comparison, chemical conversions, and biogenetic considerations. Compounds 1-7 possessed high structural diversity and exhibited cytotoxicity at different levels. The selected new compounds 1, 2, and 5 showed Topo I inhibition properties and the most potent compound 1, an atropisomer of compound 2, was confirmed to inhibit Topo I-mediated DNA relaxation by targeting Topo I, thereby, arresting the cell cycle process and inducing necrosis in cancer cells. Molecular docking studies showed that compound 1 could bind DNA by - interaction and DNA Topo I by hydrogen bonds to form a ternary complex.\n",
            "1382608\n",
            "Inhibition of DNA topoisomerase-1 (unknown origin) at 10 uM using supercoiled pBR322 DNA as substrate preincubated for 15 mins followed by substrate addition measured after 30 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Structure-based discovery of cytotoxic dimeric tetrahydroxanthones as potential topoisomerase I inhibitors from a marine-derived fungus.  Abstract: DNA topoisomerase I (Topo I) is an important anticancer drug target, and xanthone dimers are considered to be a new kind of Topo I inhibitor chemotypes. Based on the characteristics of dimeric xanthone structures, five new dimeric xanthones (1-5) and two known SAD isomers (6 and 7) were isolated from the mangrove-derived fungus Aspergillus vericolor. The absolute configurations of compounds 1-7, entailing both central and axial chirality elements, were established by a combination of ECD comparison, chemical conversions, and biogenetic considerations. Compounds 1-7 possessed high structural diversity and exhibited cytotoxicity at different levels. The selected new compounds 1, 2, and 5 showed Topo I inhibition properties and the most potent compound 1, an atropisomer of compound 2, was confirmed to inhibit Topo I-mediated DNA relaxation by targeting Topo I, thereby, arresting the cell cycle process and inducing necrosis in cancer cells. Molecular docking studies showed that compound 1 could bind DNA by - interaction and DNA Topo I by hydrogen bonds to form a ternary complex.\n",
            "1383386\n",
            "Inhibition of recombinant human topoisomerase 1-mediated DNA relaxation expressed in Saccharomyces cerevisiae TopI null strain RS190 at 80 uM using negatively supercoiled pUC18 as substrate pretreated with enzyme for 15 mins followed by substrate addition measured after 15 secs by agarose gel electrophoresis\n",
            "Title: Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity.  Abstract: This work describes the synthesis of 1,2,3,4-tetrahydroquinolinylphosphine oxides, phosphanes and phosphine sulfides as well as that of quinolinylphosphine oxides and phosphine sulfides, which were synthesized in good to high overall yield. The synthetic route involves a multicomponent reaction of (2-phosphine-oxide)-, 2-phosphine- or (2-phosphine-sulfide)-aniline, aldehydes and olefins and allows the selective generation of two stereogenic centres in a short, efficient and reliable synthesis. The selective dehydrogenation of 1,2,3,4-tetrahydroquinolinylphosphine oxides and phosphine sulfides leads to the formation of corresponding phosphorus substituted quinolines. Some of the products which were prepared showed excellent activity as topoisomerase I (Top1) inhibitors. In addition, prolonged effect of the most potent compounds is maintained with the same intensity even after 3min of the beginning of the enzymatic reaction. The cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV03) and human embryonic kidney (HEK293) was also screened. 1,2,3,4-Tetrahydroquinolinylphosphine oxide 6g with an IC50 value of 0.250.03M showed excellent activity against the A549cell line in vitro, while 1,2,3,4-tetrahydroquinolinylphosphane 9c with an IC50 value of 0.080.01M and 1,2,3,4-tetrahydroquinolinylphosphine sulfide derivative 10f with an IC50 value of 0.030.04M are more active against the A549cell line. Moreover, selectivity towards cancer cell (A549) over non-malignant cells (MRC5) has been observed. According to their structure, they may be excellent antiproliferative candidates.\n",
            "1383387\n",
            "Inhibition of recombinant human topoisomerase 1-mediated DNA relaxation expressed in Saccharomyces cerevisiae TopI null strain RS190 at 80 uM using negatively supercoiled pUC18 as substrate pretreated with enzyme for 15 mins followed by substrate addition measured after 1 min by agarose gel electrophoresis\n",
            "Title: Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity.  Abstract: This work describes the synthesis of 1,2,3,4-tetrahydroquinolinylphosphine oxides, phosphanes and phosphine sulfides as well as that of quinolinylphosphine oxides and phosphine sulfides, which were synthesized in good to high overall yield. The synthetic route involves a multicomponent reaction of (2-phosphine-oxide)-, 2-phosphine- or (2-phosphine-sulfide)-aniline, aldehydes and olefins and allows the selective generation of two stereogenic centres in a short, efficient and reliable synthesis. The selective dehydrogenation of 1,2,3,4-tetrahydroquinolinylphosphine oxides and phosphine sulfides leads to the formation of corresponding phosphorus substituted quinolines. Some of the products which were prepared showed excellent activity as topoisomerase I (Top1) inhibitors. In addition, prolonged effect of the most potent compounds is maintained with the same intensity even after 3min of the beginning of the enzymatic reaction. The cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV03) and human embryonic kidney (HEK293) was also screened. 1,2,3,4-Tetrahydroquinolinylphosphine oxide 6g with an IC50 value of 0.250.03M showed excellent activity against the A549cell line in vitro, while 1,2,3,4-tetrahydroquinolinylphosphane 9c with an IC50 value of 0.080.01M and 1,2,3,4-tetrahydroquinolinylphosphine sulfide derivative 10f with an IC50 value of 0.030.04M are more active against the A549cell line. Moreover, selectivity towards cancer cell (A549) over non-malignant cells (MRC5) has been observed. According to their structure, they may be excellent antiproliferative candidates.\n",
            "1383388\n",
            "Inhibition of recombinant human topoisomerase 1-mediated DNA relaxation expressed in Saccharomyces cerevisiae TopI null strain RS190 at 80 uM using negatively supercoiled pUC18 as substrate pretreated with enzyme for 15 mins followed by substrate addition measured after 3 mins by agarose gel electrophoresis\n",
            "Title: Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity.  Abstract: This work describes the synthesis of 1,2,3,4-tetrahydroquinolinylphosphine oxides, phosphanes and phosphine sulfides as well as that of quinolinylphosphine oxides and phosphine sulfides, which were synthesized in good to high overall yield. The synthetic route involves a multicomponent reaction of (2-phosphine-oxide)-, 2-phosphine- or (2-phosphine-sulfide)-aniline, aldehydes and olefins and allows the selective generation of two stereogenic centres in a short, efficient and reliable synthesis. The selective dehydrogenation of 1,2,3,4-tetrahydroquinolinylphosphine oxides and phosphine sulfides leads to the formation of corresponding phosphorus substituted quinolines. Some of the products which were prepared showed excellent activity as topoisomerase I (Top1) inhibitors. In addition, prolonged effect of the most potent compounds is maintained with the same intensity even after 3min of the beginning of the enzymatic reaction. The cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV03) and human embryonic kidney (HEK293) was also screened. 1,2,3,4-Tetrahydroquinolinylphosphine oxide 6g with an IC50 value of 0.250.03M showed excellent activity against the A549cell line in vitro, while 1,2,3,4-tetrahydroquinolinylphosphane 9c with an IC50 value of 0.080.01M and 1,2,3,4-tetrahydroquinolinylphosphine sulfide derivative 10f with an IC50 value of 0.030.04M are more active against the A549cell line. Moreover, selectivity towards cancer cell (A549) over non-malignant cells (MRC5) has been observed. According to their structure, they may be excellent antiproliferative candidates.\n",
            "1383389\n",
            "Inhibition of recombinant human topoisomerase 1-mediated DNA relaxation expressed in Saccharomyces cerevisiae TopI null strain RS190 at 60 uM using negatively supercoiled pUC18 as substrate pretreated with enzyme for 15 mins followed by substrate addition measured after 3 mins by agarose gel electrophoresis\n",
            "Title: Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity.  Abstract: This work describes the synthesis of 1,2,3,4-tetrahydroquinolinylphosphine oxides, phosphanes and phosphine sulfides as well as that of quinolinylphosphine oxides and phosphine sulfides, which were synthesized in good to high overall yield. The synthetic route involves a multicomponent reaction of (2-phosphine-oxide)-, 2-phosphine- or (2-phosphine-sulfide)-aniline, aldehydes and olefins and allows the selective generation of two stereogenic centres in a short, efficient and reliable synthesis. The selective dehydrogenation of 1,2,3,4-tetrahydroquinolinylphosphine oxides and phosphine sulfides leads to the formation of corresponding phosphorus substituted quinolines. Some of the products which were prepared showed excellent activity as topoisomerase I (Top1) inhibitors. In addition, prolonged effect of the most potent compounds is maintained with the same intensity even after 3min of the beginning of the enzymatic reaction. The cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV03) and human embryonic kidney (HEK293) was also screened. 1,2,3,4-Tetrahydroquinolinylphosphine oxide 6g with an IC50 value of 0.250.03M showed excellent activity against the A549cell line in vitro, while 1,2,3,4-tetrahydroquinolinylphosphane 9c with an IC50 value of 0.080.01M and 1,2,3,4-tetrahydroquinolinylphosphine sulfide derivative 10f with an IC50 value of 0.030.04M are more active against the A549cell line. Moreover, selectivity towards cancer cell (A549) over non-malignant cells (MRC5) has been observed. According to their structure, they may be excellent antiproliferative candidates.\n",
            "1383390\n",
            "Inhibition of recombinant human topoisomerase 1-mediated DNA relaxation expressed in Saccharomyces cerevisiae TopI null strain RS190 at 40 uM using negatively supercoiled pUC18 as substrate pretreated with enzyme for 15 mins followed by substrate addition measured after 3 mins by agarose gel electrophoresis\n",
            "Title: Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity.  Abstract: This work describes the synthesis of 1,2,3,4-tetrahydroquinolinylphosphine oxides, phosphanes and phosphine sulfides as well as that of quinolinylphosphine oxides and phosphine sulfides, which were synthesized in good to high overall yield. The synthetic route involves a multicomponent reaction of (2-phosphine-oxide)-, 2-phosphine- or (2-phosphine-sulfide)-aniline, aldehydes and olefins and allows the selective generation of two stereogenic centres in a short, efficient and reliable synthesis. The selective dehydrogenation of 1,2,3,4-tetrahydroquinolinylphosphine oxides and phosphine sulfides leads to the formation of corresponding phosphorus substituted quinolines. Some of the products which were prepared showed excellent activity as topoisomerase I (Top1) inhibitors. In addition, prolonged effect of the most potent compounds is maintained with the same intensity even after 3min of the beginning of the enzymatic reaction. The cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV03) and human embryonic kidney (HEK293) was also screened. 1,2,3,4-Tetrahydroquinolinylphosphine oxide 6g with an IC50 value of 0.250.03M showed excellent activity against the A549cell line in vitro, while 1,2,3,4-tetrahydroquinolinylphosphane 9c with an IC50 value of 0.080.01M and 1,2,3,4-tetrahydroquinolinylphosphine sulfide derivative 10f with an IC50 value of 0.030.04M are more active against the A549cell line. Moreover, selectivity towards cancer cell (A549) over non-malignant cells (MRC5) has been observed. According to their structure, they may be excellent antiproliferative candidates.\n",
            "1383391\n",
            "Inhibition of recombinant human topoisomerase 1-mediated DNA relaxation expressed in Saccharomyces cerevisiae TopI null strain RS190 at 20 uM using negatively supercoiled pUC18 as substrate pretreated with enzyme for 15 mins followed by substrate addition measured after 3 mins by agarose gel electrophoresis\n",
            "Title: Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity.  Abstract: This work describes the synthesis of 1,2,3,4-tetrahydroquinolinylphosphine oxides, phosphanes and phosphine sulfides as well as that of quinolinylphosphine oxides and phosphine sulfides, which were synthesized in good to high overall yield. The synthetic route involves a multicomponent reaction of (2-phosphine-oxide)-, 2-phosphine- or (2-phosphine-sulfide)-aniline, aldehydes and olefins and allows the selective generation of two stereogenic centres in a short, efficient and reliable synthesis. The selective dehydrogenation of 1,2,3,4-tetrahydroquinolinylphosphine oxides and phosphine sulfides leads to the formation of corresponding phosphorus substituted quinolines. Some of the products which were prepared showed excellent activity as topoisomerase I (Top1) inhibitors. In addition, prolonged effect of the most potent compounds is maintained with the same intensity even after 3min of the beginning of the enzymatic reaction. The cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV03) and human embryonic kidney (HEK293) was also screened. 1,2,3,4-Tetrahydroquinolinylphosphine oxide 6g with an IC50 value of 0.250.03M showed excellent activity against the A549cell line in vitro, while 1,2,3,4-tetrahydroquinolinylphosphane 9c with an IC50 value of 0.080.01M and 1,2,3,4-tetrahydroquinolinylphosphine sulfide derivative 10f with an IC50 value of 0.030.04M are more active against the A549cell line. Moreover, selectivity towards cancer cell (A549) over non-malignant cells (MRC5) has been observed. According to their structure, they may be excellent antiproliferative candidates.\n",
            "1383392\n",
            "Inhibition of recombinant human topoisomerase 1-mediated DNA relaxation expressed in Saccharomyces cerevisiae TopI null strain RS190 at 10 uM using negatively supercoiled pUC18 as substrate pretreated with enzyme for 15 mins followed by substrate addition measured after 3 mins by agarose gel electrophoresis\n",
            "Title: Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity.  Abstract: This work describes the synthesis of 1,2,3,4-tetrahydroquinolinylphosphine oxides, phosphanes and phosphine sulfides as well as that of quinolinylphosphine oxides and phosphine sulfides, which were synthesized in good to high overall yield. The synthetic route involves a multicomponent reaction of (2-phosphine-oxide)-, 2-phosphine- or (2-phosphine-sulfide)-aniline, aldehydes and olefins and allows the selective generation of two stereogenic centres in a short, efficient and reliable synthesis. The selective dehydrogenation of 1,2,3,4-tetrahydroquinolinylphosphine oxides and phosphine sulfides leads to the formation of corresponding phosphorus substituted quinolines. Some of the products which were prepared showed excellent activity as topoisomerase I (Top1) inhibitors. In addition, prolonged effect of the most potent compounds is maintained with the same intensity even after 3min of the beginning of the enzymatic reaction. The cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV03) and human embryonic kidney (HEK293) was also screened. 1,2,3,4-Tetrahydroquinolinylphosphine oxide 6g with an IC50 value of 0.250.03M showed excellent activity against the A549cell line in vitro, while 1,2,3,4-tetrahydroquinolinylphosphane 9c with an IC50 value of 0.080.01M and 1,2,3,4-tetrahydroquinolinylphosphine sulfide derivative 10f with an IC50 value of 0.030.04M are more active against the A549cell line. Moreover, selectivity towards cancer cell (A549) over non-malignant cells (MRC5) has been observed. According to their structure, they may be excellent antiproliferative candidates.\n",
            "1387408\n",
            "Inhibition of human recombinant topoisomerase-1 activity at 50 uM using supercoiled pHOT-1 DNA incubated for 30 mins by ethidium bromide free agarose gel elctrophoresis method\n",
            "Title: Structure-Based Drug Design and Identification of H2O-Soluble and Low Toxic Hexacyclic Camptothecin Derivatives with Improved Efficacy in Cancer and Lethal Inflammation Models in Vivo.  Abstract: Camptothecin (CPT) has been shown to block disassembly of the topoisomerase I (Topo I)/DNA cleavable complex. However, the poor aqueous solubility, intrinsic instability, and severe toxicity of CPTs have limited their clinical applications. Herein, we report the design and synthesis of H2O-soluble and orally bioavailable hexacyclic CPT derivatives. By analysis of a virtual chemical library and cytotoxicity screening in vitro, 9 and 11 were identified as potential prodrugs and chosen for further characterization in vivo. Both compounds exhibited remarkable anticancer and anti-inflammation efficacies in animals and improved drug-like profiles.\n",
            "1387409\n",
            "Inhibition of human recombinant topoisomerase-1 activity at 100 uM using supercoiled pHOT-1 DNA incubated for 30 mins by ethidium bromide free agarose gel elctrophoresis method\n",
            "Title: Structure-Based Drug Design and Identification of H2O-Soluble and Low Toxic Hexacyclic Camptothecin Derivatives with Improved Efficacy in Cancer and Lethal Inflammation Models in Vivo.  Abstract: Camptothecin (CPT) has been shown to block disassembly of the topoisomerase I (Topo I)/DNA cleavable complex. However, the poor aqueous solubility, intrinsic instability, and severe toxicity of CPTs have limited their clinical applications. Herein, we report the design and synthesis of H2O-soluble and orally bioavailable hexacyclic CPT derivatives. By analysis of a virtual chemical library and cytotoxicity screening in vitro, 9 and 11 were identified as potential prodrugs and chosen for further characterization in vivo. Both compounds exhibited remarkable anticancer and anti-inflammation efficacies in animals and improved drug-like profiles.\n",
            "1387410\n",
            "Inhibition of human recombinant topoisomerase-1-mediated DNA cleavage in at 50 uM using supercoiled pHOT-1 DNA incubated for 30 mins by ethidium bromide staining based agarose gel elctrophoresis method\n",
            "Title: Structure-Based Drug Design and Identification of H2O-Soluble and Low Toxic Hexacyclic Camptothecin Derivatives with Improved Efficacy in Cancer and Lethal Inflammation Models in Vivo.  Abstract: Camptothecin (CPT) has been shown to block disassembly of the topoisomerase I (Topo I)/DNA cleavable complex. However, the poor aqueous solubility, intrinsic instability, and severe toxicity of CPTs have limited their clinical applications. Herein, we report the design and synthesis of H2O-soluble and orally bioavailable hexacyclic CPT derivatives. By analysis of a virtual chemical library and cytotoxicity screening in vitro, 9 and 11 were identified as potential prodrugs and chosen for further characterization in vivo. Both compounds exhibited remarkable anticancer and anti-inflammation efficacies in animals and improved drug-like profiles.\n",
            "1387411\n",
            "Inhibition of human recombinant topoisomerase-1-mediated DNA cleavage in at 100 uM using supercoiled pHOT-1 DNA incubated for 30 mins by ethidium bromide staining based agarose gel elctrophoresis method\n",
            "Title: Structure-Based Drug Design and Identification of H2O-Soluble and Low Toxic Hexacyclic Camptothecin Derivatives with Improved Efficacy in Cancer and Lethal Inflammation Models in Vivo.  Abstract: Camptothecin (CPT) has been shown to block disassembly of the topoisomerase I (Topo I)/DNA cleavable complex. However, the poor aqueous solubility, intrinsic instability, and severe toxicity of CPTs have limited their clinical applications. Herein, we report the design and synthesis of H2O-soluble and orally bioavailable hexacyclic CPT derivatives. By analysis of a virtual chemical library and cytotoxicity screening in vitro, 9 and 11 were identified as potential prodrugs and chosen for further characterization in vivo. Both compounds exhibited remarkable anticancer and anti-inflammation efficacies in animals and improved drug-like profiles.\n",
            "1390166\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as decrease in relaxation of supercoiled pBR322 DNA at 100 uM after 30 mins by agarose gel electrophoresis relative to control\n",
            "Title: Synthesis and SAR study of new hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines as selective topoisomerase II-targeting anticancer agents.  Abstract: As part of our effort to develop potential topoisomerase II (topo II) targeting anticancer agents, we systematically designed a new series of hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines. Total eighteen compounds were synthesized and tested for their ability to inhibit the function of topo I and II, and proliferation of human breast (T47D), colorectal (HCT15), and cervix (HeLa) cancer cells. Except compound 11, all of the tested compounds displayed selective topo II inhibitory activity. Compounds 8-18, 22, 24, and 25 showed excellent topo II inhibitory activity than a positive control, etoposide. Most of the compounds appeared to be superior to reference compounds in their antiproliferative activity. Structure-activity relationship (SAR) study has shown that it is better to place the hydroxyphenyl group at the 4-position of the central pyridine for superior topo II inhibition and antiproliferative activity. Similarly, the 3'-, or 4'-hydroxyphenyl substitution at the 2- and 4-positon of pyridine ring is important for better activity than 2'-substitution.\n",
            "1390167\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as decrease in relaxation of supercoiled pBR322 DNA at 20 uM after 30 mins by agarose gel electrophoresis relative to control\n",
            "Title: Synthesis and SAR study of new hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines as selective topoisomerase II-targeting anticancer agents.  Abstract: As part of our effort to develop potential topoisomerase II (topo II) targeting anticancer agents, we systematically designed a new series of hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines. Total eighteen compounds were synthesized and tested for their ability to inhibit the function of topo I and II, and proliferation of human breast (T47D), colorectal (HCT15), and cervix (HeLa) cancer cells. Except compound 11, all of the tested compounds displayed selective topo II inhibitory activity. Compounds 8-18, 22, 24, and 25 showed excellent topo II inhibitory activity than a positive control, etoposide. Most of the compounds appeared to be superior to reference compounds in their antiproliferative activity. Structure-activity relationship (SAR) study has shown that it is better to place the hydroxyphenyl group at the 4-position of the central pyridine for superior topo II inhibition and antiproliferative activity. Similarly, the 3'-, or 4'-hydroxyphenyl substitution at the 2- and 4-positon of pyridine ring is important for better activity than 2'-substitution.\n",
            "1390176\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as decrease in relaxation of supercoiled pBR322 DNA at 100 uM after 30 mins by agarose gel electrophoresis relative to camptothecin\n",
            "Title: Synthesis and SAR study of new hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines as selective topoisomerase II-targeting anticancer agents.  Abstract: As part of our effort to develop potential topoisomerase II (topo II) targeting anticancer agents, we systematically designed a new series of hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines. Total eighteen compounds were synthesized and tested for their ability to inhibit the function of topo I and II, and proliferation of human breast (T47D), colorectal (HCT15), and cervix (HeLa) cancer cells. Except compound 11, all of the tested compounds displayed selective topo II inhibitory activity. Compounds 8-18, 22, 24, and 25 showed excellent topo II inhibitory activity than a positive control, etoposide. Most of the compounds appeared to be superior to reference compounds in their antiproliferative activity. Structure-activity relationship (SAR) study has shown that it is better to place the hydroxyphenyl group at the 4-position of the central pyridine for superior topo II inhibition and antiproliferative activity. Similarly, the 3'-, or 4'-hydroxyphenyl substitution at the 2- and 4-positon of pyridine ring is important for better activity than 2'-substitution.\n",
            "1390177\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as decrease in relaxation of supercoiled pBR322 DNA at 20 uM after 30 mins by agarose gel electrophoresis relative to camptothecin\n",
            "Title: Synthesis and SAR study of new hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines as selective topoisomerase II-targeting anticancer agents.  Abstract: As part of our effort to develop potential topoisomerase II (topo II) targeting anticancer agents, we systematically designed a new series of hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines. Total eighteen compounds were synthesized and tested for their ability to inhibit the function of topo I and II, and proliferation of human breast (T47D), colorectal (HCT15), and cervix (HeLa) cancer cells. Except compound 11, all of the tested compounds displayed selective topo II inhibitory activity. Compounds 8-18, 22, 24, and 25 showed excellent topo II inhibitory activity than a positive control, etoposide. Most of the compounds appeared to be superior to reference compounds in their antiproliferative activity. Structure-activity relationship (SAR) study has shown that it is better to place the hydroxyphenyl group at the 4-position of the central pyridine for superior topo II inhibition and antiproliferative activity. Similarly, the 3'-, or 4'-hydroxyphenyl substitution at the 2- and 4-positon of pyridine ring is important for better activity than 2'-substitution.\n",
            "1390208\n",
            "Inhibition of human topoisomerase1-mediated DNA relaxation assessed as DNA intercalation at 5 to 50 uM using supercoiled pUC19 as substrate pretreated with substrate for 45 mins followed by enzyme addition measured by agarose gel electrophoresis\n",
            "Title: Synthesis, antitumor activity and DNA binding features of benzothiazolyl and benzimidazolyl substituted isoindolines.  Abstract: In this paper novel isoindolines substituted with cyano and amidino benzimidazoles and benzothiazoles were synthesized as new potential anti-cancer agents. The new structures were evaluated for antiproliferative activity, cell cycle changes, cell death, as well as DNA binding and topoisomerase inhibition properties on selected compounds. Results showed that all tested compounds exerted antitumor activity, especially amidinobenzothiazole and amidinobenzimidazole substituted isoindolin-1-ones and benzimidazole substituted 1-iminoisoindoline that showed antiproliferative effect in the submicromolar range. Moreover, the DNA-binding properties of selected compounds were evaluated by biophysical and biochemical approaches including thermal denaturation studies, circular dichroism spectra analyses and topoisomerase I/II inhibition assays and results identified some of them as strong DNA ligands, harboring or not additional topoisomerase II inhibition and able to locate in the nucleus as determined by fluorescence microscopy. In conclusion, we evidenced novel cyano- and amidino-substituted isoindolines coupled with benzimidazoles and benzothiazoles as topoisomerase inhibitors and/or DNA binding compounds with potent antitumor activities.\n",
            "1390209\n",
            "Poison activity at human topoisomerase1 assessed as accumulation of nicked DNA at 5 to 50 uM using supercoiled pUC19 as substrate pretreated with substrate for 45 mins followed by enzyme addition measured by agarose gel electrophoresis\n",
            "Title: Synthesis, antitumor activity and DNA binding features of benzothiazolyl and benzimidazolyl substituted isoindolines.  Abstract: In this paper novel isoindolines substituted with cyano and amidino benzimidazoles and benzothiazoles were synthesized as new potential anti-cancer agents. The new structures were evaluated for antiproliferative activity, cell cycle changes, cell death, as well as DNA binding and topoisomerase inhibition properties on selected compounds. Results showed that all tested compounds exerted antitumor activity, especially amidinobenzothiazole and amidinobenzimidazole substituted isoindolin-1-ones and benzimidazole substituted 1-iminoisoindoline that showed antiproliferative effect in the submicromolar range. Moreover, the DNA-binding properties of selected compounds were evaluated by biophysical and biochemical approaches including thermal denaturation studies, circular dichroism spectra analyses and topoisomerase I/II inhibition assays and results identified some of them as strong DNA ligands, harboring or not additional topoisomerase II inhibition and able to locate in the nucleus as determined by fluorescence microscopy. In conclusion, we evidenced novel cyano- and amidino-substituted isoindolines coupled with benzimidazoles and benzothiazoles as topoisomerase inhibitors and/or DNA binding compounds with potent antitumor activities.\n",
            "1390210\n",
            "Poison activity at human topoisomerase1 assessed as accumulation of nicked DNA at 10 uM using supercoiled pUC19 as substrate pretreated with substrate for 45 mins followed by enzyme addition measured by agarose gel electrophoresis relative to control\n",
            "Title: Synthesis, antitumor activity and DNA binding features of benzothiazolyl and benzimidazolyl substituted isoindolines.  Abstract: In this paper novel isoindolines substituted with cyano and amidino benzimidazoles and benzothiazoles were synthesized as new potential anti-cancer agents. The new structures were evaluated for antiproliferative activity, cell cycle changes, cell death, as well as DNA binding and topoisomerase inhibition properties on selected compounds. Results showed that all tested compounds exerted antitumor activity, especially amidinobenzothiazole and amidinobenzimidazole substituted isoindolin-1-ones and benzimidazole substituted 1-iminoisoindoline that showed antiproliferative effect in the submicromolar range. Moreover, the DNA-binding properties of selected compounds were evaluated by biophysical and biochemical approaches including thermal denaturation studies, circular dichroism spectra analyses and topoisomerase I/II inhibition assays and results identified some of them as strong DNA ligands, harboring or not additional topoisomerase II inhibition and able to locate in the nucleus as determined by fluorescence microscopy. In conclusion, we evidenced novel cyano- and amidino-substituted isoindolines coupled with benzimidazoles and benzothiazoles as topoisomerase inhibitors and/or DNA binding compounds with potent antitumor activities.\n",
            "1390211\n",
            "Poison activity at human topoisomerase1 assessed as accumulation of nicked DNA at 20 uM using supercoiled pUC19 as substrate pretreated with substrate for 45 mins followed by enzyme addition measured by agarose gel electrophoresis relative to control\n",
            "Title: Synthesis, antitumor activity and DNA binding features of benzothiazolyl and benzimidazolyl substituted isoindolines.  Abstract: In this paper novel isoindolines substituted with cyano and amidino benzimidazoles and benzothiazoles were synthesized as new potential anti-cancer agents. The new structures were evaluated for antiproliferative activity, cell cycle changes, cell death, as well as DNA binding and topoisomerase inhibition properties on selected compounds. Results showed that all tested compounds exerted antitumor activity, especially amidinobenzothiazole and amidinobenzimidazole substituted isoindolin-1-ones and benzimidazole substituted 1-iminoisoindoline that showed antiproliferative effect in the submicromolar range. Moreover, the DNA-binding properties of selected compounds were evaluated by biophysical and biochemical approaches including thermal denaturation studies, circular dichroism spectra analyses and topoisomerase I/II inhibition assays and results identified some of them as strong DNA ligands, harboring or not additional topoisomerase II inhibition and able to locate in the nucleus as determined by fluorescence microscopy. In conclusion, we evidenced novel cyano- and amidino-substituted isoindolines coupled with benzimidazoles and benzothiazoles as topoisomerase inhibitors and/or DNA binding compounds with potent antitumor activities.\n",
            "1390212\n",
            "Poison activity at human topoisomerase1 assessed as accumulation of nicked DNA at 50 uM using supercoiled pUC19 as substrate pretreated with substrate for 45 mins followed by enzyme addition measured by agarose gel electrophoresis relative to control\n",
            "Title: Synthesis, antitumor activity and DNA binding features of benzothiazolyl and benzimidazolyl substituted isoindolines.  Abstract: In this paper novel isoindolines substituted with cyano and amidino benzimidazoles and benzothiazoles were synthesized as new potential anti-cancer agents. The new structures were evaluated for antiproliferative activity, cell cycle changes, cell death, as well as DNA binding and topoisomerase inhibition properties on selected compounds. Results showed that all tested compounds exerted antitumor activity, especially amidinobenzothiazole and amidinobenzimidazole substituted isoindolin-1-ones and benzimidazole substituted 1-iminoisoindoline that showed antiproliferative effect in the submicromolar range. Moreover, the DNA-binding properties of selected compounds were evaluated by biophysical and biochemical approaches including thermal denaturation studies, circular dichroism spectra analyses and topoisomerase I/II inhibition assays and results identified some of them as strong DNA ligands, harboring or not additional topoisomerase II inhibition and able to locate in the nucleus as determined by fluorescence microscopy. In conclusion, we evidenced novel cyano- and amidino-substituted isoindolines coupled with benzimidazoles and benzothiazoles as topoisomerase inhibitors and/or DNA binding compounds with potent antitumor activities.\n",
            "1396987\n",
            "Inhibition of human topoisomerase 1 assessed as reduction in supercoiled pBR322 plasmid DNA relaxation at 100 uM after 10 to 15 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Design, synthesis and anticancer evaluation of acridine hydroxamic acid derivatives as dual Topo and HDAC inhibitors.  Abstract: Multitarget inhibitors design has generated great interest in cancer treatment. Based on the synergistic effects of topoisomerase and histone deacetylase inhibitors, we designed and synthesized a new series of acridine hydroxamic acid derivatives as potential novel dual Topo and HDAC inhibitors. MTT assays indicated that all the hybrid compounds displayed good antiproliferative activities with IC50 values in low micromolar range, among which compound 8c displayed potent activity against U937 (IC50=0.90M). In addition, compound 8c also displayed the best HDAC inhibitory activity, which was several times more potent than HDAC inhibitor SAHA. Subsequent studies indicated that all the compounds displayed Topo II inhibition activity at 50M. Moreover, compound 8c could interact with DNA and induce U937 apoptosis. This study provides a suite of compounds for further exploration of dual Topo and HDAC inhibitors, and compound 8c can be a new dual Topo and HDAC inhibitory anticancer agent.\n",
            "1400707\n",
            "Inhibition of recombinant human DNA topoisomerase 1 at 100 uM using supercoiled pBR322 DNA as substrate after 30 mins by densitometric analysis relative to control\n",
            "Title: Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/II inhibitors.  Abstract: A novel series of 35 angularly fused pentacyclic 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridin-5-ium chlorides were designed and synthesized. Their cytotoxic activities were investigated against six human cancer cell lines (NCIH23, HCT15, NUGC-3, ACHN, PC-3, and MDA-MB-231). Among all screened compounds; 28, 30, 34, 35, 46, 48, 52, and 53 compounds exhibited potent cytotoxic activities against all tested human cancer cell lines. Further, these potent lead cytotoxic agents were evaluated against human Topoisomerase I and II inhibition. Among them, the compound 48 exhibited dual Topoisomerase I and II inhibition especially at 20M concentrations the compound 48 exhibited 1.25times more potent Topoisomerase II inhibitory activity (38.3%) than the reference drug etoposide (30.6%). The compound 52 also exhibited excellent (88.4%) topoisomerase I inhibition than the reference drug camptothecin (66.7%) at 100M concentrations. Molecular docking studies of the compounds 48 and 52 with topo I discovered that they both intercalated into the DNA single-strand cleavage site where the compound 48 have van der Waals interactions with residues Arg364, Pro431, and Asn722 whilst the compound 52 have with Arg364, Thr718, and Asn722 residues. Both the compounds 48 and 52 have - stacking interactions with the stacked DNA bases. The docking studies of the compound 48 with topo II explored that it was bound to the topo II DNA cleavage site where etoposide was situated. The benzo[f]chromeno[4,3-b][1,7]naphthyridine ring of the compound 48 was stacked between the DNA bases of the cleavage site with - stacking interactions and there were no hydrogen bond interactions with topo II.\n",
            "1400708\n",
            "Inhibition of recombinant human DNA topoisomerase 1 at 20 uM using supercoiled pBR322 DNA as substrate after 30 mins by densitometric analysis relative to control\n",
            "Title: Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/II inhibitors.  Abstract: A novel series of 35 angularly fused pentacyclic 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridin-5-ium chlorides were designed and synthesized. Their cytotoxic activities were investigated against six human cancer cell lines (NCIH23, HCT15, NUGC-3, ACHN, PC-3, and MDA-MB-231). Among all screened compounds; 28, 30, 34, 35, 46, 48, 52, and 53 compounds exhibited potent cytotoxic activities against all tested human cancer cell lines. Further, these potent lead cytotoxic agents were evaluated against human Topoisomerase I and II inhibition. Among them, the compound 48 exhibited dual Topoisomerase I and II inhibition especially at 20M concentrations the compound 48 exhibited 1.25times more potent Topoisomerase II inhibitory activity (38.3%) than the reference drug etoposide (30.6%). The compound 52 also exhibited excellent (88.4%) topoisomerase I inhibition than the reference drug camptothecin (66.7%) at 100M concentrations. Molecular docking studies of the compounds 48 and 52 with topo I discovered that they both intercalated into the DNA single-strand cleavage site where the compound 48 have van der Waals interactions with residues Arg364, Pro431, and Asn722 whilst the compound 52 have with Arg364, Thr718, and Asn722 residues. Both the compounds 48 and 52 have - stacking interactions with the stacked DNA bases. The docking studies of the compound 48 with topo II explored that it was bound to the topo II DNA cleavage site where etoposide was situated. The benzo[f]chromeno[4,3-b][1,7]naphthyridine ring of the compound 48 was stacked between the DNA bases of the cleavage site with - stacking interactions and there were no hydrogen bond interactions with topo II.\n",
            "1400711\n",
            "Potency index, ratio of test compound activity to camptothecin activity for recombinant human DNA topoisomerase 1 at 100 uM\n",
            "Title: Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/II inhibitors.  Abstract: A novel series of 35 angularly fused pentacyclic 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridin-5-ium chlorides were designed and synthesized. Their cytotoxic activities were investigated against six human cancer cell lines (NCIH23, HCT15, NUGC-3, ACHN, PC-3, and MDA-MB-231). Among all screened compounds; 28, 30, 34, 35, 46, 48, 52, and 53 compounds exhibited potent cytotoxic activities against all tested human cancer cell lines. Further, these potent lead cytotoxic agents were evaluated against human Topoisomerase I and II inhibition. Among them, the compound 48 exhibited dual Topoisomerase I and II inhibition especially at 20M concentrations the compound 48 exhibited 1.25times more potent Topoisomerase II inhibitory activity (38.3%) than the reference drug etoposide (30.6%). The compound 52 also exhibited excellent (88.4%) topoisomerase I inhibition than the reference drug camptothecin (66.7%) at 100M concentrations. Molecular docking studies of the compounds 48 and 52 with topo I discovered that they both intercalated into the DNA single-strand cleavage site where the compound 48 have van der Waals interactions with residues Arg364, Pro431, and Asn722 whilst the compound 52 have with Arg364, Thr718, and Asn722 residues. Both the compounds 48 and 52 have - stacking interactions with the stacked DNA bases. The docking studies of the compound 48 with topo II explored that it was bound to the topo II DNA cleavage site where etoposide was situated. The benzo[f]chromeno[4,3-b][1,7]naphthyridine ring of the compound 48 was stacked between the DNA bases of the cleavage site with - stacking interactions and there were no hydrogen bond interactions with topo II.\n",
            "1401812\n",
            "Inhibition of human recombinant DNA topoisomerase 1-mediated DNA relaxation at 100 uM incubated for 30 mins using pBR322 DNA substrate by ethidium bromide dye-based agarose gel electrophoresis relative to control camptothecin\n",
            "Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.\n",
            "1401813\n",
            "Inhibition of human recombinant DNA topoisomerase 1-mediated DNA relaxation at 20 uM incubated for 30 mins using pBR322 DNA substrate by ethidium bromide dye-based agarose gel electrophoresis relative to control camptothecin\n",
            "Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.\n",
            "1401818\n",
            "Poison activity at topoisomerase 1 (unknown origin) assessed as reduction in enzyme mediated DNA cleavage complex formation by measuring increase in nicked DNA level at 500 uM using supercoiled pBR322 plasmid DNA as substrate after 20 mins by ethidium bromine dye-based agarose gel electrophoresis analysis\n",
            "Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.\n",
            "1401819\n",
            "Poison activity at topoisomerase 1 in human T47D cells assessed as induction of induction of DNA damage by measuring tail DNA levels at 10 uM after 24 hrs by SYBR Green staining-based comet assay (Rvb = 2.99 +/- 1.27%)\n",
            "Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.\n",
            "1401820\n",
            "Poison activity at topoisomerase 1 in human T47D cells assessed as induction of induction of DNA damage by measuring tail DNA levels at 5 uM after 24 hrs by SYBR Green staining-based comet assay (Rvb = 2.99 +/- 1.27%)\n",
            "Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.\n",
            "1401822\n",
            "Poison activity at human topoisomerase 1 assessed as induction of relaxation of pHOT1 DNA substrate at 100 to 1000 uM incubated for 30 mins by ethidium bromide dye-based agarose gel electrophoresis analysis\n",
            "Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.\n",
            "1401823\n",
            "Poison activity at human topoisomerase 1 assessed as induction of relaxation of pHOT1 DNA substrate at 1000 uM incubated for 30 mins by ethidium bromide dye-based agarose gel electrophoresis analysis\n",
            "Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.\n",
            "1401824\n",
            "Inhibition of DNA topoisomerase-1 in human T47D cells assessed as decrease in free topoisomerase-1 levels incubated for 2 hrs by band depletion assay\n",
            "Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.\n",
            "1401825\n",
            "Inhibition of human recombinant DNA topoisomerase 1-mediated DNA relaxation at 100 uM incubated for 30 mins using pBR322 DNA substrate by ethidium bromide dye-based agarose gel electrophoresis\n",
            "Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.\n",
            "1401826\n",
            "Inhibition of human recombinant DNA topoisomerase 1-mediated DNA relaxation at 20 uM incubated for 30 mins using pBR322 DNA substrate by ethidium bromide dye-based agarose gel electrophoresis\n",
            "Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.\n",
            "1401830\n",
            "Poison activity at topoisomerase 1 (unknown origin) assessed as reduction in enzyme mediated DNA cleavage complex formation by measuring increase in nicked DNA level at 100 and 300 uM using supercoiled pBR322 plasmid DNA as substrate after 20 mins by ethidium bromine dye-based agarose gel electrophoresis analysis\n",
            "Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.\n",
            "1401831\n",
            "Inhibition of free DNA topoisomerase-1 in human T47D cells at 50 uM assessed as suppression of camptothecin-induced decrease in free topoisomerase-1 levels pre-treated before camptothecin addition and measured after 2 hrs by band depletion assay\n",
            "Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.\n",
            "1407988\n",
            "Inhibition of recombinant human topoisomerase-1 using supercoiled pBR322 DNA as substrate after 45 mins by ethidium bromide staining based gel electrophoresis method\n",
            "Title: Design, synthesis, biological evaluation and structure-activity relationship of sophoridine derivatives bearing pyrrole or indole scaffold as potential antitumor agents.  Abstract: Taking sophoridine as a lead compound, 58 sophoridine derivatives were designed, synthesized and evaluated for their antiproliferative activity in the HepG2 cancer cell line. Among the 58 compounds, 33 compounds showed potent antiproliferative activity with IC50 less than 10M. Compound 5w showed the most potent anti-proliferative activity in the HepG2 cancer cell line. Thus, we further extended our characterization of the antiproliferative activity of 5w in six cancer cell lines (HepG2, SMMC-7721, Hela, CNE1, CNE2 and MCF7). The representative compound 5w displayed robust anti-proliferative activities in all the tested cell lines with IC50 values in range of 0.93-1.89M which were much lower than that of sophoridine. Here, we report the structure-activity relationships (SAR) in a sophoridine series of compounds, which indicated that introduction of N-benzyl indole group on the 14-carbon atom of sophoridine can significantly enhance the antiproliferative activity. By molecular docking and enzymatic assay, compound 5w was found to be able to inhibit the activity of DNA Topo I. Furthermore, apoptosis assay displayed that compound 5w could significantly induce the apoptosis of HepG2 cells in a dose-dependent manner by activating caspase-3, increasing expression of cleaved caspase-3 and reducing the ratio of Bcl-2/Bax. The in vivo antitumor assay demonstrated that 5w suppressed the growth of HepG2 xenografts in nude mice without any obvious side effects.\n",
            "1413829\n",
            "Inhibition of topoisomerase 1 (unknown origin)-mediated pBR322 DNA relaxation at 50 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: Design, synthesis and biological evaluation of benzimidazole-rhodanine conjugates as potent topoisomerase II inhibitors.  Abstract: In this study, a series of benzimidazole-rhodanine conjugates were designed, synthesized and investigated for their topoisomerase II (Topo II) inhibitory and cytotoxic activities. The results from Topo II-mediated pBR322 DNA relaxation and cleavage assays showed that the synthesized compounds might act as Topo II catalytic inhibitors. Certain compounds displayed potent Topo II inhibition at 10 M. The cytotoxic activities of these compounds against HeLa, A549, Raji, PC-3, MDA-MB-201, and HL-60 cancer cell lines were evaluated. The results indicated that these compounds exhibited strong antiproliferative activity. A good relationship was observed between the Topo II inhibitory potency and the cytotoxicity of these compounds. The structure-activity relationship revealed that the electronic effects, the phenyl group, and the rhodanine moiety were particularly important for the Topo II inhibitory potency and cytotoxicity.\n",
            "1415044\n",
            "Inhibition of Top1 (unknown origin) assessed as Top 1-mediated DNA cleavage at 0.1 to 100 uM by PAGE analysis\n",
            "Title: Application of Sequential Palladium Catalysis for the Discovery of Janus Kinase Inhibitors in the Benzo[ c]pyrrolo[2,3- h][1,6]naphthyridin-5-one (BPN) Series.  Abstract: The present account describes the discovery and development of a new benzo[ c]pyrrolo[2,3- h][1,6]naphthyridin-5-one (BPN) JAK inhibitory chemotype that has produced selective JAK inhibitors. Sequential palladium chemistry was optimized for the rapid access to a focused library of derivatives to explore the structure-activity relationships of the new scaffold. Several compounds from the series displayed potencies in the low nanomolar range against the four members of the JAK family with various selectivity profiles. Compound 20a, with an azetidine amide side chain, showed the best selectivity for JAK1 kinase vs JAK2, JAK3, and TYK2, with low nanomolar potency (IC50 = 3.4 nM). On the other hand, BPNs 17b and 18 had good general activity against the JAK family with excellent kinome selectivity profiles. Many of the new BPNs inhibited JAK3-mediated STAT-5 phosphorylation, the production of inflammatory cytokines, and the proliferation of primary T cells. Moreover, BPN 17b showed very similar in vivo results to tofacitinib in a rheumatoid arthritis animal model.\n",
            "1426110\n",
            "Inhibition of DNA topoisomerase-1 (unknown origin) assessed as reduction in enzyme-catalyzed relaxation of pBR322 DNA substrate at 20 uM after 30 mins by ethidium bromide staining based electrophoresis\n",
            "Title: Design, facile synthesis and biological evaluations of novel pyrano[3,2-a]phenazine hybrid molecules as antitumor agents.  Abstract: A series of novel pyrano[3,2-a]phenazine derivatives (1a-1r and 2a-2q), designed as hybrid molecules of phenazine and pyran pharmocophores, were facilely synthesized in two steps with 77-93% overall yields in this study. Cytotoxic evaluation indicates that many compounds exhibited cytotoxicity against HCT116, MCF7, HepG2 and A549 cancer cell lines in vitro, in which compounds 1c, 1i, 2e, and 2l were found to have excellent antiproliferative activity against the HepG2 cancer cell line. Thus, inhibitory effect of subcutaneously implanted xenografted mice in vivo (H22H8D8 cells) of the four compounds as well as topoisomerase I and II inhibitory activities in vitro (HepG2 cells) were determined. Significantly, compound 1i showed more potent than positive control drug both in vivo and in vitro. Further mechanism studies against HepG2 cells in vitro revealed that compound 1i up-regulated the expression of both p53 and p21, which inhibited the expression of both cyclin B and CDK1, and arrested HepG2 cells in the G2/M phase. Concomitantly, after treating with compound 1i, Bax/Bcl-2 ratio was significantly increased, the cytochrome C was released from mitochondria to cytosol, and the cleavage of caspase-3 and caspase-9 expression levels were both increased. Together, all these evidences implicated that compound 1i acts as topoisomerase I and II dual inhibitor, cell cycle arrester and apoptosis inducer against HepG2 cells.\n",
            "1426112\n",
            "Inhibition of DNA topoisomerase-1 (unknown origin) assessed as reduction in enzyme-catalyzed relaxation of pBR322 DNA substrate at 2.5 to 5 uM after 30 mins by ethidium bromide staining based electrophoresis\n",
            "Title: Design, facile synthesis and biological evaluations of novel pyrano[3,2-a]phenazine hybrid molecules as antitumor agents.  Abstract: A series of novel pyrano[3,2-a]phenazine derivatives (1a-1r and 2a-2q), designed as hybrid molecules of phenazine and pyran pharmocophores, were facilely synthesized in two steps with 77-93% overall yields in this study. Cytotoxic evaluation indicates that many compounds exhibited cytotoxicity against HCT116, MCF7, HepG2 and A549 cancer cell lines in vitro, in which compounds 1c, 1i, 2e, and 2l were found to have excellent antiproliferative activity against the HepG2 cancer cell line. Thus, inhibitory effect of subcutaneously implanted xenografted mice in vivo (H22H8D8 cells) of the four compounds as well as topoisomerase I and II inhibitory activities in vitro (HepG2 cells) were determined. Significantly, compound 1i showed more potent than positive control drug both in vivo and in vitro. Further mechanism studies against HepG2 cells in vitro revealed that compound 1i up-regulated the expression of both p53 and p21, which inhibited the expression of both cyclin B and CDK1, and arrested HepG2 cells in the G2/M phase. Concomitantly, after treating with compound 1i, Bax/Bcl-2 ratio was significantly increased, the cytochrome C was released from mitochondria to cytosol, and the cleavage of caspase-3 and caspase-9 expression levels were both increased. Together, all these evidences implicated that compound 1i acts as topoisomerase I and II dual inhibitor, cell cycle arrester and apoptosis inducer against HepG2 cells.\n",
            "1428609\n",
            "Inhibition of recombinant human topoisomerase-1 assessed as reduction in relaxation of supercoiled pBR322 DNA substrate at 100 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to control\n",
            "Title: Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors.  Abstract: In this study, two series of novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives containing an ,-unsaturated lactone fragment were synthesized and screened for Topo I inhibition and antitumor activity. The topoisomerase I inhibitory activities and cytotoxicities against three human cancer cell lines (MCF-7,Hela,A549) were evaluated. The results revealed that series 2, compounds bearing an exocyclic double bond on the furanone ring, generally showed more potent activity than series 1, compounds lacking an exocyclic double bond. Several compounds of series 2 possess significant Topo I inhibitory activity and potent antiproliferative activity against cancer cell lines. Further mechanism studies of the most active compound of series 2 (B-15) indicated that synthetic compounds can not only stabilize the drug-enzyme-DNA covalent ternary complex as well as camptothecin, but also interfere with the binding between Topo I and DNA. The binding patterns of these compounds with Topo I and structure-activity relationships are discussed.\n",
            "1428613\n",
            "Inhibition of recombinant human topoisomerase-1 assessed as DNA insertion by measuring drug-DNA-enzyme ternary complex formation up to 100 uM using supercoiled pBR322 DNA substrate after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors.  Abstract: In this study, two series of novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives containing an ,-unsaturated lactone fragment were synthesized and screened for Topo I inhibition and antitumor activity. The topoisomerase I inhibitory activities and cytotoxicities against three human cancer cell lines (MCF-7,Hela,A549) were evaluated. The results revealed that series 2, compounds bearing an exocyclic double bond on the furanone ring, generally showed more potent activity than series 1, compounds lacking an exocyclic double bond. Several compounds of series 2 possess significant Topo I inhibitory activity and potent antiproliferative activity against cancer cell lines. Further mechanism studies of the most active compound of series 2 (B-15) indicated that synthetic compounds can not only stabilize the drug-enzyme-DNA covalent ternary complex as well as camptothecin, but also interfere with the binding between Topo I and DNA. The binding patterns of these compounds with Topo I and structure-activity relationships are discussed.\n",
            "1428614\n",
            "Inhibition of recombinant human topoisomerase-1 assessed as DNA insertion by measuring drug-DNA-enzyme ternary complex formation up to 25 uM using supercoiled pBR322 DNA substrate after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors.  Abstract: In this study, two series of novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives containing an ,-unsaturated lactone fragment were synthesized and screened for Topo I inhibition and antitumor activity. The topoisomerase I inhibitory activities and cytotoxicities against three human cancer cell lines (MCF-7,Hela,A549) were evaluated. The results revealed that series 2, compounds bearing an exocyclic double bond on the furanone ring, generally showed more potent activity than series 1, compounds lacking an exocyclic double bond. Several compounds of series 2 possess significant Topo I inhibitory activity and potent antiproliferative activity against cancer cell lines. Further mechanism studies of the most active compound of series 2 (B-15) indicated that synthetic compounds can not only stabilize the drug-enzyme-DNA covalent ternary complex as well as camptothecin, but also interfere with the binding between Topo I and DNA. The binding patterns of these compounds with Topo I and structure-activity relationships are discussed.\n",
            "1428615\n",
            "Poison activity at recombinant human topoisomerase-1 assessed as stabilization of DNA-enzyme cleavage complex by measuring increase in linear DNA up to 50 uM using supercoiled pBR322 DNA substrate after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors.  Abstract: In this study, two series of novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives containing an ,-unsaturated lactone fragment were synthesized and screened for Topo I inhibition and antitumor activity. The topoisomerase I inhibitory activities and cytotoxicities against three human cancer cell lines (MCF-7,Hela,A549) were evaluated. The results revealed that series 2, compounds bearing an exocyclic double bond on the furanone ring, generally showed more potent activity than series 1, compounds lacking an exocyclic double bond. Several compounds of series 2 possess significant Topo I inhibitory activity and potent antiproliferative activity against cancer cell lines. Further mechanism studies of the most active compound of series 2 (B-15) indicated that synthetic compounds can not only stabilize the drug-enzyme-DNA covalent ternary complex as well as camptothecin, but also interfere with the binding between Topo I and DNA. The binding patterns of these compounds with Topo I and structure-activity relationships are discussed.\n",
            "1428616\n",
            "Poison activity at recombinant human topoisomerase-1 assessed as stabilization of DNA-enzyme cleavage complex by measuring increase in linear DNA using supercoiled pBR322 DNA substrate after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors.  Abstract: In this study, two series of novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives containing an ,-unsaturated lactone fragment were synthesized and screened for Topo I inhibition and antitumor activity. The topoisomerase I inhibitory activities and cytotoxicities against three human cancer cell lines (MCF-7,Hela,A549) were evaluated. The results revealed that series 2, compounds bearing an exocyclic double bond on the furanone ring, generally showed more potent activity than series 1, compounds lacking an exocyclic double bond. Several compounds of series 2 possess significant Topo I inhibitory activity and potent antiproliferative activity against cancer cell lines. Further mechanism studies of the most active compound of series 2 (B-15) indicated that synthetic compounds can not only stabilize the drug-enzyme-DNA covalent ternary complex as well as camptothecin, but also interfere with the binding between Topo I and DNA. The binding patterns of these compounds with Topo I and structure-activity relationships are discussed.\n",
            "1428617\n",
            "Inhibition of recombinant human topoisomerase-1 assessed as interference in DNA binding to enzyme by measuring reduction in enzyme-DNA complex using supercoiled pBR322 DNA substrate preincubated for 20 mins followed by substrate addition measured after 3 mins by electrophoretic mobility shift assay\n",
            "Title: Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors.  Abstract: In this study, two series of novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives containing an ,-unsaturated lactone fragment were synthesized and screened for Topo I inhibition and antitumor activity. The topoisomerase I inhibitory activities and cytotoxicities against three human cancer cell lines (MCF-7,Hela,A549) were evaluated. The results revealed that series 2, compounds bearing an exocyclic double bond on the furanone ring, generally showed more potent activity than series 1, compounds lacking an exocyclic double bond. Several compounds of series 2 possess significant Topo I inhibitory activity and potent antiproliferative activity against cancer cell lines. Further mechanism studies of the most active compound of series 2 (B-15) indicated that synthetic compounds can not only stabilize the drug-enzyme-DNA covalent ternary complex as well as camptothecin, but also interfere with the binding between Topo I and DNA. The binding patterns of these compounds with Topo I and structure-activity relationships are discussed.\n",
            "1428618\n",
            "Inhibition of recombinant human topoisomerase-1 assessed as interference in DNA binding to enzyme by measuring reduction in enzyme-DNA complex at 50 to 100 uM using supercoiled pBR322 DNA substrate preincubated for 20 mins followed by substrate addition measured after 3 mins by electrophoretic mobility shift assay\n",
            "Title: Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors.  Abstract: In this study, two series of novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives containing an ,-unsaturated lactone fragment were synthesized and screened for Topo I inhibition and antitumor activity. The topoisomerase I inhibitory activities and cytotoxicities against three human cancer cell lines (MCF-7,Hela,A549) were evaluated. The results revealed that series 2, compounds bearing an exocyclic double bond on the furanone ring, generally showed more potent activity than series 1, compounds lacking an exocyclic double bond. Several compounds of series 2 possess significant Topo I inhibitory activity and potent antiproliferative activity against cancer cell lines. Further mechanism studies of the most active compound of series 2 (B-15) indicated that synthetic compounds can not only stabilize the drug-enzyme-DNA covalent ternary complex as well as camptothecin, but also interfere with the binding between Topo I and DNA. The binding patterns of these compounds with Topo I and structure-activity relationships are discussed.\n",
            "1428690\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 100 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis method relative to control\n",
            "Title: Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.  Abstract: Novel series of conformationally constrained 2,4-chloro- and hydroxy-substituted diphenyl benzofuro[3,2-b]pyridines were rationally designed and synthesized. Their biological activities were evaluated for topoisomerase I and II inhibitory activity, and antiproliferative activity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds with phenol moiety at 4-position of central pyridine exhibited significant dual topoisomerase I and II inhibitory activities, and strong antiproliferative activity in low micromolar range. Structure activity relationship study suggested that phenol moiety at 4-position of the central pyridine regardless of chlorophenyl moiety at 2-position of the central pyridine has an important role in dual topoisomerase inhibitory activity as well as antiproliferative activity. For investigation of mode of action for compound 14 which displayed the most strong dual topoisomerase I and II inhibitory activity and antiproliferative activity against HCT15 cell, we performed cleavable complex assay, band depletion assay, comet assay, and competitive EtBr displacement assay. Compound 14 functioned as non-intercalative catalytic topo I and II dual inhibitor. In addition, compound 14 induced apoptosis in HCT15 cells through increase of Bax, decrease of Bcl-2 and increase of PARP cleavage.\n",
            "1428691\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 20 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis method relative to control\n",
            "Title: Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.  Abstract: Novel series of conformationally constrained 2,4-chloro- and hydroxy-substituted diphenyl benzofuro[3,2-b]pyridines were rationally designed and synthesized. Their biological activities were evaluated for topoisomerase I and II inhibitory activity, and antiproliferative activity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds with phenol moiety at 4-position of central pyridine exhibited significant dual topoisomerase I and II inhibitory activities, and strong antiproliferative activity in low micromolar range. Structure activity relationship study suggested that phenol moiety at 4-position of the central pyridine regardless of chlorophenyl moiety at 2-position of the central pyridine has an important role in dual topoisomerase inhibitory activity as well as antiproliferative activity. For investigation of mode of action for compound 14 which displayed the most strong dual topoisomerase I and II inhibitory activity and antiproliferative activity against HCT15 cell, we performed cleavable complex assay, band depletion assay, comet assay, and competitive EtBr displacement assay. Compound 14 functioned as non-intercalative catalytic topo I and II dual inhibitor. In addition, compound 14 induced apoptosis in HCT15 cells through increase of Bax, decrease of Bcl-2 and increase of PARP cleavage.\n",
            "1428700\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 100 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis method relative to camptothecin\n",
            "Title: Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.  Abstract: Novel series of conformationally constrained 2,4-chloro- and hydroxy-substituted diphenyl benzofuro[3,2-b]pyridines were rationally designed and synthesized. Their biological activities were evaluated for topoisomerase I and II inhibitory activity, and antiproliferative activity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds with phenol moiety at 4-position of central pyridine exhibited significant dual topoisomerase I and II inhibitory activities, and strong antiproliferative activity in low micromolar range. Structure activity relationship study suggested that phenol moiety at 4-position of the central pyridine regardless of chlorophenyl moiety at 2-position of the central pyridine has an important role in dual topoisomerase inhibitory activity as well as antiproliferative activity. For investigation of mode of action for compound 14 which displayed the most strong dual topoisomerase I and II inhibitory activity and antiproliferative activity against HCT15 cell, we performed cleavable complex assay, band depletion assay, comet assay, and competitive EtBr displacement assay. Compound 14 functioned as non-intercalative catalytic topo I and II dual inhibitor. In addition, compound 14 induced apoptosis in HCT15 cells through increase of Bax, decrease of Bcl-2 and increase of PARP cleavage.\n",
            "1428701\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 20 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis method relative to camptothecin\n",
            "Title: Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.  Abstract: Novel series of conformationally constrained 2,4-chloro- and hydroxy-substituted diphenyl benzofuro[3,2-b]pyridines were rationally designed and synthesized. Their biological activities were evaluated for topoisomerase I and II inhibitory activity, and antiproliferative activity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds with phenol moiety at 4-position of central pyridine exhibited significant dual topoisomerase I and II inhibitory activities, and strong antiproliferative activity in low micromolar range. Structure activity relationship study suggested that phenol moiety at 4-position of the central pyridine regardless of chlorophenyl moiety at 2-position of the central pyridine has an important role in dual topoisomerase inhibitory activity as well as antiproliferative activity. For investigation of mode of action for compound 14 which displayed the most strong dual topoisomerase I and II inhibitory activity and antiproliferative activity against HCT15 cell, we performed cleavable complex assay, band depletion assay, comet assay, and competitive EtBr displacement assay. Compound 14 functioned as non-intercalative catalytic topo I and II dual inhibitor. In addition, compound 14 induced apoptosis in HCT15 cells through increase of Bax, decrease of Bcl-2 and increase of PARP cleavage.\n",
            "1428712\n",
            "Inhibition of topoisomerase-1/topoisomerase-2 in human HCT15 cell nuclear extract at 25 uM preincubated for 24 hrs followed by supercoiled pBR322 DNA addition measured after 20 mins by ethidium bromide staining based agarose gel electrophoresis method relative to control\n",
            "Title: Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.  Abstract: Novel series of conformationally constrained 2,4-chloro- and hydroxy-substituted diphenyl benzofuro[3,2-b]pyridines were rationally designed and synthesized. Their biological activities were evaluated for topoisomerase I and II inhibitory activity, and antiproliferative activity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds with phenol moiety at 4-position of central pyridine exhibited significant dual topoisomerase I and II inhibitory activities, and strong antiproliferative activity in low micromolar range. Structure activity relationship study suggested that phenol moiety at 4-position of the central pyridine regardless of chlorophenyl moiety at 2-position of the central pyridine has an important role in dual topoisomerase inhibitory activity as well as antiproliferative activity. For investigation of mode of action for compound 14 which displayed the most strong dual topoisomerase I and II inhibitory activity and antiproliferative activity against HCT15 cell, we performed cleavable complex assay, band depletion assay, comet assay, and competitive EtBr displacement assay. Compound 14 functioned as non-intercalative catalytic topo I and II dual inhibitor. In addition, compound 14 induced apoptosis in HCT15 cells through increase of Bax, decrease of Bcl-2 and increase of PARP cleavage.\n",
            "1428713\n",
            "Inhibition of topoisomerase-1/topoisomerase-2 in human HCT15 cell nuclear extract at 50 uM preincubated for 24 hrs followed by supercoiled pBR322 DNA addition measured after 20 mins by ethidium bromide staining based agarose gel electrophoresis method relative to control\n",
            "Title: Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.  Abstract: Novel series of conformationally constrained 2,4-chloro- and hydroxy-substituted diphenyl benzofuro[3,2-b]pyridines were rationally designed and synthesized. Their biological activities were evaluated for topoisomerase I and II inhibitory activity, and antiproliferative activity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds with phenol moiety at 4-position of central pyridine exhibited significant dual topoisomerase I and II inhibitory activities, and strong antiproliferative activity in low micromolar range. Structure activity relationship study suggested that phenol moiety at 4-position of the central pyridine regardless of chlorophenyl moiety at 2-position of the central pyridine has an important role in dual topoisomerase inhibitory activity as well as antiproliferative activity. For investigation of mode of action for compound 14 which displayed the most strong dual topoisomerase I and II inhibitory activity and antiproliferative activity against HCT15 cell, we performed cleavable complex assay, band depletion assay, comet assay, and competitive EtBr displacement assay. Compound 14 functioned as non-intercalative catalytic topo I and II dual inhibitor. In addition, compound 14 induced apoptosis in HCT15 cells through increase of Bax, decrease of Bcl-2 and increase of PARP cleavage.\n",
            "1428714\n",
            "Inhibition of topoisomerase-1/topoisomerase-2 in human HCT15 cell nuclear extract at 100 uM preincubated for 24 hrs followed by supercoiled pBR322 DNA addition measured after 20 mins by ethidium bromide staining based agarose gel electrophoresis method relative to control\n",
            "Title: Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.  Abstract: Novel series of conformationally constrained 2,4-chloro- and hydroxy-substituted diphenyl benzofuro[3,2-b]pyridines were rationally designed and synthesized. Their biological activities were evaluated for topoisomerase I and II inhibitory activity, and antiproliferative activity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds with phenol moiety at 4-position of central pyridine exhibited significant dual topoisomerase I and II inhibitory activities, and strong antiproliferative activity in low micromolar range. Structure activity relationship study suggested that phenol moiety at 4-position of the central pyridine regardless of chlorophenyl moiety at 2-position of the central pyridine has an important role in dual topoisomerase inhibitory activity as well as antiproliferative activity. For investigation of mode of action for compound 14 which displayed the most strong dual topoisomerase I and II inhibitory activity and antiproliferative activity against HCT15 cell, we performed cleavable complex assay, band depletion assay, comet assay, and competitive EtBr displacement assay. Compound 14 functioned as non-intercalative catalytic topo I and II dual inhibitor. In addition, compound 14 induced apoptosis in HCT15 cells through increase of Bax, decrease of Bcl-2 and increase of PARP cleavage.\n",
            "1428715\n",
            "Inhibition of topoisomerase-1/topoisomerase-2 in human HCT15 cell nuclear extract preincubated for 24 hrs followed by supercoiled pBR322 DNA addition measured after 20 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.  Abstract: Novel series of conformationally constrained 2,4-chloro- and hydroxy-substituted diphenyl benzofuro[3,2-b]pyridines were rationally designed and synthesized. Their biological activities were evaluated for topoisomerase I and II inhibitory activity, and antiproliferative activity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds with phenol moiety at 4-position of central pyridine exhibited significant dual topoisomerase I and II inhibitory activities, and strong antiproliferative activity in low micromolar range. Structure activity relationship study suggested that phenol moiety at 4-position of the central pyridine regardless of chlorophenyl moiety at 2-position of the central pyridine has an important role in dual topoisomerase inhibitory activity as well as antiproliferative activity. For investigation of mode of action for compound 14 which displayed the most strong dual topoisomerase I and II inhibitory activity and antiproliferative activity against HCT15 cell, we performed cleavable complex assay, band depletion assay, comet assay, and competitive EtBr displacement assay. Compound 14 functioned as non-intercalative catalytic topo I and II dual inhibitor. In addition, compound 14 induced apoptosis in HCT15 cells through increase of Bax, decrease of Bcl-2 and increase of PARP cleavage.\n",
            "1431482\n",
            "Inhibition of recombinant human DNA-topoisomerase 1 assessed as decrease in supercoiled pHOT DNA relaxation at 20 uM after 30 mins by ethidium bromide staining-based agarose gel electrophoresis method\n",
            "Title: Novel indolizino[8,7-b]indole hybrids as anti-small cell lung cancer agents: Regioselective modulation of topoisomerase II inhibitory and DNA crosslinking activities.  Abstract: A novel series of bis(hydroxymethyl)indolizino[8,7-b]indole hybrids composed of -carboline (topoisomerase I/II inhibition) and bis(hydroxymethyl)pyrrole (DNA cross-linking) are synthesized for antitumor evaluation. Of tumor cell lines tested, small cell lung cancer (SCLC) cell lines are the most sensitive to the newly synthesized compounds. These hybrids induce cell cycle arrest at the G2/M phase, trigger tumor cell apoptotic death, and display diverse mechanisms of action involving topoisomerase II (Topo II) inhibition and induction of DNA cross-linking. Intriguingly, the substituent at N11 (H or Me) plays a critical role in modulating Topo II inhibition and DNA cross-linking activities. N11-Me derivatives predispose to induce DNA crosslinks, whereas N11-H derivatives potently inhibit Topo II. Computational analysis implicates that N11-Me restrict the torsion angles of the two adjacent OH on pyrrole resulting in a favorable of DNA cross-linking. Among these hybrids, compound 17a with N11-H is more effective than cisplatin and etoposide, but as potent as irinotecan, against the growth of SCLC H526 cells in xenograft model.\n",
            "1431483\n",
            "Inhibition of recombinant human DNA-topoisomerase 1 assessed as decrease in supercoiled pHOT DNA relaxation at 100 uM after 30 mins by ethidium bromide staining-based agarose gel electrophoresis method\n",
            "Title: Novel indolizino[8,7-b]indole hybrids as anti-small cell lung cancer agents: Regioselective modulation of topoisomerase II inhibitory and DNA crosslinking activities.  Abstract: A novel series of bis(hydroxymethyl)indolizino[8,7-b]indole hybrids composed of -carboline (topoisomerase I/II inhibition) and bis(hydroxymethyl)pyrrole (DNA cross-linking) are synthesized for antitumor evaluation. Of tumor cell lines tested, small cell lung cancer (SCLC) cell lines are the most sensitive to the newly synthesized compounds. These hybrids induce cell cycle arrest at the G2/M phase, trigger tumor cell apoptotic death, and display diverse mechanisms of action involving topoisomerase II (Topo II) inhibition and induction of DNA cross-linking. Intriguingly, the substituent at N11 (H or Me) plays a critical role in modulating Topo II inhibition and DNA cross-linking activities. N11-Me derivatives predispose to induce DNA crosslinks, whereas N11-H derivatives potently inhibit Topo II. Computational analysis implicates that N11-Me restrict the torsion angles of the two adjacent OH on pyrrole resulting in a favorable of DNA cross-linking. Among these hybrids, compound 17a with N11-H is more effective than cisplatin and etoposide, but as potent as irinotecan, against the growth of SCLC H526 cells in xenograft model.\n",
            "1442286\n",
            "Inhibition of recombinant human topoisomerase-1-mediated relaxation of pBR322 DNA substrate after 30 mins agarose gel electrophoresis method\n",
            "Title: Novel multi-substituted benzyl acridone derivatives as survivin inhibitors for hepatocellular carcinoma treatment.  Abstract: Sorafenib was the only small-molecule drug approved by FDA for treatment of the advanced hepatocellular carcinoma (HCC). Recent study indicated that YM155 was a promising agent for HCC cells with high survivin expression, however, the antitumor activity needs to be further improved. Based on molecular docking and rational design method, a series of multi-substituted benzyl acridone derivatives were designed and synthesized. MTT assay indicated that some of the synthesized compounds displayed better antiproliferative activity against HepG2 cells than YM155. Later study indicated that the representive compound 8u may directly interact with survivin protein and induce HepG2 cells apoptosis, which is different from YM155. In addition, ADME property was predicted in silico, and it performed well. Moreover, in vivo preliminary experiments showed that 8u may be a good lead compound in the treatment of HCC.\n",
            "1443965\n",
            "Inhibition of recombinant Top1 (unknown origin) assessed as increase in [32P]-DNA breaks at 0.1 to 100 uM after 20 mins by PAGE analysis\n",
            "Title: Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl-DNA Phosphodiesterase 2 (Tdp2).  Abstract: Tdp1 and Tdp2 are two tyrosyl-DNA phosphodiesterases that can repair damaged DNA resulting from topoisomerase inhibitors and a variety of other DNA-damaging agents. Both Tdp1 and Tdp2 inhibition could hypothetically potentiate the cytotoxicities of topoisomerase inhibitors. This study reports the successful structure-based design and synthesis of new 7-azaindenoisoquinolines that act as triple inhibitors of Top1, Tdp1, and Tdp2. Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures establish that modification of the lactam side chain of the 7-azaindenoisoquinolines can modulate their inhibitory potencies and selectivities vs Top1, Tdp1, and Tdp2. Molecular modeling of selected target compounds bound to Top1, Tdp1, and Tdp2 was used to design the inhibitors and facilitate the structure-activity relationship analysis. The monitoring of DNA damage by -H2AX foci formation in human PBMCs (lymphocytes) and acute lymphoblastic leukemia CCRF-CEM cells documented significantly more DNA damage in the cancer cells vs normal cells.\n",
            "1443966\n",
            "Poison activity at recombinant Top1 (unknown origin) assessed as inhibition of [32P]-DNA religation in drug-DNA-Top1 ternary complex at 0.1 to 10 uM after 20 mins by PAGE analysis\n",
            "Title: Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl-DNA Phosphodiesterase 2 (Tdp2).  Abstract: Tdp1 and Tdp2 are two tyrosyl-DNA phosphodiesterases that can repair damaged DNA resulting from topoisomerase inhibitors and a variety of other DNA-damaging agents. Both Tdp1 and Tdp2 inhibition could hypothetically potentiate the cytotoxicities of topoisomerase inhibitors. This study reports the successful structure-based design and synthesis of new 7-azaindenoisoquinolines that act as triple inhibitors of Top1, Tdp1, and Tdp2. Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures establish that modification of the lactam side chain of the 7-azaindenoisoquinolines can modulate their inhibitory potencies and selectivities vs Top1, Tdp1, and Tdp2. Molecular modeling of selected target compounds bound to Top1, Tdp1, and Tdp2 was used to design the inhibitors and facilitate the structure-activity relationship analysis. The monitoring of DNA damage by -H2AX foci formation in human PBMCs (lymphocytes) and acute lymphoblastic leukemia CCRF-CEM cells documented significantly more DNA damage in the cancer cells vs normal cells.\n",
            "1443967\n",
            "Suppressor activity at recombinant Top1 (unknown origin) assessed as decrease in [32P]-DNA breaks at 100 uM after 20 mins by PAGE analysis\n",
            "Title: Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl-DNA Phosphodiesterase 2 (Tdp2).  Abstract: Tdp1 and Tdp2 are two tyrosyl-DNA phosphodiesterases that can repair damaged DNA resulting from topoisomerase inhibitors and a variety of other DNA-damaging agents. Both Tdp1 and Tdp2 inhibition could hypothetically potentiate the cytotoxicities of topoisomerase inhibitors. This study reports the successful structure-based design and synthesis of new 7-azaindenoisoquinolines that act as triple inhibitors of Top1, Tdp1, and Tdp2. Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures establish that modification of the lactam side chain of the 7-azaindenoisoquinolines can modulate their inhibitory potencies and selectivities vs Top1, Tdp1, and Tdp2. Molecular modeling of selected target compounds bound to Top1, Tdp1, and Tdp2 was used to design the inhibitors and facilitate the structure-activity relationship analysis. The monitoring of DNA damage by -H2AX foci formation in human PBMCs (lymphocytes) and acute lymphoblastic leukemia CCRF-CEM cells documented significantly more DNA damage in the cancer cells vs normal cells.\n",
            "1443978\n",
            "Inhibition of recombinant Top1 (unknown origin) assessed as increase in [32P]-DNA breaks at 1 uM after 20 mins by PAGE analysis\n",
            "Title: Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl-DNA Phosphodiesterase 2 (Tdp2).  Abstract: Tdp1 and Tdp2 are two tyrosyl-DNA phosphodiesterases that can repair damaged DNA resulting from topoisomerase inhibitors and a variety of other DNA-damaging agents. Both Tdp1 and Tdp2 inhibition could hypothetically potentiate the cytotoxicities of topoisomerase inhibitors. This study reports the successful structure-based design and synthesis of new 7-azaindenoisoquinolines that act as triple inhibitors of Top1, Tdp1, and Tdp2. Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures establish that modification of the lactam side chain of the 7-azaindenoisoquinolines can modulate their inhibitory potencies and selectivities vs Top1, Tdp1, and Tdp2. Molecular modeling of selected target compounds bound to Top1, Tdp1, and Tdp2 was used to design the inhibitors and facilitate the structure-activity relationship analysis. The monitoring of DNA damage by -H2AX foci formation in human PBMCs (lymphocytes) and acute lymphoblastic leukemia CCRF-CEM cells documented significantly more DNA damage in the cancer cells vs normal cells.\n",
            "1443979\n",
            "Inhibition of recombinant Top1 (unknown origin) assessed as increase in [32P]-DNA breaks after 20 mins by PAGE analysis\n",
            "Title: Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl-DNA Phosphodiesterase 2 (Tdp2).  Abstract: Tdp1 and Tdp2 are two tyrosyl-DNA phosphodiesterases that can repair damaged DNA resulting from topoisomerase inhibitors and a variety of other DNA-damaging agents. Both Tdp1 and Tdp2 inhibition could hypothetically potentiate the cytotoxicities of topoisomerase inhibitors. This study reports the successful structure-based design and synthesis of new 7-azaindenoisoquinolines that act as triple inhibitors of Top1, Tdp1, and Tdp2. Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures establish that modification of the lactam side chain of the 7-azaindenoisoquinolines can modulate their inhibitory potencies and selectivities vs Top1, Tdp1, and Tdp2. Molecular modeling of selected target compounds bound to Top1, Tdp1, and Tdp2 was used to design the inhibitors and facilitate the structure-activity relationship analysis. The monitoring of DNA damage by -H2AX foci formation in human PBMCs (lymphocytes) and acute lymphoblastic leukemia CCRF-CEM cells documented significantly more DNA damage in the cancer cells vs normal cells.\n",
            "1447300\n",
            "Inhibition of DNA topoisomerase 1 (unknown origin) assessed as reduction in supercoiled pBR322 plasmid DNA relaxation at 100 uM after 15 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors.  Abstract: Previously, 4-tosylanthra[1,2-c][1,2,5]thiadiazole-6,11-dione (1) was identified as a novel non-camptothecin topoisomerase I (Top1) inhibitor by structure-based virtual screening. Herein, a series of 4-substituted derivatives were designed and synthesized. Most of them showed potent Top1 inhibitory activity. Their in vitro antiproliferative activity was also evaluated in A549, HCT-116 and ZR-75-30 human cancer cell lines. Compound 8s showed good antiproliferative activity with IC50 of 0.52M and 0.42M against HCT-116 and ZR-75-30 cell line, respectively. Top1 unwinding assay and molecular modeling studies rationalized the mode of action of this new class of inhibitors.\n",
            "1447301\n",
            "Inhibition of DNA topoisomerase-1 (unknown origin) mediated DNA relaxation assessed as DNA intercalation at 100 uM using supercoiled pBR322 plasmid DNA as substrate after 60 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors.  Abstract: Previously, 4-tosylanthra[1,2-c][1,2,5]thiadiazole-6,11-dione (1) was identified as a novel non-camptothecin topoisomerase I (Top1) inhibitor by structure-based virtual screening. Herein, a series of 4-substituted derivatives were designed and synthesized. Most of them showed potent Top1 inhibitory activity. Their in vitro antiproliferative activity was also evaluated in A549, HCT-116 and ZR-75-30 human cancer cell lines. Compound 8s showed good antiproliferative activity with IC50 of 0.52M and 0.42M against HCT-116 and ZR-75-30 cell line, respectively. Top1 unwinding assay and molecular modeling studies rationalized the mode of action of this new class of inhibitors.\n",
            "1447305\n",
            "Inhibition of DNA topoisomerase 1 (unknown origin) assessed as reduction in supercoiled pBR322 plasmid DNA relaxation after 15 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors.  Abstract: Previously, 4-tosylanthra[1,2-c][1,2,5]thiadiazole-6,11-dione (1) was identified as a novel non-camptothecin topoisomerase I (Top1) inhibitor by structure-based virtual screening. Herein, a series of 4-substituted derivatives were designed and synthesized. Most of them showed potent Top1 inhibitory activity. Their in vitro antiproliferative activity was also evaluated in A549, HCT-116 and ZR-75-30 human cancer cell lines. Compound 8s showed good antiproliferative activity with IC50 of 0.52M and 0.42M against HCT-116 and ZR-75-30 cell line, respectively. Top1 unwinding assay and molecular modeling studies rationalized the mode of action of this new class of inhibitors.\n",
            "1447306\n",
            "Inhibition of DNA topoisomerase 1 (unknown origin) assessed as reduction in supercoiled pBR322 plasmid DNA relaxation at 1 uM after 15 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors.  Abstract: Previously, 4-tosylanthra[1,2-c][1,2,5]thiadiazole-6,11-dione (1) was identified as a novel non-camptothecin topoisomerase I (Top1) inhibitor by structure-based virtual screening. Herein, a series of 4-substituted derivatives were designed and synthesized. Most of them showed potent Top1 inhibitory activity. Their in vitro antiproliferative activity was also evaluated in A549, HCT-116 and ZR-75-30 human cancer cell lines. Compound 8s showed good antiproliferative activity with IC50 of 0.52M and 0.42M against HCT-116 and ZR-75-30 cell line, respectively. Top1 unwinding assay and molecular modeling studies rationalized the mode of action of this new class of inhibitors.\n",
            "1447307\n",
            "Inhibition of DNA topoisomerase-1 (unknown origin) mediated DNA relaxation assessed as DNA intercalation at 1 ug/ml using supercoiled pBR322 plasmid DNA as substrate after 60 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors.  Abstract: Previously, 4-tosylanthra[1,2-c][1,2,5]thiadiazole-6,11-dione (1) was identified as a novel non-camptothecin topoisomerase I (Top1) inhibitor by structure-based virtual screening. Herein, a series of 4-substituted derivatives were designed and synthesized. Most of them showed potent Top1 inhibitory activity. Their in vitro antiproliferative activity was also evaluated in A549, HCT-116 and ZR-75-30 human cancer cell lines. Compound 8s showed good antiproliferative activity with IC50 of 0.52M and 0.42M against HCT-116 and ZR-75-30 cell line, respectively. Top1 unwinding assay and molecular modeling studies rationalized the mode of action of this new class of inhibitors.\n",
            "1448230\n",
            "Inhibition of human DNA topoisomerase 1 using plasmid pBAD-GFPuv as substrate after 30 mins by agarose gel electrophoresis\n",
            "Title: Selective Inhibition of Escherichia coli RNA and DNA Topoisomerase I by Hoechst 33258 Derived Mono- and Bisbenzimidazoles.  Abstract: A series of Hoechst 33258 based mono- and bisbenzimidazoles have been synthesized and their Escherichia coli DNA topoisomerase I inhibition, binding to B-DNA duplex, and antibacterial activity has been evaluated. Bisbenzimidazoles with alkynyl side chains display excellent E. coli DNA topoisomerase I inhibition properties with IC50 values <5.0 M. Several bisbenzimidazoles (3, 6, 7, 8) also inhibit RNA topoisomerase activity of E. coli DNA topoisomerase I. Bisbenzimidazoles inhibit bacterial growth much better than monobenzimidazoles for Gram-positive strains. The minimum inhibitory concentration (MIC) was much lower for Gram positive bacteria (Enterococcus spp. and Staphylococcus spp., including two MRSA strains 0.3-8 g/mL) than for the majority of Gram negative bacteria (Pseudomonas aeruginosa, 16-32 g/mL, Klebsiella pneumoniae > 32 g/mL). Bisbenzimidazoles showed varied stabilization of B-DNA duplex (1.2-23.4 C), and cytotoxicity studies show similar variation dependent upon the side chain length. Modeling studies suggest critical interactions between the inhibitor side chain and amino acids of the active site of DNA topoisomerase I.\n",
            "1453061\n",
            "Inhibition of human recombinant topoisomerase-1 assessed as decrease in relaxation of supercoiled DNA pBR322 at 100 uM after 30 mins by ethidium bromide staining-based agarose gel electrophoresis relative to control\n",
            "Title: Synthesis and biological evaluation of N-(carbobenzyloxy)-l-phenylalanine and N-(carbobenzyloxy)-l-aspartic acid--benzyl ester derivatives as potent topoisomerase II inhibitors.  Abstract: A new series of thirteen N-(carbobenzyloxy)-l-phenylalanine and N-(carbobenzyloxy)-l-aspartic acid--benzyl ester compounds were synthesized and evaluated for antiproliferative activity against four different human cancer cell lines: cervical cancer (HeLa), lung cancer (A549), gastric cancer (MGC-803) and breast cancer (MCF-7) as well as topoisomerase I and II inhibitory activity. Compounds (5a, 5b, 5e, 8a, 8b) showed significant antiproliferative activity with low IC50 values against the four cancer cell lines. Equally, compounds 5a, 5b, 5e, 5f, 8a, 8d, 8e and 8f showed topoisomerase II inhibitory activity at 100M with 5b, 5e, 8f exhibiting potential topoisomerase II inhibitory activity compared to positive control at 100M and 20M, respectively. Conversely compounds 5e, 5f, 5g and 8a showed weaker topoisomerase I inhibitory activity compared to positive control at 100M. Compound 5b exhibited the most potent topoisomerase II inhibitory activity at low concentration and better antiproliferative activity against the four human cancer cell lines. The molecular interactions between compounds 5a-5g, 8a-8f and the topoisomerase II (PDB ID: 1ZXM) were further investigated through molecular docking. The results indicated that these compounds could serve as promising leads for further optimization as novel antitumor agents.\n",
            "1453062\n",
            "Inhibition of human recombinant topoisomerase-1 assessed as decrease in relaxation of supercoiled DNA pBR322 at 20 uM after 30 mins by ethidium bromide staining-based agarose gel electrophoresis relative to control\n",
            "Title: Synthesis and biological evaluation of N-(carbobenzyloxy)-l-phenylalanine and N-(carbobenzyloxy)-l-aspartic acid--benzyl ester derivatives as potent topoisomerase II inhibitors.  Abstract: A new series of thirteen N-(carbobenzyloxy)-l-phenylalanine and N-(carbobenzyloxy)-l-aspartic acid--benzyl ester compounds were synthesized and evaluated for antiproliferative activity against four different human cancer cell lines: cervical cancer (HeLa), lung cancer (A549), gastric cancer (MGC-803) and breast cancer (MCF-7) as well as topoisomerase I and II inhibitory activity. Compounds (5a, 5b, 5e, 8a, 8b) showed significant antiproliferative activity with low IC50 values against the four cancer cell lines. Equally, compounds 5a, 5b, 5e, 5f, 8a, 8d, 8e and 8f showed topoisomerase II inhibitory activity at 100M with 5b, 5e, 8f exhibiting potential topoisomerase II inhibitory activity compared to positive control at 100M and 20M, respectively. Conversely compounds 5e, 5f, 5g and 8a showed weaker topoisomerase I inhibitory activity compared to positive control at 100M. Compound 5b exhibited the most potent topoisomerase II inhibitory activity at low concentration and better antiproliferative activity against the four human cancer cell lines. The molecular interactions between compounds 5a-5g, 8a-8f and the topoisomerase II (PDB ID: 1ZXM) were further investigated through molecular docking. The results indicated that these compounds could serve as promising leads for further optimization as novel antitumor agents.\n",
            "1453394\n",
            "Inhibition of human topoisomerase-1 at 100 uM using supercoiled pBR322 DNA as substrate after 10 to 15 mins by ethidium bromide staining based electrophoresis\n",
            "Title: Synthesis and biological research of novel azaacridine derivatives as potent DNA-binding ligands and topoisomerase II inhibitors.  Abstract: DNA and DNA-related enzymes are one of the most effective and common used intracellular anticancer targets in clinic and laboratory studies, however, most of DNA-targeting drugs suffered from toxic side effects. Development of new molecules with good antitumor activity and low side effects is important. Based on computer aided design and our previous studies, a series of novel azaacridine derivatives were synthesized as DNA and topoisomerases binding agents, among which compound 9 displayed the best antiproliferative activity with an IC50 value of 0.57M against U937 cells, which was slightly better than m-AMSA. In addition, compound 9 displayed low cytotoxicity against human normal liver cells (QSG-7701), the IC50 of which was more than 3 times lower than m-AMSA. Later study indicated that all the compounds displayed topoisomerases II inhibition activity at 50M. The representative compound 9 could bind with DNA and induce U937 apoptosis through the exogenous pathway.\n",
            "1457569\n",
            "Inhibition of recombinant Top1 (unknown origin) assessed as Top 1 mediated DNA cleavage using 3'-[32P]-labeled 117 bp DNA as substrate at 0.1 to 100 uM after 20 mins by PAGE analysis\n",
            "Title: Design and Synthesis of Chlorinated and Fluorinated 7-Azaindenoisoquinolines as Potent Cytotoxic Anticancer Agents That Inhibit Topoisomerase I.  Abstract: The 7-azaindenoisoquinolines are cytotoxic topoisomerase I (Top1) inhibitors. Previously reported representatives bear a 3-nitro group. The present report documents the replacement of the potentially genotoxic 3-nitro group by 3-chloro and 3-fluoro substituents, resulting in compounds with high Top1 inhibitory activities and potent cytotoxicities in human cancer cell cultures and reduced lethality in an animal model. Some of the new Top1 inhibitors also possess moderate inhibitory activities against tyrosyl-DNA phosphodiesterase 1 (TDP1) and tyrosyl-DNA phosphodiesterase 2 (TDP2), two enzymes that are involved in DNA damage repair resulting from Top1 inhibitors, and they produce significantly more DNA damage in cancer cells than in normal cells. Eighteen of the new compounds had cytotoxicity mean-graph midpoint (MGM) GI50 values in the submicromolar (0.033-0.630 M) range. Compounds 16b and 17b are the most potent in human cancer cell cultures with MGM GI50 values of 0.063 and 0.033 M, respectively. Possible binding modes to Top1 and TDP1were investigated by molecular modeling.\n",
            "1472923\n",
            "Inhibition of recombinant human topoisomerase-1 expressed in baculovirus infected sf9 cells using supercoiled pBS SK(+) DNA as substrate after 15 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472924\n",
            "Inhibition of recombinant human topoisomerase-1 expressed in baculovirus infected sf9 cells using supercoiled pBS SK(+) DNA as substrate preincubated for 5 mins followed by substrate addition measured after 15 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472925\n",
            "Inhibition of recombinant human topoisomerase-1 expressed in baculovirus infected sf9 cells at 1 uM using supercoiled pBS SK(+) DNA as substrate after 15 mins by ethidium bromide staining based agarose gel electrophoresis method relative to control\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472926\n",
            "Inhibition of recombinant human topoisomerase-1 expressed in baculovirus infected sf9 cells at 1 uM using supercoiled pBS SK(+) DNA as substrate preincubated for 5 mins followed by substrate addition measured after 15 mins by ethidium bromide staining based agarose gel electrophoresis method relative to control\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472927\n",
            "Ratio of EC50 for recombinant human topoisomerase-1 expressed in baculovirus infected sf9 cells simultaneously incubated with substrate to EC50 for recombinant human topoisomerase-1 expressed in baculovirus infected sf9 cells preincubated for 5 mins followed by substrate addition\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472928\n",
            "Inhibition of topoisomerase-1 in human MCF7 whole cell extracts at 0.25 to 5 uM using supercoiled pBS SK(+) DNA as substrate after 15 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472929\n",
            "Inhibition of topoisomerase-1 in human MCF7 whole cell extracts at 0.25 to 5 uM using supercoiled pBS SK(+) DNA as substrate preincubated for 5 mins followed by substrate addition measured after 15 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472930\n",
            "Ratio of compound effect for inhibition of recombinant human topoisomerase-1 expressed in baculovirus infected sf9 cells preincubated for 5 mins followed by substrate addition to compound effect for recombinant human topoisomerase-1 expressed in baculovirus infected sf9 cells simultaneously incubated with substrate\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472931\n",
            "Inhibition of recombinant human topoisomerase-1 expressed in baculovirus infected sf9 cells assessed as reduction in cleavage complex formation with supercoiled pBS SK(+) DNA at 10 to 50 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472932\n",
            "Stabilization of recombinant human topoisomerase-1-supercoiled pBS SK(+) DNA cleavage complex at 10 to 50 uM after 30 mins using topoisomerase1 expressed in baculovirus infected sf9 cells by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472933\n",
            "Inhibition of CPT-induced recombinant human topoisomerase1-supercoiled pBS SK(+) DNA cleavage complex after 30 mins using topoisomerase1 expressed in baculovirus infected sf9 cells by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472934\n",
            "Inhibition of recombinant human topoisomerase1-[32P]-labeled 25-mer duplex oligonucleotide cleavage complex formation at 10 to 50 uM after 30 mins using topoisomerase1 expressed in baculovirus infected sf9 cells by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472935\n",
            "Inhibition of CPT-induced recombinant human topoisomerase1-12-mer duplex oligonucleotide cleavage complex at 10 to 50 uM after 30 mins using topoisomerase1 expressed in baculovirus infected sf9 cells by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472936\n",
            "Stabilization of recombinant human EGFP-tagged topoisomerase-1- DNA cleavage complex assessed as Top1 immobile population at 5 uM after 10 mins by FRAP assay\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472937\n",
            "Inhibition of recombinant human EGFP-tagged topoisomerase-1- DNA cleavage complex formation at 20 uM after 10 mins by FRAP assay\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472938\n",
            "Inhibition of CPT-induced recombinant human EGFP-tagged topoisomerase-1- DNA cleavage complex formation assessed as restoration of Top1 mobility at 20 uM after 10 mins by FRAP assay\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472940\n",
            "Binding affinity to recombinant human topoisomerase-1 expressed in baculovirus infected sf9 cells assessed as intrinsic tryptophan fluorescence quenching up to 1.25 uM by Job's plot analysis\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472941\n",
            "Binding affinity to recombinant human topoisomerase-1 expressed in baculovirus infected sf9 cells by spectrofluorimetric method\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472942\n",
            "Reversible inhibition of recombinant human topoisomerase-1 expressed in baculovirus infected sf9 cells at 1 uM using supercoiled pBS SK(+) DNA as substrate preincubated for 5 mins followed by substrate addition and subsequent 40 fold compound dilution measured after 15 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472947\n",
            "Induction of proteasome-mediated topoisomerase-1 degradation in human MCF7 cells at 10 uM by Western blot method\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472948\n",
            "Induction of proteasome-mediated topoisomerase-1 degradation in human MCF7 cells at 10 uM up to 12 hrs in presence of proteasome inhibitor MG132 by Western blot method\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472950\n",
            "Stabilization of topoisomerase-1- genomic DNA cleavage complex in human MCF7 cells at 10 uM after 12 hrs by ICE assay\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472951\n",
            "Inhibition of topoisomerase-1- genomic DNA cleavage complex in human MCF7 cells at 20 uM after 12 hrs by ICE assay\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1472952\n",
            "Inhibition of CPE-induced topoisomerase-1- genomic DNA cleavage complex in human MCF7 cells at 20 uM after 6 hrs by ICE assay\n",
            "Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.\n",
            "1478721\n",
            "Inhibition of recombinant human topoisomerase-1 assessed as decrease in relaxation of supercoiled pBR322 plasmid DNA at 100 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to control\n",
            "Title: Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and II dual inhibitors with DNA non-intercalative catalytic activity.  Abstract: With the aim to develop novel antiproliferative agents, a new series of eighteen dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines were systematically designed, prepared, and investigated for their topoisomerase (topo) I and II inhibitory properties and antiproliferative effect in three different human cancer cell lines (HCT15, T47D, and HeLa). Compounds 22-30 which possess a meta- or para-phenol on 2-, or 6-position of central pyridine ring showed significant dual topo I and topo II inhibitory activities with strong antiproliferative activities against all the tested human cancer cell lines. However, compounds 13-21 which possess an ortho-phenol on 2-, or 6-position of central pyridine ring did not show significant topo I and topo II inhibitory activities but displayed moderate antiproliferative activities against all the tested human cancer cell lines. Compound 23 exhibited the highest antiproliferative potency as much as 348.5 and 105 times compared to etoposide and camptothecin, respectively, in T47D cancer cell line. The structure-activity relationship study revealed that the para position of a hydroxyl group at 2-and 6-phenyl ring and chlorine atom at the para position of 4-phenyl ring of the central pyridine exhibited the most significant topo I and topo II inhibition, which might indicate introduction of the chlorine atom at the phenyl ring of 4-pyridine have an important role as dual inhibitors of topo I and topo II. Compound 30 which showed the most potent dual topo I and topo II inhibition with strong antiproliferative activity in T47D cell line was selected to perform further study on the mechanism of action, which revealed that compound 30 functions as a potent DNA non-intercalative catalytic topo I and II dual inhibitor.\n",
            "1478722\n",
            "Inhibition of recombinant human topoisomerase-1 assessed as decrease in relaxation of supercoiled pBR322 plasmid DNA at 20 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to control\n",
            "Title: Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and II dual inhibitors with DNA non-intercalative catalytic activity.  Abstract: With the aim to develop novel antiproliferative agents, a new series of eighteen dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines were systematically designed, prepared, and investigated for their topoisomerase (topo) I and II inhibitory properties and antiproliferative effect in three different human cancer cell lines (HCT15, T47D, and HeLa). Compounds 22-30 which possess a meta- or para-phenol on 2-, or 6-position of central pyridine ring showed significant dual topo I and topo II inhibitory activities with strong antiproliferative activities against all the tested human cancer cell lines. However, compounds 13-21 which possess an ortho-phenol on 2-, or 6-position of central pyridine ring did not show significant topo I and topo II inhibitory activities but displayed moderate antiproliferative activities against all the tested human cancer cell lines. Compound 23 exhibited the highest antiproliferative potency as much as 348.5 and 105 times compared to etoposide and camptothecin, respectively, in T47D cancer cell line. The structure-activity relationship study revealed that the para position of a hydroxyl group at 2-and 6-phenyl ring and chlorine atom at the para position of 4-phenyl ring of the central pyridine exhibited the most significant topo I and topo II inhibition, which might indicate introduction of the chlorine atom at the phenyl ring of 4-pyridine have an important role as dual inhibitors of topo I and topo II. Compound 30 which showed the most potent dual topo I and topo II inhibition with strong antiproliferative activity in T47D cell line was selected to perform further study on the mechanism of action, which revealed that compound 30 functions as a potent DNA non-intercalative catalytic topo I and II dual inhibitor.\n",
            "1478733\n",
            "Inhibition of recombinant human topoisomerase-1 assessed as decrease in relaxation of supercoiled pBR322 plasmid DNA at 100 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to camptothecin\n",
            "Title: Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and II dual inhibitors with DNA non-intercalative catalytic activity.  Abstract: With the aim to develop novel antiproliferative agents, a new series of eighteen dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines were systematically designed, prepared, and investigated for their topoisomerase (topo) I and II inhibitory properties and antiproliferative effect in three different human cancer cell lines (HCT15, T47D, and HeLa). Compounds 22-30 which possess a meta- or para-phenol on 2-, or 6-position of central pyridine ring showed significant dual topo I and topo II inhibitory activities with strong antiproliferative activities against all the tested human cancer cell lines. However, compounds 13-21 which possess an ortho-phenol on 2-, or 6-position of central pyridine ring did not show significant topo I and topo II inhibitory activities but displayed moderate antiproliferative activities against all the tested human cancer cell lines. Compound 23 exhibited the highest antiproliferative potency as much as 348.5 and 105 times compared to etoposide and camptothecin, respectively, in T47D cancer cell line. The structure-activity relationship study revealed that the para position of a hydroxyl group at 2-and 6-phenyl ring and chlorine atom at the para position of 4-phenyl ring of the central pyridine exhibited the most significant topo I and topo II inhibition, which might indicate introduction of the chlorine atom at the phenyl ring of 4-pyridine have an important role as dual inhibitors of topo I and topo II. Compound 30 which showed the most potent dual topo I and topo II inhibition with strong antiproliferative activity in T47D cell line was selected to perform further study on the mechanism of action, which revealed that compound 30 functions as a potent DNA non-intercalative catalytic topo I and II dual inhibitor.\n",
            "1478734\n",
            "Inhibition of recombinant human topoisomerase-1 assessed as decrease in relaxation of supercoiled pBR322 plasmid DNA at 20 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to camptothecin\n",
            "Title: Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and II dual inhibitors with DNA non-intercalative catalytic activity.  Abstract: With the aim to develop novel antiproliferative agents, a new series of eighteen dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines were systematically designed, prepared, and investigated for their topoisomerase (topo) I and II inhibitory properties and antiproliferative effect in three different human cancer cell lines (HCT15, T47D, and HeLa). Compounds 22-30 which possess a meta- or para-phenol on 2-, or 6-position of central pyridine ring showed significant dual topo I and topo II inhibitory activities with strong antiproliferative activities against all the tested human cancer cell lines. However, compounds 13-21 which possess an ortho-phenol on 2-, or 6-position of central pyridine ring did not show significant topo I and topo II inhibitory activities but displayed moderate antiproliferative activities against all the tested human cancer cell lines. Compound 23 exhibited the highest antiproliferative potency as much as 348.5 and 105 times compared to etoposide and camptothecin, respectively, in T47D cancer cell line. The structure-activity relationship study revealed that the para position of a hydroxyl group at 2-and 6-phenyl ring and chlorine atom at the para position of 4-phenyl ring of the central pyridine exhibited the most significant topo I and topo II inhibition, which might indicate introduction of the chlorine atom at the phenyl ring of 4-pyridine have an important role as dual inhibitors of topo I and topo II. Compound 30 which showed the most potent dual topo I and topo II inhibition with strong antiproliferative activity in T47D cell line was selected to perform further study on the mechanism of action, which revealed that compound 30 functions as a potent DNA non-intercalative catalytic topo I and II dual inhibitor.\n",
            "1481805\n",
            "Poison activity at DNA topoisomerase 1 in human Bel7402 cells assessed as induction of DNA damage by measuring upregulated gamma-H2AX levels at 1 uM after 1 hr by Western blot analysis\n",
            "Title: 6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression.  Abstract: To discover new phenanthroindolizidine and phenanthroquinolizidine alkaloids as potential anticancer drug candidates, non-natural 6-O-desmethylcryptopleurine (2) and its derivatives were prepared. Most of the new compounds exhibited potent antiproliferative activity against A549 and BEL-7402 cells, with the lowest IC50 being 3 nM. Optically pure 2-R was further evaluated against a panel of 30 cancer cell lines and found to inhibit the proliferation of all tested cell lines, including three multidrug-resistant cell lines, with an average IC50 value of 2.1 nM, which is much lower than that of previously reported phenanthroindolizidine DCB-3503 (1, IC50: 166.7 nM). A mechanistic evaluation showed that 2-R potently inhibited cell growth and colony formation, which are associated with a delay in S phase progression through the inhibition of DNA synthesis. These results along with further study on the safety profile of these compounds will facilitate the discovery of new phenanthroindolizidine and phenanthroquinolizidine alkaloids for use as anticancer drug candidates.\n",
            "1481806\n",
            "Poison activity at DNA topoisomerase 1 in human Bel7402 cells assessed as induction of DNA damage by measuring upregulated levels of CHK1 phosphorylation at Ser345 residue at 1 uM after 1 hr by Western blot analysis\n",
            "Title: 6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression.  Abstract: To discover new phenanthroindolizidine and phenanthroquinolizidine alkaloids as potential anticancer drug candidates, non-natural 6-O-desmethylcryptopleurine (2) and its derivatives were prepared. Most of the new compounds exhibited potent antiproliferative activity against A549 and BEL-7402 cells, with the lowest IC50 being 3 nM. Optically pure 2-R was further evaluated against a panel of 30 cancer cell lines and found to inhibit the proliferation of all tested cell lines, including three multidrug-resistant cell lines, with an average IC50 value of 2.1 nM, which is much lower than that of previously reported phenanthroindolizidine DCB-3503 (1, IC50: 166.7 nM). A mechanistic evaluation showed that 2-R potently inhibited cell growth and colony formation, which are associated with a delay in S phase progression through the inhibition of DNA synthesis. These results along with further study on the safety profile of these compounds will facilitate the discovery of new phenanthroindolizidine and phenanthroquinolizidine alkaloids for use as anticancer drug candidates.\n",
            "1481807\n",
            "Poison activity at DNA topoisomerase 1 in human Bel7402 cells assessed as induction of DNA damage by measuring upregulated levels of CHK2 phosphorylation at Thr68 residue at 1 nM after 1 hr by Western blot analysis\n",
            "Title: 6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression.  Abstract: To discover new phenanthroindolizidine and phenanthroquinolizidine alkaloids as potential anticancer drug candidates, non-natural 6-O-desmethylcryptopleurine (2) and its derivatives were prepared. Most of the new compounds exhibited potent antiproliferative activity against A549 and BEL-7402 cells, with the lowest IC50 being 3 nM. Optically pure 2-R was further evaluated against a panel of 30 cancer cell lines and found to inhibit the proliferation of all tested cell lines, including three multidrug-resistant cell lines, with an average IC50 value of 2.1 nM, which is much lower than that of previously reported phenanthroindolizidine DCB-3503 (1, IC50: 166.7 nM). A mechanistic evaluation showed that 2-R potently inhibited cell growth and colony formation, which are associated with a delay in S phase progression through the inhibition of DNA synthesis. These results along with further study on the safety profile of these compounds will facilitate the discovery of new phenanthroindolizidine and phenanthroquinolizidine alkaloids for use as anticancer drug candidates.\n",
            "1486385\n",
            "Inhibition of human placenta DNA topoisomerase-1 assessed as decrease in relaxation of supercoiled pUC19 DNA at 200 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Design, synthesis, and evaluation of DNA topoisomerase II-targeted nucleosides.  Abstract: We developed novel nucleoside-based topoisomerase II selective inhibitors and showed that small structural units, such as catechols, are essential for DNA topoisomerase II inhibitory activity. Moreover, nucleoside analogues containing TBS and 1,3-dithian moieties had potent and selective DNA topoisomerase II inhibitory activities. In further experiments, compound 25b having a beta configuration of the thymine moiety showed relatively strong growth inhibitory activity against cancer cell lines, and was more potent against all cancer cell lines than compound 26b, which carries a thymine moiety in the alpha configuration.\n",
            "1486759\n",
            "Inhibition of human recombinant DNA topoisomerase 1 assessed as reduction in enzyme-mediated relaxation of supercoiled pBR322 plasmid DNA at 100 uM in presence of 0.1% BSA by ethidium bromide staining based gel electrophoresis and UV spectroscopy relative to camptothecin\n",
            "Title: 2-Chlorophenyl-substituted benzofuro[3,2-b]pyridines with enhanced topoisomerase inhibitory activity: The role of the chlorine substituent.  Abstract: A new series of 2-chloropheny-substituted benzofuro[3,2-b]pyridines were designed, synthesized, and evaluated for topoisomerase I and II inhibition and antiproliferative activity. Compounds 17-19, 23, 24, 26, and 27 exhibited excellent topo II inhibitory activity. A systematic structure-activity relationship study revealed the important role of chlorine substitution in the strong topoisomerase inhibitory activity.\n",
            "1486765\n",
            "Inhibition of human recombinant DNA topoisomerase 1 assessed as reduction in enzyme-mediated relaxation of supercoiled pBR322 plasmid DNA at 100 uM in presence of 0.1% BSA by ethidium bromide staining based gel electrophoresis and UV spectroscopy\n",
            "Title: 2-Chlorophenyl-substituted benzofuro[3,2-b]pyridines with enhanced topoisomerase inhibitory activity: The role of the chlorine substituent.  Abstract: A new series of 2-chloropheny-substituted benzofuro[3,2-b]pyridines were designed, synthesized, and evaluated for topoisomerase I and II inhibition and antiproliferative activity. Compounds 17-19, 23, 24, 26, and 27 exhibited excellent topo II inhibitory activity. A systematic structure-activity relationship study revealed the important role of chlorine substitution in the strong topoisomerase inhibitory activity.\n",
            "1500678\n",
            "Inhibition of human topoisomerase-1 at 2 to 100 uM using supercoiled pBR322 DNA as substrate after 10 to 15 mins by ethidium bromide staining based electrophoresis method\n",
            "Title: Design, synthesis and biological evaluation of 4-amidobenzimidazole acridine derivatives as dual PARP and Topo inhibitors for cancer therapy.  Abstract: PARP-1 could repair the DNA damages induced by Topo inhibitors, therefore inhibiting Topo and PARP-1 simultaneously might be able to overcome resistance and improve outcomes. In this study a series of 4-amidobenzimidazole acridines were designed and synthesized as dual Topo and PARP-1 inhibitors. Compound 11l displayed good inhibitory activities against Topo and PARP-1, as well as significantly inhibited cancer cells proliferation. Further mechanistic evaluations indicated that 11l treatment in MCF-7 cells induced accumulated DNA double-strand breaks, prompted remarkable apoptosis, and caused prominent G0/G1 cell cycle arrest. Moreover, 11l greatly suppressed tumor growth in mice, and displayed favorable metabolic properties in liver microsomes. Our study suggested that single agents inhibiting Topo and PARP concurrently might be an alternative for cancer therapy and 11l represented a potential lead compound for development of antitumor agents.\n",
            "1500679\n",
            "Inhibition of human topoisomerase-1 at 100 uM using supercoiled pBR322 DNA as substrate after 10 to 15 mins by ethidium bromide staining based electrophoresis method\n",
            "Title: Design, synthesis and biological evaluation of 4-amidobenzimidazole acridine derivatives as dual PARP and Topo inhibitors for cancer therapy.  Abstract: PARP-1 could repair the DNA damages induced by Topo inhibitors, therefore inhibiting Topo and PARP-1 simultaneously might be able to overcome resistance and improve outcomes. In this study a series of 4-amidobenzimidazole acridines were designed and synthesized as dual Topo and PARP-1 inhibitors. Compound 11l displayed good inhibitory activities against Topo and PARP-1, as well as significantly inhibited cancer cells proliferation. Further mechanistic evaluations indicated that 11l treatment in MCF-7 cells induced accumulated DNA double-strand breaks, prompted remarkable apoptosis, and caused prominent G0/G1 cell cycle arrest. Moreover, 11l greatly suppressed tumor growth in mice, and displayed favorable metabolic properties in liver microsomes. Our study suggested that single agents inhibiting Topo and PARP concurrently might be an alternative for cancer therapy and 11l represented a potential lead compound for development of antitumor agents.\n",
            "1500681\n",
            "Inhibition of topoisomerase-1 in human MCF7 cells assessed as enzyme-DNA cleavage complex formation by measuring decrease in topoisomerase-1 protein expression after 24 hrs by Western blot analysis\n",
            "Title: Design, synthesis and biological evaluation of 4-amidobenzimidazole acridine derivatives as dual PARP and Topo inhibitors for cancer therapy.  Abstract: PARP-1 could repair the DNA damages induced by Topo inhibitors, therefore inhibiting Topo and PARP-1 simultaneously might be able to overcome resistance and improve outcomes. In this study a series of 4-amidobenzimidazole acridines were designed and synthesized as dual Topo and PARP-1 inhibitors. Compound 11l displayed good inhibitory activities against Topo and PARP-1, as well as significantly inhibited cancer cells proliferation. Further mechanistic evaluations indicated that 11l treatment in MCF-7 cells induced accumulated DNA double-strand breaks, prompted remarkable apoptosis, and caused prominent G0/G1 cell cycle arrest. Moreover, 11l greatly suppressed tumor growth in mice, and displayed favorable metabolic properties in liver microsomes. Our study suggested that single agents inhibiting Topo and PARP concurrently might be an alternative for cancer therapy and 11l represented a potential lead compound for development of antitumor agents.\n",
            "1507687\n",
            "Inhibition of human topoisomerase-1 assessed as increase in accumulation of supercoiled pUC19 DNA at 1 to 50 uM by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Novel amidino substituted benzimidazole and benzothiazole benzo[b]thieno-2-carboxamides exert strong antiproliferative and DNA binding properties.  Abstract: Within this manuscript design, synthesis of novel 2-imidazolinyl substituted benzo[b]thieno-2-carboxamides bearing either benzimidazole or benzothiazole subunit and biological activity are presented and described. The antiproliferative activities were assessed in vitro on a panel of human cancer cell lines. Tested compounds showed moderate activity while cytotoxicity on normal fibroblasts was lower in comparison with 5-fluorouracile. The variations of 2-imidazolinyl substituent at heteroaromatic subunits in different positions led to different cytotoxic properties. The strongest selective activity against HeLa cells was observed for the benzothiazole derivative 4d with 2-imidazolinyl group at the benzo[b]thiophene subunit with a corresponding IC50 = 1.16 M. Additionally, several biological experiments were performed to explain the mode of biological action. Fluorescence microscopy evidenced nuclear subcellular localization of compounds 3a, 4a and 4c. Additionally, detailed DNA binding studies confirmed a strong DNA groove binding for derivatives 4a and 4c while DNase I footprinting experiments evidenced sequence-selective binding of compound 4c in the A-T rich side. Furthermore, topoisomerase suppressive effect was for compounds 4a-4c.\n",
            "1507689\n",
            "Poison activity at human topoisomerase-1 assessed as increase in relaxation of supercoiled pUC19 DNA at 50 uM by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Novel amidino substituted benzimidazole and benzothiazole benzo[b]thieno-2-carboxamides exert strong antiproliferative and DNA binding properties.  Abstract: Within this manuscript design, synthesis of novel 2-imidazolinyl substituted benzo[b]thieno-2-carboxamides bearing either benzimidazole or benzothiazole subunit and biological activity are presented and described. The antiproliferative activities were assessed in vitro on a panel of human cancer cell lines. Tested compounds showed moderate activity while cytotoxicity on normal fibroblasts was lower in comparison with 5-fluorouracile. The variations of 2-imidazolinyl substituent at heteroaromatic subunits in different positions led to different cytotoxic properties. The strongest selective activity against HeLa cells was observed for the benzothiazole derivative 4d with 2-imidazolinyl group at the benzo[b]thiophene subunit with a corresponding IC50 = 1.16 M. Additionally, several biological experiments were performed to explain the mode of biological action. Fluorescence microscopy evidenced nuclear subcellular localization of compounds 3a, 4a and 4c. Additionally, detailed DNA binding studies confirmed a strong DNA groove binding for derivatives 4a and 4c while DNase I footprinting experiments evidenced sequence-selective binding of compound 4c in the A-T rich side. Furthermore, topoisomerase suppressive effect was for compounds 4a-4c.\n",
            "1507694\n",
            "Inhibition of human topoisomerase-1 assessed as increase in accumulation of supercoiled pUC19 DNA at 1 to 50 uM in absence of ethidium bromide staining by agarose gel electrophoresis\n",
            "Title: Novel amidino substituted benzimidazole and benzothiazole benzo[b]thieno-2-carboxamides exert strong antiproliferative and DNA binding properties.  Abstract: Within this manuscript design, synthesis of novel 2-imidazolinyl substituted benzo[b]thieno-2-carboxamides bearing either benzimidazole or benzothiazole subunit and biological activity are presented and described. The antiproliferative activities were assessed in vitro on a panel of human cancer cell lines. Tested compounds showed moderate activity while cytotoxicity on normal fibroblasts was lower in comparison with 5-fluorouracile. The variations of 2-imidazolinyl substituent at heteroaromatic subunits in different positions led to different cytotoxic properties. The strongest selective activity against HeLa cells was observed for the benzothiazole derivative 4d with 2-imidazolinyl group at the benzo[b]thiophene subunit with a corresponding IC50 = 1.16 M. Additionally, several biological experiments were performed to explain the mode of biological action. Fluorescence microscopy evidenced nuclear subcellular localization of compounds 3a, 4a and 4c. Additionally, detailed DNA binding studies confirmed a strong DNA groove binding for derivatives 4a and 4c while DNase I footprinting experiments evidenced sequence-selective binding of compound 4c in the A-T rich side. Furthermore, topoisomerase suppressive effect was for compounds 4a-4c.\n",
            "1507695\n",
            "Poison activity at human topoisomerase-1 assessed as increase in relaxation of supercoiled pUC19 DNA at 1 to 50 uM by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Novel amidino substituted benzimidazole and benzothiazole benzo[b]thieno-2-carboxamides exert strong antiproliferative and DNA binding properties.  Abstract: Within this manuscript design, synthesis of novel 2-imidazolinyl substituted benzo[b]thieno-2-carboxamides bearing either benzimidazole or benzothiazole subunit and biological activity are presented and described. The antiproliferative activities were assessed in vitro on a panel of human cancer cell lines. Tested compounds showed moderate activity while cytotoxicity on normal fibroblasts was lower in comparison with 5-fluorouracile. The variations of 2-imidazolinyl substituent at heteroaromatic subunits in different positions led to different cytotoxic properties. The strongest selective activity against HeLa cells was observed for the benzothiazole derivative 4d with 2-imidazolinyl group at the benzo[b]thiophene subunit with a corresponding IC50 = 1.16 M. Additionally, several biological experiments were performed to explain the mode of biological action. Fluorescence microscopy evidenced nuclear subcellular localization of compounds 3a, 4a and 4c. Additionally, detailed DNA binding studies confirmed a strong DNA groove binding for derivatives 4a and 4c while DNase I footprinting experiments evidenced sequence-selective binding of compound 4c in the A-T rich side. Furthermore, topoisomerase suppressive effect was for compounds 4a-4c.\n",
            "1507750\n",
            "Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pUC19 DNA at 10 to 50 uM after 45 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Synthesis of novel indole derivatives as promising DNA-binding agents and evaluation of antitumor and antitopoisomerase I activities.  Abstract: Molecules bearing indole nucleus present diverse biological properties such as antitumor and anti-inflammatory activities that can be associated both to DNA and protein interactions. This study focused on the synthesis of new indole derivatives with thiazolidines and imidazolidine rings condensed as side chains as well as the evaluation of their ability to interact with the DNA and antitumor and topoisomerase inhibition activities. All derivatives were successfully synthesized and their structures were elucidated by mass spectrometry (MS), infrared (IR), spectroscopy 1H NMR, 13C NMR, COSY 1H-1H and HSQC 1H-13C. The antitumor activity was evaluated against different cancer cell lines using the antiproliferative MTT assay. DNA binding ability was analyzed by absorption spectroscopy and fluorescence technique using ethidium bromide (EB) as a fluorescent probe. Changes were observed in spectroscopic properties of the compounds after interacting with ctDNA (calf thymus DNA), with hypochromic and hyperchromic effects, besides blue or red shifts in the maxima of spectra. The indole derivative 5-(1H-Indol-3-ylmethylene)-thiazolidin-2,4-dione (4c) presented the best results in antitumor assay against the breast line tested (T47D), with IC50 value lower than the positive control, doxorubicin (1.93 and 4.61 M, respectively). On the other hand, the compound 3-amino-5-(1H-indol-3-ylmethylene)-2-thioxo-thiazolidin-4-one (4a) was active against leukemia cell lines (HL60 and K562) with the high value of the DNA binding constant, Kb of 5.69  104. However, this compound (4a) did not inhibit the topoisomerase-I activity evaluated by relaxation assay. These results show that the indole nucleus contribute to the incorporation of molecules into the DNA. Moreover, it was highlighted that basic side chains, such as thiazolidines and imidazolidines, and free amino group, are relevant for design of promising antitumor and DNA binding compounds.\n",
            "1508588\n",
            "RNAi screen for vemurafenib enhancer genes in BRAFV600 melanoma - Primary Screen\n",
            "Genome wide protein coding siRNA screen for genes that enhance the effects of vemurafenib on cell viability and glycolysis in human BRAFV600 melanoma cells\n",
            "1520397\n",
            "Inhibition of topoisomerase 1 (unknown origin) at 50 uM using pBR322 DNA as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ethidium bromide staining-based agarose gel electrophoresis analysis\n",
            "Title: Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo.  Abstract: Inspired by the common structural characteristics of numerous known antitumor compounds targeting DNA or topoisomerase I, 3-(benzazol-2-yl)-quinoxaline-based scaffold was designed via the combination of two important privileged structure units -quinoxaline and benzazole. Thirty novel 3-(benzazol-2-yl)-quinoxaline derivatives were synthesized and evaluated for their biological activities. The MTT assay indicated that most compounds possessed moderate to potent antiproliferation effects against MGC-803, HepG2, A549, HeLa, T-24 and WI-38cell lines. 3-(Benzoxazol- -2-yl)-2-(N-3-dimethylaminopropyl)aminoquinoxaline (12a) exhibited the most potent cytotoxicity, with IC50 values ranging from 1.49 to 10.99M against the five tested cancer and one normal cell line. Agarose-gel electrophoresis assays suggested that 12a did not interact with intact DNA, but rather it strongly inhibited topoisomerase I (Topo I) via Topo I-mediated DNA unwinding to exert its anticancer activity. The molecular modeling study indicated that 12a adopt a unique mode to interact with DNA and Topo I. Detailed biological study of 12a in MGC-803cells revealed that 12a could arrest the cell cycle in G2 phase, inducing the generation of reactive oxygen species (ROS), the fluctuation of intracellular Ca2+, and the loss of mitochondrial membrane potential (m). Western Blot analysis indicated that 12a-treatment could significantly up-regulate the levels of pro-apoptosis proteins Bak, Bax, and Bim, down-regulate anti-apoptosis proteins Bcl-2 and Bcl-xl, and increase levels of cyclin B1 and CDKs inhibitor p21, cytochrome c, caspase-3, caspase-9 and their activated form in MGC-803cells in a dose-dependent manner to induce cell apoptosis via a caspase-dependent intrinsic mitochondria-mediated pathway. Studies in MGC-803 xenograft tumors models demonstrated that 12a could signicantly reduce tumor growth in vivo at doses as low as 6mg/kg with low toxicity. Its convenient preparation and potent anticancer efficacy in vivo makes the 3-(benzazol-2-yl)quinoxaline scaffold a promising new chemistry entity for the development of novel chemotherapeutic agents.\n",
            "1520398\n",
            "Inhibition of topoisomerase 1 (unknown origin) at 40 uM using pBR322 DNA as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ethidium bromide staining-based agarose gel electrophoresis analysis\n",
            "Title: Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo.  Abstract: Inspired by the common structural characteristics of numerous known antitumor compounds targeting DNA or topoisomerase I, 3-(benzazol-2-yl)-quinoxaline-based scaffold was designed via the combination of two important privileged structure units -quinoxaline and benzazole. Thirty novel 3-(benzazol-2-yl)-quinoxaline derivatives were synthesized and evaluated for their biological activities. The MTT assay indicated that most compounds possessed moderate to potent antiproliferation effects against MGC-803, HepG2, A549, HeLa, T-24 and WI-38cell lines. 3-(Benzoxazol- -2-yl)-2-(N-3-dimethylaminopropyl)aminoquinoxaline (12a) exhibited the most potent cytotoxicity, with IC50 values ranging from 1.49 to 10.99M against the five tested cancer and one normal cell line. Agarose-gel electrophoresis assays suggested that 12a did not interact with intact DNA, but rather it strongly inhibited topoisomerase I (Topo I) via Topo I-mediated DNA unwinding to exert its anticancer activity. The molecular modeling study indicated that 12a adopt a unique mode to interact with DNA and Topo I. Detailed biological study of 12a in MGC-803cells revealed that 12a could arrest the cell cycle in G2 phase, inducing the generation of reactive oxygen species (ROS), the fluctuation of intracellular Ca2+, and the loss of mitochondrial membrane potential (m). Western Blot analysis indicated that 12a-treatment could significantly up-regulate the levels of pro-apoptosis proteins Bak, Bax, and Bim, down-regulate anti-apoptosis proteins Bcl-2 and Bcl-xl, and increase levels of cyclin B1 and CDKs inhibitor p21, cytochrome c, caspase-3, caspase-9 and their activated form in MGC-803cells in a dose-dependent manner to induce cell apoptosis via a caspase-dependent intrinsic mitochondria-mediated pathway. Studies in MGC-803 xenograft tumors models demonstrated that 12a could signicantly reduce tumor growth in vivo at doses as low as 6mg/kg with low toxicity. Its convenient preparation and potent anticancer efficacy in vivo makes the 3-(benzazol-2-yl)quinoxaline scaffold a promising new chemistry entity for the development of novel chemotherapeutic agents.\n",
            "1520399\n",
            "Inhibition of topoisomerase 1 (unknown origin) using pBR322 DNA as substrate assessed as reduction in pBR322 DNA unwinding at 50 uM after 30 mins by ethidium bromide staining-based agarose gel electrophoresis analysis\n",
            "Title: Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo.  Abstract: Inspired by the common structural characteristics of numerous known antitumor compounds targeting DNA or topoisomerase I, 3-(benzazol-2-yl)-quinoxaline-based scaffold was designed via the combination of two important privileged structure units -quinoxaline and benzazole. Thirty novel 3-(benzazol-2-yl)-quinoxaline derivatives were synthesized and evaluated for their biological activities. The MTT assay indicated that most compounds possessed moderate to potent antiproliferation effects against MGC-803, HepG2, A549, HeLa, T-24 and WI-38cell lines. 3-(Benzoxazol- -2-yl)-2-(N-3-dimethylaminopropyl)aminoquinoxaline (12a) exhibited the most potent cytotoxicity, with IC50 values ranging from 1.49 to 10.99M against the five tested cancer and one normal cell line. Agarose-gel electrophoresis assays suggested that 12a did not interact with intact DNA, but rather it strongly inhibited topoisomerase I (Topo I) via Topo I-mediated DNA unwinding to exert its anticancer activity. The molecular modeling study indicated that 12a adopt a unique mode to interact with DNA and Topo I. Detailed biological study of 12a in MGC-803cells revealed that 12a could arrest the cell cycle in G2 phase, inducing the generation of reactive oxygen species (ROS), the fluctuation of intracellular Ca2+, and the loss of mitochondrial membrane potential (m). Western Blot analysis indicated that 12a-treatment could significantly up-regulate the levels of pro-apoptosis proteins Bak, Bax, and Bim, down-regulate anti-apoptosis proteins Bcl-2 and Bcl-xl, and increase levels of cyclin B1 and CDKs inhibitor p21, cytochrome c, caspase-3, caspase-9 and their activated form in MGC-803cells in a dose-dependent manner to induce cell apoptosis via a caspase-dependent intrinsic mitochondria-mediated pathway. Studies in MGC-803 xenograft tumors models demonstrated that 12a could signicantly reduce tumor growth in vivo at doses as low as 6mg/kg with low toxicity. Its convenient preparation and potent anticancer efficacy in vivo makes the 3-(benzazol-2-yl)quinoxaline scaffold a promising new chemistry entity for the development of novel chemotherapeutic agents.\n",
            "1520400\n",
            "Inhibition of topoisomerase 1 (unknown origin) using pBR322 DNA as substrate assessed as reduction in pBR322 DNA unwinding at 20 uM after 30 mins by ethidium bromide staining-based agarose gel electrophoresis analysis\n",
            "Title: Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo.  Abstract: Inspired by the common structural characteristics of numerous known antitumor compounds targeting DNA or topoisomerase I, 3-(benzazol-2-yl)-quinoxaline-based scaffold was designed via the combination of two important privileged structure units -quinoxaline and benzazole. Thirty novel 3-(benzazol-2-yl)-quinoxaline derivatives were synthesized and evaluated for their biological activities. The MTT assay indicated that most compounds possessed moderate to potent antiproliferation effects against MGC-803, HepG2, A549, HeLa, T-24 and WI-38cell lines. 3-(Benzoxazol- -2-yl)-2-(N-3-dimethylaminopropyl)aminoquinoxaline (12a) exhibited the most potent cytotoxicity, with IC50 values ranging from 1.49 to 10.99M against the five tested cancer and one normal cell line. Agarose-gel electrophoresis assays suggested that 12a did not interact with intact DNA, but rather it strongly inhibited topoisomerase I (Topo I) via Topo I-mediated DNA unwinding to exert its anticancer activity. The molecular modeling study indicated that 12a adopt a unique mode to interact with DNA and Topo I. Detailed biological study of 12a in MGC-803cells revealed that 12a could arrest the cell cycle in G2 phase, inducing the generation of reactive oxygen species (ROS), the fluctuation of intracellular Ca2+, and the loss of mitochondrial membrane potential (m). Western Blot analysis indicated that 12a-treatment could significantly up-regulate the levels of pro-apoptosis proteins Bak, Bax, and Bim, down-regulate anti-apoptosis proteins Bcl-2 and Bcl-xl, and increase levels of cyclin B1 and CDKs inhibitor p21, cytochrome c, caspase-3, caspase-9 and their activated form in MGC-803cells in a dose-dependent manner to induce cell apoptosis via a caspase-dependent intrinsic mitochondria-mediated pathway. Studies in MGC-803 xenograft tumors models demonstrated that 12a could signicantly reduce tumor growth in vivo at doses as low as 6mg/kg with low toxicity. Its convenient preparation and potent anticancer efficacy in vivo makes the 3-(benzazol-2-yl)quinoxaline scaffold a promising new chemistry entity for the development of novel chemotherapeutic agents.\n",
            "1537211\n",
            "Inhibition of topoisomerase-1 (unknown origin) at 100 uM using pBR322 DNA as substrate after 30 mins by agarose gel electrophoresis method\n",
            "Title: Synthesis and biological evaluation of pyrazole linked benzothiazole--naphthol derivatives as topoisomerase I inhibitors with DNA binding ability.  Abstract: A series of new pyrazole linked benzothiazole--naphthol derivatives were designed and synthesized using a simple, efficient and ecofriendly route under catalyst-free conditions in good to excellent yields. These derivatives were evaluated for their cytotoxicity on selected human cancer cell lines. Among those, the derivatives 4j, 4k and 4l exhibited considerable cytotoxicity with IC50 values ranging between 4.63 and 5.54M against human cervical cancer cells (HeLa). Structure activity relationship was elucidated by varying different substituents on benzothiazoles and pyrazoles. Further, flow cytometric analysis revealed that these derivatives induced cell cycle arrest in G2/M phase and spectroscopic studies such as UV-visible, fluorescence and circular dichroism studies showed that these derivatives exhibited good DNA binding affinity. Additionally, these derivatives can effectively inhibit the topoisomerase I activity. Viscosity studies and molecular docking studies demonstrated that the derivatives bind with the minor groove of the DNA.\n",
            "1544044\n",
            "Inhibition of TOP1-mediated DNA cleavage in human MCF7 cells assessed as induction of protein-DNA covalent cleavage complex formation by measuring increase in gammaH2AX foci formation preincubated for 3 to 5 hrs followed by compound washout and measured after 5 hrs by DAPI staining-based immunofluorescence microscopic method relative to control\n",
            "Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.\n",
            "1544048\n",
            "Poison activity at recombinant human TOP1 expressed in baculovirus infected Sf9 insect cells assessed as decrease in relaxed supercoiled pBS(SK+) DNA mobility measured after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.\n",
            "1544049\n",
            "Poison activity at recombinant human TOP1 expressed in baculovirus infected Sf9 insect cells assessed as decrease in relaxed supercoiled pBS(SK+) DNA mobility at 100 uM measured after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to control\n",
            "Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.\n",
            "1544050\n",
            "Poison activity at recombinant human TOP1 expressed in baculovirus infected Sf9 insect cells assessed as decrease in relaxed supercoiled pBS(SK+) DNA mobility at 10 uM measured after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to control\n",
            "Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.\n",
            "1544057\n",
            "Poison activity at recombinant human TOP1 expressed in baculovirus infected Sf9 insect cells assessed as decrease in relaxed supercoiled pBS(SK+) DNA mobility at 0.1 uM measured after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to control\n",
            "Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.\n",
            "1544058\n",
            "Poison activity at TOP1 in human MCF7 cells assessed as decrease in relaxed supercoiled pBS(SK+) DNA mobility at 0.25 to 2 uM measured after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.\n",
            "1544059\n",
            "Poison activity at recombinant human TOP1 expressed in baculovirus infected Sf9 insect cells assessed as stabilization of enzyme-pBS(SK+) DNA cleavable complex formation at 2 to 25 uM measured after 30 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.\n",
            "1544060\n",
            "Poison activity at recombinant human TOP1 expressed in baculovirus infected Sf9 insect cells assessed as stabilization of enzyme-pBS(SK+) DNA cleavable complex formation at 10 to 25 uM measured after 30 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.\n",
            "1544061\n",
            "Poison activity at recombinant human TOP1 expressed in baculovirus infected Sf9 insect cells assessed as stabilization of enzyme-25mer duplex oligonucleotide cleavable complex formation at 5 to 25 uM measured after 30 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.\n",
            "1544067\n",
            "Inhibition of human EGFP-tagged TOP1 expressed in human MCF7 cells assessed as accumulation of enzyme-compound complex in nucleus by measuring fluorescence recovery of enzyme at 1 to 5 uM incubated for 10 mins prior to 30 millisecs photobleaching and measured at 3 millisecs interval for 90 secs by confocal microscopic analysis (Rvb = 85 to 90%)\n",
            "Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.\n",
            "1544068\n",
            "Inhibition of human EGFP-tagged TOP1 N722S mutant expressed in human MCF7 cells assessed as accumulation of enzyme-compound complex in nucleus by measuring reduction in fluorescence recovery of enzyme at 1 to 5 uM incubated for 10 mins prior to 30 millisecs photobleaching and measured at 3 millisecs interval for 90 secs by confocal microscopic analysis DNA topoisomerase 1\n",
            "Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.\n",
            "1544069\n",
            "Inhibition of TOP1-mediated DNA cleavage in human MCF7 cells assessed as induction of protein-DNA covalent cleavage complex formation by measuring increase in gammaH2AX foci formation by DAPI staining-based immunofluorescence microscopic method\n",
            "Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.\n",
            "1544070\n",
            "Inhibition of TOP1-mediated DNA cleavage in human MCF7 cells assessed as induction of protein-DNA covalent cleavage complex formation by measuring increase in gammaH2AX foci formation preincubated for 3 to 5 hrs followed by compound washout and measured after 5 hrs by DAPI staining-based immunofluorescence microscopic method\n",
            "Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.\n",
            "1544076\n",
            "Poison activity at TOP1 in human MCF7 cells assessed as decrease in relaxed supercoiled pBS(SK+) DNA mobility measured after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.\n",
            "1551202\n",
            "Inhibition of human topoisomerase 1 at 200 uM using supercoiled pBR322 plasmid DNA as substrate after 15 mins by ethidium bromide staining based agarose gel electrophoresis method relative to control\n",
            "Title: Probing structural requirements for human topoisomerase I inhibition by a novel N1-Biphenyl fluoroquinolone.  Abstract: Fluoroquinolones substituted with N-1 biphenyl and napthyl groups were discovered to act as catalytically inhibitors of human topoisomerases I and II, and to possess anti-proliferative activity in vivo. Structural requirements for these novel quinolones to inhibit catalytic activity of human topoisomerase I have not been explored. In this work novel derivatives of the N-1 biphenyl fluoroquinolone were designed, synthesized and evaluated to understand structural requirements of the C-3 carboxylic acid, C-6 fluorine, C-7 aminomethylpyrrolidine, C-8 methoxy, and the N-1 biphenyl functional groups for hTopoI inhibition. Characterization of each analog for inhibition of hTopoI catalytic inhibition reveals critical insight into structural requirements of these novel quinolones for activity. Additionally, results of DNA binding and modeling studies suggest that N-1 biphenyl fluoroquinolones intercalate between the DNA base pairs with the N-1 biphenyl functional group, rather than the quinolone core, and that this mode of DNA intercalation contributes to inhibition of hTopoI by these novel structures. The results presented here support further development and evaluation of N-1 biphenyl fluoroquinolone analogs as a novel class of anti-cancer agents that act through catalytic inhibition of hTopoI.\n",
            "1551203\n",
            "Inhibition of human topoisomerase 1 using supercoiled pBR322 plasmid DNA as substrate after 15 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Probing structural requirements for human topoisomerase I inhibition by a novel N1-Biphenyl fluoroquinolone.  Abstract: Fluoroquinolones substituted with N-1 biphenyl and napthyl groups were discovered to act as catalytically inhibitors of human topoisomerases I and II, and to possess anti-proliferative activity in vivo. Structural requirements for these novel quinolones to inhibit catalytic activity of human topoisomerase I have not been explored. In this work novel derivatives of the N-1 biphenyl fluoroquinolone were designed, synthesized and evaluated to understand structural requirements of the C-3 carboxylic acid, C-6 fluorine, C-7 aminomethylpyrrolidine, C-8 methoxy, and the N-1 biphenyl functional groups for hTopoI inhibition. Characterization of each analog for inhibition of hTopoI catalytic inhibition reveals critical insight into structural requirements of these novel quinolones for activity. Additionally, results of DNA binding and modeling studies suggest that N-1 biphenyl fluoroquinolones intercalate between the DNA base pairs with the N-1 biphenyl functional group, rather than the quinolone core, and that this mode of DNA intercalation contributes to inhibition of hTopoI by these novel structures. The results presented here support further development and evaluation of N-1 biphenyl fluoroquinolone analogs as a novel class of anti-cancer agents that act through catalytic inhibition of hTopoI.\n",
            "1551900\n",
            "Inhibition of recombinant human topoisomerase-1-mediated relaxation of supercoiled pRYG DNA after 30 mins by ethidium bromide staining based assay\n",
            "Title: Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y.  Abstract: Ganoderma lucidum is a multi-purpose plant medicine that is homologous to functional food. The most attractive properties of G. lucidum are its immunomodulatory and antitumour activities, which are mainly attributed to the following two major active components: G. lucidum polysaccharides and G. lucidum triterpenoids (GLTs). GLTs are effective as supplemental therapies and improve health when combined with other medications to treat hepatitis, fatigue syndrome, and prostate cancer. However, research investigating the mechanism and application of G. lucidum or GLTs in the treatment of diseases remains preliminary in terms of both the utilization efficacy and product type. This review offers comprehensive insight into the pharmacological activities of GLTs and their potential applications in the development of functional foods and nutraceuticals. Specifically, 83 GLTs were selected, and their molecular structures and chemical formulas were described. We also describe 7 ganoderic acids that are currently at different stages of clinical trials (ganoderic acids A, C2, D, F, DM, X and Y). The related pharmacodynamic mechanisms and targeted signalling proteins were further analysed. Notably, the specific relationship between autophagy and apoptosis induced by ganoderic acid DM is summarized here for the first time.\n",
            "1562002\n",
            "Inhibition of topoisomerase 1 in human A549 cells assessed as increase in phosphorylated KAP1 expression after 24 hrs by Western blot analysis\n",
            "Title: Design, Synthesis, and Biological Evaluation of HSP90 Inhibitor-SN38 Conjugates for Targeted Drug Accumulation.  Abstract: Herein, a series of HSP90 inhibitor-SN38 conjugates through ester and carbamate linkage in the 20-OH and 10-OH positions of SN38 were developed for improving the tumor-specific penetration and accumulation of SN38 via extracellular HSP90 (eHSP90)-mediated endocytosis. Mechanistic analyses confirmed that these novel conjugates could bind to eHSP90 and be selectively internalized into the tumor cells, which led to prolonged tumor regression in multiple models of cancer. Among all studied conjugates, compound 18b showed excellent in vitro activities, including acceptable HSP90 affinity and potent antitumor activity. Moreover, compound 18b exhibited superior antitumor activity and low toxicity in HCT116 and Capan-1 xenograft models. Pharmacokinetic analyses in HCT116 and Capan-1 xenografts further confirmed that compound 18b treatment could lead to effective cleavage and extended SN38 exposure at tumor sites. All these encouraging data indicate that this compound is a promising new candidate for cancer therapy and merits further chemical and biological evaluation.\n",
            "1562003\n",
            "Inhibition of topoisomerase 1 in human HCT116 cells assessed as increase in phosphorylated KAP1 expression after 24 hrs by Western blot analysis\n",
            "Title: Design, Synthesis, and Biological Evaluation of HSP90 Inhibitor-SN38 Conjugates for Targeted Drug Accumulation.  Abstract: Herein, a series of HSP90 inhibitor-SN38 conjugates through ester and carbamate linkage in the 20-OH and 10-OH positions of SN38 were developed for improving the tumor-specific penetration and accumulation of SN38 via extracellular HSP90 (eHSP90)-mediated endocytosis. Mechanistic analyses confirmed that these novel conjugates could bind to eHSP90 and be selectively internalized into the tumor cells, which led to prolonged tumor regression in multiple models of cancer. Among all studied conjugates, compound 18b showed excellent in vitro activities, including acceptable HSP90 affinity and potent antitumor activity. Moreover, compound 18b exhibited superior antitumor activity and low toxicity in HCT116 and Capan-1 xenograft models. Pharmacokinetic analyses in HCT116 and Capan-1 xenografts further confirmed that compound 18b treatment could lead to effective cleavage and extended SN38 exposure at tumor sites. All these encouraging data indicate that this compound is a promising new candidate for cancer therapy and merits further chemical and biological evaluation.\n",
            "1562010\n",
            "Inhibition of topoisomerase 1 in human A549 cells assessed as increase in phosphorylated KAP1 expression at 0.04 uM after 24 hrs by Western blot analysis\n",
            "Title: Design, Synthesis, and Biological Evaluation of HSP90 Inhibitor-SN38 Conjugates for Targeted Drug Accumulation.  Abstract: Herein, a series of HSP90 inhibitor-SN38 conjugates through ester and carbamate linkage in the 20-OH and 10-OH positions of SN38 were developed for improving the tumor-specific penetration and accumulation of SN38 via extracellular HSP90 (eHSP90)-mediated endocytosis. Mechanistic analyses confirmed that these novel conjugates could bind to eHSP90 and be selectively internalized into the tumor cells, which led to prolonged tumor regression in multiple models of cancer. Among all studied conjugates, compound 18b showed excellent in vitro activities, including acceptable HSP90 affinity and potent antitumor activity. Moreover, compound 18b exhibited superior antitumor activity and low toxicity in HCT116 and Capan-1 xenograft models. Pharmacokinetic analyses in HCT116 and Capan-1 xenografts further confirmed that compound 18b treatment could lead to effective cleavage and extended SN38 exposure at tumor sites. All these encouraging data indicate that this compound is a promising new candidate for cancer therapy and merits further chemical and biological evaluation.\n",
            "1562011\n",
            "Inhibition of topoisomerase 1 in human HCT116 cells assessed as increase in phosphorylated KAP1 expression at 0.04 uM after 24 hrs by Western blot analysis\n",
            "Title: Design, Synthesis, and Biological Evaluation of HSP90 Inhibitor-SN38 Conjugates for Targeted Drug Accumulation.  Abstract: Herein, a series of HSP90 inhibitor-SN38 conjugates through ester and carbamate linkage in the 20-OH and 10-OH positions of SN38 were developed for improving the tumor-specific penetration and accumulation of SN38 via extracellular HSP90 (eHSP90)-mediated endocytosis. Mechanistic analyses confirmed that these novel conjugates could bind to eHSP90 and be selectively internalized into the tumor cells, which led to prolonged tumor regression in multiple models of cancer. Among all studied conjugates, compound 18b showed excellent in vitro activities, including acceptable HSP90 affinity and potent antitumor activity. Moreover, compound 18b exhibited superior antitumor activity and low toxicity in HCT116 and Capan-1 xenograft models. Pharmacokinetic analyses in HCT116 and Capan-1 xenografts further confirmed that compound 18b treatment could lead to effective cleavage and extended SN38 exposure at tumor sites. All these encouraging data indicate that this compound is a promising new candidate for cancer therapy and merits further chemical and biological evaluation.\n",
            "1562101\n",
            "Inhibition of topoisomerase 1 in human A549 cells assessed as increase in phosphorylated KAP1 expression at 0.2 to 5 uM after 24 hrs by Western blot analysis\n",
            "Title: Design, Synthesis, and Biological Evaluation of HSP90 Inhibitor-SN38 Conjugates for Targeted Drug Accumulation.  Abstract: Herein, a series of HSP90 inhibitor-SN38 conjugates through ester and carbamate linkage in the 20-OH and 10-OH positions of SN38 were developed for improving the tumor-specific penetration and accumulation of SN38 via extracellular HSP90 (eHSP90)-mediated endocytosis. Mechanistic analyses confirmed that these novel conjugates could bind to eHSP90 and be selectively internalized into the tumor cells, which led to prolonged tumor regression in multiple models of cancer. Among all studied conjugates, compound 18b showed excellent in vitro activities, including acceptable HSP90 affinity and potent antitumor activity. Moreover, compound 18b exhibited superior antitumor activity and low toxicity in HCT116 and Capan-1 xenograft models. Pharmacokinetic analyses in HCT116 and Capan-1 xenografts further confirmed that compound 18b treatment could lead to effective cleavage and extended SN38 exposure at tumor sites. All these encouraging data indicate that this compound is a promising new candidate for cancer therapy and merits further chemical and biological evaluation.\n",
            "1562102\n",
            "Inhibition of topoisomerase 1 in human HCT116 cells assessed as increase in phosphorylated KAP1 expression at 0.2 to 5 uM after 24 hrs by Western blot analysis\n",
            "Title: Design, Synthesis, and Biological Evaluation of HSP90 Inhibitor-SN38 Conjugates for Targeted Drug Accumulation.  Abstract: Herein, a series of HSP90 inhibitor-SN38 conjugates through ester and carbamate linkage in the 20-OH and 10-OH positions of SN38 were developed for improving the tumor-specific penetration and accumulation of SN38 via extracellular HSP90 (eHSP90)-mediated endocytosis. Mechanistic analyses confirmed that these novel conjugates could bind to eHSP90 and be selectively internalized into the tumor cells, which led to prolonged tumor regression in multiple models of cancer. Among all studied conjugates, compound 18b showed excellent in vitro activities, including acceptable HSP90 affinity and potent antitumor activity. Moreover, compound 18b exhibited superior antitumor activity and low toxicity in HCT116 and Capan-1 xenograft models. Pharmacokinetic analyses in HCT116 and Capan-1 xenografts further confirmed that compound 18b treatment could lead to effective cleavage and extended SN38 exposure at tumor sites. All these encouraging data indicate that this compound is a promising new candidate for cancer therapy and merits further chemical and biological evaluation.\n",
            "1563007\n",
            "Inhibition of recombinant human Top1 expressed in Saccharomyces cerevisiae null strain RS190 assessed as decrease in relaxation of supercoiled plasmid DNA at 100 uM using supercoiled plasmid DNA as substrate incubated for 15 sec by red staining based DNA relaxation assay relative to camptothecin\n",
            "Title: Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones.  Abstract: This work describes the synthesis of hybrid tetrahydro-1,5-naphthyridine and 1,5-naphthyridine derivatives fused with heterocycles such as chromenes and chromen-2-ones or coumarins, which were synthesized in good to high general yields. The synthetic route involves an intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and aldehydes containing a double or triple carbon-carbon bond in orto position and allows the selective generation of three stereogenic centers in a short, efficient and reliable synthesis. The subsequent dehydrogenation of the fused tetrahydrochromeno[4,3-b][1,5]naphthyridines and/or tetrahydrochromeno[4,3-b][1,5]naphthyridin-6-ones leads to the formation of the corresponding tetracyclic chromeno[4,3-b][1,5]naphthyridine derivatives and/or chromeno[4,3-b][1,5]naphthyridin-6-ones in quantitative yields. Some of the prepared products showed activity as inhibitors of Topoisomerase I (TopI). Additionally, the cytotoxic behavior of these compounds has been studied in cell lines derived from human lung adenocarcinoma (A549) and human ovarian carcinoma (SKOV03), and on non-cancerous lung fibroblasts cell line (MRC5) where, on the last ones, the absence of cytotoxicity was observed. 7-Phenyl-6H-6a,7,12,12a-tetrahydrochromeno[4,3-b][1,5]naphthyridine 5a showed excellent cytotoxic activity with a IC<sub>50</sub> value of 1.030.30M against the A549cell line and a IC<sub>50</sub> value of 1.750.20M against the SKOV03cell line. The obtained results point to these compounds as good antiproliferative candidates.\n",
            "1563008\n",
            "Inhibition of recombinant human Top1 expressed in Saccharomyces cerevisiae null strain RS190 assessed as decrease in relaxation of supercoiled plasmid DNA at 100 uM using supercoiled plasmid DNA as substrate incubated for 1 min by red staining based DNA relaxation assay relative to camptothecin\n",
            "Title: Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones.  Abstract: This work describes the synthesis of hybrid tetrahydro-1,5-naphthyridine and 1,5-naphthyridine derivatives fused with heterocycles such as chromenes and chromen-2-ones or coumarins, which were synthesized in good to high general yields. The synthetic route involves an intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and aldehydes containing a double or triple carbon-carbon bond in orto position and allows the selective generation of three stereogenic centers in a short, efficient and reliable synthesis. The subsequent dehydrogenation of the fused tetrahydrochromeno[4,3-b][1,5]naphthyridines and/or tetrahydrochromeno[4,3-b][1,5]naphthyridin-6-ones leads to the formation of the corresponding tetracyclic chromeno[4,3-b][1,5]naphthyridine derivatives and/or chromeno[4,3-b][1,5]naphthyridin-6-ones in quantitative yields. Some of the prepared products showed activity as inhibitors of Topoisomerase I (TopI). Additionally, the cytotoxic behavior of these compounds has been studied in cell lines derived from human lung adenocarcinoma (A549) and human ovarian carcinoma (SKOV03), and on non-cancerous lung fibroblasts cell line (MRC5) where, on the last ones, the absence of cytotoxicity was observed. 7-Phenyl-6H-6a,7,12,12a-tetrahydrochromeno[4,3-b][1,5]naphthyridine 5a showed excellent cytotoxic activity with a IC<sub>50</sub> value of 1.030.30M against the A549cell line and a IC<sub>50</sub> value of 1.750.20M against the SKOV03cell line. The obtained results point to these compounds as good antiproliferative candidates.\n",
            "1563009\n",
            "Inhibition of recombinant human Top1 expressed in Saccharomyces cerevisiae null strain RS190 assessed as decrease in relaxation of supercoiled plasmid DNA at 100 uM using supercoiled plasmid DNA as substrate incubated for 3 min by red staining based DNA relaxation assay relative to camptothecin\n",
            "Title: Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones.  Abstract: This work describes the synthesis of hybrid tetrahydro-1,5-naphthyridine and 1,5-naphthyridine derivatives fused with heterocycles such as chromenes and chromen-2-ones or coumarins, which were synthesized in good to high general yields. The synthetic route involves an intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and aldehydes containing a double or triple carbon-carbon bond in orto position and allows the selective generation of three stereogenic centers in a short, efficient and reliable synthesis. The subsequent dehydrogenation of the fused tetrahydrochromeno[4,3-b][1,5]naphthyridines and/or tetrahydrochromeno[4,3-b][1,5]naphthyridin-6-ones leads to the formation of the corresponding tetracyclic chromeno[4,3-b][1,5]naphthyridine derivatives and/or chromeno[4,3-b][1,5]naphthyridin-6-ones in quantitative yields. Some of the prepared products showed activity as inhibitors of Topoisomerase I (TopI). Additionally, the cytotoxic behavior of these compounds has been studied in cell lines derived from human lung adenocarcinoma (A549) and human ovarian carcinoma (SKOV03), and on non-cancerous lung fibroblasts cell line (MRC5) where, on the last ones, the absence of cytotoxicity was observed. 7-Phenyl-6H-6a,7,12,12a-tetrahydrochromeno[4,3-b][1,5]naphthyridine 5a showed excellent cytotoxic activity with a IC<sub>50</sub> value of 1.030.30M against the A549cell line and a IC<sub>50</sub> value of 1.750.20M against the SKOV03cell line. The obtained results point to these compounds as good antiproliferative candidates.\n",
            "1563013\n",
            "Inhibition of recombinant human Top1 expressed in Saccharomyces cerevisiae null strain RS190 assessed as decrease in relaxation of supercoiled plasmid DNA at 100 uM using supercoiled plasmid DNA as substrate incubated for 15 sec by red staining based DNA relaxation assay relative to control\n",
            "Title: Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones.  Abstract: This work describes the synthesis of hybrid tetrahydro-1,5-naphthyridine and 1,5-naphthyridine derivatives fused with heterocycles such as chromenes and chromen-2-ones or coumarins, which were synthesized in good to high general yields. The synthetic route involves an intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and aldehydes containing a double or triple carbon-carbon bond in orto position and allows the selective generation of three stereogenic centers in a short, efficient and reliable synthesis. The subsequent dehydrogenation of the fused tetrahydrochromeno[4,3-b][1,5]naphthyridines and/or tetrahydrochromeno[4,3-b][1,5]naphthyridin-6-ones leads to the formation of the corresponding tetracyclic chromeno[4,3-b][1,5]naphthyridine derivatives and/or chromeno[4,3-b][1,5]naphthyridin-6-ones in quantitative yields. Some of the prepared products showed activity as inhibitors of Topoisomerase I (TopI). Additionally, the cytotoxic behavior of these compounds has been studied in cell lines derived from human lung adenocarcinoma (A549) and human ovarian carcinoma (SKOV03), and on non-cancerous lung fibroblasts cell line (MRC5) where, on the last ones, the absence of cytotoxicity was observed. 7-Phenyl-6H-6a,7,12,12a-tetrahydrochromeno[4,3-b][1,5]naphthyridine 5a showed excellent cytotoxic activity with a IC<sub>50</sub> value of 1.030.30M against the A549cell line and a IC<sub>50</sub> value of 1.750.20M against the SKOV03cell line. The obtained results point to these compounds as good antiproliferative candidates.\n",
            "1563014\n",
            "Inhibition of recombinant human Top1 expressed in Saccharomyces cerevisiae null strain RS190 assessed as decrease in relaxation of supercoiled plasmid DNA at 100 uM using supercoiled plasmid DNA as substrate incubated for 1 min by red staining based DNA relaxation assay relative to control\n",
            "Title: Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones.  Abstract: This work describes the synthesis of hybrid tetrahydro-1,5-naphthyridine and 1,5-naphthyridine derivatives fused with heterocycles such as chromenes and chromen-2-ones or coumarins, which were synthesized in good to high general yields. The synthetic route involves an intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and aldehydes containing a double or triple carbon-carbon bond in orto position and allows the selective generation of three stereogenic centers in a short, efficient and reliable synthesis. The subsequent dehydrogenation of the fused tetrahydrochromeno[4,3-b][1,5]naphthyridines and/or tetrahydrochromeno[4,3-b][1,5]naphthyridin-6-ones leads to the formation of the corresponding tetracyclic chromeno[4,3-b][1,5]naphthyridine derivatives and/or chromeno[4,3-b][1,5]naphthyridin-6-ones in quantitative yields. Some of the prepared products showed activity as inhibitors of Topoisomerase I (TopI). Additionally, the cytotoxic behavior of these compounds has been studied in cell lines derived from human lung adenocarcinoma (A549) and human ovarian carcinoma (SKOV03), and on non-cancerous lung fibroblasts cell line (MRC5) where, on the last ones, the absence of cytotoxicity was observed. 7-Phenyl-6H-6a,7,12,12a-tetrahydrochromeno[4,3-b][1,5]naphthyridine 5a showed excellent cytotoxic activity with a IC<sub>50</sub> value of 1.030.30M against the A549cell line and a IC<sub>50</sub> value of 1.750.20M against the SKOV03cell line. The obtained results point to these compounds as good antiproliferative candidates.\n",
            "1563015\n",
            "Inhibition of recombinant human Top1 expressed in Saccharomyces cerevisiae null strain RS190 assessed as decrease in relaxation of supercoiled plasmid DNA at 100 uM using supercoiled plasmid DNA as substrate incubated for 3 min by red staining based DNA relaxation assay relative to control\n",
            "Title: Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones.  Abstract: This work describes the synthesis of hybrid tetrahydro-1,5-naphthyridine and 1,5-naphthyridine derivatives fused with heterocycles such as chromenes and chromen-2-ones or coumarins, which were synthesized in good to high general yields. The synthetic route involves an intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and aldehydes containing a double or triple carbon-carbon bond in orto position and allows the selective generation of three stereogenic centers in a short, efficient and reliable synthesis. The subsequent dehydrogenation of the fused tetrahydrochromeno[4,3-b][1,5]naphthyridines and/or tetrahydrochromeno[4,3-b][1,5]naphthyridin-6-ones leads to the formation of the corresponding tetracyclic chromeno[4,3-b][1,5]naphthyridine derivatives and/or chromeno[4,3-b][1,5]naphthyridin-6-ones in quantitative yields. Some of the prepared products showed activity as inhibitors of Topoisomerase I (TopI). Additionally, the cytotoxic behavior of these compounds has been studied in cell lines derived from human lung adenocarcinoma (A549) and human ovarian carcinoma (SKOV03), and on non-cancerous lung fibroblasts cell line (MRC5) where, on the last ones, the absence of cytotoxicity was observed. 7-Phenyl-6H-6a,7,12,12a-tetrahydrochromeno[4,3-b][1,5]naphthyridine 5a showed excellent cytotoxic activity with a IC<sub>50</sub> value of 1.030.30M against the A549cell line and a IC<sub>50</sub> value of 1.750.20M against the SKOV03cell line. The obtained results point to these compounds as good antiproliferative candidates.\n",
            "1564585\n",
            "Inhibition of recombinant human topoisomerase 1 mediated DNA relaxation assessed as uncleaved plasmid DNA at 50 uM using supercoiled pHOT1 plasmid as substrate after 1 hr by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Benzothienoquinazolinones as new multi-target scaffolds: Dual inhibition of human Topoisomerase I and tubulin polymerization.  Abstract: 3-(Alkyl(dialkyl)amino)benzothieno[2,3-f]quinazolin-1(2H)-ones (4-9) have been designed using Ellipticine structure as a model, replacing the carbazole core and the pyridine ring with a dibenzothiophene and a pyrimidine moiety, respectively. New benzothienoquinazolinones (4-9) have been synthesized by a simple one-pot reaction employing 3-aminodibenzothiophene as starting material. The benzothienoquinazolinones obtained (4-9), were evaluated for their anticancer activity against two breast cancer cell lines, MDA-MB-231 and MCF-7. The results revealed that compounds 4 and 7 presented a good antitumor activity toward the triple negative MDA-MB-231, without cytotoxicity against non-tumoral cells. Furthermore, the compounds 4 and 7 can be considered important molecular multi-target tools for their dual inhibition of different cellular proteins, i.e. Tubulin and human Topoisomerase I, involved in relevant cellular processes, as predicted by in silico studies and demonstrated by in vitro assays (for compound 4).\n",
            "1566675\n",
            "Inhibition of recombinant TOP1 (unknown origin) using 3'-[32P]-labeled 117 bp DNA oligonucleotide assessed as decrease in TOP1-mediated DNA cleavage incubated for 20 mins by PAGE analysis relative to 1 uM CPT\n",
            "Title: Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors.  Abstract: DNA topoisomerase IB (TOP1) regulates DNA topological structure in many cellular metabolic processes and is a validated target for development of antitumor agents. Our previous study revealed that the benzophenanthridone scaffold is a novel chemotype for the discovery of TOP1 inhibitors. In this work, a series of novel 5-aminoethyl substituted benzophenanthridone derivatives have been synthesized and evaluated for TOP1 inhibition and cytotoxicity. Compound 12 exhibits the most potent TOP1 inhibition (+++) and cytotoxicity in human cancer cell lines with GI<sub>50</sub> values at nanomolar concentration range. 12 induces the cellular TOP1cc formation and DNA damage, resulting in HCT116cell apoptosis. The pharmacokinetics, acute toxicity and antitumor efficiency in vivo of 12 were also studied.\n",
            "1566676\n",
            "Inhibition of recombinant TOP1 (unknown origin) using 3'-[32P]-labeled 117 bp DNA oligonucleotide assessed as TOP1-mediated DNA cleavage by measuring induction and stabilization of cleavage sites 17, 35 and 79 incubated for 20 mins by PAGE analysis\n",
            "Title: Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors.  Abstract: DNA topoisomerase IB (TOP1) regulates DNA topological structure in many cellular metabolic processes and is a validated target for development of antitumor agents. Our previous study revealed that the benzophenanthridone scaffold is a novel chemotype for the discovery of TOP1 inhibitors. In this work, a series of novel 5-aminoethyl substituted benzophenanthridone derivatives have been synthesized and evaluated for TOP1 inhibition and cytotoxicity. Compound 12 exhibits the most potent TOP1 inhibition (+++) and cytotoxicity in human cancer cell lines with GI<sub>50</sub> values at nanomolar concentration range. 12 induces the cellular TOP1cc formation and DNA damage, resulting in HCT116cell apoptosis. The pharmacokinetics, acute toxicity and antitumor efficiency in vivo of 12 were also studied.\n",
            "1566743\n",
            "Inhibition of TOP1 in human HCT116 cells assessed as induction of cellular TOP1cc formation incubated for 1 hr by chemiluminescence based assay\n",
            "Title: Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors.  Abstract: DNA topoisomerase IB (TOP1) regulates DNA topological structure in many cellular metabolic processes and is a validated target for development of antitumor agents. Our previous study revealed that the benzophenanthridone scaffold is a novel chemotype for the discovery of TOP1 inhibitors. In this work, a series of novel 5-aminoethyl substituted benzophenanthridone derivatives have been synthesized and evaluated for TOP1 inhibition and cytotoxicity. Compound 12 exhibits the most potent TOP1 inhibition (+++) and cytotoxicity in human cancer cell lines with GI<sub>50</sub> values at nanomolar concentration range. 12 induces the cellular TOP1cc formation and DNA damage, resulting in HCT116cell apoptosis. The pharmacokinetics, acute toxicity and antitumor efficiency in vivo of 12 were also studied.\n",
            "1566744\n",
            "Inhibition of TOP1 in human HCT116 cells assessed as induction of cellular TOP1cc formation at 25 uM incubated for 1 hr by chemiluminescence based assay\n",
            "Title: Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors.  Abstract: DNA topoisomerase IB (TOP1) regulates DNA topological structure in many cellular metabolic processes and is a validated target for development of antitumor agents. Our previous study revealed that the benzophenanthridone scaffold is a novel chemotype for the discovery of TOP1 inhibitors. In this work, a series of novel 5-aminoethyl substituted benzophenanthridone derivatives have been synthesized and evaluated for TOP1 inhibition and cytotoxicity. Compound 12 exhibits the most potent TOP1 inhibition (+++) and cytotoxicity in human cancer cell lines with GI<sub>50</sub> values at nanomolar concentration range. 12 induces the cellular TOP1cc formation and DNA damage, resulting in HCT116cell apoptosis. The pharmacokinetics, acute toxicity and antitumor efficiency in vivo of 12 were also studied.\n",
            "1566745\n",
            "Inhibition of TOP1 in human HCT116 cells assessed as induction of DNA damage by measuring increase in gammaH2AX foci at 1 uM incubated for 3 hrs by DAPI staining based immunofluorescence microscopic method\n",
            "Title: Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors.  Abstract: DNA topoisomerase IB (TOP1) regulates DNA topological structure in many cellular metabolic processes and is a validated target for development of antitumor agents. Our previous study revealed that the benzophenanthridone scaffold is a novel chemotype for the discovery of TOP1 inhibitors. In this work, a series of novel 5-aminoethyl substituted benzophenanthridone derivatives have been synthesized and evaluated for TOP1 inhibition and cytotoxicity. Compound 12 exhibits the most potent TOP1 inhibition (+++) and cytotoxicity in human cancer cell lines with GI<sub>50</sub> values at nanomolar concentration range. 12 induces the cellular TOP1cc formation and DNA damage, resulting in HCT116cell apoptosis. The pharmacokinetics, acute toxicity and antitumor efficiency in vivo of 12 were also studied.\n",
            "1566778\n",
            "Inhibition of recombinant TOP1 (unknown origin) using 3'-[32P]-labeled 117 bp DNA oligonucleotide assessed as TOP1-mediated DNA cleavage by measuring induction and stabilization of cleavage sites 17, 35 and 79 at 1 uM incubated for 20 mins by PAGE analysis\n",
            "Title: Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors.  Abstract: DNA topoisomerase IB (TOP1) regulates DNA topological structure in many cellular metabolic processes and is a validated target for development of antitumor agents. Our previous study revealed that the benzophenanthridone scaffold is a novel chemotype for the discovery of TOP1 inhibitors. In this work, a series of novel 5-aminoethyl substituted benzophenanthridone derivatives have been synthesized and evaluated for TOP1 inhibition and cytotoxicity. Compound 12 exhibits the most potent TOP1 inhibition (+++) and cytotoxicity in human cancer cell lines with GI<sub>50</sub> values at nanomolar concentration range. 12 induces the cellular TOP1cc formation and DNA damage, resulting in HCT116cell apoptosis. The pharmacokinetics, acute toxicity and antitumor efficiency in vivo of 12 were also studied.\n",
            "1577582\n",
            "Inhibition of recombinant human topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 100 uM measured after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to control\n",
            "Title: Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2-<i>b</i>]pyridinol Derivatives as Potent Topoisomerase II-Targeted Chemotherapeutic Agents for Breast Cancer.  Abstract: With the aim of developing new effective topoisomerase II-targeted anticancer agents, we synthesized a series of hydroxy- and halogenated 2,4-diphenyl indeno[1,2-<i>b</i>]pyridinols using a microwave-assisted single step synthetic method and investigated structure-activity relationships. The majority of compounds with chlorophenyl group at 2-position and phenol group at the 4-position of indeno[1,2-<i>b</i>]pyridinols exhibited potent antiproliferative activity and topoisomerase II-selective inhibition. Of the 172 compounds tested, <b>89</b> showed highly potent and selective topoisomerase II inhibition and antiproliferative activity in the nanomolar range against human T47D breast (2.6 nM) cancer cell lines. In addition, mechanistic studies revealed compound <b>89</b> is a nonintercalative topoisomerase II poison, and in vitro studies showed it had promising cytotoxic effects in diverse breast cancer cell lines and was particularly effective at inducing apoptosis in T47D cells. Furthermore, in vivo administration of compound <b>89</b> had significant antitumor effects in orthotopic mouse model of breast cancer.\n",
            "1577583\n",
            "Inhibition of recombinant human topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 20 uM measured after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to control\n",
            "Title: Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2-<i>b</i>]pyridinol Derivatives as Potent Topoisomerase II-Targeted Chemotherapeutic Agents for Breast Cancer.  Abstract: With the aim of developing new effective topoisomerase II-targeted anticancer agents, we synthesized a series of hydroxy- and halogenated 2,4-diphenyl indeno[1,2-<i>b</i>]pyridinols using a microwave-assisted single step synthetic method and investigated structure-activity relationships. The majority of compounds with chlorophenyl group at 2-position and phenol group at the 4-position of indeno[1,2-<i>b</i>]pyridinols exhibited potent antiproliferative activity and topoisomerase II-selective inhibition. Of the 172 compounds tested, <b>89</b> showed highly potent and selective topoisomerase II inhibition and antiproliferative activity in the nanomolar range against human T47D breast (2.6 nM) cancer cell lines. In addition, mechanistic studies revealed compound <b>89</b> is a nonintercalative topoisomerase II poison, and in vitro studies showed it had promising cytotoxic effects in diverse breast cancer cell lines and was particularly effective at inducing apoptosis in T47D cells. Furthermore, in vivo administration of compound <b>89</b> had significant antitumor effects in orthotopic mouse model of breast cancer.\n",
            "1585186\n",
            "Inhibition of human Top1B expressed in Top1B deficient Saccharomyces cerevisiae EKY3 assessed as decrease in relaxation of supercoiled pSK DNA preincubated for 15 mins followed by DNA addition and measured after 2 to 16 mins by agarose gel electrophoresis\n",
            "Title: Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents.  Abstract: Heterocyclic compounds, such as hybrid tetrahydroquinoline and quinoline derivatives with phosphorated groups, have been prepared by multicomponent cycloaddition reaction between phosphorus-substituted anilines, aldehydes and styrenes. The antileishmanial activity of these compounds has been evaluated on both promastigotes and intramacrophagic amastigotes of Leishmania infantum. Good antileishmanial activity of functionalized tetrahydroquinolines 4a, 5a, 6b and quinoline 8b has been observed with similar activity than the standard drug amphotericin B and close selective index (SI between 43 and 57) towards L. infantum amastigotes to amphotericin B. Special interest shows tetrahydroquinolylphosphine sulfide 5a with an EC<sub>50</sub> value (0.610.18M) similar to the standard drug amphotericin B (0.320.05M) and selective index (SI=56.87). In addition, compound 4c shows remarkable inhibition on Leishmania topoisomerase IB. Parallel theoretical study of stereoelectronic properties, application of docking-based virtual screening methods, along with molecular electrostatic potential and predictive druggability analyses are also reported.\n",
            "1585187\n",
            "Inhibition of human Top1B expressed in Top1B deficient Saccharomyces cerevisiae EKY3 assessed as decrease in relaxation of supercoiled pSK DNA preincubated for 15 mins followed by DNA addition and measured after 2 to 4 mins by agarose gel electrophoresis\n",
            "Title: Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents.  Abstract: Heterocyclic compounds, such as hybrid tetrahydroquinoline and quinoline derivatives with phosphorated groups, have been prepared by multicomponent cycloaddition reaction between phosphorus-substituted anilines, aldehydes and styrenes. The antileishmanial activity of these compounds has been evaluated on both promastigotes and intramacrophagic amastigotes of Leishmania infantum. Good antileishmanial activity of functionalized tetrahydroquinolines 4a, 5a, 6b and quinoline 8b has been observed with similar activity than the standard drug amphotericin B and close selective index (SI between 43 and 57) towards L. infantum amastigotes to amphotericin B. Special interest shows tetrahydroquinolylphosphine sulfide 5a with an EC<sub>50</sub> value (0.610.18M) similar to the standard drug amphotericin B (0.320.05M) and selective index (SI=56.87). In addition, compound 4c shows remarkable inhibition on Leishmania topoisomerase IB. Parallel theoretical study of stereoelectronic properties, application of docking-based virtual screening methods, along with molecular electrostatic potential and predictive druggability analyses are also reported.\n",
            "1585188\n",
            "Inhibition of human Top1B expressed in Top1B deficient Saccharomyces cerevisiae EKY3 assessed as decrease in relaxation of supercoiled pSK DNA preincubated for 15 mins followed by DNA addition and measured after 8 to 16 mins by agarose gel electrophoresis\n",
            "Title: Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents.  Abstract: Heterocyclic compounds, such as hybrid tetrahydroquinoline and quinoline derivatives with phosphorated groups, have been prepared by multicomponent cycloaddition reaction between phosphorus-substituted anilines, aldehydes and styrenes. The antileishmanial activity of these compounds has been evaluated on both promastigotes and intramacrophagic amastigotes of Leishmania infantum. Good antileishmanial activity of functionalized tetrahydroquinolines 4a, 5a, 6b and quinoline 8b has been observed with similar activity than the standard drug amphotericin B and close selective index (SI between 43 and 57) towards L. infantum amastigotes to amphotericin B. Special interest shows tetrahydroquinolylphosphine sulfide 5a with an EC<sub>50</sub> value (0.610.18M) similar to the standard drug amphotericin B (0.320.05M) and selective index (SI=56.87). In addition, compound 4c shows remarkable inhibition on Leishmania topoisomerase IB. Parallel theoretical study of stereoelectronic properties, application of docking-based virtual screening methods, along with molecular electrostatic potential and predictive druggability analyses are also reported.\n",
            "1585189\n",
            "Inhibition of human Top1B expressed in Top1B deficient Saccharomyces cerevisiae EKY3 assessed as decrease in relaxation of supercoiled pSK DNA preincubated for 15 mins followed by DNA addition and measured after 2 to 8 mins by agarose gel electrophoresis\n",
            "Title: Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents.  Abstract: Heterocyclic compounds, such as hybrid tetrahydroquinoline and quinoline derivatives with phosphorated groups, have been prepared by multicomponent cycloaddition reaction between phosphorus-substituted anilines, aldehydes and styrenes. The antileishmanial activity of these compounds has been evaluated on both promastigotes and intramacrophagic amastigotes of Leishmania infantum. Good antileishmanial activity of functionalized tetrahydroquinolines 4a, 5a, 6b and quinoline 8b has been observed with similar activity than the standard drug amphotericin B and close selective index (SI between 43 and 57) towards L. infantum amastigotes to amphotericin B. Special interest shows tetrahydroquinolylphosphine sulfide 5a with an EC<sub>50</sub> value (0.610.18M) similar to the standard drug amphotericin B (0.320.05M) and selective index (SI=56.87). In addition, compound 4c shows remarkable inhibition on Leishmania topoisomerase IB. Parallel theoretical study of stereoelectronic properties, application of docking-based virtual screening methods, along with molecular electrostatic potential and predictive druggability analyses are also reported.\n",
            "1585190\n",
            "Inhibition of human Top1B expressed in Top1B deficient Saccharomyces cerevisiae EKY3 assessed as decrease in relaxation of supercoiled pSK DNA preincubated for 15 mins followed by DNA addition and measured after 16 mins by agarose gel electrophoresis\n",
            "Title: Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents.  Abstract: Heterocyclic compounds, such as hybrid tetrahydroquinoline and quinoline derivatives with phosphorated groups, have been prepared by multicomponent cycloaddition reaction between phosphorus-substituted anilines, aldehydes and styrenes. The antileishmanial activity of these compounds has been evaluated on both promastigotes and intramacrophagic amastigotes of Leishmania infantum. Good antileishmanial activity of functionalized tetrahydroquinolines 4a, 5a, 6b and quinoline 8b has been observed with similar activity than the standard drug amphotericin B and close selective index (SI between 43 and 57) towards L. infantum amastigotes to amphotericin B. Special interest shows tetrahydroquinolylphosphine sulfide 5a with an EC<sub>50</sub> value (0.610.18M) similar to the standard drug amphotericin B (0.320.05M) and selective index (SI=56.87). In addition, compound 4c shows remarkable inhibition on Leishmania topoisomerase IB. Parallel theoretical study of stereoelectronic properties, application of docking-based virtual screening methods, along with molecular electrostatic potential and predictive druggability analyses are also reported.\n",
            "1585191\n",
            "Inhibition of human Top1B expressed in Top1B deficient Saccharomyces cerevisiae EKY3 assessed as decrease in relaxation of supercoiled pSK DNA preincubated for 15 mins followed by DNA addition and measured after 2 mins by agarose gel electrophoresis\n",
            "Title: Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents.  Abstract: Heterocyclic compounds, such as hybrid tetrahydroquinoline and quinoline derivatives with phosphorated groups, have been prepared by multicomponent cycloaddition reaction between phosphorus-substituted anilines, aldehydes and styrenes. The antileishmanial activity of these compounds has been evaluated on both promastigotes and intramacrophagic amastigotes of Leishmania infantum. Good antileishmanial activity of functionalized tetrahydroquinolines 4a, 5a, 6b and quinoline 8b has been observed with similar activity than the standard drug amphotericin B and close selective index (SI between 43 and 57) towards L. infantum amastigotes to amphotericin B. Special interest shows tetrahydroquinolylphosphine sulfide 5a with an EC<sub>50</sub> value (0.610.18M) similar to the standard drug amphotericin B (0.320.05M) and selective index (SI=56.87). In addition, compound 4c shows remarkable inhibition on Leishmania topoisomerase IB. Parallel theoretical study of stereoelectronic properties, application of docking-based virtual screening methods, along with molecular electrostatic potential and predictive druggability analyses are also reported.\n",
            "1585192\n",
            "Inhibition of human Top1B expressed in Top1B deficient Saccharomyces cerevisiae EKY3 assessed as decrease in relaxation of supercoiled pSK DNA preincubated for 15 mins followed by DNA addition and measured after 4 to 16 mins by agarose gel electrophoresis\n",
            "Title: Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents.  Abstract: Heterocyclic compounds, such as hybrid tetrahydroquinoline and quinoline derivatives with phosphorated groups, have been prepared by multicomponent cycloaddition reaction between phosphorus-substituted anilines, aldehydes and styrenes. The antileishmanial activity of these compounds has been evaluated on both promastigotes and intramacrophagic amastigotes of Leishmania infantum. Good antileishmanial activity of functionalized tetrahydroquinolines 4a, 5a, 6b and quinoline 8b has been observed with similar activity than the standard drug amphotericin B and close selective index (SI between 43 and 57) towards L. infantum amastigotes to amphotericin B. Special interest shows tetrahydroquinolylphosphine sulfide 5a with an EC<sub>50</sub> value (0.610.18M) similar to the standard drug amphotericin B (0.320.05M) and selective index (SI=56.87). In addition, compound 4c shows remarkable inhibition on Leishmania topoisomerase IB. Parallel theoretical study of stereoelectronic properties, application of docking-based virtual screening methods, along with molecular electrostatic potential and predictive druggability analyses are also reported.\n",
            "1585193\n",
            "Inhibition of human Top1B expressed in Top1B deficient Saccharomyces cerevisiae EKY3 assessed as decrease in relaxation of supercoiled pSK DNA preincubated for 15 mins followed by DNA addition and measured after 5 mins by agarose gel electrophoresis\n",
            "Title: Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents.  Abstract: Heterocyclic compounds, such as hybrid tetrahydroquinoline and quinoline derivatives with phosphorated groups, have been prepared by multicomponent cycloaddition reaction between phosphorus-substituted anilines, aldehydes and styrenes. The antileishmanial activity of these compounds has been evaluated on both promastigotes and intramacrophagic amastigotes of Leishmania infantum. Good antileishmanial activity of functionalized tetrahydroquinolines 4a, 5a, 6b and quinoline 8b has been observed with similar activity than the standard drug amphotericin B and close selective index (SI between 43 and 57) towards L. infantum amastigotes to amphotericin B. Special interest shows tetrahydroquinolylphosphine sulfide 5a with an EC<sub>50</sub> value (0.610.18M) similar to the standard drug amphotericin B (0.320.05M) and selective index (SI=56.87). In addition, compound 4c shows remarkable inhibition on Leishmania topoisomerase IB. Parallel theoretical study of stereoelectronic properties, application of docking-based virtual screening methods, along with molecular electrostatic potential and predictive druggability analyses are also reported.\n",
            "1601654\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as decrease in relaxation of supercoiled pBR322 DNA after 60 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases.  Abstract: New benzothiopyranoindoles (5a-l) and pyridothiopyranoindoles (5m-t), featuring different combinations of substituents (H, Cl, OCH<sub>3</sub>) at R<sup>2</sup>-R<sup>4</sup> positions and protonatable R<sup>1</sup>-dialkylaminoalkyl chains, were synthesized and biologically assayed on three human tumor cell lines, showing significant antiproliferative activity (GI<sub>50</sub> values spanning from 0.31 to 6.93M) and pro-apoptotic effect. Linear flow dichroism experiments indicate the ability of both chromophores to form a molecular complex with DNA, following an intercalative mode of binding. All compounds displayed a moderate ability to inhibit the relaxation activity of both topoisomerases I and II, reasonably correlated to their intercalative capacities. Cleavable assay performed with topoisomerase I revealed a significant poisoning effect for compounds 5g, 5h, 5s, and 5t. A theoretical model provided by hydrated docking calculations clarified the role of the R<sup>1</sup>-R<sup>4</sup> substituents on the topoisomerase I poison activity, revealing a crucial role of the R<sup>2</sup>-OCH<sub>3</sub> group.\n",
            "1601657\n",
            "Poison activity at recombinant human topoisomerase-1 assessed as stabilization of covalent topo-1-DNA cleavage complex by measuring nicked DNA formation at 0.5 uM using supercoiled pBR322 DNA as substrate after 60 mins by agarose gel electrophoresis method\n",
            "Title: Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases.  Abstract: New benzothiopyranoindoles (5a-l) and pyridothiopyranoindoles (5m-t), featuring different combinations of substituents (H, Cl, OCH<sub>3</sub>) at R<sup>2</sup>-R<sup>4</sup> positions and protonatable R<sup>1</sup>-dialkylaminoalkyl chains, were synthesized and biologically assayed on three human tumor cell lines, showing significant antiproliferative activity (GI<sub>50</sub> values spanning from 0.31 to 6.93M) and pro-apoptotic effect. Linear flow dichroism experiments indicate the ability of both chromophores to form a molecular complex with DNA, following an intercalative mode of binding. All compounds displayed a moderate ability to inhibit the relaxation activity of both topoisomerases I and II, reasonably correlated to their intercalative capacities. Cleavable assay performed with topoisomerase I revealed a significant poisoning effect for compounds 5g, 5h, 5s, and 5t. A theoretical model provided by hydrated docking calculations clarified the role of the R<sup>1</sup>-R<sup>4</sup> substituents on the topoisomerase I poison activity, revealing a crucial role of the R<sup>2</sup>-OCH<sub>3</sub> group.\n",
            "1601658\n",
            "Poison activity at recombinant human topoisomerase-1 assessed as stabilization of covalent topo-1-DNA cleavage complex by measuring nicked DNA formation using supercoiled pBR322 DNA as substrate after 60 mins by agarose gel electrophoresis method\n",
            "Title: Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases.  Abstract: New benzothiopyranoindoles (5a-l) and pyridothiopyranoindoles (5m-t), featuring different combinations of substituents (H, Cl, OCH<sub>3</sub>) at R<sup>2</sup>-R<sup>4</sup> positions and protonatable R<sup>1</sup>-dialkylaminoalkyl chains, were synthesized and biologically assayed on three human tumor cell lines, showing significant antiproliferative activity (GI<sub>50</sub> values spanning from 0.31 to 6.93M) and pro-apoptotic effect. Linear flow dichroism experiments indicate the ability of both chromophores to form a molecular complex with DNA, following an intercalative mode of binding. All compounds displayed a moderate ability to inhibit the relaxation activity of both topoisomerases I and II, reasonably correlated to their intercalative capacities. Cleavable assay performed with topoisomerase I revealed a significant poisoning effect for compounds 5g, 5h, 5s, and 5t. A theoretical model provided by hydrated docking calculations clarified the role of the R<sup>1</sup>-R<sup>4</sup> substituents on the topoisomerase I poison activity, revealing a crucial role of the R<sup>2</sup>-OCH<sub>3</sub> group.\n",
            "1601659\n",
            "Poison activity at recombinant human topoisomerase-1 assessed as stabilization of covalent topo-1-DNA cleavage complex by measuring nicked DNA formation at 0.5 to 50 uM using supercoiled pBR322 DNA as substrate after 60 mins by agarose gel electrophoresis method\n",
            "Title: Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases.  Abstract: New benzothiopyranoindoles (5a-l) and pyridothiopyranoindoles (5m-t), featuring different combinations of substituents (H, Cl, OCH<sub>3</sub>) at R<sup>2</sup>-R<sup>4</sup> positions and protonatable R<sup>1</sup>-dialkylaminoalkyl chains, were synthesized and biologically assayed on three human tumor cell lines, showing significant antiproliferative activity (GI<sub>50</sub> values spanning from 0.31 to 6.93M) and pro-apoptotic effect. Linear flow dichroism experiments indicate the ability of both chromophores to form a molecular complex with DNA, following an intercalative mode of binding. All compounds displayed a moderate ability to inhibit the relaxation activity of both topoisomerases I and II, reasonably correlated to their intercalative capacities. Cleavable assay performed with topoisomerase I revealed a significant poisoning effect for compounds 5g, 5h, 5s, and 5t. A theoretical model provided by hydrated docking calculations clarified the role of the R<sup>1</sup>-R<sup>4</sup> substituents on the topoisomerase I poison activity, revealing a crucial role of the R<sup>2</sup>-OCH<sub>3</sub> group.\n",
            "1609804\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as supercoiled pBR322 DNA at 25 uM incubated for 1 hr by ethidium bromide staining based agarose gel electrophoresis method relative to control\n",
            "Title: Novel water soluble BODIPY compounds: Synthesis, photochemical, DNA interaction, topoisomerases inhibition and photodynamic activity properties.  Abstract: In this study, BODIPY compounds (2, 3, 5 and 6) bearing 3,4-bis(3-pyridin-3-ylpropoxy)benzyl, 4-(3-pyridin-3-ylpropoxy)benzyl groups were synthesized for the first time and further functionalized in a Knoevenagel condensation reaction with 3,4-bis(3-pyridin-3-ylpropoxy)benzaldehyde and 4-(3-pyridin-3-ylpropoxy)benzaldehyde. The water soluble derivatives of BODIPY compounds (3a and 6a) were synthesized by treating BODIPY compounds 3 and 6 with excess iodomethane in DMF. The photochemical properties and DNA binding modes of 3a and 6a were determined using ct-DNA by UV-Vis spectrophotometer and viscometer. DNA cleavage and topoisomerases inhibition properties were studied DNA using agarose gel electrophoresis. Their topoisomerase inhibition mechanisms were investigated at molecular level and correlations with the in vitro results were searched for using molecular docking method. In addition, cytotoxicity and phototoxicity of both compounds were performed on colorectal cancer cells (HCT-116) using MTT assay for 24h. Annexin V-FITC/PI test was performed to determine the cell death mechanism of 6a induced by irradiation. Finally, 6a-loaded liposomes (LP6a) and PLGA nanoparticles (NP6a) were prepared and their cytotoxic and phototoxic effects were evaluated by MTT assay. The results claimed that 6a had great potential as photosensitizer agent for colorectal cancer owing to its photochemical, DNA interaction and phototoxic properties.\n",
            "1609821\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as supercoiled pBR322 DNA at 12.5 uM incubated for 1 hr by ethidium bromide staining based agarose gel electrophoresis method relative to control\n",
            "Title: Novel water soluble BODIPY compounds: Synthesis, photochemical, DNA interaction, topoisomerases inhibition and photodynamic activity properties.  Abstract: In this study, BODIPY compounds (2, 3, 5 and 6) bearing 3,4-bis(3-pyridin-3-ylpropoxy)benzyl, 4-(3-pyridin-3-ylpropoxy)benzyl groups were synthesized for the first time and further functionalized in a Knoevenagel condensation reaction with 3,4-bis(3-pyridin-3-ylpropoxy)benzaldehyde and 4-(3-pyridin-3-ylpropoxy)benzaldehyde. The water soluble derivatives of BODIPY compounds (3a and 6a) were synthesized by treating BODIPY compounds 3 and 6 with excess iodomethane in DMF. The photochemical properties and DNA binding modes of 3a and 6a were determined using ct-DNA by UV-Vis spectrophotometer and viscometer. DNA cleavage and topoisomerases inhibition properties were studied DNA using agarose gel electrophoresis. Their topoisomerase inhibition mechanisms were investigated at molecular level and correlations with the in vitro results were searched for using molecular docking method. In addition, cytotoxicity and phototoxicity of both compounds were performed on colorectal cancer cells (HCT-116) using MTT assay for 24h. Annexin V-FITC/PI test was performed to determine the cell death mechanism of 6a induced by irradiation. Finally, 6a-loaded liposomes (LP6a) and PLGA nanoparticles (NP6a) were prepared and their cytotoxic and phototoxic effects were evaluated by MTT assay. The results claimed that 6a had great potential as photosensitizer agent for colorectal cancer owing to its photochemical, DNA interaction and phototoxic properties.\n",
            "1609822\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as linear DNA at 50 uM incubated for 1 hr by ethidium bromide staining based agarose gel electrophoresis method relative to control\n",
            "Title: Novel water soluble BODIPY compounds: Synthesis, photochemical, DNA interaction, topoisomerases inhibition and photodynamic activity properties.  Abstract: In this study, BODIPY compounds (2, 3, 5 and 6) bearing 3,4-bis(3-pyridin-3-ylpropoxy)benzyl, 4-(3-pyridin-3-ylpropoxy)benzyl groups were synthesized for the first time and further functionalized in a Knoevenagel condensation reaction with 3,4-bis(3-pyridin-3-ylpropoxy)benzaldehyde and 4-(3-pyridin-3-ylpropoxy)benzaldehyde. The water soluble derivatives of BODIPY compounds (3a and 6a) were synthesized by treating BODIPY compounds 3 and 6 with excess iodomethane in DMF. The photochemical properties and DNA binding modes of 3a and 6a were determined using ct-DNA by UV-Vis spectrophotometer and viscometer. DNA cleavage and topoisomerases inhibition properties were studied DNA using agarose gel electrophoresis. Their topoisomerase inhibition mechanisms were investigated at molecular level and correlations with the in vitro results were searched for using molecular docking method. In addition, cytotoxicity and phototoxicity of both compounds were performed on colorectal cancer cells (HCT-116) using MTT assay for 24h. Annexin V-FITC/PI test was performed to determine the cell death mechanism of 6a induced by irradiation. Finally, 6a-loaded liposomes (LP6a) and PLGA nanoparticles (NP6a) were prepared and their cytotoxic and phototoxic effects were evaluated by MTT assay. The results claimed that 6a had great potential as photosensitizer agent for colorectal cancer owing to its photochemical, DNA interaction and phototoxic properties.\n",
            "1609823\n",
            "Inhibition of recombinant human topoisomerase 1 at 12.50 uM incubated for 1 hr by ethidium bromide staining based agarose gel electrophoresis method relative to control\n",
            "Title: Novel water soluble BODIPY compounds: Synthesis, photochemical, DNA interaction, topoisomerases inhibition and photodynamic activity properties.  Abstract: In this study, BODIPY compounds (2, 3, 5 and 6) bearing 3,4-bis(3-pyridin-3-ylpropoxy)benzyl, 4-(3-pyridin-3-ylpropoxy)benzyl groups were synthesized for the first time and further functionalized in a Knoevenagel condensation reaction with 3,4-bis(3-pyridin-3-ylpropoxy)benzaldehyde and 4-(3-pyridin-3-ylpropoxy)benzaldehyde. The water soluble derivatives of BODIPY compounds (3a and 6a) were synthesized by treating BODIPY compounds 3 and 6 with excess iodomethane in DMF. The photochemical properties and DNA binding modes of 3a and 6a were determined using ct-DNA by UV-Vis spectrophotometer and viscometer. DNA cleavage and topoisomerases inhibition properties were studied DNA using agarose gel electrophoresis. Their topoisomerase inhibition mechanisms were investigated at molecular level and correlations with the in vitro results were searched for using molecular docking method. In addition, cytotoxicity and phototoxicity of both compounds were performed on colorectal cancer cells (HCT-116) using MTT assay for 24h. Annexin V-FITC/PI test was performed to determine the cell death mechanism of 6a induced by irradiation. Finally, 6a-loaded liposomes (LP6a) and PLGA nanoparticles (NP6a) were prepared and their cytotoxic and phototoxic effects were evaluated by MTT assay. The results claimed that 6a had great potential as photosensitizer agent for colorectal cancer owing to its photochemical, DNA interaction and phototoxic properties.\n",
            "1609824\n",
            "Inhibition of recombinant human topoisomerase 1 at 25 uM incubated for 1 hr by ethidium bromide staining based agarose gel electrophoresis method relative to control\n",
            "Title: Novel water soluble BODIPY compounds: Synthesis, photochemical, DNA interaction, topoisomerases inhibition and photodynamic activity properties.  Abstract: In this study, BODIPY compounds (2, 3, 5 and 6) bearing 3,4-bis(3-pyridin-3-ylpropoxy)benzyl, 4-(3-pyridin-3-ylpropoxy)benzyl groups were synthesized for the first time and further functionalized in a Knoevenagel condensation reaction with 3,4-bis(3-pyridin-3-ylpropoxy)benzaldehyde and 4-(3-pyridin-3-ylpropoxy)benzaldehyde. The water soluble derivatives of BODIPY compounds (3a and 6a) were synthesized by treating BODIPY compounds 3 and 6 with excess iodomethane in DMF. The photochemical properties and DNA binding modes of 3a and 6a were determined using ct-DNA by UV-Vis spectrophotometer and viscometer. DNA cleavage and topoisomerases inhibition properties were studied DNA using agarose gel electrophoresis. Their topoisomerase inhibition mechanisms were investigated at molecular level and correlations with the in vitro results were searched for using molecular docking method. In addition, cytotoxicity and phototoxicity of both compounds were performed on colorectal cancer cells (HCT-116) using MTT assay for 24h. Annexin V-FITC/PI test was performed to determine the cell death mechanism of 6a induced by irradiation. Finally, 6a-loaded liposomes (LP6a) and PLGA nanoparticles (NP6a) were prepared and their cytotoxic and phototoxic effects were evaluated by MTT assay. The results claimed that 6a had great potential as photosensitizer agent for colorectal cancer owing to its photochemical, DNA interaction and phototoxic properties.\n",
            "1609825\n",
            "Inhibition of recombinant human topoisomerase 1 at 50 uM incubated for 1 hr by ethidium bromide staining based agarose gel electrophoresis method relative to control\n",
            "Title: Novel water soluble BODIPY compounds: Synthesis, photochemical, DNA interaction, topoisomerases inhibition and photodynamic activity properties.  Abstract: In this study, BODIPY compounds (2, 3, 5 and 6) bearing 3,4-bis(3-pyridin-3-ylpropoxy)benzyl, 4-(3-pyridin-3-ylpropoxy)benzyl groups were synthesized for the first time and further functionalized in a Knoevenagel condensation reaction with 3,4-bis(3-pyridin-3-ylpropoxy)benzaldehyde and 4-(3-pyridin-3-ylpropoxy)benzaldehyde. The water soluble derivatives of BODIPY compounds (3a and 6a) were synthesized by treating BODIPY compounds 3 and 6 with excess iodomethane in DMF. The photochemical properties and DNA binding modes of 3a and 6a were determined using ct-DNA by UV-Vis spectrophotometer and viscometer. DNA cleavage and topoisomerases inhibition properties were studied DNA using agarose gel electrophoresis. Their topoisomerase inhibition mechanisms were investigated at molecular level and correlations with the in vitro results were searched for using molecular docking method. In addition, cytotoxicity and phototoxicity of both compounds were performed on colorectal cancer cells (HCT-116) using MTT assay for 24h. Annexin V-FITC/PI test was performed to determine the cell death mechanism of 6a induced by irradiation. Finally, 6a-loaded liposomes (LP6a) and PLGA nanoparticles (NP6a) were prepared and their cytotoxic and phototoxic effects were evaluated by MTT assay. The results claimed that 6a had great potential as photosensitizer agent for colorectal cancer owing to its photochemical, DNA interaction and phototoxic properties.\n",
            "1609859\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as supercoiled pBR322 DNA at 50 uM incubated for 1 hr by ethidium bromide staining based agarose gel electrophoresis method relative to control\n",
            "Title: Novel water soluble BODIPY compounds: Synthesis, photochemical, DNA interaction, topoisomerases inhibition and photodynamic activity properties.  Abstract: In this study, BODIPY compounds (2, 3, 5 and 6) bearing 3,4-bis(3-pyridin-3-ylpropoxy)benzyl, 4-(3-pyridin-3-ylpropoxy)benzyl groups were synthesized for the first time and further functionalized in a Knoevenagel condensation reaction with 3,4-bis(3-pyridin-3-ylpropoxy)benzaldehyde and 4-(3-pyridin-3-ylpropoxy)benzaldehyde. The water soluble derivatives of BODIPY compounds (3a and 6a) were synthesized by treating BODIPY compounds 3 and 6 with excess iodomethane in DMF. The photochemical properties and DNA binding modes of 3a and 6a were determined using ct-DNA by UV-Vis spectrophotometer and viscometer. DNA cleavage and topoisomerases inhibition properties were studied DNA using agarose gel electrophoresis. Their topoisomerase inhibition mechanisms were investigated at molecular level and correlations with the in vitro results were searched for using molecular docking method. In addition, cytotoxicity and phototoxicity of both compounds were performed on colorectal cancer cells (HCT-116) using MTT assay for 24h. Annexin V-FITC/PI test was performed to determine the cell death mechanism of 6a induced by irradiation. Finally, 6a-loaded liposomes (LP6a) and PLGA nanoparticles (NP6a) were prepared and their cytotoxic and phototoxic effects were evaluated by MTT assay. The results claimed that 6a had great potential as photosensitizer agent for colorectal cancer owing to its photochemical, DNA interaction and phototoxic properties.\n",
            "1610469\n",
            "Inhibition of DNA topoisomerase-1 (unknown origin) at 100 uM relative to control\n",
            "Title: Design, synthesis and biological research of novel N-phenylbenzamide-4-methylamine acridine derivatives as potential topoisomerase I/II and apoptosis-inducing agents.  Abstract: A series of novel N-phenylbenzamide-4-methylamine acridine derivatives were designed and synthesized based initially on the structure of amsacrine (m-AMSA). Molecular docking suggested that the representative compound 9a had affinity for binding DNA topoisomerase (Topo) II, which was comparable with that of m-AMSA, and furthermore that 9a could have preferential interactions with Topo I. After synthesis of 9a and analogues 9b-9f, these were all tested in vitro and the synthesized compounds displayed potent antiproliferative activity against three different cancer cell lines (K562, CCRF-CEM and U937). Among them, compounds 9b, 9c and 9d exhibiting the highest activity with IC<sub>50</sub> value ranging from 0.82 to 0.91M against CCRF-CEM cells. In addition, 9b and 9d also showed high antiproliferative activity against U937 cells, with IC<sub>50</sub> values of 0.33 and 0.23M, respectively. The pharmacological mechanistic studies of these compounds were evaluated by Topo I/II inhibition, western blot assay and cell apoptosis detection. In summary, 9b effectively inhibited the activity of Topo I/II and induced DNA damage in CCRF-CEM cells and, moreover, significantly induced cell apoptosis in a concentration-dependent manner. These observations provide new information and guidance for the structural optimization of more novel acridine derivatives.\n",
            "1631081\n",
            "Inhibition of topoisomerase-1 (unknown origin) using pBR 322 DNA as substrate\n",
            "Title: Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential.  Abstract: DNA topoisomerases are essential during transcription and replication. The therapeutic mechanism of action of topoisomerase inhibitors is enzyme poisoning rather than catalytic inhibition. Tyrosyl-DNA phosphodiesterases 1 or 2 were found as DNA repair enzymes hydrolyzing the covalent bond between the tyrosyl residue of topoisomerases I or II and the 3'- or 5'-phosphate groups in DNA, respectively. Tyrosyl-DNA phosphodiesterase 1 is a key enzyme in DNA repair machinery and a promising target for antitumor and neurodegenerative therapy. Inhibitors of tyrosyl-DNA phosphodiesterase 1 could act synergistically with topoisomerase I inhibitors and thereby potentiate the effects of topoisomerase I poisons. Tyrosyl-DNA phosphodiesterase 2 is an enzyme that specifically repairs DNA damages induced by topoisomerase II poisons and causes resistance to these drugs. Selective inhibition of tyrosyl-DNA phosphodiesterase 2 may be a novel approach to overcome intrinsic or acquired resistance to topoisomerase II-targeted drug therapy. Thus, agents that inhibit tyrosyl-DNA phosphodiesterases 1 and 2 have many applications in biochemical and physiological research and they have the potential to become anticancer and antiviral drugs. The structures, mechanism of action and therapeutic rationale of tyrosyl-DNA phosphodiesterase inhibitors and their development for combinations with topoisomerase inhibitors and DNA damaging agents are discussed.\n",
            "1638092\n",
            "Inhibition of human topoisomerase-1-mediated relaxed pBR322 DNA unwinding at 10 uM after 30 mins by agarose gel electrophoresis\n",
            "Title: New anthra[2,3-b]furancarboxamides: A role of positioning of the carboxamide moiety in antitumor properties.  Abstract: Derivatives of the anthraquinone (anthracene-9,10-dione) such as doxorubicin, mitoxantrone and others have proved great clinical efficacy for decades. Currently the search in this exceptionally productive chemical class is aimed at optimization of antitumor properties including circumvention of drug resistance. Previously we have reported that heteroarene-fused anthraquinones fused to a 5-membered heterocyclic ring are advantageous in killing drug resistant tumor cells. Herein we present the synthesis and antitumor properties of a series of new anthra[2,3-b]furan-2-carboxamides. Vast majority of new derivatives were similarly cytotoxic to wild type tumor cell lines and their isogenic sublines with P-glycoprotein overexpression and/or p53 inactivation. Comparison of structurally close derivatives varying in their position relative to the furan moiety, that is, furan-3-carboxamide 1vs furan-2-carboxamides 5 and 6, revealed fundamental differences in the cytotoxicity profiles, formation of drug-DNA complexes, efficacy of topoisomerase 1 inhibition and mechanisms of tumor cell death. Together with previous SAR data on the role of individual substituents, these results provide evidence that regioisomerization of anthra[2,3-b]furancarboxamides generates the practically perspective derivatives whose properties may vary significantly.\n",
            "1638093\n",
            "Inhibition of human topoisomerase-1-mediated relaxed pBR322 DNA unwinding after 30 mins by agarose gel electrophoresis\n",
            "Title: New anthra[2,3-b]furancarboxamides: A role of positioning of the carboxamide moiety in antitumor properties.  Abstract: Derivatives of the anthraquinone (anthracene-9,10-dione) such as doxorubicin, mitoxantrone and others have proved great clinical efficacy for decades. Currently the search in this exceptionally productive chemical class is aimed at optimization of antitumor properties including circumvention of drug resistance. Previously we have reported that heteroarene-fused anthraquinones fused to a 5-membered heterocyclic ring are advantageous in killing drug resistant tumor cells. Herein we present the synthesis and antitumor properties of a series of new anthra[2,3-b]furan-2-carboxamides. Vast majority of new derivatives were similarly cytotoxic to wild type tumor cell lines and their isogenic sublines with P-glycoprotein overexpression and/or p53 inactivation. Comparison of structurally close derivatives varying in their position relative to the furan moiety, that is, furan-3-carboxamide 1vs furan-2-carboxamides 5 and 6, revealed fundamental differences in the cytotoxicity profiles, formation of drug-DNA complexes, efficacy of topoisomerase 1 inhibition and mechanisms of tumor cell death. Together with previous SAR data on the role of individual substituents, these results provide evidence that regioisomerization of anthra[2,3-b]furancarboxamides generates the practically perspective derivatives whose properties may vary significantly.\n",
            "1648729\n",
            "Inhibition of Top1 (unknown origin) at 500 uM using supercoiled pBR322 plasmid DNA as substrate incubated for 15 mins by PI staining based agarose gel electrophoresis analysis\n",
            "Title: Natural Product Evodiamine with Borate Trigger Unit: Discovery of Potent Antitumor Agents against Colon Cancer.  Abstract: In order to improve the antitumor potency of the natural product evodiamine, novel boron-containing evodiamine derivatives were designed by incorporating boronic acid and boronate as trigger units. Boronate derivative <b>13a</b> could be triggered by reactive oxygen species (ROS) in the HCT116 colon cancer cell line and showed excellent antitumor activity <i>in vitro</i> and <i>in vivo</i>. It induced apoptosis in HCT116 cancer cells in a dose-dependent manner and cell growth arrest at the G2 phase.\n",
            "1648730\n",
            "Inhibition of Top1 (unknown origin) at 125 uM using supercoiled pBR322 plasmid DNA as substrate incubated for 15 mins by PI staining based agarose gel electrophoresis analysis\n",
            "Title: Natural Product Evodiamine with Borate Trigger Unit: Discovery of Potent Antitumor Agents against Colon Cancer.  Abstract: In order to improve the antitumor potency of the natural product evodiamine, novel boron-containing evodiamine derivatives were designed by incorporating boronic acid and boronate as trigger units. Boronate derivative <b>13a</b> could be triggered by reactive oxygen species (ROS) in the HCT116 colon cancer cell line and showed excellent antitumor activity <i>in vitro</i> and <i>in vivo</i>. It induced apoptosis in HCT116 cancer cells in a dose-dependent manner and cell growth arrest at the G2 phase.\n",
            "1648731\n",
            "Inhibition of Top1 (unknown origin) at 83.3 uM using supercoiled pBR322 plasmid DNA as substrate incubated for 15 mins by PI staining based agarose gel electrophoresis analysis\n",
            "Title: Natural Product Evodiamine with Borate Trigger Unit: Discovery of Potent Antitumor Agents against Colon Cancer.  Abstract: In order to improve the antitumor potency of the natural product evodiamine, novel boron-containing evodiamine derivatives were designed by incorporating boronic acid and boronate as trigger units. Boronate derivative <b>13a</b> could be triggered by reactive oxygen species (ROS) in the HCT116 colon cancer cell line and showed excellent antitumor activity <i>in vitro</i> and <i>in vivo</i>. It induced apoptosis in HCT116 cancer cells in a dose-dependent manner and cell growth arrest at the G2 phase.\n",
            "1651221\n",
            "Poison activity at Top1 (unknown origin) assessed as decrease in relaxed supercoiled DNA at 300 uM\n",
            "Title: Synthesis and biological evaluation of novel indole-pyrazoline hybrid derivatives as potential topoisomerase 1 inhibitors.  Abstract: A series of novel indole-pyrazoline hybrid derivatives were designed, synthesized, and evaluated for topoisomerase 1 (Top1) inhibitory activity. Top1-mediated relaxation assays showed that our synthesized compounds had variable Top1 inhibitory activity. Among these compounds, 3-(5-(naphthalen-1-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)-1-(phenylsulfonyl)-1H-indole (6n) was found to be a strong Top1 inhibitor with better inhibitory activity than CPT and hit compounds. Our further experiments rationalized the mode of action for this new type of inhibitors, which showed no significant binding to supercoiled DNA.\n",
            "1651222\n",
            "Poison activity at Top1 (unknown origin) assessed as decrease in relaxed supercoiled DNA at 25 uM by ethidium bromide staining based agarose gel electrophoresis relative to control\n",
            "Title: Synthesis and biological evaluation of novel indole-pyrazoline hybrid derivatives as potential topoisomerase 1 inhibitors.  Abstract: A series of novel indole-pyrazoline hybrid derivatives were designed, synthesized, and evaluated for topoisomerase 1 (Top1) inhibitory activity. Top1-mediated relaxation assays showed that our synthesized compounds had variable Top1 inhibitory activity. Among these compounds, 3-(5-(naphthalen-1-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)-1-(phenylsulfonyl)-1H-indole (6n) was found to be a strong Top1 inhibitor with better inhibitory activity than CPT and hit compounds. Our further experiments rationalized the mode of action for this new type of inhibitors, which showed no significant binding to supercoiled DNA.\n",
            "1651223\n",
            "Poison activity at Top1 (unknown origin) assessed as increase in supercoiled DNA by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Synthesis and biological evaluation of novel indole-pyrazoline hybrid derivatives as potential topoisomerase 1 inhibitors.  Abstract: A series of novel indole-pyrazoline hybrid derivatives were designed, synthesized, and evaluated for topoisomerase 1 (Top1) inhibitory activity. Top1-mediated relaxation assays showed that our synthesized compounds had variable Top1 inhibitory activity. Among these compounds, 3-(5-(naphthalen-1-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)-1-(phenylsulfonyl)-1H-indole (6n) was found to be a strong Top1 inhibitor with better inhibitory activity than CPT and hit compounds. Our further experiments rationalized the mode of action for this new type of inhibitors, which showed no significant binding to supercoiled DNA.\n",
            "1651224\n",
            "Poison activity at Top1 (unknown origin) assessed as increase in supercoiled DNA at 25 uM by ethidium bromide staining based agarose gel electrophoresis relative to control\n",
            "Title: Synthesis and biological evaluation of novel indole-pyrazoline hybrid derivatives as potential topoisomerase 1 inhibitors.  Abstract: A series of novel indole-pyrazoline hybrid derivatives were designed, synthesized, and evaluated for topoisomerase 1 (Top1) inhibitory activity. Top1-mediated relaxation assays showed that our synthesized compounds had variable Top1 inhibitory activity. Among these compounds, 3-(5-(naphthalen-1-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)-1-(phenylsulfonyl)-1H-indole (6n) was found to be a strong Top1 inhibitor with better inhibitory activity than CPT and hit compounds. Our further experiments rationalized the mode of action for this new type of inhibitors, which showed no significant binding to supercoiled DNA.\n",
            "1651225\n",
            "Poison activity at Top1 (unknown origin) assessed as increase in supercoiled DNA at 125 uM by ethidium bromide staining based agarose gel electrophoresis relative to control\n",
            "Title: Synthesis and biological evaluation of novel indole-pyrazoline hybrid derivatives as potential topoisomerase 1 inhibitors.  Abstract: A series of novel indole-pyrazoline hybrid derivatives were designed, synthesized, and evaluated for topoisomerase 1 (Top1) inhibitory activity. Top1-mediated relaxation assays showed that our synthesized compounds had variable Top1 inhibitory activity. Among these compounds, 3-(5-(naphthalen-1-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)-1-(phenylsulfonyl)-1H-indole (6n) was found to be a strong Top1 inhibitor with better inhibitory activity than CPT and hit compounds. Our further experiments rationalized the mode of action for this new type of inhibitors, which showed no significant binding to supercoiled DNA.\n",
            "1651226\n",
            "Poison activity at Top1 (unknown origin) assessed as increase in supercoiled DNA at 1 and 5 uM by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Synthesis and biological evaluation of novel indole-pyrazoline hybrid derivatives as potential topoisomerase 1 inhibitors.  Abstract: A series of novel indole-pyrazoline hybrid derivatives were designed, synthesized, and evaluated for topoisomerase 1 (Top1) inhibitory activity. Top1-mediated relaxation assays showed that our synthesized compounds had variable Top1 inhibitory activity. Among these compounds, 3-(5-(naphthalen-1-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)-1-(phenylsulfonyl)-1H-indole (6n) was found to be a strong Top1 inhibitor with better inhibitory activity than CPT and hit compounds. Our further experiments rationalized the mode of action for this new type of inhibitors, which showed no significant binding to supercoiled DNA.\n",
            "1655966\n",
            "Inhibition of human TOP1B expressed in Saccharomyces cerevisiae EKY3 lacking top1 assessed as reduction in yeast cell growth at 1 to 30 uM\n",
            "Title: Artemisinin Derivatives with Antimelanoma Activity Show Inhibitory Effect against Human DNA Topoisomerase 1.  Abstract: Artesunic acid and artemisinin are natural substances with promiscuous anticancer activity against different types of cancer cell lines. The mechanism of action of these compounds is associated with the formation of reactive radical species by cleavage of the sesquiterpene pharmacophore endoperoxide bridge. Here we suggested topoisomerase 1 as a possible molecular target for the improvement of the anticancer activity of these compounds. In this context, we report that novel hybrid and dimer derivatives of artesunic acid and artemisinin, bearing camptothecin and SN38 as side-chain biological effectors, can inhibit growth of yeast cells overexpressing human topoisomerase 1 and its enzymatic activity <i>in vitro</i>. These derivatives showed also anticancer activity in melanoma cell lines higher than camptothecin and paclitaxel. <i>In silico</i> molecular docking calculations highlighted a common binding mode for the novel derivatives, with the sesquiterpene lactone scaffold being located near the traditional recognition site for camptothecin, while the bioactive side-chain effector laid in the camptothecin cleft.\n",
            "1655967\n",
            "Inhibition of human TOP1B expressed in Saccharomyces cerevisiae EKY3 lacking top1 assessed as reduction in yeast cell growth at 30 uM\n",
            "Title: Artemisinin Derivatives with Antimelanoma Activity Show Inhibitory Effect against Human DNA Topoisomerase 1.  Abstract: Artesunic acid and artemisinin are natural substances with promiscuous anticancer activity against different types of cancer cell lines. The mechanism of action of these compounds is associated with the formation of reactive radical species by cleavage of the sesquiterpene pharmacophore endoperoxide bridge. Here we suggested topoisomerase 1 as a possible molecular target for the improvement of the anticancer activity of these compounds. In this context, we report that novel hybrid and dimer derivatives of artesunic acid and artemisinin, bearing camptothecin and SN38 as side-chain biological effectors, can inhibit growth of yeast cells overexpressing human topoisomerase 1 and its enzymatic activity <i>in vitro</i>. These derivatives showed also anticancer activity in melanoma cell lines higher than camptothecin and paclitaxel. <i>In silico</i> molecular docking calculations highlighted a common binding mode for the novel derivatives, with the sesquiterpene lactone scaffold being located near the traditional recognition site for camptothecin, while the bioactive side-chain effector laid in the camptothecin cleft.\n",
            "1655968\n",
            "Inhibition of human TOP1B expressed in Saccharomyces cerevisiae EKY3 lacking top1 assessed as reduction in yeast cell growth at 10 uM\n",
            "Title: Artemisinin Derivatives with Antimelanoma Activity Show Inhibitory Effect against Human DNA Topoisomerase 1.  Abstract: Artesunic acid and artemisinin are natural substances with promiscuous anticancer activity against different types of cancer cell lines. The mechanism of action of these compounds is associated with the formation of reactive radical species by cleavage of the sesquiterpene pharmacophore endoperoxide bridge. Here we suggested topoisomerase 1 as a possible molecular target for the improvement of the anticancer activity of these compounds. In this context, we report that novel hybrid and dimer derivatives of artesunic acid and artemisinin, bearing camptothecin and SN38 as side-chain biological effectors, can inhibit growth of yeast cells overexpressing human topoisomerase 1 and its enzymatic activity <i>in vitro</i>. These derivatives showed also anticancer activity in melanoma cell lines higher than camptothecin and paclitaxel. <i>In silico</i> molecular docking calculations highlighted a common binding mode for the novel derivatives, with the sesquiterpene lactone scaffold being located near the traditional recognition site for camptothecin, while the bioactive side-chain effector laid in the camptothecin cleft.\n",
            "1655970\n",
            "Inhibition of human TOP1B-medaited negatively supercoiled pBlue-Script KSII(+) DNA relaxation at 0.3 to 30 uM by ethidium bromide staining based gel electrophoresis method\n",
            "Title: Artemisinin Derivatives with Antimelanoma Activity Show Inhibitory Effect against Human DNA Topoisomerase 1.  Abstract: Artesunic acid and artemisinin are natural substances with promiscuous anticancer activity against different types of cancer cell lines. The mechanism of action of these compounds is associated with the formation of reactive radical species by cleavage of the sesquiterpene pharmacophore endoperoxide bridge. Here we suggested topoisomerase 1 as a possible molecular target for the improvement of the anticancer activity of these compounds. In this context, we report that novel hybrid and dimer derivatives of artesunic acid and artemisinin, bearing camptothecin and SN38 as side-chain biological effectors, can inhibit growth of yeast cells overexpressing human topoisomerase 1 and its enzymatic activity <i>in vitro</i>. These derivatives showed also anticancer activity in melanoma cell lines higher than camptothecin and paclitaxel. <i>In silico</i> molecular docking calculations highlighted a common binding mode for the novel derivatives, with the sesquiterpene lactone scaffold being located near the traditional recognition site for camptothecin, while the bioactive side-chain effector laid in the camptothecin cleft.\n",
            "1655971\n",
            "Inhibition of human TOP1B expressed in Saccharomyces cerevisiae EKY3 lacking top1 assessed as induction of cell cycle defect at 30 uM measured after 24 hrs\n",
            "Title: Artemisinin Derivatives with Antimelanoma Activity Show Inhibitory Effect against Human DNA Topoisomerase 1.  Abstract: Artesunic acid and artemisinin are natural substances with promiscuous anticancer activity against different types of cancer cell lines. The mechanism of action of these compounds is associated with the formation of reactive radical species by cleavage of the sesquiterpene pharmacophore endoperoxide bridge. Here we suggested topoisomerase 1 as a possible molecular target for the improvement of the anticancer activity of these compounds. In this context, we report that novel hybrid and dimer derivatives of artesunic acid and artemisinin, bearing camptothecin and SN38 as side-chain biological effectors, can inhibit growth of yeast cells overexpressing human topoisomerase 1 and its enzymatic activity <i>in vitro</i>. These derivatives showed also anticancer activity in melanoma cell lines higher than camptothecin and paclitaxel. <i>In silico</i> molecular docking calculations highlighted a common binding mode for the novel derivatives, with the sesquiterpene lactone scaffold being located near the traditional recognition site for camptothecin, while the bioactive side-chain effector laid in the camptothecin cleft.\n",
            "1655972\n",
            "Inhibition of human TOP1B expressed in Saccharomyces cerevisiae EKY3 lacking top1 assessed as reduction in yeast growth at 3 uM\n",
            "Title: Artemisinin Derivatives with Antimelanoma Activity Show Inhibitory Effect against Human DNA Topoisomerase 1.  Abstract: Artesunic acid and artemisinin are natural substances with promiscuous anticancer activity against different types of cancer cell lines. The mechanism of action of these compounds is associated with the formation of reactive radical species by cleavage of the sesquiterpene pharmacophore endoperoxide bridge. Here we suggested topoisomerase 1 as a possible molecular target for the improvement of the anticancer activity of these compounds. In this context, we report that novel hybrid and dimer derivatives of artesunic acid and artemisinin, bearing camptothecin and SN38 as side-chain biological effectors, can inhibit growth of yeast cells overexpressing human topoisomerase 1 and its enzymatic activity <i>in vitro</i>. These derivatives showed also anticancer activity in melanoma cell lines higher than camptothecin and paclitaxel. <i>In silico</i> molecular docking calculations highlighted a common binding mode for the novel derivatives, with the sesquiterpene lactone scaffold being located near the traditional recognition site for camptothecin, while the bioactive side-chain effector laid in the camptothecin cleft.\n",
            "1655973\n",
            "Inhibition of human TOP1B-medaited negatively supercoiled pBlue-Script KSII(+) DNA relaxation at 300 nM by ethidium bromide staining based gel electrophoresis method\n",
            "Title: Artemisinin Derivatives with Antimelanoma Activity Show Inhibitory Effect against Human DNA Topoisomerase 1.  Abstract: Artesunic acid and artemisinin are natural substances with promiscuous anticancer activity against different types of cancer cell lines. The mechanism of action of these compounds is associated with the formation of reactive radical species by cleavage of the sesquiterpene pharmacophore endoperoxide bridge. Here we suggested topoisomerase 1 as a possible molecular target for the improvement of the anticancer activity of these compounds. In this context, we report that novel hybrid and dimer derivatives of artesunic acid and artemisinin, bearing camptothecin and SN38 as side-chain biological effectors, can inhibit growth of yeast cells overexpressing human topoisomerase 1 and its enzymatic activity <i>in vitro</i>. These derivatives showed also anticancer activity in melanoma cell lines higher than camptothecin and paclitaxel. <i>In silico</i> molecular docking calculations highlighted a common binding mode for the novel derivatives, with the sesquiterpene lactone scaffold being located near the traditional recognition site for camptothecin, while the bioactive side-chain effector laid in the camptothecin cleft.\n",
            "1659501\n",
            "Inhibition of human TOP1 assessed as decrease in relaxation of supercoiled DNA using supercoiled plasmid DNA pGEM1 as substrate at 100 uM preincubated for 30 mins by SDS gel electrophoresis method (Rvb = 1%)\n",
            "Title: A-ring and E-ring modifications of the cytotoxic alkaloid Luotonin A: Synthesis, computational and biological studies.  Abstract: A series of new Luotonin A derivatives with substituents at rings A and E was synthesized, together with some E-ring-unsubstituted derivatives. Subsequently, the compound library was examined in silico for their binding into a previously proposed site in the DNA/topoisomerase I binary complex. Whereas no convincing correlation between docking scores and biological data from in vitro assays could be found, one novel 4,9-diamino Luotonin A derivative had strong antiproliferative activity based on massive G2/M phase arrest. As this biological activity clearly differs from the reference compound Camptothecin, this strongly indicates that at least some Luotonin A derivatives may be potent antiproliferative agents, however with a different mode of action.\n",
            "1659502\n",
            "Inhibition of human TOP1 assessed as decrease in relaxation of supercoiled DNA using supercoiled plasmid DNA pGEM1 as substrate at 10 uM preincubated for 30 mins by SDS gel electrophoresis method (Rvb = 1%)\n",
            "Title: A-ring and E-ring modifications of the cytotoxic alkaloid Luotonin A: Synthesis, computational and biological studies.  Abstract: A series of new Luotonin A derivatives with substituents at rings A and E was synthesized, together with some E-ring-unsubstituted derivatives. Subsequently, the compound library was examined in silico for their binding into a previously proposed site in the DNA/topoisomerase I binary complex. Whereas no convincing correlation between docking scores and biological data from in vitro assays could be found, one novel 4,9-diamino Luotonin A derivative had strong antiproliferative activity based on massive G2/M phase arrest. As this biological activity clearly differs from the reference compound Camptothecin, this strongly indicates that at least some Luotonin A derivatives may be potent antiproliferative agents, however with a different mode of action.\n",
            "1659503\n",
            "Inhibition of human TOP1 assessed as decrease in relaxation of supercoiled DNA using supercoiled plasmid DNA pGEM1 as substrate at 1 uM preincubated for 30 mins by SDS gel electrophoresis method (Rvb = 1%)\n",
            "Title: A-ring and E-ring modifications of the cytotoxic alkaloid Luotonin A: Synthesis, computational and biological studies.  Abstract: A series of new Luotonin A derivatives with substituents at rings A and E was synthesized, together with some E-ring-unsubstituted derivatives. Subsequently, the compound library was examined in silico for their binding into a previously proposed site in the DNA/topoisomerase I binary complex. Whereas no convincing correlation between docking scores and biological data from in vitro assays could be found, one novel 4,9-diamino Luotonin A derivative had strong antiproliferative activity based on massive G2/M phase arrest. As this biological activity clearly differs from the reference compound Camptothecin, this strongly indicates that at least some Luotonin A derivatives may be potent antiproliferative agents, however with a different mode of action.\n",
            "1667417\n",
            "Inhibition of topoisomerase 1 (unknown origin) mediated DNA relaxation at 5 uM by gel electrophoresis assay\n",
            "Title: Design, synthesis and biological evaluation of 3-nitro-1,8-naphthalimides as potential antitumor agents.  Abstract: A series of 3-nitro-naphthalimides 1(1a-1h) were designed and synthesized as antitumor agents. MTT assay results showed that all these compounds exhibited obvious antiproliferative activity against SKOV3, HepG2, A549, T-24 and SMMC-7721 cancer cell lines, while compound 1a displayed the best antiproliferative activity against HepG2 and T-24 cell lines in comparison with mitonafide, with IC<sub>50</sub> of 9.2  1.8 and 4.133  0.9 M, respectively. In vivo antiproliferative activity assay results showed that compound 1a exhibited good antiproliferative activity in the HepG2 and T-24 models, compared with mitonafide. Action mechanism results showed that compound 1a could induced the damage of DNA and the inhibition topo I, accompanying by inducing the G2-stage arresting and the apoptosis of T-24 cancer cells through up-regulating expression levels of cyclin B1, cdc 2-pTy, Wee1, H2AX, p21, Bax and cytochrome c and down-regulating expression of Bcl-2.\n",
            "1667418\n",
            "Inhibition of topoisomerase 1 (unknown origin) mediated DNA relaxation at 20 uM by gel electrophoresis assay\n",
            "Title: Design, synthesis and biological evaluation of 3-nitro-1,8-naphthalimides as potential antitumor agents.  Abstract: A series of 3-nitro-naphthalimides 1(1a-1h) were designed and synthesized as antitumor agents. MTT assay results showed that all these compounds exhibited obvious antiproliferative activity against SKOV3, HepG2, A549, T-24 and SMMC-7721 cancer cell lines, while compound 1a displayed the best antiproliferative activity against HepG2 and T-24 cell lines in comparison with mitonafide, with IC<sub>50</sub> of 9.2  1.8 and 4.133  0.9 M, respectively. In vivo antiproliferative activity assay results showed that compound 1a exhibited good antiproliferative activity in the HepG2 and T-24 models, compared with mitonafide. Action mechanism results showed that compound 1a could induced the damage of DNA and the inhibition topo I, accompanying by inducing the G2-stage arresting and the apoptosis of T-24 cancer cells through up-regulating expression levels of cyclin B1, cdc 2-pTy, Wee1, H2AX, p21, Bax and cytochrome c and down-regulating expression of Bcl-2.\n",
            "1673144\n",
            "Inhibition of topoisomerase 1 in human MCF7 cells nuclear extract assessed as decrease in relaxation/nicking of supercoiled DNA using supercoiled DNA as substrate at 40 uM after 1 hr by ethidium bromide staining based agarose gel electrophoresis analysis\n",
            "Title: Design, synthesis and evaluation of antiproliferative activity of fluorinated betulinic acid.  Abstract: Betulinic acid (BA), a pentacyclic triterpenoid, exhibits broad spectrum antiproliferative activity, but generally with only modest potency. To improve BA's pharmacological properties, fluorine was introduced as a single atom at C-2, creating two diastereomers, or in a trifluoromethyl group at C-3. We evaluated the impact of these groups on antiproliferative activity against five human tumor cell lines. A racemic 2-F-BA (compound 6) showed significantly improved antiproliferative activity, while each diastereomer exhibited similar effects. We also demonstrated that 2-F-BA is a topoisomerase (Topo) I and II dual inhibitor in cell-based and cell-free assays. A hypothetical mode of binding to the Topo I-DNA suggested a difference between the hydrogen bonding of BA and 2-F-BA to DNA, which may account for the difference in bioactivity against Topo I.\n",
            "1673146\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as decrease in relaxation/nicking of supercoiled DNA using supercoiled DNA as substrate at 10 uM after 1 hr by ethidium bromide staining based agarose gel electrophoresis analysis\n",
            "Title: Design, synthesis and evaluation of antiproliferative activity of fluorinated betulinic acid.  Abstract: Betulinic acid (BA), a pentacyclic triterpenoid, exhibits broad spectrum antiproliferative activity, but generally with only modest potency. To improve BA's pharmacological properties, fluorine was introduced as a single atom at C-2, creating two diastereomers, or in a trifluoromethyl group at C-3. We evaluated the impact of these groups on antiproliferative activity against five human tumor cell lines. A racemic 2-F-BA (compound 6) showed significantly improved antiproliferative activity, while each diastereomer exhibited similar effects. We also demonstrated that 2-F-BA is a topoisomerase (Topo) I and II dual inhibitor in cell-based and cell-free assays. A hypothetical mode of binding to the Topo I-DNA suggested a difference between the hydrogen bonding of BA and 2-F-BA to DNA, which may account for the difference in bioactivity against Topo I.\n",
            "1673147\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as decrease in relaxation/nicking of supercoiled DNA using supercoiled DNA as substrate at 30 uM after 1 hr by ethidium bromide staining based agarose gel electrophoresis analysis\n",
            "Title: Design, synthesis and evaluation of antiproliferative activity of fluorinated betulinic acid.  Abstract: Betulinic acid (BA), a pentacyclic triterpenoid, exhibits broad spectrum antiproliferative activity, but generally with only modest potency. To improve BA's pharmacological properties, fluorine was introduced as a single atom at C-2, creating two diastereomers, or in a trifluoromethyl group at C-3. We evaluated the impact of these groups on antiproliferative activity against five human tumor cell lines. A racemic 2-F-BA (compound 6) showed significantly improved antiproliferative activity, while each diastereomer exhibited similar effects. We also demonstrated that 2-F-BA is a topoisomerase (Topo) I and II dual inhibitor in cell-based and cell-free assays. A hypothetical mode of binding to the Topo I-DNA suggested a difference between the hydrogen bonding of BA and 2-F-BA to DNA, which may account for the difference in bioactivity against Topo I.\n",
            "1673148\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as decrease in relaxation/nicking of supercoiled DNA using supercoiled DNA as substrate after 1 hr by ethidium bromide staining based agarose gel electrophoresis analysis\n",
            "Title: Design, synthesis and evaluation of antiproliferative activity of fluorinated betulinic acid.  Abstract: Betulinic acid (BA), a pentacyclic triterpenoid, exhibits broad spectrum antiproliferative activity, but generally with only modest potency. To improve BA's pharmacological properties, fluorine was introduced as a single atom at C-2, creating two diastereomers, or in a trifluoromethyl group at C-3. We evaluated the impact of these groups on antiproliferative activity against five human tumor cell lines. A racemic 2-F-BA (compound 6) showed significantly improved antiproliferative activity, while each diastereomer exhibited similar effects. We also demonstrated that 2-F-BA is a topoisomerase (Topo) I and II dual inhibitor in cell-based and cell-free assays. A hypothetical mode of binding to the Topo I-DNA suggested a difference between the hydrogen bonding of BA and 2-F-BA to DNA, which may account for the difference in bioactivity against Topo I.\n",
            "1673149\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as decrease in relaxation/nicking of supercoiled DNA using supercoiled DNA as substrate at 3 uM after 1 hr by ethidium bromide staining based agarose gel electrophoresis analysis\n",
            "Title: Design, synthesis and evaluation of antiproliferative activity of fluorinated betulinic acid.  Abstract: Betulinic acid (BA), a pentacyclic triterpenoid, exhibits broad spectrum antiproliferative activity, but generally with only modest potency. To improve BA's pharmacological properties, fluorine was introduced as a single atom at C-2, creating two diastereomers, or in a trifluoromethyl group at C-3. We evaluated the impact of these groups on antiproliferative activity against five human tumor cell lines. A racemic 2-F-BA (compound 6) showed significantly improved antiproliferative activity, while each diastereomer exhibited similar effects. We also demonstrated that 2-F-BA is a topoisomerase (Topo) I and II dual inhibitor in cell-based and cell-free assays. A hypothetical mode of binding to the Topo I-DNA suggested a difference between the hydrogen bonding of BA and 2-F-BA to DNA, which may account for the difference in bioactivity against Topo I.\n",
            "1673154\n",
            "Inhibition of topoisomerase 1 in human MCF7 cells nuclear extract assessed as decrease in relaxation/nicking of supercoiled DNA using supercoiled DNA as substrate at 1 uM after 1 hr by ethidium bromide staining based agarose gel electrophoresis analysis\n",
            "Title: Design, synthesis and evaluation of antiproliferative activity of fluorinated betulinic acid.  Abstract: Betulinic acid (BA), a pentacyclic triterpenoid, exhibits broad spectrum antiproliferative activity, but generally with only modest potency. To improve BA's pharmacological properties, fluorine was introduced as a single atom at C-2, creating two diastereomers, or in a trifluoromethyl group at C-3. We evaluated the impact of these groups on antiproliferative activity against five human tumor cell lines. A racemic 2-F-BA (compound 6) showed significantly improved antiproliferative activity, while each diastereomer exhibited similar effects. We also demonstrated that 2-F-BA is a topoisomerase (Topo) I and II dual inhibitor in cell-based and cell-free assays. A hypothetical mode of binding to the Topo I-DNA suggested a difference between the hydrogen bonding of BA and 2-F-BA to DNA, which may account for the difference in bioactivity against Topo I.\n",
            "1673156\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as decrease in relaxation/nicking of supercoiled DNA using supercoiled DNA as substrate at 1 uM after 1 hr by ethidium bromide staining based agarose gel electrophoresis analysis\n",
            "Title: Design, synthesis and evaluation of antiproliferative activity of fluorinated betulinic acid.  Abstract: Betulinic acid (BA), a pentacyclic triterpenoid, exhibits broad spectrum antiproliferative activity, but generally with only modest potency. To improve BA's pharmacological properties, fluorine was introduced as a single atom at C-2, creating two diastereomers, or in a trifluoromethyl group at C-3. We evaluated the impact of these groups on antiproliferative activity against five human tumor cell lines. A racemic 2-F-BA (compound 6) showed significantly improved antiproliferative activity, while each diastereomer exhibited similar effects. We also demonstrated that 2-F-BA is a topoisomerase (Topo) I and II dual inhibitor in cell-based and cell-free assays. A hypothetical mode of binding to the Topo I-DNA suggested a difference between the hydrogen bonding of BA and 2-F-BA to DNA, which may account for the difference in bioactivity against Topo I.\n",
            "1689290\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as relaxation of supercoiled plasmid pBR322 DNA incubated for 30 mins by Western blot analysis\n",
            "Title: Synthesis, mechanisms of action, and toxicity of novel aminophosphonates derivatives conjugated irinotecan in vitro and in vivo as potent antitumor agents.  Abstract: Twenty novel aminophosphonates derivatives (5a-5j and 6a-6j) conjugated irinotecan were synthesized through esterification reaction, and evaluated their anticancer activities using MTT assay. In vitro evaluation revealed that they displayed similar or superior cytotoxicity compared to the positive drug irinotecan against A549, MCF-7, SK-OV-3, MG-63, U2OS and multidrug-resistant (MDR) SK-OV-3/CDDP cancer cell lines. Among them, 9b displayed the most potent activity, with IC values of 0.92-3.23 M against five human cancer cells, which exhibited a 5.4-19.1-fold increase in activity compared to the reference drug irinotecan, respectively. Moreover, cellular mechanism studies suggested that 9b arrested cell cycle at S stage and induced cell apoptosis along with the decrease of mitochondrial membrane potential (MMP). Interestingly, 9b significantly inhibited tumor growth in SK-OV-3 xenograft models in vivo without apparent toxicity, which was better than the positive drug irinotecan. Taken together, 9b possessed potent antitumor activity and may be a promising candidate for the potential treatment of human ovarian cancer cells.\n",
            "1689313\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as relaxation of supercoiled plasmid pBR322 DNA at 150 uM incubated for 30 mins by Western blot analysis\n",
            "Title: Synthesis, mechanisms of action, and toxicity of novel aminophosphonates derivatives conjugated irinotecan in vitro and in vivo as potent antitumor agents.  Abstract: Twenty novel aminophosphonates derivatives (5a-5j and 6a-6j) conjugated irinotecan were synthesized through esterification reaction, and evaluated their anticancer activities using MTT assay. In vitro evaluation revealed that they displayed similar or superior cytotoxicity compared to the positive drug irinotecan against A549, MCF-7, SK-OV-3, MG-63, U2OS and multidrug-resistant (MDR) SK-OV-3/CDDP cancer cell lines. Among them, 9b displayed the most potent activity, with IC values of 0.92-3.23 M against five human cancer cells, which exhibited a 5.4-19.1-fold increase in activity compared to the reference drug irinotecan, respectively. Moreover, cellular mechanism studies suggested that 9b arrested cell cycle at S stage and induced cell apoptosis along with the decrease of mitochondrial membrane potential (MMP). Interestingly, 9b significantly inhibited tumor growth in SK-OV-3 xenograft models in vivo without apparent toxicity, which was better than the positive drug irinotecan. Taken together, 9b possessed potent antitumor activity and may be a promising candidate for the potential treatment of human ovarian cancer cells.\n",
            "1692473\n",
            "Inhibition of human topoisomerase 1 assessed as decrease in relaxation of supercoiled pBR322 plasmid DNA at 100 uM using pBR322 plasmid DNA as substrate incubated for 30 mins by agarose gel electrophoresis\n",
            "Title: Synthesis and biological evaluation of novel pyrazoline derivatives containing indole skeleton as anti-cancer agents targeting topoisomerase II.  Abstract: In order to develop potent anticaner agents, a novel series of 3-(1H-indol-3-yl)-2,3,3a,4-tetrahydrothiochromeno[4,3-c]pyrazole derivatives were synthesized. Structures of all compounds were confirmed. MTT assay has been employed to study antiproliferative activity of these compounds with four human cancer cell lines (MGC-803, Hela, MCF-7 and Bel-7404) and a normal cell line L929. Most of these compounds showed potential anticancer activity and low cytotoxicity on normal cell in vitro. 7d and 7f showed the best anticancer activity, whose IC value is 15.43 M and 20.54 M towards MGC-803, respectively. Most of them exhibited topoisomerase II selective inhibitory. Cleavage reaction assay and DNA unwinding assay showed that 7f was a nonintercalative Topo II catalytic inhibitor, which was consistent with the docking results. Laser scanning confocal microscopy system tracks the location of representative compounds 7d and 7f which can be abundantly entering the nucleus. In particular, the most potent compounds 7d and 7f were shown to be able to induce G2/M cell cycle arrest and apoptosis in MGC-803 cells.\n",
            "1701969\n",
            "Inhibition of wild-type recombinant human topoisomerase 1 expressed in baculovirus infected Sf9 cells assessed as decrease in relaxation of supercoiled pBlue-Script KS(+) plasmid DNA at 200 uM incubated for 30 mins by ethidium bromide staining based gel electrophoresis method\n",
            "Title: Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues.  Abstract: A series of calothrixin B (2) analogues bearing substituents at the 'E' ring and their corresponding deoxygenated quinocarbazoles lacking quinone unit were synthesized. The cytotoxicities of calothrixins 1, 2, and 15b-p and quinocarbazole analogues were investigated against nine cancer cell lines. The quinocarbazoles 21a and 25a inhibited the catalytic activity of human topoisomerase II. The plasmid DNA cleavage abilities of calothrixins 1, 2, and 15b-p identified compound 15h causing DNA cleavage comparable to that of calothrixin A (1). Calothrixin A (1), 3-fluorocalothrixin 15h and 4-fluoroquinocarbazole 21b induced extensive DNA damage followed by apoptotic cell death. Spectral and plasmid unwinding studies demonstrated an intercalative mode of binding for quinocarbazoles. We identified two promising drug candidates, the 3-fluorocalothrixin B 15h with low toxicity in animal model and its deoxygenated derivative 4-fluoroquinocarbazole 21b as having potent cytotoxicity against NCI-H460 cell line with a GI of 1 nM.\n",
            "1702012\n",
            "Inhibition of human topoisomerase 1 assessed as induction of negative supercoiled DNA using relaxed pBlue-Script KS(+) plasmid DNA as substrate measured after 15 mins by agarose gel electrophoresis analysis\n",
            "Title: Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues.  Abstract: A series of calothrixin B (2) analogues bearing substituents at the 'E' ring and their corresponding deoxygenated quinocarbazoles lacking quinone unit were synthesized. The cytotoxicities of calothrixins 1, 2, and 15b-p and quinocarbazole analogues were investigated against nine cancer cell lines. The quinocarbazoles 21a and 25a inhibited the catalytic activity of human topoisomerase II. The plasmid DNA cleavage abilities of calothrixins 1, 2, and 15b-p identified compound 15h causing DNA cleavage comparable to that of calothrixin A (1). Calothrixin A (1), 3-fluorocalothrixin 15h and 4-fluoroquinocarbazole 21b induced extensive DNA damage followed by apoptotic cell death. Spectral and plasmid unwinding studies demonstrated an intercalative mode of binding for quinocarbazoles. We identified two promising drug candidates, the 3-fluorocalothrixin B 15h with low toxicity in animal model and its deoxygenated derivative 4-fluoroquinocarbazole 21b as having potent cytotoxicity against NCI-H460 cell line with a GI of 1 nM.\n",
            "1702822\n",
            "Inhibition of topoisomerase 1 in human A549 cells nuclear extract assessed as stabilization of nicked DNA preincubated for 6 hrs followed by supercoiled DNA addition and further incubated for 30 mins by SYBR-green staining based agarose gel electrophoresis\n",
            "Title: Design, synthesis and antineoplastic activity of novel 20(S)-acylthiourea derivatives of camptothecin.  Abstract: For the purpose of advancing our research on diverse C-20 decorated derivatives of camptothecin (CPT), 46 new CPT acylthiourea derivatives were synthesized and evaluated in vitro for their cytotoxicity. All the compounds showed promising in vitro cytotoxicity against six tumor cell lines (Hep3B, MCF7, A549, MDA-MB-231, KB and KB-vin). Out of them, compound c20 possesses remarkable in vitro cytotoxic activity and is more potent than topotecan. Mechanistically, c20 not only induces cell cycle arrest and cell apoptosis in A549 cells, but also inhibits Topo I activity in the cell and cell-free system in a manner similar to that of topotecan. In both xenograft and primary HCC mouse models, c20 displays significant in vivo anti-cancer activity and is more potent than topotecan. In addition, the acute toxicity assay showed that c20 has no apparent toxicity to mouse liver, kidney and hemopoietic system of the FVB/N mice. Take together, these results indicated that compound c20 could be a potential anti-cancer candidate for further clinical trial.\n",
            "1702823\n",
            "Inhibition of topoisomerase 1 in human A549 cells nuclear extract assessed as reduction in supercoiled DNA relaxation at 0.2 uM incubated for 6 hrs by SYBR-green staining based agarose gel electrophoresis\n",
            "Title: Design, synthesis and antineoplastic activity of novel 20(S)-acylthiourea derivatives of camptothecin.  Abstract: For the purpose of advancing our research on diverse C-20 decorated derivatives of camptothecin (CPT), 46 new CPT acylthiourea derivatives were synthesized and evaluated in vitro for their cytotoxicity. All the compounds showed promising in vitro cytotoxicity against six tumor cell lines (Hep3B, MCF7, A549, MDA-MB-231, KB and KB-vin). Out of them, compound c20 possesses remarkable in vitro cytotoxic activity and is more potent than topotecan. Mechanistically, c20 not only induces cell cycle arrest and cell apoptosis in A549 cells, but also inhibits Topo I activity in the cell and cell-free system in a manner similar to that of topotecan. In both xenograft and primary HCC mouse models, c20 displays significant in vivo anti-cancer activity and is more potent than topotecan. In addition, the acute toxicity assay showed that c20 has no apparent toxicity to mouse liver, kidney and hemopoietic system of the FVB/N mice. Take together, these results indicated that compound c20 could be a potential anti-cancer candidate for further clinical trial.\n",
            "1702824\n",
            "Inhibition of topoisomerase 1 in human A549 cells nuclear extract assessed as reduction in supercoiled DNA relaxation at 0.2 uM preincubated for 6 hrs followed by supercoiled DNA addition and further incubated for 30 mins by SYBR-green staining based agarose gel electrophoresis\n",
            "Title: Design, synthesis and antineoplastic activity of novel 20(S)-acylthiourea derivatives of camptothecin.  Abstract: For the purpose of advancing our research on diverse C-20 decorated derivatives of camptothecin (CPT), 46 new CPT acylthiourea derivatives were synthesized and evaluated in vitro for their cytotoxicity. All the compounds showed promising in vitro cytotoxicity against six tumor cell lines (Hep3B, MCF7, A549, MDA-MB-231, KB and KB-vin). Out of them, compound c20 possesses remarkable in vitro cytotoxic activity and is more potent than topotecan. Mechanistically, c20 not only induces cell cycle arrest and cell apoptosis in A549 cells, but also inhibits Topo I activity in the cell and cell-free system in a manner similar to that of topotecan. In both xenograft and primary HCC mouse models, c20 displays significant in vivo anti-cancer activity and is more potent than topotecan. In addition, the acute toxicity assay showed that c20 has no apparent toxicity to mouse liver, kidney and hemopoietic system of the FVB/N mice. Take together, these results indicated that compound c20 could be a potential anti-cancer candidate for further clinical trial.\n",
            "1702825\n",
            "Inhibition of human recombinant topoisomerase 1 expressed in baculovirus expression system at 0.3 uM using supercoiled plasmid DNA as substrate preincubated 20 mins followed by substrate addition and measured after 30 mins by SYBR-green staining based agarose gel electrophoresis\n",
            "Title: Design, synthesis and antineoplastic activity of novel 20(S)-acylthiourea derivatives of camptothecin.  Abstract: For the purpose of advancing our research on diverse C-20 decorated derivatives of camptothecin (CPT), 46 new CPT acylthiourea derivatives were synthesized and evaluated in vitro for their cytotoxicity. All the compounds showed promising in vitro cytotoxicity against six tumor cell lines (Hep3B, MCF7, A549, MDA-MB-231, KB and KB-vin). Out of them, compound c20 possesses remarkable in vitro cytotoxic activity and is more potent than topotecan. Mechanistically, c20 not only induces cell cycle arrest and cell apoptosis in A549 cells, but also inhibits Topo I activity in the cell and cell-free system in a manner similar to that of topotecan. In both xenograft and primary HCC mouse models, c20 displays significant in vivo anti-cancer activity and is more potent than topotecan. In addition, the acute toxicity assay showed that c20 has no apparent toxicity to mouse liver, kidney and hemopoietic system of the FVB/N mice. Take together, these results indicated that compound c20 could be a potential anti-cancer candidate for further clinical trial.\n",
            "1702826\n",
            "Inhibition of human recombinant topoisomerase 1 expressed in baculovirus expression system at 0.5 uM using supercoiled plasmid DNA as substrate preincubated 20 mins followed by substrate addition and measured after 30 mins by SYBR-green staining based agarose gel electrophoresis\n",
            "Title: Design, synthesis and antineoplastic activity of novel 20(S)-acylthiourea derivatives of camptothecin.  Abstract: For the purpose of advancing our research on diverse C-20 decorated derivatives of camptothecin (CPT), 46 new CPT acylthiourea derivatives were synthesized and evaluated in vitro for their cytotoxicity. All the compounds showed promising in vitro cytotoxicity against six tumor cell lines (Hep3B, MCF7, A549, MDA-MB-231, KB and KB-vin). Out of them, compound c20 possesses remarkable in vitro cytotoxic activity and is more potent than topotecan. Mechanistically, c20 not only induces cell cycle arrest and cell apoptosis in A549 cells, but also inhibits Topo I activity in the cell and cell-free system in a manner similar to that of topotecan. In both xenograft and primary HCC mouse models, c20 displays significant in vivo anti-cancer activity and is more potent than topotecan. In addition, the acute toxicity assay showed that c20 has no apparent toxicity to mouse liver, kidney and hemopoietic system of the FVB/N mice. Take together, these results indicated that compound c20 could be a potential anti-cancer candidate for further clinical trial.\n",
            "1703217\n",
            "Inhibition of human recombinant topoisomerase I using DNA pBR322 as substrate assessed as relaxed DNA at 1 uM incubated for 30 mins by gel electrophoresis analysis relative to control\n",
            "Title: F10, a new camptothecin derivative, was identified as a new orally-bioavailable, potent antitumor agent.  Abstract: Topoisomerases are interesting targets for drug discovery. In the present study, we attached saturated carbon atoms to the 10-position of camptothecin and synthesized 10 new camptothecin derivatives from 10-HCPT or SN-38. The activities of new compounds were evaluated both in vitro and in vivo. The most promising compound F10, 7-ethyl-10-(2-oxo-2-(piperidin-1-yl)ethoxy)camptothecin, inhibited cancer cells growth with the IC of 0.002, 0.003, 0.011 and 0.081 M on Raji, HCT116, A549 and Lovo cells, respectively. Meanwhile, oral administration of F10 remarkably suppressed the HCT116-xenograft tumor growth in the nude-mice model at the dosage of 0.5, 2.0 and 8.0 mg/kg in vivo. Intraperitoneal administration of F10 can completely inhibit Raji-xenograft tumor growth in established NPG mouse model at 2.0 and 4.0 mg/kg. In addition, the minimum lethal doses of F10 and SN-38 in mice by intravenous administration were 80 and 40 mg/kg (or 0.155, 0.102 mmol/kg), respectively. The solubility of F10 reached 9.86 g/mL in a buffer solution of pH 4.5. The oral bioavailability of F10 achieved 22.4% in mice. The molecular docking model revealed that F10 can interact with topoisomerase I-DNA complex. Our findings indicate that F10 is a new orally-oavailable antitumor agent with potent anticancer effect. Furthermore, attaching a ring hydrophobic moiety to the 10-position of camptothecin provides a favorable approach in the optimization of camptothecin.\n",
            "1703218\n",
            "Inhibition of human recombinant topoisomerase I using DNA pBR322 as substrate assessed as relaxed DNA at 10 uM incubated for 30 mins by gel electrophoresis analysis relative to control\n",
            "Title: F10, a new camptothecin derivative, was identified as a new orally-bioavailable, potent antitumor agent.  Abstract: Topoisomerases are interesting targets for drug discovery. In the present study, we attached saturated carbon atoms to the 10-position of camptothecin and synthesized 10 new camptothecin derivatives from 10-HCPT or SN-38. The activities of new compounds were evaluated both in vitro and in vivo. The most promising compound F10, 7-ethyl-10-(2-oxo-2-(piperidin-1-yl)ethoxy)camptothecin, inhibited cancer cells growth with the IC of 0.002, 0.003, 0.011 and 0.081 M on Raji, HCT116, A549 and Lovo cells, respectively. Meanwhile, oral administration of F10 remarkably suppressed the HCT116-xenograft tumor growth in the nude-mice model at the dosage of 0.5, 2.0 and 8.0 mg/kg in vivo. Intraperitoneal administration of F10 can completely inhibit Raji-xenograft tumor growth in established NPG mouse model at 2.0 and 4.0 mg/kg. In addition, the minimum lethal doses of F10 and SN-38 in mice by intravenous administration were 80 and 40 mg/kg (or 0.155, 0.102 mmol/kg), respectively. The solubility of F10 reached 9.86 g/mL in a buffer solution of pH 4.5. The oral bioavailability of F10 achieved 22.4% in mice. The molecular docking model revealed that F10 can interact with topoisomerase I-DNA complex. Our findings indicate that F10 is a new orally-oavailable antitumor agent with potent anticancer effect. Furthermore, attaching a ring hydrophobic moiety to the 10-position of camptothecin provides a favorable approach in the optimization of camptothecin.\n",
            "1703219\n",
            "Inhibition of human recombinant topoisomerase I using DNA pBR322 as substrate assessed as relaxed DNA at 100 uM incubated for 30 mins by gel electrophoresis analysis relative to control\n",
            "Title: F10, a new camptothecin derivative, was identified as a new orally-bioavailable, potent antitumor agent.  Abstract: Topoisomerases are interesting targets for drug discovery. In the present study, we attached saturated carbon atoms to the 10-position of camptothecin and synthesized 10 new camptothecin derivatives from 10-HCPT or SN-38. The activities of new compounds were evaluated both in vitro and in vivo. The most promising compound F10, 7-ethyl-10-(2-oxo-2-(piperidin-1-yl)ethoxy)camptothecin, inhibited cancer cells growth with the IC of 0.002, 0.003, 0.011 and 0.081 M on Raji, HCT116, A549 and Lovo cells, respectively. Meanwhile, oral administration of F10 remarkably suppressed the HCT116-xenograft tumor growth in the nude-mice model at the dosage of 0.5, 2.0 and 8.0 mg/kg in vivo. Intraperitoneal administration of F10 can completely inhibit Raji-xenograft tumor growth in established NPG mouse model at 2.0 and 4.0 mg/kg. In addition, the minimum lethal doses of F10 and SN-38 in mice by intravenous administration were 80 and 40 mg/kg (or 0.155, 0.102 mmol/kg), respectively. The solubility of F10 reached 9.86 g/mL in a buffer solution of pH 4.5. The oral bioavailability of F10 achieved 22.4% in mice. The molecular docking model revealed that F10 can interact with topoisomerase I-DNA complex. Our findings indicate that F10 is a new orally-oavailable antitumor agent with potent anticancer effect. Furthermore, attaching a ring hydrophobic moiety to the 10-position of camptothecin provides a favorable approach in the optimization of camptothecin.\n",
            "1703331\n",
            "Inhibition of human recombinant Topoisomerase 1 using supercoiled pBR322 DNA as substrate at 50 uM incubated for 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Oligosaccharide-camptothecin conjugates as potential antineoplastic drugs: Design, synthesis and biological evaluation.  Abstract: Thirty novel 20 (S)-O-linked camptothecin (CPT) glycoconjugates were synthesized. They showed more potent in vitro cytotoxicities over irinotecan, but very weak direct topoisomerase I (Topo I) inhibition was observed at 100.0 M. Oligosaccharide types, length of a PEG linker and acetyl groups exerted obvious effects on cytotoxicity, selectivity, water solubility and stability of the newly synthesized CPT glycoconjugates. Construct 40, with a bleomycin (BLM) disaccharide linked to diethylene glycol in the introduced ester moiety, demonstrated a superior antitumor activity and a distinct selectivity compared to CPT. No toxicity was detectable in animal acute toxicity intravenously (160 mg/kg). Collectively, attachment of oligosaccharides with tumor targeting to 20 (S)-OH of CPT could offer a solution to the daunting problems posed by current Topo I poisons.\n",
            "1703332\n",
            "Inhibition of human recombinant Topoisomerase 1 using supercoiled pBR322 DNA as substrate at 100 uM incubated for 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Oligosaccharide-camptothecin conjugates as potential antineoplastic drugs: Design, synthesis and biological evaluation.  Abstract: Thirty novel 20 (S)-O-linked camptothecin (CPT) glycoconjugates were synthesized. They showed more potent in vitro cytotoxicities over irinotecan, but very weak direct topoisomerase I (Topo I) inhibition was observed at 100.0 M. Oligosaccharide types, length of a PEG linker and acetyl groups exerted obvious effects on cytotoxicity, selectivity, water solubility and stability of the newly synthesized CPT glycoconjugates. Construct 40, with a bleomycin (BLM) disaccharide linked to diethylene glycol in the introduced ester moiety, demonstrated a superior antitumor activity and a distinct selectivity compared to CPT. No toxicity was detectable in animal acute toxicity intravenously (160 mg/kg). Collectively, attachment of oligosaccharides with tumor targeting to 20 (S)-OH of CPT could offer a solution to the daunting problems posed by current Topo I poisons.\n",
            "1708523\n",
            "Inhibition of human topoisomerase 1 assessed as stabilization of Topl-DNA cleavable complex by measuring DNA cleavage at 50 uM by ethidium bromide dye based agarose gel electrophoresis\n",
            "Title: Copper(I)-Catalyzed Nitrile-Addition/N-Arylation Ring-Closure Cascade: Synthesis of 5,11-Dihydro-6H-indolo[3,2-c]quinolin-6-ones as Potent Topoisomerase-I Inhibitors.  Abstract: In this paper, we present a copper(I)-catalyzed nitrile-addition/N-arylation ring-closure cascade for the synthesis of 5,11-dihydro-6H-indolo[3,2-c]quinolin-6-ones from 2-(2-bromophenyl)-N-(2-cyanophenyl)acetamides. Using CuBr and t-BuONa in dimethylformamide (DMF) as the optimal reaction conditions, the cascade reaction gave the target products, in high yields, with a good substrate scope. Application of the cascade reaction was demonstrated on the concise total syntheses of alkaloid isocryptolepine. Further optimization of the products from the cascade reaction led to 3-chloro-5,12-bis[2-(dimethylamino)ethyl]-5,12-dihydro-6H-[1,3]dioxolo[4',5':5,6]indolo[3,2-c]quinolin-6-one (2k), which exhibited the characteristic DNA topoisomerase-I inhibitory mechanism of action with potent in vitro anticancer activity. Compound 2k actively inhibited ARC-111- and SN-38-resistant HCT-116 cells and showed in vivo activity in mice bearing human HCT-116 and SJCRH30 xenografts. The interaction of 2k with the Top-DNA cleavable complex was revealed by docking simulations to guide the future optimization of 5,11-dihydro-6H-indolo[3,2-c]quinolin-6-ones as topoisomerase-I inhibitors.\n",
            "1708533\n",
            "Inhibition of human topoisomerase 1\n",
            "Title: Copper(I)-Catalyzed Nitrile-Addition/N-Arylation Ring-Closure Cascade: Synthesis of 5,11-Dihydro-6H-indolo[3,2-c]quinolin-6-ones as Potent Topoisomerase-I Inhibitors.  Abstract: In this paper, we present a copper(I)-catalyzed nitrile-addition/N-arylation ring-closure cascade for the synthesis of 5,11-dihydro-6H-indolo[3,2-c]quinolin-6-ones from 2-(2-bromophenyl)-N-(2-cyanophenyl)acetamides. Using CuBr and t-BuONa in dimethylformamide (DMF) as the optimal reaction conditions, the cascade reaction gave the target products, in high yields, with a good substrate scope. Application of the cascade reaction was demonstrated on the concise total syntheses of alkaloid isocryptolepine. Further optimization of the products from the cascade reaction led to 3-chloro-5,12-bis[2-(dimethylamino)ethyl]-5,12-dihydro-6H-[1,3]dioxolo[4',5':5,6]indolo[3,2-c]quinolin-6-one (2k), which exhibited the characteristic DNA topoisomerase-I inhibitory mechanism of action with potent in vitro anticancer activity. Compound 2k actively inhibited ARC-111- and SN-38-resistant HCT-116 cells and showed in vivo activity in mice bearing human HCT-116 and SJCRH30 xenografts. The interaction of 2k with the Top-DNA cleavable complex was revealed by docking simulations to guide the future optimization of 5,11-dihydro-6H-indolo[3,2-c]quinolin-6-ones as topoisomerase-I inhibitors.\n",
            "1708534\n",
            "Inhibition of human topoisomerase 1 assessed as stabilization of Topl-DNA cleavable complex by measuring band intensity of free Top-l at 0.1 to 1 uM by band-depletion assay\n",
            "Title: Copper(I)-Catalyzed Nitrile-Addition/N-Arylation Ring-Closure Cascade: Synthesis of 5,11-Dihydro-6H-indolo[3,2-c]quinolin-6-ones as Potent Topoisomerase-I Inhibitors.  Abstract: In this paper, we present a copper(I)-catalyzed nitrile-addition/N-arylation ring-closure cascade for the synthesis of 5,11-dihydro-6H-indolo[3,2-c]quinolin-6-ones from 2-(2-bromophenyl)-N-(2-cyanophenyl)acetamides. Using CuBr and t-BuONa in dimethylformamide (DMF) as the optimal reaction conditions, the cascade reaction gave the target products, in high yields, with a good substrate scope. Application of the cascade reaction was demonstrated on the concise total syntheses of alkaloid isocryptolepine. Further optimization of the products from the cascade reaction led to 3-chloro-5,12-bis[2-(dimethylamino)ethyl]-5,12-dihydro-6H-[1,3]dioxolo[4',5':5,6]indolo[3,2-c]quinolin-6-one (2k), which exhibited the characteristic DNA topoisomerase-I inhibitory mechanism of action with potent in vitro anticancer activity. Compound 2k actively inhibited ARC-111- and SN-38-resistant HCT-116 cells and showed in vivo activity in mice bearing human HCT-116 and SJCRH30 xenografts. The interaction of 2k with the Top-DNA cleavable complex was revealed by docking simulations to guide the future optimization of 5,11-dihydro-6H-indolo[3,2-c]quinolin-6-ones as topoisomerase-I inhibitors.\n",
            "1713804\n",
            "Inhibition of recombinant human DNA topoisomerase 1 expressed in baculovirus expression system assessed as decrease in relaxation of supercoiled pBR322 plasmid DNA at 20 uM using supercoiled pBR322 plasmid DNA as substrate incubated for 30 mins by ethidium bromide staining-based UV imaging analysis relative to control\n",
            "Title: Synthesis and topoisomerases inhibitory activity of heteroaromatic chalcones.  Abstract: The critical role of nuclear topoisomerase enzymes during cell proliferation process guided topoisomerases to be one of the major targets for anticancer drug development. We have designed and synthesized 22 heteroaromatic ring incorporated chalcone derivatives substituted with epoxide or thioepoxide. Topoisomerase enzyme inhibitory activity and cytotoxic tests were also conducted to evaluate compounds' pharmacological efficacy. In the topoisomerase I inhibitory test, compound 1 was most active one, 24% of inhibition at 20M, among all the compounds but it was lower than camptothecin. Compounds 9, 11, and 13 inhibited the function of topoisomerase II more strongly than etoposide with almost same magnitude (around 90% and 30% inhibition at 100 and 20M, respectively) which were higher than those of etoposide (72% and 18% inhibition). In the cytotoxicity test, compound 9 inhibited T47D cancer cell growth with the IC value of 6.610.21M. On the other hand, compound 13 (IC: 4.320.18M) effectively suppressed MDA-MB468 cancer cell growth.\n",
            "1713805\n",
            "Inhibition of recombinant human DNA topoisomerase 1 expressed in baculovirus expression system assessed as decrease in relaxation of supercoiled pBR322 plasmid DNA at 100 uM using supercoiled pBR322 plasmid DNA as substrate incubated for 30 mins by ethidium bromide staining-based UV imaging analysis relative to control\n",
            "Title: Synthesis and topoisomerases inhibitory activity of heteroaromatic chalcones.  Abstract: The critical role of nuclear topoisomerase enzymes during cell proliferation process guided topoisomerases to be one of the major targets for anticancer drug development. We have designed and synthesized 22 heteroaromatic ring incorporated chalcone derivatives substituted with epoxide or thioepoxide. Topoisomerase enzyme inhibitory activity and cytotoxic tests were also conducted to evaluate compounds' pharmacological efficacy. In the topoisomerase I inhibitory test, compound 1 was most active one, 24% of inhibition at 20M, among all the compounds but it was lower than camptothecin. Compounds 9, 11, and 13 inhibited the function of topoisomerase II more strongly than etoposide with almost same magnitude (around 90% and 30% inhibition at 100 and 20M, respectively) which were higher than those of etoposide (72% and 18% inhibition). In the cytotoxicity test, compound 9 inhibited T47D cancer cell growth with the IC value of 6.610.21M. On the other hand, compound 13 (IC: 4.320.18M) effectively suppressed MDA-MB468 cancer cell growth.\n",
            "1723562\n",
            "Inhibition of Top (unknown origin) mediated supercoiled DNA relaxation at 100 uM\n",
            "Title: Discovery of Evodiamine Derivatives as Highly Selective PDE5 Inhibitors Targeting a Unique Allosteric Pocket.  Abstract: Clinical use of phosphodiesterase-5 (PDE5) inhibitors is limited by several side effects due to weak isoform selectivity. Herein, a unique allosteric pocket of PDE5 is identified by molecular modeling and structural biology, which enables the discovery of highly selective PDE5 inhibitors from natural product evodiamine (EVO). The crystal structure of PDE5 with bound EVO derivative ( S )-7e revealed that binding of ( S )-7e to the novel allosteric pocket induced dramatic conformation changes in the H-loop with a maximum 24  movement of their C atoms. This movement directly blocks the binding of substrate/inhibitors to the PDE5 active site, which is different from all traditional PDE5 inhibitors such as sildenafil, tadalafil, and vardenafil. These derivatives showed >570-fold selectivity over PDE6C and PDE11A and achieved potent efficacy for the effective treatment of pulmonary hypertension in vivo.\n",
            "1724032\n",
            "Inhibition of Topoisomerase 1 (unknown origin)\n",
            "Title: Design, synthesis, biological evaluation, QSAR analysis and molecular modelling of new thiazol-benzimidazoles as EGFR inhibitors.  Abstract: Heterocyclic rings such as thiazole and benzimidazole are considered as privileged structures, since they constitute several FDA-approved drugs for cancer treatment. In this work, a new set of 2-(2-(substituted) hydrazinyl)-4-(1-methyl-1H-benzo[d]imidazol-2-yl) thiazoles 4a-q were designed as epidermal growth factor receptor (EGFR) inhibitors and synthesized using concise synthetic methods. The new target compounds have been evaluated in vitro for their suppression activity against EGFR TK. Compounds 4n, 4h, 4i, 4a and 4d exhibited significant potency in comparison with erlotinib which served as a reference drug (IC50, 71.67-152.59 nM; IC50 erlotinib, 152.59 nM). Furthermore, MTT assay revealed that compounds 4j, 4a, 4f, 4h, 4n produced the most promising cytotoxic potency against the human breast cancer cell line (MCF-7) (IC50; 5.96-11.91 M; IC50 erlotinib; 4.15 M). Compound 4a showed promising activity as EGFR TK inhibitor as well as anti-breast cancer agent. In addition, 4a induced apoptotic effect and cell cycle arrest at G2/M phase preventing the mitotic cycle in MCF-7 cells. Moreover, 4a upregulated the oncogenic parameters; caspase-3, p53, Bax/Bcl-2 as well as it inhibited the level of PARP-1 enzyme. QSAR study was carried out for the new derivatives and it revealed the goodness of the models. Furthermore, molecular docking studies represented the binding modes of the promising compounds in the active pocket of EGFR.\n",
            "1727988\n",
            "Inhibition of topoisomerase 1 (unknown origin) using pBR322 DNA as substrate at 20 uM by gel electrophoresis\n",
            "Title: Design, synthesis and antitumor evaluation of new 1,8-naphthalimide derivatives targeting nuclear DNA.  Abstract: Four series of new 3-nitro naphthalimides derivatives, 4(4a4f), 5(5a5i), 6(6a6e) and 7 (7a7j), were designed and synthesized as antitumor agents. Methyl thiazolyl tetrazolium (MTT) screening assay results revealed that some compounds displayed effective in vitro antiproliferative activity on SMMC-7721, T24, SKOV-3, A549 and MGC-803 cancer cell lines in comparison with 5-fluorouracil (5-FU), mitonafide and amonafide. Nude mouse xenotransplantation model assay results indicated that compounds 6b and 7b exhibited good in vivo antiproliferative activity in MGC-803 xenografts in comparison with amonafide and cisplatin, suggesting that compounds 6b and 7b could be good candidates for antitumor agents. Gel electrophoresis assay indicated that DNA and Topo I were the potential targets of compounds 6b and 7b, and comet assay confirmed that compounds 6b and 7b could induce DNA damage, while the further study showed that the 6b- and 7b-induced DNA damage was accompanied by the upregulation of p-ATM, P-Chk2, Cdc25A and p-H2AX. Cell cycle arrest studies demonstrated that compounds 6b and 7b arrested the cell cycle at the S phase, accompanied by the upregulation of the expression levels of the antioncogene p21 and the down-regulation of the expression levels of cyclin E. Apoptosis assays indicated that compounds 6b and 7b caused the apoptosis of tumor cells along with the upregulation of the expression of Bax, caspase-3, caspase-9 and PARP and the downregulation of Bcl-2. These mechanistic studies suggested that compounds 6b and 7b exerted their antitumor activity by targeting to DNA, thereby inducing DNA damage and Topo I inhibition, and consequently causing S stage arrest and the induction of apoptosis.\n",
            "1727989\n",
            "Inhibition of topoisomerase 1 (unknown origin) using pBR322 DNA as substrate at 10 uM by gel electrophoresis\n",
            "Title: Design, synthesis and antitumor evaluation of new 1,8-naphthalimide derivatives targeting nuclear DNA.  Abstract: Four series of new 3-nitro naphthalimides derivatives, 4(4a4f), 5(5a5i), 6(6a6e) and 7 (7a7j), were designed and synthesized as antitumor agents. Methyl thiazolyl tetrazolium (MTT) screening assay results revealed that some compounds displayed effective in vitro antiproliferative activity on SMMC-7721, T24, SKOV-3, A549 and MGC-803 cancer cell lines in comparison with 5-fluorouracil (5-FU), mitonafide and amonafide. Nude mouse xenotransplantation model assay results indicated that compounds 6b and 7b exhibited good in vivo antiproliferative activity in MGC-803 xenografts in comparison with amonafide and cisplatin, suggesting that compounds 6b and 7b could be good candidates for antitumor agents. Gel electrophoresis assay indicated that DNA and Topo I were the potential targets of compounds 6b and 7b, and comet assay confirmed that compounds 6b and 7b could induce DNA damage, while the further study showed that the 6b- and 7b-induced DNA damage was accompanied by the upregulation of p-ATM, P-Chk2, Cdc25A and p-H2AX. Cell cycle arrest studies demonstrated that compounds 6b and 7b arrested the cell cycle at the S phase, accompanied by the upregulation of the expression levels of the antioncogene p21 and the down-regulation of the expression levels of cyclin E. Apoptosis assays indicated that compounds 6b and 7b caused the apoptosis of tumor cells along with the upregulation of the expression of Bax, caspase-3, caspase-9 and PARP and the downregulation of Bcl-2. These mechanistic studies suggested that compounds 6b and 7b exerted their antitumor activity by targeting to DNA, thereby inducing DNA damage and Topo I inhibition, and consequently causing S stage arrest and the induction of apoptosis.\n",
            "1727990\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as DNA relaxation using pBR322 DNA as substrate at < 20 uM by gel electrophoresis\n",
            "Title: Design, synthesis and antitumor evaluation of new 1,8-naphthalimide derivatives targeting nuclear DNA.  Abstract: Four series of new 3-nitro naphthalimides derivatives, 4(4a4f), 5(5a5i), 6(6a6e) and 7 (7a7j), were designed and synthesized as antitumor agents. Methyl thiazolyl tetrazolium (MTT) screening assay results revealed that some compounds displayed effective in vitro antiproliferative activity on SMMC-7721, T24, SKOV-3, A549 and MGC-803 cancer cell lines in comparison with 5-fluorouracil (5-FU), mitonafide and amonafide. Nude mouse xenotransplantation model assay results indicated that compounds 6b and 7b exhibited good in vivo antiproliferative activity in MGC-803 xenografts in comparison with amonafide and cisplatin, suggesting that compounds 6b and 7b could be good candidates for antitumor agents. Gel electrophoresis assay indicated that DNA and Topo I were the potential targets of compounds 6b and 7b, and comet assay confirmed that compounds 6b and 7b could induce DNA damage, while the further study showed that the 6b- and 7b-induced DNA damage was accompanied by the upregulation of p-ATM, P-Chk2, Cdc25A and p-H2AX. Cell cycle arrest studies demonstrated that compounds 6b and 7b arrested the cell cycle at the S phase, accompanied by the upregulation of the expression levels of the antioncogene p21 and the down-regulation of the expression levels of cyclin E. Apoptosis assays indicated that compounds 6b and 7b caused the apoptosis of tumor cells along with the upregulation of the expression of Bax, caspase-3, caspase-9 and PARP and the downregulation of Bcl-2. These mechanistic studies suggested that compounds 6b and 7b exerted their antitumor activity by targeting to DNA, thereby inducing DNA damage and Topo I inhibition, and consequently causing S stage arrest and the induction of apoptosis.\n",
            "1728398\n",
            "Inhibition of human topoisomerase-1 beta incubated for 2 hrs by ELISA\n",
            "Title: Design, synthesis and screening of benzimidazole containing compounds with methoxylated aryl radicals as cytotoxic molecules on (HCT-116) colon cancer cells.  Abstract: A novel series of benzimidazole derivatives with methoxylated aryl groups was designed and synthesized as molecules with potential cytotoxic activity. In vitro cytotoxic activity over HCT-116 cells showed that N-(benzimidazothiazolone)acetamides 11a, 11b and 11c were found to be the most cytotoxic compounds compared camptothecin (CPT). The tested compounds had a dual topoisomerase I- (Topo I-) and tubulin inhibiting activities when compared to CPT and Podophyllotoxin (Podo) where, compounds l0a, l0b, 11a and 11b exhibited a potent inhibitory activity on Topo I- enzyme in nano-molar concentration, on the other hand, compounds 12b and 13b exhibited the best inhibitory activity -tubulin polymerization. Results of the cell cycle analysis as well as the results of annexin-V on HCT-116 cells showed that benzimidazothiazoles 12b and 13b had a pro-apoptotic activity higher than CPT by 1.33- and 1.30-folds, respectively. Moreover, the concentration of p53, Bax/Bcl-2 ratio and caspase 3/7 increased in compounds l0b, 11b, l2b, 13b, especially, compounds 11b and 13b exhibited an increased level of these mediators than CPT. Finally, compound 11b regulated the radiosensitizing activity of the HCT-116 cells by modulating the chromosomal instability.\n",
            "1728414\n",
            "Potency index, ratio of camptothecin IC50 to test compound IC50 for inhibition of human topoisomerase-1 beta incubated for 2 hrs by ELISA\n",
            "Title: Design, synthesis and screening of benzimidazole containing compounds with methoxylated aryl radicals as cytotoxic molecules on (HCT-116) colon cancer cells.  Abstract: A novel series of benzimidazole derivatives with methoxylated aryl groups was designed and synthesized as molecules with potential cytotoxic activity. In vitro cytotoxic activity over HCT-116 cells showed that N-(benzimidazothiazolone)acetamides 11a, 11b and 11c were found to be the most cytotoxic compounds compared camptothecin (CPT). The tested compounds had a dual topoisomerase I- (Topo I-) and tubulin inhibiting activities when compared to CPT and Podophyllotoxin (Podo) where, compounds l0a, l0b, 11a and 11b exhibited a potent inhibitory activity on Topo I- enzyme in nano-molar concentration, on the other hand, compounds 12b and 13b exhibited the best inhibitory activity -tubulin polymerization. Results of the cell cycle analysis as well as the results of annexin-V on HCT-116 cells showed that benzimidazothiazoles 12b and 13b had a pro-apoptotic activity higher than CPT by 1.33- and 1.30-folds, respectively. Moreover, the concentration of p53, Bax/Bcl-2 ratio and caspase 3/7 increased in compounds l0b, 11b, l2b, 13b, especially, compounds 11b and 13b exhibited an increased level of these mediators than CPT. Finally, compound 11b regulated the radiosensitizing activity of the HCT-116 cells by modulating the chromosomal instability.\n",
            "1732040\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as reduction in relaxation of supercoiled plasmid pBR322 DNA at 10 uM incubated for 30 mins by agarose gel electrophoresis\n",
            "Title: Design, Synthesis and Structure-Activity Relationship Studies of Glycosylated Derivatives of Marine Natural Product Lamellarin D.  Abstract: Lamellarin D, a marine natural product, acts as a potent inhibitor of DNA topoisomerase I (Topo I). To modify its physicochemical property and biological activity, a series of mono- and di-glycosylated derivatives were designed and synthesized through 22-26 multi-steps. Their inhibition of human Topo I was evaluated, and most of the glycosylated derivatives exhibited high potency in inhibiting Topo I activity as well as lamellarin D. All the 15 target compounds were evaluated for their cytotoxic activities against five human cancer cell lines. The typical lamellarin derivative ZL-3 exhibited the best activity with IC values of 3 nM, 10 nM, and 15 nM against human lung cancer A549 cells, human colon cancer HCT116 cells and human hepatocellular carcinoma HepG2 cells. Compound ZL-1 exhibited anti-cancer activity with IC of 14 nM and 24 nM against human colon cancer HCT116 cells and human hepatocellular carcinoma HepG2 cells, respectively. Cell cycle analysis in MDA-MB-231 suggested ZL-3 inhibited cell growth through arresting cells at the G2/M phase of the cell cycle. Further tests showed a significant improvement in aqueous solubility of ZL-1 and ZL-7. This study suggested that glycosylation could be utilized as a useful strategy to optimize lamellarin D derivatives as Topo I inhibitors and anticancer agents.\n",
            "1733013\n",
            "Inhibition of recombinant human TOPO1 assessed as TOP1-DNA cleavage complexes at 1 uM using 3'-[32-P]-117 labeled bp DNA as substrate incubated for 30 mins by SDS-PAGE analysis relative to control\n",
            "Title: Discovery of 4-alkoxy-2-aryl-6,7-dimethoxyquinolines as a new class of topoisomerase I inhibitors endowed with potent in vitro anticancer activity.  Abstract: In our attempt to develop potential anticancer agents targeting Topoisomerase I (TOP1), two novel series of 4-alkoxy-2-arylquinolines 14a-p and 19a-c were designed and synthesized based on structure activity relationships of the reported TOP1 inhibitors and structural features required for stabilization of TOP1-DNA cleavage complexes (TOP1ccs). The in vitro anticancer activity of these two series of compounds was evaluated at one dose level using NCI-60 cancer cell lines panel. Compounds 14e-h and 14m-p, with p-substituted phenyl at C2 and propyl linker at C4, were the most potent and were selected for assay at five doses level in which they exhibited potent anticancer activity at sub-micromolar level against diverse cancer cell lines. Compound 14m was the most potent with full panel GI MG-MID 1.26 M and the most sensitive cancers were colon cancer, leukemia and melanoma with GI MG-MID 0.875, 0.904 and 0.926 M, respectively. Melanoma (LOX IMVI) was the most sensitive cell line to all tested compounds displaying GI from 0.116 to 0.227 M, TGI from 0.275 to 0.592 M and LC at sub-micromolar concentration against almost of the tested compounds. Compounds 14e-h and 14m-p were assayed using TOP1-mediated DNA cleavage assay to evaluate their ability to stabilize TOP1ccs resulting in cancer cell death. The morpholino analogs 14h and 14p exhibited moderate TOP1 inhibitory activity compared to 1 M camptothecin suggesting their use as lead compounds that can be optimized for the development of more potent anticancer agents with potential TOP1 inhibitory activity. Finally, Swiss ADME online web tool predicted that compounds 14h and 14p possessed good oral bioavailability and druglikeness characteristics.\n",
            "1736595\n",
            "Inhibition of human recombinant topoisomerase 1 expressed in baculovirus-infected insect cells assessed as inhibition of DNA relaxation at 10 uM incubated for 30 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Design, synthesis, and biological evaluation of heterotetracyclic quinolinone derivatives as anticancer agents targeting topoisomerases.  Abstract: A series of thiochromeno[2,3-c]quinolin-12-one derivatives with various substitutions were synthesized and evaluated as topoisomerase (Topo) inhibitors. Six (8, 10, 12, 14, 19, and 26) of 23 compounds showed strong inhibitory activities against Topo-mediated DNA relaxation and proliferation of five human cell lines including breast (MDA-MB-231, MDA-MB-468 and MCF7), colorectal (HCT116) and non-small cell lung (H1299) cancers. Among these, compounds 14 and 26 exhibited full inhibitory activities against Topo I at 3 M and Topo II at 1 M. Cancer cells treated with 26 accumulated DNA damage and were arrested at the G/M phase. With time, cells proceeded to apoptosis, as revealed by increased amounts of cells with fragmented DNA and cleavage of caspase-8 and -9. In contrast, normal breast epithelial cells showed low sensitivity to 26. Taken together, our study identifies 26 as a potent Topo dual-inhibitor with low toxicity to normal cells, and elucidates that the terminal amino group of N-2-aminoethylamino or N-3-aminopropylamino at the 6th position and 8,10-di-halogen substituents on thiochromeno[2,3-c]quinolin-12-one are critical for the Topo-inhibiting and cancer-killing activities.\n",
            "1736602\n",
            "Inhibition of human recombinant topoisomerase 1 expressed in baculovirus-infected insect cells assessed as inhibition of DNA relaxation at 3 uM incubated for 30 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Design, synthesis, and biological evaluation of heterotetracyclic quinolinone derivatives as anticancer agents targeting topoisomerases.  Abstract: A series of thiochromeno[2,3-c]quinolin-12-one derivatives with various substitutions were synthesized and evaluated as topoisomerase (Topo) inhibitors. Six (8, 10, 12, 14, 19, and 26) of 23 compounds showed strong inhibitory activities against Topo-mediated DNA relaxation and proliferation of five human cell lines including breast (MDA-MB-231, MDA-MB-468 and MCF7), colorectal (HCT116) and non-small cell lung (H1299) cancers. Among these, compounds 14 and 26 exhibited full inhibitory activities against Topo I at 3 M and Topo II at 1 M. Cancer cells treated with 26 accumulated DNA damage and were arrested at the G/M phase. With time, cells proceeded to apoptosis, as revealed by increased amounts of cells with fragmented DNA and cleavage of caspase-8 and -9. In contrast, normal breast epithelial cells showed low sensitivity to 26. Taken together, our study identifies 26 as a potent Topo dual-inhibitor with low toxicity to normal cells, and elucidates that the terminal amino group of N-2-aminoethylamino or N-3-aminopropylamino at the 6th position and 8,10-di-halogen substituents on thiochromeno[2,3-c]quinolin-12-one are critical for the Topo-inhibiting and cancer-killing activities.\n",
            "1736603\n",
            "Inhibition of human recombinant topoisomerase 1 expressed in baculovirus-infected insect cells assessed as inhibition of DNA relaxation at 1 uM incubated for 30 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Design, synthesis, and biological evaluation of heterotetracyclic quinolinone derivatives as anticancer agents targeting topoisomerases.  Abstract: A series of thiochromeno[2,3-c]quinolin-12-one derivatives with various substitutions were synthesized and evaluated as topoisomerase (Topo) inhibitors. Six (8, 10, 12, 14, 19, and 26) of 23 compounds showed strong inhibitory activities against Topo-mediated DNA relaxation and proliferation of five human cell lines including breast (MDA-MB-231, MDA-MB-468 and MCF7), colorectal (HCT116) and non-small cell lung (H1299) cancers. Among these, compounds 14 and 26 exhibited full inhibitory activities against Topo I at 3 M and Topo II at 1 M. Cancer cells treated with 26 accumulated DNA damage and were arrested at the G/M phase. With time, cells proceeded to apoptosis, as revealed by increased amounts of cells with fragmented DNA and cleavage of caspase-8 and -9. In contrast, normal breast epithelial cells showed low sensitivity to 26. Taken together, our study identifies 26 as a potent Topo dual-inhibitor with low toxicity to normal cells, and elucidates that the terminal amino group of N-2-aminoethylamino or N-3-aminopropylamino at the 6th position and 8,10-di-halogen substituents on thiochromeno[2,3-c]quinolin-12-one are critical for the Topo-inhibiting and cancer-killing activities.\n",
            "1736606\n",
            "Poison activity at human recombinant topoisomerase I assessed as accumulation of supercoiled DNA at 10 uM measured after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Design, synthesis, and biological evaluation of heterotetracyclic quinolinone derivatives as anticancer agents targeting topoisomerases.  Abstract: A series of thiochromeno[2,3-c]quinolin-12-one derivatives with various substitutions were synthesized and evaluated as topoisomerase (Topo) inhibitors. Six (8, 10, 12, 14, 19, and 26) of 23 compounds showed strong inhibitory activities against Topo-mediated DNA relaxation and proliferation of five human cell lines including breast (MDA-MB-231, MDA-MB-468 and MCF7), colorectal (HCT116) and non-small cell lung (H1299) cancers. Among these, compounds 14 and 26 exhibited full inhibitory activities against Topo I at 3 M and Topo II at 1 M. Cancer cells treated with 26 accumulated DNA damage and were arrested at the G/M phase. With time, cells proceeded to apoptosis, as revealed by increased amounts of cells with fragmented DNA and cleavage of caspase-8 and -9. In contrast, normal breast epithelial cells showed low sensitivity to 26. Taken together, our study identifies 26 as a potent Topo dual-inhibitor with low toxicity to normal cells, and elucidates that the terminal amino group of N-2-aminoethylamino or N-3-aminopropylamino at the 6th position and 8,10-di-halogen substituents on thiochromeno[2,3-c]quinolin-12-one are critical for the Topo-inhibiting and cancer-killing activities.\n",
            "1736607\n",
            "Poison activity at human recombinant topoisomerase I assessed as accumulation of supercoiled DNA by measuring restricted DNA mobility at 30 uM measured after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Design, synthesis, and biological evaluation of heterotetracyclic quinolinone derivatives as anticancer agents targeting topoisomerases.  Abstract: A series of thiochromeno[2,3-c]quinolin-12-one derivatives with various substitutions were synthesized and evaluated as topoisomerase (Topo) inhibitors. Six (8, 10, 12, 14, 19, and 26) of 23 compounds showed strong inhibitory activities against Topo-mediated DNA relaxation and proliferation of five human cell lines including breast (MDA-MB-231, MDA-MB-468 and MCF7), colorectal (HCT116) and non-small cell lung (H1299) cancers. Among these, compounds 14 and 26 exhibited full inhibitory activities against Topo I at 3 M and Topo II at 1 M. Cancer cells treated with 26 accumulated DNA damage and were arrested at the G/M phase. With time, cells proceeded to apoptosis, as revealed by increased amounts of cells with fragmented DNA and cleavage of caspase-8 and -9. In contrast, normal breast epithelial cells showed low sensitivity to 26. Taken together, our study identifies 26 as a potent Topo dual-inhibitor with low toxicity to normal cells, and elucidates that the terminal amino group of N-2-aminoethylamino or N-3-aminopropylamino at the 6th position and 8,10-di-halogen substituents on thiochromeno[2,3-c]quinolin-12-one are critical for the Topo-inhibiting and cancer-killing activities.\n",
            "1736608\n",
            "Poison activity at human recombinant topoisomerase I in human MDA-MB-231 cells assessed as increase in chromatin incubated for 30 mins by Western blot analysis\n",
            "Title: Design, synthesis, and biological evaluation of heterotetracyclic quinolinone derivatives as anticancer agents targeting topoisomerases.  Abstract: A series of thiochromeno[2,3-c]quinolin-12-one derivatives with various substitutions were synthesized and evaluated as topoisomerase (Topo) inhibitors. Six (8, 10, 12, 14, 19, and 26) of 23 compounds showed strong inhibitory activities against Topo-mediated DNA relaxation and proliferation of five human cell lines including breast (MDA-MB-231, MDA-MB-468 and MCF7), colorectal (HCT116) and non-small cell lung (H1299) cancers. Among these, compounds 14 and 26 exhibited full inhibitory activities against Topo I at 3 M and Topo II at 1 M. Cancer cells treated with 26 accumulated DNA damage and were arrested at the G/M phase. With time, cells proceeded to apoptosis, as revealed by increased amounts of cells with fragmented DNA and cleavage of caspase-8 and -9. In contrast, normal breast epithelial cells showed low sensitivity to 26. Taken together, our study identifies 26 as a potent Topo dual-inhibitor with low toxicity to normal cells, and elucidates that the terminal amino group of N-2-aminoethylamino or N-3-aminopropylamino at the 6th position and 8,10-di-halogen substituents on thiochromeno[2,3-c]quinolin-12-one are critical for the Topo-inhibiting and cancer-killing activities.\n",
            "1737446\n",
            "Inhibition of recombinant human TOP1B expressed in yeast TopI null strain (RS190) using supercoiled pUC18 DNA as substrate incubated for 15 sec by agarose gel electrophoresis method\n",
            "Title: Synthesis of novel hybrid quinolino[4,3-b][1,5]naphthyridines and quinolino[4,3-b][1,5]naphthyridin-6(5H)-one derivatives and biological evaluation as topoisomerase I inhibitors and antiproliferatives.  Abstract: The topoisomerase I enzymatic inhibition of hybrid quinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridines and quinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-ones was investigated. First, the synthesis of these fused compounds was performed by intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and unsaturated aldehydes affording corresponding hybrid 5-tosylhexahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine and tetrahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one compounds with good to high general yields. Subsequent dehydrogenation led to the corresponding more unsaturated dihydro (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine and (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one derivatives in quantitative yields. The new polycyclic products show excellent-good activity as topoisomerase I (TopI) inhibitors that lead to TopI induced nicking of plasmids. This is consistent with the compounds acting as TopI poisons resulting in the accumulation of trapped cleavage complexes in the DNA. The cytotoxic effect on cell lines A549, SKOV3 and on non-cancerous MRC5 was also screened. Tetrahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one 9 resulted the most cytotoxic compound with IC values of 3.25  0.91 M and 2.08  1.89 M against the A549 cell line and the SKOV3 cell line, respectively. Also, hexahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine 8a and dihydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine 10a showed good cytotoxicity against these cell lines. None of the compounds presented cytotoxic effects against non-malignant pulmonary fibroblasts (MRC-5).\n",
            "1737447\n",
            "Inhibition of recombinant human TOP1B expressed in yeast TopI null strain (RS190) using supercoiled pUC18 DNA as substrate incubated for 1 min by agarose gel electrophoresis method\n",
            "Title: Synthesis of novel hybrid quinolino[4,3-b][1,5]naphthyridines and quinolino[4,3-b][1,5]naphthyridin-6(5H)-one derivatives and biological evaluation as topoisomerase I inhibitors and antiproliferatives.  Abstract: The topoisomerase I enzymatic inhibition of hybrid quinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridines and quinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-ones was investigated. First, the synthesis of these fused compounds was performed by intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and unsaturated aldehydes affording corresponding hybrid 5-tosylhexahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine and tetrahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one compounds with good to high general yields. Subsequent dehydrogenation led to the corresponding more unsaturated dihydro (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine and (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one derivatives in quantitative yields. The new polycyclic products show excellent-good activity as topoisomerase I (TopI) inhibitors that lead to TopI induced nicking of plasmids. This is consistent with the compounds acting as TopI poisons resulting in the accumulation of trapped cleavage complexes in the DNA. The cytotoxic effect on cell lines A549, SKOV3 and on non-cancerous MRC5 was also screened. Tetrahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one 9 resulted the most cytotoxic compound with IC values of 3.25  0.91 M and 2.08  1.89 M against the A549 cell line and the SKOV3 cell line, respectively. Also, hexahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine 8a and dihydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine 10a showed good cytotoxicity against these cell lines. None of the compounds presented cytotoxic effects against non-malignant pulmonary fibroblasts (MRC-5).\n",
            "1737448\n",
            "Inhibition of recombinant human TOP1B expressed in yeast TopI null strain (RS190) using supercoiled pUC18 DNA as substrate incubated for 3 min by agarose gel electrophoresis method\n",
            "Title: Synthesis of novel hybrid quinolino[4,3-b][1,5]naphthyridines and quinolino[4,3-b][1,5]naphthyridin-6(5H)-one derivatives and biological evaluation as topoisomerase I inhibitors and antiproliferatives.  Abstract: The topoisomerase I enzymatic inhibition of hybrid quinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridines and quinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-ones was investigated. First, the synthesis of these fused compounds was performed by intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and unsaturated aldehydes affording corresponding hybrid 5-tosylhexahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine and tetrahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one compounds with good to high general yields. Subsequent dehydrogenation led to the corresponding more unsaturated dihydro (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine and (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one derivatives in quantitative yields. The new polycyclic products show excellent-good activity as topoisomerase I (TopI) inhibitors that lead to TopI induced nicking of plasmids. This is consistent with the compounds acting as TopI poisons resulting in the accumulation of trapped cleavage complexes in the DNA. The cytotoxic effect on cell lines A549, SKOV3 and on non-cancerous MRC5 was also screened. Tetrahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one 9 resulted the most cytotoxic compound with IC values of 3.25  0.91 M and 2.08  1.89 M against the A549 cell line and the SKOV3 cell line, respectively. Also, hexahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine 8a and dihydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine 10a showed good cytotoxicity against these cell lines. None of the compounds presented cytotoxic effects against non-malignant pulmonary fibroblasts (MRC-5).\n",
            "1737449\n",
            "Poison activity at recombinant human TOP1B expressed in yeast TopI null strain (RS190) assessed as increase in nicked plasmid DNA at 100 uM using supercoiled pUC19 plasmid DNA as substrate by agarose gel electrophoresis analysis\n",
            "Title: Synthesis of novel hybrid quinolino[4,3-b][1,5]naphthyridines and quinolino[4,3-b][1,5]naphthyridin-6(5H)-one derivatives and biological evaluation as topoisomerase I inhibitors and antiproliferatives.  Abstract: The topoisomerase I enzymatic inhibition of hybrid quinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridines and quinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-ones was investigated. First, the synthesis of these fused compounds was performed by intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and unsaturated aldehydes affording corresponding hybrid 5-tosylhexahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine and tetrahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one compounds with good to high general yields. Subsequent dehydrogenation led to the corresponding more unsaturated dihydro (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine and (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one derivatives in quantitative yields. The new polycyclic products show excellent-good activity as topoisomerase I (TopI) inhibitors that lead to TopI induced nicking of plasmids. This is consistent with the compounds acting as TopI poisons resulting in the accumulation of trapped cleavage complexes in the DNA. The cytotoxic effect on cell lines A549, SKOV3 and on non-cancerous MRC5 was also screened. Tetrahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one 9 resulted the most cytotoxic compound with IC values of 3.25  0.91 M and 2.08  1.89 M against the A549 cell line and the SKOV3 cell line, respectively. Also, hexahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine 8a and dihydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine 10a showed good cytotoxicity against these cell lines. None of the compounds presented cytotoxic effects against non-malignant pulmonary fibroblasts (MRC-5).\n",
            "1737450\n",
            "Poison activity at wild type human TOP1B assessed as induction of accumulation of DNA cleavage complex formation using Cy3-labelled duplex DNA as substrate by agarose gel electrophoresis analysis\n",
            "Title: Synthesis of novel hybrid quinolino[4,3-b][1,5]naphthyridines and quinolino[4,3-b][1,5]naphthyridin-6(5H)-one derivatives and biological evaluation as topoisomerase I inhibitors and antiproliferatives.  Abstract: The topoisomerase I enzymatic inhibition of hybrid quinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridines and quinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-ones was investigated. First, the synthesis of these fused compounds was performed by intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and unsaturated aldehydes affording corresponding hybrid 5-tosylhexahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine and tetrahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one compounds with good to high general yields. Subsequent dehydrogenation led to the corresponding more unsaturated dihydro (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine and (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one derivatives in quantitative yields. The new polycyclic products show excellent-good activity as topoisomerase I (TopI) inhibitors that lead to TopI induced nicking of plasmids. This is consistent with the compounds acting as TopI poisons resulting in the accumulation of trapped cleavage complexes in the DNA. The cytotoxic effect on cell lines A549, SKOV3 and on non-cancerous MRC5 was also screened. Tetrahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one 9 resulted the most cytotoxic compound with IC values of 3.25  0.91 M and 2.08  1.89 M against the A549 cell line and the SKOV3 cell line, respectively. Also, hexahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine 8a and dihydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine 10a showed good cytotoxicity against these cell lines. None of the compounds presented cytotoxic effects against non-malignant pulmonary fibroblasts (MRC-5).\n",
            "1738949\n",
            "Inhibition of human topoisomerase 1-mediated relaxation of supercoiled plasmid using pBR322 plasmid as substrate at 40 uM measured after 30 mins by ethidium bromide dye based agarose gel electrophoresis method\n",
            "Title: Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties.  Abstract: Heteroarene-fused anthraquinone derivatives represent a class of perspective anticancer drug candidates capable of targeting multiple vital processes including drug resistance. Taking advantage of previously demonstrated potential of amide derivatives of heteroarene-fused anthraquinones, we herein dissected the role of the heterocyclic core in antitumor properties. A new series of naphtho[2,3-f]indole-3- and anthra[2,3-b]thiophene-3-carboxamides was synthesized via coupling the respective acids with cyclic diamines. New compounds demonstrated a submicromolar antiproliferative potency close to doxorubicin (Dox) against five tumor cell lines of various tissue origin. In contrast to Dox, the new compounds were similarly cytotoxic for HCT116 colon carcinoma cells (wild type p53) and their isogenic p53 knockout counterparts. Modification of the heterocyclic core changed the targeting properties: the best-in-series naphtho[2,3-f]indole-3-carboxamide 8 formed more affine complexes with DNA duplex than furan and thiophene analogs, a property that can be translated into a stronger inhibition of topoisomerase 1 mediated DNA unwinding. At tolerable doses the water soluble derivative 8 significantly inhibited tumor growth (up to 79%) and increased the lifespan (153%) of mice bearing P388 lymphoma transplants. Together with better solubility for parenteral administration and well tolerance by animals of the indole derivative 8 indicates prospects for further search of new antitumor drug candidates among the heteroarene-fused anthraquinones.\n",
            "1740932\n",
            "Inhibition of recombinant human Top1 expressed in baculovirus infected sf9 insect cells using supercoiled pBS (SK+) DNA as substrate incubated for 30 mins by ethidium bromide staining based agarose gel electrophoresis analysis\n",
            "Title: Development of a metabolically stable topoisomerase I poison as anticancer agent.  Abstract: We have recently reported a new chemotype of a potent topoisomerase I poison with compound 1 as a potential anticancer chemotherapeutic agent. During further optimization, it has been observed that compound 1 suffers from high intrinsic clearance in human liver microsomes. To overcome the metabolic instability of compound 1, we report design and synthesis of metabolically stable Top1 poison 3. Newly identified Top1 poison 3 exhibits t of 69.1 min in human liver microsomes in comparison to compound 1 with t of 9.9 min. Molecular dynamic study of the newly optimized Top1 poison 3 was performed to get the insight into the stability of the binding pose in the active site. Compound 3 was able to trap DNA-Top1 cleavage complex and found to be less cytotoxic in non-cancerous cell line as compared to compound 1.\n",
            "1740933\n",
            "Inhibition of Top1 in human MCF7 cells using supercoiled pBS (SK+) DNA as substrate incubated for 30 mins by ethidium bromide staining based agarose gel electrophoresis analysis\n",
            "Title: Development of a metabolically stable topoisomerase I poison as anticancer agent.  Abstract: We have recently reported a new chemotype of a potent topoisomerase I poison with compound 1 as a potential anticancer chemotherapeutic agent. During further optimization, it has been observed that compound 1 suffers from high intrinsic clearance in human liver microsomes. To overcome the metabolic instability of compound 1, we report design and synthesis of metabolically stable Top1 poison 3. Newly identified Top1 poison 3 exhibits t of 69.1 min in human liver microsomes in comparison to compound 1 with t of 9.9 min. Molecular dynamic study of the newly optimized Top1 poison 3 was performed to get the insight into the stability of the binding pose in the active site. Compound 3 was able to trap DNA-Top1 cleavage complex and found to be less cytotoxic in non-cancerous cell line as compared to compound 1.\n",
            "1758341\n",
            "Inhibition of TOP1 (unknown origin) assessed as decrease in relaxation of supercoiled DNA using supercoiled plasmid DNA at 500 uM relative to camptothecin\n",
            "Title: Structural simplification of evodiamine: Discovery of novel tetrahydro--carboline derivatives as potent antitumor agents.  Abstract: Natural products (NPs) have played a crucial role in the discovery and development of antitumor drugs. However, the high structural complexity of NPs generally results in unfavorable physicochemical profiles and poor drug-likeness. A powerful strategy to tackle this obstacle is the structural simplification of NPs by truncating nonessential structures. Herein, a series of tetrahydro--carboline derivatives were designed by elimination of the D ring of NP evodiamine. Structure-activity relationship studies led to the discovery of compound 45, which displayed highly potent antitumor activity against all the tested cancer cell lines and excellent in vivo antitumor activity in the HCT116 xenograft model with low toxicity. Further mechanistic research indicated that compound 45 acted by dual Top1/2 inhibition and induced caspase-dependent cell apoptosis coupled with G<sub>2</sub>/M cell cycle arrest. This proof-of-concept study validated the effectiveness of structural simplification in NP-based drug development, discovered compound 45 as a potent antitumor lead compound and enriched the structure-activity relationships of evodiamine.\n",
            "1758342\n",
            "Inhibition of TOP1 (unknown origin) assessed as decrease in relaxation of supercoiled DNA using supercoiled plasmid DNA at 100 uM relative to camptothecin\n",
            "Title: Structural simplification of evodiamine: Discovery of novel tetrahydro--carboline derivatives as potent antitumor agents.  Abstract: Natural products (NPs) have played a crucial role in the discovery and development of antitumor drugs. However, the high structural complexity of NPs generally results in unfavorable physicochemical profiles and poor drug-likeness. A powerful strategy to tackle this obstacle is the structural simplification of NPs by truncating nonessential structures. Herein, a series of tetrahydro--carboline derivatives were designed by elimination of the D ring of NP evodiamine. Structure-activity relationship studies led to the discovery of compound 45, which displayed highly potent antitumor activity against all the tested cancer cell lines and excellent in vivo antitumor activity in the HCT116 xenograft model with low toxicity. Further mechanistic research indicated that compound 45 acted by dual Top1/2 inhibition and induced caspase-dependent cell apoptosis coupled with G<sub>2</sub>/M cell cycle arrest. This proof-of-concept study validated the effectiveness of structural simplification in NP-based drug development, discovered compound 45 as a potent antitumor lead compound and enriched the structure-activity relationships of evodiamine.\n",
            "1758988\n",
            "Inhibition of DNA topoisomerase 1 (unknown origin)\n",
            "Title: Synthesis, biological evaluation, and correlation of cytotoxicity versus redox potential of 1,4-naphthoquinone derivatives.  Abstract: A series of 1,4-naphthoquinone derivatives of lawsone (1), 6-hydroxy-1,4-naphthoquinone (2), and juglone (3) were synthesized by alkylation, acylation, and sulfonylation reactions. The yields of lawsone derivatives 1a-1k (type A), 6-hydroxy-1,4-naphthoquinone derivatives 2a-2j (type B), and juglone derivatives 3a-3h (type C) were 52-99%, 53-96%, and 28-95%, respectively. All compounds were tested in vitro for the cytotoxicity against human oral epidermoid carcinoma (KB) and cervix epithelioid carcinoma (HeLa) cells and their structure-activity relationship was studied. Compound 3c was found to be most potent in KB cell line (IC<sub>50</sub> = 1.39 M). Some compounds were evaluated for DNA topoisomerase I inhibition. Compounds 2c, 3, 3a, and 3d showed topoisomerase inhibition activity with IC<sub>50</sub> values of 8.3-91 M. Standard redox potentials (E) of all naphthoquinones in phosphate buffer at pH 7.2 were examined by means of cyclic voltammetry. A definite correlation has been found between the redox potentials and inhibitory effects of type A compounds.\n",
            "1759310\n",
            "Inhibition of human Topoisomerase 1 at 0.1 to 100 uM\n",
            "Title: Design and synthesis of C-aryl angular luotonins via a one-pot aza-Nazarov-Friedlander sequence and their Topo-I inhibition studies along with C-aryl vasicinones and luotonins.  Abstract: A facile one-pot synthesis of C-ring substituted angular luotonins has been realized via a methanesulfonic acid mediated aza-Nazarov-Friedlander condensation sequence on quinazolinonyl enones. Topoisomerase I (topo-I) inhibition studies revealed that the angular luotonin library (7a-7l) and their regioisomeric analogs (linear luotonins, 8a-8l) are weak negative modulators, compared to camptothecin. These results would fare well for the design of topo-I-inert luotonins for non-oncological applications such as anti-fungal and insecticide lead developments. Surprisingly, the tricyclic vasicinones (9h, 9i, and 9j) showed better topo-I inhibition compared to pentacyclic C-aryl luotonins providing a novel pharmacophore for further explorations.\n",
            "1759311\n",
            "Inhibition of human Topoisomerase 1 at 100 uM\n",
            "Title: Design and synthesis of C-aryl angular luotonins via a one-pot aza-Nazarov-Friedlander sequence and their Topo-I inhibition studies along with C-aryl vasicinones and luotonins.  Abstract: A facile one-pot synthesis of C-ring substituted angular luotonins has been realized via a methanesulfonic acid mediated aza-Nazarov-Friedlander condensation sequence on quinazolinonyl enones. Topoisomerase I (topo-I) inhibition studies revealed that the angular luotonin library (7a-7l) and their regioisomeric analogs (linear luotonins, 8a-8l) are weak negative modulators, compared to camptothecin. These results would fare well for the design of topo-I-inert luotonins for non-oncological applications such as anti-fungal and insecticide lead developments. Surprisingly, the tricyclic vasicinones (9h, 9i, and 9j) showed better topo-I inhibition compared to pentacyclic C-aryl luotonins providing a novel pharmacophore for further explorations.\n",
            "1759312\n",
            "Inhibition of human Topoisomerase 1 at 10 to 100 uM\n",
            "Title: Design and synthesis of C-aryl angular luotonins via a one-pot aza-Nazarov-Friedlander sequence and their Topo-I inhibition studies along with C-aryl vasicinones and luotonins.  Abstract: A facile one-pot synthesis of C-ring substituted angular luotonins has been realized via a methanesulfonic acid mediated aza-Nazarov-Friedlander condensation sequence on quinazolinonyl enones. Topoisomerase I (topo-I) inhibition studies revealed that the angular luotonin library (7a-7l) and their regioisomeric analogs (linear luotonins, 8a-8l) are weak negative modulators, compared to camptothecin. These results would fare well for the design of topo-I-inert luotonins for non-oncological applications such as anti-fungal and insecticide lead developments. Surprisingly, the tricyclic vasicinones (9h, 9i, and 9j) showed better topo-I inhibition compared to pentacyclic C-aryl luotonins providing a novel pharmacophore for further explorations.\n",
            "1759313\n",
            "Inhibition of human Topoisomerase 1 at 1 uM\n",
            "Title: Design and synthesis of C-aryl angular luotonins via a one-pot aza-Nazarov-Friedlander sequence and their Topo-I inhibition studies along with C-aryl vasicinones and luotonins.  Abstract: A facile one-pot synthesis of C-ring substituted angular luotonins has been realized via a methanesulfonic acid mediated aza-Nazarov-Friedlander condensation sequence on quinazolinonyl enones. Topoisomerase I (topo-I) inhibition studies revealed that the angular luotonin library (7a-7l) and their regioisomeric analogs (linear luotonins, 8a-8l) are weak negative modulators, compared to camptothecin. These results would fare well for the design of topo-I-inert luotonins for non-oncological applications such as anti-fungal and insecticide lead developments. Surprisingly, the tricyclic vasicinones (9h, 9i, and 9j) showed better topo-I inhibition compared to pentacyclic C-aryl luotonins providing a novel pharmacophore for further explorations.\n",
            "1759314\n",
            "Inhibition of human Topoisomerase 1 at 1 to 100 uM\n",
            "Title: Design and synthesis of C-aryl angular luotonins via a one-pot aza-Nazarov-Friedlander sequence and their Topo-I inhibition studies along with C-aryl vasicinones and luotonins.  Abstract: A facile one-pot synthesis of C-ring substituted angular luotonins has been realized via a methanesulfonic acid mediated aza-Nazarov-Friedlander condensation sequence on quinazolinonyl enones. Topoisomerase I (topo-I) inhibition studies revealed that the angular luotonin library (7a-7l) and their regioisomeric analogs (linear luotonins, 8a-8l) are weak negative modulators, compared to camptothecin. These results would fare well for the design of topo-I-inert luotonins for non-oncological applications such as anti-fungal and insecticide lead developments. Surprisingly, the tricyclic vasicinones (9h, 9i, and 9j) showed better topo-I inhibition compared to pentacyclic C-aryl luotonins providing a novel pharmacophore for further explorations.\n",
            "1763576\n",
            "Inhibition of recombinant human topoisomerase 1 expressed in yeast TopI null strain RS190 at 100 uM using negatively supercoiled pUC18 plasmid DNA as substrate incubated for 15 secs by agarose gel electrophoresis method\n",
            "Title: Fused chromeno and quinolino[1,8]naphthyridines: Synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.  Abstract: The synthesis of 1,8-naphthyridine derivatives fused with other heterocycles, such as chromenes and quinolines, as well as their behaviour as topoisomerase I inhibitors is studied. The preparation is carried out through a direct and simple process as an intramolecular [4 + 2] cycloaddition reaction between functionalized aldimines, obtained by the condensation of 2-aminopyridine and unsaturated aldehydes, and olefins. In particular, while no clear inhibitory activity is observed for chromeno[4,3-b][1,8]naphthyridine fused heterocycles, a very different result is observed for quinolino[4,3-b][1,8]naphthyridine derivatives. Experimental assays indicated that quinolino[4,3-b][1,8]naphthyridines inhibited the topoisomerase I enzymatic reaction behaving like a poison, as occurs with the natural TopI inhibitor, camptothecin. Furthermore, the cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV3), and on non-cancerous lung fibroblasts cell line (MRC5) was also screened.\n",
            "1763577\n",
            "Inhibition of recombinant human topoisomerase 1 expressed in yeast TopI null strain RS190 at 100 uM using negatively supercoiled pUC18 plasmid DNA as substrate incubated for 1 min by agarose gel electrophoresis method\n",
            "Title: Fused chromeno and quinolino[1,8]naphthyridines: Synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.  Abstract: The synthesis of 1,8-naphthyridine derivatives fused with other heterocycles, such as chromenes and quinolines, as well as their behaviour as topoisomerase I inhibitors is studied. The preparation is carried out through a direct and simple process as an intramolecular [4 + 2] cycloaddition reaction between functionalized aldimines, obtained by the condensation of 2-aminopyridine and unsaturated aldehydes, and olefins. In particular, while no clear inhibitory activity is observed for chromeno[4,3-b][1,8]naphthyridine fused heterocycles, a very different result is observed for quinolino[4,3-b][1,8]naphthyridine derivatives. Experimental assays indicated that quinolino[4,3-b][1,8]naphthyridines inhibited the topoisomerase I enzymatic reaction behaving like a poison, as occurs with the natural TopI inhibitor, camptothecin. Furthermore, the cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV3), and on non-cancerous lung fibroblasts cell line (MRC5) was also screened.\n",
            "1763578\n",
            "Inhibition of recombinant human topoisomerase 1 expressed in yeast TopI null strain RS190 at 100 uM using negatively supercoiled pUC18 plasmid DNA as substrate incubated for 3 min by agarose gel electrophoresis method\n",
            "Title: Fused chromeno and quinolino[1,8]naphthyridines: Synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.  Abstract: The synthesis of 1,8-naphthyridine derivatives fused with other heterocycles, such as chromenes and quinolines, as well as their behaviour as topoisomerase I inhibitors is studied. The preparation is carried out through a direct and simple process as an intramolecular [4 + 2] cycloaddition reaction between functionalized aldimines, obtained by the condensation of 2-aminopyridine and unsaturated aldehydes, and olefins. In particular, while no clear inhibitory activity is observed for chromeno[4,3-b][1,8]naphthyridine fused heterocycles, a very different result is observed for quinolino[4,3-b][1,8]naphthyridine derivatives. Experimental assays indicated that quinolino[4,3-b][1,8]naphthyridines inhibited the topoisomerase I enzymatic reaction behaving like a poison, as occurs with the natural TopI inhibitor, camptothecin. Furthermore, the cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV3), and on non-cancerous lung fibroblasts cell line (MRC5) was also screened.\n",
            "1763579\n",
            "Poison activity at recombinant human topoisomerase 1 expressed in yeast TopI null strain RS190 assessed as increase in nicked plasmid DNA at 100 uM using supercoiled pUC18 plasmid DNA as substrate incubated for 15 to 180 secs by Ethidium bromide staining based agarose gel electrophoresis analysis\n",
            "Title: Fused chromeno and quinolino[1,8]naphthyridines: Synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.  Abstract: The synthesis of 1,8-naphthyridine derivatives fused with other heterocycles, such as chromenes and quinolines, as well as their behaviour as topoisomerase I inhibitors is studied. The preparation is carried out through a direct and simple process as an intramolecular [4 + 2] cycloaddition reaction between functionalized aldimines, obtained by the condensation of 2-aminopyridine and unsaturated aldehydes, and olefins. In particular, while no clear inhibitory activity is observed for chromeno[4,3-b][1,8]naphthyridine fused heterocycles, a very different result is observed for quinolino[4,3-b][1,8]naphthyridine derivatives. Experimental assays indicated that quinolino[4,3-b][1,8]naphthyridines inhibited the topoisomerase I enzymatic reaction behaving like a poison, as occurs with the natural TopI inhibitor, camptothecin. Furthermore, the cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV3), and on non-cancerous lung fibroblasts cell line (MRC5) was also screened.\n",
            "1765566\n",
            "Inhibition of topoisomerase 1 in human MDA-MB-231 cells assessed as DNA damage by measuring phosphorylated histone H2AX at IC50 concentration incubated for 24 hrs by staining based confocal fluorescence microscopy\n",
            "Title: Effects of substituent pattern on the intracellular target of antiproliferative benzo[b]thiophenyl chromone derivatives.  Abstract: A new biological scaffold was produced by replacing the 6-electron phenyl ring-B of a natural flavone skeleton with a 10-electron benzothiophene (BT). Since aromatic rings are important for ligand protein interactions, this expansion of the -electron system of ring-B might change the bioactivity profile. One of the resulting novel natural product-inspired compounds, 2-(benzo[b]thiophen-3-yl)-5-hydroxy-7-isopropoxy-6-methoxyflavone (6), effectively arrested the cell cycle at the G2/M phase and displayed significant antiproliferative effects with IC<sub>50</sub> values of 0.05-0.08 M against multiple human tumor cell lines, including a multidrug resistant line. A structure-activity relationship study revealed that a 10-electron system with high aromaticity, juxtaposed 4-oxo and 5-hydroxy groups, and 7-alkoxy groups were important for potent antimitotic activity. Interestingly, two BT-flavonols (3-hydroxyflavone), 16 and 20, with 3-hydroxy and 5-alkoxy groups, induced distinct biological profiles affecting the cell cycle at the G1/S phase by inhibition of DNA replication through an interaction with topoisomerase I.\n",
            "1765569\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as relaxation of supercoiled plasmid pBR322 DNA incubated for 30 mins by agarose gel electrophoresis\n",
            "Title: Effects of substituent pattern on the intracellular target of antiproliferative benzo[b]thiophenyl chromone derivatives.  Abstract: A new biological scaffold was produced by replacing the 6-electron phenyl ring-B of a natural flavone skeleton with a 10-electron benzothiophene (BT). Since aromatic rings are important for ligand protein interactions, this expansion of the -electron system of ring-B might change the bioactivity profile. One of the resulting novel natural product-inspired compounds, 2-(benzo[b]thiophen-3-yl)-5-hydroxy-7-isopropoxy-6-methoxyflavone (6), effectively arrested the cell cycle at the G2/M phase and displayed significant antiproliferative effects with IC<sub>50</sub> values of 0.05-0.08 M against multiple human tumor cell lines, including a multidrug resistant line. A structure-activity relationship study revealed that a 10-electron system with high aromaticity, juxtaposed 4-oxo and 5-hydroxy groups, and 7-alkoxy groups were important for potent antimitotic activity. Interestingly, two BT-flavonols (3-hydroxyflavone), 16 and 20, with 3-hydroxy and 5-alkoxy groups, induced distinct biological profiles affecting the cell cycle at the G1/S phase by inhibition of DNA replication through an interaction with topoisomerase I.\n",
            "1779158\n",
            "Inhibition of TOP1 (unknown origin) assessed as decrease in relaxation of supercoiled DNA using pBR322 plasmid DNA as substrate at 100 uM by ethidium bromide staining based gel electrophoresis\n",
            "Title: Water-soluble derivatives of evodiamine: Discovery of evodiamine-10-phosphate as an orally active antitumor lead compound.  Abstract: 10-Hydroxyevodiamine is a multitargeting antitumor lead compound with excellent in vitro activity. However, its in vivo antitumor potency is rather limited, which has hampered its further clinical development. To overcome this obstacle, a series of novel water-soluble derivatives of 10-hydroxyevodiamine were designed and synthesized. Most of them exhibited good to excellent antitumor activities against several cancer cell lines. In particular, phosphate derivative 9 was orally active and showed improved in vivo antitumor efficacy in HCT116 xenograft models. Further antitumor mechanism studies indicated that compound 9 acted by triple Top1/Top2/tubulin inhibition and induced apoptosis with G<sub>2</sub>/M cell cycle arrest. Taken together, this study extended the structure-activity relationship of evodiamine and identified phosphate derivative 9 as a promising antitumor lead compound.\n",
            "1779194\n",
            "Inhibition of TOP1 (unknown origin) assessed as decrease in relaxation of supercoiled DNA using pBR322 plasmid DNA by ethidium bromide staining based gel electrophoresis\n",
            "Title: Water-soluble derivatives of evodiamine: Discovery of evodiamine-10-phosphate as an orally active antitumor lead compound.  Abstract: 10-Hydroxyevodiamine is a multitargeting antitumor lead compound with excellent in vitro activity. However, its in vivo antitumor potency is rather limited, which has hampered its further clinical development. To overcome this obstacle, a series of novel water-soluble derivatives of 10-hydroxyevodiamine were designed and synthesized. Most of them exhibited good to excellent antitumor activities against several cancer cell lines. In particular, phosphate derivative 9 was orally active and showed improved in vivo antitumor efficacy in HCT116 xenograft models. Further antitumor mechanism studies indicated that compound 9 acted by triple Top1/Top2/tubulin inhibition and induced apoptosis with G<sub>2</sub>/M cell cycle arrest. Taken together, this study extended the structure-activity relationship of evodiamine and identified phosphate derivative 9 as a promising antitumor lead compound.\n",
            "1779228\n",
            "Inhibition of human recombinant topoisomerase I using supercoiled pHOT1 plasmid DNA as substrate at 10 to 100 uM measured after 1 hr by agarose gel electrophoresis analysis\n",
            "Title: Discovery of pyrrole derivatives for the treatment of glioblastoma and chronic myeloid leukemia.  Abstract: Long-term survivors of glioblastoma multiforme (GBM) are at high risk of developing second primary neoplasms, including leukemia. For these patients, the use of classic tyrosine kinase inhibitors (TKIs), such as imatinib mesylate, is strongly discouraged, since this treatment causes a tremendous increase of tumor and stem cell migration and invasion. We aimed to develop agents useful for the treatment of patients with GBM and chronic myeloid leukemia (CML) using an alternative mechanism of action from the TKIs, specifically based on the inhibition of tubulin polymerization. Compounds 7 and 25, as planned, not only inhibited tubulin polymerization, but also inhibited the proliferation of both GMB and CML cells, including those expressing the T315I mutation, at nanomolar concentrations. In in vivo experiments in BALB/cnu/nu mice injected subcutaneously with U87MG cells, in vivo, 7 significantly inhibited GBM cancer cell proliferation, in vivo tumorigenesis, and tumor growth, tumorigenesis and angiogenesis. Compound 7 was found to block human topoisomerase II (hTopoII) selectively and completely, at a concentration of 100 M.\n",
            "1779229\n",
            "Inhibition of human recombinant topoisomerase I assessed as DNA cleavage using supercoiled pHOT1 plasmid DNA as substrate at 100 uM measured after 1 hr by agarose gel electrophoresis analysis\n",
            "Title: Discovery of pyrrole derivatives for the treatment of glioblastoma and chronic myeloid leukemia.  Abstract: Long-term survivors of glioblastoma multiforme (GBM) are at high risk of developing second primary neoplasms, including leukemia. For these patients, the use of classic tyrosine kinase inhibitors (TKIs), such as imatinib mesylate, is strongly discouraged, since this treatment causes a tremendous increase of tumor and stem cell migration and invasion. We aimed to develop agents useful for the treatment of patients with GBM and chronic myeloid leukemia (CML) using an alternative mechanism of action from the TKIs, specifically based on the inhibition of tubulin polymerization. Compounds 7 and 25, as planned, not only inhibited tubulin polymerization, but also inhibited the proliferation of both GMB and CML cells, including those expressing the T315I mutation, at nanomolar concentrations. In in vivo experiments in BALB/cnu/nu mice injected subcutaneously with U87MG cells, in vivo, 7 significantly inhibited GBM cancer cell proliferation, in vivo tumorigenesis, and tumor growth, tumorigenesis and angiogenesis. Compound 7 was found to block human topoisomerase II (hTopoII) selectively and completely, at a concentration of 100 M.\n",
            "1779298\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as relaxation of supercoiled plasmid pBR322 DNA at 1 to 5 uM incubated for 30 mins by electrophoresis\n",
            "Title: Thiophene-2-carboxamide derivatives of anthraquinone: A new potent antitumor chemotype.  Abstract: The anthraquinone scaffold has long been known as a source of efficacious antitumor drugs. In particular, the various chemical modifications of the side chains in this scaffold have yielded the compounds potent for the wild type tumor cells, their counterparts with molecular determinants of altered drug response, as well as in vivo settings. Further exploring the chemotype of anticancer heteroarene-fused anthraquinones, we herein demonstrate that derivative of anthra[2,3-b]thiophene-2-carboxamide, (compound 8) is highly potent against a panel of human tumor cell lines and their drug resistant variants. Treatment with submicromolar or low micromolar concentrations of 8 for only 30 min was sufficient to trigger lethal damage of K562 chronic myelogenous leukemia cells. Compound 8 (2.5 M, 3-6 h) induced an apoptotic cell death as determined by concomitant activation of caspases 3 and 9, cleavage of poly(ADP-ribose) polymerase, increase of Annexin V/propidium iodide double stained cells, DNA fragmentation (subG1 fraction) and a decrease of mitochondrial membrane potential. Neither a significant interaction with double stranded DNA nor strong inhibition of the DNA dependent enzyme topoisomerase 1 by 8 were detectable in cell free systems. Laser scanning confocal microscopy revealed that some amount of 8 was detectable in mitochondria as early as 5 min after the addition to the cells; exposure for 1 h caused significant morphological changes and clustering of mitochondria. The bioisosteric analog 2 in which the thiophene ring was replaced with furan was less active although the patterns of cytotoxicity of both derivatives were similar. These results point at the specific role of the sulfur atom in the antitumor properties of carboxamide derivatives of heteroarene-fused anthraquinone.\n",
            "1781535\n",
            "Inhibition of human DNA topoisomerase 1 at 100 uM incubated for 30 mins by electrophoresis\n",
            "Title: Discovery of Oral Anticancer 1,2-Bis(hydroxymethyl)benzo[<i>g</i>]pyrrolo[2,1-<i>a</i>]phthalazine Hybrids That Inhibit Angiogenesis and Induce DNA Cross-Links.  Abstract: Designing hybrid molecules with dual functions is one approach to improve the therapeutic efficacy of combination treatment. We have previously conjugated phthalazine and bis(hydroxymethyl)pyrrole pharmacophores to form hybrids bearing antiangiogenesis and DNA interstrand cross-linking activities. To improve the bioavailability, we adopted a benzology approach to design and synthesize a new series of 1,2-bis(hydroxymethyl)benzo[<i>g</i>]pyrrolo[2,1-<i>a</i>]phthalazines. These new hybrids retained the dual functions and could be formulated into vehicles for intravenous and oral administration. Among them, we demonstrated that compound <b>19a</b> with dimethylamine at the C6 position markedly suppressed the tumor growth of human small cell lung cancer cell line H526, squamous lung cancer cell line H520, and renal cancer cell line 786-O in nude mice, implying that compound <b>19a</b> is a broad-spectrum anticancer agent. Our results implicated that the conjugation of antiangiogenic and DNA cross-linking is likely to be a helpful approach to improving the efficacy of combination therapy.\n",
            "1798415\n",
            "Human Topoisomerase I Relaxation Inhibition Assay from US Patent US10266550: \"Bacterial topoisomerase I inhibitors with antibacterial activity\"\n",
            "Human topoisomerase I relaxation assays were carried out with 0.5 U of enzyme in reaction buffer supplied by the manufacturer. The enzyme was mixed with the indicated concentration of compound dissolved before 200 ng of supercoiled pBAD/Thio plasmid DNA was added in the same buffer, for a final volume of 20 &#956;L. Following incubation at 37 C. for 30 minutes, the reactions were terminated with a buffer containing 5% SDS, 0.25% bromophenol blue, and 25% glycerol, and analyzed by agarose gel electrophoresis.Human topoisomerase I and topoisomerase II&#945; were purchased from TopoGen (Buena vista, CO, USA).\n",
            "1803398\n",
            "Topoisomerase I Relaxation Assay from Article 10.3109/14756366.2013.768987: \"Cytotoxicity and topoisomerase I/II inhibition activity of novel 4-aryl/alkyl-1-(piperidin-4-yl)-carbonylthiosemicarbazides and 4-benzoylthiosemicarbazides.\"\n",
            "Supercoiled pHOT1 DNA (0.5 &mu;g) was incubated with four units of human topoisomerase I in relaxation buffer (10mM Tris-HCl (pH 7.8), 1mM EDTA, 0.15M NaCl, 0.1% BSA, 0.1 spermidine, 5% glycerol), in the presence of varying concentrations of the test compounds. Reactions were carried out at 37 Cfor 1 h and then terminated by the addition of sodium dodecyl sulfate (SDS) to 0.25% and proteinase K to 50 &mu;g/ml. The reaction mixture was subjected to electrophoresis through a 0.8% agarose gel containing 0.5 mg/ml ethidium bromide in TAE buffer (40mM Tris-borate and 1mM EDTA). The gels were stained with ethidium bromide and photographed under UV light. For the quantitative determination of topoisomerase concentration activity, photographic negatives were scanned and the area representing supercoiled DNA, migrating as a single band at the bottom of the gel was measured using UVI-KS4000i gel documentation and analysis system (SyngenBiotech, Sacramento, CA).\n",
            "1808044\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as relaxation of supercoiled plasmid pBR322 DNA at 50 uM incubated for 15 mins by agarose gel electrophoresis\n",
            "Title: Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer.  Abstract: Evodiamine (Evo) is a quinazolinocarboline alkaloid found in <i>Evodia rutaecarpa</i> and exhibits moderate antiproliferative activity. Herein, we report using a scaffold-hopping approach to identify a series of novel polycyclic heterocyclic derivatives based on Evo as the topoisomerase I (Top1) inhibitor for the treatment of triple-negative breast cancer (TNBC), which is an aggressive subtype of breast cancer with limited treatment options. The most potent compound <b>7f</b> inhibited cell growth in a human breast carcinoma cell line (MDA-MB-231) with an IC<sub>50</sub> value of 0.36 M. Further studies revealed that Top1 was the target of <b>7f</b>, which directly induced irreversible Top1-DNA covalent complex formation or induced an oxidative DNA lesion through an indirect mechanism mediated by reactive oxygen species. More importantly, <i>in vivo</i> studies showed that <b>7f</b> exhibited potent antitumor activity in a TNBC-patient-derived tumor xenograft model. These results suggest that compound <b>7f</b> deserves further investigation as a promising candidate for the treatment of TNBC.\n",
            "1808045\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as relaxation of supercoiled plasmid pBR322 DNA at 20 uM incubated for 15 mins by agarose gel electrophoresis\n",
            "Title: Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer.  Abstract: Evodiamine (Evo) is a quinazolinocarboline alkaloid found in <i>Evodia rutaecarpa</i> and exhibits moderate antiproliferative activity. Herein, we report using a scaffold-hopping approach to identify a series of novel polycyclic heterocyclic derivatives based on Evo as the topoisomerase I (Top1) inhibitor for the treatment of triple-negative breast cancer (TNBC), which is an aggressive subtype of breast cancer with limited treatment options. The most potent compound <b>7f</b> inhibited cell growth in a human breast carcinoma cell line (MDA-MB-231) with an IC<sub>50</sub> value of 0.36 M. Further studies revealed that Top1 was the target of <b>7f</b>, which directly induced irreversible Top1-DNA covalent complex formation or induced an oxidative DNA lesion through an indirect mechanism mediated by reactive oxygen species. More importantly, <i>in vivo</i> studies showed that <b>7f</b> exhibited potent antitumor activity in a TNBC-patient-derived tumor xenograft model. These results suggest that compound <b>7f</b> deserves further investigation as a promising candidate for the treatment of TNBC.\n",
            "1808046\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as relaxation of supercoiled plasmid pBR322 DNA upto 500 uM incubated for 15 mins by agarose gel electrophoresis\n",
            "Title: Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer.  Abstract: Evodiamine (Evo) is a quinazolinocarboline alkaloid found in <i>Evodia rutaecarpa</i> and exhibits moderate antiproliferative activity. Herein, we report using a scaffold-hopping approach to identify a series of novel polycyclic heterocyclic derivatives based on Evo as the topoisomerase I (Top1) inhibitor for the treatment of triple-negative breast cancer (TNBC), which is an aggressive subtype of breast cancer with limited treatment options. The most potent compound <b>7f</b> inhibited cell growth in a human breast carcinoma cell line (MDA-MB-231) with an IC<sub>50</sub> value of 0.36 M. Further studies revealed that Top1 was the target of <b>7f</b>, which directly induced irreversible Top1-DNA covalent complex formation or induced an oxidative DNA lesion through an indirect mechanism mediated by reactive oxygen species. More importantly, <i>in vivo</i> studies showed that <b>7f</b> exhibited potent antitumor activity in a TNBC-patient-derived tumor xenograft model. These results suggest that compound <b>7f</b> deserves further investigation as a promising candidate for the treatment of TNBC.\n",
            "1808048\n",
            "Induction of topoisomerase 1-DNA cleavable complex in human MDA-MB-231 cells assessed as increase in cleavable complex by measuring SDS-K+ precipitable complex at 15 uM measured up to 15 hrs by liquid scintillation counting analysis\n",
            "Title: Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer.  Abstract: Evodiamine (Evo) is a quinazolinocarboline alkaloid found in <i>Evodia rutaecarpa</i> and exhibits moderate antiproliferative activity. Herein, we report using a scaffold-hopping approach to identify a series of novel polycyclic heterocyclic derivatives based on Evo as the topoisomerase I (Top1) inhibitor for the treatment of triple-negative breast cancer (TNBC), which is an aggressive subtype of breast cancer with limited treatment options. The most potent compound <b>7f</b> inhibited cell growth in a human breast carcinoma cell line (MDA-MB-231) with an IC<sub>50</sub> value of 0.36 M. Further studies revealed that Top1 was the target of <b>7f</b>, which directly induced irreversible Top1-DNA covalent complex formation or induced an oxidative DNA lesion through an indirect mechanism mediated by reactive oxygen species. More importantly, <i>in vivo</i> studies showed that <b>7f</b> exhibited potent antitumor activity in a TNBC-patient-derived tumor xenograft model. These results suggest that compound <b>7f</b> deserves further investigation as a promising candidate for the treatment of TNBC.\n",
            "1808049\n",
            "Induction of topoisomerase 1-DNA cleavable complex in human MDA-MB-231 cells assessed as decrease in free Top1 in nuclear extract at 15 uM measured up to 9 hrs by Immunoband depletion assay\n",
            "Title: Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer.  Abstract: Evodiamine (Evo) is a quinazolinocarboline alkaloid found in <i>Evodia rutaecarpa</i> and exhibits moderate antiproliferative activity. Herein, we report using a scaffold-hopping approach to identify a series of novel polycyclic heterocyclic derivatives based on Evo as the topoisomerase I (Top1) inhibitor for the treatment of triple-negative breast cancer (TNBC), which is an aggressive subtype of breast cancer with limited treatment options. The most potent compound <b>7f</b> inhibited cell growth in a human breast carcinoma cell line (MDA-MB-231) with an IC<sub>50</sub> value of 0.36 M. Further studies revealed that Top1 was the target of <b>7f</b>, which directly induced irreversible Top1-DNA covalent complex formation or induced an oxidative DNA lesion through an indirect mechanism mediated by reactive oxygen species. More importantly, <i>in vivo</i> studies showed that <b>7f</b> exhibited potent antitumor activity in a TNBC-patient-derived tumor xenograft model. These results suggest that compound <b>7f</b> deserves further investigation as a promising candidate for the treatment of TNBC.\n",
            "1808050\n",
            "Induction of topoisomerase 1-DNA cleavable complex in human MDA-MB-231 cells assessed as decrease in free Top1 in nuclear extract at 30 uM measured up to 9 hrs by Immunoband depletion assay\n",
            "Title: Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer.  Abstract: Evodiamine (Evo) is a quinazolinocarboline alkaloid found in <i>Evodia rutaecarpa</i> and exhibits moderate antiproliferative activity. Herein, we report using a scaffold-hopping approach to identify a series of novel polycyclic heterocyclic derivatives based on Evo as the topoisomerase I (Top1) inhibitor for the treatment of triple-negative breast cancer (TNBC), which is an aggressive subtype of breast cancer with limited treatment options. The most potent compound <b>7f</b> inhibited cell growth in a human breast carcinoma cell line (MDA-MB-231) with an IC<sub>50</sub> value of 0.36 M. Further studies revealed that Top1 was the target of <b>7f</b>, which directly induced irreversible Top1-DNA covalent complex formation or induced an oxidative DNA lesion through an indirect mechanism mediated by reactive oxygen species. More importantly, <i>in vivo</i> studies showed that <b>7f</b> exhibited potent antitumor activity in a TNBC-patient-derived tumor xenograft model. These results suggest that compound <b>7f</b> deserves further investigation as a promising candidate for the treatment of TNBC.\n",
            "1808110\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as relaxation of pBR322 plasmid DNA at 20 uM incubated for 30 mins by ethidium bromide staining based UV absorbance method\n",
            "Title: Integration of a Diselenide Unit Generates Fluorogenic Camptothecin Prodrugs with Improved Cytotoxicity to Cancer Cells.  Abstract: A diselenide/disulfide unit was introduced into camptothecin (CPT), and two selenoprodrugs (e.g., CPT-Se3 and CPT-Se4) were identified to show improved potency in killing cancer cells and inhibiting tumor growth <i>in vivo</i>. Interestingly, the intrinsic fluorescence of CPT was severely quenched by the diselenide bond. Both the selenoprodrugs were activated by glutathione with a nearly complete recovery of CPT's fluorescence. The activation of prodrugs was accompanied by the production of selenol intermediates, which catalyzed the constant conversion of glutathione and oxygen to oxidized glutathione and superoxides. The diselenide unit is widely employed in constructing thiol-responsive materials. However, the selenol intermediates were largely ignored in the activation process prior to this study. Our work verified that integration of the diselenide unit may further enhance the parent drug's efficacy. Also, the discovery of the fluorescence quenching property of the diselenide/disulfide bond further shed light on constructing novel theranostic agents.\n",
            "1810247\n",
            "Poison activity at human topoisomerase 1 assessed as formation of cleavage complex using pHOT-1 DNA as substrate incubated for 30 mins by agarose gel electrophoresis\n",
            "Title: New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the <i>c-MYC</i> G-Quadruplex.  Abstract: As <i>c-MYC</i> is one of the central players in triple-negative breast cancer (TNBC) oncogenesis, inhibiting <i>c-MYC</i> expression would be an effective anticancer strategy. Transcription-induced negative supercoiling is crucial in the regulation of <i>c-MYC</i> transcription, which facilitates the formation of a G4 structure in NHE III<sub>1</sub> that can silence the transcription. However, topoisomerase 1 (Topo1) can dissipate this negative supercoiling, leading to continuous activation of <i>c-MYC</i> transcription. Thus, dual ligands targeting both Topo1 and <i>c-MYC</i> G4 appear to be significant in cancer therapy. In this study, a series of new dibenzoquinoxaline derivatives were designed, synthesized, and evaluated for both Topo1 and <i>c-MYC</i> inhibition. Among them, <b>5</b> was identified as the most promising dual ligand, which could effectively inhibit Topo1 activity and strongly stabilize <i>c-MYC</i> G4, thereby inhibiting cancer cell growth. Accordingly, this work suggests that this dual-targeting strategy may be effective in cancer therapy.\n",
            "1810249\n",
            "Inhibition of human topoisomerase 1 mediated relaxation of supercoiled pHOT1 DNA at 5 to 20 uM incubated for 30 mins by agarose gel electrophoresis\n",
            "Title: New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the <i>c-MYC</i> G-Quadruplex.  Abstract: As <i>c-MYC</i> is one of the central players in triple-negative breast cancer (TNBC) oncogenesis, inhibiting <i>c-MYC</i> expression would be an effective anticancer strategy. Transcription-induced negative supercoiling is crucial in the regulation of <i>c-MYC</i> transcription, which facilitates the formation of a G4 structure in NHE III<sub>1</sub> that can silence the transcription. However, topoisomerase 1 (Topo1) can dissipate this negative supercoiling, leading to continuous activation of <i>c-MYC</i> transcription. Thus, dual ligands targeting both Topo1 and <i>c-MYC</i> G4 appear to be significant in cancer therapy. In this study, a series of new dibenzoquinoxaline derivatives were designed, synthesized, and evaluated for both Topo1 and <i>c-MYC</i> inhibition. Among them, <b>5</b> was identified as the most promising dual ligand, which could effectively inhibit Topo1 activity and strongly stabilize <i>c-MYC</i> G4, thereby inhibiting cancer cell growth. Accordingly, this work suggests that this dual-targeting strategy may be effective in cancer therapy.\n",
            "1810251\n",
            "Inhibition of human topoisomerase 1 assessed as DNA intercalation at 1.2 uM using relaxed pHOT-1 DNA as substrate preincubated with DNA for 10 mins followed by enzyme addition and measured after 30 mins by agarose gel electrophoresis\n",
            "Title: New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the <i>c-MYC</i> G-Quadruplex.  Abstract: As <i>c-MYC</i> is one of the central players in triple-negative breast cancer (TNBC) oncogenesis, inhibiting <i>c-MYC</i> expression would be an effective anticancer strategy. Transcription-induced negative supercoiling is crucial in the regulation of <i>c-MYC</i> transcription, which facilitates the formation of a G4 structure in NHE III<sub>1</sub> that can silence the transcription. However, topoisomerase 1 (Topo1) can dissipate this negative supercoiling, leading to continuous activation of <i>c-MYC</i> transcription. Thus, dual ligands targeting both Topo1 and <i>c-MYC</i> G4 appear to be significant in cancer therapy. In this study, a series of new dibenzoquinoxaline derivatives were designed, synthesized, and evaluated for both Topo1 and <i>c-MYC</i> inhibition. Among them, <b>5</b> was identified as the most promising dual ligand, which could effectively inhibit Topo1 activity and strongly stabilize <i>c-MYC</i> G4, thereby inhibiting cancer cell growth. Accordingly, this work suggests that this dual-targeting strategy may be effective in cancer therapy.\n",
            "1810252\n",
            "Inhibition of human topoisomerase 1 assessed as DNA intercalation at 1.2 to 10 uM using relaxed pHOT-1 DNA as substrate preincubated with DNA for 10 mins followed by enzyme addition and measured after 30 mins by agarose gel electrophoresis\n",
            "Title: New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the <i>c-MYC</i> G-Quadruplex.  Abstract: As <i>c-MYC</i> is one of the central players in triple-negative breast cancer (TNBC) oncogenesis, inhibiting <i>c-MYC</i> expression would be an effective anticancer strategy. Transcription-induced negative supercoiling is crucial in the regulation of <i>c-MYC</i> transcription, which facilitates the formation of a G4 structure in NHE III<sub>1</sub> that can silence the transcription. However, topoisomerase 1 (Topo1) can dissipate this negative supercoiling, leading to continuous activation of <i>c-MYC</i> transcription. Thus, dual ligands targeting both Topo1 and <i>c-MYC</i> G4 appear to be significant in cancer therapy. In this study, a series of new dibenzoquinoxaline derivatives were designed, synthesized, and evaluated for both Topo1 and <i>c-MYC</i> inhibition. Among them, <b>5</b> was identified as the most promising dual ligand, which could effectively inhibit Topo1 activity and strongly stabilize <i>c-MYC</i> G4, thereby inhibiting cancer cell growth. Accordingly, this work suggests that this dual-targeting strategy may be effective in cancer therapy.\n",
            "1811235\n",
            "Inhibition of human topoisomerase I using DNA pBR322 as substrate assessed as DNA relaxation incubated for 45 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents: Synthesis and biological evaluation.  Abstract: Glioblastoma is one of the most lethal brain tumors. The crucial chemotherapy is mainly alkylating agents with modest clinical success. Given this desperate need and inspired by the encouraging results of a phase II trial via concomitant Topo I inhibitor plus COX-2 inhibitor, we designed a series of N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents based on structure modification on 1,5-naphthyridine derivatives (Topo I inhibitors). Notably, the target compounds I-1 (33.61  1.15 M) and I-8 (45.01  2.37 M) were confirmed to inhibit COX-2, while a previous reported compound (1,5-naphthyridine derivative) resulted nearly inactive towards COX-2 (IC<sub>50</sub> > 150 M). Besides, I-1 and I-8 exhibited higher anti-proliferation, anti-migration, anti-invasion effects than the parent compound 1,5-naphthyridine derivative, suggesting the success of modification based on the parent. Moreover, I-1 obviously repressed tumor growth in the C6 glioma orthotopic model (TGI = 66.7%) and U87MG xenograft model (TGI = 69.4%). Besides, I-1 downregulated PGE<sub>2</sub>, VEGF, MMP-9, and STAT3 activation, upregulated E-cadherin in the orthotopic model. More importantly, I-1 showed higher safety than temozolomide and different mechanism from temozolomide in the C6 glioma orthotopic model. All the evidence demonstrated that N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents could be promising for the glioma management.\n",
            "1811236\n",
            "Inhibition of human topoisomerase I using DNA pBR322 as substrate assessed as DNA intercalation at 100 uM incubated for 30 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents: Synthesis and biological evaluation.  Abstract: Glioblastoma is one of the most lethal brain tumors. The crucial chemotherapy is mainly alkylating agents with modest clinical success. Given this desperate need and inspired by the encouraging results of a phase II trial via concomitant Topo I inhibitor plus COX-2 inhibitor, we designed a series of N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents based on structure modification on 1,5-naphthyridine derivatives (Topo I inhibitors). Notably, the target compounds I-1 (33.61  1.15 M) and I-8 (45.01  2.37 M) were confirmed to inhibit COX-2, while a previous reported compound (1,5-naphthyridine derivative) resulted nearly inactive towards COX-2 (IC<sub>50</sub> > 150 M). Besides, I-1 and I-8 exhibited higher anti-proliferation, anti-migration, anti-invasion effects than the parent compound 1,5-naphthyridine derivative, suggesting the success of modification based on the parent. Moreover, I-1 obviously repressed tumor growth in the C6 glioma orthotopic model (TGI = 66.7%) and U87MG xenograft model (TGI = 69.4%). Besides, I-1 downregulated PGE<sub>2</sub>, VEGF, MMP-9, and STAT3 activation, upregulated E-cadherin in the orthotopic model. More importantly, I-1 showed higher safety than temozolomide and different mechanism from temozolomide in the C6 glioma orthotopic model. All the evidence demonstrated that N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents could be promising for the glioma management.\n",
            "1817036\n",
            "Inhibition of recombinant TOP1 (unknown origin) at 1 uM using 3'-[32P]-labeled 117 bp DNA oligonucleotides as substrate incubated for 20 mins by PAGE analysis relative to CPT\n",
            "Title: Synthesis of Methoxy-, Methylenedioxy-, Hydroxy-, and Halo-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors and Their Biological Activity for Drug-Resistant Cancer.  Abstract: As a recently discovered DNA repair enzyme, tyrosyl-DNA phosphodiesterase 1 (TDP1) removes topoisomerase IB (TOP1)-mediated DNA protein cross-links. Inhibiting TDP1 can potentiate the cytotoxicity of TOP1 inhibitors and overcome cancer cell resistance to TOP1 inhibitors. On the basis of our previous study, herein we report the synthesis of benzophenanthridinone derivatives as TOP1 and TDP1 inhibitors. Seven compounds (<b>C2</b>, <b>C4</b>, <b>C5</b>, <b>C7</b>, <b>C8</b>, <b>C12</b>, and <b>C14</b>) showed a robust TOP1 inhibitory activity (+++ or ++++), and four compounds (<b>A13</b>, <b>C12</b>, <b>C13</b>, and <b>C26</b>) showed a TDP1 inhibition (half-maximal inhibitory concentration values of 15 or 19 M). We also show that the dual TOP1 and TDP1 inhibitor <b>C12</b> induces both cellular TOP1cc, TDP1cc formation and DNA damage, resulting in cancer cell apoptosis at a sub-micromolar concentration. In addition, <b>C12</b> showed an enhanced activity in drug-resistant MCF-7/TDP1 cancer cells and was synergistic with topotecan in both MCF-7 and MCF-7/TDP1 cells.\n",
            "1823979\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed at 100 uM incubated for 15 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer.  Abstract: Gastric cancer represents a significant health burden worldwide. Previously, inspired by the traditional Chinese medicine Wu-Chu-Yu to treat the spleen and stomach system for thousands of years, we identified N14-phenyl substituted evodiamine derivatives as potential antitumor agents with favorable inhibition on Top1. Herein, structural optimization and structure-activity relationship studies (SARs) led us to discovering a highly active evodiamine derivative compound 6t against gastric cancer. Further anti-tumor mechanism studies revealed that compound 6t played as the inhibition of topoisomerase 1 (Top1), effectively induced apoptosis, obviously arrested the cell cycle at the G2/M phase, and significantly inhibited the migration and invasion of SGC-7901 and MGC-803 cell lines in a dose-dependent manner. Moreover, the compound 6t was low toxicity in vivo and exhibited excellent anti-tumor activity (TGI = 70.12%) in the MGC-803 xenograft models. In summary, compound 6t represents a promising candidate as a potential chemotherapeutic agent against gastric cancer.\n",
            "1823980\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as relaxation of supercoiled plasmid pBR322 DNA at 100 uM incubated for 15 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer.  Abstract: Gastric cancer represents a significant health burden worldwide. Previously, inspired by the traditional Chinese medicine Wu-Chu-Yu to treat the spleen and stomach system for thousands of years, we identified N14-phenyl substituted evodiamine derivatives as potential antitumor agents with favorable inhibition on Top1. Herein, structural optimization and structure-activity relationship studies (SARs) led us to discovering a highly active evodiamine derivative compound 6t against gastric cancer. Further anti-tumor mechanism studies revealed that compound 6t played as the inhibition of topoisomerase 1 (Top1), effectively induced apoptosis, obviously arrested the cell cycle at the G2/M phase, and significantly inhibited the migration and invasion of SGC-7901 and MGC-803 cell lines in a dose-dependent manner. Moreover, the compound 6t was low toxicity in vivo and exhibited excellent anti-tumor activity (TGI = 70.12%) in the MGC-803 xenograft models. In summary, compound 6t represents a promising candidate as a potential chemotherapeutic agent against gastric cancer.\n",
            "1823981\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as relaxation of supercoiled plasmid pBR322 DNA at 200 uM incubated for 15 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer.  Abstract: Gastric cancer represents a significant health burden worldwide. Previously, inspired by the traditional Chinese medicine Wu-Chu-Yu to treat the spleen and stomach system for thousands of years, we identified N14-phenyl substituted evodiamine derivatives as potential antitumor agents with favorable inhibition on Top1. Herein, structural optimization and structure-activity relationship studies (SARs) led us to discovering a highly active evodiamine derivative compound 6t against gastric cancer. Further anti-tumor mechanism studies revealed that compound 6t played as the inhibition of topoisomerase 1 (Top1), effectively induced apoptosis, obviously arrested the cell cycle at the G2/M phase, and significantly inhibited the migration and invasion of SGC-7901 and MGC-803 cell lines in a dose-dependent manner. Moreover, the compound 6t was low toxicity in vivo and exhibited excellent anti-tumor activity (TGI = 70.12%) in the MGC-803 xenograft models. In summary, compound 6t represents a promising candidate as a potential chemotherapeutic agent against gastric cancer.\n",
            "1823982\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as relaxation of supercoiled plasmid pBR322 DNA at 50 uM incubated for 15 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer.  Abstract: Gastric cancer represents a significant health burden worldwide. Previously, inspired by the traditional Chinese medicine Wu-Chu-Yu to treat the spleen and stomach system for thousands of years, we identified N14-phenyl substituted evodiamine derivatives as potential antitumor agents with favorable inhibition on Top1. Herein, structural optimization and structure-activity relationship studies (SARs) led us to discovering a highly active evodiamine derivative compound 6t against gastric cancer. Further anti-tumor mechanism studies revealed that compound 6t played as the inhibition of topoisomerase 1 (Top1), effectively induced apoptosis, obviously arrested the cell cycle at the G2/M phase, and significantly inhibited the migration and invasion of SGC-7901 and MGC-803 cell lines in a dose-dependent manner. Moreover, the compound 6t was low toxicity in vivo and exhibited excellent anti-tumor activity (TGI = 70.12%) in the MGC-803 xenograft models. In summary, compound 6t represents a promising candidate as a potential chemotherapeutic agent against gastric cancer.\n",
            "1823983\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as relaxation of supercoiled plasmid pBR322 DNA at 25 uM incubated for 15 mins by ethidium bromide staining based agarose gel electrophoresis method\n",
            "Title: Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer.  Abstract: Gastric cancer represents a significant health burden worldwide. Previously, inspired by the traditional Chinese medicine Wu-Chu-Yu to treat the spleen and stomach system for thousands of years, we identified N14-phenyl substituted evodiamine derivatives as potential antitumor agents with favorable inhibition on Top1. Herein, structural optimization and structure-activity relationship studies (SARs) led us to discovering a highly active evodiamine derivative compound 6t against gastric cancer. Further anti-tumor mechanism studies revealed that compound 6t played as the inhibition of topoisomerase 1 (Top1), effectively induced apoptosis, obviously arrested the cell cycle at the G2/M phase, and significantly inhibited the migration and invasion of SGC-7901 and MGC-803 cell lines in a dose-dependent manner. Moreover, the compound 6t was low toxicity in vivo and exhibited excellent anti-tumor activity (TGI = 70.12%) in the MGC-803 xenograft models. In summary, compound 6t represents a promising candidate as a potential chemotherapeutic agent against gastric cancer.\n",
            "1826593\n",
            "Inhibition of recombinant Top1 (unknown origin) assessed as inhibition of relaxation of supercoiled pBR322 plasmid DNA at 100 uM incubated for 15 mins by ethidium bromide staining based agarose gel electrophoresis analysis\n",
            "Title: Evodiamine-Inspired Topoisomerase-Histone Deacetylase Dual Inhibitors: Novel Orally Active Antitumor Agents for Leukemia Therapy.  Abstract: On the basis of the synergism of topoisomerase (Top) and histone deacetylase (HDAC) inhibitors in antitumor therapy, a series of novel Top/HDAC dual inhibitors were designed and synthesized by the pharmacophore fusion strategy. After systematic structure-activity relationship studies, lead compound <b>16j</b> was identified to simultaneously inhibit both Top and HDAC with good potency, which showed potent antiproliferative activities with a broad spectrum. Mechanistic studies indicated that compound <b>16j</b> efficiently induced apoptosis with S cell-cycle arrest in HEL cancer cells. It was orally active in HEL xenograft models and exhibited excellent <i>in vivo</i> antitumor efficacy (TGI = 68.5%; 10 mg/kg). Altogether, this work highlights the therapeutic potential of evodiamine-inspired Top/HDAC dual inhibitors and provides a valuable lead compound for the development of novel antitumor agents for leukemia therapy.\n",
            "1826602\n",
            "Inhibition of recombinant Top1 (unknown origin) assessed as inhibition of relaxation of supercoiled pBR322 plasmid DNA at 50 uM incubated for 15 mins by ethidium bromide staining based agarose gel electrophoresis analysis\n",
            "Title: Evodiamine-Inspired Topoisomerase-Histone Deacetylase Dual Inhibitors: Novel Orally Active Antitumor Agents for Leukemia Therapy.  Abstract: On the basis of the synergism of topoisomerase (Top) and histone deacetylase (HDAC) inhibitors in antitumor therapy, a series of novel Top/HDAC dual inhibitors were designed and synthesized by the pharmacophore fusion strategy. After systematic structure-activity relationship studies, lead compound <b>16j</b> was identified to simultaneously inhibit both Top and HDAC with good potency, which showed potent antiproliferative activities with a broad spectrum. Mechanistic studies indicated that compound <b>16j</b> efficiently induced apoptosis with S cell-cycle arrest in HEL cancer cells. It was orally active in HEL xenograft models and exhibited excellent <i>in vivo</i> antitumor efficacy (TGI = 68.5%; 10 mg/kg). Altogether, this work highlights the therapeutic potential of evodiamine-inspired Top/HDAC dual inhibitors and provides a valuable lead compound for the development of novel antitumor agents for leukemia therapy.\n",
            "1830490\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as relaxation of supercoiled plasmid pUC18 measured after 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Insights into Ergochromes of the Plant Pathogen <i>Claviceps purpurea</i>.  Abstract: <i>Claviceps purpurea</i> is an ergot fungus known for its neurotropic alkaloids, which have been identified as the main cause of ergotism, a livestock and human disease triggered by ergot consumption. Tetrahydroxanthone dimers, the so-called ergopigments, presumably also contribute to this toxic effect. Overexpression of the cluster-specific transcription factor responsible for the formation of these pigments in <i>C. purpurea</i> led to the isolation of three new metabolites (<b>8</b>-<b>10</b>). The new pigments were characterized utilizing HRMS, NMR techniques, and CD spectroscopy and shown to be xanthone dimers. Secalonic acid A and its 2,4'- and 4,4'-linked isomers were also isolated, and their absolute configuration was investigated. The contribution of secalonic acid A, its isomers, and new metabolites to the toxicity of <i>C. purpurea</i> was investigated in HepG2 and CCF-STTG1 cells. Along with cytotoxic properties, secalonic acid A was found to inhibit topoisomerase I and II activity.\n",
            "1830496\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as relaxation of supercoiled plasmid pUC18 DNA at 100 uM measured after 30 mins by ethidium bromide staining based agarose gel electrophoresis relative to control\n",
            "Title: Insights into Ergochromes of the Plant Pathogen <i>Claviceps purpurea</i>.  Abstract: <i>Claviceps purpurea</i> is an ergot fungus known for its neurotropic alkaloids, which have been identified as the main cause of ergotism, a livestock and human disease triggered by ergot consumption. Tetrahydroxanthone dimers, the so-called ergopigments, presumably also contribute to this toxic effect. Overexpression of the cluster-specific transcription factor responsible for the formation of these pigments in <i>C. purpurea</i> led to the isolation of three new metabolites (<b>8</b>-<b>10</b>). The new pigments were characterized utilizing HRMS, NMR techniques, and CD spectroscopy and shown to be xanthone dimers. Secalonic acid A and its 2,4'- and 4,4'-linked isomers were also isolated, and their absolute configuration was investigated. The contribution of secalonic acid A, its isomers, and new metabolites to the toxicity of <i>C. purpurea</i> was investigated in HepG2 and CCF-STTG1 cells. Along with cytotoxic properties, secalonic acid A was found to inhibit topoisomerase I and II activity.\n",
            "1849130\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as relaxation of supercoiled plasmid pBR322 DNA at 10 uM preincubated for 20 mins followed by pBR322 DNA addition and measured after 30 mins by agarose gel electrophoresis analysis\n",
            "Title: <i>In Silico</i> Exploration and Biological Evaluation of Bispecific Peptides Derived from Anti-HER2 Antibodies and Peptide-Camptothecin Conjugates for HER2-Positive Breast Cancer.  Abstract: To enhance the affinity of the human epidermal growth receptor 2 (HER2) targeted peptide developed previously, bispecific fusion peptides <b>P1GCGT1</b> and <b>P1GCGCGT1</b> were designed using an <i>in silico</i> approach. Molecular dynamic simulation showed that both peptides strongly interacted with HER2 domains II and IV. Compared with peptides targeting each single domain, <b>P1GCGT1</b> and <b>P1GCGCGT1</b> could bind to HER2 more significantly and targeted HER2-positive cells specifically. Additionally, both peptides were used to generate peptide-drug conjugates with camptothecin (CPT), among which <b>I-1</b> and <b>I-4</b> were screened for enhanced cellular activity and selectivity. Biological evaluation demonstrated that <b>I-1</b> and <b>I-4</b> induced cell apoptosis, promoted cell cycle arrestin S-phase, and inhibited Topo I activity. The binding affinity assay and confocal analysis revealed that <b>I-1</b> and <b>I-4</b> were effective at targeting HER2. Moreover, <b>I-1</b> and <b>I-4</b> showed better stability than single targeting peptide and presented enhanced antitumor activity and safety than CPT in tumor-bearing mice.\n",
            "1849131\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as relaxation of supercoiled plasmid pBR322 DNA at 100 uM preincubated for 20 mins followed by pBR322 DNA addition and measured after 30 mins by agarose gel electrophoresis analysis\n",
            "Title: <i>In Silico</i> Exploration and Biological Evaluation of Bispecific Peptides Derived from Anti-HER2 Antibodies and Peptide-Camptothecin Conjugates for HER2-Positive Breast Cancer.  Abstract: To enhance the affinity of the human epidermal growth receptor 2 (HER2) targeted peptide developed previously, bispecific fusion peptides <b>P1GCGT1</b> and <b>P1GCGCGT1</b> were designed using an <i>in silico</i> approach. Molecular dynamic simulation showed that both peptides strongly interacted with HER2 domains II and IV. Compared with peptides targeting each single domain, <b>P1GCGT1</b> and <b>P1GCGCGT1</b> could bind to HER2 more significantly and targeted HER2-positive cells specifically. Additionally, both peptides were used to generate peptide-drug conjugates with camptothecin (CPT), among which <b>I-1</b> and <b>I-4</b> were screened for enhanced cellular activity and selectivity. Biological evaluation demonstrated that <b>I-1</b> and <b>I-4</b> induced cell apoptosis, promoted cell cycle arrestin S-phase, and inhibited Topo I activity. The binding affinity assay and confocal analysis revealed that <b>I-1</b> and <b>I-4</b> were effective at targeting HER2. Moreover, <b>I-1</b> and <b>I-4</b> showed better stability than single targeting peptide and presented enhanced antitumor activity and safety than CPT in tumor-bearing mice.\n",
            "1854846\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as relaxation of supercoiled pBR322 plasmid DNA incubated for 30 mins by ethidium bromide staining based UV absorbance method\n",
            "Title: Design, synthesis, and biological evaluation of novel 7-substituted 10,11-methylenedioxy-camptothecin derivatives against drug-resistant small-cell lung cancer in vitro and in vivo.  Abstract: A series of novel 7-substituted 10,11-methylenedioxy-camptothecin (FL118) derivatives were designed, synthesized, and biologically evaluated. All the FL118 analogues showed significant cytotoxic activities in vitro with IC<sub>50</sub> values in the nanomolar range and were more potent than topotecan. The most active compound 9c exhibited more significant anti-tumor activity against small-cell lung cancer (NCI-H446, H69, drug-resistant H69AR cells, drug-resistant NCI-H446/Irinotecan cells and drug-resistant NCI-H446/EP cells) in vitro. Additionally, 9c could also induce the expression of apoptosis proteins such as caspase-3, caspase-9, and PARP in small-cell lung cancer. Further studies showed that 9c induced apoptosis by inhibiting the expression of Mcl-1, Bcl-2, XIAP and survivin in small-cell lung cancer. In vivo9c also showed better anti-tumor efficacy, with the tumor growth inhibition rates were 40.4% (0.75 mg/kg), 73.7% (1.5 mg/kg), and 95.5% (3 mg/kg). It is noteworthy that 9c also demonstrated potent inhibition of drug-resistant tumor growth in NCI-H446/Irinotecan and NCI-H446/EP xenograft models, the tumor growth inhibition rates were 93.42% and 84.46%, respectively. Taken together, these findings indicated that compound 9c displays outstanding antitumor activity and drug-resistance in small-cell lung cancer both in vivo and in vitro, which could be worth further research as a novel anti-tumor drug against small-cell lung cancer.\n",
            "1858607\n",
            "Inhibition of human Top1 using negatively supercoiled DNA as substrate\n",
            "Title: Paradigm shift of \"classical\" HDAC inhibitors to \"hybrid\" HDAC inhibitors in therapeutic interventions.  Abstract: 'Epigenetic' regulation of genes via post-translational modulation of proteins is the current mainstay approach for the disease therapies, particularly explored in the Histone Deacetylase (HDAC) class of enzymes. Mainly sight saw in cancer chemotherapeutics, HDAC inhibitors have also found a promising role in other diseases (neurodegenerative disorders, cardiovascular diseases, and viral infections) and successfully entered in various combination therapies (pre-clinical/clinical stages). The prevalent flexibility in the structural design of HDAC inhibitors makes them easily tuneable to merge with other pharmacophore modules for generating multi-targeted single hybrids as a novel tactic to overcome drawbacks of polypharmacy. Herein, we reviewed the putative role of prevalent HDAC hybrids inhibitors in the current and prospective stage as a translational approach to overcome the limitations of the existing conventional drug candidates (parent molecule) when used either alone (drug resistance, solubility issues, adverse side effects, selectivity profile) or in combination (pharmacokinetic interactions, patient compliance) for treating various diseases.\n",
            "1859455\n",
            "Inhibition of Top1 in [3H]-Thymidine-labeled human MCF7 cells assessed as Top1-DNA complex formation at 30 uM incubated for 60 mins followed by addition of salmon sperm DNA and subsequent addition of KCl relative to control\n",
            "Title: Topoisomerase I inhibitors: Challenges, progress and the road ahead.  Abstract: Topoisomerase IB (Top1), a subcategory of DNA topoisomerase enzymes is expressed much higher in several tumor cells. Therefore, modulating the activity of Top1 in tumor cells to prevent DNA replication and subsequent cell division made it an important drug target for anticancer therapy. FDA-approved camptothecin (CPT) derivatives topotecan and irinotecan exert anticancer activity through stabilization of enzyme-mediated DNA cleavage complex forming a ternary complex between DNA-Top1-drug. However, CPT derivatives suffer from several limitations which prompted interest in the development of 'non-camptothecin' Top1 poisons as anticancer agents. This review aims to provide chronological development of different classes of Top1 poisons from both natural and synthetic sources through strategic structure-activity relationship (SAR) analysis with insight into the important structural features in different chemotypes that imparted Top1 inhibition along with the understanding of the structural basis of inhibition. This review also provides a snapshot of the application of Top1 poisons in various combination therapies in recent times. We believe such a comprehensive review is going to be beneficial for the medicinal chemistry community to design efficient drug development strategies using existing knowledge.\n",
            "1859464\n",
            "Inhibition of full-length recombinant human Top1 expressed in baculovirus infected Sf9 insect cells at 5 uM incubated for 30 mins relative to control\n",
            "Title: Topoisomerase I inhibitors: Challenges, progress and the road ahead.  Abstract: Topoisomerase IB (Top1), a subcategory of DNA topoisomerase enzymes is expressed much higher in several tumor cells. Therefore, modulating the activity of Top1 in tumor cells to prevent DNA replication and subsequent cell division made it an important drug target for anticancer therapy. FDA-approved camptothecin (CPT) derivatives topotecan and irinotecan exert anticancer activity through stabilization of enzyme-mediated DNA cleavage complex forming a ternary complex between DNA-Top1-drug. However, CPT derivatives suffer from several limitations which prompted interest in the development of 'non-camptothecin' Top1 poisons as anticancer agents. This review aims to provide chronological development of different classes of Top1 poisons from both natural and synthetic sources through strategic structure-activity relationship (SAR) analysis with insight into the important structural features in different chemotypes that imparted Top1 inhibition along with the understanding of the structural basis of inhibition. This review also provides a snapshot of the application of Top1 poisons in various combination therapies in recent times. We believe such a comprehensive review is going to be beneficial for the medicinal chemistry community to design efficient drug development strategies using existing knowledge.\n",
            "1859467\n",
            "Inhibition of recombinant human Top1 derived from human MCF7 cell extract incubated for 30 mins\n",
            "Title: Topoisomerase I inhibitors: Challenges, progress and the road ahead.  Abstract: Topoisomerase IB (Top1), a subcategory of DNA topoisomerase enzymes is expressed much higher in several tumor cells. Therefore, modulating the activity of Top1 in tumor cells to prevent DNA replication and subsequent cell division made it an important drug target for anticancer therapy. FDA-approved camptothecin (CPT) derivatives topotecan and irinotecan exert anticancer activity through stabilization of enzyme-mediated DNA cleavage complex forming a ternary complex between DNA-Top1-drug. However, CPT derivatives suffer from several limitations which prompted interest in the development of 'non-camptothecin' Top1 poisons as anticancer agents. This review aims to provide chronological development of different classes of Top1 poisons from both natural and synthetic sources through strategic structure-activity relationship (SAR) analysis with insight into the important structural features in different chemotypes that imparted Top1 inhibition along with the understanding of the structural basis of inhibition. This review also provides a snapshot of the application of Top1 poisons in various combination therapies in recent times. We believe such a comprehensive review is going to be beneficial for the medicinal chemistry community to design efficient drug development strategies using existing knowledge.\n",
            "1859469\n",
            "Inhibition of human Top1 expressed in Escherichia coli assessed as enzyme-mediated DNA cleavage by measuring relative effective concentration incubated for 30 mins relative to topotecan\n",
            "Title: Topoisomerase I inhibitors: Challenges, progress and the road ahead.  Abstract: Topoisomerase IB (Top1), a subcategory of DNA topoisomerase enzymes is expressed much higher in several tumor cells. Therefore, modulating the activity of Top1 in tumor cells to prevent DNA replication and subsequent cell division made it an important drug target for anticancer therapy. FDA-approved camptothecin (CPT) derivatives topotecan and irinotecan exert anticancer activity through stabilization of enzyme-mediated DNA cleavage complex forming a ternary complex between DNA-Top1-drug. However, CPT derivatives suffer from several limitations which prompted interest in the development of 'non-camptothecin' Top1 poisons as anticancer agents. This review aims to provide chronological development of different classes of Top1 poisons from both natural and synthetic sources through strategic structure-activity relationship (SAR) analysis with insight into the important structural features in different chemotypes that imparted Top1 inhibition along with the understanding of the structural basis of inhibition. This review also provides a snapshot of the application of Top1 poisons in various combination therapies in recent times. We believe such a comprehensive review is going to be beneficial for the medicinal chemistry community to design efficient drug development strategies using existing knowledge.\n",
            "1862078\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as relaxation of supercoiled plasmid pBR322 DNA at 10 uM incubated for 45 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Discovery of dual inhibitors of topoisomerase I and Cyclooxygenase-2 for colon cancer therapy.  Abstract: Novel tolfenamic acid derivatives based on the structure of I-1 were designed and synthesized to improve its poor target inhibition and solubility. Among them, W10 was identified as a potent dual-target inhibitor of Topo I (IC<sub>50</sub> = 0.90  0.17 M) and COX-2 (IC<sub>50</sub> = 2.31  0.07 M) with improved water solubility (32.33 g/mL). Moreover, W10 also exhibited fairly potent anti-proliferative and pro-apoptosis activity via the mitochondrial pathway, as well as suppressed aberrant NF-B/IB activation in colon cancer cells in vitro. Additionally, W10 possessed favorable pharmacokinetic properties and excellent antitumor effects in vivo. In general, our study has demonstrated the potency of a novel Topo I/COX-2 dual inhibitor, which can potentially be developed into a chemotherapeutic candidate for colon cancer.\n",
            "1862079\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as relaxation of supercoiled plasmid pBR322 DNA at 1 uM incubated for 45 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: Discovery of dual inhibitors of topoisomerase I and Cyclooxygenase-2 for colon cancer therapy.  Abstract: Novel tolfenamic acid derivatives based on the structure of I-1 were designed and synthesized to improve its poor target inhibition and solubility. Among them, W10 was identified as a potent dual-target inhibitor of Topo I (IC<sub>50</sub> = 0.90  0.17 M) and COX-2 (IC<sub>50</sub> = 2.31  0.07 M) with improved water solubility (32.33 g/mL). Moreover, W10 also exhibited fairly potent anti-proliferative and pro-apoptosis activity via the mitochondrial pathway, as well as suppressed aberrant NF-B/IB activation in colon cancer cells in vitro. Additionally, W10 possessed favorable pharmacokinetic properties and excellent antitumor effects in vivo. In general, our study has demonstrated the potency of a novel Topo I/COX-2 dual inhibitor, which can potentially be developed into a chemotherapeutic candidate for colon cancer.\n",
            "1862088\n",
            "Poison activity at topoisomerase 1 (unknown origin) assessed as s increase in nicked DNA formation at 1 mM using supercoiled plasmid DNA as substrate at 200 to 400 uM incubated for 35 mins by agarose gel electrophoresis\n",
            "Title: Discovery of dual inhibitors of topoisomerase I and Cyclooxygenase-2 for colon cancer therapy.  Abstract: Novel tolfenamic acid derivatives based on the structure of I-1 were designed and synthesized to improve its poor target inhibition and solubility. Among them, W10 was identified as a potent dual-target inhibitor of Topo I (IC<sub>50</sub> = 0.90  0.17 M) and COX-2 (IC<sub>50</sub> = 2.31  0.07 M) with improved water solubility (32.33 g/mL). Moreover, W10 also exhibited fairly potent anti-proliferative and pro-apoptosis activity via the mitochondrial pathway, as well as suppressed aberrant NF-B/IB activation in colon cancer cells in vitro. Additionally, W10 possessed favorable pharmacokinetic properties and excellent antitumor effects in vivo. In general, our study has demonstrated the potency of a novel Topo I/COX-2 dual inhibitor, which can potentially be developed into a chemotherapeutic candidate for colon cancer.\n",
            "1867660\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as reduction in relaxation of supercoiled plasmid pBR322 DNA at 12.5 to 100 uM incubated for 30 mins by agarose gel electrophoresis\n",
            "Title: Design, synthesis and biological evaluation of 3-arylisoquinoline derivatives as topoisomerase I and II dual inhibitors for the therapy of liver cancer.  Abstract: To explore novel topoisomerase inhibitors with high activity and druggability, 3-aryl isoquinoline alkaloids based on the corydamine modification and preliminary SARs of isoquinoline alkaloids in our previous works were re-designed. Currently, the design strategy is mainly revolved around the rigidity and flexibility of the molecular side chain and the molecular size. Consequently, not only the activity and druggability of the compound could be further improved, also the mechanism behind could been discovered. In vitro pharmacological studies, the outstanding nature with the excellent activity and the researchable depth of azepane-substituted compound 7 has been found through the vitro cytotoxicity test (IC<sub>50</sub> = 1.93 M in HuH7 cells and 2.10 M in LM9 cells) and topoisomerase test. It was found that compound 7 had dual inhibitory effects on topoisomerase I and II, and its inhibitory activity on topoisomerase II is stronger than the positive drug etoposide. From the perspective of molecular docking, it had been verified that compound 7 could insert between DNA base pairs, which was consistent with the results of the DNA unwinding experiment. And the comet experiment confirmed 7 caused DNA damage. Meanwhile, compound 7 could inhibit cell proliferation, invasion and migration, and induce apoptosis by inhibiting PI3K/Akt/mTOR signaling pathway. Therefore, this study may lay a foundation for the discovery of 3-arylisoquinoline compounds with anti-liver cancer potential.\n",
            "1867663\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as DNA intercalation at 25 to 100 uM using pBR322 DNA as substrate measured after 30 mins by agarose gel electrophoresis\n",
            "Title: Design, synthesis and biological evaluation of 3-arylisoquinoline derivatives as topoisomerase I and II dual inhibitors for the therapy of liver cancer.  Abstract: To explore novel topoisomerase inhibitors with high activity and druggability, 3-aryl isoquinoline alkaloids based on the corydamine modification and preliminary SARs of isoquinoline alkaloids in our previous works were re-designed. Currently, the design strategy is mainly revolved around the rigidity and flexibility of the molecular side chain and the molecular size. Consequently, not only the activity and druggability of the compound could be further improved, also the mechanism behind could been discovered. In vitro pharmacological studies, the outstanding nature with the excellent activity and the researchable depth of azepane-substituted compound 7 has been found through the vitro cytotoxicity test (IC<sub>50</sub> = 1.93 M in HuH7 cells and 2.10 M in LM9 cells) and topoisomerase test. It was found that compound 7 had dual inhibitory effects on topoisomerase I and II, and its inhibitory activity on topoisomerase II is stronger than the positive drug etoposide. From the perspective of molecular docking, it had been verified that compound 7 could insert between DNA base pairs, which was consistent with the results of the DNA unwinding experiment. And the comet experiment confirmed 7 caused DNA damage. Meanwhile, compound 7 could inhibit cell proliferation, invasion and migration, and induce apoptosis by inhibiting PI3K/Akt/mTOR signaling pathway. Therefore, this study may lay a foundation for the discovery of 3-arylisoquinoline compounds with anti-liver cancer potential.\n",
            "1877736\n",
            "Inhibition of recombinant human topoisomerase 1 expressed in Saccharomyces cerevisiae RS190 assessed as relaxation of supercoiled plasmid pUC18 at 100 uM preincubated for 15 mins followed by substrate addition and measured after 3 mins by GelRed staining based agarose gel electrophoresis method relative to control\n",
            "Title: Synthesis of hybrid phosphorated indenoquinolines and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.  Abstract: This work describes the first synthesis of diethyl 6,6a,7,11b-tetrahydro-5H-indeno[2,1-c]quinolinylphosphonates 5, diethyl 7H-indeno[2,1-c]quinolinylphosphonates 6 and diethyl 7-oxo-7H-indeno[2,1-c]quinolinylphosphonates 7, which were prepared in good to high overall yields. The synthetic route involves a multicomponent reaction of 2-phosphonateaniline, aldehydes and indene as olefin and allows the selective generation of three stereogenic centres in a short, efficient and reliable manner. The selective dehydrogenation of 1,2,3,4-tetrahydroindenoquinolines leads to the formation of corresponding indenoquinolines, and subsequent oxidation of methylene group of the indenoquinolines allows the access to indenoquinolinones.\n",
            "1877737\n",
            "Inhibition of recombinant human topoisomerase 1 expressed in Saccharomyces cerevisiae RS190 assessed as relaxation of supercoiled plasmid pUC18 at 100 uM preincubated for 15 mins followed by substrate addition and measured after 15 secs by GelRed staining based agarose gel electrophoresis method relative to control\n",
            "Title: Synthesis of hybrid phosphorated indenoquinolines and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.  Abstract: This work describes the first synthesis of diethyl 6,6a,7,11b-tetrahydro-5H-indeno[2,1-c]quinolinylphosphonates 5, diethyl 7H-indeno[2,1-c]quinolinylphosphonates 6 and diethyl 7-oxo-7H-indeno[2,1-c]quinolinylphosphonates 7, which were prepared in good to high overall yields. The synthetic route involves a multicomponent reaction of 2-phosphonateaniline, aldehydes and indene as olefin and allows the selective generation of three stereogenic centres in a short, efficient and reliable manner. The selective dehydrogenation of 1,2,3,4-tetrahydroindenoquinolines leads to the formation of corresponding indenoquinolines, and subsequent oxidation of methylene group of the indenoquinolines allows the access to indenoquinolinones.\n",
            "1877738\n",
            "Inhibition of recombinant human topoisomerase 1 expressed in Saccharomyces cerevisiae RS190 assessed as relaxation of supercoiled plasmid pUC18 at 100 uM preincubated for 15 mins followed by substrate addition and measured after 1 min by GelRed staining based agarose gel electrophoresis method relative to control\n",
            "Title: Synthesis of hybrid phosphorated indenoquinolines and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.  Abstract: This work describes the first synthesis of diethyl 6,6a,7,11b-tetrahydro-5H-indeno[2,1-c]quinolinylphosphonates 5, diethyl 7H-indeno[2,1-c]quinolinylphosphonates 6 and diethyl 7-oxo-7H-indeno[2,1-c]quinolinylphosphonates 7, which were prepared in good to high overall yields. The synthetic route involves a multicomponent reaction of 2-phosphonateaniline, aldehydes and indene as olefin and allows the selective generation of three stereogenic centres in a short, efficient and reliable manner. The selective dehydrogenation of 1,2,3,4-tetrahydroindenoquinolines leads to the formation of corresponding indenoquinolines, and subsequent oxidation of methylene group of the indenoquinolines allows the access to indenoquinolinones.\n",
            "1884188\n",
            "Inhibition of DNA topoisomerase 1 (unknown origin) assessed as reduction in pBR322 DNA relaxation at 10 uM incubated for 30 mins measured by agarose gel electrophoresis method relative to control\n",
            "Title: Design, synthesis of DNA-interactive 4-thiazolidinone-based indolo-/pyrroloazepinone conjugates as potential cytotoxic and topoisomerase I inhibitors.  Abstract: With the rising cancer incidence and mortality globally, there is a prerequisite for effective design strategies towards the discovery of newer small molecular entities in chemotherapy. Hence, a series of new thiazolidinone-based indolo-/pyrroloazepinone conjugates was designed, synthesized via molecular hybridization, and evaluated for their in vitro cytotoxicity potential and DNA topoisomerase I and II inhibition. Among this series, conjugate 11g emerged as the most active compound with an IC<sub>50</sub> value of 1.24 M against A549 and 3.02-10.91 M in the other tested cancer cell lines. Gratifyingly, 11g displayed 43-fold higher selectivity towards A549 cancer cells as compared to the non-cancer cells. Subsequently, conjugate 12g also demonstrated significant cytotoxicity against SK-MEL-28 cells. Basing the in vitro cytotoxicity results, SAR was established. Later, the conjugates 11g and 12g were further evaluated for their apoptosis-inducing ability, which was quantified by flow cytometric analysis, DNA-binding, Topo I inhibitory activity and IC<sub>50</sub> value calculation. Molecular modeling studies provided profound insights about the binding nature of these compounds with DNA-Topo I complex. In silico ADME/T and prediction studies corroborated the drug-likeness of the two investigated compounds. TOPKAT toxicity profiling studies demonstrated the compounds' safety in many animal models with a minimal toxicological profile. Encouraging results obtained from in vitro and in silico studies could put this series of conjugates at the forefront of cancer drug discovery.\n",
            "1884189\n",
            "Inhibition of human DNA topoisomerase 1 assessed as reduction in pBR322 DNA relaxation incubated for 1 hrs measured by agarose gel electrophoresis method\n",
            "Title: Design, synthesis of DNA-interactive 4-thiazolidinone-based indolo-/pyrroloazepinone conjugates as potential cytotoxic and topoisomerase I inhibitors.  Abstract: With the rising cancer incidence and mortality globally, there is a prerequisite for effective design strategies towards the discovery of newer small molecular entities in chemotherapy. Hence, a series of new thiazolidinone-based indolo-/pyrroloazepinone conjugates was designed, synthesized via molecular hybridization, and evaluated for their in vitro cytotoxicity potential and DNA topoisomerase I and II inhibition. Among this series, conjugate 11g emerged as the most active compound with an IC<sub>50</sub> value of 1.24 M against A549 and 3.02-10.91 M in the other tested cancer cell lines. Gratifyingly, 11g displayed 43-fold higher selectivity towards A549 cancer cells as compared to the non-cancer cells. Subsequently, conjugate 12g also demonstrated significant cytotoxicity against SK-MEL-28 cells. Basing the in vitro cytotoxicity results, SAR was established. Later, the conjugates 11g and 12g were further evaluated for their apoptosis-inducing ability, which was quantified by flow cytometric analysis, DNA-binding, Topo I inhibitory activity and IC<sub>50</sub> value calculation. Molecular modeling studies provided profound insights about the binding nature of these compounds with DNA-Topo I complex. In silico ADME/T and prediction studies corroborated the drug-likeness of the two investigated compounds. TOPKAT toxicity profiling studies demonstrated the compounds' safety in many animal models with a minimal toxicological profile. Encouraging results obtained from in vitro and in silico studies could put this series of conjugates at the forefront of cancer drug discovery.\n",
            "1885559\n",
            "Inhibition of human topoisomerase I assessed as DNA unwinding using DNA pBR322 as substrate at 2 uM incubated for 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: <i>N</i>-2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX-2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression.  Abstract: Given the close association between inflammation and cancer, combining anti-inflammation therapy is prominent to improve the anticancer effect. Based on <b>I-1</b>, a series of agents targeting COX-2 and Topo I were designed by combining fenamates and phenols. The optimal compound <b>1H-30</b> displayed an enhanced inhibitory effect on COX-2 compared to tolfenamic acid and <b>I-1</b> and showed better inhibition of Topo I than <b>I-1</b>. Importantly, <b>1H-30</b> showed potential anticancer effects and suppressed the activation of the NF-B pathway in cancer cells. <b>1H-30</b> inhibited the nuclear translocation of NF-B and suppressed the production of NO, COX-2, and IL-1 in RAW264.7. In vivo, <b>1H-30</b> showed acceptable pharmacokinetic parameters, decreased the tumor growth without affecting the body weight, down-regulated COX-2 and MMP-9, and induced apoptosis in the CT26.WT tumor-bearing mice. Accordingly, <b>1H-30</b> as a potential Topo I/COX-2 inhibitor which possessed anti-inflammatory and anticancer effects, with inhibition of the NF-B pathway, is promising for gastrointestinal cancer therapy.\n",
            "1885561\n",
            "Inhibition of human topoisomerase I assessed as DNA relaxation using DNA pBR322 as substrate incubated for 30 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: <i>N</i>-2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX-2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression.  Abstract: Given the close association between inflammation and cancer, combining anti-inflammation therapy is prominent to improve the anticancer effect. Based on <b>I-1</b>, a series of agents targeting COX-2 and Topo I were designed by combining fenamates and phenols. The optimal compound <b>1H-30</b> displayed an enhanced inhibitory effect on COX-2 compared to tolfenamic acid and <b>I-1</b> and showed better inhibition of Topo I than <b>I-1</b>. Importantly, <b>1H-30</b> showed potential anticancer effects and suppressed the activation of the NF-B pathway in cancer cells. <b>1H-30</b> inhibited the nuclear translocation of NF-B and suppressed the production of NO, COX-2, and IL-1 in RAW264.7. In vivo, <b>1H-30</b> showed acceptable pharmacokinetic parameters, decreased the tumor growth without affecting the body weight, down-regulated COX-2 and MMP-9, and induced apoptosis in the CT26.WT tumor-bearing mice. Accordingly, <b>1H-30</b> as a potential Topo I/COX-2 inhibitor which possessed anti-inflammatory and anticancer effects, with inhibition of the NF-B pathway, is promising for gastrointestinal cancer therapy.\n",
            "1885562\n",
            "Inhibition of human topoisomerase I assessed as DNA intercalation using DNA pBR322 as substrate incubated for 20 mins by ethidium bromide staining based agarose gel electrophoresis\n",
            "Title: <i>N</i>-2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX-2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression.  Abstract: Given the close association between inflammation and cancer, combining anti-inflammation therapy is prominent to improve the anticancer effect. Based on <b>I-1</b>, a series of agents targeting COX-2 and Topo I were designed by combining fenamates and phenols. The optimal compound <b>1H-30</b> displayed an enhanced inhibitory effect on COX-2 compared to tolfenamic acid and <b>I-1</b> and showed better inhibition of Topo I than <b>I-1</b>. Importantly, <b>1H-30</b> showed potential anticancer effects and suppressed the activation of the NF-B pathway in cancer cells. <b>1H-30</b> inhibited the nuclear translocation of NF-B and suppressed the production of NO, COX-2, and IL-1 in RAW264.7. In vivo, <b>1H-30</b> showed acceptable pharmacokinetic parameters, decreased the tumor growth without affecting the body weight, down-regulated COX-2 and MMP-9, and induced apoptosis in the CT26.WT tumor-bearing mice. Accordingly, <b>1H-30</b> as a potential Topo I/COX-2 inhibitor which possessed anti-inflammatory and anticancer effects, with inhibition of the NF-B pathway, is promising for gastrointestinal cancer therapy.\n",
            "1888016\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as relaxation of supercoiled plasmid pBR322 DNA at 100 uM by agarose gel electrophoresis (Rvb = 83.2%)\n",
            "Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.\n",
            "1888017\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as relaxation of supercoiled plasmid pBR322 DNA at 100 uM by agarose gel electrophoresis (Rvb = 81.9%)\n",
            "Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.\n",
            "1888018\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as relaxation of supercoiled plasmid pBR322 DNA at 20 uM by agarose gel electrophoresis (Rvb = 40.4%)\n",
            "Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.\n",
            "1888019\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as relaxation of supercoiled plasmid pBR322 DNA at 20 uM by agarose gel electrophoresis (Rvb = 38.3%)\n",
            "Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.\n",
            "1888020\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as relaxation of supercoiled plasmid pBR322 DNA at 100 uM by agarose gel electrophoresis (Rvb = 90.6%)\n",
            "Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.\n",
            "1888021\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as relaxation of supercoiled plasmid pBR322 DNA at 100 uM by agarose gel electrophoresis (Rvb = 74.7%)\n",
            "Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.\n",
            "1888022\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as relaxation of supercoiled plasmid pBR322 DNA at 20 uM by agarose gel electrophoresis (Rvb = 38.4%)\n",
            "Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.\n",
            "1888023\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as relaxation of supercoiled plasmid pBR322 DNA at 20 uM by agarose gel electrophoresis relative to control\n",
            "Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.\n",
            "1888036\n",
            "Catalytic inhibitor of non-intercalative topoisomerase 1 (unknown origin) assessed as binding to minor groove at 100 to 500 uM measured by cleavage complex assay\n",
            "Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.\n",
            "1888037\n",
            "Catalytic inhibitor of non-intercalative topoisomerase 1 (unknown origin) assessed as increase in nicked DNA level at 100 to 250 uM measured by cleavage complex assay\n",
            "Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.\n",
            "1888098\n",
            "Inhibition of recombinant human topoisomerase 1 assessed as relaxation of supercoiled plasmid pBR322 DNA at 100 uM by agarose gel electrophoresis relative to control\n",
            "Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.\n",
            "1891163\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as reduction in relaxation of supercoiled DNA at 1 mM using pBR322 plasmid DNA as substrate measured after 30 mins by gel electrophoresis relative to control\n",
            "Title: Discovery, Topo I inhibitory activity and mechanism evaluation of two novel cytisine-type alkaloid dimers from the seeds of Sophora alopecuroides L.  Abstract: Alopecurosines A and B (CMs 1 and 2, respectively) are two novel cytisine-type alkaloid dimers first isolated from the aerial parts of Sophora alopecuroides L. CMs 1 and 2 are new dimeric alkaloids whose piperidine matrine ring is cleaved and connected via the N'-1 bond. Their chemical structures have been confirmed by IR, UV, HR-ESI-MS, and NMR. Preliminary screening shows that they have topoisomerase I (Topo I)-based anti-tumor activity. Their Topo I inhibitory activities and mechanism have been evaluated by agarose gel electrophoresis assay and a molecular docking study. The results show that the inhibition rate of CM 1 is 82.26% at 1 mM concentration and that it exhibits significantly Topo I inhibitory activity. Further research has illustrated that CMs 1 and 2 exert inhibitory activity by stabilising the Topo I-DNA cleavage complex, implying that they have the potential to be developed as novel Topo I inhibitors.\n",
            "1891164\n",
            "Poison activity at topoisomerase 1 (unknown origin) assessed as stabilization of enzyme-DNA cleavage complex by measuring increase in nicked DNA formation at 1 to 3 mM using pBR322 DNA as substrate after 30 mins by agarose gel electrophoresis\n",
            "Title: Discovery, Topo I inhibitory activity and mechanism evaluation of two novel cytisine-type alkaloid dimers from the seeds of Sophora alopecuroides L.  Abstract: Alopecurosines A and B (CMs 1 and 2, respectively) are two novel cytisine-type alkaloid dimers first isolated from the aerial parts of Sophora alopecuroides L. CMs 1 and 2 are new dimeric alkaloids whose piperidine matrine ring is cleaved and connected via the N'-1 bond. Their chemical structures have been confirmed by IR, UV, HR-ESI-MS, and NMR. Preliminary screening shows that they have topoisomerase I (Topo I)-based anti-tumor activity. Their Topo I inhibitory activities and mechanism have been evaluated by agarose gel electrophoresis assay and a molecular docking study. The results show that the inhibition rate of CM 1 is 82.26% at 1 mM concentration and that it exhibits significantly Topo I inhibitory activity. Further research has illustrated that CMs 1 and 2 exert inhibitory activity by stabilising the Topo I-DNA cleavage complex, implying that they have the potential to be developed as novel Topo I inhibitors.\n",
            "1891165\n",
            "Poison activity at topoisomerase 1 (unknown origin) assessed as stabilization of enzyme-DNA cleavage complex by measuring increase in nicked DNA formation at 1 mM using pBR322 DNA as substrate after 30 mins by agarose gel electrophoresis\n",
            "Title: Discovery, Topo I inhibitory activity and mechanism evaluation of two novel cytisine-type alkaloid dimers from the seeds of Sophora alopecuroides L.  Abstract: Alopecurosines A and B (CMs 1 and 2, respectively) are two novel cytisine-type alkaloid dimers first isolated from the aerial parts of Sophora alopecuroides L. CMs 1 and 2 are new dimeric alkaloids whose piperidine matrine ring is cleaved and connected via the N'-1 bond. Their chemical structures have been confirmed by IR, UV, HR-ESI-MS, and NMR. Preliminary screening shows that they have topoisomerase I (Topo I)-based anti-tumor activity. Their Topo I inhibitory activities and mechanism have been evaluated by agarose gel electrophoresis assay and a molecular docking study. The results show that the inhibition rate of CM 1 is 82.26% at 1 mM concentration and that it exhibits significantly Topo I inhibitory activity. Further research has illustrated that CMs 1 and 2 exert inhibitory activity by stabilising the Topo I-DNA cleavage complex, implying that they have the potential to be developed as novel Topo I inhibitors.\n",
            "1891166\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as DNA intercalation at 1 mM using pBR322 DNA as substrate measured after 30 mins by gel electrophoresis relative to control\n",
            "Title: Discovery, Topo I inhibitory activity and mechanism evaluation of two novel cytisine-type alkaloid dimers from the seeds of Sophora alopecuroides L.  Abstract: Alopecurosines A and B (CMs 1 and 2, respectively) are two novel cytisine-type alkaloid dimers first isolated from the aerial parts of Sophora alopecuroides L. CMs 1 and 2 are new dimeric alkaloids whose piperidine matrine ring is cleaved and connected via the N'-1 bond. Their chemical structures have been confirmed by IR, UV, HR-ESI-MS, and NMR. Preliminary screening shows that they have topoisomerase I (Topo I)-based anti-tumor activity. Their Topo I inhibitory activities and mechanism have been evaluated by agarose gel electrophoresis assay and a molecular docking study. The results show that the inhibition rate of CM 1 is 82.26% at 1 mM concentration and that it exhibits significantly Topo I inhibitory activity. Further research has illustrated that CMs 1 and 2 exert inhibitory activity by stabilising the Topo I-DNA cleavage complex, implying that they have the potential to be developed as novel Topo I inhibitors.\n",
            "1891167\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as DNA intercalation at 1 to 5 mM using pBR322 DNA as substrate measured after 30 mins by gel electrophoresis relative to control\n",
            "Title: Discovery, Topo I inhibitory activity and mechanism evaluation of two novel cytisine-type alkaloid dimers from the seeds of Sophora alopecuroides L.  Abstract: Alopecurosines A and B (CMs 1 and 2, respectively) are two novel cytisine-type alkaloid dimers first isolated from the aerial parts of Sophora alopecuroides L. CMs 1 and 2 are new dimeric alkaloids whose piperidine matrine ring is cleaved and connected via the N'-1 bond. Their chemical structures have been confirmed by IR, UV, HR-ESI-MS, and NMR. Preliminary screening shows that they have topoisomerase I (Topo I)-based anti-tumor activity. Their Topo I inhibitory activities and mechanism have been evaluated by agarose gel electrophoresis assay and a molecular docking study. The results show that the inhibition rate of CM 1 is 82.26% at 1 mM concentration and that it exhibits significantly Topo I inhibitory activity. Further research has illustrated that CMs 1 and 2 exert inhibitory activity by stabilising the Topo I-DNA cleavage complex, implying that they have the potential to be developed as novel Topo I inhibitors.\n",
            "1891168\n",
            "Inhibition of pBR322 DNA binding to topoisomerase 1 (unknown origin) at 1 to 5 mM measured after 30 mins by electrophoretic mobility shift assay\n",
            "Title: Discovery, Topo I inhibitory activity and mechanism evaluation of two novel cytisine-type alkaloid dimers from the seeds of Sophora alopecuroides L.  Abstract: Alopecurosines A and B (CMs 1 and 2, respectively) are two novel cytisine-type alkaloid dimers first isolated from the aerial parts of Sophora alopecuroides L. CMs 1 and 2 are new dimeric alkaloids whose piperidine matrine ring is cleaved and connected via the N'-1 bond. Their chemical structures have been confirmed by IR, UV, HR-ESI-MS, and NMR. Preliminary screening shows that they have topoisomerase I (Topo I)-based anti-tumor activity. Their Topo I inhibitory activities and mechanism have been evaluated by agarose gel electrophoresis assay and a molecular docking study. The results show that the inhibition rate of CM 1 is 82.26% at 1 mM concentration and that it exhibits significantly Topo I inhibitory activity. Further research has illustrated that CMs 1 and 2 exert inhibitory activity by stabilising the Topo I-DNA cleavage complex, implying that they have the potential to be developed as novel Topo I inhibitors.\n",
            "1894518\n",
            "Inhibition of topoisomerase 1 (unknown origin) assessed as relaxation of pBR322 plasmid DNA and incubated for 10 mins\n",
            "Title: -Carbolines as potential anticancer agents.  Abstract: -Carbolines are indole alkaloids having a tricyclic pyrido[3,4-b]indole ring in their structure. Since the isolation of first -carboline from Peganum harmala in 1841, the isolation and synthesis of various -carboline derivatives surged in the following centuries. -Carboline derivatives due to their widespread availability from natural sources, structural flexibility, quick reactivity and interaction with varied anticancer targets such as DNA (intercalation, groove binding, etc.), enzymes (GPX4, topoisomerases, kinases, etc.) and proteins (tubulin, ABCG2/BRCP1, etc.) have established themselves as promising lead compounds for the synthesis of various anticancer active agents. The current review covers the synthesis and isolation, anticancer activity, mechanism of action and SAR of various -carboline containing molecules, its derivatives and congeners.\n",
            "1899156\n",
            "Inhibition of DNA topoisomerase 1 (unknown origin) at 25 to 50 uM measured by agar gel electrophoresis relative to control\n",
            "Title: Design, synthesis and anti-hepatocellular carcinoma activity of 3-arylisoquinoline alkaloids.  Abstract: This article describes the syntheses and biological activity of five 3-arylisoquinoline natural products corydamine (1), N-formyl Corydamine (2), hypecumine (3), Decumbenine B (XW) and 2-(1,3-dioxolo [4,5-h]isoquinolin-7-yl)-4,5-dimethoxy-N-methyl-Benzeneethanamine (A), and twelve analogues. Among them, 1, 2, and A were synthesized for the first time. In vitro screening for anti-proliferative activity showed that derivative 1a could significantly inhibit the proliferation of HCC cells (IC<sub>50</sub> = 9.82 M on Huh7 cells and 6.83 M on LM9 cells), and arrest cell cycle at G<sub>2</sub>/M phase. The mechanistic studies further suggested compound 1a was a dual inhibitor of Topo I and Topo II, and Topo II inhibitory activity was superior to etoposide. In addition, 1a could significantly inhibit the invasion and migration of cancer cells by inhibiting the expression of MMP-9, and induce apoptosis through inhibiting the activation of the PI3K/Akt/mTOR signaling pathway. Moreover, in vivo studies demonstrated 1a could obviously reduce the growth of xenograft tumor and possessed good pharmacokinetic parameters, which indicated the potential value of 1a in treating liver cancer.\n",
            "1906038\n",
            "Inhibition of human DNA topoisomerase 1 assessed as reduction in pBR322 DNA relaxation at 50 to 100 uM measured by gel electrophoresis method\n",
            "Title: Development of oxoisoaporphine derivatives with topoisomerase I inhibition and reversal of multidrug resistance in breast cancer MCF-7/ADR cells.  Abstract: A series of oxoisoaporphine derivatives with topoisomerase I inhibition and cytotoxic activities. Among them, compound 14 showed the most potent cytotoxic activity against all cancer cell lines tested, and substantially lower cytotoxicity to LO2 cells. Molecular docking studies, dynamics simulation and a follow-up enzyme inhibition assay indicated that 14 could interfere with DNA and significantly inhibit the activity of topoisomerase I. Further mechanistic studies revealed that 14 could arrest cell cycle at the G1 phase, and finally killed MCF-7 cells via apoptosis. In addition, 14 exhibited remarkable chemoreversal ability on multidrug-resistant MCF-7/ADR breast cancer cells. Some of its mechanisms may be related to inhibition of MCF-7/ADR P-gp-mediated Rhodamine (Rh123) efflux function and expression level, as well as inhibition of ROS, increase of ADR accumulation in MCF7/ADR cells, and enhancement of ADR in inducing apoptosis of MCF7/ADR cells. As 14 has little toxic and side effects, it may have the potential for further research.\n",
            "1911379\n",
            "Inhibition of DNA topoisomerase I (unknown origin) relaxation activity at 100 uM incubated for 30 mins by chemiDoc system\n",
            "Title: Optimization of the Natural Product Calothrixin A to Discover Novel Dual Topoisomerase I and II Inhibitors with Improved Anticancer Activity.  Abstract: Calothrixin A (<b>CAA</b>) is a dual Topo I and II inhibitor but exhibits poor antiproliferative activities and water solubility. Herein, a library of novel <b>CAA</b> analogues was synthesized. Among them, compound <b>F16</b> exhibited superior water solubility (>5 mg/mL) as compared to <b>CAA</b> (<5 g/mL). The mechanism of action studies confirmed that <b>F16</b> acted as a dual Topo I and II poison. Furthermore, <b>F16</b> displayed potent antiproliferative activities against high Topo I and II expression cell lines A375 and HCT116, with IC<sub>50</sub> values of 20 and 50 nM, respectively. In xenograft models, <b>F16</b> reduced the tumor growth at a dose of 10 or 20 mg/kg without apparent effect on the mouse weight, while the clinically used Topo II inhibitor <b>VP-16</b> dramatically reduced the mouse weight. Collectively, our data demonstrated that <b>F16</b> could be a promising lead for the development of novel dual Topo I and II antitumor agents.\n",
            "1911380\n",
            "Inhibition of DNA topoisomerase I (unknown origin) relaxation activity at 50 uM incubated for 30 mins by chemiDoc system\n",
            "Title: Optimization of the Natural Product Calothrixin A to Discover Novel Dual Topoisomerase I and II Inhibitors with Improved Anticancer Activity.  Abstract: Calothrixin A (<b>CAA</b>) is a dual Topo I and II inhibitor but exhibits poor antiproliferative activities and water solubility. Herein, a library of novel <b>CAA</b> analogues was synthesized. Among them, compound <b>F16</b> exhibited superior water solubility (>5 mg/mL) as compared to <b>CAA</b> (<5 g/mL). The mechanism of action studies confirmed that <b>F16</b> acted as a dual Topo I and II poison. Furthermore, <b>F16</b> displayed potent antiproliferative activities against high Topo I and II expression cell lines A375 and HCT116, with IC<sub>50</sub> values of 20 and 50 nM, respectively. In xenograft models, <b>F16</b> reduced the tumor growth at a dose of 10 or 20 mg/kg without apparent effect on the mouse weight, while the clinically used Topo II inhibitor <b>VP-16</b> dramatically reduced the mouse weight. Collectively, our data demonstrated that <b>F16</b> could be a promising lead for the development of novel dual Topo I and II antitumor agents.\n",
            "1911382\n",
            "Poison activity at human topoisomerase I assessed as stabilization of enzyme-DNA cleavage complex by measuring nicked DNA formation at 100 uM after 60 mins by agarose gel electrophoresis method\n",
            "Title: Optimization of the Natural Product Calothrixin A to Discover Novel Dual Topoisomerase I and II Inhibitors with Improved Anticancer Activity.  Abstract: Calothrixin A (<b>CAA</b>) is a dual Topo I and II inhibitor but exhibits poor antiproliferative activities and water solubility. Herein, a library of novel <b>CAA</b> analogues was synthesized. Among them, compound <b>F16</b> exhibited superior water solubility (>5 mg/mL) as compared to <b>CAA</b> (<5 g/mL). The mechanism of action studies confirmed that <b>F16</b> acted as a dual Topo I and II poison. Furthermore, <b>F16</b> displayed potent antiproliferative activities against high Topo I and II expression cell lines A375 and HCT116, with IC<sub>50</sub> values of 20 and 50 nM, respectively. In xenograft models, <b>F16</b> reduced the tumor growth at a dose of 10 or 20 mg/kg without apparent effect on the mouse weight, while the clinically used Topo II inhibitor <b>VP-16</b> dramatically reduced the mouse weight. Collectively, our data demonstrated that <b>F16</b> could be a promising lead for the development of novel dual Topo I and II antitumor agents.\n",
            "1911684\n",
            "Inhibition of Top1 (unknown origin) assessed as inhibition of relaxation of supercoiled pBR322 plasmid DNA at 50 uM incubated for 25 mins by ethidium bromide staining based agarose gel electrophoresis analysis relative to control\n",
            "Title: Design, Synthesis, and Biological Evaluation of Novel Evodiamine Derivatives as Potential Antihepatocellular Carcinoma Agents.  Abstract: Evodiamine has many biological activities. Herein, we synthesize 23 disubstituted derivatives of N14-phenyl or the E-ring of evodiamine and conduct systematic structure-activity relationship studies. <i>In vitro</i> antiproliferative activity indicated that compounds <b>F-3</b> and <b>F-4</b> dramatically inhibited the proliferation of Huh7 (IC<sub>50</sub> = 0.05 or 0.04 M, respectively) and SK-Hep-1 (IC<sub>50</sub> = 0.07 or 0.06 M, respectively) cells. Furthermore, compounds <b>F-3</b> and <b>F-4</b> could double inhibit topoisomerases I and II, inhibit invasion and migration, block the cell cycle to the G2/M stage, and induce apoptosis as well. Additionally, compounds <b>F-3</b> and <b>F-4</b> could also inhibit the activation of HSC-T6 and reduce the secretion of collagen type I to slow down the progression of liver fibrosis. Most importantly, compound <b>F-4</b> (TGI = 60.36%) inhibited tumor growth more significantly than the positive drug sorafenib. To sum up, compound <b>F-4</b> has excellent potential as a strong candidate for the therapy of hepatocellular carcinoma.\n",
            "1911685\n",
            "Inhibition of Top1 (unknown origin) assessed as inhibition of relaxation of supercoiled pBR322 plasmid DNA at 12.5 uM incubated for 25 mins by ethidium bromide staining based agarose gel electrophoresis analysis relative to control\n",
            "Title: Design, Synthesis, and Biological Evaluation of Novel Evodiamine Derivatives as Potential Antihepatocellular Carcinoma Agents.  Abstract: Evodiamine has many biological activities. Herein, we synthesize 23 disubstituted derivatives of N14-phenyl or the E-ring of evodiamine and conduct systematic structure-activity relationship studies. <i>In vitro</i> antiproliferative activity indicated that compounds <b>F-3</b> and <b>F-4</b> dramatically inhibited the proliferation of Huh7 (IC<sub>50</sub> = 0.05 or 0.04 M, respectively) and SK-Hep-1 (IC<sub>50</sub> = 0.07 or 0.06 M, respectively) cells. Furthermore, compounds <b>F-3</b> and <b>F-4</b> could double inhibit topoisomerases I and II, inhibit invasion and migration, block the cell cycle to the G2/M stage, and induce apoptosis as well. Additionally, compounds <b>F-3</b> and <b>F-4</b> could also inhibit the activation of HSC-T6 and reduce the secretion of collagen type I to slow down the progression of liver fibrosis. Most importantly, compound <b>F-4</b> (TGI = 60.36%) inhibited tumor growth more significantly than the positive drug sorafenib. To sum up, compound <b>F-4</b> has excellent potential as a strong candidate for the therapy of hepatocellular carcinoma.\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "print(Assay_Descriptions_List)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "U8irBaS5PoiR",
        "outputId": "8876ccfb-4a0e-43bb-f1bb-9b091f759b09"
      },
      "execution_count": 20,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "['Description:  To identify additional clock genes and modifiers, we conducted a genome-wide screen of ~90,000 siRNAs (QIAGEN Inc) in a human cellular model of clock function. Knockdown of nearly a thousand genes reduced rhythm amplitude; these are presumably due to toxic effects on cells. Hundreds of genes potently modified period length or increased amplitude.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.', 'Title: seco-Cyclothialidines: new concise synthesis, inhibitory activity toward bacterial and human DNA topoisomerases, and antibacterial properties.  Abstract: seco-Cyclothialidines are a promising class of bacterial DNA gyrase B subunit inhibitors. A new seco-cyclothialidine derivative containing a dioxazine moiety, BAY 50-7952, was synthesized through a new concise pathway. One key step of the synthesis is the straightforward formation of the 2-aminothiazole derivative of S-tritylcysteine. In biological tests, BAY 50-7952 and other known seco-cyclothialidines exhibited high and selective activity toward bacterial DNA gyrase and toward Gram-positive bacteria. The dioxazine moiety and other similar groups were found to be important for the ability of the seco-cyclothialidines to penetrate bacterial membranes. The opposite enantiomer ((S)-form) of BAY 50-7952 was also synthesized, and neither significant target activity nor in vitro antibacterial activity were found, suggesting a highly selective fit of the (R)-form. Despite promising in vitro activity, only poor activity was found in the murine infection model.', 'Title: Inhibition of herpes simplex virus type 1 helicase-primase by (dichloroanilino)purines and -pyrimidines.  Abstract: Herpes simplex virus type 1 (HSV1) encodes a heterotrimeric helicase-primase comprised of the products of three of the seven DNA replication-specific genes. Several dihalo-substituted derivatives of N2-phenylguanines and 2-anilinoadenines weakly inhibited the intrinsic DNA-dependent NTPase activity of the HSV1 helicase-primase, and these compounds inhibited the DNA-unwinding activity of the enzyme. The primase activity of the enzyme was strongly inhibited by 3,4- and 3,5-dichloroanilino derivatives of adenine and 2-aminopyrimidines. These compounds and nucleoside analogs of 2-(3,5-dichloroanilino)purines inhibited viral DNA synthesis in HSV1-infected HeLa cells in culture but also inhibited cellular DNA synthesis, likely as a result of inhibition of cellular primase and/or DNA polymerases.', 'Title: Inhibition of herpes simplex virus type 1 helicase-primase by (dichloroanilino)purines and -pyrimidines.  Abstract: Herpes simplex virus type 1 (HSV1) encodes a heterotrimeric helicase-primase comprised of the products of three of the seven DNA replication-specific genes. Several dihalo-substituted derivatives of N2-phenylguanines and 2-anilinoadenines weakly inhibited the intrinsic DNA-dependent NTPase activity of the HSV1 helicase-primase, and these compounds inhibited the DNA-unwinding activity of the enzyme. The primase activity of the enzyme was strongly inhibited by 3,4- and 3,5-dichloroanilino derivatives of adenine and 2-aminopyrimidines. These compounds and nucleoside analogs of 2-(3,5-dichloroanilino)purines inhibited viral DNA synthesis in HSV1-infected HeLa cells in culture but also inhibited cellular DNA synthesis, likely as a result of inhibition of cellular primase and/or DNA polymerases.', 'Title: Quantized surface complementarity diversity (QSCD): a model based on small molecule-target complementarity.  Abstract: A model of molecular diversity is presented. The model, termed \"Quantized Surface Complementarity Diversity\" (QSCD), defines molecular diversity by measuring molecular complementarity to a fully enumerated set of theoretical target surfaces. Molecular diversity space is defined as the molecular complement to this set of enumerated surfaces. Using a set of known test compounds, the model is shown to be biologically relevant, consistently scoring known actives as similar. At the resolution of the model, which examines molecules \"quantized\" into 4.24 A cubic units and treats four points of specific energetic complementarity, the minimum number of compounds needed to fully cover molecular diversity space up to volume 1070 cubic A is estimated to be on the order of 24 million molecules. Most importantly, QSCD allows for individual points in diversity space to be filled by direct modeling of molecular libraries into detailed 3D templates of shape and functionality.', 'Title: Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity.  Abstract: Water-soluble analogues of the antitumor alkaloid camptothecin (1) were prepared in which aminoalkyl groups were introduced into ring A or B. Most of the analogues were prepared by oxidation of camptothecin to 10-hydroxycamptothecin (2) followed by a Mannich reaction to give N-substituted 9-(aminomethyl)-10-hydroxycamptothecins (4-12) or by subsequent modification of Mannich product 4 (13, 15, 17, 19, 21). Others were obtained by modification of the hydroxyl group of 2 (25,26) or by total synthesis (35,42,43). These analogues, as well as some of their synthetic precursors, were evaluated for inhibition of topoisomerase I, cytotoxicity, and antitumor activity. Although there was not a quantitative correlation between these assays, compounds that inhibited topoisomerase I were also cytotoxic and demonstrated antitumor activity in vivo. Further evaluation of the most active water-soluble analogue led to the selection of 9-[(dimethylamino)methyl]-10-hydroxycamptothecin (4, SK&F 104864) for development as an antitumor agent. In addition to its water solubility, ease of synthesis from natural camptothecin, and high potency, 4 demonstrated broad-spectrum activity in preclinical tumor models and is currently undergoing Phase I clinical trials in cancer patients.', 'Title: Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity.  Abstract: Several camptothecin derivatives containing a modified hydroxy lactone ring have been synthesized and evaluated for inhibition of topoisomerase I and cytotoxicity to mammalian cells. Each of the groups of the hydroxy lactone moiety, the carbonyl oxygen, the ring lactone oxygen, and the 20-hydroxy group, were shown to be critical for enzyme inhibition. For example the lactol, lactam, thiolactone, and 20-deoxy derivatives did not stabilize the covalent DNA-topoisomerase I complex. With a few exceptions, those compounds that did not inhibit topoisomerase I were not cytotoxic to mammalian cells. Two cytotoxic derivatives that did not inhibit topoisomerase I were shown to produce non-protein-associated DNA single-strand breaks and are likely to have a different mechanism of action. One of these compounds was tested for antitumor activity and was found to be inactive. The present findings, as well as other reports that the hydroxy lactone ring of camptothecin is critical for antitumor activity in vivo, correlate with the structure-activity relationships at the level of topoisomerase I and support the hypothesis that antitumor activity is related to inhibition of this target enzyme.', 'Title: Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity.  Abstract: Several camptothecin derivatives containing a modified hydroxy lactone ring have been synthesized and evaluated for inhibition of topoisomerase I and cytotoxicity to mammalian cells. Each of the groups of the hydroxy lactone moiety, the carbonyl oxygen, the ring lactone oxygen, and the 20-hydroxy group, were shown to be critical for enzyme inhibition. For example the lactol, lactam, thiolactone, and 20-deoxy derivatives did not stabilize the covalent DNA-topoisomerase I complex. With a few exceptions, those compounds that did not inhibit topoisomerase I were not cytotoxic to mammalian cells. Two cytotoxic derivatives that did not inhibit topoisomerase I were shown to produce non-protein-associated DNA single-strand breaks and are likely to have a different mechanism of action. One of these compounds was tested for antitumor activity and was found to be inactive. The present findings, as well as other reports that the hydroxy lactone ring of camptothecin is critical for antitumor activity in vivo, correlate with the structure-activity relationships at the level of topoisomerase I and support the hypothesis that antitumor activity is related to inhibition of this target enzyme.', 'Title: seco-Cyclothialidines: new concise synthesis, inhibitory activity toward bacterial and human DNA topoisomerases, and antibacterial properties.  Abstract: seco-Cyclothialidines are a promising class of bacterial DNA gyrase B subunit inhibitors. A new seco-cyclothialidine derivative containing a dioxazine moiety, BAY 50-7952, was synthesized through a new concise pathway. One key step of the synthesis is the straightforward formation of the 2-aminothiazole derivative of S-tritylcysteine. In biological tests, BAY 50-7952 and other known seco-cyclothialidines exhibited high and selective activity toward bacterial DNA gyrase and toward Gram-positive bacteria. The dioxazine moiety and other similar groups were found to be important for the ability of the seco-cyclothialidines to penetrate bacterial membranes. The opposite enantiomer ((S)-form) of BAY 50-7952 was also synthesized, and neither significant target activity nor in vitro antibacterial activity were found, suggesting a highly selective fit of the (R)-form. Despite promising in vitro activity, only poor activity was found in the murine infection model.', 'Title: Water soluble inhibitors of topoisomerase I: quaternary salt derivatives of camptothecin.  Abstract: Eleven water soluble 7-substituted quaternary ammonium salt derivatives of 10,11-(methylenedioxy)- and 10,11-(ethylenedioxy)-(20S)-camptothecin were synthesized via the Friedlander reaction followed by nucleophilic displacement with an aromatic amine. All of these compounds were more potent than camptothecin in the in vitro cleavable complex assay. These inherently charged camptothecin derivatives were cytotoxic against three different human tumor cell lines (SKOV3, an ovarian adenocarcinoma; SKVLB a multidrug resistant ovarian adenocarcinoma; and HT-29, a colon carcinoma). A selected group of five compounds was evaluated in the nude mouse HT-29 xenograft model. Two of these quaternary salts (17 and 18) were more efficacious than Topotecan in delaying tumor growth. In an extended in vivo model, 18 demonstrated tumor regression.', 'Title: Water soluble inhibitors of topoisomerase I: quaternary salt derivatives of camptothecin.  Abstract: Eleven water soluble 7-substituted quaternary ammonium salt derivatives of 10,11-(methylenedioxy)- and 10,11-(ethylenedioxy)-(20S)-camptothecin were synthesized via the Friedlander reaction followed by nucleophilic displacement with an aromatic amine. All of these compounds were more potent than camptothecin in the in vitro cleavable complex assay. These inherently charged camptothecin derivatives were cytotoxic against three different human tumor cell lines (SKOV3, an ovarian adenocarcinoma; SKVLB a multidrug resistant ovarian adenocarcinoma; and HT-29, a colon carcinoma). A selected group of five compounds was evaluated in the nude mouse HT-29 xenograft model. Two of these quaternary salts (17 and 18) were more efficacious than Topotecan in delaying tumor growth. In an extended in vivo model, 18 demonstrated tumor regression.', 'Title: Naphthazarin derivatives (II): formation of glutathione conjugate, inhibition of DNA topoisomerase-I and cytotoxicity.  Abstract: 6-(1-Hydroxyalkyl)-5,8-dimethoxy-1,4-naphthoquinones, expressing a higher reactivity in conjugation with glutathione, showed a greater potency in the inhibition of DNA topoisomerase-I and the cytotoxicity against L1210 cells than 2-(1-hydroxyalkyl)-DMNQ derivatives, implying the participation of electrophilic arylation in the bioactivities. In further study 6-(1-Hydroxyalkyl)-5,8-dimethoxy-1,4-naphthoquinones with an alkyl group of shorter chain length (C2-C6) exerted a greater bioactivities than those with longer chain length(>C6).', 'Title: Naphthazarin derivatives (II): formation of glutathione conjugate, inhibition of DNA topoisomerase-I and cytotoxicity.  Abstract: 6-(1-Hydroxyalkyl)-5,8-dimethoxy-1,4-naphthoquinones, expressing a higher reactivity in conjugation with glutathione, showed a greater potency in the inhibition of DNA topoisomerase-I and the cytotoxicity against L1210 cells than 2-(1-hydroxyalkyl)-DMNQ derivatives, implying the participation of electrophilic arylation in the bioactivities. In further study 6-(1-Hydroxyalkyl)-5,8-dimethoxy-1,4-naphthoquinones with an alkyl group of shorter chain length (C2-C6) exerted a greater bioactivities than those with longer chain length(>C6).', \"Title: Synthesis and antitumor activity of novel water soluble derivatives of camptothecin as specific inhibitors of topoisomerase I.  Abstract: The synthesis and antitumor activities of the novel water soluble camptothecin derivatives 7-[(4-methylpiperazino)methyl]-10,11-(methylenedioxy)-(20S)-campto thecin trifluoroacetate (6) and 7-[(4-methylpiperazino)methyl]-10,11-(ethylenedioxy)-(20S)-camptot hecin trifluoroacetate (7) are described. The solubilities of compounds 6 and 7 were measured to be 4.5 and 5.8 mg/mL, respectively, in pH 5 acetate buffer in contrast to < 0.003 mg/mL for camptothecin in the same buffer. In the purified topoisomerase I cleavable complex enzyme assay, compounds 6 and 7 demonstrated potent inhibition of topoisomerase I with IC50's of 300 and 416 nM, respectively, in comparison to 679 nM for camptothecin and 1028 nM for topotecan. In human tumor cell cytotoxicity assays, compounds 6 and 7 demonstrated potent antitumor activity against ovarian (SKOV3), ovarian with upregulated MDRp-glycoprotein (SKVLB), melanoma (LOX), breast (T47D), and colon (HT29) with IC50's ranging from 0.5 to 102 nM. Compounds 6 and 7 induced tumor regressions in the HT29 human colon tumor xenograft model and demonstrated similar rank order of potency compared to in vitro assay results.\", \"Title: Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.  Abstract: The human immunodeficiency virus type one integrase (HIV-1 integrase) is required for integration of a double-stranded DNA copy of the viral RNA genome into a host chromosome and for HIV replication. We have previously reported that phenolic moieties in compounds such as flavones, caffeic acid phenethyl ester (CAPE), tyrphostins, and curcumin confer inhibitory activity against HIV-1 integrase. We have investigated the actions of several recently described protease inhibitors, possessing novel structural features, on HIV-1 integrase. NSC 158393, which contains four 4-hydroxycoumarin residues, was found to exhibit antiviral, antiprotease, and antiintegrase activity. Both the DNA binding and catalytic activities (3'-processing and strand transfer) of integrase were inhibited at micromolar concentrations. Disintegration catalyzed by an integrase mutant containing only the central catalytic domain was also inhibited, indicating that the binding site for these compounds resides in the central 50-212 amino acids of HIV-1 integrase. Binding at or near the integrase catalytic site was also suggested by a global inhibition of the choice of attacking nucleophile in the 3'-processing reaction. NSC 158393 inhibited HIV-2, feline, and simian immunodeficiency virus integrases while eukaryotic topoisomerase I was inhibited at higher concentrations, suggesting selective inhibition of retroviral integrases. Molecular modeling studies revealed that the two hydroxyls and two carbonyl moieties in NSC 158393 may represent essential elements of the pharmacophore. Antiviral efficacy was observed with NSC 158393 derivatives that inhibited both HIV protease and integrase, and the most potent integrase inhibitors also inhibited HIV protease. Hydroxycoumarins may provide lead compounds for development of novel antiviral agents based upon the concurrent inhibition of two viral targets, HIV-1 integrase and protease.\", 'Title: Synthesis, topoisomerase I inhibition and structure-activity relationship study of 2,4,6-trisubstituted pyridine derivatives.  Abstract: For the development of new anticancer agents, phenyl, 2-pyridyl, 2-furyl, 2-thienyl, 2-furylvinyl and 2-thienylvinyl substituted derivatives on 2,4,6-position in pyridine moiety were prepared and evaluated for their topoisomerase I inhibitory activity. Among the thirteen prepared compounds, four compounds exhibited strong topoisomerase I inhibitory activity. A structure-activity relationship study indicated that the 2-thienyl-4-furylpyridine skeleton was important for topoisomerase I inhibitory activity.', 'Title: Rigid analogs of camptothecin as DNA topoisomerase I inhibitors.  Abstract: Substituted 8-ethyl-2-(2-oxo-1,2-dihydroindol-3-ylidene)-8-hydroxy-2,3,5,8- tetrahydro-6-oxa-3a-azacyclopenta[b]naphthalene-1,4,7-triones were synthesized and evaluated as topoisomerase I inhibitors in an in vitro cleavable complex assay. The activity of these compounds may be attributed to their rigid, planar geometry, and an attempt was made to correlate the SAR in this series to known attributes of camptothecin.', 'Title: Synthesis, topoisomerase I inhibitory activity, and in vivo evaluation of 11-azacamptothecin analogs.  Abstract: A series of analogs based on a novel template, 11-aza-(20S)-camptothecin, were obtained from total synthesis and tested as potential anticancer drugs in the topoisomerase I enzyme cleavable complex assay. The parent compound 11-aza-(20S)-camptothecin (8) was derived from a Friedlander condensation between the known aminopyridine derivative 3-(3-amino-4-picolylidene)-p-toluidine and optically active tricyclic ketone 7. Compound 8 had activity approximately twice that of (20S)-camptothecin in the calf thymus topoisomerase I cleavable complex assay. Compounds were prepared wherein the 11-aza nitrogen atom was quaternized as either the corresponding N-oxide or methyl iodide. Compounds with quaternized N-11 showed improved water solubility and were equipotent to the clinically investigated camptothecin analog topotecan in the cleavable complex assay. These compounds were evaluated in vivo in nude mice bearing HT-29 human colon carcinoma xenografts. The analog 11-aza-(20S)-camptothecin 11-N-oxide was found to significantly retard tumor growth when compared to untreated controls. Finally, 7,10-disubstituted 11-azacamptothecin analogs were synthesized using Pd(0) coupling reactions of 10-bromo-7-alkyl-11-aza-(20S)-camptothecins 19 and 20, which in turn were available from a Friedlander condensation of the novel bromopyridine derivatives 17a and 17b with 7. Among the 10-substituted series, a number of analogs displayed extremely high in vitro potency against topoisomerase I and improved aqueous solubility. A significant number of the compounds were found to be active in whole cell cytotoxicity assays and several were evaluated in nude mice bearing the HT-29 tumor xenografts. The most effective of these proved to be (S)-11-aza-7-ethyl-10-(aminohydroximinomethyl)camptothecin trifluoracetic acid salt (27), a potent topoisomerase I inhibitor which demonstrated excellent efficacy in both short term and in extended in vivo assays. A comparison between in vitro enzyme data and in vivo data from nude mouse studies in other compounds in this series revealed a poor overall correlation between topoisomerase inhibition in vitro and antitumor efficacy in vivo.', 'Title: Synthesis, topoisomerase I inhibitory activity, and in vivo evaluation of 11-azacamptothecin analogs.  Abstract: A series of analogs based on a novel template, 11-aza-(20S)-camptothecin, were obtained from total synthesis and tested as potential anticancer drugs in the topoisomerase I enzyme cleavable complex assay. The parent compound 11-aza-(20S)-camptothecin (8) was derived from a Friedlander condensation between the known aminopyridine derivative 3-(3-amino-4-picolylidene)-p-toluidine and optically active tricyclic ketone 7. Compound 8 had activity approximately twice that of (20S)-camptothecin in the calf thymus topoisomerase I cleavable complex assay. Compounds were prepared wherein the 11-aza nitrogen atom was quaternized as either the corresponding N-oxide or methyl iodide. Compounds with quaternized N-11 showed improved water solubility and were equipotent to the clinically investigated camptothecin analog topotecan in the cleavable complex assay. These compounds were evaluated in vivo in nude mice bearing HT-29 human colon carcinoma xenografts. The analog 11-aza-(20S)-camptothecin 11-N-oxide was found to significantly retard tumor growth when compared to untreated controls. Finally, 7,10-disubstituted 11-azacamptothecin analogs were synthesized using Pd(0) coupling reactions of 10-bromo-7-alkyl-11-aza-(20S)-camptothecins 19 and 20, which in turn were available from a Friedlander condensation of the novel bromopyridine derivatives 17a and 17b with 7. Among the 10-substituted series, a number of analogs displayed extremely high in vitro potency against topoisomerase I and improved aqueous solubility. A significant number of the compounds were found to be active in whole cell cytotoxicity assays and several were evaluated in nude mice bearing the HT-29 tumor xenografts. The most effective of these proved to be (S)-11-aza-7-ethyl-10-(aminohydroximinomethyl)camptothecin trifluoracetic acid salt (27), a potent topoisomerase I inhibitor which demonstrated excellent efficacy in both short term and in extended in vivo assays. A comparison between in vitro enzyme data and in vivo data from nude mouse studies in other compounds in this series revealed a poor overall correlation between topoisomerase inhibition in vitro and antitumor efficacy in vivo.', 'Title: Rigid analogs of camptothecin as DNA topoisomerase I inhibitors.  Abstract: Substituted 8-ethyl-2-(2-oxo-1,2-dihydroindol-3-ylidene)-8-hydroxy-2,3,5,8- tetrahydro-6-oxa-3a-azacyclopenta[b]naphthalene-1,4,7-triones were synthesized and evaluated as topoisomerase I inhibitors in an in vitro cleavable complex assay. The activity of these compounds may be attributed to their rigid, planar geometry, and an attempt was made to correlate the SAR in this series to known attributes of camptothecin.', 'In vitro inhibition of DNA topoisomerase I activity (ATP-independent DNA relaxation) at a concentration of 50 uM', 'In vitro inhibition of DNA topoisomerase I activity (ATP-independent DNA relaxation) at a concentration of 50 uM; no activity', 'Title: Structure-activity relationships in a series of substituted indolocarbazoles: topoisomerase I and protein kinase C inhibition and antitumoral and antimicrobial properties.  Abstract: A series of compounds structurally related to staurosporine, rebeccamycin, and corresponding aglycones was synthesized, and their activities toward protein kinase C and topoisomerases I and II were tested together with their in vitro antitumor efficiency against murine B16 melanoma and P388 leukemia cells. Their antimicrobial activities were also examined against a Gram-negative bacterium (Escherichia coli), a yeast (Candida albicans), and three Gram-positive bacteria (Bacillus cereus, Streptomyces chartreusis, and Streptomyces griseus). To avoid side effects expected with protein kinase C inhibitors, we introduced substitution on the maleimide nitrogen and/or a sugar moiety linked to one of the indole nitrogens to obtain specific inhibitors of topoisomerase I with minimal activities on protein kinase C. As expected, these structures were inefficient on topoisomerase II, and some of them exhibited a strong activity against topoisomerase I. Generally, dechlorinated compounds were found to be more active than chlorinated analogues against both purified topoisomerase I and protein kinase C. On the other hand, opposite results were obtained in the cell antiproliferative assays. These results suggest lack of cell membrane permeability in the absence of the chlorine residue or cleavage of carbon-chlorine bonds inside the cell.', 'Title: Syntheses and biological activities of rebeccamycin analogues. Introduction of a halogenoacetyl substituent.  Abstract: In the course of structure-activity relationships on rebeccamycin analogues, a series of compounds bearing a halogenoacetyl substituent were synthesized with the expectation of increasing the interaction with DNA, possibly via covalent reaction with the double helix. Two rebeccamycin analogues bearing an acetyl instead of a bromoacetyl substituent were prepared to gain an insight into the role of the halogen atom. The new compounds show very little effect on protein kinase C and no covalent reaction with DNA was detected. However, the drugs behave as typical topoisomerase I poisons, and they are significantly more toxic toward P388 leukemia cells than to P388/CPT5 cells resistant to camptothecin. The introduction of a bromo- or chloro-acetyl substituent does not affect the capacity of the drug to interfere with topoisomerase I either in vitro or in cells. One of the bromoacetyl derivatives, compound 8, is the most cytotoxic rebeccamycin derivative among the hundred of derivatives we have synthesized to date. In addition, we determined the antimicrobial activities against two Gram-positive bacteria, Bacillus cereus and Streptomyces chartreusis, and against the Gram-negative bacterium Escherichia coli. The effect of the drugs on Candida albicans yeast growth and their anti-HIV-1 activities were also measured.', \"Title: Substituted 2,5'-Bi-1H-benzimidazoles: topoisomerase I inhibition and cytotoxicity.  Abstract: Several 2'-aryl-5-substituted-2,5'bi-1H-benzimidazole derivatives were synthesized and evaluated as topoisomerase I poisons and for their cytotoxicity toward the human lymphoblast cell line RPMI 8402. This study focused on 18 2,5'-bi-1H-benzimidazole derivatives which contained either a 5-cyano, a 5-(aminocarbonyl), or a 5-(4-methylpiperazinyl) group. Among these bibenzimidazoles, the pharmacological activity of 2'-phenyl derivatives and the influence of the different positional isomers of either a 2'-tolyl group or a 2'-naphthyl moiety on cytotoxicity and topoisomerase I inhibitory activity were determined.\", 'Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.', 'Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.', 'Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.', 'Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.', 'Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.', 'Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.', 'Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.', 'Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.', 'Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.', 'Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.', 'Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.', 'Title: Synthesis and evaluation of terbenzimidazoles as topoisomerase I inhibitors.  Abstract: The synthesis and pharmacological activity of a series of terbenzimidazoles are described. The ability of these derivatives to induce DNA cleavage in the presence of topoisomerase I was evaluated in vitro. These analogs were also assayed for their cytotoxicity in RPMI 8402 cells and the camptothecin-resistant CPT-K5 cells. In addition the potential for these compounds to serve as substrates for MDR1 was also determined. Several terbenzimidazoles exhibited similar cytotoxicity against variants of human tumor cells that either overexpress MDR1 or are camptothecin-resistant.', \"Title: Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-camptothecin hybrids.  Abstract: The indenoisoquinolines are a novel class of topoisomerase I (top1) inhibitors that are cytotoxic in cancer cell cultures and are therefore under development as potential anticancer agents. As inhibitors of the DNA religation reaction occurring after DNA cleavage by the enzyme, they are classified as top1 poisons, similar to the camptothecins. Two strategies were employed in order to further develop the structure-activity relationships of the indenoisoquinolines and enhance their therapeutic potential. The first strategy involved the synthesis of indenoisoquinoline-camptothecin hybrid molecules to take advantage of a proposed structural analogy between the indenoisoquinolines and camptothecin. The desired hybrids were synthesized by reaction of halogenated phthalides with a dihydropyrroloquinoline. The second strategy involved the attachment of various alkenyl substituents to the C-11 position of the indenoisoquinolines, which were assumed to project into the DNA minor groove. The required C-11-substituted indenoisoquinolines were synthesized by McMurry reactions of 11-ketoindenoisoquinolines with aldehydes, and the geometries of the resulting alkenes were established by nuclear Overhauser effect difference NMR spectroscopy. All of the new indenoisoquinolines were examined for cytotoxicity in human cancer cell cultures as well as for activity vs top1. Although the indenoisoquinoline-camptothecin hybrid molecules proved to be less cytotoxic and displayed less activity against top1, an analogue incorporating a 3'-aminoalkenyl substituent at the C-11 position of the indenoisoquinoline system was significantly more potent than the prototype indenoisoquinoline in both assays. These results indicate that C-11 aminoalkyl substituents that are assumed to project into the minor groove enhance the cytotoxicity and top1 inhibitory activity of the parent indenoisoquinoline system.\", \"Title: Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-camptothecin hybrids.  Abstract: The indenoisoquinolines are a novel class of topoisomerase I (top1) inhibitors that are cytotoxic in cancer cell cultures and are therefore under development as potential anticancer agents. As inhibitors of the DNA religation reaction occurring after DNA cleavage by the enzyme, they are classified as top1 poisons, similar to the camptothecins. Two strategies were employed in order to further develop the structure-activity relationships of the indenoisoquinolines and enhance their therapeutic potential. The first strategy involved the synthesis of indenoisoquinoline-camptothecin hybrid molecules to take advantage of a proposed structural analogy between the indenoisoquinolines and camptothecin. The desired hybrids were synthesized by reaction of halogenated phthalides with a dihydropyrroloquinoline. The second strategy involved the attachment of various alkenyl substituents to the C-11 position of the indenoisoquinolines, which were assumed to project into the DNA minor groove. The required C-11-substituted indenoisoquinolines were synthesized by McMurry reactions of 11-ketoindenoisoquinolines with aldehydes, and the geometries of the resulting alkenes were established by nuclear Overhauser effect difference NMR spectroscopy. All of the new indenoisoquinolines were examined for cytotoxicity in human cancer cell cultures as well as for activity vs top1. Although the indenoisoquinoline-camptothecin hybrid molecules proved to be less cytotoxic and displayed less activity against top1, an analogue incorporating a 3'-aminoalkenyl substituent at the C-11 position of the indenoisoquinoline system was significantly more potent than the prototype indenoisoquinoline in both assays. These results indicate that C-11 aminoalkyl substituents that are assumed to project into the minor groove enhance the cytotoxicity and top1 inhibitory activity of the parent indenoisoquinoline system.\", \"Title: Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-camptothecin hybrids.  Abstract: The indenoisoquinolines are a novel class of topoisomerase I (top1) inhibitors that are cytotoxic in cancer cell cultures and are therefore under development as potential anticancer agents. As inhibitors of the DNA religation reaction occurring after DNA cleavage by the enzyme, they are classified as top1 poisons, similar to the camptothecins. Two strategies were employed in order to further develop the structure-activity relationships of the indenoisoquinolines and enhance their therapeutic potential. The first strategy involved the synthesis of indenoisoquinoline-camptothecin hybrid molecules to take advantage of a proposed structural analogy between the indenoisoquinolines and camptothecin. The desired hybrids were synthesized by reaction of halogenated phthalides with a dihydropyrroloquinoline. The second strategy involved the attachment of various alkenyl substituents to the C-11 position of the indenoisoquinolines, which were assumed to project into the DNA minor groove. The required C-11-substituted indenoisoquinolines were synthesized by McMurry reactions of 11-ketoindenoisoquinolines with aldehydes, and the geometries of the resulting alkenes were established by nuclear Overhauser effect difference NMR spectroscopy. All of the new indenoisoquinolines were examined for cytotoxicity in human cancer cell cultures as well as for activity vs top1. Although the indenoisoquinoline-camptothecin hybrid molecules proved to be less cytotoxic and displayed less activity against top1, an analogue incorporating a 3'-aminoalkenyl substituent at the C-11 position of the indenoisoquinoline system was significantly more potent than the prototype indenoisoquinoline in both assays. These results indicate that C-11 aminoalkyl substituents that are assumed to project into the minor groove enhance the cytotoxicity and top1 inhibitory activity of the parent indenoisoquinoline system.\", \"Title: Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-camptothecin hybrids.  Abstract: The indenoisoquinolines are a novel class of topoisomerase I (top1) inhibitors that are cytotoxic in cancer cell cultures and are therefore under development as potential anticancer agents. As inhibitors of the DNA religation reaction occurring after DNA cleavage by the enzyme, they are classified as top1 poisons, similar to the camptothecins. Two strategies were employed in order to further develop the structure-activity relationships of the indenoisoquinolines and enhance their therapeutic potential. The first strategy involved the synthesis of indenoisoquinoline-camptothecin hybrid molecules to take advantage of a proposed structural analogy between the indenoisoquinolines and camptothecin. The desired hybrids were synthesized by reaction of halogenated phthalides with a dihydropyrroloquinoline. The second strategy involved the attachment of various alkenyl substituents to the C-11 position of the indenoisoquinolines, which were assumed to project into the DNA minor groove. The required C-11-substituted indenoisoquinolines were synthesized by McMurry reactions of 11-ketoindenoisoquinolines with aldehydes, and the geometries of the resulting alkenes were established by nuclear Overhauser effect difference NMR spectroscopy. All of the new indenoisoquinolines were examined for cytotoxicity in human cancer cell cultures as well as for activity vs top1. Although the indenoisoquinoline-camptothecin hybrid molecules proved to be less cytotoxic and displayed less activity against top1, an analogue incorporating a 3'-aminoalkenyl substituent at the C-11 position of the indenoisoquinoline system was significantly more potent than the prototype indenoisoquinoline in both assays. These results indicate that C-11 aminoalkyl substituents that are assumed to project into the minor groove enhance the cytotoxicity and top1 inhibitory activity of the parent indenoisoquinoline system.\", \"Title: Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-camptothecin hybrids.  Abstract: The indenoisoquinolines are a novel class of topoisomerase I (top1) inhibitors that are cytotoxic in cancer cell cultures and are therefore under development as potential anticancer agents. As inhibitors of the DNA religation reaction occurring after DNA cleavage by the enzyme, they are classified as top1 poisons, similar to the camptothecins. Two strategies were employed in order to further develop the structure-activity relationships of the indenoisoquinolines and enhance their therapeutic potential. The first strategy involved the synthesis of indenoisoquinoline-camptothecin hybrid molecules to take advantage of a proposed structural analogy between the indenoisoquinolines and camptothecin. The desired hybrids were synthesized by reaction of halogenated phthalides with a dihydropyrroloquinoline. The second strategy involved the attachment of various alkenyl substituents to the C-11 position of the indenoisoquinolines, which were assumed to project into the DNA minor groove. The required C-11-substituted indenoisoquinolines were synthesized by McMurry reactions of 11-ketoindenoisoquinolines with aldehydes, and the geometries of the resulting alkenes were established by nuclear Overhauser effect difference NMR spectroscopy. All of the new indenoisoquinolines were examined for cytotoxicity in human cancer cell cultures as well as for activity vs top1. Although the indenoisoquinoline-camptothecin hybrid molecules proved to be less cytotoxic and displayed less activity against top1, an analogue incorporating a 3'-aminoalkenyl substituent at the C-11 position of the indenoisoquinoline system was significantly more potent than the prototype indenoisoquinoline in both assays. These results indicate that C-11 aminoalkyl substituents that are assumed to project into the minor groove enhance the cytotoxicity and top1 inhibitory activity of the parent indenoisoquinoline system.\", 'Title: Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen.  Abstract: The indenoisoquinolines are a class of noncamptothecin topoisomerase I inhibitors that display significant cytotoxicity in human cancer cell cultures. They offer a number of potential advantages over the camptothecins, including greater chemical stability, formation of more persistent cleavage complexes, and induction of a unique pattern of DNA cleavage sites. Molecular modeling has suggested that substituents on the indenoisoquinoline lactam nitrogen would protrude out of the DNA duplex in the ternary cleavage complex through the major groove. This indicates that relatively large substituents in that location would be tolerated without compromising biological activity. As a strategy for increasing the potencies and potential therapeutic usefulness of the indenoisoquinolines, a series of compounds was synthesized containing polyamine side chains on the lactam nitrogen. The rationale for the synthesis of these compounds was that the positively charged ammonium cations would increase DNA affinity through electrostatic binding to the negatively charged DNA backbone, and the polyamines might also facilitate cellular uptake by utilization of polyamine transporters. The key step in the synthesis involved the condensation of Schiff bases, containing protected amine side chains, with substituted homophthalic anhydrides, to afford cis-3-aryl-4-carboxy-1-isoquinolones. These isoquinolones were then converted to indenoisoquinolines with thionyl chloride. Although monoamines were much more potent than the lead compound, no significant increase in potency was observed through incorporation of additional amino groups in the side chain. However, one of the monoamine analogues, which features a bis(2-hydroxyethyl)amino group in the side chain, proved to be one of the most cytotoxic indenoisoquinoline synthesized to date, with a GI50 mean-graph midpoint (MGM) of 0.07 microM in the NIH human cancer cell culture screen, and topoisomerase I inhibitory activity comparable to that of camptothecin.', 'Title: Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen.  Abstract: The indenoisoquinolines are a class of noncamptothecin topoisomerase I inhibitors that display significant cytotoxicity in human cancer cell cultures. They offer a number of potential advantages over the camptothecins, including greater chemical stability, formation of more persistent cleavage complexes, and induction of a unique pattern of DNA cleavage sites. Molecular modeling has suggested that substituents on the indenoisoquinoline lactam nitrogen would protrude out of the DNA duplex in the ternary cleavage complex through the major groove. This indicates that relatively large substituents in that location would be tolerated without compromising biological activity. As a strategy for increasing the potencies and potential therapeutic usefulness of the indenoisoquinolines, a series of compounds was synthesized containing polyamine side chains on the lactam nitrogen. The rationale for the synthesis of these compounds was that the positively charged ammonium cations would increase DNA affinity through electrostatic binding to the negatively charged DNA backbone, and the polyamines might also facilitate cellular uptake by utilization of polyamine transporters. The key step in the synthesis involved the condensation of Schiff bases, containing protected amine side chains, with substituted homophthalic anhydrides, to afford cis-3-aryl-4-carboxy-1-isoquinolones. These isoquinolones were then converted to indenoisoquinolines with thionyl chloride. Although monoamines were much more potent than the lead compound, no significant increase in potency was observed through incorporation of additional amino groups in the side chain. However, one of the monoamine analogues, which features a bis(2-hydroxyethyl)amino group in the side chain, proved to be one of the most cytotoxic indenoisoquinoline synthesized to date, with a GI50 mean-graph midpoint (MGM) of 0.07 microM in the NIH human cancer cell culture screen, and topoisomerase I inhibitory activity comparable to that of camptothecin.', 'Title: Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen.  Abstract: The indenoisoquinolines are a class of noncamptothecin topoisomerase I inhibitors that display significant cytotoxicity in human cancer cell cultures. They offer a number of potential advantages over the camptothecins, including greater chemical stability, formation of more persistent cleavage complexes, and induction of a unique pattern of DNA cleavage sites. Molecular modeling has suggested that substituents on the indenoisoquinoline lactam nitrogen would protrude out of the DNA duplex in the ternary cleavage complex through the major groove. This indicates that relatively large substituents in that location would be tolerated without compromising biological activity. As a strategy for increasing the potencies and potential therapeutic usefulness of the indenoisoquinolines, a series of compounds was synthesized containing polyamine side chains on the lactam nitrogen. The rationale for the synthesis of these compounds was that the positively charged ammonium cations would increase DNA affinity through electrostatic binding to the negatively charged DNA backbone, and the polyamines might also facilitate cellular uptake by utilization of polyamine transporters. The key step in the synthesis involved the condensation of Schiff bases, containing protected amine side chains, with substituted homophthalic anhydrides, to afford cis-3-aryl-4-carboxy-1-isoquinolones. These isoquinolones were then converted to indenoisoquinolines with thionyl chloride. Although monoamines were much more potent than the lead compound, no significant increase in potency was observed through incorporation of additional amino groups in the side chain. However, one of the monoamine analogues, which features a bis(2-hydroxyethyl)amino group in the side chain, proved to be one of the most cytotoxic indenoisoquinoline synthesized to date, with a GI50 mean-graph midpoint (MGM) of 0.07 microM in the NIH human cancer cell culture screen, and topoisomerase I inhibitory activity comparable to that of camptothecin.', 'Title: Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen.  Abstract: The indenoisoquinolines are a class of noncamptothecin topoisomerase I inhibitors that display significant cytotoxicity in human cancer cell cultures. They offer a number of potential advantages over the camptothecins, including greater chemical stability, formation of more persistent cleavage complexes, and induction of a unique pattern of DNA cleavage sites. Molecular modeling has suggested that substituents on the indenoisoquinoline lactam nitrogen would protrude out of the DNA duplex in the ternary cleavage complex through the major groove. This indicates that relatively large substituents in that location would be tolerated without compromising biological activity. As a strategy for increasing the potencies and potential therapeutic usefulness of the indenoisoquinolines, a series of compounds was synthesized containing polyamine side chains on the lactam nitrogen. The rationale for the synthesis of these compounds was that the positively charged ammonium cations would increase DNA affinity through electrostatic binding to the negatively charged DNA backbone, and the polyamines might also facilitate cellular uptake by utilization of polyamine transporters. The key step in the synthesis involved the condensation of Schiff bases, containing protected amine side chains, with substituted homophthalic anhydrides, to afford cis-3-aryl-4-carboxy-1-isoquinolones. These isoquinolones were then converted to indenoisoquinolines with thionyl chloride. Although monoamines were much more potent than the lead compound, no significant increase in potency was observed through incorporation of additional amino groups in the side chain. However, one of the monoamine analogues, which features a bis(2-hydroxyethyl)amino group in the side chain, proved to be one of the most cytotoxic indenoisoquinoline synthesized to date, with a GI50 mean-graph midpoint (MGM) of 0.07 microM in the NIH human cancer cell culture screen, and topoisomerase I inhibitory activity comparable to that of camptothecin.', 'Title: Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen.  Abstract: The indenoisoquinolines are a class of noncamptothecin topoisomerase I inhibitors that display significant cytotoxicity in human cancer cell cultures. They offer a number of potential advantages over the camptothecins, including greater chemical stability, formation of more persistent cleavage complexes, and induction of a unique pattern of DNA cleavage sites. Molecular modeling has suggested that substituents on the indenoisoquinoline lactam nitrogen would protrude out of the DNA duplex in the ternary cleavage complex through the major groove. This indicates that relatively large substituents in that location would be tolerated without compromising biological activity. As a strategy for increasing the potencies and potential therapeutic usefulness of the indenoisoquinolines, a series of compounds was synthesized containing polyamine side chains on the lactam nitrogen. The rationale for the synthesis of these compounds was that the positively charged ammonium cations would increase DNA affinity through electrostatic binding to the negatively charged DNA backbone, and the polyamines might also facilitate cellular uptake by utilization of polyamine transporters. The key step in the synthesis involved the condensation of Schiff bases, containing protected amine side chains, with substituted homophthalic anhydrides, to afford cis-3-aryl-4-carboxy-1-isoquinolones. These isoquinolones were then converted to indenoisoquinolines with thionyl chloride. Although monoamines were much more potent than the lead compound, no significant increase in potency was observed through incorporation of additional amino groups in the side chain. However, one of the monoamine analogues, which features a bis(2-hydroxyethyl)amino group in the side chain, proved to be one of the most cytotoxic indenoisoquinoline synthesized to date, with a GI50 mean-graph midpoint (MGM) of 0.07 microM in the NIH human cancer cell culture screen, and topoisomerase I inhibitory activity comparable to that of camptothecin.', 'Title: Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen.  Abstract: The indenoisoquinolines are a class of noncamptothecin topoisomerase I inhibitors that display significant cytotoxicity in human cancer cell cultures. They offer a number of potential advantages over the camptothecins, including greater chemical stability, formation of more persistent cleavage complexes, and induction of a unique pattern of DNA cleavage sites. Molecular modeling has suggested that substituents on the indenoisoquinoline lactam nitrogen would protrude out of the DNA duplex in the ternary cleavage complex through the major groove. This indicates that relatively large substituents in that location would be tolerated without compromising biological activity. As a strategy for increasing the potencies and potential therapeutic usefulness of the indenoisoquinolines, a series of compounds was synthesized containing polyamine side chains on the lactam nitrogen. The rationale for the synthesis of these compounds was that the positively charged ammonium cations would increase DNA affinity through electrostatic binding to the negatively charged DNA backbone, and the polyamines might also facilitate cellular uptake by utilization of polyamine transporters. The key step in the synthesis involved the condensation of Schiff bases, containing protected amine side chains, with substituted homophthalic anhydrides, to afford cis-3-aryl-4-carboxy-1-isoquinolones. These isoquinolones were then converted to indenoisoquinolines with thionyl chloride. Although monoamines were much more potent than the lead compound, no significant increase in potency was observed through incorporation of additional amino groups in the side chain. However, one of the monoamine analogues, which features a bis(2-hydroxyethyl)amino group in the side chain, proved to be one of the most cytotoxic indenoisoquinoline synthesized to date, with a GI50 mean-graph midpoint (MGM) of 0.07 microM in the NIH human cancer cell culture screen, and topoisomerase I inhibitory activity comparable to that of camptothecin.', 'Title: Benzo[f]azino[2,1-a]phthalazinium cations: novel DNA intercalating chromophores with antiproliferative activity.  Abstract: New azaquinolizinium-type cations have been obtained from isochromane. The synthesis was completed over seven steps and included as the key feature an intramolecular Westphal condensation. This first example of the intramolecular process allowed the preparation of benzo[f]pyrido[2,1-a]phthalazinium and benzo[f]quino[2,1-a]phthalazinium salts, which were evaluated as DNA intercalators, DNA topoisomerase I inhibitors, and antiproliferative compounds. Both cationic systems behave as DNA intercalators and exhibit antiproliferative activity. The pentacyclic benzo[f]quino[2,1-a]phthalazinium cations also have an inhibitory effect on the catalytic activity of DNA topoisomerase I, without trapping of cleavage complexes. Structural characterization using density functional theory indicates that the fused ring systems are slightly nonplanar, and additional molecular modeling studies suggest a preferred orientation for the intercalating chromophores within a typical CpG or TpG intercalation site.', 'Title: Benzo[f]azino[2,1-a]phthalazinium cations: novel DNA intercalating chromophores with antiproliferative activity.  Abstract: New azaquinolizinium-type cations have been obtained from isochromane. The synthesis was completed over seven steps and included as the key feature an intramolecular Westphal condensation. This first example of the intramolecular process allowed the preparation of benzo[f]pyrido[2,1-a]phthalazinium and benzo[f]quino[2,1-a]phthalazinium salts, which were evaluated as DNA intercalators, DNA topoisomerase I inhibitors, and antiproliferative compounds. Both cationic systems behave as DNA intercalators and exhibit antiproliferative activity. The pentacyclic benzo[f]quino[2,1-a]phthalazinium cations also have an inhibitory effect on the catalytic activity of DNA topoisomerase I, without trapping of cleavage complexes. Structural characterization using density functional theory indicates that the fused ring systems are slightly nonplanar, and additional molecular modeling studies suggest a preferred orientation for the intercalating chromophores within a typical CpG or TpG intercalation site.', 'Title: Benzo[f]azino[2,1-a]phthalazinium cations: novel DNA intercalating chromophores with antiproliferative activity.  Abstract: New azaquinolizinium-type cations have been obtained from isochromane. The synthesis was completed over seven steps and included as the key feature an intramolecular Westphal condensation. This first example of the intramolecular process allowed the preparation of benzo[f]pyrido[2,1-a]phthalazinium and benzo[f]quino[2,1-a]phthalazinium salts, which were evaluated as DNA intercalators, DNA topoisomerase I inhibitors, and antiproliferative compounds. Both cationic systems behave as DNA intercalators and exhibit antiproliferative activity. The pentacyclic benzo[f]quino[2,1-a]phthalazinium cations also have an inhibitory effect on the catalytic activity of DNA topoisomerase I, without trapping of cleavage complexes. Structural characterization using density functional theory indicates that the fused ring systems are slightly nonplanar, and additional molecular modeling studies suggest a preferred orientation for the intercalating chromophores within a typical CpG or TpG intercalation site.', 'Title: Synthesis of new dihydroindeno[1,2-c]isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model.  Abstract: A number of novel dihydroindenoisoquinolines and indenoisoquinolinium salts were synthesized and examined for cytotoxicity in cancer cell cultures and for inhibition of topoisomerase I (top1). The top1-mediated DNA cleavage patterns produced in the presence of several of the new analogues were also investigated, and a few of the more potent compounds were examined for activity in hollow fiber animal models. Very cytotoxic dihydroindenoisoquinoline and isoquinolinium salts were obtained with mean graph midpoints (MGMs) for growth inhibition in the low submicromolar range. Two of the new dihydroindenoisoquinolines were found to be weaker top1 inhibitors than the lead compound 1, while two of the indenoisoquinolinium salts were more potent. The top1-mediated DNA cleavage patterns of the indenoisoquinolines examined were found to be similar to each other but different from that of camptothecin. Several of the more potent indenoisoquinolines displayed promising anticancer activities in hollow fiber animal models.', 'Title: Synthesis of new dihydroindeno[1,2-c]isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model.  Abstract: A number of novel dihydroindenoisoquinolines and indenoisoquinolinium salts were synthesized and examined for cytotoxicity in cancer cell cultures and for inhibition of topoisomerase I (top1). The top1-mediated DNA cleavage patterns produced in the presence of several of the new analogues were also investigated, and a few of the more potent compounds were examined for activity in hollow fiber animal models. Very cytotoxic dihydroindenoisoquinoline and isoquinolinium salts were obtained with mean graph midpoints (MGMs) for growth inhibition in the low submicromolar range. Two of the new dihydroindenoisoquinolines were found to be weaker top1 inhibitors than the lead compound 1, while two of the indenoisoquinolinium salts were more potent. The top1-mediated DNA cleavage patterns of the indenoisoquinolines examined were found to be similar to each other but different from that of camptothecin. Several of the more potent indenoisoquinolines displayed promising anticancer activities in hollow fiber animal models.', 'Title: Synthesis of new dihydroindeno[1,2-c]isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model.  Abstract: A number of novel dihydroindenoisoquinolines and indenoisoquinolinium salts were synthesized and examined for cytotoxicity in cancer cell cultures and for inhibition of topoisomerase I (top1). The top1-mediated DNA cleavage patterns produced in the presence of several of the new analogues were also investigated, and a few of the more potent compounds were examined for activity in hollow fiber animal models. Very cytotoxic dihydroindenoisoquinoline and isoquinolinium salts were obtained with mean graph midpoints (MGMs) for growth inhibition in the low submicromolar range. Two of the new dihydroindenoisoquinolines were found to be weaker top1 inhibitors than the lead compound 1, while two of the indenoisoquinolinium salts were more potent. The top1-mediated DNA cleavage patterns of the indenoisoquinolines examined were found to be similar to each other but different from that of camptothecin. Several of the more potent indenoisoquinolines displayed promising anticancer activities in hollow fiber animal models.', 'Title: Synthesis of new dihydroindeno[1,2-c]isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model.  Abstract: A number of novel dihydroindenoisoquinolines and indenoisoquinolinium salts were synthesized and examined for cytotoxicity in cancer cell cultures and for inhibition of topoisomerase I (top1). The top1-mediated DNA cleavage patterns produced in the presence of several of the new analogues were also investigated, and a few of the more potent compounds were examined for activity in hollow fiber animal models. Very cytotoxic dihydroindenoisoquinoline and isoquinolinium salts were obtained with mean graph midpoints (MGMs) for growth inhibition in the low submicromolar range. Two of the new dihydroindenoisoquinolines were found to be weaker top1 inhibitors than the lead compound 1, while two of the indenoisoquinolinium salts were more potent. The top1-mediated DNA cleavage patterns of the indenoisoquinolines examined were found to be similar to each other but different from that of camptothecin. Several of the more potent indenoisoquinolines displayed promising anticancer activities in hollow fiber animal models.', 'Title: Synthesis of new dihydroindeno[1,2-c]isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model.  Abstract: A number of novel dihydroindenoisoquinolines and indenoisoquinolinium salts were synthesized and examined for cytotoxicity in cancer cell cultures and for inhibition of topoisomerase I (top1). The top1-mediated DNA cleavage patterns produced in the presence of several of the new analogues were also investigated, and a few of the more potent compounds were examined for activity in hollow fiber animal models. Very cytotoxic dihydroindenoisoquinoline and isoquinolinium salts were obtained with mean graph midpoints (MGMs) for growth inhibition in the low submicromolar range. Two of the new dihydroindenoisoquinolines were found to be weaker top1 inhibitors than the lead compound 1, while two of the indenoisoquinolinium salts were more potent. The top1-mediated DNA cleavage patterns of the indenoisoquinolines examined were found to be similar to each other but different from that of camptothecin. Several of the more potent indenoisoquinolines displayed promising anticancer activities in hollow fiber animal models.', 'Title: Synthesis and pharmacological evaluation of novel non-lactone analogues of camptothecin.  Abstract: Ten novel camptothecin (CPT) derivatives devoid of the lactone function in the E-ring were synthesized and evaluated as anticancer agents. Several of these CPT analogues bearing a five-membered E-ring are potent inhibitors of the DNA relaxation and cleavage reactions catalyzed by topoisomerase I and exhibit promising cytotoxic activities with IC(50) values in the nM range. This is the first successful design of lactone-free CPT, providing thus a new avenue to the development of topoisomerase I targeted antitumor agents.', 'Title: Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitors.  Abstract: In an attempt to design and synthesize potential anticancer agents acting by inhibition of topoisomerase I (top1), a new series of indenoisoquinolines was prepared and tested for cytotoxicity in human cancer cell cultures and for activity against top1. The synthesis relied on the condensation of substituted Schiff bases with homophthalic anhydrides to produce cis-3-aryl-4-carboxyisoquinolones that were cyclized to indenoisoquinolines in the presence of thionyl chloride. Both top1 inhibitory activity and cytotoxicity maximized in a single compound, 6-[3-(2-hydroxyethyl)aminopropyl]-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride (19a), which proved to be a very potent top1 inhibitor having a 110 nM mean graph midpoint (MGM) when tested for cytotoxicity in 55 human cancer cell cultures. A number of structurally related indenoisoquinolines were also obtained that had both potent cytotoxicity as well as top1 inhibitory activity. The key feature of the more potent compounds was the presence of an aminoalkyl side chain on the indenoisoquinoline nitrogen atom. The DNA cleavage patterns induced by top1 in the presence of the indenoisoquinolines were different from those seen with camptothecin. Some of the cleavage sites induced by the indenoisoquinolines were different from those seen with camptothecin, and conversely, camptothecin induced unique cleavage sites not apparent with the indenoisoquinolines. However, both camptothecin and the indenoisoquinolines also induced DNA cleavage sites that were the same in both series but varied in intensity. In addition, some of the DNA cleavages seen with the free base of 19a (compound 18c) in the presence of top1 were inhibited at higher drug concentrations, suggesting either a direct inhibition of the enzyme or an alternative mechanism involving DNA intercalation. Consistent with intercalation, compound 18c did unwind DNA.', 'Title: Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitors.  Abstract: In an attempt to design and synthesize potential anticancer agents acting by inhibition of topoisomerase I (top1), a new series of indenoisoquinolines was prepared and tested for cytotoxicity in human cancer cell cultures and for activity against top1. The synthesis relied on the condensation of substituted Schiff bases with homophthalic anhydrides to produce cis-3-aryl-4-carboxyisoquinolones that were cyclized to indenoisoquinolines in the presence of thionyl chloride. Both top1 inhibitory activity and cytotoxicity maximized in a single compound, 6-[3-(2-hydroxyethyl)aminopropyl]-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride (19a), which proved to be a very potent top1 inhibitor having a 110 nM mean graph midpoint (MGM) when tested for cytotoxicity in 55 human cancer cell cultures. A number of structurally related indenoisoquinolines were also obtained that had both potent cytotoxicity as well as top1 inhibitory activity. The key feature of the more potent compounds was the presence of an aminoalkyl side chain on the indenoisoquinoline nitrogen atom. The DNA cleavage patterns induced by top1 in the presence of the indenoisoquinolines were different from those seen with camptothecin. Some of the cleavage sites induced by the indenoisoquinolines were different from those seen with camptothecin, and conversely, camptothecin induced unique cleavage sites not apparent with the indenoisoquinolines. However, both camptothecin and the indenoisoquinolines also induced DNA cleavage sites that were the same in both series but varied in intensity. In addition, some of the DNA cleavages seen with the free base of 19a (compound 18c) in the presence of top1 were inhibited at higher drug concentrations, suggesting either a direct inhibition of the enzyme or an alternative mechanism involving DNA intercalation. Consistent with intercalation, compound 18c did unwind DNA.', 'Title: Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitors.  Abstract: In an attempt to design and synthesize potential anticancer agents acting by inhibition of topoisomerase I (top1), a new series of indenoisoquinolines was prepared and tested for cytotoxicity in human cancer cell cultures and for activity against top1. The synthesis relied on the condensation of substituted Schiff bases with homophthalic anhydrides to produce cis-3-aryl-4-carboxyisoquinolones that were cyclized to indenoisoquinolines in the presence of thionyl chloride. Both top1 inhibitory activity and cytotoxicity maximized in a single compound, 6-[3-(2-hydroxyethyl)aminopropyl]-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride (19a), which proved to be a very potent top1 inhibitor having a 110 nM mean graph midpoint (MGM) when tested for cytotoxicity in 55 human cancer cell cultures. A number of structurally related indenoisoquinolines were also obtained that had both potent cytotoxicity as well as top1 inhibitory activity. The key feature of the more potent compounds was the presence of an aminoalkyl side chain on the indenoisoquinoline nitrogen atom. The DNA cleavage patterns induced by top1 in the presence of the indenoisoquinolines were different from those seen with camptothecin. Some of the cleavage sites induced by the indenoisoquinolines were different from those seen with camptothecin, and conversely, camptothecin induced unique cleavage sites not apparent with the indenoisoquinolines. However, both camptothecin and the indenoisoquinolines also induced DNA cleavage sites that were the same in both series but varied in intensity. In addition, some of the DNA cleavages seen with the free base of 19a (compound 18c) in the presence of top1 were inhibited at higher drug concentrations, suggesting either a direct inhibition of the enzyme or an alternative mechanism involving DNA intercalation. Consistent with intercalation, compound 18c did unwind DNA.', 'Title: Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitors.  Abstract: In an attempt to design and synthesize potential anticancer agents acting by inhibition of topoisomerase I (top1), a new series of indenoisoquinolines was prepared and tested for cytotoxicity in human cancer cell cultures and for activity against top1. The synthesis relied on the condensation of substituted Schiff bases with homophthalic anhydrides to produce cis-3-aryl-4-carboxyisoquinolones that were cyclized to indenoisoquinolines in the presence of thionyl chloride. Both top1 inhibitory activity and cytotoxicity maximized in a single compound, 6-[3-(2-hydroxyethyl)aminopropyl]-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride (19a), which proved to be a very potent top1 inhibitor having a 110 nM mean graph midpoint (MGM) when tested for cytotoxicity in 55 human cancer cell cultures. A number of structurally related indenoisoquinolines were also obtained that had both potent cytotoxicity as well as top1 inhibitory activity. The key feature of the more potent compounds was the presence of an aminoalkyl side chain on the indenoisoquinoline nitrogen atom. The DNA cleavage patterns induced by top1 in the presence of the indenoisoquinolines were different from those seen with camptothecin. Some of the cleavage sites induced by the indenoisoquinolines were different from those seen with camptothecin, and conversely, camptothecin induced unique cleavage sites not apparent with the indenoisoquinolines. However, both camptothecin and the indenoisoquinolines also induced DNA cleavage sites that were the same in both series but varied in intensity. In addition, some of the DNA cleavages seen with the free base of 19a (compound 18c) in the presence of top1 were inhibited at higher drug concentrations, suggesting either a direct inhibition of the enzyme or an alternative mechanism involving DNA intercalation. Consistent with intercalation, compound 18c did unwind DNA.', 'Title: seco-Cyclothialidines: new concise synthesis, inhibitory activity toward bacterial and human DNA topoisomerases, and antibacterial properties.  Abstract: seco-Cyclothialidines are a promising class of bacterial DNA gyrase B subunit inhibitors. A new seco-cyclothialidine derivative containing a dioxazine moiety, BAY 50-7952, was synthesized through a new concise pathway. One key step of the synthesis is the straightforward formation of the 2-aminothiazole derivative of S-tritylcysteine. In biological tests, BAY 50-7952 and other known seco-cyclothialidines exhibited high and selective activity toward bacterial DNA gyrase and toward Gram-positive bacteria. The dioxazine moiety and other similar groups were found to be important for the ability of the seco-cyclothialidines to penetrate bacterial membranes. The opposite enantiomer ((S)-form) of BAY 50-7952 was also synthesized, and neither significant target activity nor in vitro antibacterial activity were found, suggesting a highly selective fit of the (R)-form. Despite promising in vitro activity, only poor activity was found in the murine infection model.', 'Title: Indolocarbazole poisons of human topoisomerase I: regioisomeric analogues of ED-110.  Abstract: All four \"symmetrical\" regioisomers of ED-110, an indolocarbazole derivative having potent activity against human topoisomerase I (Topo I) were synthesized. The isomer containing hydroxyl groups in the 3- and 9-positions was approximately ten-fold more active against Topo I, and 5- to 35-fold more active against human solid tumor cell lines in vitro, relative to ED-110.', \"Title: Acylshikonin analogues: synthesis and inhibition of DNA topoisomerase-I.  Abstract: Compounds bearing an acyl group of a various size at 1'-OH of shikonin were synthesized as acyl analogues of shikonin, which was isolated from the root of Lithospermum erythrorhizon, and evaluated for inhibitory effect on topoisomerase-I activity. A selective acylation at 1'-OH of shikonin in the presence of dicyclohexylcarbodiimide and 4-(dimethylamino)pyridine gave rise to a good yield of corresponding acylshikonin derivatives. In general, analogues with an acyl group of shorter chain lengths (C2-C6) exerted a stronger inhibitory action than those with longer chain lengths (C7-C20). While the halogen substitution at C-2 of the acetyl moiety failed to increase the inhibitory potency, the placement of double bonds in the acyl group (C5-C7) augmented the potency remarkably. Of the 32 derivatives evaluated, 15 compounds exhibited a higher inhibitory effect than shikonin. Noteworthy, the inhibitory potency of acetylshikonin, propanoylshikonin, and 4-pentenoylshikonin was approximately 4-fold greater than that of camptothecin. All these data suggest that the size of acyl moiety is important for the enhancement of potency, and the presence of olefinic double bonds is also beneficial.\", 'Title: Antitumor agents. 166. Synthesis and biological evaluation of 5,6,7,8-substituted-2-phenylthiochromen-4-ones.  Abstract: As a continuation of our structure--activity relationship study of substituted 2-phenyl-4-quinolones and flavonoids as antitumor and antiviral agents, a series of 5,6,7,8-substituted-2-phenylthiochromen-4-ones has been synthesized by condensation of substituted thiophenols and ethyl benzoylacetates. Target compounds were evaluated for biological activity. Among them, compounds 7, 10, 12, and 13 displayed significant growth inhibitory action against a panel of tumor cell lines including human ileocecal carcinoma (HCT-8), murine leukemia (P-388), human melanoma (RPMI), and human central nervous system tumor (TE671) cells. Compounds 10, 12, and 19 displayed DNA topoisomerase I inhibitory activity in vitro and compound 11 was an in vitro, inhibitor of DNA topoisomerase II. Compound 11 was most active (ED50 value, 0.65 microM) against HIV in acutely infected H9 lymphocytes and had a therapeutic index of about 5.', 'Title: Antitumor agents. 166. Synthesis and biological evaluation of 5,6,7,8-substituted-2-phenylthiochromen-4-ones.  Abstract: As a continuation of our structure--activity relationship study of substituted 2-phenyl-4-quinolones and flavonoids as antitumor and antiviral agents, a series of 5,6,7,8-substituted-2-phenylthiochromen-4-ones has been synthesized by condensation of substituted thiophenols and ethyl benzoylacetates. Target compounds were evaluated for biological activity. Among them, compounds 7, 10, 12, and 13 displayed significant growth inhibitory action against a panel of tumor cell lines including human ileocecal carcinoma (HCT-8), murine leukemia (P-388), human melanoma (RPMI), and human central nervous system tumor (TE671) cells. Compounds 10, 12, and 19 displayed DNA topoisomerase I inhibitory activity in vitro and compound 11 was an in vitro, inhibitor of DNA topoisomerase II. Compound 11 was most active (ED50 value, 0.65 microM) against HIV in acutely infected H9 lymphocytes and had a therapeutic index of about 5.', 'Title: Antitumor agents. 166. Synthesis and biological evaluation of 5,6,7,8-substituted-2-phenylthiochromen-4-ones.  Abstract: As a continuation of our structure--activity relationship study of substituted 2-phenyl-4-quinolones and flavonoids as antitumor and antiviral agents, a series of 5,6,7,8-substituted-2-phenylthiochromen-4-ones has been synthesized by condensation of substituted thiophenols and ethyl benzoylacetates. Target compounds were evaluated for biological activity. Among them, compounds 7, 10, 12, and 13 displayed significant growth inhibitory action against a panel of tumor cell lines including human ileocecal carcinoma (HCT-8), murine leukemia (P-388), human melanoma (RPMI), and human central nervous system tumor (TE671) cells. Compounds 10, 12, and 19 displayed DNA topoisomerase I inhibitory activity in vitro and compound 11 was an in vitro, inhibitor of DNA topoisomerase II. Compound 11 was most active (ED50 value, 0.65 microM) against HIV in acutely infected H9 lymphocytes and had a therapeutic index of about 5.', 'Title: Antitumor agents. 166. Synthesis and biological evaluation of 5,6,7,8-substituted-2-phenylthiochromen-4-ones.  Abstract: As a continuation of our structure--activity relationship study of substituted 2-phenyl-4-quinolones and flavonoids as antitumor and antiviral agents, a series of 5,6,7,8-substituted-2-phenylthiochromen-4-ones has been synthesized by condensation of substituted thiophenols and ethyl benzoylacetates. Target compounds were evaluated for biological activity. Among them, compounds 7, 10, 12, and 13 displayed significant growth inhibitory action against a panel of tumor cell lines including human ileocecal carcinoma (HCT-8), murine leukemia (P-388), human melanoma (RPMI), and human central nervous system tumor (TE671) cells. Compounds 10, 12, and 19 displayed DNA topoisomerase I inhibitory activity in vitro and compound 11 was an in vitro, inhibitor of DNA topoisomerase II. Compound 11 was most active (ED50 value, 0.65 microM) against HIV in acutely infected H9 lymphocytes and had a therapeutic index of about 5.', 'Title: 6-Arylamino-7-chloro-quinazoline-5,8-diones as novel cytotoxic and DNA topoisomerase inhibitory agents.  Abstract: A series of 6-arylamino-7-chloro-quinazoline-5,8-diones were prepared and evaluated for their in vitro cytotoxicity in cultured human cancer cell lines A549 (lung cancer), Col2 (colon cancer), and SNU-638 (stomach cancer). The preliminary structure-activity relationship has been described for providing further development of potent antitumor agents. To further investigate the cytotoxic mechanism, the effects of test compounds on DNA topoisomerase I and II activities have been assessed.', 'Title: Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitors.  Abstract: In an attempt to design and synthesize potential anticancer agents acting by inhibition of topoisomerase I (top1), a new series of indenoisoquinolines was prepared and tested for cytotoxicity in human cancer cell cultures and for activity against top1. The synthesis relied on the condensation of substituted Schiff bases with homophthalic anhydrides to produce cis-3-aryl-4-carboxyisoquinolones that were cyclized to indenoisoquinolines in the presence of thionyl chloride. Both top1 inhibitory activity and cytotoxicity maximized in a single compound, 6-[3-(2-hydroxyethyl)aminopropyl]-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride (19a), which proved to be a very potent top1 inhibitor having a 110 nM mean graph midpoint (MGM) when tested for cytotoxicity in 55 human cancer cell cultures. A number of structurally related indenoisoquinolines were also obtained that had both potent cytotoxicity as well as top1 inhibitory activity. The key feature of the more potent compounds was the presence of an aminoalkyl side chain on the indenoisoquinoline nitrogen atom. The DNA cleavage patterns induced by top1 in the presence of the indenoisoquinolines were different from those seen with camptothecin. Some of the cleavage sites induced by the indenoisoquinolines were different from those seen with camptothecin, and conversely, camptothecin induced unique cleavage sites not apparent with the indenoisoquinolines. However, both camptothecin and the indenoisoquinolines also induced DNA cleavage sites that were the same in both series but varied in intensity. In addition, some of the DNA cleavages seen with the free base of 19a (compound 18c) in the presence of top1 were inhibited at higher drug concentrations, suggesting either a direct inhibition of the enzyme or an alternative mechanism involving DNA intercalation. Consistent with intercalation, compound 18c did unwind DNA.', 'Title: Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitors.  Abstract: In an attempt to design and synthesize potential anticancer agents acting by inhibition of topoisomerase I (top1), a new series of indenoisoquinolines was prepared and tested for cytotoxicity in human cancer cell cultures and for activity against top1. The synthesis relied on the condensation of substituted Schiff bases with homophthalic anhydrides to produce cis-3-aryl-4-carboxyisoquinolones that were cyclized to indenoisoquinolines in the presence of thionyl chloride. Both top1 inhibitory activity and cytotoxicity maximized in a single compound, 6-[3-(2-hydroxyethyl)aminopropyl]-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride (19a), which proved to be a very potent top1 inhibitor having a 110 nM mean graph midpoint (MGM) when tested for cytotoxicity in 55 human cancer cell cultures. A number of structurally related indenoisoquinolines were also obtained that had both potent cytotoxicity as well as top1 inhibitory activity. The key feature of the more potent compounds was the presence of an aminoalkyl side chain on the indenoisoquinoline nitrogen atom. The DNA cleavage patterns induced by top1 in the presence of the indenoisoquinolines were different from those seen with camptothecin. Some of the cleavage sites induced by the indenoisoquinolines were different from those seen with camptothecin, and conversely, camptothecin induced unique cleavage sites not apparent with the indenoisoquinolines. However, both camptothecin and the indenoisoquinolines also induced DNA cleavage sites that were the same in both series but varied in intensity. In addition, some of the DNA cleavages seen with the free base of 19a (compound 18c) in the presence of top1 were inhibited at higher drug concentrations, suggesting either a direct inhibition of the enzyme or an alternative mechanism involving DNA intercalation. Consistent with intercalation, compound 18c did unwind DNA.', 'Title: 5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones and related compounds as TOP1-targeting agents: influence of structure on the ternary cleavable complex formation.  Abstract: In this paper, we present our results from a docking study of the title compounds with the DNA/topoisomerase I complex based on the recently published X-ray crystal structure of the topotecan/DNA/topoisomerase I ternary cleavable complex (Staker, B.L., et al. PNAS 2002, 99, 15387) using the Autodock program. Simple intermolecular docking energies (E(dock)) correlate well with in vitro DNA cleavage data suggesting that the binding mode from the crystal structure is a reasonable binding mode for these compounds.', 'Title: Nitro and amino substitution in the D-ring of 5-(2-dimethylaminoethyl)- 2,3-methylenedioxy-5H-dibenzo[c,h][1,6]naphthyridin-6-ones: effect on topoisomerase-I targeting activity and cytotoxicity.  Abstract: 5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)-2,3-methylenedioxydibenzo[c,h][1,6]naphthyridin-6-one exhibits potent TOP1-targeting activity and pronounced antitumor activity. It was hypothesized that replacement of the two methoxyl groups with a nitro substituent would allow for retention of similar activity. In this study 8-, 9-, and 10-nitro-5H-2,3-methylenedioxy-5-(2-N,N-dimethylaminoethyl)dibenzo[c,h][1,6]naphthyridin-6-one and their amino derivatives were synthesized and assessed for their relative TOP1-targeting activity and cytotoxicity. In the case of both the 8- and 9-nitro analogues, their TOP1-targeting activity and cytotoxicity are greater than that of camptothecin and comparable to that of 5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)-2,3-methylenedioxydibenzo[c,h][1,6]naphthyridin-6-one.', 'Title: Diaza- and triazachrysenes: potent topoisomerase-targeting agents with exceptional antitumor activity against the human tumor xenograft, MDA-MB-435.  Abstract: Several 5,12-diazachrysen-6-ones and 5,6,11-triazachrysen-12-ones were synthesized with varied substituents at the 5- or 11-position, respectively. Each compound was evaluated for its potential to stabilize the cleavable complex formed with TOP1 and DNA. Two analogues with very potent TOP1-targeting activity, 3a and 4a, exhibited cytotoxic activity with IC(50) values at or below 2nM against RPMI8402. Compound 3a was active in vivo by either ip or po administration in the human tumor xenograft athymic nude mice model.', 'Title: Topoisomerase I-mediated antiproliferative activity of enantiomerically pure fluorinated homocamptothecins.  Abstract: Homocamptothecin (hCPT) is an E-ring modified camptothecin (CPT) analogue bearing a methylene spacer between the alcohol and carboxyl functions of the CPT lactone. Combining pronounced inhibitory activity of topoisomerase I (Topo I) with enhanced plasma stability, hCPT constitutes an attractive template for the elaboration of new anticancer agents. Fluorinated hCPT analogues, prepared in enantiomerically pure form, were assayed by their stimulation of Topo I-mediated DNA cleavage. Translation into cytotoxicity against tumor cells was evaluated on HT29 human colon adenocarcinoma and on the multidrug resistant lung and bladder tumor cell lines, A549 and T24r. Good correlation is observed between the ability of the drugs to stimulate Topo I-mediated DNA cleavage and the respective 50% inhibitory concentrations (IC(50) values) of the HT29, A549, and T24r cell growth. Fluorine substitution in the A-ring of hCPT was found to have a pronounced influence on biological activity, providing several compounds which are up to 100-fold more potent than CPT in terms of IC(50). Among these, 10,11-difluoro-hCPT has been selected for further development.', 'Title: Synthesis, topoisomerase I inhibition and structure-activity relationship study of 2,4,6-trisubstituted pyridine derivatives.  Abstract: For the development of new anticancer agents, phenyl, 2-pyridyl, 2-furyl, 2-thienyl, 2-furylvinyl and 2-thienylvinyl substituted derivatives on 2,4,6-position in pyridine moiety were prepared and evaluated for their topoisomerase I inhibitory activity. Among the thirteen prepared compounds, four compounds exhibited strong topoisomerase I inhibitory activity. A structure-activity relationship study indicated that the 2-thienyl-4-furylpyridine skeleton was important for topoisomerase I inhibitory activity.', 'Title: Structural modifications of camptothecin and effects on topoisomerase I inhibition.  Abstract: Camptothecin (1), a potent antitumor alkaloid, is known to inhibit topoisomerase I, an enzyme that relaxes supercoiled DNA. Modifications have been made to the B, D, and E rings of this natural product. Specifically, compounds 2-10 either have an ester moiety in place of the E ring lactone, a methyl ester attached to position 14, a saturated (or nonexistent) deaza B ring, or contain a combination of these permutations. We have conducted in vitro assays against the topoisomerase I relaxation reaction which verify the necessity for a lactone in the E ring. Furthermore, steric requirements at position 14 are shown to be crucial for activity, and planarity of the A and B rings of camptothecin is also implicated in the ability of the drug to inhibit topoisomerase I. Speculation on the nature of the drug binding pocket is presented.', \"Title: Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.  Abstract: Indenoisoquinolines and dihydroindenoisoquinolines have been synthesized possessing a nitro-substituted isoquinoline ring in an effort to explore the effects of electron-withdrawing substituents on biological activity. The in vitro anticancer activities of these molecules have been tested in the National Cancer Institute's screen of 55 cell lines. The compounds have also been tested for topoisomerase I (top1) inhibition. The results indicate that these substances are a potent class of top1 inhibitors with sub-micromolar cytotoxicity mean graph midpoints (MGM) and top1 inhibition equal to camptothecin.\", \"Title: Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.  Abstract: Indenoisoquinolines and dihydroindenoisoquinolines have been synthesized possessing a nitro-substituted isoquinoline ring in an effort to explore the effects of electron-withdrawing substituents on biological activity. The in vitro anticancer activities of these molecules have been tested in the National Cancer Institute's screen of 55 cell lines. The compounds have also been tested for topoisomerase I (top1) inhibition. The results indicate that these substances are a potent class of top1 inhibitors with sub-micromolar cytotoxicity mean graph midpoints (MGM) and top1 inhibition equal to camptothecin.\", \"Title: Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.  Abstract: Indenoisoquinolines and dihydroindenoisoquinolines have been synthesized possessing a nitro-substituted isoquinoline ring in an effort to explore the effects of electron-withdrawing substituents on biological activity. The in vitro anticancer activities of these molecules have been tested in the National Cancer Institute's screen of 55 cell lines. The compounds have also been tested for topoisomerase I (top1) inhibition. The results indicate that these substances are a potent class of top1 inhibitors with sub-micromolar cytotoxicity mean graph midpoints (MGM) and top1 inhibition equal to camptothecin.\", \"Title: Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.  Abstract: Indenoisoquinolines and dihydroindenoisoquinolines have been synthesized possessing a nitro-substituted isoquinoline ring in an effort to explore the effects of electron-withdrawing substituents on biological activity. The in vitro anticancer activities of these molecules have been tested in the National Cancer Institute's screen of 55 cell lines. The compounds have also been tested for topoisomerase I (top1) inhibition. The results indicate that these substances are a potent class of top1 inhibitors with sub-micromolar cytotoxicity mean graph midpoints (MGM) and top1 inhibition equal to camptothecin.\", \"Title: Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.  Abstract: Indenoisoquinolines and dihydroindenoisoquinolines have been synthesized possessing a nitro-substituted isoquinoline ring in an effort to explore the effects of electron-withdrawing substituents on biological activity. The in vitro anticancer activities of these molecules have been tested in the National Cancer Institute's screen of 55 cell lines. The compounds have also been tested for topoisomerase I (top1) inhibition. The results indicate that these substances are a potent class of top1 inhibitors with sub-micromolar cytotoxicity mean graph midpoints (MGM) and top1 inhibition equal to camptothecin.\", \"Title: Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.  Abstract: Indenoisoquinolines and dihydroindenoisoquinolines have been synthesized possessing a nitro-substituted isoquinoline ring in an effort to explore the effects of electron-withdrawing substituents on biological activity. The in vitro anticancer activities of these molecules have been tested in the National Cancer Institute's screen of 55 cell lines. The compounds have also been tested for topoisomerase I (top1) inhibition. The results indicate that these substances are a potent class of top1 inhibitors with sub-micromolar cytotoxicity mean graph midpoints (MGM) and top1 inhibition equal to camptothecin.\", \"Title: Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.  Abstract: Indenoisoquinolines and dihydroindenoisoquinolines have been synthesized possessing a nitro-substituted isoquinoline ring in an effort to explore the effects of electron-withdrawing substituents on biological activity. The in vitro anticancer activities of these molecules have been tested in the National Cancer Institute's screen of 55 cell lines. The compounds have also been tested for topoisomerase I (top1) inhibition. The results indicate that these substances are a potent class of top1 inhibitors with sub-micromolar cytotoxicity mean graph midpoints (MGM) and top1 inhibition equal to camptothecin.\", 'Title: Synthesis of new 3-arylisoquinolinamines: effect on topoisomerase I inhibition and cytotoxicity.  Abstract: To investigate the structure-activity relationships of 3-arylisoquinolines, diverse substituted 3-aryisoquinolinamines were synthesized and tested in vitro antitumor activity against four tumor cell lines. Some of the compounds showed potent topoisomerase I inhibitory activity. Docking study of 7d with topoisomerase I-DNA complex was also performed.', 'Title: Synthesis of new 3-arylisoquinolinamines: effect on topoisomerase I inhibition and cytotoxicity.  Abstract: To investigate the structure-activity relationships of 3-arylisoquinolines, diverse substituted 3-aryisoquinolinamines were synthesized and tested in vitro antitumor activity against four tumor cell lines. Some of the compounds showed potent topoisomerase I inhibitory activity. Docking study of 7d with topoisomerase I-DNA complex was also performed.', 'Title: Synthesis of new 3-arylisoquinolinamines: effect on topoisomerase I inhibition and cytotoxicity.  Abstract: To investigate the structure-activity relationships of 3-arylisoquinolines, diverse substituted 3-aryisoquinolinamines were synthesized and tested in vitro antitumor activity against four tumor cell lines. Some of the compounds showed potent topoisomerase I inhibitory activity. Docking study of 7d with topoisomerase I-DNA complex was also performed.', 'Title: Synthesis of new 3-arylisoquinolinamines: effect on topoisomerase I inhibition and cytotoxicity.  Abstract: To investigate the structure-activity relationships of 3-arylisoquinolines, diverse substituted 3-aryisoquinolinamines were synthesized and tested in vitro antitumor activity against four tumor cell lines. Some of the compounds showed potent topoisomerase I inhibitory activity. Docking study of 7d with topoisomerase I-DNA complex was also performed.', 'Title: Inhibitory activities against topoisomerase I and II by polyhydroxybenzoyl amide derivatives and their structure-activity relationship.  Abstract: o-, m-, p-Phenylenediamines having 2,3,4-trihydroxy, 3,4 dihydroxy, and 4-hydroxybenzoyl moieties were prepared and their inhibitory activities were measured against topoisomerase I and II. More hydroxy groups on two aromatic rings increased the activities. Bis(trihydroxybenzoyl)-o-phenylenediamide showed IC(50)=0.90 and 0.09 microM against topoisomerase I and II, respectively. Compounds with hydroxy groups protected by acetyl moiety still had the activities. Less hydroxy groups decreased their activities. Benzothiazole derivatives also indicated the activities.', 'Title: Inhibitory activities against topoisomerase I and II by polyhydroxybenzoyl amide derivatives and their structure-activity relationship.  Abstract: o-, m-, p-Phenylenediamines having 2,3,4-trihydroxy, 3,4 dihydroxy, and 4-hydroxybenzoyl moieties were prepared and their inhibitory activities were measured against topoisomerase I and II. More hydroxy groups on two aromatic rings increased the activities. Bis(trihydroxybenzoyl)-o-phenylenediamide showed IC(50)=0.90 and 0.09 microM against topoisomerase I and II, respectively. Compounds with hydroxy groups protected by acetyl moiety still had the activities. Less hydroxy groups decreased their activities. Benzothiazole derivatives also indicated the activities.', 'Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.', 'Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.', 'Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.', 'Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.', 'Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.', 'Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.', 'Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.', 'Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.', 'Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.', 'Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.', 'Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.', 'Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.', 'Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.', 'Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.', 'Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.', 'Title: Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.  Abstract: A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs topoisomerase 1 (top1). The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar mean graph midpoints when tested in 55 human cancer cell cultures. Two of the most potent top1 inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27), both of which also inhibited top2, unwound DNA, and are assumed to be DNA intercalators. However, two additional potent top1 inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8, 9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect top2. Some of the DNA cleavage sites detected in the presence of the indenoisoquinolines were different from those seen with the camptothecins. The cleavage sites induced by the indenoisoquinolines were reversed by salt treatment, which is consistent with the reversible trapping of top1 cleavable complexes by the indenoisoquinolines. In general, the potencies of the indenoisoquinolines as top1 inhibitors did not correlate with their potencies as cytotoxic agents, as some of the most cytotoxic agents had little if any effect on top1. On the other hand, the most potent of the indenoisoquinolines vs top1 were not the most cytotoxic. In several cases, moderate activity was observed for both cytotoxicity and activity vs top1.', 'Title: Homocamptothecins: synthesis and antitumor activity of novel E-ring-modified camptothecin analogues.  Abstract: Homocamptothecin (hCPT), a camptothecin (CPT) analogue with a seven membered beta-hydroxylactone which combines enhanced plasma stability and potent topoisomerase I (Topo I)-mediated activity, is an attractive template for the elaboration of new anticancer agents. Like CPT, hCPT carries an asymmetric tertiary alcohol and displays stereoselective inhibition of Topo I. The preparation and biological screening of racemic hCPT analogues are described. The 10 hCPTs tested were better Topo I inhibitors than CPT. Fluorinated hCPTs 23c, d,f,g were found to have potent cytotoxic activity on A427 and PC-3 tumor cell lines. Their cytotoxicity remained high on the K562adr and MCF7mdr cell lines, which overexpress a functionally active P-glycoprotein. Fluorinated hCPTs were more efficacious in vivo than CPT on HT-29 xenografts. In this model, a tumor growth delay of 25 days was reached with hCPT 23g at a daily dose of 0.32 mg/kg, compared to 4 days with CPT at 0.625 mg/kg. Thus difluorinated hCPT 23g warrants further investigation as a novel Topo I inhibitor with high cytotoxicity toward tumor cells and promising in vivo efficacy.', 'Title: Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity.  Abstract: Several camptothecin derivatives containing a modified hydroxy lactone ring have been synthesized and evaluated for inhibition of topoisomerase I and cytotoxicity to mammalian cells. Each of the groups of the hydroxy lactone moiety, the carbonyl oxygen, the ring lactone oxygen, and the 20-hydroxy group, were shown to be critical for enzyme inhibition. For example the lactol, lactam, thiolactone, and 20-deoxy derivatives did not stabilize the covalent DNA-topoisomerase I complex. With a few exceptions, those compounds that did not inhibit topoisomerase I were not cytotoxic to mammalian cells. Two cytotoxic derivatives that did not inhibit topoisomerase I were shown to produce non-protein-associated DNA single-strand breaks and are likely to have a different mechanism of action. One of these compounds was tested for antitumor activity and was found to be inactive. The present findings, as well as other reports that the hydroxy lactone ring of camptothecin is critical for antitumor activity in vivo, correlate with the structure-activity relationships at the level of topoisomerase I and support the hypothesis that antitumor activity is related to inhibition of this target enzyme.', 'Ability (200 uM) to satbilize DNA-topoisomerase (from calf) I-compound ternary complex was determined; not active', 'Ability to satbilize DNA-topoisomerase (from calf) I-compound ternary complex was determined', 'Ability to inhibit calf thymus topoisomerase I when assayed in the cleavable complex formation', 'Compound was evaluated for in vitro percent inhibition of purified calf thymus topoisomerase I at 100 uM', 'Title: Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group.  Abstract: As a part of studies on structure-activity relationships, several potential topoisomerase I inhibitors were prepared. Different analogues of the antitumor antibiotic rebeccamycin substituted on the imide nitrogen with a methyl group were synthesized. These compounds bore either the sugar residue of rebeccamycin, with or without the chlorine atoms on the indole moieties, or modified sugar residues (galactopyranosyl, glucopyranosyl, or fucopyranosyl) linked to the aglycone via a beta- or alpha-N-glycosidic bond. Their inhibitory properties toward protein kinase C, topoisomerase I, and topoisomerase II were examined, and their DNA-binding properties were investigated. Their in vitro antitumor activities against murine B16 melanoma and P388 leukemia cells were determined. Their antimicrobial activities were tested against Gram-positive bacteria Bacillus cereus and Streptomyces chartreusis, Gram-negative bacterium Escherichia coli, and yeast Candida albicans. These compounds are inactive toward topoisomerase II but inhibit topoisomerase I. A substitution with a methyl group on the imide nitrogen led to a loss of proteine kinase C inhibition in the maleimide indolocarbazole series but did not prevent topoisomerase I inhibition. Compounds possessing a beta-N-glycosidic bond, which fully intercalated into DNA, were more efficient at inhibiting topoisomerase I than their analogues with an alpha-N-glycosidic bond; however, both were equally toxic toward P388 leukemia cells. Dechlorinated rebeccamycin possessing a methyl group on the imide nitrogen was about 10 times more efficient in terms of cytotoxicity and inhibition of topoisomerase I than the natural metabolite.', 'Title: Synthesis and evaluation of new 6-amino-substituted benzo[c]phenanthridine derivatives.  Abstract: Different 7,8,9,10-tetrahydrobenzo[c]phenanthridin-6(5H)-ones (10a-e) were prepared by using a one-pot procedure which includes the preparation of various 6- and 7-alkoxy-1-naphthylisocyanates from 1-naphthylamines and triphosgene, followed by addition of 1-N-morpholino-1-cyclohexenes, and cyclization of the resulting amides upon heating in the presence of hydrogen chloride. Subsequent aromatization, chlorination, and substitution with (dimethylamino)alkylamines, followed by a demethylation or a selective desisopropylation, allowed us to synthesize the derivatives 6a-i and 7a-h bearing a [(dimethylamino)alkyl]amino side chain at their 6-position. These compounds, as the other analogs 5a-b, were devised to further study the structure-activity relationships in the benzo[c]phenanthridine family of antitumor alkaloids led by fagaronine (1a) and nitidine (1b). Topoisomerases I and II cleavable complex assay and evaluation of the cytotoxicity and antitumor properties were performed. In vitro cytotoxicity (L1210 and Calc 18) shows a relationship between the cytotoxicity of these compounds and their topoisomerase poisoning properties. However, all these compounds were devoid of significant antitumor effect on the P388 murine leukemia system.', 'Title: Plant antitumor agents. 30. Synthesis and structure activity of novel camptothecin analogs.  Abstract: A large number of camptothecin (CPT) analogs have been prepared in the 20S, 20RS, and 20R configurations with a number of ring A substituents. Topoisomerase I (T-I) inhibition data (IC50) have been obtained by standard procedures. In general, substitution at the 9 or 10 positions with amino, halogeno, or hydroxyl groups in compounds with 20S configuration results in compounds with enhanced T-I inhibition. Compounds in the 20RS configuration were less active in vitro and in vivo and those in the 20R configuration were inactive. Compounds with 10,11-methylenedioxy substitution on ring A displayed a marked increase in potency in the T-I inhibition assay. The activities of some of the analogs as determined in a variety of in vivo assays including the L-1210 mouse leukemia assay were, in general, in accord with T-I inhibition. A number of water-soluble analogs such as 20-glycinate esters, 9-glycinamides, or hydrolyzed lactone salts were prepared and tested in in vitro and in vivo assays. In general, these compounds were less active than CPT both in terms of T-I inhibition and life prolongation in the L-1210 assay. However, certain 20-glycinate esters showed good in vivo activity after iv administration.', 'Title: Plant antitumor agents. 30. Synthesis and structure activity of novel camptothecin analogs.  Abstract: A large number of camptothecin (CPT) analogs have been prepared in the 20S, 20RS, and 20R configurations with a number of ring A substituents. Topoisomerase I (T-I) inhibition data (IC50) have been obtained by standard procedures. In general, substitution at the 9 or 10 positions with amino, halogeno, or hydroxyl groups in compounds with 20S configuration results in compounds with enhanced T-I inhibition. Compounds in the 20RS configuration were less active in vitro and in vivo and those in the 20R configuration were inactive. Compounds with 10,11-methylenedioxy substitution on ring A displayed a marked increase in potency in the T-I inhibition assay. The activities of some of the analogs as determined in a variety of in vivo assays including the L-1210 mouse leukemia assay were, in general, in accord with T-I inhibition. A number of water-soluble analogs such as 20-glycinate esters, 9-glycinamides, or hydrolyzed lactone salts were prepared and tested in in vitro and in vivo assays. In general, these compounds were less active than CPT both in terms of T-I inhibition and life prolongation in the L-1210 assay. However, certain 20-glycinate esters showed good in vivo activity after iv administration.', 'Title: Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.  Abstract: The present studies provide a three-dimensional model for the postulated ternary cleavable complex of topoisomerase I (top1), DNA, and camptothecin (CPT). Molecular simulations were done using the AMBER force field. The results suggest that a ternary cleavable complex might be stabilized by several hydrogen bonds in the binding site. In this proposed \"drug-stacking\" model, CPT is pseudointercalated in the top1-linked DNA cleavage site and interacts with the protein near its catalytic tyrosine through hydrogen bonding and stacking. The structural model is consistent with the following experimental observations: (i) the N3 position of the 5\\' terminal purine of the cleaved DNA strand is readily alkylated by 7-chloromethyl 10,11-methylenedioxy CPT; (ii) CPT generally tolerates substituents at positions 7, 9, and 10 but is inactivated by additions at position 12; (iii) 10,11-methylenedioxy (MDO) CPT is much more potent than 10,11-dimethoxy (DMO) CPT; (iv) the lactone portion of CPT is essential for top1 inhibitory activity; (v) 20S derivatives of CPT are much more potent than the 20R analogues; (vi) a catalytic tyrosine hydroxyl in top1 covalently links to the 3\\' terminal base, T, of the cleaved DNA strand; and (vii) top1 mutation Asn722Ser leads to CPT resistance. A total of 18 camptothecin derivatives with different DNA cleavage potencies were docked into the hypothetical cleavable complex binding site to test and refine the model. These studies provide insight into a possible mechanism of top1 inhibition by CPT derivatives and suggest rational approaches for the design of new CPT derivatives.', 'Title: Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.  Abstract: The present studies provide a three-dimensional model for the postulated ternary cleavable complex of topoisomerase I (top1), DNA, and camptothecin (CPT). Molecular simulations were done using the AMBER force field. The results suggest that a ternary cleavable complex might be stabilized by several hydrogen bonds in the binding site. In this proposed \"drug-stacking\" model, CPT is pseudointercalated in the top1-linked DNA cleavage site and interacts with the protein near its catalytic tyrosine through hydrogen bonding and stacking. The structural model is consistent with the following experimental observations: (i) the N3 position of the 5\\' terminal purine of the cleaved DNA strand is readily alkylated by 7-chloromethyl 10,11-methylenedioxy CPT; (ii) CPT generally tolerates substituents at positions 7, 9, and 10 but is inactivated by additions at position 12; (iii) 10,11-methylenedioxy (MDO) CPT is much more potent than 10,11-dimethoxy (DMO) CPT; (iv) the lactone portion of CPT is essential for top1 inhibitory activity; (v) 20S derivatives of CPT are much more potent than the 20R analogues; (vi) a catalytic tyrosine hydroxyl in top1 covalently links to the 3\\' terminal base, T, of the cleaved DNA strand; and (vii) top1 mutation Asn722Ser leads to CPT resistance. A total of 18 camptothecin derivatives with different DNA cleavage potencies were docked into the hypothetical cleavable complex binding site to test and refine the model. These studies provide insight into a possible mechanism of top1 inhibition by CPT derivatives and suggest rational approaches for the design of new CPT derivatives.', 'Title: Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.  Abstract: The present studies provide a three-dimensional model for the postulated ternary cleavable complex of topoisomerase I (top1), DNA, and camptothecin (CPT). Molecular simulations were done using the AMBER force field. The results suggest that a ternary cleavable complex might be stabilized by several hydrogen bonds in the binding site. In this proposed \"drug-stacking\" model, CPT is pseudointercalated in the top1-linked DNA cleavage site and interacts with the protein near its catalytic tyrosine through hydrogen bonding and stacking. The structural model is consistent with the following experimental observations: (i) the N3 position of the 5\\' terminal purine of the cleaved DNA strand is readily alkylated by 7-chloromethyl 10,11-methylenedioxy CPT; (ii) CPT generally tolerates substituents at positions 7, 9, and 10 but is inactivated by additions at position 12; (iii) 10,11-methylenedioxy (MDO) CPT is much more potent than 10,11-dimethoxy (DMO) CPT; (iv) the lactone portion of CPT is essential for top1 inhibitory activity; (v) 20S derivatives of CPT are much more potent than the 20R analogues; (vi) a catalytic tyrosine hydroxyl in top1 covalently links to the 3\\' terminal base, T, of the cleaved DNA strand; and (vii) top1 mutation Asn722Ser leads to CPT resistance. A total of 18 camptothecin derivatives with different DNA cleavage potencies were docked into the hypothetical cleavable complex binding site to test and refine the model. These studies provide insight into a possible mechanism of top1 inhibition by CPT derivatives and suggest rational approaches for the design of new CPT derivatives.', 'Title: Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.  Abstract: The present studies provide a three-dimensional model for the postulated ternary cleavable complex of topoisomerase I (top1), DNA, and camptothecin (CPT). Molecular simulations were done using the AMBER force field. The results suggest that a ternary cleavable complex might be stabilized by several hydrogen bonds in the binding site. In this proposed \"drug-stacking\" model, CPT is pseudointercalated in the top1-linked DNA cleavage site and interacts with the protein near its catalytic tyrosine through hydrogen bonding and stacking. The structural model is consistent with the following experimental observations: (i) the N3 position of the 5\\' terminal purine of the cleaved DNA strand is readily alkylated by 7-chloromethyl 10,11-methylenedioxy CPT; (ii) CPT generally tolerates substituents at positions 7, 9, and 10 but is inactivated by additions at position 12; (iii) 10,11-methylenedioxy (MDO) CPT is much more potent than 10,11-dimethoxy (DMO) CPT; (iv) the lactone portion of CPT is essential for top1 inhibitory activity; (v) 20S derivatives of CPT are much more potent than the 20R analogues; (vi) a catalytic tyrosine hydroxyl in top1 covalently links to the 3\\' terminal base, T, of the cleaved DNA strand; and (vii) top1 mutation Asn722Ser leads to CPT resistance. A total of 18 camptothecin derivatives with different DNA cleavage potencies were docked into the hypothetical cleavable complex binding site to test and refine the model. These studies provide insight into a possible mechanism of top1 inhibition by CPT derivatives and suggest rational approaches for the design of new CPT derivatives.', 'Title: Syntheses and biological evaluation of indolocarbazoles, analogues of rebeccamycin, modified at the imide heterocycle.  Abstract: A series of 10 indolocarbazole derivatives, analogues to the antitumor antibiotic rebeccamycin, bearing modifications at the imide heterocycle were synthesized. They bear an N-methyl imide, N-methyl amide, or anhydride function instead of the original imide. Their inhibitory potencies toward topoisomerase I were examined using a DNA relaxation assay and by analyzing the drug-induced cleavage of 32P-labeled DNA. Protein kinase C (PKC) inhibition and interaction with DNA were also studied together with the in vitro antiproliferative activities against B16 melanoma and P388 leukemia cells. The antimicrobial activities against two Gram-positive bacteria (Bacillus cereus and Streptomyces chartreusis), a Gram-negative bacterium (Escherichia coli), and a yeast (Candida albicans) were tested as well as their antiviral activities toward HIV-1. The efficiency of the anhydride compounds was compared to that of the parent compound rebeccamycin and its dechlorinated analogue. All the compounds studied were inactive against PKC. The structural requirements for PKC and topoisomerase I inhibition are markedly different. In sharp contrast with the structure-PKC inhibition relationships, we found that an anhydride function does not affect topoisomerase I inhibition, whereas a methyl group on the indole nitrogen prevents the poisoning of topoisomerase I. The compounds exhibiting a marked toxicity to P388 leukemia cells had little or no effect on the growth of P388CPT5 cells which are resistant to the topoisomerase I inhibitor camptothecin. This study reinforces the conclusion that the DNA-topoisomerase I cleavable complex is the primary cellular target of the indolocarbazoles and significantly contributes to their cytotoxicity and possibly to their weak but noticeable anti-HIV-1 activities. The structure-activity relationships are also discussed.', 'Title: Terbenzimidazoles: influence of 2\"-, 4-, and 5-substituents on cytotoxicity and relative potency as topoisomerase I poisons.  Abstract: Terbenzimidazoles poison the nuclear enzyme topoisomerase I and possess significant cytotoxic activity against several human tumor cell lines. The relative pharmacological activity of 4,5- and 5,6-benzoterbenzimidazoles was compared to that of 5-phenylterbenzimidazole (3). 5,6-Benzoterbenzimidazole is inactive as a topoisomerase I poison and did not exhibit significant cytotoxic activity. In contrast, 4,5-benzoterbenzimidazole retained activity as a topoisomerase I poison but exhibited weak cytotoxic activity relative to 3. While 5-(1-naphthyl)terbenzimidazole is less potent than 3 as a topoisomerase I poison and cytotoxic agent, 5-(2-naphthyl)-terbenzimidazole has comparable activity to 3. The presence of a p-methoxy or p-chloro substituent on the phenyl moiety did not dramatically alter the pharmacological activity of 3. Several analogs of 3 were synthesized wherein the 2\"-substituent varied from methyl, ethyl, propyl, isopropyl, phenyl to p-methoxyphenyl. Evaluation of the intrinsic activity of these analogs as topoisomerase I poisons indicates that topoisomerase I poisoning was not diminished by the presence of a methyl, ethyl, propyl, and isopropyl substituent at the 2\"-position. Among the various 2\"-substituted analogs evaluated, only in the case of 2\"-(p-methoxyphenyl)-5-phenylterbenzimidazole was a significant decrease in cytotoxicity observed.', \"Title: Heterocyclic bibenzimidazole derivatives as topoisomerase I inhibitors.  Abstract: A series of 2'-heterocyclic derivatives of 5-phenyl-2,5'-1H-bibenzimidazoles were evaluated for topoisomerase I poisoning activity and cytotoxicity. Topo I poisoning activity was associated with 2'-derivatives that possessed a hydrogen atom capable of hydrogen bond formation, suggesting that the interatomic distances between such hydrogen atoms and the heteroatoms on the adjacent benzimidazole influence activity.\", 'Title: Synthesis and biological activities of NB-506 analogues modified at the glucose group.  Abstract: A new indolocarbazole compound, NB-506 (1), modified at the glucose group yielded a beta-D-glucopyranoside, J-107,088 (2), which showed potent anticancer activity. A beta-D-ribofuranoside, J-109,534 (3), was found to be 6 times more potent than J-107,088 at inhibiting topoisomerase I.', 'Title: Synthesis and biological activities of NB-506 analogues: Effects of the positions of two hydroxyl groups at the indole rings.  Abstract: In the course of a study of 6-N-amino-substituted analogues of NB-506 (1), a more potent anticancer drug, J-109,404 (2), in which the formyl group of NB-506 was replaced with a 1,3-dihydroxypropane group, was reported. A study of further modification in the positions of two hydroxyl groups at the indole rings of 2 resulted in the discovery of a 2,10-dihydroxy analogue, J-107,088 (3), which is a promising anticancer agent with a broader therapeutic window than J-109,404.', 'Compound was tested in vitro for inhibition of topoisomerase I.', 'Title: Camptothecin and minor-groove binder hybrid molecules: synthesis, inhibition of topoisomerase I, and anticancer cytotoxicity in vitro.  Abstract: The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of 14 camptothecin derivatives of polypyrrolecarboxamide (lexitropsin) conjugates of two structural classes: (A) camptothecin-NHCO-lexitropsin 44-51 and (B) camptothecin-CONH-lexitropsin 38-43 are described. All 16 compounds tested, 14 conjugates plus two functionalized camptothecin controls, inhibit topoisomerase I in the concentration range 1.12-16.6 microM that divide into three distinct categories based on activity. The most active enzyme inhibitors belong to structure class A with either cationic dimethylaminium or neutral amide end groups. Generally class B conjugates are less effective in inhibiting topoisomerase I. Cytotoxic potencies of the drugs was tested against four representative human tumor cell lines: SKOV3, SKLVB, HT29, and KB. All 16 drugs gave measurable IC50 values against the KB cell line and fell into two categories with IC50 values of 0.049-0.66 microM (largely structure class B) and 1.0-48 microM (largely class A). Thus the class B conjugates, while less potent against the enzyme, contain two of the most potent drugs, 38 and 39, against KB cell lines. In contrast, in the case of the cell lines SKOV3 and HT29 there was a general correlation between the better topoisomerase inhibitors and their cell cytotoxicities.', 'Concentration required to inhibit 50% relaxation of 250 ng of SV40 DNA obtained with 0.5 I.U topoisomerase I at 37 degrees C for 30 min', 'Compound was tested for the inhibition of Topoisomerase I when administered at a dose of 25 ug/mL', 'Title: Antitumor agents. 185. Synthesis and biological evaluation of tridemethylthiocolchicine analogues as novel topoisomerase II inhibitors.  Abstract: Several 1,2,3-tridemethyldeacetylthiocolchicine derivatives have been synthesized and evaluated for cytotoxic activity against various human tumor cell lines and for their inhibitory effects on DNA topoisomerases in vitro. Exhaustive demethylation of thiocolchicine analogues completely changes their biological profiles. Instead of displaying antitubulin activity, most target compounds inhibited topoisomerase II activity. Only compounds with a larger side chain, such as 15a, 23a, and 24a, did not interfere with topoisomerase II enzymatic functions. The cytotoxicity of target compounds was reduced by 3 orders of magnitude compared to that of colchicine in most cell lines. The hydrophilicity of phenolic compounds might prevent drug passage through the cell plasma membrane and, thus, be responsible for the relatively weak cytotoxicity. To test this hypothesis, 27-30 were prepared from 16a by protecting all hydroxy groups with esters with an aim to facilitate drug transportation. In vitro cytotoxicity assays indicated that 27 was more potent than its parent compound in all tested tumor cell lines and showed tissue selective cytotoxicity with a significant inhibitory effect against KB cells (IC50 = 2.7 microg/mL). Therefore, we propose that 27 acts as a prodrug, liberating 16a to exert its antitopoisomerase activity and, finally, to cause cell death.', 'Title: Antitumor agents. 185. Synthesis and biological evaluation of tridemethylthiocolchicine analogues as novel topoisomerase II inhibitors.  Abstract: Several 1,2,3-tridemethyldeacetylthiocolchicine derivatives have been synthesized and evaluated for cytotoxic activity against various human tumor cell lines and for their inhibitory effects on DNA topoisomerases in vitro. Exhaustive demethylation of thiocolchicine analogues completely changes their biological profiles. Instead of displaying antitubulin activity, most target compounds inhibited topoisomerase II activity. Only compounds with a larger side chain, such as 15a, 23a, and 24a, did not interfere with topoisomerase II enzymatic functions. The cytotoxicity of target compounds was reduced by 3 orders of magnitude compared to that of colchicine in most cell lines. The hydrophilicity of phenolic compounds might prevent drug passage through the cell plasma membrane and, thus, be responsible for the relatively weak cytotoxicity. To test this hypothesis, 27-30 were prepared from 16a by protecting all hydroxy groups with esters with an aim to facilitate drug transportation. In vitro cytotoxicity assays indicated that 27 was more potent than its parent compound in all tested tumor cell lines and showed tissue selective cytotoxicity with a significant inhibitory effect against KB cells (IC50 = 2.7 microg/mL). Therefore, we propose that 27 acts as a prodrug, liberating 16a to exert its antitopoisomerase activity and, finally, to cause cell death.', 'Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.', 'Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.', 'Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.', 'Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.', 'Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.', \"Title: Synthesis, mode of action, and biological activities of rebeccamycin bromo derivatives.  Abstract: Bromo analogues of the natural metabolite rebeccamycin with and without a methyl substituent on the imide nitrogen were synthesized. The effects of the drugs on protein kinase C, the binding to DNA, and the effect on topoisomerase I were determined. The drugs' uptake and their antiproliferative activities against P388 leukemia cells sensitive and resistant to camptothecin, their antimicrobial activity against a Gram-positive bacterium (B. cereus), and their anti-HIV-1 activity were measured and compared to those of the chlorinated and dechlorinated analogues. Dibrominated imide 5 shows a remarkable activity against topoisomerase I, affecting both the kinase and DNA cleavage activity of the enzyme. The marked cytotoxic potency of this compound depends essentially on its capacity to inhibit topoisomerase I.\", 'Title: Synthesis and antitumor activity of ring A- and F-modified hexacyclic camptothecin analogues.  Abstract: Nineteen ring A- and F-modified hexacyclic analogues of camptothecin were synthesized by Friedlnder condensation of appropriately substituted bicyclic amino ketones with tricyclic ketone and were evaluated for cytotoxicity and topoisomerase I inhibitory activity. Seventeen of the compounds showed cytotoxic effects comparable or superior to those of 7-ethyl-10-hydroxycamptothecin (SN-38) against mouse leukemia P388 and human tumor cell lines HOC-21 and QG-56. Introduction of a compact and inductively electron-withdrawing substituent such as a hydroxy, methoxy, chloro, or fluoro group into position 5 of ring A of the hexacyclic compound remarkably increased the antitumor activity. The potency of topoisomerase I inhibition of these compounds showed good correlation with their cytotoxicity. Among them, the 4-methyl-5-fluoro hexacyclic compound was the most potent of all and was 10 times as active as SN-38 in in vitro antitumor activity.', 'Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.', 'Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.', 'Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.', 'Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.', 'Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.', 'Title: Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.  Abstract: Inhibition of eukaryotic topoisomerase I by daunomycin and structurally modified daunomycin analogues is demonstrated. These studies suggest that binding of the drug to DNA, at low ratios of drug to base pairs of DNA, is sufficient for inhibition that is nonspecific, i.e., inhibition that does not involve the trapping of covalent DNA-topoisomerase I cleavable complexes. Inhibition of numerous DNA-processing enzymes by DNA-binding agents is also implicated.', 'Title: Synthesis and biological activities of topoisomerase I inhibitors, 6-N-amino analogues of NB-506.  Abstract: 6-N-Amino analogues of NB-506 [6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13-(beta-D-glucopyranosyl) -5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione] (3b) were synthesized and tested with respect to topoisomerase inhibition, cytotoxicity and anticancer effects. Among them, a 1,3-dihydroxypropane analogue (J-109,404, 5t) showed more than ten times more potent anticancer activity in MKN-45 human stomach cancer cells implanted in mice than NB-506.', 'Compound was tested for 50% DNA cleavage in presence of calf thymus topoisomerase I between hoechst 33342 and drug', 'Title: Inhibition of topoisomerase I by naphthoquinone derivatives.  Abstract: Alkannin and shikonin are naturally occurring naphthoquinones. We have tested several derivatives of the title compounds and we have found that naphthoquinones bearing at least one phenolic hydroxyl group are potent inhibitors of topoisomerase I. The ability of the tested compounds to complex Zn++ parallels with a few exceptions their topoisomerase I inhibition properties while their intercalation and redox properties do not.', 'Title: Design and synthesis of a fluoroindolocarbazole series as selective topoisomerase I active agents. Discovery of water-soluble 3,9-difluoro-12,13-dihydro-13-[6-amino-beta-D-glucopyranosyl]-5H,13H-benzo[b]- thienyl[2,3-a]pyrrolo[3,4-c]carbazole- 5,7(6H)-dione (BMS-251873) with curative antitumor activity against prostate carcinoma xenograft tumor model.  Abstract: A series of fluoroindolocarbazoles were studied with respect to their topoisomerase I activity, cytotoxicity, selectivity, and in vivo antitumor activity. Emerging from this series was BMS-251873, a potential clinical candidate possessing a robust pharmacological profile including curative antitumor activity against prostate carcinoma.', 'Title: Naphthazarin derivatives (II): formation of glutathione conjugate, inhibition of DNA topoisomerase-I and cytotoxicity.  Abstract: 6-(1-Hydroxyalkyl)-5,8-dimethoxy-1,4-naphthoquinones, expressing a higher reactivity in conjugation with glutathione, showed a greater potency in the inhibition of DNA topoisomerase-I and the cytotoxicity against L1210 cells than 2-(1-hydroxyalkyl)-DMNQ derivatives, implying the participation of electrophilic arylation in the bioactivities. In further study 6-(1-Hydroxyalkyl)-5,8-dimethoxy-1,4-naphthoquinones with an alkyl group of shorter chain length (C2-C6) exerted a greater bioactivities than those with longer chain length(>C6).', 'Title: Inhibitory activities against topoisomerase I and II by isoaurostatin derivatives and their structure-activity relationships.  Abstract: Isoaurostatin A (IAS-A) isolated from Thermomonospora alba showed weak inhibition against topoisomerase (topo) I (IC(50)=307microM). To get more strong inhibition, derivatives of IAS-A were prepared and their structure-activity relationships against topo I and II were investigated. The addition of hydroxyl group on aromatic rings increased the activities, 3-(3,4,5-trihydroxybenzylidene)-5-hydroxy-3H-benzofuran-2-one (IAS-9) showed strong inhibition (IC(50)=3microM) against topo I. And also, the increasing of hydroxyl group increased growth inhibition against a variety of cancer cells, and IAS-9 showed most potent inhibition. Unlike camptothecin and etoposide, IAS-9 neither stabilized DNA-topo cleavable complex nor intercalated into DNA, and it inhibited topo I and II noncompetitively. The inhibitory activities also increased by opening of lactone ring in the molecule of IAS-9.', 'Title: Dimethoxybenzo[i]phenanthridine-12-carboxylic acid derivatives and 6H-dibenzo[c,h][2,6]naphthyridin-5-ones with potent topoisomerase I-targeting activity and cytotoxicity.  Abstract: The exceptional TOP1-targeting activity and antitumor activity of ARC-111, 1, prompted studies on similarly substituted benzo[i]phenanthridine-12-carboxylic ester and amide derivatives. These studies were extended to include 6-substituted 8,9-dimethoxy-2,3-methylenedioxy-dibenzo[c,h][2,6]naphthyridin-5-ones, which represent reversed lactam analogues of 1. Several of these analogues retained the potent TOP1-targeting activity and cytotoxicity observed for ARC-111.', 'Title: Camptothecin analogs with bulky, hydrophobic substituents at the 7-position via a Grignard reaction.  Abstract: By developing a new synthetic procedure for introduction of side chains onto the camptothecin ring system, we were able to achieve the preparation of a number of analogs bearing bulky, hydrophobic groups directly attached to the 7-position. These include 7-tert-butylcamptothecin, 7-benzylcamptothecin and the corresponding 10,11-methylenedioxycamptothecins. This method involves the reaction of an appropriate orthoaminobenzonitrile with various Grignard reagents to give the corresponding orthoaminoketones. Friedlander condensation of the latter with the key tricyclic ketone leads to 7-substituted camptothecin analogs. We report the activity of these compounds as topoisomerase I poisons and their ability to inhibit growth of selected tumor cell lines.', 'Title: Discovery of a fluoroindolo[2,3-a]carbazole clinical candidate with broad spectrum antitumor activity in preclinical tumor models superior to the marketed oncology drug, CPT-11.  Abstract: A series of fluoroglycosylated fluoroindolocarbazoles was examined with respect to their topoisomerase I activity, cytotoxicity, and selectivity. The lead clinical candidate from this series, BMS-250749, displays broad spectrum antitumor activity superior to CPT-11 against some preclinical xenograft models, including curative antitumor activity against Lewis lung carcinoma.', 'Title: Inhibitory activities against topoisomerase I and II by isoaurostatin derivatives and their structure-activity relationships.  Abstract: Isoaurostatin A (IAS-A) isolated from Thermomonospora alba showed weak inhibition against topoisomerase (topo) I (IC(50)=307microM). To get more strong inhibition, derivatives of IAS-A were prepared and their structure-activity relationships against topo I and II were investigated. The addition of hydroxyl group on aromatic rings increased the activities, 3-(3,4,5-trihydroxybenzylidene)-5-hydroxy-3H-benzofuran-2-one (IAS-9) showed strong inhibition (IC(50)=3microM) against topo I. And also, the increasing of hydroxyl group increased growth inhibition against a variety of cancer cells, and IAS-9 showed most potent inhibition. Unlike camptothecin and etoposide, IAS-9 neither stabilized DNA-topo cleavable complex nor intercalated into DNA, and it inhibited topo I and II noncompetitively. The inhibitory activities also increased by opening of lactone ring in the molecule of IAS-9.', 'Title: Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex.  Abstract: Human topoisomerase I (top1) is the molecular target of a diverse set of anticancer compounds, including the camptothecins, indolocarbazoles, and indenoisoquinolines. These compounds bind to a transient top1-DNA covalent complex and inhibit the resealing of a single-strand nick that the enzyme creates to relieve superhelical tension in duplex DNA. (Hertzberg, R. P.; et al. Biochem. 1989, 28, 4629-4638. Hsiang, Y. H.; et al. J. Biol. Chem 1985, 260, 14873-14878. Champoux, J. J. Annu. Rev. Biochem. 2001, 70, 369-413. Stewart, L.; et al. Science 1998, 729, 1534-1541.) We report the X-ray crystal structures of the human top1-DNA complex bound with camptothecin and representative members of the indenoisoquinoline and indolocarbazole classes of top1 poisons. The planar nature of all three structurally diverse classes allows them to intercalate between DNA base pairs at the site of single-strand cleavage. All three classes of compounds have a free electron pair near Arg364, a residue that if mutated confers resistance to all three classes of drugs. The common intercalative binding mode is augmented by unexpected chemotype-specific contacts with amino acid residues Asn352 and Glu356, which adopt alternative side-chain conformations to accommodate the bound compounds. These new X-ray structures explain how very different molecules can stabilize top1-DNA covalent complexes and will aid the rational design of completely novel structural classes of anticancer drugs.', 'Title: Camptothecin analogs with bulky, hydrophobic substituents at the 7-position via a Grignard reaction.  Abstract: By developing a new synthetic procedure for introduction of side chains onto the camptothecin ring system, we were able to achieve the preparation of a number of analogs bearing bulky, hydrophobic groups directly attached to the 7-position. These include 7-tert-butylcamptothecin, 7-benzylcamptothecin and the corresponding 10,11-methylenedioxycamptothecins. This method involves the reaction of an appropriate orthoaminobenzonitrile with various Grignard reagents to give the corresponding orthoaminoketones. Friedlander condensation of the latter with the key tricyclic ketone leads to 7-substituted camptothecin analogs. We report the activity of these compounds as topoisomerase I poisons and their ability to inhibit growth of selected tumor cell lines.', 'Title: DNA topoisomerase I inhibitors from Rinorea anguifera.  Abstract: An organic extract prepared from Rinorea anguifera was investigated in order to identify the natural principle(s) responsible for stabilization of a topoisomerase I-DNA covalent binary complex. Bioassay-guided fractionation resulted in the isolation of mauritianin and (+)-syringaresinol as new topoisomerase I inhibitors, and also of the known inhibitor camptothecin.', 'Title: DNA topoisomerase I inhibitors from Rinorea anguifera.  Abstract: An organic extract prepared from Rinorea anguifera was investigated in order to identify the natural principle(s) responsible for stabilization of a topoisomerase I-DNA covalent binary complex. Bioassay-guided fractionation resulted in the isolation of mauritianin and (+)-syringaresinol as new topoisomerase I inhibitors, and also of the known inhibitor camptothecin.', 'Title: DNA topoisomerase I inhibitors from Rinorea anguifera.  Abstract: An organic extract prepared from Rinorea anguifera was investigated in order to identify the natural principle(s) responsible for stabilization of a topoisomerase I-DNA covalent binary complex. Bioassay-guided fractionation resulted in the isolation of mauritianin and (+)-syringaresinol as new topoisomerase I inhibitors, and also of the known inhibitor camptothecin.', 'Title: DNA topoisomerase I inhibitors from Rinorea anguifera.  Abstract: An organic extract prepared from Rinorea anguifera was investigated in order to identify the natural principle(s) responsible for stabilization of a topoisomerase I-DNA covalent binary complex. Bioassay-guided fractionation resulted in the isolation of mauritianin and (+)-syringaresinol as new topoisomerase I inhibitors, and also of the known inhibitor camptothecin.', 'Title: DNA topoisomerase I inhibitors from Rinorea anguifera.  Abstract: An organic extract prepared from Rinorea anguifera was investigated in order to identify the natural principle(s) responsible for stabilization of a topoisomerase I-DNA covalent binary complex. Bioassay-guided fractionation resulted in the isolation of mauritianin and (+)-syringaresinol as new topoisomerase I inhibitors, and also of the known inhibitor camptothecin.', 'Title: DNA topoisomerase I inhibitors from Rinorea anguifera.  Abstract: An organic extract prepared from Rinorea anguifera was investigated in order to identify the natural principle(s) responsible for stabilization of a topoisomerase I-DNA covalent binary complex. Bioassay-guided fractionation resulted in the isolation of mauritianin and (+)-syringaresinol as new topoisomerase I inhibitors, and also of the known inhibitor camptothecin.', 'Title: DNA topoisomerase I inhibitors from Rinorea anguifera.  Abstract: An organic extract prepared from Rinorea anguifera was investigated in order to identify the natural principle(s) responsible for stabilization of a topoisomerase I-DNA covalent binary complex. Bioassay-guided fractionation resulted in the isolation of mauritianin and (+)-syringaresinol as new topoisomerase I inhibitors, and also of the known inhibitor camptothecin.', 'Title: Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis.  Abstract: Several norindenoisoquinolines substituted with methoxy or methylenedioxy groups have been prepared and their anticancer properties evaluated in cancer cell cultures and in topoisomerase I inhibition assays. 2,3-Dimethoxy-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline hydrochloride (14) is a strong topoisomerase I inhibitor and also displays very high cytotoxicity in the NCI cancer cell culture screen (mean graph midpoint of 50 nM). The X-ray crystal structure of norindenoisoquinoline 14 in complex with topoisomerase I and DNA has been solved, providing insight into the structure-activity relationships within this class of new anticancer agents. The number and position of the norindenoisoquinoline substituents have a significant influence on biological activity and demonstrate that substitution on the nitrogen atom is not an absolute requirement for the antitumor effect of the indenoisoquinolines. Removal of the 11-keto group from the lead compound 1 and replacement of the N-alkyllactam with an unsubstituted pyridine ring causes the indenoisoquinoline ring system to flip over in the DNA-enzyme-inhibitor ternary complex. This allows the nitrogen atom to assume the hydrogen bond acceptor role of the 11-keto group, resulting in hydrogen bonding to Arg364.', 'Title: Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis.  Abstract: Several norindenoisoquinolines substituted with methoxy or methylenedioxy groups have been prepared and their anticancer properties evaluated in cancer cell cultures and in topoisomerase I inhibition assays. 2,3-Dimethoxy-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline hydrochloride (14) is a strong topoisomerase I inhibitor and also displays very high cytotoxicity in the NCI cancer cell culture screen (mean graph midpoint of 50 nM). The X-ray crystal structure of norindenoisoquinoline 14 in complex with topoisomerase I and DNA has been solved, providing insight into the structure-activity relationships within this class of new anticancer agents. The number and position of the norindenoisoquinoline substituents have a significant influence on biological activity and demonstrate that substitution on the nitrogen atom is not an absolute requirement for the antitumor effect of the indenoisoquinolines. Removal of the 11-keto group from the lead compound 1 and replacement of the N-alkyllactam with an unsubstituted pyridine ring causes the indenoisoquinoline ring system to flip over in the DNA-enzyme-inhibitor ternary complex. This allows the nitrogen atom to assume the hydrogen bond acceptor role of the 11-keto group, resulting in hydrogen bonding to Arg364.', 'Title: Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis.  Abstract: Several norindenoisoquinolines substituted with methoxy or methylenedioxy groups have been prepared and their anticancer properties evaluated in cancer cell cultures and in topoisomerase I inhibition assays. 2,3-Dimethoxy-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline hydrochloride (14) is a strong topoisomerase I inhibitor and also displays very high cytotoxicity in the NCI cancer cell culture screen (mean graph midpoint of 50 nM). The X-ray crystal structure of norindenoisoquinoline 14 in complex with topoisomerase I and DNA has been solved, providing insight into the structure-activity relationships within this class of new anticancer agents. The number and position of the norindenoisoquinoline substituents have a significant influence on biological activity and demonstrate that substitution on the nitrogen atom is not an absolute requirement for the antitumor effect of the indenoisoquinolines. Removal of the 11-keto group from the lead compound 1 and replacement of the N-alkyllactam with an unsubstituted pyridine ring causes the indenoisoquinoline ring system to flip over in the DNA-enzyme-inhibitor ternary complex. This allows the nitrogen atom to assume the hydrogen bond acceptor role of the 11-keto group, resulting in hydrogen bonding to Arg364.', 'Title: On the binding of indeno[1,2-c]isoquinolines in the DNA-topoisomerase I cleavage complex.  Abstract: An ab initio quantum mechanics calculation is reported which predicts the orientation of indenoisoquinoline 4 in the ternary cleavage complex formed from DNA and topoisomerase I (top1). The results of this calculation are consistent with the hypothetical structures previously proposed for the indenoisoquinoline-DNA-top1 ternary complexes based on molecular modeling, the crystal structure of a recently reported ternary complex, and the biological results obtained with a pair of diaminoalkyl-substituted indenoisoquinoline enantiomers. The results of these studies indicate that the pi-pi stacking interactions between the indenoisoquinolines and the neighboring DNA base pairs play a major role in determining binding orientation. The calculation of the electrostatic potential surface maps of the indenoisoquinolines and the adjacent DNA base pairs shows electrostatic complementarity in the observed binding orientation, leading to the conclusion that electrostatic attraction between the intercalators and the base pairs in the cleavage complex plays a major stabilizing role. On the other hand, the calculation of LUMO and HOMO energies of indenoisoquinoline 13b and neighboring DNA base pairs in conjunction with NBO analysis indicates that charge transfer complex formation plays a relatively minor role in stabilizing the ternary complexes derived from indenoisoquinolines, DNA, and top1. The results of these studies are important in understanding the existing structure-activity relationships for the indenoisoquinolines as top1 inhibitors and as anticancer agents, and they will be important in the future design of indenoisoquinoline-based top1 inhibitors.', 'Title: On the binding of indeno[1,2-c]isoquinolines in the DNA-topoisomerase I cleavage complex.  Abstract: An ab initio quantum mechanics calculation is reported which predicts the orientation of indenoisoquinoline 4 in the ternary cleavage complex formed from DNA and topoisomerase I (top1). The results of this calculation are consistent with the hypothetical structures previously proposed for the indenoisoquinoline-DNA-top1 ternary complexes based on molecular modeling, the crystal structure of a recently reported ternary complex, and the biological results obtained with a pair of diaminoalkyl-substituted indenoisoquinoline enantiomers. The results of these studies indicate that the pi-pi stacking interactions between the indenoisoquinolines and the neighboring DNA base pairs play a major role in determining binding orientation. The calculation of the electrostatic potential surface maps of the indenoisoquinolines and the adjacent DNA base pairs shows electrostatic complementarity in the observed binding orientation, leading to the conclusion that electrostatic attraction between the intercalators and the base pairs in the cleavage complex plays a major stabilizing role. On the other hand, the calculation of LUMO and HOMO energies of indenoisoquinoline 13b and neighboring DNA base pairs in conjunction with NBO analysis indicates that charge transfer complex formation plays a relatively minor role in stabilizing the ternary complexes derived from indenoisoquinolines, DNA, and top1. The results of these studies are important in understanding the existing structure-activity relationships for the indenoisoquinolines as top1 inhibitors and as anticancer agents, and they will be important in the future design of indenoisoquinoline-based top1 inhibitors.', 'Title: Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase I inhibitors lacking substituents on the aromatic rings.  Abstract: The indenoisoquinolines are a class of cytotoxic topoisomerase I inhibitors that offer certain advantages over the camptothecins, including the greater stabilities of the compounds themselves, as well as the greater stabilities of their drug-enzyme-DNA cleavage complexes. To investigate the possible biological roles of the di(methoxy) and methylenedioxy substituents present on the aromatic rings of the previously synthesized indenoisoquinoline topoisomerase I inhibitors, a series of compounds lacking these substituents was synthesized and tested for both cytotoxicity in cancer cell cultures and for enzyme inhibitory activity. The results indicate that the aromatic substituents make a small, but consistently observable contribution to the biological activity. Molecular models derived for the binding of the unsubstituted indenoisoquinolines in ternary complex with DNA and topoisomerase I indicate that the substituents on the lactam nitrogen project out of the major groove, and the carbonyl group is directed out of the minor groove, where it is involved in a hydrogen bonding interaction with the side chain guanidine group of Arg364. The DNA cleavage patterns observed in the presence of topoisomerase I and various indenoisoquinolines were similar, although significant differences were detected. There were also variations in the DNA cleavage pattern seen with camptothecin vs the indenoisoquinolines, which indicates that these two classes of topoisomerase I inhibitors are likely to target the cancer cell genome differently, resulting in different spectra of anticancer activity. The most cytotoxic of the presently synthesized indenoisoquinolines has a 4-amino-n-butyl group on the lactam nitrogen.', 'Title: Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase I inhibitors lacking substituents on the aromatic rings.  Abstract: The indenoisoquinolines are a class of cytotoxic topoisomerase I inhibitors that offer certain advantages over the camptothecins, including the greater stabilities of the compounds themselves, as well as the greater stabilities of their drug-enzyme-DNA cleavage complexes. To investigate the possible biological roles of the di(methoxy) and methylenedioxy substituents present on the aromatic rings of the previously synthesized indenoisoquinoline topoisomerase I inhibitors, a series of compounds lacking these substituents was synthesized and tested for both cytotoxicity in cancer cell cultures and for enzyme inhibitory activity. The results indicate that the aromatic substituents make a small, but consistently observable contribution to the biological activity. Molecular models derived for the binding of the unsubstituted indenoisoquinolines in ternary complex with DNA and topoisomerase I indicate that the substituents on the lactam nitrogen project out of the major groove, and the carbonyl group is directed out of the minor groove, where it is involved in a hydrogen bonding interaction with the side chain guanidine group of Arg364. The DNA cleavage patterns observed in the presence of topoisomerase I and various indenoisoquinolines were similar, although significant differences were detected. There were also variations in the DNA cleavage pattern seen with camptothecin vs the indenoisoquinolines, which indicates that these two classes of topoisomerase I inhibitors are likely to target the cancer cell genome differently, resulting in different spectra of anticancer activity. The most cytotoxic of the presently synthesized indenoisoquinolines has a 4-amino-n-butyl group on the lactam nitrogen.', 'Title: Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase I inhibitors lacking substituents on the aromatic rings.  Abstract: The indenoisoquinolines are a class of cytotoxic topoisomerase I inhibitors that offer certain advantages over the camptothecins, including the greater stabilities of the compounds themselves, as well as the greater stabilities of their drug-enzyme-DNA cleavage complexes. To investigate the possible biological roles of the di(methoxy) and methylenedioxy substituents present on the aromatic rings of the previously synthesized indenoisoquinoline topoisomerase I inhibitors, a series of compounds lacking these substituents was synthesized and tested for both cytotoxicity in cancer cell cultures and for enzyme inhibitory activity. The results indicate that the aromatic substituents make a small, but consistently observable contribution to the biological activity. Molecular models derived for the binding of the unsubstituted indenoisoquinolines in ternary complex with DNA and topoisomerase I indicate that the substituents on the lactam nitrogen project out of the major groove, and the carbonyl group is directed out of the minor groove, where it is involved in a hydrogen bonding interaction with the side chain guanidine group of Arg364. The DNA cleavage patterns observed in the presence of topoisomerase I and various indenoisoquinolines were similar, although significant differences were detected. There were also variations in the DNA cleavage pattern seen with camptothecin vs the indenoisoquinolines, which indicates that these two classes of topoisomerase I inhibitors are likely to target the cancer cell genome differently, resulting in different spectra of anticancer activity. The most cytotoxic of the presently synthesized indenoisoquinolines has a 4-amino-n-butyl group on the lactam nitrogen.', 'Title: Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase I inhibitors lacking substituents on the aromatic rings.  Abstract: The indenoisoquinolines are a class of cytotoxic topoisomerase I inhibitors that offer certain advantages over the camptothecins, including the greater stabilities of the compounds themselves, as well as the greater stabilities of their drug-enzyme-DNA cleavage complexes. To investigate the possible biological roles of the di(methoxy) and methylenedioxy substituents present on the aromatic rings of the previously synthesized indenoisoquinoline topoisomerase I inhibitors, a series of compounds lacking these substituents was synthesized and tested for both cytotoxicity in cancer cell cultures and for enzyme inhibitory activity. The results indicate that the aromatic substituents make a small, but consistently observable contribution to the biological activity. Molecular models derived for the binding of the unsubstituted indenoisoquinolines in ternary complex with DNA and topoisomerase I indicate that the substituents on the lactam nitrogen project out of the major groove, and the carbonyl group is directed out of the minor groove, where it is involved in a hydrogen bonding interaction with the side chain guanidine group of Arg364. The DNA cleavage patterns observed in the presence of topoisomerase I and various indenoisoquinolines were similar, although significant differences were detected. There were also variations in the DNA cleavage pattern seen with camptothecin vs the indenoisoquinolines, which indicates that these two classes of topoisomerase I inhibitors are likely to target the cancer cell genome differently, resulting in different spectra of anticancer activity. The most cytotoxic of the presently synthesized indenoisoquinolines has a 4-amino-n-butyl group on the lactam nitrogen.', 'Title: Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase I inhibitors lacking substituents on the aromatic rings.  Abstract: The indenoisoquinolines are a class of cytotoxic topoisomerase I inhibitors that offer certain advantages over the camptothecins, including the greater stabilities of the compounds themselves, as well as the greater stabilities of their drug-enzyme-DNA cleavage complexes. To investigate the possible biological roles of the di(methoxy) and methylenedioxy substituents present on the aromatic rings of the previously synthesized indenoisoquinoline topoisomerase I inhibitors, a series of compounds lacking these substituents was synthesized and tested for both cytotoxicity in cancer cell cultures and for enzyme inhibitory activity. The results indicate that the aromatic substituents make a small, but consistently observable contribution to the biological activity. Molecular models derived for the binding of the unsubstituted indenoisoquinolines in ternary complex with DNA and topoisomerase I indicate that the substituents on the lactam nitrogen project out of the major groove, and the carbonyl group is directed out of the minor groove, where it is involved in a hydrogen bonding interaction with the side chain guanidine group of Arg364. The DNA cleavage patterns observed in the presence of topoisomerase I and various indenoisoquinolines were similar, although significant differences were detected. There were also variations in the DNA cleavage pattern seen with camptothecin vs the indenoisoquinolines, which indicates that these two classes of topoisomerase I inhibitors are likely to target the cancer cell genome differently, resulting in different spectra of anticancer activity. The most cytotoxic of the presently synthesized indenoisoquinolines has a 4-amino-n-butyl group on the lactam nitrogen.', 'Title: Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase I inhibitors lacking substituents on the aromatic rings.  Abstract: The indenoisoquinolines are a class of cytotoxic topoisomerase I inhibitors that offer certain advantages over the camptothecins, including the greater stabilities of the compounds themselves, as well as the greater stabilities of their drug-enzyme-DNA cleavage complexes. To investigate the possible biological roles of the di(methoxy) and methylenedioxy substituents present on the aromatic rings of the previously synthesized indenoisoquinoline topoisomerase I inhibitors, a series of compounds lacking these substituents was synthesized and tested for both cytotoxicity in cancer cell cultures and for enzyme inhibitory activity. The results indicate that the aromatic substituents make a small, but consistently observable contribution to the biological activity. Molecular models derived for the binding of the unsubstituted indenoisoquinolines in ternary complex with DNA and topoisomerase I indicate that the substituents on the lactam nitrogen project out of the major groove, and the carbonyl group is directed out of the minor groove, where it is involved in a hydrogen bonding interaction with the side chain guanidine group of Arg364. The DNA cleavage patterns observed in the presence of topoisomerase I and various indenoisoquinolines were similar, although significant differences were detected. There were also variations in the DNA cleavage pattern seen with camptothecin vs the indenoisoquinolines, which indicates that these two classes of topoisomerase I inhibitors are likely to target the cancer cell genome differently, resulting in different spectra of anticancer activity. The most cytotoxic of the presently synthesized indenoisoquinolines has a 4-amino-n-butyl group on the lactam nitrogen.', 'Title: 5-(2-aminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: variation of n-alkyl substituents modulates sensitivity to efflux transporters associated with multidrug resistance.  Abstract: 5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)-2,3-methylenedioxydibenzo[c,h][1,6]naphthyridin-6-one (ARC-111) has potent TOP1-targeting activity and pronounced antitumor activity. Several analogues of ARC-111 were synthesized with NH2, N-alkyl, N,N-dialkyl, pyrrolidinyl, piperidinyl, and piperazinyl substituents at the 2-position of the 5-ethyl group. The relative TOP1-targeting activity and cytotoxicity of these structural analogues were assessed in RPMI8402 and P388 tumor cells and their camptothecin-resistant variants CPT-K5 and P388/CPT45, respectively. Potent TOP1-targeting activity was retained within a series of mono N-alkyl analogues that included NHCH2CH3, NHCH(CH3)2, and NHC(CH3)3. TOP1-targeting activity was diminished by the presence of a N-benzyl moiety. In a comparison of a series of N-alkyl-N-isopropyl analogues, activity decreased in the order CH3 > CH2CH3 > CH(CH3)2. Cytotoxicity in RPMI8402 and P388 did correlate with TOP1-targeting activity. Cytotoxic activity was also determined in KB3-1 cells and its variants KB/V-1 and KBH5.0. As KB/V-1 cells overexpress MDR1 and KBH5.0 cells overexpress BCRP, decreased cytotoxicity in these cell lines relative to the parent cell line is indicative of compounds that are substrates for these efflux transporters. In view of their diminished cytotoxicity in KB/V-1 cells, it appears that the likely demethylated metabolites of ARC-111, i.e., where NH2 or NHCH3 replaces the N(CH3)2 at the 2-position of the 5-ethyl substituent, are substrates for MDR1. In contrast, no significant difference in cytotoxicity among these three cell lines was observed with other N-alkyl analogues, including NHC2H5, NHCH(CH3)2, NHC(CH3)3, N(CH3)2, N(CH2CH3)2, NCH3(CH(CH3)2), and either the pyrrolidinyl or the piperidinyl analogues. The 2-(piperazinyl) analogues were associated with diminished cytotoxicity in KB/V-1 cells, suggesting that the second basic amino substituent is associated with their recognition as substrates by MDR1. Comparative studies on the antitumor activity of ARC-111 and its N-demethylated derivatives (the NHCH3 and NH2 analogues) against SJ-BT45 medulloblastoma xenografts in scid mice revealed that the secondary amine metabolite is at least as active as ARC-111 in vivo, although the primary amine derivative was significantly less potent.', 'Title: 5-(2-aminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: variation of n-alkyl substituents modulates sensitivity to efflux transporters associated with multidrug resistance.  Abstract: 5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)-2,3-methylenedioxydibenzo[c,h][1,6]naphthyridin-6-one (ARC-111) has potent TOP1-targeting activity and pronounced antitumor activity. Several analogues of ARC-111 were synthesized with NH2, N-alkyl, N,N-dialkyl, pyrrolidinyl, piperidinyl, and piperazinyl substituents at the 2-position of the 5-ethyl group. The relative TOP1-targeting activity and cytotoxicity of these structural analogues were assessed in RPMI8402 and P388 tumor cells and their camptothecin-resistant variants CPT-K5 and P388/CPT45, respectively. Potent TOP1-targeting activity was retained within a series of mono N-alkyl analogues that included NHCH2CH3, NHCH(CH3)2, and NHC(CH3)3. TOP1-targeting activity was diminished by the presence of a N-benzyl moiety. In a comparison of a series of N-alkyl-N-isopropyl analogues, activity decreased in the order CH3 > CH2CH3 > CH(CH3)2. Cytotoxicity in RPMI8402 and P388 did correlate with TOP1-targeting activity. Cytotoxic activity was also determined in KB3-1 cells and its variants KB/V-1 and KBH5.0. As KB/V-1 cells overexpress MDR1 and KBH5.0 cells overexpress BCRP, decreased cytotoxicity in these cell lines relative to the parent cell line is indicative of compounds that are substrates for these efflux transporters. In view of their diminished cytotoxicity in KB/V-1 cells, it appears that the likely demethylated metabolites of ARC-111, i.e., where NH2 or NHCH3 replaces the N(CH3)2 at the 2-position of the 5-ethyl substituent, are substrates for MDR1. In contrast, no significant difference in cytotoxicity among these three cell lines was observed with other N-alkyl analogues, including NHC2H5, NHCH(CH3)2, NHC(CH3)3, N(CH3)2, N(CH2CH3)2, NCH3(CH(CH3)2), and either the pyrrolidinyl or the piperidinyl analogues. The 2-(piperazinyl) analogues were associated with diminished cytotoxicity in KB/V-1 cells, suggesting that the second basic amino substituent is associated with their recognition as substrates by MDR1. Comparative studies on the antitumor activity of ARC-111 and its N-demethylated derivatives (the NHCH3 and NH2 analogues) against SJ-BT45 medulloblastoma xenografts in scid mice revealed that the secondary amine metabolite is at least as active as ARC-111 in vivo, although the primary amine derivative was significantly less potent.', 'Title: Dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines.  Abstract: Dihydroindenoisoquinolines are analogs of cytotoxic indenoisoquinoline topoisomerase I (Top1) inhibitors, exhibiting potent cytotoxicity but weak inhibitory activity toward Top1. Through COMPARE analysis, cytotoxicity studies in Top1-deficient cells, chemical synthesis and biological evaluation of methylated dihydroindenoisoquinoline 5, we demonstrated that dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines in cancer cells.', 'Title: Dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines.  Abstract: Dihydroindenoisoquinolines are analogs of cytotoxic indenoisoquinoline topoisomerase I (Top1) inhibitors, exhibiting potent cytotoxicity but weak inhibitory activity toward Top1. Through COMPARE analysis, cytotoxicity studies in Top1-deficient cells, chemical synthesis and biological evaluation of methylated dihydroindenoisoquinoline 5, we demonstrated that dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines in cancer cells.', 'Title: Dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines.  Abstract: Dihydroindenoisoquinolines are analogs of cytotoxic indenoisoquinoline topoisomerase I (Top1) inhibitors, exhibiting potent cytotoxicity but weak inhibitory activity toward Top1. Through COMPARE analysis, cytotoxicity studies in Top1-deficient cells, chemical synthesis and biological evaluation of methylated dihydroindenoisoquinoline 5, we demonstrated that dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines in cancer cells.', 'Title: Dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines.  Abstract: Dihydroindenoisoquinolines are analogs of cytotoxic indenoisoquinoline topoisomerase I (Top1) inhibitors, exhibiting potent cytotoxicity but weak inhibitory activity toward Top1. Through COMPARE analysis, cytotoxicity studies in Top1-deficient cells, chemical synthesis and biological evaluation of methylated dihydroindenoisoquinoline 5, we demonstrated that dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines in cancer cells.', 'Title: Dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines.  Abstract: Dihydroindenoisoquinolines are analogs of cytotoxic indenoisoquinoline topoisomerase I (Top1) inhibitors, exhibiting potent cytotoxicity but weak inhibitory activity toward Top1. Through COMPARE analysis, cytotoxicity studies in Top1-deficient cells, chemical synthesis and biological evaluation of methylated dihydroindenoisoquinoline 5, we demonstrated that dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines in cancer cells.', 'Title: Dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines.  Abstract: Dihydroindenoisoquinolines are analogs of cytotoxic indenoisoquinoline topoisomerase I (Top1) inhibitors, exhibiting potent cytotoxicity but weak inhibitory activity toward Top1. Through COMPARE analysis, cytotoxicity studies in Top1-deficient cells, chemical synthesis and biological evaluation of methylated dihydroindenoisoquinoline 5, we demonstrated that dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines in cancer cells.', 'Title: A new synthesis of isoaurones: cytotoxic activity of compounds related to the alleged structure of isoaurostatin.  Abstract: A new synthesis of isoaurones related to the alleged structure of isoaurostatin, via Heck intramolecular cyclization of cinnamic esters of 2-iodophenols, is reported. The cytotoxic activity of these isoaurones is lower than that of the structurally very similar 4-arylcoumarins.', 'Title: Total and semisynthesis and in vitro studies of both enantiomers of 20-fluorocamptothecin.  Abstract: Both enantiomers of 20-fluorocamptothecin and the racemate have been prepared by total synthesis. The (R)-enantiomer is essentially inactive in a topoisomerase-I/DNA assay, while the (S)-enantiomer is much less active than (20S)-camptothecin. The lactone ring of 20-fluorocamptothecin hydrolyzes more rapidly than that of camptothecin in PBS. The results provide insight into the role of the 20-hydroxy group in the binding of camptothecin to topoisomerase-I and DNA.', 'Title: Aza-analogues of the marine pyrroloquinoline alkaloids wakayin and tsitsikammamines: synthesis and topoisomerase inhibition.  Abstract: Two aza-analogues of the marine pyrroloquinoline alkaloids wakayin and tsitsikammamines A and B have been synthesized. The strategy used was based on a 1,3-dipolar cycloaddition reaction between indole 4,7-dione and a diazo-aminopropane derivative. One of the two analogues partially inhibits human topoisomerase I, whereas synthetic intermediates inhibit the enzyme DNA cleavage activity at a concentration comparable to that of the control drug camptothecin.', 'Title: Synthesis and antitumor characterization of pyrazolic analogues of the marine pyrroloquinoline alkaloids: wakayin and tsitsikammamines.  Abstract: A series of aza analogues of the marine alkaloids wakayin and tsitsikammamines A and B have been synthesized. The strategy used was based on [3 + 2] cycloaddition reactions involving 3-ethylamine-indole-4,7-dione and different diazo reagents. All the compounds were evaluated in vitro for antiproliferative activity against five distinct cancer cell lines and for their inhibitory effect on topoisomerase isoenzymes I and II. Some of the compounds inhibited the topoisomerase I and/or II catalyzed relaxation of supercoiled DNA at a concentration comparable to the drugs camptothecin and etoposide. Only a few of them exhibited cytotoxic activity with IC50 values in the micromolar range.', 'Title: CA224, a non-planar analogue of fascaplysin, inhibits Cdk4 but not Cdk2 and arrests cells at G0/G1 inhibiting pRB phosphorylation.  Abstract: Tryptamine derivatives, non-planar and potentially less toxic analogues of the anti-cancer agent fascaplysin, have been synthesised. They specifically inhibit Cdk4-D1 vis a vis Cdk2-A but, unlike fascaplysin, do not bind or intercalate DNA. CA224 is the most potent compound identified (Cdk4-D1 IC(50) approximately 5.5 microM). As would be expected of a Cdk4 inhibitor that does not inhibit Cdk2, it maintains a G(0)/G(1) block in synchronised cancer cells and inhibits Cdk4-specific phosphorylation of the retinoblastoma protein.', 'Title: CA224, a non-planar analogue of fascaplysin, inhibits Cdk4 but not Cdk2 and arrests cells at G0/G1 inhibiting pRB phosphorylation.  Abstract: Tryptamine derivatives, non-planar and potentially less toxic analogues of the anti-cancer agent fascaplysin, have been synthesised. They specifically inhibit Cdk4-D1 vis a vis Cdk2-A but, unlike fascaplysin, do not bind or intercalate DNA. CA224 is the most potent compound identified (Cdk4-D1 IC(50) approximately 5.5 microM). As would be expected of a Cdk4 inhibitor that does not inhibit Cdk2, it maintains a G(0)/G(1) block in synchronised cancer cells and inhibits Cdk4-specific phosphorylation of the retinoblastoma protein.', 'Title: CA224, a non-planar analogue of fascaplysin, inhibits Cdk4 but not Cdk2 and arrests cells at G0/G1 inhibiting pRB phosphorylation.  Abstract: Tryptamine derivatives, non-planar and potentially less toxic analogues of the anti-cancer agent fascaplysin, have been synthesised. They specifically inhibit Cdk4-D1 vis a vis Cdk2-A but, unlike fascaplysin, do not bind or intercalate DNA. CA224 is the most potent compound identified (Cdk4-D1 IC(50) approximately 5.5 microM). As would be expected of a Cdk4 inhibitor that does not inhibit Cdk2, it maintains a G(0)/G(1) block in synchronised cancer cells and inhibits Cdk4-specific phosphorylation of the retinoblastoma protein.', 'Title: Antitumor agents. 5. synthesis, structure-activity relationships, and biological evaluation of dimethyl-5H-pyridophenoxazin-5-ones, tetrahydro-5h-benzopyridophenoxazin-5-ones, and 5h-benzopyridophenoxazin-5-ones with potent antiproliferative activity.  Abstract: New antiproliferative compounds, dimethyl-5H-pyrido[3,2-a]phenoxazin-5-ones (1-6), tetrahydro-5H-benzopyrido[2,3-j]phenoxazin-5-ones (7-9), and 5H-benzopyrido[3,2-a]phenoxazin-5-ones (10-12) were synthesized and evaluated against representative human neoplastic cell lines. Dimethyl derivatives 1-6 were more active against carcinoma than leukemia cell lines. The tetrahydrobenzo derivatives 7-9 were scarcely active, whereas the corresponding benzo derivatives 10-12 showed notable cytotoxicity against a majority of the tested cell lines. Molecular modeling studies indicated that the high potency of 10 and 11, the most cytotoxic compounds of the whole series, could be due to the position of the condensed benzene ring, which favors pi-pi stacking interactions with purine and pyrimidine bases in the DNA active site. Biological studies suggested that 10-12 have no effect on human topoisomerases I and II and that they induce arrest at the G2/M phase.', 'Title: Antitumor agents. 5. synthesis, structure-activity relationships, and biological evaluation of dimethyl-5H-pyridophenoxazin-5-ones, tetrahydro-5h-benzopyridophenoxazin-5-ones, and 5h-benzopyridophenoxazin-5-ones with potent antiproliferative activity.  Abstract: New antiproliferative compounds, dimethyl-5H-pyrido[3,2-a]phenoxazin-5-ones (1-6), tetrahydro-5H-benzopyrido[2,3-j]phenoxazin-5-ones (7-9), and 5H-benzopyrido[3,2-a]phenoxazin-5-ones (10-12) were synthesized and evaluated against representative human neoplastic cell lines. Dimethyl derivatives 1-6 were more active against carcinoma than leukemia cell lines. The tetrahydrobenzo derivatives 7-9 were scarcely active, whereas the corresponding benzo derivatives 10-12 showed notable cytotoxicity against a majority of the tested cell lines. Molecular modeling studies indicated that the high potency of 10 and 11, the most cytotoxic compounds of the whole series, could be due to the position of the condensed benzene ring, which favors pi-pi stacking interactions with purine and pyrimidine bases in the DNA active site. Biological studies suggested that 10-12 have no effect on human topoisomerases I and II and that they induce arrest at the G2/M phase.', \"Title: Synthesis and biological evaluation of bisindenoisoquinolines as topoisomerase I inhibitors.  Abstract: The indenoisoquinolines represent a class of non-camptothecin topoisomerase I (Top1) inhibitors that exert cytotoxicity by trapping the covalent complex formed between DNA and Top1 during relaxation of DNA supercoils. As an ongoing evaluation of Top1 inhibition and anticancer activity, indenoisoquinolines were linked via their lactam side chains to provide polyamines end-capped with intercalating motifs. The resulting bisindenoisoquinolines were evaluated for cytotoxicity in the National Cancer Institute's human cancer cell screen and for Top1 inhibition. Preliminary findings suggested that the 2-3-2 and 3-3-3 linkers, referring to the number of carbons between nitrogen atoms, were optimal for both potent Top1 inhibition and cytotoxicity. Using optimized linkers, bisindenoisoquinolines were synthesized with nitro and methoxy substituents on the aromatic rings. The biological results for substituted compounds revealed a disagreement between the structure-activity relationships of monomeric indenoisoquinolines and bisindenoisoquinolines as Top1 inhibitors, but cytotoxicity was maintained for both series of compounds.\", 'Title: Synthesis and cytotoxic activity of polyamine analogues of camptothecin.  Abstract: A number of derivatives of camptothecin with a polyamine chain linked to position 7 of camptothecin via an amino, imino, or oxyiminomethyl group were synthesized and tested for their biological activity. All compounds showed marked growth inhibitory activity against the H460 human lung carcinoma cell line. In particular, the iminomethyl derivatives where the amino groups of the chain were protected with Boc groups exhibited a high potency, with IC50 values of approximately 10(-8) M. The pattern of DNA cleavage in vitro and the persistence of the cleavable ternary complex drug-DNA-topoisomerase I observed with polyamine conjugates containing free amino groups support a contribution of specific drug interaction with DNA as a determinant of activity. Modeling of compound 7c in the complex with topoisomerase 1 and DNA is consistent with this hypothesis. The lack of a specific correlation between stabilization of the cleavable complex and growth inhibition likely reflects multiple factors including the cellular pharmacokinetic behavior related to the variable lipophilicity of the conjugate, and the nature and linkage of the polyamine moiety.', 'Title: Synthesis of 6-chloroisoquinoline-5,8-diones and pyrido[3,4-b]phenazine-5,12-diones and evaluation of their cytotoxicity and DNA topoisomerase II inhibitory activity.  Abstract: The substituted chloroisoquinolinediones and pyrido[3,4-b]phenazinediones were synthesized, and the cytotoxic activity and topoisomerase II inhibitory activity of the prepared compounds were evaluated. Chloroisoquinolinediones have been prepared by the reported method employing 6,7-dichloroisoquinoline-5,8-dione. The cyclization to pyrido[3,4-b]phenazinediones was achieved by adding the aqueous sodium azide solution to the dimethylformamide solution of corresponding chloroisoquinoline-5,8-dione. The cytotoxicity of the synthesized compounds was evaluated by a SRB (Sulforhodamine B) assay against various cancer cell lines such as A549 (human lung cancer cell line), SNU-638 (human stomach cancer cell), Col2 (human colon cancer cell line), HT1080 (human fibrosarcoma cell line), and HL-60 (human leukemia cell line). Almost all the synthesized pyrido[3,4-b]phenazinediones showed greater cytotoxic potential than ellipticine (IC(50)=1.82-5.97 microM). In general, the cytotoxicity of the pyrido[3,4-b]phenazinediones was higher than that of the corresponding chloroisoquinolinediones. The caco-2 cell permeability of selected compounds was 0.62 x 10(-6)-35.3 x 10(-6)cm/s. The difference in cytotoxic activity among tested compounds was correlated with the difference in permeability to some degree. To further investigate the cytotoxic mechanism, the topoisomerase II inhibitory activity of the synthesized compounds was estimated by a plasmid cleavage assay. Most of compounds showed the topoisomerase II inhibitory activity (28-100%) at 200 microM. IC(50) values for the most active compound 6a were 0.082 microM. However, the compounds were inactive for DNA relaxation by topoisomerase I at 200 microM.', 'Title: Synthesis of 6-chloroisoquinoline-5,8-diones and pyrido[3,4-b]phenazine-5,12-diones and evaluation of their cytotoxicity and DNA topoisomerase II inhibitory activity.  Abstract: The substituted chloroisoquinolinediones and pyrido[3,4-b]phenazinediones were synthesized, and the cytotoxic activity and topoisomerase II inhibitory activity of the prepared compounds were evaluated. Chloroisoquinolinediones have been prepared by the reported method employing 6,7-dichloroisoquinoline-5,8-dione. The cyclization to pyrido[3,4-b]phenazinediones was achieved by adding the aqueous sodium azide solution to the dimethylformamide solution of corresponding chloroisoquinoline-5,8-dione. The cytotoxicity of the synthesized compounds was evaluated by a SRB (Sulforhodamine B) assay against various cancer cell lines such as A549 (human lung cancer cell line), SNU-638 (human stomach cancer cell), Col2 (human colon cancer cell line), HT1080 (human fibrosarcoma cell line), and HL-60 (human leukemia cell line). Almost all the synthesized pyrido[3,4-b]phenazinediones showed greater cytotoxic potential than ellipticine (IC(50)=1.82-5.97 microM). In general, the cytotoxicity of the pyrido[3,4-b]phenazinediones was higher than that of the corresponding chloroisoquinolinediones. The caco-2 cell permeability of selected compounds was 0.62 x 10(-6)-35.3 x 10(-6)cm/s. The difference in cytotoxic activity among tested compounds was correlated with the difference in permeability to some degree. To further investigate the cytotoxic mechanism, the topoisomerase II inhibitory activity of the synthesized compounds was estimated by a plasmid cleavage assay. Most of compounds showed the topoisomerase II inhibitory activity (28-100%) at 200 microM. IC(50) values for the most active compound 6a were 0.082 microM. However, the compounds were inactive for DNA relaxation by topoisomerase I at 200 microM.', 'Title: Investigation of the lactam side chain length necessary for optimal indenoisoquinoline topoisomerase I inhibition and cytotoxicity in human cancer cell cultures.  Abstract: Indenoisoquinolines with lactam substituents such as ethylamino, propylamino, and butylamino have previously demonstrated potent biological activity, but an optimal length has never been established. In the present study, a series of simplified indenoisoquinoline analogues possessing a linker spacing of 0-12 carbon atoms between the lactam nitrogen and the terminal amino group have been prepared, determining that 2-4-atom lengths are optimal for topoisomerase I inhibition and cytotoxicity. Using these lengths, analogues were prepared with the amino group and portions of the linker replaced by a pyridine ring. A three-carbon spacer within the pyridine series still demonstrated potent topoisomerase I inhibition.', 'Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.', 'Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.', 'Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.', 'Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.', 'Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.', 'Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.', 'Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.', 'Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.', 'Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.', 'Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.', 'Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.', 'Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.', 'Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.', 'Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.', 'Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.', 'Title: Cells lacking DNA topoisomerase II beta are resistant to genistein.  Abstract: Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.', 'Title: Naphthoindole-based analogues of tryptophan and tryptamine: synthesis and cytotoxic properties.  Abstract: The efficacy of anthracycline based anticancer drugs is limited by pleiotropic drug resistance of tumor cells. Aiming at the design of anthracyclinone congeners capable of circumventing drug resistance, we synthesized naphthoindole containing derivatives of tryptophan and tryptamine. In doing so we adapted the traditional, gramine based approach for tryptophan and tryptamine synthesis. The most potent new compound, 3-(2-aminoethyl)-4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione (16), was equally cytotoxic (IC(50) within low micromolar concentrations) for human K562 leukemia and HCT116 colon carcinoma cell lines and their isogenic sublines with genetically defined determinants of altered drug response, that is, the expression of the multidrug transporter P-glycoprotein and loss of pro-apoptotic p53. Each of these mechanisms conferred resistance to the reference drug adriamycin. In contrast, naphthotryptamine 16, although less potent than adriamycin, was equally toxic for wild type cell lines and drug resistant counterparts. Moreover, at 3-5 microM 16 inhibited topoisomerase I in vitro. Thus, our novel naphthoindole based derivative of tryptamine gained new activities important for anticancer therapy, namely, suppression of topoisomerase I and the ability to overcome resistance mediated by P-glycoprotein expression and p53 dysfunction.', 'Title: Naphthoindole-based analogues of tryptophan and tryptamine: synthesis and cytotoxic properties.  Abstract: The efficacy of anthracycline based anticancer drugs is limited by pleiotropic drug resistance of tumor cells. Aiming at the design of anthracyclinone congeners capable of circumventing drug resistance, we synthesized naphthoindole containing derivatives of tryptophan and tryptamine. In doing so we adapted the traditional, gramine based approach for tryptophan and tryptamine synthesis. The most potent new compound, 3-(2-aminoethyl)-4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione (16), was equally cytotoxic (IC(50) within low micromolar concentrations) for human K562 leukemia and HCT116 colon carcinoma cell lines and their isogenic sublines with genetically defined determinants of altered drug response, that is, the expression of the multidrug transporter P-glycoprotein and loss of pro-apoptotic p53. Each of these mechanisms conferred resistance to the reference drug adriamycin. In contrast, naphthotryptamine 16, although less potent than adriamycin, was equally toxic for wild type cell lines and drug resistant counterparts. Moreover, at 3-5 microM 16 inhibited topoisomerase I in vitro. Thus, our novel naphthoindole based derivative of tryptamine gained new activities important for anticancer therapy, namely, suppression of topoisomerase I and the ability to overcome resistance mediated by P-glycoprotein expression and p53 dysfunction.', 'Title: Naphthoindole-based analogues of tryptophan and tryptamine: synthesis and cytotoxic properties.  Abstract: The efficacy of anthracycline based anticancer drugs is limited by pleiotropic drug resistance of tumor cells. Aiming at the design of anthracyclinone congeners capable of circumventing drug resistance, we synthesized naphthoindole containing derivatives of tryptophan and tryptamine. In doing so we adapted the traditional, gramine based approach for tryptophan and tryptamine synthesis. The most potent new compound, 3-(2-aminoethyl)-4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione (16), was equally cytotoxic (IC(50) within low micromolar concentrations) for human K562 leukemia and HCT116 colon carcinoma cell lines and their isogenic sublines with genetically defined determinants of altered drug response, that is, the expression of the multidrug transporter P-glycoprotein and loss of pro-apoptotic p53. Each of these mechanisms conferred resistance to the reference drug adriamycin. In contrast, naphthotryptamine 16, although less potent than adriamycin, was equally toxic for wild type cell lines and drug resistant counterparts. Moreover, at 3-5 microM 16 inhibited topoisomerase I in vitro. Thus, our novel naphthoindole based derivative of tryptamine gained new activities important for anticancer therapy, namely, suppression of topoisomerase I and the ability to overcome resistance mediated by P-glycoprotein expression and p53 dysfunction.', 'Title: Naphthoindole-based analogues of tryptophan and tryptamine: synthesis and cytotoxic properties.  Abstract: The efficacy of anthracycline based anticancer drugs is limited by pleiotropic drug resistance of tumor cells. Aiming at the design of anthracyclinone congeners capable of circumventing drug resistance, we synthesized naphthoindole containing derivatives of tryptophan and tryptamine. In doing so we adapted the traditional, gramine based approach for tryptophan and tryptamine synthesis. The most potent new compound, 3-(2-aminoethyl)-4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione (16), was equally cytotoxic (IC(50) within low micromolar concentrations) for human K562 leukemia and HCT116 colon carcinoma cell lines and their isogenic sublines with genetically defined determinants of altered drug response, that is, the expression of the multidrug transporter P-glycoprotein and loss of pro-apoptotic p53. Each of these mechanisms conferred resistance to the reference drug adriamycin. In contrast, naphthotryptamine 16, although less potent than adriamycin, was equally toxic for wild type cell lines and drug resistant counterparts. Moreover, at 3-5 microM 16 inhibited topoisomerase I in vitro. Thus, our novel naphthoindole based derivative of tryptamine gained new activities important for anticancer therapy, namely, suppression of topoisomerase I and the ability to overcome resistance mediated by P-glycoprotein expression and p53 dysfunction.', 'Title: Binding mode and affinity studies of DNA-binding agents using topoisomerase I DNA unwinding assay.  Abstract: A topoisomerase I DNA unwinding assay has been used to determine the relative DNA-binding affinities of a model pair of homologous naphthalene diimides. Binding affinity data were corroborated using calorimetric (ITC) and spectrophotometric (titration and T(m)) studies, with substituent size playing a significant role in binding. The assay was also used to investigate the mode of binding adopted by several known DNA-binding agents, including SYBR Green and PicoGreen. Some of the compounds exhibited unexpected binding modes.', 'Title: Synthesis, cytotoxicity, and DNA topoisomerase II inhibitory activity of benzofuroquinolinediones.  Abstract: Benzofuroquinolinediones (7c and 7d) were synthesized by base-catalyzed condensation of dichloroquinolinediones with phenolic derivatives. Their dialkylaminoalkoxy derivatives (8i-8p) were prepared by reaction with various dialkylaminoalkyl chlorides. The cytotoxicity of the synthesized compounds was evaluated against eight types of human cancer cell lines, and their topoisomerase II inhibition was assessed. In general, the cytotoxicity of benzofuroquinolinediones (8i-8p) was similar or superior to that of doxorubicin and showed more potent inhibitory activity than naphthofurandiones (8a-8h). Also, most of the compounds exhibited excellent topoisomerase II inhibitory activity at a concentration of 5 microM and two compounds, 8d and 8i, showed IC50 values of 1.19 and 0.68 microM, respectively, and were much more potent than etoposide (IC50=78.4 microM), but similar to doxorubicin (IC50=2.67 microM). However their inhibitory activity on topoisomerase I was lower, and 8d and 8i showed IC50 values of 42.0 and 64.3 microM, respectively.', 'Title: Synthesis, cytotoxicity, and DNA topoisomerase II inhibitory activity of benzofuroquinolinediones.  Abstract: Benzofuroquinolinediones (7c and 7d) were synthesized by base-catalyzed condensation of dichloroquinolinediones with phenolic derivatives. Their dialkylaminoalkoxy derivatives (8i-8p) were prepared by reaction with various dialkylaminoalkyl chlorides. The cytotoxicity of the synthesized compounds was evaluated against eight types of human cancer cell lines, and their topoisomerase II inhibition was assessed. In general, the cytotoxicity of benzofuroquinolinediones (8i-8p) was similar or superior to that of doxorubicin and showed more potent inhibitory activity than naphthofurandiones (8a-8h). Also, most of the compounds exhibited excellent topoisomerase II inhibitory activity at a concentration of 5 microM and two compounds, 8d and 8i, showed IC50 values of 1.19 and 0.68 microM, respectively, and were much more potent than etoposide (IC50=78.4 microM), but similar to doxorubicin (IC50=2.67 microM). However their inhibitory activity on topoisomerase I was lower, and 8d and 8i showed IC50 values of 42.0 and 64.3 microM, respectively.', 'Title: Synthesis, cytotoxicity, and DNA topoisomerase II inhibitory activity of benzofuroquinolinediones.  Abstract: Benzofuroquinolinediones (7c and 7d) were synthesized by base-catalyzed condensation of dichloroquinolinediones with phenolic derivatives. Their dialkylaminoalkoxy derivatives (8i-8p) were prepared by reaction with various dialkylaminoalkyl chlorides. The cytotoxicity of the synthesized compounds was evaluated against eight types of human cancer cell lines, and their topoisomerase II inhibition was assessed. In general, the cytotoxicity of benzofuroquinolinediones (8i-8p) was similar or superior to that of doxorubicin and showed more potent inhibitory activity than naphthofurandiones (8a-8h). Also, most of the compounds exhibited excellent topoisomerase II inhibitory activity at a concentration of 5 microM and two compounds, 8d and 8i, showed IC50 values of 1.19 and 0.68 microM, respectively, and were much more potent than etoposide (IC50=78.4 microM), but similar to doxorubicin (IC50=2.67 microM). However their inhibitory activity on topoisomerase I was lower, and 8d and 8i showed IC50 values of 42.0 and 64.3 microM, respectively.', 'Title: Design, synthesis and biological evaluation of new oligopyrrole carboxamides linked with tricyclic DNA-intercalators as potential DNA ligands or topoisomerase inhibitors.  Abstract: In the context of the design and synthesis of minor groove binding and intercalating DNA ligands some new oligopyrrole carboxamides were synthesized. These hybrid molecules (combilexins) possess a variable and conformatively flexible spacer at the N-terminal end. As intercalating tricyclic systems acridone, acridine, anthraquinones and in a special case iminostilbene terminate the N-terminal end of the pyrrole chain. The cytotoxicity was examined by the NCI antitumor screening, furthermore, biophysical as well as biochemical studies were performed in order to get some information about the DNA binding properties and topoisomerase inhibition effect of this new series of molecules.', 'Title: 2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin- 5-yl}carbamoyl)acetamide (UNBS3157), a novel nonhematotoxic naphthalimide derivative with potent antitumor activity.  Abstract: Amonafide (1), a naphthalimide which binds to DNA by intercalation and poisons topoisomerase IIalpha, has demonstrated activity in phase II breast cancer trials, but has failed thus far to enter clinical phase III because of dose-limiting bone marrow toxicity. Compound 17 (one of 41 new compounds synthesized) is a novel anticancer naphthalimide with a distinct mechanism of action, notably inducing autophagy and senescence in cancer cells. Compound 17 (2,2,2-trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-5-yl}carbamoyl)acetamide (UNBS3157)) was found to have a 3-4-fold higher maximum tolerated dose compared to amonafide and not to provoke hematotoxicity in mice at doses that display significant antitumor effects. Furthermore, 17 has shown itself to be superior to amonafide in vivo in models of (i) L1210 murine leukemia, (ii) MXT-HI murine mammary adenocarcinoma, and (iii) orthotopic models of human A549 NSCLC and BxPC3 pancreatic cancer. Compound 17, therefore, merits further investigation as a potential anticancer agent.', 'Title: Design, docking, and synthesis of novel indeno[1,2-c]isoquinolines for the development of antitumor agents as topoisomerase I inhibitors.  Abstract: An intramolecular radical cyclization reaction of 4-bromo-3-arylisoquinolines 11a-c allowed the efficient synthesis of 11-methylindenoisoquinolines 2a-c. 5-(2-Aminoethylamino)indeno[1,2-c]isoquinolin-11-one 4 was also prepared in the convenient manner. The synthesized compounds were tested in vitro for cytotoxicity and DNA-topoisomerase 1 (top 1) inhibitory activity. The dramatic enhancement of top 1 inhibitory activity of 4 was explained by a docking study using the FlexX program.', 'Title: Design, docking, and synthesis of novel indeno[1,2-c]isoquinolines for the development of antitumor agents as topoisomerase I inhibitors.  Abstract: An intramolecular radical cyclization reaction of 4-bromo-3-arylisoquinolines 11a-c allowed the efficient synthesis of 11-methylindenoisoquinolines 2a-c. 5-(2-Aminoethylamino)indeno[1,2-c]isoquinolin-11-one 4 was also prepared in the convenient manner. The synthesized compounds were tested in vitro for cytotoxicity and DNA-topoisomerase 1 (top 1) inhibitory activity. The dramatic enhancement of top 1 inhibitory activity of 4 was explained by a docking study using the FlexX program.', 'Title: Synthesis and biological activities of isogranulatimide analogues.  Abstract: The synthesis of new isogranulatimide analogues, their inhibitory activities toward the Checkpoint 1 kinase (Chk1), and their in vitro cytotoxicities toward four tumor cell lines (one murine L1210 leukemia, and three human cell lines: DU145 prostate carcinoma, A549 non-small cell lung carcinoma, and HT29 colon carcinoma) are described. The affinity for DNA of some representative compounds and their ability to induce DNA cleavage mediated by topoisomerase I have been examined. In some of the newly synthesized compounds, the imidazole heterocycle of isogranulatimide is replaced by a pyrrole and/or the indole unit is replaced by a 7-azaindole. Compounds in which a sugar part is attached to the 7-azaindole moiety have also been prepared. Some of the newly synthesized compounds are more potent Chk1 inhibitors than granulatimide. The selectivity of two potent Chk1 inhibitors 24 and 26 has been evaluated using various kinases. The strongest inhibitory properties are found toward Chk1.', 'Title: Synthesis and biological activities of isogranulatimide analogues.  Abstract: The synthesis of new isogranulatimide analogues, their inhibitory activities toward the Checkpoint 1 kinase (Chk1), and their in vitro cytotoxicities toward four tumor cell lines (one murine L1210 leukemia, and three human cell lines: DU145 prostate carcinoma, A549 non-small cell lung carcinoma, and HT29 colon carcinoma) are described. The affinity for DNA of some representative compounds and their ability to induce DNA cleavage mediated by topoisomerase I have been examined. In some of the newly synthesized compounds, the imidazole heterocycle of isogranulatimide is replaced by a pyrrole and/or the indole unit is replaced by a 7-azaindole. Compounds in which a sugar part is attached to the 7-azaindole moiety have also been prepared. Some of the newly synthesized compounds are more potent Chk1 inhibitors than granulatimide. The selectivity of two potent Chk1 inhibitors 24 and 26 has been evaluated using various kinases. The strongest inhibitory properties are found toward Chk1.', 'Title: Convenient synthesis of indeno[1,2-c]isoquinolines as constrained forms of 3-arylisoquinolines and docking study of a topoisomerase I inhibitor into DNA-topoisomerase I complex.  Abstract: 11-hydroxyindeno[1,2-c]isoquinolines 12a-c were prepared as constrained forms of 3-arylisoquinolines through an intramolecular cyclization reaction. Among the synthesized compounds, the 11-(i)butoxy analog 15l displayed potent in vitro cytotoxicity against four different tumor cell lines as well as topoisomerase 1 inhibitory activity. A FlexX docking study was performed to explain the topoisomerase 1 activity of 15l.', 'Title: Curcumin induces high levels of topoisomerase I- and II-DNA complexes in K562 leukemia cells.  Abstract: Recent data suggest that curcumin, a phytochemical with cancer chemopreventive potential, might be useful in the treatment of several solid and hematological malignancies. DNA topoisomerases (topos) are the target of several drugs commonly used in cancer chemotherapy. These drugs induce topo-DNA complexes with either topo I or topo II; then cellular processing converts these complexes into permanent DNA strand breaks that trigger cell death. Using the TARDIS in vivo assay, this study shows for the first time that curcumin induces topo I and topo II (alpha and beta)-DNA complexes in K562 leukemia cells. A comparative analysis revealed that the levels of these complexes were higher than those induced by several standard topo I and topo II inhibitors at equitoxic doses. Curcumin-induced topo I and topo II-DNA complexes were prevented by the antioxidant N-acetylcysteine; this suggests that, unlike the standard topo inhibitors, reactive oxygen species may mediate the formation of these complexes. Overall, this work shows that curcumin is capable of inducing topo-DNA complexes in cells with both topo I and topo II and increases the evidence suggesting that this dietary agent has potential to be tested in cancer chemotherapy.', 'Title: Curcumin induces high levels of topoisomerase I- and II-DNA complexes in K562 leukemia cells.  Abstract: Recent data suggest that curcumin, a phytochemical with cancer chemopreventive potential, might be useful in the treatment of several solid and hematological malignancies. DNA topoisomerases (topos) are the target of several drugs commonly used in cancer chemotherapy. These drugs induce topo-DNA complexes with either topo I or topo II; then cellular processing converts these complexes into permanent DNA strand breaks that trigger cell death. Using the TARDIS in vivo assay, this study shows for the first time that curcumin induces topo I and topo II (alpha and beta)-DNA complexes in K562 leukemia cells. A comparative analysis revealed that the levels of these complexes were higher than those induced by several standard topo I and topo II inhibitors at equitoxic doses. Curcumin-induced topo I and topo II-DNA complexes were prevented by the antioxidant N-acetylcysteine; this suggests that, unlike the standard topo inhibitors, reactive oxygen species may mediate the formation of these complexes. Overall, this work shows that curcumin is capable of inducing topo-DNA complexes in cells with both topo I and topo II and increases the evidence suggesting that this dietary agent has potential to be tested in cancer chemotherapy.', 'Title: Synthesis and cytotoxic activity of a new series of topoisomerase I inhibitors.  Abstract: A series of structurally simple analogues of natural topopyrone C were synthesized and tested for cytotoxic and topoisomerase I inhibitory activities. The removal of the hydroxyl groups at the 5 and 9 positions resulted in an increased cytotoxic potency and ability to stabilize topoisomerase-mediated cleavage. In addition, the results suggest that some structural features, such as the pyrone ring and a polar group in position 11, are fundamental for topoisomerase I inhibitory effect. These structural requirements are also consistent with the cytotoxic activity.', 'Title: Synthesis and cytotoxic activity of a new series of topoisomerase I inhibitors.  Abstract: A series of structurally simple analogues of natural topopyrone C were synthesized and tested for cytotoxic and topoisomerase I inhibitory activities. The removal of the hydroxyl groups at the 5 and 9 positions resulted in an increased cytotoxic potency and ability to stabilize topoisomerase-mediated cleavage. In addition, the results suggest that some structural features, such as the pyrone ring and a polar group in position 11, are fundamental for topoisomerase I inhibitory effect. These structural requirements are also consistent with the cytotoxic activity.', 'Title: Synthesis and biological evaluation of bengacarboline derivatives.  Abstract: Novel derivatives of the marine alkaloid bengacarboline have been synthesized. The seco derivatives 11 and 12 were evaluated for topoisomerase inhibition, DNA damages, cytotoxicity and cell cycle perturbation. The two synthetic analogs are more potent cytotoxic agents than bengacarboline and they both induce an accumulation of cells in the S phase of DNA synthesis. They do not function as topoisomerase inhibitors but trigger DNA damages in cells.', 'Title: 1-deoxyrubralactone, a novel specific inhibitor of families X and Y of eukaryotic DNA polymerases from a fungal strain derived from sea algae.  Abstract: Talaroflavone (1) and 1-deoxyrubralactone (2) are natural compounds isolated from cultures of a fungal strain derived from sea algae, and their structures were determined by spectroscopic analyses. Compound 2 is a novel rubralactone derivative, 6-hydroxy-8-methoxy-1-methyl-1,2,3a,9b-tetrahydrocyclopenta[c]isochromene-3,5-dione. These compounds selectively inhibited the activities of families X and Y of eukaryotic DNA polymerases (pols), and compound 2 was a stronger inhibitor than compound 1. The IC(50) values of compound 2 on rat pol beta, which is a pol of family X, and human pol kappa, which is a pol of family Y, were 11.9 and 59.8 microM, respectively. On the other hand, compounds 1 and 2 did not influence the activities of the other families of eukaryotic pols, such as family A (i.e., pol gamma) and family B (i.e., pols alpha, delta, and epsilon), and showed no effect even on the activities of plant pols alpha and beta, prokaryotic pols, and other DNA metabolic enzymes, such as calf primase of pol alpha, human immunodeficiency virus type-1 (HIV-1) reverse transcriptase, human telomerase, T7 RNA polymerase, mouse IMP dehydrogenase (type II), human topoisomerase I and II, T4 polynucleotide kinase, and bovine deoxyribonuclease I. This is the first report about the selective inhibitors of families X and Y of eukaryotic pols.', \"Title: Isoindolo[2,1-a]quinoxaline derivatives, novel potent antitumor agents with dual inhibition of tubulin polymerization and topoisomerase I.  Abstract: Isoindoloquinoxalines 4 and 5 were obtained by refluxing 2-(2'-aminoaryl)-1-cyanoisoindoles 3a- e in acetic or formic acid. All derivatives were screened by the National Cancer Institute (Bethesda, MD) for the in vitro one dose primary anticancer assay against a 3-cell line panel. Compounds 4a- e, screened against a panel of about 60 human tumor cell lines, showed remarkable antineoplastic activity; they had GI 50 values in the low micromolar or submicromolar range and reached, in the case of 4c, nanomolar concentrations on 88% of the 59 tested cell lines. Flow cytometric analysis of cell cycle after treatment with 4c demonstrated an arrest of the cell cycle in G2/M phase. This effect was accompanied with apoptosis of the cells, mitochondrial depolarization, generation of reactive oxygen species, and activation of caspase-3 and caspase-9. Moreover, 4c induced a clear increase in the mitotic index, inhibited microtubule assembly in vitro, and interestingly also acted as a topoisomerase I inhibitor.\", \"Title: Isoindolo[2,1-a]quinoxaline derivatives, novel potent antitumor agents with dual inhibition of tubulin polymerization and topoisomerase I.  Abstract: Isoindoloquinoxalines 4 and 5 were obtained by refluxing 2-(2'-aminoaryl)-1-cyanoisoindoles 3a- e in acetic or formic acid. All derivatives were screened by the National Cancer Institute (Bethesda, MD) for the in vitro one dose primary anticancer assay against a 3-cell line panel. Compounds 4a- e, screened against a panel of about 60 human tumor cell lines, showed remarkable antineoplastic activity; they had GI 50 values in the low micromolar or submicromolar range and reached, in the case of 4c, nanomolar concentrations on 88% of the 59 tested cell lines. Flow cytometric analysis of cell cycle after treatment with 4c demonstrated an arrest of the cell cycle in G2/M phase. This effect was accompanied with apoptosis of the cells, mitochondrial depolarization, generation of reactive oxygen species, and activation of caspase-3 and caspase-9. Moreover, 4c induced a clear increase in the mitotic index, inhibited microtubule assembly in vitro, and interestingly also acted as a topoisomerase I inhibitor.\", 'Title: Facile formation of hydrophilic derivatives of 5H-8,9-dimethoxy-5-[2-(N,N-dimethylamino)ethyl]-2,3-methylenedioxydibenzo[c,h] [1,6]naphthyridin-6-one (ARC-111) and its 12-aza analog via quaternary ammonium intermediates.  Abstract: Several new TOP1-targeting agents were prepared using as intermediates the N,N,N-trimethyl quaternary ammonium salts of either ARC-111 or its 12-aza analog (ARC-31), 3 and 4, respectively. Direct displacement of the quaternary ammonium group with water, imidazole, alkylethylenediamines, or polyhydroxylated alkylamines provides a convenient means for furthering the structure-activity relationships associated with these non-camptothecin TOP1-targeting agents.', 'Title: E-ring-modified 7-oxyiminomethyl camptothecins: Synthesis and preliminary in vitro and in vivo biological evaluation.  Abstract: In contrast to five-membered E-ring analogues, 7-oxyiminomethyl derivatives of homocamptothecins showed ability to form stable ternary complexes with DNA and topoisomerase I. The 7-oxyiminomethyl derivatives of homocamptothecins were evaluated as a racemic mixture. Following the isolation of the two enantiomers, the 20 (R)-hydroxy isomer confirms the best activity. By using a panel of human tumor cells, all tested homocamptothecins showed a potent antiproliferative activity, correlating to the persistence of the cleavable complex. No significant difference was observed between the natural scaffold and the corresponding homocamptothecin homologue. A selected compound of this series exhibited an excellent antitumor activity against human gastrointestinal tumor xenografts.', 'Title: Cytotoxic pyrroloiminoquinones from four new species of South African latrunculid sponges.  Abstract: An examination of organic extracts of four new species of South African latrunculid sponges, Tsitsikamma pedunculata, T. favus, Latrunculia bellae, and Strongylodesma algoaensis, yielded 13 known and eight new pyrroloiminoquinone alkaloids, 3-dihydro-7,8-dehydrodiscorhabdin C (4), 14-bromo-3-dihydro-7,8-dehydrodiscorhabdin C (5), discorhabdin V (6), 14-bromo-1-hydroxydiscorhabdin V (7), tsitsikammamine A N-18 oxime (10), tsitsikammamine B N-18 oxime (11), 1-methoxydiscorhabdin D (12), and 1-aminodiscorhabdin D (13). Standard spectroscopic methods provided the structures of the pyrroloiminoquinone metabolites, while chiral GC-MS analysis of the acylated ozonolysis products of 21 confirmed the stereochemistry of the l-histidine residue in this compound. The anticancer activity of 20 pyrroloiminoquinone compounds was explored in the HCT-116 cancer cell line screen, and the DNA intercalation of the tsitsikammamines, together with their ability to cleave DNA through topoisomerase I inhibition, is discussed.', 'Title: Cytotoxic pyrroloiminoquinones from four new species of South African latrunculid sponges.  Abstract: An examination of organic extracts of four new species of South African latrunculid sponges, Tsitsikamma pedunculata, T. favus, Latrunculia bellae, and Strongylodesma algoaensis, yielded 13 known and eight new pyrroloiminoquinone alkaloids, 3-dihydro-7,8-dehydrodiscorhabdin C (4), 14-bromo-3-dihydro-7,8-dehydrodiscorhabdin C (5), discorhabdin V (6), 14-bromo-1-hydroxydiscorhabdin V (7), tsitsikammamine A N-18 oxime (10), tsitsikammamine B N-18 oxime (11), 1-methoxydiscorhabdin D (12), and 1-aminodiscorhabdin D (13). Standard spectroscopic methods provided the structures of the pyrroloiminoquinone metabolites, while chiral GC-MS analysis of the acylated ozonolysis products of 21 confirmed the stereochemistry of the l-histidine residue in this compound. The anticancer activity of 20 pyrroloiminoquinone compounds was explored in the HCT-116 cancer cell line screen, and the DNA intercalation of the tsitsikammamines, together with their ability to cleave DNA through topoisomerase I inhibition, is discussed.', 'Title: A strategy for identifying novel, mechanistically unique inhibitors of topoisomerase I.  Abstract: While the design of molecules that inhibit or antagonize the functions of specific macromolecules is now well precedented, in many cases the structural information requisite to the design process is lacking. The tools of molecular biology can now furnish the target macromolecules for use in mechanism-based exploration; highly defined assays can be devised based upon the known biochemistry of these macromolecules to permit the discovery of novel inhibitors or antagonists present in chemical collections. Presently, we describe a set of assays directed toward the discovery of novel inhibitors of eukaryotic topoisomerase I, an enzyme critical to maintenance of chromosomal DNA topology and therefore essential for normal replication and transcription. The identification of chebulagic acid as an extraordinarily potent and mechanically novel inhibitor of topoisomerase I illustrates the potential of this approach.', 'Title: A strategy for identifying novel, mechanistically unique inhibitors of topoisomerase I.  Abstract: While the design of molecules that inhibit or antagonize the functions of specific macromolecules is now well precedented, in many cases the structural information requisite to the design process is lacking. The tools of molecular biology can now furnish the target macromolecules for use in mechanism-based exploration; highly defined assays can be devised based upon the known biochemistry of these macromolecules to permit the discovery of novel inhibitors or antagonists present in chemical collections. Presently, we describe a set of assays directed toward the discovery of novel inhibitors of eukaryotic topoisomerase I, an enzyme critical to maintenance of chromosomal DNA topology and therefore essential for normal replication and transcription. The identification of chebulagic acid as an extraordinarily potent and mechanically novel inhibitor of topoisomerase I illustrates the potential of this approach.', 'Title: A strategy for identifying novel, mechanistically unique inhibitors of topoisomerase I.  Abstract: While the design of molecules that inhibit or antagonize the functions of specific macromolecules is now well precedented, in many cases the structural information requisite to the design process is lacking. The tools of molecular biology can now furnish the target macromolecules for use in mechanism-based exploration; highly defined assays can be devised based upon the known biochemistry of these macromolecules to permit the discovery of novel inhibitors or antagonists present in chemical collections. Presently, we describe a set of assays directed toward the discovery of novel inhibitors of eukaryotic topoisomerase I, an enzyme critical to maintenance of chromosomal DNA topology and therefore essential for normal replication and transcription. The identification of chebulagic acid as an extraordinarily potent and mechanically novel inhibitor of topoisomerase I illustrates the potential of this approach.', 'Inhibition of DNA topoisomerase 1', 'Title: Synthesis and evaluation of unsymmetrical polyamine derivatives as antitumor agents.  Abstract: A series of unsymmetrically substituted polyamine derivatives were prepared and their cytotoxicities in mouse leukemia L1210, melanoma B16, and HeLa cells were investigated. The in vitro cytotoxicity revealed that these conjugates could recognize the polyamine transporter, and the N-ethyl modified homospermidine moiety may be another efficient carrier as homospermidine even though the introduction of terminal alkyl groups led to reduced cytotoxicity in comparison with the un-substituted counterpart 1. The ornithine decarboxylase and topoisomerase II inhibition experiments indicated that ODC and TOPO II were potential, but not unique targets of these conjugates. Furthermore, the in vivo antitumor activities illustrated that the representative conjugate 2f and the homospermidine analogue 1 evidently inhibited the tumor growth and significantly increased the survival time of mice-bearing sarcoma 180 cells.', 'Title: The contribution of plukenetione A to the anti-tumoral activity of Cuban propolis.  Abstract: Increasing efforts are directed toward finding applications for natural products and their derivatives in the treatment of human diseases. Among such products, propolis, a resinous substance produced by honey bees from various plant sources, has been found to be a promising source of potential therapeutics. In the present work, we aimed at studying the perspective of Cuban propolis as a source of possible anti-cancer agents. We found an anti-metastatic effect in mice and considerable cytotoxicity without cross-resistance in both wild-type and chemoresistant human tumor cell lines. Plukenetione A--identified for the first time in Cuban propolis--induced G0/G1 arrest and DNA fragmentation in colon carcinoma cells. Furthermore, the activities of both topoisomerase I and DNA polymerase were inhibited, while the expression of topoisomerase II-beta, EGF receptor, and multidrug resistance-related protein genes was found repressed. We assume that plukenetione A contributes to the anti-tumoral effect of Cuban propolis mainly by targeting topoisomerase I as well as DNA polymerase.', 'Title: The contribution of plukenetione A to the anti-tumoral activity of Cuban propolis.  Abstract: Increasing efforts are directed toward finding applications for natural products and their derivatives in the treatment of human diseases. Among such products, propolis, a resinous substance produced by honey bees from various plant sources, has been found to be a promising source of potential therapeutics. In the present work, we aimed at studying the perspective of Cuban propolis as a source of possible anti-cancer agents. We found an anti-metastatic effect in mice and considerable cytotoxicity without cross-resistance in both wild-type and chemoresistant human tumor cell lines. Plukenetione A--identified for the first time in Cuban propolis--induced G0/G1 arrest and DNA fragmentation in colon carcinoma cells. Furthermore, the activities of both topoisomerase I and DNA polymerase were inhibited, while the expression of topoisomerase II-beta, EGF receptor, and multidrug resistance-related protein genes was found repressed. We assume that plukenetione A contributes to the anti-tumoral effect of Cuban propolis mainly by targeting topoisomerase I as well as DNA polymerase.', 'Title: Semisynthesis, biological activity, and molecular modeling studies of C-ring-modified camptothecins.  Abstract: The synthesis, biological activity, and molecular modeling studies of C-ring-modified camptothecins are reported. A general synthetic protocol, based on \"C-5 camptothecin (C-5-CPT) enolate chemistry\", allows one to obtain various C5-substituted analogues. All new compounds, obtained as 1:1 epimeric mixtures, were tested for their antiproliferative activity. Experimental data showed that all novel derivatives are less active than the reference compounds and that one of the two epimers is more active than the other. Molecular docking simulations were performed to achieve more insight into the interactions between the new C5-modified CPTs and Topo I. A good correlation was observed when the data of cytotoxicity and the values calculated for the free binding energy were combined.', 'Title: Synthesis and biological activities of topoisomerase I inhibitors, 6-arylmethylamino analogues of edotecarin.  Abstract: The replacement of 1,3-dihydroxy-2-propylamino moiety at the N6-position of edotecarin (1) by arylmethylamino groups yielded a number of more potent topoisomerase I inhibitors with better cytotoxic (CTX) activities in vitro than edotecarin. Among them, the three most potent pyridylmethyl analogues, compounds 22g, 22m, and 23c, showed better antitumor activities against MKN-45 human stomach cancer or MX-1 human breast cancer xenografted mice than those of edotecarin. Furthermore, compounds 22m and 23c exhibited complete response against MX-1 cells implanted in mice.', 'Title: Molecular design, synthesis and docking study of benz[b]oxepines and 12-oxobenzo[c]phenanthridinones as topoisomerase 1 inhibitors.  Abstract: Benz[b]oxepines 4a-g and 12-oxobenzo[c]phenanthridines 5a-d were designed and synthesized as constrained forms of 3-arylisoquinolines through an intramolecular radical cyclization reaction. Radical cyclization of O-vinyl compounds preferentially led to the 7-endo-trig cyclization pathway to the benz[b]oxepines and 12-oxobenzo[c]phenanthridines through 6-exo-trig path as minor products. Among the synthesized compounds, benz[b]oxepine derivative 4e exhibited potent in vitro cytotoxicity against three different tumor cell lines, as well as topoisomerase 1 inhibitory activity. A Surflex-Dock docking study was performed to clarify the topoisomerase 1 activity of 4e.', \"Title: DNA topoisomerase I inhibitors: cytotoxic flavones from Lethedon tannaensis.  Abstract: From ethyl acetate and methanolic extracts of Lethedon tannaensis leaves, which were cytotoxic against murine leukemia (P-388) and human nasopharynx carcinoma (KB) cells, one new and six known 5-hydroxy-7-methoxyflavones variously substituted on the B ring were isolated and their structures determined by spectral analysis. Compounds active against KB cells were velutin (4) (IC50 4.8 microM), 7,3',5'-tri-O-methyltricetin (2) (IC50 22.2 microM), genkwanin (6) (IC50 30.6 microM), and the novel compound, 7,3',4'-tri-O-methyltricetin, named lethedocin (1) (IC50 47.6 microM). These flavones required the presence of hydroxyl groups at C-5 and C-4' and methoxyl groups at C-7 and C-3' for inhibition of calf thymus DNA topoisomerase I activity.\", 'Title: Screening of triterpenoids isolated from Phyllanthus flexuosus for DNA topoisomerase inhibitory activity.  Abstract: DNA topoisomerases (Topos) are enzymes that play a crucial role in DNA metabolism events such as replication, transcription, recombination, and chromosome segregation at mitosis. Thus, Topo inhibitors could be expected to have antitumor effects. Naturally occurring lupane- and oleanane-type triterpenoids isolated from the bark of Phyllanthus flexuosus were screened for human Topos I and II inhibitory activities. Olean-12-en-3 beta,15 alpha-diol (1), olean-12-en-3 beta,15 alpha,24-triol (3), lupeol (4), and betulin (6) were found to be selective catalytic inhibitors of human Topo II activity with IC(50) values in the range of 10-39 microM.', \"Title: Isoaurostatin, a novel topoisomerase inhibitor produced by Thermomonospora alba.  Abstract: A novel inhibitor of topoisomerase I designated as isoaurostatin (1) was isolated from the culture filtrate of Thermomonospora alba strain No. 1520. The structure of 1 was determined to be 6,4'-dihydroxyisoaurone on the basis of spectroscopic (NMR and MS) methods. Compound 1 inhibited the relaxation activity of calf thymus topoisomerase I in a noncompetitive manner and did not inhibit the relaxation and decatenation of human placenta topoisomerase II. Compound 1 is an inhibitor belonging to cleavable complex-nonforming type without DNA intercalation.\", \"Title: Isoaurostatin, a novel topoisomerase inhibitor produced by Thermomonospora alba.  Abstract: A novel inhibitor of topoisomerase I designated as isoaurostatin (1) was isolated from the culture filtrate of Thermomonospora alba strain No. 1520. The structure of 1 was determined to be 6,4'-dihydroxyisoaurone on the basis of spectroscopic (NMR and MS) methods. Compound 1 inhibited the relaxation activity of calf thymus topoisomerase I in a noncompetitive manner and did not inhibit the relaxation and decatenation of human placenta topoisomerase II. Compound 1 is an inhibitor belonging to cleavable complex-nonforming type without DNA intercalation.\", \"Title: Isoaurostatin, a novel topoisomerase inhibitor produced by Thermomonospora alba.  Abstract: A novel inhibitor of topoisomerase I designated as isoaurostatin (1) was isolated from the culture filtrate of Thermomonospora alba strain No. 1520. The structure of 1 was determined to be 6,4'-dihydroxyisoaurone on the basis of spectroscopic (NMR and MS) methods. Compound 1 inhibited the relaxation activity of calf thymus topoisomerase I in a noncompetitive manner and did not inhibit the relaxation and decatenation of human placenta topoisomerase II. Compound 1 is an inhibitor belonging to cleavable complex-nonforming type without DNA intercalation.\", 'Title: Total synthesis and biological evaluation of (5Z,9Z)-5,9-hexadecadienoic acid, an inhibitor of human topoisomerase I.  Abstract: The naturally occurring (5Z,9Z)-5,9-hexadecadienoic acid was synthesized stereochemically pure in six steps starting with commercially available 1,5-hexadiyne. The title compound was antimicrobial against the Gram-positive bacteria Staphylococcus aureus (MIC 80 microM) and Streptococcus faecalis (MIC 200 microM), but inactive against Gram-negative bacteria such as Pseudomonas aeruginosa. In addition, the (5Z,9Z)-5,9-hexadecadienoic acid completely inhibits human topoisomerase I at a concentration of 800 microM, while 5,9-hexadecadiynoic acid and hexadecanoic acid do not inhibit topoisomerase I (>1000 microM). This comparison reveals that the cis double bond geometry in the title compound is required for topoisomerase I inhibition. Moreover, these results suggest that the antimicrobial activity of (5Z,9Z)-5,9-hexadecadienoic acid against either S. aureus or S. faecalis could be a result, at least in part, of the inhibitory activity of the acid against topoisomerases.', 'Title: Total synthesis and biological evaluation of (5Z,9Z)-5,9-hexadecadienoic acid, an inhibitor of human topoisomerase I.  Abstract: The naturally occurring (5Z,9Z)-5,9-hexadecadienoic acid was synthesized stereochemically pure in six steps starting with commercially available 1,5-hexadiyne. The title compound was antimicrobial against the Gram-positive bacteria Staphylococcus aureus (MIC 80 microM) and Streptococcus faecalis (MIC 200 microM), but inactive against Gram-negative bacteria such as Pseudomonas aeruginosa. In addition, the (5Z,9Z)-5,9-hexadecadienoic acid completely inhibits human topoisomerase I at a concentration of 800 microM, while 5,9-hexadecadiynoic acid and hexadecanoic acid do not inhibit topoisomerase I (>1000 microM). This comparison reveals that the cis double bond geometry in the title compound is required for topoisomerase I inhibition. Moreover, these results suggest that the antimicrobial activity of (5Z,9Z)-5,9-hexadecadienoic acid against either S. aureus or S. faecalis could be a result, at least in part, of the inhibitory activity of the acid against topoisomerases.', 'Title: Total synthesis and biological evaluation of (5Z,9Z)-5,9-hexadecadienoic acid, an inhibitor of human topoisomerase I.  Abstract: The naturally occurring (5Z,9Z)-5,9-hexadecadienoic acid was synthesized stereochemically pure in six steps starting with commercially available 1,5-hexadiyne. The title compound was antimicrobial against the Gram-positive bacteria Staphylococcus aureus (MIC 80 microM) and Streptococcus faecalis (MIC 200 microM), but inactive against Gram-negative bacteria such as Pseudomonas aeruginosa. In addition, the (5Z,9Z)-5,9-hexadecadienoic acid completely inhibits human topoisomerase I at a concentration of 800 microM, while 5,9-hexadecadiynoic acid and hexadecanoic acid do not inhibit topoisomerase I (>1000 microM). This comparison reveals that the cis double bond geometry in the title compound is required for topoisomerase I inhibition. Moreover, these results suggest that the antimicrobial activity of (5Z,9Z)-5,9-hexadecadienoic acid against either S. aureus or S. faecalis could be a result, at least in part, of the inhibitory activity of the acid against topoisomerases.', 'Title: Total synthesis and biological evaluation of (5Z,9Z)-5,9-hexadecadienoic acid, an inhibitor of human topoisomerase I.  Abstract: The naturally occurring (5Z,9Z)-5,9-hexadecadienoic acid was synthesized stereochemically pure in six steps starting with commercially available 1,5-hexadiyne. The title compound was antimicrobial against the Gram-positive bacteria Staphylococcus aureus (MIC 80 microM) and Streptococcus faecalis (MIC 200 microM), but inactive against Gram-negative bacteria such as Pseudomonas aeruginosa. In addition, the (5Z,9Z)-5,9-hexadecadienoic acid completely inhibits human topoisomerase I at a concentration of 800 microM, while 5,9-hexadecadiynoic acid and hexadecanoic acid do not inhibit topoisomerase I (>1000 microM). This comparison reveals that the cis double bond geometry in the title compound is required for topoisomerase I inhibition. Moreover, these results suggest that the antimicrobial activity of (5Z,9Z)-5,9-hexadecadienoic acid against either S. aureus or S. faecalis could be a result, at least in part, of the inhibitory activity of the acid against topoisomerases.', 'Title: Total synthesis and biological evaluation of (5Z,9Z)-5,9-hexadecadienoic acid, an inhibitor of human topoisomerase I.  Abstract: The naturally occurring (5Z,9Z)-5,9-hexadecadienoic acid was synthesized stereochemically pure in six steps starting with commercially available 1,5-hexadiyne. The title compound was antimicrobial against the Gram-positive bacteria Staphylococcus aureus (MIC 80 microM) and Streptococcus faecalis (MIC 200 microM), but inactive against Gram-negative bacteria such as Pseudomonas aeruginosa. In addition, the (5Z,9Z)-5,9-hexadecadienoic acid completely inhibits human topoisomerase I at a concentration of 800 microM, while 5,9-hexadecadiynoic acid and hexadecanoic acid do not inhibit topoisomerase I (>1000 microM). This comparison reveals that the cis double bond geometry in the title compound is required for topoisomerase I inhibition. Moreover, these results suggest that the antimicrobial activity of (5Z,9Z)-5,9-hexadecadienoic acid against either S. aureus or S. faecalis could be a result, at least in part, of the inhibitory activity of the acid against topoisomerases.', 'Title: Syntheses and biological evaluation of topoisomerase I-targeting agents related to 11-[2-(N,N-dimethylamino)ethyl]-2,3-dimethoxy-8,9-methylenedioxy-11H-isoquino[4,3-c]cinnolin-12-one (ARC-31).  Abstract: Several 11-ethyl-2,3-dimethoxy-8,9-methylenedioxy-11H-isoquino[4,3-c]cinnolin-12-ones with varied functionality on the ethyl substituent have exhibited potent topoisomerase I (TOP1) targeting activity and antitumor activity. The influence of various polar substituents at the 2-position of the 11-ethyl substituent, including N-methylamine, N-isopropylamine, hydroxyl, and hydroxylamino groups, on TOP1-targeting activity and cytotoxicity was assessed. The N-methylamine and N-isopropylamine derivatives were also evaluated as antitumor agents in athymic nude mice with MDA-MB-435 human tumor xenografts. Both compounds were active as antitumor agents upon either parenteral or oral administration.', 'Title: Design, synthesis, and biological evaluation of 14-substituted aromathecins as topoisomerase I inhibitors.  Abstract: The aromathecin or \"rosettacin\" class of topoisomerase I (top1) inhibitors is effectively a \"composite\" of the natural products camptothecin and luotonin A and the synthetic indenoisoquinolines. The aromathecins have aroused considerable interest following the isolation and total synthesis of 22-hydroxyacuminatine, a rare cytotoxic natural product containing the 12 H-5,11a-diazadibenzo[ b, h]fluoren-11-one system. We have developed two novel syntheses of this system and prepared a series of 14-substituted aromathecins as novel antiproliferative topoisomerase I poisons. These inhibitors are proposed to act via an intercalation and \"poisoning\" mechanism identical to camptothecin and the indenoisoquinolines. Many of these compounds possess greater antiproliferative activity and anti-top1 activity than the parent unsubstituted compound (rosettacin) and previously synthesized aromathecins, as well as greater top1 inhibitory activity than 22-hydroxyacuminatine. In addition to potentially aiding solubility and localization to the DNA-enzyme complex, nitrogenous substituents located at the 14-position of the aromathecin system have been proposed to project into the major groove of the top1-DNA complex and hydrogen-bond to major-groove amino acids, thereby stabilizing the ternary complex.', 'Title: Design, synthesis, and biological evaluation of 14-substituted aromathecins as topoisomerase I inhibitors.  Abstract: The aromathecin or \"rosettacin\" class of topoisomerase I (top1) inhibitors is effectively a \"composite\" of the natural products camptothecin and luotonin A and the synthetic indenoisoquinolines. The aromathecins have aroused considerable interest following the isolation and total synthesis of 22-hydroxyacuminatine, a rare cytotoxic natural product containing the 12 H-5,11a-diazadibenzo[ b, h]fluoren-11-one system. We have developed two novel syntheses of this system and prepared a series of 14-substituted aromathecins as novel antiproliferative topoisomerase I poisons. These inhibitors are proposed to act via an intercalation and \"poisoning\" mechanism identical to camptothecin and the indenoisoquinolines. Many of these compounds possess greater antiproliferative activity and anti-top1 activity than the parent unsubstituted compound (rosettacin) and previously synthesized aromathecins, as well as greater top1 inhibitory activity than 22-hydroxyacuminatine. In addition to potentially aiding solubility and localization to the DNA-enzyme complex, nitrogenous substituents located at the 14-position of the aromathecin system have been proposed to project into the major groove of the top1-DNA complex and hydrogen-bond to major-groove amino acids, thereby stabilizing the ternary complex.', 'Title: Lyngbyastatin 2 and norlyngbyastatin 2, analogues of dolastatin G and nordolastatin G from the marine cyanobacterium Lyngbya majuscula.  Abstract: Lyngbyastatin 2 (1) and norlyngbyastatin 2 (2), new cytotoxic analogues of dolastatin G (3) and nordolastatin G (4), respectively, have been isolated as constituents from a Guamanian variety of the marine cyanobacterium Lyngbya majuscula. Structure elucidation of these cyclic depsipeptides relied on extensive application of 2D NMR techniques. The finding of these new metabolites further supports the proposal that many compounds originally isolated from the sea hare Dolabella auricularia are most likely of cyanobacterial origin.', \"Title: Use of COMPARE analysis to discover new natural product drugs: isolation of camptothecin and 9-methoxycamptothecin from a new source.  Abstract: Analysis of cytotoxicity data of extracts from the National Cancer Institute's Active Repository by the COMPARE protocol was carried out using camptothecin as a reference point. Extracts identified by this process were further characterized by a selective yeast bioassay for inhibitors of topoisomerase I and by a biochemical assay for compounds that stabilize the topoisomerase I-DNA covalent binary complex. Five of the extracts were positive in the yeast bioassay, and eight extracts showed activity on the assay that monitors stabilization of the topoisomerase I-DNA complex. Four of the latter extracts were inactive in the yeast bioassay, and thus would not have been identified as hits without the COMPARE preselection process. One of the extracts, from Pyrenacantha klaineana, was selected for detailed investigation, and fractionation of this extract yielded camptothecin and 9-methoxycamptothecin as the bioactive constituents.\", 'Title: Cytotoxic sesquiterpenoids from Ratibida columnifera.  Abstract: Bioassay-directed fractionation of the flowers and leaves of Ratibida columnifera using a hormone-dependent human prostate (LNCaP) cancer cell line led to the isolation of 10 cytotoxic substances, composed of five novel xanthanolide derivatives (2-4, 7, and 8), a novel nerolidol derivative (9), and three known sesquiterpene lactones, 9alpha-hydroxy-seco-ratiferolide-5alpha-O-angelate+ ++ (1), 9alpha-hydroxy-seco-ratiferolide-5alpha-O-(2-methylbut yrate) (5), 9-oxo-seco-ratiferolide-5alpha-O-(2-methylbutyrate) (6), as well as a known flavonoid, hispidulin (10). On the basis of its cytotoxicity profile, compound 5 was selected for further biological evaluation, and was found to induce G1 arrest and slow S traverse time in parental wild type p53 A2780S cells, but only G2/M arrest in p53 mutant A2780R cells, with strong apoptosis shown for both cell lines. The activity of 5 was not mediated by the multidrug resistance (MDR) pump, and it was not active against several anticancer molecular targets (i.e., tubulin polymerization/depolymerization, topoisomerases, and DNA intercalation). While these results indicate that compound 5 acts as a cytotoxic agent via a novel mechanism, this substance was inactive in in vivo evaluations using the murine lung carcinoma (M109) and human colon carcinoma (HCT116) models.', 'Title: Isolation and biochemical characterization of a new topoisomerase I inhibitor from Ocotea leucoxylon.  Abstract: In a continuation of our search for potential tumor inhibitors from plants, we found that a crude extract from Ocotea leucoxylon showed selective activity typical of inhibitors of the enzyme topoisomerase I in a yeast assay for DNA-damaging agents. Using a bioassay-directed fractionation approach, the major bioactive compound was isolated and identified as the known aporphine alkaloid dicentrinone (4); the inactive alkaloid dicentrine (3) was also isolated. Compound 4 showed selective bioactivity against the rad52 repair-deficient yeast strain RS322 (IC(12) 49 microg/mL) and was inactive against the rad52- and topo1-deficient strain RS321 (IC(12) > 2000 microg/mL) and against the repair-proficient strain RJ03 (IC(12) > 2000 microg/mL). Biochemical studies with recombinant human topoisomerase I indicated that dicentrinone (4) is an inhibitor of the human enzyme. Colony formation studies suggest that it is weakly cytotoxic, but that its mechanism of toxicity differs from that of camptothecin and its derivatives.', 'Title: Isolation and biochemical characterization of a new topoisomerase I inhibitor from Ocotea leucoxylon.  Abstract: In a continuation of our search for potential tumor inhibitors from plants, we found that a crude extract from Ocotea leucoxylon showed selective activity typical of inhibitors of the enzyme topoisomerase I in a yeast assay for DNA-damaging agents. Using a bioassay-directed fractionation approach, the major bioactive compound was isolated and identified as the known aporphine alkaloid dicentrinone (4); the inactive alkaloid dicentrine (3) was also isolated. Compound 4 showed selective bioactivity against the rad52 repair-deficient yeast strain RS322 (IC(12) 49 microg/mL) and was inactive against the rad52- and topo1-deficient strain RS321 (IC(12) > 2000 microg/mL) and against the repair-proficient strain RJ03 (IC(12) > 2000 microg/mL). Biochemical studies with recombinant human topoisomerase I indicated that dicentrinone (4) is an inhibitor of the human enzyme. Colony formation studies suggest that it is weakly cytotoxic, but that its mechanism of toxicity differs from that of camptothecin and its derivatives.', 'Title: Isolation and biochemical characterization of a new topoisomerase I inhibitor from Ocotea leucoxylon.  Abstract: In a continuation of our search for potential tumor inhibitors from plants, we found that a crude extract from Ocotea leucoxylon showed selective activity typical of inhibitors of the enzyme topoisomerase I in a yeast assay for DNA-damaging agents. Using a bioassay-directed fractionation approach, the major bioactive compound was isolated and identified as the known aporphine alkaloid dicentrinone (4); the inactive alkaloid dicentrine (3) was also isolated. Compound 4 showed selective bioactivity against the rad52 repair-deficient yeast strain RS322 (IC(12) 49 microg/mL) and was inactive against the rad52- and topo1-deficient strain RS321 (IC(12) > 2000 microg/mL) and against the repair-proficient strain RJ03 (IC(12) > 2000 microg/mL). Biochemical studies with recombinant human topoisomerase I indicated that dicentrinone (4) is an inhibitor of the human enzyme. Colony formation studies suggest that it is weakly cytotoxic, but that its mechanism of toxicity differs from that of camptothecin and its derivatives.', \"Title: A cyclitol derivative as a replication inhibitor from the marine sponge Petrosia sp.  Abstract: A bioactive cyclitol derivative (1) was isolated from the marine sponge Petrosia sp. The chemical structure of 1 was determined as (2S)-1-O-(2',3',4',5'-tetrahydroxycyclopentyl)-3-O-(10' '-methylhexadecyl)glycerol. Compound 1 inhibited DNA replication in vitro at the level of initiation.\", 'Title: Isolation, structure determination, and biological activity of Lyngbyabellin A from the marine cyanobacterium lyngbya majuscula.  Abstract: Lyngbyabellin A (1), a significantly cytotoxic compound with unusual structural features, was isolated from a Guamanian strain of the marine cyanobacterium Lyngbya majuscula. This novel peptolide is structurally related to dolabellin (2) in that both depsipeptides bear a dichlorinated beta-hydroxy acid and two functionalized thiazole carboxylic acid units. Its gross structure has been elucidated by spectral analysis, including 2D NMR techniques. The absolute stereochemistry of 1 was determined by chiral HPLC analysis of hydrolysis products and by characterization of the degradation products methyl 7,7-dichloro-3-hydroxy-2,2-dimethyloctanoate (3) and the corresponding acid 4. The total structure was further supported by molecular modeling studies. The isolation of 1 from L. majuscula once more supports the proposal that many compounds originally isolated from the sea hare Dolabella auricularia are of cyanobacterial origin. Lyngbyabellin A (1) was shown to be a potent disrupter of the cellular microfilament network.', 'Title: Isolation, structure determination, and biological activity of Lyngbyabellin A from the marine cyanobacterium lyngbya majuscula.  Abstract: Lyngbyabellin A (1), a significantly cytotoxic compound with unusual structural features, was isolated from a Guamanian strain of the marine cyanobacterium Lyngbya majuscula. This novel peptolide is structurally related to dolabellin (2) in that both depsipeptides bear a dichlorinated beta-hydroxy acid and two functionalized thiazole carboxylic acid units. Its gross structure has been elucidated by spectral analysis, including 2D NMR techniques. The absolute stereochemistry of 1 was determined by chiral HPLC analysis of hydrolysis products and by characterization of the degradation products methyl 7,7-dichloro-3-hydroxy-2,2-dimethyloctanoate (3) and the corresponding acid 4. The total structure was further supported by molecular modeling studies. The isolation of 1 from L. majuscula once more supports the proposal that many compounds originally isolated from the sea hare Dolabella auricularia are of cyanobacterial origin. Lyngbyabellin A (1) was shown to be a potent disrupter of the cellular microfilament network.', 'Title: Cucurbitane triterpenes from the fruiting bodies and cultivated mycelia of Leucopaxillus gentianeus.  Abstract: A reinvestigation of the fruiting bodies of the mushroom Leucopaxillus gentianeus, allowed the isolation of two minor cucurbitane triterpenes, namely, cucurbitacin D (5) and the new metabolite 16-deoxycucurbitacin B (6). The latter compound lacks an oxygenated substituent at C-16, an unprecedented structural feature among congeners of cucurbitacin B. The cucurbitanes present in the fruiting bodies were compared with those extracted from mycelia grown on the modified Melin-Norkans (MMN) culture medium. Cucurbitacins B (1) and D (5), as well as leucopaxillones A (3) and B (4), were isolated from both sources; in contrast, 16-deoxycucurbitacin B (6) and a mixture of fatty acid esters of cucurbitacin B (2) were absent in the mycelia. A new triterpene, 18-deoxyleucopaxillone A (7), was isolated from the mycelia, but was not detected in the fruiting bodies. The antiproliferative activity of the isolated triterpenes was determined against the NCI-H460 human tumor cell line, in comparison with the antitumor compound topotecan, a well-known topoisomerase I inhibitor.', \"Title: Novel azaphilones, kasanosins A and B, which are specific inhibitors of eukaryotic DNA polymerases beta and lambda from Talaromyces sp.  Abstract: Kasanosins A (1) and B (2) are novel azaphilones isolated from cultures of Talaromyces sp. derived from seaweed, and their structures were determined by spectroscopic analyses. These compounds selectively inhibited the activities of eukaryotic DNA polymerases beta and lambda (pols beta and lambda) in family X of pols, and compound 1 was a stronger inhibitor than compound 2. The IC(50) values of compound 1 on rat pol beta and human pol lambda were 27.3 and 35.0 microM, respectively. On the other hand, compounds 1 and 2 did not influence the activities of terminal deoxynucleotidyl transferase (TdT), which is a pol of family X, and the other families of eukaryotic pols, such as family A (i.e., pol gamma), family B (i.e., pols alpha, delta, and epsilon) and family Y (i.e., pols eta, iota, and kappa), and showed no effect even on the activities of plant pol alpha, fish pol delta, prokaryotic pols, and other DNA metabolic enzymes, such as calf primase of pol alpha, human immunodeficiency virus type-1 (HIV-1) reverse transcriptase, human telomerase, T7 RNA polymerase, mouse inosine 5'-monophosphate (IMP) dehydrogenase (type II), human topoisomerases I and II, T4 polynucleotide kinase, and bovine deoxyribonuclease I. The results suggested that these novel compounds could identify the inhibition between pols beta, lambda, and TdT in family X.\", 'Title: Synthesis of N-substituted 5-[2-(N-alkylamino)ethyl]dibenzo[c,h][1,6]naphthyridines as novel topoisomerase I-targeting antitumor agents.  Abstract: Several N-alkyl and N,N-dialkyl 5H-8,9-dimethoxy-5-(2-aminoethyl)-2,3-methylenedioxydibenzo[c,h][1,6]naphthyridin-6-ones have been identified as topoisomerase I-targeting agents with potent antitumor activity. In the present study, the impact on biological activity of substitution of a trifluoromethyl, cyano, aminocarbonyl, or ethynyl group on a N-methyl substituent of N,N-dimethyl-, N-methyl-N-ethyl-, and N-methyl-N-isopropyl 5H-8,9-dimethoxy-5-(2-aminoethyl)-2,3-methylenedioxydibenzo[c,h][1,6]naphthyridin-6-ones was assessed.', 'Title: Synthesis and cytotoxic properties of 4,11-bis[(aminoethyl)amino]anthra[2,3-b]thiophene-5,10-diones, novel analogues of antitumor anthracene-9,10-diones.  Abstract: We developed the synthesis of a series of thiophene-fused tetracyclic analogues of the antitumor drug ametantrone. The reactions included nucleophilic substitution of methoxy groups in 4,11-dimethoxyanthra[2,3-b]thiophene-5,10-diones with ethylenediamines, producing the derivatives of 4,11-diaminoanthra[2,3-b]thiophene-5,10-dione in good yields. Several compounds showed marked antiproliferative potency against doxorubicin-selected, P-glycoprotein-expressing tumor cells and p53(-/-) cells. The cytotoxicity of some novel compounds for P-glycoprotein-positive cells is highly dependent on N-substituent at the terminal amino group of ethylenediamine moiety. The cytotoxic potency of selected compounds correlated with their ability to attenuate the functions of topoisomerase I and telomerase, strongly suggesting that these enzymes are the major targets of antitumor activity of anthra[2,3-b]thiophene-5,10-dione derivatives.', 'Title: Penicilliols A and B, novel inhibitors specific to mammalian Y-family DNA polymerases.  Abstract: Penicilliols A (1) and B (2) are novel 5-methoxy-3(2H)-furanones isolated from cultures of a fungus (Penicillium daleae K.M. Zalessky) derived from a sea moss, and their structures were determined by spectroscopic analyses. These compounds selectively inhibited activities of eukaryotic Y-family DNA polymerases (pols) (i.e., pols eta, iota and kappa), and compound 1 was a stronger inhibitor than compound 2. Among mammalian Y-family pols, mouse pol iota activity was most strongly inhibited by compounds 1 and 2, with IC(50) values of 19.8 and 32.5 microM, respectively. On the other hand, activities of many other pols, such as A-family (i.e., pol gamma), B-family (i.e., pols alpha, delta and epsilon) or X-family (i.e., pols beta, lambda and terminal deoxynucleotidyl transferase), and some DNA metabolic enzymes, such as calf primase of pol alpha, human immunodeficiency virus type-1 (HIV-1) reverse transcriptase, human telomerase, T7 RNA polymerase, mouse IMP dehydrogenase (type II), human topoisomerases I and II, T4 polynucleotide kinase or bovine deoxyribonuclease I, are not influenced by these compounds. In conclusion, this is the first report on potent inhibitors of mammalian Y-family pols.', \"Title: Novel imidazo[1,2-a]naphthyridinic systems (part 1): synthesis, antiproliferative and DNA-intercalating activities.  Abstract: Novel imidazo[1,2-a]naphthyridinic systems 6a-15a and 6b-15b were obtained from Friedlnder's reaction in imidazo[1,2-a]pyridine series. Most of the compounds were evaluated for their antitumor activity in the NCIs in vitro human tumor cell line screening panel. Among them, pentacyclic derivatives 13b and 14a exhibited in vitro activity comparable to anticancer agent such as amsacrine. Their mechanism of cytotoxicity action was unrelated to poisoning or inhibiting abilities against topo1. On the contrary, we highlighted a direct intercalation of the drugs into DNA by electrophoresis on agarose gel.\", 'Title: Design and synthesis of N-methylmaleimide indolocarbazole bearing modified 2-acetamino acid moieties as Topoisomerase I inhibitors.  Abstract: A novel series of N-methylmaleimide indolocarbazole derivatives bearing modified 2-acetamino acid moieties are first reported. The cytotoxic effects of these compounds were tested in five human tumor cell lines. The potent compounds 9a, 9b, 9d, and 9e have been further evaluated for their effect on Topoisomerase I (TOPO I) and cancer cell cycle. It is concluded that the indolocarbazoles with alkyl piperazine or morpholine substituent groups instead of esters or glycosyl residues would have better activities against tumors.', \"Title: Indole alkaloids and other constituents of Rauwolfia serpentina.  Abstract: From the dried roots of Rauwolfia serpentina were isolated five new indole alkaloids, N(b)-methylajmaline (1), N(b)-methylisoajmaline (2), 3-hydroxysarpagine (3), yohimbinic acid (4), isorauhimbinic acid (5), a new iridoid glucoside, 7-epiloganin (6), and a new sucrose derivative, 6'-O-(3,4,5-trimethoxybenzoyl)glomeratose A (7), together with 20 known compounds. The structures of the new compounds were determined by spectroscopic and chemical means. The inhibitory activities of the selected alkaloids on topoisomerase I and II and their cytotoxicity against the human promyelocytic leukemia (HL-60) cell lines were assessed.\", \"Title: Antitumor agents 6. Synthesis, structure-activity relationships, and biological evaluation of spiro[imidazolidine-4,3'-thieno[2,3-g]quinoline]-tetraones and spiro[thieno[2,3-g]quinoline-3,5'-[1,2,4]triazinane]-tetraones with potent antiproliferative activity.  Abstract: Two series of quinolinquinone derivatives, 2'H-spiro[imidazolidine-4,3'-thieno[2,3-g]quinoline]-2,4',5,9'-tetraones (2a-n) and 2H-spiro[thieno[2,3-g]quinoline-3,5'-[1,2,4]triazinane]-3',4,6',9-tetraones (3a-e), were designed and synthesized using the previously described ethyl 3-amino-4,9-dioxo-2,3,4,9-tetrahydrothieno[2,3-g]quinoline-3-carboxylate (1) as a starting material. All compounds were evaluated for their antiproliferative activity against a panel of representative liquid and solid human tumor cell lines and exhibit IC(50) values in the micromolar/submicromolar range. Series 2 displayed higher cytotoxicity than did series 3. The nature of the substituents on both imidazoline and triazinane N1 nitrogen markedly affected the activity profile of these series. Spectrophotometric and fluorescence measurements as well as unwinding assays performed on the most cytotoxic compounds, 2c, 2g, and 2k, showed that they are nonintercalative DNA agents and inhibit the catalytic activity of Topo II in a concentration-dependent mode. 2g was the most active Topo II inhibitor with activity levels comparable to those of VP-16.\", \"Title: Antitumor agents 6. Synthesis, structure-activity relationships, and biological evaluation of spiro[imidazolidine-4,3'-thieno[2,3-g]quinoline]-tetraones and spiro[thieno[2,3-g]quinoline-3,5'-[1,2,4]triazinane]-tetraones with potent antiproliferative activity.  Abstract: Two series of quinolinquinone derivatives, 2'H-spiro[imidazolidine-4,3'-thieno[2,3-g]quinoline]-2,4',5,9'-tetraones (2a-n) and 2H-spiro[thieno[2,3-g]quinoline-3,5'-[1,2,4]triazinane]-3',4,6',9-tetraones (3a-e), were designed and synthesized using the previously described ethyl 3-amino-4,9-dioxo-2,3,4,9-tetrahydrothieno[2,3-g]quinoline-3-carboxylate (1) as a starting material. All compounds were evaluated for their antiproliferative activity against a panel of representative liquid and solid human tumor cell lines and exhibit IC(50) values in the micromolar/submicromolar range. Series 2 displayed higher cytotoxicity than did series 3. The nature of the substituents on both imidazoline and triazinane N1 nitrogen markedly affected the activity profile of these series. Spectrophotometric and fluorescence measurements as well as unwinding assays performed on the most cytotoxic compounds, 2c, 2g, and 2k, showed that they are nonintercalative DNA agents and inhibit the catalytic activity of Topo II in a concentration-dependent mode. 2g was the most active Topo II inhibitor with activity levels comparable to those of VP-16.\", \"Title: Antitumor agents 6. Synthesis, structure-activity relationships, and biological evaluation of spiro[imidazolidine-4,3'-thieno[2,3-g]quinoline]-tetraones and spiro[thieno[2,3-g]quinoline-3,5'-[1,2,4]triazinane]-tetraones with potent antiproliferative activity.  Abstract: Two series of quinolinquinone derivatives, 2'H-spiro[imidazolidine-4,3'-thieno[2,3-g]quinoline]-2,4',5,9'-tetraones (2a-n) and 2H-spiro[thieno[2,3-g]quinoline-3,5'-[1,2,4]triazinane]-3',4,6',9-tetraones (3a-e), were designed and synthesized using the previously described ethyl 3-amino-4,9-dioxo-2,3,4,9-tetrahydrothieno[2,3-g]quinoline-3-carboxylate (1) as a starting material. All compounds were evaluated for their antiproliferative activity against a panel of representative liquid and solid human tumor cell lines and exhibit IC(50) values in the micromolar/submicromolar range. Series 2 displayed higher cytotoxicity than did series 3. The nature of the substituents on both imidazoline and triazinane N1 nitrogen markedly affected the activity profile of these series. Spectrophotometric and fluorescence measurements as well as unwinding assays performed on the most cytotoxic compounds, 2c, 2g, and 2k, showed that they are nonintercalative DNA agents and inhibit the catalytic activity of Topo II in a concentration-dependent mode. 2g was the most active Topo II inhibitor with activity levels comparable to those of VP-16.\", 'Title: 11-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine derivatives as novel topoisomerase I-targeting agents.  Abstract: Several 11-substituted benzo[i]phenanthridine derivatives were synthesized, and their TOP1-targeting activity and cytotoxicity were assessed. Comparative data indicate that TOP1-targeting was often the primary molecular target associated with their cytotoxicity. Several 11-aminoalkyl derivatives, 11-aminocarboxy derivatives as well as the 11-[(2-dimethylamino)ethyl]carboxamide of 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine were synthesized and did exhibit considerable cytotoxicity with IC(50) values ranging from 20 to 120 nM in the human lymphoblast tumor cell line RPMI8402.', 'Title: Substituent control of DNA binding modes in a series of chalcogenoxanthylium photosensitizers as determined by isothermal titration calorimetry and topoisomerase I DNA unwinding assay.  Abstract: The DNA binding efficacy and preferred mode of binding of a series of rhodamine-related chalcogenoxanthylium dyes was investigated by isothermal titration calorimetry (ITC) using ctDNA, [poly(dCdG)](2) and [poly(dAdT)](2), and by a topoisomerase I DNA unwinding (Topo I) assay. The dyes of this study showed tight binding to ctDNA with binding constants, K(b), on the order of 10(6)-10(7)M(-1). The ITC and Topo I assay studies suggested that the 9-substituent has a strong impact on binding modes ranging from an apparent preference for intercalation with a 9-2-thienyl substituent (similar binding to [poly(dCdG)](2) and [poly(dAdT)](2), re-supercoiling of DNA in the Topo I assay at <10(-5)M dye), to mixed binding modes with 9-phenyl derivatives (2- to 3-fold preference for binding to [poly(dAdT)](2), re-supercoiling of DNA in the Topo I assay at approximately 2 x 10(-5)M dye), to minor groove binding in a 9-(2-thienyl-5-diethylcarboxamide) derivative (strong preference for binding to [poly(dAdT)](2), did not show complete re-supercoiling in the Topo I assay). No binding to ctDNA was observed in one derivative with a 9-(3-thienyl-2-diethylcarboxamide) substituent, which cannot be co-planar with the xanthylium core. In series of dyes where the chalcogen atom was varied, the selenoxanthylium derivatives had 2- to 3-fold higher values of K(b) than the corresponding xanthylium, thioxanthylium, or telluroxanthylium derivatives, which all showed comparable values of K(b). The chalcogen atom appeared to have little influence on binding mode.', 'Title: Substituent control of DNA binding modes in a series of chalcogenoxanthylium photosensitizers as determined by isothermal titration calorimetry and topoisomerase I DNA unwinding assay.  Abstract: The DNA binding efficacy and preferred mode of binding of a series of rhodamine-related chalcogenoxanthylium dyes was investigated by isothermal titration calorimetry (ITC) using ctDNA, [poly(dCdG)](2) and [poly(dAdT)](2), and by a topoisomerase I DNA unwinding (Topo I) assay. The dyes of this study showed tight binding to ctDNA with binding constants, K(b), on the order of 10(6)-10(7)M(-1). The ITC and Topo I assay studies suggested that the 9-substituent has a strong impact on binding modes ranging from an apparent preference for intercalation with a 9-2-thienyl substituent (similar binding to [poly(dCdG)](2) and [poly(dAdT)](2), re-supercoiling of DNA in the Topo I assay at <10(-5)M dye), to mixed binding modes with 9-phenyl derivatives (2- to 3-fold preference for binding to [poly(dAdT)](2), re-supercoiling of DNA in the Topo I assay at approximately 2 x 10(-5)M dye), to minor groove binding in a 9-(2-thienyl-5-diethylcarboxamide) derivative (strong preference for binding to [poly(dAdT)](2), did not show complete re-supercoiling in the Topo I assay). No binding to ctDNA was observed in one derivative with a 9-(3-thienyl-2-diethylcarboxamide) substituent, which cannot be co-planar with the xanthylium core. In series of dyes where the chalcogen atom was varied, the selenoxanthylium derivatives had 2- to 3-fold higher values of K(b) than the corresponding xanthylium, thioxanthylium, or telluroxanthylium derivatives, which all showed comparable values of K(b). The chalcogen atom appeared to have little influence on binding mode.', 'Title: 12-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridines as novel topoisomerase I-targeting antitumor agents.  Abstract: 2,3-Dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine and a few of its 12-substituted analogs are active as TOP1-targeting agents. Studies were performed to further evaluate the potential of this series of non-camptothecin TOP1-targeting agents. The influence of a hydroxymethyl, formyl, N,N-dimethylaminomethyl, 2-(N,N-dimethylamino)ethyl, 3-(N,N-dimethylamino)propyl), and 4-(N,N-dimethylamino)butyl substituent at the 12-position on TOP1-targeting activity and tumor cell growth was evaluated. In addition, the relative pharmacologic activities of the 12-carboxamide analog, as well as its N-methyl and N,N-dimethyl derivatives were assessed.', 'Title: Synthesis of new camptothecin analogs with improved antitumor activities.  Abstract: Novel hexacyclic camptothecin analogs containing cyclic amidine, urea, or thiourea moiety were designed and synthesized based on the proposed 3D-structure of the topoisomerase I (Topo I)/DNA/camptothecin ternary complex. The analogs were prepared from 9-nitrocamptothecin via 7,9-diaminocamptothecin derivatives as a key intermediate. Among them, 7c exhibited in vivo antitumor activities superior to CPT-11 in human cancer xenograft models in mice at their maximum tolerated doses though its in vitro antiproliferative activity was comparable to SN-38 against corresponding cell lines.', 'Title: Calothrixins, a new class of human DNA topoisomerase I poisons.  Abstract: Calothrixins A (1) and B (2) were converted to their O- and N-methylated derivatives, respectively. All four compounds were found to act as poisons of DNA topoisomerase I and to do so reversibly. Three of the calothrixins (1-3) were tested for their cytotoxicity toward cultured (p53 proficient) CEM leukemia cells and found to exhibit IC(50) values ranging from 0.20 to 5.13 muM. The cell cycle effects of calothrixins 1-3 were also studied. Calothrixin B (2) produced G(1) arrest at 0.1 muM concentration, while higher concentrations of calothrixins 1 and 3 resulted in cell accumulation in both the S and G(2)/M phases of the cell cycle. The cell cycle effects produced by the calothrixins were more readily reversible upon removal of the compounds than those produced by camptothecin.', 'Title: Calothrixins, a new class of human DNA topoisomerase I poisons.  Abstract: Calothrixins A (1) and B (2) were converted to their O- and N-methylated derivatives, respectively. All four compounds were found to act as poisons of DNA topoisomerase I and to do so reversibly. Three of the calothrixins (1-3) were tested for their cytotoxicity toward cultured (p53 proficient) CEM leukemia cells and found to exhibit IC(50) values ranging from 0.20 to 5.13 muM. The cell cycle effects of calothrixins 1-3 were also studied. Calothrixin B (2) produced G(1) arrest at 0.1 muM concentration, while higher concentrations of calothrixins 1 and 3 resulted in cell accumulation in both the S and G(2)/M phases of the cell cycle. The cell cycle effects produced by the calothrixins were more readily reversible upon removal of the compounds than those produced by camptothecin.', 'Title: Calothrixins, a new class of human DNA topoisomerase I poisons.  Abstract: Calothrixins A (1) and B (2) were converted to their O- and N-methylated derivatives, respectively. All four compounds were found to act as poisons of DNA topoisomerase I and to do so reversibly. Three of the calothrixins (1-3) were tested for their cytotoxicity toward cultured (p53 proficient) CEM leukemia cells and found to exhibit IC(50) values ranging from 0.20 to 5.13 muM. The cell cycle effects of calothrixins 1-3 were also studied. Calothrixin B (2) produced G(1) arrest at 0.1 muM concentration, while higher concentrations of calothrixins 1 and 3 resulted in cell accumulation in both the S and G(2)/M phases of the cell cycle. The cell cycle effects produced by the calothrixins were more readily reversible upon removal of the compounds than those produced by camptothecin.', 'Title: Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification.  Abstract: A novel series of topoisomerase I (Top I) inhibitors were designed on the basis of camptothecin using scaffold modification strategy. Thirty-one new compounds were synthesized and evaluated for anticell proliferation activity. The most potent compound 26 presented a significant inhibitory effect on Top I, leading to Top I-mediated cleavage and influences on Top I expression at the cellular level. Moreover, 26 was proved to induce cell death via apoptosis and accelerated DNA strand breaks without significant alteration in cell cycle populations. All of the experimental results herein indicated that 26 could interact with DNA-Top I complex and induce cancer cell apoptosis to produce antitumor effects. The in vivo evaluation of 26 on the growth of HT-29 tumor xenografts in nude mice suggested its therapeutic potential for further development.', 'Title: Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification.  Abstract: A novel series of topoisomerase I (Top I) inhibitors were designed on the basis of camptothecin using scaffold modification strategy. Thirty-one new compounds were synthesized and evaluated for anticell proliferation activity. The most potent compound 26 presented a significant inhibitory effect on Top I, leading to Top I-mediated cleavage and influences on Top I expression at the cellular level. Moreover, 26 was proved to induce cell death via apoptosis and accelerated DNA strand breaks without significant alteration in cell cycle populations. All of the experimental results herein indicated that 26 could interact with DNA-Top I complex and induce cancer cell apoptosis to produce antitumor effects. The in vivo evaluation of 26 on the growth of HT-29 tumor xenografts in nude mice suggested its therapeutic potential for further development.', 'Title: Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification.  Abstract: A novel series of topoisomerase I (Top I) inhibitors were designed on the basis of camptothecin using scaffold modification strategy. Thirty-one new compounds were synthesized and evaluated for anticell proliferation activity. The most potent compound 26 presented a significant inhibitory effect on Top I, leading to Top I-mediated cleavage and influences on Top I expression at the cellular level. Moreover, 26 was proved to induce cell death via apoptosis and accelerated DNA strand breaks without significant alteration in cell cycle populations. All of the experimental results herein indicated that 26 could interact with DNA-Top I complex and induce cancer cell apoptosis to produce antitumor effects. The in vivo evaluation of 26 on the growth of HT-29 tumor xenografts in nude mice suggested its therapeutic potential for further development.', 'Title: Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification.  Abstract: A novel series of topoisomerase I (Top I) inhibitors were designed on the basis of camptothecin using scaffold modification strategy. Thirty-one new compounds were synthesized and evaluated for anticell proliferation activity. The most potent compound 26 presented a significant inhibitory effect on Top I, leading to Top I-mediated cleavage and influences on Top I expression at the cellular level. Moreover, 26 was proved to induce cell death via apoptosis and accelerated DNA strand breaks without significant alteration in cell cycle populations. All of the experimental results herein indicated that 26 could interact with DNA-Top I complex and induce cancer cell apoptosis to produce antitumor effects. The in vivo evaluation of 26 on the growth of HT-29 tumor xenografts in nude mice suggested its therapeutic potential for further development.', 'Title: Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification.  Abstract: A novel series of topoisomerase I (Top I) inhibitors were designed on the basis of camptothecin using scaffold modification strategy. Thirty-one new compounds were synthesized and evaluated for anticell proliferation activity. The most potent compound 26 presented a significant inhibitory effect on Top I, leading to Top I-mediated cleavage and influences on Top I expression at the cellular level. Moreover, 26 was proved to induce cell death via apoptosis and accelerated DNA strand breaks without significant alteration in cell cycle populations. All of the experimental results herein indicated that 26 could interact with DNA-Top I complex and induce cancer cell apoptosis to produce antitumor effects. The in vivo evaluation of 26 on the growth of HT-29 tumor xenografts in nude mice suggested its therapeutic potential for further development.', 'Title: Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification.  Abstract: A novel series of topoisomerase I (Top I) inhibitors were designed on the basis of camptothecin using scaffold modification strategy. Thirty-one new compounds were synthesized and evaluated for anticell proliferation activity. The most potent compound 26 presented a significant inhibitory effect on Top I, leading to Top I-mediated cleavage and influences on Top I expression at the cellular level. Moreover, 26 was proved to induce cell death via apoptosis and accelerated DNA strand breaks without significant alteration in cell cycle populations. All of the experimental results herein indicated that 26 could interact with DNA-Top I complex and induce cancer cell apoptosis to produce antitumor effects. The in vivo evaluation of 26 on the growth of HT-29 tumor xenografts in nude mice suggested its therapeutic potential for further development.', 'Title: Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification.  Abstract: A novel series of topoisomerase I (Top I) inhibitors were designed on the basis of camptothecin using scaffold modification strategy. Thirty-one new compounds were synthesized and evaluated for anticell proliferation activity. The most potent compound 26 presented a significant inhibitory effect on Top I, leading to Top I-mediated cleavage and influences on Top I expression at the cellular level. Moreover, 26 was proved to induce cell death via apoptosis and accelerated DNA strand breaks without significant alteration in cell cycle populations. All of the experimental results herein indicated that 26 could interact with DNA-Top I complex and induce cancer cell apoptosis to produce antitumor effects. The in vivo evaluation of 26 on the growth of HT-29 tumor xenografts in nude mice suggested its therapeutic potential for further development.', 'Title: On the role of topoisomerase I in mediating the cytotoxicity of 9-aminoacridine-based anticancer agents.  Abstract: The cytotoxicity and mechanism of action of a series of substituted 9-aminoacridines is evaluated using topoisomerase I and cancer cell growth inhibition assays. In previous work, compounds of this type were shown to catalytically inhibit topoisomerase II, leading to a G1-S phase arrest of the cell cycle and apoptosis in pancreatic cancer cells in vitro and in vivo. The present study expands the potential utility of these compounds in the development of cancer therapeutics by showing that these compounds inhibit proliferation of cell lines derived from the nine most common human cancers. Further results show that at least one of the compounds effectively stabilizes topoisomerase I-DNA adduct formation in intact cells. RNA interference experiments, however, indicate that this interaction does not contribute to the drug-induced killing of cancer cells indicating the compounds may be non-lethal poisons of topoisomerase I.', 'Title: On the role of topoisomerase I in mediating the cytotoxicity of 9-aminoacridine-based anticancer agents.  Abstract: The cytotoxicity and mechanism of action of a series of substituted 9-aminoacridines is evaluated using topoisomerase I and cancer cell growth inhibition assays. In previous work, compounds of this type were shown to catalytically inhibit topoisomerase II, leading to a G1-S phase arrest of the cell cycle and apoptosis in pancreatic cancer cells in vitro and in vivo. The present study expands the potential utility of these compounds in the development of cancer therapeutics by showing that these compounds inhibit proliferation of cell lines derived from the nine most common human cancers. Further results show that at least one of the compounds effectively stabilizes topoisomerase I-DNA adduct formation in intact cells. RNA interference experiments, however, indicate that this interaction does not contribute to the drug-induced killing of cancer cells indicating the compounds may be non-lethal poisons of topoisomerase I.', 'Title: On the role of topoisomerase I in mediating the cytotoxicity of 9-aminoacridine-based anticancer agents.  Abstract: The cytotoxicity and mechanism of action of a series of substituted 9-aminoacridines is evaluated using topoisomerase I and cancer cell growth inhibition assays. In previous work, compounds of this type were shown to catalytically inhibit topoisomerase II, leading to a G1-S phase arrest of the cell cycle and apoptosis in pancreatic cancer cells in vitro and in vivo. The present study expands the potential utility of these compounds in the development of cancer therapeutics by showing that these compounds inhibit proliferation of cell lines derived from the nine most common human cancers. Further results show that at least one of the compounds effectively stabilizes topoisomerase I-DNA adduct formation in intact cells. RNA interference experiments, however, indicate that this interaction does not contribute to the drug-induced killing of cancer cells indicating the compounds may be non-lethal poisons of topoisomerase I.', 'Title: On the role of topoisomerase I in mediating the cytotoxicity of 9-aminoacridine-based anticancer agents.  Abstract: The cytotoxicity and mechanism of action of a series of substituted 9-aminoacridines is evaluated using topoisomerase I and cancer cell growth inhibition assays. In previous work, compounds of this type were shown to catalytically inhibit topoisomerase II, leading to a G1-S phase arrest of the cell cycle and apoptosis in pancreatic cancer cells in vitro and in vivo. The present study expands the potential utility of these compounds in the development of cancer therapeutics by showing that these compounds inhibit proliferation of cell lines derived from the nine most common human cancers. Further results show that at least one of the compounds effectively stabilizes topoisomerase I-DNA adduct formation in intact cells. RNA interference experiments, however, indicate that this interaction does not contribute to the drug-induced killing of cancer cells indicating the compounds may be non-lethal poisons of topoisomerase I.', 'Title: On the role of topoisomerase I in mediating the cytotoxicity of 9-aminoacridine-based anticancer agents.  Abstract: The cytotoxicity and mechanism of action of a series of substituted 9-aminoacridines is evaluated using topoisomerase I and cancer cell growth inhibition assays. In previous work, compounds of this type were shown to catalytically inhibit topoisomerase II, leading to a G1-S phase arrest of the cell cycle and apoptosis in pancreatic cancer cells in vitro and in vivo. The present study expands the potential utility of these compounds in the development of cancer therapeutics by showing that these compounds inhibit proliferation of cell lines derived from the nine most common human cancers. Further results show that at least one of the compounds effectively stabilizes topoisomerase I-DNA adduct formation in intact cells. RNA interference experiments, however, indicate that this interaction does not contribute to the drug-induced killing of cancer cells indicating the compounds may be non-lethal poisons of topoisomerase I.', 'Title: On the role of topoisomerase I in mediating the cytotoxicity of 9-aminoacridine-based anticancer agents.  Abstract: The cytotoxicity and mechanism of action of a series of substituted 9-aminoacridines is evaluated using topoisomerase I and cancer cell growth inhibition assays. In previous work, compounds of this type were shown to catalytically inhibit topoisomerase II, leading to a G1-S phase arrest of the cell cycle and apoptosis in pancreatic cancer cells in vitro and in vivo. The present study expands the potential utility of these compounds in the development of cancer therapeutics by showing that these compounds inhibit proliferation of cell lines derived from the nine most common human cancers. Further results show that at least one of the compounds effectively stabilizes topoisomerase I-DNA adduct formation in intact cells. RNA interference experiments, however, indicate that this interaction does not contribute to the drug-induced killing of cancer cells indicating the compounds may be non-lethal poisons of topoisomerase I.', 'Title: Novel topoisomerase I-targeting antitumor agents synthesized from the N,N,N-trimethylammonium derivative of ARC-111, 5H-2,3-dimethoxy-8,9-methylenedioxy-5-[(2-N,N,N-trimethylammonium)ethyl]dibenzo[c,h][1,6]naphthyridin-6-one iodide.  Abstract: Several new TOP1-targeting agents were prepared using as an intermediate the N,N,N-trimethyl quaternary ammonium salt 2 of ARC-111. Direct displacement of the quaternary ammonium group with hydroxide, cyclopropylamine, imidazole, 1H-1,2,3-triazole, alkylethylenediamines, ethanolamine, and polyhydroxylated alkylamines provides a convenient means for furthering insight into the structure-activity relationships within this series of non-camptothecin TOP1-targeting agents. The relative TOP1-targeting activities and cytotoxicities were evaluated in RPMI8402 and P388 cells and their camptothecin-resistant variants. Their potential to serve as substrates for the efflux transporters MDR1 and BCRP, which are associated with multidrug resistance, was also assessed.', 'Title: Photochemical electrocyclisation of 3-vinylindoles to pyrido[2,3-a]-, pyrido[4,3-a]- and thieno[2,3-a]-carbazoles: design, synthesis, DNA binding and antitumor cell cytotoxicity.  Abstract: In the context of the design and synthesis of DNA ligands, some new hetarene annelated carbazoles were synthesized. As lead structure the intercalating tetracyclic systems pyrido[2,3-a]- and pyrido[4,3-a]-carbazoles and in one case a thieno[2,3-a]-carbazole were taken into account. A dialkyl amino amidic chain was introduced to the planar chromophoric system with the intent to generate minor groove binding properties. The cytotoxicity of some compounds was examined by the NCI antitumor screening. Furthermore, biophysical as well as biochemical studies were performed in order to get some information about the DNA-binding properties and inhibition of DNA related functional enzymes of this new series of molecules.', 'Title: Photochemical electrocyclisation of 3-vinylindoles to pyrido[2,3-a]-, pyrido[4,3-a]- and thieno[2,3-a]-carbazoles: design, synthesis, DNA binding and antitumor cell cytotoxicity.  Abstract: In the context of the design and synthesis of DNA ligands, some new hetarene annelated carbazoles were synthesized. As lead structure the intercalating tetracyclic systems pyrido[2,3-a]- and pyrido[4,3-a]-carbazoles and in one case a thieno[2,3-a]-carbazole were taken into account. A dialkyl amino amidic chain was introduced to the planar chromophoric system with the intent to generate minor groove binding properties. The cytotoxicity of some compounds was examined by the NCI antitumor screening. Furthermore, biophysical as well as biochemical studies were performed in order to get some information about the DNA-binding properties and inhibition of DNA related functional enzymes of this new series of molecules.', 'Title: A 2-substituted prodiginine, 2-(p-hydroxybenzyl)prodigiosin, from Pseudoalteromonas rubra.  Abstract: In the course of work aimed at the discovery of new pharmaceutical lead compounds from marine bacteria, a lipophilic extract of the bacterium Pseudoalteromonas rubra displayed significant cytotoxicity against SKOV-3, a human ovarian adenocarcinoma cell line. Bioassay-directed fractionation of this extract resulted in the isolation of a series of known and new prodiginine-type azafulvenes. The structure of the major metabolite was elucidated by interpretation of spectroscopic data as a 2-substituted prodigiosin, which we named 2-(p-hydroxybenzyl)prodigiosin (HBPG).', \"Title: Synthesis and antitumoral activity of novel thiazolobenzotriazole, thiazoloindolo[3,2-c]quinoline and quinolinoquinoline derivatives.  Abstract: The biological evaluation of some novel thiazoloindolo[3,2-c]quinoline, 8-substituted-11H-indolo[3,2-c]quinolines is described. These compounds were obtained via Graebe-Ullmann thermal cyclization from appropriated N-arylated benzotriazoles. 7H-4,7-Diaza-benzo[de]anthracene, a reaction by-product structurally closed to the pyridoacridine skeleton was also identified. All thiazolobenzotriazole intermediates were tested in vitro for their capacity to inhibit the growth of two breast cancer cell lines, MCF-7 and MDA-MB-231. In parallel, the newly synthesized skeletons were evaluated for DNA interaction, topoisomerases' inhibition, and cytotoxicity against HL60 and HL60/MX2 human leukemia cells. Most compounds showed a potent growth inhibitory effect on all the tested cell lines, with IC(50) in the muM range.\", 'Title: Reaction of the antitumor antibiotic olivomycin I with aryl diazonium salts. Synthesis, cytotoxic and antiretroviral potency of 5-aryldiazenyl-6-O-deglycosyl derivatives of olivomycin I.  Abstract: The azo coupling of the antibiotic olivomycin I (1) with aryl diazonium tetrafluoroborates produced 5-aryldiazenyl-6-O-deglycosyl derivatives of 1. The structures of new compounds were confirmed by (1)H NMR and mass spectrometry analysis. A quantum-chemical study was performed to analyze the possible directions of electrophilic substitution of 1 and the easiness of 6-O-disaccharide hydrolysis in the course of azo coupling. The antiproliferative and anti-retroviral activities of novel derivatives were studied.', 'Title: Reaction of the antitumor antibiotic olivomycin I with aryl diazonium salts. Synthesis, cytotoxic and antiretroviral potency of 5-aryldiazenyl-6-O-deglycosyl derivatives of olivomycin I.  Abstract: The azo coupling of the antibiotic olivomycin I (1) with aryl diazonium tetrafluoroborates produced 5-aryldiazenyl-6-O-deglycosyl derivatives of 1. The structures of new compounds were confirmed by (1)H NMR and mass spectrometry analysis. A quantum-chemical study was performed to analyze the possible directions of electrophilic substitution of 1 and the easiness of 6-O-disaccharide hydrolysis in the course of azo coupling. The antiproliferative and anti-retroviral activities of novel derivatives were studied.', 'Title: Reaction of the antitumor antibiotic olivomycin I with aryl diazonium salts. Synthesis, cytotoxic and antiretroviral potency of 5-aryldiazenyl-6-O-deglycosyl derivatives of olivomycin I.  Abstract: The azo coupling of the antibiotic olivomycin I (1) with aryl diazonium tetrafluoroborates produced 5-aryldiazenyl-6-O-deglycosyl derivatives of 1. The structures of new compounds were confirmed by (1)H NMR and mass spectrometry analysis. A quantum-chemical study was performed to analyze the possible directions of electrophilic substitution of 1 and the easiness of 6-O-disaccharide hydrolysis in the course of azo coupling. The antiproliferative and anti-retroviral activities of novel derivatives were studied.', 'Title: Reaction of the antitumor antibiotic olivomycin I with aryl diazonium salts. Synthesis, cytotoxic and antiretroviral potency of 5-aryldiazenyl-6-O-deglycosyl derivatives of olivomycin I.  Abstract: The azo coupling of the antibiotic olivomycin I (1) with aryl diazonium tetrafluoroborates produced 5-aryldiazenyl-6-O-deglycosyl derivatives of 1. The structures of new compounds were confirmed by (1)H NMR and mass spectrometry analysis. A quantum-chemical study was performed to analyze the possible directions of electrophilic substitution of 1 and the easiness of 6-O-disaccharide hydrolysis in the course of azo coupling. The antiproliferative and anti-retroviral activities of novel derivatives were studied.', 'Title: Synthesis of gibberellin derivatives with anti-tumor bioactivities.  Abstract: A series of gibberellin based molecules were designed and synthesized. Gibberellin derivatives bearing two alpha,beta-unsaturated ketone units showed strong anticancer activities in MTT assay towards a number of human cancer cell lines including HT29, A549, HepG2 and MKN28. The most potent gibberellin derivative (compound 10, IC(50)=2.9 microM against HT29) inhibited completely the topoisomerase I activity at 8 microg/mL level.', 'Title: Synthesis of gibberellin derivatives with anti-tumor bioactivities.  Abstract: A series of gibberellin based molecules were designed and synthesized. Gibberellin derivatives bearing two alpha,beta-unsaturated ketone units showed strong anticancer activities in MTT assay towards a number of human cancer cell lines including HT29, A549, HepG2 and MKN28. The most potent gibberellin derivative (compound 10, IC(50)=2.9 microM against HT29) inhibited completely the topoisomerase I activity at 8 microg/mL level.', 'Title: Synthesis, tautomerism, and antimicrobial, anti-HCV, anti-SSPE, antioxidant, and antitumor activities of arylazobenzosuberones.  Abstract: 2-Dimethylaminomethylene-1-benzosuberone 1 was coupled with diazotized aniline derivatives to afford a series of the hitherto unreported 2-arylazo-1-benzosuberones 3a-i. The tautomeric structure and the effect of substituents on the tautomeric form (s) of the products 3a-i were discussed. Similar coupling of the enaminone 1 with diazonium salts of heterocyclic amines gave the respective fused azolotriazino-benzosuberones. Some of the newly synthesized compounds showed potent antimicrobial, anti-HCV, antioxidant, antitumor (as topoisomerase I inhibitors), and antimicrobial activities.', \"Title: Synthesis and biological evaluation of 14-(aminoalkyl-aminomethyl)aromathecins as topoisomerase I inhibitors: investigating the hypothesis of shared structure-activity relationships.  Abstract: The aromathecin topoisomerase I (top1) inhibitors offer promising scaffolds for the development of novel cancer chemotherapeutics. They are 'composites' of the camptothecin and indenoisoquinoline top1 inhibitors. Interestingly, some structure-activity relationship (SAR) overlap between the aromathecins and the indenoisoquinolines has been observed. For both classes, placement of certain polar groups in similar regions of the heteroaromatic system improves top1 inhibitory and antiproliferative activities. A series of water-soluble aromathecins substituted at position 14 with diaminoalkanes of various lengths has been prepared. These compounds all possess similar antiproliferative potency, but a general trend is observed: aromathecins with longer diaminoalkane substituents (>6 carbons) possess lower anti-top1 activity than their smaller counterparts (2-4 carbons), presumably as a result of unfavorable hydrophobic interactions. This trend is also noted with the indenoisoquinolines, revealing additional SAR overlap that supports the hypothesis that there is a 'universal' top1 inhibitor SAR.\", 'Title: 2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.  Abstract: Designed and synthesized 60 2-thienyl-4-furyl-6-aryl pyridine derivatives were evaluated for their topoisomerase I and II inhibitory activities at 20 microM and 100 microM and cytotoxicity against several human cancer cell lines. Compounds 8, 9, 11-29 showed significant topoisomerase II inhibitory activity and compounds 10 and 11 showed significant topoisomerase I inhibitory activity. Most of the compounds (7-21) possessing 2-(5-chlorothiophen-2-yl)-4-(furan-3-yl) moiety showed higher or similar cytotoxicity against HCT15 cell line as compared to standards. Most of the selected compounds displayed moderate cytotoxicity against MCF-7, HeLa, DU145, and K562 cell lines. Structure-activity relationship study revealed that 2-(5-chlorothiophen-2-yl)-4-(furan-3-yl) moiety has an important role in displaying biological activities.', 'Title: 2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.  Abstract: Designed and synthesized 60 2-thienyl-4-furyl-6-aryl pyridine derivatives were evaluated for their topoisomerase I and II inhibitory activities at 20 microM and 100 microM and cytotoxicity against several human cancer cell lines. Compounds 8, 9, 11-29 showed significant topoisomerase II inhibitory activity and compounds 10 and 11 showed significant topoisomerase I inhibitory activity. Most of the compounds (7-21) possessing 2-(5-chlorothiophen-2-yl)-4-(furan-3-yl) moiety showed higher or similar cytotoxicity against HCT15 cell line as compared to standards. Most of the selected compounds displayed moderate cytotoxicity against MCF-7, HeLa, DU145, and K562 cell lines. Structure-activity relationship study revealed that 2-(5-chlorothiophen-2-yl)-4-(furan-3-yl) moiety has an important role in displaying biological activities.', 'Title: Structure-based design, synthesis, and biological studies of new anticancer norindenoisoquinoline topoisomerase I inhibitors.  Abstract: On the basis of the superimposition of the crystal structures of norindenoisoquinoline 5 and topotecan (2) bound in the topoisomerase I-DNA covalent complex, as well as molecular docking and quantum chemical calculations, the substituted norindenoisoquinoline 14a was designed by transporting the 9-dimethylaminomethyl group of topotecan to the 10-position of the norindenoisoquinoline 5. The desired compound 14a was synthesized and found to possess topoisomerase I inhibitory activity that was slightly better than that of the starting compound 5. A focused set of 10-substitued norindenoisoquinoline analogues were then synthesized. The imidazole-substituted compound 14c was highly cytotoxic when evaluated in a series of human leukemia, ovarian, and breast cancer cells.', 'Title: New benzoxanthone derivatives as topoisomerase inhibitors and DNA cross-linkers.  Abstract: We synthesized 12 benzoxanthone derivatives classified as three different groups based on the tetracyclic ring shapes and evaluated their pharmacological activities to find potential anticancer agents. In the cytotoxicity test, most compounds showed effective cancer cell growth inhibition against the HT29 and DU145 cell lines. Among the compounds tested, compound 19 was the most effective in the cancer cell lines tested. Compound 9 showed dual inhibitory activities against DNA relaxation by topoisomerases I and II. The% inhibition of compound 9 on topoisomerase I was comparable to that of camptothecin. Compound 9 efficiently blocked topoisomerase II function by almost threefold than etoposide at 20 microM. Compound 19 had selective topoisomerase II inhibitory activity at 100 microM. The DNA cross-linking test revealed that only compounds 8 and 19, which possess epoxy groups, cross-linked DNA duplex, while 14 did not. From the combined pharmacological results, we proposed that the target through which compound 19 inhibits cancer cell growth may be the DNA duplex itself and/or DNA-topoisomerase II complex.', 'Title: New benzoxanthone derivatives as topoisomerase inhibitors and DNA cross-linkers.  Abstract: We synthesized 12 benzoxanthone derivatives classified as three different groups based on the tetracyclic ring shapes and evaluated their pharmacological activities to find potential anticancer agents. In the cytotoxicity test, most compounds showed effective cancer cell growth inhibition against the HT29 and DU145 cell lines. Among the compounds tested, compound 19 was the most effective in the cancer cell lines tested. Compound 9 showed dual inhibitory activities against DNA relaxation by topoisomerases I and II. The% inhibition of compound 9 on topoisomerase I was comparable to that of camptothecin. Compound 9 efficiently blocked topoisomerase II function by almost threefold than etoposide at 20 microM. Compound 19 had selective topoisomerase II inhibitory activity at 100 microM. The DNA cross-linking test revealed that only compounds 8 and 19, which possess epoxy groups, cross-linked DNA duplex, while 14 did not. From the combined pharmacological results, we proposed that the target through which compound 19 inhibits cancer cell growth may be the DNA duplex itself and/or DNA-topoisomerase II complex.', 'Title: Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.  Abstract: A series of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives were designed, synthesized, and evaluated for their topoisomerase I and II inhibition and cytotoxic activity against several human cancer cell lines. Compounds 10-19 showed moderate topoisomerase I and II inhibitory activity and 20-29 showed significant topoisomerase II inhibitory activity. Structure-activity relationship study revealed that 4-(5-chlorofuran-2-yl)-2-(thiophen-3-yl) moiety has an important role in displaying topoisomerase II inhibition.', 'Title: Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.  Abstract: A series of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives were designed, synthesized, and evaluated for their topoisomerase I and II inhibition and cytotoxic activity against several human cancer cell lines. Compounds 10-19 showed moderate topoisomerase I and II inhibitory activity and 20-29 showed significant topoisomerase II inhibitory activity. Structure-activity relationship study revealed that 4-(5-chlorofuran-2-yl)-2-(thiophen-3-yl) moiety has an important role in displaying topoisomerase II inhibition.', 'Title: Synthesis and antiproliferative evaluation of certain indolo[3,2-c]quinoline derivatives.  Abstract: The present report describes the synthesis and antiproliferative evaluation of certain indolo[3,2-c]quinoline derivatives. For the C(6) anilino-substituted derivatives, (11H-indolo[3,2-c]quinolin-6-yl)phenylamine (6a) was inactive. Structural optimization of 6a by the introduction of a hydroxyl group at the anilino-moiety resulted in the enhancement of antiproliferative activity in which the activity decreased in an order of para-OH, 7a>meta-OH, 8a>ortho-OH, 9a. For the C(6) alkylamino-substituted derivatives, 11a, 12a, 13a, 14a, and 15a exhibited comparable antiproliferative activities against all cancer cells tested and the skin Detroit 551 normal fibroblast cells. Three cancer cells, HeLa, A549, and SKHep, are very susceptible with IC(50) of less than 2.17 microM while PC-3 is relatively resistant to this group of indolo[3,2-c]quinolines. For the 2-phenylethylamino derivatives, compound 20a is active against the growth of HeLa with an IC(50) of 0.52 microM, but is less effective against the growth of Detroit 551 with an IC(50) of 19.32 microM. For the bis-indolo[3,2-c]quinolines, N,N-bis-[3-(11H-indolo[3,2-c]quinolin-6-yl)aminopropyl]amine hydrochloride (25) is more active than its N-methyl derivative 26 and the positive Doxorubicin. Mechanism studies indicated 25 can induce caspase-3 activation, gamma-H2AX phosphorylation, cleavage of poly(ADP-ribose)polymerase and DNA fragmentation. These results provide evidence that DNA, topo I, and topo II are the primary targets of indolo[3,2-c]quinoline derivatives and that consequently inhibits proliferation and causes apoptosis in cancer cells.', 'Title: Synthesis and antiproliferative evaluation of certain indolo[3,2-c]quinoline derivatives.  Abstract: The present report describes the synthesis and antiproliferative evaluation of certain indolo[3,2-c]quinoline derivatives. For the C(6) anilino-substituted derivatives, (11H-indolo[3,2-c]quinolin-6-yl)phenylamine (6a) was inactive. Structural optimization of 6a by the introduction of a hydroxyl group at the anilino-moiety resulted in the enhancement of antiproliferative activity in which the activity decreased in an order of para-OH, 7a>meta-OH, 8a>ortho-OH, 9a. For the C(6) alkylamino-substituted derivatives, 11a, 12a, 13a, 14a, and 15a exhibited comparable antiproliferative activities against all cancer cells tested and the skin Detroit 551 normal fibroblast cells. Three cancer cells, HeLa, A549, and SKHep, are very susceptible with IC(50) of less than 2.17 microM while PC-3 is relatively resistant to this group of indolo[3,2-c]quinolines. For the 2-phenylethylamino derivatives, compound 20a is active against the growth of HeLa with an IC(50) of 0.52 microM, but is less effective against the growth of Detroit 551 with an IC(50) of 19.32 microM. For the bis-indolo[3,2-c]quinolines, N,N-bis-[3-(11H-indolo[3,2-c]quinolin-6-yl)aminopropyl]amine hydrochloride (25) is more active than its N-methyl derivative 26 and the positive Doxorubicin. Mechanism studies indicated 25 can induce caspase-3 activation, gamma-H2AX phosphorylation, cleavage of poly(ADP-ribose)polymerase and DNA fragmentation. These results provide evidence that DNA, topo I, and topo II are the primary targets of indolo[3,2-c]quinoline derivatives and that consequently inhibits proliferation and causes apoptosis in cancer cells.', 'Title: Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.  Abstract: A total of seven new oxyranylmethyloxy or thiiranylmethyloxy group substituted 5-azaxanthones and -acridones analogues were synthesized and tested for their biological activities for cancer cell lines and topoisomerases. Among the compounds, compound 5, 3-thiiranylmethyloxy-1-hydroxy-5-azaxanthone, showed effective topoisomerase I inhibitory activity, 50% and 27% inhibition ratio at 100 and 20muM, respectively. This result is the first finding of the function of 5-azaxanthone compounds for topoisomerase I inhibition and can provide a novel skeleton for the anticancer drug development process.', 'Title: Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.  Abstract: A total of seven new oxyranylmethyloxy or thiiranylmethyloxy group substituted 5-azaxanthones and -acridones analogues were synthesized and tested for their biological activities for cancer cell lines and topoisomerases. Among the compounds, compound 5, 3-thiiranylmethyloxy-1-hydroxy-5-azaxanthone, showed effective topoisomerase I inhibitory activity, 50% and 27% inhibition ratio at 100 and 20muM, respectively. This result is the first finding of the function of 5-azaxanthone compounds for topoisomerase I inhibition and can provide a novel skeleton for the anticancer drug development process.', 'Title: Rational design and semisynthesis of betulinic acid analogues as potent topoisomerase inhibitors.  Abstract: Chemical transformation studies were conducted on betulinic acid (1), a common plant-derived lupane-type triterpene. Eleven new rationally designed derivatives of 1 (2-5 and 7-13) were synthesized based on docking studies and tested for their topoisomerase I and IIalpha inhibitory activity. Semisynthetic reactions targeted C-3, C-20, and C-28 in 1. Structures of the new compounds were confirmed by spectroscopic methods (1D and 2D NMR and MS). Compound 9, 3-O-[N-(phenylsulfonyl)carbamoyl-17beta-N-(phenylsulfonyl)amide]betulinic acid, showed 1.5-fold the activity of CPT in a topoisomerase I DNA relaxation assay. Four out of 14 betulinic acid analogues (5, 9, 11, and 12) showed 1.5-fold the activity of etoposide in a topoisomerase II assay. The new analogues exhibited better cytotoxic activities against the human colon cancer cells SW948 and HCT-116 and the breast cancer cell line MDA-MB-231 compared to the parent (1). Betulinic acid (1) is a potential scaffold for the design of new topoisomerase I and IIalpha inhibitors.', \"Title: 4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors.  Abstract: Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is an enzyme that catalyzes the hydrolysis of 3'-phosphotyrosyl bonds. Such linkages form in vivo when topoisomerase I (Top1) processes DNA. For this reason, Tdp1 has been implicated in the repair of irreversible Top1-DNA covalent complexes. Tdp1 inhibitors have been regarded as potential therapeutics in combination with Top1 inhibitors, such as the camptothecin derivatives, topotecan, and irinotecan, which are used to treat human cancers. Using a novel high-throughput screening assay, we have identified the C21-substituted progesterone derivative, NSC 88915 (1), as a potential Tdp1 inhibitor. Secondary screening and cross-reactivity studies with related DNA processing enzymes confirmed that compound 1 possesses specific Tdp1 inhibitory activity. Deconstruction of compound 1 into discrete functional groups reveals that both components are required for inhibition of Tdp1 activity. Moreover, the synthesis of analogues of compound 1 has provided insight into the structural requirements for the inhibition of Tdp1. Surface plasmon resonance shows that compound 1 binds to Tdp1, whereas an inactive analogue fails to interact with the enzyme. On the basis of molecular docking and mechanistic studies, we propose that these compounds are competitive inhibitors, which mimics the oligonucleotide-peptide Tdp1 substrate. These steroid derivatives represent a novel chemotype and provide a new scaffold for developing small molecule inhibitors of Tdp1.\", 'Title: A series of alpha-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity.  Abstract: A series of novel thiosemicarbazone derivatives bearing condensed heterocyclic carboxaldehyde moieties were designed and synthesized. Among them, TSC24 exhibited broad antiproliferative activity in a panel of human tumor cells and suppressed tumor growth in mice. The mechanism research revealed that TSC24 was not only an iron chelator but also a topoisomerase IIalpha catalytic inhibitor. Its inhibition on topoisomerase IIalpha was due to direct interaction with the ATPase domain of topoisomerase IIalpha which led to the block of ATP hydrolysis. Molecular docking predicted that TSC24 might bind at the ATP binding site, which was confirmed by the competitive inhibition assay. These results about the mechanisms involved in the anticancer activities of thiosemicarbazones will aid in the rational design of novel topoisomerase II-targeted drugs and will provide insights into the discovery and development of novel cancer therapeutics based on the dual activity to chelate iron and to inhibit the catalytic activity of topoisomerase IIalpha.', 'Title: A series of alpha-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity.  Abstract: A series of novel thiosemicarbazone derivatives bearing condensed heterocyclic carboxaldehyde moieties were designed and synthesized. Among them, TSC24 exhibited broad antiproliferative activity in a panel of human tumor cells and suppressed tumor growth in mice. The mechanism research revealed that TSC24 was not only an iron chelator but also a topoisomerase IIalpha catalytic inhibitor. Its inhibition on topoisomerase IIalpha was due to direct interaction with the ATPase domain of topoisomerase IIalpha which led to the block of ATP hydrolysis. Molecular docking predicted that TSC24 might bind at the ATP binding site, which was confirmed by the competitive inhibition assay. These results about the mechanisms involved in the anticancer activities of thiosemicarbazones will aid in the rational design of novel topoisomerase II-targeted drugs and will provide insights into the discovery and development of novel cancer therapeutics based on the dual activity to chelate iron and to inhibit the catalytic activity of topoisomerase IIalpha.', 'Title: A series of alpha-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity.  Abstract: A series of novel thiosemicarbazone derivatives bearing condensed heterocyclic carboxaldehyde moieties were designed and synthesized. Among them, TSC24 exhibited broad antiproliferative activity in a panel of human tumor cells and suppressed tumor growth in mice. The mechanism research revealed that TSC24 was not only an iron chelator but also a topoisomerase IIalpha catalytic inhibitor. Its inhibition on topoisomerase IIalpha was due to direct interaction with the ATPase domain of topoisomerase IIalpha which led to the block of ATP hydrolysis. Molecular docking predicted that TSC24 might bind at the ATP binding site, which was confirmed by the competitive inhibition assay. These results about the mechanisms involved in the anticancer activities of thiosemicarbazones will aid in the rational design of novel topoisomerase II-targeted drugs and will provide insights into the discovery and development of novel cancer therapeutics based on the dual activity to chelate iron and to inhibit the catalytic activity of topoisomerase IIalpha.', 'Title: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines.  Abstract: A new series of 2,4-diphenyl-6-aryl pyridines containing hydroxyl group(s) at the ortho, meta, or para position of the phenyl ring were synthesized, and evaluated for topoisomerase I and II inhibitory activity and cytotoxicity against several human cancer cell lines for the development of novel anticancer agents. Structure-activity relationship study revealed that the substitution of hydroxyl group(s) increased topoisomerase I and II inhibitory activity in the order of meta > para > ortho position. Substitution of hydroxyl group on the para position showed better cytotoxicity.', 'Title: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines.  Abstract: A new series of 2,4-diphenyl-6-aryl pyridines containing hydroxyl group(s) at the ortho, meta, or para position of the phenyl ring were synthesized, and evaluated for topoisomerase I and II inhibitory activity and cytotoxicity against several human cancer cell lines for the development of novel anticancer agents. Structure-activity relationship study revealed that the substitution of hydroxyl group(s) increased topoisomerase I and II inhibitory activity in the order of meta > para > ortho position. Substitution of hydroxyl group on the para position showed better cytotoxicity.', 'Title: Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.  Abstract: Cytotoxicity and inhibition on human DNA topoisomerase I (TOP1) and II (TOP2) of 74 plant-originated triterpenoids and triterpenoid glycosides were investigated. The cytotoxic compounds are primarily polyhydroxylated oleananes (GI(50) of A549: 1.0-10.19 microM). Sixteen cytotoxic aesculiosides isolated from Aesculus pavia inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, hydrolysis of six active aesculiosides (1, 4, 6, 8, 10, and 23) lost their TOP1 activities but enhanced their cytotoxicities. None of the test compounds showed any activity against TOP2. Structure-activity relationship (SAR) investigations indicated that cytotoxic oleananes required at least one angeloyl moiety at either C-21 or C-22 but the sugar moiety at C-3 may decrease their cytotoxicities. An angeloyl or tigeloyl group at C-21 is required for oleananes to bind the free TOP1 enzyme although the type and length of acyl moiety at C-22 also affects their activity. However, sugar moiety at C-3 is necessary for their TOP1 activities.', 'Title: Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.  Abstract: Cytotoxicity and inhibition on human DNA topoisomerase I (TOP1) and II (TOP2) of 74 plant-originated triterpenoids and triterpenoid glycosides were investigated. The cytotoxic compounds are primarily polyhydroxylated oleananes (GI(50) of A549: 1.0-10.19 microM). Sixteen cytotoxic aesculiosides isolated from Aesculus pavia inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, hydrolysis of six active aesculiosides (1, 4, 6, 8, 10, and 23) lost their TOP1 activities but enhanced their cytotoxicities. None of the test compounds showed any activity against TOP2. Structure-activity relationship (SAR) investigations indicated that cytotoxic oleananes required at least one angeloyl moiety at either C-21 or C-22 but the sugar moiety at C-3 may decrease their cytotoxicities. An angeloyl or tigeloyl group at C-21 is required for oleananes to bind the free TOP1 enzyme although the type and length of acyl moiety at C-22 also affects their activity. However, sugar moiety at C-3 is necessary for their TOP1 activities.', 'Title: Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.  Abstract: Cytotoxicity and inhibition on human DNA topoisomerase I (TOP1) and II (TOP2) of 74 plant-originated triterpenoids and triterpenoid glycosides were investigated. The cytotoxic compounds are primarily polyhydroxylated oleananes (GI(50) of A549: 1.0-10.19 microM). Sixteen cytotoxic aesculiosides isolated from Aesculus pavia inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, hydrolysis of six active aesculiosides (1, 4, 6, 8, 10, and 23) lost their TOP1 activities but enhanced their cytotoxicities. None of the test compounds showed any activity against TOP2. Structure-activity relationship (SAR) investigations indicated that cytotoxic oleananes required at least one angeloyl moiety at either C-21 or C-22 but the sugar moiety at C-3 may decrease their cytotoxicities. An angeloyl or tigeloyl group at C-21 is required for oleananes to bind the free TOP1 enzyme although the type and length of acyl moiety at C-22 also affects their activity. However, sugar moiety at C-3 is necessary for their TOP1 activities.', 'Title: Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.  Abstract: Cytotoxicity and inhibition on human DNA topoisomerase I (TOP1) and II (TOP2) of 74 plant-originated triterpenoids and triterpenoid glycosides were investigated. The cytotoxic compounds are primarily polyhydroxylated oleananes (GI(50) of A549: 1.0-10.19 microM). Sixteen cytotoxic aesculiosides isolated from Aesculus pavia inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, hydrolysis of six active aesculiosides (1, 4, 6, 8, 10, and 23) lost their TOP1 activities but enhanced their cytotoxicities. None of the test compounds showed any activity against TOP2. Structure-activity relationship (SAR) investigations indicated that cytotoxic oleananes required at least one angeloyl moiety at either C-21 or C-22 but the sugar moiety at C-3 may decrease their cytotoxicities. An angeloyl or tigeloyl group at C-21 is required for oleananes to bind the free TOP1 enzyme although the type and length of acyl moiety at C-22 also affects their activity. However, sugar moiety at C-3 is necessary for their TOP1 activities.', 'Title: Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.  Abstract: Cytotoxicity and inhibition on human DNA topoisomerase I (TOP1) and II (TOP2) of 74 plant-originated triterpenoids and triterpenoid glycosides were investigated. The cytotoxic compounds are primarily polyhydroxylated oleananes (GI(50) of A549: 1.0-10.19 microM). Sixteen cytotoxic aesculiosides isolated from Aesculus pavia inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, hydrolysis of six active aesculiosides (1, 4, 6, 8, 10, and 23) lost their TOP1 activities but enhanced their cytotoxicities. None of the test compounds showed any activity against TOP2. Structure-activity relationship (SAR) investigations indicated that cytotoxic oleananes required at least one angeloyl moiety at either C-21 or C-22 but the sugar moiety at C-3 may decrease their cytotoxicities. An angeloyl or tigeloyl group at C-21 is required for oleananes to bind the free TOP1 enzyme although the type and length of acyl moiety at C-22 also affects their activity. However, sugar moiety at C-3 is necessary for their TOP1 activities.', 'Title: Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.  Abstract: Cytotoxicity and inhibition on human DNA topoisomerase I (TOP1) and II (TOP2) of 74 plant-originated triterpenoids and triterpenoid glycosides were investigated. The cytotoxic compounds are primarily polyhydroxylated oleananes (GI(50) of A549: 1.0-10.19 microM). Sixteen cytotoxic aesculiosides isolated from Aesculus pavia inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, hydrolysis of six active aesculiosides (1, 4, 6, 8, 10, and 23) lost their TOP1 activities but enhanced their cytotoxicities. None of the test compounds showed any activity against TOP2. Structure-activity relationship (SAR) investigations indicated that cytotoxic oleananes required at least one angeloyl moiety at either C-21 or C-22 but the sugar moiety at C-3 may decrease their cytotoxicities. An angeloyl or tigeloyl group at C-21 is required for oleananes to bind the free TOP1 enzyme although the type and length of acyl moiety at C-22 also affects their activity. However, sugar moiety at C-3 is necessary for their TOP1 activities.', 'Title: Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.  Abstract: Cytotoxicity and inhibition on human DNA topoisomerase I (TOP1) and II (TOP2) of 74 plant-originated triterpenoids and triterpenoid glycosides were investigated. The cytotoxic compounds are primarily polyhydroxylated oleananes (GI(50) of A549: 1.0-10.19 microM). Sixteen cytotoxic aesculiosides isolated from Aesculus pavia inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, hydrolysis of six active aesculiosides (1, 4, 6, 8, 10, and 23) lost their TOP1 activities but enhanced their cytotoxicities. None of the test compounds showed any activity against TOP2. Structure-activity relationship (SAR) investigations indicated that cytotoxic oleananes required at least one angeloyl moiety at either C-21 or C-22 but the sugar moiety at C-3 may decrease their cytotoxicities. An angeloyl or tigeloyl group at C-21 is required for oleananes to bind the free TOP1 enzyme although the type and length of acyl moiety at C-22 also affects their activity. However, sugar moiety at C-3 is necessary for their TOP1 activities.', 'Title: Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.  Abstract: Cytotoxicity and inhibition on human DNA topoisomerase I (TOP1) and II (TOP2) of 74 plant-originated triterpenoids and triterpenoid glycosides were investigated. The cytotoxic compounds are primarily polyhydroxylated oleananes (GI(50) of A549: 1.0-10.19 microM). Sixteen cytotoxic aesculiosides isolated from Aesculus pavia inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, hydrolysis of six active aesculiosides (1, 4, 6, 8, 10, and 23) lost their TOP1 activities but enhanced their cytotoxicities. None of the test compounds showed any activity against TOP2. Structure-activity relationship (SAR) investigations indicated that cytotoxic oleananes required at least one angeloyl moiety at either C-21 or C-22 but the sugar moiety at C-3 may decrease their cytotoxicities. An angeloyl or tigeloyl group at C-21 is required for oleananes to bind the free TOP1 enzyme although the type and length of acyl moiety at C-22 also affects their activity. However, sugar moiety at C-3 is necessary for their TOP1 activities.', 'Title: Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.  Abstract: Cytotoxicity and inhibition on human DNA topoisomerase I (TOP1) and II (TOP2) of 74 plant-originated triterpenoids and triterpenoid glycosides were investigated. The cytotoxic compounds are primarily polyhydroxylated oleananes (GI(50) of A549: 1.0-10.19 microM). Sixteen cytotoxic aesculiosides isolated from Aesculus pavia inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, hydrolysis of six active aesculiosides (1, 4, 6, 8, 10, and 23) lost their TOP1 activities but enhanced their cytotoxicities. None of the test compounds showed any activity against TOP2. Structure-activity relationship (SAR) investigations indicated that cytotoxic oleananes required at least one angeloyl moiety at either C-21 or C-22 but the sugar moiety at C-3 may decrease their cytotoxicities. An angeloyl or tigeloyl group at C-21 is required for oleananes to bind the free TOP1 enzyme although the type and length of acyl moiety at C-22 also affects their activity. However, sugar moiety at C-3 is necessary for their TOP1 activities.', 'Title: Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.  Abstract: Cytotoxicity and inhibition on human DNA topoisomerase I (TOP1) and II (TOP2) of 74 plant-originated triterpenoids and triterpenoid glycosides were investigated. The cytotoxic compounds are primarily polyhydroxylated oleananes (GI(50) of A549: 1.0-10.19 microM). Sixteen cytotoxic aesculiosides isolated from Aesculus pavia inhibited TOP1 catalytic activity by interacting directly with the free enzyme and preventing the formation of the DNA-TOP1 complex. Interestingly, hydrolysis of six active aesculiosides (1, 4, 6, 8, 10, and 23) lost their TOP1 activities but enhanced their cytotoxicities. None of the test compounds showed any activity against TOP2. Structure-activity relationship (SAR) investigations indicated that cytotoxic oleananes required at least one angeloyl moiety at either C-21 or C-22 but the sugar moiety at C-3 may decrease their cytotoxicities. An angeloyl or tigeloyl group at C-21 is required for oleananes to bind the free TOP1 enzyme although the type and length of acyl moiety at C-22 also affects their activity. However, sugar moiety at C-3 is necessary for their TOP1 activities.', 'Title: Antimicrobial activity of tryptanthrins in Escherichia coli.  Abstract: Tryptanthrins have potential therapeutic activity against a wide variety of pathogenic organisms, although little is known about their mechanism. Activity against Escherichia coli, however, has not been examined. The effects of tryptanthrin (indolo[2,1-b]quinazolin-6,12-dione) and nine derivatives on growth, survival, and mutagenesis in E. coli were examined. Analogues with a nitrogen atom at the 4-position of tryptanthrin stopped log phase growth of E. coli cultures at concentrations as low as 5 microM. Tryptanthrins decreased viability during incubation with cells in buffer by factors of 10(-2) to <10(-6) at 0.2-40 microM. Derivatives with an oxime group at the 6-position exhibited the greatest bactericidal activity. Most tryptanthrins were not mutagenic in several independent assays, although the 4-aza and 4 aza-8-fluoro derivatives increased frameshift mutations about 22- and 4-fold, respectively. Given the structure of trypanthrins, binding to DNA may occur by intercalation. From analysis using a sensitive linking number assay, several tryptanthrins, especially the 4-aza and 6-oximo derivatives, intercalate into DNA.', 'Title: Antimicrobial activity of tryptanthrins in Escherichia coli.  Abstract: Tryptanthrins have potential therapeutic activity against a wide variety of pathogenic organisms, although little is known about their mechanism. Activity against Escherichia coli, however, has not been examined. The effects of tryptanthrin (indolo[2,1-b]quinazolin-6,12-dione) and nine derivatives on growth, survival, and mutagenesis in E. coli were examined. Analogues with a nitrogen atom at the 4-position of tryptanthrin stopped log phase growth of E. coli cultures at concentrations as low as 5 microM. Tryptanthrins decreased viability during incubation with cells in buffer by factors of 10(-2) to <10(-6) at 0.2-40 microM. Derivatives with an oxime group at the 6-position exhibited the greatest bactericidal activity. Most tryptanthrins were not mutagenic in several independent assays, although the 4-aza and 4 aza-8-fluoro derivatives increased frameshift mutations about 22- and 4-fold, respectively. Given the structure of trypanthrins, binding to DNA may occur by intercalation. From analysis using a sensitive linking number assay, several tryptanthrins, especially the 4-aza and 6-oximo derivatives, intercalate into DNA.', 'Title: Design, synthesis and biological evaluation of a novel series of anthrapyrazoles linked with netropsin-like oligopyrrole carboxamides as anticancer agents.  Abstract: Anticancer drugs that bind to DNA and inhibit DNA-processing enzymes represent an important class of anticancer drugs. Combilexin molecules, which combine DNA minor groove binding and intercalating functionalities, have the potential for increased DNA binding affinity and increased selectivity due to their dual mode of DNA binding. This study describes the synthesis of DNA minor groove binder netropsin analogs containing either one or two N-methylpyrrole carboxamide groups linked to DNA-intercalating anthrapyrazoles. Those hybrid molecules which had both two N-methylpyrrole groups and terminal (dimethylamino)alkyl side chains displayed submicromolar cytotoxicity towards K562 human leukemia cells. The combilexins were also evaluated for DNA binding by measuring the increase in DNA melting temperature, for DNA topoisomerase IIalpha-mediated double strand cleavage of DNA, for inhibition of DNA topoisomerase IIalpha decatenation activity, and for inhibition of DNA topoisomerase I relaxation of DNA. Several of the compounds stabilized the DNA-topoisomerase IIalpha covalent complex indicating that they acted as topoisomerase IIalpha poisons. Some of the combilexins had higher affinity for DNA than their parent anthrapyrazoles. In conclusion, a novel group of compounds combining DNA intercalating anthrapyrazole groups and minor groove binding netropsin analogs have been designed, synthesized and biologically evaluated as possible novel anticancer agents.', 'Title: Synthesis and structure-activity relationship study of novel cytotoxic carbamate and N-acylheterocyclic bearing derivatives of betulin and betulinic acid.  Abstract: Chemical transformation studies were conducted on betulin and betulinic acid, common plant-derived lupane-type triterpenes. The concise synthesis, via a stepwise approach, of betulin and betulinic acid carbamate and N-acylheterocyclic containing derivatives is described. All new compounds, as well as betulinic acid were tested in vitro for their cytotoxic activity. Most of the compounds have shown a better cytotoxic profile than betulinic acid, including the synthesized betulin derivatives. Compounds 25 and 32 were the most promising derivatives, being up to 12-fold more potent than betulinic acid against human PC-3 cell lines (IC(50) values of 1.1 and 1.8 microM, respectively).', 'Title: Synthesis and biological evaluation of dialkylaminoalkylamino benzo[c][1,7] and [1,8]phenanthrolines as antiproliferative agents.  Abstract: Benzo[c][1,7] and [1,8]phenanthroline substituted by dialkylaminoalkyl side chains at position C2 and C1, respectively, were synthesized and their biological activity evaluated. These compounds displayed more potent cytotoxicity toward L1210 cells than the parent unsubstituted compounds, associated with strong DNA interaction. The moderate TopoI inhibitory activity induced by the novel compounds suggests that other cellular targets should be responsible for the antiproliferative activity.', 'Title: Synthesis and biological evaluation of dialkylaminoalkylamino benzo[c][1,7] and [1,8]phenanthrolines as antiproliferative agents.  Abstract: Benzo[c][1,7] and [1,8]phenanthroline substituted by dialkylaminoalkyl side chains at position C2 and C1, respectively, were synthesized and their biological activity evaluated. These compounds displayed more potent cytotoxicity toward L1210 cells than the parent unsubstituted compounds, associated with strong DNA interaction. The moderate TopoI inhibitory activity induced by the novel compounds suggests that other cellular targets should be responsible for the antiproliferative activity.', \"Title: Montmorillonite K-10 catalyzed cyclization of N-ethoxycarbonyl-N'-arylguanidines: access to pyrimido[4,5-c]carbazole and pyrimido[5,4-b]indole derivatives.  Abstract: Two new heterocycles, pyrimido[4,5-c]carbazole and pyrimido[5,4-b]indole, were prepared in three steps from 3-aminocarbazole and 3-aminoindole, respectively. The key Friedel-Crafts intramolecular cyclization was realized under microwave irradiation using montmorillonite K-10 clay as a catalyst. The pyrimido[4,5-c]carbazole derivative shows significant micromolar IC(50) against cancer cell lines. Unlike similar carbazole and indolocarbazole compounds, the molecule does not interfere with topoisomerase activity.\", 'Title: Cytotoxicity and topo I targeting activity of substituted 10--nitrogenous heterocyclic aromatic group derivatives of SN-38.  Abstract: A series of 10-position substituted nitrogenous heterocyclic aromatic group derivatives of SN-38 were prepared. Most of these compounds possessed lower cytotoxicities than CPT. Compound 13 revealed potent cytotoxicity similar to CPT, and compounds 17, 18, and 19 showed similar cytotoxic activity to topotecan. All of the pyridine salt derivatives (7-16) revealed comparable or superior topo I inhibitory activity in relation to CPT. Ethyl in the 7-position of these compounds can increase the cytotoxicity and inhibitory activity to topo I compared with corresponding pyridine salts CPT derivatives (7a-13a) and simultaneously maintain good water solubility. This result is consistent with the SAR of CPT.', 'Title: Synthesis and biological evaluation of novel benzodioxinocarbazoles (BDCZs) as potential anticancer agents.  Abstract: We report the efficient synthesis and biological evaluation of new benzodioxinoindolocarbazoles heterocycles (BDCZs) designed as potential anticancer agents. Indolic substitution and maleimide variations were performed to design a new library of BDCZs and their cytotoxicity were evaluated on two representative cancer cell lines. Several derivatives have shown a marked cytotoxicity with IC(50) values in the nanomolar range. Results are reported in this Letter.', \"Title: The structure-activity relationships of A-ring-substituted aromathecin topoisomerase I inhibitors strongly support a camptothecin-like binding mode.  Abstract: Aromathecins are inhibitors of human topoisomerase I (Top1). These compounds are composites of several heteroaromatic systems, namely the camptothecins and indenoisoquinolines, and they possess notable Top1 inhibition and cytotoxicity when substituted at position 14. The SAR of these compounds overlaps with indenoisoquinolines, suggesting that they may intercalate into the Top1-DNA complex similarly. Nonetheless, the proposed binding mode for aromathecins is purely hypothetical, as an X-ray structure is unavailable. In the present communication, we have synthesized eight novel series of A-ring-substituted (positions 1-3) aromathecins, through a simple, modular route, as part of a comprehensive SAR study. Certain groups (such as 2,3-ethylenedioxy) moderately improve Top1 inhibition, and, often, antiproliferative activity, whereas other groups (2,3-dimethoxy and 3-substituents) attenuate bioactivity. Strikingly, these trends are very similar to those previously observed for the A-ring of camptothecins, and this considerable SAR overlap lends further support (in the absence of crystallographic data) to the hypothesis that aromathecins bind in the Top1 cleavage complex as interfacial inhibitors in a 'camptothecin-like' pose.\", \"Title: The structure-activity relationships of A-ring-substituted aromathecin topoisomerase I inhibitors strongly support a camptothecin-like binding mode.  Abstract: Aromathecins are inhibitors of human topoisomerase I (Top1). These compounds are composites of several heteroaromatic systems, namely the camptothecins and indenoisoquinolines, and they possess notable Top1 inhibition and cytotoxicity when substituted at position 14. The SAR of these compounds overlaps with indenoisoquinolines, suggesting that they may intercalate into the Top1-DNA complex similarly. Nonetheless, the proposed binding mode for aromathecins is purely hypothetical, as an X-ray structure is unavailable. In the present communication, we have synthesized eight novel series of A-ring-substituted (positions 1-3) aromathecins, through a simple, modular route, as part of a comprehensive SAR study. Certain groups (such as 2,3-ethylenedioxy) moderately improve Top1 inhibition, and, often, antiproliferative activity, whereas other groups (2,3-dimethoxy and 3-substituents) attenuate bioactivity. Strikingly, these trends are very similar to those previously observed for the A-ring of camptothecins, and this considerable SAR overlap lends further support (in the absence of crystallographic data) to the hypothesis that aromathecins bind in the Top1 cleavage complex as interfacial inhibitors in a 'camptothecin-like' pose.\", 'Title: Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives. Part 2.  Abstract: Certain indeno[1,2-c]quinoline derivatives were synthesized and evaluated for their antiproliferation, DNA binding affinity, and topoisomerases (topo I and topo II) inhibitory activities. The preliminary results are the following: (1) substituent of the aminoalkoxyimino side chain at C11 is important for antiproliferative activities in which the terminal amine preferred to be a tertiary or the cyclic five-membered pyrrolidino ring; (2) among the indeno[1,2-c]quinoline derivatives evaluated, (E)-6-hydroxy-9-methoxy-11H-indeno[1,2-c]quinolin-11-one O-2-(pyrrolidin-1-yl)ethyl oxime (8c) was found to be one of the most cytotoxic agents with a GI50 value of 0.84, 0.89, and 0.79 microM against SAS, A549, and BT483, respectively, which is more active than camptothecin; (3) substituent at C6 is crucial for the selective cytotoxicity in which the OH group is the most preferred while hydrogen or piperazine exhibited cytotoxicity on both cancer cells and Detroit-551; (4) a positive correlation of antiproliferative activity, DNA binding affinity, and topo I and topo II inhibitory activities has been observed for indeno[1,2-c]quinoline derivatives; (5) compound 8c induced DNA fragmentation may through caspase-3 activation, phosphorylation of the histone protein H2AX at Ser139 (gamma-H2AX), and PARP cleavage; (6) compound 8c demonstrated significant tumor regression in the human breast xenograft model; (7) indeno[1,2-c]quinoline derivatives are a new class of molecules that have the potential to be developed as dual topo I and topo II inhibitory agents.', 'Title: Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives. Part 2.  Abstract: Certain indeno[1,2-c]quinoline derivatives were synthesized and evaluated for their antiproliferation, DNA binding affinity, and topoisomerases (topo I and topo II) inhibitory activities. The preliminary results are the following: (1) substituent of the aminoalkoxyimino side chain at C11 is important for antiproliferative activities in which the terminal amine preferred to be a tertiary or the cyclic five-membered pyrrolidino ring; (2) among the indeno[1,2-c]quinoline derivatives evaluated, (E)-6-hydroxy-9-methoxy-11H-indeno[1,2-c]quinolin-11-one O-2-(pyrrolidin-1-yl)ethyl oxime (8c) was found to be one of the most cytotoxic agents with a GI50 value of 0.84, 0.89, and 0.79 microM against SAS, A549, and BT483, respectively, which is more active than camptothecin; (3) substituent at C6 is crucial for the selective cytotoxicity in which the OH group is the most preferred while hydrogen or piperazine exhibited cytotoxicity on both cancer cells and Detroit-551; (4) a positive correlation of antiproliferative activity, DNA binding affinity, and topo I and topo II inhibitory activities has been observed for indeno[1,2-c]quinoline derivatives; (5) compound 8c induced DNA fragmentation may through caspase-3 activation, phosphorylation of the histone protein H2AX at Ser139 (gamma-H2AX), and PARP cleavage; (6) compound 8c demonstrated significant tumor regression in the human breast xenograft model; (7) indeno[1,2-c]quinoline derivatives are a new class of molecules that have the potential to be developed as dual topo I and topo II inhibitory agents.', 'Title: Novel synthetic 2-amino-10-(3,5-dimethoxy)benzyl-9(10H)-acridinone derivatives as potent DNA-binding antiproliferative agents.  Abstract: A series of novel 9(10H)-acridinone derivatives with terminal amino substituents at C2 position on the acridinone ring were synthesized and studied for their antiproliferative activity and underlying mechanisms. These compounds demonstrated promising cytotoxicity to leukemia cells CCRF-CEM, displaying IC(50) values in the low micromolar range. Structure-activity relationships (SAR) indicated that the compound 6d bearing a pyrrolidine substituent and 8a with a methyl ammonium side chain displayed higher cytotoxicity to CCRF-CEM cells and also solid tumor cells A549, HepG2, and MCF7. Furthermore, the compounds 6d and 8a had strong binding activity to calf thymus DNA (ct DNA), as detected by UV absorption and fluorescence quenching assays, but limited inhibitory activity to human topoisomerase 1 (topo 1). Taken together, this study discovered a series of new synthetic 9(10H)-acridinone derivatives with potent DNA binding and anticancer activity.', 'Title: Novel synthetic 2-amino-10-(3,5-dimethoxy)benzyl-9(10H)-acridinone derivatives as potent DNA-binding antiproliferative agents.  Abstract: A series of novel 9(10H)-acridinone derivatives with terminal amino substituents at C2 position on the acridinone ring were synthesized and studied for their antiproliferative activity and underlying mechanisms. These compounds demonstrated promising cytotoxicity to leukemia cells CCRF-CEM, displaying IC(50) values in the low micromolar range. Structure-activity relationships (SAR) indicated that the compound 6d bearing a pyrrolidine substituent and 8a with a methyl ammonium side chain displayed higher cytotoxicity to CCRF-CEM cells and also solid tumor cells A549, HepG2, and MCF7. Furthermore, the compounds 6d and 8a had strong binding activity to calf thymus DNA (ct DNA), as detected by UV absorption and fluorescence quenching assays, but limited inhibitory activity to human topoisomerase 1 (topo 1). Taken together, this study discovered a series of new synthetic 9(10H)-acridinone derivatives with potent DNA binding and anticancer activity.', 'Title: Indeno[1,2-c]isoquinolin-5,11-diones conjugated to amino acids: Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties.  Abstract: Three series of indeno[1,2-c]isoquinolin-5,11-dione-amino acid conjugates were designed and synthesized. Amino acids were connected to the tetracycle through linkers with lengths of n=2 and 3 atoms using ester (series I), amide (series II), and secondary amine (series III) functions. DNA binding was evaluated by thermal denaturation and fluorescence measurements. Lysine and arginine substituted derivatives with n=3 provided the highest DNA binding. Arginine derivative 32 (n=2, series II) and glycine derivative 34 (n=2, series III) displayed high topoisomerase II inhibition. Incrementing the length of the N-6 side chain from two to three methylene units provided a significant increase in DNA affinity but a substantial loss in topoisomerase II inhibition. The most cytotoxic compounds toward HL60 leukemia cells were 19, 33, and 34 displaying micromolar IC(50) values. When tested with the topoisomerase II-mutated HL60/MX2 cell line, little variation of IC(50) values was found, suggesting that topoisomerase II might not be the main target of these compounds and that additional targets could be involved.', 'Title: Indeno[1,2-c]isoquinolin-5,11-diones conjugated to amino acids: Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties.  Abstract: Three series of indeno[1,2-c]isoquinolin-5,11-dione-amino acid conjugates were designed and synthesized. Amino acids were connected to the tetracycle through linkers with lengths of n=2 and 3 atoms using ester (series I), amide (series II), and secondary amine (series III) functions. DNA binding was evaluated by thermal denaturation and fluorescence measurements. Lysine and arginine substituted derivatives with n=3 provided the highest DNA binding. Arginine derivative 32 (n=2, series II) and glycine derivative 34 (n=2, series III) displayed high topoisomerase II inhibition. Incrementing the length of the N-6 side chain from two to three methylene units provided a significant increase in DNA affinity but a substantial loss in topoisomerase II inhibition. The most cytotoxic compounds toward HL60 leukemia cells were 19, 33, and 34 displaying micromolar IC(50) values. When tested with the topoisomerase II-mutated HL60/MX2 cell line, little variation of IC(50) values was found, suggesting that topoisomerase II might not be the main target of these compounds and that additional targets could be involved.', 'Title: Design, synthesis, and DNA-binding of N-alkyl(anilino)quinazoline derivatives.  Abstract: New N-alkylanilinoquinazoline derivatives 5, 12, 20, and 22 have been prepared from 4-chloro-6,7-dimethoxyquinazoline 3, 4-chloro-6,7-methylenedioxyquinazoline 19, and commercially available anilines. Differents classes of compounds substituted by an aryloxygroup (6a-c, 16a,b, and 17a,b), (aminophenyl)ureas (12a,b and 13a-f), anilines (4a-m, 20a,b), N-alkyl(aniline) (5a-m, 21a,b, 22a,d), and N-aminoalkyl(aniline) (22e-g) have been synthesized. These molecules were evaluated for their cytotoxic activities and as potential DNA intercalating agents. We studied the strength and mode of binding to DNA of these molecules by DNA melting temperature measurements, fluorescence emission, and circular dichroism. The results of various spectral and gel electrophoresis techniques obtained with the different compounds, in particular compounds 5g and 22f, revealed significant DNA interaction. These experiments confirm that the N-aminoalkyl(anilino)-6,7-dimethoxyquinazoline nucleus is an efficient pharmacophore to trigger binding to DNA, via an intercalative binding process.', 'Title: Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents.  Abstract: Human topoisomerase I (TopoI) is recognized as a valuable target for the development of effective antitumor agents. Structure-based virtual screening was applied to the discovery of structurally diverse TopoI inhibitors. From 23 compounds selected by virtual screening, a total of 14 compounds were found to be TopoI inhibitors. Five hits (compounds 1, 14, 20, 21, and 23) also showed moderate to good in vitro antitumor activity. These novel structures can be considered as good starting points for the development of new antitumor lead compounds. Hit 20 (evodiamine) was chosen for preliminary structure-activity relationship studies. Various groups, including alkyl, benzoyl, benzyl and ester, were introduced to the indole nitrogen atom of evodiamine. The substituted benzoyl groups were found to be favorable for the antitumor activity and spectrum. The 4-Cl benzoyl derivative, compound 29u, was the most active one with IC(50) values in the range 0.049-2.6 M.', 'Title: Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents.  Abstract: Human topoisomerase I (TopoI) is recognized as a valuable target for the development of effective antitumor agents. Structure-based virtual screening was applied to the discovery of structurally diverse TopoI inhibitors. From 23 compounds selected by virtual screening, a total of 14 compounds were found to be TopoI inhibitors. Five hits (compounds 1, 14, 20, 21, and 23) also showed moderate to good in vitro antitumor activity. These novel structures can be considered as good starting points for the development of new antitumor lead compounds. Hit 20 (evodiamine) was chosen for preliminary structure-activity relationship studies. Various groups, including alkyl, benzoyl, benzyl and ester, were introduced to the indole nitrogen atom of evodiamine. The substituted benzoyl groups were found to be favorable for the antitumor activity and spectrum. The 4-Cl benzoyl derivative, compound 29u, was the most active one with IC(50) values in the range 0.049-2.6 M.', 'Title: Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents.  Abstract: Human topoisomerase I (TopoI) is recognized as a valuable target for the development of effective antitumor agents. Structure-based virtual screening was applied to the discovery of structurally diverse TopoI inhibitors. From 23 compounds selected by virtual screening, a total of 14 compounds were found to be TopoI inhibitors. Five hits (compounds 1, 14, 20, 21, and 23) also showed moderate to good in vitro antitumor activity. These novel structures can be considered as good starting points for the development of new antitumor lead compounds. Hit 20 (evodiamine) was chosen for preliminary structure-activity relationship studies. Various groups, including alkyl, benzoyl, benzyl and ester, were introduced to the indole nitrogen atom of evodiamine. The substituted benzoyl groups were found to be favorable for the antitumor activity and spectrum. The 4-Cl benzoyl derivative, compound 29u, was the most active one with IC(50) values in the range 0.049-2.6 M.', 'Title: Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents.  Abstract: Human topoisomerase I (TopoI) is recognized as a valuable target for the development of effective antitumor agents. Structure-based virtual screening was applied to the discovery of structurally diverse TopoI inhibitors. From 23 compounds selected by virtual screening, a total of 14 compounds were found to be TopoI inhibitors. Five hits (compounds 1, 14, 20, 21, and 23) also showed moderate to good in vitro antitumor activity. These novel structures can be considered as good starting points for the development of new antitumor lead compounds. Hit 20 (evodiamine) was chosen for preliminary structure-activity relationship studies. Various groups, including alkyl, benzoyl, benzyl and ester, were introduced to the indole nitrogen atom of evodiamine. The substituted benzoyl groups were found to be favorable for the antitumor activity and spectrum. The 4-Cl benzoyl derivative, compound 29u, was the most active one with IC(50) values in the range 0.049-2.6 M.', 'Title: Design, synthesis, and evaluation of dibenzo[c,h][1,6]naphthyridines as topoisomerase I inhibitors and potential anticancer agents.  Abstract: Indenoisoquinoline topoisomerase I (Top1) inhibitors are a novel class of anticancer agents. Modifications of the indenoisoquinoline A, B, and D rings have been extensively studied in order to optimize Top1 inhibitory activity and cytotoxicity. To improve understanding of the forces that stabilize drug-Top1-DNA ternary complexes, the five-membered cyclopentadienone C-ring of the indenoisoquinoline system was replaced by six-membered nitrogen heterocyclic rings, resulting in dibenzo[c,h][1,6]naphthyridines that were synthesized by a novel route and tested for Top1 inhibition. This resulted in several compounds that have unique DNA cleavage site selectivities and potent antitumor activities in a number of cancer cell lines.', 'Title: Design, synthesis, and evaluation of dibenzo[c,h][1,6]naphthyridines as topoisomerase I inhibitors and potential anticancer agents.  Abstract: Indenoisoquinoline topoisomerase I (Top1) inhibitors are a novel class of anticancer agents. Modifications of the indenoisoquinoline A, B, and D rings have been extensively studied in order to optimize Top1 inhibitory activity and cytotoxicity. To improve understanding of the forces that stabilize drug-Top1-DNA ternary complexes, the five-membered cyclopentadienone C-ring of the indenoisoquinoline system was replaced by six-membered nitrogen heterocyclic rings, resulting in dibenzo[c,h][1,6]naphthyridines that were synthesized by a novel route and tested for Top1 inhibition. This resulted in several compounds that have unique DNA cleavage site selectivities and potent antitumor activities in a number of cancer cell lines.', 'Title: Design, synthesis, and evaluation of dibenzo[c,h][1,6]naphthyridines as topoisomerase I inhibitors and potential anticancer agents.  Abstract: Indenoisoquinoline topoisomerase I (Top1) inhibitors are a novel class of anticancer agents. Modifications of the indenoisoquinoline A, B, and D rings have been extensively studied in order to optimize Top1 inhibitory activity and cytotoxicity. To improve understanding of the forces that stabilize drug-Top1-DNA ternary complexes, the five-membered cyclopentadienone C-ring of the indenoisoquinoline system was replaced by six-membered nitrogen heterocyclic rings, resulting in dibenzo[c,h][1,6]naphthyridines that were synthesized by a novel route and tested for Top1 inhibition. This resulted in several compounds that have unique DNA cleavage site selectivities and potent antitumor activities in a number of cancer cell lines.', 'Title: Cytotoxicity and topoisomerase I/II inhibition of glycosylated 2-phenyl-indoles, 2-phenyl-benzo[b]thiophenes and 2-phenyl-benzo[b]furans.  Abstract: A panel of glycosylated DNA binding agents (1-12) designed as functional anthracycline mimics was screened against three solid-tumor cell lines (MCF-7, HT 29 and HepG2/C3A) and three non-tumor cell lines by the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) cell viability assay. Several compounds showed better in vitro cytotoxicity and selectivity against MCF-7 cells than daunomycin and doxorubicin, two known DNA binding agents that are clinically-used anti-cancer agents. Although the selectivity for HT 29 and HepG2/C3A cells is generally lower, the IC(50) values of some analogs against these two cancer cell lines were of the same magnitude as doxorubicin. Because there was no correlation between DNA binding affinity and cytotoxicity, and because topoisomerase (Topo) inhibition is another biological mechanism of action of most anthracycline drugs, Topo I/II inhibition assays with 1-12 were performed. Some of the compounds showed strong inhibition against these enzymes at 100M, but there was no clear correlation between cytotoxicity and Topo I/II inhibition ability. Topo I/II inhibition mode assays were also performed, which verified that these compounds are topoisomerase suppressors, not poisons. Based on these results, we conclude that although DNA binding and/or topoisomerase inhibition may contribute to the observed cytotoxicity of 1-12, other mechanisms of action are also likely to be important.', 'Title: Cytotoxicity and topoisomerase I/II inhibition of glycosylated 2-phenyl-indoles, 2-phenyl-benzo[b]thiophenes and 2-phenyl-benzo[b]furans.  Abstract: A panel of glycosylated DNA binding agents (1-12) designed as functional anthracycline mimics was screened against three solid-tumor cell lines (MCF-7, HT 29 and HepG2/C3A) and three non-tumor cell lines by the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) cell viability assay. Several compounds showed better in vitro cytotoxicity and selectivity against MCF-7 cells than daunomycin and doxorubicin, two known DNA binding agents that are clinically-used anti-cancer agents. Although the selectivity for HT 29 and HepG2/C3A cells is generally lower, the IC(50) values of some analogs against these two cancer cell lines were of the same magnitude as doxorubicin. Because there was no correlation between DNA binding affinity and cytotoxicity, and because topoisomerase (Topo) inhibition is another biological mechanism of action of most anthracycline drugs, Topo I/II inhibition assays with 1-12 were performed. Some of the compounds showed strong inhibition against these enzymes at 100M, but there was no clear correlation between cytotoxicity and Topo I/II inhibition ability. Topo I/II inhibition mode assays were also performed, which verified that these compounds are topoisomerase suppressors, not poisons. Based on these results, we conclude that although DNA binding and/or topoisomerase inhibition may contribute to the observed cytotoxicity of 1-12, other mechanisms of action are also likely to be important.', 'Title: Cytotoxicity and topoisomerase I/II inhibition of glycosylated 2-phenyl-indoles, 2-phenyl-benzo[b]thiophenes and 2-phenyl-benzo[b]furans.  Abstract: A panel of glycosylated DNA binding agents (1-12) designed as functional anthracycline mimics was screened against three solid-tumor cell lines (MCF-7, HT 29 and HepG2/C3A) and three non-tumor cell lines by the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) cell viability assay. Several compounds showed better in vitro cytotoxicity and selectivity against MCF-7 cells than daunomycin and doxorubicin, two known DNA binding agents that are clinically-used anti-cancer agents. Although the selectivity for HT 29 and HepG2/C3A cells is generally lower, the IC(50) values of some analogs against these two cancer cell lines were of the same magnitude as doxorubicin. Because there was no correlation between DNA binding affinity and cytotoxicity, and because topoisomerase (Topo) inhibition is another biological mechanism of action of most anthracycline drugs, Topo I/II inhibition assays with 1-12 were performed. Some of the compounds showed strong inhibition against these enzymes at 100M, but there was no clear correlation between cytotoxicity and Topo I/II inhibition ability. Topo I/II inhibition mode assays were also performed, which verified that these compounds are topoisomerase suppressors, not poisons. Based on these results, we conclude that although DNA binding and/or topoisomerase inhibition may contribute to the observed cytotoxicity of 1-12, other mechanisms of action are also likely to be important.', 'Title: Cytotoxicity and topoisomerase I/II inhibition of glycosylated 2-phenyl-indoles, 2-phenyl-benzo[b]thiophenes and 2-phenyl-benzo[b]furans.  Abstract: A panel of glycosylated DNA binding agents (1-12) designed as functional anthracycline mimics was screened against three solid-tumor cell lines (MCF-7, HT 29 and HepG2/C3A) and three non-tumor cell lines by the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) cell viability assay. Several compounds showed better in vitro cytotoxicity and selectivity against MCF-7 cells than daunomycin and doxorubicin, two known DNA binding agents that are clinically-used anti-cancer agents. Although the selectivity for HT 29 and HepG2/C3A cells is generally lower, the IC(50) values of some analogs against these two cancer cell lines were of the same magnitude as doxorubicin. Because there was no correlation between DNA binding affinity and cytotoxicity, and because topoisomerase (Topo) inhibition is another biological mechanism of action of most anthracycline drugs, Topo I/II inhibition assays with 1-12 were performed. Some of the compounds showed strong inhibition against these enzymes at 100M, but there was no clear correlation between cytotoxicity and Topo I/II inhibition ability. Topo I/II inhibition mode assays were also performed, which verified that these compounds are topoisomerase suppressors, not poisons. Based on these results, we conclude that although DNA binding and/or topoisomerase inhibition may contribute to the observed cytotoxicity of 1-12, other mechanisms of action are also likely to be important.', 'Title: Cytotoxicity and topoisomerase I/II inhibition of glycosylated 2-phenyl-indoles, 2-phenyl-benzo[b]thiophenes and 2-phenyl-benzo[b]furans.  Abstract: A panel of glycosylated DNA binding agents (1-12) designed as functional anthracycline mimics was screened against three solid-tumor cell lines (MCF-7, HT 29 and HepG2/C3A) and three non-tumor cell lines by the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) cell viability assay. Several compounds showed better in vitro cytotoxicity and selectivity against MCF-7 cells than daunomycin and doxorubicin, two known DNA binding agents that are clinically-used anti-cancer agents. Although the selectivity for HT 29 and HepG2/C3A cells is generally lower, the IC(50) values of some analogs against these two cancer cell lines were of the same magnitude as doxorubicin. Because there was no correlation between DNA binding affinity and cytotoxicity, and because topoisomerase (Topo) inhibition is another biological mechanism of action of most anthracycline drugs, Topo I/II inhibition assays with 1-12 were performed. Some of the compounds showed strong inhibition against these enzymes at 100M, but there was no clear correlation between cytotoxicity and Topo I/II inhibition ability. Topo I/II inhibition mode assays were also performed, which verified that these compounds are topoisomerase suppressors, not poisons. Based on these results, we conclude that although DNA binding and/or topoisomerase inhibition may contribute to the observed cytotoxicity of 1-12, other mechanisms of action are also likely to be important.', 'Title: Cytotoxicity and topoisomerase I/II inhibition of glycosylated 2-phenyl-indoles, 2-phenyl-benzo[b]thiophenes and 2-phenyl-benzo[b]furans.  Abstract: A panel of glycosylated DNA binding agents (1-12) designed as functional anthracycline mimics was screened against three solid-tumor cell lines (MCF-7, HT 29 and HepG2/C3A) and three non-tumor cell lines by the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) cell viability assay. Several compounds showed better in vitro cytotoxicity and selectivity against MCF-7 cells than daunomycin and doxorubicin, two known DNA binding agents that are clinically-used anti-cancer agents. Although the selectivity for HT 29 and HepG2/C3A cells is generally lower, the IC(50) values of some analogs against these two cancer cell lines were of the same magnitude as doxorubicin. Because there was no correlation between DNA binding affinity and cytotoxicity, and because topoisomerase (Topo) inhibition is another biological mechanism of action of most anthracycline drugs, Topo I/II inhibition assays with 1-12 were performed. Some of the compounds showed strong inhibition against these enzymes at 100M, but there was no clear correlation between cytotoxicity and Topo I/II inhibition ability. Topo I/II inhibition mode assays were also performed, which verified that these compounds are topoisomerase suppressors, not poisons. Based on these results, we conclude that although DNA binding and/or topoisomerase inhibition may contribute to the observed cytotoxicity of 1-12, other mechanisms of action are also likely to be important.', 'Title: 3-Arylisoquinolines as novel topoisomerase I inhibitors.  Abstract: Topoisomerase I (topo I) is an essential enzyme for vital cellular processes. Inhibition of topo I activities is lethal and leads to cell death, thus establishing topo I as a promising target for cancer treatment. Camptothecin, a natural alkaloid, inhibits topo I. Topotecan and irinotecan, synthetic derivatives of camptothecin, are the most potent anticancer drugs in clinical use. However, several limitations of camptothecins such as solubility, toxicity, stability, resistance and the required high drug dose have encouraged the development of non-camptothecin topo I inhibitors. Natural alkaloid benzo[c]phenanthridines and synthetic indenoisoquinolines have been extensively studied as alternatives to camptothecin. Interestingly, these non-camptothecin topo I inhibitors share a common 3-arylisoquinoline scaffold. This review will describe the development of novel indeno[1,2-c]isoquinolines, isoindolo[2,1-b]isoquinolines, 12-oxobenzo[c]phenanthridines and benz[b]oxepines with a 3-arylisoquinoline nucleus as topo I inhibitors.', 'Title: Synthesis and topoisomerase II inhibitory and cytotoxic activity of oxiranylmethoxy- and thiiranylmethoxy-chalcone derivatives.  Abstract: In order to find potential anticancer drug candidate targeting topoisomerases enzyme, we have designed and synthesized oxiranylmethoxy- and thiiranylmethoxy-retrochalcone derivatives and evaluated their pharmacological activity including topoisomerases inhibitory and cytotoxic activity. Of the compounds prepared compound 25 showed comparable or better cytotoxic activity against cancer cell lines tested. Compound 25 inhibited MCF7 (IC(50): 0.49  0.21 M) and HCT15 (IC(50): 0.23  0.02 M) carcinoma cell growth more efficiently than references. In the topoisomerases inhibition test, all the compounds were inactive to topoisomerase I but moderate inhibitors to topoisomerase II enzyme. Especially, compound 25 inhibited topoisomerase II activity with comparable extent to etoposide at 100 M concentrations. Correlation between cytotoxicity and topoisomerase II inhibitory activity implies that compound 25 can be a possible lead compound for anticancer drug impeding the topoisomerase II function.', 'Title: The first series of 4,11-bis[(2-aminoethyl)amino]anthra[2,3-b]furan-5,10-diones: Synthesis and anti-proliferative characteristics.  Abstract: We developed the synthesis of a series of furan-fused tetracyclic analogues of the antitumor agent ametantrone. The reactions included nucleophilic substitution of propoxy groups in 4,11-dipropoxyanthra[2,3-b]furan-5,10-diones with ethylenediamines, producing the derivatives of 4,11-diaminoanthra[2,3-b]furan-5,10-dione in good yields. Studies of anti-proliferative activity on a panel of mammalian tumor cell lines demonstrated that anthra[2,3-b]furan-5,10-diones were the most potent derivatives among heteroarene-fused ametantrone analogues with one heteroatom. We identified several compounds that evoked a growth inhibitory effect at submicromolar concentrations. The anthra[2,3-b]furan-5,10-dione 9 with distal methylamino groups was markedly potent against drug-resistant cell lines with P-glycoprotein overexpression or p53 gene deletion. Furthermore, this derivative attenuated in vitro topoisomerase I-mediated DNA uncoiling at low micromolar concentrations. These results demonstrate that anthrafurandiones are a new class of heterocyclic anthraquinone derivatives with the properties potentially valuable for anticancer therapy.', 'Title: The first series of 4,11-bis[(2-aminoethyl)amino]anthra[2,3-b]furan-5,10-diones: Synthesis and anti-proliferative characteristics.  Abstract: We developed the synthesis of a series of furan-fused tetracyclic analogues of the antitumor agent ametantrone. The reactions included nucleophilic substitution of propoxy groups in 4,11-dipropoxyanthra[2,3-b]furan-5,10-diones with ethylenediamines, producing the derivatives of 4,11-diaminoanthra[2,3-b]furan-5,10-dione in good yields. Studies of anti-proliferative activity on a panel of mammalian tumor cell lines demonstrated that anthra[2,3-b]furan-5,10-diones were the most potent derivatives among heteroarene-fused ametantrone analogues with one heteroatom. We identified several compounds that evoked a growth inhibitory effect at submicromolar concentrations. The anthra[2,3-b]furan-5,10-dione 9 with distal methylamino groups was markedly potent against drug-resistant cell lines with P-glycoprotein overexpression or p53 gene deletion. Furthermore, this derivative attenuated in vitro topoisomerase I-mediated DNA uncoiling at low micromolar concentrations. These results demonstrate that anthrafurandiones are a new class of heterocyclic anthraquinone derivatives with the properties potentially valuable for anticancer therapy.', 'Title: The first series of 4,11-bis[(2-aminoethyl)amino]anthra[2,3-b]furan-5,10-diones: Synthesis and anti-proliferative characteristics.  Abstract: We developed the synthesis of a series of furan-fused tetracyclic analogues of the antitumor agent ametantrone. The reactions included nucleophilic substitution of propoxy groups in 4,11-dipropoxyanthra[2,3-b]furan-5,10-diones with ethylenediamines, producing the derivatives of 4,11-diaminoanthra[2,3-b]furan-5,10-dione in good yields. Studies of anti-proliferative activity on a panel of mammalian tumor cell lines demonstrated that anthra[2,3-b]furan-5,10-diones were the most potent derivatives among heteroarene-fused ametantrone analogues with one heteroatom. We identified several compounds that evoked a growth inhibitory effect at submicromolar concentrations. The anthra[2,3-b]furan-5,10-dione 9 with distal methylamino groups was markedly potent against drug-resistant cell lines with P-glycoprotein overexpression or p53 gene deletion. Furthermore, this derivative attenuated in vitro topoisomerase I-mediated DNA uncoiling at low micromolar concentrations. These results demonstrate that anthrafurandiones are a new class of heterocyclic anthraquinone derivatives with the properties potentially valuable for anticancer therapy.', 'Title: Electron paramagnetic resonance (EPR) study of spin-labeled camptothecin derivatives: a different look of the ternary complex.  Abstract: Camptothecin (CPT) derivatives are clinically effective poisons of DNA topoisomerase I (Top1) able to form a ternary complex with the Top1-DNA complex. The aim of this investigation was to examine the dynamic aspects of the ternary complex formation by means of site-directed spin labeling electron paramagnetic resonance (SDSL-EPR). Two semisynthetic CPT derivatives bearing the paramagnetic moiety were synthesized, and their biological activity was tested. A 22-mer DNA oligonucleotide sequence with high affinity cleavage site for Top1 was also synthesized. EPR experiments were carried out on modified CPT in the presence of DNA, of Top1, or of both. In the last case, a slow motion component in the EPR signal appeared, indicating the formation of the ternary complex. Deconvolution of the EPR spectrum allowed to obtain the relative drug amounts in the complex. It was also possible to demonstrate that the residence time of CPT \"trapped\" in the ternary complex is longer than hundreds of microseconds.', 'Title: Electron paramagnetic resonance (EPR) study of spin-labeled camptothecin derivatives: a different look of the ternary complex.  Abstract: Camptothecin (CPT) derivatives are clinically effective poisons of DNA topoisomerase I (Top1) able to form a ternary complex with the Top1-DNA complex. The aim of this investigation was to examine the dynamic aspects of the ternary complex formation by means of site-directed spin labeling electron paramagnetic resonance (SDSL-EPR). Two semisynthetic CPT derivatives bearing the paramagnetic moiety were synthesized, and their biological activity was tested. A 22-mer DNA oligonucleotide sequence with high affinity cleavage site for Top1 was also synthesized. EPR experiments were carried out on modified CPT in the presence of DNA, of Top1, or of both. In the last case, a slow motion component in the EPR signal appeared, indicating the formation of the ternary complex. Deconvolution of the EPR spectrum allowed to obtain the relative drug amounts in the complex. It was also possible to demonstrate that the residence time of CPT \"trapped\" in the ternary complex is longer than hundreds of microseconds.', 'Title: Electron paramagnetic resonance (EPR) study of spin-labeled camptothecin derivatives: a different look of the ternary complex.  Abstract: Camptothecin (CPT) derivatives are clinically effective poisons of DNA topoisomerase I (Top1) able to form a ternary complex with the Top1-DNA complex. The aim of this investigation was to examine the dynamic aspects of the ternary complex formation by means of site-directed spin labeling electron paramagnetic resonance (SDSL-EPR). Two semisynthetic CPT derivatives bearing the paramagnetic moiety were synthesized, and their biological activity was tested. A 22-mer DNA oligonucleotide sequence with high affinity cleavage site for Top1 was also synthesized. EPR experiments were carried out on modified CPT in the presence of DNA, of Top1, or of both. In the last case, a slow motion component in the EPR signal appeared, indicating the formation of the ternary complex. Deconvolution of the EPR spectrum allowed to obtain the relative drug amounts in the complex. It was also possible to demonstrate that the residence time of CPT \"trapped\" in the ternary complex is longer than hundreds of microseconds.', 'Title: Design, synthesis and docking study of 5-amino substituted indeno[1,2-c]isoquinolines as novel topoisomerase I inhibitors.  Abstract: Various 5-amino group-substituted indeno[1,2-c]isoquinolines 7a-f were synthesized based on the previous QSAR study as rigid structures of 3-arylisoquinolines. Amino group-substituted compounds, especially 5-piperazinyl indeno[1,2-c]isoquinoline 7f, displayed potent topoisomerase I inhibitory activity as well as cytotoxicities against five different tumor cell lines. A Surflex-Dock docking model of 7f was also studied.', 'Title: Design, synthesis and docking study of 5-amino substituted indeno[1,2-c]isoquinolines as novel topoisomerase I inhibitors.  Abstract: Various 5-amino group-substituted indeno[1,2-c]isoquinolines 7a-f were synthesized based on the previous QSAR study as rigid structures of 3-arylisoquinolines. Amino group-substituted compounds, especially 5-piperazinyl indeno[1,2-c]isoquinoline 7f, displayed potent topoisomerase I inhibitory activity as well as cytotoxicities against five different tumor cell lines. A Surflex-Dock docking model of 7f was also studied.', 'Title: Synthesis and antitumor activity of 10-arylcamptothecin derivatives.  Abstract: A series of 10-arylcamptothecin derivatives was designed and synthesized. The key step of the synthesis was achieved by employing Suzuki cross-coupling chemistry. All of the new derivatives were tested for cytotoxicity against three human tumor cell lines, BEL-7402, A549, and HL-60; most of the derivatives exhibited potent cytotoxicity. The stability study showed that compound 30 was more stable than its lead compound 10-hydroxycamptothecin under the physiological condition. Mechanistic study demonstrated that compound 30 and its hydrochloride 31 had a pharmacological profile similar with camptothecin.', \"Title: Structural simplification of bioactive natural products with multicomponent synthesis. 3. Fused uracil-containing heterocycles as novel topoisomerase-targeting agents.  Abstract: After the initial discovery of antiproliferative and apoptosis-inducing properties of a camptothecin-inspired pentacycle based on a 1H-indeno[2',1':5,6]dihydropyrido[2,3-d]pyrimidine scaffold, a library of its analogues as well as their oxidized planar counterparts were prepared utilizing a practical multicomponent synthetic protocol. The synthesized compounds exhibited submicromolar to low micromolar antiproliferative potencies toward a panel of human cancer cell lines. Biochemical experiments are consistent with the dihydropyridine library members undergoing intracellular oxidation to the corresponding planar pyridines, which then inhibit topoisomerase II activity, leading to inhibition of proliferation and cell death. Because of facile synthetic preparation and promising antitopoisomerase activity, both the dihydropyridine and planar pyridine-based compounds represent a convenient starting point for anticancer drug discovery.\", \"Title: Structural simplification of bioactive natural products with multicomponent synthesis. 3. Fused uracil-containing heterocycles as novel topoisomerase-targeting agents.  Abstract: After the initial discovery of antiproliferative and apoptosis-inducing properties of a camptothecin-inspired pentacycle based on a 1H-indeno[2',1':5,6]dihydropyrido[2,3-d]pyrimidine scaffold, a library of its analogues as well as their oxidized planar counterparts were prepared utilizing a practical multicomponent synthetic protocol. The synthesized compounds exhibited submicromolar to low micromolar antiproliferative potencies toward a panel of human cancer cell lines. Biochemical experiments are consistent with the dihydropyridine library members undergoing intracellular oxidation to the corresponding planar pyridines, which then inhibit topoisomerase II activity, leading to inhibition of proliferation and cell death. Because of facile synthetic preparation and promising antitopoisomerase activity, both the dihydropyridine and planar pyridine-based compounds represent a convenient starting point for anticancer drug discovery.\", \"Title: Structural simplification of bioactive natural products with multicomponent synthesis. 3. Fused uracil-containing heterocycles as novel topoisomerase-targeting agents.  Abstract: After the initial discovery of antiproliferative and apoptosis-inducing properties of a camptothecin-inspired pentacycle based on a 1H-indeno[2',1':5,6]dihydropyrido[2,3-d]pyrimidine scaffold, a library of its analogues as well as their oxidized planar counterparts were prepared utilizing a practical multicomponent synthetic protocol. The synthesized compounds exhibited submicromolar to low micromolar antiproliferative potencies toward a panel of human cancer cell lines. Biochemical experiments are consistent with the dihydropyridine library members undergoing intracellular oxidation to the corresponding planar pyridines, which then inhibit topoisomerase II activity, leading to inhibition of proliferation and cell death. Because of facile synthetic preparation and promising antitopoisomerase activity, both the dihydropyridine and planar pyridine-based compounds represent a convenient starting point for anticancer drug discovery.\", \"Title: Structural simplification of bioactive natural products with multicomponent synthesis. 3. Fused uracil-containing heterocycles as novel topoisomerase-targeting agents.  Abstract: After the initial discovery of antiproliferative and apoptosis-inducing properties of a camptothecin-inspired pentacycle based on a 1H-indeno[2',1':5,6]dihydropyrido[2,3-d]pyrimidine scaffold, a library of its analogues as well as their oxidized planar counterparts were prepared utilizing a practical multicomponent synthetic protocol. The synthesized compounds exhibited submicromolar to low micromolar antiproliferative potencies toward a panel of human cancer cell lines. Biochemical experiments are consistent with the dihydropyridine library members undergoing intracellular oxidation to the corresponding planar pyridines, which then inhibit topoisomerase II activity, leading to inhibition of proliferation and cell death. Because of facile synthetic preparation and promising antitopoisomerase activity, both the dihydropyridine and planar pyridine-based compounds represent a convenient starting point for anticancer drug discovery.\", 'Title: Solid phase synthesis and biological activity of tuftsin conjugates.  Abstract: New tuftsin/retro-tuftsin conjugates were designed and synthesized using a classical fluorenylmethoxycarbonyl (Fmoc) solid phase procedure. All the peptide conjugates were divided into three series: 1,4-dihydroxyanthraquinone (type A), 1-nitroacridine (type B), and 4-carboxyacridone (type C) derivatives. In type A conjugates, the N-terminal group of the peptide chain is directly connected to the anthraquinone ring at C1 (Scheme 1), whereas types B and C conjugates possess an amide bond formed between the carboxyl group of heterocyclic molecule and the N-termini of the tuftsin chain. The in vitro cytotoxic activity of the tuftsin conjugates and their precursors using two human tumor cell lines (lung adenocarcinoma (A549) and myeloblastic leukemia (HL-60)) was investigated. The analogues from groups A and C exhibited low cytotoxic activity, whereas several compounds of type B showed a potent and selective cytotoxic activity against tested tumor cell lines. None of the examined tuftsin conjugates demonstrated any significant effect on the catalytic activity of types I and II DNA topoisomerases.', 'Title: Solid phase synthesis and biological activity of tuftsin conjugates.  Abstract: New tuftsin/retro-tuftsin conjugates were designed and synthesized using a classical fluorenylmethoxycarbonyl (Fmoc) solid phase procedure. All the peptide conjugates were divided into three series: 1,4-dihydroxyanthraquinone (type A), 1-nitroacridine (type B), and 4-carboxyacridone (type C) derivatives. In type A conjugates, the N-terminal group of the peptide chain is directly connected to the anthraquinone ring at C1 (Scheme 1), whereas types B and C conjugates possess an amide bond formed between the carboxyl group of heterocyclic molecule and the N-termini of the tuftsin chain. The in vitro cytotoxic activity of the tuftsin conjugates and their precursors using two human tumor cell lines (lung adenocarcinoma (A549) and myeloblastic leukemia (HL-60)) was investigated. The analogues from groups A and C exhibited low cytotoxic activity, whereas several compounds of type B showed a potent and selective cytotoxic activity against tested tumor cell lines. None of the examined tuftsin conjugates demonstrated any significant effect on the catalytic activity of types I and II DNA topoisomerases.', \"Title: Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase II catalytic inhibitor.  Abstract: Epoxide ring-opened xanthone derivatives were synthesized and tested for their topoisomerase inhibitory activity and cytotoxicity. Most of the compounds showed topo II specific inhibitory activity. To clarify the mechanism of action of these compounds, the most potent compound (compound 14) of the synthesized analogues was further studied by testing its ATPase inhibitory activity and through molecular docking experiments. The results showed that the topo II inhibitory activity of compound 14 was inversely proportional to ATP concentration. In the ATPase inhibitory test, ATP hydrolysis was reduced less efficiently by compound 14 (28.54.6%) than novobiocin (60.48.1%). Molecular docking study revealed compound 14 to have a stable binding pattern to the ATP-binding domain of human topo II.\", 'Title: Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents.  Abstract: Benzo[c]phenanthrolines and benzo[c]phenanthrolinones substituted by dialkylaminoalkyl side chains at position N5 and C6, respectively, were synthesised and their biological activity evaluated. They displayed interessant cytotoxicity associated with some DNA interactions. However, the low topoisomerase 1 affinity suggests that other cellular targets are responsible for the antiproliferative activity.', 'Title: Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents.  Abstract: Benzo[c]phenanthrolines and benzo[c]phenanthrolinones substituted by dialkylaminoalkyl side chains at position N5 and C6, respectively, were synthesised and their biological activity evaluated. They displayed interessant cytotoxicity associated with some DNA interactions. However, the low topoisomerase 1 affinity suggests that other cellular targets are responsible for the antiproliferative activity.', 'Title: Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents.  Abstract: Benzo[c]phenanthrolines and benzo[c]phenanthrolinones substituted by dialkylaminoalkyl side chains at position N5 and C6, respectively, were synthesised and their biological activity evaluated. They displayed interessant cytotoxicity associated with some DNA interactions. However, the low topoisomerase 1 affinity suggests that other cellular targets are responsible for the antiproliferative activity.', 'Title: Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents.  Abstract: Benzo[c]phenanthrolines and benzo[c]phenanthrolinones substituted by dialkylaminoalkyl side chains at position N5 and C6, respectively, were synthesised and their biological activity evaluated. They displayed interessant cytotoxicity associated with some DNA interactions. However, the low topoisomerase 1 affinity suggests that other cellular targets are responsible for the antiproliferative activity.', 'Title: Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents.  Abstract: Benzo[c]phenanthrolines and benzo[c]phenanthrolinones substituted by dialkylaminoalkyl side chains at position N5 and C6, respectively, were synthesised and their biological activity evaluated. They displayed interessant cytotoxicity associated with some DNA interactions. However, the low topoisomerase 1 affinity suggests that other cellular targets are responsible for the antiproliferative activity.', 'Title: Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents.  Abstract: Benzo[c]phenanthrolines and benzo[c]phenanthrolinones substituted by dialkylaminoalkyl side chains at position N5 and C6, respectively, were synthesised and their biological activity evaluated. They displayed interessant cytotoxicity associated with some DNA interactions. However, the low topoisomerase 1 affinity suggests that other cellular targets are responsible for the antiproliferative activity.', 'Title: Discovery of 4-anilinofuro[2,3-b]quinoline derivatives as selective and orally active compounds against non-small-cell lung cancers.  Abstract: We have reported the preparation and anticancer evaluation of certain 4-anilinofuro[2,3-b]quinolines. However, drawbacks such as lack of selective cytotoxicity, poor oral bioavailability, and poor water solubility exhibited by these compounds prompted us to search for newer derivatives. Among them, (E)-1-(4-(furo[2,3-b]quinolin-4-ylamino)phenyl)ethanone O-2-aminoethyloxime (13a) is selectively active against the growth of NCI-H460 and is highly water-soluble (63 g/mL). Its hydrochloride salt, 13aHCl exhibited not only excellent water solubility (1049 g/mL) but also a high oral bioavailability (57.1%). Compound 13a may cause cancer cell apoptosis through inducing mitotic arrest and mitotic catastrophe mechanism. Xenographic studies indicated the tumor size with 13aHCl treated nude mice was significantly lower than control. Further evaluation in an orthotopic lung cancer model indicated that 13aHCl can be absorbed readily through oral administration, distributed to lung tissue, and exhibited significant efficacy in inhibiting the growth of lung cancers.', 'Title: Structure-activity relationships of carboline and carbazole derivatives as a novel class of ATP-competitive kinesin spindle protein inhibitors.  Abstract: The kinesin spindle protein (KSP) is a mitotic kinesin involved in the establishment of a functional bipolar mitotic spindle during cell division. It is considered to be an attractive target for cancer chemotherapy with reduced side effects. Based on natural product scaffold-derived fused indole-based inhibitors and known biphenyl-type KSP inhibitors, various carboline and carbazole derivatives were synthesized and biologically evaluated. -Carboline and lactam-fused carbazole derivatives exhibited remarkably potent KSP inhibitory activity and mitotic arrest in prometaphase with formation of an irregular monopolar spindle. The planar tri- and tetracyclic analogs inhibited KSP ATPase in an ATP-competitive manner just like biphenyl-type inhibitors.', 'Title: Substituent effect on the preferred DNA binding mode and affinity of a homologous series of naphthalene diimides.  Abstract: A combination of isothermal titration calorimetry (ITC), topoisomerase I DNA unwinding assays, and ethidium bromide displacement studies were employed to investigate the binding of a homologous series of naphthalene diimides (NDI) to DNA. Our results suggest that the nature of the substituent plays a significant role in both the preferred binding mode and relative binding affinity of the compounds of this study. Only intercalative-type binding (K=15310(6)M(-1)) was observed for the NDI with the smallest substituent (trimethyl-ethylamino), while larger members of the series (diethylmethyl-, dipropylmethyl- and dibutylmethyl-ethylamino substituents) adopted an additional binding mode of higher affinity (K(1)=31-7810(6)M(-1)).', 'Title: Synthesis of 2,4-diaryl chromenopyridines and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.  Abstract: Designed and synthesized were a series of 5H-chromeno[4,3-b]pyridines with substitution at 2- and 4-positions with various 5- or 6-membered heteroaromatics as antitumor agents. They were evaluated for topoisomerase I and II inhibitory activities as well as cytotoxicities against several human cancer cell lines. Structure-activity relationship study showed that 2-furyl or 2-thienyl at 2- or 4-position of central pyridine is crucial in displaying topo I or II inhibitory activity and cytotoxicity.', 'Title: Synthesis of 2,4-diaryl chromenopyridines and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.  Abstract: Designed and synthesized were a series of 5H-chromeno[4,3-b]pyridines with substitution at 2- and 4-positions with various 5- or 6-membered heteroaromatics as antitumor agents. They were evaluated for topoisomerase I and II inhibitory activities as well as cytotoxicities against several human cancer cell lines. Structure-activity relationship study showed that 2-furyl or 2-thienyl at 2- or 4-position of central pyridine is crucial in displaying topo I or II inhibitory activity and cytotoxicity.', 'Title: Inverse virtual screening of antitumor targets: pilot study on a small database of natural bioactive compounds.  Abstract: An inverse virtual screening in silico approach has been applied to natural bioactive molecules to screen their efficacy against proteins involved in cancer processes, with the aim of directing future experimental assays. Docking studies were performed on a panel of 126 protein targets extracted from the Protein Data Bank, to analyze their possible interactions with a small library of 43 bioactive compounds. Analysis of the molecular docking results was performed through the use of tables containing energy data organized in a matrix. The application of this approach may facilitate the prediction of the activity of unknown ligands for known targets involved in the development of cancer and could be applied to other models based on different libraries of ligands and different panels of targets.', 'Title: Synthesis and evaluation of mansonone F derivatives as topoisomerase inhibitors.  Abstract: A series of mansonone F (MF) derivatives were designed and synthesized. These compounds were found to be strong inhibitors for topoisomerases, with much more significant inhibition for topoisomerase II rather than topoisomerase I. The best inhibitor showed 20 times stronger anti-topoisomerase II activity than a positive control Etoposide. The cytotoxic activity of these MF derivatives was evaluated against human cancer cell lines CNE-2 and Glc-82, which showed that these compounds were potent antitumor agents. The structure-activity relationships (SARs) study revealed that o-quinone group and pyran ring are important for their cytotoxic activity.', 'Title: Synthesis and evaluation of mansonone F derivatives as topoisomerase inhibitors.  Abstract: A series of mansonone F (MF) derivatives were designed and synthesized. These compounds were found to be strong inhibitors for topoisomerases, with much more significant inhibition for topoisomerase II rather than topoisomerase I. The best inhibitor showed 20 times stronger anti-topoisomerase II activity than a positive control Etoposide. The cytotoxic activity of these MF derivatives was evaluated against human cancer cell lines CNE-2 and Glc-82, which showed that these compounds were potent antitumor agents. The structure-activity relationships (SARs) study revealed that o-quinone group and pyran ring are important for their cytotoxic activity.', 'Title: Synthesis and topoisomerase I inhibitory activity of a novel diazaindeno[2,1-b]phenanthrene analogue of Lamellarin D.  Abstract: A novel 5-oxa-6a,8-diazaindeno[2,1-b]phenanthren-7-one scaffold was designed and synthesized as an active analogue of the cytotoxic marine alkaloid Lamellarin D. The design was based on molecular modeling of the site of interaction of Lamellarin D with DNA-topoisomerase I cleavable complex, whereas the synthesis capitalized on a simple Friedel-Crafts cyclization of indole to a -carbolinone nucleus. The product exhibited topoisomerase I poisoning activity and submicromolar cytotoxicity on human non-small cell lung cancer H460 cell line.', 'Title: Synthesis and topoisomerase I inhibitory activity of a novel diazaindeno[2,1-b]phenanthrene analogue of Lamellarin D.  Abstract: A novel 5-oxa-6a,8-diazaindeno[2,1-b]phenanthren-7-one scaffold was designed and synthesized as an active analogue of the cytotoxic marine alkaloid Lamellarin D. The design was based on molecular modeling of the site of interaction of Lamellarin D with DNA-topoisomerase I cleavable complex, whereas the synthesis capitalized on a simple Friedel-Crafts cyclization of indole to a -carbolinone nucleus. The product exhibited topoisomerase I poisoning activity and submicromolar cytotoxicity on human non-small cell lung cancer H460 cell line.', 'Title: Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase I inhibitors: investigating the relationships involving stereochemistry, hydrogen bonding, and biological activity.  Abstract: The DNA-relaxing enzyme topoisomerase I (Top1) can be inhibited by heterocyclic compounds such as indolocarbazoles and indenoisoquinolines. Carbohydrate and hydroxyl-containing side chains are essential for the biological activity of indolocarbazoles. The current study investigated how similar functionalities could be \"translated\" to the indenoisoquinoline system and how stereochemistry and hydrogen bonding affect biological activity. Herein is described the preparation and assay of indenoisoquinolines substituted with short-chain alcohols, diols, and carbohydrates. Several compounds (including those derived from sugars) display potent Top1 poisoning and antiproliferative activities. The Top1 poisoning activity of diol-substituted indenoisoquinolines is dependent upon stereochemistry. Although the effect is striking, molecular modeling and docking studies do not indicate any reason for the difference in activity due to similar calculated interactions between the ligand and Top1-DNA complex and ambiguity about the binding mode. A stereochemical dependence was also observed for carbohydrate-derived indenoisoquinolines. Although similar trends were observed in other classes of Top1 inhibitors, the exact nature of this effect has yet to be elucidated.', 'Title: Synthesis, structure-activity relationship and biological evaluation of anticancer activity for novel N-substituted sophoridinic acid derivatives.  Abstract: Sophoridine (1), a natural anticancer drug, has been used in China for decades. A series of novel N-substituted sophoridinic acid derivatives were synthesized and evaluated for their cytotoxicity with 1 as the lead. The structure-activity relationship indicated that introduction of an aliphatic acyl on the nitrogen atom might significantly enhance the anticancer activity. Among the compounds, 6b bearing bromoacetyl side-chain afforded a potential effect against four human tumor cell lines (liver, colon, breast, and lung). The mechanism of action of 6b is to inhibit the activity of DNA topoisomerase I, followed by the S-phase arrest and then cause apoptotic cell death, similar to that of its parent 1. We consider 6b promising for further anticancer investigation.', 'Title: 7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents.  Abstract: A series of 7-azaindenoisoquinoline topoisomerase I (Top1) inhibitors have been prepared to investigate the effect of increased electron affinity of the aromatic system on the ability to stabilize the Top1-DNA cleavage complex. Ab initio calculations suggest that introduction of nitrogen into the aromatic system of the indenoisoquinolines would facilitate charge transfer complex formation with DNA, thus improving the - stacking interactions. The present study shows that 7-azaindenoisoquinolines demonstrate improved water solubility without any decrease in Top1 inhibitory activity or cytotoxicity. Analysis of the biological results reveals that smaller lactam ring substituents enable intercalation into both free DNA and Top1-DNA cleavage complex, whereas larger substituents only allow binding to the cleavage complex but not free DNA. Free DNA binding suppresses Top1-catalyzed DNA cleavage at high drug concentrations, whereas DNA cleavage and inhibition of religation occurs at low drug concentration.', 'Title: 7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents.  Abstract: A series of 7-azaindenoisoquinoline topoisomerase I (Top1) inhibitors have been prepared to investigate the effect of increased electron affinity of the aromatic system on the ability to stabilize the Top1-DNA cleavage complex. Ab initio calculations suggest that introduction of nitrogen into the aromatic system of the indenoisoquinolines would facilitate charge transfer complex formation with DNA, thus improving the - stacking interactions. The present study shows that 7-azaindenoisoquinolines demonstrate improved water solubility without any decrease in Top1 inhibitory activity or cytotoxicity. Analysis of the biological results reveals that smaller lactam ring substituents enable intercalation into both free DNA and Top1-DNA cleavage complex, whereas larger substituents only allow binding to the cleavage complex but not free DNA. Free DNA binding suppresses Top1-catalyzed DNA cleavage at high drug concentrations, whereas DNA cleavage and inhibition of religation occurs at low drug concentration.', 'Title: 7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents.  Abstract: A series of 7-azaindenoisoquinoline topoisomerase I (Top1) inhibitors have been prepared to investigate the effect of increased electron affinity of the aromatic system on the ability to stabilize the Top1-DNA cleavage complex. Ab initio calculations suggest that introduction of nitrogen into the aromatic system of the indenoisoquinolines would facilitate charge transfer complex formation with DNA, thus improving the - stacking interactions. The present study shows that 7-azaindenoisoquinolines demonstrate improved water solubility without any decrease in Top1 inhibitory activity or cytotoxicity. Analysis of the biological results reveals that smaller lactam ring substituents enable intercalation into both free DNA and Top1-DNA cleavage complex, whereas larger substituents only allow binding to the cleavage complex but not free DNA. Free DNA binding suppresses Top1-catalyzed DNA cleavage at high drug concentrations, whereas DNA cleavage and inhibition of religation occurs at low drug concentration.', 'Title: 7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents.  Abstract: A series of 7-azaindenoisoquinoline topoisomerase I (Top1) inhibitors have been prepared to investigate the effect of increased electron affinity of the aromatic system on the ability to stabilize the Top1-DNA cleavage complex. Ab initio calculations suggest that introduction of nitrogen into the aromatic system of the indenoisoquinolines would facilitate charge transfer complex formation with DNA, thus improving the - stacking interactions. The present study shows that 7-azaindenoisoquinolines demonstrate improved water solubility without any decrease in Top1 inhibitory activity or cytotoxicity. Analysis of the biological results reveals that smaller lactam ring substituents enable intercalation into both free DNA and Top1-DNA cleavage complex, whereas larger substituents only allow binding to the cleavage complex but not free DNA. Free DNA binding suppresses Top1-catalyzed DNA cleavage at high drug concentrations, whereas DNA cleavage and inhibition of religation occurs at low drug concentration.', 'Title: 7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents.  Abstract: A series of 7-azaindenoisoquinoline topoisomerase I (Top1) inhibitors have been prepared to investigate the effect of increased electron affinity of the aromatic system on the ability to stabilize the Top1-DNA cleavage complex. Ab initio calculations suggest that introduction of nitrogen into the aromatic system of the indenoisoquinolines would facilitate charge transfer complex formation with DNA, thus improving the - stacking interactions. The present study shows that 7-azaindenoisoquinolines demonstrate improved water solubility without any decrease in Top1 inhibitory activity or cytotoxicity. Analysis of the biological results reveals that smaller lactam ring substituents enable intercalation into both free DNA and Top1-DNA cleavage complex, whereas larger substituents only allow binding to the cleavage complex but not free DNA. Free DNA binding suppresses Top1-catalyzed DNA cleavage at high drug concentrations, whereas DNA cleavage and inhibition of religation occurs at low drug concentration.', 'Title: 7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents.  Abstract: A series of 7-azaindenoisoquinoline topoisomerase I (Top1) inhibitors have been prepared to investigate the effect of increased electron affinity of the aromatic system on the ability to stabilize the Top1-DNA cleavage complex. Ab initio calculations suggest that introduction of nitrogen into the aromatic system of the indenoisoquinolines would facilitate charge transfer complex formation with DNA, thus improving the - stacking interactions. The present study shows that 7-azaindenoisoquinolines demonstrate improved water solubility without any decrease in Top1 inhibitory activity or cytotoxicity. Analysis of the biological results reveals that smaller lactam ring substituents enable intercalation into both free DNA and Top1-DNA cleavage complex, whereas larger substituents only allow binding to the cleavage complex but not free DNA. Free DNA binding suppresses Top1-catalyzed DNA cleavage at high drug concentrations, whereas DNA cleavage and inhibition of religation occurs at low drug concentration.', 'Title: 7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents.  Abstract: A series of 7-azaindenoisoquinoline topoisomerase I (Top1) inhibitors have been prepared to investigate the effect of increased electron affinity of the aromatic system on the ability to stabilize the Top1-DNA cleavage complex. Ab initio calculations suggest that introduction of nitrogen into the aromatic system of the indenoisoquinolines would facilitate charge transfer complex formation with DNA, thus improving the - stacking interactions. The present study shows that 7-azaindenoisoquinolines demonstrate improved water solubility without any decrease in Top1 inhibitory activity or cytotoxicity. Analysis of the biological results reveals that smaller lactam ring substituents enable intercalation into both free DNA and Top1-DNA cleavage complex, whereas larger substituents only allow binding to the cleavage complex but not free DNA. Free DNA binding suppresses Top1-catalyzed DNA cleavage at high drug concentrations, whereas DNA cleavage and inhibition of religation occurs at low drug concentration.', 'An essential step in the pathogenesis of human papillomavirus (HPV)-associated cancers is the dysregulated expression of the viral oncogenes. The papillomavirus E2 protein can silence the long control region (LCR) promoter that controls viral E6 and E7 oncogene expression. The mechanisms by which E2 represses oncogene expression and the cellular factors through which E2 mediates this silencing are largely unknown. We conducted an unbiased, genome-wide siRNA screen and series of secondary screens that identified 96 cellular genes that contribute to the repression of the HPV18 LCR. In addition to confirming a role for the E2-binding bromodomain protein Brd4 in E2-mediated silencing, we identified a number of genes that have not previously been implicated in E2 repression, including the demethylase JARID1C/SMCX as well as EP400, a component of the NuA4/TIP60 histone acetyltransferase complex. Each of these genes contributes independently and additively to E2-mediated silencing, indicating that E2 functions through several distinct cellular complexes to repress E6 and E7 expression.  This screen was conducted in the lab of Peter Howley (Harvard Medical School) at the ICCB-Longwood Screening Facility, Harvard Medical School.', 'Title: Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.  Abstract: From the methanol extract of the bulbs of Pancratium illyricum L., three phenanthridine type alkaloids, ungeremine (1), (-)-lycorine (2) and (+)-vittatine (3) were isolated. For the evaluation of their anticancer and antibacterial potential, compounds 1-3 were tested against human (I, II) and bacterial (IA, IV) topoisomerases. Our data demonstrated that ungeremine impairs the activity of both, human and bacterial topoisomerases. Remarkably, ungeremine was found to largely increments the DNA cleavage promoted by bacterial topoisomerase IA, a new target in antimicrobial chemotherapy.', 'Title: Design, synthesis, and biological evaluation of a novel series of bisintercalating DNA-binding piperazine-linked bisanthrapyrazole compounds as anticancer agents.  Abstract: A series of bisintercalating DNA binding bisanthrapyrazole compounds containing piperazine linkers were designed by molecular modeling and docking techniques. Because the anthrapyrazoles are not quinones they are unable to be reductively activated like doxorubicin and other anthracyclines and thus they should not be cardiotoxic. The concentration dependent increase in DNA melting temperature was used to determine the strength of DNA binding and the bisintercalation potential of the compounds. Compounds with more than a three-carbon linker that could span four DNA base pairs achieved bisintercalation. All of the bisanthrapyrazoles inhibited human erythroleukemic K562 cell growth in the low to submicromolar concentration range. They also strongly inhibited the decatenation activity of topoisomerase II and the relaxation activity of topoisomerase I. However, as measured by their ability to induce double strand breaks in plasmid DNA, the bisanthrapyrazole compounds did not act as topoisomerase II poisons. In conclusion, a novel group of bisanthrapyrazole compounds were designed, synthesized, and biologically evaluated as potential anticancer agents.', 'Title: Catalytic inhibition of eukaryotic topoisomerases I and II by flavonol glycosides extracted from Vicia faba and Lotus edulis.  Abstract: Topoisomerases are essential enzymes involved in all processes of DNA metabolism, and their inhibitors have been identified as potential anticancer agents. The present study examined the effect of nine polyphenolic compounds derived from parts of two unique varieties of the Leguminosae, Vicia faba and Lotus edulis, on the activity of eukaryotic topoisomerases. We identified polyphenolic compounds that act as catalytic inhibitors of wheat germ topoisomerase I (IC50: 120-350 M), human topoisomerase I (IC50: 110-260 M), and human topoisomerase II (IC50: 240-600 M) activities. Some compounds inhibited all enzymatic activities to a similar extent, while others exhibited specificity toward individual enzymes. The strongest catalytic inhibitor of all the examined enzymes was a kaempherol glycoside with an acetyl group linked to a sugar moiety. In addition, this compound inhibited the growth of human cancer cell lines MCF7, HeLa, and HepG2. The inhibition of topoisomerase I and II activities observed by the specific compounds possibly implies a role as potential agents in the prevention and therapy of cancer.', 'Title: Catalytic inhibition of eukaryotic topoisomerases I and II by flavonol glycosides extracted from Vicia faba and Lotus edulis.  Abstract: Topoisomerases are essential enzymes involved in all processes of DNA metabolism, and their inhibitors have been identified as potential anticancer agents. The present study examined the effect of nine polyphenolic compounds derived from parts of two unique varieties of the Leguminosae, Vicia faba and Lotus edulis, on the activity of eukaryotic topoisomerases. We identified polyphenolic compounds that act as catalytic inhibitors of wheat germ topoisomerase I (IC50: 120-350 M), human topoisomerase I (IC50: 110-260 M), and human topoisomerase II (IC50: 240-600 M) activities. Some compounds inhibited all enzymatic activities to a similar extent, while others exhibited specificity toward individual enzymes. The strongest catalytic inhibitor of all the examined enzymes was a kaempherol glycoside with an acetyl group linked to a sugar moiety. In addition, this compound inhibited the growth of human cancer cell lines MCF7, HeLa, and HepG2. The inhibition of topoisomerase I and II activities observed by the specific compounds possibly implies a role as potential agents in the prevention and therapy of cancer.', 'Title: Catalytic inhibition of eukaryotic topoisomerases I and II by flavonol glycosides extracted from Vicia faba and Lotus edulis.  Abstract: Topoisomerases are essential enzymes involved in all processes of DNA metabolism, and their inhibitors have been identified as potential anticancer agents. The present study examined the effect of nine polyphenolic compounds derived from parts of two unique varieties of the Leguminosae, Vicia faba and Lotus edulis, on the activity of eukaryotic topoisomerases. We identified polyphenolic compounds that act as catalytic inhibitors of wheat germ topoisomerase I (IC50: 120-350 M), human topoisomerase I (IC50: 110-260 M), and human topoisomerase II (IC50: 240-600 M) activities. Some compounds inhibited all enzymatic activities to a similar extent, while others exhibited specificity toward individual enzymes. The strongest catalytic inhibitor of all the examined enzymes was a kaempherol glycoside with an acetyl group linked to a sugar moiety. In addition, this compound inhibited the growth of human cancer cell lines MCF7, HeLa, and HepG2. The inhibition of topoisomerase I and II activities observed by the specific compounds possibly implies a role as potential agents in the prevention and therapy of cancer.', 'Title: Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues: a novel DYRK1A inhibitor class.  Abstract: A library of substituted chromeno[3,4-b]indoles was developed as Lamellarin isosters. Synthesis was achieved from indoles after a four-step pathway sequence involving C-3 iodination, a Suzuki cross-coupling reaction, and a one pot deprotection/lactonisation step. Twenty final compounds were tested in order to determine their activity against topoisomerase I and kinases, the two major biological activities of Lamellarins. One newly synthesized derivative exhibited a strong topoisomerase activity comparable to reference compounds such as campthotecin and Lamellarin with only a weak kinase inhibition. Two other lead compounds were identified as new nanomolar DYRK1A inhibitors and several other drugs affected the kinases in the sub-micromolar range. These results will enable us to use the chromeno[3,4-b]indole as a pharmacophore to develop potent treatments for neurological or oncological disorders in which DYRK1A is fully involved.', 'Title: Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues: a novel DYRK1A inhibitor class.  Abstract: A library of substituted chromeno[3,4-b]indoles was developed as Lamellarin isosters. Synthesis was achieved from indoles after a four-step pathway sequence involving C-3 iodination, a Suzuki cross-coupling reaction, and a one pot deprotection/lactonisation step. Twenty final compounds were tested in order to determine their activity against topoisomerase I and kinases, the two major biological activities of Lamellarins. One newly synthesized derivative exhibited a strong topoisomerase activity comparable to reference compounds such as campthotecin and Lamellarin with only a weak kinase inhibition. Two other lead compounds were identified as new nanomolar DYRK1A inhibitors and several other drugs affected the kinases in the sub-micromolar range. These results will enable us to use the chromeno[3,4-b]indole as a pharmacophore to develop potent treatments for neurological or oncological disorders in which DYRK1A is fully involved.', 'Title: Dihydroxylated 2,4,6-triphenyl pyridines: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.  Abstract: Twelve dihydroxylated 2,4,6-triphenyl pyridines were designed and synthesized which contain hydroxyl groups at ortho, meta or para position of 2- and 6-phenyl, or 2- and 4-phenyl rings attached to the central pyridine. They were evaluated for topoisomerase I and II inhibitory activity, and cytotoxicity against several human cancer cell lines for the development of novel anticancer agents. Generally, dihydroxylated 2,4,6-triphenyl pyridines exhibited stronger topoisomerase II inhibitory activity, and cytotoxicity compared to those of monohydroxylated 2,4,6-triphenyl pyridines. The concrete structure-activity relationship was observed that dihydroxylated 2,4,6-triphenyl pyridines with hydroxyl group at meta or para position of 2-phenyl ring displayed significant topoisomerase II inhibitory activity as well as cytotoxicity. Positive correlation between topoisomerase II inhibitory activity and cytotoxicity was observed for compounds 10, 12, 13, 17-20 and 22.', \"High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagy  An increasing body of evidence points to mitochondrial dysfunction as a contributor to the molecular pathogenesis of neurodegenerative diseases such as Parkinson's (1).  Recent studies of the PD-associated genes PINK12 and PARK2 (Parkin) (3) suggest that they may act in a quality control pathway preventing the accumulation of dysfunctional mitochondria (4-7).  Following the loss of mitochondrial membrane potential, the kinase Pink1 and the E3-ubiquitin ligase Parkin coordinate a rapid proteasomal (8) and autophagic (mitophagy) (6) response that may attenuate cell death (9-11).  Given that enhanced mitophagy may ameliorate the deleterious consequences of mitochondrial dysfunction (12-14), we hypothesized that genes regulating Parkin translocation would be useful drug targets for increasing mitochondrial quality control.  However, the mechanism of Parkin recruitment following Pink1 accumulation on the outer mitochondrial membrane is too poorly understood to target, and may involve a host of coordinated events.  To identify genes important for the Pink1-dependent recruitment of Parkin to damaged mitochondria, we conducted two diverse genome-wide siRNA screens with high-throughput automation.  Our screening approach took advantage of the well-characterized phenotype of Parkin accumulation on depolarized mitochondria in cells (6).  Cells stably expressing GFP-Parkin and a mitochondrial-targeted red fluorescent protein were transfected with siRNA duplexes in 384-well plates.  After a 48 hour siRNA knockdown, the proton ionophore carbonyl cyanide 3-chlorophenylhydrazone (CCCP) was added to each well to induce rapid mitochondrial depolarization.  Following bulk mitochondrial depolarization in all cells within each well, GFP-Parkin translocation to the damaged mitochondria was allowed to progress for 2.5 hours and then cells were fixed.  The degree of Parkin translocation to the mitochondria of each cell was assessed by high-content analysis.  Primary screening yielded gene candidates involved in an array of diverse cellular processes that were validated in confirmatory assays.        References: 1.) Schapira, A. H. & Tolosa, E. Molecular and clinical prodrome of Parkinson disease: implications for treatment. Nat Rev Neurol 6, 309-317, (2010). 2.) Valente, E. M. et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158-1160, (2004). 3.) Kitada, T. et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608, (1998). 4.) Vives-Bauza, C. et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A 107, 378-383, (2010). 5.) Narendra, D. P. et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8, e1000298, (2010). 6.) Narendra, D., Tanaka, A., Suen, D. F. & Youle, R. J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183, 795-803, (2008). 7.) Geisler, S. et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12, 119-131, (2010). 8.) Chan, N. C. et al. Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum Mol Genet 20, 1726-1737, (2011). 9.) Bouman, L. et al. Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stress. Cell Death Differ 18, 769-782, (2011). 10.) Darios, F. et al. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum Mol Genet 12, 517-526, (2003). 11.) Gautier, C. A., Kitada, T. & Shen, J. Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci U S A 105, 11364-11369, (2008). 12.) Pimenta de Castro, I. et al. Genetic analysis of mitochondrial protein misfolding in Drosophila melanogaster. Cell Death Differ, (2012). 13.) Suen, D. F., Narendra, D. P., Tanaka, A., Manfredi, G. & Youle, R. J. Parkin overexpression selects against a deleterious mtDNA mutation in heteroplasmic cybrid cells. Proc Natl Acad Sci U S A 107, 11835-11840, (2010). 14.) Burman, J. L., Yu, S., Poole, A. C., Decal, R. B. & Pallanck, L. Analysis of neural subtypes reveals selective mitochondrial dysfunction in dopaminergic neurons from parkin mutants. Proc Natl Acad Sci U S A, (2012). Keywords:  Parkin, PARK2, PINK1, mitophagy, autophagy, CCCP, mitochondrial damage, Parkinson's disease, neurodegeneration, siRNA, RNAi screen, HTS, genome-wide, functional genomics, assay, high content screening, 384 well, National Institutes of Health, National Center for Advancing Translational Sciences, NIH Center for Translational Therapeutics, National Institute of Neurological Disorders and Stroke\", \"High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagy  An increasing body of evidence points to mitochondrial dysfunction as a contributor to the molecular pathogenesis of neurodegenerative diseases such as Parkinson's (1).  Recent studies of the PD-associated genes PINK12 and PARK2 (Parkin) (3) suggest that they may act in a quality control pathway preventing the accumulation of dysfunctional mitochondria (4-7).  Following the loss of mitochondrial membrane potential, the kinase Pink1 and the E3-ubiquitin ligase Parkin coordinate a rapid proteasomal (8) and autophagic (mitophagy) (6) response that may attenuate cell death (9-11).  Given that enhanced mitophagy may ameliorate the deleterious consequences of mitochondrial dysfunction (12-14), we hypothesized that genes regulating Parkin translocation would be useful drug targets for increasing mitochondrial quality control.  However, the mechanism of Parkin recruitment following Pink1 accumulation on the outer mitochondrial membrane is too poorly understood to target, and may involve a host of coordinated events.  To identify genes important for the Pink1-dependent recruitment of Parkin to damaged mitochondria, we conducted two diverse genome-wide siRNA screens with high-throughput automation.  Our screening approach took advantage of the well-characterized phenotype of Parkin accumulation on depolarized mitochondria in cells (6).  Cells stably expressing GFP-Parkin and a mitochondrial-targeted red fluorescent protein were transfected with siRNA duplexes in 384-well plates.  After a 48 hour siRNA knockdown, the proton ionophore carbonyl cyanide 3-chlorophenylhydrazone (CCCP) was added to each well to induce rapid mitochondrial depolarization.  Following bulk mitochondrial depolarization in all cells within each well, GFP-Parkin translocation to the damaged mitochondria was allowed to progress for 2.5 hours and then cells were fixed.  The degree of Parkin translocation to the mitochondria of each cell was assessed by high-content analysis.  Primary screening yielded gene candidates involved in an array of diverse cellular processes that were validated in confirmatory assays.  References: 1.) Schapira, A. H. & Tolosa, E. Molecular and clinical prodrome of Parkinson disease: implications for treatment. Nat Rev Neurol 6, 309-317, (2010). 2.) Valente, E. M. et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158-1160, (2004). 3.) Kitada, T. et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608, (1998). 4.) Vives-Bauza, C. et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A 107, 378-383, (2010). 5.) Narendra, D. P. et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8, e1000298, (2010). 6.) Narendra, D., Tanaka, A., Suen, D. F. & Youle, R. J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183, 795-803, (2008). 7.) Geisler, S. et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12, 119-131, (2010). 8.) Chan, N. C. et al. Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum Mol Genet 20, 1726-1737, (2011). 9.) Bouman, L. et al. Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stress. Cell Death Differ 18, 769-782, (2011). 10.) Darios, F. et al. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum Mol Genet 12, 517-526, (2003). 11.) Gautier, C. A., Kitada, T. & Shen, J. Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci U S A 105, 11364-11369, (2008). 12.) Pimenta de Castro, I. et al. Genetic analysis of mitochondrial protein misfolding in Drosophila melanogaster. Cell Death Differ, (2012). 13.) Suen, D. F., Narendra, D. P., Tanaka, A., Manfredi, G. & Youle, R. J. Parkin overexpression selects against a deleterious mtDNA mutation in heteroplasmic cybrid cells. Proc Natl Acad Sci U S A 107, 11835-11840, (2010). 14.) Burman, J. L., Yu, S., Poole, A. C., Decal, R. B. & Pallanck, L. Analysis of neural subtypes reveals selective mitochondrial dysfunction in dopaminergic neurons from parkin mutants. Proc Natl Acad Sci U S A, (2012). Keywords:  Parkin, PARK2, PINK1, mitophagy, autophagy, CCCP, mitochondrial damage, Parkinson's disease, neurodegeneration, siRNA, RNAi screen, HTS, genome-wide, functional genomics, assay, high content screening, 384 well, National Institutes of Health, National Center for Advancing Translational Sciences, NIH Center for Translational Therapeutics, National Institute of Neurological Disorders and Stroke\", 'Title: Imidazonaphthyridine systems (part 2): Functionalization of the phenyl ring linked to the pyridine pharmacophore and its replacement by a pyridinone ring produces intriguing differences in cytocidal activity.  Abstract: We recently discovered that five- and pseudo-five-fused-ring derivatives in an imidazonaphthyridine series were promising hit compounds for the development of new DNA-intercalators. In this study, novel (dihydro)imidazo[1,6] and [1,7]naphthyridi(no)nes were prepared including pseudo-pentacycles. All the compounds synthesized were screened against four tumor cell lines. Compounds 3(b-d) showed significant in vitro cytotoxicity, and DNA intercalation properties were demonstrated at 25 M. Imidazonaphthyridinones exhibited no DNA binding affinity despite significant growth inhibition activity. Interestingly, when a pyridinone pharmacophore was linked to the imidazo[1,2-a]pyridine scaffold, the geometric orientation of the link had a strong impact on the growth inhibition activity. From these results we conclude that the moderate cytotoxicity observed for these compounds is independent of their DNA-binding and topoisomerase inhibition activities.', 'Title: Imidazonaphthyridine systems (part 2): Functionalization of the phenyl ring linked to the pyridine pharmacophore and its replacement by a pyridinone ring produces intriguing differences in cytocidal activity.  Abstract: We recently discovered that five- and pseudo-five-fused-ring derivatives in an imidazonaphthyridine series were promising hit compounds for the development of new DNA-intercalators. In this study, novel (dihydro)imidazo[1,6] and [1,7]naphthyridi(no)nes were prepared including pseudo-pentacycles. All the compounds synthesized were screened against four tumor cell lines. Compounds 3(b-d) showed significant in vitro cytotoxicity, and DNA intercalation properties were demonstrated at 25 M. Imidazonaphthyridinones exhibited no DNA binding affinity despite significant growth inhibition activity. Interestingly, when a pyridinone pharmacophore was linked to the imidazo[1,2-a]pyridine scaffold, the geometric orientation of the link had a strong impact on the growth inhibition activity. From these results we conclude that the moderate cytotoxicity observed for these compounds is independent of their DNA-binding and topoisomerase inhibition activities.', 'Title: Imidazonaphthyridine systems (part 2): Functionalization of the phenyl ring linked to the pyridine pharmacophore and its replacement by a pyridinone ring produces intriguing differences in cytocidal activity.  Abstract: We recently discovered that five- and pseudo-five-fused-ring derivatives in an imidazonaphthyridine series were promising hit compounds for the development of new DNA-intercalators. In this study, novel (dihydro)imidazo[1,6] and [1,7]naphthyridi(no)nes were prepared including pseudo-pentacycles. All the compounds synthesized were screened against four tumor cell lines. Compounds 3(b-d) showed significant in vitro cytotoxicity, and DNA intercalation properties were demonstrated at 25 M. Imidazonaphthyridinones exhibited no DNA binding affinity despite significant growth inhibition activity. Interestingly, when a pyridinone pharmacophore was linked to the imidazo[1,2-a]pyridine scaffold, the geometric orientation of the link had a strong impact on the growth inhibition activity. From these results we conclude that the moderate cytotoxicity observed for these compounds is independent of their DNA-binding and topoisomerase inhibition activities.', 'Title: Imidazonaphthyridine systems (part 2): Functionalization of the phenyl ring linked to the pyridine pharmacophore and its replacement by a pyridinone ring produces intriguing differences in cytocidal activity.  Abstract: We recently discovered that five- and pseudo-five-fused-ring derivatives in an imidazonaphthyridine series were promising hit compounds for the development of new DNA-intercalators. In this study, novel (dihydro)imidazo[1,6] and [1,7]naphthyridi(no)nes were prepared including pseudo-pentacycles. All the compounds synthesized were screened against four tumor cell lines. Compounds 3(b-d) showed significant in vitro cytotoxicity, and DNA intercalation properties were demonstrated at 25 M. Imidazonaphthyridinones exhibited no DNA binding affinity despite significant growth inhibition activity. Interestingly, when a pyridinone pharmacophore was linked to the imidazo[1,2-a]pyridine scaffold, the geometric orientation of the link had a strong impact on the growth inhibition activity. From these results we conclude that the moderate cytotoxicity observed for these compounds is independent of their DNA-binding and topoisomerase inhibition activities.', 'Title: Imidazonaphthyridine systems (part 2): Functionalization of the phenyl ring linked to the pyridine pharmacophore and its replacement by a pyridinone ring produces intriguing differences in cytocidal activity.  Abstract: We recently discovered that five- and pseudo-five-fused-ring derivatives in an imidazonaphthyridine series were promising hit compounds for the development of new DNA-intercalators. In this study, novel (dihydro)imidazo[1,6] and [1,7]naphthyridi(no)nes were prepared including pseudo-pentacycles. All the compounds synthesized were screened against four tumor cell lines. Compounds 3(b-d) showed significant in vitro cytotoxicity, and DNA intercalation properties were demonstrated at 25 M. Imidazonaphthyridinones exhibited no DNA binding affinity despite significant growth inhibition activity. Interestingly, when a pyridinone pharmacophore was linked to the imidazo[1,2-a]pyridine scaffold, the geometric orientation of the link had a strong impact on the growth inhibition activity. From these results we conclude that the moderate cytotoxicity observed for these compounds is independent of their DNA-binding and topoisomerase inhibition activities.', 'Title: Imidazonaphthyridine systems (part 2): Functionalization of the phenyl ring linked to the pyridine pharmacophore and its replacement by a pyridinone ring produces intriguing differences in cytocidal activity.  Abstract: We recently discovered that five- and pseudo-five-fused-ring derivatives in an imidazonaphthyridine series were promising hit compounds for the development of new DNA-intercalators. In this study, novel (dihydro)imidazo[1,6] and [1,7]naphthyridi(no)nes were prepared including pseudo-pentacycles. All the compounds synthesized were screened against four tumor cell lines. Compounds 3(b-d) showed significant in vitro cytotoxicity, and DNA intercalation properties were demonstrated at 25 M. Imidazonaphthyridinones exhibited no DNA binding affinity despite significant growth inhibition activity. Interestingly, when a pyridinone pharmacophore was linked to the imidazo[1,2-a]pyridine scaffold, the geometric orientation of the link had a strong impact on the growth inhibition activity. From these results we conclude that the moderate cytotoxicity observed for these compounds is independent of their DNA-binding and topoisomerase inhibition activities.', 'Title: Imidazonaphthyridine systems (part 2): Functionalization of the phenyl ring linked to the pyridine pharmacophore and its replacement by a pyridinone ring produces intriguing differences in cytocidal activity.  Abstract: We recently discovered that five- and pseudo-five-fused-ring derivatives in an imidazonaphthyridine series were promising hit compounds for the development of new DNA-intercalators. In this study, novel (dihydro)imidazo[1,6] and [1,7]naphthyridi(no)nes were prepared including pseudo-pentacycles. All the compounds synthesized were screened against four tumor cell lines. Compounds 3(b-d) showed significant in vitro cytotoxicity, and DNA intercalation properties were demonstrated at 25 M. Imidazonaphthyridinones exhibited no DNA binding affinity despite significant growth inhibition activity. Interestingly, when a pyridinone pharmacophore was linked to the imidazo[1,2-a]pyridine scaffold, the geometric orientation of the link had a strong impact on the growth inhibition activity. From these results we conclude that the moderate cytotoxicity observed for these compounds is independent of their DNA-binding and topoisomerase inhibition activities.', 'Title: Azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents: a systematic study of structure-activity relationships.  Abstract: A comprehensive study of a series of azaindenoisoquinoline topoisomerase I (Top1) inhibitors is reported. The synthetic pathways have been developed to prepare 7-, 8-, 9-, and 10-azaindenoisoquinolines. The present study shows that 7-azaindenoisoquinolines possess the greatest Top1 inhibitory activity and cytotoxicity. Additionally, the introduction of a methoxy group into the D-ring of 7-azaindenoisoquinolines improved their biological activities, leading to new lead molecules for further development. A series of QM calculations were performed on the model \"sandwich\" complexes of azaindenoisoquinolines with flanking DNA base pairs from the Drug-Top1-DNA ternary complex. The results of these calculations demonstrate how changes in two forces contributing to the - stacking (dispersion and charge-transfer interactions) affect the binding of the drug to the Top1-DNA cleavage complex and thus modulate the drug\\'s Top1 inhibitory activity.', 'Title: Azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents: a systematic study of structure-activity relationships.  Abstract: A comprehensive study of a series of azaindenoisoquinoline topoisomerase I (Top1) inhibitors is reported. The synthetic pathways have been developed to prepare 7-, 8-, 9-, and 10-azaindenoisoquinolines. The present study shows that 7-azaindenoisoquinolines possess the greatest Top1 inhibitory activity and cytotoxicity. Additionally, the introduction of a methoxy group into the D-ring of 7-azaindenoisoquinolines improved their biological activities, leading to new lead molecules for further development. A series of QM calculations were performed on the model \"sandwich\" complexes of azaindenoisoquinolines with flanking DNA base pairs from the Drug-Top1-DNA ternary complex. The results of these calculations demonstrate how changes in two forces contributing to the - stacking (dispersion and charge-transfer interactions) affect the binding of the drug to the Top1-DNA cleavage complex and thus modulate the drug\\'s Top1 inhibitory activity.', 'Title: Azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents: a systematic study of structure-activity relationships.  Abstract: A comprehensive study of a series of azaindenoisoquinoline topoisomerase I (Top1) inhibitors is reported. The synthetic pathways have been developed to prepare 7-, 8-, 9-, and 10-azaindenoisoquinolines. The present study shows that 7-azaindenoisoquinolines possess the greatest Top1 inhibitory activity and cytotoxicity. Additionally, the introduction of a methoxy group into the D-ring of 7-azaindenoisoquinolines improved their biological activities, leading to new lead molecules for further development. A series of QM calculations were performed on the model \"sandwich\" complexes of azaindenoisoquinolines with flanking DNA base pairs from the Drug-Top1-DNA ternary complex. The results of these calculations demonstrate how changes in two forces contributing to the - stacking (dispersion and charge-transfer interactions) affect the binding of the drug to the Top1-DNA cleavage complex and thus modulate the drug\\'s Top1 inhibitory activity.', 'Title: Synthesis and biological evaluation of new homocamptothecin analogs.  Abstract: In order to increase the stability of E-ring of homocamptothecins, the electron-withdrawing group -OH or -OAc was induced to  position of ring-E lactone. Ten new homocamptothecin analogs were synthesized. Most compounds showed potent in vitro anticancer activity and potent Topo I inhibition, which was equal or superior to that of CPT, SN-38 and 10-HCPT. The stability studies of this series also displayed significant improvement of the stability.', 'Title: Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors.  Abstract: Substances with dual tyrosyl-DNA phosphodiesterase I-topoisomerase I inhibitory activity in one low molecular weight compound would constitute a unique class of anticancer agents that could potentially have significant advantages over drugs that work against the individual enzymes. The present study demonstrates the successful synthesis and evaluation of the first dual Top1-Tdp1 inhibitors, which are based on the indenoisoquinoline chemotype. One bis(indenoisoquinoline) had significant activity against human Tdp1 (IC(50) = 1.52  0.05 M), and it was also equipotent to camptothecin as a Top1 inhibitor. Significant insights into enzyme-drug interactions were gained via structure-activity relationship studies of the series. The present results also document the failure of the previously reported sulfonyl ester pharmacophore to confer Tdp1 inhibition in this indenoisoquinoline class of inhibitors even though it was demonstrated to work well for the steroid NSC 88915 (7). The current study will facilitate future efforts to optimize dual Top1-Tdp1 inhibitors.', \"Title: Novel substituted benzothiophene and thienothiophene carboxanilides and quinolones: synthesis, photochemical synthesis, DNA-binding properties, antitumor evaluation and 3D-derived QSAR analysis.  Abstract: A series of new N,N-dimethylaminopropyl- and 2-imidazolinyl-substituted derivatives of benzo[b]thienyl- and thieno[2,3-b]thienylcarboxanilides and benzo[b]thieno[2,3-c]- and thieno[3',2':4,5]thieno[2,3-c]quinolones were prepared. Quinolones were prepared by the reaction of photochemical dehydrohalogenation of corresponding anilides. Carboxanilides and quinolones were tested for the antiproliferative activity. 2-Imidazolinyl-substituted derivatives showed very prominent activity. By use of the experimentally obtained antitumor measurements, 3D-derived QSAR analysis was performed for the set of compounds. Highly predictive 3D-derived QSAR models were obtained, and molecular properties that have the highest impact on antitumor activity were identified. Carboxanilides 6a-c and quinolones 9a-c and 11a were evaluated for DNA binding propensities and topoisomerases I and II inhibition as part of their mechanism of action assessment. The evaluated differences in the mode of action nicely correlate with the results of the 3D-QSAR analysis. Taken together, the results indicate which modifications of the compounds from the series should further improve their anticancer properties.\", \"Title: Novel substituted benzothiophene and thienothiophene carboxanilides and quinolones: synthesis, photochemical synthesis, DNA-binding properties, antitumor evaluation and 3D-derived QSAR analysis.  Abstract: A series of new N,N-dimethylaminopropyl- and 2-imidazolinyl-substituted derivatives of benzo[b]thienyl- and thieno[2,3-b]thienylcarboxanilides and benzo[b]thieno[2,3-c]- and thieno[3',2':4,5]thieno[2,3-c]quinolones were prepared. Quinolones were prepared by the reaction of photochemical dehydrohalogenation of corresponding anilides. Carboxanilides and quinolones were tested for the antiproliferative activity. 2-Imidazolinyl-substituted derivatives showed very prominent activity. By use of the experimentally obtained antitumor measurements, 3D-derived QSAR analysis was performed for the set of compounds. Highly predictive 3D-derived QSAR models were obtained, and molecular properties that have the highest impact on antitumor activity were identified. Carboxanilides 6a-c and quinolones 9a-c and 11a were evaluated for DNA binding propensities and topoisomerases I and II inhibition as part of their mechanism of action assessment. The evaluated differences in the mode of action nicely correlate with the results of the 3D-QSAR analysis. Taken together, the results indicate which modifications of the compounds from the series should further improve their anticancer properties.\", \"Title: Novel substituted benzothiophene and thienothiophene carboxanilides and quinolones: synthesis, photochemical synthesis, DNA-binding properties, antitumor evaluation and 3D-derived QSAR analysis.  Abstract: A series of new N,N-dimethylaminopropyl- and 2-imidazolinyl-substituted derivatives of benzo[b]thienyl- and thieno[2,3-b]thienylcarboxanilides and benzo[b]thieno[2,3-c]- and thieno[3',2':4,5]thieno[2,3-c]quinolones were prepared. Quinolones were prepared by the reaction of photochemical dehydrohalogenation of corresponding anilides. Carboxanilides and quinolones were tested for the antiproliferative activity. 2-Imidazolinyl-substituted derivatives showed very prominent activity. By use of the experimentally obtained antitumor measurements, 3D-derived QSAR analysis was performed for the set of compounds. Highly predictive 3D-derived QSAR models were obtained, and molecular properties that have the highest impact on antitumor activity were identified. Carboxanilides 6a-c and quinolones 9a-c and 11a were evaluated for DNA binding propensities and topoisomerases I and II inhibition as part of their mechanism of action assessment. The evaluated differences in the mode of action nicely correlate with the results of the 3D-QSAR analysis. Taken together, the results indicate which modifications of the compounds from the series should further improve their anticancer properties.\", \"Title: Novel substituted benzothiophene and thienothiophene carboxanilides and quinolones: synthesis, photochemical synthesis, DNA-binding properties, antitumor evaluation and 3D-derived QSAR analysis.  Abstract: A series of new N,N-dimethylaminopropyl- and 2-imidazolinyl-substituted derivatives of benzo[b]thienyl- and thieno[2,3-b]thienylcarboxanilides and benzo[b]thieno[2,3-c]- and thieno[3',2':4,5]thieno[2,3-c]quinolones were prepared. Quinolones were prepared by the reaction of photochemical dehydrohalogenation of corresponding anilides. Carboxanilides and quinolones were tested for the antiproliferative activity. 2-Imidazolinyl-substituted derivatives showed very prominent activity. By use of the experimentally obtained antitumor measurements, 3D-derived QSAR analysis was performed for the set of compounds. Highly predictive 3D-derived QSAR models were obtained, and molecular properties that have the highest impact on antitumor activity were identified. Carboxanilides 6a-c and quinolones 9a-c and 11a were evaluated for DNA binding propensities and topoisomerases I and II inhibition as part of their mechanism of action assessment. The evaluated differences in the mode of action nicely correlate with the results of the 3D-QSAR analysis. Taken together, the results indicate which modifications of the compounds from the series should further improve their anticancer properties.\", \"Title: Antitumor agents 294. Novel E-ring-modified camptothecin-4-anilino-4'-O-demethyl-epipodophyllotoxin conjugates as DNA topoisomerase I inhibitors and cytotoxic agents.  Abstract: Two conjugates (1 and 2) of camptothecin (CPT) and 4-anilino-4'-O-demethylepipodophyllotoxin were previously shown to exert antitumor activity through inhibition of topoisomerase I (topo I). In this current study, two novel conjugates (1E and 2E) with an open E-ring in the CPT moiety were first synthesized and evaluated for biological activity in comparison with their intact E-ring congeners. This novel class of CPT-derivatives exhibits its antitumor effect against CPT-sensitive and -resistant cells, in part, by inhibiting topo I-linked DNA (TLD) religation. An intact E-ring was not essential for the inhibition of TLD religation, although conjugates with an open E-ring were less potent than the closed ring analogs. This lower religation potency resulted in decreased formation of protein-linked DNA breaks (PLDBs), and hence, less cell growth inhibition. In addition to their impact on topo I, conjugates 1E, 2, and 2E exhibited a minor inhibitory effect on topo II-induced DNA cleavage. The novel structures of 1E and 2E may present scaffolds for further development of dual function topo I and II inhibitors with improved pharmacological profiles and physicochemical properties.\", \"Title: Antitumor agents 294. Novel E-ring-modified camptothecin-4-anilino-4'-O-demethyl-epipodophyllotoxin conjugates as DNA topoisomerase I inhibitors and cytotoxic agents.  Abstract: Two conjugates (1 and 2) of camptothecin (CPT) and 4-anilino-4'-O-demethylepipodophyllotoxin were previously shown to exert antitumor activity through inhibition of topoisomerase I (topo I). In this current study, two novel conjugates (1E and 2E) with an open E-ring in the CPT moiety were first synthesized and evaluated for biological activity in comparison with their intact E-ring congeners. This novel class of CPT-derivatives exhibits its antitumor effect against CPT-sensitive and -resistant cells, in part, by inhibiting topo I-linked DNA (TLD) religation. An intact E-ring was not essential for the inhibition of TLD religation, although conjugates with an open E-ring were less potent than the closed ring analogs. This lower religation potency resulted in decreased formation of protein-linked DNA breaks (PLDBs), and hence, less cell growth inhibition. In addition to their impact on topo I, conjugates 1E, 2, and 2E exhibited a minor inhibitory effect on topo II-induced DNA cleavage. The novel structures of 1E and 2E may present scaffolds for further development of dual function topo I and II inhibitors with improved pharmacological profiles and physicochemical properties.\", \"Title: Antitumor agents 294. Novel E-ring-modified camptothecin-4-anilino-4'-O-demethyl-epipodophyllotoxin conjugates as DNA topoisomerase I inhibitors and cytotoxic agents.  Abstract: Two conjugates (1 and 2) of camptothecin (CPT) and 4-anilino-4'-O-demethylepipodophyllotoxin were previously shown to exert antitumor activity through inhibition of topoisomerase I (topo I). In this current study, two novel conjugates (1E and 2E) with an open E-ring in the CPT moiety were first synthesized and evaluated for biological activity in comparison with their intact E-ring congeners. This novel class of CPT-derivatives exhibits its antitumor effect against CPT-sensitive and -resistant cells, in part, by inhibiting topo I-linked DNA (TLD) religation. An intact E-ring was not essential for the inhibition of TLD religation, although conjugates with an open E-ring were less potent than the closed ring analogs. This lower religation potency resulted in decreased formation of protein-linked DNA breaks (PLDBs), and hence, less cell growth inhibition. In addition to their impact on topo I, conjugates 1E, 2, and 2E exhibited a minor inhibitory effect on topo II-induced DNA cleavage. The novel structures of 1E and 2E may present scaffolds for further development of dual function topo I and II inhibitors with improved pharmacological profiles and physicochemical properties.\", \"Title: Antitumor agents 294. Novel E-ring-modified camptothecin-4-anilino-4'-O-demethyl-epipodophyllotoxin conjugates as DNA topoisomerase I inhibitors and cytotoxic agents.  Abstract: Two conjugates (1 and 2) of camptothecin (CPT) and 4-anilino-4'-O-demethylepipodophyllotoxin were previously shown to exert antitumor activity through inhibition of topoisomerase I (topo I). In this current study, two novel conjugates (1E and 2E) with an open E-ring in the CPT moiety were first synthesized and evaluated for biological activity in comparison with their intact E-ring congeners. This novel class of CPT-derivatives exhibits its antitumor effect against CPT-sensitive and -resistant cells, in part, by inhibiting topo I-linked DNA (TLD) religation. An intact E-ring was not essential for the inhibition of TLD religation, although conjugates with an open E-ring were less potent than the closed ring analogs. This lower religation potency resulted in decreased formation of protein-linked DNA breaks (PLDBs), and hence, less cell growth inhibition. In addition to their impact on topo I, conjugates 1E, 2, and 2E exhibited a minor inhibitory effect on topo II-induced DNA cleavage. The novel structures of 1E and 2E may present scaffolds for further development of dual function topo I and II inhibitors with improved pharmacological profiles and physicochemical properties.\", \"Title: Antitumor agents 294. Novel E-ring-modified camptothecin-4-anilino-4'-O-demethyl-epipodophyllotoxin conjugates as DNA topoisomerase I inhibitors and cytotoxic agents.  Abstract: Two conjugates (1 and 2) of camptothecin (CPT) and 4-anilino-4'-O-demethylepipodophyllotoxin were previously shown to exert antitumor activity through inhibition of topoisomerase I (topo I). In this current study, two novel conjugates (1E and 2E) with an open E-ring in the CPT moiety were first synthesized and evaluated for biological activity in comparison with their intact E-ring congeners. This novel class of CPT-derivatives exhibits its antitumor effect against CPT-sensitive and -resistant cells, in part, by inhibiting topo I-linked DNA (TLD) religation. An intact E-ring was not essential for the inhibition of TLD religation, although conjugates with an open E-ring were less potent than the closed ring analogs. This lower religation potency resulted in decreased formation of protein-linked DNA breaks (PLDBs), and hence, less cell growth inhibition. In addition to their impact on topo I, conjugates 1E, 2, and 2E exhibited a minor inhibitory effect on topo II-induced DNA cleavage. The novel structures of 1E and 2E may present scaffolds for further development of dual function topo I and II inhibitors with improved pharmacological profiles and physicochemical properties.\", 'Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.', 'Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.', 'Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.', 'Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.', 'Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.', 'Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.', 'Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.', 'Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.', 'Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.', 'Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.', 'Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.', 'Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.', 'Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.', 'Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.', 'Title: Inhibition of human topoisomerases I and II by simocyclinone D8.  Abstract: Simocyclinone D8 is an antibiotic isolated from Streptomyces antibioticus T 6040 that inhibits the supercoiling activity of DNA gyrase. It also exhibits an inhibitory effect on human topoisomerase II and an antiproliferative activity against some cancer cell lines. Our biochemical studies have revealed that simocyclinone D8 can inhibit the catalytic activity of human topoisomerase I. Thus, simocyclinone D8 is a dual catalytic inhibitor of human topoisomerases I and II.', 'Title: 3,6-bis(3-alkylguanidino)acridines as DNA-intercalating antitumor agents.  Abstract: A series of 3,6-bis(3-alkylguanidino) acridines was prepared and the interaction of these novel compounds with calf thymus DNA was investigated with UV-vis, fluorescence and circular dichroism spectroscopy, in addition to DNA melting techniques. The binding constants K were estimated to range from 1.25 to 5.26  10(5) M(-1), and the percentage of hypochromism was found to be 17-42% (from spectral titration). UV-vis, fluorescence and circular dichroism measurements indicated that the compounds act as effective DNA-intercalating agents. Electrophoretic separation proved that ligands 6a-e relaxed topoisomerase I at a concentration of 60 M, although only those with longer alkyl chains were able to penetrate cell membranes and suppress cell proliferation effectively. The biological activity of novel compounds was assessed using different techniques (cell cycle distribution, phosphatidylserine externalization, caspase-3 activation, changes in mitochondrial membrane potential) and demonstrated mostly transient cytostatic action of the ethyl 6c and pentyl 6d derivatives. The hexyl derivative 6e proved to be the most cytotoxic. Different patterns of cell penetration were also observed for individual derivatives. Principles of molecular dynamics were applied to explore DNA-ligand interactions at the molecular level.', 'Title: 3,6-bis(3-alkylguanidino)acridines as DNA-intercalating antitumor agents.  Abstract: A series of 3,6-bis(3-alkylguanidino) acridines was prepared and the interaction of these novel compounds with calf thymus DNA was investigated with UV-vis, fluorescence and circular dichroism spectroscopy, in addition to DNA melting techniques. The binding constants K were estimated to range from 1.25 to 5.26  10(5) M(-1), and the percentage of hypochromism was found to be 17-42% (from spectral titration). UV-vis, fluorescence and circular dichroism measurements indicated that the compounds act as effective DNA-intercalating agents. Electrophoretic separation proved that ligands 6a-e relaxed topoisomerase I at a concentration of 60 M, although only those with longer alkyl chains were able to penetrate cell membranes and suppress cell proliferation effectively. The biological activity of novel compounds was assessed using different techniques (cell cycle distribution, phosphatidylserine externalization, caspase-3 activation, changes in mitochondrial membrane potential) and demonstrated mostly transient cytostatic action of the ethyl 6c and pentyl 6d derivatives. The hexyl derivative 6e proved to be the most cytotoxic. Different patterns of cell penetration were also observed for individual derivatives. Principles of molecular dynamics were applied to explore DNA-ligand interactions at the molecular level.', 'Title: New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations.  Abstract: Evodiamine is a quinazolinocarboline alkaloid isolated from the fruits of traditional Chinese herb  Evodiae fructus . Previously, we identified N13-substituted evodiamine derivatives as potent topoisomerase I inhibitors by structure-based virtual screening and lead optimization. Herein, a library of novel evodiamine derivatives bearing various substitutions or modified scaffold were synthesized. Among them, a number of evodiamine derivatives showed substantial increase of the antitumor activity, with GI(50) values lower than 3 nM. Moreover, these highly potent compounds can effectively induce the apoptosis of A549 cells. Interestingly, further computational target prediction calculations in combination with biological assays confirmed that the evodiamine derivatives acted by dual inhibition of topoisomerases I and II. Moreover, several hydroxyl derivatives, such as 10-hydroxyl evodiamine (10j) and 3-amino-10-hydroxyl evodiamine (18g), also showed good in vivo antitumor efficacy and low toxicity at the dose of 1 mg/kg or 2 mg/kg. They represent promising candidates for the development of novel antitumor agents.', 'Title: New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations.  Abstract: Evodiamine is a quinazolinocarboline alkaloid isolated from the fruits of traditional Chinese herb  Evodiae fructus . Previously, we identified N13-substituted evodiamine derivatives as potent topoisomerase I inhibitors by structure-based virtual screening and lead optimization. Herein, a library of novel evodiamine derivatives bearing various substitutions or modified scaffold were synthesized. Among them, a number of evodiamine derivatives showed substantial increase of the antitumor activity, with GI(50) values lower than 3 nM. Moreover, these highly potent compounds can effectively induce the apoptosis of A549 cells. Interestingly, further computational target prediction calculations in combination with biological assays confirmed that the evodiamine derivatives acted by dual inhibition of topoisomerases I and II. Moreover, several hydroxyl derivatives, such as 10-hydroxyl evodiamine (10j) and 3-amino-10-hydroxyl evodiamine (18g), also showed good in vivo antitumor efficacy and low toxicity at the dose of 1 mg/kg or 2 mg/kg. They represent promising candidates for the development of novel antitumor agents.', 'Title: New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations.  Abstract: Evodiamine is a quinazolinocarboline alkaloid isolated from the fruits of traditional Chinese herb  Evodiae fructus . Previously, we identified N13-substituted evodiamine derivatives as potent topoisomerase I inhibitors by structure-based virtual screening and lead optimization. Herein, a library of novel evodiamine derivatives bearing various substitutions or modified scaffold were synthesized. Among them, a number of evodiamine derivatives showed substantial increase of the antitumor activity, with GI(50) values lower than 3 nM. Moreover, these highly potent compounds can effectively induce the apoptosis of A549 cells. Interestingly, further computational target prediction calculations in combination with biological assays confirmed that the evodiamine derivatives acted by dual inhibition of topoisomerases I and II. Moreover, several hydroxyl derivatives, such as 10-hydroxyl evodiamine (10j) and 3-amino-10-hydroxyl evodiamine (18g), also showed good in vivo antitumor efficacy and low toxicity at the dose of 1 mg/kg or 2 mg/kg. They represent promising candidates for the development of novel antitumor agents.', 'Title: New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations.  Abstract: Evodiamine is a quinazolinocarboline alkaloid isolated from the fruits of traditional Chinese herb  Evodiae fructus . Previously, we identified N13-substituted evodiamine derivatives as potent topoisomerase I inhibitors by structure-based virtual screening and lead optimization. Herein, a library of novel evodiamine derivatives bearing various substitutions or modified scaffold were synthesized. Among them, a number of evodiamine derivatives showed substantial increase of the antitumor activity, with GI(50) values lower than 3 nM. Moreover, these highly potent compounds can effectively induce the apoptosis of A549 cells. Interestingly, further computational target prediction calculations in combination with biological assays confirmed that the evodiamine derivatives acted by dual inhibition of topoisomerases I and II. Moreover, several hydroxyl derivatives, such as 10-hydroxyl evodiamine (10j) and 3-amino-10-hydroxyl evodiamine (18g), also showed good in vivo antitumor efficacy and low toxicity at the dose of 1 mg/kg or 2 mg/kg. They represent promising candidates for the development of novel antitumor agents.', 'Title: Design, synthesis, and antitumor evaluation of 2,4,6-triaryl pyridines containing chlorophenyl and phenolic moiety.  Abstract: We have designed and synthesized a series of 2,4,6-triaryl pyridine derivatives containing chlorophenyl and phenolic moeity at 2- and 4- position of the central pyridine, respectively, resulting in a total of 42 compounds. They were evaluated for topoisomerase I and II inhibitory activities as well as cytotoxicities against several human cancer cell lines. Most compounds showed better topoisomerase II inhibitory activity compared to topoisomerase I inhibitory activity. Compounds 19, 20, 26-28, and 47-50 especially showed stronger topo II inhibitory activity than etoposide.', 'Title: Design, synthesis, and antitumor evaluation of 2,4,6-triaryl pyridines containing chlorophenyl and phenolic moiety.  Abstract: We have designed and synthesized a series of 2,4,6-triaryl pyridine derivatives containing chlorophenyl and phenolic moeity at 2- and 4- position of the central pyridine, respectively, resulting in a total of 42 compounds. They were evaluated for topoisomerase I and II inhibitory activities as well as cytotoxicities against several human cancer cell lines. Most compounds showed better topoisomerase II inhibitory activity compared to topoisomerase I inhibitory activity. Compounds 19, 20, 26-28, and 47-50 especially showed stronger topo II inhibitory activity than etoposide.', 'Title: Identification, synthesis, and biological evaluation of metabolites of the experimental cancer treatment drugs indotecan (LMP400) and indimitecan (LMP776) and investigation of isomerically hydroxylated indenoisoquinoline analogues as topoisomerase I poisons.  Abstract: Hydroxylated analogues of the anticancer topoisomerase I (Top1) inhibitors indotecan (LMP400) and indimitecan (LMP776) have been prepared because (1) a variety of potent Top1 poisons are known that contain strategically placed hydroxyl groups, which provides a clear rationale for incorporating them in the present case, and (2) the hydroxylated compounds could conceivably serve as synthetic standards for the identification of metabolites. Indeed, incubating LMP400 and LMP776 with human liver microsomes resulted in two major metabolites of each drug, which had HPLC retention times and mass fragmentation patterns identical to those of the synthetic standards. The hydroxylated indotecan and indimitecan metabolites and analogues were tested as Top1 poisons and for antiproliferative activity in a variety of human cancer cell cultures and in general were found to be very potent. Differences in activity resulting from the placement of the hydroxyl group are explained by molecular modeling analyses.', 'Title: Lanostanoids from fungi: a group of potential anticancer compounds.  Abstract: Lanostanes are a group of tetracyclic triterpenoids derived from lanosterol. They have relevant biological and pharmacological properties, such as their cytotoxic effects via induction of apoptosis. This review compiles the most relevant lanostanoids studied from 2000 to 2011, principally those isolated from Ganoderma lucidum and other related fungi, such as Poria cocos, Laetiporus sulphureus, Inonotus obliquus, Antrodia camphorata, Daedalea dickinsii, and Elfvingia applanata, which have great potential as anticancer agents because of their cytotoxic or apoptotic effects. The compounds were selected on the basis of their proapoptotic mechanisms, through their ability to modify transcriptional activities via nuclear factors or genes and the activation or inhibition of pro- or antiapoptotic proteins; studies based only on their cytotoxicity were excluded from this review in the absence of complementary studies on their mechanisms of action. A total of 81 compounds from Ganoderma lucidum and other species from this genus are included, as well as 96 compounds isolated from other fungi, principally Poria cocos. Some of these compounds were found to arrest the cell cycle in the G1 phase, increase levels of p53 and Bax, or inhibit the phosphorylation of Erk1/2 or the activation of NF-B and AP-1. Other lanostanes have inhibitory effects on the growth of androgen prostate carcinoma through increasing the expression of p21, which activates the tumor suppressor protein p53, while other compounds have been shown to selectively inhibit topo II activity without affecting topo I. General considerations concerning the chemical structure-biological activities of these compounds are also discussed.', 'Title: Lanostanoids from fungi: a group of potential anticancer compounds.  Abstract: Lanostanes are a group of tetracyclic triterpenoids derived from lanosterol. They have relevant biological and pharmacological properties, such as their cytotoxic effects via induction of apoptosis. This review compiles the most relevant lanostanoids studied from 2000 to 2011, principally those isolated from Ganoderma lucidum and other related fungi, such as Poria cocos, Laetiporus sulphureus, Inonotus obliquus, Antrodia camphorata, Daedalea dickinsii, and Elfvingia applanata, which have great potential as anticancer agents because of their cytotoxic or apoptotic effects. The compounds were selected on the basis of their proapoptotic mechanisms, through their ability to modify transcriptional activities via nuclear factors or genes and the activation or inhibition of pro- or antiapoptotic proteins; studies based only on their cytotoxicity were excluded from this review in the absence of complementary studies on their mechanisms of action. A total of 81 compounds from Ganoderma lucidum and other species from this genus are included, as well as 96 compounds isolated from other fungi, principally Poria cocos. Some of these compounds were found to arrest the cell cycle in the G1 phase, increase levels of p53 and Bax, or inhibit the phosphorylation of Erk1/2 or the activation of NF-B and AP-1. Other lanostanes have inhibitory effects on the growth of androgen prostate carcinoma through increasing the expression of p21, which activates the tumor suppressor protein p53, while other compounds have been shown to selectively inhibit topo II activity without affecting topo I. General considerations concerning the chemical structure-biological activities of these compounds are also discussed.', 'Title: Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.  Abstract: Tumor hypoxia has been recognized as a common feature of solid tumors and a negative prognostic factor for response to treatment and survival of cancer patients. The discovery of hypoxia-inducible factor-1 (HIF-1), a molecular determinant of responses to hypoxia in mammalian cells, has renewed enthusiasm for discovery and development of targeted therapies exploiting the hypoxic tumor microenvironment. HIF-1 activity in tumors depends on availability of the HIF-1 subunit, the levels of which increase under hypoxic conditions and through activation of oncogenes and/or inactivation of tumor suppressor genes. Increased HIF-1 has been correlated with increased angiogenesis, aggressive tumor growth, and poor patient prognosis, leading to current interest in HIF-1 as promising anticancer drug target. In spite of an ever increasing number of putative small molecule inhibitors of HIF-1, only a few are progressing through preclinical and early clinical development. In this review, we will discuss recent advances in discovery and development of small molecule inhibitors that target the HIF-1 pathway as potential anticancer agents.', 'Title: Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.  Abstract: Tumor hypoxia has been recognized as a common feature of solid tumors and a negative prognostic factor for response to treatment and survival of cancer patients. The discovery of hypoxia-inducible factor-1 (HIF-1), a molecular determinant of responses to hypoxia in mammalian cells, has renewed enthusiasm for discovery and development of targeted therapies exploiting the hypoxic tumor microenvironment. HIF-1 activity in tumors depends on availability of the HIF-1 subunit, the levels of which increase under hypoxic conditions and through activation of oncogenes and/or inactivation of tumor suppressor genes. Increased HIF-1 has been correlated with increased angiogenesis, aggressive tumor growth, and poor patient prognosis, leading to current interest in HIF-1 as promising anticancer drug target. In spite of an ever increasing number of putative small molecule inhibitors of HIF-1, only a few are progressing through preclinical and early clinical development. In this review, we will discuss recent advances in discovery and development of small molecule inhibitors that target the HIF-1 pathway as potential anticancer agents.', 'Title: Break-induced replication repair of damaged forks induces genomic duplications in human cells  Abstract: In budding yeast, one-ended DNA double-strand breaks (DSBs) and damaged replication forks are repaired by break-induced replication (BIR), a homologous recombination pathway that requires the Pol32 subunit of DNA polymerase delta. DNA replication stress is prevalent in cancer, but BIR has not been characterized in mammals. In a cyclin E overexpression model of DNA replication stress, POLD3, the human ortholog of POL32, was required for cell cycle progression and processive DNA synthesis. Segmental genomic duplications induced by cyclin E overexpression were also dependent on POLD3, as were BIR-mediated recombination events captured with a specialized DSB repair assay. We propose that BIR repairs damaged replication forks in mammals, accounting for the high frequency of genomic duplications in human cancers.  This RNAi screen aimed to identify genes whose functional inhibition would sensitize U-2 OS cells overexpressing cyclin-E (CCNE1) to oncogene induced DNA replication stress.', 'Title: Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1).  Abstract: Tyrosyl-DNA phosphodiesterase I (Tdp1) plays a key role in the repair of damaged DNA resulting from the topoisomerase I (Top1) inhibitor camptothecin and a variety of other DNA-damaging anticancer agents. This report documents the design, synthesis, and evaluation of new indenoisoquinolines that are dual inhibitors of both Tdp1 and Top1. Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures were used to establish structure-activity relationships. The potencies of the indenoisoquinolines against Tdp1 ranged from 5 M to 111 M, which places the more active compounds among the most potent known inhibitors of this target. The cytotoxicity mean graph midpoints ranged from 0.02 to 2.34 M. Dual Tdp1-Top1 inhibitors are of interest because the Top1 and Tdp1 inhibitory activities could theoretically work synergistically to create more effective anticancer agents.', 'Title: Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1).  Abstract: Tyrosyl-DNA phosphodiesterase I (Tdp1) plays a key role in the repair of damaged DNA resulting from the topoisomerase I (Top1) inhibitor camptothecin and a variety of other DNA-damaging anticancer agents. This report documents the design, synthesis, and evaluation of new indenoisoquinolines that are dual inhibitors of both Tdp1 and Top1. Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures were used to establish structure-activity relationships. The potencies of the indenoisoquinolines against Tdp1 ranged from 5 M to 111 M, which places the more active compounds among the most potent known inhibitors of this target. The cytotoxicity mean graph midpoints ranged from 0.02 to 2.34 M. Dual Tdp1-Top1 inhibitors are of interest because the Top1 and Tdp1 inhibitory activities could theoretically work synergistically to create more effective anticancer agents.', 'Title: Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1).  Abstract: Tyrosyl-DNA phosphodiesterase I (Tdp1) plays a key role in the repair of damaged DNA resulting from the topoisomerase I (Top1) inhibitor camptothecin and a variety of other DNA-damaging anticancer agents. This report documents the design, synthesis, and evaluation of new indenoisoquinolines that are dual inhibitors of both Tdp1 and Top1. Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures were used to establish structure-activity relationships. The potencies of the indenoisoquinolines against Tdp1 ranged from 5 M to 111 M, which places the more active compounds among the most potent known inhibitors of this target. The cytotoxicity mean graph midpoints ranged from 0.02 to 2.34 M. Dual Tdp1-Top1 inhibitors are of interest because the Top1 and Tdp1 inhibitory activities could theoretically work synergistically to create more effective anticancer agents.', 'Title: Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1).  Abstract: Tyrosyl-DNA phosphodiesterase I (Tdp1) plays a key role in the repair of damaged DNA resulting from the topoisomerase I (Top1) inhibitor camptothecin and a variety of other DNA-damaging anticancer agents. This report documents the design, synthesis, and evaluation of new indenoisoquinolines that are dual inhibitors of both Tdp1 and Top1. Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures were used to establish structure-activity relationships. The potencies of the indenoisoquinolines against Tdp1 ranged from 5 M to 111 M, which places the more active compounds among the most potent known inhibitors of this target. The cytotoxicity mean graph midpoints ranged from 0.02 to 2.34 M. Dual Tdp1-Top1 inhibitors are of interest because the Top1 and Tdp1 inhibitory activities could theoretically work synergistically to create more effective anticancer agents.', 'Title: Synthesis, antiproliferative activity and tubulin targeting effect of acridinone and dioxophenothiazine derivatives.  Abstract: The synthesis of new acridinone and dioxophenothiazine derivatives along with their tubulin polymerization inhibitory and antiproliferative activities is reported. The analysis of correlation for cytotoxic and antitubulin potential of tested compounds showed that 4-methoxyphenylethyl derivatives 18a and 19a were highly cytotoxic but were regarded to have no significant antitubulin activity. However, the introduction of a 3-hydroxy substituent leading to compounds 18e and 19e, strongly increased the antitubulin potential but was associated with a loss of the antiproliferative activity. Modeling studies, topoisomerase inhibition assays and cell cycle analysis have been performed to better investigate the mechanism of action of such compounds.', 'Title: Synthesis, antiproliferative activity and tubulin targeting effect of acridinone and dioxophenothiazine derivatives.  Abstract: The synthesis of new acridinone and dioxophenothiazine derivatives along with their tubulin polymerization inhibitory and antiproliferative activities is reported. The analysis of correlation for cytotoxic and antitubulin potential of tested compounds showed that 4-methoxyphenylethyl derivatives 18a and 19a were highly cytotoxic but were regarded to have no significant antitubulin activity. However, the introduction of a 3-hydroxy substituent leading to compounds 18e and 19e, strongly increased the antitubulin potential but was associated with a loss of the antiproliferative activity. Modeling studies, topoisomerase inhibition assays and cell cycle analysis have been performed to better investigate the mechanism of action of such compounds.', 'Title: Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.  Abstract: The plant alkaloid lycobetaine has potent topoisomerase-targeting properties and shows anticancer activity. Based on these findings, several lycobetaine analogs were synthesized mainly differing in their substituents at 2, 8 and 9 position and their biological activities were evaluated. The topoisomerase-targeting properties and cytotoxicity of these structural analogs were assessed in the human gastric carcinoma cell line GXF251L. Performing a plasmid relaxation assay, an increased inhibition of topoisomerase I was found with N-methylphenanthridinium chlorides bearing a 8,9-methylenedioxy moiety or a methoxy group in 2-position. Furthermore, quaternized phenanthridinium derivatives bearing either a 2-methoxy or a 8,9-methylenedioxy moiety in conjunction with a 2-hydroxy or 2-methoxy group display potent topoisomerase II inhibition as shown by decatenation of kinetoplast DNA. In general, the N-methylphenanthridinium chlorides possess more potency in inhibiting topoisomerase I than topoisomerase II. All quaternized derivatives also exhibited potent inhibition of tumor cell growth in the low micromolar concentration range. Hence, N-methylphenanthridinium compounds were found to represent a promising class of compounds, potently inhibiting both, topoisomerases I and II, and may be further developed into clinically useful topoisomerase inhibitors.', 'Title: Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.  Abstract: The plant alkaloid lycobetaine has potent topoisomerase-targeting properties and shows anticancer activity. Based on these findings, several lycobetaine analogs were synthesized mainly differing in their substituents at 2, 8 and 9 position and their biological activities were evaluated. The topoisomerase-targeting properties and cytotoxicity of these structural analogs were assessed in the human gastric carcinoma cell line GXF251L. Performing a plasmid relaxation assay, an increased inhibition of topoisomerase I was found with N-methylphenanthridinium chlorides bearing a 8,9-methylenedioxy moiety or a methoxy group in 2-position. Furthermore, quaternized phenanthridinium derivatives bearing either a 2-methoxy or a 8,9-methylenedioxy moiety in conjunction with a 2-hydroxy or 2-methoxy group display potent topoisomerase II inhibition as shown by decatenation of kinetoplast DNA. In general, the N-methylphenanthridinium chlorides possess more potency in inhibiting topoisomerase I than topoisomerase II. All quaternized derivatives also exhibited potent inhibition of tumor cell growth in the low micromolar concentration range. Hence, N-methylphenanthridinium compounds were found to represent a promising class of compounds, potently inhibiting both, topoisomerases I and II, and may be further developed into clinically useful topoisomerase inhibitors.', 'Title: Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.  Abstract: The plant alkaloid lycobetaine has potent topoisomerase-targeting properties and shows anticancer activity. Based on these findings, several lycobetaine analogs were synthesized mainly differing in their substituents at 2, 8 and 9 position and their biological activities were evaluated. The topoisomerase-targeting properties and cytotoxicity of these structural analogs were assessed in the human gastric carcinoma cell line GXF251L. Performing a plasmid relaxation assay, an increased inhibition of topoisomerase I was found with N-methylphenanthridinium chlorides bearing a 8,9-methylenedioxy moiety or a methoxy group in 2-position. Furthermore, quaternized phenanthridinium derivatives bearing either a 2-methoxy or a 8,9-methylenedioxy moiety in conjunction with a 2-hydroxy or 2-methoxy group display potent topoisomerase II inhibition as shown by decatenation of kinetoplast DNA. In general, the N-methylphenanthridinium chlorides possess more potency in inhibiting topoisomerase I than topoisomerase II. All quaternized derivatives also exhibited potent inhibition of tumor cell growth in the low micromolar concentration range. Hence, N-methylphenanthridinium compounds were found to represent a promising class of compounds, potently inhibiting both, topoisomerases I and II, and may be further developed into clinically useful topoisomerase inhibitors.', 'Title: Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.  Abstract: The plant alkaloid lycobetaine has potent topoisomerase-targeting properties and shows anticancer activity. Based on these findings, several lycobetaine analogs were synthesized mainly differing in their substituents at 2, 8 and 9 position and their biological activities were evaluated. The topoisomerase-targeting properties and cytotoxicity of these structural analogs were assessed in the human gastric carcinoma cell line GXF251L. Performing a plasmid relaxation assay, an increased inhibition of topoisomerase I was found with N-methylphenanthridinium chlorides bearing a 8,9-methylenedioxy moiety or a methoxy group in 2-position. Furthermore, quaternized phenanthridinium derivatives bearing either a 2-methoxy or a 8,9-methylenedioxy moiety in conjunction with a 2-hydroxy or 2-methoxy group display potent topoisomerase II inhibition as shown by decatenation of kinetoplast DNA. In general, the N-methylphenanthridinium chlorides possess more potency in inhibiting topoisomerase I than topoisomerase II. All quaternized derivatives also exhibited potent inhibition of tumor cell growth in the low micromolar concentration range. Hence, N-methylphenanthridinium compounds were found to represent a promising class of compounds, potently inhibiting both, topoisomerases I and II, and may be further developed into clinically useful topoisomerase inhibitors.', 'Title: Novel antitumor indolizino[6,7-b]indoles with multiple modes of action: DNA cross-linking and topoisomerase I and II inhibition.  Abstract: A series of bis(hydroxymethyl)indolizino[6,7-b]indoles and their bis(alkylcarbamates) were synthesized for antitumor studies. These agents were designed as hybrid molecules of -carboline (topoisomerase inhibition moiety) and bis(hydroxymethyl)pyrrole (DNA cross-linking moiety). The preliminary antitumor studies indicated that these agents exhibited significant cytotoxicity against a variety of human tumor cells in vitro. Treatment of human breast carcinoma MX-1 xenograft-bearing nude mice with compounds 18b and 28c achieved more than 99% tumor remission. We also observed that 18a displayed potent therapeutic efficacy against human lung adenocarcinoma A549 and colon cancer HT-29 xenografts. These results revealed that compound 18a was more potent than irinotecan against HT-29 cells and was as potent as irinotecan against A549 cells in xenograft models. Furthermore, we demonstrated that these derivatives possess multiple modes of action, such as induction of DNA cross-linking, inhibition of topoisomerase I and II, and cell-cycle arrest at the S-phase.', 'Title: Novel antitumor indolizino[6,7-b]indoles with multiple modes of action: DNA cross-linking and topoisomerase I and II inhibition.  Abstract: A series of bis(hydroxymethyl)indolizino[6,7-b]indoles and their bis(alkylcarbamates) were synthesized for antitumor studies. These agents were designed as hybrid molecules of -carboline (topoisomerase inhibition moiety) and bis(hydroxymethyl)pyrrole (DNA cross-linking moiety). The preliminary antitumor studies indicated that these agents exhibited significant cytotoxicity against a variety of human tumor cells in vitro. Treatment of human breast carcinoma MX-1 xenograft-bearing nude mice with compounds 18b and 28c achieved more than 99% tumor remission. We also observed that 18a displayed potent therapeutic efficacy against human lung adenocarcinoma A549 and colon cancer HT-29 xenografts. These results revealed that compound 18a was more potent than irinotecan against HT-29 cells and was as potent as irinotecan against A549 cells in xenograft models. Furthermore, we demonstrated that these derivatives possess multiple modes of action, such as induction of DNA cross-linking, inhibition of topoisomerase I and II, and cell-cycle arrest at the S-phase.', 'Title: Solphenazines A-F, glycosylated phenazines from Streptomyces sp. strain DL-93.  Abstract: During a survey of actinobacteria known to suppress the growth of Streptomyces scabies (the causative agent of potato scab disease) in vivo, six new rhamnosylated alkaloids, the solphenazines A-F (1-6), were isolated from a biological control strain of Streptomyces (DL-93). The known rhamnosyl analogue of paraben (9) was also isolated along with a new rhamnosylated derivative of N-methyl-p-aminobenzoic acid (10). None of the compounds exhibited any antibacterial or antifungal activity against a standard panel of microorganisms, but compounds 1, 2, and 6 displayed some cytotoxicity against HCT-116 cancer cells. Additional in vitro testing provided data suggesting that the cytotoxic activity is not due to DNA intercalation or topoisomerase inhibition.', 'Title: Polycyclic hybrid isoprenoids from a reed rhizosphere soil derived Streptomyces sp. CHQ-64.  Abstract: Two new hybrid isoprenoids, named indotertine B (2) and drimentine H (3), along with the known analogue drimentine C (4), were isolated from the reed rhizosphere soil derived actinomycete Streptomyces sp. CHQ-64. The structures of these compounds, including absolute configurations, were elucidated by extensive NMR, MS, and CD analyses. Indotertine B (2) exists as a pair of rotamers about the N-C(O) bond with a 2:1 ratio and displays activities against HCT-8 and A549 tumor cell lines with IC50 values of 6.96 and 4.88 M, respectively.', 'Title: Indenoindolone derivatives as topoisomerase II-inhibiting anticancer agents.  Abstract: Based on known heterocyclic topoisomerase II inhibitors and anticancer agents, various indenoindolone derivatives were predicted as potential topoisomerase II-inhibiting anticancer agents. They are hydrazones, (thio)semicarbazones, and oximes of indenoindolones, and indenoindolols. These derivatives with suitable substitutions exhibited potent specific inhibition of human DNA TopoII while not showing inhibition of topoisomerase I and DNA intercalation, despite the fact that parent indenoindolones are known poor/moderate inhibitors of topoisomerase II. The potent topoisomerase II inhibitor indenoindolone derivatives exhibited good anticancer activities compared to etoposide and 5-fluorouracil, and relatively low toxicity to normal cells. These derivatizations of indenoindolones were found to result in enhancement of anticancer activities.', 'Camptothecin, a specific topoisomerase I inhibitor is a potent anticancer drug, especially against solid tumors. This agent produces well-characterized double-strand breaks upon collision of replication forks with topoisomerase I cleavage complexes. In an attempt to improve its efficacy, we conducted a synthetic lethal siRNA screening using a library that targets nearly 7000 human genes. Depletion of ATR, the main transducer of replication stress-induced DNA damage response exacerbated cytotoxic response to both camptothecin and the indenoisoquinoline LMP-400, a novel class of topoisomerase inhibitors in clinical trial. Inhibition of ATR by the recently developed specific inhibitor VE-821 induced synergistic antiproliferative activity when combined with either topoisomerase inhibitor.', 'Assay description will be published shortly and manuscript citation added here.', \"Title: Evolution in medicinal chemistry of E-ring-modified Camptothecin analogs as anticancer agents.  Abstract: Camptothecin (CPT), a natural topoisomerase (Topo) I inhibitor, exhibits powerful antineoplastic activity against colorectal, breast, lung and ovarian cancers. However, the poor solubility and the inherent instability of the lactone E-ring in physiological pH resulted in low therapeutic efficacy and severe toxicity. In the past several decades' substantial progress toward understanding its pharmacology, lots of analogs have been prepared to overcome its drawbacks. The review provides a detailed discussion of the evolution in medicinal chemistry of CPT analogs with modification of the E-ring lactone.\", 'Title: Synthesis, cytotoxicity and topoisomerase II inhibitory activity of lomefloxacin derivatives.  Abstract: A novel series of amide derivatives of lomefloxacin were synthesized and evaluated for their topoisomerase I and II inhibitory activity as well as cytotoxicity against a panel of five human cancer cell lines. Of the compounds prepared compounds 9d and 9g exhibited strong inhibition against topoisomerase II at 100M. In addition, docking studies were performed to predict the inhibition mode.', 'Title: New anticancer active and selective phenylene-bisbenzothiazoles: synthesis, antiproliferative evaluation and DNA binding.  Abstract: Novel amidino-derivatives of phenylene-bisbenzothiazoles were synthesized and tested for their antiproliferative activity against several human cancer cell lines, as well as DNA-binding properties. The synthetic approach used for preparation of isomeric amidino substituted-phenylene-bis-benzothyazoles 3a-3f was achieved by condensation reaction of isophthaloyl dichloride 1a and terephthaloyl dichloride 1b or with phthalic acid 1c with 5-amidinium-2-aminobenzothiolate 2a and 5-(imidazolinium-2-yl)-2-aminobenzothiolate 2b in good yields. The targeted compounds were converted in the desired water soluble dihydrochloride salts by reaction of appropriate free base with concd HCl in ethanol or acetic acid. All tested compounds (3a-3f) showed antiproliferative effects on tumour cells in a concentration-dependant manner. The strongest activity and cytotoxicity was observed for diimidazolinyl substituted phenylene-bisbenzothiazole compound 3b. These effects were shown to be related to DNA-binding properties, topoisomerase I and II poisoning effects and apoptosis induction. The highest tested selectivity towards tumour cells was observed for the imidazolyl substituted phenylene-benzothiazole 3d that showed no cytotoxic effects on normal fibroblasts making it an excellent candidate for further chemical optimization and preclinical evaluation.', 'Title: New anticancer active and selective phenylene-bisbenzothiazoles: synthesis, antiproliferative evaluation and DNA binding.  Abstract: Novel amidino-derivatives of phenylene-bisbenzothiazoles were synthesized and tested for their antiproliferative activity against several human cancer cell lines, as well as DNA-binding properties. The synthetic approach used for preparation of isomeric amidino substituted-phenylene-bis-benzothyazoles 3a-3f was achieved by condensation reaction of isophthaloyl dichloride 1a and terephthaloyl dichloride 1b or with phthalic acid 1c with 5-amidinium-2-aminobenzothiolate 2a and 5-(imidazolinium-2-yl)-2-aminobenzothiolate 2b in good yields. The targeted compounds were converted in the desired water soluble dihydrochloride salts by reaction of appropriate free base with concd HCl in ethanol or acetic acid. All tested compounds (3a-3f) showed antiproliferative effects on tumour cells in a concentration-dependant manner. The strongest activity and cytotoxicity was observed for diimidazolinyl substituted phenylene-bisbenzothiazole compound 3b. These effects were shown to be related to DNA-binding properties, topoisomerase I and II poisoning effects and apoptosis induction. The highest tested selectivity towards tumour cells was observed for the imidazolyl substituted phenylene-benzothiazole 3d that showed no cytotoxic effects on normal fibroblasts making it an excellent candidate for further chemical optimization and preclinical evaluation.', 'Title: Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents.  Abstract: In order to diversify the pharmacological activity of chalcones and extend the scaffold of topoisomerase and cathepsins B and L inhibitors, we have designed and synthesized total 18 chalcone compounds and tested their biological activity. In the topoisomerase inhibition test, most analogues in group III and IV except compound 11 exhibited more efficient topoisomerase I inhibitory activity than camptothecin at 20 M. Compounds 15, 16 and 18 in group IV showed significant cathepsin B and L inhibitory activity. Among the compounds, compound 15 was most active with IC50 values of 1.810.05 M on cathepsin B and 3.150.07 M on cathepsin L, respectively. Compound 15 also showed most potent cytotoxic activity against T47D and SNU638 cells with IC50 values of 1.370.05 M and 0.620.01 M, respectively. Overall, although more compounds should be tested and analyzed for clear SAR against topoisomerase I and cathepsin B and L, compound 15 showed consistent inhibitory ability on the tested assays, which can implicate the cytotoxic activity of compound 15 on topoisomerase I and cathepsin B and L inhibitory pathways.', 'Title: Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents.  Abstract: In order to diversify the pharmacological activity of chalcones and extend the scaffold of topoisomerase and cathepsins B and L inhibitors, we have designed and synthesized total 18 chalcone compounds and tested their biological activity. In the topoisomerase inhibition test, most analogues in group III and IV except compound 11 exhibited more efficient topoisomerase I inhibitory activity than camptothecin at 20 M. Compounds 15, 16 and 18 in group IV showed significant cathepsin B and L inhibitory activity. Among the compounds, compound 15 was most active with IC50 values of 1.810.05 M on cathepsin B and 3.150.07 M on cathepsin L, respectively. Compound 15 also showed most potent cytotoxic activity against T47D and SNU638 cells with IC50 values of 1.370.05 M and 0.620.01 M, respectively. Overall, although more compounds should be tested and analyzed for clear SAR against topoisomerase I and cathepsin B and L, compound 15 showed consistent inhibitory ability on the tested assays, which can implicate the cytotoxic activity of compound 15 on topoisomerase I and cathepsin B and L inhibitory pathways.', 'Title: Selective inhibition of bacterial and human topoisomerases by N-arylacyl O-sulfonated aminoglycoside derivatives.  Abstract: Numerous therapeutic applications have been proposed for molecules that bind heparin-binding proteins. Development of such compounds has primarily focused on optimizing the degree and orientation of anionic groups on a scaffold, but utility of these polyanions has been diminished by their typically large size and non-specific interactions with many proteins. In this study N-arylacyl O-sulfonated aminoglycosides were synthesized and evaluated for their ability to selectively inhibit structurally similar bacterial and human topoisomerases. It is demonstrated that the structure of the aminoglycoside and of the N-arylacyl moiety imparts selective inhibition of different topoisomerases and alters mechanism. The results here outline a strategy that will be applicable to identifying small, structurally defined oligosaccharides that bind heparin-binding proteins with a high degree of selectivity.', 'Title: Dual-acting histone deacetylase-topoisomerase I inhibitors.  Abstract: Current chemotherapy regimens are comprised mostly of single-target drugs which are often plagued by toxic side effects and resistance development. A pharmacological strategy for circumventing these drawbacks could involve designing multivalent ligands that can modulate multiple targets while avoiding the toxicity of a single-targeted agent. Two attractive targets, histone deacetylase (HDAC) and topoisomerase I (Topo I), are cellular modulators that can broadly arrest cancer proliferation through a range of downstream effects. Both are clinically validated targets with multiple inhibitors in therapeutic use. We describe herein the design and synthesis of dual-acting histone deacetylase-topoisomerase I inhibitors. We also show that these dual-acting agents retain activity against HDAC and Topo I, and potently arrest cancer proliferation.', 'Title: Synthesis and biological evaluation of novel tamoxifen analogues.  Abstract: A collection of compounds, structurally related to the anticancer drug tamoxifen, used in breast cancer therapy, were designed and synthesized as potential anticancer agents. McMurry coupling reaction was used as the key synthetic step in the preparation of these analogues and the structural assignment of E, Z isomers was determined on the basis of 2D-NOESY experiments. The compounds were evaluated for their antiproliferative activity on breast cancer (MCF-7), cervix adenocarcinoma (HeLa) and biphasic mesothelioma (MSTO-211H) human tumor cell lines. The estrogen like properties of the novel compounds were compared with those of the untreated controls using an estrogen responsive element-based (ERE) luciferase reporter assay and compared to 17-estradiol (E2). Finally, with the aim to correlate the antiproliferative activity with an intracellular target(s), the effect on relaxation activity of DNA topoisomerases I and II was assayed.', 'Title: Novel synthetic acridine derivatives as potent DNA-binding and apoptosis-inducing antitumor agents.  Abstract: Acridine derivatives have been explored as DNA-binding anticancer agents. Some derivatives show undesired pharmacokinetic properties and new derivatives need to be explored. In this work, a series of novel acridine analogues were synthesized by modifying previously unexplored linkers between the acridine and benzene groups and their antiproliferative activity and the DNA-binding ability were evaluated. Among these derivatives, compound 5c demonstrated DNA-binding capability and topoisomerase I inhibitory activity. In K562 cell lines, 5c induced apoptosis through mitochondria-dependent intrinsic pathways. These data suggested that compound 5c and other acridine derivatives with modified linkers between the acridine and benzene groups might be potent DNA-binding agents.', 'Title: Synthesis of imine-pyrazolopyrimidinones and their mechanistic interventions on anticancer activity.  Abstract: Design, synthesis and anticancer activity of a series of imine-pyrazolopyrimidinones is reported for the first time. Compounds 9d, 9n and 9o in the series show encouraging in vitro anticancer activity with low micromolar IC50 values against prostate (PC3) and breast (MCF7) cancer cell lines. Some notions about structure-activity relationships and plausible mechanism of biological activity are presented.', \"Title: 4-[4'-(1-(Aryl)ureido)benzamide]podophyllotoxins as DNA topoisomerase I and II inhibitors and apoptosis inducing agents.  Abstract: A series of 4-[4'-(1-(aryl)ureido)benzamide]podophyllotoxin congeners (11a-l) were synthesized and evaluated for their cytotoxic activity against six human cancer cell lines. Some of the compounds like 11a, 11h, 11k and 11l showed significant anti-proliferative activity in Colo-205 cells and were superior to etoposide. The flow-cytometric analysis studies indicated that these compounds show strong G1 cell cycle arrest, as well exhibited improved inhibitory activities on DNA topoisomerase I and II enzymes. These compounds induce apoptosis by up regulating caspase-3 protein as observed by ELISA and Western blotting analysis. In addition, a brief structure-activity relationship studies within the series along with docking results of representative compounds 11a, 11h, 11k, 11l were presented.\", 'Title: Design, synthesis and biological evaluation of novel mansonone E derivatives prepared via CuAAC click chemistry as topoisomerase II inhibitors.  Abstract: Two series of novel C-9 chloro- and bromo-substituted mansonone E derivatives with triazole moieties at the C-3 position were prepared by using copper-catalysed azide-alkyne cycloaddition click chemistry. These compounds were found as potent inhibitors of topoisomerase II (Topo II) and topoisomerase I (Topo I). The Topo II-mediated pBR322 DNA relaxation and cleavage assay showed that the derivatives might act as catalytic inhibitors. Their cytotoxic activities against A549, HL-60, K562 and HeLa cells were evaluated, indicating that these compounds were potent antitumour agents. Their structure activity relationships and molecular docking study revealed that the substituents of the triazole were particularly important for cytotoxicity.', 'Title: Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin topoisomerase I (Top1) inhibitors.  Abstract: In search for a novel chemotype to develop topoisomerase I (Top1) inhibitors, the pyrazolo[1,5-a]quinazoline nucleus, structurally related to the indenoisoquinoline system precursor of well-known Top1 poisons, was variously decorated (i.e., a substituted phenyl ring at 2- or 3-position, a protonable side chain at 4- or 5-position), affording a number of Top1 inhibitors with cleavage patterns common to CPT and MJ-III-65. SARs data were rationalized by means of an advanced docking protocol.', 'Title: Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin topoisomerase I (Top1) inhibitors.  Abstract: In search for a novel chemotype to develop topoisomerase I (Top1) inhibitors, the pyrazolo[1,5-a]quinazoline nucleus, structurally related to the indenoisoquinoline system precursor of well-known Top1 poisons, was variously decorated (i.e., a substituted phenyl ring at 2- or 3-position, a protonable side chain at 4- or 5-position), affording a number of Top1 inhibitors with cleavage patterns common to CPT and MJ-III-65. SARs data were rationalized by means of an advanced docking protocol.', 'Title: Discovery, synthesis and biological evaluation of cycloprotoberberine derivatives as potential antitumor agents.  Abstract: A series of new 1,13-cycloprotoberberine derivatives defined through variations at the 9-position were designed, synthesized and evaluated for their cytotoxicities in human HepG2 (hepatoma), HT1080 (fibrosarcoma) and HCT116 (colon cancer) cells. The preliminary structure-activity relationship (SAR) revealed that the replacement of 9-methoxyl with an ester moiety might significantly enhance the antiproliferative activity in vitro. Notably, compound 7f demonstrated equipotent cytotoxicity activity against breast cancer MCF-7 (parent) and doxorubicin (DOX)-resistant MCF-7 (MCF-7/ADrR) cells, indicating a mode of action different from that of DOX. Further mechanism study showed that 7f significantly inhibited activity of DNA topoisomerase I (Top I) and Top II. G2/M phase arrest and tumor cell growth reduction was observed thereafter. Thus, we consider cycloprotoberberine analogues to be a new family of promising antitumor agents with an advantage of inhibiting drug-resistant cancer cells.', 'Title: Discovery, synthesis and biological evaluation of cycloprotoberberine derivatives as potential antitumor agents.  Abstract: A series of new 1,13-cycloprotoberberine derivatives defined through variations at the 9-position were designed, synthesized and evaluated for their cytotoxicities in human HepG2 (hepatoma), HT1080 (fibrosarcoma) and HCT116 (colon cancer) cells. The preliminary structure-activity relationship (SAR) revealed that the replacement of 9-methoxyl with an ester moiety might significantly enhance the antiproliferative activity in vitro. Notably, compound 7f demonstrated equipotent cytotoxicity activity against breast cancer MCF-7 (parent) and doxorubicin (DOX)-resistant MCF-7 (MCF-7/ADrR) cells, indicating a mode of action different from that of DOX. Further mechanism study showed that 7f significantly inhibited activity of DNA topoisomerase I (Top I) and Top II. G2/M phase arrest and tumor cell growth reduction was observed thereafter. Thus, we consider cycloprotoberberine analogues to be a new family of promising antitumor agents with an advantage of inhibiting drug-resistant cancer cells.', 'Title: 3-(3-Butylamino-2-hydroxy-propoxy)-1-hydroxy-xanthen-9-one acts as a topoisomerase II catalytic inhibitor with low DNA damage.  Abstract: As a continuous study we prepared several alkylamine (n = 3-6) and evaluated for the pharmacological activity and mode of action. In the topoisomerase II (topo II) inhibition test, compound 4 showed strongest inhibitory activity among the compounds at 10 M. Inhibitory activities of the compounds are in the order of 4 (n = 4) > 1 (n = 3) >> 5 (n = 5)  6 (n = 6); 8 (n = 4) >> 7 (n = 3)  9 (n = 5)  10 (n = 6) where n is the number of carbon in the aliphatic side chain in ring C and compounds 7-10 have additional methoxy group in ring A compared to compounds 1, 4-6. Compound 4 showed efficient cytotoxicities against T47D (IC: 0.93  0.04 M) and HCT15 (IC50: 0.78  0.01 M) cells, which are higher than etoposide. Compound 4 was also an ATP-competitive human topo II catalytic inhibitor with partially blocking human topo II-catalyzed ATP hydrolysis and intercalating into DNA. Compound 4 induced much less DNA damage than etoposide in HCT15 human colorectal carcinoma cells. Overall, compound 4 can be a potential anticancer agent acting as topo II catalytic inhibitor with low DNA damage.', 'Title: A new strategy to improve the metabolic stability of lactone: discovery of (20S,21S)-21-fluorocamptothecins as novel, hydrolytically stable topoisomerase I inhibitors.  Abstract: Lactone is a common structural motif in biologically active natural products. However, the metabolic instability of lactone significantly reduces their in vivo potency. In the present investigation, a new strategy to improve the metabolic stability of lactone was provided by the design of -fluoro ether as a novel bioisostere of lactone. The effectiveness of the -fluoro ether/lactone replacement was validated by the discovery of (20S,21S)-21-fluorocamptothecins as hydrolytically stable topoisomerase I inhibitors. A highly potent camptothecin derivative, 8l, was successfully identified, which showed excellent in vitro and in vivo antitumor activities and represents a promising lead for the discovery of novel antitumor agents. Interestingly, this study also provided a new structure-activity relationship for the C21-carbonyl group of camptothecin, which has been regarded as an essential pharmacophore. Our results revealed that the conserved C21-carbonyl group can be replaced by a fluorine substituent. -Fluoro ether may have general application in improving the metabolic stability of lactone.', 'Title: A new strategy to improve the metabolic stability of lactone: discovery of (20S,21S)-21-fluorocamptothecins as novel, hydrolytically stable topoisomerase I inhibitors.  Abstract: Lactone is a common structural motif in biologically active natural products. However, the metabolic instability of lactone significantly reduces their in vivo potency. In the present investigation, a new strategy to improve the metabolic stability of lactone was provided by the design of -fluoro ether as a novel bioisostere of lactone. The effectiveness of the -fluoro ether/lactone replacement was validated by the discovery of (20S,21S)-21-fluorocamptothecins as hydrolytically stable topoisomerase I inhibitors. A highly potent camptothecin derivative, 8l, was successfully identified, which showed excellent in vitro and in vivo antitumor activities and represents a promising lead for the discovery of novel antitumor agents. Interestingly, this study also provided a new structure-activity relationship for the C21-carbonyl group of camptothecin, which has been regarded as an essential pharmacophore. Our results revealed that the conserved C21-carbonyl group can be replaced by a fluorine substituent. -Fluoro ether may have general application in improving the metabolic stability of lactone.', 'Title: Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity.  Abstract: A group of novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids was prepared. One-dose anticancer test results indicated that compounds 3a and 3g exhibited the highest ability to inhibit the proliferation of different cancer cell lines. Compound 3a exhibited a broad-spectrum of anti-tumor activity without pronounced selectivity while compound 3g revealed high selectivity toward the leukemia subpanel with selectivity ratio of 6.71 at GI level. Moreover, compounds 3e and 3j have shown remarkable topo II inhibitory activity compared to etoposide at 100 M and 20 M concentrations. Compounds 3e and 3j exhibited comparably potent topo I inhibitory activity at 20 M concentration compared to camptothecin. Compounds 3e and 3j exhibited strong topo II inhibitory activities compared to topo I at 20 M concentration. Studying of the solubility and partition coefficient revealed higher lipophilicity of the hybrids 3a-j compared to the parent ciprofloxacin.', 'Title: Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity.  Abstract: A group of novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids was prepared. One-dose anticancer test results indicated that compounds 3a and 3g exhibited the highest ability to inhibit the proliferation of different cancer cell lines. Compound 3a exhibited a broad-spectrum of anti-tumor activity without pronounced selectivity while compound 3g revealed high selectivity toward the leukemia subpanel with selectivity ratio of 6.71 at GI level. Moreover, compounds 3e and 3j have shown remarkable topo II inhibitory activity compared to etoposide at 100 M and 20 M concentrations. Compounds 3e and 3j exhibited comparably potent topo I inhibitory activity at 20 M concentration compared to camptothecin. Compounds 3e and 3j exhibited strong topo II inhibitory activities compared to topo I at 20 M concentration. Studying of the solubility and partition coefficient revealed higher lipophilicity of the hybrids 3a-j compared to the parent ciprofloxacin.', 'Title: Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity.  Abstract: A group of novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids was prepared. One-dose anticancer test results indicated that compounds 3a and 3g exhibited the highest ability to inhibit the proliferation of different cancer cell lines. Compound 3a exhibited a broad-spectrum of anti-tumor activity without pronounced selectivity while compound 3g revealed high selectivity toward the leukemia subpanel with selectivity ratio of 6.71 at GI level. Moreover, compounds 3e and 3j have shown remarkable topo II inhibitory activity compared to etoposide at 100 M and 20 M concentrations. Compounds 3e and 3j exhibited comparably potent topo I inhibitory activity at 20 M concentration compared to camptothecin. Compounds 3e and 3j exhibited strong topo II inhibitory activities compared to topo I at 20 M concentration. Studying of the solubility and partition coefficient revealed higher lipophilicity of the hybrids 3a-j compared to the parent ciprofloxacin.', 'Title: Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity.  Abstract: A group of novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids was prepared. One-dose anticancer test results indicated that compounds 3a and 3g exhibited the highest ability to inhibit the proliferation of different cancer cell lines. Compound 3a exhibited a broad-spectrum of anti-tumor activity without pronounced selectivity while compound 3g revealed high selectivity toward the leukemia subpanel with selectivity ratio of 6.71 at GI level. Moreover, compounds 3e and 3j have shown remarkable topo II inhibitory activity compared to etoposide at 100 M and 20 M concentrations. Compounds 3e and 3j exhibited comparably potent topo I inhibitory activity at 20 M concentration compared to camptothecin. Compounds 3e and 3j exhibited strong topo II inhibitory activities compared to topo I at 20 M concentration. Studying of the solubility and partition coefficient revealed higher lipophilicity of the hybrids 3a-j compared to the parent ciprofloxacin.', 'Title: Synthesis, cytotoxicity and DNA binding of oxoazabenzo[de]anthracenes derivatives in colon cancer Caco-2 cells.  Abstract: New oxoazabenzo[de]anthracenes derivatives were synthesised and characterised. Their interactions with calf thymus DNA were studied by UV spectrophotometric analysis and a competitive ethidium bromide displacement assay. Cytotoxicity was determined by MTT assay, against colon adenocarcinoma (Caco-2 cells). Among all the oxoazabenzo[de]anthracenes derivatives reported herein only the piperidino derivative exhibited strong DNA binding properties and cytotoxic activity with IC values in the range of 16  1.5 M (72-h treatment). In addition, the piperidino derivative did not directly inhibit topoisomerase I and topoisomerase II enzymes. The results confirm that the presence of the oxoazabenzo[de]anthracenes together with the piperidino functionality is crucial in exerting DNA binding and cytotoxic properties, hence demonstrating promise as a chemical scaffold for further development of new anticancer agents.', 'Title: Synthesis, cytotoxicity and DNA binding of oxoazabenzo[de]anthracenes derivatives in colon cancer Caco-2 cells.  Abstract: New oxoazabenzo[de]anthracenes derivatives were synthesised and characterised. Their interactions with calf thymus DNA were studied by UV spectrophotometric analysis and a competitive ethidium bromide displacement assay. Cytotoxicity was determined by MTT assay, against colon adenocarcinoma (Caco-2 cells). Among all the oxoazabenzo[de]anthracenes derivatives reported herein only the piperidino derivative exhibited strong DNA binding properties and cytotoxic activity with IC values in the range of 16  1.5 M (72-h treatment). In addition, the piperidino derivative did not directly inhibit topoisomerase I and topoisomerase II enzymes. The results confirm that the presence of the oxoazabenzo[de]anthracenes together with the piperidino functionality is crucial in exerting DNA binding and cytotoxic properties, hence demonstrating promise as a chemical scaffold for further development of new anticancer agents.', \"Title: Synthesis and study of antiproliferative, antitopoisomerase II, DNA-intercalating and DNA-damaging activities of arylnaphthalimides.  Abstract: A series of arylnaphthalimides were designed and synthesized to overcome the dose-limiting cytotoxicity of N-acetylated metabolites arising from amonafide, the prototypical antitumour naphthalimide whose biomedical properties have been related to its ability to intercalate the DNA and poison the enzyme Topoisomerase II. Thus, these arylnaphthalimides were first evaluated for their antiproliferative activity against two tumour cell lines and for their antitopoisomerase II in vitro activities, together with their ability to intercalate the DNA in vitro and also through docking modelization. Then, the well-known DNA damage response in Saccharomyces cerevisiae was employed to critically evaluate whether these novel compounds can damage the DNA in vivo. By performing all these assays we conclude that the 5-arylsubstituted naphthalimides not only keep but also improve amonafide's biological activities.\", \"Title: Synthesis and study of antiproliferative, antitopoisomerase II, DNA-intercalating and DNA-damaging activities of arylnaphthalimides.  Abstract: A series of arylnaphthalimides were designed and synthesized to overcome the dose-limiting cytotoxicity of N-acetylated metabolites arising from amonafide, the prototypical antitumour naphthalimide whose biomedical properties have been related to its ability to intercalate the DNA and poison the enzyme Topoisomerase II. Thus, these arylnaphthalimides were first evaluated for their antiproliferative activity against two tumour cell lines and for their antitopoisomerase II in vitro activities, together with their ability to intercalate the DNA in vitro and also through docking modelization. Then, the well-known DNA damage response in Saccharomyces cerevisiae was employed to critically evaluate whether these novel compounds can damage the DNA in vivo. By performing all these assays we conclude that the 5-arylsubstituted naphthalimides not only keep but also improve amonafide's biological activities.\", 'Title: Design, synthesis and antiproliferative evaluation of fluorenone analogs with DNA topoisomerase I inhibitory properties.  Abstract: A series of 2,7-diamidofluorenones were designed, synthesized, and screened by SRB assay. Some synthesized compounds exhibited antitumor activities in submicromolar range. Ten compounds (3a, 3b, 3c, 3g, 3j, 3l, 4a, 4h, 4i, and 4j) were also selected by NCI screening system and 3c (GI50=1.66 M) appeared to be the most active agent of this series. Furthermore, 3c attenuated topoisomerase I-mediated DNA relaxation at low micromolar concentrations. These results indicated that fluorenones have potential to be further developed into anticancer drugs.', 'Title: Design, synthesis and antiproliferative evaluation of fluorenone analogs with DNA topoisomerase I inhibitory properties.  Abstract: A series of 2,7-diamidofluorenones were designed, synthesized, and screened by SRB assay. Some synthesized compounds exhibited antitumor activities in submicromolar range. Ten compounds (3a, 3b, 3c, 3g, 3j, 3l, 4a, 4h, 4i, and 4j) were also selected by NCI screening system and 3c (GI50=1.66 M) appeared to be the most active agent of this series. Furthermore, 3c attenuated topoisomerase I-mediated DNA relaxation at low micromolar concentrations. These results indicated that fluorenones have potential to be further developed into anticancer drugs.', 'Title: Design, synthesis and antiproliferative evaluation of fluorenone analogs with DNA topoisomerase I inhibitory properties.  Abstract: A series of 2,7-diamidofluorenones were designed, synthesized, and screened by SRB assay. Some synthesized compounds exhibited antitumor activities in submicromolar range. Ten compounds (3a, 3b, 3c, 3g, 3j, 3l, 4a, 4h, 4i, and 4j) were also selected by NCI screening system and 3c (GI50=1.66 M) appeared to be the most active agent of this series. Furthermore, 3c attenuated topoisomerase I-mediated DNA relaxation at low micromolar concentrations. These results indicated that fluorenones have potential to be further developed into anticancer drugs.', 'Title: Quinazolinecarboline alkaloid evodiamine as scaffold for targeting topoisomerase I and sirtuins.  Abstract: This paper reports the synthesis of a series of evodiamine derivatives. We assayed the ability to inhibit cell growth on three human tumour cell lines (H460, MCF-7 and HepG2) and we evaluated the capacity to interfere with the catalytic activity of topoisomerase I both by the relaxation assay and the occurrence of the cleavable complex. Moreover, whose effect on sirtuins 1, 2 and 3 was investigated. Finally, molecular docking analyses were performed in an attempt to rationalize the biological results.', 'Title: Quinazolinecarboline alkaloid evodiamine as scaffold for targeting topoisomerase I and sirtuins.  Abstract: This paper reports the synthesis of a series of evodiamine derivatives. We assayed the ability to inhibit cell growth on three human tumour cell lines (H460, MCF-7 and HepG2) and we evaluated the capacity to interfere with the catalytic activity of topoisomerase I both by the relaxation assay and the occurrence of the cleavable complex. Moreover, whose effect on sirtuins 1, 2 and 3 was investigated. Finally, molecular docking analyses were performed in an attempt to rationalize the biological results.', 'Title: Quinazolinecarboline alkaloid evodiamine as scaffold for targeting topoisomerase I and sirtuins.  Abstract: This paper reports the synthesis of a series of evodiamine derivatives. We assayed the ability to inhibit cell growth on three human tumour cell lines (H460, MCF-7 and HepG2) and we evaluated the capacity to interfere with the catalytic activity of topoisomerase I both by the relaxation assay and the occurrence of the cleavable complex. Moreover, whose effect on sirtuins 1, 2 and 3 was investigated. Finally, molecular docking analyses were performed in an attempt to rationalize the biological results.', 'Title: Quinazolinecarboline alkaloid evodiamine as scaffold for targeting topoisomerase I and sirtuins.  Abstract: This paper reports the synthesis of a series of evodiamine derivatives. We assayed the ability to inhibit cell growth on three human tumour cell lines (H460, MCF-7 and HepG2) and we evaluated the capacity to interfere with the catalytic activity of topoisomerase I both by the relaxation assay and the occurrence of the cleavable complex. Moreover, whose effect on sirtuins 1, 2 and 3 was investigated. Finally, molecular docking analyses were performed in an attempt to rationalize the biological results.', 'Title: Rational design and synthesis of topoisomerase I and II inhibitors based on oleanolic acid moiety for new anti-cancer drugs.  Abstract: Semisynthetic reactions were conducted on oleanolic acid, a common plant-derived oleanane-type triterpene. Ten rationally designed derivatives of oleanolic acid were synthesized based on docking studies and tested for their topoisomerase I and II inhibitory activity. Semisynthetic reactions targeted C-3, C-12, C-13, and C-17. Nine of the synthesized compounds were identified as new compounds. The structures of these compounds were confirmed by spectroscopic methods (1D, 2D NMR and MS). Five oleanolic acid analogues (S2, S3, S5, S7 and S9) showed higher activity than camptothecin (CPT) in the topoisomerase I DNA relaxation assay. Four oleanolic acid analogues (S2, S3, S5 and S6) showed higher activity than etoposide in a topoisomerase II assay. The results indicated that the C12-C13 double bond of the oleanolic acid skeleton is important for the inhibitory activity against both types of topoisomerases, while insertion of a longer chain at either position 3 or 17 increases the activity against topoisomerases by various degrees. Some of the synthesized compounds act as dual inhibitors for both topoisomerase I and II.', 'Title: Rational design and synthesis of topoisomerase I and II inhibitors based on oleanolic acid moiety for new anti-cancer drugs.  Abstract: Semisynthetic reactions were conducted on oleanolic acid, a common plant-derived oleanane-type triterpene. Ten rationally designed derivatives of oleanolic acid were synthesized based on docking studies and tested for their topoisomerase I and II inhibitory activity. Semisynthetic reactions targeted C-3, C-12, C-13, and C-17. Nine of the synthesized compounds were identified as new compounds. The structures of these compounds were confirmed by spectroscopic methods (1D, 2D NMR and MS). Five oleanolic acid analogues (S2, S3, S5, S7 and S9) showed higher activity than camptothecin (CPT) in the topoisomerase I DNA relaxation assay. Four oleanolic acid analogues (S2, S3, S5 and S6) showed higher activity than etoposide in a topoisomerase II assay. The results indicated that the C12-C13 double bond of the oleanolic acid skeleton is important for the inhibitory activity against both types of topoisomerases, while insertion of a longer chain at either position 3 or 17 increases the activity against topoisomerases by various degrees. Some of the synthesized compounds act as dual inhibitors for both topoisomerase I and II.', 'Title: Rational design and synthesis of topoisomerase I and II inhibitors based on oleanolic acid moiety for new anti-cancer drugs.  Abstract: Semisynthetic reactions were conducted on oleanolic acid, a common plant-derived oleanane-type triterpene. Ten rationally designed derivatives of oleanolic acid were synthesized based on docking studies and tested for their topoisomerase I and II inhibitory activity. Semisynthetic reactions targeted C-3, C-12, C-13, and C-17. Nine of the synthesized compounds were identified as new compounds. The structures of these compounds were confirmed by spectroscopic methods (1D, 2D NMR and MS). Five oleanolic acid analogues (S2, S3, S5, S7 and S9) showed higher activity than camptothecin (CPT) in the topoisomerase I DNA relaxation assay. Four oleanolic acid analogues (S2, S3, S5 and S6) showed higher activity than etoposide in a topoisomerase II assay. The results indicated that the C12-C13 double bond of the oleanolic acid skeleton is important for the inhibitory activity against both types of topoisomerases, while insertion of a longer chain at either position 3 or 17 increases the activity against topoisomerases by various degrees. Some of the synthesized compounds act as dual inhibitors for both topoisomerase I and II.', \"Title: Anilides and quinolones with nitrogen-bearing substituents from benzothiophene and thienothiophene series: synthesis, photochemical synthesis, cytostatic evaluation, 3D-derived QSAR analysis and DNA-binding properties.  Abstract: A series of new anilides (2a-c, 4-7, 17a-c, 18) and quinolones (3a-b, 8a-b, 9a-b, 10-15, 19) with nitrogen-bearing substituents from benzo[b]thiophene and thieno[2,3-c]thiophene series are prepared. Benzo[b]thieno[2,3-c]- and thieno[3',2':4,5]thieno[2,3-c]quinolones (3a-b, 8a-b) are synthesized by the reaction of photochemical dehydrohalogenation from corresponding anilides. Anilides and quinolones were tested for the antiproliferative activity. Fused quinolones bearing protonated aminium group, quaternary ammonium group, N-methylated and protonated aminium group, amino and protonated amino group (8a, 9b, 10-12) showed very prominent anticancer activity, whereby the hydrochloride salt of N',N'-dimethylaminopropyl-substituted quinolone (14) was the most active one, having the IC50 concentration at submicromolar range in accordance with previous QSAR predictions. On the other hand, flexible anilides were among the less active. Chemometric analysis of investigated compounds was performed. 3D-derived QSAR analysis identified solubility, metabolitic stability and the possibility of the compound to be ionized at pH 4-8 as molecular properties that are positively correlated with anticancer activity of investigated compounds, while molecular flexibility, polarizability and sum of hydrophobic surface areas were found to be negatively correlated. Anilides 2a-b, 4-7 and quinolones 3a-b, 8a-b, 9b and 10-14 were evaluated for DNA binding propensities and topoisomerases I/II inhibition as part of their mechanism of action. Among the anilides, only compound 7 presented some DNA binding propensity whereas the quinolones 8b, 9b and 10-14 intercalate in the DNA base pairs, compounds 8b, 9b and 14 being the most efficient ones. The strongest DNA intercalators, compounds 8b, 9b and 14, were clearly distinguished from the other compounds according to their molecular descriptors by the PCA and PLS analysis.\", 'Title: Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells.  Abstract: Optimization of the lactam -aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities. The new compounds 14-17 and 19 exhibited mean graph midpoint cytotoxicity (GI50) values of 21-71 nM in the NCI panel of 60 human cancer cell cultures. Ternary 7-azaindenoisoquinoline-DNA-Top1 cleavage complexes that persist for up to 6 h were detected in HCT116 colon cancer cells. Ternary complexes containing 7-azaindenoisoquinolines were significantly more stable than those in which camptothecin was incorporated. DNA content distribution histograms showed S-phase block 3 h after drug removal. Drug-induced DNA damage in HCT116 cells was revealed by induction of the histone -H2AX marker. The 7-azaindenoisoquinolines were able to partially overcome resistance in several drug-resistant cell lines, and they were not substrates for the ABCB1 drug efflux transporter. Molecular modeling studies indicate that the 7-azaindenoisoquinolines intercalate at the DNA cleavage site in DNA-Top1 covalent complexes with the lactam side chain projecting into the major groove. Overall, the results indicate that the 7-azaindenoisoquinolines are promising anticancer agents that merit further development.', 'Title: Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells.  Abstract: Optimization of the lactam -aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities. The new compounds 14-17 and 19 exhibited mean graph midpoint cytotoxicity (GI50) values of 21-71 nM in the NCI panel of 60 human cancer cell cultures. Ternary 7-azaindenoisoquinoline-DNA-Top1 cleavage complexes that persist for up to 6 h were detected in HCT116 colon cancer cells. Ternary complexes containing 7-azaindenoisoquinolines were significantly more stable than those in which camptothecin was incorporated. DNA content distribution histograms showed S-phase block 3 h after drug removal. Drug-induced DNA damage in HCT116 cells was revealed by induction of the histone -H2AX marker. The 7-azaindenoisoquinolines were able to partially overcome resistance in several drug-resistant cell lines, and they were not substrates for the ABCB1 drug efflux transporter. Molecular modeling studies indicate that the 7-azaindenoisoquinolines intercalate at the DNA cleavage site in DNA-Top1 covalent complexes with the lactam side chain projecting into the major groove. Overall, the results indicate that the 7-azaindenoisoquinolines are promising anticancer agents that merit further development.', 'Title: Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells.  Abstract: Optimization of the lactam -aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities. The new compounds 14-17 and 19 exhibited mean graph midpoint cytotoxicity (GI50) values of 21-71 nM in the NCI panel of 60 human cancer cell cultures. Ternary 7-azaindenoisoquinoline-DNA-Top1 cleavage complexes that persist for up to 6 h were detected in HCT116 colon cancer cells. Ternary complexes containing 7-azaindenoisoquinolines were significantly more stable than those in which camptothecin was incorporated. DNA content distribution histograms showed S-phase block 3 h after drug removal. Drug-induced DNA damage in HCT116 cells was revealed by induction of the histone -H2AX marker. The 7-azaindenoisoquinolines were able to partially overcome resistance in several drug-resistant cell lines, and they were not substrates for the ABCB1 drug efflux transporter. Molecular modeling studies indicate that the 7-azaindenoisoquinolines intercalate at the DNA cleavage site in DNA-Top1 covalent complexes with the lactam side chain projecting into the major groove. Overall, the results indicate that the 7-azaindenoisoquinolines are promising anticancer agents that merit further development.', 'Title: Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells.  Abstract: Optimization of the lactam -aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities. The new compounds 14-17 and 19 exhibited mean graph midpoint cytotoxicity (GI50) values of 21-71 nM in the NCI panel of 60 human cancer cell cultures. Ternary 7-azaindenoisoquinoline-DNA-Top1 cleavage complexes that persist for up to 6 h were detected in HCT116 colon cancer cells. Ternary complexes containing 7-azaindenoisoquinolines were significantly more stable than those in which camptothecin was incorporated. DNA content distribution histograms showed S-phase block 3 h after drug removal. Drug-induced DNA damage in HCT116 cells was revealed by induction of the histone -H2AX marker. The 7-azaindenoisoquinolines were able to partially overcome resistance in several drug-resistant cell lines, and they were not substrates for the ABCB1 drug efflux transporter. Molecular modeling studies indicate that the 7-azaindenoisoquinolines intercalate at the DNA cleavage site in DNA-Top1 covalent complexes with the lactam side chain projecting into the major groove. Overall, the results indicate that the 7-azaindenoisoquinolines are promising anticancer agents that merit further development.', 'Title: Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells.  Abstract: Optimization of the lactam -aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities. The new compounds 14-17 and 19 exhibited mean graph midpoint cytotoxicity (GI50) values of 21-71 nM in the NCI panel of 60 human cancer cell cultures. Ternary 7-azaindenoisoquinoline-DNA-Top1 cleavage complexes that persist for up to 6 h were detected in HCT116 colon cancer cells. Ternary complexes containing 7-azaindenoisoquinolines were significantly more stable than those in which camptothecin was incorporated. DNA content distribution histograms showed S-phase block 3 h after drug removal. Drug-induced DNA damage in HCT116 cells was revealed by induction of the histone -H2AX marker. The 7-azaindenoisoquinolines were able to partially overcome resistance in several drug-resistant cell lines, and they were not substrates for the ABCB1 drug efflux transporter. Molecular modeling studies indicate that the 7-azaindenoisoquinolines intercalate at the DNA cleavage site in DNA-Top1 covalent complexes with the lactam side chain projecting into the major groove. Overall, the results indicate that the 7-azaindenoisoquinolines are promising anticancer agents that merit further development.', 'Title: Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells.  Abstract: Optimization of the lactam -aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities. The new compounds 14-17 and 19 exhibited mean graph midpoint cytotoxicity (GI50) values of 21-71 nM in the NCI panel of 60 human cancer cell cultures. Ternary 7-azaindenoisoquinoline-DNA-Top1 cleavage complexes that persist for up to 6 h were detected in HCT116 colon cancer cells. Ternary complexes containing 7-azaindenoisoquinolines were significantly more stable than those in which camptothecin was incorporated. DNA content distribution histograms showed S-phase block 3 h after drug removal. Drug-induced DNA damage in HCT116 cells was revealed by induction of the histone -H2AX marker. The 7-azaindenoisoquinolines were able to partially overcome resistance in several drug-resistant cell lines, and they were not substrates for the ABCB1 drug efflux transporter. Molecular modeling studies indicate that the 7-azaindenoisoquinolines intercalate at the DNA cleavage site in DNA-Top1 covalent complexes with the lactam side chain projecting into the major groove. Overall, the results indicate that the 7-azaindenoisoquinolines are promising anticancer agents that merit further development.', 'Title: Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells.  Abstract: Optimization of the lactam -aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities. The new compounds 14-17 and 19 exhibited mean graph midpoint cytotoxicity (GI50) values of 21-71 nM in the NCI panel of 60 human cancer cell cultures. Ternary 7-azaindenoisoquinoline-DNA-Top1 cleavage complexes that persist for up to 6 h were detected in HCT116 colon cancer cells. Ternary complexes containing 7-azaindenoisoquinolines were significantly more stable than those in which camptothecin was incorporated. DNA content distribution histograms showed S-phase block 3 h after drug removal. Drug-induced DNA damage in HCT116 cells was revealed by induction of the histone -H2AX marker. The 7-azaindenoisoquinolines were able to partially overcome resistance in several drug-resistant cell lines, and they were not substrates for the ABCB1 drug efflux transporter. Molecular modeling studies indicate that the 7-azaindenoisoquinolines intercalate at the DNA cleavage site in DNA-Top1 covalent complexes with the lactam side chain projecting into the major groove. Overall, the results indicate that the 7-azaindenoisoquinolines are promising anticancer agents that merit further development.', 'Title: Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells.  Abstract: Optimization of the lactam -aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities. The new compounds 14-17 and 19 exhibited mean graph midpoint cytotoxicity (GI50) values of 21-71 nM in the NCI panel of 60 human cancer cell cultures. Ternary 7-azaindenoisoquinoline-DNA-Top1 cleavage complexes that persist for up to 6 h were detected in HCT116 colon cancer cells. Ternary complexes containing 7-azaindenoisoquinolines were significantly more stable than those in which camptothecin was incorporated. DNA content distribution histograms showed S-phase block 3 h after drug removal. Drug-induced DNA damage in HCT116 cells was revealed by induction of the histone -H2AX marker. The 7-azaindenoisoquinolines were able to partially overcome resistance in several drug-resistant cell lines, and they were not substrates for the ABCB1 drug efflux transporter. Molecular modeling studies indicate that the 7-azaindenoisoquinolines intercalate at the DNA cleavage site in DNA-Top1 covalent complexes with the lactam side chain projecting into the major groove. Overall, the results indicate that the 7-azaindenoisoquinolines are promising anticancer agents that merit further development.', 'Title: Optimization of the lactam side chain of 7-azaindenoisoquinoline topoisomerase I inhibitors and mechanism of action studies in cancer cells.  Abstract: Optimization of the lactam -aminoalkyl substituents in a series of 7-azaindenoisoquinolines resulted in new anticancer agents with improved Top1 inhibitory potencies and cancer cell cytotoxicities. The new compounds 14-17 and 19 exhibited mean graph midpoint cytotoxicity (GI50) values of 21-71 nM in the NCI panel of 60 human cancer cell cultures. Ternary 7-azaindenoisoquinoline-DNA-Top1 cleavage complexes that persist for up to 6 h were detected in HCT116 colon cancer cells. Ternary complexes containing 7-azaindenoisoquinolines were significantly more stable than those in which camptothecin was incorporated. DNA content distribution histograms showed S-phase block 3 h after drug removal. Drug-induced DNA damage in HCT116 cells was revealed by induction of the histone -H2AX marker. The 7-azaindenoisoquinolines were able to partially overcome resistance in several drug-resistant cell lines, and they were not substrates for the ABCB1 drug efflux transporter. Molecular modeling studies indicate that the 7-azaindenoisoquinolines intercalate at the DNA cleavage site in DNA-Top1 covalent complexes with the lactam side chain projecting into the major groove. Overall, the results indicate that the 7-azaindenoisoquinolines are promising anticancer agents that merit further development.', 'Title: Further constituents of Galianthe thalictroides (Rubiaceae) and inhibition of DNA topoisomerases I and II by its cytotoxic -carboline alkaloids.  Abstract: A new cytotoxic -carboline alkaloid, 1-methyl-3-(2-hydroxypropan-2-yl)-2-(5-methoxy-9H--carbolin-1-yl)-cyclopentanol (1), was isolated from roots of Galianthe thalictroides, together with the alkaloid 1-(hydroxymethyl)-3-(2-hydroxypropan-2-yl)-2-(5-methoxy-9H--carbolin-1-yl)-cyclopentanol (2), the anthraquinones 1-methyl-alizarin and morindaparvin-A, the coumarin scopoletin, homovanillic alcohol, (-)-epicatechin, and the steroids stigmast-4-en-3-one, 4,22-stigmastadien-3-one, campest-4-en-3-one, stigmast-4-en-3,6-dione, 6--hydroxy-stigmast-4-en-3-one, stigmasterol, campesterol, -sitosterol, and -sitosterol-3-O--D-glucopyranoside. Among the previously known compounds, homovanillic alcohol is a novel finding in Rubiaceae, while 1-methyl-alizarin, morindaparvin-A, scopoletin, stigmast-4-en-3-one, 4,22-stigmastadien-3-one, campest-4-en-3-one, stigmast-4-en-3,6-dione, and 6--hydroxy-stigmast-4-en-3-one is reported for the first time in the genus Galianthe. The cytotoxic -carboline alkaloids 1 and 2 exhibited potent antitopoisomerase I and II activities and strong evidence is provided for their action as topoisomerase II poisons and redox-independent inhibitors.', 'Title: Further constituents of Galianthe thalictroides (Rubiaceae) and inhibition of DNA topoisomerases I and II by its cytotoxic -carboline alkaloids.  Abstract: A new cytotoxic -carboline alkaloid, 1-methyl-3-(2-hydroxypropan-2-yl)-2-(5-methoxy-9H--carbolin-1-yl)-cyclopentanol (1), was isolated from roots of Galianthe thalictroides, together with the alkaloid 1-(hydroxymethyl)-3-(2-hydroxypropan-2-yl)-2-(5-methoxy-9H--carbolin-1-yl)-cyclopentanol (2), the anthraquinones 1-methyl-alizarin and morindaparvin-A, the coumarin scopoletin, homovanillic alcohol, (-)-epicatechin, and the steroids stigmast-4-en-3-one, 4,22-stigmastadien-3-one, campest-4-en-3-one, stigmast-4-en-3,6-dione, 6--hydroxy-stigmast-4-en-3-one, stigmasterol, campesterol, -sitosterol, and -sitosterol-3-O--D-glucopyranoside. Among the previously known compounds, homovanillic alcohol is a novel finding in Rubiaceae, while 1-methyl-alizarin, morindaparvin-A, scopoletin, stigmast-4-en-3-one, 4,22-stigmastadien-3-one, campest-4-en-3-one, stigmast-4-en-3,6-dione, and 6--hydroxy-stigmast-4-en-3-one is reported for the first time in the genus Galianthe. The cytotoxic -carboline alkaloids 1 and 2 exhibited potent antitopoisomerase I and II activities and strong evidence is provided for their action as topoisomerase II poisons and redox-independent inhibitors.', 'Title: Further constituents of Galianthe thalictroides (Rubiaceae) and inhibition of DNA topoisomerases I and II by its cytotoxic -carboline alkaloids.  Abstract: A new cytotoxic -carboline alkaloid, 1-methyl-3-(2-hydroxypropan-2-yl)-2-(5-methoxy-9H--carbolin-1-yl)-cyclopentanol (1), was isolated from roots of Galianthe thalictroides, together with the alkaloid 1-(hydroxymethyl)-3-(2-hydroxypropan-2-yl)-2-(5-methoxy-9H--carbolin-1-yl)-cyclopentanol (2), the anthraquinones 1-methyl-alizarin and morindaparvin-A, the coumarin scopoletin, homovanillic alcohol, (-)-epicatechin, and the steroids stigmast-4-en-3-one, 4,22-stigmastadien-3-one, campest-4-en-3-one, stigmast-4-en-3,6-dione, 6--hydroxy-stigmast-4-en-3-one, stigmasterol, campesterol, -sitosterol, and -sitosterol-3-O--D-glucopyranoside. Among the previously known compounds, homovanillic alcohol is a novel finding in Rubiaceae, while 1-methyl-alizarin, morindaparvin-A, scopoletin, stigmast-4-en-3-one, 4,22-stigmastadien-3-one, campest-4-en-3-one, stigmast-4-en-3,6-dione, and 6--hydroxy-stigmast-4-en-3-one is reported for the first time in the genus Galianthe. The cytotoxic -carboline alkaloids 1 and 2 exhibited potent antitopoisomerase I and II activities and strong evidence is provided for their action as topoisomerase II poisons and redox-independent inhibitors.', 'Title: Synthesis and biological evaluation of new carbohydrate-substituted indenoisoquinoline topoisomerase I inhibitors and improved syntheses of the experimental anticancer agents indotecan (LMP400) and indimitecan (LMP776).  Abstract: Carbohydrate moieties were strategically transported from the indolocarbazole topoisomerase I (Top1) inhibitor class to the indenoisoquinoline system in search of structurally novel and potent Top1 inhibitors. The syntheses and biological evaluation of 20 new indenoisoquinolines glycosylated with linear and cyclic sugar moieties are reported. Aromatic ring substitution with 2,3-dimethoxy-8,9-methylenedioxy or 3-nitro groups exerted strong effects on antiproliferative and Top1 inhibitory activities. While the length of the carbohydrate side chain clearly correlated with antiproliferative activity, the relationship between stereochemistry and biological activity was less clearly defined. Twelve of the new indenoisoquinolines exhibit Top1 inhibitory activity equal to or better than that of camptothecin. An advanced synthetic intermediate from this study was also used to efficiently prepare indotecan (LMP400) and indimitecan (LMP776), two anticancer agents currently under investigation in a Phase I clinical trial at the National Institutes of Health.', 'Title: Suzuki coupling based synthesis and in vitro cytotoxic evaluation of 7-heteroaryl-substituted camptothecin analogs.  Abstract: In an effort to discover potent antitumor agents, a series of novel C-7-heteroaryl-substituted camptothecin derivatives were designed and synthesized via microwave-promoted Suzuki coupling reaction. These analogs were then assessed for cytotoxicity against three human tumor cell lines, A549, HCT116, HT-29, and inhibitory effects on topoisomerase I. All of the new compounds showed potent inhibition of human tumor cell growth, among which compound 10a showed higher cytotoxic activity than that of SN-38. Furthermore, this series of compounds retained or enhanced Topo I inhibition.', 'Title: Suzuki coupling based synthesis and in vitro cytotoxic evaluation of 7-heteroaryl-substituted camptothecin analogs.  Abstract: In an effort to discover potent antitumor agents, a series of novel C-7-heteroaryl-substituted camptothecin derivatives were designed and synthesized via microwave-promoted Suzuki coupling reaction. These analogs were then assessed for cytotoxicity against three human tumor cell lines, A549, HCT116, HT-29, and inhibitory effects on topoisomerase I. All of the new compounds showed potent inhibition of human tumor cell growth, among which compound 10a showed higher cytotoxic activity than that of SN-38. Furthermore, this series of compounds retained or enhanced Topo I inhibition.', 'Inhibition of DNA topoisomerase 1 (unknown origin)', 'Inhibition of DNA topoisomerase 1 in Homo sapiens (human) SW480 cells', 'Inhibition of DNA topoisomerase 1 in Homo sapiens (human) VACO 241 cells', 'Inhibition of DNA topoisomerase 1 in Homo sapiens (human) HCT116 cells', 'Inhibition of Homo sapiens (human) topoisomerase 1 assessed as relaxation of supercoiled DNA up to 25 uM by agarose gel electrophoresis', 'Inhibition of Homo sapiens (human) topoisomerase 1 assessed as production of nicked DNA up to 25 uM by agarose gel electrophoresis', 'Immunotoxins (antibody-toxin fusion proteins) target surface antigens on cancer cells and kill these cells via toxin-mediated inhibition of protein synthesis leading to apoptosis.  To identify genes controlling this process, a whole RNAi genome screen (approximately 22,000 genes at 3 siRNAs per gene) was conducted via monitoring the cytotoxicity of the mesothelin-directed immunotoxin, SS1P.  SS1P, a Pseudomonas exotoxin-based immunotoxin, was chosen because it is now in clinical trials and has produced some significant tumor regressions in patients.  High and low concentrations of SS1P were chosen to allow for the identification of both mitigators and sensitizers, respectively.  As expected, silencing known essential genes in the immunotoxin pathway such as mesothelin, furin, KDEL receptor 2 or the members of the diphthamide pathway protected cells.  Of potential greater interest was the observation that many RNAi targets increased immunotoxin sensitivity, indicating that these gene products normally contribute to inefficiencies in the killing pathway.  Of top sensitizers, many genes encode proteins that locate to either the ER or Golgi and in particular are annotated as part of the secretory system.  Our results highlight new potential targets for chemical intervention that could increase immunotoxin killing of cancer cells and enhance our understanding of toxin trafficking.', 'Pathogen infection siRNA screens for Bartonella henselae, Brucella abortus and Salmonella typhimurium performed within the InfectX consortium (http://www.infectx.ch).', 'Inhibition of human topoisomerase 1 activity assessed as DNA triplex formation and presence of supercoiled DNA by microplate assay', 'Inhibition of human DNA topoisomerase 1 assessed as inhibition of DNA cleavage', 'Title: Haloemodin as novel antibacterial agent inhibiting DNA gyrase and bacterial topoisomerase I.  Abstract: Drug-resistant bacterial infections and lack of available antibacterial agents in clinical practice are becoming serious risks to public health. We synthesized a new class of haloemodins by modifying a traditional Chinese medicine component, emodin. The novel haloemodin exerts strong inhibitory activity on bacterial topoisomerase I and DNA gyrase, and not on the topoisomerases of human origin. In principle, it shows remarkable antibacterial activities against laboratory and clinically isolated Gram-positive bacteria, including vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus. We further expanded its antibacterial spectrum into against Gram-negative bacteria with the assistance of polymyxin B nonapeptide, which helps haloemodin to penetrate through the bacterial outer membrane. Finally, the therapeutic effect of haloemodin in vivo was confirmed in curing S. aureus-induced keratitis on rabbit model. With distinctive structural difference from the antibiotics we used, the haloemodins are of value as promising antibacterial pharmacophore, especially for combat the infections caused by drug-resistant pathogens.', \"Title: Synthesis, antiproliferative activity and DNA binding properties of novel 5-aminobenzimidazo[1,2-a]quinoline-6-carbonitriles.  Abstract: The synthesis of 5-amino substituted benzimidazo[1,2-a]quinolines prepared by microwave assisted amination from halogeno substituted precursor was described. The majority of compounds were active at micromolar concentrations against colon, lung and breast carcinoma cell lines in vitro. The N,N-dimethylaminopropyl 9 and piperazinyl substituted derivative 19 showed the most pronounced activity towards all of the three tested tumor cell lines, which could be correlated to the presence of another N heteroatom and its potential interactions with biological targets. The DNA binding studies, consisting of UV/Visible absorbency, melting temperature studies, and fluorescence and circular dichroism titrations, revealed that compounds 9, 19 and 20 bind to DNA as strong intercalators. The cellular distribution analysis, based on compounds' intrinsic fluorescence, showed that compound 20 does not enter the cell, while compounds 9 and 19 do, which is in agreement with their cytotoxic effects. Compound 9 efficiently targets the nucleus whereas 19, which also showed DNA intercalating properties in vitro, was mostly localised in the cytoplasm suggesting that the antitumor mechanism of action is DNA-independent.\", \"Title: Synthesis, antiproliferative activity and DNA binding properties of novel 5-aminobenzimidazo[1,2-a]quinoline-6-carbonitriles.  Abstract: The synthesis of 5-amino substituted benzimidazo[1,2-a]quinolines prepared by microwave assisted amination from halogeno substituted precursor was described. The majority of compounds were active at micromolar concentrations against colon, lung and breast carcinoma cell lines in vitro. The N,N-dimethylaminopropyl 9 and piperazinyl substituted derivative 19 showed the most pronounced activity towards all of the three tested tumor cell lines, which could be correlated to the presence of another N heteroatom and its potential interactions with biological targets. The DNA binding studies, consisting of UV/Visible absorbency, melting temperature studies, and fluorescence and circular dichroism titrations, revealed that compounds 9, 19 and 20 bind to DNA as strong intercalators. The cellular distribution analysis, based on compounds' intrinsic fluorescence, showed that compound 20 does not enter the cell, while compounds 9 and 19 do, which is in agreement with their cytotoxic effects. Compound 9 efficiently targets the nucleus whereas 19, which also showed DNA intercalating properties in vitro, was mostly localised in the cytoplasm suggesting that the antitumor mechanism of action is DNA-independent.\", \"Title: Synthesis, antiproliferative activity and DNA binding properties of novel 5-aminobenzimidazo[1,2-a]quinoline-6-carbonitriles.  Abstract: The synthesis of 5-amino substituted benzimidazo[1,2-a]quinolines prepared by microwave assisted amination from halogeno substituted precursor was described. The majority of compounds were active at micromolar concentrations against colon, lung and breast carcinoma cell lines in vitro. The N,N-dimethylaminopropyl 9 and piperazinyl substituted derivative 19 showed the most pronounced activity towards all of the three tested tumor cell lines, which could be correlated to the presence of another N heteroatom and its potential interactions with biological targets. The DNA binding studies, consisting of UV/Visible absorbency, melting temperature studies, and fluorescence and circular dichroism titrations, revealed that compounds 9, 19 and 20 bind to DNA as strong intercalators. The cellular distribution analysis, based on compounds' intrinsic fluorescence, showed that compound 20 does not enter the cell, while compounds 9 and 19 do, which is in agreement with their cytotoxic effects. Compound 9 efficiently targets the nucleus whereas 19, which also showed DNA intercalating properties in vitro, was mostly localised in the cytoplasm suggesting that the antitumor mechanism of action is DNA-independent.\", \"Title: Synthesis, antiproliferative activity and DNA binding properties of novel 5-aminobenzimidazo[1,2-a]quinoline-6-carbonitriles.  Abstract: The synthesis of 5-amino substituted benzimidazo[1,2-a]quinolines prepared by microwave assisted amination from halogeno substituted precursor was described. The majority of compounds were active at micromolar concentrations against colon, lung and breast carcinoma cell lines in vitro. The N,N-dimethylaminopropyl 9 and piperazinyl substituted derivative 19 showed the most pronounced activity towards all of the three tested tumor cell lines, which could be correlated to the presence of another N heteroatom and its potential interactions with biological targets. The DNA binding studies, consisting of UV/Visible absorbency, melting temperature studies, and fluorescence and circular dichroism titrations, revealed that compounds 9, 19 and 20 bind to DNA as strong intercalators. The cellular distribution analysis, based on compounds' intrinsic fluorescence, showed that compound 20 does not enter the cell, while compounds 9 and 19 do, which is in agreement with their cytotoxic effects. Compound 9 efficiently targets the nucleus whereas 19, which also showed DNA intercalating properties in vitro, was mostly localised in the cytoplasm suggesting that the antitumor mechanism of action is DNA-independent.\", \"Title: Synthesis, antiproliferative activity and DNA binding properties of novel 5-aminobenzimidazo[1,2-a]quinoline-6-carbonitriles.  Abstract: The synthesis of 5-amino substituted benzimidazo[1,2-a]quinolines prepared by microwave assisted amination from halogeno substituted precursor was described. The majority of compounds were active at micromolar concentrations against colon, lung and breast carcinoma cell lines in vitro. The N,N-dimethylaminopropyl 9 and piperazinyl substituted derivative 19 showed the most pronounced activity towards all of the three tested tumor cell lines, which could be correlated to the presence of another N heteroatom and its potential interactions with biological targets. The DNA binding studies, consisting of UV/Visible absorbency, melting temperature studies, and fluorescence and circular dichroism titrations, revealed that compounds 9, 19 and 20 bind to DNA as strong intercalators. The cellular distribution analysis, based on compounds' intrinsic fluorescence, showed that compound 20 does not enter the cell, while compounds 9 and 19 do, which is in agreement with their cytotoxic effects. Compound 9 efficiently targets the nucleus whereas 19, which also showed DNA intercalating properties in vitro, was mostly localised in the cytoplasm suggesting that the antitumor mechanism of action is DNA-independent.\", 'Title: Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitors.  Abstract: Tyrosyl-DNA phosphodiesterase I (TDP1) repairs stalled topoisomerase I (Top1)-DNA covalent complexes and has been proposed to be a promising and attractive target for cancer treatment. Inhibitors of TDP1 could conceivably act synergistically with Top1 inhibitors and thereby potentiate the effects of Top1 poisons. This study describes the successful design and synthesis of 2-position-modified indenoisoquinolines as dual Top1-TDP1 inhibitors using a structure-based drug design approach. Enzyme inhibition studies indicate that indenoisoquinolines modified at the 2-position with three-carbon side chains ending with amino substituents show both promising Top1 and TDP1 inhibitory activity. Molecular modeling of selected target compounds bound to Top1 and TDP1 was used to rationalize the enzyme inhibition results and structure-activity relationship analysis.', 'Title: Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitors.  Abstract: Tyrosyl-DNA phosphodiesterase I (TDP1) repairs stalled topoisomerase I (Top1)-DNA covalent complexes and has been proposed to be a promising and attractive target for cancer treatment. Inhibitors of TDP1 could conceivably act synergistically with Top1 inhibitors and thereby potentiate the effects of Top1 poisons. This study describes the successful design and synthesis of 2-position-modified indenoisoquinolines as dual Top1-TDP1 inhibitors using a structure-based drug design approach. Enzyme inhibition studies indicate that indenoisoquinolines modified at the 2-position with three-carbon side chains ending with amino substituents show both promising Top1 and TDP1 inhibitory activity. Molecular modeling of selected target compounds bound to Top1 and TDP1 was used to rationalize the enzyme inhibition results and structure-activity relationship analysis.', 'Title: Novel N-substituted sophoridinol derivatives as anticancer agents.  Abstract: Using sophoridine (1) as the lead compound, a series of new N-substituted sophoridinic acid derivatives were designed, synthesized and evaluated for their cytotoxicity. SAR analysis indicated that introduction of a chlorobenzyl on the 12-nitrogen atom of sophoridinol might significantly enhance the antiproliferative activity. Of the newly synthesized compounds, sophoridinol analogue 9k exhibited a potent effect against six human tumor cell lines (liver, colon, breast, lung, glioma and nasopharyngeal). The mode of action of 9k was to inhibit the DNA topoisomerase I activity, followed by the G0/G1 phase arrest. It also showed a moderate oral bioavailability and good safety in vivo. Therefore, compound 9k has been selected as a novel-scaffold lead for further structural optimizations or as a chemical probe for exploring anticancer pathways of this kinds of compounds.', 'Title: Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.  Abstract: A series of 3-heteroarylisoquinolinamines were designed, synthesized and evaluated for cytotoxicity, topoisomerases (topos) inhibitory activities and cell cycle inhibition. Several of the 3-heteroarylisoquinolines exhibited selective cytotoxicity against human ductal breast epithelial tumor (T47D) cells over non-cancerous human breast epithelial (MCF-10A) and human prostate cancer (DU145) cells. Most of the derivatives showed greater cytotoxicity in human colorectal adenocarcinoma (HCT-15) cells than camptothecin (CPT), etoposide and doxorubicin (DOX). Generally, 3-heteroarylisoquinolinamines displayed greater affinity for topo I than topo II. 3-Heteroarylisoquinolinamines with greater topo I inhibitory effect exhibited potent cytotoxicity. Piperazine-substituted derivative, 5b, with potent topo I and moderate topo II activities intercalated between DNA bases and interacted with topos through H-bonds at the DNA cleavage site of a docking model. Moreover, flow cytometry indicated that cytotoxic 3-heteroarylisoquinolinamines led to accumulation of human cervical (HeLa) cancer cells in the different phases of the cell cycle before apoptosis. Taken together, 3-heteroarylisoquinolinamines possessed potent cytotoxicity with topos and cell cycle inhibitory activities.', 'Title: Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.  Abstract: A series of 3-heteroarylisoquinolinamines were designed, synthesized and evaluated for cytotoxicity, topoisomerases (topos) inhibitory activities and cell cycle inhibition. Several of the 3-heteroarylisoquinolines exhibited selective cytotoxicity against human ductal breast epithelial tumor (T47D) cells over non-cancerous human breast epithelial (MCF-10A) and human prostate cancer (DU145) cells. Most of the derivatives showed greater cytotoxicity in human colorectal adenocarcinoma (HCT-15) cells than camptothecin (CPT), etoposide and doxorubicin (DOX). Generally, 3-heteroarylisoquinolinamines displayed greater affinity for topo I than topo II. 3-Heteroarylisoquinolinamines with greater topo I inhibitory effect exhibited potent cytotoxicity. Piperazine-substituted derivative, 5b, with potent topo I and moderate topo II activities intercalated between DNA bases and interacted with topos through H-bonds at the DNA cleavage site of a docking model. Moreover, flow cytometry indicated that cytotoxic 3-heteroarylisoquinolinamines led to accumulation of human cervical (HeLa) cancer cells in the different phases of the cell cycle before apoptosis. Taken together, 3-heteroarylisoquinolinamines possessed potent cytotoxicity with topos and cell cycle inhibitory activities.', 'Ewing sarcoma (ES) cells depend on the EWS-FLI1 fusion transcription factor for cell survival. Using an assay of EWS-FLI1 activity and genome-wide siRNA screening we have identified proteins required for the processing of the EWS-FLI1 nascent transcript. Parallel genome-wide siRNA-mediated RNAi screens were conducted in Ewing sarcoma TC32 cell lines expressing a luciferase (luc) reporter protein driven by either the promoter of the EWS-FLI1 target gene NR0B1 (TC32-NR0B1-luc) or the CMV promoter (TC32-CMV-luc). Luciferase activity was assessed 48 hours post siRNA-transfection.', 'Genome wide siRNA screen for modulators of lymphatic endothelial cell migration', 'Genome wide protein coding siRNA screen to identify synthetic lethal interactions with E-cadherin in an MCF10A isogenic cell line', 'Title: Ring fusion strategy for the synthesis of anthra[2,3-d]oxazole-2-thione-5,10-dione homologues as DNA topoisomerase inhibitors and as antitumor agents.  Abstract: The efficient synthesis of mono-substituted anthraquinones and ring fusion into anthra[2,3-d]oxazole-2-thione-5,10-dione derivatives were developed, and all the compounds were tested for their cytotoxicity against PC-3 cancer cell lines. Compounds 8, 14, 17 and 23 were selected by the NCI and 12, 17 and 19 were evaluated for topoisomerase I-mediated DNA relaxation. Among them, 17 appeared to be the most active compound of this series and not only showed higher inhibition when indicated from the low IC50 values against PC-3 cancer cell line but also attenuated the in vitro topoisomerase I-mediated DNA relaxation at low micromolar concentrations. All test compounds exhibited different cytostatic and cytotoxic activities for further developing potential anticancer drugs.', 'Title: Ring fusion strategy for the synthesis of anthra[2,3-d]oxazole-2-thione-5,10-dione homologues as DNA topoisomerase inhibitors and as antitumor agents.  Abstract: The efficient synthesis of mono-substituted anthraquinones and ring fusion into anthra[2,3-d]oxazole-2-thione-5,10-dione derivatives were developed, and all the compounds were tested for their cytotoxicity against PC-3 cancer cell lines. Compounds 8, 14, 17 and 23 were selected by the NCI and 12, 17 and 19 were evaluated for topoisomerase I-mediated DNA relaxation. Among them, 17 appeared to be the most active compound of this series and not only showed higher inhibition when indicated from the low IC50 values against PC-3 cancer cell line but also attenuated the in vitro topoisomerase I-mediated DNA relaxation at low micromolar concentrations. All test compounds exhibited different cytostatic and cytotoxic activities for further developing potential anticancer drugs.', 'Title: Synthesis and evaluation of new antitumor 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones.  Abstract: A series of new 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones 6-13 bearing the cyclic diamine in the position 3 of the indole ring was synthesized. The majority of new compounds demonstrated a superior cytotoxicity than doxorubicin against a panel of mammalian tumor cells with determinants of altered drug response, that is, Pgp expression or p53 inactivation. For naphtho[2,3-f]indole-5,10-diones 6-9 bearing 3-aminopyrrolidine in the side chains, the ability to bind double-stranded DNA and inhibit topoisomerases 1 and 2 mediated relaxation of supercoiled DNA were demonstrated. Only one isomer, (R)-4,11-dihydroxy-3-((pyrrolidin-3-ylamino)methyl)-1H-naphtho[2,3-f]indole-5,10-dione (7) induced the formation of specific DNA cleavage products similar to the known topoisomerase 1 inhibitors camptothecin and indenoisoquinoline MJ-III-65, suggesting a role of the structure of the side chain of 3-aminomethylnaphtho[2,3-f]indole-5,10-diones in interaction with the target. Compound 7 demonstrated an antitumor activity in mice with P388 leukemia transplants whereas its enantiomer 6 was inactive. Thus, 3-aminomethyl derivatives of 4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione emerge as a new prospective chemotype for the search of antitumor agents.', 'Title: Synthesis and evaluation of new antitumor 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones.  Abstract: A series of new 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones 6-13 bearing the cyclic diamine in the position 3 of the indole ring was synthesized. The majority of new compounds demonstrated a superior cytotoxicity than doxorubicin against a panel of mammalian tumor cells with determinants of altered drug response, that is, Pgp expression or p53 inactivation. For naphtho[2,3-f]indole-5,10-diones 6-9 bearing 3-aminopyrrolidine in the side chains, the ability to bind double-stranded DNA and inhibit topoisomerases 1 and 2 mediated relaxation of supercoiled DNA were demonstrated. Only one isomer, (R)-4,11-dihydroxy-3-((pyrrolidin-3-ylamino)methyl)-1H-naphtho[2,3-f]indole-5,10-dione (7) induced the formation of specific DNA cleavage products similar to the known topoisomerase 1 inhibitors camptothecin and indenoisoquinoline MJ-III-65, suggesting a role of the structure of the side chain of 3-aminomethylnaphtho[2,3-f]indole-5,10-diones in interaction with the target. Compound 7 demonstrated an antitumor activity in mice with P388 leukemia transplants whereas its enantiomer 6 was inactive. Thus, 3-aminomethyl derivatives of 4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione emerge as a new prospective chemotype for the search of antitumor agents.', 'Title: Synthesis and evaluation of new antitumor 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones.  Abstract: A series of new 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones 6-13 bearing the cyclic diamine in the position 3 of the indole ring was synthesized. The majority of new compounds demonstrated a superior cytotoxicity than doxorubicin against a panel of mammalian tumor cells with determinants of altered drug response, that is, Pgp expression or p53 inactivation. For naphtho[2,3-f]indole-5,10-diones 6-9 bearing 3-aminopyrrolidine in the side chains, the ability to bind double-stranded DNA and inhibit topoisomerases 1 and 2 mediated relaxation of supercoiled DNA were demonstrated. Only one isomer, (R)-4,11-dihydroxy-3-((pyrrolidin-3-ylamino)methyl)-1H-naphtho[2,3-f]indole-5,10-dione (7) induced the formation of specific DNA cleavage products similar to the known topoisomerase 1 inhibitors camptothecin and indenoisoquinoline MJ-III-65, suggesting a role of the structure of the side chain of 3-aminomethylnaphtho[2,3-f]indole-5,10-diones in interaction with the target. Compound 7 demonstrated an antitumor activity in mice with P388 leukemia transplants whereas its enantiomer 6 was inactive. Thus, 3-aminomethyl derivatives of 4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione emerge as a new prospective chemotype for the search of antitumor agents.', 'Title: Synthesis and evaluation of new antitumor 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones.  Abstract: A series of new 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones 6-13 bearing the cyclic diamine in the position 3 of the indole ring was synthesized. The majority of new compounds demonstrated a superior cytotoxicity than doxorubicin against a panel of mammalian tumor cells with determinants of altered drug response, that is, Pgp expression or p53 inactivation. For naphtho[2,3-f]indole-5,10-diones 6-9 bearing 3-aminopyrrolidine in the side chains, the ability to bind double-stranded DNA and inhibit topoisomerases 1 and 2 mediated relaxation of supercoiled DNA were demonstrated. Only one isomer, (R)-4,11-dihydroxy-3-((pyrrolidin-3-ylamino)methyl)-1H-naphtho[2,3-f]indole-5,10-dione (7) induced the formation of specific DNA cleavage products similar to the known topoisomerase 1 inhibitors camptothecin and indenoisoquinoline MJ-III-65, suggesting a role of the structure of the side chain of 3-aminomethylnaphtho[2,3-f]indole-5,10-diones in interaction with the target. Compound 7 demonstrated an antitumor activity in mice with P388 leukemia transplants whereas its enantiomer 6 was inactive. Thus, 3-aminomethyl derivatives of 4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione emerge as a new prospective chemotype for the search of antitumor agents.', 'Title: Synthesis and evaluation of new antitumor 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones.  Abstract: A series of new 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones 6-13 bearing the cyclic diamine in the position 3 of the indole ring was synthesized. The majority of new compounds demonstrated a superior cytotoxicity than doxorubicin against a panel of mammalian tumor cells with determinants of altered drug response, that is, Pgp expression or p53 inactivation. For naphtho[2,3-f]indole-5,10-diones 6-9 bearing 3-aminopyrrolidine in the side chains, the ability to bind double-stranded DNA and inhibit topoisomerases 1 and 2 mediated relaxation of supercoiled DNA were demonstrated. Only one isomer, (R)-4,11-dihydroxy-3-((pyrrolidin-3-ylamino)methyl)-1H-naphtho[2,3-f]indole-5,10-dione (7) induced the formation of specific DNA cleavage products similar to the known topoisomerase 1 inhibitors camptothecin and indenoisoquinoline MJ-III-65, suggesting a role of the structure of the side chain of 3-aminomethylnaphtho[2,3-f]indole-5,10-diones in interaction with the target. Compound 7 demonstrated an antitumor activity in mice with P388 leukemia transplants whereas its enantiomer 6 was inactive. Thus, 3-aminomethyl derivatives of 4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione emerge as a new prospective chemotype for the search of antitumor agents.', 'Title: Synthesis and evaluation of new antitumor 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones.  Abstract: A series of new 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones 6-13 bearing the cyclic diamine in the position 3 of the indole ring was synthesized. The majority of new compounds demonstrated a superior cytotoxicity than doxorubicin against a panel of mammalian tumor cells with determinants of altered drug response, that is, Pgp expression or p53 inactivation. For naphtho[2,3-f]indole-5,10-diones 6-9 bearing 3-aminopyrrolidine in the side chains, the ability to bind double-stranded DNA and inhibit topoisomerases 1 and 2 mediated relaxation of supercoiled DNA were demonstrated. Only one isomer, (R)-4,11-dihydroxy-3-((pyrrolidin-3-ylamino)methyl)-1H-naphtho[2,3-f]indole-5,10-dione (7) induced the formation of specific DNA cleavage products similar to the known topoisomerase 1 inhibitors camptothecin and indenoisoquinoline MJ-III-65, suggesting a role of the structure of the side chain of 3-aminomethylnaphtho[2,3-f]indole-5,10-diones in interaction with the target. Compound 7 demonstrated an antitumor activity in mice with P388 leukemia transplants whereas its enantiomer 6 was inactive. Thus, 3-aminomethyl derivatives of 4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione emerge as a new prospective chemotype for the search of antitumor agents.', 'Title: Novel phenyl and pyridyl substituted derivatives of isoindolines: Synthesis, antitumor activity and DNA binding features.  Abstract: Novel phenyl-substituted (3a-3d, 4a, 5, 8a, 8b and 9a) and pyridyl-substituted (3e-3i, 4b, 8c-8e, 9b and 9c) isoindolines were prepared in the reaction of o-phthalaldehyde and corresponding substituted aromatic and heteroaromatic amines by modification of reaction conditions from low to high temperature and from neutral to acidic environment. The antiproliferative activity of chosen substituted isoindolines was assessed on a panel of tumour cell lines and normal human fibroblasts. The majority of tested compounds was active at the highest tested concentrations phenyl-substituted isoindolines 3a and 3b and pyridyl-substituted isoindoline 3g showed a selective effect at micromolar concentrations on HepG2 cell line in comparison with other tested tumour cell lines and normal human fibroblasts. The strongest yet non-selective effect was observed for the pyridyl-substituted isoindoline 8c. These isoindoline derivatives showed diverse mechanism of action on tumour cell death induction as compounds 3a and 8c probably induced mitotic catastrophe while compound 3b induced apoptosis. Indeed, DNA binding properties evidenced that compounds 8a, 8c and 8d bind to DNA as highly potent DNA intercalators. By contrast, compounds 3b, 3e, 3i, 4a and 5 did not target the DNA. At last, the phenyl-substituted compound 8b proved to be a strong DNA binding compound with sequence selective binding and without DNA intercalation profile.', 'Title: Novel phenyl and pyridyl substituted derivatives of isoindolines: Synthesis, antitumor activity and DNA binding features.  Abstract: Novel phenyl-substituted (3a-3d, 4a, 5, 8a, 8b and 9a) and pyridyl-substituted (3e-3i, 4b, 8c-8e, 9b and 9c) isoindolines were prepared in the reaction of o-phthalaldehyde and corresponding substituted aromatic and heteroaromatic amines by modification of reaction conditions from low to high temperature and from neutral to acidic environment. The antiproliferative activity of chosen substituted isoindolines was assessed on a panel of tumour cell lines and normal human fibroblasts. The majority of tested compounds was active at the highest tested concentrations phenyl-substituted isoindolines 3a and 3b and pyridyl-substituted isoindoline 3g showed a selective effect at micromolar concentrations on HepG2 cell line in comparison with other tested tumour cell lines and normal human fibroblasts. The strongest yet non-selective effect was observed for the pyridyl-substituted isoindoline 8c. These isoindoline derivatives showed diverse mechanism of action on tumour cell death induction as compounds 3a and 8c probably induced mitotic catastrophe while compound 3b induced apoptosis. Indeed, DNA binding properties evidenced that compounds 8a, 8c and 8d bind to DNA as highly potent DNA intercalators. By contrast, compounds 3b, 3e, 3i, 4a and 5 did not target the DNA. At last, the phenyl-substituted compound 8b proved to be a strong DNA binding compound with sequence selective binding and without DNA intercalation profile.', \"Title: 11H-Pyrido[3',2':4,5]pyrrolo[3,2-c]cinnoline and pyrido[3',2':4,5]pyrrolo[1,2-c][1,2,3]benzotriazine: two new ring systems with antitumor activity.  Abstract: Derivatives of new ring systems 11H-pyrido[3',2':4,5]pyrrolo[3,2-c]cinnoline and pyrido[3',2':4,5]pyrrolo[1,2-c][1,2,3]benzotriazine have been prepared from the key intermediates 2-(1H-pyrrolo[2,3-b]pyridin-2-yl)anilines in excellent yields (94-99%) and screened by the National Cancer Institute (Bethesda, MD) on about 60 human tumor cell lines derived from nine cancer cell types. The tested compounds exhibited antiproliferative activity against all the human cell lines, showing comparable MG_MID (mean graph midpoint) values in the range of 0.74-1.15 M. A particular efficacy was observed against the leukemia subpanel (GI50 = 0.73-0.0090 M). Flow cytometric analysis of the cell cycle demonstrated an increase in the percentage of cells in the G2/M phase. The compounds caused apoptosis of the cells, mitochondrial depolarization, generation of reactive oxygen species, and activation of caspase-3, caspase-8, and caspase-9. Moreover, they acted as topoisomerase I inhibitors.\", \"Title: 11H-Pyrido[3',2':4,5]pyrrolo[3,2-c]cinnoline and pyrido[3',2':4,5]pyrrolo[1,2-c][1,2,3]benzotriazine: two new ring systems with antitumor activity.  Abstract: Derivatives of new ring systems 11H-pyrido[3',2':4,5]pyrrolo[3,2-c]cinnoline and pyrido[3',2':4,5]pyrrolo[1,2-c][1,2,3]benzotriazine have been prepared from the key intermediates 2-(1H-pyrrolo[2,3-b]pyridin-2-yl)anilines in excellent yields (94-99%) and screened by the National Cancer Institute (Bethesda, MD) on about 60 human tumor cell lines derived from nine cancer cell types. The tested compounds exhibited antiproliferative activity against all the human cell lines, showing comparable MG_MID (mean graph midpoint) values in the range of 0.74-1.15 M. A particular efficacy was observed against the leukemia subpanel (GI50 = 0.73-0.0090 M). Flow cytometric analysis of the cell cycle demonstrated an increase in the percentage of cells in the G2/M phase. The compounds caused apoptosis of the cells, mitochondrial depolarization, generation of reactive oxygen species, and activation of caspase-3, caspase-8, and caspase-9. Moreover, they acted as topoisomerase I inhibitors.\", 'Title: Synthesis of novel 10-hydroxycamptothecin derivatives utilizing topotecan hydrochloride as ortho-quinonemethide precursor.  Abstract: A series of 9-(alkylthiomethyl)-10-hydroxycamptothecins and pyrano-fused camptothecin derivatives were synthesized via the reaction of topotecan hydrochloride with various thiols and alkyl vinyl ethers respectively. In the reactions, topotecan hydrochloride was utilized as ortho-quinonemethide (o-QM) precursor. The configuration of 19 was determined by (1)H NMR and NOESY spectra as syn-isomers, suggesting that the cycloaddition of topotecan with alkyl vinyl ethers could undergo a hetero Diels-Alder reaction. All the synthesized compounds were screened on cancer cell lines HepG2, KB, HCT-8 and SGC7901. Some compounds were selected to assess their inhibitory activity against Topo I via Topo I mediated DNA cleavage assays. The results showed that among those tested 9-(alkylthiomethyl)-10-hydroxycamptothecins, the compounds with bulkier hydrophobic side chains at 9-position have better bioactivities. As well as all pyrano-fused camptothecins possess antiproliferative activity against the tested cancer cell lines. Docking studies suggested that there are more interactions between the novel analogues and the binding site of Topo I.', 'Title: Design and synthesis of novel 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives, and their evaluation of topoisomerase inhibitory activity and cytotoxicity.  Abstract: For the development of potential anticancer agents, we designed and synthesized 30 new 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives containing aryl moiety such as furyl, thienyl, pyridyl, and phenyl at 2- and 4-position of 5H-indeno[1,2-b]pyridine. They were evaluated for topoisomerase I and II inhibitory activity, and cytotoxicity against several human cancer cell lines. Among prepared 30 compounds, 7, 8, 9, 10, 12, 14, 16, 19, 20, 22, and 23 with 2- or 3-furyl and/or 2- or 3-thienyl either at 2- or 4-position of central pyridine showed the significant or moderate topoisomerase II inhibitory activity. Compounds 7, 8, 11, 12, 13, and 22 with 2-furyl, 2-thienyl or 3-thienyl at 2-position of central pyridine showed the significant or moderate topoisomerase I inhibitory activity. Especially, compound 12 with strong topoisomerase II inhibitory activity at 100 M and 20 M, and moderate topoisomerase I inhibitory activity displayed strong cytotoxicity against several human cancer cell lines.', 'Title: Design and synthesis of novel 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives, and their evaluation of topoisomerase inhibitory activity and cytotoxicity.  Abstract: For the development of potential anticancer agents, we designed and synthesized 30 new 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives containing aryl moiety such as furyl, thienyl, pyridyl, and phenyl at 2- and 4-position of 5H-indeno[1,2-b]pyridine. They were evaluated for topoisomerase I and II inhibitory activity, and cytotoxicity against several human cancer cell lines. Among prepared 30 compounds, 7, 8, 9, 10, 12, 14, 16, 19, 20, 22, and 23 with 2- or 3-furyl and/or 2- or 3-thienyl either at 2- or 4-position of central pyridine showed the significant or moderate topoisomerase II inhibitory activity. Compounds 7, 8, 11, 12, 13, and 22 with 2-furyl, 2-thienyl or 3-thienyl at 2-position of central pyridine showed the significant or moderate topoisomerase I inhibitory activity. Especially, compound 12 with strong topoisomerase II inhibitory activity at 100 M and 20 M, and moderate topoisomerase I inhibitory activity displayed strong cytotoxicity against several human cancer cell lines.', 'Title: Design and synthesis of novel 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives, and their evaluation of topoisomerase inhibitory activity and cytotoxicity.  Abstract: For the development of potential anticancer agents, we designed and synthesized 30 new 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives containing aryl moiety such as furyl, thienyl, pyridyl, and phenyl at 2- and 4-position of 5H-indeno[1,2-b]pyridine. They were evaluated for topoisomerase I and II inhibitory activity, and cytotoxicity against several human cancer cell lines. Among prepared 30 compounds, 7, 8, 9, 10, 12, 14, 16, 19, 20, 22, and 23 with 2- or 3-furyl and/or 2- or 3-thienyl either at 2- or 4-position of central pyridine showed the significant or moderate topoisomerase II inhibitory activity. Compounds 7, 8, 11, 12, 13, and 22 with 2-furyl, 2-thienyl or 3-thienyl at 2-position of central pyridine showed the significant or moderate topoisomerase I inhibitory activity. Especially, compound 12 with strong topoisomerase II inhibitory activity at 100 M and 20 M, and moderate topoisomerase I inhibitory activity displayed strong cytotoxicity against several human cancer cell lines.', 'Title: Design and synthesis of novel 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives, and their evaluation of topoisomerase inhibitory activity and cytotoxicity.  Abstract: For the development of potential anticancer agents, we designed and synthesized 30 new 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives containing aryl moiety such as furyl, thienyl, pyridyl, and phenyl at 2- and 4-position of 5H-indeno[1,2-b]pyridine. They were evaluated for topoisomerase I and II inhibitory activity, and cytotoxicity against several human cancer cell lines. Among prepared 30 compounds, 7, 8, 9, 10, 12, 14, 16, 19, 20, 22, and 23 with 2- or 3-furyl and/or 2- or 3-thienyl either at 2- or 4-position of central pyridine showed the significant or moderate topoisomerase II inhibitory activity. Compounds 7, 8, 11, 12, 13, and 22 with 2-furyl, 2-thienyl or 3-thienyl at 2-position of central pyridine showed the significant or moderate topoisomerase I inhibitory activity. Especially, compound 12 with strong topoisomerase II inhibitory activity at 100 M and 20 M, and moderate topoisomerase I inhibitory activity displayed strong cytotoxicity against several human cancer cell lines.', 'Title: Design and synthesis of novel 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives, and their evaluation of topoisomerase inhibitory activity and cytotoxicity.  Abstract: For the development of potential anticancer agents, we designed and synthesized 30 new 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives containing aryl moiety such as furyl, thienyl, pyridyl, and phenyl at 2- and 4-position of 5H-indeno[1,2-b]pyridine. They were evaluated for topoisomerase I and II inhibitory activity, and cytotoxicity against several human cancer cell lines. Among prepared 30 compounds, 7, 8, 9, 10, 12, 14, 16, 19, 20, 22, and 23 with 2- or 3-furyl and/or 2- or 3-thienyl either at 2- or 4-position of central pyridine showed the significant or moderate topoisomerase II inhibitory activity. Compounds 7, 8, 11, 12, 13, and 22 with 2-furyl, 2-thienyl or 3-thienyl at 2-position of central pyridine showed the significant or moderate topoisomerase I inhibitory activity. Especially, compound 12 with strong topoisomerase II inhibitory activity at 100 M and 20 M, and moderate topoisomerase I inhibitory activity displayed strong cytotoxicity against several human cancer cell lines.', 'Title: Design and synthesis of novel 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives, and their evaluation of topoisomerase inhibitory activity and cytotoxicity.  Abstract: For the development of potential anticancer agents, we designed and synthesized 30 new 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives containing aryl moiety such as furyl, thienyl, pyridyl, and phenyl at 2- and 4-position of 5H-indeno[1,2-b]pyridine. They were evaluated for topoisomerase I and II inhibitory activity, and cytotoxicity against several human cancer cell lines. Among prepared 30 compounds, 7, 8, 9, 10, 12, 14, 16, 19, 20, 22, and 23 with 2- or 3-furyl and/or 2- or 3-thienyl either at 2- or 4-position of central pyridine showed the significant or moderate topoisomerase II inhibitory activity. Compounds 7, 8, 11, 12, 13, and 22 with 2-furyl, 2-thienyl or 3-thienyl at 2-position of central pyridine showed the significant or moderate topoisomerase I inhibitory activity. Especially, compound 12 with strong topoisomerase II inhibitory activity at 100 M and 20 M, and moderate topoisomerase I inhibitory activity displayed strong cytotoxicity against several human cancer cell lines.', 'Title: Topoisomerase II inhibitors from the roots of Stellera chamaejasme L.  Abstract: Three new compounds, including one daphnane diterpene (1), one sesquiterpene (6), and one lignan (7) have been isolated from the Stellera chamaejasme L., together with five other known compounds, including four daphnane diterpenenoids (2-5) and one lignan (8). The structures of the new compounds were elucidated by spectroscopic analysis. The cytotoxicities of compounds 1-8 towards human lung adenocarcinoma cells (A549 cells) were evaluated using a sulforhodamine B assay. All of the compounds displayed significant cytotoxicity, with IC values in the ranging of 0.2 nM to 2.0 M. Mechanistic studies revealed that the antitumor activities of compounds 1-3 and 7 were derived from their inhibition of topoisomerase II (Topo II). Furthermore, as a Topo II inhibitor, compound 1 was found to effectively induced G2-M phase cell cycle arrest and apoptosis in cancer cells.', 'Title: Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agents.  Abstract: Twelve novel 20-sulfonylamidine derivatives (9a-9l) of camptothecin (1) were synthesized via a Cu-catalyzed three-component reaction. They showed similar or superior cytotoxicity compared with that of irinotecan (3) against A-549, DU-145, KB, and multidrug-resistant (MDR) KBvin tumor cell lines. Compound 9a demonstrated better cytotoxicity against MDR cells compared with that of 1 and 3. Mechanistically, 9a induced significant DNA damage by selectively inhibiting Topoisomerase (Topo) I and activating the ATM/Chk related DNA damage-response pathway. In xenograft models, 9a demonstrated significant activity without overt adverse effects at 5 and 10 mg/kg, comparable to 3 at 100 mg/kg. Notably, 9a at 300 mg/kg (i.p.) showed no overt toxicity in contrast to 1 (LD50 56.2 mg/kg, i.p.) and 3 (LD50 177.5 mg/kg, i.p.). Intact 9a inhibited Topo I activity in a cell-free assay in a manner similar to that of 1, confirming that 9a is a new class of Topo I inhibitor. 20-Sulfonylamidine 1-derivative 9a merits development as an anticancer clinical trial candidate.', 'Title: Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agents.  Abstract: Twelve novel 20-sulfonylamidine derivatives (9a-9l) of camptothecin (1) were synthesized via a Cu-catalyzed three-component reaction. They showed similar or superior cytotoxicity compared with that of irinotecan (3) against A-549, DU-145, KB, and multidrug-resistant (MDR) KBvin tumor cell lines. Compound 9a demonstrated better cytotoxicity against MDR cells compared with that of 1 and 3. Mechanistically, 9a induced significant DNA damage by selectively inhibiting Topoisomerase (Topo) I and activating the ATM/Chk related DNA damage-response pathway. In xenograft models, 9a demonstrated significant activity without overt adverse effects at 5 and 10 mg/kg, comparable to 3 at 100 mg/kg. Notably, 9a at 300 mg/kg (i.p.) showed no overt toxicity in contrast to 1 (LD50 56.2 mg/kg, i.p.) and 3 (LD50 177.5 mg/kg, i.p.). Intact 9a inhibited Topo I activity in a cell-free assay in a manner similar to that of 1, confirming that 9a is a new class of Topo I inhibitor. 20-Sulfonylamidine 1-derivative 9a merits development as an anticancer clinical trial candidate.', 'Title: Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agents.  Abstract: Twelve novel 20-sulfonylamidine derivatives (9a-9l) of camptothecin (1) were synthesized via a Cu-catalyzed three-component reaction. They showed similar or superior cytotoxicity compared with that of irinotecan (3) against A-549, DU-145, KB, and multidrug-resistant (MDR) KBvin tumor cell lines. Compound 9a demonstrated better cytotoxicity against MDR cells compared with that of 1 and 3. Mechanistically, 9a induced significant DNA damage by selectively inhibiting Topoisomerase (Topo) I and activating the ATM/Chk related DNA damage-response pathway. In xenograft models, 9a demonstrated significant activity without overt adverse effects at 5 and 10 mg/kg, comparable to 3 at 100 mg/kg. Notably, 9a at 300 mg/kg (i.p.) showed no overt toxicity in contrast to 1 (LD50 56.2 mg/kg, i.p.) and 3 (LD50 177.5 mg/kg, i.p.). Intact 9a inhibited Topo I activity in a cell-free assay in a manner similar to that of 1, confirming that 9a is a new class of Topo I inhibitor. 20-Sulfonylamidine 1-derivative 9a merits development as an anticancer clinical trial candidate.', 'Title: Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agents.  Abstract: Twelve novel 20-sulfonylamidine derivatives (9a-9l) of camptothecin (1) were synthesized via a Cu-catalyzed three-component reaction. They showed similar or superior cytotoxicity compared with that of irinotecan (3) against A-549, DU-145, KB, and multidrug-resistant (MDR) KBvin tumor cell lines. Compound 9a demonstrated better cytotoxicity against MDR cells compared with that of 1 and 3. Mechanistically, 9a induced significant DNA damage by selectively inhibiting Topoisomerase (Topo) I and activating the ATM/Chk related DNA damage-response pathway. In xenograft models, 9a demonstrated significant activity without overt adverse effects at 5 and 10 mg/kg, comparable to 3 at 100 mg/kg. Notably, 9a at 300 mg/kg (i.p.) showed no overt toxicity in contrast to 1 (LD50 56.2 mg/kg, i.p.) and 3 (LD50 177.5 mg/kg, i.p.). Intact 9a inhibited Topo I activity in a cell-free assay in a manner similar to that of 1, confirming that 9a is a new class of Topo I inhibitor. 20-Sulfonylamidine 1-derivative 9a merits development as an anticancer clinical trial candidate.', 'Title: Synthesis, antitumor activity, and structure-activity relationship study of trihydroxylated 2,4,6-triphenyl pyridines as potent and selective topoisomerase II inhibitors.  Abstract: A series of eighteen trihydroxylated 2,4,6-triphenyl pyridines were designed and synthesized which contain hydroxyl groups at ortho, meta or para position of each phenyl rings attached to the central pyridine. They were evaluated for topoisomerase I and II inhibitory activity, and cytotoxicity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds exhibited strong and selective topoisomerase II inhibitory activity compared to the positive control, etoposide, and also displayed significant cytotoxicity in low micromolar range. Trihydroxylated 2,4,6-triphenyl pyridines were more potent than mono- and di-hydroxylated 2,4,6-triphenyl pyridines, which have been previously studied in our research group. Positive correlation between topoisomerase II inhibitory activity and cytotoxicity was observed for the most compounds. Molecular docking study shows qualitatively consistent with the results of biological assays.', 'Title: Novel multi-targeting anthra[2,3-b]thiophene-5,10-diones with guanidine-containing side chains: interaction with telomeric G-quadruplex, inhibition of telomerase and topoisomerase I and cytotoxic properties.  Abstract: Novel generations of antitumor anthraquinones are expected to be advantageous over the conventional chemotherapeutic agents. Previous structure-activity relationship studies demonstrated an importance of the positively charged side chains conjugated to anthra[2,3-b]thiophene-5,10-dione scaffolds. Exploring a role of individual side chain moieties in binding to the duplex and G-quadruplex DNA, modulation of telomerase and topoisomerase I activities, intracellular accumulation and cytostatic potency, we herein analyzed a series of reported and newly synthesized guanidine-containing derivatives of anthra[2,3-b]thiophene-5,10-dione. We found that the number of cationic side chains (namely, two) is critical for a tight interaction with human telomeric G-quadruplex (TelQ). Along with a larger drug-TelQ association constant, the telomerase attenuation by anthrathiophenediones with two basic groups in the side chains was more pronounced than by the analogs bearing one basic group. For mono-guanidinated compounds the substituent with the amino group in the side chain provided better TelQ affinity than the methylamine residue. The intracellular uptake of the mono-guanidino derivative with two side chains was >2-fold higher than the respective value for the bis(guanidino) derivative. This difference can explain a lower antiproliferative potency of bis(guanidine) containing compounds. Thus, the modifications of side chains of anthra[2,3-b]thiophene-5,10-dione differently modulated drug-target interactions and cellular effects. Nevertheless, the selected compound 11-(3-aminopropylamino)-4-(2-guanidinoethylamino)anthra[2,3-b]thiophene-5,10-dione 13 demonstrated a high affinity to TelQ and the ability to stabilize the quadruplex structure. These properties were paralleled by reasonable potency of 13 as a telomerase/topoisomerase I inhibitor and an antiproliferative agent. These results indicate that the structural elements of anthra[2,3-b]thiophene-5,10-dione derivatives can be balanced to yield a candidate for further preclinical study.', 'Title: Synthesis and biological evaluation of benzimidazole acridine derivatives as potential DNA-binding and apoptosis-inducing agents.  Abstract: The discovery of new effective DNA-targeted antitumor agent is needed because of their clinical significance. As acridines can intercalate into DNA and benzimidazoles have the ability to bind in the DNA minor groove, a series of novel benzimidazole acridine derivatives were designed and synthesized to be new DNA-targeted compounds. MTT assay indicated that most of the synthesized compounds displayed good antiproliferative activity, among which compound 8l demonstrated the highest activity against both K562 and HepG-2 cells. Further experiments showed that 8l displayed good DNA-binding capability and inhibited topoisomerase I activity. Moreover, compound 8l could induce apoptosis in K562 cell lines through mitochondrial pathway. These data suggested that compound 8l might be potential as new DNA-binding and apoptosis-inducing antitumor agents.', 'Title: Design, synthesis and biological evaluation of novel homocamptothecin analogues as potent antitumor agents.  Abstract: Fifteen novel homocamptothecin derivatives with -OMe substituted E-rings were designed and synthesized. All of the derivatives exhibited similar or superior cytotoxicities compared with that of SN-38, and they inhibited Topo I activity in a cell-free assay in a manner similar to that of SN-38, confirming that they represent a new class of Topo I inhibitors. Notably, the water soluble compound 36o (1.2 mg/mL) exhibited increased lactone stability, and at 0.5 mg/kg and 3.0 mg/kg, it demonstrated significant antitumor activity in mice bearing a xenograft model using human colon cancer cell line HT-29. On the basis of these positive results, further development of 36o-related compounds as potential anticancer clinical trial candidates is definitely warranted.', 'Title: Design, synthesis and biological evaluation of novel homocamptothecin analogues as potent antitumor agents.  Abstract: Fifteen novel homocamptothecin derivatives with -OMe substituted E-rings were designed and synthesized. All of the derivatives exhibited similar or superior cytotoxicities compared with that of SN-38, and they inhibited Topo I activity in a cell-free assay in a manner similar to that of SN-38, confirming that they represent a new class of Topo I inhibitors. Notably, the water soluble compound 36o (1.2 mg/mL) exhibited increased lactone stability, and at 0.5 mg/kg and 3.0 mg/kg, it demonstrated significant antitumor activity in mice bearing a xenograft model using human colon cancer cell line HT-29. On the basis of these positive results, further development of 36o-related compounds as potential anticancer clinical trial candidates is definitely warranted.', 'Title: Synthesis of novel C5-curcuminoid-fatty acid conjugates and mechanistic investigation of their anticancer activity.  Abstract: The first synthesis of C5-curcumin-fatty acid (C5-Curc-FA) conjugates was successfully performed. Through a two-step synthetic route, 10 analogs were synthesized for a structure-activity relationship (SAR) study. It was found that C5-Curc-FA conjugates containing either decanoic acid or palmitic acid moieties were cytotoxic against colorectal adenocarcinoma cell (CCL-229) at IC50s ranging from 22.5 to 56.1g/mL, being 5c the most active C5-Curc-FA conjugate. Our results strongly suggests that a decanoic acid moiety at the meta position in C5-Curc-FA conjugates is important for their anticancer activity effect. Possible mechanisms for the anticancer activity of C5-Curc-FA conjugates were also investigated including apoptosis induction, mitochondrial damage and caspases activation. It was shown that 5c inhibited the luminescence activity of NFB, a key signaling molecule involved in cell apoptosis and cell proliferation, at IC50=18.2g/mL. In addition, it was demonstrated that 5c displayed significant apoptotic effect at GI50=46.0g/mL in colorectal adenocarcinoma cell line (ATCC CCL-222), which can be explained by the significant mitochondrial membrane permeabilization and caspases 3 and 7 activation effect of 5c. Finally, it was investigated that C5-Curc-FA conjugates can affect the replication process of cancer cells, since compounds 5c, 5e, and 6c inhibited the relaxing activity of the human DNA topoisomerase I at minimum inhibitory concentrations (MICs) that range from 50 to 250g/mL. Our results strongly support the hypothesis that the inhibition of both NFB and DNA topoisomerase I by C5-Curc-FA conjugates is associated with their anticancer activity.', 'Title: Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors.  Abstract: A novel series of benzo[a]phenazin derivatives bearing alkylamino side chains were designed, synthesized and evaluated for their topoisomerases inhibitory activity as well as cytotoxicity against four human cancer cell lines (HL-60, K-562, HeLa, and A549). These compounds were found to be dual inhibitors of topoisomerase (Topo) I and Topo II, and exhibited excellent antiproliferative activity, in particular against HL-60 cells with submicromolar IC50 values. Further mechanistic studies showed that this class of compounds acted as Topo I poisons by stabilizing the Topo I-DNA cleavage complexes and Topo II catalytic inhibitors by inhibiting the ATPase activity of hTopo II. Molecular docking studies revealed the binding modes of these compounds for Topo I and Topo II.', 'Title: Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors.  Abstract: A novel series of benzo[a]phenazin derivatives bearing alkylamino side chains were designed, synthesized and evaluated for their topoisomerases inhibitory activity as well as cytotoxicity against four human cancer cell lines (HL-60, K-562, HeLa, and A549). These compounds were found to be dual inhibitors of topoisomerase (Topo) I and Topo II, and exhibited excellent antiproliferative activity, in particular against HL-60 cells with submicromolar IC50 values. Further mechanistic studies showed that this class of compounds acted as Topo I poisons by stabilizing the Topo I-DNA cleavage complexes and Topo II catalytic inhibitors by inhibiting the ATPase activity of hTopo II. Molecular docking studies revealed the binding modes of these compounds for Topo I and Topo II.', 'Title: Boehmeriasin A as new lead compound for the inhibition of topoisomerases and SIRT2.  Abstract: Two synthetic approaches to boehmeriasin A are described. A gram scale racemic preparation is accompanied by an efficient preparation of both the pure enantiomers using the conformationally stable 2-piperidin-2-yl acetaldehyde as starting material. The anti-proliferative activity in three cancer cell lines (CEM, HeLa and L1210) and two endothelial cell lines (HMEC-1, BAEC) indicates promising activity at the nanomolar range. Topoisomerases and SIRT2 are identified as biological targets and the experimental data has been supported by docking studies.', 'Title: Boehmeriasin A as new lead compound for the inhibition of topoisomerases and SIRT2.  Abstract: Two synthetic approaches to boehmeriasin A are described. A gram scale racemic preparation is accompanied by an efficient preparation of both the pure enantiomers using the conformationally stable 2-piperidin-2-yl acetaldehyde as starting material. The anti-proliferative activity in three cancer cell lines (CEM, HeLa and L1210) and two endothelial cell lines (HMEC-1, BAEC) indicates promising activity at the nanomolar range. Topoisomerases and SIRT2 are identified as biological targets and the experimental data has been supported by docking studies.', 'Title: Molecular design, synthesis and biological research of novel pyridyl acridones as potent DNA-binding and apoptosis-inducing agents.  Abstract: A series of novel pyridyl acridone derivatives comprised of a pseudo-five-cyclic system to extend the -conjugated acridone chromophore, were designed and synthesized as potent DNA binding antitumor compounds. Most synthesized compounds displayed good activity against human leukemia K562 cells in MTT tests, with compound 6d exhibiting the highest activity with IC50 value at 0.46 M. Moreover, 6d showed potent activities against solid tumor cell lines (0.16-3.79 M). Several experimental studies demonstrated that the antitumor mode of action of compound 6d involves DNA intercalation, topoisomerase I inhibition, and apoptosis induction through the mitochondrial pathway. In summary, compound 6d represents a novel and promising lead structure for the development of new potent anticancer DNA-binding agents.', \"Title: Water-soluble isoindolo[2,1-a]quinoxalin-6-imines: in vitro antiproliferative activity and molecular mechanism(s) of action.  Abstract: Water-soluble isoindoloquinoxalin (IIQ) imines and the corresponding acetates were conveniently prepared from the key intermediates 2-(2'-aminophenyl)-2H-isoindole-1-carbonitriles obtained by a Strecker reaction between substituted 1,2-dicarbaldehydes and 1,2-phenylenediamines. Both series were screened by the National Cancer Institute (Bethesda, MD) and showed potent antiproliferative activity against a panel of 60 human tumor cell lines. Several of the novel compounds showed GI50 values at a nanomolar level on the majority of the tested cell lines. Among IIQ derivatives, methoxy substituents at positions 3 and 8 or/and 9 were especially effective in impairing cell cycle progression and inducing apoptosis in cancer cells. These effects were associated to IIQ-mediated impairment of tubulin polymerization at pharmacologically significant concentrations of tested compounds. In addition, impaired DNA topoisomerase I functions and perturbation in telomere architecture were observed in cells exposed to micromolar concentrations of IIQ derivatives. The above results suggest that IIQ derivatives exhibit multi-target cytotoxic activities.\", \"Title: Water-soluble isoindolo[2,1-a]quinoxalin-6-imines: in vitro antiproliferative activity and molecular mechanism(s) of action.  Abstract: Water-soluble isoindoloquinoxalin (IIQ) imines and the corresponding acetates were conveniently prepared from the key intermediates 2-(2'-aminophenyl)-2H-isoindole-1-carbonitriles obtained by a Strecker reaction between substituted 1,2-dicarbaldehydes and 1,2-phenylenediamines. Both series were screened by the National Cancer Institute (Bethesda, MD) and showed potent antiproliferative activity against a panel of 60 human tumor cell lines. Several of the novel compounds showed GI50 values at a nanomolar level on the majority of the tested cell lines. Among IIQ derivatives, methoxy substituents at positions 3 and 8 or/and 9 were especially effective in impairing cell cycle progression and inducing apoptosis in cancer cells. These effects were associated to IIQ-mediated impairment of tubulin polymerization at pharmacologically significant concentrations of tested compounds. In addition, impaired DNA topoisomerase I functions and perturbation in telomere architecture were observed in cells exposed to micromolar concentrations of IIQ derivatives. The above results suggest that IIQ derivatives exhibit multi-target cytotoxic activities.\", 'Title: Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.  Abstract: The structure-activity relationships and hit-to-lead optimization of dual Top1-TDP1 inhibitors in the indenoisoquinoline drug class were investigated. A series of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines were synthesized and evaluated. Several compounds displayed potent dual Top1-TDP1 inhibition. The 9-hydroxy series exhibited potencies and cytotoxicities vs Top1 that surpassed those of camptothecin (CPT), the natural alkaloid that is being used as a standard in the Top1-mediated DNA cleavage assay. One member of this series was a more potent Top1 inhibitor at a concentration of 5 nM and produced a more stable ternary drug-DNA-Top1 cleavage complex than CPT.', 'Title: Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.  Abstract: The structure-activity relationships and hit-to-lead optimization of dual Top1-TDP1 inhibitors in the indenoisoquinoline drug class were investigated. A series of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines were synthesized and evaluated. Several compounds displayed potent dual Top1-TDP1 inhibition. The 9-hydroxy series exhibited potencies and cytotoxicities vs Top1 that surpassed those of camptothecin (CPT), the natural alkaloid that is being used as a standard in the Top1-mediated DNA cleavage assay. One member of this series was a more potent Top1 inhibitor at a concentration of 5 nM and produced a more stable ternary drug-DNA-Top1 cleavage complex than CPT.', 'Title: Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.  Abstract: The structure-activity relationships and hit-to-lead optimization of dual Top1-TDP1 inhibitors in the indenoisoquinoline drug class were investigated. A series of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines were synthesized and evaluated. Several compounds displayed potent dual Top1-TDP1 inhibition. The 9-hydroxy series exhibited potencies and cytotoxicities vs Top1 that surpassed those of camptothecin (CPT), the natural alkaloid that is being used as a standard in the Top1-mediated DNA cleavage assay. One member of this series was a more potent Top1 inhibitor at a concentration of 5 nM and produced a more stable ternary drug-DNA-Top1 cleavage complex than CPT.', 'Title: Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.  Abstract: The structure-activity relationships and hit-to-lead optimization of dual Top1-TDP1 inhibitors in the indenoisoquinoline drug class were investigated. A series of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines were synthesized and evaluated. Several compounds displayed potent dual Top1-TDP1 inhibition. The 9-hydroxy series exhibited potencies and cytotoxicities vs Top1 that surpassed those of camptothecin (CPT), the natural alkaloid that is being used as a standard in the Top1-mediated DNA cleavage assay. One member of this series was a more potent Top1 inhibitor at a concentration of 5 nM and produced a more stable ternary drug-DNA-Top1 cleavage complex than CPT.', 'Title: Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.  Abstract: The structure-activity relationships and hit-to-lead optimization of dual Top1-TDP1 inhibitors in the indenoisoquinoline drug class were investigated. A series of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines were synthesized and evaluated. Several compounds displayed potent dual Top1-TDP1 inhibition. The 9-hydroxy series exhibited potencies and cytotoxicities vs Top1 that surpassed those of camptothecin (CPT), the natural alkaloid that is being used as a standard in the Top1-mediated DNA cleavage assay. One member of this series was a more potent Top1 inhibitor at a concentration of 5 nM and produced a more stable ternary drug-DNA-Top1 cleavage complex than CPT.', 'Title: Stereoselective synthesis of 11-phenylundeca-5Z,9Z-dienoic acid and investigation of its human topoisomerase I and II inhibitory activity.  Abstract: (5Z,9Z)-11-Phenylundeca-5,9-dienoic acid was stereoselectively synthesized, based on original cross-cyclomagnesiation of 2-(hepta-5,6-dien-1-yloxy)tetrahydro-2H-pyran and buta-2,3-dien-1-ylbenzene with EtMgBr in the presence of Cp2TiCl2 catalyst giving 2,5-dialkylidenemagnesacyclopentane in 86% yield. The acid hydrolysis of the product and the Jones oxidation of the resulting 2-{[(5Z,9Z)-11-phenylundeca-5,9-dien-1-yl]oxy}tetrahydro-2-pyran afforded (5Z,9Z)-11-phenylundeca-5,9-dienoic acid in an overall yield of 75%. A high inhibitory activity of the synthesized acid with respect to human topoisomerase I (hTop1) and II (hTop2) was determined.', 'Title: Stereoselective synthesis of 11-phenylundeca-5Z,9Z-dienoic acid and investigation of its human topoisomerase I and II inhibitory activity.  Abstract: (5Z,9Z)-11-Phenylundeca-5,9-dienoic acid was stereoselectively synthesized, based on original cross-cyclomagnesiation of 2-(hepta-5,6-dien-1-yloxy)tetrahydro-2H-pyran and buta-2,3-dien-1-ylbenzene with EtMgBr in the presence of Cp2TiCl2 catalyst giving 2,5-dialkylidenemagnesacyclopentane in 86% yield. The acid hydrolysis of the product and the Jones oxidation of the resulting 2-{[(5Z,9Z)-11-phenylundeca-5,9-dien-1-yl]oxy}tetrahydro-2-pyran afforded (5Z,9Z)-11-phenylundeca-5,9-dienoic acid in an overall yield of 75%. A high inhibitory activity of the synthesized acid with respect to human topoisomerase I (hTop1) and II (hTop2) was determined.', 'Title: Stereoselective synthesis of 11-phenylundeca-5Z,9Z-dienoic acid and investigation of its human topoisomerase I and II inhibitory activity.  Abstract: (5Z,9Z)-11-Phenylundeca-5,9-dienoic acid was stereoselectively synthesized, based on original cross-cyclomagnesiation of 2-(hepta-5,6-dien-1-yloxy)tetrahydro-2H-pyran and buta-2,3-dien-1-ylbenzene with EtMgBr in the presence of Cp2TiCl2 catalyst giving 2,5-dialkylidenemagnesacyclopentane in 86% yield. The acid hydrolysis of the product and the Jones oxidation of the resulting 2-{[(5Z,9Z)-11-phenylundeca-5,9-dien-1-yl]oxy}tetrahydro-2-pyran afforded (5Z,9Z)-11-phenylundeca-5,9-dienoic acid in an overall yield of 75%. A high inhibitory activity of the synthesized acid with respect to human topoisomerase I (hTop1) and II (hTop2) was determined.', 'Title: Stereoselective synthesis of 11-phenylundeca-5Z,9Z-dienoic acid and investigation of its human topoisomerase I and II inhibitory activity.  Abstract: (5Z,9Z)-11-Phenylundeca-5,9-dienoic acid was stereoselectively synthesized, based on original cross-cyclomagnesiation of 2-(hepta-5,6-dien-1-yloxy)tetrahydro-2H-pyran and buta-2,3-dien-1-ylbenzene with EtMgBr in the presence of Cp2TiCl2 catalyst giving 2,5-dialkylidenemagnesacyclopentane in 86% yield. The acid hydrolysis of the product and the Jones oxidation of the resulting 2-{[(5Z,9Z)-11-phenylundeca-5,9-dien-1-yl]oxy}tetrahydro-2-pyran afforded (5Z,9Z)-11-phenylundeca-5,9-dienoic acid in an overall yield of 75%. A high inhibitory activity of the synthesized acid with respect to human topoisomerase I (hTop1) and II (hTop2) was determined.', 'The mammalian innate immune system senses many bacterial stimuli through the toll-like receptor (TLR) family. Activation of the TLR4 receptor by bacterial lipopolysaccharide (LPS) is the most widely studied TLR pathway due to its central role in host responses to gram-negative bacterial infection and its contribution to endotoxemia and sepsis. Here we describe a genome-wide siRNA screen to identify genes regulating the human macrophage TNF-alpha response to LPS. We also conducted a secondary validation screen with six independent siRNAs per gene to facilitate removal of off-target screen hits, and we generated microarray data from the same LPS-treated macrophage cells to facilitate downstream data analysis. These data provide a resource for analyzing gene function in the predominant pathway driving inflammatory cytokine expression in human macrophages.', 'Title: Discovery of Novel Multiacting Topoisomerase I/II and Histone Deacetylase Inhibitors.  Abstract: Designing multitarget drugs remains a significant challenge in current antitumor drug discovery. Because of the synergistic effect between topoisomerase and HDAC inhibitors, the present study reported the first-in-class triple inhibitors of topoisomerase I/II and HDAC. On the basis of 3-amino-10-hydroxylevodiamine and SAHA, a series of hybrid molecules was successfully designed and synthesized. In particular, compound 8c was proven to be a potent inhibitor of topoisomerase I/II and HDAC with good antiproliferative and apoptotic activities. This proof-of-concept study also validated the effectiveness of discovering triple topoisomerase I/II and HDAC inhibitors as novel antitumor agents.', 'Title: Switch in Site of Inhibition: A Strategy for Structure-Based Discovery of Human Topoisomerase II Catalytic Inhibitors.  Abstract: A study of structure-based modulation of known ligands of hTopoII, an important enzyme involved in DNA processes, coupled with synthesis and in vitro assays led to the establishment of a strategy of rational switch in mode of inhibition of the enzyme\\'s catalytic cycle. 6-Arylated derivatives of known imidazopyridine ligands were found to be selective inhibitors of hTopoII, while not showing TopoI inhibition and DNA binding. Interestingly, while the parent imidazopyridines acted as ATP-competitive inhibitors, arylated derivatives inhibited DNA cleavage similar to merbarone, indicating a switch in mode of inhibition from ATP-hydrolysis to the DNA-cleavage stage of catalytic cycle of the enzyme. The 6-aryl-imidazopyridines were relatively more cytotoxic than etoposide in cancer cells and less toxic to normal cells. Such unprecedented strategy will encourage research on \"choice-based change\" in target-specific mode of action for rapid drug discovery.', 'Title: Selective Inhibition of Bacterial Topoisomerase I by alkynyl-bisbenzimidazoles.  Abstract: Hoechst dyes are well known DNA binders that non-selectively inhibit the function of mammalian topoisomerase I and II. Herein, we show that Hoechst 33258 based bisbenzimidazoles (DPA 151-154), containing a terminal alkyne, are effective and selective inhibitors of E. coli. topoisomerase I. These bisbenzimidazoles displayed topoisomerase I inhibition much better than Hoechst 33342 or Hoechst 33258 with IC50 values in the range of 2.47-6.63 M. Bisbenzimidazoles DPA 151-154 also display selective inhibition of E. coli. topoisomerase I over DNA gyrase and Human topoisomerases I and II, and effectively inhibit bacterial growth.', 'Title: Selective Inhibition of Bacterial Topoisomerase I by alkynyl-bisbenzimidazoles.  Abstract: Hoechst dyes are well known DNA binders that non-selectively inhibit the function of mammalian topoisomerase I and II. Herein, we show that Hoechst 33258 based bisbenzimidazoles (DPA 151-154), containing a terminal alkyne, are effective and selective inhibitors of E. coli. topoisomerase I. These bisbenzimidazoles displayed topoisomerase I inhibition much better than Hoechst 33342 or Hoechst 33258 with IC50 values in the range of 2.47-6.63 M. Bisbenzimidazoles DPA 151-154 also display selective inhibition of E. coli. topoisomerase I over DNA gyrase and Human topoisomerases I and II, and effectively inhibit bacterial growth.', \"Title: Discovery of potent indenoisoquinoline topoisomerase I poisons lacking the 3-nitro toxicophore.  Abstract: 3-Nitroindenoisoquinoline human topoisomerase IB (Top1) poisons have potent antiproliferative effects on cancer cells. The undesirable nitro toxicophore could hypothetically be replaced by other functional groups that would retain the desired biological activities and minimize potential safety risks. Eleven series of indenoisoquinolines bearing 3-nitro bioisosteres were synthesized. The molecules were evaluated in the Top1-mediated DNA cleavage assay and in the National Cancer Institute's 60 cell line cytotoxicity assay. The data reveal that fluorine and chlorine may substitute for the 3-nitro group with minimal loss of Top1 poisoning activity. The new information gained from these efforts can be used to design novel indenoisoquinolines with improved safety.\", \"Title: Discovery of potent indenoisoquinoline topoisomerase I poisons lacking the 3-nitro toxicophore.  Abstract: 3-Nitroindenoisoquinoline human topoisomerase IB (Top1) poisons have potent antiproliferative effects on cancer cells. The undesirable nitro toxicophore could hypothetically be replaced by other functional groups that would retain the desired biological activities and minimize potential safety risks. Eleven series of indenoisoquinolines bearing 3-nitro bioisosteres were synthesized. The molecules were evaluated in the Top1-mediated DNA cleavage assay and in the National Cancer Institute's 60 cell line cytotoxicity assay. The data reveal that fluorine and chlorine may substitute for the 3-nitro group with minimal loss of Top1 poisoning activity. The new information gained from these efforts can be used to design novel indenoisoquinolines with improved safety.\", \"Title: Discovery of potent indenoisoquinoline topoisomerase I poisons lacking the 3-nitro toxicophore.  Abstract: 3-Nitroindenoisoquinoline human topoisomerase IB (Top1) poisons have potent antiproliferative effects on cancer cells. The undesirable nitro toxicophore could hypothetically be replaced by other functional groups that would retain the desired biological activities and minimize potential safety risks. Eleven series of indenoisoquinolines bearing 3-nitro bioisosteres were synthesized. The molecules were evaluated in the Top1-mediated DNA cleavage assay and in the National Cancer Institute's 60 cell line cytotoxicity assay. The data reveal that fluorine and chlorine may substitute for the 3-nitro group with minimal loss of Top1 poisoning activity. The new information gained from these efforts can be used to design novel indenoisoquinolines with improved safety.\", \"Title: Discovery of potent indenoisoquinoline topoisomerase I poisons lacking the 3-nitro toxicophore.  Abstract: 3-Nitroindenoisoquinoline human topoisomerase IB (Top1) poisons have potent antiproliferative effects on cancer cells. The undesirable nitro toxicophore could hypothetically be replaced by other functional groups that would retain the desired biological activities and minimize potential safety risks. Eleven series of indenoisoquinolines bearing 3-nitro bioisosteres were synthesized. The molecules were evaluated in the Top1-mediated DNA cleavage assay and in the National Cancer Institute's 60 cell line cytotoxicity assay. The data reveal that fluorine and chlorine may substitute for the 3-nitro group with minimal loss of Top1 poisoning activity. The new information gained from these efforts can be used to design novel indenoisoquinolines with improved safety.\", 'Title: Topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of dihydroxylated 2,6-diphenyl-4-aryl pyridines.  Abstract: A new series of thirty-six dihydroxylated 2,6-diphenyl-4-aryl pyridines containing hydroxyl groups at the ortho, meta, or para position of 2- and 6-phenyl rings attached to the central pyridine were designed and synthesized. They were evaluated for topoisomerase I and II inhibitory activity and cytotoxicity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds with hydroxyl moiety either at the meta or para position of 2- or 6-phenyl ring in combination with thienyl or furyl group at 4-position of central pyridine displayed significant topoisomerase II inhibitory activity and cytotoxicity. Positive correlation between topoisomerase II inhibitory activity and cytotoxicity was observed for the compounds 9-11, 15-17, 19, 21-23, 28, and 41. Among all the synthesized compounds, compound 17 emerged as the most promising topoisomerase II inhibitor with significant cytotoxicity.', 'Title: Topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of dihydroxylated 2,6-diphenyl-4-aryl pyridines.  Abstract: A new series of thirty-six dihydroxylated 2,6-diphenyl-4-aryl pyridines containing hydroxyl groups at the ortho, meta, or para position of 2- and 6-phenyl rings attached to the central pyridine were designed and synthesized. They were evaluated for topoisomerase I and II inhibitory activity and cytotoxicity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds with hydroxyl moiety either at the meta or para position of 2- or 6-phenyl ring in combination with thienyl or furyl group at 4-position of central pyridine displayed significant topoisomerase II inhibitory activity and cytotoxicity. Positive correlation between topoisomerase II inhibitory activity and cytotoxicity was observed for the compounds 9-11, 15-17, 19, 21-23, 28, and 41. Among all the synthesized compounds, compound 17 emerged as the most promising topoisomerase II inhibitor with significant cytotoxicity.', 'Title: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines.  Abstract: A series of novel twenty-eight rigid 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines were synthesized and evaluated for their topoisomerase inhibitory activity as well as their cytotoxicity against several human cancer cell lines. Generally, hydroxylated compounds (16-18, 22-25, and 29-31) containing furyl or thienyl moiety at 4-position of central pyridine exhibited strong topoisomerase I and II inhibitory activity compared to positive control, camptothecin and etoposide, respectively, in low micromolar range. Structure-activity relationship study revealed that indenopyridine compounds with hydroxyl group at 2-phenyl ring in combination with furyl or thienyl moiety at 4-position are important for topoisomerase inhibition. Compounds (22-25) which contain hydroxyl group at meta position of the 2-phenyl ring at 2-position and furanyl or thienyl substitution at 4-position of indenopyridine, showed concrete correlations between topo I and II inhibitory activity, and cytotoxicity against evaluated human cancer cell lines.', 'Title: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines.  Abstract: A series of novel twenty-eight rigid 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines were synthesized and evaluated for their topoisomerase inhibitory activity as well as their cytotoxicity against several human cancer cell lines. Generally, hydroxylated compounds (16-18, 22-25, and 29-31) containing furyl or thienyl moiety at 4-position of central pyridine exhibited strong topoisomerase I and II inhibitory activity compared to positive control, camptothecin and etoposide, respectively, in low micromolar range. Structure-activity relationship study revealed that indenopyridine compounds with hydroxyl group at 2-phenyl ring in combination with furyl or thienyl moiety at 4-position are important for topoisomerase inhibition. Compounds (22-25) which contain hydroxyl group at meta position of the 2-phenyl ring at 2-position and furanyl or thienyl substitution at 4-position of indenopyridine, showed concrete correlations between topo I and II inhibitory activity, and cytotoxicity against evaluated human cancer cell lines.', 'Title: Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents.  Abstract: A critical question in natural product-based drug discovery is how to translate the product into drug-like molecules with optimal pharmacological properties. The generation of natural product-inspired scaffold diversity is an effective but challenging strategy to investigate the broader chemical space and identify promising drug leads. Extending our efforts to the natural product evodiamine, a diverse library containing 11 evodiamine-inspired novel scaffolds and their derivatives were designed and synthesized. Most of them showed good to excellent antitumor activity against various human cancer cell lines. In particular, 3-chloro-10-hydroxyl thio-evodiamine (66c) showed excellent in vitro and in vivo antitumor efficacy with good tolerability and low toxicity. Antitumor mechanism and target profiling studies indicate that compound 66c is the first-in-class triple topoisomerase I/topoisomerase II/tubulin inhibitor. Overall, this study provided an effective strategy for natural product-based drug discovery.', 'Title: Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents.  Abstract: A critical question in natural product-based drug discovery is how to translate the product into drug-like molecules with optimal pharmacological properties. The generation of natural product-inspired scaffold diversity is an effective but challenging strategy to investigate the broader chemical space and identify promising drug leads. Extending our efforts to the natural product evodiamine, a diverse library containing 11 evodiamine-inspired novel scaffolds and their derivatives were designed and synthesized. Most of them showed good to excellent antitumor activity against various human cancer cell lines. In particular, 3-chloro-10-hydroxyl thio-evodiamine (66c) showed excellent in vitro and in vivo antitumor efficacy with good tolerability and low toxicity. Antitumor mechanism and target profiling studies indicate that compound 66c is the first-in-class triple topoisomerase I/topoisomerase II/tubulin inhibitor. Overall, this study provided an effective strategy for natural product-based drug discovery.', 'Title: Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents.  Abstract: A critical question in natural product-based drug discovery is how to translate the product into drug-like molecules with optimal pharmacological properties. The generation of natural product-inspired scaffold diversity is an effective but challenging strategy to investigate the broader chemical space and identify promising drug leads. Extending our efforts to the natural product evodiamine, a diverse library containing 11 evodiamine-inspired novel scaffolds and their derivatives were designed and synthesized. Most of them showed good to excellent antitumor activity against various human cancer cell lines. In particular, 3-chloro-10-hydroxyl thio-evodiamine (66c) showed excellent in vitro and in vivo antitumor efficacy with good tolerability and low toxicity. Antitumor mechanism and target profiling studies indicate that compound 66c is the first-in-class triple topoisomerase I/topoisomerase II/tubulin inhibitor. Overall, this study provided an effective strategy for natural product-based drug discovery.', 'Title: Imine/amide-imidazole conjugates derived from 5-amino-4-cyano-N1-substituted benzyl imidazole: Microwave-assisted synthesis and anticancer activity via selective topoisomerase-II- inhibition.  Abstract: Microwave-accelerated synthesis and anticancer activity of novel imine/amide-imidazole conjugates derived from 5-amino-4-cyano-N1-substituted benzyl imidazole against a panel of seven cancer cell lines are reported for the first time. Compounds ARK-4, 10 and 12 in the series show promising in vitro anti proliferative activity with low micromolar IC50 values against A-459 (lung), Hep-G2 (liver) and H-460 (liver) cancer cell lines. Compounds caused the increase in ROS levels as well as mitochondrial membrane depolarization, which might induce apoptosis. Further, mechanistic interventions on biological and molecular modeling data supported that compounds inhibited topoisomerase-II selectively.', 'Title: Synthesis and biological evaluation of 6-substituted indolizinoquinolinediones as catalytic DNA topoisomerase I inhibitors.  Abstract: In our previous work, indolizinoquinolinedione derivative 1 was identified as a Top1 catalytic inhibitor. Herein, a series of 6-substituted indolizinoquinolinedione derivatives were synthesized through modification of the parent compound 1. Top1 cleavage and relaxation assays indicate that none of these novel compounds act as classical Top1 poison, and that the compounds with alkylamino terminus at C-6 side chain, including 8, 11-16, 18-21, 25, 26 and 28-30, are the most potent Top1 catalytic inhibitors. Top1-mediated unwinding assay demonstrated that 14, 22 and 26 were Top1 catalytic inhibitors without Top1-mediated unwinding effect. Moreover, MTT results showed that compounds 26, 28-30 exhibit significant cytotoxicity against human leukemia HL-60 cells, and that compound 26 exerts potent cytotoxicity against A549 lung cancer cells at nanomolar range.', 'Title: Synthesis and biological evaluation of 6-substituted indolizinoquinolinediones as catalytic DNA topoisomerase I inhibitors.  Abstract: In our previous work, indolizinoquinolinedione derivative 1 was identified as a Top1 catalytic inhibitor. Herein, a series of 6-substituted indolizinoquinolinedione derivatives were synthesized through modification of the parent compound 1. Top1 cleavage and relaxation assays indicate that none of these novel compounds act as classical Top1 poison, and that the compounds with alkylamino terminus at C-6 side chain, including 8, 11-16, 18-21, 25, 26 and 28-30, are the most potent Top1 catalytic inhibitors. Top1-mediated unwinding assay demonstrated that 14, 22 and 26 were Top1 catalytic inhibitors without Top1-mediated unwinding effect. Moreover, MTT results showed that compounds 26, 28-30 exhibit significant cytotoxicity against human leukemia HL-60 cells, and that compound 26 exerts potent cytotoxicity against A549 lung cancer cells at nanomolar range.', 'Title: Design and synthesis of conformationally constrained hydroxylated 4-phenyl-2-aryl chromenopyridines as novel and selective topoisomerase II-targeted antiproliferative agents.  Abstract: To develop novel selective topoisomerase II inhibitors, we designed and synthesized a series of conformationally constrained hydroxylated 4-phenyl-2-aryl chromenopyridines and evaluated their topoisomerase inhibitory activity and cytotoxicity against three human cancer cell lines (DU145, HCT15, and T47D) and a normal cell line (MCF10A). All of the prepared compounds displayed stronger or similar topoisomerase II inhibitory activity as well as cytotoxicity against three human cancer cell lines compared to etoposide. Compounds 10a, 10g, 11a, 11f, 11g, 12a, 12f, and 12g especially showed stronger topoisomerase II inhibitory activity as compared to etoposide at both 100 M and 20 M. A structure-activity relationship study revealed that hydroxyphenyl moiety at 4-position of pyridine and ortho-hydroxyphenyl or thienyl moiety at 2-position of pyridine has an important role in displaying selective topoisomerase II inhibition. The compound 12b with para-hydroxyphenyl and meta-hydroxyphenyl at 4- and 2-position of pyridine, respectively, showed the most significant cytotoxicity against all three cancer cell lines, whereas less cytotoxicity to a normal cell line as compared to adriamycin.', 'Title: Design and synthesis of conformationally constrained hydroxylated 4-phenyl-2-aryl chromenopyridines as novel and selective topoisomerase II-targeted antiproliferative agents.  Abstract: To develop novel selective topoisomerase II inhibitors, we designed and synthesized a series of conformationally constrained hydroxylated 4-phenyl-2-aryl chromenopyridines and evaluated their topoisomerase inhibitory activity and cytotoxicity against three human cancer cell lines (DU145, HCT15, and T47D) and a normal cell line (MCF10A). All of the prepared compounds displayed stronger or similar topoisomerase II inhibitory activity as well as cytotoxicity against three human cancer cell lines compared to etoposide. Compounds 10a, 10g, 11a, 11f, 11g, 12a, 12f, and 12g especially showed stronger topoisomerase II inhibitory activity as compared to etoposide at both 100 M and 20 M. A structure-activity relationship study revealed that hydroxyphenyl moiety at 4-position of pyridine and ortho-hydroxyphenyl or thienyl moiety at 2-position of pyridine has an important role in displaying selective topoisomerase II inhibition. The compound 12b with para-hydroxyphenyl and meta-hydroxyphenyl at 4- and 2-position of pyridine, respectively, showed the most significant cytotoxicity against all three cancer cell lines, whereas less cytotoxicity to a normal cell line as compared to adriamycin.', 'Title: Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.  Abstract: DNA topoisomerase I is a potential chemotherapeutic target. Here, we designed and synthesized a library comprising of hydantoin and thiohydantoin derivatives and tested them against human and Leishmania Top1. One of the thiohydantoin compounds with substituted thiophenyl as the central moiety (compound 15) exhibited potent inhibition of human Top1 (HTop1) through stabilization of Top1-DNA cleavage complexes and showed selective anticancer activity against human cervical carcinoma (HeLa) and breast carcinoma (MCF-7) cell lines. Molecular modeling studies with HTop1 rationalized the inhibitory mechanism of compound 15.', 'Title: Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.  Abstract: DNA topoisomerase I is a potential chemotherapeutic target. Here, we designed and synthesized a library comprising of hydantoin and thiohydantoin derivatives and tested them against human and Leishmania Top1. One of the thiohydantoin compounds with substituted thiophenyl as the central moiety (compound 15) exhibited potent inhibition of human Top1 (HTop1) through stabilization of Top1-DNA cleavage complexes and showed selective anticancer activity against human cervical carcinoma (HeLa) and breast carcinoma (MCF-7) cell lines. Molecular modeling studies with HTop1 rationalized the inhibitory mechanism of compound 15.', 'Title: Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.  Abstract: DNA topoisomerase I is a potential chemotherapeutic target. Here, we designed and synthesized a library comprising of hydantoin and thiohydantoin derivatives and tested them against human and Leishmania Top1. One of the thiohydantoin compounds with substituted thiophenyl as the central moiety (compound 15) exhibited potent inhibition of human Top1 (HTop1) through stabilization of Top1-DNA cleavage complexes and showed selective anticancer activity against human cervical carcinoma (HeLa) and breast carcinoma (MCF-7) cell lines. Molecular modeling studies with HTop1 rationalized the inhibitory mechanism of compound 15.', 'Title: Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.  Abstract: DNA topoisomerase I is a potential chemotherapeutic target. Here, we designed and synthesized a library comprising of hydantoin and thiohydantoin derivatives and tested them against human and Leishmania Top1. One of the thiohydantoin compounds with substituted thiophenyl as the central moiety (compound 15) exhibited potent inhibition of human Top1 (HTop1) through stabilization of Top1-DNA cleavage complexes and showed selective anticancer activity against human cervical carcinoma (HeLa) and breast carcinoma (MCF-7) cell lines. Molecular modeling studies with HTop1 rationalized the inhibitory mechanism of compound 15.', 'Title: Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.  Abstract: DNA topoisomerase I is a potential chemotherapeutic target. Here, we designed and synthesized a library comprising of hydantoin and thiohydantoin derivatives and tested them against human and Leishmania Top1. One of the thiohydantoin compounds with substituted thiophenyl as the central moiety (compound 15) exhibited potent inhibition of human Top1 (HTop1) through stabilization of Top1-DNA cleavage complexes and showed selective anticancer activity against human cervical carcinoma (HeLa) and breast carcinoma (MCF-7) cell lines. Molecular modeling studies with HTop1 rationalized the inhibitory mechanism of compound 15.', 'Title: Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.  Abstract: DNA topoisomerase I is a potential chemotherapeutic target. Here, we designed and synthesized a library comprising of hydantoin and thiohydantoin derivatives and tested them against human and Leishmania Top1. One of the thiohydantoin compounds with substituted thiophenyl as the central moiety (compound 15) exhibited potent inhibition of human Top1 (HTop1) through stabilization of Top1-DNA cleavage complexes and showed selective anticancer activity against human cervical carcinoma (HeLa) and breast carcinoma (MCF-7) cell lines. Molecular modeling studies with HTop1 rationalized the inhibitory mechanism of compound 15.', 'Title: Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.  Abstract: DNA topoisomerase I is a potential chemotherapeutic target. Here, we designed and synthesized a library comprising of hydantoin and thiohydantoin derivatives and tested them against human and Leishmania Top1. One of the thiohydantoin compounds with substituted thiophenyl as the central moiety (compound 15) exhibited potent inhibition of human Top1 (HTop1) through stabilization of Top1-DNA cleavage complexes and showed selective anticancer activity against human cervical carcinoma (HeLa) and breast carcinoma (MCF-7) cell lines. Molecular modeling studies with HTop1 rationalized the inhibitory mechanism of compound 15.', 'Title: Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.  Abstract: DNA topoisomerase I is a potential chemotherapeutic target. Here, we designed and synthesized a library comprising of hydantoin and thiohydantoin derivatives and tested them against human and Leishmania Top1. One of the thiohydantoin compounds with substituted thiophenyl as the central moiety (compound 15) exhibited potent inhibition of human Top1 (HTop1) through stabilization of Top1-DNA cleavage complexes and showed selective anticancer activity against human cervical carcinoma (HeLa) and breast carcinoma (MCF-7) cell lines. Molecular modeling studies with HTop1 rationalized the inhibitory mechanism of compound 15.', 'Title: Design, synthesis and antitumor activity of non-camptothecin topoisomerase I inhibitors.  Abstract: Three groups of non-camptothecin compounds with four to five fused rings have been designed and synthesized. Their in vitro anti-proliferative activity has been evaluated with five different cancer cell lines (HCT116, PC3, U87MG, HepG2, SK-OV-3). Compounds B-2 and B-3 showed the most potent cell growth inhibition with IC50 of 169 nM and 325 nM against U87MG cell line correspondingly.', 'Title: Design, synthesis and antitumor activity of non-camptothecin topoisomerase I inhibitors.  Abstract: Three groups of non-camptothecin compounds with four to five fused rings have been designed and synthesized. Their in vitro anti-proliferative activity has been evaluated with five different cancer cell lines (HCT116, PC3, U87MG, HepG2, SK-OV-3). Compounds B-2 and B-3 showed the most potent cell growth inhibition with IC50 of 169 nM and 325 nM against U87MG cell line correspondingly.', 'Title: Structure-based hybridization, synthesis and biological evaluation of novel tetracyclic heterocyclic azathioxanthone analogues as potential antitumor agents.  Abstract: A series of tetracyclic heterocyclic azathioxanthones were synthesized and evaluated for cell proliferations, topoisomerase inhibitions, and NCI-60 cell panel assay, respectively. Compounds 5, 7, 8, 16, and 19 were selected for topoisomerase assay after MTT assay. 7 not only showed cytotoxic effect (IC50 = 2.84  0.64 M) in PC-3 cells but also revealed topoisomerases inhibition with IC50 (10-25 M) and increased apoptotic cleavage of PARP and caspase 3 activity. The overall of novel azathioxanthones with different cytostatic and cytotoxic activities should be further developed as new potential candidates for anticancer drugs.', 'Title: Structure-based hybridization, synthesis and biological evaluation of novel tetracyclic heterocyclic azathioxanthone analogues as potential antitumor agents.  Abstract: A series of tetracyclic heterocyclic azathioxanthones were synthesized and evaluated for cell proliferations, topoisomerase inhibitions, and NCI-60 cell panel assay, respectively. Compounds 5, 7, 8, 16, and 19 were selected for topoisomerase assay after MTT assay. 7 not only showed cytotoxic effect (IC50 = 2.84  0.64 M) in PC-3 cells but also revealed topoisomerases inhibition with IC50 (10-25 M) and increased apoptotic cleavage of PARP and caspase 3 activity. The overall of novel azathioxanthones with different cytostatic and cytotoxic activities should be further developed as new potential candidates for anticancer drugs.', 'Title: Structure-based hybridization, synthesis and biological evaluation of novel tetracyclic heterocyclic azathioxanthone analogues as potential antitumor agents.  Abstract: A series of tetracyclic heterocyclic azathioxanthones were synthesized and evaluated for cell proliferations, topoisomerase inhibitions, and NCI-60 cell panel assay, respectively. Compounds 5, 7, 8, 16, and 19 were selected for topoisomerase assay after MTT assay. 7 not only showed cytotoxic effect (IC50 = 2.84  0.64 M) in PC-3 cells but also revealed topoisomerases inhibition with IC50 (10-25 M) and increased apoptotic cleavage of PARP and caspase 3 activity. The overall of novel azathioxanthones with different cytostatic and cytotoxic activities should be further developed as new potential candidates for anticancer drugs.', 'Title: Structure-based hybridization, synthesis and biological evaluation of novel tetracyclic heterocyclic azathioxanthone analogues as potential antitumor agents.  Abstract: A series of tetracyclic heterocyclic azathioxanthones were synthesized and evaluated for cell proliferations, topoisomerase inhibitions, and NCI-60 cell panel assay, respectively. Compounds 5, 7, 8, 16, and 19 were selected for topoisomerase assay after MTT assay. 7 not only showed cytotoxic effect (IC50 = 2.84  0.64 M) in PC-3 cells but also revealed topoisomerases inhibition with IC50 (10-25 M) and increased apoptotic cleavage of PARP and caspase 3 activity. The overall of novel azathioxanthones with different cytostatic and cytotoxic activities should be further developed as new potential candidates for anticancer drugs.', 'Title: Substituted 2-arylquinazolinones: Design, synthesis, and evaluation of cytotoxicity and inhibition of topoisomerases.  Abstract: A series of 2-arylquinazolinones with structural homology to known 3-arylisoquinolines were designed and synthesized in order to develop safe, effective, and selective cytotoxic agents targeting topoisomerases (topos). 2-Arylquinzolinones with various substitutions on the aromatic rings were obtained by thermal cyclodehydration/dehydrogenation on reacting anthranilamides and benzaldehydes. The compounds had superior topo I-inhibitory activities but were generally inactive against topo II. Among the 6-methyl-, 6-amino-, and 7-methylquinazolinones, 6-amino-substituted derivatives displayed potent cytotoxicity at submicromolar to nanomolar concentrations against human colorectal adenocarcinoma cells (HCT-15), human ductal breast epithelial tumor cells (T47D), and cervical cancer cells (HeLa). There was a good correlation between topo I inhibition and the cytotoxic effects of 6-aminoquinazolinones. Docking models demonstrated that topo I inhibition by these compounds is owing to intercalation and H-bond interactions with the DNA bases and amino acid residues at the enzymatic site.', 'Title: Substituted 2-arylquinazolinones: Design, synthesis, and evaluation of cytotoxicity and inhibition of topoisomerases.  Abstract: A series of 2-arylquinazolinones with structural homology to known 3-arylisoquinolines were designed and synthesized in order to develop safe, effective, and selective cytotoxic agents targeting topoisomerases (topos). 2-Arylquinzolinones with various substitutions on the aromatic rings were obtained by thermal cyclodehydration/dehydrogenation on reacting anthranilamides and benzaldehydes. The compounds had superior topo I-inhibitory activities but were generally inactive against topo II. Among the 6-methyl-, 6-amino-, and 7-methylquinazolinones, 6-amino-substituted derivatives displayed potent cytotoxicity at submicromolar to nanomolar concentrations against human colorectal adenocarcinoma cells (HCT-15), human ductal breast epithelial tumor cells (T47D), and cervical cancer cells (HeLa). There was a good correlation between topo I inhibition and the cytotoxic effects of 6-aminoquinazolinones. Docking models demonstrated that topo I inhibition by these compounds is owing to intercalation and H-bond interactions with the DNA bases and amino acid residues at the enzymatic site.', 'Title: Substituted 2-arylquinazolinones: Design, synthesis, and evaluation of cytotoxicity and inhibition of topoisomerases.  Abstract: A series of 2-arylquinazolinones with structural homology to known 3-arylisoquinolines were designed and synthesized in order to develop safe, effective, and selective cytotoxic agents targeting topoisomerases (topos). 2-Arylquinzolinones with various substitutions on the aromatic rings were obtained by thermal cyclodehydration/dehydrogenation on reacting anthranilamides and benzaldehydes. The compounds had superior topo I-inhibitory activities but were generally inactive against topo II. Among the 6-methyl-, 6-amino-, and 7-methylquinazolinones, 6-amino-substituted derivatives displayed potent cytotoxicity at submicromolar to nanomolar concentrations against human colorectal adenocarcinoma cells (HCT-15), human ductal breast epithelial tumor cells (T47D), and cervical cancer cells (HeLa). There was a good correlation between topo I inhibition and the cytotoxic effects of 6-aminoquinazolinones. Docking models demonstrated that topo I inhibition by these compounds is owing to intercalation and H-bond interactions with the DNA bases and amino acid residues at the enzymatic site.', 'Title: Substituted 2-arylquinazolinones: Design, synthesis, and evaluation of cytotoxicity and inhibition of topoisomerases.  Abstract: A series of 2-arylquinazolinones with structural homology to known 3-arylisoquinolines were designed and synthesized in order to develop safe, effective, and selective cytotoxic agents targeting topoisomerases (topos). 2-Arylquinzolinones with various substitutions on the aromatic rings were obtained by thermal cyclodehydration/dehydrogenation on reacting anthranilamides and benzaldehydes. The compounds had superior topo I-inhibitory activities but were generally inactive against topo II. Among the 6-methyl-, 6-amino-, and 7-methylquinazolinones, 6-amino-substituted derivatives displayed potent cytotoxicity at submicromolar to nanomolar concentrations against human colorectal adenocarcinoma cells (HCT-15), human ductal breast epithelial tumor cells (T47D), and cervical cancer cells (HeLa). There was a good correlation between topo I inhibition and the cytotoxic effects of 6-aminoquinazolinones. Docking models demonstrated that topo I inhibition by these compounds is owing to intercalation and H-bond interactions with the DNA bases and amino acid residues at the enzymatic site.', 'Title: Versixanthones A-F, Cytotoxic Xanthone-Chromanone Dimers from the Marine-Derived Fungus Aspergillus versicolor HDN1009.  Abstract: Six unusual xanthone-chromanone dimers, versixanthones A-F (1-6), featuring different formal linkages of tetrahydroxanthone and 2,2-disubstituted chroman-4-one monomers, were isolated from a culture of the mangrove-derived fungus Aspergillus versicolor HDN1009. The absolute configurations of 1-6, representing the central and axial chirality elements or preferred helicities, were established by a combination of X-ray diffraction analysis, chemical conversions, and TDDFT-ECD calculations. The interconversion of different biaryl linkages between 1 and 4 and between 2 and 3 in DMSO by a retro-oxa-Michael mechanism provided insight into the formation of the xanthone-chromanone dimers and supported the assignments of their absolute configurations. Compounds 1-6 exhibited cytotoxicities against the seven tested cancer cell lines, with the best IC50 value of 0.7 M. Compound 5 showed further inhibitory activity against topoisomerase I.', 'Title: Synthesis of functionalized new conjugates of batracylin with tuftsin/retro-tuftsin derivatives and their biological evaluation.  Abstract: New batracylin conjugates with tuftsin/retro-tuftsin derivatives were designed and synthesized using T3P as a coupling agent. The conjugates possess an amide bond formed between the carboxyl group of heterocyclic molecule and the N-termini of the tuftsin/retro-tuftsin chain. The in vitro cytotoxic activity of the new analogues and their precursors was evaluated using a series of human and murine tumor cells. BAT conjugates containing retro-tuftsin with branched side aminoacid chain, in particular with leucine or isoleucine, were about 10-fold more cytotoxic toward two human tumor cell lines (lung adenocarcinoma (A549) and myeloblastic leukemia (HL-60)). These compounds showed about 10-fold increased cytotoxicity against the two types of tumor cells compared to parent BAT. We have not observed important differences in the mechanism of action between BAT and its cytotoxic tuftsin/retro-tuftsin conjugates. We propose that high biological activity of the most active BAT conjugates is a result of their greatly increased intracellular accumulation.', 'Title: Synthesis and Characterization of 4,11-Diaminoanthra[2,3-b]furan-5,10-diones: Tumor Cell Apoptosis through tNOX-Modulated NAD(+)/NADH Ratio and SIRT1.  Abstract: A series of new 4,11-diaminoanthra[2,3-b]furan-5,10-dione derivatives with different side chains were synthesized. Selected 2-unsubstituted derivatives 11-14 showed high antiproliferative potency on a panel of mammalian tumor cell lines including multidrug resistance variants. Compounds 11-14 utilized multiple mechanisms of cytotoxicity including inhibition of Top1/Top2-mediated DNA relaxation, reduced NAD(+)/NADH ratio through tNOX inhibition, suppression of a NAD(+)-dependent sirtuin 1 (SIRT1) deacetylase activity, and activation of caspase-mediated apoptosis. Here, for the first time, we report that tumor-associated NADH oxidase (tNOX) and SIRT1 are important cellular targets of antitumor anthracene-9,10-diones.', 'Title: Synthesis and Characterization of 4,11-Diaminoanthra[2,3-b]furan-5,10-diones: Tumor Cell Apoptosis through tNOX-Modulated NAD(+)/NADH Ratio and SIRT1.  Abstract: A series of new 4,11-diaminoanthra[2,3-b]furan-5,10-dione derivatives with different side chains were synthesized. Selected 2-unsubstituted derivatives 11-14 showed high antiproliferative potency on a panel of mammalian tumor cell lines including multidrug resistance variants. Compounds 11-14 utilized multiple mechanisms of cytotoxicity including inhibition of Top1/Top2-mediated DNA relaxation, reduced NAD(+)/NADH ratio through tNOX inhibition, suppression of a NAD(+)-dependent sirtuin 1 (SIRT1) deacetylase activity, and activation of caspase-mediated apoptosis. Here, for the first time, we report that tumor-associated NADH oxidase (tNOX) and SIRT1 are important cellular targets of antitumor anthracene-9,10-diones.', 'Title: Synthesis and Characterization of 4,11-Diaminoanthra[2,3-b]furan-5,10-diones: Tumor Cell Apoptosis through tNOX-Modulated NAD(+)/NADH Ratio and SIRT1.  Abstract: A series of new 4,11-diaminoanthra[2,3-b]furan-5,10-dione derivatives with different side chains were synthesized. Selected 2-unsubstituted derivatives 11-14 showed high antiproliferative potency on a panel of mammalian tumor cell lines including multidrug resistance variants. Compounds 11-14 utilized multiple mechanisms of cytotoxicity including inhibition of Top1/Top2-mediated DNA relaxation, reduced NAD(+)/NADH ratio through tNOX inhibition, suppression of a NAD(+)-dependent sirtuin 1 (SIRT1) deacetylase activity, and activation of caspase-mediated apoptosis. Here, for the first time, we report that tumor-associated NADH oxidase (tNOX) and SIRT1 are important cellular targets of antitumor anthracene-9,10-diones.', 'Title: Design, synthesis and biological evaluation of 3-substituted indenoisoquinoline derivatives as topoisomerase I inhibitors.  Abstract: A new series of indenoisoquinoline derivatives was designed and synthesized. The in vitro anti-proliferative activity of these novel compounds was evaluated in HepG2, A549 and HCT-116 cell lines. Compounds 9a, 9b, 10a, 10c, 10e, 18a and 18b manifested potent inhibitory activity against the three tested cancer cell lines. Nineteen compounds were also tested for Top I inhibition at 50 M. Almost all the tested compounds showed potent Top I inhibition activity at this concentration. The most potent compounds 9a and 10a demonstrated more cytotoxicity than HCPT and TPT and was comparable to CPT in inhibitory activities on Top I in our biological assay.', 'Title: 3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression.  Abstract: A series of unknown 3-(alkyl(dialkyl)amino)benzofuro[2,3-f]quinazolin-1(2H)-ones 4-17 has been synthesized as new ellipticine analogs, in which the carbazole moiety and the pyridine ring were replaced by a dibenzofuran residue and a pyrimidine ring, respectively. The synthesis of these benzofuroquinazolinones 4-17 was performed in a simple one-pot reaction using 3-aminodibenzofuran or its 2-methoxy derivative, as starting materials. From 3-(dipropylamino)-5-methoxybenzofuro[2,3-f] quinazolin-1(2H)-one (13), we prepared 3-(dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (18), referred to as DPA-HBFQ-1. The cytotoxic activities of all the synthesized compounds, tested in different human breast cancer cell lines, revealed that DPA-HBFQ-1 was the most active compound. In particular, the latter was able to inhibit anchorage-dependent and -independent cell growth and to induce apoptosis in estrogen receptor alpha (ER)-positive and -negative breast cancer cells. It did not affect proliferation and apoptotic responses in MCF-10A normal breast epithelial cells. The observed effects have been ascribed to an enhanced p21(Cip1/WAF1) expression in a p53-dependent manner of tumor suppressor and to a selective inhibition of human topoisomerase II. In addition, DPA-HBFQ-1 exerted growth inhibitory effects also in other cancer cell lines, even though with a lower cytotoxic activity. Our results indicate DPA-HBFQ-1 as a good candidate to be useful as cancer therapeutic agent, particularly for breast cancer.', 'Title: 3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression.  Abstract: A series of unknown 3-(alkyl(dialkyl)amino)benzofuro[2,3-f]quinazolin-1(2H)-ones 4-17 has been synthesized as new ellipticine analogs, in which the carbazole moiety and the pyridine ring were replaced by a dibenzofuran residue and a pyrimidine ring, respectively. The synthesis of these benzofuroquinazolinones 4-17 was performed in a simple one-pot reaction using 3-aminodibenzofuran or its 2-methoxy derivative, as starting materials. From 3-(dipropylamino)-5-methoxybenzofuro[2,3-f] quinazolin-1(2H)-one (13), we prepared 3-(dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (18), referred to as DPA-HBFQ-1. The cytotoxic activities of all the synthesized compounds, tested in different human breast cancer cell lines, revealed that DPA-HBFQ-1 was the most active compound. In particular, the latter was able to inhibit anchorage-dependent and -independent cell growth and to induce apoptosis in estrogen receptor alpha (ER)-positive and -negative breast cancer cells. It did not affect proliferation and apoptotic responses in MCF-10A normal breast epithelial cells. The observed effects have been ascribed to an enhanced p21(Cip1/WAF1) expression in a p53-dependent manner of tumor suppressor and to a selective inhibition of human topoisomerase II. In addition, DPA-HBFQ-1 exerted growth inhibitory effects also in other cancer cell lines, even though with a lower cytotoxic activity. Our results indicate DPA-HBFQ-1 as a good candidate to be useful as cancer therapeutic agent, particularly for breast cancer.', 'Title: Synthesis and Mechanism Studies of 1,3-Benzoazolyl Substituted Pyrrolo[2,3-b]pyrazine Derivatives as Nonintercalative Topoisomerase II Catalytic Inhibitors.  Abstract: Novel topoisomerase II (Topo II) inhibitors have gained considerable interest for the development of anticancer agents. In this study, a series of 1,3-benzoazolyl-substituted pyrrolo[2,3-b]pyrazine derivatives were designed, synthesized, and evaluated as potential Topo II catalytic inhibitors. It was found that some of derivatives had good antiproliferative activity on seven cancer cell lines, especially on HL-60/MX2, a cancer cell line derivative from HL-60 that is resistant to Topo II poison. Topo II mediated DNA relaxation assay results showed that derivatives could significantly inhibit the activity of Topo II, and the structure-activity relationship studies indicated the importance of the alkylamino side chain and the benzoazolyl group. Further mechanism studies revealed that derivatives function as Topo II nonintercalative catalytic inhibitors and may block the ATP binding site of Topo II. Moreover, flow cytometric analysis showed that this class of compounds could induce apoptosis of HL-60 cells.', 'Title: Synthesis and Mechanism Studies of 1,3-Benzoazolyl Substituted Pyrrolo[2,3-b]pyrazine Derivatives as Nonintercalative Topoisomerase II Catalytic Inhibitors.  Abstract: Novel topoisomerase II (Topo II) inhibitors have gained considerable interest for the development of anticancer agents. In this study, a series of 1,3-benzoazolyl-substituted pyrrolo[2,3-b]pyrazine derivatives were designed, synthesized, and evaluated as potential Topo II catalytic inhibitors. It was found that some of derivatives had good antiproliferative activity on seven cancer cell lines, especially on HL-60/MX2, a cancer cell line derivative from HL-60 that is resistant to Topo II poison. Topo II mediated DNA relaxation assay results showed that derivatives could significantly inhibit the activity of Topo II, and the structure-activity relationship studies indicated the importance of the alkylamino side chain and the benzoazolyl group. Further mechanism studies revealed that derivatives function as Topo II nonintercalative catalytic inhibitors and may block the ATP binding site of Topo II. Moreover, flow cytometric analysis showed that this class of compounds could induce apoptosis of HL-60 cells.', 'Title: Synthesis and Mechanism Studies of 1,3-Benzoazolyl Substituted Pyrrolo[2,3-b]pyrazine Derivatives as Nonintercalative Topoisomerase II Catalytic Inhibitors.  Abstract: Novel topoisomerase II (Topo II) inhibitors have gained considerable interest for the development of anticancer agents. In this study, a series of 1,3-benzoazolyl-substituted pyrrolo[2,3-b]pyrazine derivatives were designed, synthesized, and evaluated as potential Topo II catalytic inhibitors. It was found that some of derivatives had good antiproliferative activity on seven cancer cell lines, especially on HL-60/MX2, a cancer cell line derivative from HL-60 that is resistant to Topo II poison. Topo II mediated DNA relaxation assay results showed that derivatives could significantly inhibit the activity of Topo II, and the structure-activity relationship studies indicated the importance of the alkylamino side chain and the benzoazolyl group. Further mechanism studies revealed that derivatives function as Topo II nonintercalative catalytic inhibitors and may block the ATP binding site of Topo II. Moreover, flow cytometric analysis showed that this class of compounds could induce apoptosis of HL-60 cells.', 'Title: Discovery of indeno[1,2-b]quinoxaline derivatives as potential anticancer agents.  Abstract: We have synthesized certain indeno[1,2-b]quinoxaline derivatives for antiproliferative evaluation. Among them, 11-{[3-(dimethylamino)propoxy]imino}-N-[3-(dimethylamino) propyl]-11H-indeno[1,2-b]quinoxaline-6-carboxamide (10a) was active against the growth of MDA-MB231, PC-3, and Huh-7 with IC50 values of 0.87 (selectivity index, SI = 36.22), 0.82 (SI = 38.43), and 0.64 M (SI = 49.23) respectively. Compound 10a was inactive against the growth of normal human fetal lung fibroblast cell line (MRC-5) with an IC50 value of 31.51 M. Its analogs, 10b and 10c, were also active against the growth of MB231, PC-3, and Huh-7 with IC50 values of <1.0 M in each case. Our results have also indicated compounds 10a-10c exhibited comparable inhibitory activities against topo I and topo II with the positive compound 2 at a concentration of 10 M. Mechanism studies indicated that compound 10a induced cell cycle arrest at S phase via activation of caspase-3, -7 and an increase in the protein expression of Bad and Bax but a decrease in expression of Bcl-2 and PARP, which consequently cause cell death. In addition, compound 10a attenuated the levels of phosphorylated Src, Akt-1, and Akt-2 protein levels but did not affect the total protein expression of Akt. We have also implanted human hepatocellular carcinoma cells into the yolk sac of zebrafish larvae and incubated larvae with various concentrations of 10a. Our results of the zebrafish xenograft assay confirmed the anti-tumor effect of 10ain vivo.', 'Title: Discovery of indeno[1,2-b]quinoxaline derivatives as potential anticancer agents.  Abstract: We have synthesized certain indeno[1,2-b]quinoxaline derivatives for antiproliferative evaluation. Among them, 11-{[3-(dimethylamino)propoxy]imino}-N-[3-(dimethylamino) propyl]-11H-indeno[1,2-b]quinoxaline-6-carboxamide (10a) was active against the growth of MDA-MB231, PC-3, and Huh-7 with IC50 values of 0.87 (selectivity index, SI = 36.22), 0.82 (SI = 38.43), and 0.64 M (SI = 49.23) respectively. Compound 10a was inactive against the growth of normal human fetal lung fibroblast cell line (MRC-5) with an IC50 value of 31.51 M. Its analogs, 10b and 10c, were also active against the growth of MB231, PC-3, and Huh-7 with IC50 values of <1.0 M in each case. Our results have also indicated compounds 10a-10c exhibited comparable inhibitory activities against topo I and topo II with the positive compound 2 at a concentration of 10 M. Mechanism studies indicated that compound 10a induced cell cycle arrest at S phase via activation of caspase-3, -7 and an increase in the protein expression of Bad and Bax but a decrease in expression of Bcl-2 and PARP, which consequently cause cell death. In addition, compound 10a attenuated the levels of phosphorylated Src, Akt-1, and Akt-2 protein levels but did not affect the total protein expression of Akt. We have also implanted human hepatocellular carcinoma cells into the yolk sac of zebrafish larvae and incubated larvae with various concentrations of 10a. Our results of the zebrafish xenograft assay confirmed the anti-tumor effect of 10ain vivo.', \"Title: Synthesis and biological evaluation of new fluorinated and chlorinated indenoisoquinoline topoisomerase I poisons.  Abstract: Fluorine and chlorine are metabolically stable, but generally less active replacements for a nitro group at the 3-position of indenoisoquinoline topoisomerase IB (Top1) poisons. A number of strategies were employed in the present investigation to enhance the Top1 inhibitory potencies and cancer cell growth inhibitory activities of halogenated indenoisoquinolines. In several cases, the new compounds' activities were found to rival or surpass those of similarly substituted 3-nitroindenoisoquinolines, and several unusually potent analogs were discovered through testing in human cancer cell cultures. A hydroxyethylaminopropyl side chain on the lactam nitrogen of two halogenated indenoisoquinoline Top1 inhibitors was found to also impart inhibitory activity against tyrosyl DNA phosphodiesterases 1 and 2 (TDP1 and TDP2), which are enzymes that participate in the repair of DNA damage induced by Top1 poisons.\", \"Title: Discovery of antitumor anthra[2,3-b]furan-3-carboxamides: Optimization of synthesis and evaluation of antitumor properties.  Abstract: Anthraquinones and their analogues, in particular heteroarene-fused anthracendiones, are prospective scaffolds for new compounds with improved antitumor characteristics. We herein report the use of a 'scaffold hopping' approach for the replacement of the core structure in the previously discovered hit compound naphtho[2,3-f]indole-5,10-dione 2 with an alternative anthra[2,3-b]furan-5,10-dione scaffold. Among 13 newly synthesized derivatives the majority of 4,11-dihydroxy-2-methyl-5,10-dioxoanthra[2,3-b]furan-3-carboxamides demonstrated a high antiproliferative potency against a panel of wild type and drug resistant tumor cell lines, a property superior over the reference drug doxorubicin or lead naphtho[2,3-f]indole-5,10-dione 2. At low micromolar concentrations the selected derivative of (R)-3-aminopyrrolidine 3c and its stereoisomer (S)-3-aminopyrrolidine 3d caused an apoptotic cell death preceded by an arrest in the G2/M phase. Studies of intracellular targets showed that 3c and 3d formed stable intercalative complexes with the duplex DNA as determined by spectral analysis and molecular docking. Both 3c and 3d attenuated topoisomerase 1 and 2 mediated unwinding of the supercoiled DNA via a mechanism different from conventional DNA-enzyme tertiary complex formation. Furthermore, 3d decreased the activity of selected human protein kinases in vitro, indicating multiple targeting by the new chemotype. Finally, 3d demonstrated an antitumor activity in a model of murine intraperitoneally transplanted P388 leukemia, achieving the increase of animal life span up to 262% at tolerable doses. Altogether, the 'scaffold hopping' demonstrated its productivity for obtaining new perspective antitumor drug candidates.\", \"Title: Discovery of antitumor anthra[2,3-b]furan-3-carboxamides: Optimization of synthesis and evaluation of antitumor properties.  Abstract: Anthraquinones and their analogues, in particular heteroarene-fused anthracendiones, are prospective scaffolds for new compounds with improved antitumor characteristics. We herein report the use of a 'scaffold hopping' approach for the replacement of the core structure in the previously discovered hit compound naphtho[2,3-f]indole-5,10-dione 2 with an alternative anthra[2,3-b]furan-5,10-dione scaffold. Among 13 newly synthesized derivatives the majority of 4,11-dihydroxy-2-methyl-5,10-dioxoanthra[2,3-b]furan-3-carboxamides demonstrated a high antiproliferative potency against a panel of wild type and drug resistant tumor cell lines, a property superior over the reference drug doxorubicin or lead naphtho[2,3-f]indole-5,10-dione 2. At low micromolar concentrations the selected derivative of (R)-3-aminopyrrolidine 3c and its stereoisomer (S)-3-aminopyrrolidine 3d caused an apoptotic cell death preceded by an arrest in the G2/M phase. Studies of intracellular targets showed that 3c and 3d formed stable intercalative complexes with the duplex DNA as determined by spectral analysis and molecular docking. Both 3c and 3d attenuated topoisomerase 1 and 2 mediated unwinding of the supercoiled DNA via a mechanism different from conventional DNA-enzyme tertiary complex formation. Furthermore, 3d decreased the activity of selected human protein kinases in vitro, indicating multiple targeting by the new chemotype. Finally, 3d demonstrated an antitumor activity in a model of murine intraperitoneally transplanted P388 leukemia, achieving the increase of animal life span up to 262% at tolerable doses. Altogether, the 'scaffold hopping' demonstrated its productivity for obtaining new perspective antitumor drug candidates.\", \"Title: Discovery of antitumor anthra[2,3-b]furan-3-carboxamides: Optimization of synthesis and evaluation of antitumor properties.  Abstract: Anthraquinones and their analogues, in particular heteroarene-fused anthracendiones, are prospective scaffolds for new compounds with improved antitumor characteristics. We herein report the use of a 'scaffold hopping' approach for the replacement of the core structure in the previously discovered hit compound naphtho[2,3-f]indole-5,10-dione 2 with an alternative anthra[2,3-b]furan-5,10-dione scaffold. Among 13 newly synthesized derivatives the majority of 4,11-dihydroxy-2-methyl-5,10-dioxoanthra[2,3-b]furan-3-carboxamides demonstrated a high antiproliferative potency against a panel of wild type and drug resistant tumor cell lines, a property superior over the reference drug doxorubicin or lead naphtho[2,3-f]indole-5,10-dione 2. At low micromolar concentrations the selected derivative of (R)-3-aminopyrrolidine 3c and its stereoisomer (S)-3-aminopyrrolidine 3d caused an apoptotic cell death preceded by an arrest in the G2/M phase. Studies of intracellular targets showed that 3c and 3d formed stable intercalative complexes with the duplex DNA as determined by spectral analysis and molecular docking. Both 3c and 3d attenuated topoisomerase 1 and 2 mediated unwinding of the supercoiled DNA via a mechanism different from conventional DNA-enzyme tertiary complex formation. Furthermore, 3d decreased the activity of selected human protein kinases in vitro, indicating multiple targeting by the new chemotype. Finally, 3d demonstrated an antitumor activity in a model of murine intraperitoneally transplanted P388 leukemia, achieving the increase of animal life span up to 262% at tolerable doses. Altogether, the 'scaffold hopping' demonstrated its productivity for obtaining new perspective antitumor drug candidates.\", \"Title: Discovery of antitumor anthra[2,3-b]furan-3-carboxamides: Optimization of synthesis and evaluation of antitumor properties.  Abstract: Anthraquinones and their analogues, in particular heteroarene-fused anthracendiones, are prospective scaffolds for new compounds with improved antitumor characteristics. We herein report the use of a 'scaffold hopping' approach for the replacement of the core structure in the previously discovered hit compound naphtho[2,3-f]indole-5,10-dione 2 with an alternative anthra[2,3-b]furan-5,10-dione scaffold. Among 13 newly synthesized derivatives the majority of 4,11-dihydroxy-2-methyl-5,10-dioxoanthra[2,3-b]furan-3-carboxamides demonstrated a high antiproliferative potency against a panel of wild type and drug resistant tumor cell lines, a property superior over the reference drug doxorubicin or lead naphtho[2,3-f]indole-5,10-dione 2. At low micromolar concentrations the selected derivative of (R)-3-aminopyrrolidine 3c and its stereoisomer (S)-3-aminopyrrolidine 3d caused an apoptotic cell death preceded by an arrest in the G2/M phase. Studies of intracellular targets showed that 3c and 3d formed stable intercalative complexes with the duplex DNA as determined by spectral analysis and molecular docking. Both 3c and 3d attenuated topoisomerase 1 and 2 mediated unwinding of the supercoiled DNA via a mechanism different from conventional DNA-enzyme tertiary complex formation. Furthermore, 3d decreased the activity of selected human protein kinases in vitro, indicating multiple targeting by the new chemotype. Finally, 3d demonstrated an antitumor activity in a model of murine intraperitoneally transplanted P388 leukemia, achieving the increase of animal life span up to 262% at tolerable doses. Altogether, the 'scaffold hopping' demonstrated its productivity for obtaining new perspective antitumor drug candidates.\", 'Title: Effect of chlorine substituent on cytotoxic activities: Design and synthesis of systematically modified 2,4-diphenyl-5H-indeno[1,2-b]pyridines.  Abstract: In continuation of our previous work, six hydroxylated 2,4-diphenyl-5H-indeno[1,2-b]pyridine analogs were modified by introducing one chlorine functionality at ortho, meta or para position of the 2- or 4-phenyl ring. Eighteen new chlorinated compounds were thus prepared and assessed for topoisomerase inhibitory activity and cytotoxicity against HCT15, T47D, and HeLa cancer cell lines. All of the chlorinated compounds displayed significant cytotoxic effect, revealing potent anticancer activity against T47D breast cancer cells. This functional group modification allowed us to explore the importance of chlorine group substitution for the cytotoxic properties. The information reported here provides valuable insight for further study to develop new anticancer agents using related scaffolds.', 'Title: Effect of chlorine substituent on cytotoxic activities: Design and synthesis of systematically modified 2,4-diphenyl-5H-indeno[1,2-b]pyridines.  Abstract: In continuation of our previous work, six hydroxylated 2,4-diphenyl-5H-indeno[1,2-b]pyridine analogs were modified by introducing one chlorine functionality at ortho, meta or para position of the 2- or 4-phenyl ring. Eighteen new chlorinated compounds were thus prepared and assessed for topoisomerase inhibitory activity and cytotoxicity against HCT15, T47D, and HeLa cancer cell lines. All of the chlorinated compounds displayed significant cytotoxic effect, revealing potent anticancer activity against T47D breast cancer cells. This functional group modification allowed us to explore the importance of chlorine group substitution for the cytotoxic properties. The information reported here provides valuable insight for further study to develop new anticancer agents using related scaffolds.', 'Title: A new series of 2-phenol-4-aryl-6-chlorophenyl pyridine derivatives as dual topoisomerase I/II inhibitors: Synthesis, biological evaluation and 3D-QSAR study.  Abstract: As a continuous effort to develop novel antitumor agents, a new series of forty-five 2-phenol-4-aryl-6-chlorophenyl pyridine compounds were synthesized and evaluated for cytotoxicity against four different human cancer cell lines (DU145, HCT15, T47D, and HeLa), and topoisomerase I and II inhibitory activity. Several compounds (10-15, 20, 22, 24, 28, 42, and 49) displayed strong to moderate dual topoisomerase I and II inhibitory activity at 100 M. It was observed that hydroxyl and chlorine moiety at meta or para position of phenyl ring is favorable for dual topoisomerase inhibitory activity and cytotoxicity. Most of the compounds displayed stronger cytotoxicities than those of all positive controls against the HCT15 and T47D cell lines. For investigation of the structure-activity relationships, a 3D-QSAR analysis using the method of comparative molecular field analysis (CoMFA) was performed. The generated 3D contour maps can be used for further rational design of novel terpyridine derivatives as highly selective and potent cytotoxic agents.', 'Title: A new series of 2-phenol-4-aryl-6-chlorophenyl pyridine derivatives as dual topoisomerase I/II inhibitors: Synthesis, biological evaluation and 3D-QSAR study.  Abstract: As a continuous effort to develop novel antitumor agents, a new series of forty-five 2-phenol-4-aryl-6-chlorophenyl pyridine compounds were synthesized and evaluated for cytotoxicity against four different human cancer cell lines (DU145, HCT15, T47D, and HeLa), and topoisomerase I and II inhibitory activity. Several compounds (10-15, 20, 22, 24, 28, 42, and 49) displayed strong to moderate dual topoisomerase I and II inhibitory activity at 100 M. It was observed that hydroxyl and chlorine moiety at meta or para position of phenyl ring is favorable for dual topoisomerase inhibitory activity and cytotoxicity. Most of the compounds displayed stronger cytotoxicities than those of all positive controls against the HCT15 and T47D cell lines. For investigation of the structure-activity relationships, a 3D-QSAR analysis using the method of comparative molecular field analysis (CoMFA) was performed. The generated 3D contour maps can be used for further rational design of novel terpyridine derivatives as highly selective and potent cytotoxic agents.', 'Title: Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase II catalytic inhibitor.  Abstract: A series of pyrazoline derivatives (5) were synthesized in 92-96% yields from chalcones (3) and hydrazides (4). Subsequently, topo-I and II-mediated relaxation and antiproliferative activity assays were evaluated for 5. Among the tested compounds, 5h had a very strong topo-I activity of 97% (Camptothecin, 74%) at concentration of 100 M. Nevertheless, all the compounds 5a-5i showed significant topo II inhibitory activity in the range of 90-94% (Etoposide, 96%) at the same concentration. Cytotoxic potential of these compounds was tested in a panel of three human tumor cell lines, HCT15, BT474 and T47D. All the compounds showed strong activity against HCT15 cell line with IC50 at the range of 1.9-10.4 M (Adriamycin, 23.0; Etoposide, 6.9; and Camptothecin, 7.1 M). Moreover, compounds 5c, 5f and 5i were observed to have strong antiproliferative activity against BT474 cell lines. Since, compound 5d showed antiproliferative activity at a very low IC50 thus 5d was then selected to study on their mode of action with diverse methods of ATP competition assay, ATPase assay and DNA-topo II cleavable complex assay and the results revealed that it functioned as a ATP-competitive human topoisomerase II catalytic inhibitor. Further evaluation of endogenous topo-mediated DNA relaxation in cells has been conducted to find that, 5d inhibited endogenous topo-mediated pBR322 plasmid relaxation is more efficient (78.0  4.7% at 50 M) than Etoposide (36.0  1.7% at 50 M).', 'Title: Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase II catalytic inhibitor.  Abstract: A series of pyrazoline derivatives (5) were synthesized in 92-96% yields from chalcones (3) and hydrazides (4). Subsequently, topo-I and II-mediated relaxation and antiproliferative activity assays were evaluated for 5. Among the tested compounds, 5h had a very strong topo-I activity of 97% (Camptothecin, 74%) at concentration of 100 M. Nevertheless, all the compounds 5a-5i showed significant topo II inhibitory activity in the range of 90-94% (Etoposide, 96%) at the same concentration. Cytotoxic potential of these compounds was tested in a panel of three human tumor cell lines, HCT15, BT474 and T47D. All the compounds showed strong activity against HCT15 cell line with IC50 at the range of 1.9-10.4 M (Adriamycin, 23.0; Etoposide, 6.9; and Camptothecin, 7.1 M). Moreover, compounds 5c, 5f and 5i were observed to have strong antiproliferative activity against BT474 cell lines. Since, compound 5d showed antiproliferative activity at a very low IC50 thus 5d was then selected to study on their mode of action with diverse methods of ATP competition assay, ATPase assay and DNA-topo II cleavable complex assay and the results revealed that it functioned as a ATP-competitive human topoisomerase II catalytic inhibitor. Further evaluation of endogenous topo-mediated DNA relaxation in cells has been conducted to find that, 5d inhibited endogenous topo-mediated pBR322 plasmid relaxation is more efficient (78.0  4.7% at 50 M) than Etoposide (36.0  1.7% at 50 M).', 'Title: Synthesis and antiproliferative activity of 9-benzylamino-6-chloro-2-methoxy-acridine derivatives as potent DNA-binding ligands and topoisomerase II inhibitors.  Abstract: A series of 9-benzylamino acridine derivatives were synthesized as an extension of our discovery of acridine antitumor agents. Most of these acridine compounds displayed good antiproliferative activity with IC50 values in low micromole range and structure-activity relationships were studied. Topo I- and II- mediated relaxation studies suggested that all of our compounds displayed strong Topo II inhibitory activity at 100 M, while only four exhibited moderate Topo I inhibitory activity. The typical compound 8p could penetrate A549 cancer cells efficiently. Compound 8p could intercalate within the double-stranded DNA structure and induce DNA damage. Moreover, compound 8p could induce A549 cells apoptosis through caspase-dependent intrinsic pathway and arrest A549 cells at the G2/M phase.', 'Title: 10-Boronic acid substituted camptothecin as prodrug of SN-38.  Abstract: Malignant tumor cells have been found to have high levels of reactive oxygen species such as hydrogen peroxide (H2O2), supporting the hypothesis that a prodrug could be activated by intracellular H2O2 and lead to a potential antitumor therapy. In this study, the 7-ethyl-10-boronic acid camptothecin (B1) was synthesized for the first time as prodrug of SN-38, by linking a cleavable aryl carbon-boron bond to the SN-38. Prodrug B1 selectively activated by H2O2, converted rapidly to the active form SN-38 under favorable oxidative conditions in cancer cells with elevated levels of H2O2. The cell survival assay showed that prodrug B1 was equally or more effective in inhibiting the growth of six different cancer cells, as compared to SN-38. Unexpectedly, prodrug B1 displayed even more potent Topo I inhibitory activity than SN-38, suggesting that it was not only a prodrug of SN-38 but also a typical Topo I inhibitor. Prodrug B1 also demonstrated a significant antitumor activity at 2.0 mg/kg in a xenograft model using human brain star glioblastoma cell lines U87MG.', \"Title: Investigation of the Structure-Activity Relationships of Aza-A-Ring Indenoisoquinoline Topoisomerase I Poisons.  Abstract: Several indenoisoquinolines have shown promise as anticancer agents in clinical trials. Incorporation of a nitrogen atom into the indenoisoquinoline scaffold offers the possibility of favorably modulating ligand-binding site interactions, physicochemical properties, and biological activities. Four series of aza-A-ring indenoisoquinolines were synthesized in which the nitrogen atom was systematically rotated through positions 1, 2, 3, and 4. The resulting compounds were tested to establish the optimal nitrogen position for topoisomerase IB (Top1) enzyme poisoning activity and cytotoxicity to human cancer cells. The 4-aza compounds were the most likely to yield derivatives with high Top1 inhibitory activity. However, the relationship between structure and cytotoxicity was more complicated since the potency was influenced strongly by the side chains on the lactam nitrogen. The most cytotoxic azaindenoisoquinolines 45 and 46 had nitrogen in the 2- or 3-positions and a 3'-dimethylaminopropyl side chain, and they had MGM GI50 values that were slightly better than the corresponding indenoisoquinoline 64.\", \"Title: Investigation of the Structure-Activity Relationships of Aza-A-Ring Indenoisoquinoline Topoisomerase I Poisons.  Abstract: Several indenoisoquinolines have shown promise as anticancer agents in clinical trials. Incorporation of a nitrogen atom into the indenoisoquinoline scaffold offers the possibility of favorably modulating ligand-binding site interactions, physicochemical properties, and biological activities. Four series of aza-A-ring indenoisoquinolines were synthesized in which the nitrogen atom was systematically rotated through positions 1, 2, 3, and 4. The resulting compounds were tested to establish the optimal nitrogen position for topoisomerase IB (Top1) enzyme poisoning activity and cytotoxicity to human cancer cells. The 4-aza compounds were the most likely to yield derivatives with high Top1 inhibitory activity. However, the relationship between structure and cytotoxicity was more complicated since the potency was influenced strongly by the side chains on the lactam nitrogen. The most cytotoxic azaindenoisoquinolines 45 and 46 had nitrogen in the 2- or 3-positions and a 3'-dimethylaminopropyl side chain, and they had MGM GI50 values that were slightly better than the corresponding indenoisoquinoline 64.\", 'Title: Synthesis and biological activity of pyrazole analogues of the staurosporine aglycon K252c.  Abstract: A derivative of the staurosporine aglycon (K252c), in which the lactam ring was replaced by a pyrazole moiety, was synthesized. The resulting indolopyrazolocarbazole (3) inhibited Pim isoforms 1-3 whereas it did not impair the activity of two known targets of K252c, protein kinase C isoforms  and . Compound 3 exhibited moderate cytotoxic activity toward human leukemia and colon carcinoma cell lines (K562 and HCT116), strongly suggesting that this new scaffold deserves further investigations for treatment of malignancies associated with Pim activity.', 'Inhibition of human recombinant topoisomerase 1-mediated relaxation of supercoiled pBS (SK+) DNA at 60 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis', 'Poisoning activity at human recombinant topoisomerase 1 assessed as stabilization of enzyme-supercoiled pBS (SK+) DNA complex at 60 uM after 30 mins by ethidium bromide staining based agarose gel electrophoresis', 'Poisoning activity at topoisomerase 1 in human MCF7 cells at 10 uM after 12 hrs by immunoband depletion assay', 'Inhibition of CPT mediated formation of topoisomerase 1-supercoiled pBS (SK+) DNA complex in human MCF7 cells at 10 uM preincubated for 2 hrs followed by CPT addition measured after 4 to 12 hrs by immunoband depletion assay', 'Title: Design, Synthesis, and Biological Evaluation of Potential Prodrugs Related to the Experimental Anticancer Agent Indotecan (LMP400).  Abstract: Indenoisoquinoline topoisomerase I (Top1) inhibitors are a novel class of anticancer agents with two compounds in clinical trials. Recent metabolism studies of indotecan (LMP400) led to the discovery of the biologically active 2-hydroxylated analogue and 3-hydroxylated metabolite, thus providing strategically placed functional groups for the preparation of a variety of potential ester prodrugs of these two compounds. The current study details the design and synthesis of two series of indenoisoquinoline prodrugs, and it also reveals how substituents on the O-2 and O-3 positions of the A ring, which are next to the cleaved DNA strand in the drug-DNA-Top1 ternary cleavage complex, affect Top1 inhibitory activity and cytotoxicity. Many of the indenoisoquinoline prodrugs were very potent antiproliferative agents with GI50 values below 10 nM in a variety of human cancer cell lines.', 'Title: Design, Synthesis, and Biological Evaluation of Potential Prodrugs Related to the Experimental Anticancer Agent Indotecan (LMP400).  Abstract: Indenoisoquinoline topoisomerase I (Top1) inhibitors are a novel class of anticancer agents with two compounds in clinical trials. Recent metabolism studies of indotecan (LMP400) led to the discovery of the biologically active 2-hydroxylated analogue and 3-hydroxylated metabolite, thus providing strategically placed functional groups for the preparation of a variety of potential ester prodrugs of these two compounds. The current study details the design and synthesis of two series of indenoisoquinoline prodrugs, and it also reveals how substituents on the O-2 and O-3 positions of the A ring, which are next to the cleaved DNA strand in the drug-DNA-Top1 ternary cleavage complex, affect Top1 inhibitory activity and cytotoxicity. Many of the indenoisoquinoline prodrugs were very potent antiproliferative agents with GI50 values below 10 nM in a variety of human cancer cell lines.', 'Title: 4-(1,2-diarylbut-1-en-1-yl)isobutyranilide derivatives as inhibitors of topoisomerase II.  Abstract: The synthesis and biological evaluation of a new library of 4-(1,2-diarylbut-1-en-1-yl)isobutyranilides is described. The new compounds were found to be cytotoxic in the micromolar range in two human tumor cell lines, MCF-7 (mammary gland adenocarcinoma) and HeLa (cervix adenocarcinoma) and two human ovarian cancer cell lines (A2780 and OVCAR5). Detailed studies on the most active compound 6g show that it was able to induce apoptosis and suggest topoisomerase II as a possible intracellular target. The relevance of the interaction of the most active compound with topoisomerase II is demonstrated and supported by docking studies.', 'Title: Design, synthesis and biological evaluation of lapachol derivatives possessing indole scaffolds as topoisomerase I inhibitors.  Abstract: A series of novel lapachol derivatives possessing indole scaffolds was designed and synthesized. The in vitro anti-proliferative activity of these novel compounds was evaluated in Eca109 and Hela cell lines. Almost all the tested compounds showed manifested potent inhibitory activity against the two tested cancer cell lines. Topo I-mediated DNA relaxation activity indicated that these novel compounds have potent Topoisomerase I inhibition activity. The most potent compounds 4n and 4k demonstrated more cytotoxicity than camptothecin and was comparable to camptothecin in inhibitory activities on Topoisomerase I in our biological assay. In addition, the Hoechst 33342 staining method also showed that the complex can induce Hela cell apoptosis.', 'Title: Design, synthesis and biological evaluation of lapachol derivatives possessing indole scaffolds as topoisomerase I inhibitors.  Abstract: A series of novel lapachol derivatives possessing indole scaffolds was designed and synthesized. The in vitro anti-proliferative activity of these novel compounds was evaluated in Eca109 and Hela cell lines. Almost all the tested compounds showed manifested potent inhibitory activity against the two tested cancer cell lines. Topo I-mediated DNA relaxation activity indicated that these novel compounds have potent Topoisomerase I inhibition activity. The most potent compounds 4n and 4k demonstrated more cytotoxicity than camptothecin and was comparable to camptothecin in inhibitory activities on Topoisomerase I in our biological assay. In addition, the Hoechst 33342 staining method also showed that the complex can induce Hela cell apoptosis.', 'Title: Design, synthesis and biological evaluation of lapachol derivatives possessing indole scaffolds as topoisomerase I inhibitors.  Abstract: A series of novel lapachol derivatives possessing indole scaffolds was designed and synthesized. The in vitro anti-proliferative activity of these novel compounds was evaluated in Eca109 and Hela cell lines. Almost all the tested compounds showed manifested potent inhibitory activity against the two tested cancer cell lines. Topo I-mediated DNA relaxation activity indicated that these novel compounds have potent Topoisomerase I inhibition activity. The most potent compounds 4n and 4k demonstrated more cytotoxicity than camptothecin and was comparable to camptothecin in inhibitory activities on Topoisomerase I in our biological assay. In addition, the Hoechst 33342 staining method also showed that the complex can induce Hela cell apoptosis.', \"Title: Synthesis of novel ethyl 2,4-disubstituted 8-(trifluoromethyl)pyrido[2',3':3,4]pyrazolo[1,5-a]pyrimidine-9-carboxylate derivatives as promising anticancer agents.  Abstract: A series of novel pyrido[2',3':3,4] pyrazolo[1,5-a]pyrimidine derivatives 6-9 were prepared in single step starting from 3-amino-6-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxylate 5 on reaction with symmetrical and unsymmetrical aliphatic and aromatic 1,3-diketones/, unsaturated ketones/, unsaturated keto ethers under conventional method. All the final compounds 6a-c, 8a-b and 9a-l were screened for anticancer activity against five human cancer cell lines such as PC-3 (CRL-1435), MDA-MB-231 (HTB-26), Hep G2 (HB-8065), HeLa (CCL-2) and normal HUVEC (CRL-1730). Compounds 8a, 9f and 9k which showed promising anticancer activity have been identified. Further, the promising compounds (8a and 9f) were able to inhibit the human topoisomerase I (TopI) activity similar to that of camptothecin.\", 'Title: Scaffold-Hopping of Aurones: 2-Arylideneimidazo[1,2-a]pyridinones as Topoisomerase II-Inhibiting Anticancer Agents.  Abstract: Scaffold-hopping of bioactive natural product aurones has been studied for the first time. 2-Arylideneimidazo[1,2-a]pyridinones as potential topoisomerase II (hTopoII)-targeting anticancer compounds were considered. A multifunctional activator, polyphosphoric acid, enabled to realize a cascade reaction of 2-aminopyridine with 2,3-epoxyesters toward synthesis of 2-arylideneimidazo[1,2-a]pyridinones. Most of the compounds exhibited hTopoII-selective poison activity with efficiency more than etoposide and DNA-binding property, while not interacting with hTopo I. The compounds showed pronounced antiproliferative activities in nanomolar range with relatively poor toxicity to normal cells, inhibition of invasiveness, and apoptotic effect. The activities for inhibition of tubulin assembly, CDK1 and pCDK1, were also observed. Interestingly, the hTopoII inhibitory (in vitro and ex vivo studies) and antiproliferative activities of representative potent compounds were found to be manifold higher compared to corresponding parent aurones bearing alike substitutions, indicating the importance of such scaffold-hopping strategy in medicinal chemistry research.', 'Title: Scaffold-hopping of bioactive flavonoids: Discovery of aryl-pyridopyrimidinones as potent anticancer agents that inhibit catalytic role of topoisomerase II.  Abstract: A strategy of scaffold-hopping of bioactive natural products, flavones and isoflavones, leading to target-based discovery of potent anticancer agents has been reported for the first time. Scaffold-hopped flavones, 2-aryl-4H-pyrido[1,2-a]pyrimidin-4-ones and the scaffold-hopped isoflavones, 3-aryl-pyrido[1,2-a]pyrimidin-4-ones were synthesized via Pd-catalyzed activation-arylation methods. Most of the compounds were found to exhibit pronounced human topoisomerase II (hTopoII) inhibitory activities and several compounds were found to be more potent than etoposide (a hTopoII-inhibiting anticancer drug). These classes of compounds were found to be hTopoII-selective catalytic inhibitors while not interfering with topoisomerase I and interacted with DNA plausibly in groove domain. Cytotoxicities against various cancer cells, low toxicity in normal cells, and apoptotic effects were observed. Interestingly, compared to parent flavones/isoflavones, their scaffold-hopped analogs bearing alike functionalities showed significant/enhanced hTopoII-inhibitory and cytotoxic properties, indicating the importance of a natural product-based scaffold-hopping strategy in the drug discovery.', \"Title: Novel securinine derivatives as topoisomerase I based antitumor agents.  Abstract: DNA topoisomerase I (Topo I) has been validated as a target for anticancer agents. In this study, a series of novel securinine derivatives bearing '-hydroxy-,-unsaturated ketone moiety were designed and synthesized via a Baylis-Hillman reaction for screening as Topo I inhibitors and antitumor agents. Their topoisomerase I inhibitory activity as well as their cytotoxicity against four human cancer cell lines (A549, HeLa, HepG2, SH-SY5Y) were evaluated, and two pairs of diastereomers 4a-1 and 4a-6 with significant Topo I inhibitory activity and potent anti-proliferative activity against cancer cell lines were identified. The diastereomers were separated, and absolute configurations of five pairs of diastereomers were identified based on X-ray crystallographic analysis and circular dichroism (CD) spectra analysis. Further mechanism studies of the most active compounds 4a-1-R and 4a-1-S indicated that this kind of securinine derivative exhibits a different inhibitory mechanism from that of camptothecin, an established Topo I inhibitor. Unlike camptothecin, compounds 4a-1-R and 4a-1-S specifically inhibits the combination of Topo I and DNA rather than forming the drug-enzyme-DNA covalent ternary complex. In addition, molecular docking and molecular dynamic studies revealed the binding patterns of these compounds with Topo I.\", \"Title: Novel securinine derivatives as topoisomerase I based antitumor agents.  Abstract: DNA topoisomerase I (Topo I) has been validated as a target for anticancer agents. In this study, a series of novel securinine derivatives bearing '-hydroxy-,-unsaturated ketone moiety were designed and synthesized via a Baylis-Hillman reaction for screening as Topo I inhibitors and antitumor agents. Their topoisomerase I inhibitory activity as well as their cytotoxicity against four human cancer cell lines (A549, HeLa, HepG2, SH-SY5Y) were evaluated, and two pairs of diastereomers 4a-1 and 4a-6 with significant Topo I inhibitory activity and potent anti-proliferative activity against cancer cell lines were identified. The diastereomers were separated, and absolute configurations of five pairs of diastereomers were identified based on X-ray crystallographic analysis and circular dichroism (CD) spectra analysis. Further mechanism studies of the most active compounds 4a-1-R and 4a-1-S indicated that this kind of securinine derivative exhibits a different inhibitory mechanism from that of camptothecin, an established Topo I inhibitor. Unlike camptothecin, compounds 4a-1-R and 4a-1-S specifically inhibits the combination of Topo I and DNA rather than forming the drug-enzyme-DNA covalent ternary complex. In addition, molecular docking and molecular dynamic studies revealed the binding patterns of these compounds with Topo I.\", \"Title: Novel securinine derivatives as topoisomerase I based antitumor agents.  Abstract: DNA topoisomerase I (Topo I) has been validated as a target for anticancer agents. In this study, a series of novel securinine derivatives bearing '-hydroxy-,-unsaturated ketone moiety were designed and synthesized via a Baylis-Hillman reaction for screening as Topo I inhibitors and antitumor agents. Their topoisomerase I inhibitory activity as well as their cytotoxicity against four human cancer cell lines (A549, HeLa, HepG2, SH-SY5Y) were evaluated, and two pairs of diastereomers 4a-1 and 4a-6 with significant Topo I inhibitory activity and potent anti-proliferative activity against cancer cell lines were identified. The diastereomers were separated, and absolute configurations of five pairs of diastereomers were identified based on X-ray crystallographic analysis and circular dichroism (CD) spectra analysis. Further mechanism studies of the most active compounds 4a-1-R and 4a-1-S indicated that this kind of securinine derivative exhibits a different inhibitory mechanism from that of camptothecin, an established Topo I inhibitor. Unlike camptothecin, compounds 4a-1-R and 4a-1-S specifically inhibits the combination of Topo I and DNA rather than forming the drug-enzyme-DNA covalent ternary complex. In addition, molecular docking and molecular dynamic studies revealed the binding patterns of these compounds with Topo I.\", \"Title: Novel securinine derivatives as topoisomerase I based antitumor agents.  Abstract: DNA topoisomerase I (Topo I) has been validated as a target for anticancer agents. In this study, a series of novel securinine derivatives bearing '-hydroxy-,-unsaturated ketone moiety were designed and synthesized via a Baylis-Hillman reaction for screening as Topo I inhibitors and antitumor agents. Their topoisomerase I inhibitory activity as well as their cytotoxicity against four human cancer cell lines (A549, HeLa, HepG2, SH-SY5Y) were evaluated, and two pairs of diastereomers 4a-1 and 4a-6 with significant Topo I inhibitory activity and potent anti-proliferative activity against cancer cell lines were identified. The diastereomers were separated, and absolute configurations of five pairs of diastereomers were identified based on X-ray crystallographic analysis and circular dichroism (CD) spectra analysis. Further mechanism studies of the most active compounds 4a-1-R and 4a-1-S indicated that this kind of securinine derivative exhibits a different inhibitory mechanism from that of camptothecin, an established Topo I inhibitor. Unlike camptothecin, compounds 4a-1-R and 4a-1-S specifically inhibits the combination of Topo I and DNA rather than forming the drug-enzyme-DNA covalent ternary complex. In addition, molecular docking and molecular dynamic studies revealed the binding patterns of these compounds with Topo I.\", 'Title: Amino substituted benzimidazo[1,2-a]quinolines: Antiproliferative potency, 3D QSAR study and DNA binding properties.  Abstract: We describe the synthesis, 3D-derived quantitative structure-activity relationship (QSAR), antiproliferative activity and DNA binding properties of a series of 2-amino, 5-amino and 2,5-diamino substituted benzimidazo[1,2-a]quinolines prepared by environmentally friendly uncatalyzed microwave assisted amination. The antiproliferative activities were assessed in vitro against colon, lung and breast carcinoma cell lines; activities ranged from submicromolar to micromolar. The strongest antiproliferative activity was demonstrated by 2-amino-substituted analogues, whereas 5-amino and or 2,5-diamino substituted derivatives resulted in much less activity. Derivatives bearing 4-methyl- or 3,5-dimethyl-1-piperazinyl substituents emerged as the most active. DNA binding properties and the mode of interaction of chosen substituted benzimidazo[1,2-a]quinolines prepared herein were studied using melting temperature studies, a series of spectroscopic studies (UV/Visible, fluorescence, and circular dichroism), and biochemical experiments (topoisomerase I-mediated DNA relaxation and DNase I footprinting experiments). Both compound 36 and its bis-quaternary iodide salt 37 intercalate between adjacent base pairs of the DNA helix while compound 33 presented a very weak topoisomerase I poisoning activity. A 3D-QSAR analysis was performed to identify hydrogen bonding properties, hydrophobicity, molecular flexibility and distribution of hydrophobic regions as these molecular properties had the highest impact on the antiproliferative activity against the three cell lines.', 'Title: Amino substituted benzimidazo[1,2-a]quinolines: Antiproliferative potency, 3D QSAR study and DNA binding properties.  Abstract: We describe the synthesis, 3D-derived quantitative structure-activity relationship (QSAR), antiproliferative activity and DNA binding properties of a series of 2-amino, 5-amino and 2,5-diamino substituted benzimidazo[1,2-a]quinolines prepared by environmentally friendly uncatalyzed microwave assisted amination. The antiproliferative activities were assessed in vitro against colon, lung and breast carcinoma cell lines; activities ranged from submicromolar to micromolar. The strongest antiproliferative activity was demonstrated by 2-amino-substituted analogues, whereas 5-amino and or 2,5-diamino substituted derivatives resulted in much less activity. Derivatives bearing 4-methyl- or 3,5-dimethyl-1-piperazinyl substituents emerged as the most active. DNA binding properties and the mode of interaction of chosen substituted benzimidazo[1,2-a]quinolines prepared herein were studied using melting temperature studies, a series of spectroscopic studies (UV/Visible, fluorescence, and circular dichroism), and biochemical experiments (topoisomerase I-mediated DNA relaxation and DNase I footprinting experiments). Both compound 36 and its bis-quaternary iodide salt 37 intercalate between adjacent base pairs of the DNA helix while compound 33 presented a very weak topoisomerase I poisoning activity. A 3D-QSAR analysis was performed to identify hydrogen bonding properties, hydrophobicity, molecular flexibility and distribution of hydrophobic regions as these molecular properties had the highest impact on the antiproliferative activity against the three cell lines.', 'Title: Amino substituted benzimidazo[1,2-a]quinolines: Antiproliferative potency, 3D QSAR study and DNA binding properties.  Abstract: We describe the synthesis, 3D-derived quantitative structure-activity relationship (QSAR), antiproliferative activity and DNA binding properties of a series of 2-amino, 5-amino and 2,5-diamino substituted benzimidazo[1,2-a]quinolines prepared by environmentally friendly uncatalyzed microwave assisted amination. The antiproliferative activities were assessed in vitro against colon, lung and breast carcinoma cell lines; activities ranged from submicromolar to micromolar. The strongest antiproliferative activity was demonstrated by 2-amino-substituted analogues, whereas 5-amino and or 2,5-diamino substituted derivatives resulted in much less activity. Derivatives bearing 4-methyl- or 3,5-dimethyl-1-piperazinyl substituents emerged as the most active. DNA binding properties and the mode of interaction of chosen substituted benzimidazo[1,2-a]quinolines prepared herein were studied using melting temperature studies, a series of spectroscopic studies (UV/Visible, fluorescence, and circular dichroism), and biochemical experiments (topoisomerase I-mediated DNA relaxation and DNase I footprinting experiments). Both compound 36 and its bis-quaternary iodide salt 37 intercalate between adjacent base pairs of the DNA helix while compound 33 presented a very weak topoisomerase I poisoning activity. A 3D-QSAR analysis was performed to identify hydrogen bonding properties, hydrophobicity, molecular flexibility and distribution of hydrophobic regions as these molecular properties had the highest impact on the antiproliferative activity against the three cell lines.', 'Title: Short Route to the Total Synthesis of Natural Muricadienin and Investigation of Its Cytotoxic Properties.  Abstract: An original synthesis of the acetogenin muricadienin, the bioprecursor of solamin, has been developed. The key step in the five-step 41% overall yield synthesis is the catalytic cross-cyclomagnesiation reaction of functionally substituted 1,2-dienes with EtMgBr in the presence of Cp2TiCl2 and magnesium metal. It has been demonstrated for the first time that muricadienin exhibits a moderate in vitro inhibitory activity against topoisomerases I and II, key cell cycle enzymes. Using flow cytometry, muricadienin was shown to have high cytotoxicity toward the HEK293 kidney cancer cells (IC50 0.39 M).', 'Title: Short Route to the Total Synthesis of Natural Muricadienin and Investigation of Its Cytotoxic Properties.  Abstract: An original synthesis of the acetogenin muricadienin, the bioprecursor of solamin, has been developed. The key step in the five-step 41% overall yield synthesis is the catalytic cross-cyclomagnesiation reaction of functionally substituted 1,2-dienes with EtMgBr in the presence of Cp2TiCl2 and magnesium metal. It has been demonstrated for the first time that muricadienin exhibits a moderate in vitro inhibitory activity against topoisomerases I and II, key cell cycle enzymes. Using flow cytometry, muricadienin was shown to have high cytotoxicity toward the HEK293 kidney cancer cells (IC50 0.39 M).', 'Title: The synthesis and biological evaluation of alkyl and benzyl naphthyridinium analogs of eupolauridine as potential antimicrobial and cytotoxic agents.  Abstract: Eupolauridine, an indenonaphthyridine alkaloid, has been previously reported by us to exhibit antifungal activity. This study describes the synthesis of new alkyl and benzyl naphthyridinium/pyridinium analogs of eupolauridine as potential antifungal agents. A majority of the analogs exhibited antifungal activity against opportunistic pathogens such as Candida albicans and Cryptococcus neoformans. Several of them were also effective against bacteria (Staphylococcus aureus, MRS, Pseudomonas and Mycobacterium) and the malaria parasite (Plasmodium falciparum) to variable extents. A number of analogs were also cytotoxic to human cancer cell lines.', 'Title: The synthesis and biological evaluation of alkyl and benzyl naphthyridinium analogs of eupolauridine as potential antimicrobial and cytotoxic agents.  Abstract: Eupolauridine, an indenonaphthyridine alkaloid, has been previously reported by us to exhibit antifungal activity. This study describes the synthesis of new alkyl and benzyl naphthyridinium/pyridinium analogs of eupolauridine as potential antifungal agents. A majority of the analogs exhibited antifungal activity against opportunistic pathogens such as Candida albicans and Cryptococcus neoformans. Several of them were also effective against bacteria (Staphylococcus aureus, MRS, Pseudomonas and Mycobacterium) and the malaria parasite (Plasmodium falciparum) to variable extents. A number of analogs were also cytotoxic to human cancer cell lines.', 'Title: Synthesis and biological evaluation of 6-fluoro-3-phenyl-7-piperazinyl quinolone derivatives as potential topoisomerase I inhibitors.  Abstract: The design and synthesis of a new series of 6-fluoro-3-phenyl-7-piperazinyl quinolone derivatives, built on the structure of 1-ethyl-3-(6-nitrobenzoxazol-2-yl)-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4(1H)-quinolone, are described. These compounds provide new scaffold for the discovery of Topoisomerase I (Top I) inhibitors and target based assay showed that they can obviously inhibited Top I at 100 M. The in vitro anti-proliferative activity of these new compounds was evaluated against A549, Hela, BGC-823, and HepG2 cell lines. Compounds 18a-g showed potent inhibitory activity against the growth of those cancer cell lines. The most positive compounds 18f and 18g demonstrated as potent as camptothecin in Top I inhibition assay and MTT assay. Compounds 18f and 18g led to an obvious increase in the percentage of S phase of the cells in 24 h. The in vivo data showed that 18f and 18g inhibited tumor growth with the inhibitory rate of 29.25% and 42.75% at 20 mg/kg, respectively. The data suggested the therapeutic potential for further development.', 'Title: A new scaffold of topoisomerase I inhibitors: Design, synthesis and biological evaluation.  Abstract: The synthesis of a new hexacyclic system was realized starting from tryptamines and exploiting as a key step a sequential Pd-catalyzed N-arylation/acylation reaction. Having topoisomerases as biological target and the campthotecins class as benchmark, the new scaffold was decorated with substituents having different polarity and tested as Topoisomerase I inhibitors.', 'Title: A new scaffold of topoisomerase I inhibitors: Design, synthesis and biological evaluation.  Abstract: The synthesis of a new hexacyclic system was realized starting from tryptamines and exploiting as a key step a sequential Pd-catalyzed N-arylation/acylation reaction. Having topoisomerases as biological target and the campthotecins class as benchmark, the new scaffold was decorated with substituents having different polarity and tested as Topoisomerase I inhibitors.', 'Title: A new scaffold of topoisomerase I inhibitors: Design, synthesis and biological evaluation.  Abstract: The synthesis of a new hexacyclic system was realized starting from tryptamines and exploiting as a key step a sequential Pd-catalyzed N-arylation/acylation reaction. Having topoisomerases as biological target and the campthotecins class as benchmark, the new scaffold was decorated with substituents having different polarity and tested as Topoisomerase I inhibitors.', 'Title: A new scaffold of topoisomerase I inhibitors: Design, synthesis and biological evaluation.  Abstract: The synthesis of a new hexacyclic system was realized starting from tryptamines and exploiting as a key step a sequential Pd-catalyzed N-arylation/acylation reaction. Having topoisomerases as biological target and the campthotecins class as benchmark, the new scaffold was decorated with substituents having different polarity and tested as Topoisomerase I inhibitors.', \"Title: Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors.  Abstract: On the basis of previous reports on the importance of thienyl, furyl or phenol group substitution on 5H-indeno[1,2-b]pyridine skeleton, a new series of rigid 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridine derivatives were systematically designed and synthesized. Topoisomerase inhibitory activity and antiproliferative activity of all the synthesized compounds were determined using human colorectal (HCT15), breast (T47D), prostate (DU145) and cervix (HeLa) cancer cells. Compounds 9, 10, 12, 13, 15, 16, 18 and 19 with thienyl or furyl moiety at the 2-position and hydroxyl group at the meta or para positions of 4-phenyl ring displayed strong to moderate topoisomerase II (topo II) inhibitory activity and significant antiproliferative activity. The evaluation of compound 16 to determine its mechanism of action was performed with topo II-DNA cleavable complex, topo II-mediated ATPase assay, DNA unwinding and in vitro and ex vivo topo II relaxation assay. Compound 16 functioned as a DNA non-intercalative topo II catalytic inhibitor with better potency than etoposide in T47D breast cancer cells. Molecular docking study revealed that compound 16 cannot intercalate into regularly stacked base-pairs of DNA duplex but can interact or intercalate to topo II-bound DNA.\", \"Title: Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors.  Abstract: On the basis of previous reports on the importance of thienyl, furyl or phenol group substitution on 5H-indeno[1,2-b]pyridine skeleton, a new series of rigid 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridine derivatives were systematically designed and synthesized. Topoisomerase inhibitory activity and antiproliferative activity of all the synthesized compounds were determined using human colorectal (HCT15), breast (T47D), prostate (DU145) and cervix (HeLa) cancer cells. Compounds 9, 10, 12, 13, 15, 16, 18 and 19 with thienyl or furyl moiety at the 2-position and hydroxyl group at the meta or para positions of 4-phenyl ring displayed strong to moderate topoisomerase II (topo II) inhibitory activity and significant antiproliferative activity. The evaluation of compound 16 to determine its mechanism of action was performed with topo II-DNA cleavable complex, topo II-mediated ATPase assay, DNA unwinding and in vitro and ex vivo topo II relaxation assay. Compound 16 functioned as a DNA non-intercalative topo II catalytic inhibitor with better potency than etoposide in T47D breast cancer cells. Molecular docking study revealed that compound 16 cannot intercalate into regularly stacked base-pairs of DNA duplex but can interact or intercalate to topo II-bound DNA.\", \"Title: Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors.  Abstract: On the basis of previous reports on the importance of thienyl, furyl or phenol group substitution on 5H-indeno[1,2-b]pyridine skeleton, a new series of rigid 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridine derivatives were systematically designed and synthesized. Topoisomerase inhibitory activity and antiproliferative activity of all the synthesized compounds were determined using human colorectal (HCT15), breast (T47D), prostate (DU145) and cervix (HeLa) cancer cells. Compounds 9, 10, 12, 13, 15, 16, 18 and 19 with thienyl or furyl moiety at the 2-position and hydroxyl group at the meta or para positions of 4-phenyl ring displayed strong to moderate topoisomerase II (topo II) inhibitory activity and significant antiproliferative activity. The evaluation of compound 16 to determine its mechanism of action was performed with topo II-DNA cleavable complex, topo II-mediated ATPase assay, DNA unwinding and in vitro and ex vivo topo II relaxation assay. Compound 16 functioned as a DNA non-intercalative topo II catalytic inhibitor with better potency than etoposide in T47D breast cancer cells. Molecular docking study revealed that compound 16 cannot intercalate into regularly stacked base-pairs of DNA duplex but can interact or intercalate to topo II-bound DNA.\", \"Title: Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors.  Abstract: On the basis of previous reports on the importance of thienyl, furyl or phenol group substitution on 5H-indeno[1,2-b]pyridine skeleton, a new series of rigid 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridine derivatives were systematically designed and synthesized. Topoisomerase inhibitory activity and antiproliferative activity of all the synthesized compounds were determined using human colorectal (HCT15), breast (T47D), prostate (DU145) and cervix (HeLa) cancer cells. Compounds 9, 10, 12, 13, 15, 16, 18 and 19 with thienyl or furyl moiety at the 2-position and hydroxyl group at the meta or para positions of 4-phenyl ring displayed strong to moderate topoisomerase II (topo II) inhibitory activity and significant antiproliferative activity. The evaluation of compound 16 to determine its mechanism of action was performed with topo II-DNA cleavable complex, topo II-mediated ATPase assay, DNA unwinding and in vitro and ex vivo topo II relaxation assay. Compound 16 functioned as a DNA non-intercalative topo II catalytic inhibitor with better potency than etoposide in T47D breast cancer cells. Molecular docking study revealed that compound 16 cannot intercalate into regularly stacked base-pairs of DNA duplex but can interact or intercalate to topo II-bound DNA.\", 'Title: Fluorescein hydrazones: A series of novel non-intercalative topoisomerase II catalytic inhibitors induce G1 arrest and apoptosis in breast and colon cancer cells.  Abstract: Fluorescein hydrazones (5 and 7) were synthesized in three/four steps with 82-92% yields. All synthesized compounds were evaluated by topoisomerase I (topo I) and topoisomerase II (topo II)-mediated relaxation and cell viability assays. Among them, most of the compounds showed topo I & II inhibitory activity and nineteen compounds showed strong anti-proliferative activity against various cell lines. In brief, 5e inhibited 53% topo II (etoposide 29%) at 20 M and showed excellent antiproliferative activity against DU145 (1.43  0.04 M), HCT15 (2.4  0.03 M) and MCF7 (11.4  0.5 M) cell lines in comparison with adriamycin, etoposide, and camptothecin. Compounds 5e, 5g and 5h were further evaluated to determine their mode of action. Compounds 5e, 5g and 5h functioned as non-intercalative topo II catalytic inhibitor with induction of G1 arrest and activation of apoptotic proteins in dose-dependent manner.', 'Title: Fluorescein hydrazones: A series of novel non-intercalative topoisomerase II catalytic inhibitors induce G1 arrest and apoptosis in breast and colon cancer cells.  Abstract: Fluorescein hydrazones (5 and 7) were synthesized in three/four steps with 82-92% yields. All synthesized compounds were evaluated by topoisomerase I (topo I) and topoisomerase II (topo II)-mediated relaxation and cell viability assays. Among them, most of the compounds showed topo I & II inhibitory activity and nineteen compounds showed strong anti-proliferative activity against various cell lines. In brief, 5e inhibited 53% topo II (etoposide 29%) at 20 M and showed excellent antiproliferative activity against DU145 (1.43  0.04 M), HCT15 (2.4  0.03 M) and MCF7 (11.4  0.5 M) cell lines in comparison with adriamycin, etoposide, and camptothecin. Compounds 5e, 5g and 5h were further evaluated to determine their mode of action. Compounds 5e, 5g and 5h functioned as non-intercalative topo II catalytic inhibitor with induction of G1 arrest and activation of apoptotic proteins in dose-dependent manner.', 'Inhibition of DNA topoisomerase-1 (unknown origin) assessed as decrease in relaxation of supercoiled pRYG DNA at 12.5 to 100 uM after 50 mins by ethidium bromide staining-based agarose gel electrophoresis', 'Inhibition of DNA topoisomerase-1 (unknown origin) assessed as decrease in relaxation of supercoiled pRYG DNA at 100 uM after 50 mins by ethidium bromide staining-based agarose gel electrophoresis', 'This assay details affinity data for ligands at human DNA topoisomerase I, part of the family \"5.99.1.2 DNA Topoisomerases\", as described in the published literature. Where possible the data described are at transfected receptors expressed in cell lines and the ligands described are those that are potent, selective, endogenous, or those used as prescription medications.', 'Title: Aminomethylation of heliomycin: Preparation and anticancer characterization of the first series of semi-synthetic derivatives.  Abstract: A series of 4-aminomethyl derivatives of heliomycin 1 was prepared using the Mannich reaction. The modification significantly improved aqueous solubility of the initially poorly soluble antibiotic. Testing the antiproliferative efficacy revealed a potent activity of heliomycin as well as its new derivatives on a panel of mammalian tumor cells including drug resistant variants. In contrast to 1 the new derivatives 7a, 7l, 7p generated a high level of ROS associated with induction of apoptosis in T24 bladder cancer cells. Introduction of 4-aminomethyl moiety increased the affinity to DNA and the ability to inhibit topoisomerase 1 making 7p the most promising candidate for further preclinical evaluation. Thus, aminomethylation is the first-in-class successful transformation of the antibiotic 1 resulting in an improved water solubility of derivatives and promising properties in search of novel anticancer drug candidates.', 'Title: Aminomethylation of heliomycin: Preparation and anticancer characterization of the first series of semi-synthetic derivatives.  Abstract: A series of 4-aminomethyl derivatives of heliomycin 1 was prepared using the Mannich reaction. The modification significantly improved aqueous solubility of the initially poorly soluble antibiotic. Testing the antiproliferative efficacy revealed a potent activity of heliomycin as well as its new derivatives on a panel of mammalian tumor cells including drug resistant variants. In contrast to 1 the new derivatives 7a, 7l, 7p generated a high level of ROS associated with induction of apoptosis in T24 bladder cancer cells. Introduction of 4-aminomethyl moiety increased the affinity to DNA and the ability to inhibit topoisomerase 1 making 7p the most promising candidate for further preclinical evaluation. Thus, aminomethylation is the first-in-class successful transformation of the antibiotic 1 resulting in an improved water solubility of derivatives and promising properties in search of novel anticancer drug candidates.', 'Title: Aminomethylation of heliomycin: Preparation and anticancer characterization of the first series of semi-synthetic derivatives.  Abstract: A series of 4-aminomethyl derivatives of heliomycin 1 was prepared using the Mannich reaction. The modification significantly improved aqueous solubility of the initially poorly soluble antibiotic. Testing the antiproliferative efficacy revealed a potent activity of heliomycin as well as its new derivatives on a panel of mammalian tumor cells including drug resistant variants. In contrast to 1 the new derivatives 7a, 7l, 7p generated a high level of ROS associated with induction of apoptosis in T24 bladder cancer cells. Introduction of 4-aminomethyl moiety increased the affinity to DNA and the ability to inhibit topoisomerase 1 making 7p the most promising candidate for further preclinical evaluation. Thus, aminomethylation is the first-in-class successful transformation of the antibiotic 1 resulting in an improved water solubility of derivatives and promising properties in search of novel anticancer drug candidates.', 'Title: Synthesis of carbazole derivatives containing chalcone analogs as non-intercalative topoisomerase II catalytic inhibitors and apoptosis inducers.  Abstract: Novel topoisomerase II (Topo II) inhibitors have gained considerable interest for the development of anticancer agents. In this study, a series of carbazole derivatives containing chalcone analogs (CDCAs) were synthesized and investigated for their Topo II inhibition and cytotoxic activities. The results from Topo II mediated DNA relaxation assay showed that CDCAs could significantly inhibit the activity of Topo II, and the structure-activity relationship indicated the halogen substituent in phenyl ring play an important role in the activity. Further mechanism studies revealed that CDCAs function as non-intercalative Topo II catalytic inhibitors. Moreover, some CDCAs showed micromolar cytotoxic activities. The most potent compound 3h exhibited notable growth inhibition against four human cancer cell lines. Flow cytometric analysis revealed that compounds 3d and 3h arrested the HL-60\\u202fcells in sub G1 phase by induction of apoptosis. It was further confirmed by Annexin-V-FITC binding assay. Western blot analysis revealed that compound 3h induces apoptosis likely through the activation of caspase proteins.', 'Title: Synthesis of carbazole derivatives containing chalcone analogs as non-intercalative topoisomerase II catalytic inhibitors and apoptosis inducers.  Abstract: Novel topoisomerase II (Topo II) inhibitors have gained considerable interest for the development of anticancer agents. In this study, a series of carbazole derivatives containing chalcone analogs (CDCAs) were synthesized and investigated for their Topo II inhibition and cytotoxic activities. The results from Topo II mediated DNA relaxation assay showed that CDCAs could significantly inhibit the activity of Topo II, and the structure-activity relationship indicated the halogen substituent in phenyl ring play an important role in the activity. Further mechanism studies revealed that CDCAs function as non-intercalative Topo II catalytic inhibitors. Moreover, some CDCAs showed micromolar cytotoxic activities. The most potent compound 3h exhibited notable growth inhibition against four human cancer cell lines. Flow cytometric analysis revealed that compounds 3d and 3h arrested the HL-60\\u202fcells in sub G1 phase by induction of apoptosis. It was further confirmed by Annexin-V-FITC binding assay. Western blot analysis revealed that compound 3h induces apoptosis likely through the activation of caspase proteins.', 'Title: Synthesis and structure-activity relationship of furoquinolinediones as inhibitors of Tyrosyl-DNA phosphodiesterase 2 (TDP2).  Abstract: Tyrosyl-DNA phosphodiesterase 2 (TDP2) is a recently discovered enzyme specifically repairing topoisomerase II (TOP2)-mediated DNA damage. It has been shown that inhibition of TDP2 synergize with TOP2 inhibitors. Herein, we report the discovery of the furoquinolinedione chemotype as a suitable skeleton for the development of selective TDP2 inhibitors. Compound 1 was identified as a TDP2 inhibitor as a result of screening our in-house compound library for compounds selective for TDP2 vs. TDP1. Further SAR studies provide several selective TDP2 inhibitors at low-micromolar range. The most potent compound 74 shows inhibitory activity with IC50 of 1.9 and 2.1\\u202fM against recombinant TDP2 and TDP2 in whole cell extracts (WCE), respectively.', 'Title: Substituted 1,5-naphthyridine derivatives as novel antileishmanial agents. Synthesis and biological evaluation.  Abstract: Visceral leishmaniasis is a parasitic disease that affects, among other areas, both sides of the Mediterranean Basin. The drugs classically used in clinical practice are pentavalent antimonials (SbV) and amphotericin B, which are nephrotoxic, require parenteral administration, and increasing drug resistance in visceral leishmaniasis has been observed. These circumstances justify the search of new families of compounds to find effective drugs against the disease. Eukaryotic type I DNA topoisomerase (TopIB) has been found essential for the viability of the parasites, and therefore represents a promising target in the development of an antileishmanial therapy. In this search, heterocyclic compounds, such as 1,5-naphthyridines, have been prepared by cycloaddition reaction between N-(3-pyridyl)aldimines and acetylenes and their antileishmanial activity on promastigotes and amastigote-infected splenocytes of Leishmania infantum has been evaluated. In addition, the cytotoxic effects of newly synthesized compounds were assessed on host murine splenocytes in order to calculate the corresponding selective indexes (SI). Excellent antileishmanial activity of 1,5-naphthyridine 19, 21, 22, 24 and 27 has been observed with similar activity than the standard drug amphotericin B and higher selective index (SI\\u202f>\\u202f100) towards L. infantum amastigotes than amphotericin B (SI\\u202f>\\u202f62.5). Special interest shows the 1,5-naphthyridine 22 with an IC50 value (0.58\\u202f\\u202f0.03\\u202fM) similar to the standard drug amphotericin B (0.32\\u202f\\u202f0.05\\u202fM) and with the highest selective index (SI\\u202f=\\u202f271.5). In addition, this compound shows remarkable inhibition on leishmanial TopIB. However, despite these interesting results, further studies are needed to disclose other potential targets involved in the antileishmanial effect of these novel compounds.', 'Title: Novel indolo-sophoridinic scaffold as Topo I inhibitors: Design, synthesis and biological evaluation as anticancer agents.  Abstract: Based on the mechanism of action, novel scaffolds as Topo I inhibitors bearing indole and sophoridinine were designed. Preliminary docking study revealed that some molecules among the designed series possessed promising Topo I inhibitor properties. Subsequently, thirty new compounds were synthesized and characterized by 1H NMR, 13C NMR, and Mass spectral analyses. The compounds were then screened for their antiproliferative and enzymatic inhibitory activities. The results affirmed the consistency between docking and activities and the rationality of the design strategy. Furthermore, compound 10b was chosen as a representative compound to test its anticancer effects in vitro and in vivo. The results showed that 10b caused prominent S phase cell cycle arrest and significantly suppressed tumor growth in HepG2 cell derived mouse model. These findings present a promising series of lead molecules which can serve as potential Topo I inhibitors for the treatment of cancer and a theoretical basis for structural modifications.', 'Title: A new phenolic series of indenopyridinone as topoisomerase inhibitors: Design, synthesis, and structure-activity relationships.  Abstract: DNA Topoisomerase II (topo II) is one of the most effective therapeutic targets to control cancer. In an effort to develop novel and effective topo II targeting anti-proliferative agent, a phenolic series of indenopyridinone and indenopyridinol were designed and prepared using efficient multi-component one pot synthetic method. Total twenty-two synthesized compounds were assessed for topo I and II inhibition, and anti-proliferation in three different human cancer cell lines. Overall structure-activity relationship study explored the significance of meta-phenolic group at 4-position and para-phenolic group at 2- and/or 4-position of indenopyridinone skeleton for strong topo II-selective inhibition and anti-proliferative activity against human cervix (HeLa) and colorectal (HCT15) cell lines. Compound 12 with excellent topo II inhibition (93.7%) was confirmed as a DNA intercalator that could be a new promising lead to develop effective topo II-targeted anticancer agents.', 'Title: A new phenolic series of indenopyridinone as topoisomerase inhibitors: Design, synthesis, and structure-activity relationships.  Abstract: DNA Topoisomerase II (topo II) is one of the most effective therapeutic targets to control cancer. In an effort to develop novel and effective topo II targeting anti-proliferative agent, a phenolic series of indenopyridinone and indenopyridinol were designed and prepared using efficient multi-component one pot synthetic method. Total twenty-two synthesized compounds were assessed for topo I and II inhibition, and anti-proliferation in three different human cancer cell lines. Overall structure-activity relationship study explored the significance of meta-phenolic group at 4-position and para-phenolic group at 2- and/or 4-position of indenopyridinone skeleton for strong topo II-selective inhibition and anti-proliferative activity against human cervix (HeLa) and colorectal (HCT15) cell lines. Compound 12 with excellent topo II inhibition (93.7%) was confirmed as a DNA intercalator that could be a new promising lead to develop effective topo II-targeted anticancer agents.', 'Title: Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.  Abstract: Tyrosyl-DNA phosphodiesterase 1 (TDP1) is a recently discovered enzyme repairing DNA lesions resulting from stalled topoisomerase IB (TOP1)-DNA covalent complex. Inhibiting TDP1 in conjunction with TOP1 inhibitors can boost the action of the latter. Herein, we report the discovery of the natural product oxynitidine scaffold as a novel chemotype for the development of TOP1 and TDP1 inhibitors. Three kinds of analogues, benzophenanthridinone, dihydrobenzophenanthridine, and benzophenanthridine derivatives, were synthesized and evaluated for both TOP1 and TDP1 inhibition and cytotoxicity. Analogue 19a showed high TOP1 inhibition (+++) and induced the formation of cellular TOP1cc and DNA damage, resulting in cancer cells apoptosis at nanomolar concentration range. In vivo studies indicated that 19a exhibits antitumor efficiency in HCT116 xenograft model. 41a exhibited additional TDP1 inhibition with IC50 value of 7 M and synergistic effect with camptothecin in MCF-7 cells. This work will facilitate future efforts for the discovery of natural product-based TOP1 and TDP1 inhibitors.', 'Title: Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.  Abstract: Tyrosyl-DNA phosphodiesterase 1 (TDP1) is a recently discovered enzyme repairing DNA lesions resulting from stalled topoisomerase IB (TOP1)-DNA covalent complex. Inhibiting TDP1 in conjunction with TOP1 inhibitors can boost the action of the latter. Herein, we report the discovery of the natural product oxynitidine scaffold as a novel chemotype for the development of TOP1 and TDP1 inhibitors. Three kinds of analogues, benzophenanthridinone, dihydrobenzophenanthridine, and benzophenanthridine derivatives, were synthesized and evaluated for both TOP1 and TDP1 inhibition and cytotoxicity. Analogue 19a showed high TOP1 inhibition (+++) and induced the formation of cellular TOP1cc and DNA damage, resulting in cancer cells apoptosis at nanomolar concentration range. In vivo studies indicated that 19a exhibits antitumor efficiency in HCT116 xenograft model. 41a exhibited additional TDP1 inhibition with IC50 value of 7 M and synergistic effect with camptothecin in MCF-7 cells. This work will facilitate future efforts for the discovery of natural product-based TOP1 and TDP1 inhibitors.', 'Title: Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.  Abstract: Tyrosyl-DNA phosphodiesterase 1 (TDP1) is a recently discovered enzyme repairing DNA lesions resulting from stalled topoisomerase IB (TOP1)-DNA covalent complex. Inhibiting TDP1 in conjunction with TOP1 inhibitors can boost the action of the latter. Herein, we report the discovery of the natural product oxynitidine scaffold as a novel chemotype for the development of TOP1 and TDP1 inhibitors. Three kinds of analogues, benzophenanthridinone, dihydrobenzophenanthridine, and benzophenanthridine derivatives, were synthesized and evaluated for both TOP1 and TDP1 inhibition and cytotoxicity. Analogue 19a showed high TOP1 inhibition (+++) and induced the formation of cellular TOP1cc and DNA damage, resulting in cancer cells apoptosis at nanomolar concentration range. In vivo studies indicated that 19a exhibits antitumor efficiency in HCT116 xenograft model. 41a exhibited additional TDP1 inhibition with IC50 value of 7 M and synergistic effect with camptothecin in MCF-7 cells. This work will facilitate future efforts for the discovery of natural product-based TOP1 and TDP1 inhibitors.', 'Title: Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.  Abstract: Tyrosyl-DNA phosphodiesterase 1 (TDP1) is a recently discovered enzyme repairing DNA lesions resulting from stalled topoisomerase IB (TOP1)-DNA covalent complex. Inhibiting TDP1 in conjunction with TOP1 inhibitors can boost the action of the latter. Herein, we report the discovery of the natural product oxynitidine scaffold as a novel chemotype for the development of TOP1 and TDP1 inhibitors. Three kinds of analogues, benzophenanthridinone, dihydrobenzophenanthridine, and benzophenanthridine derivatives, were synthesized and evaluated for both TOP1 and TDP1 inhibition and cytotoxicity. Analogue 19a showed high TOP1 inhibition (+++) and induced the formation of cellular TOP1cc and DNA damage, resulting in cancer cells apoptosis at nanomolar concentration range. In vivo studies indicated that 19a exhibits antitumor efficiency in HCT116 xenograft model. 41a exhibited additional TDP1 inhibition with IC50 value of 7 M and synergistic effect with camptothecin in MCF-7 cells. This work will facilitate future efforts for the discovery of natural product-based TOP1 and TDP1 inhibitors.', 'Title: Design, synthesis, and structure-activity relationships of new benzofuro[3,2-b]pyridin-7-ols as DNA topoisomerase II inhibitors.  Abstract: Human DNA topoisomerases have become attractive targets for developing more effective anticancer drugs. In this study, a series of new benzofuro[3,2-b]pyridin-7-ols were designed and synthesized for the first time and screened for their topoisomerase I and II inhibitory and antiproliferative activity. Structure-activity relationships revealed the position of ortho- and para-hydroxyl group at 2-phenyl ring, and meta-hydroxyl group at 4-phenyl ring of benzofuro[3,2-b]pyridin-7-ol are important for potent and selective topo II inhibitory activity. Compound 11 showed the most selective and potent topo II inhibition (100% inhibition at 100\\u202fM) and strongest antiproliferative activity (IC50\\u202f=\\u202f0.86\\u202fM) than all the positive controls in HeLa cell line.', 'Title: Design, synthesis, and structure-activity relationships of new benzofuro[3,2-b]pyridin-7-ols as DNA topoisomerase II inhibitors.  Abstract: Human DNA topoisomerases have become attractive targets for developing more effective anticancer drugs. In this study, a series of new benzofuro[3,2-b]pyridin-7-ols were designed and synthesized for the first time and screened for their topoisomerase I and II inhibitory and antiproliferative activity. Structure-activity relationships revealed the position of ortho- and para-hydroxyl group at 2-phenyl ring, and meta-hydroxyl group at 4-phenyl ring of benzofuro[3,2-b]pyridin-7-ol are important for potent and selective topo II inhibitory activity. Compound 11 showed the most selective and potent topo II inhibition (100% inhibition at 100\\u202fM) and strongest antiproliferative activity (IC50\\u202f=\\u202f0.86\\u202fM) than all the positive controls in HeLa cell line.', 'Title: Design, synthesis and antiproliferative activity of decarbonyl luotonin analogues.  Abstract: A small library of benzimidazole-fused pyrrolo[3,4-b]quinoline has been synthesized from readily available benzimidazole 2-carbaldehyde and various substituted arylamines in good to excellent yields utilizing an intramolecular Povarov reaction catalyzed by boron trifluoride diethyl etharate as the key final step. The compounds thus synthesized can be considered as decarbonyl analogues of the anticancer alkaloid luotonin A and were evaluated in a DNA relaxation assay for their ability to inhibit human topoisomerase I. Interestingly, two of the compounds showed a remarkable activity that is comparable to that of the standard drug camptothecin. The compounds were also evaluated for their cytotoxic effect in four highly aggressive human cancer cell lines, namely KB, MDA-MB231 (breast), LNCap (prostate), and HT1080 (fibrosarcoma). Some of the compounds obtained showed promising cytotoxicities for these four cell lines.', 'Title: New antitumor anthra[2,3-b]furan-3-carboxamides: Synthesis and structure-activity relationship.  Abstract: Chemical modifications of the anthraquinone scaffold are aimed at optimization of this exceptionally productive class of antitumor drugs. In particular, our previously reported anthra[2,3-b]furan-3-carboxamides demonstrated a high cytotoxic potency in cell culture and in vivo. In this study, we expanded our series of anthra[2,3-b]furan-3-carboxamides by modifying the key functional groups and dissected the structure-activity relationship within this chemotype. The majority of new compounds inhibited the growth of mammalian tumor cell lines at submicromolar to low micromolar concentrations. We found that 4,11-hydroxy groups as well as the carbonyl moiety in the carboxamide fragment were critical for cytotoxicity whereas the substituent at the 2-position of anthra[2,3-b]furan was not. Importantly, the new derivatives were similarly potent against wild type cells and their variants resistant to doxorubicin due to P-glycoprotein (Pgp) expression or p53 inactivation. The most cytotoxic derivatives 6 and 9 attenuated plasmid DNA relaxation by topoisomerase 1. Finally, we demonstrated that 6 and 9\\u202fat 1\\u202fM induced intracellular oxidative stress, accumulation in G2/M phase of the cell cycle, and apoptosis in gastric carcinoma cell lines regardless of their p53 status. These results further substantiate the potential of anthra[2,3-b]furan-3-carboxamides as antitumor drug candidates.', 'Title: New antitumor anthra[2,3-b]furan-3-carboxamides: Synthesis and structure-activity relationship.  Abstract: Chemical modifications of the anthraquinone scaffold are aimed at optimization of this exceptionally productive class of antitumor drugs. In particular, our previously reported anthra[2,3-b]furan-3-carboxamides demonstrated a high cytotoxic potency in cell culture and in vivo. In this study, we expanded our series of anthra[2,3-b]furan-3-carboxamides by modifying the key functional groups and dissected the structure-activity relationship within this chemotype. The majority of new compounds inhibited the growth of mammalian tumor cell lines at submicromolar to low micromolar concentrations. We found that 4,11-hydroxy groups as well as the carbonyl moiety in the carboxamide fragment were critical for cytotoxicity whereas the substituent at the 2-position of anthra[2,3-b]furan was not. Importantly, the new derivatives were similarly potent against wild type cells and their variants resistant to doxorubicin due to P-glycoprotein (Pgp) expression or p53 inactivation. The most cytotoxic derivatives 6 and 9 attenuated plasmid DNA relaxation by topoisomerase 1. Finally, we demonstrated that 6 and 9\\u202fat 1\\u202fM induced intracellular oxidative stress, accumulation in G2/M phase of the cell cycle, and apoptosis in gastric carcinoma cell lines regardless of their p53 status. These results further substantiate the potential of anthra[2,3-b]furan-3-carboxamides as antitumor drug candidates.', 'Title: New antitumor anthra[2,3-b]furan-3-carboxamides: Synthesis and structure-activity relationship.  Abstract: Chemical modifications of the anthraquinone scaffold are aimed at optimization of this exceptionally productive class of antitumor drugs. In particular, our previously reported anthra[2,3-b]furan-3-carboxamides demonstrated a high cytotoxic potency in cell culture and in vivo. In this study, we expanded our series of anthra[2,3-b]furan-3-carboxamides by modifying the key functional groups and dissected the structure-activity relationship within this chemotype. The majority of new compounds inhibited the growth of mammalian tumor cell lines at submicromolar to low micromolar concentrations. We found that 4,11-hydroxy groups as well as the carbonyl moiety in the carboxamide fragment were critical for cytotoxicity whereas the substituent at the 2-position of anthra[2,3-b]furan was not. Importantly, the new derivatives were similarly potent against wild type cells and their variants resistant to doxorubicin due to P-glycoprotein (Pgp) expression or p53 inactivation. The most cytotoxic derivatives 6 and 9 attenuated plasmid DNA relaxation by topoisomerase 1. Finally, we demonstrated that 6 and 9\\u202fat 1\\u202fM induced intracellular oxidative stress, accumulation in G2/M phase of the cell cycle, and apoptosis in gastric carcinoma cell lines regardless of their p53 status. These results further substantiate the potential of anthra[2,3-b]furan-3-carboxamides as antitumor drug candidates.', 'Title: Structure-based discovery of cytotoxic dimeric tetrahydroxanthones as potential topoisomerase I inhibitors from a marine-derived fungus.  Abstract: DNA topoisomerase I (Topo I) is an important anticancer drug target, and xanthone dimers are considered to be a new kind of Topo I inhibitor chemotypes. Based on the characteristics of dimeric xanthone structures, five new dimeric xanthones (1-5) and two known SAD isomers (6 and 7) were isolated from the mangrove-derived fungus Aspergillus vericolor. The absolute configurations of compounds 1-7, entailing both central and axial chirality elements, were established by a combination of ECD comparison, chemical conversions, and biogenetic considerations. Compounds 1-7 possessed high structural diversity and exhibited cytotoxicity at different levels. The selected new compounds 1, 2, and 5 showed Topo I inhibition properties and the most potent compound 1, an atropisomer of compound 2, was confirmed to inhibit Topo I-mediated DNA relaxation by targeting Topo I, thereby, arresting the cell cycle process and inducing necrosis in cancer cells. Molecular docking studies showed that compound 1 could bind DNA by - interaction and DNA Topo I by hydrogen bonds to form a ternary complex.', 'Title: Structure-based discovery of cytotoxic dimeric tetrahydroxanthones as potential topoisomerase I inhibitors from a marine-derived fungus.  Abstract: DNA topoisomerase I (Topo I) is an important anticancer drug target, and xanthone dimers are considered to be a new kind of Topo I inhibitor chemotypes. Based on the characteristics of dimeric xanthone structures, five new dimeric xanthones (1-5) and two known SAD isomers (6 and 7) were isolated from the mangrove-derived fungus Aspergillus vericolor. The absolute configurations of compounds 1-7, entailing both central and axial chirality elements, were established by a combination of ECD comparison, chemical conversions, and biogenetic considerations. Compounds 1-7 possessed high structural diversity and exhibited cytotoxicity at different levels. The selected new compounds 1, 2, and 5 showed Topo I inhibition properties and the most potent compound 1, an atropisomer of compound 2, was confirmed to inhibit Topo I-mediated DNA relaxation by targeting Topo I, thereby, arresting the cell cycle process and inducing necrosis in cancer cells. Molecular docking studies showed that compound 1 could bind DNA by - interaction and DNA Topo I by hydrogen bonds to form a ternary complex.', 'Title: Structure-based discovery of cytotoxic dimeric tetrahydroxanthones as potential topoisomerase I inhibitors from a marine-derived fungus.  Abstract: DNA topoisomerase I (Topo I) is an important anticancer drug target, and xanthone dimers are considered to be a new kind of Topo I inhibitor chemotypes. Based on the characteristics of dimeric xanthone structures, five new dimeric xanthones (1-5) and two known SAD isomers (6 and 7) were isolated from the mangrove-derived fungus Aspergillus vericolor. The absolute configurations of compounds 1-7, entailing both central and axial chirality elements, were established by a combination of ECD comparison, chemical conversions, and biogenetic considerations. Compounds 1-7 possessed high structural diversity and exhibited cytotoxicity at different levels. The selected new compounds 1, 2, and 5 showed Topo I inhibition properties and the most potent compound 1, an atropisomer of compound 2, was confirmed to inhibit Topo I-mediated DNA relaxation by targeting Topo I, thereby, arresting the cell cycle process and inducing necrosis in cancer cells. Molecular docking studies showed that compound 1 could bind DNA by - interaction and DNA Topo I by hydrogen bonds to form a ternary complex.', 'Title: Structure-based discovery of cytotoxic dimeric tetrahydroxanthones as potential topoisomerase I inhibitors from a marine-derived fungus.  Abstract: DNA topoisomerase I (Topo I) is an important anticancer drug target, and xanthone dimers are considered to be a new kind of Topo I inhibitor chemotypes. Based on the characteristics of dimeric xanthone structures, five new dimeric xanthones (1-5) and two known SAD isomers (6 and 7) were isolated from the mangrove-derived fungus Aspergillus vericolor. The absolute configurations of compounds 1-7, entailing both central and axial chirality elements, were established by a combination of ECD comparison, chemical conversions, and biogenetic considerations. Compounds 1-7 possessed high structural diversity and exhibited cytotoxicity at different levels. The selected new compounds 1, 2, and 5 showed Topo I inhibition properties and the most potent compound 1, an atropisomer of compound 2, was confirmed to inhibit Topo I-mediated DNA relaxation by targeting Topo I, thereby, arresting the cell cycle process and inducing necrosis in cancer cells. Molecular docking studies showed that compound 1 could bind DNA by - interaction and DNA Topo I by hydrogen bonds to form a ternary complex.', 'Title: Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity.  Abstract: This work describes the synthesis of 1,2,3,4-tetrahydroquinolinylphosphine oxides, phosphanes and phosphine sulfides as well as that of quinolinylphosphine oxides and phosphine sulfides, which were synthesized in good to high overall yield. The synthetic route involves a multicomponent reaction of (2-phosphine-oxide)-, 2-phosphine- or (2-phosphine-sulfide)-aniline, aldehydes and olefins and allows the selective generation of two stereogenic centres in a short, efficient and reliable synthesis. The selective dehydrogenation of 1,2,3,4-tetrahydroquinolinylphosphine oxides and phosphine sulfides leads to the formation of corresponding phosphorus substituted quinolines. Some of the products which were prepared showed excellent activity as topoisomerase I (Top1) inhibitors. In addition, prolonged effect of the most potent compounds is maintained with the same intensity even after 3\\u202fmin of the beginning of the enzymatic reaction. The cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV03) and human embryonic kidney (HEK293) was also screened. 1,2,3,4-Tetrahydroquinolinylphosphine oxide 6g with an IC50 value of 0.25\\u202f\\u202f0.03\\u202fM showed excellent activity against the A549\\u202fcell line in vitro, while 1,2,3,4-tetrahydroquinolinylphosphane 9c with an IC50 value of 0.08\\u202f\\u202f0.01\\u202fM and 1,2,3,4-tetrahydroquinolinylphosphine sulfide derivative 10f with an IC50 value of 0.03\\u202f\\u202f0.04\\u202fM are more active against the A549\\u202fcell line. Moreover, selectivity towards cancer cell (A549) over non-malignant cells (MRC5) has been observed. According to their structure, they may be excellent antiproliferative candidates.', 'Title: Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity.  Abstract: This work describes the synthesis of 1,2,3,4-tetrahydroquinolinylphosphine oxides, phosphanes and phosphine sulfides as well as that of quinolinylphosphine oxides and phosphine sulfides, which were synthesized in good to high overall yield. The synthetic route involves a multicomponent reaction of (2-phosphine-oxide)-, 2-phosphine- or (2-phosphine-sulfide)-aniline, aldehydes and olefins and allows the selective generation of two stereogenic centres in a short, efficient and reliable synthesis. The selective dehydrogenation of 1,2,3,4-tetrahydroquinolinylphosphine oxides and phosphine sulfides leads to the formation of corresponding phosphorus substituted quinolines. Some of the products which were prepared showed excellent activity as topoisomerase I (Top1) inhibitors. In addition, prolonged effect of the most potent compounds is maintained with the same intensity even after 3\\u202fmin of the beginning of the enzymatic reaction. The cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV03) and human embryonic kidney (HEK293) was also screened. 1,2,3,4-Tetrahydroquinolinylphosphine oxide 6g with an IC50 value of 0.25\\u202f\\u202f0.03\\u202fM showed excellent activity against the A549\\u202fcell line in vitro, while 1,2,3,4-tetrahydroquinolinylphosphane 9c with an IC50 value of 0.08\\u202f\\u202f0.01\\u202fM and 1,2,3,4-tetrahydroquinolinylphosphine sulfide derivative 10f with an IC50 value of 0.03\\u202f\\u202f0.04\\u202fM are more active against the A549\\u202fcell line. Moreover, selectivity towards cancer cell (A549) over non-malignant cells (MRC5) has been observed. According to their structure, they may be excellent antiproliferative candidates.', 'Title: Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity.  Abstract: This work describes the synthesis of 1,2,3,4-tetrahydroquinolinylphosphine oxides, phosphanes and phosphine sulfides as well as that of quinolinylphosphine oxides and phosphine sulfides, which were synthesized in good to high overall yield. The synthetic route involves a multicomponent reaction of (2-phosphine-oxide)-, 2-phosphine- or (2-phosphine-sulfide)-aniline, aldehydes and olefins and allows the selective generation of two stereogenic centres in a short, efficient and reliable synthesis. The selective dehydrogenation of 1,2,3,4-tetrahydroquinolinylphosphine oxides and phosphine sulfides leads to the formation of corresponding phosphorus substituted quinolines. Some of the products which were prepared showed excellent activity as topoisomerase I (Top1) inhibitors. In addition, prolonged effect of the most potent compounds is maintained with the same intensity even after 3\\u202fmin of the beginning of the enzymatic reaction. The cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV03) and human embryonic kidney (HEK293) was also screened. 1,2,3,4-Tetrahydroquinolinylphosphine oxide 6g with an IC50 value of 0.25\\u202f\\u202f0.03\\u202fM showed excellent activity against the A549\\u202fcell line in vitro, while 1,2,3,4-tetrahydroquinolinylphosphane 9c with an IC50 value of 0.08\\u202f\\u202f0.01\\u202fM and 1,2,3,4-tetrahydroquinolinylphosphine sulfide derivative 10f with an IC50 value of 0.03\\u202f\\u202f0.04\\u202fM are more active against the A549\\u202fcell line. Moreover, selectivity towards cancer cell (A549) over non-malignant cells (MRC5) has been observed. According to their structure, they may be excellent antiproliferative candidates.', 'Title: Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity.  Abstract: This work describes the synthesis of 1,2,3,4-tetrahydroquinolinylphosphine oxides, phosphanes and phosphine sulfides as well as that of quinolinylphosphine oxides and phosphine sulfides, which were synthesized in good to high overall yield. The synthetic route involves a multicomponent reaction of (2-phosphine-oxide)-, 2-phosphine- or (2-phosphine-sulfide)-aniline, aldehydes and olefins and allows the selective generation of two stereogenic centres in a short, efficient and reliable synthesis. The selective dehydrogenation of 1,2,3,4-tetrahydroquinolinylphosphine oxides and phosphine sulfides leads to the formation of corresponding phosphorus substituted quinolines. Some of the products which were prepared showed excellent activity as topoisomerase I (Top1) inhibitors. In addition, prolonged effect of the most potent compounds is maintained with the same intensity even after 3\\u202fmin of the beginning of the enzymatic reaction. The cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV03) and human embryonic kidney (HEK293) was also screened. 1,2,3,4-Tetrahydroquinolinylphosphine oxide 6g with an IC50 value of 0.25\\u202f\\u202f0.03\\u202fM showed excellent activity against the A549\\u202fcell line in vitro, while 1,2,3,4-tetrahydroquinolinylphosphane 9c with an IC50 value of 0.08\\u202f\\u202f0.01\\u202fM and 1,2,3,4-tetrahydroquinolinylphosphine sulfide derivative 10f with an IC50 value of 0.03\\u202f\\u202f0.04\\u202fM are more active against the A549\\u202fcell line. Moreover, selectivity towards cancer cell (A549) over non-malignant cells (MRC5) has been observed. According to their structure, they may be excellent antiproliferative candidates.', 'Title: Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity.  Abstract: This work describes the synthesis of 1,2,3,4-tetrahydroquinolinylphosphine oxides, phosphanes and phosphine sulfides as well as that of quinolinylphosphine oxides and phosphine sulfides, which were synthesized in good to high overall yield. The synthetic route involves a multicomponent reaction of (2-phosphine-oxide)-, 2-phosphine- or (2-phosphine-sulfide)-aniline, aldehydes and olefins and allows the selective generation of two stereogenic centres in a short, efficient and reliable synthesis. The selective dehydrogenation of 1,2,3,4-tetrahydroquinolinylphosphine oxides and phosphine sulfides leads to the formation of corresponding phosphorus substituted quinolines. Some of the products which were prepared showed excellent activity as topoisomerase I (Top1) inhibitors. In addition, prolonged effect of the most potent compounds is maintained with the same intensity even after 3\\u202fmin of the beginning of the enzymatic reaction. The cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV03) and human embryonic kidney (HEK293) was also screened. 1,2,3,4-Tetrahydroquinolinylphosphine oxide 6g with an IC50 value of 0.25\\u202f\\u202f0.03\\u202fM showed excellent activity against the A549\\u202fcell line in vitro, while 1,2,3,4-tetrahydroquinolinylphosphane 9c with an IC50 value of 0.08\\u202f\\u202f0.01\\u202fM and 1,2,3,4-tetrahydroquinolinylphosphine sulfide derivative 10f with an IC50 value of 0.03\\u202f\\u202f0.04\\u202fM are more active against the A549\\u202fcell line. Moreover, selectivity towards cancer cell (A549) over non-malignant cells (MRC5) has been observed. According to their structure, they may be excellent antiproliferative candidates.', 'Title: Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity.  Abstract: This work describes the synthesis of 1,2,3,4-tetrahydroquinolinylphosphine oxides, phosphanes and phosphine sulfides as well as that of quinolinylphosphine oxides and phosphine sulfides, which were synthesized in good to high overall yield. The synthetic route involves a multicomponent reaction of (2-phosphine-oxide)-, 2-phosphine- or (2-phosphine-sulfide)-aniline, aldehydes and olefins and allows the selective generation of two stereogenic centres in a short, efficient and reliable synthesis. The selective dehydrogenation of 1,2,3,4-tetrahydroquinolinylphosphine oxides and phosphine sulfides leads to the formation of corresponding phosphorus substituted quinolines. Some of the products which were prepared showed excellent activity as topoisomerase I (Top1) inhibitors. In addition, prolonged effect of the most potent compounds is maintained with the same intensity even after 3\\u202fmin of the beginning of the enzymatic reaction. The cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV03) and human embryonic kidney (HEK293) was also screened. 1,2,3,4-Tetrahydroquinolinylphosphine oxide 6g with an IC50 value of 0.25\\u202f\\u202f0.03\\u202fM showed excellent activity against the A549\\u202fcell line in vitro, while 1,2,3,4-tetrahydroquinolinylphosphane 9c with an IC50 value of 0.08\\u202f\\u202f0.01\\u202fM and 1,2,3,4-tetrahydroquinolinylphosphine sulfide derivative 10f with an IC50 value of 0.03\\u202f\\u202f0.04\\u202fM are more active against the A549\\u202fcell line. Moreover, selectivity towards cancer cell (A549) over non-malignant cells (MRC5) has been observed. According to their structure, they may be excellent antiproliferative candidates.', 'Title: Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity.  Abstract: This work describes the synthesis of 1,2,3,4-tetrahydroquinolinylphosphine oxides, phosphanes and phosphine sulfides as well as that of quinolinylphosphine oxides and phosphine sulfides, which were synthesized in good to high overall yield. The synthetic route involves a multicomponent reaction of (2-phosphine-oxide)-, 2-phosphine- or (2-phosphine-sulfide)-aniline, aldehydes and olefins and allows the selective generation of two stereogenic centres in a short, efficient and reliable synthesis. The selective dehydrogenation of 1,2,3,4-tetrahydroquinolinylphosphine oxides and phosphine sulfides leads to the formation of corresponding phosphorus substituted quinolines. Some of the products which were prepared showed excellent activity as topoisomerase I (Top1) inhibitors. In addition, prolonged effect of the most potent compounds is maintained with the same intensity even after 3\\u202fmin of the beginning of the enzymatic reaction. The cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV03) and human embryonic kidney (HEK293) was also screened. 1,2,3,4-Tetrahydroquinolinylphosphine oxide 6g with an IC50 value of 0.25\\u202f\\u202f0.03\\u202fM showed excellent activity against the A549\\u202fcell line in vitro, while 1,2,3,4-tetrahydroquinolinylphosphane 9c with an IC50 value of 0.08\\u202f\\u202f0.01\\u202fM and 1,2,3,4-tetrahydroquinolinylphosphine sulfide derivative 10f with an IC50 value of 0.03\\u202f\\u202f0.04\\u202fM are more active against the A549\\u202fcell line. Moreover, selectivity towards cancer cell (A549) over non-malignant cells (MRC5) has been observed. According to their structure, they may be excellent antiproliferative candidates.', 'Title: Structure-Based Drug Design and Identification of H2O-Soluble and Low Toxic Hexacyclic Camptothecin Derivatives with Improved Efficacy in Cancer and Lethal Inflammation Models in Vivo.  Abstract: Camptothecin (CPT) has been shown to block disassembly of the topoisomerase I (Topo I)/DNA cleavable complex. However, the poor aqueous solubility, intrinsic instability, and severe toxicity of CPTs have limited their clinical applications. Herein, we report the design and synthesis of H2O-soluble and orally bioavailable hexacyclic CPT derivatives. By analysis of a virtual chemical library and cytotoxicity screening in vitro, 9 and 11 were identified as potential prodrugs and chosen for further characterization in vivo. Both compounds exhibited remarkable anticancer and anti-inflammation efficacies in animals and improved drug-like profiles.', 'Title: Structure-Based Drug Design and Identification of H2O-Soluble and Low Toxic Hexacyclic Camptothecin Derivatives with Improved Efficacy in Cancer and Lethal Inflammation Models in Vivo.  Abstract: Camptothecin (CPT) has been shown to block disassembly of the topoisomerase I (Topo I)/DNA cleavable complex. However, the poor aqueous solubility, intrinsic instability, and severe toxicity of CPTs have limited their clinical applications. Herein, we report the design and synthesis of H2O-soluble and orally bioavailable hexacyclic CPT derivatives. By analysis of a virtual chemical library and cytotoxicity screening in vitro, 9 and 11 were identified as potential prodrugs and chosen for further characterization in vivo. Both compounds exhibited remarkable anticancer and anti-inflammation efficacies in animals and improved drug-like profiles.', 'Title: Structure-Based Drug Design and Identification of H2O-Soluble and Low Toxic Hexacyclic Camptothecin Derivatives with Improved Efficacy in Cancer and Lethal Inflammation Models in Vivo.  Abstract: Camptothecin (CPT) has been shown to block disassembly of the topoisomerase I (Topo I)/DNA cleavable complex. However, the poor aqueous solubility, intrinsic instability, and severe toxicity of CPTs have limited their clinical applications. Herein, we report the design and synthesis of H2O-soluble and orally bioavailable hexacyclic CPT derivatives. By analysis of a virtual chemical library and cytotoxicity screening in vitro, 9 and 11 were identified as potential prodrugs and chosen for further characterization in vivo. Both compounds exhibited remarkable anticancer and anti-inflammation efficacies in animals and improved drug-like profiles.', 'Title: Structure-Based Drug Design and Identification of H2O-Soluble and Low Toxic Hexacyclic Camptothecin Derivatives with Improved Efficacy in Cancer and Lethal Inflammation Models in Vivo.  Abstract: Camptothecin (CPT) has been shown to block disassembly of the topoisomerase I (Topo I)/DNA cleavable complex. However, the poor aqueous solubility, intrinsic instability, and severe toxicity of CPTs have limited their clinical applications. Herein, we report the design and synthesis of H2O-soluble and orally bioavailable hexacyclic CPT derivatives. By analysis of a virtual chemical library and cytotoxicity screening in vitro, 9 and 11 were identified as potential prodrugs and chosen for further characterization in vivo. Both compounds exhibited remarkable anticancer and anti-inflammation efficacies in animals and improved drug-like profiles.', \"Title: Synthesis and SAR study of new hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines as selective topoisomerase II-targeting anticancer agents.  Abstract: As part of our effort to develop potential topoisomerase II (topo II) targeting anticancer agents, we systematically designed a new series of hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines. Total eighteen compounds were synthesized and tested for their ability to inhibit the function of topo I and II, and proliferation of human breast (T47D), colorectal (HCT15), and cervix (HeLa) cancer cells. Except compound 11, all of the tested compounds displayed selective topo II inhibitory activity. Compounds 8-18, 22, 24, and 25 showed excellent topo II inhibitory activity than a positive control, etoposide. Most of the compounds appeared to be superior to reference compounds in their antiproliferative activity. Structure-activity relationship (SAR) study has shown that it is better to place the hydroxyphenyl group at the 4-position of the central pyridine for superior topo II inhibition and antiproliferative activity. Similarly, the 3'-, or 4'-hydroxyphenyl substitution at the 2- and 4-positon of pyridine ring is important for better activity than 2'-substitution.\", \"Title: Synthesis and SAR study of new hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines as selective topoisomerase II-targeting anticancer agents.  Abstract: As part of our effort to develop potential topoisomerase II (topo II) targeting anticancer agents, we systematically designed a new series of hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines. Total eighteen compounds were synthesized and tested for their ability to inhibit the function of topo I and II, and proliferation of human breast (T47D), colorectal (HCT15), and cervix (HeLa) cancer cells. Except compound 11, all of the tested compounds displayed selective topo II inhibitory activity. Compounds 8-18, 22, 24, and 25 showed excellent topo II inhibitory activity than a positive control, etoposide. Most of the compounds appeared to be superior to reference compounds in their antiproliferative activity. Structure-activity relationship (SAR) study has shown that it is better to place the hydroxyphenyl group at the 4-position of the central pyridine for superior topo II inhibition and antiproliferative activity. Similarly, the 3'-, or 4'-hydroxyphenyl substitution at the 2- and 4-positon of pyridine ring is important for better activity than 2'-substitution.\", \"Title: Synthesis and SAR study of new hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines as selective topoisomerase II-targeting anticancer agents.  Abstract: As part of our effort to develop potential topoisomerase II (topo II) targeting anticancer agents, we systematically designed a new series of hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines. Total eighteen compounds were synthesized and tested for their ability to inhibit the function of topo I and II, and proliferation of human breast (T47D), colorectal (HCT15), and cervix (HeLa) cancer cells. Except compound 11, all of the tested compounds displayed selective topo II inhibitory activity. Compounds 8-18, 22, 24, and 25 showed excellent topo II inhibitory activity than a positive control, etoposide. Most of the compounds appeared to be superior to reference compounds in their antiproliferative activity. Structure-activity relationship (SAR) study has shown that it is better to place the hydroxyphenyl group at the 4-position of the central pyridine for superior topo II inhibition and antiproliferative activity. Similarly, the 3'-, or 4'-hydroxyphenyl substitution at the 2- and 4-positon of pyridine ring is important for better activity than 2'-substitution.\", \"Title: Synthesis and SAR study of new hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines as selective topoisomerase II-targeting anticancer agents.  Abstract: As part of our effort to develop potential topoisomerase II (topo II) targeting anticancer agents, we systematically designed a new series of hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines. Total eighteen compounds were synthesized and tested for their ability to inhibit the function of topo I and II, and proliferation of human breast (T47D), colorectal (HCT15), and cervix (HeLa) cancer cells. Except compound 11, all of the tested compounds displayed selective topo II inhibitory activity. Compounds 8-18, 22, 24, and 25 showed excellent topo II inhibitory activity than a positive control, etoposide. Most of the compounds appeared to be superior to reference compounds in their antiproliferative activity. Structure-activity relationship (SAR) study has shown that it is better to place the hydroxyphenyl group at the 4-position of the central pyridine for superior topo II inhibition and antiproliferative activity. Similarly, the 3'-, or 4'-hydroxyphenyl substitution at the 2- and 4-positon of pyridine ring is important for better activity than 2'-substitution.\", 'Title: Synthesis, antitumor activity and DNA binding features of benzothiazolyl and benzimidazolyl substituted isoindolines.  Abstract: In this paper novel isoindolines substituted with cyano and amidino benzimidazoles and benzothiazoles were synthesized as new potential anti-cancer agents. The new structures were evaluated for antiproliferative activity, cell cycle changes, cell death, as well as DNA binding and topoisomerase inhibition properties on selected compounds. Results showed that all tested compounds exerted antitumor activity, especially amidinobenzothiazole and amidinobenzimidazole substituted isoindolin-1-ones and benzimidazole substituted 1-iminoisoindoline that showed antiproliferative effect in the submicromolar range. Moreover, the DNA-binding properties of selected compounds were evaluated by biophysical and biochemical approaches including thermal denaturation studies, circular dichroism spectra analyses and topoisomerase I/II inhibition assays and results identified some of them as strong DNA ligands, harboring or not additional topoisomerase II inhibition and able to locate in the nucleus as determined by fluorescence microscopy. In conclusion, we evidenced novel cyano- and amidino-substituted isoindolines coupled with benzimidazoles and benzothiazoles as topoisomerase inhibitors and/or DNA binding compounds with potent antitumor activities.', 'Title: Synthesis, antitumor activity and DNA binding features of benzothiazolyl and benzimidazolyl substituted isoindolines.  Abstract: In this paper novel isoindolines substituted with cyano and amidino benzimidazoles and benzothiazoles were synthesized as new potential anti-cancer agents. The new structures were evaluated for antiproliferative activity, cell cycle changes, cell death, as well as DNA binding and topoisomerase inhibition properties on selected compounds. Results showed that all tested compounds exerted antitumor activity, especially amidinobenzothiazole and amidinobenzimidazole substituted isoindolin-1-ones and benzimidazole substituted 1-iminoisoindoline that showed antiproliferative effect in the submicromolar range. Moreover, the DNA-binding properties of selected compounds were evaluated by biophysical and biochemical approaches including thermal denaturation studies, circular dichroism spectra analyses and topoisomerase I/II inhibition assays and results identified some of them as strong DNA ligands, harboring or not additional topoisomerase II inhibition and able to locate in the nucleus as determined by fluorescence microscopy. In conclusion, we evidenced novel cyano- and amidino-substituted isoindolines coupled with benzimidazoles and benzothiazoles as topoisomerase inhibitors and/or DNA binding compounds with potent antitumor activities.', 'Title: Synthesis, antitumor activity and DNA binding features of benzothiazolyl and benzimidazolyl substituted isoindolines.  Abstract: In this paper novel isoindolines substituted with cyano and amidino benzimidazoles and benzothiazoles were synthesized as new potential anti-cancer agents. The new structures were evaluated for antiproliferative activity, cell cycle changes, cell death, as well as DNA binding and topoisomerase inhibition properties on selected compounds. Results showed that all tested compounds exerted antitumor activity, especially amidinobenzothiazole and amidinobenzimidazole substituted isoindolin-1-ones and benzimidazole substituted 1-iminoisoindoline that showed antiproliferative effect in the submicromolar range. Moreover, the DNA-binding properties of selected compounds were evaluated by biophysical and biochemical approaches including thermal denaturation studies, circular dichroism spectra analyses and topoisomerase I/II inhibition assays and results identified some of them as strong DNA ligands, harboring or not additional topoisomerase II inhibition and able to locate in the nucleus as determined by fluorescence microscopy. In conclusion, we evidenced novel cyano- and amidino-substituted isoindolines coupled with benzimidazoles and benzothiazoles as topoisomerase inhibitors and/or DNA binding compounds with potent antitumor activities.', 'Title: Synthesis, antitumor activity and DNA binding features of benzothiazolyl and benzimidazolyl substituted isoindolines.  Abstract: In this paper novel isoindolines substituted with cyano and amidino benzimidazoles and benzothiazoles were synthesized as new potential anti-cancer agents. The new structures were evaluated for antiproliferative activity, cell cycle changes, cell death, as well as DNA binding and topoisomerase inhibition properties on selected compounds. Results showed that all tested compounds exerted antitumor activity, especially amidinobenzothiazole and amidinobenzimidazole substituted isoindolin-1-ones and benzimidazole substituted 1-iminoisoindoline that showed antiproliferative effect in the submicromolar range. Moreover, the DNA-binding properties of selected compounds were evaluated by biophysical and biochemical approaches including thermal denaturation studies, circular dichroism spectra analyses and topoisomerase I/II inhibition assays and results identified some of them as strong DNA ligands, harboring or not additional topoisomerase II inhibition and able to locate in the nucleus as determined by fluorescence microscopy. In conclusion, we evidenced novel cyano- and amidino-substituted isoindolines coupled with benzimidazoles and benzothiazoles as topoisomerase inhibitors and/or DNA binding compounds with potent antitumor activities.', 'Title: Synthesis, antitumor activity and DNA binding features of benzothiazolyl and benzimidazolyl substituted isoindolines.  Abstract: In this paper novel isoindolines substituted with cyano and amidino benzimidazoles and benzothiazoles were synthesized as new potential anti-cancer agents. The new structures were evaluated for antiproliferative activity, cell cycle changes, cell death, as well as DNA binding and topoisomerase inhibition properties on selected compounds. Results showed that all tested compounds exerted antitumor activity, especially amidinobenzothiazole and amidinobenzimidazole substituted isoindolin-1-ones and benzimidazole substituted 1-iminoisoindoline that showed antiproliferative effect in the submicromolar range. Moreover, the DNA-binding properties of selected compounds were evaluated by biophysical and biochemical approaches including thermal denaturation studies, circular dichroism spectra analyses and topoisomerase I/II inhibition assays and results identified some of them as strong DNA ligands, harboring or not additional topoisomerase II inhibition and able to locate in the nucleus as determined by fluorescence microscopy. In conclusion, we evidenced novel cyano- and amidino-substituted isoindolines coupled with benzimidazoles and benzothiazoles as topoisomerase inhibitors and/or DNA binding compounds with potent antitumor activities.', 'Title: Design, synthesis and anticancer evaluation of acridine hydroxamic acid derivatives as dual Topo and HDAC inhibitors.  Abstract: Multitarget inhibitors design has generated great interest in cancer treatment. Based on the synergistic effects of topoisomerase and histone deacetylase inhibitors, we designed and synthesized a new series of acridine hydroxamic acid derivatives as potential novel dual Topo and HDAC inhibitors. MTT assays indicated that all the hybrid compounds displayed good antiproliferative activities with IC50 values in low micromolar range, among which compound 8c displayed potent activity against U937 (IC50\\u202f=\\u202f0.90\\u202fM). In addition, compound 8c also displayed the best HDAC inhibitory activity, which was several times more potent than HDAC inhibitor SAHA. Subsequent studies indicated that all the compounds displayed Topo II inhibition activity at 50\\u202fM. Moreover, compound 8c could interact with DNA and induce U937 apoptosis. This study provides a suite of compounds for further exploration of dual Topo and HDAC inhibitors, and compound 8c can be a new dual Topo and HDAC inhibitory anticancer agent.', 'Title: Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/II inhibitors.  Abstract: A novel series of 35 angularly fused pentacyclic 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridin-5-ium chlorides were designed and synthesized. Their cytotoxic activities were investigated against six human cancer cell lines (NCIH23, HCT15, NUGC-3, ACHN, PC-3, and MDA-MB-231). Among all screened compounds; 28, 30, 34, 35, 46, 48, 52, and 53 compounds exhibited potent cytotoxic activities against all tested human cancer cell lines. Further, these potent lead cytotoxic agents were evaluated against human Topoisomerase I and II inhibition. Among them, the compound 48 exhibited dual Topoisomerase I and II inhibition especially at 20\\u202fM concentrations the compound 48 exhibited 1.25\\u202ftimes more potent Topoisomerase II inhibitory activity (38.3%) than the reference drug etoposide (30.6%). The compound 52 also exhibited excellent (88.4%) topoisomerase I inhibition than the reference drug camptothecin (66.7%) at 100\\u202fM concentrations. Molecular docking studies of the compounds 48 and 52 with topo I discovered that they both intercalated into the DNA single-strand cleavage site where the compound 48 have van der Waals interactions with residues Arg364, Pro431, and Asn722 whilst the compound 52 have with Arg364, Thr718, and Asn722 residues. Both the compounds 48 and 52 have - stacking interactions with the stacked DNA bases. The docking studies of the compound 48 with topo II explored that it was bound to the topo II DNA cleavage site where etoposide was situated. The benzo[f]chromeno[4,3-b][1,7]naphthyridine ring of the compound 48 was stacked between the DNA bases of the cleavage site with - stacking interactions and there were no hydrogen bond interactions with topo II.', 'Title: Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/II inhibitors.  Abstract: A novel series of 35 angularly fused pentacyclic 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridin-5-ium chlorides were designed and synthesized. Their cytotoxic activities were investigated against six human cancer cell lines (NCIH23, HCT15, NUGC-3, ACHN, PC-3, and MDA-MB-231). Among all screened compounds; 28, 30, 34, 35, 46, 48, 52, and 53 compounds exhibited potent cytotoxic activities against all tested human cancer cell lines. Further, these potent lead cytotoxic agents were evaluated against human Topoisomerase I and II inhibition. Among them, the compound 48 exhibited dual Topoisomerase I and II inhibition especially at 20\\u202fM concentrations the compound 48 exhibited 1.25\\u202ftimes more potent Topoisomerase II inhibitory activity (38.3%) than the reference drug etoposide (30.6%). The compound 52 also exhibited excellent (88.4%) topoisomerase I inhibition than the reference drug camptothecin (66.7%) at 100\\u202fM concentrations. Molecular docking studies of the compounds 48 and 52 with topo I discovered that they both intercalated into the DNA single-strand cleavage site where the compound 48 have van der Waals interactions with residues Arg364, Pro431, and Asn722 whilst the compound 52 have with Arg364, Thr718, and Asn722 residues. Both the compounds 48 and 52 have - stacking interactions with the stacked DNA bases. The docking studies of the compound 48 with topo II explored that it was bound to the topo II DNA cleavage site where etoposide was situated. The benzo[f]chromeno[4,3-b][1,7]naphthyridine ring of the compound 48 was stacked between the DNA bases of the cleavage site with - stacking interactions and there were no hydrogen bond interactions with topo II.', 'Title: Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/II inhibitors.  Abstract: A novel series of 35 angularly fused pentacyclic 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridin-5-ium chlorides were designed and synthesized. Their cytotoxic activities were investigated against six human cancer cell lines (NCIH23, HCT15, NUGC-3, ACHN, PC-3, and MDA-MB-231). Among all screened compounds; 28, 30, 34, 35, 46, 48, 52, and 53 compounds exhibited potent cytotoxic activities against all tested human cancer cell lines. Further, these potent lead cytotoxic agents were evaluated against human Topoisomerase I and II inhibition. Among them, the compound 48 exhibited dual Topoisomerase I and II inhibition especially at 20\\u202fM concentrations the compound 48 exhibited 1.25\\u202ftimes more potent Topoisomerase II inhibitory activity (38.3%) than the reference drug etoposide (30.6%). The compound 52 also exhibited excellent (88.4%) topoisomerase I inhibition than the reference drug camptothecin (66.7%) at 100\\u202fM concentrations. Molecular docking studies of the compounds 48 and 52 with topo I discovered that they both intercalated into the DNA single-strand cleavage site where the compound 48 have van der Waals interactions with residues Arg364, Pro431, and Asn722 whilst the compound 52 have with Arg364, Thr718, and Asn722 residues. Both the compounds 48 and 52 have - stacking interactions with the stacked DNA bases. The docking studies of the compound 48 with topo II explored that it was bound to the topo II DNA cleavage site where etoposide was situated. The benzo[f]chromeno[4,3-b][1,7]naphthyridine ring of the compound 48 was stacked between the DNA bases of the cleavage site with - stacking interactions and there were no hydrogen bond interactions with topo II.', 'Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.', 'Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.', 'Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.', 'Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.', 'Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.', 'Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.', 'Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.', 'Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.', 'Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.', 'Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.', 'Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.', 'Title: Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.  Abstract: With a goal of identifying potent topoisomerase (topo) inhibitor, the C4-aromatic ring of the anticancer agent, 3,4-diarylisoquinolone, was strategically shifted to design 1,3-diarylisoquinoline. Twenty-two target compounds were synthesized in three simple and efficient steps. The 1,3-diarylisoquinolines exhibited potent anti-proliferative effects on cancer cells but few compounds spared non-cancerous cells. Inhibition of topo I/II-mediated DNA relaxation by several derivatives was greater than that by camptothecin (CPT)/etoposide even at low concentration (20 M). In addition, these compounds had little or no effect on polymerization of tubulin. A series of biological evaluations performed with the most potent derivative 4cc revealed that the compound is a non-intercalative topo I catalytic inhibitor interacting with free topo I. Collectively, the potent cytotoxic effect on cancer cells including the drug resistance ones, absence of lethal effect on normal cells, and different mechanism of action than topo I poisons suggest that the 1,3-diarylisoquinolines might be a promising class of anticancer agents worthy of further pursuit.', 'Title: Design, synthesis, biological evaluation and structure-activity relationship of sophoridine derivatives bearing pyrrole or indole scaffold as potential antitumor agents.  Abstract: Taking sophoridine as a lead compound, 58 sophoridine derivatives were designed, synthesized and evaluated for their antiproliferative activity in the HepG2 cancer cell line. Among the 58 compounds, 33 compounds showed potent antiproliferative activity with IC50 less than 10\\u202fM. Compound 5w showed the most potent anti-proliferative activity in the HepG2 cancer cell line. Thus, we further extended our characterization of the antiproliferative activity of 5w in six cancer cell lines (HepG2, SMMC-7721, Hela, CNE1, CNE2 and MCF7). The representative compound 5w displayed robust anti-proliferative activities in all the tested cell lines with IC50 values in range of 0.93-1.89\\u202fM which were much lower than that of sophoridine. Here, we report the structure-activity relationships (SAR) in a sophoridine series of compounds, which indicated that introduction of N-benzyl indole group on the 14-carbon atom of sophoridine can significantly enhance the antiproliferative activity. By molecular docking and enzymatic assay, compound 5w was found to be able to inhibit the activity of DNA Topo I. Furthermore, apoptosis assay displayed that compound 5w could significantly induce the apoptosis of HepG2 cells in a dose-dependent manner by activating caspase-3, increasing expression of cleaved caspase-3 and reducing the ratio of Bcl-2/Bax. The in vivo antitumor assay demonstrated that 5w suppressed the growth of HepG2 xenografts in nude mice without any obvious side effects.', 'Title: Design, synthesis and biological evaluation of benzimidazole-rhodanine conjugates as potent topoisomerase II inhibitors.  Abstract: In this study, a series of benzimidazole-rhodanine conjugates were designed, synthesized and investigated for their topoisomerase II (Topo II) inhibitory and cytotoxic activities. The results from Topo II-mediated pBR322 DNA relaxation and cleavage assays showed that the synthesized compounds might act as Topo II catalytic inhibitors. Certain compounds displayed potent Topo II inhibition at 10 M. The cytotoxic activities of these compounds against HeLa, A549, Raji, PC-3, MDA-MB-201, and HL-60 cancer cell lines were evaluated. The results indicated that these compounds exhibited strong antiproliferative activity. A good relationship was observed between the Topo II inhibitory potency and the cytotoxicity of these compounds. The structure-activity relationship revealed that the electronic effects, the phenyl group, and the rhodanine moiety were particularly important for the Topo II inhibitory potency and cytotoxicity.', 'Title: Application of Sequential Palladium Catalysis for the Discovery of Janus Kinase Inhibitors in the Benzo[ c]pyrrolo[2,3- h][1,6]naphthyridin-5-one (BPN) Series.  Abstract: The present account describes the discovery and development of a new benzo[ c]pyrrolo[2,3- h][1,6]naphthyridin-5-one (BPN) JAK inhibitory chemotype that has produced selective JAK inhibitors. Sequential palladium chemistry was optimized for the rapid access to a focused library of derivatives to explore the structure-activity relationships of the new scaffold. Several compounds from the series displayed potencies in the low nanomolar range against the four members of the JAK family with various selectivity profiles. Compound 20a, with an azetidine amide side chain, showed the best selectivity for JAK1 kinase vs JAK2, JAK3, and TYK2, with low nanomolar potency (IC50 = 3.4 nM). On the other hand, BPNs 17b and 18 had good general activity against the JAK family with excellent kinome selectivity profiles. Many of the new BPNs inhibited JAK3-mediated STAT-5 phosphorylation, the production of inflammatory cytokines, and the proliferation of primary T cells. Moreover, BPN 17b showed very similar in vivo results to tofacitinib in a rheumatoid arthritis animal model.', 'Title: Design, facile synthesis and biological evaluations of novel pyrano[3,2-a]phenazine hybrid molecules as antitumor agents.  Abstract: A series of novel pyrano[3,2-a]phenazine derivatives (1a-1r and 2a-2q), designed as hybrid molecules of phenazine and pyran pharmocophores, were facilely synthesized in two steps with 77-93% overall yields in this study. Cytotoxic evaluation indicates that many compounds exhibited cytotoxicity against HCT116, MCF7, HepG2 and A549 cancer cell lines in vitro, in which compounds 1c, 1i, 2e, and 2l were found to have excellent antiproliferative activity against the HepG2 cancer cell line. Thus, inhibitory effect of subcutaneously implanted xenografted mice in vivo (H22H8D8 cells) of the four compounds as well as topoisomerase I and II inhibitory activities in vitro (HepG2 cells) were determined. Significantly, compound 1i showed more potent than positive control drug both in vivo and in vitro. Further mechanism studies against HepG2 cells in vitro revealed that compound 1i up-regulated the expression of both p53 and p21, which inhibited the expression of both cyclin B and CDK1, and arrested HepG2 cells in the G2/M phase. Concomitantly, after treating with compound 1i, Bax/Bcl-2 ratio was significantly increased, the cytochrome C was released from mitochondria to cytosol, and the cleavage of caspase-3 and caspase-9 expression levels were both increased. Together, all these evidences implicated that compound 1i acts as topoisomerase I and II dual inhibitor, cell cycle arrester and apoptosis inducer against HepG2 cells.', 'Title: Design, facile synthesis and biological evaluations of novel pyrano[3,2-a]phenazine hybrid molecules as antitumor agents.  Abstract: A series of novel pyrano[3,2-a]phenazine derivatives (1a-1r and 2a-2q), designed as hybrid molecules of phenazine and pyran pharmocophores, were facilely synthesized in two steps with 77-93% overall yields in this study. Cytotoxic evaluation indicates that many compounds exhibited cytotoxicity against HCT116, MCF7, HepG2 and A549 cancer cell lines in vitro, in which compounds 1c, 1i, 2e, and 2l were found to have excellent antiproliferative activity against the HepG2 cancer cell line. Thus, inhibitory effect of subcutaneously implanted xenografted mice in vivo (H22H8D8 cells) of the four compounds as well as topoisomerase I and II inhibitory activities in vitro (HepG2 cells) were determined. Significantly, compound 1i showed more potent than positive control drug both in vivo and in vitro. Further mechanism studies against HepG2 cells in vitro revealed that compound 1i up-regulated the expression of both p53 and p21, which inhibited the expression of both cyclin B and CDK1, and arrested HepG2 cells in the G2/M phase. Concomitantly, after treating with compound 1i, Bax/Bcl-2 ratio was significantly increased, the cytochrome C was released from mitochondria to cytosol, and the cleavage of caspase-3 and caspase-9 expression levels were both increased. Together, all these evidences implicated that compound 1i acts as topoisomerase I and II dual inhibitor, cell cycle arrester and apoptosis inducer against HepG2 cells.', 'Title: Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors.  Abstract: In this study, two series of novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives containing an ,-unsaturated lactone fragment were synthesized and screened for Topo I inhibition and antitumor activity. The topoisomerase I inhibitory activities and cytotoxicities against three human cancer cell lines (MCF-7,Hela,A549) were evaluated. The results revealed that series 2, compounds bearing an exocyclic double bond on the furanone ring, generally showed more potent activity than series 1, compounds lacking an exocyclic double bond. Several compounds of series 2 possess significant Topo I inhibitory activity and potent antiproliferative activity against cancer cell lines. Further mechanism studies of the most active compound of series 2 (B-15) indicated that synthetic compounds can not only stabilize the drug-enzyme-DNA covalent ternary complex as well as camptothecin, but also interfere with the binding between Topo I and DNA. The binding patterns of these compounds with Topo I and structure-activity relationships are discussed.', 'Title: Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors.  Abstract: In this study, two series of novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives containing an ,-unsaturated lactone fragment were synthesized and screened for Topo I inhibition and antitumor activity. The topoisomerase I inhibitory activities and cytotoxicities against three human cancer cell lines (MCF-7,Hela,A549) were evaluated. The results revealed that series 2, compounds bearing an exocyclic double bond on the furanone ring, generally showed more potent activity than series 1, compounds lacking an exocyclic double bond. Several compounds of series 2 possess significant Topo I inhibitory activity and potent antiproliferative activity against cancer cell lines. Further mechanism studies of the most active compound of series 2 (B-15) indicated that synthetic compounds can not only stabilize the drug-enzyme-DNA covalent ternary complex as well as camptothecin, but also interfere with the binding between Topo I and DNA. The binding patterns of these compounds with Topo I and structure-activity relationships are discussed.', 'Title: Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors.  Abstract: In this study, two series of novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives containing an ,-unsaturated lactone fragment were synthesized and screened for Topo I inhibition and antitumor activity. The topoisomerase I inhibitory activities and cytotoxicities against three human cancer cell lines (MCF-7,Hela,A549) were evaluated. The results revealed that series 2, compounds bearing an exocyclic double bond on the furanone ring, generally showed more potent activity than series 1, compounds lacking an exocyclic double bond. Several compounds of series 2 possess significant Topo I inhibitory activity and potent antiproliferative activity against cancer cell lines. Further mechanism studies of the most active compound of series 2 (B-15) indicated that synthetic compounds can not only stabilize the drug-enzyme-DNA covalent ternary complex as well as camptothecin, but also interfere with the binding between Topo I and DNA. The binding patterns of these compounds with Topo I and structure-activity relationships are discussed.', 'Title: Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors.  Abstract: In this study, two series of novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives containing an ,-unsaturated lactone fragment were synthesized and screened for Topo I inhibition and antitumor activity. The topoisomerase I inhibitory activities and cytotoxicities against three human cancer cell lines (MCF-7,Hela,A549) were evaluated. The results revealed that series 2, compounds bearing an exocyclic double bond on the furanone ring, generally showed more potent activity than series 1, compounds lacking an exocyclic double bond. Several compounds of series 2 possess significant Topo I inhibitory activity and potent antiproliferative activity against cancer cell lines. Further mechanism studies of the most active compound of series 2 (B-15) indicated that synthetic compounds can not only stabilize the drug-enzyme-DNA covalent ternary complex as well as camptothecin, but also interfere with the binding between Topo I and DNA. The binding patterns of these compounds with Topo I and structure-activity relationships are discussed.', 'Title: Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors.  Abstract: In this study, two series of novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives containing an ,-unsaturated lactone fragment were synthesized and screened for Topo I inhibition and antitumor activity. The topoisomerase I inhibitory activities and cytotoxicities against three human cancer cell lines (MCF-7,Hela,A549) were evaluated. The results revealed that series 2, compounds bearing an exocyclic double bond on the furanone ring, generally showed more potent activity than series 1, compounds lacking an exocyclic double bond. Several compounds of series 2 possess significant Topo I inhibitory activity and potent antiproliferative activity against cancer cell lines. Further mechanism studies of the most active compound of series 2 (B-15) indicated that synthetic compounds can not only stabilize the drug-enzyme-DNA covalent ternary complex as well as camptothecin, but also interfere with the binding between Topo I and DNA. The binding patterns of these compounds with Topo I and structure-activity relationships are discussed.', 'Title: Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors.  Abstract: In this study, two series of novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives containing an ,-unsaturated lactone fragment were synthesized and screened for Topo I inhibition and antitumor activity. The topoisomerase I inhibitory activities and cytotoxicities against three human cancer cell lines (MCF-7,Hela,A549) were evaluated. The results revealed that series 2, compounds bearing an exocyclic double bond on the furanone ring, generally showed more potent activity than series 1, compounds lacking an exocyclic double bond. Several compounds of series 2 possess significant Topo I inhibitory activity and potent antiproliferative activity against cancer cell lines. Further mechanism studies of the most active compound of series 2 (B-15) indicated that synthetic compounds can not only stabilize the drug-enzyme-DNA covalent ternary complex as well as camptothecin, but also interfere with the binding between Topo I and DNA. The binding patterns of these compounds with Topo I and structure-activity relationships are discussed.', 'Title: Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors.  Abstract: In this study, two series of novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives containing an ,-unsaturated lactone fragment were synthesized and screened for Topo I inhibition and antitumor activity. The topoisomerase I inhibitory activities and cytotoxicities against three human cancer cell lines (MCF-7,Hela,A549) were evaluated. The results revealed that series 2, compounds bearing an exocyclic double bond on the furanone ring, generally showed more potent activity than series 1, compounds lacking an exocyclic double bond. Several compounds of series 2 possess significant Topo I inhibitory activity and potent antiproliferative activity against cancer cell lines. Further mechanism studies of the most active compound of series 2 (B-15) indicated that synthetic compounds can not only stabilize the drug-enzyme-DNA covalent ternary complex as well as camptothecin, but also interfere with the binding between Topo I and DNA. The binding patterns of these compounds with Topo I and structure-activity relationships are discussed.', 'Title: Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.  Abstract: Novel series of conformationally constrained 2,4-chloro- and hydroxy-substituted diphenyl benzofuro[3,2-b]pyridines were rationally designed and synthesized. Their biological activities were evaluated for topoisomerase I and II inhibitory activity, and antiproliferative activity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds with phenol moiety at 4-position of central pyridine exhibited significant dual topoisomerase I and II inhibitory activities, and strong antiproliferative activity in low micromolar range. Structure activity relationship study suggested that phenol moiety at 4-position of the central pyridine regardless of chlorophenyl moiety at 2-position of the central pyridine has an important role in dual topoisomerase inhibitory activity as well as antiproliferative activity. For investigation of mode of action for compound 14 which displayed the most strong dual topoisomerase I and II inhibitory activity and antiproliferative activity against HCT15 cell, we performed cleavable complex assay, band depletion assay, comet assay, and competitive EtBr displacement assay. Compound 14 functioned as non-intercalative catalytic topo I and II dual inhibitor. In addition, compound 14 induced apoptosis in HCT15 cells through increase of Bax, decrease of Bcl-2 and increase of PARP cleavage.', 'Title: Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.  Abstract: Novel series of conformationally constrained 2,4-chloro- and hydroxy-substituted diphenyl benzofuro[3,2-b]pyridines were rationally designed and synthesized. Their biological activities were evaluated for topoisomerase I and II inhibitory activity, and antiproliferative activity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds with phenol moiety at 4-position of central pyridine exhibited significant dual topoisomerase I and II inhibitory activities, and strong antiproliferative activity in low micromolar range. Structure activity relationship study suggested that phenol moiety at 4-position of the central pyridine regardless of chlorophenyl moiety at 2-position of the central pyridine has an important role in dual topoisomerase inhibitory activity as well as antiproliferative activity. For investigation of mode of action for compound 14 which displayed the most strong dual topoisomerase I and II inhibitory activity and antiproliferative activity against HCT15 cell, we performed cleavable complex assay, band depletion assay, comet assay, and competitive EtBr displacement assay. Compound 14 functioned as non-intercalative catalytic topo I and II dual inhibitor. In addition, compound 14 induced apoptosis in HCT15 cells through increase of Bax, decrease of Bcl-2 and increase of PARP cleavage.', 'Title: Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.  Abstract: Novel series of conformationally constrained 2,4-chloro- and hydroxy-substituted diphenyl benzofuro[3,2-b]pyridines were rationally designed and synthesized. Their biological activities were evaluated for topoisomerase I and II inhibitory activity, and antiproliferative activity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds with phenol moiety at 4-position of central pyridine exhibited significant dual topoisomerase I and II inhibitory activities, and strong antiproliferative activity in low micromolar range. Structure activity relationship study suggested that phenol moiety at 4-position of the central pyridine regardless of chlorophenyl moiety at 2-position of the central pyridine has an important role in dual topoisomerase inhibitory activity as well as antiproliferative activity. For investigation of mode of action for compound 14 which displayed the most strong dual topoisomerase I and II inhibitory activity and antiproliferative activity against HCT15 cell, we performed cleavable complex assay, band depletion assay, comet assay, and competitive EtBr displacement assay. Compound 14 functioned as non-intercalative catalytic topo I and II dual inhibitor. In addition, compound 14 induced apoptosis in HCT15 cells through increase of Bax, decrease of Bcl-2 and increase of PARP cleavage.', 'Title: Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.  Abstract: Novel series of conformationally constrained 2,4-chloro- and hydroxy-substituted diphenyl benzofuro[3,2-b]pyridines were rationally designed and synthesized. Their biological activities were evaluated for topoisomerase I and II inhibitory activity, and antiproliferative activity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds with phenol moiety at 4-position of central pyridine exhibited significant dual topoisomerase I and II inhibitory activities, and strong antiproliferative activity in low micromolar range. Structure activity relationship study suggested that phenol moiety at 4-position of the central pyridine regardless of chlorophenyl moiety at 2-position of the central pyridine has an important role in dual topoisomerase inhibitory activity as well as antiproliferative activity. For investigation of mode of action for compound 14 which displayed the most strong dual topoisomerase I and II inhibitory activity and antiproliferative activity against HCT15 cell, we performed cleavable complex assay, band depletion assay, comet assay, and competitive EtBr displacement assay. Compound 14 functioned as non-intercalative catalytic topo I and II dual inhibitor. In addition, compound 14 induced apoptosis in HCT15 cells through increase of Bax, decrease of Bcl-2 and increase of PARP cleavage.', 'Title: Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.  Abstract: Novel series of conformationally constrained 2,4-chloro- and hydroxy-substituted diphenyl benzofuro[3,2-b]pyridines were rationally designed and synthesized. Their biological activities were evaluated for topoisomerase I and II inhibitory activity, and antiproliferative activity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds with phenol moiety at 4-position of central pyridine exhibited significant dual topoisomerase I and II inhibitory activities, and strong antiproliferative activity in low micromolar range. Structure activity relationship study suggested that phenol moiety at 4-position of the central pyridine regardless of chlorophenyl moiety at 2-position of the central pyridine has an important role in dual topoisomerase inhibitory activity as well as antiproliferative activity. For investigation of mode of action for compound 14 which displayed the most strong dual topoisomerase I and II inhibitory activity and antiproliferative activity against HCT15 cell, we performed cleavable complex assay, band depletion assay, comet assay, and competitive EtBr displacement assay. Compound 14 functioned as non-intercalative catalytic topo I and II dual inhibitor. In addition, compound 14 induced apoptosis in HCT15 cells through increase of Bax, decrease of Bcl-2 and increase of PARP cleavage.', 'Title: Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.  Abstract: Novel series of conformationally constrained 2,4-chloro- and hydroxy-substituted diphenyl benzofuro[3,2-b]pyridines were rationally designed and synthesized. Their biological activities were evaluated for topoisomerase I and II inhibitory activity, and antiproliferative activity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds with phenol moiety at 4-position of central pyridine exhibited significant dual topoisomerase I and II inhibitory activities, and strong antiproliferative activity in low micromolar range. Structure activity relationship study suggested that phenol moiety at 4-position of the central pyridine regardless of chlorophenyl moiety at 2-position of the central pyridine has an important role in dual topoisomerase inhibitory activity as well as antiproliferative activity. For investigation of mode of action for compound 14 which displayed the most strong dual topoisomerase I and II inhibitory activity and antiproliferative activity against HCT15 cell, we performed cleavable complex assay, band depletion assay, comet assay, and competitive EtBr displacement assay. Compound 14 functioned as non-intercalative catalytic topo I and II dual inhibitor. In addition, compound 14 induced apoptosis in HCT15 cells through increase of Bax, decrease of Bcl-2 and increase of PARP cleavage.', 'Title: Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.  Abstract: Novel series of conformationally constrained 2,4-chloro- and hydroxy-substituted diphenyl benzofuro[3,2-b]pyridines were rationally designed and synthesized. Their biological activities were evaluated for topoisomerase I and II inhibitory activity, and antiproliferative activity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds with phenol moiety at 4-position of central pyridine exhibited significant dual topoisomerase I and II inhibitory activities, and strong antiproliferative activity in low micromolar range. Structure activity relationship study suggested that phenol moiety at 4-position of the central pyridine regardless of chlorophenyl moiety at 2-position of the central pyridine has an important role in dual topoisomerase inhibitory activity as well as antiproliferative activity. For investigation of mode of action for compound 14 which displayed the most strong dual topoisomerase I and II inhibitory activity and antiproliferative activity against HCT15 cell, we performed cleavable complex assay, band depletion assay, comet assay, and competitive EtBr displacement assay. Compound 14 functioned as non-intercalative catalytic topo I and II dual inhibitor. In addition, compound 14 induced apoptosis in HCT15 cells through increase of Bax, decrease of Bcl-2 and increase of PARP cleavage.', 'Title: Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.  Abstract: Novel series of conformationally constrained 2,4-chloro- and hydroxy-substituted diphenyl benzofuro[3,2-b]pyridines were rationally designed and synthesized. Their biological activities were evaluated for topoisomerase I and II inhibitory activity, and antiproliferative activity against several human cancer cell lines for the development of novel anticancer agents. Most of the compounds with phenol moiety at 4-position of central pyridine exhibited significant dual topoisomerase I and II inhibitory activities, and strong antiproliferative activity in low micromolar range. Structure activity relationship study suggested that phenol moiety at 4-position of the central pyridine regardless of chlorophenyl moiety at 2-position of the central pyridine has an important role in dual topoisomerase inhibitory activity as well as antiproliferative activity. For investigation of mode of action for compound 14 which displayed the most strong dual topoisomerase I and II inhibitory activity and antiproliferative activity against HCT15 cell, we performed cleavable complex assay, band depletion assay, comet assay, and competitive EtBr displacement assay. Compound 14 functioned as non-intercalative catalytic topo I and II dual inhibitor. In addition, compound 14 induced apoptosis in HCT15 cells through increase of Bax, decrease of Bcl-2 and increase of PARP cleavage.', 'Title: Novel indolizino[8,7-b]indole hybrids as anti-small cell lung cancer agents: Regioselective modulation of topoisomerase II inhibitory and DNA crosslinking activities.  Abstract: A novel series of bis(hydroxymethyl)indolizino[8,7-b]indole hybrids composed of -carboline (topoisomerase I/II inhibition) and bis(hydroxymethyl)pyrrole (DNA cross-linking) are synthesized for antitumor evaluation. Of tumor cell lines tested, small cell lung cancer (SCLC) cell lines are the most sensitive to the newly synthesized compounds. These hybrids induce cell cycle arrest at the G2/M phase, trigger tumor cell apoptotic death, and display diverse mechanisms of action involving topoisomerase II (Topo II) inhibition and induction of DNA cross-linking. Intriguingly, the substituent at N11 (H or Me) plays a critical role in modulating Topo II inhibition and DNA cross-linking activities. N11-Me derivatives predispose to induce DNA crosslinks, whereas N11-H derivatives potently inhibit Topo II. Computational analysis implicates that N11-Me restrict the torsion angles of the two adjacent OH on pyrrole resulting in a favorable of DNA cross-linking. Among these hybrids, compound 17a with N11-H is more effective than cisplatin and etoposide, but as potent as irinotecan, against the growth of SCLC H526 cells in xenograft model.', 'Title: Novel indolizino[8,7-b]indole hybrids as anti-small cell lung cancer agents: Regioselective modulation of topoisomerase II inhibitory and DNA crosslinking activities.  Abstract: A novel series of bis(hydroxymethyl)indolizino[8,7-b]indole hybrids composed of -carboline (topoisomerase I/II inhibition) and bis(hydroxymethyl)pyrrole (DNA cross-linking) are synthesized for antitumor evaluation. Of tumor cell lines tested, small cell lung cancer (SCLC) cell lines are the most sensitive to the newly synthesized compounds. These hybrids induce cell cycle arrest at the G2/M phase, trigger tumor cell apoptotic death, and display diverse mechanisms of action involving topoisomerase II (Topo II) inhibition and induction of DNA cross-linking. Intriguingly, the substituent at N11 (H or Me) plays a critical role in modulating Topo II inhibition and DNA cross-linking activities. N11-Me derivatives predispose to induce DNA crosslinks, whereas N11-H derivatives potently inhibit Topo II. Computational analysis implicates that N11-Me restrict the torsion angles of the two adjacent OH on pyrrole resulting in a favorable of DNA cross-linking. Among these hybrids, compound 17a with N11-H is more effective than cisplatin and etoposide, but as potent as irinotecan, against the growth of SCLC H526 cells in xenograft model.', 'Title: Novel multi-substituted benzyl acridone derivatives as survivin inhibitors for hepatocellular carcinoma treatment.  Abstract: Sorafenib was the only small-molecule drug approved by FDA for treatment of the advanced hepatocellular carcinoma (HCC). Recent study indicated that YM155 was a promising agent for HCC cells with high survivin expression, however, the antitumor activity needs to be further improved. Based on molecular docking and rational design method, a series of multi-substituted benzyl acridone derivatives were designed and synthesized. MTT assay indicated that some of the synthesized compounds displayed better antiproliferative activity against HepG2 cells than YM155. Later study indicated that the representive compound 8u may directly interact with survivin protein and induce HepG2 cells apoptosis, which is different from YM155. In addition, ADME property was predicted in silico, and it performed well. Moreover, in vivo preliminary experiments showed that 8u may be a good lead compound in the treatment of HCC.', 'Title: Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl-DNA Phosphodiesterase 2 (Tdp2).  Abstract: Tdp1 and Tdp2 are two tyrosyl-DNA phosphodiesterases that can repair damaged DNA resulting from topoisomerase inhibitors and a variety of other DNA-damaging agents. Both Tdp1 and Tdp2 inhibition could hypothetically potentiate the cytotoxicities of topoisomerase inhibitors. This study reports the successful structure-based design and synthesis of new 7-azaindenoisoquinolines that act as triple inhibitors of Top1, Tdp1, and Tdp2. Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures establish that modification of the lactam side chain of the 7-azaindenoisoquinolines can modulate their inhibitory potencies and selectivities vs Top1, Tdp1, and Tdp2. Molecular modeling of selected target compounds bound to Top1, Tdp1, and Tdp2 was used to design the inhibitors and facilitate the structure-activity relationship analysis. The monitoring of DNA damage by -H2AX foci formation in human PBMCs (lymphocytes) and acute lymphoblastic leukemia CCRF-CEM cells documented significantly more DNA damage in the cancer cells vs normal cells.', 'Title: Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl-DNA Phosphodiesterase 2 (Tdp2).  Abstract: Tdp1 and Tdp2 are two tyrosyl-DNA phosphodiesterases that can repair damaged DNA resulting from topoisomerase inhibitors and a variety of other DNA-damaging agents. Both Tdp1 and Tdp2 inhibition could hypothetically potentiate the cytotoxicities of topoisomerase inhibitors. This study reports the successful structure-based design and synthesis of new 7-azaindenoisoquinolines that act as triple inhibitors of Top1, Tdp1, and Tdp2. Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures establish that modification of the lactam side chain of the 7-azaindenoisoquinolines can modulate their inhibitory potencies and selectivities vs Top1, Tdp1, and Tdp2. Molecular modeling of selected target compounds bound to Top1, Tdp1, and Tdp2 was used to design the inhibitors and facilitate the structure-activity relationship analysis. The monitoring of DNA damage by -H2AX foci formation in human PBMCs (lymphocytes) and acute lymphoblastic leukemia CCRF-CEM cells documented significantly more DNA damage in the cancer cells vs normal cells.', 'Title: Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl-DNA Phosphodiesterase 2 (Tdp2).  Abstract: Tdp1 and Tdp2 are two tyrosyl-DNA phosphodiesterases that can repair damaged DNA resulting from topoisomerase inhibitors and a variety of other DNA-damaging agents. Both Tdp1 and Tdp2 inhibition could hypothetically potentiate the cytotoxicities of topoisomerase inhibitors. This study reports the successful structure-based design and synthesis of new 7-azaindenoisoquinolines that act as triple inhibitors of Top1, Tdp1, and Tdp2. Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures establish that modification of the lactam side chain of the 7-azaindenoisoquinolines can modulate their inhibitory potencies and selectivities vs Top1, Tdp1, and Tdp2. Molecular modeling of selected target compounds bound to Top1, Tdp1, and Tdp2 was used to design the inhibitors and facilitate the structure-activity relationship analysis. The monitoring of DNA damage by -H2AX foci formation in human PBMCs (lymphocytes) and acute lymphoblastic leukemia CCRF-CEM cells documented significantly more DNA damage in the cancer cells vs normal cells.', 'Title: Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl-DNA Phosphodiesterase 2 (Tdp2).  Abstract: Tdp1 and Tdp2 are two tyrosyl-DNA phosphodiesterases that can repair damaged DNA resulting from topoisomerase inhibitors and a variety of other DNA-damaging agents. Both Tdp1 and Tdp2 inhibition could hypothetically potentiate the cytotoxicities of topoisomerase inhibitors. This study reports the successful structure-based design and synthesis of new 7-azaindenoisoquinolines that act as triple inhibitors of Top1, Tdp1, and Tdp2. Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures establish that modification of the lactam side chain of the 7-azaindenoisoquinolines can modulate their inhibitory potencies and selectivities vs Top1, Tdp1, and Tdp2. Molecular modeling of selected target compounds bound to Top1, Tdp1, and Tdp2 was used to design the inhibitors and facilitate the structure-activity relationship analysis. The monitoring of DNA damage by -H2AX foci formation in human PBMCs (lymphocytes) and acute lymphoblastic leukemia CCRF-CEM cells documented significantly more DNA damage in the cancer cells vs normal cells.', 'Title: Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl-DNA Phosphodiesterase 2 (Tdp2).  Abstract: Tdp1 and Tdp2 are two tyrosyl-DNA phosphodiesterases that can repair damaged DNA resulting from topoisomerase inhibitors and a variety of other DNA-damaging agents. Both Tdp1 and Tdp2 inhibition could hypothetically potentiate the cytotoxicities of topoisomerase inhibitors. This study reports the successful structure-based design and synthesis of new 7-azaindenoisoquinolines that act as triple inhibitors of Top1, Tdp1, and Tdp2. Enzyme inhibitory data and cytotoxicity data from human cancer cell cultures establish that modification of the lactam side chain of the 7-azaindenoisoquinolines can modulate their inhibitory potencies and selectivities vs Top1, Tdp1, and Tdp2. Molecular modeling of selected target compounds bound to Top1, Tdp1, and Tdp2 was used to design the inhibitors and facilitate the structure-activity relationship analysis. The monitoring of DNA damage by -H2AX foci formation in human PBMCs (lymphocytes) and acute lymphoblastic leukemia CCRF-CEM cells documented significantly more DNA damage in the cancer cells vs normal cells.', 'Title: Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors.  Abstract: Previously, 4-tosylanthra[1,2-c][1,2,5]thiadiazole-6,11-dione (1) was identified as a novel non-camptothecin topoisomerase I (Top1) inhibitor by structure-based virtual screening. Herein, a series of 4-substituted derivatives were designed and synthesized. Most of them showed potent Top1 inhibitory activity. Their in vitro antiproliferative activity was also evaluated in A549, HCT-116 and ZR-75-30 human cancer cell lines. Compound 8s showed good antiproliferative activity with IC50 of 0.52M and 0.42M against HCT-116 and ZR-75-30 cell line, respectively. Top1 unwinding assay and molecular modeling studies rationalized the mode of action of this new class of inhibitors.', 'Title: Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors.  Abstract: Previously, 4-tosylanthra[1,2-c][1,2,5]thiadiazole-6,11-dione (1) was identified as a novel non-camptothecin topoisomerase I (Top1) inhibitor by structure-based virtual screening. Herein, a series of 4-substituted derivatives were designed and synthesized. Most of them showed potent Top1 inhibitory activity. Their in vitro antiproliferative activity was also evaluated in A549, HCT-116 and ZR-75-30 human cancer cell lines. Compound 8s showed good antiproliferative activity with IC50 of 0.52M and 0.42M against HCT-116 and ZR-75-30 cell line, respectively. Top1 unwinding assay and molecular modeling studies rationalized the mode of action of this new class of inhibitors.', 'Title: Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors.  Abstract: Previously, 4-tosylanthra[1,2-c][1,2,5]thiadiazole-6,11-dione (1) was identified as a novel non-camptothecin topoisomerase I (Top1) inhibitor by structure-based virtual screening. Herein, a series of 4-substituted derivatives were designed and synthesized. Most of them showed potent Top1 inhibitory activity. Their in vitro antiproliferative activity was also evaluated in A549, HCT-116 and ZR-75-30 human cancer cell lines. Compound 8s showed good antiproliferative activity with IC50 of 0.52M and 0.42M against HCT-116 and ZR-75-30 cell line, respectively. Top1 unwinding assay and molecular modeling studies rationalized the mode of action of this new class of inhibitors.', 'Title: Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors.  Abstract: Previously, 4-tosylanthra[1,2-c][1,2,5]thiadiazole-6,11-dione (1) was identified as a novel non-camptothecin topoisomerase I (Top1) inhibitor by structure-based virtual screening. Herein, a series of 4-substituted derivatives were designed and synthesized. Most of them showed potent Top1 inhibitory activity. Their in vitro antiproliferative activity was also evaluated in A549, HCT-116 and ZR-75-30 human cancer cell lines. Compound 8s showed good antiproliferative activity with IC50 of 0.52M and 0.42M against HCT-116 and ZR-75-30 cell line, respectively. Top1 unwinding assay and molecular modeling studies rationalized the mode of action of this new class of inhibitors.', 'Title: Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors.  Abstract: Previously, 4-tosylanthra[1,2-c][1,2,5]thiadiazole-6,11-dione (1) was identified as a novel non-camptothecin topoisomerase I (Top1) inhibitor by structure-based virtual screening. Herein, a series of 4-substituted derivatives were designed and synthesized. Most of them showed potent Top1 inhibitory activity. Their in vitro antiproliferative activity was also evaluated in A549, HCT-116 and ZR-75-30 human cancer cell lines. Compound 8s showed good antiproliferative activity with IC50 of 0.52M and 0.42M against HCT-116 and ZR-75-30 cell line, respectively. Top1 unwinding assay and molecular modeling studies rationalized the mode of action of this new class of inhibitors.', 'Title: Selective Inhibition of Escherichia coli RNA and DNA Topoisomerase I by Hoechst 33258 Derived Mono- and Bisbenzimidazoles.  Abstract: A series of Hoechst 33258 based mono- and bisbenzimidazoles have been synthesized and their Escherichia coli DNA topoisomerase I inhibition, binding to B-DNA duplex, and antibacterial activity has been evaluated. Bisbenzimidazoles with alkynyl side chains display excellent E. coli DNA topoisomerase I inhibition properties with IC50 values <5.0 M. Several bisbenzimidazoles (3, 6, 7, 8) also inhibit RNA topoisomerase activity of E. coli DNA topoisomerase I. Bisbenzimidazoles inhibit bacterial growth much better than monobenzimidazoles for Gram-positive strains. The minimum inhibitory concentration (MIC) was much lower for Gram positive bacteria (Enterococcus spp. and Staphylococcus spp., including two MRSA strains 0.3-8 g/mL) than for the majority of Gram negative bacteria (Pseudomonas aeruginosa, 16-32 g/mL, Klebsiella pneumoniae > 32 g/mL). Bisbenzimidazoles showed varied stabilization of B-DNA duplex (1.2-23.4 C), and cytotoxicity studies show similar variation dependent upon the side chain length. Modeling studies suggest critical interactions between the inhibitor side chain and amino acids of the active site of DNA topoisomerase I.', 'Title: Synthesis and biological evaluation of N-(carbobenzyloxy)-l-phenylalanine and N-(carbobenzyloxy)-l-aspartic acid--benzyl ester derivatives as potent topoisomerase II inhibitors.  Abstract: A new series of thirteen N-(carbobenzyloxy)-l-phenylalanine and N-(carbobenzyloxy)-l-aspartic acid--benzyl ester compounds were synthesized and evaluated for antiproliferative activity against four different human cancer cell lines: cervical cancer (HeLa), lung cancer (A549), gastric cancer (MGC-803) and breast cancer (MCF-7) as well as topoisomerase I and II inhibitory activity. Compounds (5a, 5b, 5e, 8a, 8b) showed significant antiproliferative activity with low IC50 values against the four cancer cell lines. Equally, compounds 5a, 5b, 5e, 5f, 8a, 8d, 8e and 8f showed topoisomerase II inhibitory activity at 100M with 5b, 5e, 8f exhibiting potential topoisomerase II inhibitory activity compared to positive control at 100M and 20M, respectively. Conversely compounds 5e, 5f, 5g and 8a showed weaker topoisomerase I inhibitory activity compared to positive control at 100M. Compound 5b exhibited the most potent topoisomerase II inhibitory activity at low concentration and better antiproliferative activity against the four human cancer cell lines. The molecular interactions between compounds 5a-5g, 8a-8f and the topoisomerase II (PDB ID: 1ZXM) were further investigated through molecular docking. The results indicated that these compounds could serve as promising leads for further optimization as novel antitumor agents.', 'Title: Synthesis and biological evaluation of N-(carbobenzyloxy)-l-phenylalanine and N-(carbobenzyloxy)-l-aspartic acid--benzyl ester derivatives as potent topoisomerase II inhibitors.  Abstract: A new series of thirteen N-(carbobenzyloxy)-l-phenylalanine and N-(carbobenzyloxy)-l-aspartic acid--benzyl ester compounds were synthesized and evaluated for antiproliferative activity against four different human cancer cell lines: cervical cancer (HeLa), lung cancer (A549), gastric cancer (MGC-803) and breast cancer (MCF-7) as well as topoisomerase I and II inhibitory activity. Compounds (5a, 5b, 5e, 8a, 8b) showed significant antiproliferative activity with low IC50 values against the four cancer cell lines. Equally, compounds 5a, 5b, 5e, 5f, 8a, 8d, 8e and 8f showed topoisomerase II inhibitory activity at 100M with 5b, 5e, 8f exhibiting potential topoisomerase II inhibitory activity compared to positive control at 100M and 20M, respectively. Conversely compounds 5e, 5f, 5g and 8a showed weaker topoisomerase I inhibitory activity compared to positive control at 100M. Compound 5b exhibited the most potent topoisomerase II inhibitory activity at low concentration and better antiproliferative activity against the four human cancer cell lines. The molecular interactions between compounds 5a-5g, 8a-8f and the topoisomerase II (PDB ID: 1ZXM) were further investigated through molecular docking. The results indicated that these compounds could serve as promising leads for further optimization as novel antitumor agents.', 'Title: Synthesis and biological research of novel azaacridine derivatives as potent DNA-binding ligands and topoisomerase II inhibitors.  Abstract: DNA and DNA-related enzymes are one of the most effective and common used intracellular anticancer targets in clinic and laboratory studies, however, most of DNA-targeting drugs suffered from toxic side effects. Development of new molecules with good antitumor activity and low side effects is important. Based on computer aided design and our previous studies, a series of novel azaacridine derivatives were synthesized as DNA and topoisomerases binding agents, among which compound 9 displayed the best antiproliferative activity with an IC50 value of 0.57M against U937 cells, which was slightly better than m-AMSA. In addition, compound 9 displayed low cytotoxicity against human normal liver cells (QSG-7701), the IC50 of which was more than 3 times lower than m-AMSA. Later study indicated that all the compounds displayed topoisomerases II inhibition activity at 50M. The representative compound 9 could bind with DNA and induce U937 apoptosis through the exogenous pathway.', 'Title: Design and Synthesis of Chlorinated and Fluorinated 7-Azaindenoisoquinolines as Potent Cytotoxic Anticancer Agents That Inhibit Topoisomerase I.  Abstract: The 7-azaindenoisoquinolines are cytotoxic topoisomerase I (Top1) inhibitors. Previously reported representatives bear a 3-nitro group. The present report documents the replacement of the potentially genotoxic 3-nitro group by 3-chloro and 3-fluoro substituents, resulting in compounds with high Top1 inhibitory activities and potent cytotoxicities in human cancer cell cultures and reduced lethality in an animal model. Some of the new Top1 inhibitors also possess moderate inhibitory activities against tyrosyl-DNA phosphodiesterase 1 (TDP1) and tyrosyl-DNA phosphodiesterase 2 (TDP2), two enzymes that are involved in DNA damage repair resulting from Top1 inhibitors, and they produce significantly more DNA damage in cancer cells than in normal cells. Eighteen of the new compounds had cytotoxicity mean-graph midpoint (MGM) GI50 values in the submicromolar (0.033-0.630 M) range. Compounds 16b and 17b are the most potent in human cancer cell cultures with MGM GI50 values of 0.063 and 0.033 M, respectively. Possible binding modes to Top1 and TDP1were investigated by molecular modeling.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.  Abstract: Camptothecin (CPT) selectively traps topoisomerase 1-DNA cleavable complexes (Top1cc) to promote anticancer activity. Here, we report the design and synthesis of a new class of neutral porphyrin derivative 5,10-bis(4-carboxyphenyl)-15, 20-bis(4-dimethylaminophenyl)porphyrin (compound 8) as a potent catalytic inhibitor of human Top1. In contrast to CPT, compound 8 reversibly binds with the free enzyme and inhibits the formation of Top1cc and promotes reversal of the preformed Top1cc with CPT. Compound 8 induced inhibition of Top1cc formation in live cells was substantiated by fluorescence recovery after photobleaching (FRAP) assays. We established that MCF7 cells treated with compound 8 trigger proteasome-mediated Top1 degradation, accumulate higher levels of reactive oxygen species (ROS), PARP1 cleavage, oxidative DNA fragmentation, and stimulate apoptotic cell death without stabilizing apoptotic Top1-DNA cleavage complexes. Finally, compound 8 shows anticancer activity by targeting cellular Top1 and preventing the enzyme from directly participating in the apoptotic process.', 'Title: Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and II dual inhibitors with DNA non-intercalative catalytic activity.  Abstract: With the aim to develop novel antiproliferative agents, a new series of eighteen dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines were systematically designed, prepared, and investigated for their topoisomerase (topo) I and II inhibitory properties and antiproliferative effect in three different human cancer cell lines (HCT15, T47D, and HeLa). Compounds 22-30 which possess a meta- or para-phenol on 2-, or 6-position of central pyridine ring showed significant dual topo I and topo II inhibitory activities with strong antiproliferative activities against all the tested human cancer cell lines. However, compounds 13-21 which possess an ortho-phenol on 2-, or 6-position of central pyridine ring did not show significant topo I and topo II inhibitory activities but displayed moderate antiproliferative activities against all the tested human cancer cell lines. Compound 23 exhibited the highest antiproliferative potency as much as 348.5 and 105 times compared to etoposide and camptothecin, respectively, in T47D cancer cell line. The structure-activity relationship study revealed that the para position of a hydroxyl group at 2-and 6-phenyl ring and chlorine atom at the para position of 4-phenyl ring of the central pyridine exhibited the most significant topo I and topo II inhibition, which might indicate introduction of the chlorine atom at the phenyl ring of 4-pyridine have an important role as dual inhibitors of topo I and topo II. Compound 30 which showed the most potent dual topo I and topo II inhibition with strong antiproliferative activity in T47D cell line was selected to perform further study on the mechanism of action, which revealed that compound 30 functions as a potent DNA non-intercalative catalytic topo I and II dual inhibitor.', 'Title: Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and II dual inhibitors with DNA non-intercalative catalytic activity.  Abstract: With the aim to develop novel antiproliferative agents, a new series of eighteen dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines were systematically designed, prepared, and investigated for their topoisomerase (topo) I and II inhibitory properties and antiproliferative effect in three different human cancer cell lines (HCT15, T47D, and HeLa). Compounds 22-30 which possess a meta- or para-phenol on 2-, or 6-position of central pyridine ring showed significant dual topo I and topo II inhibitory activities with strong antiproliferative activities against all the tested human cancer cell lines. However, compounds 13-21 which possess an ortho-phenol on 2-, or 6-position of central pyridine ring did not show significant topo I and topo II inhibitory activities but displayed moderate antiproliferative activities against all the tested human cancer cell lines. Compound 23 exhibited the highest antiproliferative potency as much as 348.5 and 105 times compared to etoposide and camptothecin, respectively, in T47D cancer cell line. The structure-activity relationship study revealed that the para position of a hydroxyl group at 2-and 6-phenyl ring and chlorine atom at the para position of 4-phenyl ring of the central pyridine exhibited the most significant topo I and topo II inhibition, which might indicate introduction of the chlorine atom at the phenyl ring of 4-pyridine have an important role as dual inhibitors of topo I and topo II. Compound 30 which showed the most potent dual topo I and topo II inhibition with strong antiproliferative activity in T47D cell line was selected to perform further study on the mechanism of action, which revealed that compound 30 functions as a potent DNA non-intercalative catalytic topo I and II dual inhibitor.', 'Title: Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and II dual inhibitors with DNA non-intercalative catalytic activity.  Abstract: With the aim to develop novel antiproliferative agents, a new series of eighteen dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines were systematically designed, prepared, and investigated for their topoisomerase (topo) I and II inhibitory properties and antiproliferative effect in three different human cancer cell lines (HCT15, T47D, and HeLa). Compounds 22-30 which possess a meta- or para-phenol on 2-, or 6-position of central pyridine ring showed significant dual topo I and topo II inhibitory activities with strong antiproliferative activities against all the tested human cancer cell lines. However, compounds 13-21 which possess an ortho-phenol on 2-, or 6-position of central pyridine ring did not show significant topo I and topo II inhibitory activities but displayed moderate antiproliferative activities against all the tested human cancer cell lines. Compound 23 exhibited the highest antiproliferative potency as much as 348.5 and 105 times compared to etoposide and camptothecin, respectively, in T47D cancer cell line. The structure-activity relationship study revealed that the para position of a hydroxyl group at 2-and 6-phenyl ring and chlorine atom at the para position of 4-phenyl ring of the central pyridine exhibited the most significant topo I and topo II inhibition, which might indicate introduction of the chlorine atom at the phenyl ring of 4-pyridine have an important role as dual inhibitors of topo I and topo II. Compound 30 which showed the most potent dual topo I and topo II inhibition with strong antiproliferative activity in T47D cell line was selected to perform further study on the mechanism of action, which revealed that compound 30 functions as a potent DNA non-intercalative catalytic topo I and II dual inhibitor.', 'Title: Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and II dual inhibitors with DNA non-intercalative catalytic activity.  Abstract: With the aim to develop novel antiproliferative agents, a new series of eighteen dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines were systematically designed, prepared, and investigated for their topoisomerase (topo) I and II inhibitory properties and antiproliferative effect in three different human cancer cell lines (HCT15, T47D, and HeLa). Compounds 22-30 which possess a meta- or para-phenol on 2-, or 6-position of central pyridine ring showed significant dual topo I and topo II inhibitory activities with strong antiproliferative activities against all the tested human cancer cell lines. However, compounds 13-21 which possess an ortho-phenol on 2-, or 6-position of central pyridine ring did not show significant topo I and topo II inhibitory activities but displayed moderate antiproliferative activities against all the tested human cancer cell lines. Compound 23 exhibited the highest antiproliferative potency as much as 348.5 and 105 times compared to etoposide and camptothecin, respectively, in T47D cancer cell line. The structure-activity relationship study revealed that the para position of a hydroxyl group at 2-and 6-phenyl ring and chlorine atom at the para position of 4-phenyl ring of the central pyridine exhibited the most significant topo I and topo II inhibition, which might indicate introduction of the chlorine atom at the phenyl ring of 4-pyridine have an important role as dual inhibitors of topo I and topo II. Compound 30 which showed the most potent dual topo I and topo II inhibition with strong antiproliferative activity in T47D cell line was selected to perform further study on the mechanism of action, which revealed that compound 30 functions as a potent DNA non-intercalative catalytic topo I and II dual inhibitor.', 'Title: 6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression.  Abstract: To discover new phenanthroindolizidine and phenanthroquinolizidine alkaloids as potential anticancer drug candidates, non-natural 6-O-desmethylcryptopleurine (2) and its derivatives were prepared. Most of the new compounds exhibited potent antiproliferative activity against A549 and BEL-7402 cells, with the lowest IC50 being 3 nM. Optically pure 2-R was further evaluated against a panel of 30 cancer cell lines and found to inhibit the proliferation of all tested cell lines, including three multidrug-resistant cell lines, with an average IC50 value of 2.1 nM, which is much lower than that of previously reported phenanthroindolizidine DCB-3503 (1, IC50: 166.7 nM). A mechanistic evaluation showed that 2-R potently inhibited cell growth and colony formation, which are associated with a delay in S phase progression through the inhibition of DNA synthesis. These results along with further study on the safety profile of these compounds will facilitate the discovery of new phenanthroindolizidine and phenanthroquinolizidine alkaloids for use as anticancer drug candidates.', 'Title: 6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression.  Abstract: To discover new phenanthroindolizidine and phenanthroquinolizidine alkaloids as potential anticancer drug candidates, non-natural 6-O-desmethylcryptopleurine (2) and its derivatives were prepared. Most of the new compounds exhibited potent antiproliferative activity against A549 and BEL-7402 cells, with the lowest IC50 being 3 nM. Optically pure 2-R was further evaluated against a panel of 30 cancer cell lines and found to inhibit the proliferation of all tested cell lines, including three multidrug-resistant cell lines, with an average IC50 value of 2.1 nM, which is much lower than that of previously reported phenanthroindolizidine DCB-3503 (1, IC50: 166.7 nM). A mechanistic evaluation showed that 2-R potently inhibited cell growth and colony formation, which are associated with a delay in S phase progression through the inhibition of DNA synthesis. These results along with further study on the safety profile of these compounds will facilitate the discovery of new phenanthroindolizidine and phenanthroquinolizidine alkaloids for use as anticancer drug candidates.', 'Title: 6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression.  Abstract: To discover new phenanthroindolizidine and phenanthroquinolizidine alkaloids as potential anticancer drug candidates, non-natural 6-O-desmethylcryptopleurine (2) and its derivatives were prepared. Most of the new compounds exhibited potent antiproliferative activity against A549 and BEL-7402 cells, with the lowest IC50 being 3 nM. Optically pure 2-R was further evaluated against a panel of 30 cancer cell lines and found to inhibit the proliferation of all tested cell lines, including three multidrug-resistant cell lines, with an average IC50 value of 2.1 nM, which is much lower than that of previously reported phenanthroindolizidine DCB-3503 (1, IC50: 166.7 nM). A mechanistic evaluation showed that 2-R potently inhibited cell growth and colony formation, which are associated with a delay in S phase progression through the inhibition of DNA synthesis. These results along with further study on the safety profile of these compounds will facilitate the discovery of new phenanthroindolizidine and phenanthroquinolizidine alkaloids for use as anticancer drug candidates.', 'Title: Design, synthesis, and evaluation of DNA topoisomerase II-targeted nucleosides.  Abstract: We developed novel nucleoside-based topoisomerase II selective inhibitors and showed that small structural units, such as catechols, are essential for DNA topoisomerase II inhibitory activity. Moreover, nucleoside analogues containing TBS and 1,3-dithian moieties had potent and selective DNA topoisomerase II inhibitory activities. In further experiments, compound 25b having a beta configuration of the thymine moiety showed relatively strong growth inhibitory activity against cancer cell lines, and was more potent against all cancer cell lines than compound 26b, which carries a thymine moiety in the alpha configuration.', 'Title: 2-Chlorophenyl-substituted benzofuro[3,2-b]pyridines with enhanced topoisomerase inhibitory activity: The role of the chlorine substituent.  Abstract: A new series of 2-chloropheny-substituted benzofuro[3,2-b]pyridines were designed, synthesized, and evaluated for topoisomerase I and II inhibition and antiproliferative activity. Compounds 17-19, 23, 24, 26, and 27 exhibited excellent topo II inhibitory activity. A systematic structure-activity relationship study revealed the important role of chlorine substitution in the strong topoisomerase inhibitory activity.', 'Title: 2-Chlorophenyl-substituted benzofuro[3,2-b]pyridines with enhanced topoisomerase inhibitory activity: The role of the chlorine substituent.  Abstract: A new series of 2-chloropheny-substituted benzofuro[3,2-b]pyridines were designed, synthesized, and evaluated for topoisomerase I and II inhibition and antiproliferative activity. Compounds 17-19, 23, 24, 26, and 27 exhibited excellent topo II inhibitory activity. A systematic structure-activity relationship study revealed the important role of chlorine substitution in the strong topoisomerase inhibitory activity.', 'Title: Design, synthesis and biological evaluation of 4-amidobenzimidazole acridine derivatives as dual PARP and Topo inhibitors for cancer therapy.  Abstract: PARP-1 could repair the DNA damages induced by Topo inhibitors, therefore inhibiting Topo and PARP-1 simultaneously might be able to overcome resistance and improve outcomes. In this study a series of 4-amidobenzimidazole acridines were designed and synthesized as dual Topo and PARP-1 inhibitors. Compound 11l displayed good inhibitory activities against Topo and PARP-1, as well as significantly inhibited cancer cells proliferation. Further mechanistic evaluations indicated that 11l treatment in MCF-7 cells induced accumulated DNA double-strand breaks, prompted remarkable apoptosis, and caused prominent G0/G1 cell cycle arrest. Moreover, 11l greatly suppressed tumor growth in mice, and displayed favorable metabolic properties in liver microsomes. Our study suggested that single agents inhibiting Topo and PARP concurrently might be an alternative for cancer therapy and 11l represented a potential lead compound for development of antitumor agents.', 'Title: Design, synthesis and biological evaluation of 4-amidobenzimidazole acridine derivatives as dual PARP and Topo inhibitors for cancer therapy.  Abstract: PARP-1 could repair the DNA damages induced by Topo inhibitors, therefore inhibiting Topo and PARP-1 simultaneously might be able to overcome resistance and improve outcomes. In this study a series of 4-amidobenzimidazole acridines were designed and synthesized as dual Topo and PARP-1 inhibitors. Compound 11l displayed good inhibitory activities against Topo and PARP-1, as well as significantly inhibited cancer cells proliferation. Further mechanistic evaluations indicated that 11l treatment in MCF-7 cells induced accumulated DNA double-strand breaks, prompted remarkable apoptosis, and caused prominent G0/G1 cell cycle arrest. Moreover, 11l greatly suppressed tumor growth in mice, and displayed favorable metabolic properties in liver microsomes. Our study suggested that single agents inhibiting Topo and PARP concurrently might be an alternative for cancer therapy and 11l represented a potential lead compound for development of antitumor agents.', 'Title: Design, synthesis and biological evaluation of 4-amidobenzimidazole acridine derivatives as dual PARP and Topo inhibitors for cancer therapy.  Abstract: PARP-1 could repair the DNA damages induced by Topo inhibitors, therefore inhibiting Topo and PARP-1 simultaneously might be able to overcome resistance and improve outcomes. In this study a series of 4-amidobenzimidazole acridines were designed and synthesized as dual Topo and PARP-1 inhibitors. Compound 11l displayed good inhibitory activities against Topo and PARP-1, as well as significantly inhibited cancer cells proliferation. Further mechanistic evaluations indicated that 11l treatment in MCF-7 cells induced accumulated DNA double-strand breaks, prompted remarkable apoptosis, and caused prominent G0/G1 cell cycle arrest. Moreover, 11l greatly suppressed tumor growth in mice, and displayed favorable metabolic properties in liver microsomes. Our study suggested that single agents inhibiting Topo and PARP concurrently might be an alternative for cancer therapy and 11l represented a potential lead compound for development of antitumor agents.', 'Title: Novel amidino substituted benzimidazole and benzothiazole benzo[b]thieno-2-carboxamides exert strong antiproliferative and DNA binding properties.  Abstract: Within this manuscript design, synthesis of novel 2-imidazolinyl substituted benzo[b]thieno-2-carboxamides bearing either benzimidazole or benzothiazole subunit and biological activity are presented and described. The antiproliferative activities were assessed in vitro on a panel of human cancer cell lines. Tested compounds showed moderate activity while cytotoxicity on normal fibroblasts was lower in comparison with 5-fluorouracile. The variations of 2-imidazolinyl substituent at heteroaromatic subunits in different positions led to different cytotoxic properties. The strongest selective activity against HeLa cells was observed for the benzothiazole derivative 4d with 2-imidazolinyl group at the benzo[b]thiophene subunit with a corresponding IC50 = 1.16 M. Additionally, several biological experiments were performed to explain the mode of biological action. Fluorescence microscopy evidenced nuclear subcellular localization of compounds 3a, 4a and 4c. Additionally, detailed DNA binding studies confirmed a strong DNA groove binding for derivatives 4a and 4c while DNase I footprinting experiments evidenced sequence-selective binding of compound 4c in the A-T rich side. Furthermore, topoisomerase suppressive effect was for compounds 4a-4c.', 'Title: Novel amidino substituted benzimidazole and benzothiazole benzo[b]thieno-2-carboxamides exert strong antiproliferative and DNA binding properties.  Abstract: Within this manuscript design, synthesis of novel 2-imidazolinyl substituted benzo[b]thieno-2-carboxamides bearing either benzimidazole or benzothiazole subunit and biological activity are presented and described. The antiproliferative activities were assessed in vitro on a panel of human cancer cell lines. Tested compounds showed moderate activity while cytotoxicity on normal fibroblasts was lower in comparison with 5-fluorouracile. The variations of 2-imidazolinyl substituent at heteroaromatic subunits in different positions led to different cytotoxic properties. The strongest selective activity against HeLa cells was observed for the benzothiazole derivative 4d with 2-imidazolinyl group at the benzo[b]thiophene subunit with a corresponding IC50 = 1.16 M. Additionally, several biological experiments were performed to explain the mode of biological action. Fluorescence microscopy evidenced nuclear subcellular localization of compounds 3a, 4a and 4c. Additionally, detailed DNA binding studies confirmed a strong DNA groove binding for derivatives 4a and 4c while DNase I footprinting experiments evidenced sequence-selective binding of compound 4c in the A-T rich side. Furthermore, topoisomerase suppressive effect was for compounds 4a-4c.', 'Title: Novel amidino substituted benzimidazole and benzothiazole benzo[b]thieno-2-carboxamides exert strong antiproliferative and DNA binding properties.  Abstract: Within this manuscript design, synthesis of novel 2-imidazolinyl substituted benzo[b]thieno-2-carboxamides bearing either benzimidazole or benzothiazole subunit and biological activity are presented and described. The antiproliferative activities were assessed in vitro on a panel of human cancer cell lines. Tested compounds showed moderate activity while cytotoxicity on normal fibroblasts was lower in comparison with 5-fluorouracile. The variations of 2-imidazolinyl substituent at heteroaromatic subunits in different positions led to different cytotoxic properties. The strongest selective activity against HeLa cells was observed for the benzothiazole derivative 4d with 2-imidazolinyl group at the benzo[b]thiophene subunit with a corresponding IC50 = 1.16 M. Additionally, several biological experiments were performed to explain the mode of biological action. Fluorescence microscopy evidenced nuclear subcellular localization of compounds 3a, 4a and 4c. Additionally, detailed DNA binding studies confirmed a strong DNA groove binding for derivatives 4a and 4c while DNase I footprinting experiments evidenced sequence-selective binding of compound 4c in the A-T rich side. Furthermore, topoisomerase suppressive effect was for compounds 4a-4c.', 'Title: Novel amidino substituted benzimidazole and benzothiazole benzo[b]thieno-2-carboxamides exert strong antiproliferative and DNA binding properties.  Abstract: Within this manuscript design, synthesis of novel 2-imidazolinyl substituted benzo[b]thieno-2-carboxamides bearing either benzimidazole or benzothiazole subunit and biological activity are presented and described. The antiproliferative activities were assessed in vitro on a panel of human cancer cell lines. Tested compounds showed moderate activity while cytotoxicity on normal fibroblasts was lower in comparison with 5-fluorouracile. The variations of 2-imidazolinyl substituent at heteroaromatic subunits in different positions led to different cytotoxic properties. The strongest selective activity against HeLa cells was observed for the benzothiazole derivative 4d with 2-imidazolinyl group at the benzo[b]thiophene subunit with a corresponding IC50 = 1.16 M. Additionally, several biological experiments were performed to explain the mode of biological action. Fluorescence microscopy evidenced nuclear subcellular localization of compounds 3a, 4a and 4c. Additionally, detailed DNA binding studies confirmed a strong DNA groove binding for derivatives 4a and 4c while DNase I footprinting experiments evidenced sequence-selective binding of compound 4c in the A-T rich side. Furthermore, topoisomerase suppressive effect was for compounds 4a-4c.', 'Title: Synthesis of novel indole derivatives as promising DNA-binding agents and evaluation of antitumor and antitopoisomerase I activities.  Abstract: Molecules bearing indole nucleus present diverse biological properties such as antitumor and anti-inflammatory activities that can be associated both to DNA and protein interactions. This study focused on the synthesis of new indole derivatives with thiazolidines and imidazolidine rings condensed as side chains as well as the evaluation of their ability to interact with the DNA and antitumor and topoisomerase inhibition activities. All derivatives were successfully synthesized and their structures were elucidated by mass spectrometry (MS), infrared (IR), spectroscopy 1H NMR, 13C NMR, COSY 1H-1H and HSQC 1H-13C. The antitumor activity was evaluated against different cancer cell lines using the antiproliferative MTT assay. DNA binding ability was analyzed by absorption spectroscopy and fluorescence technique using ethidium bromide (EB) as a fluorescent probe. Changes were observed in spectroscopic properties of the compounds after interacting with ctDNA (calf thymus DNA), with hypochromic and hyperchromic effects, besides blue or red shifts in the maxima of spectra. The indole derivative 5-(1H-Indol-3-ylmethylene)-thiazolidin-2,4-dione (4c) presented the best results in antitumor assay against the breast line tested (T47D), with IC50 value lower than the positive control, doxorubicin (1.93 and 4.61 M, respectively). On the other hand, the compound 3-amino-5-(1H-indol-3-ylmethylene)-2-thioxo-thiazolidin-4-one (4a) was active against leukemia cell lines (HL60 and K562) with the high value of the DNA binding constant, Kb of 5.69  104. However, this compound (4a) did not inhibit the topoisomerase-I activity evaluated by relaxation assay. These results show that the indole nucleus contribute to the incorporation of molecules into the DNA. Moreover, it was highlighted that basic side chains, such as thiazolidines and imidazolidines, and free amino group, are relevant for design of promising antitumor and DNA binding compounds.', 'Genome wide protein coding siRNA screen for genes that enhance the effects of vemurafenib on cell viability and glycolysis in human BRAFV600 melanoma cells', 'Title: Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo.  Abstract: Inspired by the common structural characteristics of numerous known antitumor compounds targeting DNA or topoisomerase I, 3-(benzazol-2-yl)-quinoxaline-based scaffold was designed via the combination of two important privileged structure units -quinoxaline and benzazole. Thirty novel 3-(benzazol-2-yl)-quinoxaline derivatives were synthesized and evaluated for their biological activities. The MTT assay indicated that most compounds possessed moderate to potent antiproliferation effects against MGC-803, HepG2, A549, HeLa, T-24 and WI-38\\u202fcell lines. 3-(Benzoxazol- -2-yl)-2-(N-3-dimethylaminopropyl)aminoquinoxaline (12a) exhibited the most potent cytotoxicity, with IC50 values ranging from 1.49 to 10.99\\u202fM against the five tested cancer and one normal cell line. Agarose-gel electrophoresis assays suggested that 12a did not interact with intact DNA, but rather it strongly inhibited topoisomerase I (Topo I) via Topo I-mediated DNA unwinding to exert its anticancer activity. The molecular modeling study indicated that 12a adopt a unique mode to interact with DNA and Topo I. Detailed biological study of 12a in MGC-803\\u202fcells revealed that 12a could arrest the cell cycle in G2 phase, inducing the generation of reactive oxygen species (ROS), the fluctuation of intracellular Ca2+, and the loss of mitochondrial membrane potential (m). Western Blot analysis indicated that 12a-treatment could significantly up-regulate the levels of pro-apoptosis proteins Bak, Bax, and Bim, down-regulate anti-apoptosis proteins Bcl-2 and Bcl-xl, and increase levels of cyclin B1 and CDKs inhibitor p21, cytochrome c, caspase-3, caspase-9 and their activated form in MGC-803\\u202fcells in a dose-dependent manner to induce cell apoptosis via a caspase-dependent intrinsic mitochondria-mediated pathway. Studies in MGC-803 xenograft tumors models demonstrated that 12a could signicantly reduce tumor growth in vivo at doses as low as 6\\u202fmg/kg with low toxicity. Its convenient preparation and potent anticancer efficacy in vivo makes the 3-(benzazol-2-yl)quinoxaline scaffold a promising new chemistry entity for the development of novel chemotherapeutic agents.', 'Title: Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo.  Abstract: Inspired by the common structural characteristics of numerous known antitumor compounds targeting DNA or topoisomerase I, 3-(benzazol-2-yl)-quinoxaline-based scaffold was designed via the combination of two important privileged structure units -quinoxaline and benzazole. Thirty novel 3-(benzazol-2-yl)-quinoxaline derivatives were synthesized and evaluated for their biological activities. The MTT assay indicated that most compounds possessed moderate to potent antiproliferation effects against MGC-803, HepG2, A549, HeLa, T-24 and WI-38\\u202fcell lines. 3-(Benzoxazol- -2-yl)-2-(N-3-dimethylaminopropyl)aminoquinoxaline (12a) exhibited the most potent cytotoxicity, with IC50 values ranging from 1.49 to 10.99\\u202fM against the five tested cancer and one normal cell line. Agarose-gel electrophoresis assays suggested that 12a did not interact with intact DNA, but rather it strongly inhibited topoisomerase I (Topo I) via Topo I-mediated DNA unwinding to exert its anticancer activity. The molecular modeling study indicated that 12a adopt a unique mode to interact with DNA and Topo I. Detailed biological study of 12a in MGC-803\\u202fcells revealed that 12a could arrest the cell cycle in G2 phase, inducing the generation of reactive oxygen species (ROS), the fluctuation of intracellular Ca2+, and the loss of mitochondrial membrane potential (m). Western Blot analysis indicated that 12a-treatment could significantly up-regulate the levels of pro-apoptosis proteins Bak, Bax, and Bim, down-regulate anti-apoptosis proteins Bcl-2 and Bcl-xl, and increase levels of cyclin B1 and CDKs inhibitor p21, cytochrome c, caspase-3, caspase-9 and their activated form in MGC-803\\u202fcells in a dose-dependent manner to induce cell apoptosis via a caspase-dependent intrinsic mitochondria-mediated pathway. Studies in MGC-803 xenograft tumors models demonstrated that 12a could signicantly reduce tumor growth in vivo at doses as low as 6\\u202fmg/kg with low toxicity. Its convenient preparation and potent anticancer efficacy in vivo makes the 3-(benzazol-2-yl)quinoxaline scaffold a promising new chemistry entity for the development of novel chemotherapeutic agents.', 'Title: Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo.  Abstract: Inspired by the common structural characteristics of numerous known antitumor compounds targeting DNA or topoisomerase I, 3-(benzazol-2-yl)-quinoxaline-based scaffold was designed via the combination of two important privileged structure units -quinoxaline and benzazole. Thirty novel 3-(benzazol-2-yl)-quinoxaline derivatives were synthesized and evaluated for their biological activities. The MTT assay indicated that most compounds possessed moderate to potent antiproliferation effects against MGC-803, HepG2, A549, HeLa, T-24 and WI-38\\u202fcell lines. 3-(Benzoxazol- -2-yl)-2-(N-3-dimethylaminopropyl)aminoquinoxaline (12a) exhibited the most potent cytotoxicity, with IC50 values ranging from 1.49 to 10.99\\u202fM against the five tested cancer and one normal cell line. Agarose-gel electrophoresis assays suggested that 12a did not interact with intact DNA, but rather it strongly inhibited topoisomerase I (Topo I) via Topo I-mediated DNA unwinding to exert its anticancer activity. The molecular modeling study indicated that 12a adopt a unique mode to interact with DNA and Topo I. Detailed biological study of 12a in MGC-803\\u202fcells revealed that 12a could arrest the cell cycle in G2 phase, inducing the generation of reactive oxygen species (ROS), the fluctuation of intracellular Ca2+, and the loss of mitochondrial membrane potential (m). Western Blot analysis indicated that 12a-treatment could significantly up-regulate the levels of pro-apoptosis proteins Bak, Bax, and Bim, down-regulate anti-apoptosis proteins Bcl-2 and Bcl-xl, and increase levels of cyclin B1 and CDKs inhibitor p21, cytochrome c, caspase-3, caspase-9 and their activated form in MGC-803\\u202fcells in a dose-dependent manner to induce cell apoptosis via a caspase-dependent intrinsic mitochondria-mediated pathway. Studies in MGC-803 xenograft tumors models demonstrated that 12a could signicantly reduce tumor growth in vivo at doses as low as 6\\u202fmg/kg with low toxicity. Its convenient preparation and potent anticancer efficacy in vivo makes the 3-(benzazol-2-yl)quinoxaline scaffold a promising new chemistry entity for the development of novel chemotherapeutic agents.', 'Title: Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo.  Abstract: Inspired by the common structural characteristics of numerous known antitumor compounds targeting DNA or topoisomerase I, 3-(benzazol-2-yl)-quinoxaline-based scaffold was designed via the combination of two important privileged structure units -quinoxaline and benzazole. Thirty novel 3-(benzazol-2-yl)-quinoxaline derivatives were synthesized and evaluated for their biological activities. The MTT assay indicated that most compounds possessed moderate to potent antiproliferation effects against MGC-803, HepG2, A549, HeLa, T-24 and WI-38\\u202fcell lines. 3-(Benzoxazol- -2-yl)-2-(N-3-dimethylaminopropyl)aminoquinoxaline (12a) exhibited the most potent cytotoxicity, with IC50 values ranging from 1.49 to 10.99\\u202fM against the five tested cancer and one normal cell line. Agarose-gel electrophoresis assays suggested that 12a did not interact with intact DNA, but rather it strongly inhibited topoisomerase I (Topo I) via Topo I-mediated DNA unwinding to exert its anticancer activity. The molecular modeling study indicated that 12a adopt a unique mode to interact with DNA and Topo I. Detailed biological study of 12a in MGC-803\\u202fcells revealed that 12a could arrest the cell cycle in G2 phase, inducing the generation of reactive oxygen species (ROS), the fluctuation of intracellular Ca2+, and the loss of mitochondrial membrane potential (m). Western Blot analysis indicated that 12a-treatment could significantly up-regulate the levels of pro-apoptosis proteins Bak, Bax, and Bim, down-regulate anti-apoptosis proteins Bcl-2 and Bcl-xl, and increase levels of cyclin B1 and CDKs inhibitor p21, cytochrome c, caspase-3, caspase-9 and their activated form in MGC-803\\u202fcells in a dose-dependent manner to induce cell apoptosis via a caspase-dependent intrinsic mitochondria-mediated pathway. Studies in MGC-803 xenograft tumors models demonstrated that 12a could signicantly reduce tumor growth in vivo at doses as low as 6\\u202fmg/kg with low toxicity. Its convenient preparation and potent anticancer efficacy in vivo makes the 3-(benzazol-2-yl)quinoxaline scaffold a promising new chemistry entity for the development of novel chemotherapeutic agents.', 'Title: Synthesis and biological evaluation of pyrazole linked benzothiazole--naphthol derivatives as topoisomerase I inhibitors with DNA binding ability.  Abstract: A series of new pyrazole linked benzothiazole--naphthol derivatives were designed and synthesized using a simple, efficient and ecofriendly route under catalyst-free conditions in good to excellent yields. These derivatives were evaluated for their cytotoxicity on selected human cancer cell lines. Among those, the derivatives 4j, 4k and 4l exhibited considerable cytotoxicity with IC50 values ranging between 4.63 and 5.54\\u202fM against human cervical cancer cells (HeLa). Structure activity relationship was elucidated by varying different substituents on benzothiazoles and pyrazoles. Further, flow cytometric analysis revealed that these derivatives induced cell cycle arrest in G2/M phase and spectroscopic studies such as UV-visible, fluorescence and circular dichroism studies showed that these derivatives exhibited good DNA binding affinity. Additionally, these derivatives can effectively inhibit the topoisomerase I activity. Viscosity studies and molecular docking studies demonstrated that the derivatives bind with the minor groove of the DNA.', 'Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.', 'Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.', 'Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.', 'Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.', 'Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.', 'Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.', 'Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.', 'Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.', 'Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.', 'Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.', 'Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.', 'Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.', 'Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.', 'Title: Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.  Abstract: To overcome chemical limitations of camptothecin (CPT), we report design, synthesis, and validation of a quinoline-based novel class of topoisomerase 1 (Top1) inhibitors and establish that compound 28 ( N-(3-(1 H-imidazol-1-yl)propyl)-6-(4-methoxyphenyl)-3-(1,3,4-oxadiazol-2-yl)quinolin-4-amine) exhibits the highest potency in inhibiting human Top1 activity with an IC<sub>50</sub> value of 29  0.04 nM. Compound 28 traps Top1-DNA cleavage complexes (Top1ccs) both in the in vitro cleavage assays and in live cells. Point mutation of Top1-N722S fails to trap compound 28-induced Top1cc because of its inability to form a hydrogen bond with compound 28. Unlike CPT, compound 28 shows excellent plasma serum stability and is not a substrate of P-glycoprotein 1 (permeability glycoprotein) advancing its potential anticancer activity. Finally, we provide evidence that compound 28 overcomes the chemical instability of CPT in human breast adenocarcinoma cells through generation of persistent and less reversible Top1cc-induced DNA double-strand breaks as detected by H2AX foci immunostaining after 5 h of drug removal.', 'Title: Probing structural requirements for human topoisomerase I inhibition by a novel N1-Biphenyl fluoroquinolone.  Abstract: Fluoroquinolones substituted with N-1 biphenyl and napthyl groups were discovered to act as catalytically inhibitors of human topoisomerases I and II, and to possess anti-proliferative activity in vivo. Structural requirements for these novel quinolones to inhibit catalytic activity of human topoisomerase I have not been explored. In this work novel derivatives of the N-1 biphenyl fluoroquinolone were designed, synthesized and evaluated to understand structural requirements of the C-3 carboxylic acid, C-6 fluorine, C-7 aminomethylpyrrolidine, C-8 methoxy, and the N-1 biphenyl functional groups for hTopoI inhibition. Characterization of each analog for inhibition of hTopoI catalytic inhibition reveals critical insight into structural requirements of these novel quinolones for activity. Additionally, results of DNA binding and modeling studies suggest that N-1 biphenyl fluoroquinolones intercalate between the DNA base pairs with the N-1 biphenyl functional group, rather than the quinolone core, and that this mode of DNA intercalation contributes to inhibition of hTopoI by these novel structures. The results presented here support further development and evaluation of N-1 biphenyl fluoroquinolone analogs as a novel class of anti-cancer agents that act through catalytic inhibition of hTopoI.', 'Title: Probing structural requirements for human topoisomerase I inhibition by a novel N1-Biphenyl fluoroquinolone.  Abstract: Fluoroquinolones substituted with N-1 biphenyl and napthyl groups were discovered to act as catalytically inhibitors of human topoisomerases I and II, and to possess anti-proliferative activity in vivo. Structural requirements for these novel quinolones to inhibit catalytic activity of human topoisomerase I have not been explored. In this work novel derivatives of the N-1 biphenyl fluoroquinolone were designed, synthesized and evaluated to understand structural requirements of the C-3 carboxylic acid, C-6 fluorine, C-7 aminomethylpyrrolidine, C-8 methoxy, and the N-1 biphenyl functional groups for hTopoI inhibition. Characterization of each analog for inhibition of hTopoI catalytic inhibition reveals critical insight into structural requirements of these novel quinolones for activity. Additionally, results of DNA binding and modeling studies suggest that N-1 biphenyl fluoroquinolones intercalate between the DNA base pairs with the N-1 biphenyl functional group, rather than the quinolone core, and that this mode of DNA intercalation contributes to inhibition of hTopoI by these novel structures. The results presented here support further development and evaluation of N-1 biphenyl fluoroquinolone analogs as a novel class of anti-cancer agents that act through catalytic inhibition of hTopoI.', 'Title: Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y.  Abstract: Ganoderma lucidum is a multi-purpose plant medicine that is homologous to functional food. The most attractive properties of G. lucidum are its immunomodulatory and antitumour activities, which are mainly attributed to the following two major active components: G. lucidum polysaccharides and G. lucidum triterpenoids (GLTs). GLTs are effective as supplemental therapies and improve health when combined with other medications to treat hepatitis, fatigue syndrome, and prostate cancer. However, research investigating the mechanism and application of G. lucidum or GLTs in the treatment of diseases remains preliminary in terms of both the utilization efficacy and product type. This review offers comprehensive insight into the pharmacological activities of GLTs and their potential applications in the development of functional foods and nutraceuticals. Specifically, 83 GLTs were selected, and their molecular structures and chemical formulas were described. We also describe 7 ganoderic acids that are currently at different stages of clinical trials (ganoderic acids A, C2, D, F, DM, X and Y). The related pharmacodynamic mechanisms and targeted signalling proteins were further analysed. Notably, the specific relationship between autophagy and apoptosis induced by ganoderic acid DM is summarized here for the first time.', 'Title: Design, Synthesis, and Biological Evaluation of HSP90 Inhibitor-SN38 Conjugates for Targeted Drug Accumulation.  Abstract: Herein, a series of HSP90 inhibitor-SN38 conjugates through ester and carbamate linkage in the 20-OH and 10-OH positions of SN38 were developed for improving the tumor-specific penetration and accumulation of SN38 via extracellular HSP90 (eHSP90)-mediated endocytosis. Mechanistic analyses confirmed that these novel conjugates could bind to eHSP90 and be selectively internalized into the tumor cells, which led to prolonged tumor regression in multiple models of cancer. Among all studied conjugates, compound 18b showed excellent in vitro activities, including acceptable HSP90 affinity and potent antitumor activity. Moreover, compound 18b exhibited superior antitumor activity and low toxicity in HCT116 and Capan-1 xenograft models. Pharmacokinetic analyses in HCT116 and Capan-1 xenografts further confirmed that compound 18b treatment could lead to effective cleavage and extended SN38 exposure at tumor sites. All these encouraging data indicate that this compound is a promising new candidate for cancer therapy and merits further chemical and biological evaluation.', 'Title: Design, Synthesis, and Biological Evaluation of HSP90 Inhibitor-SN38 Conjugates for Targeted Drug Accumulation.  Abstract: Herein, a series of HSP90 inhibitor-SN38 conjugates through ester and carbamate linkage in the 20-OH and 10-OH positions of SN38 were developed for improving the tumor-specific penetration and accumulation of SN38 via extracellular HSP90 (eHSP90)-mediated endocytosis. Mechanistic analyses confirmed that these novel conjugates could bind to eHSP90 and be selectively internalized into the tumor cells, which led to prolonged tumor regression in multiple models of cancer. Among all studied conjugates, compound 18b showed excellent in vitro activities, including acceptable HSP90 affinity and potent antitumor activity. Moreover, compound 18b exhibited superior antitumor activity and low toxicity in HCT116 and Capan-1 xenograft models. Pharmacokinetic analyses in HCT116 and Capan-1 xenografts further confirmed that compound 18b treatment could lead to effective cleavage and extended SN38 exposure at tumor sites. All these encouraging data indicate that this compound is a promising new candidate for cancer therapy and merits further chemical and biological evaluation.', 'Title: Design, Synthesis, and Biological Evaluation of HSP90 Inhibitor-SN38 Conjugates for Targeted Drug Accumulation.  Abstract: Herein, a series of HSP90 inhibitor-SN38 conjugates through ester and carbamate linkage in the 20-OH and 10-OH positions of SN38 were developed for improving the tumor-specific penetration and accumulation of SN38 via extracellular HSP90 (eHSP90)-mediated endocytosis. Mechanistic analyses confirmed that these novel conjugates could bind to eHSP90 and be selectively internalized into the tumor cells, which led to prolonged tumor regression in multiple models of cancer. Among all studied conjugates, compound 18b showed excellent in vitro activities, including acceptable HSP90 affinity and potent antitumor activity. Moreover, compound 18b exhibited superior antitumor activity and low toxicity in HCT116 and Capan-1 xenograft models. Pharmacokinetic analyses in HCT116 and Capan-1 xenografts further confirmed that compound 18b treatment could lead to effective cleavage and extended SN38 exposure at tumor sites. All these encouraging data indicate that this compound is a promising new candidate for cancer therapy and merits further chemical and biological evaluation.', 'Title: Design, Synthesis, and Biological Evaluation of HSP90 Inhibitor-SN38 Conjugates for Targeted Drug Accumulation.  Abstract: Herein, a series of HSP90 inhibitor-SN38 conjugates through ester and carbamate linkage in the 20-OH and 10-OH positions of SN38 were developed for improving the tumor-specific penetration and accumulation of SN38 via extracellular HSP90 (eHSP90)-mediated endocytosis. Mechanistic analyses confirmed that these novel conjugates could bind to eHSP90 and be selectively internalized into the tumor cells, which led to prolonged tumor regression in multiple models of cancer. Among all studied conjugates, compound 18b showed excellent in vitro activities, including acceptable HSP90 affinity and potent antitumor activity. Moreover, compound 18b exhibited superior antitumor activity and low toxicity in HCT116 and Capan-1 xenograft models. Pharmacokinetic analyses in HCT116 and Capan-1 xenografts further confirmed that compound 18b treatment could lead to effective cleavage and extended SN38 exposure at tumor sites. All these encouraging data indicate that this compound is a promising new candidate for cancer therapy and merits further chemical and biological evaluation.', 'Title: Design, Synthesis, and Biological Evaluation of HSP90 Inhibitor-SN38 Conjugates for Targeted Drug Accumulation.  Abstract: Herein, a series of HSP90 inhibitor-SN38 conjugates through ester and carbamate linkage in the 20-OH and 10-OH positions of SN38 were developed for improving the tumor-specific penetration and accumulation of SN38 via extracellular HSP90 (eHSP90)-mediated endocytosis. Mechanistic analyses confirmed that these novel conjugates could bind to eHSP90 and be selectively internalized into the tumor cells, which led to prolonged tumor regression in multiple models of cancer. Among all studied conjugates, compound 18b showed excellent in vitro activities, including acceptable HSP90 affinity and potent antitumor activity. Moreover, compound 18b exhibited superior antitumor activity and low toxicity in HCT116 and Capan-1 xenograft models. Pharmacokinetic analyses in HCT116 and Capan-1 xenografts further confirmed that compound 18b treatment could lead to effective cleavage and extended SN38 exposure at tumor sites. All these encouraging data indicate that this compound is a promising new candidate for cancer therapy and merits further chemical and biological evaluation.', 'Title: Design, Synthesis, and Biological Evaluation of HSP90 Inhibitor-SN38 Conjugates for Targeted Drug Accumulation.  Abstract: Herein, a series of HSP90 inhibitor-SN38 conjugates through ester and carbamate linkage in the 20-OH and 10-OH positions of SN38 were developed for improving the tumor-specific penetration and accumulation of SN38 via extracellular HSP90 (eHSP90)-mediated endocytosis. Mechanistic analyses confirmed that these novel conjugates could bind to eHSP90 and be selectively internalized into the tumor cells, which led to prolonged tumor regression in multiple models of cancer. Among all studied conjugates, compound 18b showed excellent in vitro activities, including acceptable HSP90 affinity and potent antitumor activity. Moreover, compound 18b exhibited superior antitumor activity and low toxicity in HCT116 and Capan-1 xenograft models. Pharmacokinetic analyses in HCT116 and Capan-1 xenografts further confirmed that compound 18b treatment could lead to effective cleavage and extended SN38 exposure at tumor sites. All these encouraging data indicate that this compound is a promising new candidate for cancer therapy and merits further chemical and biological evaluation.', 'Title: Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones.  Abstract: This work describes the synthesis of hybrid tetrahydro-1,5-naphthyridine and 1,5-naphthyridine derivatives fused with heterocycles such as chromenes and chromen-2-ones or coumarins, which were synthesized in good to high general yields. The synthetic route involves an intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and aldehydes containing a double or triple carbon-carbon bond in orto position and allows the selective generation of three stereogenic centers in a short, efficient and reliable synthesis. The subsequent dehydrogenation of the fused tetrahydrochromeno[4,3-b][1,5]naphthyridines and/or tetrahydrochromeno[4,3-b][1,5]naphthyridin-6-ones leads to the formation of the corresponding tetracyclic chromeno[4,3-b][1,5]naphthyridine derivatives and/or chromeno[4,3-b][1,5]naphthyridin-6-ones in quantitative yields. Some of the prepared products showed activity as inhibitors of Topoisomerase I (TopI). Additionally, the cytotoxic behavior of these compounds has been studied in cell lines derived from human lung adenocarcinoma (A549) and human ovarian carcinoma (SKOV03), and on non-cancerous lung fibroblasts cell line (MRC5) where, on the last ones, the absence of cytotoxicity was observed. 7-Phenyl-6H-6a,7,12,12a-tetrahydrochromeno[4,3-b][1,5]naphthyridine 5a showed excellent cytotoxic activity with a IC<sub>50</sub> value of 1.03\\u202f\\u202f0.30\\u202fM against the A549\\u202fcell line and a IC<sub>50</sub> value of 1.75\\u202f\\u202f0.20\\u202fM against the SKOV03\\u202fcell line. The obtained results point to these compounds as good antiproliferative candidates.', 'Title: Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones.  Abstract: This work describes the synthesis of hybrid tetrahydro-1,5-naphthyridine and 1,5-naphthyridine derivatives fused with heterocycles such as chromenes and chromen-2-ones or coumarins, which were synthesized in good to high general yields. The synthetic route involves an intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and aldehydes containing a double or triple carbon-carbon bond in orto position and allows the selective generation of three stereogenic centers in a short, efficient and reliable synthesis. The subsequent dehydrogenation of the fused tetrahydrochromeno[4,3-b][1,5]naphthyridines and/or tetrahydrochromeno[4,3-b][1,5]naphthyridin-6-ones leads to the formation of the corresponding tetracyclic chromeno[4,3-b][1,5]naphthyridine derivatives and/or chromeno[4,3-b][1,5]naphthyridin-6-ones in quantitative yields. Some of the prepared products showed activity as inhibitors of Topoisomerase I (TopI). Additionally, the cytotoxic behavior of these compounds has been studied in cell lines derived from human lung adenocarcinoma (A549) and human ovarian carcinoma (SKOV03), and on non-cancerous lung fibroblasts cell line (MRC5) where, on the last ones, the absence of cytotoxicity was observed. 7-Phenyl-6H-6a,7,12,12a-tetrahydrochromeno[4,3-b][1,5]naphthyridine 5a showed excellent cytotoxic activity with a IC<sub>50</sub> value of 1.03\\u202f\\u202f0.30\\u202fM against the A549\\u202fcell line and a IC<sub>50</sub> value of 1.75\\u202f\\u202f0.20\\u202fM against the SKOV03\\u202fcell line. The obtained results point to these compounds as good antiproliferative candidates.', 'Title: Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones.  Abstract: This work describes the synthesis of hybrid tetrahydro-1,5-naphthyridine and 1,5-naphthyridine derivatives fused with heterocycles such as chromenes and chromen-2-ones or coumarins, which were synthesized in good to high general yields. The synthetic route involves an intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and aldehydes containing a double or triple carbon-carbon bond in orto position and allows the selective generation of three stereogenic centers in a short, efficient and reliable synthesis. The subsequent dehydrogenation of the fused tetrahydrochromeno[4,3-b][1,5]naphthyridines and/or tetrahydrochromeno[4,3-b][1,5]naphthyridin-6-ones leads to the formation of the corresponding tetracyclic chromeno[4,3-b][1,5]naphthyridine derivatives and/or chromeno[4,3-b][1,5]naphthyridin-6-ones in quantitative yields. Some of the prepared products showed activity as inhibitors of Topoisomerase I (TopI). Additionally, the cytotoxic behavior of these compounds has been studied in cell lines derived from human lung adenocarcinoma (A549) and human ovarian carcinoma (SKOV03), and on non-cancerous lung fibroblasts cell line (MRC5) where, on the last ones, the absence of cytotoxicity was observed. 7-Phenyl-6H-6a,7,12,12a-tetrahydrochromeno[4,3-b][1,5]naphthyridine 5a showed excellent cytotoxic activity with a IC<sub>50</sub> value of 1.03\\u202f\\u202f0.30\\u202fM against the A549\\u202fcell line and a IC<sub>50</sub> value of 1.75\\u202f\\u202f0.20\\u202fM against the SKOV03\\u202fcell line. The obtained results point to these compounds as good antiproliferative candidates.', 'Title: Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones.  Abstract: This work describes the synthesis of hybrid tetrahydro-1,5-naphthyridine and 1,5-naphthyridine derivatives fused with heterocycles such as chromenes and chromen-2-ones or coumarins, which were synthesized in good to high general yields. The synthetic route involves an intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and aldehydes containing a double or triple carbon-carbon bond in orto position and allows the selective generation of three stereogenic centers in a short, efficient and reliable synthesis. The subsequent dehydrogenation of the fused tetrahydrochromeno[4,3-b][1,5]naphthyridines and/or tetrahydrochromeno[4,3-b][1,5]naphthyridin-6-ones leads to the formation of the corresponding tetracyclic chromeno[4,3-b][1,5]naphthyridine derivatives and/or chromeno[4,3-b][1,5]naphthyridin-6-ones in quantitative yields. Some of the prepared products showed activity as inhibitors of Topoisomerase I (TopI). Additionally, the cytotoxic behavior of these compounds has been studied in cell lines derived from human lung adenocarcinoma (A549) and human ovarian carcinoma (SKOV03), and on non-cancerous lung fibroblasts cell line (MRC5) where, on the last ones, the absence of cytotoxicity was observed. 7-Phenyl-6H-6a,7,12,12a-tetrahydrochromeno[4,3-b][1,5]naphthyridine 5a showed excellent cytotoxic activity with a IC<sub>50</sub> value of 1.03\\u202f\\u202f0.30\\u202fM against the A549\\u202fcell line and a IC<sub>50</sub> value of 1.75\\u202f\\u202f0.20\\u202fM against the SKOV03\\u202fcell line. The obtained results point to these compounds as good antiproliferative candidates.', 'Title: Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones.  Abstract: This work describes the synthesis of hybrid tetrahydro-1,5-naphthyridine and 1,5-naphthyridine derivatives fused with heterocycles such as chromenes and chromen-2-ones or coumarins, which were synthesized in good to high general yields. The synthetic route involves an intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and aldehydes containing a double or triple carbon-carbon bond in orto position and allows the selective generation of three stereogenic centers in a short, efficient and reliable synthesis. The subsequent dehydrogenation of the fused tetrahydrochromeno[4,3-b][1,5]naphthyridines and/or tetrahydrochromeno[4,3-b][1,5]naphthyridin-6-ones leads to the formation of the corresponding tetracyclic chromeno[4,3-b][1,5]naphthyridine derivatives and/or chromeno[4,3-b][1,5]naphthyridin-6-ones in quantitative yields. Some of the prepared products showed activity as inhibitors of Topoisomerase I (TopI). Additionally, the cytotoxic behavior of these compounds has been studied in cell lines derived from human lung adenocarcinoma (A549) and human ovarian carcinoma (SKOV03), and on non-cancerous lung fibroblasts cell line (MRC5) where, on the last ones, the absence of cytotoxicity was observed. 7-Phenyl-6H-6a,7,12,12a-tetrahydrochromeno[4,3-b][1,5]naphthyridine 5a showed excellent cytotoxic activity with a IC<sub>50</sub> value of 1.03\\u202f\\u202f0.30\\u202fM against the A549\\u202fcell line and a IC<sub>50</sub> value of 1.75\\u202f\\u202f0.20\\u202fM against the SKOV03\\u202fcell line. The obtained results point to these compounds as good antiproliferative candidates.', 'Title: Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones.  Abstract: This work describes the synthesis of hybrid tetrahydro-1,5-naphthyridine and 1,5-naphthyridine derivatives fused with heterocycles such as chromenes and chromen-2-ones or coumarins, which were synthesized in good to high general yields. The synthetic route involves an intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and aldehydes containing a double or triple carbon-carbon bond in orto position and allows the selective generation of three stereogenic centers in a short, efficient and reliable synthesis. The subsequent dehydrogenation of the fused tetrahydrochromeno[4,3-b][1,5]naphthyridines and/or tetrahydrochromeno[4,3-b][1,5]naphthyridin-6-ones leads to the formation of the corresponding tetracyclic chromeno[4,3-b][1,5]naphthyridine derivatives and/or chromeno[4,3-b][1,5]naphthyridin-6-ones in quantitative yields. Some of the prepared products showed activity as inhibitors of Topoisomerase I (TopI). Additionally, the cytotoxic behavior of these compounds has been studied in cell lines derived from human lung adenocarcinoma (A549) and human ovarian carcinoma (SKOV03), and on non-cancerous lung fibroblasts cell line (MRC5) where, on the last ones, the absence of cytotoxicity was observed. 7-Phenyl-6H-6a,7,12,12a-tetrahydrochromeno[4,3-b][1,5]naphthyridine 5a showed excellent cytotoxic activity with a IC<sub>50</sub> value of 1.03\\u202f\\u202f0.30\\u202fM against the A549\\u202fcell line and a IC<sub>50</sub> value of 1.75\\u202f\\u202f0.20\\u202fM against the SKOV03\\u202fcell line. The obtained results point to these compounds as good antiproliferative candidates.', 'Title: Benzothienoquinazolinones as new multi-target scaffolds: Dual inhibition of human Topoisomerase I and tubulin polymerization.  Abstract: 3-(Alkyl(dialkyl)amino)benzothieno[2,3-f]quinazolin-1(2H)-ones (4-9) have been designed using Ellipticine structure as a model, replacing the carbazole core and the pyridine ring with a dibenzothiophene and a pyrimidine moiety, respectively. New benzothienoquinazolinones (4-9) have been synthesized by a simple one-pot reaction employing 3-aminodibenzothiophene as starting material. The benzothienoquinazolinones obtained (4-9), were evaluated for their anticancer activity against two breast cancer cell lines, MDA-MB-231 and MCF-7. The results revealed that compounds 4 and 7 presented a good antitumor activity toward the triple negative MDA-MB-231, without cytotoxicity against non-tumoral cells. Furthermore, the compounds 4 and 7 can be considered important molecular multi-target tools for their dual inhibition of different cellular proteins, i.e. Tubulin and human Topoisomerase I, involved in relevant cellular processes, as predicted by in silico studies and demonstrated by in vitro assays (for compound 4).', 'Title: Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors.  Abstract: DNA topoisomerase IB (TOP1) regulates DNA topological structure in many cellular metabolic processes and is a validated target for development of antitumor agents. Our previous study revealed that the benzophenanthridone scaffold is a novel chemotype for the discovery of TOP1 inhibitors. In this work, a series of novel 5-aminoethyl substituted benzophenanthridone derivatives have been synthesized and evaluated for TOP1 inhibition and cytotoxicity. Compound 12 exhibits the most potent TOP1 inhibition (+++) and cytotoxicity in human cancer cell lines with GI<sub>50</sub> values at nanomolar concentration range. 12 induces the cellular TOP1cc formation and DNA damage, resulting in HCT116\\u202fcell apoptosis. The pharmacokinetics, acute toxicity and antitumor efficiency in vivo of 12 were also studied.', 'Title: Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors.  Abstract: DNA topoisomerase IB (TOP1) regulates DNA topological structure in many cellular metabolic processes and is a validated target for development of antitumor agents. Our previous study revealed that the benzophenanthridone scaffold is a novel chemotype for the discovery of TOP1 inhibitors. In this work, a series of novel 5-aminoethyl substituted benzophenanthridone derivatives have been synthesized and evaluated for TOP1 inhibition and cytotoxicity. Compound 12 exhibits the most potent TOP1 inhibition (+++) and cytotoxicity in human cancer cell lines with GI<sub>50</sub> values at nanomolar concentration range. 12 induces the cellular TOP1cc formation and DNA damage, resulting in HCT116\\u202fcell apoptosis. The pharmacokinetics, acute toxicity and antitumor efficiency in vivo of 12 were also studied.', 'Title: Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors.  Abstract: DNA topoisomerase IB (TOP1) regulates DNA topological structure in many cellular metabolic processes and is a validated target for development of antitumor agents. Our previous study revealed that the benzophenanthridone scaffold is a novel chemotype for the discovery of TOP1 inhibitors. In this work, a series of novel 5-aminoethyl substituted benzophenanthridone derivatives have been synthesized and evaluated for TOP1 inhibition and cytotoxicity. Compound 12 exhibits the most potent TOP1 inhibition (+++) and cytotoxicity in human cancer cell lines with GI<sub>50</sub> values at nanomolar concentration range. 12 induces the cellular TOP1cc formation and DNA damage, resulting in HCT116\\u202fcell apoptosis. The pharmacokinetics, acute toxicity and antitumor efficiency in vivo of 12 were also studied.', 'Title: Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors.  Abstract: DNA topoisomerase IB (TOP1) regulates DNA topological structure in many cellular metabolic processes and is a validated target for development of antitumor agents. Our previous study revealed that the benzophenanthridone scaffold is a novel chemotype for the discovery of TOP1 inhibitors. In this work, a series of novel 5-aminoethyl substituted benzophenanthridone derivatives have been synthesized and evaluated for TOP1 inhibition and cytotoxicity. Compound 12 exhibits the most potent TOP1 inhibition (+++) and cytotoxicity in human cancer cell lines with GI<sub>50</sub> values at nanomolar concentration range. 12 induces the cellular TOP1cc formation and DNA damage, resulting in HCT116\\u202fcell apoptosis. The pharmacokinetics, acute toxicity and antitumor efficiency in vivo of 12 were also studied.', 'Title: Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors.  Abstract: DNA topoisomerase IB (TOP1) regulates DNA topological structure in many cellular metabolic processes and is a validated target for development of antitumor agents. Our previous study revealed that the benzophenanthridone scaffold is a novel chemotype for the discovery of TOP1 inhibitors. In this work, a series of novel 5-aminoethyl substituted benzophenanthridone derivatives have been synthesized and evaluated for TOP1 inhibition and cytotoxicity. Compound 12 exhibits the most potent TOP1 inhibition (+++) and cytotoxicity in human cancer cell lines with GI<sub>50</sub> values at nanomolar concentration range. 12 induces the cellular TOP1cc formation and DNA damage, resulting in HCT116\\u202fcell apoptosis. The pharmacokinetics, acute toxicity and antitumor efficiency in vivo of 12 were also studied.', 'Title: Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors.  Abstract: DNA topoisomerase IB (TOP1) regulates DNA topological structure in many cellular metabolic processes and is a validated target for development of antitumor agents. Our previous study revealed that the benzophenanthridone scaffold is a novel chemotype for the discovery of TOP1 inhibitors. In this work, a series of novel 5-aminoethyl substituted benzophenanthridone derivatives have been synthesized and evaluated for TOP1 inhibition and cytotoxicity. Compound 12 exhibits the most potent TOP1 inhibition (+++) and cytotoxicity in human cancer cell lines with GI<sub>50</sub> values at nanomolar concentration range. 12 induces the cellular TOP1cc formation and DNA damage, resulting in HCT116\\u202fcell apoptosis. The pharmacokinetics, acute toxicity and antitumor efficiency in vivo of 12 were also studied.', 'Title: Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2-<i>b</i>]pyridinol Derivatives as Potent Topoisomerase II-Targeted Chemotherapeutic Agents for Breast Cancer.  Abstract: With the aim of developing new effective topoisomerase II-targeted anticancer agents, we synthesized a series of hydroxy- and halogenated 2,4-diphenyl indeno[1,2-<i>b</i>]pyridinols using a microwave-assisted single step synthetic method and investigated structure-activity relationships. The majority of compounds with chlorophenyl group at 2-position and phenol group at the 4-position of indeno[1,2-<i>b</i>]pyridinols exhibited potent antiproliferative activity and topoisomerase II-selective inhibition. Of the 172 compounds tested, <b>89</b> showed highly potent and selective topoisomerase II inhibition and antiproliferative activity in the nanomolar range against human T47D breast (2.6 nM) cancer cell lines. In addition, mechanistic studies revealed compound <b>89</b> is a nonintercalative topoisomerase II poison, and in vitro studies showed it had promising cytotoxic effects in diverse breast cancer cell lines and was particularly effective at inducing apoptosis in T47D cells. Furthermore, in vivo administration of compound <b>89</b> had significant antitumor effects in orthotopic mouse model of breast cancer.', 'Title: Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2-<i>b</i>]pyridinol Derivatives as Potent Topoisomerase II-Targeted Chemotherapeutic Agents for Breast Cancer.  Abstract: With the aim of developing new effective topoisomerase II-targeted anticancer agents, we synthesized a series of hydroxy- and halogenated 2,4-diphenyl indeno[1,2-<i>b</i>]pyridinols using a microwave-assisted single step synthetic method and investigated structure-activity relationships. The majority of compounds with chlorophenyl group at 2-position and phenol group at the 4-position of indeno[1,2-<i>b</i>]pyridinols exhibited potent antiproliferative activity and topoisomerase II-selective inhibition. Of the 172 compounds tested, <b>89</b> showed highly potent and selective topoisomerase II inhibition and antiproliferative activity in the nanomolar range against human T47D breast (2.6 nM) cancer cell lines. In addition, mechanistic studies revealed compound <b>89</b> is a nonintercalative topoisomerase II poison, and in vitro studies showed it had promising cytotoxic effects in diverse breast cancer cell lines and was particularly effective at inducing apoptosis in T47D cells. Furthermore, in vivo administration of compound <b>89</b> had significant antitumor effects in orthotopic mouse model of breast cancer.', 'Title: Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents.  Abstract: Heterocyclic compounds, such as hybrid tetrahydroquinoline and quinoline derivatives with phosphorated groups, have been prepared by multicomponent cycloaddition reaction between phosphorus-substituted anilines, aldehydes and styrenes. The antileishmanial activity of these compounds has been evaluated on both promastigotes and intramacrophagic amastigotes of Leishmania infantum. Good antileishmanial activity of functionalized tetrahydroquinolines 4a, 5a, 6b and quinoline 8b has been observed with similar activity than the standard drug amphotericin B and close selective index (SI between 43 and 57) towards L. infantum amastigotes to amphotericin B. Special interest shows tetrahydroquinolylphosphine sulfide 5a with an EC<sub>50</sub> value (0.61\\u202f\\u202f0.18\\u202fM) similar to the standard drug amphotericin B (0.32\\u202f\\u202f0.05\\u202fM) and selective index (SI\\u202f=\\u202f56.87). In addition, compound 4c shows remarkable inhibition on Leishmania topoisomerase IB. Parallel theoretical study of stereoelectronic properties, application of docking-based virtual screening methods, along with molecular electrostatic potential and predictive druggability analyses are also reported.', 'Title: Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents.  Abstract: Heterocyclic compounds, such as hybrid tetrahydroquinoline and quinoline derivatives with phosphorated groups, have been prepared by multicomponent cycloaddition reaction between phosphorus-substituted anilines, aldehydes and styrenes. The antileishmanial activity of these compounds has been evaluated on both promastigotes and intramacrophagic amastigotes of Leishmania infantum. Good antileishmanial activity of functionalized tetrahydroquinolines 4a, 5a, 6b and quinoline 8b has been observed with similar activity than the standard drug amphotericin B and close selective index (SI between 43 and 57) towards L. infantum amastigotes to amphotericin B. Special interest shows tetrahydroquinolylphosphine sulfide 5a with an EC<sub>50</sub> value (0.61\\u202f\\u202f0.18\\u202fM) similar to the standard drug amphotericin B (0.32\\u202f\\u202f0.05\\u202fM) and selective index (SI\\u202f=\\u202f56.87). In addition, compound 4c shows remarkable inhibition on Leishmania topoisomerase IB. Parallel theoretical study of stereoelectronic properties, application of docking-based virtual screening methods, along with molecular electrostatic potential and predictive druggability analyses are also reported.', 'Title: Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents.  Abstract: Heterocyclic compounds, such as hybrid tetrahydroquinoline and quinoline derivatives with phosphorated groups, have been prepared by multicomponent cycloaddition reaction between phosphorus-substituted anilines, aldehydes and styrenes. The antileishmanial activity of these compounds has been evaluated on both promastigotes and intramacrophagic amastigotes of Leishmania infantum. Good antileishmanial activity of functionalized tetrahydroquinolines 4a, 5a, 6b and quinoline 8b has been observed with similar activity than the standard drug amphotericin B and close selective index (SI between 43 and 57) towards L. infantum amastigotes to amphotericin B. Special interest shows tetrahydroquinolylphosphine sulfide 5a with an EC<sub>50</sub> value (0.61\\u202f\\u202f0.18\\u202fM) similar to the standard drug amphotericin B (0.32\\u202f\\u202f0.05\\u202fM) and selective index (SI\\u202f=\\u202f56.87). In addition, compound 4c shows remarkable inhibition on Leishmania topoisomerase IB. Parallel theoretical study of stereoelectronic properties, application of docking-based virtual screening methods, along with molecular electrostatic potential and predictive druggability analyses are also reported.', 'Title: Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents.  Abstract: Heterocyclic compounds, such as hybrid tetrahydroquinoline and quinoline derivatives with phosphorated groups, have been prepared by multicomponent cycloaddition reaction between phosphorus-substituted anilines, aldehydes and styrenes. The antileishmanial activity of these compounds has been evaluated on both promastigotes and intramacrophagic amastigotes of Leishmania infantum. Good antileishmanial activity of functionalized tetrahydroquinolines 4a, 5a, 6b and quinoline 8b has been observed with similar activity than the standard drug amphotericin B and close selective index (SI between 43 and 57) towards L. infantum amastigotes to amphotericin B. Special interest shows tetrahydroquinolylphosphine sulfide 5a with an EC<sub>50</sub> value (0.61\\u202f\\u202f0.18\\u202fM) similar to the standard drug amphotericin B (0.32\\u202f\\u202f0.05\\u202fM) and selective index (SI\\u202f=\\u202f56.87). In addition, compound 4c shows remarkable inhibition on Leishmania topoisomerase IB. Parallel theoretical study of stereoelectronic properties, application of docking-based virtual screening methods, along with molecular electrostatic potential and predictive druggability analyses are also reported.', 'Title: Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents.  Abstract: Heterocyclic compounds, such as hybrid tetrahydroquinoline and quinoline derivatives with phosphorated groups, have been prepared by multicomponent cycloaddition reaction between phosphorus-substituted anilines, aldehydes and styrenes. The antileishmanial activity of these compounds has been evaluated on both promastigotes and intramacrophagic amastigotes of Leishmania infantum. Good antileishmanial activity of functionalized tetrahydroquinolines 4a, 5a, 6b and quinoline 8b has been observed with similar activity than the standard drug amphotericin B and close selective index (SI between 43 and 57) towards L. infantum amastigotes to amphotericin B. Special interest shows tetrahydroquinolylphosphine sulfide 5a with an EC<sub>50</sub> value (0.61\\u202f\\u202f0.18\\u202fM) similar to the standard drug amphotericin B (0.32\\u202f\\u202f0.05\\u202fM) and selective index (SI\\u202f=\\u202f56.87). In addition, compound 4c shows remarkable inhibition on Leishmania topoisomerase IB. Parallel theoretical study of stereoelectronic properties, application of docking-based virtual screening methods, along with molecular electrostatic potential and predictive druggability analyses are also reported.', 'Title: Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents.  Abstract: Heterocyclic compounds, such as hybrid tetrahydroquinoline and quinoline derivatives with phosphorated groups, have been prepared by multicomponent cycloaddition reaction between phosphorus-substituted anilines, aldehydes and styrenes. The antileishmanial activity of these compounds has been evaluated on both promastigotes and intramacrophagic amastigotes of Leishmania infantum. Good antileishmanial activity of functionalized tetrahydroquinolines 4a, 5a, 6b and quinoline 8b has been observed with similar activity than the standard drug amphotericin B and close selective index (SI between 43 and 57) towards L. infantum amastigotes to amphotericin B. Special interest shows tetrahydroquinolylphosphine sulfide 5a with an EC<sub>50</sub> value (0.61\\u202f\\u202f0.18\\u202fM) similar to the standard drug amphotericin B (0.32\\u202f\\u202f0.05\\u202fM) and selective index (SI\\u202f=\\u202f56.87). In addition, compound 4c shows remarkable inhibition on Leishmania topoisomerase IB. Parallel theoretical study of stereoelectronic properties, application of docking-based virtual screening methods, along with molecular electrostatic potential and predictive druggability analyses are also reported.', 'Title: Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents.  Abstract: Heterocyclic compounds, such as hybrid tetrahydroquinoline and quinoline derivatives with phosphorated groups, have been prepared by multicomponent cycloaddition reaction between phosphorus-substituted anilines, aldehydes and styrenes. The antileishmanial activity of these compounds has been evaluated on both promastigotes and intramacrophagic amastigotes of Leishmania infantum. Good antileishmanial activity of functionalized tetrahydroquinolines 4a, 5a, 6b and quinoline 8b has been observed with similar activity than the standard drug amphotericin B and close selective index (SI between 43 and 57) towards L. infantum amastigotes to amphotericin B. Special interest shows tetrahydroquinolylphosphine sulfide 5a with an EC<sub>50</sub> value (0.61\\u202f\\u202f0.18\\u202fM) similar to the standard drug amphotericin B (0.32\\u202f\\u202f0.05\\u202fM) and selective index (SI\\u202f=\\u202f56.87). In addition, compound 4c shows remarkable inhibition on Leishmania topoisomerase IB. Parallel theoretical study of stereoelectronic properties, application of docking-based virtual screening methods, along with molecular electrostatic potential and predictive druggability analyses are also reported.', 'Title: Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents.  Abstract: Heterocyclic compounds, such as hybrid tetrahydroquinoline and quinoline derivatives with phosphorated groups, have been prepared by multicomponent cycloaddition reaction between phosphorus-substituted anilines, aldehydes and styrenes. The antileishmanial activity of these compounds has been evaluated on both promastigotes and intramacrophagic amastigotes of Leishmania infantum. Good antileishmanial activity of functionalized tetrahydroquinolines 4a, 5a, 6b and quinoline 8b has been observed with similar activity than the standard drug amphotericin B and close selective index (SI between 43 and 57) towards L. infantum amastigotes to amphotericin B. Special interest shows tetrahydroquinolylphosphine sulfide 5a with an EC<sub>50</sub> value (0.61\\u202f\\u202f0.18\\u202fM) similar to the standard drug amphotericin B (0.32\\u202f\\u202f0.05\\u202fM) and selective index (SI\\u202f=\\u202f56.87). In addition, compound 4c shows remarkable inhibition on Leishmania topoisomerase IB. Parallel theoretical study of stereoelectronic properties, application of docking-based virtual screening methods, along with molecular electrostatic potential and predictive druggability analyses are also reported.', 'Title: Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases.  Abstract: New benzothiopyranoindoles (5a-l) and pyridothiopyranoindoles (5m-t), featuring different combinations of substituents (H, Cl, OCH<sub>3</sub>) at R<sup>2</sup>-R<sup>4</sup> positions and protonatable R<sup>1</sup>-dialkylaminoalkyl chains, were synthesized and biologically assayed on three human tumor cell lines, showing significant antiproliferative activity (GI<sub>50</sub> values spanning from 0.31 to 6.93\\u202fM) and pro-apoptotic effect. Linear flow dichroism experiments indicate the ability of both chromophores to form a molecular complex with DNA, following an intercalative mode of binding. All compounds displayed a moderate ability to inhibit the relaxation activity of both topoisomerases I and II, reasonably correlated to their intercalative capacities. Cleavable assay performed with topoisomerase I revealed a significant poisoning effect for compounds 5g, 5h, 5s, and 5t. A theoretical model provided by hydrated docking calculations clarified the role of the R<sup>1</sup>-R<sup>4</sup> substituents on the topoisomerase I poison activity, revealing a crucial role of the R<sup>2</sup>-OCH<sub>3</sub> group.', 'Title: Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases.  Abstract: New benzothiopyranoindoles (5a-l) and pyridothiopyranoindoles (5m-t), featuring different combinations of substituents (H, Cl, OCH<sub>3</sub>) at R<sup>2</sup>-R<sup>4</sup> positions and protonatable R<sup>1</sup>-dialkylaminoalkyl chains, were synthesized and biologically assayed on three human tumor cell lines, showing significant antiproliferative activity (GI<sub>50</sub> values spanning from 0.31 to 6.93\\u202fM) and pro-apoptotic effect. Linear flow dichroism experiments indicate the ability of both chromophores to form a molecular complex with DNA, following an intercalative mode of binding. All compounds displayed a moderate ability to inhibit the relaxation activity of both topoisomerases I and II, reasonably correlated to their intercalative capacities. Cleavable assay performed with topoisomerase I revealed a significant poisoning effect for compounds 5g, 5h, 5s, and 5t. A theoretical model provided by hydrated docking calculations clarified the role of the R<sup>1</sup>-R<sup>4</sup> substituents on the topoisomerase I poison activity, revealing a crucial role of the R<sup>2</sup>-OCH<sub>3</sub> group.', 'Title: Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases.  Abstract: New benzothiopyranoindoles (5a-l) and pyridothiopyranoindoles (5m-t), featuring different combinations of substituents (H, Cl, OCH<sub>3</sub>) at R<sup>2</sup>-R<sup>4</sup> positions and protonatable R<sup>1</sup>-dialkylaminoalkyl chains, were synthesized and biologically assayed on three human tumor cell lines, showing significant antiproliferative activity (GI<sub>50</sub> values spanning from 0.31 to 6.93\\u202fM) and pro-apoptotic effect. Linear flow dichroism experiments indicate the ability of both chromophores to form a molecular complex with DNA, following an intercalative mode of binding. All compounds displayed a moderate ability to inhibit the relaxation activity of both topoisomerases I and II, reasonably correlated to their intercalative capacities. Cleavable assay performed with topoisomerase I revealed a significant poisoning effect for compounds 5g, 5h, 5s, and 5t. A theoretical model provided by hydrated docking calculations clarified the role of the R<sup>1</sup>-R<sup>4</sup> substituents on the topoisomerase I poison activity, revealing a crucial role of the R<sup>2</sup>-OCH<sub>3</sub> group.', 'Title: Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases.  Abstract: New benzothiopyranoindoles (5a-l) and pyridothiopyranoindoles (5m-t), featuring different combinations of substituents (H, Cl, OCH<sub>3</sub>) at R<sup>2</sup>-R<sup>4</sup> positions and protonatable R<sup>1</sup>-dialkylaminoalkyl chains, were synthesized and biologically assayed on three human tumor cell lines, showing significant antiproliferative activity (GI<sub>50</sub> values spanning from 0.31 to 6.93\\u202fM) and pro-apoptotic effect. Linear flow dichroism experiments indicate the ability of both chromophores to form a molecular complex with DNA, following an intercalative mode of binding. All compounds displayed a moderate ability to inhibit the relaxation activity of both topoisomerases I and II, reasonably correlated to their intercalative capacities. Cleavable assay performed with topoisomerase I revealed a significant poisoning effect for compounds 5g, 5h, 5s, and 5t. A theoretical model provided by hydrated docking calculations clarified the role of the R<sup>1</sup>-R<sup>4</sup> substituents on the topoisomerase I poison activity, revealing a crucial role of the R<sup>2</sup>-OCH<sub>3</sub> group.', 'Title: Novel water soluble BODIPY compounds: Synthesis, photochemical, DNA interaction, topoisomerases inhibition and photodynamic activity properties.  Abstract: In this study, BODIPY compounds (2, 3, 5 and 6) bearing 3,4-bis(3-pyridin-3-ylpropoxy)benzyl, 4-(3-pyridin-3-ylpropoxy)benzyl groups were synthesized for the first time and further functionalized in a Knoevenagel condensation reaction with 3,4-bis(3-pyridin-3-ylpropoxy)benzaldehyde and 4-(3-pyridin-3-ylpropoxy)benzaldehyde. The water soluble derivatives of BODIPY compounds (3a and 6a) were synthesized by treating BODIPY compounds 3 and 6 with excess iodomethane in DMF. The photochemical properties and DNA binding modes of 3a and 6a were determined using ct-DNA by UV-Vis spectrophotometer and viscometer. DNA cleavage and topoisomerases inhibition properties were studied DNA using agarose gel electrophoresis. Their topoisomerase inhibition mechanisms were investigated at molecular level and correlations with the in vitro results were searched for using molecular docking method. In addition, cytotoxicity and phototoxicity of both compounds were performed on colorectal cancer cells (HCT-116) using MTT assay for 24\\u202fh. Annexin V-FITC/PI test was performed to determine the cell death mechanism of 6a induced by irradiation. Finally, 6a-loaded liposomes (LP6a) and PLGA nanoparticles (NP6a) were prepared and their cytotoxic and phototoxic effects were evaluated by MTT assay. The results claimed that 6a had great potential as photosensitizer agent for colorectal cancer owing to its photochemical, DNA interaction and phototoxic properties.', 'Title: Novel water soluble BODIPY compounds: Synthesis, photochemical, DNA interaction, topoisomerases inhibition and photodynamic activity properties.  Abstract: In this study, BODIPY compounds (2, 3, 5 and 6) bearing 3,4-bis(3-pyridin-3-ylpropoxy)benzyl, 4-(3-pyridin-3-ylpropoxy)benzyl groups were synthesized for the first time and further functionalized in a Knoevenagel condensation reaction with 3,4-bis(3-pyridin-3-ylpropoxy)benzaldehyde and 4-(3-pyridin-3-ylpropoxy)benzaldehyde. The water soluble derivatives of BODIPY compounds (3a and 6a) were synthesized by treating BODIPY compounds 3 and 6 with excess iodomethane in DMF. The photochemical properties and DNA binding modes of 3a and 6a were determined using ct-DNA by UV-Vis spectrophotometer and viscometer. DNA cleavage and topoisomerases inhibition properties were studied DNA using agarose gel electrophoresis. Their topoisomerase inhibition mechanisms were investigated at molecular level and correlations with the in vitro results were searched for using molecular docking method. In addition, cytotoxicity and phototoxicity of both compounds were performed on colorectal cancer cells (HCT-116) using MTT assay for 24\\u202fh. Annexin V-FITC/PI test was performed to determine the cell death mechanism of 6a induced by irradiation. Finally, 6a-loaded liposomes (LP6a) and PLGA nanoparticles (NP6a) were prepared and their cytotoxic and phototoxic effects were evaluated by MTT assay. The results claimed that 6a had great potential as photosensitizer agent for colorectal cancer owing to its photochemical, DNA interaction and phototoxic properties.', 'Title: Novel water soluble BODIPY compounds: Synthesis, photochemical, DNA interaction, topoisomerases inhibition and photodynamic activity properties.  Abstract: In this study, BODIPY compounds (2, 3, 5 and 6) bearing 3,4-bis(3-pyridin-3-ylpropoxy)benzyl, 4-(3-pyridin-3-ylpropoxy)benzyl groups were synthesized for the first time and further functionalized in a Knoevenagel condensation reaction with 3,4-bis(3-pyridin-3-ylpropoxy)benzaldehyde and 4-(3-pyridin-3-ylpropoxy)benzaldehyde. The water soluble derivatives of BODIPY compounds (3a and 6a) were synthesized by treating BODIPY compounds 3 and 6 with excess iodomethane in DMF. The photochemical properties and DNA binding modes of 3a and 6a were determined using ct-DNA by UV-Vis spectrophotometer and viscometer. DNA cleavage and topoisomerases inhibition properties were studied DNA using agarose gel electrophoresis. Their topoisomerase inhibition mechanisms were investigated at molecular level and correlations with the in vitro results were searched for using molecular docking method. In addition, cytotoxicity and phototoxicity of both compounds were performed on colorectal cancer cells (HCT-116) using MTT assay for 24\\u202fh. Annexin V-FITC/PI test was performed to determine the cell death mechanism of 6a induced by irradiation. Finally, 6a-loaded liposomes (LP6a) and PLGA nanoparticles (NP6a) were prepared and their cytotoxic and phototoxic effects were evaluated by MTT assay. The results claimed that 6a had great potential as photosensitizer agent for colorectal cancer owing to its photochemical, DNA interaction and phototoxic properties.', 'Title: Novel water soluble BODIPY compounds: Synthesis, photochemical, DNA interaction, topoisomerases inhibition and photodynamic activity properties.  Abstract: In this study, BODIPY compounds (2, 3, 5 and 6) bearing 3,4-bis(3-pyridin-3-ylpropoxy)benzyl, 4-(3-pyridin-3-ylpropoxy)benzyl groups were synthesized for the first time and further functionalized in a Knoevenagel condensation reaction with 3,4-bis(3-pyridin-3-ylpropoxy)benzaldehyde and 4-(3-pyridin-3-ylpropoxy)benzaldehyde. The water soluble derivatives of BODIPY compounds (3a and 6a) were synthesized by treating BODIPY compounds 3 and 6 with excess iodomethane in DMF. The photochemical properties and DNA binding modes of 3a and 6a were determined using ct-DNA by UV-Vis spectrophotometer and viscometer. DNA cleavage and topoisomerases inhibition properties were studied DNA using agarose gel electrophoresis. Their topoisomerase inhibition mechanisms were investigated at molecular level and correlations with the in vitro results were searched for using molecular docking method. In addition, cytotoxicity and phototoxicity of both compounds were performed on colorectal cancer cells (HCT-116) using MTT assay for 24\\u202fh. Annexin V-FITC/PI test was performed to determine the cell death mechanism of 6a induced by irradiation. Finally, 6a-loaded liposomes (LP6a) and PLGA nanoparticles (NP6a) were prepared and their cytotoxic and phototoxic effects were evaluated by MTT assay. The results claimed that 6a had great potential as photosensitizer agent for colorectal cancer owing to its photochemical, DNA interaction and phototoxic properties.', 'Title: Novel water soluble BODIPY compounds: Synthesis, photochemical, DNA interaction, topoisomerases inhibition and photodynamic activity properties.  Abstract: In this study, BODIPY compounds (2, 3, 5 and 6) bearing 3,4-bis(3-pyridin-3-ylpropoxy)benzyl, 4-(3-pyridin-3-ylpropoxy)benzyl groups were synthesized for the first time and further functionalized in a Knoevenagel condensation reaction with 3,4-bis(3-pyridin-3-ylpropoxy)benzaldehyde and 4-(3-pyridin-3-ylpropoxy)benzaldehyde. The water soluble derivatives of BODIPY compounds (3a and 6a) were synthesized by treating BODIPY compounds 3 and 6 with excess iodomethane in DMF. The photochemical properties and DNA binding modes of 3a and 6a were determined using ct-DNA by UV-Vis spectrophotometer and viscometer. DNA cleavage and topoisomerases inhibition properties were studied DNA using agarose gel electrophoresis. Their topoisomerase inhibition mechanisms were investigated at molecular level and correlations with the in vitro results were searched for using molecular docking method. In addition, cytotoxicity and phototoxicity of both compounds were performed on colorectal cancer cells (HCT-116) using MTT assay for 24\\u202fh. Annexin V-FITC/PI test was performed to determine the cell death mechanism of 6a induced by irradiation. Finally, 6a-loaded liposomes (LP6a) and PLGA nanoparticles (NP6a) were prepared and their cytotoxic and phototoxic effects were evaluated by MTT assay. The results claimed that 6a had great potential as photosensitizer agent for colorectal cancer owing to its photochemical, DNA interaction and phototoxic properties.', 'Title: Novel water soluble BODIPY compounds: Synthesis, photochemical, DNA interaction, topoisomerases inhibition and photodynamic activity properties.  Abstract: In this study, BODIPY compounds (2, 3, 5 and 6) bearing 3,4-bis(3-pyridin-3-ylpropoxy)benzyl, 4-(3-pyridin-3-ylpropoxy)benzyl groups were synthesized for the first time and further functionalized in a Knoevenagel condensation reaction with 3,4-bis(3-pyridin-3-ylpropoxy)benzaldehyde and 4-(3-pyridin-3-ylpropoxy)benzaldehyde. The water soluble derivatives of BODIPY compounds (3a and 6a) were synthesized by treating BODIPY compounds 3 and 6 with excess iodomethane in DMF. The photochemical properties and DNA binding modes of 3a and 6a were determined using ct-DNA by UV-Vis spectrophotometer and viscometer. DNA cleavage and topoisomerases inhibition properties were studied DNA using agarose gel electrophoresis. Their topoisomerase inhibition mechanisms were investigated at molecular level and correlations with the in vitro results were searched for using molecular docking method. In addition, cytotoxicity and phototoxicity of both compounds were performed on colorectal cancer cells (HCT-116) using MTT assay for 24\\u202fh. Annexin V-FITC/PI test was performed to determine the cell death mechanism of 6a induced by irradiation. Finally, 6a-loaded liposomes (LP6a) and PLGA nanoparticles (NP6a) were prepared and their cytotoxic and phototoxic effects were evaluated by MTT assay. The results claimed that 6a had great potential as photosensitizer agent for colorectal cancer owing to its photochemical, DNA interaction and phototoxic properties.', 'Title: Novel water soluble BODIPY compounds: Synthesis, photochemical, DNA interaction, topoisomerases inhibition and photodynamic activity properties.  Abstract: In this study, BODIPY compounds (2, 3, 5 and 6) bearing 3,4-bis(3-pyridin-3-ylpropoxy)benzyl, 4-(3-pyridin-3-ylpropoxy)benzyl groups were synthesized for the first time and further functionalized in a Knoevenagel condensation reaction with 3,4-bis(3-pyridin-3-ylpropoxy)benzaldehyde and 4-(3-pyridin-3-ylpropoxy)benzaldehyde. The water soluble derivatives of BODIPY compounds (3a and 6a) were synthesized by treating BODIPY compounds 3 and 6 with excess iodomethane in DMF. The photochemical properties and DNA binding modes of 3a and 6a were determined using ct-DNA by UV-Vis spectrophotometer and viscometer. DNA cleavage and topoisomerases inhibition properties were studied DNA using agarose gel electrophoresis. Their topoisomerase inhibition mechanisms were investigated at molecular level and correlations with the in vitro results were searched for using molecular docking method. In addition, cytotoxicity and phototoxicity of both compounds were performed on colorectal cancer cells (HCT-116) using MTT assay for 24\\u202fh. Annexin V-FITC/PI test was performed to determine the cell death mechanism of 6a induced by irradiation. Finally, 6a-loaded liposomes (LP6a) and PLGA nanoparticles (NP6a) were prepared and their cytotoxic and phototoxic effects were evaluated by MTT assay. The results claimed that 6a had great potential as photosensitizer agent for colorectal cancer owing to its photochemical, DNA interaction and phototoxic properties.', 'Title: Design, synthesis and biological research of novel N-phenylbenzamide-4-methylamine acridine derivatives as potential topoisomerase I/II and apoptosis-inducing agents.  Abstract: A series of novel N-phenylbenzamide-4-methylamine acridine derivatives were designed and synthesized based initially on the structure of amsacrine (m-AMSA). Molecular docking suggested that the representative compound 9a had affinity for binding DNA topoisomerase (Topo) II, which was comparable with that of m-AMSA, and furthermore that 9a could have preferential interactions with Topo I. After synthesis of 9a and analogues 9b-9f, these were all tested in vitro and the synthesized compounds displayed potent antiproliferative activity against three different cancer cell lines (K562, CCRF-CEM and U937). Among them, compounds 9b, 9c and 9d exhibiting the highest activity with IC<sub>50</sub> value ranging from 0.82 to 0.91\\u202fM against CCRF-CEM cells. In addition, 9b and 9d also showed high antiproliferative activity against U937 cells, with IC<sub>50</sub> values of 0.33 and 0.23\\u202fM, respectively. The pharmacological mechanistic studies of these compounds were evaluated by Topo I/II inhibition, western blot assay and cell apoptosis detection. In summary, 9b effectively inhibited the activity of Topo I/II and induced DNA damage in CCRF-CEM cells and, moreover, significantly induced cell apoptosis in a concentration-dependent manner. These observations provide new information and guidance for the structural optimization of more novel acridine derivatives.', \"Title: Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential.  Abstract: DNA topoisomerases are essential during transcription and replication. The therapeutic mechanism of action of topoisomerase inhibitors is enzyme poisoning rather than catalytic inhibition. Tyrosyl-DNA phosphodiesterases 1 or 2 were found as DNA repair enzymes hydrolyzing the covalent bond between the tyrosyl residue of topoisomerases I or II and the 3'- or 5'-phosphate groups in DNA, respectively. Tyrosyl-DNA phosphodiesterase 1 is a key enzyme in DNA repair machinery and a promising target for antitumor and neurodegenerative therapy. Inhibitors of tyrosyl-DNA phosphodiesterase 1 could act synergistically with topoisomerase I inhibitors and thereby potentiate the effects of topoisomerase I poisons. Tyrosyl-DNA phosphodiesterase 2 is an enzyme that specifically repairs DNA damages induced by topoisomerase II poisons and causes resistance to these drugs. Selective inhibition of tyrosyl-DNA phosphodiesterase 2 may be a novel approach to overcome intrinsic or acquired resistance to topoisomerase II-targeted drug therapy. Thus, agents that inhibit tyrosyl-DNA phosphodiesterases 1 and 2 have many applications in biochemical and physiological research and they have the potential to become anticancer and antiviral drugs. The structures, mechanism of action and therapeutic rationale of tyrosyl-DNA phosphodiesterase inhibitors and their development for combinations with topoisomerase inhibitors and DNA damaging agents are discussed.\", 'Title: New anthra[2,3-b]furancarboxamides: A role of positioning of the carboxamide moiety in antitumor properties.  Abstract: Derivatives of the anthraquinone (anthracene-9,10-dione) such as doxorubicin, mitoxantrone and others have proved great clinical efficacy for decades. Currently the search in this exceptionally productive chemical class is aimed at optimization of antitumor properties including circumvention of drug resistance. Previously we have reported that heteroarene-fused anthraquinones fused to a 5-membered heterocyclic ring are advantageous in killing drug resistant tumor cells. Herein we present the synthesis and antitumor properties of a series of new anthra[2,3-b]furan-2-carboxamides. Vast majority of new derivatives were similarly cytotoxic to wild type tumor cell lines and their isogenic sublines with P-glycoprotein overexpression and/or p53 inactivation. Comparison of structurally close derivatives varying in their position relative to the furan moiety, that is, furan-3-carboxamide 1vs furan-2-carboxamides 5 and 6, revealed fundamental differences in the cytotoxicity profiles, formation of drug-DNA complexes, efficacy of topoisomerase 1 inhibition and mechanisms of tumor cell death. Together with previous SAR data on the role of individual substituents, these results provide evidence that regioisomerization of anthra[2,3-b]furancarboxamides generates the practically perspective derivatives whose properties may vary significantly.', 'Title: New anthra[2,3-b]furancarboxamides: A role of positioning of the carboxamide moiety in antitumor properties.  Abstract: Derivatives of the anthraquinone (anthracene-9,10-dione) such as doxorubicin, mitoxantrone and others have proved great clinical efficacy for decades. Currently the search in this exceptionally productive chemical class is aimed at optimization of antitumor properties including circumvention of drug resistance. Previously we have reported that heteroarene-fused anthraquinones fused to a 5-membered heterocyclic ring are advantageous in killing drug resistant tumor cells. Herein we present the synthesis and antitumor properties of a series of new anthra[2,3-b]furan-2-carboxamides. Vast majority of new derivatives were similarly cytotoxic to wild type tumor cell lines and their isogenic sublines with P-glycoprotein overexpression and/or p53 inactivation. Comparison of structurally close derivatives varying in their position relative to the furan moiety, that is, furan-3-carboxamide 1vs furan-2-carboxamides 5 and 6, revealed fundamental differences in the cytotoxicity profiles, formation of drug-DNA complexes, efficacy of topoisomerase 1 inhibition and mechanisms of tumor cell death. Together with previous SAR data on the role of individual substituents, these results provide evidence that regioisomerization of anthra[2,3-b]furancarboxamides generates the practically perspective derivatives whose properties may vary significantly.', 'Title: Natural Product Evodiamine with Borate Trigger Unit: Discovery of Potent Antitumor Agents against Colon Cancer.  Abstract: In order to improve the antitumor potency of the natural product evodiamine, novel boron-containing evodiamine derivatives were designed by incorporating boronic acid and boronate as trigger units. Boronate derivative <b>13a</b> could be triggered by reactive oxygen species (ROS) in the HCT116 colon cancer cell line and showed excellent antitumor activity <i>in vitro</i> and <i>in vivo</i>. It induced apoptosis in HCT116 cancer cells in a dose-dependent manner and cell growth arrest at the G2 phase.', 'Title: Natural Product Evodiamine with Borate Trigger Unit: Discovery of Potent Antitumor Agents against Colon Cancer.  Abstract: In order to improve the antitumor potency of the natural product evodiamine, novel boron-containing evodiamine derivatives were designed by incorporating boronic acid and boronate as trigger units. Boronate derivative <b>13a</b> could be triggered by reactive oxygen species (ROS) in the HCT116 colon cancer cell line and showed excellent antitumor activity <i>in vitro</i> and <i>in vivo</i>. It induced apoptosis in HCT116 cancer cells in a dose-dependent manner and cell growth arrest at the G2 phase.', 'Title: Natural Product Evodiamine with Borate Trigger Unit: Discovery of Potent Antitumor Agents against Colon Cancer.  Abstract: In order to improve the antitumor potency of the natural product evodiamine, novel boron-containing evodiamine derivatives were designed by incorporating boronic acid and boronate as trigger units. Boronate derivative <b>13a</b> could be triggered by reactive oxygen species (ROS) in the HCT116 colon cancer cell line and showed excellent antitumor activity <i>in vitro</i> and <i>in vivo</i>. It induced apoptosis in HCT116 cancer cells in a dose-dependent manner and cell growth arrest at the G2 phase.', 'Title: Synthesis and biological evaluation of novel indole-pyrazoline hybrid derivatives as potential topoisomerase 1 inhibitors.  Abstract: A series of novel indole-pyrazoline hybrid derivatives were designed, synthesized, and evaluated for topoisomerase 1 (Top1) inhibitory activity. Top1-mediated relaxation assays showed that our synthesized compounds had variable Top1 inhibitory activity. Among these compounds, 3-(5-(naphthalen-1-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)-1-(phenylsulfonyl)-1H-indole (6n) was found to be a strong Top1 inhibitor with better inhibitory activity than CPT and hit compounds. Our further experiments rationalized the mode of action for this new type of inhibitors, which showed no significant binding to supercoiled DNA.', 'Title: Synthesis and biological evaluation of novel indole-pyrazoline hybrid derivatives as potential topoisomerase 1 inhibitors.  Abstract: A series of novel indole-pyrazoline hybrid derivatives were designed, synthesized, and evaluated for topoisomerase 1 (Top1) inhibitory activity. Top1-mediated relaxation assays showed that our synthesized compounds had variable Top1 inhibitory activity. Among these compounds, 3-(5-(naphthalen-1-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)-1-(phenylsulfonyl)-1H-indole (6n) was found to be a strong Top1 inhibitor with better inhibitory activity than CPT and hit compounds. Our further experiments rationalized the mode of action for this new type of inhibitors, which showed no significant binding to supercoiled DNA.', 'Title: Synthesis and biological evaluation of novel indole-pyrazoline hybrid derivatives as potential topoisomerase 1 inhibitors.  Abstract: A series of novel indole-pyrazoline hybrid derivatives were designed, synthesized, and evaluated for topoisomerase 1 (Top1) inhibitory activity. Top1-mediated relaxation assays showed that our synthesized compounds had variable Top1 inhibitory activity. Among these compounds, 3-(5-(naphthalen-1-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)-1-(phenylsulfonyl)-1H-indole (6n) was found to be a strong Top1 inhibitor with better inhibitory activity than CPT and hit compounds. Our further experiments rationalized the mode of action for this new type of inhibitors, which showed no significant binding to supercoiled DNA.', 'Title: Synthesis and biological evaluation of novel indole-pyrazoline hybrid derivatives as potential topoisomerase 1 inhibitors.  Abstract: A series of novel indole-pyrazoline hybrid derivatives were designed, synthesized, and evaluated for topoisomerase 1 (Top1) inhibitory activity. Top1-mediated relaxation assays showed that our synthesized compounds had variable Top1 inhibitory activity. Among these compounds, 3-(5-(naphthalen-1-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)-1-(phenylsulfonyl)-1H-indole (6n) was found to be a strong Top1 inhibitor with better inhibitory activity than CPT and hit compounds. Our further experiments rationalized the mode of action for this new type of inhibitors, which showed no significant binding to supercoiled DNA.', 'Title: Synthesis and biological evaluation of novel indole-pyrazoline hybrid derivatives as potential topoisomerase 1 inhibitors.  Abstract: A series of novel indole-pyrazoline hybrid derivatives were designed, synthesized, and evaluated for topoisomerase 1 (Top1) inhibitory activity. Top1-mediated relaxation assays showed that our synthesized compounds had variable Top1 inhibitory activity. Among these compounds, 3-(5-(naphthalen-1-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)-1-(phenylsulfonyl)-1H-indole (6n) was found to be a strong Top1 inhibitor with better inhibitory activity than CPT and hit compounds. Our further experiments rationalized the mode of action for this new type of inhibitors, which showed no significant binding to supercoiled DNA.', 'Title: Synthesis and biological evaluation of novel indole-pyrazoline hybrid derivatives as potential topoisomerase 1 inhibitors.  Abstract: A series of novel indole-pyrazoline hybrid derivatives were designed, synthesized, and evaluated for topoisomerase 1 (Top1) inhibitory activity. Top1-mediated relaxation assays showed that our synthesized compounds had variable Top1 inhibitory activity. Among these compounds, 3-(5-(naphthalen-1-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)-1-(phenylsulfonyl)-1H-indole (6n) was found to be a strong Top1 inhibitor with better inhibitory activity than CPT and hit compounds. Our further experiments rationalized the mode of action for this new type of inhibitors, which showed no significant binding to supercoiled DNA.', 'Title: Artemisinin Derivatives with Antimelanoma Activity Show Inhibitory Effect against Human DNA Topoisomerase 1.  Abstract: Artesunic acid and artemisinin are natural substances with promiscuous anticancer activity against different types of cancer cell lines. The mechanism of action of these compounds is associated with the formation of reactive radical species by cleavage of the sesquiterpene pharmacophore endoperoxide bridge. Here we suggested topoisomerase 1 as a possible molecular target for the improvement of the anticancer activity of these compounds. In this context, we report that novel hybrid and dimer derivatives of artesunic acid and artemisinin, bearing camptothecin and SN38 as side-chain biological effectors, can inhibit growth of yeast cells overexpressing human topoisomerase 1 and its enzymatic activity <i>in vitro</i>. These derivatives showed also anticancer activity in melanoma cell lines higher than camptothecin and paclitaxel. <i>In silico</i> molecular docking calculations highlighted a common binding mode for the novel derivatives, with the sesquiterpene lactone scaffold being located near the traditional recognition site for camptothecin, while the bioactive side-chain effector laid in the camptothecin cleft.', 'Title: Artemisinin Derivatives with Antimelanoma Activity Show Inhibitory Effect against Human DNA Topoisomerase 1.  Abstract: Artesunic acid and artemisinin are natural substances with promiscuous anticancer activity against different types of cancer cell lines. The mechanism of action of these compounds is associated with the formation of reactive radical species by cleavage of the sesquiterpene pharmacophore endoperoxide bridge. Here we suggested topoisomerase 1 as a possible molecular target for the improvement of the anticancer activity of these compounds. In this context, we report that novel hybrid and dimer derivatives of artesunic acid and artemisinin, bearing camptothecin and SN38 as side-chain biological effectors, can inhibit growth of yeast cells overexpressing human topoisomerase 1 and its enzymatic activity <i>in vitro</i>. These derivatives showed also anticancer activity in melanoma cell lines higher than camptothecin and paclitaxel. <i>In silico</i> molecular docking calculations highlighted a common binding mode for the novel derivatives, with the sesquiterpene lactone scaffold being located near the traditional recognition site for camptothecin, while the bioactive side-chain effector laid in the camptothecin cleft.', 'Title: Artemisinin Derivatives with Antimelanoma Activity Show Inhibitory Effect against Human DNA Topoisomerase 1.  Abstract: Artesunic acid and artemisinin are natural substances with promiscuous anticancer activity against different types of cancer cell lines. The mechanism of action of these compounds is associated with the formation of reactive radical species by cleavage of the sesquiterpene pharmacophore endoperoxide bridge. Here we suggested topoisomerase 1 as a possible molecular target for the improvement of the anticancer activity of these compounds. In this context, we report that novel hybrid and dimer derivatives of artesunic acid and artemisinin, bearing camptothecin and SN38 as side-chain biological effectors, can inhibit growth of yeast cells overexpressing human topoisomerase 1 and its enzymatic activity <i>in vitro</i>. These derivatives showed also anticancer activity in melanoma cell lines higher than camptothecin and paclitaxel. <i>In silico</i> molecular docking calculations highlighted a common binding mode for the novel derivatives, with the sesquiterpene lactone scaffold being located near the traditional recognition site for camptothecin, while the bioactive side-chain effector laid in the camptothecin cleft.', 'Title: Artemisinin Derivatives with Antimelanoma Activity Show Inhibitory Effect against Human DNA Topoisomerase 1.  Abstract: Artesunic acid and artemisinin are natural substances with promiscuous anticancer activity against different types of cancer cell lines. The mechanism of action of these compounds is associated with the formation of reactive radical species by cleavage of the sesquiterpene pharmacophore endoperoxide bridge. Here we suggested topoisomerase 1 as a possible molecular target for the improvement of the anticancer activity of these compounds. In this context, we report that novel hybrid and dimer derivatives of artesunic acid and artemisinin, bearing camptothecin and SN38 as side-chain biological effectors, can inhibit growth of yeast cells overexpressing human topoisomerase 1 and its enzymatic activity <i>in vitro</i>. These derivatives showed also anticancer activity in melanoma cell lines higher than camptothecin and paclitaxel. <i>In silico</i> molecular docking calculations highlighted a common binding mode for the novel derivatives, with the sesquiterpene lactone scaffold being located near the traditional recognition site for camptothecin, while the bioactive side-chain effector laid in the camptothecin cleft.', 'Title: Artemisinin Derivatives with Antimelanoma Activity Show Inhibitory Effect against Human DNA Topoisomerase 1.  Abstract: Artesunic acid and artemisinin are natural substances with promiscuous anticancer activity against different types of cancer cell lines. The mechanism of action of these compounds is associated with the formation of reactive radical species by cleavage of the sesquiterpene pharmacophore endoperoxide bridge. Here we suggested topoisomerase 1 as a possible molecular target for the improvement of the anticancer activity of these compounds. In this context, we report that novel hybrid and dimer derivatives of artesunic acid and artemisinin, bearing camptothecin and SN38 as side-chain biological effectors, can inhibit growth of yeast cells overexpressing human topoisomerase 1 and its enzymatic activity <i>in vitro</i>. These derivatives showed also anticancer activity in melanoma cell lines higher than camptothecin and paclitaxel. <i>In silico</i> molecular docking calculations highlighted a common binding mode for the novel derivatives, with the sesquiterpene lactone scaffold being located near the traditional recognition site for camptothecin, while the bioactive side-chain effector laid in the camptothecin cleft.', 'Title: Artemisinin Derivatives with Antimelanoma Activity Show Inhibitory Effect against Human DNA Topoisomerase 1.  Abstract: Artesunic acid and artemisinin are natural substances with promiscuous anticancer activity against different types of cancer cell lines. The mechanism of action of these compounds is associated with the formation of reactive radical species by cleavage of the sesquiterpene pharmacophore endoperoxide bridge. Here we suggested topoisomerase 1 as a possible molecular target for the improvement of the anticancer activity of these compounds. In this context, we report that novel hybrid and dimer derivatives of artesunic acid and artemisinin, bearing camptothecin and SN38 as side-chain biological effectors, can inhibit growth of yeast cells overexpressing human topoisomerase 1 and its enzymatic activity <i>in vitro</i>. These derivatives showed also anticancer activity in melanoma cell lines higher than camptothecin and paclitaxel. <i>In silico</i> molecular docking calculations highlighted a common binding mode for the novel derivatives, with the sesquiterpene lactone scaffold being located near the traditional recognition site for camptothecin, while the bioactive side-chain effector laid in the camptothecin cleft.', 'Title: Artemisinin Derivatives with Antimelanoma Activity Show Inhibitory Effect against Human DNA Topoisomerase 1.  Abstract: Artesunic acid and artemisinin are natural substances with promiscuous anticancer activity against different types of cancer cell lines. The mechanism of action of these compounds is associated with the formation of reactive radical species by cleavage of the sesquiterpene pharmacophore endoperoxide bridge. Here we suggested topoisomerase 1 as a possible molecular target for the improvement of the anticancer activity of these compounds. In this context, we report that novel hybrid and dimer derivatives of artesunic acid and artemisinin, bearing camptothecin and SN38 as side-chain biological effectors, can inhibit growth of yeast cells overexpressing human topoisomerase 1 and its enzymatic activity <i>in vitro</i>. These derivatives showed also anticancer activity in melanoma cell lines higher than camptothecin and paclitaxel. <i>In silico</i> molecular docking calculations highlighted a common binding mode for the novel derivatives, with the sesquiterpene lactone scaffold being located near the traditional recognition site for camptothecin, while the bioactive side-chain effector laid in the camptothecin cleft.', 'Title: A-ring and E-ring modifications of the cytotoxic alkaloid Luotonin A: Synthesis, computational and biological studies.  Abstract: A series of new Luotonin A derivatives with substituents at rings A and E was synthesized, together with some E-ring-unsubstituted derivatives. Subsequently, the compound library was examined in silico for their binding into a previously proposed site in the DNA/topoisomerase I binary complex. Whereas no convincing correlation between docking scores and biological data from in vitro assays could be found, one novel 4,9-diamino Luotonin A derivative had strong antiproliferative activity based on massive G2/M phase arrest. As this biological activity clearly differs from the reference compound Camptothecin, this strongly indicates that at least some Luotonin A derivatives may be potent antiproliferative agents, however with a different mode of action.', 'Title: A-ring and E-ring modifications of the cytotoxic alkaloid Luotonin A: Synthesis, computational and biological studies.  Abstract: A series of new Luotonin A derivatives with substituents at rings A and E was synthesized, together with some E-ring-unsubstituted derivatives. Subsequently, the compound library was examined in silico for their binding into a previously proposed site in the DNA/topoisomerase I binary complex. Whereas no convincing correlation between docking scores and biological data from in vitro assays could be found, one novel 4,9-diamino Luotonin A derivative had strong antiproliferative activity based on massive G2/M phase arrest. As this biological activity clearly differs from the reference compound Camptothecin, this strongly indicates that at least some Luotonin A derivatives may be potent antiproliferative agents, however with a different mode of action.', 'Title: A-ring and E-ring modifications of the cytotoxic alkaloid Luotonin A: Synthesis, computational and biological studies.  Abstract: A series of new Luotonin A derivatives with substituents at rings A and E was synthesized, together with some E-ring-unsubstituted derivatives. Subsequently, the compound library was examined in silico for their binding into a previously proposed site in the DNA/topoisomerase I binary complex. Whereas no convincing correlation between docking scores and biological data from in vitro assays could be found, one novel 4,9-diamino Luotonin A derivative had strong antiproliferative activity based on massive G2/M phase arrest. As this biological activity clearly differs from the reference compound Camptothecin, this strongly indicates that at least some Luotonin A derivatives may be potent antiproliferative agents, however with a different mode of action.', 'Title: Design, synthesis and biological evaluation of 3-nitro-1,8-naphthalimides as potential antitumor agents.  Abstract: A series of 3-nitro-naphthalimides 1(1a-1h) were designed and synthesized as antitumor agents. MTT assay results showed that all these compounds exhibited obvious antiproliferative activity against SKOV3, HepG2, A549, T-24 and SMMC-7721 cancer cell lines, while compound 1a displayed the best antiproliferative activity against HepG2 and T-24 cell lines in comparison with mitonafide, with IC<sub>50</sub> of 9.2  1.8 and 4.133  0.9 M, respectively. In vivo antiproliferative activity assay results showed that compound 1a exhibited good antiproliferative activity in the HepG2 and T-24 models, compared with mitonafide. Action mechanism results showed that compound 1a could induced the damage of DNA and the inhibition topo I, accompanying by inducing the G2-stage arresting and the apoptosis of T-24 cancer cells through up-regulating expression levels of cyclin B1, cdc 2-pTy, Wee1, H2AX, p21, Bax and cytochrome c and down-regulating expression of Bcl-2.', 'Title: Design, synthesis and biological evaluation of 3-nitro-1,8-naphthalimides as potential antitumor agents.  Abstract: A series of 3-nitro-naphthalimides 1(1a-1h) were designed and synthesized as antitumor agents. MTT assay results showed that all these compounds exhibited obvious antiproliferative activity against SKOV3, HepG2, A549, T-24 and SMMC-7721 cancer cell lines, while compound 1a displayed the best antiproliferative activity against HepG2 and T-24 cell lines in comparison with mitonafide, with IC<sub>50</sub> of 9.2  1.8 and 4.133  0.9 M, respectively. In vivo antiproliferative activity assay results showed that compound 1a exhibited good antiproliferative activity in the HepG2 and T-24 models, compared with mitonafide. Action mechanism results showed that compound 1a could induced the damage of DNA and the inhibition topo I, accompanying by inducing the G2-stage arresting and the apoptosis of T-24 cancer cells through up-regulating expression levels of cyclin B1, cdc 2-pTy, Wee1, H2AX, p21, Bax and cytochrome c and down-regulating expression of Bcl-2.', \"Title: Design, synthesis and evaluation of antiproliferative activity of fluorinated betulinic acid.  Abstract: Betulinic acid (BA), a pentacyclic triterpenoid, exhibits broad spectrum antiproliferative activity, but generally with only modest potency. To improve BA's pharmacological properties, fluorine was introduced as a single atom at C-2, creating two diastereomers, or in a trifluoromethyl group at C-3. We evaluated the impact of these groups on antiproliferative activity against five human tumor cell lines. A racemic 2-F-BA (compound 6) showed significantly improved antiproliferative activity, while each diastereomer exhibited similar effects. We also demonstrated that 2-F-BA is a topoisomerase (Topo) I and II dual inhibitor in cell-based and cell-free assays. A hypothetical mode of binding to the Topo I-DNA suggested a difference between the hydrogen bonding of BA and 2-F-BA to DNA, which may account for the difference in bioactivity against Topo I.\", \"Title: Design, synthesis and evaluation of antiproliferative activity of fluorinated betulinic acid.  Abstract: Betulinic acid (BA), a pentacyclic triterpenoid, exhibits broad spectrum antiproliferative activity, but generally with only modest potency. To improve BA's pharmacological properties, fluorine was introduced as a single atom at C-2, creating two diastereomers, or in a trifluoromethyl group at C-3. We evaluated the impact of these groups on antiproliferative activity against five human tumor cell lines. A racemic 2-F-BA (compound 6) showed significantly improved antiproliferative activity, while each diastereomer exhibited similar effects. We also demonstrated that 2-F-BA is a topoisomerase (Topo) I and II dual inhibitor in cell-based and cell-free assays. A hypothetical mode of binding to the Topo I-DNA suggested a difference between the hydrogen bonding of BA and 2-F-BA to DNA, which may account for the difference in bioactivity against Topo I.\", \"Title: Design, synthesis and evaluation of antiproliferative activity of fluorinated betulinic acid.  Abstract: Betulinic acid (BA), a pentacyclic triterpenoid, exhibits broad spectrum antiproliferative activity, but generally with only modest potency. To improve BA's pharmacological properties, fluorine was introduced as a single atom at C-2, creating two diastereomers, or in a trifluoromethyl group at C-3. We evaluated the impact of these groups on antiproliferative activity against five human tumor cell lines. A racemic 2-F-BA (compound 6) showed significantly improved antiproliferative activity, while each diastereomer exhibited similar effects. We also demonstrated that 2-F-BA is a topoisomerase (Topo) I and II dual inhibitor in cell-based and cell-free assays. A hypothetical mode of binding to the Topo I-DNA suggested a difference between the hydrogen bonding of BA and 2-F-BA to DNA, which may account for the difference in bioactivity against Topo I.\", \"Title: Design, synthesis and evaluation of antiproliferative activity of fluorinated betulinic acid.  Abstract: Betulinic acid (BA), a pentacyclic triterpenoid, exhibits broad spectrum antiproliferative activity, but generally with only modest potency. To improve BA's pharmacological properties, fluorine was introduced as a single atom at C-2, creating two diastereomers, or in a trifluoromethyl group at C-3. We evaluated the impact of these groups on antiproliferative activity against five human tumor cell lines. A racemic 2-F-BA (compound 6) showed significantly improved antiproliferative activity, while each diastereomer exhibited similar effects. We also demonstrated that 2-F-BA is a topoisomerase (Topo) I and II dual inhibitor in cell-based and cell-free assays. A hypothetical mode of binding to the Topo I-DNA suggested a difference between the hydrogen bonding of BA and 2-F-BA to DNA, which may account for the difference in bioactivity against Topo I.\", \"Title: Design, synthesis and evaluation of antiproliferative activity of fluorinated betulinic acid.  Abstract: Betulinic acid (BA), a pentacyclic triterpenoid, exhibits broad spectrum antiproliferative activity, but generally with only modest potency. To improve BA's pharmacological properties, fluorine was introduced as a single atom at C-2, creating two diastereomers, or in a trifluoromethyl group at C-3. We evaluated the impact of these groups on antiproliferative activity against five human tumor cell lines. A racemic 2-F-BA (compound 6) showed significantly improved antiproliferative activity, while each diastereomer exhibited similar effects. We also demonstrated that 2-F-BA is a topoisomerase (Topo) I and II dual inhibitor in cell-based and cell-free assays. A hypothetical mode of binding to the Topo I-DNA suggested a difference between the hydrogen bonding of BA and 2-F-BA to DNA, which may account for the difference in bioactivity against Topo I.\", \"Title: Design, synthesis and evaluation of antiproliferative activity of fluorinated betulinic acid.  Abstract: Betulinic acid (BA), a pentacyclic triterpenoid, exhibits broad spectrum antiproliferative activity, but generally with only modest potency. To improve BA's pharmacological properties, fluorine was introduced as a single atom at C-2, creating two diastereomers, or in a trifluoromethyl group at C-3. We evaluated the impact of these groups on antiproliferative activity against five human tumor cell lines. A racemic 2-F-BA (compound 6) showed significantly improved antiproliferative activity, while each diastereomer exhibited similar effects. We also demonstrated that 2-F-BA is a topoisomerase (Topo) I and II dual inhibitor in cell-based and cell-free assays. A hypothetical mode of binding to the Topo I-DNA suggested a difference between the hydrogen bonding of BA and 2-F-BA to DNA, which may account for the difference in bioactivity against Topo I.\", \"Title: Design, synthesis and evaluation of antiproliferative activity of fluorinated betulinic acid.  Abstract: Betulinic acid (BA), a pentacyclic triterpenoid, exhibits broad spectrum antiproliferative activity, but generally with only modest potency. To improve BA's pharmacological properties, fluorine was introduced as a single atom at C-2, creating two diastereomers, or in a trifluoromethyl group at C-3. We evaluated the impact of these groups on antiproliferative activity against five human tumor cell lines. A racemic 2-F-BA (compound 6) showed significantly improved antiproliferative activity, while each diastereomer exhibited similar effects. We also demonstrated that 2-F-BA is a topoisomerase (Topo) I and II dual inhibitor in cell-based and cell-free assays. A hypothetical mode of binding to the Topo I-DNA suggested a difference between the hydrogen bonding of BA and 2-F-BA to DNA, which may account for the difference in bioactivity against Topo I.\", 'Title: Synthesis, mechanisms of action, and toxicity of novel aminophosphonates derivatives conjugated irinotecan in vitro and in vivo as potent antitumor agents.  Abstract: Twenty novel aminophosphonates derivatives (5a-5j and 6a-6j) conjugated irinotecan were synthesized through esterification reaction, and evaluated their anticancer activities using MTT assay. In vitro evaluation revealed that they displayed similar or superior cytotoxicity compared to the positive drug irinotecan against A549, MCF-7, SK-OV-3, MG-63, U2OS and multidrug-resistant (MDR) SK-OV-3/CDDP cancer cell lines. Among them, 9b displayed the most potent activity, with IC values of 0.92-3.23 M against five human cancer cells, which exhibited a 5.4-19.1-fold increase in activity compared to the reference drug irinotecan, respectively. Moreover, cellular mechanism studies suggested that 9b arrested cell cycle at S stage and induced cell apoptosis along with the decrease of mitochondrial membrane potential (MMP). Interestingly, 9b significantly inhibited tumor growth in SK-OV-3 xenograft models in vivo without apparent toxicity, which was better than the positive drug irinotecan. Taken together, 9b possessed potent antitumor activity and may be a promising candidate for the potential treatment of human ovarian cancer cells.', 'Title: Synthesis, mechanisms of action, and toxicity of novel aminophosphonates derivatives conjugated irinotecan in vitro and in vivo as potent antitumor agents.  Abstract: Twenty novel aminophosphonates derivatives (5a-5j and 6a-6j) conjugated irinotecan were synthesized through esterification reaction, and evaluated their anticancer activities using MTT assay. In vitro evaluation revealed that they displayed similar or superior cytotoxicity compared to the positive drug irinotecan against A549, MCF-7, SK-OV-3, MG-63, U2OS and multidrug-resistant (MDR) SK-OV-3/CDDP cancer cell lines. Among them, 9b displayed the most potent activity, with IC values of 0.92-3.23 M against five human cancer cells, which exhibited a 5.4-19.1-fold increase in activity compared to the reference drug irinotecan, respectively. Moreover, cellular mechanism studies suggested that 9b arrested cell cycle at S stage and induced cell apoptosis along with the decrease of mitochondrial membrane potential (MMP). Interestingly, 9b significantly inhibited tumor growth in SK-OV-3 xenograft models in vivo without apparent toxicity, which was better than the positive drug irinotecan. Taken together, 9b possessed potent antitumor activity and may be a promising candidate for the potential treatment of human ovarian cancer cells.', 'Title: Synthesis and biological evaluation of novel pyrazoline derivatives containing indole skeleton as anti-cancer agents targeting topoisomerase II.  Abstract: In order to develop potent anticaner agents, a novel series of 3-(1H-indol-3-yl)-2,3,3a,4-tetrahydrothiochromeno[4,3-c]pyrazole derivatives were synthesized. Structures of all compounds were confirmed. MTT assay has been employed to study antiproliferative activity of these compounds with four human cancer cell lines (MGC-803, Hela, MCF-7 and Bel-7404) and a normal cell line L929. Most of these compounds showed potential anticancer activity and low cytotoxicity on normal cell in vitro. 7d and 7f showed the best anticancer activity, whose IC value is 15.43 M and 20.54 M towards MGC-803, respectively. Most of them exhibited topoisomerase II selective inhibitory. Cleavage reaction assay and DNA unwinding assay showed that 7f was a nonintercalative Topo II catalytic inhibitor, which was consistent with the docking results. Laser scanning confocal microscopy system tracks the location of representative compounds 7d and 7f which can be abundantly entering the nucleus. In particular, the most potent compounds 7d and 7f were shown to be able to induce G2/M cell cycle arrest and apoptosis in MGC-803 cells.', \"Title: Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues.  Abstract: A series of calothrixin B (2) analogues bearing substituents at the 'E' ring and their corresponding deoxygenated quinocarbazoles lacking quinone unit were synthesized. The cytotoxicities of calothrixins 1, 2, and 15b-p and quinocarbazole analogues were investigated against nine cancer cell lines. The quinocarbazoles 21a and 25a inhibited the catalytic activity of human topoisomerase II. The plasmid DNA cleavage abilities of calothrixins 1, 2, and 15b-p identified compound 15h causing DNA cleavage comparable to that of calothrixin A (1). Calothrixin A (1), 3-fluorocalothrixin 15h and 4-fluoroquinocarbazole 21b induced extensive DNA damage followed by apoptotic cell death. Spectral and plasmid unwinding studies demonstrated an intercalative mode of binding for quinocarbazoles. We identified two promising drug candidates, the 3-fluorocalothrixin B 15h with low toxicity in animal model and its deoxygenated derivative 4-fluoroquinocarbazole 21b as having potent cytotoxicity against NCI-H460 cell line with a GI of 1 nM.\", \"Title: Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues.  Abstract: A series of calothrixin B (2) analogues bearing substituents at the 'E' ring and their corresponding deoxygenated quinocarbazoles lacking quinone unit were synthesized. The cytotoxicities of calothrixins 1, 2, and 15b-p and quinocarbazole analogues were investigated against nine cancer cell lines. The quinocarbazoles 21a and 25a inhibited the catalytic activity of human topoisomerase II. The plasmid DNA cleavage abilities of calothrixins 1, 2, and 15b-p identified compound 15h causing DNA cleavage comparable to that of calothrixin A (1). Calothrixin A (1), 3-fluorocalothrixin 15h and 4-fluoroquinocarbazole 21b induced extensive DNA damage followed by apoptotic cell death. Spectral and plasmid unwinding studies demonstrated an intercalative mode of binding for quinocarbazoles. We identified two promising drug candidates, the 3-fluorocalothrixin B 15h with low toxicity in animal model and its deoxygenated derivative 4-fluoroquinocarbazole 21b as having potent cytotoxicity against NCI-H460 cell line with a GI of 1 nM.\", 'Title: Design, synthesis and antineoplastic activity of novel 20(S)-acylthiourea derivatives of camptothecin.  Abstract: For the purpose of advancing our research on diverse C-20 decorated derivatives of camptothecin (CPT), 46 new CPT acylthiourea derivatives were synthesized and evaluated in vitro for their cytotoxicity. All the compounds showed promising in vitro cytotoxicity against six tumor cell lines (Hep3B, MCF7, A549, MDA-MB-231, KB and KB-vin). Out of them, compound c20 possesses remarkable in vitro cytotoxic activity and is more potent than topotecan. Mechanistically, c20 not only induces cell cycle arrest and cell apoptosis in A549 cells, but also inhibits Topo I activity in the cell and cell-free system in a manner similar to that of topotecan. In both xenograft and primary HCC mouse models, c20 displays significant in vivo anti-cancer activity and is more potent than topotecan. In addition, the acute toxicity assay showed that c20 has no apparent toxicity to mouse liver, kidney and hemopoietic system of the FVB/N mice. Take together, these results indicated that compound c20 could be a potential anti-cancer candidate for further clinical trial.', 'Title: Design, synthesis and antineoplastic activity of novel 20(S)-acylthiourea derivatives of camptothecin.  Abstract: For the purpose of advancing our research on diverse C-20 decorated derivatives of camptothecin (CPT), 46 new CPT acylthiourea derivatives were synthesized and evaluated in vitro for their cytotoxicity. All the compounds showed promising in vitro cytotoxicity against six tumor cell lines (Hep3B, MCF7, A549, MDA-MB-231, KB and KB-vin). Out of them, compound c20 possesses remarkable in vitro cytotoxic activity and is more potent than topotecan. Mechanistically, c20 not only induces cell cycle arrest and cell apoptosis in A549 cells, but also inhibits Topo I activity in the cell and cell-free system in a manner similar to that of topotecan. In both xenograft and primary HCC mouse models, c20 displays significant in vivo anti-cancer activity and is more potent than topotecan. In addition, the acute toxicity assay showed that c20 has no apparent toxicity to mouse liver, kidney and hemopoietic system of the FVB/N mice. Take together, these results indicated that compound c20 could be a potential anti-cancer candidate for further clinical trial.', 'Title: Design, synthesis and antineoplastic activity of novel 20(S)-acylthiourea derivatives of camptothecin.  Abstract: For the purpose of advancing our research on diverse C-20 decorated derivatives of camptothecin (CPT), 46 new CPT acylthiourea derivatives were synthesized and evaluated in vitro for their cytotoxicity. All the compounds showed promising in vitro cytotoxicity against six tumor cell lines (Hep3B, MCF7, A549, MDA-MB-231, KB and KB-vin). Out of them, compound c20 possesses remarkable in vitro cytotoxic activity and is more potent than topotecan. Mechanistically, c20 not only induces cell cycle arrest and cell apoptosis in A549 cells, but also inhibits Topo I activity in the cell and cell-free system in a manner similar to that of topotecan. In both xenograft and primary HCC mouse models, c20 displays significant in vivo anti-cancer activity and is more potent than topotecan. In addition, the acute toxicity assay showed that c20 has no apparent toxicity to mouse liver, kidney and hemopoietic system of the FVB/N mice. Take together, these results indicated that compound c20 could be a potential anti-cancer candidate for further clinical trial.', 'Title: Design, synthesis and antineoplastic activity of novel 20(S)-acylthiourea derivatives of camptothecin.  Abstract: For the purpose of advancing our research on diverse C-20 decorated derivatives of camptothecin (CPT), 46 new CPT acylthiourea derivatives were synthesized and evaluated in vitro for their cytotoxicity. All the compounds showed promising in vitro cytotoxicity against six tumor cell lines (Hep3B, MCF7, A549, MDA-MB-231, KB and KB-vin). Out of them, compound c20 possesses remarkable in vitro cytotoxic activity and is more potent than topotecan. Mechanistically, c20 not only induces cell cycle arrest and cell apoptosis in A549 cells, but also inhibits Topo I activity in the cell and cell-free system in a manner similar to that of topotecan. In both xenograft and primary HCC mouse models, c20 displays significant in vivo anti-cancer activity and is more potent than topotecan. In addition, the acute toxicity assay showed that c20 has no apparent toxicity to mouse liver, kidney and hemopoietic system of the FVB/N mice. Take together, these results indicated that compound c20 could be a potential anti-cancer candidate for further clinical trial.', 'Title: Design, synthesis and antineoplastic activity of novel 20(S)-acylthiourea derivatives of camptothecin.  Abstract: For the purpose of advancing our research on diverse C-20 decorated derivatives of camptothecin (CPT), 46 new CPT acylthiourea derivatives were synthesized and evaluated in vitro for their cytotoxicity. All the compounds showed promising in vitro cytotoxicity against six tumor cell lines (Hep3B, MCF7, A549, MDA-MB-231, KB and KB-vin). Out of them, compound c20 possesses remarkable in vitro cytotoxic activity and is more potent than topotecan. Mechanistically, c20 not only induces cell cycle arrest and cell apoptosis in A549 cells, but also inhibits Topo I activity in the cell and cell-free system in a manner similar to that of topotecan. In both xenograft and primary HCC mouse models, c20 displays significant in vivo anti-cancer activity and is more potent than topotecan. In addition, the acute toxicity assay showed that c20 has no apparent toxicity to mouse liver, kidney and hemopoietic system of the FVB/N mice. Take together, these results indicated that compound c20 could be a potential anti-cancer candidate for further clinical trial.', 'Title: F10, a new camptothecin derivative, was identified as a new orally-bioavailable, potent antitumor agent.  Abstract: Topoisomerases are interesting targets for drug discovery. In the present study, we attached saturated carbon atoms to the 10-position of camptothecin and synthesized 10 new camptothecin derivatives from 10-HCPT or SN-38. The activities of new compounds were evaluated both in vitro and in vivo. The most promising compound F10, 7-ethyl-10-(2-oxo-2-(piperidin-1-yl)ethoxy)camptothecin, inhibited cancer cells growth with the IC of 0.002, 0.003, 0.011 and 0.081 M on Raji, HCT116, A549 and Lovo cells, respectively. Meanwhile, oral administration of F10 remarkably suppressed the HCT116-xenograft tumor growth in the nude-mice model at the dosage of 0.5, 2.0 and 8.0 mg/kg in vivo. Intraperitoneal administration of F10 can completely inhibit Raji-xenograft tumor growth in established NPG mouse model at 2.0 and 4.0 mg/kg. In addition, the minimum lethal doses of F10 and SN-38 in mice by intravenous administration were 80 and 40 mg/kg (or 0.155, 0.102 mmol/kg), respectively. The solubility of F10 reached 9.86 g/mL in a buffer solution of pH 4.5. The oral bioavailability of F10 achieved 22.4% in mice. The molecular docking model revealed that F10 can interact with topoisomerase I-DNA complex. Our findings indicate that F10 is a new orally-oavailable antitumor agent with potent anticancer effect. Furthermore, attaching a ring hydrophobic moiety to the 10-position of camptothecin provides a favorable approach in the optimization of camptothecin.', 'Title: F10, a new camptothecin derivative, was identified as a new orally-bioavailable, potent antitumor agent.  Abstract: Topoisomerases are interesting targets for drug discovery. In the present study, we attached saturated carbon atoms to the 10-position of camptothecin and synthesized 10 new camptothecin derivatives from 10-HCPT or SN-38. The activities of new compounds were evaluated both in vitro and in vivo. The most promising compound F10, 7-ethyl-10-(2-oxo-2-(piperidin-1-yl)ethoxy)camptothecin, inhibited cancer cells growth with the IC of 0.002, 0.003, 0.011 and 0.081 M on Raji, HCT116, A549 and Lovo cells, respectively. Meanwhile, oral administration of F10 remarkably suppressed the HCT116-xenograft tumor growth in the nude-mice model at the dosage of 0.5, 2.0 and 8.0 mg/kg in vivo. Intraperitoneal administration of F10 can completely inhibit Raji-xenograft tumor growth in established NPG mouse model at 2.0 and 4.0 mg/kg. In addition, the minimum lethal doses of F10 and SN-38 in mice by intravenous administration were 80 and 40 mg/kg (or 0.155, 0.102 mmol/kg), respectively. The solubility of F10 reached 9.86 g/mL in a buffer solution of pH 4.5. The oral bioavailability of F10 achieved 22.4% in mice. The molecular docking model revealed that F10 can interact with topoisomerase I-DNA complex. Our findings indicate that F10 is a new orally-oavailable antitumor agent with potent anticancer effect. Furthermore, attaching a ring hydrophobic moiety to the 10-position of camptothecin provides a favorable approach in the optimization of camptothecin.', 'Title: F10, a new camptothecin derivative, was identified as a new orally-bioavailable, potent antitumor agent.  Abstract: Topoisomerases are interesting targets for drug discovery. In the present study, we attached saturated carbon atoms to the 10-position of camptothecin and synthesized 10 new camptothecin derivatives from 10-HCPT or SN-38. The activities of new compounds were evaluated both in vitro and in vivo. The most promising compound F10, 7-ethyl-10-(2-oxo-2-(piperidin-1-yl)ethoxy)camptothecin, inhibited cancer cells growth with the IC of 0.002, 0.003, 0.011 and 0.081 M on Raji, HCT116, A549 and Lovo cells, respectively. Meanwhile, oral administration of F10 remarkably suppressed the HCT116-xenograft tumor growth in the nude-mice model at the dosage of 0.5, 2.0 and 8.0 mg/kg in vivo. Intraperitoneal administration of F10 can completely inhibit Raji-xenograft tumor growth in established NPG mouse model at 2.0 and 4.0 mg/kg. In addition, the minimum lethal doses of F10 and SN-38 in mice by intravenous administration were 80 and 40 mg/kg (or 0.155, 0.102 mmol/kg), respectively. The solubility of F10 reached 9.86 g/mL in a buffer solution of pH 4.5. The oral bioavailability of F10 achieved 22.4% in mice. The molecular docking model revealed that F10 can interact with topoisomerase I-DNA complex. Our findings indicate that F10 is a new orally-oavailable antitumor agent with potent anticancer effect. Furthermore, attaching a ring hydrophobic moiety to the 10-position of camptothecin provides a favorable approach in the optimization of camptothecin.', 'Title: Oligosaccharide-camptothecin conjugates as potential antineoplastic drugs: Design, synthesis and biological evaluation.  Abstract: Thirty novel 20 (S)-O-linked camptothecin (CPT) glycoconjugates were synthesized. They showed more potent in vitro cytotoxicities over irinotecan, but very weak direct topoisomerase I (Topo I) inhibition was observed at 100.0 M. Oligosaccharide types, length of a PEG linker and acetyl groups exerted obvious effects on cytotoxicity, selectivity, water solubility and stability of the newly synthesized CPT glycoconjugates. Construct 40, with a bleomycin (BLM) disaccharide linked to diethylene glycol in the introduced ester moiety, demonstrated a superior antitumor activity and a distinct selectivity compared to CPT. No toxicity was detectable in animal acute toxicity intravenously (160 mg/kg). Collectively, attachment of oligosaccharides with tumor targeting to 20 (S)-OH of CPT could offer a solution to the daunting problems posed by current Topo I poisons.', 'Title: Oligosaccharide-camptothecin conjugates as potential antineoplastic drugs: Design, synthesis and biological evaluation.  Abstract: Thirty novel 20 (S)-O-linked camptothecin (CPT) glycoconjugates were synthesized. They showed more potent in vitro cytotoxicities over irinotecan, but very weak direct topoisomerase I (Topo I) inhibition was observed at 100.0 M. Oligosaccharide types, length of a PEG linker and acetyl groups exerted obvious effects on cytotoxicity, selectivity, water solubility and stability of the newly synthesized CPT glycoconjugates. Construct 40, with a bleomycin (BLM) disaccharide linked to diethylene glycol in the introduced ester moiety, demonstrated a superior antitumor activity and a distinct selectivity compared to CPT. No toxicity was detectable in animal acute toxicity intravenously (160 mg/kg). Collectively, attachment of oligosaccharides with tumor targeting to 20 (S)-OH of CPT could offer a solution to the daunting problems posed by current Topo I poisons.', \"Title: Copper(I)-Catalyzed Nitrile-Addition/N-Arylation Ring-Closure Cascade: Synthesis of 5,11-Dihydro-6H-indolo[3,2-c]quinolin-6-ones as Potent Topoisomerase-I Inhibitors.  Abstract: In this paper, we present a copper(I)-catalyzed nitrile-addition/N-arylation ring-closure cascade for the synthesis of 5,11-dihydro-6H-indolo[3,2-c]quinolin-6-ones from 2-(2-bromophenyl)-N-(2-cyanophenyl)acetamides. Using CuBr and t-BuONa in dimethylformamide (DMF) as the optimal reaction conditions, the cascade reaction gave the target products, in high yields, with a good substrate scope. Application of the cascade reaction was demonstrated on the concise total syntheses of alkaloid isocryptolepine. Further optimization of the products from the cascade reaction led to 3-chloro-5,12-bis[2-(dimethylamino)ethyl]-5,12-dihydro-6H-[1,3]dioxolo[4',5':5,6]indolo[3,2-c]quinolin-6-one (2k), which exhibited the characteristic DNA topoisomerase-I inhibitory mechanism of action with potent in vitro anticancer activity. Compound 2k actively inhibited ARC-111- and SN-38-resistant HCT-116 cells and showed in vivo activity in mice bearing human HCT-116 and SJCRH30 xenografts. The interaction of 2k with the Top-DNA cleavable complex was revealed by docking simulations to guide the future optimization of 5,11-dihydro-6H-indolo[3,2-c]quinolin-6-ones as topoisomerase-I inhibitors.\", \"Title: Copper(I)-Catalyzed Nitrile-Addition/N-Arylation Ring-Closure Cascade: Synthesis of 5,11-Dihydro-6H-indolo[3,2-c]quinolin-6-ones as Potent Topoisomerase-I Inhibitors.  Abstract: In this paper, we present a copper(I)-catalyzed nitrile-addition/N-arylation ring-closure cascade for the synthesis of 5,11-dihydro-6H-indolo[3,2-c]quinolin-6-ones from 2-(2-bromophenyl)-N-(2-cyanophenyl)acetamides. Using CuBr and t-BuONa in dimethylformamide (DMF) as the optimal reaction conditions, the cascade reaction gave the target products, in high yields, with a good substrate scope. Application of the cascade reaction was demonstrated on the concise total syntheses of alkaloid isocryptolepine. Further optimization of the products from the cascade reaction led to 3-chloro-5,12-bis[2-(dimethylamino)ethyl]-5,12-dihydro-6H-[1,3]dioxolo[4',5':5,6]indolo[3,2-c]quinolin-6-one (2k), which exhibited the characteristic DNA topoisomerase-I inhibitory mechanism of action with potent in vitro anticancer activity. Compound 2k actively inhibited ARC-111- and SN-38-resistant HCT-116 cells and showed in vivo activity in mice bearing human HCT-116 and SJCRH30 xenografts. The interaction of 2k with the Top-DNA cleavable complex was revealed by docking simulations to guide the future optimization of 5,11-dihydro-6H-indolo[3,2-c]quinolin-6-ones as topoisomerase-I inhibitors.\", \"Title: Copper(I)-Catalyzed Nitrile-Addition/N-Arylation Ring-Closure Cascade: Synthesis of 5,11-Dihydro-6H-indolo[3,2-c]quinolin-6-ones as Potent Topoisomerase-I Inhibitors.  Abstract: In this paper, we present a copper(I)-catalyzed nitrile-addition/N-arylation ring-closure cascade for the synthesis of 5,11-dihydro-6H-indolo[3,2-c]quinolin-6-ones from 2-(2-bromophenyl)-N-(2-cyanophenyl)acetamides. Using CuBr and t-BuONa in dimethylformamide (DMF) as the optimal reaction conditions, the cascade reaction gave the target products, in high yields, with a good substrate scope. Application of the cascade reaction was demonstrated on the concise total syntheses of alkaloid isocryptolepine. Further optimization of the products from the cascade reaction led to 3-chloro-5,12-bis[2-(dimethylamino)ethyl]-5,12-dihydro-6H-[1,3]dioxolo[4',5':5,6]indolo[3,2-c]quinolin-6-one (2k), which exhibited the characteristic DNA topoisomerase-I inhibitory mechanism of action with potent in vitro anticancer activity. Compound 2k actively inhibited ARC-111- and SN-38-resistant HCT-116 cells and showed in vivo activity in mice bearing human HCT-116 and SJCRH30 xenografts. The interaction of 2k with the Top-DNA cleavable complex was revealed by docking simulations to guide the future optimization of 5,11-dihydro-6H-indolo[3,2-c]quinolin-6-ones as topoisomerase-I inhibitors.\", \"Title: Synthesis and topoisomerases inhibitory activity of heteroaromatic chalcones.  Abstract: The critical role of nuclear topoisomerase enzymes during cell proliferation process guided topoisomerases to be one of the major targets for anticancer drug development. We have designed and synthesized 22 heteroaromatic ring incorporated chalcone derivatives substituted with epoxide or thioepoxide. Topoisomerase enzyme inhibitory activity and cytotoxic tests were also conducted to evaluate compounds' pharmacological efficacy. In the topoisomerase I inhibitory test, compound 1 was most active one, 24% of inhibition at 20M, among all the compounds but it was lower than camptothecin. Compounds 9, 11, and 13 inhibited the function of topoisomerase II more strongly than etoposide with almost same magnitude (around 90% and 30% inhibition at 100 and 20M, respectively) which were higher than those of etoposide (72% and 18% inhibition). In the cytotoxicity test, compound 9 inhibited T47D cancer cell growth with the IC value of 6.610.21M. On the other hand, compound 13 (IC: 4.320.18M) effectively suppressed MDA-MB468 cancer cell growth.\", \"Title: Synthesis and topoisomerases inhibitory activity of heteroaromatic chalcones.  Abstract: The critical role of nuclear topoisomerase enzymes during cell proliferation process guided topoisomerases to be one of the major targets for anticancer drug development. We have designed and synthesized 22 heteroaromatic ring incorporated chalcone derivatives substituted with epoxide or thioepoxide. Topoisomerase enzyme inhibitory activity and cytotoxic tests were also conducted to evaluate compounds' pharmacological efficacy. In the topoisomerase I inhibitory test, compound 1 was most active one, 24% of inhibition at 20M, among all the compounds but it was lower than camptothecin. Compounds 9, 11, and 13 inhibited the function of topoisomerase II more strongly than etoposide with almost same magnitude (around 90% and 30% inhibition at 100 and 20M, respectively) which were higher than those of etoposide (72% and 18% inhibition). In the cytotoxicity test, compound 9 inhibited T47D cancer cell growth with the IC value of 6.610.21M. On the other hand, compound 13 (IC: 4.320.18M) effectively suppressed MDA-MB468 cancer cell growth.\", 'Title: Discovery of Evodiamine Derivatives as Highly Selective PDE5 Inhibitors Targeting a Unique Allosteric Pocket.  Abstract: Clinical use of phosphodiesterase-5 (PDE5) inhibitors is limited by several side effects due to weak isoform selectivity. Herein, a unique allosteric pocket of PDE5 is identified by molecular modeling and structural biology, which enables the discovery of highly selective PDE5 inhibitors from natural product evodiamine (EVO). The crystal structure of PDE5 with bound EVO derivative ( S )-7e revealed that binding of ( S )-7e to the novel allosteric pocket induced dramatic conformation changes in the H-loop with a maximum 24  movement of their C atoms. This movement directly blocks the binding of substrate/inhibitors to the PDE5 active site, which is different from all traditional PDE5 inhibitors such as sildenafil, tadalafil, and vardenafil. These derivatives showed >570-fold selectivity over PDE6C and PDE11A and achieved potent efficacy for the effective treatment of pulmonary hypertension in vivo.', 'Title: Design, synthesis, biological evaluation, QSAR analysis and molecular modelling of new thiazol-benzimidazoles as EGFR inhibitors.  Abstract: Heterocyclic rings such as thiazole and benzimidazole are considered as privileged structures, since they constitute several FDA-approved drugs for cancer treatment. In this work, a new set of 2-(2-(substituted) hydrazinyl)-4-(1-methyl-1H-benzo[d]imidazol-2-yl) thiazoles 4a-q were designed as epidermal growth factor receptor (EGFR) inhibitors and synthesized using concise synthetic methods. The new target compounds have been evaluated in vitro for their suppression activity against EGFR TK. Compounds 4n, 4h, 4i, 4a and 4d exhibited significant potency in comparison with erlotinib which served as a reference drug (IC50, 71.67-152.59 nM; IC50 erlotinib, 152.59 nM). Furthermore, MTT assay revealed that compounds 4j, 4a, 4f, 4h, 4n produced the most promising cytotoxic potency against the human breast cancer cell line (MCF-7) (IC50; 5.96-11.91 M; IC50 erlotinib; 4.15 M). Compound 4a showed promising activity as EGFR TK inhibitor as well as anti-breast cancer agent. In addition, 4a induced apoptotic effect and cell cycle arrest at G2/M phase preventing the mitotic cycle in MCF-7 cells. Moreover, 4a upregulated the oncogenic parameters; caspase-3, p53, Bax/Bcl-2 as well as it inhibited the level of PARP-1 enzyme. QSAR study was carried out for the new derivatives and it revealed the goodness of the models. Furthermore, molecular docking studies represented the binding modes of the promising compounds in the active pocket of EGFR.', 'Title: Design, synthesis and antitumor evaluation of new 1,8-naphthalimide derivatives targeting nuclear DNA.  Abstract: Four series of new 3-nitro naphthalimides derivatives, 4(4a4f), 5(5a5i), 6(6a6e) and 7 (7a7j), were designed and synthesized as antitumor agents. Methyl thiazolyl tetrazolium (MTT) screening assay results revealed that some compounds displayed effective in vitro antiproliferative activity on SMMC-7721, T24, SKOV-3, A549 and MGC-803 cancer cell lines in comparison with 5-fluorouracil (5-FU), mitonafide and amonafide. Nude mouse xenotransplantation model assay results indicated that compounds 6b and 7b exhibited good in vivo antiproliferative activity in MGC-803 xenografts in comparison with amonafide and cisplatin, suggesting that compounds 6b and 7b could be good candidates for antitumor agents. Gel electrophoresis assay indicated that DNA and Topo I were the potential targets of compounds 6b and 7b, and comet assay confirmed that compounds 6b and 7b could induce DNA damage, while the further study showed that the 6b- and 7b-induced DNA damage was accompanied by the upregulation of p-ATM, P-Chk2, Cdc25A and p-H2AX. Cell cycle arrest studies demonstrated that compounds 6b and 7b arrested the cell cycle at the S phase, accompanied by the upregulation of the expression levels of the antioncogene p21 and the down-regulation of the expression levels of cyclin E. Apoptosis assays indicated that compounds 6b and 7b caused the apoptosis of tumor cells along with the upregulation of the expression of Bax, caspase-3, caspase-9 and PARP and the downregulation of Bcl-2. These mechanistic studies suggested that compounds 6b and 7b exerted their antitumor activity by targeting to DNA, thereby inducing DNA damage and Topo I inhibition, and consequently causing S stage arrest and the induction of apoptosis.', 'Title: Design, synthesis and antitumor evaluation of new 1,8-naphthalimide derivatives targeting nuclear DNA.  Abstract: Four series of new 3-nitro naphthalimides derivatives, 4(4a4f), 5(5a5i), 6(6a6e) and 7 (7a7j), were designed and synthesized as antitumor agents. Methyl thiazolyl tetrazolium (MTT) screening assay results revealed that some compounds displayed effective in vitro antiproliferative activity on SMMC-7721, T24, SKOV-3, A549 and MGC-803 cancer cell lines in comparison with 5-fluorouracil (5-FU), mitonafide and amonafide. Nude mouse xenotransplantation model assay results indicated that compounds 6b and 7b exhibited good in vivo antiproliferative activity in MGC-803 xenografts in comparison with amonafide and cisplatin, suggesting that compounds 6b and 7b could be good candidates for antitumor agents. Gel electrophoresis assay indicated that DNA and Topo I were the potential targets of compounds 6b and 7b, and comet assay confirmed that compounds 6b and 7b could induce DNA damage, while the further study showed that the 6b- and 7b-induced DNA damage was accompanied by the upregulation of p-ATM, P-Chk2, Cdc25A and p-H2AX. Cell cycle arrest studies demonstrated that compounds 6b and 7b arrested the cell cycle at the S phase, accompanied by the upregulation of the expression levels of the antioncogene p21 and the down-regulation of the expression levels of cyclin E. Apoptosis assays indicated that compounds 6b and 7b caused the apoptosis of tumor cells along with the upregulation of the expression of Bax, caspase-3, caspase-9 and PARP and the downregulation of Bcl-2. These mechanistic studies suggested that compounds 6b and 7b exerted their antitumor activity by targeting to DNA, thereby inducing DNA damage and Topo I inhibition, and consequently causing S stage arrest and the induction of apoptosis.', 'Title: Design, synthesis and antitumor evaluation of new 1,8-naphthalimide derivatives targeting nuclear DNA.  Abstract: Four series of new 3-nitro naphthalimides derivatives, 4(4a4f), 5(5a5i), 6(6a6e) and 7 (7a7j), were designed and synthesized as antitumor agents. Methyl thiazolyl tetrazolium (MTT) screening assay results revealed that some compounds displayed effective in vitro antiproliferative activity on SMMC-7721, T24, SKOV-3, A549 and MGC-803 cancer cell lines in comparison with 5-fluorouracil (5-FU), mitonafide and amonafide. Nude mouse xenotransplantation model assay results indicated that compounds 6b and 7b exhibited good in vivo antiproliferative activity in MGC-803 xenografts in comparison with amonafide and cisplatin, suggesting that compounds 6b and 7b could be good candidates for antitumor agents. Gel electrophoresis assay indicated that DNA and Topo I were the potential targets of compounds 6b and 7b, and comet assay confirmed that compounds 6b and 7b could induce DNA damage, while the further study showed that the 6b- and 7b-induced DNA damage was accompanied by the upregulation of p-ATM, P-Chk2, Cdc25A and p-H2AX. Cell cycle arrest studies demonstrated that compounds 6b and 7b arrested the cell cycle at the S phase, accompanied by the upregulation of the expression levels of the antioncogene p21 and the down-regulation of the expression levels of cyclin E. Apoptosis assays indicated that compounds 6b and 7b caused the apoptosis of tumor cells along with the upregulation of the expression of Bax, caspase-3, caspase-9 and PARP and the downregulation of Bcl-2. These mechanistic studies suggested that compounds 6b and 7b exerted their antitumor activity by targeting to DNA, thereby inducing DNA damage and Topo I inhibition, and consequently causing S stage arrest and the induction of apoptosis.', 'Title: Design, synthesis and screening of benzimidazole containing compounds with methoxylated aryl radicals as cytotoxic molecules on (HCT-116) colon cancer cells.  Abstract: A novel series of benzimidazole derivatives with methoxylated aryl groups was designed and synthesized as molecules with potential cytotoxic activity. In vitro cytotoxic activity over HCT-116 cells showed that N-(benzimidazothiazolone)acetamides 11a, 11b and 11c were found to be the most cytotoxic compounds compared camptothecin (CPT). The tested compounds had a dual topoisomerase I- (Topo I-) and tubulin inhibiting activities when compared to CPT and Podophyllotoxin (Podo) where, compounds l0a, l0b, 11a and 11b exhibited a potent inhibitory activity on Topo I- enzyme in nano-molar concentration, on the other hand, compounds 12b and 13b exhibited the best inhibitory activity -tubulin polymerization. Results of the cell cycle analysis as well as the results of annexin-V on HCT-116 cells showed that benzimidazothiazoles 12b and 13b had a pro-apoptotic activity higher than CPT by 1.33- and 1.30-folds, respectively. Moreover, the concentration of p53, Bax/Bcl-2 ratio and caspase 3/7 increased in compounds l0b, 11b, l2b, 13b, especially, compounds 11b and 13b exhibited an increased level of these mediators than CPT. Finally, compound 11b regulated the radiosensitizing activity of the HCT-116 cells by modulating the chromosomal instability.', 'Title: Design, synthesis and screening of benzimidazole containing compounds with methoxylated aryl radicals as cytotoxic molecules on (HCT-116) colon cancer cells.  Abstract: A novel series of benzimidazole derivatives with methoxylated aryl groups was designed and synthesized as molecules with potential cytotoxic activity. In vitro cytotoxic activity over HCT-116 cells showed that N-(benzimidazothiazolone)acetamides 11a, 11b and 11c were found to be the most cytotoxic compounds compared camptothecin (CPT). The tested compounds had a dual topoisomerase I- (Topo I-) and tubulin inhibiting activities when compared to CPT and Podophyllotoxin (Podo) where, compounds l0a, l0b, 11a and 11b exhibited a potent inhibitory activity on Topo I- enzyme in nano-molar concentration, on the other hand, compounds 12b and 13b exhibited the best inhibitory activity -tubulin polymerization. Results of the cell cycle analysis as well as the results of annexin-V on HCT-116 cells showed that benzimidazothiazoles 12b and 13b had a pro-apoptotic activity higher than CPT by 1.33- and 1.30-folds, respectively. Moreover, the concentration of p53, Bax/Bcl-2 ratio and caspase 3/7 increased in compounds l0b, 11b, l2b, 13b, especially, compounds 11b and 13b exhibited an increased level of these mediators than CPT. Finally, compound 11b regulated the radiosensitizing activity of the HCT-116 cells by modulating the chromosomal instability.', 'Title: Design, Synthesis and Structure-Activity Relationship Studies of Glycosylated Derivatives of Marine Natural Product Lamellarin D.  Abstract: Lamellarin D, a marine natural product, acts as a potent inhibitor of DNA topoisomerase I (Topo I). To modify its physicochemical property and biological activity, a series of mono- and di-glycosylated derivatives were designed and synthesized through 22-26 multi-steps. Their inhibition of human Topo I was evaluated, and most of the glycosylated derivatives exhibited high potency in inhibiting Topo I activity as well as lamellarin D. All the 15 target compounds were evaluated for their cytotoxic activities against five human cancer cell lines. The typical lamellarin derivative ZL-3 exhibited the best activity with IC values of 3 nM, 10 nM, and 15 nM against human lung cancer A549 cells, human colon cancer HCT116 cells and human hepatocellular carcinoma HepG2 cells. Compound ZL-1 exhibited anti-cancer activity with IC of 14 nM and 24 nM against human colon cancer HCT116 cells and human hepatocellular carcinoma HepG2 cells, respectively. Cell cycle analysis in MDA-MB-231 suggested ZL-3 inhibited cell growth through arresting cells at the G2/M phase of the cell cycle. Further tests showed a significant improvement in aqueous solubility of ZL-1 and ZL-7. This study suggested that glycosylation could be utilized as a useful strategy to optimize lamellarin D derivatives as Topo I inhibitors and anticancer agents.', 'Title: Discovery of 4-alkoxy-2-aryl-6,7-dimethoxyquinolines as a new class of topoisomerase I inhibitors endowed with potent in vitro anticancer activity.  Abstract: In our attempt to develop potential anticancer agents targeting Topoisomerase I (TOP1), two novel series of 4-alkoxy-2-arylquinolines 14a-p and 19a-c were designed and synthesized based on structure activity relationships of the reported TOP1 inhibitors and structural features required for stabilization of TOP1-DNA cleavage complexes (TOP1ccs). The in vitro anticancer activity of these two series of compounds was evaluated at one dose level using NCI-60 cancer cell lines panel. Compounds 14e-h and 14m-p, with p-substituted phenyl at C2 and propyl linker at C4, were the most potent and were selected for assay at five doses level in which they exhibited potent anticancer activity at sub-micromolar level against diverse cancer cell lines. Compound 14m was the most potent with full panel GI MG-MID 1.26 M and the most sensitive cancers were colon cancer, leukemia and melanoma with GI MG-MID 0.875, 0.904 and 0.926 M, respectively. Melanoma (LOX IMVI) was the most sensitive cell line to all tested compounds displaying GI from 0.116 to 0.227 M, TGI from 0.275 to 0.592 M and LC at sub-micromolar concentration against almost of the tested compounds. Compounds 14e-h and 14m-p were assayed using TOP1-mediated DNA cleavage assay to evaluate their ability to stabilize TOP1ccs resulting in cancer cell death. The morpholino analogs 14h and 14p exhibited moderate TOP1 inhibitory activity compared to 1 M camptothecin suggesting their use as lead compounds that can be optimized for the development of more potent anticancer agents with potential TOP1 inhibitory activity. Finally, Swiss ADME online web tool predicted that compounds 14h and 14p possessed good oral bioavailability and druglikeness characteristics.', 'Title: Design, synthesis, and biological evaluation of heterotetracyclic quinolinone derivatives as anticancer agents targeting topoisomerases.  Abstract: A series of thiochromeno[2,3-c]quinolin-12-one derivatives with various substitutions were synthesized and evaluated as topoisomerase (Topo) inhibitors. Six (8, 10, 12, 14, 19, and 26) of 23 compounds showed strong inhibitory activities against Topo-mediated DNA relaxation and proliferation of five human cell lines including breast (MDA-MB-231, MDA-MB-468 and MCF7), colorectal (HCT116) and non-small cell lung (H1299) cancers. Among these, compounds 14 and 26 exhibited full inhibitory activities against Topo I at 3 M and Topo II at 1 M. Cancer cells treated with 26 accumulated DNA damage and were arrested at the G/M phase. With time, cells proceeded to apoptosis, as revealed by increased amounts of cells with fragmented DNA and cleavage of caspase-8 and -9. In contrast, normal breast epithelial cells showed low sensitivity to 26. Taken together, our study identifies 26 as a potent Topo dual-inhibitor with low toxicity to normal cells, and elucidates that the terminal amino group of N-2-aminoethylamino or N-3-aminopropylamino at the 6th position and 8,10-di-halogen substituents on thiochromeno[2,3-c]quinolin-12-one are critical for the Topo-inhibiting and cancer-killing activities.', 'Title: Design, synthesis, and biological evaluation of heterotetracyclic quinolinone derivatives as anticancer agents targeting topoisomerases.  Abstract: A series of thiochromeno[2,3-c]quinolin-12-one derivatives with various substitutions were synthesized and evaluated as topoisomerase (Topo) inhibitors. Six (8, 10, 12, 14, 19, and 26) of 23 compounds showed strong inhibitory activities against Topo-mediated DNA relaxation and proliferation of five human cell lines including breast (MDA-MB-231, MDA-MB-468 and MCF7), colorectal (HCT116) and non-small cell lung (H1299) cancers. Among these, compounds 14 and 26 exhibited full inhibitory activities against Topo I at 3 M and Topo II at 1 M. Cancer cells treated with 26 accumulated DNA damage and were arrested at the G/M phase. With time, cells proceeded to apoptosis, as revealed by increased amounts of cells with fragmented DNA and cleavage of caspase-8 and -9. In contrast, normal breast epithelial cells showed low sensitivity to 26. Taken together, our study identifies 26 as a potent Topo dual-inhibitor with low toxicity to normal cells, and elucidates that the terminal amino group of N-2-aminoethylamino or N-3-aminopropylamino at the 6th position and 8,10-di-halogen substituents on thiochromeno[2,3-c]quinolin-12-one are critical for the Topo-inhibiting and cancer-killing activities.', 'Title: Design, synthesis, and biological evaluation of heterotetracyclic quinolinone derivatives as anticancer agents targeting topoisomerases.  Abstract: A series of thiochromeno[2,3-c]quinolin-12-one derivatives with various substitutions were synthesized and evaluated as topoisomerase (Topo) inhibitors. Six (8, 10, 12, 14, 19, and 26) of 23 compounds showed strong inhibitory activities against Topo-mediated DNA relaxation and proliferation of five human cell lines including breast (MDA-MB-231, MDA-MB-468 and MCF7), colorectal (HCT116) and non-small cell lung (H1299) cancers. Among these, compounds 14 and 26 exhibited full inhibitory activities against Topo I at 3 M and Topo II at 1 M. Cancer cells treated with 26 accumulated DNA damage and were arrested at the G/M phase. With time, cells proceeded to apoptosis, as revealed by increased amounts of cells with fragmented DNA and cleavage of caspase-8 and -9. In contrast, normal breast epithelial cells showed low sensitivity to 26. Taken together, our study identifies 26 as a potent Topo dual-inhibitor with low toxicity to normal cells, and elucidates that the terminal amino group of N-2-aminoethylamino or N-3-aminopropylamino at the 6th position and 8,10-di-halogen substituents on thiochromeno[2,3-c]quinolin-12-one are critical for the Topo-inhibiting and cancer-killing activities.', 'Title: Design, synthesis, and biological evaluation of heterotetracyclic quinolinone derivatives as anticancer agents targeting topoisomerases.  Abstract: A series of thiochromeno[2,3-c]quinolin-12-one derivatives with various substitutions were synthesized and evaluated as topoisomerase (Topo) inhibitors. Six (8, 10, 12, 14, 19, and 26) of 23 compounds showed strong inhibitory activities against Topo-mediated DNA relaxation and proliferation of five human cell lines including breast (MDA-MB-231, MDA-MB-468 and MCF7), colorectal (HCT116) and non-small cell lung (H1299) cancers. Among these, compounds 14 and 26 exhibited full inhibitory activities against Topo I at 3 M and Topo II at 1 M. Cancer cells treated with 26 accumulated DNA damage and were arrested at the G/M phase. With time, cells proceeded to apoptosis, as revealed by increased amounts of cells with fragmented DNA and cleavage of caspase-8 and -9. In contrast, normal breast epithelial cells showed low sensitivity to 26. Taken together, our study identifies 26 as a potent Topo dual-inhibitor with low toxicity to normal cells, and elucidates that the terminal amino group of N-2-aminoethylamino or N-3-aminopropylamino at the 6th position and 8,10-di-halogen substituents on thiochromeno[2,3-c]quinolin-12-one are critical for the Topo-inhibiting and cancer-killing activities.', 'Title: Design, synthesis, and biological evaluation of heterotetracyclic quinolinone derivatives as anticancer agents targeting topoisomerases.  Abstract: A series of thiochromeno[2,3-c]quinolin-12-one derivatives with various substitutions were synthesized and evaluated as topoisomerase (Topo) inhibitors. Six (8, 10, 12, 14, 19, and 26) of 23 compounds showed strong inhibitory activities against Topo-mediated DNA relaxation and proliferation of five human cell lines including breast (MDA-MB-231, MDA-MB-468 and MCF7), colorectal (HCT116) and non-small cell lung (H1299) cancers. Among these, compounds 14 and 26 exhibited full inhibitory activities against Topo I at 3 M and Topo II at 1 M. Cancer cells treated with 26 accumulated DNA damage and were arrested at the G/M phase. With time, cells proceeded to apoptosis, as revealed by increased amounts of cells with fragmented DNA and cleavage of caspase-8 and -9. In contrast, normal breast epithelial cells showed low sensitivity to 26. Taken together, our study identifies 26 as a potent Topo dual-inhibitor with low toxicity to normal cells, and elucidates that the terminal amino group of N-2-aminoethylamino or N-3-aminopropylamino at the 6th position and 8,10-di-halogen substituents on thiochromeno[2,3-c]quinolin-12-one are critical for the Topo-inhibiting and cancer-killing activities.', 'Title: Design, synthesis, and biological evaluation of heterotetracyclic quinolinone derivatives as anticancer agents targeting topoisomerases.  Abstract: A series of thiochromeno[2,3-c]quinolin-12-one derivatives with various substitutions were synthesized and evaluated as topoisomerase (Topo) inhibitors. Six (8, 10, 12, 14, 19, and 26) of 23 compounds showed strong inhibitory activities against Topo-mediated DNA relaxation and proliferation of five human cell lines including breast (MDA-MB-231, MDA-MB-468 and MCF7), colorectal (HCT116) and non-small cell lung (H1299) cancers. Among these, compounds 14 and 26 exhibited full inhibitory activities against Topo I at 3 M and Topo II at 1 M. Cancer cells treated with 26 accumulated DNA damage and were arrested at the G/M phase. With time, cells proceeded to apoptosis, as revealed by increased amounts of cells with fragmented DNA and cleavage of caspase-8 and -9. In contrast, normal breast epithelial cells showed low sensitivity to 26. Taken together, our study identifies 26 as a potent Topo dual-inhibitor with low toxicity to normal cells, and elucidates that the terminal amino group of N-2-aminoethylamino or N-3-aminopropylamino at the 6th position and 8,10-di-halogen substituents on thiochromeno[2,3-c]quinolin-12-one are critical for the Topo-inhibiting and cancer-killing activities.', 'Title: Synthesis of novel hybrid quinolino[4,3-b][1,5]naphthyridines and quinolino[4,3-b][1,5]naphthyridin-6(5H)-one derivatives and biological evaluation as topoisomerase I inhibitors and antiproliferatives.  Abstract: The topoisomerase I enzymatic inhibition of hybrid quinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridines and quinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-ones was investigated. First, the synthesis of these fused compounds was performed by intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and unsaturated aldehydes affording corresponding hybrid 5-tosylhexahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine and tetrahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one compounds with good to high general yields. Subsequent dehydrogenation led to the corresponding more unsaturated dihydro (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine and (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one derivatives in quantitative yields. The new polycyclic products show excellent-good activity as topoisomerase I (TopI) inhibitors that lead to TopI induced nicking of plasmids. This is consistent with the compounds acting as TopI poisons resulting in the accumulation of trapped cleavage complexes in the DNA. The cytotoxic effect on cell lines A549, SKOV3 and on non-cancerous MRC5 was also screened. Tetrahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one 9 resulted the most cytotoxic compound with IC values of 3.25  0.91 M and 2.08  1.89 M against the A549 cell line and the SKOV3 cell line, respectively. Also, hexahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine 8a and dihydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine 10a showed good cytotoxicity against these cell lines. None of the compounds presented cytotoxic effects against non-malignant pulmonary fibroblasts (MRC-5).', 'Title: Synthesis of novel hybrid quinolino[4,3-b][1,5]naphthyridines and quinolino[4,3-b][1,5]naphthyridin-6(5H)-one derivatives and biological evaluation as topoisomerase I inhibitors and antiproliferatives.  Abstract: The topoisomerase I enzymatic inhibition of hybrid quinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridines and quinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-ones was investigated. First, the synthesis of these fused compounds was performed by intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and unsaturated aldehydes affording corresponding hybrid 5-tosylhexahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine and tetrahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one compounds with good to high general yields. Subsequent dehydrogenation led to the corresponding more unsaturated dihydro (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine and (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one derivatives in quantitative yields. The new polycyclic products show excellent-good activity as topoisomerase I (TopI) inhibitors that lead to TopI induced nicking of plasmids. This is consistent with the compounds acting as TopI poisons resulting in the accumulation of trapped cleavage complexes in the DNA. The cytotoxic effect on cell lines A549, SKOV3 and on non-cancerous MRC5 was also screened. Tetrahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one 9 resulted the most cytotoxic compound with IC values of 3.25  0.91 M and 2.08  1.89 M against the A549 cell line and the SKOV3 cell line, respectively. Also, hexahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine 8a and dihydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine 10a showed good cytotoxicity against these cell lines. None of the compounds presented cytotoxic effects against non-malignant pulmonary fibroblasts (MRC-5).', 'Title: Synthesis of novel hybrid quinolino[4,3-b][1,5]naphthyridines and quinolino[4,3-b][1,5]naphthyridin-6(5H)-one derivatives and biological evaluation as topoisomerase I inhibitors and antiproliferatives.  Abstract: The topoisomerase I enzymatic inhibition of hybrid quinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridines and quinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-ones was investigated. First, the synthesis of these fused compounds was performed by intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and unsaturated aldehydes affording corresponding hybrid 5-tosylhexahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine and tetrahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one compounds with good to high general yields. Subsequent dehydrogenation led to the corresponding more unsaturated dihydro (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine and (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one derivatives in quantitative yields. The new polycyclic products show excellent-good activity as topoisomerase I (TopI) inhibitors that lead to TopI induced nicking of plasmids. This is consistent with the compounds acting as TopI poisons resulting in the accumulation of trapped cleavage complexes in the DNA. The cytotoxic effect on cell lines A549, SKOV3 and on non-cancerous MRC5 was also screened. Tetrahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one 9 resulted the most cytotoxic compound with IC values of 3.25  0.91 M and 2.08  1.89 M against the A549 cell line and the SKOV3 cell line, respectively. Also, hexahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine 8a and dihydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine 10a showed good cytotoxicity against these cell lines. None of the compounds presented cytotoxic effects against non-malignant pulmonary fibroblasts (MRC-5).', 'Title: Synthesis of novel hybrid quinolino[4,3-b][1,5]naphthyridines and quinolino[4,3-b][1,5]naphthyridin-6(5H)-one derivatives and biological evaluation as topoisomerase I inhibitors and antiproliferatives.  Abstract: The topoisomerase I enzymatic inhibition of hybrid quinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridines and quinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-ones was investigated. First, the synthesis of these fused compounds was performed by intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and unsaturated aldehydes affording corresponding hybrid 5-tosylhexahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine and tetrahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one compounds with good to high general yields. Subsequent dehydrogenation led to the corresponding more unsaturated dihydro (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine and (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one derivatives in quantitative yields. The new polycyclic products show excellent-good activity as topoisomerase I (TopI) inhibitors that lead to TopI induced nicking of plasmids. This is consistent with the compounds acting as TopI poisons resulting in the accumulation of trapped cleavage complexes in the DNA. The cytotoxic effect on cell lines A549, SKOV3 and on non-cancerous MRC5 was also screened. Tetrahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one 9 resulted the most cytotoxic compound with IC values of 3.25  0.91 M and 2.08  1.89 M against the A549 cell line and the SKOV3 cell line, respectively. Also, hexahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine 8a and dihydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine 10a showed good cytotoxicity against these cell lines. None of the compounds presented cytotoxic effects against non-malignant pulmonary fibroblasts (MRC-5).', 'Title: Synthesis of novel hybrid quinolino[4,3-b][1,5]naphthyridines and quinolino[4,3-b][1,5]naphthyridin-6(5H)-one derivatives and biological evaluation as topoisomerase I inhibitors and antiproliferatives.  Abstract: The topoisomerase I enzymatic inhibition of hybrid quinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridines and quinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-ones was investigated. First, the synthesis of these fused compounds was performed by intramolecular [4 + 2]-cycloaddition reaction of functionalized aldimines obtained by the condensation of 3-aminopyridine and unsaturated aldehydes affording corresponding hybrid 5-tosylhexahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine and tetrahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one compounds with good to high general yields. Subsequent dehydrogenation led to the corresponding more unsaturated dihydro (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine and (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one derivatives in quantitative yields. The new polycyclic products show excellent-good activity as topoisomerase I (TopI) inhibitors that lead to TopI induced nicking of plasmids. This is consistent with the compounds acting as TopI poisons resulting in the accumulation of trapped cleavage complexes in the DNA. The cytotoxic effect on cell lines A549, SKOV3 and on non-cancerous MRC5 was also screened. Tetrahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridin-6(5H)-one 9 resulted the most cytotoxic compound with IC values of 3.25  0.91 M and 2.08  1.89 M against the A549 cell line and the SKOV3 cell line, respectively. Also, hexahydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine 8a and dihydroquinolino [4,3-b] (Siegel et al., 2013; Antony et al., 2003) [1,5]naphthyridine 10a showed good cytotoxicity against these cell lines. None of the compounds presented cytotoxic effects against non-malignant pulmonary fibroblasts (MRC-5).', 'Title: Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties.  Abstract: Heteroarene-fused anthraquinone derivatives represent a class of perspective anticancer drug candidates capable of targeting multiple vital processes including drug resistance. Taking advantage of previously demonstrated potential of amide derivatives of heteroarene-fused anthraquinones, we herein dissected the role of the heterocyclic core in antitumor properties. A new series of naphtho[2,3-f]indole-3- and anthra[2,3-b]thiophene-3-carboxamides was synthesized via coupling the respective acids with cyclic diamines. New compounds demonstrated a submicromolar antiproliferative potency close to doxorubicin (Dox) against five tumor cell lines of various tissue origin. In contrast to Dox, the new compounds were similarly cytotoxic for HCT116 colon carcinoma cells (wild type p53) and their isogenic p53 knockout counterparts. Modification of the heterocyclic core changed the targeting properties: the best-in-series naphtho[2,3-f]indole-3-carboxamide 8 formed more affine complexes with DNA duplex than furan and thiophene analogs, a property that can be translated into a stronger inhibition of topoisomerase 1 mediated DNA unwinding. At tolerable doses the water soluble derivative 8 significantly inhibited tumor growth (up to 79%) and increased the lifespan (153%) of mice bearing P388 lymphoma transplants. Together with better solubility for parenteral administration and well tolerance by animals of the indole derivative 8 indicates prospects for further search of new antitumor drug candidates among the heteroarene-fused anthraquinones.', 'Title: Development of a metabolically stable topoisomerase I poison as anticancer agent.  Abstract: We have recently reported a new chemotype of a potent topoisomerase I poison with compound 1 as a potential anticancer chemotherapeutic agent. During further optimization, it has been observed that compound 1 suffers from high intrinsic clearance in human liver microsomes. To overcome the metabolic instability of compound 1, we report design and synthesis of metabolically stable Top1 poison 3. Newly identified Top1 poison 3 exhibits t of 69.1 min in human liver microsomes in comparison to compound 1 with t of 9.9 min. Molecular dynamic study of the newly optimized Top1 poison 3 was performed to get the insight into the stability of the binding pose in the active site. Compound 3 was able to trap DNA-Top1 cleavage complex and found to be less cytotoxic in non-cancerous cell line as compared to compound 1.', 'Title: Development of a metabolically stable topoisomerase I poison as anticancer agent.  Abstract: We have recently reported a new chemotype of a potent topoisomerase I poison with compound 1 as a potential anticancer chemotherapeutic agent. During further optimization, it has been observed that compound 1 suffers from high intrinsic clearance in human liver microsomes. To overcome the metabolic instability of compound 1, we report design and synthesis of metabolically stable Top1 poison 3. Newly identified Top1 poison 3 exhibits t of 69.1 min in human liver microsomes in comparison to compound 1 with t of 9.9 min. Molecular dynamic study of the newly optimized Top1 poison 3 was performed to get the insight into the stability of the binding pose in the active site. Compound 3 was able to trap DNA-Top1 cleavage complex and found to be less cytotoxic in non-cancerous cell line as compared to compound 1.', 'Title: Structural simplification of evodiamine: Discovery of novel tetrahydro--carboline derivatives as potent antitumor agents.  Abstract: Natural products (NPs) have played a crucial role in the discovery and development of antitumor drugs. However, the high structural complexity of NPs generally results in unfavorable physicochemical profiles and poor drug-likeness. A powerful strategy to tackle this obstacle is the structural simplification of NPs by truncating nonessential structures. Herein, a series of tetrahydro--carboline derivatives were designed by elimination of the D ring of NP evodiamine. Structure-activity relationship studies led to the discovery of compound 45, which displayed highly potent antitumor activity against all the tested cancer cell lines and excellent in vivo antitumor activity in the HCT116 xenograft model with low toxicity. Further mechanistic research indicated that compound 45 acted by dual Top1/2 inhibition and induced caspase-dependent cell apoptosis coupled with G<sub>2</sub>/M cell cycle arrest. This proof-of-concept study validated the effectiveness of structural simplification in NP-based drug development, discovered compound 45 as a potent antitumor lead compound and enriched the structure-activity relationships of evodiamine.', 'Title: Structural simplification of evodiamine: Discovery of novel tetrahydro--carboline derivatives as potent antitumor agents.  Abstract: Natural products (NPs) have played a crucial role in the discovery and development of antitumor drugs. However, the high structural complexity of NPs generally results in unfavorable physicochemical profiles and poor drug-likeness. A powerful strategy to tackle this obstacle is the structural simplification of NPs by truncating nonessential structures. Herein, a series of tetrahydro--carboline derivatives were designed by elimination of the D ring of NP evodiamine. Structure-activity relationship studies led to the discovery of compound 45, which displayed highly potent antitumor activity against all the tested cancer cell lines and excellent in vivo antitumor activity in the HCT116 xenograft model with low toxicity. Further mechanistic research indicated that compound 45 acted by dual Top1/2 inhibition and induced caspase-dependent cell apoptosis coupled with G<sub>2</sub>/M cell cycle arrest. This proof-of-concept study validated the effectiveness of structural simplification in NP-based drug development, discovered compound 45 as a potent antitumor lead compound and enriched the structure-activity relationships of evodiamine.', 'Title: Synthesis, biological evaluation, and correlation of cytotoxicity versus redox potential of 1,4-naphthoquinone derivatives.  Abstract: A series of 1,4-naphthoquinone derivatives of lawsone (1), 6-hydroxy-1,4-naphthoquinone (2), and juglone (3) were synthesized by alkylation, acylation, and sulfonylation reactions. The yields of lawsone derivatives 1a-1k (type A), 6-hydroxy-1,4-naphthoquinone derivatives 2a-2j (type B), and juglone derivatives 3a-3h (type C) were 52-99%, 53-96%, and 28-95%, respectively. All compounds were tested in vitro for the cytotoxicity against human oral epidermoid carcinoma (KB) and cervix epithelioid carcinoma (HeLa) cells and their structure-activity relationship was studied. Compound 3c was found to be most potent in KB cell line (IC<sub>50</sub> = 1.39 M). Some compounds were evaluated for DNA topoisomerase I inhibition. Compounds 2c, 3, 3a, and 3d showed topoisomerase inhibition activity with IC<sub>50</sub> values of 8.3-91 M. Standard redox potentials (E) of all naphthoquinones in phosphate buffer at pH 7.2 were examined by means of cyclic voltammetry. A definite correlation has been found between the redox potentials and inhibitory effects of type A compounds.', 'Title: Design and synthesis of C-aryl angular luotonins via a one-pot aza-Nazarov-Friedlander sequence and their Topo-I inhibition studies along with C-aryl vasicinones and luotonins.  Abstract: A facile one-pot synthesis of C-ring substituted angular luotonins has been realized via a methanesulfonic acid mediated aza-Nazarov-Friedlander condensation sequence on quinazolinonyl enones. Topoisomerase I (topo-I) inhibition studies revealed that the angular luotonin library (7a-7l) and their regioisomeric analogs (linear luotonins, 8a-8l) are weak negative modulators, compared to camptothecin. These results would fare well for the design of topo-I-inert luotonins for non-oncological applications such as anti-fungal and insecticide lead developments. Surprisingly, the tricyclic vasicinones (9h, 9i, and 9j) showed better topo-I inhibition compared to pentacyclic C-aryl luotonins providing a novel pharmacophore for further explorations.', 'Title: Design and synthesis of C-aryl angular luotonins via a one-pot aza-Nazarov-Friedlander sequence and their Topo-I inhibition studies along with C-aryl vasicinones and luotonins.  Abstract: A facile one-pot synthesis of C-ring substituted angular luotonins has been realized via a methanesulfonic acid mediated aza-Nazarov-Friedlander condensation sequence on quinazolinonyl enones. Topoisomerase I (topo-I) inhibition studies revealed that the angular luotonin library (7a-7l) and their regioisomeric analogs (linear luotonins, 8a-8l) are weak negative modulators, compared to camptothecin. These results would fare well for the design of topo-I-inert luotonins for non-oncological applications such as anti-fungal and insecticide lead developments. Surprisingly, the tricyclic vasicinones (9h, 9i, and 9j) showed better topo-I inhibition compared to pentacyclic C-aryl luotonins providing a novel pharmacophore for further explorations.', 'Title: Design and synthesis of C-aryl angular luotonins via a one-pot aza-Nazarov-Friedlander sequence and their Topo-I inhibition studies along with C-aryl vasicinones and luotonins.  Abstract: A facile one-pot synthesis of C-ring substituted angular luotonins has been realized via a methanesulfonic acid mediated aza-Nazarov-Friedlander condensation sequence on quinazolinonyl enones. Topoisomerase I (topo-I) inhibition studies revealed that the angular luotonin library (7a-7l) and their regioisomeric analogs (linear luotonins, 8a-8l) are weak negative modulators, compared to camptothecin. These results would fare well for the design of topo-I-inert luotonins for non-oncological applications such as anti-fungal and insecticide lead developments. Surprisingly, the tricyclic vasicinones (9h, 9i, and 9j) showed better topo-I inhibition compared to pentacyclic C-aryl luotonins providing a novel pharmacophore for further explorations.', 'Title: Design and synthesis of C-aryl angular luotonins via a one-pot aza-Nazarov-Friedlander sequence and their Topo-I inhibition studies along with C-aryl vasicinones and luotonins.  Abstract: A facile one-pot synthesis of C-ring substituted angular luotonins has been realized via a methanesulfonic acid mediated aza-Nazarov-Friedlander condensation sequence on quinazolinonyl enones. Topoisomerase I (topo-I) inhibition studies revealed that the angular luotonin library (7a-7l) and their regioisomeric analogs (linear luotonins, 8a-8l) are weak negative modulators, compared to camptothecin. These results would fare well for the design of topo-I-inert luotonins for non-oncological applications such as anti-fungal and insecticide lead developments. Surprisingly, the tricyclic vasicinones (9h, 9i, and 9j) showed better topo-I inhibition compared to pentacyclic C-aryl luotonins providing a novel pharmacophore for further explorations.', 'Title: Design and synthesis of C-aryl angular luotonins via a one-pot aza-Nazarov-Friedlander sequence and their Topo-I inhibition studies along with C-aryl vasicinones and luotonins.  Abstract: A facile one-pot synthesis of C-ring substituted angular luotonins has been realized via a methanesulfonic acid mediated aza-Nazarov-Friedlander condensation sequence on quinazolinonyl enones. Topoisomerase I (topo-I) inhibition studies revealed that the angular luotonin library (7a-7l) and their regioisomeric analogs (linear luotonins, 8a-8l) are weak negative modulators, compared to camptothecin. These results would fare well for the design of topo-I-inert luotonins for non-oncological applications such as anti-fungal and insecticide lead developments. Surprisingly, the tricyclic vasicinones (9h, 9i, and 9j) showed better topo-I inhibition compared to pentacyclic C-aryl luotonins providing a novel pharmacophore for further explorations.', 'Title: Fused chromeno and quinolino[1,8]naphthyridines: Synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.  Abstract: The synthesis of 1,8-naphthyridine derivatives fused with other heterocycles, such as chromenes and quinolines, as well as their behaviour as topoisomerase I inhibitors is studied. The preparation is carried out through a direct and simple process as an intramolecular [4 + 2] cycloaddition reaction between functionalized aldimines, obtained by the condensation of 2-aminopyridine and unsaturated aldehydes, and olefins. In particular, while no clear inhibitory activity is observed for chromeno[4,3-b][1,8]naphthyridine fused heterocycles, a very different result is observed for quinolino[4,3-b][1,8]naphthyridine derivatives. Experimental assays indicated that quinolino[4,3-b][1,8]naphthyridines inhibited the topoisomerase I enzymatic reaction behaving like a poison, as occurs with the natural TopI inhibitor, camptothecin. Furthermore, the cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV3), and on non-cancerous lung fibroblasts cell line (MRC5) was also screened.', 'Title: Fused chromeno and quinolino[1,8]naphthyridines: Synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.  Abstract: The synthesis of 1,8-naphthyridine derivatives fused with other heterocycles, such as chromenes and quinolines, as well as their behaviour as topoisomerase I inhibitors is studied. The preparation is carried out through a direct and simple process as an intramolecular [4 + 2] cycloaddition reaction between functionalized aldimines, obtained by the condensation of 2-aminopyridine and unsaturated aldehydes, and olefins. In particular, while no clear inhibitory activity is observed for chromeno[4,3-b][1,8]naphthyridine fused heterocycles, a very different result is observed for quinolino[4,3-b][1,8]naphthyridine derivatives. Experimental assays indicated that quinolino[4,3-b][1,8]naphthyridines inhibited the topoisomerase I enzymatic reaction behaving like a poison, as occurs with the natural TopI inhibitor, camptothecin. Furthermore, the cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV3), and on non-cancerous lung fibroblasts cell line (MRC5) was also screened.', 'Title: Fused chromeno and quinolino[1,8]naphthyridines: Synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.  Abstract: The synthesis of 1,8-naphthyridine derivatives fused with other heterocycles, such as chromenes and quinolines, as well as their behaviour as topoisomerase I inhibitors is studied. The preparation is carried out through a direct and simple process as an intramolecular [4 + 2] cycloaddition reaction between functionalized aldimines, obtained by the condensation of 2-aminopyridine and unsaturated aldehydes, and olefins. In particular, while no clear inhibitory activity is observed for chromeno[4,3-b][1,8]naphthyridine fused heterocycles, a very different result is observed for quinolino[4,3-b][1,8]naphthyridine derivatives. Experimental assays indicated that quinolino[4,3-b][1,8]naphthyridines inhibited the topoisomerase I enzymatic reaction behaving like a poison, as occurs with the natural TopI inhibitor, camptothecin. Furthermore, the cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV3), and on non-cancerous lung fibroblasts cell line (MRC5) was also screened.', 'Title: Fused chromeno and quinolino[1,8]naphthyridines: Synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.  Abstract: The synthesis of 1,8-naphthyridine derivatives fused with other heterocycles, such as chromenes and quinolines, as well as their behaviour as topoisomerase I inhibitors is studied. The preparation is carried out through a direct and simple process as an intramolecular [4 + 2] cycloaddition reaction between functionalized aldimines, obtained by the condensation of 2-aminopyridine and unsaturated aldehydes, and olefins. In particular, while no clear inhibitory activity is observed for chromeno[4,3-b][1,8]naphthyridine fused heterocycles, a very different result is observed for quinolino[4,3-b][1,8]naphthyridine derivatives. Experimental assays indicated that quinolino[4,3-b][1,8]naphthyridines inhibited the topoisomerase I enzymatic reaction behaving like a poison, as occurs with the natural TopI inhibitor, camptothecin. Furthermore, the cytotoxic effect on cell lines derived from human lung adenocarcinoma (A549), human ovarian carcinoma (SKOV3), and on non-cancerous lung fibroblasts cell line (MRC5) was also screened.', 'Title: Effects of substituent pattern on the intracellular target of antiproliferative benzo[b]thiophenyl chromone derivatives.  Abstract: A new biological scaffold was produced by replacing the 6-electron phenyl ring-B of a natural flavone skeleton with a 10-electron benzothiophene (BT). Since aromatic rings are important for ligand protein interactions, this expansion of the -electron system of ring-B might change the bioactivity profile. One of the resulting novel natural product-inspired compounds, 2-(benzo[b]thiophen-3-yl)-5-hydroxy-7-isopropoxy-6-methoxyflavone (6), effectively arrested the cell cycle at the G2/M phase and displayed significant antiproliferative effects with IC<sub>50</sub> values of 0.05-0.08 M against multiple human tumor cell lines, including a multidrug resistant line. A structure-activity relationship study revealed that a 10-electron system with high aromaticity, juxtaposed 4-oxo and 5-hydroxy groups, and 7-alkoxy groups were important for potent antimitotic activity. Interestingly, two BT-flavonols (3-hydroxyflavone), 16 and 20, with 3-hydroxy and 5-alkoxy groups, induced distinct biological profiles affecting the cell cycle at the G1/S phase by inhibition of DNA replication through an interaction with topoisomerase I.', 'Title: Effects of substituent pattern on the intracellular target of antiproliferative benzo[b]thiophenyl chromone derivatives.  Abstract: A new biological scaffold was produced by replacing the 6-electron phenyl ring-B of a natural flavone skeleton with a 10-electron benzothiophene (BT). Since aromatic rings are important for ligand protein interactions, this expansion of the -electron system of ring-B might change the bioactivity profile. One of the resulting novel natural product-inspired compounds, 2-(benzo[b]thiophen-3-yl)-5-hydroxy-7-isopropoxy-6-methoxyflavone (6), effectively arrested the cell cycle at the G2/M phase and displayed significant antiproliferative effects with IC<sub>50</sub> values of 0.05-0.08 M against multiple human tumor cell lines, including a multidrug resistant line. A structure-activity relationship study revealed that a 10-electron system with high aromaticity, juxtaposed 4-oxo and 5-hydroxy groups, and 7-alkoxy groups were important for potent antimitotic activity. Interestingly, two BT-flavonols (3-hydroxyflavone), 16 and 20, with 3-hydroxy and 5-alkoxy groups, induced distinct biological profiles affecting the cell cycle at the G1/S phase by inhibition of DNA replication through an interaction with topoisomerase I.', 'Title: Water-soluble derivatives of evodiamine: Discovery of evodiamine-10-phosphate as an orally active antitumor lead compound.  Abstract: 10-Hydroxyevodiamine is a multitargeting antitumor lead compound with excellent in vitro activity. However, its in vivo antitumor potency is rather limited, which has hampered its further clinical development. To overcome this obstacle, a series of novel water-soluble derivatives of 10-hydroxyevodiamine were designed and synthesized. Most of them exhibited good to excellent antitumor activities against several cancer cell lines. In particular, phosphate derivative 9 was orally active and showed improved in vivo antitumor efficacy in HCT116 xenograft models. Further antitumor mechanism studies indicated that compound 9 acted by triple Top1/Top2/tubulin inhibition and induced apoptosis with G<sub>2</sub>/M cell cycle arrest. Taken together, this study extended the structure-activity relationship of evodiamine and identified phosphate derivative 9 as a promising antitumor lead compound.', 'Title: Water-soluble derivatives of evodiamine: Discovery of evodiamine-10-phosphate as an orally active antitumor lead compound.  Abstract: 10-Hydroxyevodiamine is a multitargeting antitumor lead compound with excellent in vitro activity. However, its in vivo antitumor potency is rather limited, which has hampered its further clinical development. To overcome this obstacle, a series of novel water-soluble derivatives of 10-hydroxyevodiamine were designed and synthesized. Most of them exhibited good to excellent antitumor activities against several cancer cell lines. In particular, phosphate derivative 9 was orally active and showed improved in vivo antitumor efficacy in HCT116 xenograft models. Further antitumor mechanism studies indicated that compound 9 acted by triple Top1/Top2/tubulin inhibition and induced apoptosis with G<sub>2</sub>/M cell cycle arrest. Taken together, this study extended the structure-activity relationship of evodiamine and identified phosphate derivative 9 as a promising antitumor lead compound.', 'Title: Discovery of pyrrole derivatives for the treatment of glioblastoma and chronic myeloid leukemia.  Abstract: Long-term survivors of glioblastoma multiforme (GBM) are at high risk of developing second primary neoplasms, including leukemia. For these patients, the use of classic tyrosine kinase inhibitors (TKIs), such as imatinib mesylate, is strongly discouraged, since this treatment causes a tremendous increase of tumor and stem cell migration and invasion. We aimed to develop agents useful for the treatment of patients with GBM and chronic myeloid leukemia (CML) using an alternative mechanism of action from the TKIs, specifically based on the inhibition of tubulin polymerization. Compounds 7 and 25, as planned, not only inhibited tubulin polymerization, but also inhibited the proliferation of both GMB and CML cells, including those expressing the T315I mutation, at nanomolar concentrations. In in vivo experiments in BALB/cnu/nu mice injected subcutaneously with U87MG cells, in vivo, 7 significantly inhibited GBM cancer cell proliferation, in vivo tumorigenesis, and tumor growth, tumorigenesis and angiogenesis. Compound 7 was found to block human topoisomerase II (hTopoII) selectively and completely, at a concentration of 100 M.', 'Title: Discovery of pyrrole derivatives for the treatment of glioblastoma and chronic myeloid leukemia.  Abstract: Long-term survivors of glioblastoma multiforme (GBM) are at high risk of developing second primary neoplasms, including leukemia. For these patients, the use of classic tyrosine kinase inhibitors (TKIs), such as imatinib mesylate, is strongly discouraged, since this treatment causes a tremendous increase of tumor and stem cell migration and invasion. We aimed to develop agents useful for the treatment of patients with GBM and chronic myeloid leukemia (CML) using an alternative mechanism of action from the TKIs, specifically based on the inhibition of tubulin polymerization. Compounds 7 and 25, as planned, not only inhibited tubulin polymerization, but also inhibited the proliferation of both GMB and CML cells, including those expressing the T315I mutation, at nanomolar concentrations. In in vivo experiments in BALB/cnu/nu mice injected subcutaneously with U87MG cells, in vivo, 7 significantly inhibited GBM cancer cell proliferation, in vivo tumorigenesis, and tumor growth, tumorigenesis and angiogenesis. Compound 7 was found to block human topoisomerase II (hTopoII) selectively and completely, at a concentration of 100 M.', 'Title: Thiophene-2-carboxamide derivatives of anthraquinone: A new potent antitumor chemotype.  Abstract: The anthraquinone scaffold has long been known as a source of efficacious antitumor drugs. In particular, the various chemical modifications of the side chains in this scaffold have yielded the compounds potent for the wild type tumor cells, their counterparts with molecular determinants of altered drug response, as well as in vivo settings. Further exploring the chemotype of anticancer heteroarene-fused anthraquinones, we herein demonstrate that derivative of anthra[2,3-b]thiophene-2-carboxamide, (compound 8) is highly potent against a panel of human tumor cell lines and their drug resistant variants. Treatment with submicromolar or low micromolar concentrations of 8 for only 30 min was sufficient to trigger lethal damage of K562 chronic myelogenous leukemia cells. Compound 8 (2.5 M, 3-6 h) induced an apoptotic cell death as determined by concomitant activation of caspases 3 and 9, cleavage of poly(ADP-ribose) polymerase, increase of Annexin V/propidium iodide double stained cells, DNA fragmentation (subG1 fraction) and a decrease of mitochondrial membrane potential. Neither a significant interaction with double stranded DNA nor strong inhibition of the DNA dependent enzyme topoisomerase 1 by 8 were detectable in cell free systems. Laser scanning confocal microscopy revealed that some amount of 8 was detectable in mitochondria as early as 5 min after the addition to the cells; exposure for 1 h caused significant morphological changes and clustering of mitochondria. The bioisosteric analog 2 in which the thiophene ring was replaced with furan was less active although the patterns of cytotoxicity of both derivatives were similar. These results point at the specific role of the sulfur atom in the antitumor properties of carboxamide derivatives of heteroarene-fused anthraquinone.', 'Title: Discovery of Oral Anticancer 1,2-Bis(hydroxymethyl)benzo[<i>g</i>]pyrrolo[2,1-<i>a</i>]phthalazine Hybrids That Inhibit Angiogenesis and Induce DNA Cross-Links.  Abstract: Designing hybrid molecules with dual functions is one approach to improve the therapeutic efficacy of combination treatment. We have previously conjugated phthalazine and bis(hydroxymethyl)pyrrole pharmacophores to form hybrids bearing antiangiogenesis and DNA interstrand cross-linking activities. To improve the bioavailability, we adopted a benzology approach to design and synthesize a new series of 1,2-bis(hydroxymethyl)benzo[<i>g</i>]pyrrolo[2,1-<i>a</i>]phthalazines. These new hybrids retained the dual functions and could be formulated into vehicles for intravenous and oral administration. Among them, we demonstrated that compound <b>19a</b> with dimethylamine at the C6 position markedly suppressed the tumor growth of human small cell lung cancer cell line H526, squamous lung cancer cell line H520, and renal cancer cell line 786-O in nude mice, implying that compound <b>19a</b> is a broad-spectrum anticancer agent. Our results implicated that the conjugation of antiangiogenic and DNA cross-linking is likely to be a helpful approach to improving the efficacy of combination therapy.', 'Human topoisomerase I relaxation assays were carried out with 0.5 U of enzyme in reaction buffer supplied by the manufacturer. The enzyme was mixed with the indicated concentration of compound dissolved before 200 ng of supercoiled pBAD/Thio plasmid DNA was added in the same buffer, for a final volume of 20 &#956;L. Following incubation at 37 C. for 30 minutes, the reactions were terminated with a buffer containing 5% SDS, 0.25% bromophenol blue, and 25% glycerol, and analyzed by agarose gel electrophoresis.Human topoisomerase I and topoisomerase II&#945; were purchased from TopoGen (Buena vista, CO, USA).', 'Supercoiled pHOT1 DNA (0.5 &mu;g) was incubated with four units of human topoisomerase I in relaxation buffer (10mM Tris-HCl (pH 7.8), 1mM EDTA, 0.15M NaCl, 0.1% BSA, 0.1 spermidine, 5% glycerol), in the presence of varying concentrations of the test compounds. Reactions were carried out at 37 Cfor 1 h and then terminated by the addition of sodium dodecyl sulfate (SDS) to 0.25% and proteinase K to 50 &mu;g/ml. The reaction mixture was subjected to electrophoresis through a 0.8% agarose gel containing 0.5 mg/ml ethidium bromide in TAE buffer (40mM Tris-borate and 1mM EDTA). The gels were stained with ethidium bromide and photographed under UV light. For the quantitative determination of topoisomerase concentration activity, photographic negatives were scanned and the area representing supercoiled DNA, migrating as a single band at the bottom of the gel was measured using UVI-KS4000i gel documentation and analysis system (SyngenBiotech, Sacramento, CA).', 'Title: Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer.  Abstract: Evodiamine (Evo) is a quinazolinocarboline alkaloid found in <i>Evodia rutaecarpa</i> and exhibits moderate antiproliferative activity. Herein, we report using a scaffold-hopping approach to identify a series of novel polycyclic heterocyclic derivatives based on Evo as the topoisomerase I (Top1) inhibitor for the treatment of triple-negative breast cancer (TNBC), which is an aggressive subtype of breast cancer with limited treatment options. The most potent compound <b>7f</b> inhibited cell growth in a human breast carcinoma cell line (MDA-MB-231) with an IC<sub>50</sub> value of 0.36 M. Further studies revealed that Top1 was the target of <b>7f</b>, which directly induced irreversible Top1-DNA covalent complex formation or induced an oxidative DNA lesion through an indirect mechanism mediated by reactive oxygen species. More importantly, <i>in vivo</i> studies showed that <b>7f</b> exhibited potent antitumor activity in a TNBC-patient-derived tumor xenograft model. These results suggest that compound <b>7f</b> deserves further investigation as a promising candidate for the treatment of TNBC.', 'Title: Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer.  Abstract: Evodiamine (Evo) is a quinazolinocarboline alkaloid found in <i>Evodia rutaecarpa</i> and exhibits moderate antiproliferative activity. Herein, we report using a scaffold-hopping approach to identify a series of novel polycyclic heterocyclic derivatives based on Evo as the topoisomerase I (Top1) inhibitor for the treatment of triple-negative breast cancer (TNBC), which is an aggressive subtype of breast cancer with limited treatment options. The most potent compound <b>7f</b> inhibited cell growth in a human breast carcinoma cell line (MDA-MB-231) with an IC<sub>50</sub> value of 0.36 M. Further studies revealed that Top1 was the target of <b>7f</b>, which directly induced irreversible Top1-DNA covalent complex formation or induced an oxidative DNA lesion through an indirect mechanism mediated by reactive oxygen species. More importantly, <i>in vivo</i> studies showed that <b>7f</b> exhibited potent antitumor activity in a TNBC-patient-derived tumor xenograft model. These results suggest that compound <b>7f</b> deserves further investigation as a promising candidate for the treatment of TNBC.', 'Title: Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer.  Abstract: Evodiamine (Evo) is a quinazolinocarboline alkaloid found in <i>Evodia rutaecarpa</i> and exhibits moderate antiproliferative activity. Herein, we report using a scaffold-hopping approach to identify a series of novel polycyclic heterocyclic derivatives based on Evo as the topoisomerase I (Top1) inhibitor for the treatment of triple-negative breast cancer (TNBC), which is an aggressive subtype of breast cancer with limited treatment options. The most potent compound <b>7f</b> inhibited cell growth in a human breast carcinoma cell line (MDA-MB-231) with an IC<sub>50</sub> value of 0.36 M. Further studies revealed that Top1 was the target of <b>7f</b>, which directly induced irreversible Top1-DNA covalent complex formation or induced an oxidative DNA lesion through an indirect mechanism mediated by reactive oxygen species. More importantly, <i>in vivo</i> studies showed that <b>7f</b> exhibited potent antitumor activity in a TNBC-patient-derived tumor xenograft model. These results suggest that compound <b>7f</b> deserves further investigation as a promising candidate for the treatment of TNBC.', 'Title: Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer.  Abstract: Evodiamine (Evo) is a quinazolinocarboline alkaloid found in <i>Evodia rutaecarpa</i> and exhibits moderate antiproliferative activity. Herein, we report using a scaffold-hopping approach to identify a series of novel polycyclic heterocyclic derivatives based on Evo as the topoisomerase I (Top1) inhibitor for the treatment of triple-negative breast cancer (TNBC), which is an aggressive subtype of breast cancer with limited treatment options. The most potent compound <b>7f</b> inhibited cell growth in a human breast carcinoma cell line (MDA-MB-231) with an IC<sub>50</sub> value of 0.36 M. Further studies revealed that Top1 was the target of <b>7f</b>, which directly induced irreversible Top1-DNA covalent complex formation or induced an oxidative DNA lesion through an indirect mechanism mediated by reactive oxygen species. More importantly, <i>in vivo</i> studies showed that <b>7f</b> exhibited potent antitumor activity in a TNBC-patient-derived tumor xenograft model. These results suggest that compound <b>7f</b> deserves further investigation as a promising candidate for the treatment of TNBC.', 'Title: Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer.  Abstract: Evodiamine (Evo) is a quinazolinocarboline alkaloid found in <i>Evodia rutaecarpa</i> and exhibits moderate antiproliferative activity. Herein, we report using a scaffold-hopping approach to identify a series of novel polycyclic heterocyclic derivatives based on Evo as the topoisomerase I (Top1) inhibitor for the treatment of triple-negative breast cancer (TNBC), which is an aggressive subtype of breast cancer with limited treatment options. The most potent compound <b>7f</b> inhibited cell growth in a human breast carcinoma cell line (MDA-MB-231) with an IC<sub>50</sub> value of 0.36 M. Further studies revealed that Top1 was the target of <b>7f</b>, which directly induced irreversible Top1-DNA covalent complex formation or induced an oxidative DNA lesion through an indirect mechanism mediated by reactive oxygen species. More importantly, <i>in vivo</i> studies showed that <b>7f</b> exhibited potent antitumor activity in a TNBC-patient-derived tumor xenograft model. These results suggest that compound <b>7f</b> deserves further investigation as a promising candidate for the treatment of TNBC.', 'Title: Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer.  Abstract: Evodiamine (Evo) is a quinazolinocarboline alkaloid found in <i>Evodia rutaecarpa</i> and exhibits moderate antiproliferative activity. Herein, we report using a scaffold-hopping approach to identify a series of novel polycyclic heterocyclic derivatives based on Evo as the topoisomerase I (Top1) inhibitor for the treatment of triple-negative breast cancer (TNBC), which is an aggressive subtype of breast cancer with limited treatment options. The most potent compound <b>7f</b> inhibited cell growth in a human breast carcinoma cell line (MDA-MB-231) with an IC<sub>50</sub> value of 0.36 M. Further studies revealed that Top1 was the target of <b>7f</b>, which directly induced irreversible Top1-DNA covalent complex formation or induced an oxidative DNA lesion through an indirect mechanism mediated by reactive oxygen species. More importantly, <i>in vivo</i> studies showed that <b>7f</b> exhibited potent antitumor activity in a TNBC-patient-derived tumor xenograft model. These results suggest that compound <b>7f</b> deserves further investigation as a promising candidate for the treatment of TNBC.', \"Title: Integration of a Diselenide Unit Generates Fluorogenic Camptothecin Prodrugs with Improved Cytotoxicity to Cancer Cells.  Abstract: A diselenide/disulfide unit was introduced into camptothecin (CPT), and two selenoprodrugs (e.g., CPT-Se3 and CPT-Se4) were identified to show improved potency in killing cancer cells and inhibiting tumor growth <i>in vivo</i>. Interestingly, the intrinsic fluorescence of CPT was severely quenched by the diselenide bond. Both the selenoprodrugs were activated by glutathione with a nearly complete recovery of CPT's fluorescence. The activation of prodrugs was accompanied by the production of selenol intermediates, which catalyzed the constant conversion of glutathione and oxygen to oxidized glutathione and superoxides. The diselenide unit is widely employed in constructing thiol-responsive materials. However, the selenol intermediates were largely ignored in the activation process prior to this study. Our work verified that integration of the diselenide unit may further enhance the parent drug's efficacy. Also, the discovery of the fluorescence quenching property of the diselenide/disulfide bond further shed light on constructing novel theranostic agents.\", 'Title: New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the <i>c-MYC</i> G-Quadruplex.  Abstract: As <i>c-MYC</i> is one of the central players in triple-negative breast cancer (TNBC) oncogenesis, inhibiting <i>c-MYC</i> expression would be an effective anticancer strategy. Transcription-induced negative supercoiling is crucial in the regulation of <i>c-MYC</i> transcription, which facilitates the formation of a G4 structure in NHE III<sub>1</sub> that can silence the transcription. However, topoisomerase 1 (Topo1) can dissipate this negative supercoiling, leading to continuous activation of <i>c-MYC</i> transcription. Thus, dual ligands targeting both Topo1 and <i>c-MYC</i> G4 appear to be significant in cancer therapy. In this study, a series of new dibenzoquinoxaline derivatives were designed, synthesized, and evaluated for both Topo1 and <i>c-MYC</i> inhibition. Among them, <b>5</b> was identified as the most promising dual ligand, which could effectively inhibit Topo1 activity and strongly stabilize <i>c-MYC</i> G4, thereby inhibiting cancer cell growth. Accordingly, this work suggests that this dual-targeting strategy may be effective in cancer therapy.', 'Title: New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the <i>c-MYC</i> G-Quadruplex.  Abstract: As <i>c-MYC</i> is one of the central players in triple-negative breast cancer (TNBC) oncogenesis, inhibiting <i>c-MYC</i> expression would be an effective anticancer strategy. Transcription-induced negative supercoiling is crucial in the regulation of <i>c-MYC</i> transcription, which facilitates the formation of a G4 structure in NHE III<sub>1</sub> that can silence the transcription. However, topoisomerase 1 (Topo1) can dissipate this negative supercoiling, leading to continuous activation of <i>c-MYC</i> transcription. Thus, dual ligands targeting both Topo1 and <i>c-MYC</i> G4 appear to be significant in cancer therapy. In this study, a series of new dibenzoquinoxaline derivatives were designed, synthesized, and evaluated for both Topo1 and <i>c-MYC</i> inhibition. Among them, <b>5</b> was identified as the most promising dual ligand, which could effectively inhibit Topo1 activity and strongly stabilize <i>c-MYC</i> G4, thereby inhibiting cancer cell growth. Accordingly, this work suggests that this dual-targeting strategy may be effective in cancer therapy.', 'Title: New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the <i>c-MYC</i> G-Quadruplex.  Abstract: As <i>c-MYC</i> is one of the central players in triple-negative breast cancer (TNBC) oncogenesis, inhibiting <i>c-MYC</i> expression would be an effective anticancer strategy. Transcription-induced negative supercoiling is crucial in the regulation of <i>c-MYC</i> transcription, which facilitates the formation of a G4 structure in NHE III<sub>1</sub> that can silence the transcription. However, topoisomerase 1 (Topo1) can dissipate this negative supercoiling, leading to continuous activation of <i>c-MYC</i> transcription. Thus, dual ligands targeting both Topo1 and <i>c-MYC</i> G4 appear to be significant in cancer therapy. In this study, a series of new dibenzoquinoxaline derivatives were designed, synthesized, and evaluated for both Topo1 and <i>c-MYC</i> inhibition. Among them, <b>5</b> was identified as the most promising dual ligand, which could effectively inhibit Topo1 activity and strongly stabilize <i>c-MYC</i> G4, thereby inhibiting cancer cell growth. Accordingly, this work suggests that this dual-targeting strategy may be effective in cancer therapy.', 'Title: New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the <i>c-MYC</i> G-Quadruplex.  Abstract: As <i>c-MYC</i> is one of the central players in triple-negative breast cancer (TNBC) oncogenesis, inhibiting <i>c-MYC</i> expression would be an effective anticancer strategy. Transcription-induced negative supercoiling is crucial in the regulation of <i>c-MYC</i> transcription, which facilitates the formation of a G4 structure in NHE III<sub>1</sub> that can silence the transcription. However, topoisomerase 1 (Topo1) can dissipate this negative supercoiling, leading to continuous activation of <i>c-MYC</i> transcription. Thus, dual ligands targeting both Topo1 and <i>c-MYC</i> G4 appear to be significant in cancer therapy. In this study, a series of new dibenzoquinoxaline derivatives were designed, synthesized, and evaluated for both Topo1 and <i>c-MYC</i> inhibition. Among them, <b>5</b> was identified as the most promising dual ligand, which could effectively inhibit Topo1 activity and strongly stabilize <i>c-MYC</i> G4, thereby inhibiting cancer cell growth. Accordingly, this work suggests that this dual-targeting strategy may be effective in cancer therapy.', 'Title: N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents: Synthesis and biological evaluation.  Abstract: Glioblastoma is one of the most lethal brain tumors. The crucial chemotherapy is mainly alkylating agents with modest clinical success. Given this desperate need and inspired by the encouraging results of a phase II trial via concomitant Topo I inhibitor plus COX-2 inhibitor, we designed a series of N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents based on structure modification on 1,5-naphthyridine derivatives (Topo I inhibitors). Notably, the target compounds I-1 (33.61  1.15 M) and I-8 (45.01  2.37 M) were confirmed to inhibit COX-2, while a previous reported compound (1,5-naphthyridine derivative) resulted nearly inactive towards COX-2 (IC<sub>50</sub> > 150 M). Besides, I-1 and I-8 exhibited higher anti-proliferation, anti-migration, anti-invasion effects than the parent compound 1,5-naphthyridine derivative, suggesting the success of modification based on the parent. Moreover, I-1 obviously repressed tumor growth in the C6 glioma orthotopic model (TGI = 66.7%) and U87MG xenograft model (TGI = 69.4%). Besides, I-1 downregulated PGE<sub>2</sub>, VEGF, MMP-9, and STAT3 activation, upregulated E-cadherin in the orthotopic model. More importantly, I-1 showed higher safety than temozolomide and different mechanism from temozolomide in the C6 glioma orthotopic model. All the evidence demonstrated that N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents could be promising for the glioma management.', 'Title: N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents: Synthesis and biological evaluation.  Abstract: Glioblastoma is one of the most lethal brain tumors. The crucial chemotherapy is mainly alkylating agents with modest clinical success. Given this desperate need and inspired by the encouraging results of a phase II trial via concomitant Topo I inhibitor plus COX-2 inhibitor, we designed a series of N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents based on structure modification on 1,5-naphthyridine derivatives (Topo I inhibitors). Notably, the target compounds I-1 (33.61  1.15 M) and I-8 (45.01  2.37 M) were confirmed to inhibit COX-2, while a previous reported compound (1,5-naphthyridine derivative) resulted nearly inactive towards COX-2 (IC<sub>50</sub> > 150 M). Besides, I-1 and I-8 exhibited higher anti-proliferation, anti-migration, anti-invasion effects than the parent compound 1,5-naphthyridine derivative, suggesting the success of modification based on the parent. Moreover, I-1 obviously repressed tumor growth in the C6 glioma orthotopic model (TGI = 66.7%) and U87MG xenograft model (TGI = 69.4%). Besides, I-1 downregulated PGE<sub>2</sub>, VEGF, MMP-9, and STAT3 activation, upregulated E-cadherin in the orthotopic model. More importantly, I-1 showed higher safety than temozolomide and different mechanism from temozolomide in the C6 glioma orthotopic model. All the evidence demonstrated that N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents could be promising for the glioma management.', 'Title: Synthesis of Methoxy-, Methylenedioxy-, Hydroxy-, and Halo-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors and Their Biological Activity for Drug-Resistant Cancer.  Abstract: As a recently discovered DNA repair enzyme, tyrosyl-DNA phosphodiesterase 1 (TDP1) removes topoisomerase IB (TOP1)-mediated DNA protein cross-links. Inhibiting TDP1 can potentiate the cytotoxicity of TOP1 inhibitors and overcome cancer cell resistance to TOP1 inhibitors. On the basis of our previous study, herein we report the synthesis of benzophenanthridinone derivatives as TOP1 and TDP1 inhibitors. Seven compounds (<b>C2</b>, <b>C4</b>, <b>C5</b>, <b>C7</b>, <b>C8</b>, <b>C12</b>, and <b>C14</b>) showed a robust TOP1 inhibitory activity (+++ or ++++), and four compounds (<b>A13</b>, <b>C12</b>, <b>C13</b>, and <b>C26</b>) showed a TDP1 inhibition (half-maximal inhibitory concentration values of 15 or 19 M). We also show that the dual TOP1 and TDP1 inhibitor <b>C12</b> induces both cellular TOP1cc, TDP1cc formation and DNA damage, resulting in cancer cell apoptosis at a sub-micromolar concentration. In addition, <b>C12</b> showed an enhanced activity in drug-resistant MCF-7/TDP1 cancer cells and was synergistic with topotecan in both MCF-7 and MCF-7/TDP1 cells.', 'Title: Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer.  Abstract: Gastric cancer represents a significant health burden worldwide. Previously, inspired by the traditional Chinese medicine Wu-Chu-Yu to treat the spleen and stomach system for thousands of years, we identified N14-phenyl substituted evodiamine derivatives as potential antitumor agents with favorable inhibition on Top1. Herein, structural optimization and structure-activity relationship studies (SARs) led us to discovering a highly active evodiamine derivative compound 6t against gastric cancer. Further anti-tumor mechanism studies revealed that compound 6t played as the inhibition of topoisomerase 1 (Top1), effectively induced apoptosis, obviously arrested the cell cycle at the G2/M phase, and significantly inhibited the migration and invasion of SGC-7901 and MGC-803 cell lines in a dose-dependent manner. Moreover, the compound 6t was low toxicity in vivo and exhibited excellent anti-tumor activity (TGI = 70.12%) in the MGC-803 xenograft models. In summary, compound 6t represents a promising candidate as a potential chemotherapeutic agent against gastric cancer.', 'Title: Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer.  Abstract: Gastric cancer represents a significant health burden worldwide. Previously, inspired by the traditional Chinese medicine Wu-Chu-Yu to treat the spleen and stomach system for thousands of years, we identified N14-phenyl substituted evodiamine derivatives as potential antitumor agents with favorable inhibition on Top1. Herein, structural optimization and structure-activity relationship studies (SARs) led us to discovering a highly active evodiamine derivative compound 6t against gastric cancer. Further anti-tumor mechanism studies revealed that compound 6t played as the inhibition of topoisomerase 1 (Top1), effectively induced apoptosis, obviously arrested the cell cycle at the G2/M phase, and significantly inhibited the migration and invasion of SGC-7901 and MGC-803 cell lines in a dose-dependent manner. Moreover, the compound 6t was low toxicity in vivo and exhibited excellent anti-tumor activity (TGI = 70.12%) in the MGC-803 xenograft models. In summary, compound 6t represents a promising candidate as a potential chemotherapeutic agent against gastric cancer.', 'Title: Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer.  Abstract: Gastric cancer represents a significant health burden worldwide. Previously, inspired by the traditional Chinese medicine Wu-Chu-Yu to treat the spleen and stomach system for thousands of years, we identified N14-phenyl substituted evodiamine derivatives as potential antitumor agents with favorable inhibition on Top1. Herein, structural optimization and structure-activity relationship studies (SARs) led us to discovering a highly active evodiamine derivative compound 6t against gastric cancer. Further anti-tumor mechanism studies revealed that compound 6t played as the inhibition of topoisomerase 1 (Top1), effectively induced apoptosis, obviously arrested the cell cycle at the G2/M phase, and significantly inhibited the migration and invasion of SGC-7901 and MGC-803 cell lines in a dose-dependent manner. Moreover, the compound 6t was low toxicity in vivo and exhibited excellent anti-tumor activity (TGI = 70.12%) in the MGC-803 xenograft models. In summary, compound 6t represents a promising candidate as a potential chemotherapeutic agent against gastric cancer.', 'Title: Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer.  Abstract: Gastric cancer represents a significant health burden worldwide. Previously, inspired by the traditional Chinese medicine Wu-Chu-Yu to treat the spleen and stomach system for thousands of years, we identified N14-phenyl substituted evodiamine derivatives as potential antitumor agents with favorable inhibition on Top1. Herein, structural optimization and structure-activity relationship studies (SARs) led us to discovering a highly active evodiamine derivative compound 6t against gastric cancer. Further anti-tumor mechanism studies revealed that compound 6t played as the inhibition of topoisomerase 1 (Top1), effectively induced apoptosis, obviously arrested the cell cycle at the G2/M phase, and significantly inhibited the migration and invasion of SGC-7901 and MGC-803 cell lines in a dose-dependent manner. Moreover, the compound 6t was low toxicity in vivo and exhibited excellent anti-tumor activity (TGI = 70.12%) in the MGC-803 xenograft models. In summary, compound 6t represents a promising candidate as a potential chemotherapeutic agent against gastric cancer.', 'Title: Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer.  Abstract: Gastric cancer represents a significant health burden worldwide. Previously, inspired by the traditional Chinese medicine Wu-Chu-Yu to treat the spleen and stomach system for thousands of years, we identified N14-phenyl substituted evodiamine derivatives as potential antitumor agents with favorable inhibition on Top1. Herein, structural optimization and structure-activity relationship studies (SARs) led us to discovering a highly active evodiamine derivative compound 6t against gastric cancer. Further anti-tumor mechanism studies revealed that compound 6t played as the inhibition of topoisomerase 1 (Top1), effectively induced apoptosis, obviously arrested the cell cycle at the G2/M phase, and significantly inhibited the migration and invasion of SGC-7901 and MGC-803 cell lines in a dose-dependent manner. Moreover, the compound 6t was low toxicity in vivo and exhibited excellent anti-tumor activity (TGI = 70.12%) in the MGC-803 xenograft models. In summary, compound 6t represents a promising candidate as a potential chemotherapeutic agent against gastric cancer.', 'Title: Evodiamine-Inspired Topoisomerase-Histone Deacetylase Dual Inhibitors: Novel Orally Active Antitumor Agents for Leukemia Therapy.  Abstract: On the basis of the synergism of topoisomerase (Top) and histone deacetylase (HDAC) inhibitors in antitumor therapy, a series of novel Top/HDAC dual inhibitors were designed and synthesized by the pharmacophore fusion strategy. After systematic structure-activity relationship studies, lead compound <b>16j</b> was identified to simultaneously inhibit both Top and HDAC with good potency, which showed potent antiproliferative activities with a broad spectrum. Mechanistic studies indicated that compound <b>16j</b> efficiently induced apoptosis with S cell-cycle arrest in HEL cancer cells. It was orally active in HEL xenograft models and exhibited excellent <i>in vivo</i> antitumor efficacy (TGI = 68.5%; 10 mg/kg). Altogether, this work highlights the therapeutic potential of evodiamine-inspired Top/HDAC dual inhibitors and provides a valuable lead compound for the development of novel antitumor agents for leukemia therapy.', 'Title: Evodiamine-Inspired Topoisomerase-Histone Deacetylase Dual Inhibitors: Novel Orally Active Antitumor Agents for Leukemia Therapy.  Abstract: On the basis of the synergism of topoisomerase (Top) and histone deacetylase (HDAC) inhibitors in antitumor therapy, a series of novel Top/HDAC dual inhibitors were designed and synthesized by the pharmacophore fusion strategy. After systematic structure-activity relationship studies, lead compound <b>16j</b> was identified to simultaneously inhibit both Top and HDAC with good potency, which showed potent antiproliferative activities with a broad spectrum. Mechanistic studies indicated that compound <b>16j</b> efficiently induced apoptosis with S cell-cycle arrest in HEL cancer cells. It was orally active in HEL xenograft models and exhibited excellent <i>in vivo</i> antitumor efficacy (TGI = 68.5%; 10 mg/kg). Altogether, this work highlights the therapeutic potential of evodiamine-inspired Top/HDAC dual inhibitors and provides a valuable lead compound for the development of novel antitumor agents for leukemia therapy.', \"Title: Insights into Ergochromes of the Plant Pathogen <i>Claviceps purpurea</i>.  Abstract: <i>Claviceps purpurea</i> is an ergot fungus known for its neurotropic alkaloids, which have been identified as the main cause of ergotism, a livestock and human disease triggered by ergot consumption. Tetrahydroxanthone dimers, the so-called ergopigments, presumably also contribute to this toxic effect. Overexpression of the cluster-specific transcription factor responsible for the formation of these pigments in <i>C. purpurea</i> led to the isolation of three new metabolites (<b>8</b>-<b>10</b>). The new pigments were characterized utilizing HRMS, NMR techniques, and CD spectroscopy and shown to be xanthone dimers. Secalonic acid A and its 2,4'- and 4,4'-linked isomers were also isolated, and their absolute configuration was investigated. The contribution of secalonic acid A, its isomers, and new metabolites to the toxicity of <i>C. purpurea</i> was investigated in HepG2 and CCF-STTG1 cells. Along with cytotoxic properties, secalonic acid A was found to inhibit topoisomerase I and II activity.\", \"Title: Insights into Ergochromes of the Plant Pathogen <i>Claviceps purpurea</i>.  Abstract: <i>Claviceps purpurea</i> is an ergot fungus known for its neurotropic alkaloids, which have been identified as the main cause of ergotism, a livestock and human disease triggered by ergot consumption. Tetrahydroxanthone dimers, the so-called ergopigments, presumably also contribute to this toxic effect. Overexpression of the cluster-specific transcription factor responsible for the formation of these pigments in <i>C. purpurea</i> led to the isolation of three new metabolites (<b>8</b>-<b>10</b>). The new pigments were characterized utilizing HRMS, NMR techniques, and CD spectroscopy and shown to be xanthone dimers. Secalonic acid A and its 2,4'- and 4,4'-linked isomers were also isolated, and their absolute configuration was investigated. The contribution of secalonic acid A, its isomers, and new metabolites to the toxicity of <i>C. purpurea</i> was investigated in HepG2 and CCF-STTG1 cells. Along with cytotoxic properties, secalonic acid A was found to inhibit topoisomerase I and II activity.\", 'Title: <i>In Silico</i> Exploration and Biological Evaluation of Bispecific Peptides Derived from Anti-HER2 Antibodies and Peptide-Camptothecin Conjugates for HER2-Positive Breast Cancer.  Abstract: To enhance the affinity of the human epidermal growth receptor 2 (HER2) targeted peptide developed previously, bispecific fusion peptides <b>P1GCGT1</b> and <b>P1GCGCGT1</b> were designed using an <i>in silico</i> approach. Molecular dynamic simulation showed that both peptides strongly interacted with HER2 domains II and IV. Compared with peptides targeting each single domain, <b>P1GCGT1</b> and <b>P1GCGCGT1</b> could bind to HER2 more significantly and targeted HER2-positive cells specifically. Additionally, both peptides were used to generate peptide-drug conjugates with camptothecin (CPT), among which <b>I-1</b> and <b>I-4</b> were screened for enhanced cellular activity and selectivity. Biological evaluation demonstrated that <b>I-1</b> and <b>I-4</b> induced cell apoptosis, promoted cell cycle arrestin S-phase, and inhibited Topo I activity. The binding affinity assay and confocal analysis revealed that <b>I-1</b> and <b>I-4</b> were effective at targeting HER2. Moreover, <b>I-1</b> and <b>I-4</b> showed better stability than single targeting peptide and presented enhanced antitumor activity and safety than CPT in tumor-bearing mice.', 'Title: <i>In Silico</i> Exploration and Biological Evaluation of Bispecific Peptides Derived from Anti-HER2 Antibodies and Peptide-Camptothecin Conjugates for HER2-Positive Breast Cancer.  Abstract: To enhance the affinity of the human epidermal growth receptor 2 (HER2) targeted peptide developed previously, bispecific fusion peptides <b>P1GCGT1</b> and <b>P1GCGCGT1</b> were designed using an <i>in silico</i> approach. Molecular dynamic simulation showed that both peptides strongly interacted with HER2 domains II and IV. Compared with peptides targeting each single domain, <b>P1GCGT1</b> and <b>P1GCGCGT1</b> could bind to HER2 more significantly and targeted HER2-positive cells specifically. Additionally, both peptides were used to generate peptide-drug conjugates with camptothecin (CPT), among which <b>I-1</b> and <b>I-4</b> were screened for enhanced cellular activity and selectivity. Biological evaluation demonstrated that <b>I-1</b> and <b>I-4</b> induced cell apoptosis, promoted cell cycle arrestin S-phase, and inhibited Topo I activity. The binding affinity assay and confocal analysis revealed that <b>I-1</b> and <b>I-4</b> were effective at targeting HER2. Moreover, <b>I-1</b> and <b>I-4</b> showed better stability than single targeting peptide and presented enhanced antitumor activity and safety than CPT in tumor-bearing mice.', 'Title: Design, synthesis, and biological evaluation of novel 7-substituted 10,11-methylenedioxy-camptothecin derivatives against drug-resistant small-cell lung cancer in vitro and in vivo.  Abstract: A series of novel 7-substituted 10,11-methylenedioxy-camptothecin (FL118) derivatives were designed, synthesized, and biologically evaluated. All the FL118 analogues showed significant cytotoxic activities in vitro with IC<sub>50</sub> values in the nanomolar range and were more potent than topotecan. The most active compound 9c exhibited more significant anti-tumor activity against small-cell lung cancer (NCI-H446, H69, drug-resistant H69AR cells, drug-resistant NCI-H446/Irinotecan cells and drug-resistant NCI-H446/EP cells) in vitro. Additionally, 9c could also induce the expression of apoptosis proteins such as caspase-3, caspase-9, and PARP in small-cell lung cancer. Further studies showed that 9c induced apoptosis by inhibiting the expression of Mcl-1, Bcl-2, XIAP and survivin in small-cell lung cancer. In vivo9c also showed better anti-tumor efficacy, with the tumor growth inhibition rates were 40.4% (0.75 mg/kg), 73.7% (1.5 mg/kg), and 95.5% (3 mg/kg). It is noteworthy that 9c also demonstrated potent inhibition of drug-resistant tumor growth in NCI-H446/Irinotecan and NCI-H446/EP xenograft models, the tumor growth inhibition rates were 93.42% and 84.46%, respectively. Taken together, these findings indicated that compound 9c displays outstanding antitumor activity and drug-resistance in small-cell lung cancer both in vivo and in vitro, which could be worth further research as a novel anti-tumor drug against small-cell lung cancer.', 'Title: Paradigm shift of \"classical\" HDAC inhibitors to \"hybrid\" HDAC inhibitors in therapeutic interventions.  Abstract: \\'Epigenetic\\' regulation of genes via post-translational modulation of proteins is the current mainstay approach for the disease therapies, particularly explored in the Histone Deacetylase (HDAC) class of enzymes. Mainly sight saw in cancer chemotherapeutics, HDAC inhibitors have also found a promising role in other diseases (neurodegenerative disorders, cardiovascular diseases, and viral infections) and successfully entered in various combination therapies (pre-clinical/clinical stages). The prevalent flexibility in the structural design of HDAC inhibitors makes them easily tuneable to merge with other pharmacophore modules for generating multi-targeted single hybrids as a novel tactic to overcome drawbacks of polypharmacy. Herein, we reviewed the putative role of prevalent HDAC hybrids inhibitors in the current and prospective stage as a translational approach to overcome the limitations of the existing conventional drug candidates (parent molecule) when used either alone (drug resistance, solubility issues, adverse side effects, selectivity profile) or in combination (pharmacokinetic interactions, patient compliance) for treating various diseases.', \"Title: Topoisomerase I inhibitors: Challenges, progress and the road ahead.  Abstract: Topoisomerase IB (Top1), a subcategory of DNA topoisomerase enzymes is expressed much higher in several tumor cells. Therefore, modulating the activity of Top1 in tumor cells to prevent DNA replication and subsequent cell division made it an important drug target for anticancer therapy. FDA-approved camptothecin (CPT) derivatives topotecan and irinotecan exert anticancer activity through stabilization of enzyme-mediated DNA cleavage complex forming a ternary complex between DNA-Top1-drug. However, CPT derivatives suffer from several limitations which prompted interest in the development of 'non-camptothecin' Top1 poisons as anticancer agents. This review aims to provide chronological development of different classes of Top1 poisons from both natural and synthetic sources through strategic structure-activity relationship (SAR) analysis with insight into the important structural features in different chemotypes that imparted Top1 inhibition along with the understanding of the structural basis of inhibition. This review also provides a snapshot of the application of Top1 poisons in various combination therapies in recent times. We believe such a comprehensive review is going to be beneficial for the medicinal chemistry community to design efficient drug development strategies using existing knowledge.\", \"Title: Topoisomerase I inhibitors: Challenges, progress and the road ahead.  Abstract: Topoisomerase IB (Top1), a subcategory of DNA topoisomerase enzymes is expressed much higher in several tumor cells. Therefore, modulating the activity of Top1 in tumor cells to prevent DNA replication and subsequent cell division made it an important drug target for anticancer therapy. FDA-approved camptothecin (CPT) derivatives topotecan and irinotecan exert anticancer activity through stabilization of enzyme-mediated DNA cleavage complex forming a ternary complex between DNA-Top1-drug. However, CPT derivatives suffer from several limitations which prompted interest in the development of 'non-camptothecin' Top1 poisons as anticancer agents. This review aims to provide chronological development of different classes of Top1 poisons from both natural and synthetic sources through strategic structure-activity relationship (SAR) analysis with insight into the important structural features in different chemotypes that imparted Top1 inhibition along with the understanding of the structural basis of inhibition. This review also provides a snapshot of the application of Top1 poisons in various combination therapies in recent times. We believe such a comprehensive review is going to be beneficial for the medicinal chemistry community to design efficient drug development strategies using existing knowledge.\", \"Title: Topoisomerase I inhibitors: Challenges, progress and the road ahead.  Abstract: Topoisomerase IB (Top1), a subcategory of DNA topoisomerase enzymes is expressed much higher in several tumor cells. Therefore, modulating the activity of Top1 in tumor cells to prevent DNA replication and subsequent cell division made it an important drug target for anticancer therapy. FDA-approved camptothecin (CPT) derivatives topotecan and irinotecan exert anticancer activity through stabilization of enzyme-mediated DNA cleavage complex forming a ternary complex between DNA-Top1-drug. However, CPT derivatives suffer from several limitations which prompted interest in the development of 'non-camptothecin' Top1 poisons as anticancer agents. This review aims to provide chronological development of different classes of Top1 poisons from both natural and synthetic sources through strategic structure-activity relationship (SAR) analysis with insight into the important structural features in different chemotypes that imparted Top1 inhibition along with the understanding of the structural basis of inhibition. This review also provides a snapshot of the application of Top1 poisons in various combination therapies in recent times. We believe such a comprehensive review is going to be beneficial for the medicinal chemistry community to design efficient drug development strategies using existing knowledge.\", \"Title: Topoisomerase I inhibitors: Challenges, progress and the road ahead.  Abstract: Topoisomerase IB (Top1), a subcategory of DNA topoisomerase enzymes is expressed much higher in several tumor cells. Therefore, modulating the activity of Top1 in tumor cells to prevent DNA replication and subsequent cell division made it an important drug target for anticancer therapy. FDA-approved camptothecin (CPT) derivatives topotecan and irinotecan exert anticancer activity through stabilization of enzyme-mediated DNA cleavage complex forming a ternary complex between DNA-Top1-drug. However, CPT derivatives suffer from several limitations which prompted interest in the development of 'non-camptothecin' Top1 poisons as anticancer agents. This review aims to provide chronological development of different classes of Top1 poisons from both natural and synthetic sources through strategic structure-activity relationship (SAR) analysis with insight into the important structural features in different chemotypes that imparted Top1 inhibition along with the understanding of the structural basis of inhibition. This review also provides a snapshot of the application of Top1 poisons in various combination therapies in recent times. We believe such a comprehensive review is going to be beneficial for the medicinal chemistry community to design efficient drug development strategies using existing knowledge.\", 'Title: Discovery of dual inhibitors of topoisomerase I and Cyclooxygenase-2 for colon cancer therapy.  Abstract: Novel tolfenamic acid derivatives based on the structure of I-1 were designed and synthesized to improve its poor target inhibition and solubility. Among them, W10 was identified as a potent dual-target inhibitor of Topo I (IC<sub>50</sub> = 0.90  0.17 M) and COX-2 (IC<sub>50</sub> = 2.31  0.07 M) with improved water solubility (32.33 g/mL). Moreover, W10 also exhibited fairly potent anti-proliferative and pro-apoptosis activity via the mitochondrial pathway, as well as suppressed aberrant NF-B/IB activation in colon cancer cells in vitro. Additionally, W10 possessed favorable pharmacokinetic properties and excellent antitumor effects in vivo. In general, our study has demonstrated the potency of a novel Topo I/COX-2 dual inhibitor, which can potentially be developed into a chemotherapeutic candidate for colon cancer.', 'Title: Discovery of dual inhibitors of topoisomerase I and Cyclooxygenase-2 for colon cancer therapy.  Abstract: Novel tolfenamic acid derivatives based on the structure of I-1 were designed and synthesized to improve its poor target inhibition and solubility. Among them, W10 was identified as a potent dual-target inhibitor of Topo I (IC<sub>50</sub> = 0.90  0.17 M) and COX-2 (IC<sub>50</sub> = 2.31  0.07 M) with improved water solubility (32.33 g/mL). Moreover, W10 also exhibited fairly potent anti-proliferative and pro-apoptosis activity via the mitochondrial pathway, as well as suppressed aberrant NF-B/IB activation in colon cancer cells in vitro. Additionally, W10 possessed favorable pharmacokinetic properties and excellent antitumor effects in vivo. In general, our study has demonstrated the potency of a novel Topo I/COX-2 dual inhibitor, which can potentially be developed into a chemotherapeutic candidate for colon cancer.', 'Title: Discovery of dual inhibitors of topoisomerase I and Cyclooxygenase-2 for colon cancer therapy.  Abstract: Novel tolfenamic acid derivatives based on the structure of I-1 were designed and synthesized to improve its poor target inhibition and solubility. Among them, W10 was identified as a potent dual-target inhibitor of Topo I (IC<sub>50</sub> = 0.90  0.17 M) and COX-2 (IC<sub>50</sub> = 2.31  0.07 M) with improved water solubility (32.33 g/mL). Moreover, W10 also exhibited fairly potent anti-proliferative and pro-apoptosis activity via the mitochondrial pathway, as well as suppressed aberrant NF-B/IB activation in colon cancer cells in vitro. Additionally, W10 possessed favorable pharmacokinetic properties and excellent antitumor effects in vivo. In general, our study has demonstrated the potency of a novel Topo I/COX-2 dual inhibitor, which can potentially be developed into a chemotherapeutic candidate for colon cancer.', 'Title: Design, synthesis and biological evaluation of 3-arylisoquinoline derivatives as topoisomerase I and II dual inhibitors for the therapy of liver cancer.  Abstract: To explore novel topoisomerase inhibitors with high activity and druggability, 3-aryl isoquinoline alkaloids based on the corydamine modification and preliminary SARs of isoquinoline alkaloids in our previous works were re-designed. Currently, the design strategy is mainly revolved around the rigidity and flexibility of the molecular side chain and the molecular size. Consequently, not only the activity and druggability of the compound could be further improved, also the mechanism behind could been discovered. In vitro pharmacological studies, the outstanding nature with the excellent activity and the researchable depth of azepane-substituted compound 7 has been found through the vitro cytotoxicity test (IC<sub>50</sub> = 1.93 M in HuH7 cells and 2.10 M in LM9 cells) and topoisomerase test. It was found that compound 7 had dual inhibitory effects on topoisomerase I and II, and its inhibitory activity on topoisomerase II is stronger than the positive drug etoposide. From the perspective of molecular docking, it had been verified that compound 7 could insert between DNA base pairs, which was consistent with the results of the DNA unwinding experiment. And the comet experiment confirmed 7 caused DNA damage. Meanwhile, compound 7 could inhibit cell proliferation, invasion and migration, and induce apoptosis by inhibiting PI3K/Akt/mTOR signaling pathway. Therefore, this study may lay a foundation for the discovery of 3-arylisoquinoline compounds with anti-liver cancer potential.', 'Title: Design, synthesis and biological evaluation of 3-arylisoquinoline derivatives as topoisomerase I and II dual inhibitors for the therapy of liver cancer.  Abstract: To explore novel topoisomerase inhibitors with high activity and druggability, 3-aryl isoquinoline alkaloids based on the corydamine modification and preliminary SARs of isoquinoline alkaloids in our previous works were re-designed. Currently, the design strategy is mainly revolved around the rigidity and flexibility of the molecular side chain and the molecular size. Consequently, not only the activity and druggability of the compound could be further improved, also the mechanism behind could been discovered. In vitro pharmacological studies, the outstanding nature with the excellent activity and the researchable depth of azepane-substituted compound 7 has been found through the vitro cytotoxicity test (IC<sub>50</sub> = 1.93 M in HuH7 cells and 2.10 M in LM9 cells) and topoisomerase test. It was found that compound 7 had dual inhibitory effects on topoisomerase I and II, and its inhibitory activity on topoisomerase II is stronger than the positive drug etoposide. From the perspective of molecular docking, it had been verified that compound 7 could insert between DNA base pairs, which was consistent with the results of the DNA unwinding experiment. And the comet experiment confirmed 7 caused DNA damage. Meanwhile, compound 7 could inhibit cell proliferation, invasion and migration, and induce apoptosis by inhibiting PI3K/Akt/mTOR signaling pathway. Therefore, this study may lay a foundation for the discovery of 3-arylisoquinoline compounds with anti-liver cancer potential.', 'Title: Synthesis of hybrid phosphorated indenoquinolines and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.  Abstract: This work describes the first synthesis of diethyl 6,6a,7,11b-tetrahydro-5H-indeno[2,1-c]quinolinylphosphonates 5, diethyl 7H-indeno[2,1-c]quinolinylphosphonates 6 and diethyl 7-oxo-7H-indeno[2,1-c]quinolinylphosphonates 7, which were prepared in good to high overall yields. The synthetic route involves a multicomponent reaction of 2-phosphonateaniline, aldehydes and indene as olefin and allows the selective generation of three stereogenic centres in a short, efficient and reliable manner. The selective dehydrogenation of 1,2,3,4-tetrahydroindenoquinolines leads to the formation of corresponding indenoquinolines, and subsequent oxidation of methylene group of the indenoquinolines allows the access to indenoquinolinones.', 'Title: Synthesis of hybrid phosphorated indenoquinolines and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.  Abstract: This work describes the first synthesis of diethyl 6,6a,7,11b-tetrahydro-5H-indeno[2,1-c]quinolinylphosphonates 5, diethyl 7H-indeno[2,1-c]quinolinylphosphonates 6 and diethyl 7-oxo-7H-indeno[2,1-c]quinolinylphosphonates 7, which were prepared in good to high overall yields. The synthetic route involves a multicomponent reaction of 2-phosphonateaniline, aldehydes and indene as olefin and allows the selective generation of three stereogenic centres in a short, efficient and reliable manner. The selective dehydrogenation of 1,2,3,4-tetrahydroindenoquinolines leads to the formation of corresponding indenoquinolines, and subsequent oxidation of methylene group of the indenoquinolines allows the access to indenoquinolinones.', 'Title: Synthesis of hybrid phosphorated indenoquinolines and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.  Abstract: This work describes the first synthesis of diethyl 6,6a,7,11b-tetrahydro-5H-indeno[2,1-c]quinolinylphosphonates 5, diethyl 7H-indeno[2,1-c]quinolinylphosphonates 6 and diethyl 7-oxo-7H-indeno[2,1-c]quinolinylphosphonates 7, which were prepared in good to high overall yields. The synthetic route involves a multicomponent reaction of 2-phosphonateaniline, aldehydes and indene as olefin and allows the selective generation of three stereogenic centres in a short, efficient and reliable manner. The selective dehydrogenation of 1,2,3,4-tetrahydroindenoquinolines leads to the formation of corresponding indenoquinolines, and subsequent oxidation of methylene group of the indenoquinolines allows the access to indenoquinolinones.', \"Title: Design, synthesis of DNA-interactive 4-thiazolidinone-based indolo-/pyrroloazepinone conjugates as potential cytotoxic and topoisomerase I inhibitors.  Abstract: With the rising cancer incidence and mortality globally, there is a prerequisite for effective design strategies towards the discovery of newer small molecular entities in chemotherapy. Hence, a series of new thiazolidinone-based indolo-/pyrroloazepinone conjugates was designed, synthesized via molecular hybridization, and evaluated for their in vitro cytotoxicity potential and DNA topoisomerase I and II inhibition. Among this series, conjugate 11g emerged as the most active compound with an IC<sub>50</sub> value of 1.24 M against A549 and 3.02-10.91 M in the other tested cancer cell lines. Gratifyingly, 11g displayed 43-fold higher selectivity towards A549 cancer cells as compared to the non-cancer cells. Subsequently, conjugate 12g also demonstrated significant cytotoxicity against SK-MEL-28 cells. Basing the in vitro cytotoxicity results, SAR was established. Later, the conjugates 11g and 12g were further evaluated for their apoptosis-inducing ability, which was quantified by flow cytometric analysis, DNA-binding, Topo I inhibitory activity and IC<sub>50</sub> value calculation. Molecular modeling studies provided profound insights about the binding nature of these compounds with DNA-Topo I complex. In silico ADME/T and prediction studies corroborated the drug-likeness of the two investigated compounds. TOPKAT toxicity profiling studies demonstrated the compounds' safety in many animal models with a minimal toxicological profile. Encouraging results obtained from in vitro and in silico studies could put this series of conjugates at the forefront of cancer drug discovery.\", \"Title: Design, synthesis of DNA-interactive 4-thiazolidinone-based indolo-/pyrroloazepinone conjugates as potential cytotoxic and topoisomerase I inhibitors.  Abstract: With the rising cancer incidence and mortality globally, there is a prerequisite for effective design strategies towards the discovery of newer small molecular entities in chemotherapy. Hence, a series of new thiazolidinone-based indolo-/pyrroloazepinone conjugates was designed, synthesized via molecular hybridization, and evaluated for their in vitro cytotoxicity potential and DNA topoisomerase I and II inhibition. Among this series, conjugate 11g emerged as the most active compound with an IC<sub>50</sub> value of 1.24 M against A549 and 3.02-10.91 M in the other tested cancer cell lines. Gratifyingly, 11g displayed 43-fold higher selectivity towards A549 cancer cells as compared to the non-cancer cells. Subsequently, conjugate 12g also demonstrated significant cytotoxicity against SK-MEL-28 cells. Basing the in vitro cytotoxicity results, SAR was established. Later, the conjugates 11g and 12g were further evaluated for their apoptosis-inducing ability, which was quantified by flow cytometric analysis, DNA-binding, Topo I inhibitory activity and IC<sub>50</sub> value calculation. Molecular modeling studies provided profound insights about the binding nature of these compounds with DNA-Topo I complex. In silico ADME/T and prediction studies corroborated the drug-likeness of the two investigated compounds. TOPKAT toxicity profiling studies demonstrated the compounds' safety in many animal models with a minimal toxicological profile. Encouraging results obtained from in vitro and in silico studies could put this series of conjugates at the forefront of cancer drug discovery.\", 'Title: <i>N</i>-2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX-2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression.  Abstract: Given the close association between inflammation and cancer, combining anti-inflammation therapy is prominent to improve the anticancer effect. Based on <b>I-1</b>, a series of agents targeting COX-2 and Topo I were designed by combining fenamates and phenols. The optimal compound <b>1H-30</b> displayed an enhanced inhibitory effect on COX-2 compared to tolfenamic acid and <b>I-1</b> and showed better inhibition of Topo I than <b>I-1</b>. Importantly, <b>1H-30</b> showed potential anticancer effects and suppressed the activation of the NF-B pathway in cancer cells. <b>1H-30</b> inhibited the nuclear translocation of NF-B and suppressed the production of NO, COX-2, and IL-1 in RAW264.7. In vivo, <b>1H-30</b> showed acceptable pharmacokinetic parameters, decreased the tumor growth without affecting the body weight, down-regulated COX-2 and MMP-9, and induced apoptosis in the CT26.WT tumor-bearing mice. Accordingly, <b>1H-30</b> as a potential Topo I/COX-2 inhibitor which possessed anti-inflammatory and anticancer effects, with inhibition of the NF-B pathway, is promising for gastrointestinal cancer therapy.', 'Title: <i>N</i>-2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX-2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression.  Abstract: Given the close association between inflammation and cancer, combining anti-inflammation therapy is prominent to improve the anticancer effect. Based on <b>I-1</b>, a series of agents targeting COX-2 and Topo I were designed by combining fenamates and phenols. The optimal compound <b>1H-30</b> displayed an enhanced inhibitory effect on COX-2 compared to tolfenamic acid and <b>I-1</b> and showed better inhibition of Topo I than <b>I-1</b>. Importantly, <b>1H-30</b> showed potential anticancer effects and suppressed the activation of the NF-B pathway in cancer cells. <b>1H-30</b> inhibited the nuclear translocation of NF-B and suppressed the production of NO, COX-2, and IL-1 in RAW264.7. In vivo, <b>1H-30</b> showed acceptable pharmacokinetic parameters, decreased the tumor growth without affecting the body weight, down-regulated COX-2 and MMP-9, and induced apoptosis in the CT26.WT tumor-bearing mice. Accordingly, <b>1H-30</b> as a potential Topo I/COX-2 inhibitor which possessed anti-inflammatory and anticancer effects, with inhibition of the NF-B pathway, is promising for gastrointestinal cancer therapy.', 'Title: <i>N</i>-2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX-2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression.  Abstract: Given the close association between inflammation and cancer, combining anti-inflammation therapy is prominent to improve the anticancer effect. Based on <b>I-1</b>, a series of agents targeting COX-2 and Topo I were designed by combining fenamates and phenols. The optimal compound <b>1H-30</b> displayed an enhanced inhibitory effect on COX-2 compared to tolfenamic acid and <b>I-1</b> and showed better inhibition of Topo I than <b>I-1</b>. Importantly, <b>1H-30</b> showed potential anticancer effects and suppressed the activation of the NF-B pathway in cancer cells. <b>1H-30</b> inhibited the nuclear translocation of NF-B and suppressed the production of NO, COX-2, and IL-1 in RAW264.7. In vivo, <b>1H-30</b> showed acceptable pharmacokinetic parameters, decreased the tumor growth without affecting the body weight, down-regulated COX-2 and MMP-9, and induced apoptosis in the CT26.WT tumor-bearing mice. Accordingly, <b>1H-30</b> as a potential Topo I/COX-2 inhibitor which possessed anti-inflammatory and anticancer effects, with inhibition of the NF-B pathway, is promising for gastrointestinal cancer therapy.', 'Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.', 'Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.', 'Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.', 'Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.', 'Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.', 'Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.', 'Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.', 'Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.', 'Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.', 'Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.', 'Title: Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors.  Abstract: Based on previous reports on the significance of halogen moieties and the indenopyridin-5-one skeleton, we designed and synthesized a novel series of halogen (F-, Cl-, Br-, CF<sub>3</sub>- and OCF<sub>3</sub>-)-containing 2,4-diphenyl indenopyridin-5-ones and their corresponding -5-ols. Unlike indenopyridin-5-ols, most of the prepared indenopyridin-5-ones with Cl-, Br-, and CF<sub>3</sub>- groups at the 2-phenyl ring conferred a strong dual topoisomerase I/II inhibitory effect. Among the series, para-bromophenyl substituted compound 9 exhibited the most potent topoisomerase inhibition and antiproliferative effects, which showed dependency upon the topoisomerase gene expression level of diverse cancer cells. In particular, as a DNA minor groove-binding non-intercalative topoisomerase I/II catalytic inhibitor, compound 9 synergistically promoted the anticancer efficacy of clinically applied topoisomerase I/II poisons both in vitro and in vivo, having the great advantage of alleviating poison-related toxicities.', \"Title: Discovery, Topo I inhibitory activity and mechanism evaluation of two novel cytisine-type alkaloid dimers from the seeds of Sophora alopecuroides L.  Abstract: Alopecurosines A and B (CMs 1 and 2, respectively) are two novel cytisine-type alkaloid dimers first isolated from the aerial parts of Sophora alopecuroides L. CMs 1 and 2 are new dimeric alkaloids whose piperidine matrine ring is cleaved and connected via the N'-1 bond. Their chemical structures have been confirmed by IR, UV, HR-ESI-MS, and NMR. Preliminary screening shows that they have topoisomerase I (Topo I)-based anti-tumor activity. Their Topo I inhibitory activities and mechanism have been evaluated by agarose gel electrophoresis assay and a molecular docking study. The results show that the inhibition rate of CM 1 is 82.26% at 1 mM concentration and that it exhibits significantly Topo I inhibitory activity. Further research has illustrated that CMs 1 and 2 exert inhibitory activity by stabilising the Topo I-DNA cleavage complex, implying that they have the potential to be developed as novel Topo I inhibitors.\", \"Title: Discovery, Topo I inhibitory activity and mechanism evaluation of two novel cytisine-type alkaloid dimers from the seeds of Sophora alopecuroides L.  Abstract: Alopecurosines A and B (CMs 1 and 2, respectively) are two novel cytisine-type alkaloid dimers first isolated from the aerial parts of Sophora alopecuroides L. CMs 1 and 2 are new dimeric alkaloids whose piperidine matrine ring is cleaved and connected via the N'-1 bond. Their chemical structures have been confirmed by IR, UV, HR-ESI-MS, and NMR. Preliminary screening shows that they have topoisomerase I (Topo I)-based anti-tumor activity. Their Topo I inhibitory activities and mechanism have been evaluated by agarose gel electrophoresis assay and a molecular docking study. The results show that the inhibition rate of CM 1 is 82.26% at 1 mM concentration and that it exhibits significantly Topo I inhibitory activity. Further research has illustrated that CMs 1 and 2 exert inhibitory activity by stabilising the Topo I-DNA cleavage complex, implying that they have the potential to be developed as novel Topo I inhibitors.\", \"Title: Discovery, Topo I inhibitory activity and mechanism evaluation of two novel cytisine-type alkaloid dimers from the seeds of Sophora alopecuroides L.  Abstract: Alopecurosines A and B (CMs 1 and 2, respectively) are two novel cytisine-type alkaloid dimers first isolated from the aerial parts of Sophora alopecuroides L. CMs 1 and 2 are new dimeric alkaloids whose piperidine matrine ring is cleaved and connected via the N'-1 bond. Their chemical structures have been confirmed by IR, UV, HR-ESI-MS, and NMR. Preliminary screening shows that they have topoisomerase I (Topo I)-based anti-tumor activity. Their Topo I inhibitory activities and mechanism have been evaluated by agarose gel electrophoresis assay and a molecular docking study. The results show that the inhibition rate of CM 1 is 82.26% at 1 mM concentration and that it exhibits significantly Topo I inhibitory activity. Further research has illustrated that CMs 1 and 2 exert inhibitory activity by stabilising the Topo I-DNA cleavage complex, implying that they have the potential to be developed as novel Topo I inhibitors.\", \"Title: Discovery, Topo I inhibitory activity and mechanism evaluation of two novel cytisine-type alkaloid dimers from the seeds of Sophora alopecuroides L.  Abstract: Alopecurosines A and B (CMs 1 and 2, respectively) are two novel cytisine-type alkaloid dimers first isolated from the aerial parts of Sophora alopecuroides L. CMs 1 and 2 are new dimeric alkaloids whose piperidine matrine ring is cleaved and connected via the N'-1 bond. Their chemical structures have been confirmed by IR, UV, HR-ESI-MS, and NMR. Preliminary screening shows that they have topoisomerase I (Topo I)-based anti-tumor activity. Their Topo I inhibitory activities and mechanism have been evaluated by agarose gel electrophoresis assay and a molecular docking study. The results show that the inhibition rate of CM 1 is 82.26% at 1 mM concentration and that it exhibits significantly Topo I inhibitory activity. Further research has illustrated that CMs 1 and 2 exert inhibitory activity by stabilising the Topo I-DNA cleavage complex, implying that they have the potential to be developed as novel Topo I inhibitors.\", \"Title: Discovery, Topo I inhibitory activity and mechanism evaluation of two novel cytisine-type alkaloid dimers from the seeds of Sophora alopecuroides L.  Abstract: Alopecurosines A and B (CMs 1 and 2, respectively) are two novel cytisine-type alkaloid dimers first isolated from the aerial parts of Sophora alopecuroides L. CMs 1 and 2 are new dimeric alkaloids whose piperidine matrine ring is cleaved and connected via the N'-1 bond. Their chemical structures have been confirmed by IR, UV, HR-ESI-MS, and NMR. Preliminary screening shows that they have topoisomerase I (Topo I)-based anti-tumor activity. Their Topo I inhibitory activities and mechanism have been evaluated by agarose gel electrophoresis assay and a molecular docking study. The results show that the inhibition rate of CM 1 is 82.26% at 1 mM concentration and that it exhibits significantly Topo I inhibitory activity. Further research has illustrated that CMs 1 and 2 exert inhibitory activity by stabilising the Topo I-DNA cleavage complex, implying that they have the potential to be developed as novel Topo I inhibitors.\", \"Title: Discovery, Topo I inhibitory activity and mechanism evaluation of two novel cytisine-type alkaloid dimers from the seeds of Sophora alopecuroides L.  Abstract: Alopecurosines A and B (CMs 1 and 2, respectively) are two novel cytisine-type alkaloid dimers first isolated from the aerial parts of Sophora alopecuroides L. CMs 1 and 2 are new dimeric alkaloids whose piperidine matrine ring is cleaved and connected via the N'-1 bond. Their chemical structures have been confirmed by IR, UV, HR-ESI-MS, and NMR. Preliminary screening shows that they have topoisomerase I (Topo I)-based anti-tumor activity. Their Topo I inhibitory activities and mechanism have been evaluated by agarose gel electrophoresis assay and a molecular docking study. The results show that the inhibition rate of CM 1 is 82.26% at 1 mM concentration and that it exhibits significantly Topo I inhibitory activity. Further research has illustrated that CMs 1 and 2 exert inhibitory activity by stabilising the Topo I-DNA cleavage complex, implying that they have the potential to be developed as novel Topo I inhibitors.\", 'Title: -Carbolines as potential anticancer agents.  Abstract: -Carbolines are indole alkaloids having a tricyclic pyrido[3,4-b]indole ring in their structure. Since the isolation of first -carboline from Peganum harmala in 1841, the isolation and synthesis of various -carboline derivatives surged in the following centuries. -Carboline derivatives due to their widespread availability from natural sources, structural flexibility, quick reactivity and interaction with varied anticancer targets such as DNA (intercalation, groove binding, etc.), enzymes (GPX4, topoisomerases, kinases, etc.) and proteins (tubulin, ABCG2/BRCP1, etc.) have established themselves as promising lead compounds for the synthesis of various anticancer active agents. The current review covers the synthesis and isolation, anticancer activity, mechanism of action and SAR of various -carboline containing molecules, its derivatives and congeners.', 'Title: Design, synthesis and anti-hepatocellular carcinoma activity of 3-arylisoquinoline alkaloids.  Abstract: This article describes the syntheses and biological activity of five 3-arylisoquinoline natural products corydamine (1), N-formyl Corydamine (2), hypecumine (3), Decumbenine B (XW) and 2-(1,3-dioxolo [4,5-h]isoquinolin-7-yl)-4,5-dimethoxy-N-methyl-Benzeneethanamine (A), and twelve analogues. Among them, 1, 2, and A were synthesized for the first time. In vitro screening for anti-proliferative activity showed that derivative 1a could significantly inhibit the proliferation of HCC cells (IC<sub>50</sub> = 9.82 M on Huh7 cells and 6.83 M on LM9 cells), and arrest cell cycle at G<sub>2</sub>/M phase. The mechanistic studies further suggested compound 1a was a dual inhibitor of Topo I and Topo II, and Topo II inhibitory activity was superior to etoposide. In addition, 1a could significantly inhibit the invasion and migration of cancer cells by inhibiting the expression of MMP-9, and induce apoptosis through inhibiting the activation of the PI3K/Akt/mTOR signaling pathway. Moreover, in vivo studies demonstrated 1a could obviously reduce the growth of xenograft tumor and possessed good pharmacokinetic parameters, which indicated the potential value of 1a in treating liver cancer.', 'Title: Development of oxoisoaporphine derivatives with topoisomerase I inhibition and reversal of multidrug resistance in breast cancer MCF-7/ADR cells.  Abstract: A series of oxoisoaporphine derivatives with topoisomerase I inhibition and cytotoxic activities. Among them, compound 14 showed the most potent cytotoxic activity against all cancer cell lines tested, and substantially lower cytotoxicity to LO2 cells. Molecular docking studies, dynamics simulation and a follow-up enzyme inhibition assay indicated that 14 could interfere with DNA and significantly inhibit the activity of topoisomerase I. Further mechanistic studies revealed that 14 could arrest cell cycle at the G1 phase, and finally killed MCF-7 cells via apoptosis. In addition, 14 exhibited remarkable chemoreversal ability on multidrug-resistant MCF-7/ADR breast cancer cells. Some of its mechanisms may be related to inhibition of MCF-7/ADR P-gp-mediated Rhodamine (Rh123) efflux function and expression level, as well as inhibition of ROS, increase of ADR accumulation in MCF7/ADR cells, and enhancement of ADR in inducing apoptosis of MCF7/ADR cells. As 14 has little toxic and side effects, it may have the potential for further research.', 'Title: Optimization of the Natural Product Calothrixin A to Discover Novel Dual Topoisomerase I and II Inhibitors with Improved Anticancer Activity.  Abstract: Calothrixin A (<b>CAA</b>) is a dual Topo I and II inhibitor but exhibits poor antiproliferative activities and water solubility. Herein, a library of novel <b>CAA</b> analogues was synthesized. Among them, compound <b>F16</b> exhibited superior water solubility (>5 mg/mL) as compared to <b>CAA</b> (<5 g/mL). The mechanism of action studies confirmed that <b>F16</b> acted as a dual Topo I and II poison. Furthermore, <b>F16</b> displayed potent antiproliferative activities against high Topo I and II expression cell lines A375 and HCT116, with IC<sub>50</sub> values of 20 and 50 nM, respectively. In xenograft models, <b>F16</b> reduced the tumor growth at a dose of 10 or 20 mg/kg without apparent effect on the mouse weight, while the clinically used Topo II inhibitor <b>VP-16</b> dramatically reduced the mouse weight. Collectively, our data demonstrated that <b>F16</b> could be a promising lead for the development of novel dual Topo I and II antitumor agents.', 'Title: Optimization of the Natural Product Calothrixin A to Discover Novel Dual Topoisomerase I and II Inhibitors with Improved Anticancer Activity.  Abstract: Calothrixin A (<b>CAA</b>) is a dual Topo I and II inhibitor but exhibits poor antiproliferative activities and water solubility. Herein, a library of novel <b>CAA</b> analogues was synthesized. Among them, compound <b>F16</b> exhibited superior water solubility (>5 mg/mL) as compared to <b>CAA</b> (<5 g/mL). The mechanism of action studies confirmed that <b>F16</b> acted as a dual Topo I and II poison. Furthermore, <b>F16</b> displayed potent antiproliferative activities against high Topo I and II expression cell lines A375 and HCT116, with IC<sub>50</sub> values of 20 and 50 nM, respectively. In xenograft models, <b>F16</b> reduced the tumor growth at a dose of 10 or 20 mg/kg without apparent effect on the mouse weight, while the clinically used Topo II inhibitor <b>VP-16</b> dramatically reduced the mouse weight. Collectively, our data demonstrated that <b>F16</b> could be a promising lead for the development of novel dual Topo I and II antitumor agents.', 'Title: Optimization of the Natural Product Calothrixin A to Discover Novel Dual Topoisomerase I and II Inhibitors with Improved Anticancer Activity.  Abstract: Calothrixin A (<b>CAA</b>) is a dual Topo I and II inhibitor but exhibits poor antiproliferative activities and water solubility. Herein, a library of novel <b>CAA</b> analogues was synthesized. Among them, compound <b>F16</b> exhibited superior water solubility (>5 mg/mL) as compared to <b>CAA</b> (<5 g/mL). The mechanism of action studies confirmed that <b>F16</b> acted as a dual Topo I and II poison. Furthermore, <b>F16</b> displayed potent antiproliferative activities against high Topo I and II expression cell lines A375 and HCT116, with IC<sub>50</sub> values of 20 and 50 nM, respectively. In xenograft models, <b>F16</b> reduced the tumor growth at a dose of 10 or 20 mg/kg without apparent effect on the mouse weight, while the clinically used Topo II inhibitor <b>VP-16</b> dramatically reduced the mouse weight. Collectively, our data demonstrated that <b>F16</b> could be a promising lead for the development of novel dual Topo I and II antitumor agents.', 'Title: Design, Synthesis, and Biological Evaluation of Novel Evodiamine Derivatives as Potential Antihepatocellular Carcinoma Agents.  Abstract: Evodiamine has many biological activities. Herein, we synthesize 23 disubstituted derivatives of N14-phenyl or the E-ring of evodiamine and conduct systematic structure-activity relationship studies. <i>In vitro</i> antiproliferative activity indicated that compounds <b>F-3</b> and <b>F-4</b> dramatically inhibited the proliferation of Huh7 (IC<sub>50</sub> = 0.05 or 0.04 M, respectively) and SK-Hep-1 (IC<sub>50</sub> = 0.07 or 0.06 M, respectively) cells. Furthermore, compounds <b>F-3</b> and <b>F-4</b> could double inhibit topoisomerases I and II, inhibit invasion and migration, block the cell cycle to the G2/M stage, and induce apoptosis as well. Additionally, compounds <b>F-3</b> and <b>F-4</b> could also inhibit the activation of HSC-T6 and reduce the secretion of collagen type I to slow down the progression of liver fibrosis. Most importantly, compound <b>F-4</b> (TGI = 60.36%) inhibited tumor growth more significantly than the positive drug sorafenib. To sum up, compound <b>F-4</b> has excellent potential as a strong candidate for the therapy of hepatocellular carcinoma.', 'Title: Design, Synthesis, and Biological Evaluation of Novel Evodiamine Derivatives as Potential Antihepatocellular Carcinoma Agents.  Abstract: Evodiamine has many biological activities. Herein, we synthesize 23 disubstituted derivatives of N14-phenyl or the E-ring of evodiamine and conduct systematic structure-activity relationship studies. <i>In vitro</i> antiproliferative activity indicated that compounds <b>F-3</b> and <b>F-4</b> dramatically inhibited the proliferation of Huh7 (IC<sub>50</sub> = 0.05 or 0.04 M, respectively) and SK-Hep-1 (IC<sub>50</sub> = 0.07 or 0.06 M, respectively) cells. Furthermore, compounds <b>F-3</b> and <b>F-4</b> could double inhibit topoisomerases I and II, inhibit invasion and migration, block the cell cycle to the G2/M stage, and induce apoptosis as well. Additionally, compounds <b>F-3</b> and <b>F-4</b> could also inhibit the activation of HSC-T6 and reduce the secretion of collagen type I to slow down the progression of liver fibrosis. Most importantly, compound <b>F-4</b> (TGI = 60.36%) inhibited tumor growth more significantly than the positive drug sorafenib. To sum up, compound <b>F-4</b> has excellent potential as a strong candidate for the therapy of hepatocellular carcinoma.']\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from sklearn.feature_extraction.text import CountVectorizer\n",
        "\n",
        "Assay_Count_Vect = CountVectorizer()\n",
        "Assay_Train_Counts = Assay_Count_Vect.fit_transform(Assay_Descriptions_List)\n",
        "print(Assay_Train_Counts.shape)\n",
        "print(Assay_Train_Counts)\n",
        "print(Assay_Train_Counts.toarray())"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "SWcufRScPwSm",
        "outputId": "877f95d2-78ca-4f96-b9ed-6c393cdfcbf7"
      },
      "execution_count": 39,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "(1137, 6076)\n",
            "  (0, 1905)\t1\n",
            "  (0, 5679)\t2\n",
            "  (0, 3013)\t1\n",
            "  (0, 574)\t1\n",
            "  (0, 1522)\t2\n",
            "  (0, 2674)\t3\n",
            "  (0, 772)\t1\n",
            "  (0, 3785)\t1\n",
            "  (0, 5989)\t1\n",
            "  (0, 1624)\t1\n",
            "  (0, 2680)\t1\n",
            "  (0, 6013)\t1\n",
            "  (0, 5070)\t1\n",
            "  (0, 4074)\t4\n",
            "  (0, 445)\t1\n",
            "  (0, 0)\t1\n",
            "  (0, 5187)\t1\n",
            "  (0, 4736)\t1\n",
            "  (0, 3087)\t1\n",
            "  (0, 3082)\t1\n",
            "  (0, 2936)\t1\n",
            "  (0, 1388)\t1\n",
            "  (0, 3773)\t1\n",
            "  (0, 2611)\t1\n",
            "  (0, 3378)\t1\n",
            "  :\t:\n",
            "  (1136, 575)\t1\n",
            "  (1136, 11)\t1\n",
            "  (1136, 4607)\t1\n",
            "  (1136, 9)\t1\n",
            "  (1136, 5427)\t1\n",
            "  (1136, 3742)\t1\n",
            "  (1136, 5294)\t1\n",
            "  (1136, 2825)\t1\n",
            "  (1136, 256)\t1\n",
            "  (1136, 2829)\t1\n",
            "  (1136, 5240)\t1\n",
            "  (1136, 2146)\t1\n",
            "  (1136, 4840)\t1\n",
            "  (1136, 5584)\t1\n",
            "  (1136, 3253)\t1\n",
            "  (1136, 3876)\t1\n",
            "  (1136, 2934)\t1\n",
            "  (1136, 828)\t1\n",
            "  (1136, 1623)\t1\n",
            "  (1136, 12)\t1\n",
            "  (1136, 2915)\t1\n",
            "  (1136, 5499)\t1\n",
            "  (1136, 5086)\t1\n",
            "  (1136, 1544)\t1\n",
            "  (1136, 2502)\t1\n",
            "[[1 0 0 ... 0 0 0]\n",
            " [0 0 0 ... 0 0 0]\n",
            " [0 0 0 ... 0 0 0]\n",
            " ...\n",
            " [0 0 0 ... 0 1 0]\n",
            " [0 0 0 ... 0 0 2]\n",
            " [0 0 0 ... 0 0 2]]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "print(Assay_Count_Vect.get_feature_names_out())\n",
        "print(Assay_Train_Counts.shape)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "RK_q0rvtQEq6",
        "outputId": "7f45bc72-46ac-47ac-8124-7032cd456de3"
      },
      "execution_count": 40,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "['000' '002' '003' ... 'b' 'g' 'm']\n",
            "(1137, 6076)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from sklearn.cluster import AgglomerativeClustering\n",
        "import numpy as np\n",
        "from scipy.cluster.hierarchy import dendrogram\n",
        "\n",
        "n_clusters = 10  # number of regions\n",
        "X = Assay_Train_Counts.toarray()\n",
        "\n",
        "ward = AgglomerativeClustering(\n",
        "    n_clusters = n_clusters, linkage=\"ward\", connectivity=None, compute_full_tree= True,compute_distances = True\n",
        ")\n",
        "ward.fit(X)\n",
        "\n",
        "ward.distances_\n",
        "ward.distances_.shape"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "jbzCtj-kQRQC",
        "outputId": "b4f3d7ee-08a8-4daa-b517-4fbde1da0869"
      },
      "execution_count": 49,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "(1136,)"
            ]
          },
          "metadata": {},
          "execution_count": 49
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from matplotlib.pyplot import hist\n",
        "from sklearn.neighbors import KernelDensity\n",
        "from scipy import stats\n",
        "#print(ward.distances_)\n",
        "#print(ward.distances_.shape)\n",
        "#print(ward.children_)\n",
        "X_Hist = ward.distances_\n",
        "#hist(X_Hist)\n",
        "kernel = stats.gaussian_kde(X_Hist)\n",
        "print(kernel(X_Hist))\n",
        "print(X_Hist)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "yCvpko_5tgYo",
        "outputId": "1c18a02d-985d-45df-abb9-e526a1d33c6c"
      },
      "execution_count": 68,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "[5.00406196e-02 5.00406196e-02 5.00406196e-02 ... 1.34621878e-04\n",
            " 7.10078818e-05 7.10078818e-05]\n",
            "[  0.           0.           0.         ... 130.54877428 174.77497065\n",
            " 202.93456959]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "!pip install seaborn"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "rg3V9zlRXrDo",
        "outputId": "d82f7a14-fc96-4721-af98-e1bdc991b0e8"
      },
      "execution_count": 26,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Requirement already satisfied: seaborn in /usr/local/lib/python3.10/dist-packages (0.12.2)\n",
            "Requirement already satisfied: numpy!=1.24.0,>=1.17 in /usr/local/lib/python3.10/dist-packages (from seaborn) (1.22.4)\n",
            "Requirement already satisfied: pandas>=0.25 in /usr/local/lib/python3.10/dist-packages (from seaborn) (1.5.3)\n",
            "Requirement already satisfied: matplotlib!=3.6.1,>=3.1 in /usr/local/lib/python3.10/dist-packages (from seaborn) (3.7.1)\n",
            "Requirement already satisfied: contourpy>=1.0.1 in /usr/local/lib/python3.10/dist-packages (from matplotlib!=3.6.1,>=3.1->seaborn) (1.1.0)\n",
            "Requirement already satisfied: cycler>=0.10 in /usr/local/lib/python3.10/dist-packages (from matplotlib!=3.6.1,>=3.1->seaborn) (0.11.0)\n",
            "Requirement already satisfied: fonttools>=4.22.0 in /usr/local/lib/python3.10/dist-packages (from matplotlib!=3.6.1,>=3.1->seaborn) (4.40.0)\n",
            "Requirement already satisfied: kiwisolver>=1.0.1 in /usr/local/lib/python3.10/dist-packages (from matplotlib!=3.6.1,>=3.1->seaborn) (1.4.4)\n",
            "Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.10/dist-packages (from matplotlib!=3.6.1,>=3.1->seaborn) (23.1)\n",
            "Requirement already satisfied: pillow>=6.2.0 in /usr/local/lib/python3.10/dist-packages (from matplotlib!=3.6.1,>=3.1->seaborn) (8.4.0)\n",
            "Requirement already satisfied: pyparsing>=2.3.1 in /usr/local/lib/python3.10/dist-packages (from matplotlib!=3.6.1,>=3.1->seaborn) (3.1.0)\n",
            "Requirement already satisfied: python-dateutil>=2.7 in /usr/local/lib/python3.10/dist-packages (from matplotlib!=3.6.1,>=3.1->seaborn) (2.8.2)\n",
            "Requirement already satisfied: pytz>=2020.1 in /usr/local/lib/python3.10/dist-packages (from pandas>=0.25->seaborn) (2022.7.1)\n",
            "Requirement already satisfied: six>=1.5 in /usr/local/lib/python3.10/dist-packages (from python-dateutil>=2.7->matplotlib!=3.6.1,>=3.1->seaborn) (1.16.0)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import seaborn\n",
        "\n",
        "seaborn.clustermap(X,method='ward')\n",
        "\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "0xlNKnGVYSS6",
        "outputId": "ab4d991e-ea41-4de2-f2c3-d3e0e8ea313b"
      },
      "execution_count": 47,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<seaborn.matrix.ClusterGrid at 0x78c2fda8a890>"
            ]
          },
          "metadata": {},
          "execution_count": 47
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1000x1000 with 4 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from sklearn.feature_extraction.text import TfidfVectorizer\n",
        "from sklearn.feature_extraction.text import TfidfTransformer\n",
        "from sklearn.feature_extraction.text import CountVectorizer\n",
        "import pandas as pd\n",
        "\n",
        "tfidf_transformer=TfidfTransformer(smooth_idf=True,use_idf=True)\n",
        "tfidf_transformer.fit(Assay_Train_Counts)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 74
        },
        "id": "0hP494F4po4j",
        "outputId": "f966d7fb-bd09-4e22-c815-11d4713021ca"
      },
      "execution_count": 42,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "TfidfTransformer()"
            ],
            "text/html": [
              "<style>#sk-container-id-7 {color: black;background-color: white;}#sk-container-id-7 pre{padding: 0;}#sk-container-id-7 div.sk-toggleable {background-color: white;}#sk-container-id-7 label.sk-toggleable__label {cursor: pointer;display: block;width: 100%;margin-bottom: 0;padding: 0.3em;box-sizing: border-box;text-align: center;}#sk-container-id-7 label.sk-toggleable__label-arrow:before {content: \"\";float: left;margin-right: 0.25em;color: #696969;}#sk-container-id-7 label.sk-toggleable__label-arrow:hover:before {color: black;}#sk-container-id-7 div.sk-estimator:hover label.sk-toggleable__label-arrow:before {color: black;}#sk-container-id-7 div.sk-toggleable__content {max-height: 0;max-width: 0;overflow: hidden;text-align: left;background-color: #f0f8ff;}#sk-container-id-7 div.sk-toggleable__content pre {margin: 0.2em;color: black;border-radius: 0.25em;background-color: #f0f8ff;}#sk-container-id-7 input.sk-toggleable__control:checked~div.sk-toggleable__content {max-height: 200px;max-width: 100%;overflow: auto;}#sk-container-id-7 input.sk-toggleable__control:checked~label.sk-toggleable__label-arrow:before {content: \"\";}#sk-container-id-7 div.sk-estimator input.sk-toggleable__control:checked~label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-7 div.sk-label input.sk-toggleable__control:checked~label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-7 input.sk-hidden--visually {border: 0;clip: rect(1px 1px 1px 1px);clip: rect(1px, 1px, 1px, 1px);height: 1px;margin: -1px;overflow: hidden;padding: 0;position: absolute;width: 1px;}#sk-container-id-7 div.sk-estimator {font-family: monospace;background-color: #f0f8ff;border: 1px dotted black;border-radius: 0.25em;box-sizing: border-box;margin-bottom: 0.5em;}#sk-container-id-7 div.sk-estimator:hover {background-color: #d4ebff;}#sk-container-id-7 div.sk-parallel-item::after {content: \"\";width: 100%;border-bottom: 1px solid gray;flex-grow: 1;}#sk-container-id-7 div.sk-label:hover label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-7 div.sk-serial::before {content: \"\";position: absolute;border-left: 1px solid gray;box-sizing: border-box;top: 0;bottom: 0;left: 50%;z-index: 0;}#sk-container-id-7 div.sk-serial {display: flex;flex-direction: column;align-items: center;background-color: white;padding-right: 0.2em;padding-left: 0.2em;position: relative;}#sk-container-id-7 div.sk-item {position: relative;z-index: 1;}#sk-container-id-7 div.sk-parallel {display: flex;align-items: stretch;justify-content: center;background-color: white;position: relative;}#sk-container-id-7 div.sk-item::before, #sk-container-id-7 div.sk-parallel-item::before {content: \"\";position: absolute;border-left: 1px solid gray;box-sizing: border-box;top: 0;bottom: 0;left: 50%;z-index: -1;}#sk-container-id-7 div.sk-parallel-item {display: flex;flex-direction: column;z-index: 1;position: relative;background-color: white;}#sk-container-id-7 div.sk-parallel-item:first-child::after {align-self: flex-end;width: 50%;}#sk-container-id-7 div.sk-parallel-item:last-child::after {align-self: flex-start;width: 50%;}#sk-container-id-7 div.sk-parallel-item:only-child::after {width: 0;}#sk-container-id-7 div.sk-dashed-wrapped {border: 1px dashed gray;margin: 0 0.4em 0.5em 0.4em;box-sizing: border-box;padding-bottom: 0.4em;background-color: white;}#sk-container-id-7 div.sk-label label {font-family: monospace;font-weight: bold;display: inline-block;line-height: 1.2em;}#sk-container-id-7 div.sk-label-container {text-align: center;}#sk-container-id-7 div.sk-container {/* jupyter's `normalize.less` sets `[hidden] { display: none; }` but bootstrap.min.css set `[hidden] { display: none !important; }` so we also need the `!important` here to be able to override the default hidden behavior on the sphinx rendered scikit-learn.org. See: https://github.com/scikit-learn/scikit-learn/issues/21755 */display: inline-block !important;position: relative;}#sk-container-id-7 div.sk-text-repr-fallback {display: none;}</style><div id=\"sk-container-id-7\" class=\"sk-top-container\"><div class=\"sk-text-repr-fallback\"><pre>TfidfTransformer()</pre><b>In a Jupyter environment, please rerun this cell to show the HTML representation or trust the notebook. <br />On GitHub, the HTML representation is unable to render, please try loading this page with nbviewer.org.</b></div><div class=\"sk-container\" hidden><div class=\"sk-item\"><div class=\"sk-estimator sk-toggleable\"><input class=\"sk-toggleable__control sk-hidden--visually\" id=\"sk-estimator-id-7\" type=\"checkbox\" checked><label for=\"sk-estimator-id-7\" class=\"sk-toggleable__label sk-toggleable__label-arrow\">TfidfTransformer</label><div class=\"sk-toggleable__content\"><pre>TfidfTransformer()</pre></div></div></div></div></div>"
            ]
          },
          "metadata": {},
          "execution_count": 42
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "\n",
        "# print idf values\n",
        "df_idf = pd.DataFrame(tfidf_transformer.idf_,index=Assay_Count_Vect.get_feature_names_out(),columns=[\"idf_weights\"])\n",
        "\n",
        "# sort ascending\n",
        "df_idf.sort_values(by=['idf_weights'])\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 423
        },
        "id": "0tayF_OlpwEI",
        "outputId": "0e1cba3b-362c-4676-d84f-8b66540008b1"
      },
      "execution_count": 43,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                  idf_weights\n",
              "of                   1.008826\n",
              "and                  1.024012\n",
              "title                1.036693\n",
              "abstract             1.036693\n",
              "the                  1.039432\n",
              "...                       ...\n",
              "invasiveness         7.343880\n",
              "inverse              7.343880\n",
              "inversely            7.343880\n",
              "protease             7.343880\n",
              "norlyngbyastatin     7.343880\n",
              "\n",
              "[6076 rows x 1 columns]"
            ],
            "text/html": [
              "\n",
              "\n",
              "  <div id=\"df-426e024a-17c1-4927-964b-0bfe2ca29891\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>idf_weights</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>of</th>\n",
              "      <td>1.008826</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>and</th>\n",
              "      <td>1.024012</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>title</th>\n",
              "      <td>1.036693</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>abstract</th>\n",
              "      <td>1.036693</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>the</th>\n",
              "      <td>1.039432</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>invasiveness</th>\n",
              "      <td>7.343880</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>inverse</th>\n",
              "      <td>7.343880</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>inversely</th>\n",
              "      <td>7.343880</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>protease</th>\n",
              "      <td>7.343880</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>norlyngbyastatin</th>\n",
              "      <td>7.343880</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>6076 rows  1 columns</p>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-426e024a-17c1-4927-964b-0bfe2ca29891')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "\n",
              "\n",
              "\n",
              "    <div id=\"df-b2eb267c-512b-4d3c-b814-518b0429b514\">\n",
              "      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-b2eb267c-512b-4d3c-b814-518b0429b514')\"\n",
              "              title=\"Suggest charts.\"\n",
              "              style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "      </button>\n",
              "    </div>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "    background-color: #E8F0FE;\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: #1967D2;\n",
              "    height: 32px;\n",
              "    padding: 0 0 0 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: #E2EBFA;\n",
              "    box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: #174EA6;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "    background-color: #3B4455;\n",
              "    fill: #D2E3FC;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart:hover {\n",
              "    background-color: #434B5C;\n",
              "    box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "    filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "    fill: #FFFFFF;\n",
              "  }\n",
              "</style>\n",
              "\n",
              "    <script>\n",
              "      async function quickchart(key) {\n",
              "        const containerElement = document.querySelector('#' + key);\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      }\n",
              "    </script>\n",
              "\n",
              "      <script>\n",
              "\n",
              "function displayQuickchartButton(domScope) {\n",
              "  let quickchartButtonEl =\n",
              "    domScope.querySelector('#df-b2eb267c-512b-4d3c-b814-518b0429b514 button.colab-df-quickchart');\n",
              "  quickchartButtonEl.style.display =\n",
              "    google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "}\n",
              "\n",
              "        displayQuickchartButton(document);\n",
              "      </script>\n",
              "      <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-426e024a-17c1-4927-964b-0bfe2ca29891 button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-426e024a-17c1-4927-964b-0bfe2ca29891');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 43
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# count matrix\n",
        "count_vector=Assay_Count_Vect.transform(Assay_Descriptions_List)\n",
        "\n",
        "# tf-idf scores\n",
        "tf_idf_vector=tfidf_transformer.transform(count_vector)\n",
        "print(tf_idf_vector)\n",
        "tf_idf_vector.shape"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "v7gsFWonp2oq",
        "outputId": "e61371b5-b287-4c86-c9b9-9f0855b2f801"
      },
      "execution_count": 44,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "  (0, 6013)\t0.13311274095529058\n",
            "  (0, 5989)\t0.057679712270489215\n",
            "  (0, 5722)\t0.11969588784908244\n",
            "  (0, 5679)\t0.060442254816748864\n",
            "  (0, 5652)\t0.17607038103363729\n",
            "  (0, 5608)\t0.04648662993978298\n",
            "  (0, 5187)\t0.1594520973771578\n",
            "  (0, 5070)\t0.11035842511422365\n",
            "  (0, 4986)\t0.17607038103363729\n",
            "  (0, 4841)\t0.1294169606144702\n",
            "  (0, 4736)\t0.17607038103363729\n",
            "  (0, 4550)\t0.15410220497932958\n",
            "  (0, 4511)\t0.13311274095529058\n",
            "  (0, 4293)\t0.17607038103363729\n",
            "  (0, 4125)\t0.052450427965983336\n",
            "  (0, 4097)\t0.04211544957222346\n",
            "  (0, 4074)\t0.09674689666605434\n",
            "  (0, 3931)\t0.14973102461177004\n",
            "  (0, 3785)\t0.17607038103363729\n",
            "  (0, 3784)\t0.10142349213559515\n",
            "  (0, 3773)\t0.0891763888466752\n",
            "  (0, 3437)\t0.11858056510492876\n",
            "  (0, 3378)\t0.1594520973771578\n",
            "  (0, 3097)\t0.09705231176803562\n",
            "  (0, 3087)\t0.17607038103363729\n",
            "  :\t:\n",
            "  (1136, 1386)\t0.02892530450044634\n",
            "  (1136, 1341)\t0.133378940465167\n",
            "  (1136, 1300)\t0.07874573894286355\n",
            "  (1136, 1175)\t0.08825445510012463\n",
            "  (1136, 1151)\t0.07662218084013911\n",
            "  (1136, 924)\t0.07226933643634587\n",
            "  (1136, 853)\t0.05548548630502132\n",
            "  (1136, 839)\t0.04560118298612644\n",
            "  (1136, 828)\t0.12915448804212723\n",
            "  (1136, 772)\t0.19061373065553167\n",
            "  (1136, 682)\t0.038548219832929824\n",
            "  (1136, 618)\t0.037754009228351156\n",
            "  (1136, 575)\t0.08968703925660379\n",
            "  (1136, 560)\t0.04714054653257089\n",
            "  (1136, 559)\t0.04252377509835435\n",
            "  (1136, 554)\t0.07833661462389342\n",
            "  (1136, 497)\t0.019297428493888637\n",
            "  (1136, 354)\t0.07605444507961241\n",
            "  (1136, 316)\t0.10214554638671205\n",
            "  (1136, 256)\t0.09799440910280414\n",
            "  (1136, 194)\t0.07754439263180282\n",
            "  (1136, 14)\t0.10048001681603826\n",
            "  (1136, 12)\t0.12915448804212723\n",
            "  (1136, 11)\t0.09686591770735713\n",
            "  (1136, 9)\t0.08825445510012463\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "(1137, 6076)"
            ]
          },
          "metadata": {},
          "execution_count": 44
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "feature_names = Assay_Count_Vect.get_feature_names_out()\n",
        "\n",
        "#get tfidf vector for first document\n",
        "first_document_vector=tf_idf_vector[0]\n",
        "\n",
        "#print the scores\n",
        "df = pd.DataFrame(first_document_vector.T.todense(), index=feature_names, columns=[\"tfidf\"])\n",
        "df.sort_values(by=[\"tfidf\"],ascending=False)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 423
        },
        "id": "jwN0Zsm-qBh_",
        "outputId": "54636ee2-49b3-48f4-a81b-d4add8e572f7"
      },
      "execution_count": 45,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                tfidf\n",
              "genes        0.366286\n",
              "clock        0.352141\n",
              "amplitude    0.352141\n",
              "inc          0.176070\n",
              "qiagen       0.176070\n",
              "...               ...\n",
              "dimer        0.000000\n",
              "dimensional  0.000000\n",
              "diketones    0.000000\n",
              "diimides     0.000000\n",
              "m           0.000000\n",
              "\n",
              "[6076 rows x 1 columns]"
            ],
            "text/html": [
              "\n",
              "\n",
              "  <div id=\"df-d730b8f9-a09a-4683-8993-186772b2026e\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>tfidf</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>genes</th>\n",
              "      <td>0.366286</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>clock</th>\n",
              "      <td>0.352141</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>amplitude</th>\n",
              "      <td>0.352141</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>inc</th>\n",
              "      <td>0.176070</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>qiagen</th>\n",
              "      <td>0.176070</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>dimer</th>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>dimensional</th>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>diketones</th>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>diimides</th>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>m</th>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>6076 rows  1 columns</p>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-d730b8f9-a09a-4683-8993-186772b2026e')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "\n",
              "\n",
              "\n",
              "    <div id=\"df-6b24f0f4-5d81-413f-bdb6-97e43a66ccb4\">\n",
              "      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-6b24f0f4-5d81-413f-bdb6-97e43a66ccb4')\"\n",
              "              title=\"Suggest charts.\"\n",
              "              style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "      </button>\n",
              "    </div>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "    background-color: #E8F0FE;\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: #1967D2;\n",
              "    height: 32px;\n",
              "    padding: 0 0 0 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: #E2EBFA;\n",
              "    box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: #174EA6;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "    background-color: #3B4455;\n",
              "    fill: #D2E3FC;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart:hover {\n",
              "    background-color: #434B5C;\n",
              "    box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "    filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "    fill: #FFFFFF;\n",
              "  }\n",
              "</style>\n",
              "\n",
              "    <script>\n",
              "      async function quickchart(key) {\n",
              "        const containerElement = document.querySelector('#' + key);\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      }\n",
              "    </script>\n",
              "\n",
              "      <script>\n",
              "\n",
              "function displayQuickchartButton(domScope) {\n",
              "  let quickchartButtonEl =\n",
              "    domScope.querySelector('#df-6b24f0f4-5d81-413f-bdb6-97e43a66ccb4 button.colab-df-quickchart');\n",
              "  quickchartButtonEl.style.display =\n",
              "    google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "}\n",
              "\n",
              "        displayQuickchartButton(document);\n",
              "      </script>\n",
              "      <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-d730b8f9-a09a-4683-8993-186772b2026e button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-d730b8f9-a09a-4683-8993-186772b2026e');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n"
            ]
          },
          "metadata": {},
          "execution_count": 45
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import seaborn\n",
        "\n",
        "seaborn.clustermap(tf_idf_vector.toarray(),method='ward')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "gJ22MvecqHE9",
        "outputId": "573fbb46-45ab-46a7-e49a-0a1a66f9bf66"
      },
      "execution_count": 46,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/seaborn/matrix.py:560: UserWarning: Clustering large matrix with scipy. Installing `fastcluster` may give better performance.\n",
            "  warnings.warn(msg)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<seaborn.matrix.ClusterGrid at 0x78c2fdd18430>"
            ]
          },
          "metadata": {},
          "execution_count": 46
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1000x1000 with 4 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    }
  ]
}